data_2rqw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rqw _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.716 ' CD1' ' CE2' ' A' ' 183' ' ' PHE . 3.2 m-85 . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 120.508 0.195 . . . . 73.22 111.007 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.515 ' CB ' ' CD1' ' A' ' 184' ' ' ILE . . . -128.51 160.96 30.71 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.514 1.134 . . . . 63.34 109.331 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.49 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.2 OUTLIER -144.69 124.3 6.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 74.42 109.337 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.478 HG22 ' CB ' ' A' ' 180' ' ' GLU . 6.4 m -83.3 127.24 39.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.486 1.116 . . . . 74.43 109.301 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.451 ' C ' ' CG ' ' A' ' 164' ' ' TYR . 0.4 OUTLIER -98.78 -2.95 36.74 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.465 1.103 . . . . 73.32 109.311 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.451 ' CG ' ' C ' ' A' ' 163' ' ' LEU . 1.5 m-85 -152.4 158.16 42.26 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.474 1.108 . . . . 74.33 111.021 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 166' ' ' PHE . 15.5 t0 -100.41 144.18 29.71 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.435 1.084 . . . . 74.03 109.268 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.439 ' N ' ' OD1' ' A' ' 165' ' ' ASP . 14.1 t80 -141.21 129.93 22.88 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.495 1.122 . . . . 75.44 110.949 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -68.56 131.06 44.6 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.439 1.087 . . . . 74.31 109.311 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.46 ' HB2' ' CA ' ' A' ' 173' ' ' GLU . . . -109.45 138.9 45.13 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.439 1.087 . . . . 74.43 109.307 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -144.6 16.55 1.64 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.506 1.129 . . . . 62.02 110.304 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.511 ' NZ ' ' CH2' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -94.92 -176.07 3.74 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.585 1.178 . . . . 71.11 109.257 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.47 -30.83 70.85 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.455 1.097 . . . . 72.32 109.306 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.445 ' OD2' ' N ' ' A' ' 206' ' ' LEU . 0.8 OUTLIER -104.59 16.45 26.04 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.473 1.108 . . . . 65.24 109.329 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.46 ' CA ' ' HB2' ' A' ' 168' ' ' ALA . 6.4 pt-20 -36.51 108.36 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.501 1.126 . . . . 73.42 110.321 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.485 ' CD1' ' HA3' ' A' ' 205' ' ' GLY . 5.4 tp -119.42 110.41 16.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.447 1.092 . . . . 72.34 109.316 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 12.9 t -84.98 108.62 17.68 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.48 1.112 . . . . 72.01 110.391 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.403 ' O ' ' OD1' ' A' ' 165' ' ' ASP . 0.7 OUTLIER -118.7 178.07 4.61 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.597 1.186 . . . . 75.23 110.432 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.424 ' O ' ' CG2' ' A' ' 162' ' ' VAL . 12.4 m-85 -121.76 162.78 20.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.577 1.173 . . . . 73.5 111.038 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.423 HG13 ' CB ' ' A' ' 165' ' ' ASP . 3.8 m -64.83 147.29 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.539 1.149 . . . . 75.24 109.244 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.419 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 53.28 62.1 6.31 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.548 1.155 . . . . 63.43 111.027 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.49 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 1.8 tp10 -126.31 161.62 27.38 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.505 0.767 . . . . 63.01 110.331 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -101.75 141.15 35.05 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.451 1.094 . . . . 73.24 109.262 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.47 ' CD2' HG12 ' A' ' 162' ' ' VAL . 2.6 pt? -159.2 141.59 13.88 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.45 1.094 . . . . 74.13 109.283 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.716 ' CE2' ' CD1' ' A' ' 159' ' ' TYR . 6.5 m-85 -106.23 126.43 52.21 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.423 1.077 . . . . 75.31 110.985 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.551 ' CD1' ' N ' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -63.0 153.42 6.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 74.25 109.331 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 194' ' ' ILE . 2.6 m -135.21 -48.25 0.72 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.424 1.078 . . . . 73.21 108.302 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.485 ' CB ' ' HB ' ' A' ' 194' ' ' ILE . . . -129.91 170.28 14.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.511 1.132 . . . . 71.44 109.231 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.36 147.45 27.61 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.413 1.071 . . . . 71.45 109.545 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.575 ' CE1' ' HB3' ' A' ' 192' ' ' TRP . 0.7 OUTLIER -152.61 138.83 18.35 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.592 1.183 . . . . 75.22 109.611 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.463 ' C ' ' N ' ' A' ' 191' ' ' GLU . 41.9 t30 53.28 22.4 2.7 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.446 1.091 . . . . 74.33 109.229 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.416 ' C ' ' O ' ' A' ' 189' ' ' ASN . 14.7 p 40.81 28.85 0.06 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.467 1.104 . . . . 60.33 108.271 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.463 ' N ' ' C ' ' A' ' 189' ' ' ASN . 7.8 tt0 -127.67 -40.4 1.75 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.409 1.068 . . . . 71.24 110.291 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.575 ' HB3' ' CE1' ' A' ' 188' ' ' HIS . 96.4 m95 -109.51 131.99 54.55 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.484 1.115 . . . . 75.02 108.002 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.615 ' CE2' ' CG1' ' A' ' 209' ' ' VAL . 20.8 m-30 -125.54 134.9 51.83 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.473 1.108 . . . . 64.34 110.972 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.485 ' HB ' ' CB ' ' A' ' 186' ' ' ALA . 5.7 mm -93.23 93.01 3.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.536 1.147 . . . . 75.41 109.282 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -97.07 -172.41 2.44 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.437 1.086 . . . . 73.54 109.381 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp -154.77 141.44 13.27 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 124.572 1.17 . . . . 71.4 109.285 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.361 1.215 0 O-C-N 124.547 1.814 . . . . 74.31 110.983 -179.992 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.412 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . . . . . . 0 CA--C 1.53 1.01 0 N-CA-C 110.997 -0.841 . . . . 72.14 110.997 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 123.77 9.42 Favored 'Cis proline' 0 C--N 1.361 1.21 0 C-N-CA 120.979 -2.509 . . . . 73.31 111.011 -0.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 195' ' ' ALA . . . -97.72 148.99 19.11 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.566 1.166 . . . . 75.21 110.991 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.574 HD23 ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -87.76 146.54 25.6 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.462 0.742 . . . . 73.14 109.324 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.442 HG22 ' CD1' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -161.12 127.64 2.48 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.537 1.148 . . . . 73.42 109.321 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.93 177.92 7.93 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.495 1.787 . . . . 70.21 110.991 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.615 ' CG1' ' CE2' ' A' ' 193' ' ' PHE . 1.4 m -96.94 5.08 9.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.54 1.15 . . . . 74.53 109.283 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . 0.497 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -108.05 0.35 33.58 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.455 1.097 . . . . 72.33 111.003 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.581 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 18.8 m-85 -131.66 8.61 4.56 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.509 0.77 . . . . 64.32 110.983 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.45 HG12 ' CG1' ' A' ' 162' ' ' VAL . 2.3 m -151.71 154.87 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.485 1.116 . . . . 72.43 109.293 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 39.9 t -123.9 147.07 47.98 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.504 1.127 . . . . 71.03 109.977 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 6.9 mm -90.87 129.33 41.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.531 1.144 . . . . 74.41 109.287 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.464 HD13 ' CG2' ' A' ' 161' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.457 0 O-C-N 124.573 1.17 . . . . 75.4 109.237 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 10.0 t0 . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 109.347 -0.612 . . . . 65.23 109.347 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 1.5 p -54.03 -40.36 45.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.135 . . . . 73.4 109.276 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 9.0 mt -69.39 -30.8 46.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.51 1.131 . . . . 71.23 109.31 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.482 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 8.9 mt-10 -78.97 -21.08 47.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.54 1.15 . . . . 70.31 110.292 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -88.79 -15.9 33.46 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.511 1.132 . . . . 72.34 109.312 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 6.5 mt -72.5 -69.8 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.529 1.143 . . . . 74.52 109.296 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.482 ' CD ' ' HA ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -49.15 -30.67 7.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.515 1.135 . . . . 72.31 109.288 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -48.14 -50.23 29.45 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 74.23 109.987 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 236' ' ' LEU . 1.3 m -90.95 -14.36 8.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.516 1.135 . . . . 71.13 109.239 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 57.58 48.63 13.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.433 1.083 . . . . 75.12 109.286 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.474 ' CD1' ' O ' ' A' ' 237' ' ' PRO . 0.8 OUTLIER -71.29 142.93 87.51 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.507 1.129 . . . . 74.35 109.318 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.474 ' O ' ' CD1' ' A' ' 236' ' ' LEU . 18.3 Cg_endo -74.99 154.35 42.49 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.447 1.761 . . . . 71.12 110.997 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 2.6 m -58.88 175.5 0.27 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.529 1.143 . . . . 74.43 110.458 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.432 ' CG1' ' N ' ' A' ' 240' ' ' GLN . 7.2 p -76.81 -51.75 18.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 124.552 1.157 . . . . 75.15 109.295 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.433 ' OE1' ' CD1' ' B' ' 471' ' ' ILE . 4.3 pm0 -71.04 -14.93 62.5 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 75.12 110.278 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -92.2 -44.73 8.62 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.464 1.102 . . . . 71.42 110.302 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.436 ' CZ3' ' O ' ' A' ' 185' ' ' CYS . 9.9 t90 -69.47 -53.4 19.39 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.548 1.155 . . . . 74.14 108.018 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.561 ' HD3' ' CD2' ' B' ' 470' ' ' PHE . 5.9 mtmp? -62.9 -23.06 67.17 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.54 1.15 . . . . 63.21 109.274 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.6 t . . . . . 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.133 . . . . 62.04 110.038 179.995 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 470' ' ' PHE . . . . . 0.561 ' CD2' ' HD3' ' A' ' 243' ' ' LYS . 8.8 m-30 . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 120.488 0.185 . . . . 74.54 111.0 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 471' ' ' ILE . . . . . 0.433 ' CD1' ' OE1' ' A' ' 240' ' ' GLN . 3.7 mm -70.31 140.18 87.57 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.516 1.135 . . . . 75.34 109.3 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 472' ' ' PRO . . . . . 0.568 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.2 Cg_endo -74.93 155.47 43.29 Favored 'Trans proline' 0 C--N 1.359 1.12 0 O-C-N 124.499 1.789 . . . . 73.44 111.055 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 38.7 t -97.49 -47.69 5.57 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.563 1.165 . . . . 73.52 110.062 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.86 165.4 17.99 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.537 1.148 . . . . 74.13 110.31 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 -166.81 0.37 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.458 1.767 . . . . 73.31 111.031 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 476' ' ' ALA . . . . . . . . . . . . . . . -65.25 134.1 95.71 Favored Pre-proline 0 C--N 1.326 -0.427 0 O-C-N 124.382 1.051 . . . . 73.43 109.302 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 477' ' ' PRO . . . . . 0.575 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -74.94 -162.65 0.16 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.5 1.789 . . . . 74.3 110.996 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 478' ' ' LYS . . . . . 0.401 ' N ' ' HD3' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -133.42 90.89 28.21 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 74.12 109.28 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 479' ' ' PRO . . . . . 0.581 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.98 152.39 40.78 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.489 1.784 . . . . 74.21 111.0 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.141 0 O-C-N 124.552 1.817 . . . . 71.3 111.005 179.964 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.556 ' CE2' HD12 ' A' ' 215' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.503 0.192 . . . . 73.54 110.966 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.615 ' CB ' ' CD1' ' A' ' 184' ' ' ILE . . . -119.89 148.28 43.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.464 1.102 . . . . 64.41 109.341 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.465 HG22 ' CD2' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -127.78 132.28 69.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.468 1.105 . . . . 74.12 109.287 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 164' ' ' TYR . 3.9 t -87.89 134.05 28.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.516 1.135 . . . . 73.1 109.336 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.465 ' CD2' HG22 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -117.97 -2.61 11.25 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.475 1.109 . . . . 73.13 109.361 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.502 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 16.9 m-85 -139.02 175.74 9.29 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.134 . . . . 71.43 110.995 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.428 ' CB ' ' HA ' ' A' ' 177' ' ' TYR . 6.5 p-10 -139.86 145.34 37.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.488 1.118 . . . . 73.12 109.332 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.567 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 1.9 p90 -160.28 166.33 29.72 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.552 1.158 . . . . 75.02 111.057 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -100.03 130.92 46.24 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.537 1.148 . . . . 65.55 109.321 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.43 ' HB2' ' CA ' ' A' ' 173' ' ' GLU . . . -100.9 157.8 16.46 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 71.23 109.271 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -156.72 24.53 0.33 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.493 1.121 . . . . 73.24 110.26 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.425 ' N ' ' HB3' ' A' ' 173' ' ' GLU . 0.3 OUTLIER -99.54 -177.25 3.52 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.527 1.142 . . . . 73.32 109.25 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.94 -27.89 65.74 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.525 1.14 . . . . 71.35 109.348 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.432 ' HB3' ' CB ' ' A' ' 206' ' ' LEU . 9.2 t0 -112.29 22.2 14.97 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 75.3 109.315 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.43 ' CA ' ' HB2' ' A' ' 168' ' ' ALA . 10.4 pt-20 -36.92 111.63 0.16 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.472 1.108 . . . . 73.05 110.29 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.482 ' CD1' ' HA3' ' A' ' 205' ' ' GLY . 4.6 tp -132.02 109.68 10.2 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.457 1.098 . . . . 74.44 109.293 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.0 t -87.26 133.17 33.71 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.444 1.09 . . . . 71.1 110.412 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 19.8 m -141.73 165.29 27.88 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.497 1.123 . . . . 75.23 110.412 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.428 ' HA ' ' CB ' ' A' ' 165' ' ' ASP . 8.1 m-85 -111.07 164.12 13.16 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.44 1.087 . . . . 75.3 110.999 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.427 HG11 ' N ' ' A' ' 165' ' ' ASP . 2.1 m -61.84 158.46 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.586 1.178 . . . . 65.23 109.281 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 46.3 70.14 0.72 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.444 1.09 . . . . 70.13 111.018 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -131.94 174.59 10.01 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 0.773 . . . . 72.21 110.353 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.445 ' ND2' ' OH ' ' A' ' 159' ' ' TYR . 0.4 OUTLIER -118.23 136.23 53.79 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.54 1.15 . . . . 74.52 109.314 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.462 HD22 ' CG2' ' A' ' 162' ' ' VAL . 2.6 pt? -157.25 146.09 19.8 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.568 1.167 . . . . 63.24 109.242 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -113.86 124.1 51.4 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.544 1.153 . . . . 74.2 110.955 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.615 ' CD1' ' CB ' ' A' ' 160' ' ' ALA . 1.7 mp -65.44 152.84 8.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.546 1.154 . . . . 72.22 109.261 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . 0.549 ' O ' ' CZ3' ' A' ' 242' ' ' TRP . 0.1 OUTLIER -135.78 -47.26 0.67 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.467 1.105 . . . . 73.24 108.319 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.469 ' CB ' HG22 ' A' ' 239' ' ' VAL . . . -126.73 167.32 15.91 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.132 . . . . 73.41 109.313 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.506 ' CE1' HG21 ' A' ' 231' ' ' ILE . 0.2 OUTLIER -148.88 146.09 27.76 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.474 1.109 . . . . 71.1 109.598 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.6 ' CE1' ' CB ' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -149.8 141.81 23.9 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.503 1.127 . . . . 75.4 109.647 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.455 ' C ' ' N ' ' A' ' 191' ' ' GLU . 19.0 t-20 51.25 22.35 1.34 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.498 1.124 . . . . 75.24 109.287 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.402 ' C ' ' O ' ' A' ' 189' ' ' ASN . 53.8 m 41.57 28.33 0.08 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.549 1.155 . . . . 73.12 108.312 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.455 ' N ' ' C ' ' A' ' 189' ' ' ASN . 6.8 tt0 -128.15 -41.1 1.61 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.416 1.073 . . . . 70.13 110.326 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.6 ' CB ' ' CE1' ' A' ' 188' ' ' HIS . 98.8 m95 -106.63 131.35 53.88 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.01 -1.107 . . . . 74.42 108.01 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.625 ' CE2' ' CG1' ' A' ' 209' ' ' VAL . 20.8 m-30 -125.41 130.47 51.94 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.476 1.11 . . . . 74.15 111.033 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.554 ' CD1' ' NE2' ' A' ' 188' ' ' HIS . 1.5 mp -89.5 96.41 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.563 1.164 . . . . 74.22 109.313 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -104.16 -174.56 2.57 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.579 1.175 . . . . 63.24 109.237 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -150.48 141.24 14.58 Favored Pre-proline 0 C--N 1.326 -0.436 0 O-C-N 124.474 1.109 . . . . 74.44 109.274 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--N 1.361 1.213 0 O-C-N 124.506 1.793 . . . . 74.11 110.972 -179.989 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.418 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . . . . . . 0 CA--C 1.53 0.989 0 N-CA-C 111.039 -0.824 . . . . 54.45 111.039 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.03 122.65 8.37 Favored 'Cis proline' 0 C--N 1.359 1.121 0 C-N-CA 121.031 -2.487 . . . . 74.23 111.002 0.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 195' ' ' ALA . . . -98.19 153.17 19.96 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.449 1.093 . . . . 74.34 111.049 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.511 HD21 ' CE3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -86.94 146.43 26.16 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.478 0.752 . . . . 74.15 109.271 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.454 HG23 ' CD1' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -158.11 126.83 2.99 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.456 1.097 . . . . 74.1 109.287 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 174.48 12.73 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.573 1.828 . . . . 62.34 110.999 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.625 ' CG1' ' CE2' ' A' ' 193' ' ' PHE . 1.2 m -93.11 4.76 7.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.541 1.151 . . . . 72.13 109.307 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . 0.446 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -109.01 4.64 31.92 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.494 1.121 . . . . 74.3 110.914 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.62 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 15.7 m-85 -134.12 8.6 3.76 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.473 0.749 . . . . 72.54 111.058 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.465 HG12 ' CG2' ' A' ' 162' ' ' VAL . 3.1 m -151.66 162.17 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.45 1.094 . . . . 73.21 109.345 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 3.6 t -128.42 133.43 48.57 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.529 1.143 . . . . 71.25 110.032 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 2.7 mm -80.77 145.87 8.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.507 1.129 . . . . 74.42 109.196 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.556 HD12 ' CE2' ' A' ' 159' ' ' TYR . 1.0 OUTLIER . . . . . 0 C--N 1.325 -0.457 0 O-C-N 124.449 1.093 . . . . 74.52 109.299 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 229' ' ' GLU . 25.6 t0 . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 109.333 -0.617 . . . . 63.3 109.333 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.401 ' C ' ' O ' ' A' ' 226' ' ' ASP . 0.2 OUTLIER -40.37 -55.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.463 1.102 . . . . 65.23 109.322 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 4.0 mp -55.9 -42.22 70.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.119 . . . . 73.0 109.315 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 226' ' ' ASP . 9.4 mt-10 -68.22 -14.59 63.09 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.455 1.097 . . . . 75.21 110.253 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -88.73 -18.91 26.83 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.528 1.142 . . . . 74.24 109.317 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.506 HG21 ' CE1' ' A' ' 187' ' ' HIS . 0.5 OUTLIER -68.34 -69.14 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.537 1.148 . . . . 72.23 109.24 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.437 ' N ' ' CG2' ' A' ' 231' ' ' ILE . 0.0 OUTLIER -59.84 -24.97 64.62 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.43 1.081 . . . . 74.14 109.226 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.51 -57.4 6.2 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.537 1.148 . . . . 71.1 109.991 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.413 ' C ' ' N ' ' A' ' 236' ' ' LEU . 1.4 m -93.3 25.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.52 1.137 . . . . 70.42 109.24 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 3.4 m120 41.66 30.28 0.14 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.487 1.117 . . . . 74.23 109.292 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.413 ' N ' ' C ' ' A' ' 234' ' ' VAL . 7.9 tp -59.28 121.3 55.15 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.506 1.129 . . . . 74.53 109.334 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 160.5 39.98 Favored 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.48 1.779 . . . . 54.11 111.029 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 2.9 m -60.15 -179.35 0.1 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.5 1.125 . . . . 62.41 110.466 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.469 HG22 ' CB ' ' A' ' 186' ' ' ALA . 11.5 p -71.08 -34.42 54.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 65.15 109.329 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -85.32 -18.0 35.15 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.444 1.09 . . . . 72.35 110.302 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -84.84 -45.49 12.25 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.476 1.11 . . . . 75.22 110.293 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.549 ' CZ3' ' O ' ' A' ' 185' ' ' CYS . 7.5 t90 -67.77 -55.05 14.56 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.51 1.131 . . . . 74.12 107.962 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt -62.72 -18.39 62.45 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.522 1.138 . . . . 70.43 109.318 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.474 1.109 . . . . 71.02 110.059 179.967 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 470' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 120.536 0.208 . . . . 74.32 110.979 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 471' ' ' ILE . . . . . . . . . . . . . 20.0 mm -83.82 142.06 41.81 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.494 1.121 . . . . 75.23 109.25 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 472' ' ' PRO . . . . . 0.532 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.2 Cg_endo -75.02 -175.95 2.63 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.456 1.766 . . . . 63.31 110.988 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 42.7 t -126.7 6.87 6.78 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.484 1.115 . . . . 63.45 109.997 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -142.44 157.04 63.47 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.545 1.153 . . . . 71.53 110.294 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 475' ' ' PRO . . . . . 0.505 ' O ' ' CB ' ' B' ' 476' ' ' ALA . 18.2 Cg_endo -75.06 -26.11 11.13 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.478 1.778 . . . . 75.32 111.002 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 476' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' B' ' 475' ' ' PRO . . . 163.1 140.1 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.489 1.118 . . . . 74.3 109.254 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 477' ' ' PRO . . . . . 0.573 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -75.02 -163.4 0.18 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.534 1.807 . . . . 73.33 111.041 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 478' ' ' LYS . . . . . 0.403 ' N ' ' HD3' ' B' ' 478' ' ' LYS . 0.1 OUTLIER -128.54 90.81 45.46 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.51 1.131 . . . . 75.23 109.277 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 479' ' ' PRO . . . . . 0.62 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.5 Cg_endo -74.96 147.16 33.72 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.512 1.796 . . . . 74.23 111.025 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.166 0 O-C-N 124.511 1.795 . . . . 72.52 111.016 179.976 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.56 ' CD1' ' O ' ' A' ' 215' ' ' ILE . 9.6 p90 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.452 0.168 . . . . 73.42 110.957 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.466 ' CB ' HD12 ' A' ' 184' ' ' ILE . . . -115.98 152.73 32.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.558 1.161 . . . . 75.14 109.323 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.462 ' CD1' ' C ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -126.72 120.81 56.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 124.533 1.146 . . . . 71.34 109.298 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.448 ' CG2' HD23 ' A' ' 182' ' ' LEU . 2.5 t -74.42 121.67 26.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.544 1.152 . . . . 74.22 109.3 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.441 ' O ' ' CD1' ' A' ' 164' ' ' TYR . 0.4 OUTLIER -100.11 -12.32 19.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.578 1.174 . . . . 75.13 109.307 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.441 ' CD1' ' O ' ' A' ' 163' ' ' LEU . 0.9 OUTLIER -150.9 154.45 37.21 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.483 1.114 . . . . 73.4 111.046 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.411 ' N ' HG13 ' A' ' 178' ' ' VAL . 2.9 p30 -74.62 158.73 33.15 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.478 1.111 . . . . 74.33 109.231 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -154.51 130.69 10.34 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.527 1.142 . . . . 75.35 111.002 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -88.95 126.51 35.43 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.46 1.1 . . . . 74.25 109.26 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -113.64 151.14 32.16 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.518 1.136 . . . . 75.42 109.325 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.71 24.08 0.39 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.419 1.074 . . . . 74.14 110.275 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.47 ' HD3' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -100.87 -175.78 2.98 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.615 1.197 . . . . 75.55 109.287 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.18 -26.08 66.05 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.456 1.097 . . . . 72.03 109.344 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.456 ' HB3' ' CB ' ' A' ' 206' ' ' LEU . 60.4 m-20 -109.68 15.5 22.77 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.44 1.088 . . . . 71.41 109.268 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.452 ' HB3' ' N ' ' A' ' 170' ' ' LYS . 17.7 pt-20 -36.1 110.01 0.1 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.439 1.087 . . . . 74.2 110.295 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.473 ' CD2' ' HA3' ' A' ' 205' ' ' GLY . 14.2 tp -128.93 103.91 7.29 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.546 1.154 . . . . 72.03 109.251 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.3 t -88.35 142.6 27.6 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.537 1.148 . . . . 53.15 110.368 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 17.0 m -155.16 162.89 40.85 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.533 1.146 . . . . 73.54 110.392 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -99.36 163.77 12.39 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.481 1.113 . . . . 74.12 111.027 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.411 HG13 ' N ' ' A' ' 165' ' ' ASP . 2.6 m -57.72 158.16 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 71.04 109.29 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.424 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 49.88 68.19 1.5 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.51 1.131 . . . . 74.43 110.99 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -128.31 167.77 16.47 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.501 0.765 . . . . 74.51 110.262 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.45 132.65 53.5 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.429 1.08 . . . . 65.23 109.328 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.448 HD23 ' CG2' ' A' ' 162' ' ' VAL . 0.4 OUTLIER -143.25 158.03 43.98 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.495 1.122 . . . . 72.43 109.36 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.403 ' C ' ' HB3' ' A' ' 195' ' ' ALA . 0.6 OUTLIER -114.55 113.09 23.95 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.483 1.115 . . . . 75.21 110.972 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.466 HD12 ' CB ' ' A' ' 160' ' ' ALA . 1.7 mp -65.54 159.96 3.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 124.453 1.096 . . . . 73.44 109.312 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 186' ' ' ALA . 9.7 p -147.03 -44.39 0.18 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.583 1.177 . . . . 63.2 108.334 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.505 ' N ' ' SG ' ' A' ' 185' ' ' CYS . . . -121.32 164.23 17.36 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.446 1.091 . . . . 74.55 109.32 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.03 140.23 18.5 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.484 1.115 . . . . 64.53 109.602 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.572 ' CD2' ' N ' ' A' ' 188' ' ' HIS . 0.1 OUTLIER -142.18 142.42 32.69 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.518 1.136 . . . . 74.12 109.577 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.48 ' C ' ' N ' ' A' ' 191' ' ' GLU . 19.2 t-20 50.62 22.1 1.02 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.469 1.105 . . . . 73.14 109.321 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.4 ' C ' ' O ' ' A' ' 189' ' ' ASN . 23.5 m 42.0 27.23 0.07 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.574 1.171 . . . . 74.51 108.245 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.48 ' N ' ' C ' ' A' ' 189' ' ' ASN . 9.3 tt0 -125.11 -37.1 2.45 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.479 1.112 . . . . 73.32 110.293 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.574 ' CD1' ' HG3' ' B' ' 472' ' ' PRO . 97.2 m95 -109.78 128.77 55.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.505 1.128 . . . . 72.14 107.96 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.596 ' CZ ' HG11 ' A' ' 209' ' ' VAL . 20.9 m-30 -122.18 127.04 49.56 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.488 1.118 . . . . 74.32 110.958 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.455 ' HB ' ' CB ' ' A' ' 186' ' ' ALA . 9.3 mm -89.23 106.34 16.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.493 1.12 . . . . 74.22 109.288 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -117.01 175.77 5.43 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.128 . . . . 74.01 109.333 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -147.56 165.56 18.42 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.442 1.089 . . . . 63.44 109.303 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--N 1.359 1.128 0 O-C-N 124.517 1.799 . . . . 74.33 110.96 -179.986 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.011 0 N-CA-C 110.959 -0.856 . . . . 54.33 110.959 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.94 129.05 17.59 Favored 'Cis proline' 0 C--N 1.362 1.248 0 C-N-CA 121.011 -2.495 . . . . 65.33 111.053 -0.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 195' ' ' ALA . . . -92.63 163.31 27.19 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.519 1.137 . . . . 74.03 110.963 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.47 ' CD2' ' HD3' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -97.62 145.41 26.31 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.496 0.762 . . . . 73.13 109.326 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.414 ' N ' ' HG ' ' A' ' 206' ' ' LEU . 0.4 OUTLIER -153.61 127.35 4.37 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.583 1.177 . . . . 65.5 109.344 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.09 174.52 12.65 Favored 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.505 1.792 . . . . 74.2 110.995 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.596 HG11 ' CZ ' ' A' ' 193' ' ' PHE . 1.6 m -97.03 7.01 8.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.484 1.115 . . . . 73.31 109.267 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . 0.457 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -106.93 -0.9 36.22 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.506 1.129 . . . . 64.13 110.948 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.573 ' CE2' ' HB3' ' B' ' 479' ' ' PRO . 12.7 m-85 -133.27 15.53 4.14 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.556 0.798 . . . . 75.22 111.046 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.444 HG11 ' CG2' ' A' ' 162' ' ' VAL . 3.4 m -152.62 157.66 4.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.548 1.155 . . . . 73.44 109.36 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 46.6 t -128.23 119.94 26.2 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.527 1.142 . . . . 61.25 110.056 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.409 ' C ' ' CG2' ' A' ' 215' ' ' ILE . 5.1 mm -64.48 153.22 7.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.495 1.122 . . . . 74.23 109.245 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.56 ' O ' ' CD1' ' A' ' 159' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.577 1.173 . . . . 73.01 109.309 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 230' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.366 -0.605 . . . . 75.43 109.366 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 1.3 p -49.11 -41.12 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.536 1.147 . . . . 72.11 109.283 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 12.3 mt -66.9 -33.94 66.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.586 1.178 . . . . 74.32 109.315 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -81.75 -17.52 47.43 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.425 1.078 . . . . 72.3 110.289 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 226' ' ' ASP . 6.5 t70 -88.7 -15.73 34.09 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.532 1.145 . . . . 72.22 109.278 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 6.7 mt -71.03 -69.44 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.459 1.099 . . . . 71.1 109.356 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -21.19 27.48 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.468 1.105 . . . . 74.44 109.281 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.4 m -56.79 -17.92 10.92 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 72.45 110.019 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.14 22.27 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.508 1.13 . . . . 71.53 109.284 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 40.75 37.22 0.47 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.618 1.199 . . . . 73.14 109.333 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 5.7 tp -66.16 119.63 63.36 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.424 1.078 . . . . 74.24 109.285 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 166.95 28.13 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.478 1.778 . . . . 74.54 111.018 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.6 m -68.43 173.58 4.81 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.446 1.091 . . . . 74.44 110.416 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.49 HG12 ' CG ' ' A' ' 188' ' ' HIS . 14.9 p -69.04 -49.02 66.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.473 1.108 . . . . 75.51 109.347 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.471 ' OE1' ' CD1' ' B' ' 471' ' ' ILE . 7.7 pm0 -73.04 -14.53 61.43 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.117 . . . . 71.24 110.292 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -90.53 -36.33 14.55 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.543 1.152 . . . . 70.14 110.313 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.402 ' CZ3' ' O ' ' A' ' 185' ' ' CYS . 1.3 t90 -80.48 -54.88 5.28 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.513 1.133 . . . . 73.54 107.997 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.504 ' HD3' ' CE2' ' B' ' 470' ' ' PHE . 3.0 mtmp? -57.85 -17.3 15.37 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.53 1.144 . . . . 71.14 109.22 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 243' ' ' LYS . 17.1 m . . . . . 0 C--N 1.324 -0.536 0 O-C-N 124.502 1.126 . . . . 73.24 109.947 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 470' ' ' PHE . . . . . 0.504 ' CE2' ' HD3' ' A' ' 243' ' ' LYS . 4.9 m-30 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.461 0.172 . . . . 75.33 110.987 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 471' ' ' ILE . . . . . 0.471 ' CD1' ' OE1' ' A' ' 240' ' ' GLN . 1.4 mp -70.51 142.98 89.66 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.48 1.112 . . . . 74.54 109.259 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 472' ' ' PRO . . . . . 0.574 ' HG3' ' CD1' ' A' ' 192' ' ' TRP . 18.5 Cg_endo -74.92 161.53 38.81 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.513 1.796 . . . . 63.0 111.01 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 473' ' ' SER . . . . . 0.44 ' OG ' ' CZ ' ' B' ' 474' ' ' ARG . 29.6 t -98.72 -27.42 13.97 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.532 1.145 . . . . 61.45 109.989 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 474' ' ' ARG . . . . . 0.44 ' CZ ' ' OG ' ' B' ' 473' ' ' SER . 2.6 mmt180 -111.08 170.38 5.33 Favored Pre-proline 0 C--N 1.326 -0.428 0 O-C-N 124.527 1.142 . . . . 71.12 110.316 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -168.48 0.52 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.48 1.779 . . . . 74.24 110.974 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 476' ' ' ALA . . . . . . . . . . . . . . . -73.28 134.93 79.71 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 74.41 109.296 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 477' ' ' PRO . . . . . 0.566 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -75.0 170.79 19.64 Favored 'Trans proline' 0 C--N 1.358 1.077 0 O-C-N 124.505 1.792 . . . . 75.32 111.027 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -113.11 95.27 34.11 Favored Pre-proline 0 C--N 1.324 -0.54 0 O-C-N 124.509 1.131 . . . . 75.1 109.284 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 479' ' ' PRO . . . . . 0.573 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 18.1 Cg_endo -74.99 168.62 24.43 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.483 1.781 . . . . 74.22 110.974 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 C--N 1.36 1.181 0 O-C-N 124.498 1.789 . . . . 73.44 110.977 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.403 ' O ' ' O ' ' A' ' 215' ' ' ILE . 1.2 t80 . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.461 0.172 . . . . 74.32 111.009 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.538 ' CB ' ' CD1' ' A' ' 184' ' ' ILE . . . -113.72 142.48 45.98 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.546 1.154 . . . . 74.33 109.289 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.431 ' CD1' ' C ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -127.78 121.59 56.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.485 1.116 . . . . 74.44 109.302 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.522 HG21 ' CB ' ' A' ' 180' ' ' GLU . 7.0 m -83.47 126.88 40.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.442 1.089 . . . . 64.01 109.325 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.491 ' C ' ' CG ' ' A' ' 164' ' ' TYR . 0.3 OUTLIER -99.6 -1.95 36.85 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.499 1.125 . . . . 73.42 109.305 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.491 ' CG ' ' C ' ' A' ' 163' ' ' LEU . 0.9 OUTLIER -154.69 155.57 34.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.486 1.116 . . . . 74.34 111.071 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.423 ' N ' HG12 ' A' ' 178' ' ' VAL . 33.0 p-10 -96.49 154.03 17.5 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.465 1.103 . . . . 65.24 109.314 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.535 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 3.4 t80 -147.23 137.94 23.58 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.49 1.119 . . . . 74.52 111.019 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.535 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 5.9 mtmt -76.56 128.96 35.74 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.499 1.124 . . . . 74.32 109.292 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.468 ' HB1' ' CA ' ' A' ' 173' ' ' GLU . . . -110.86 141.99 43.5 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.46 1.1 . . . . 73.12 109.286 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -148.22 18.87 1.09 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.506 1.129 . . . . 72.12 110.266 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.455 ' O ' ' CG ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -100.25 -176.49 3.24 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.48 1.113 . . . . 71.42 109.306 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.06 -30.73 69.4 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.472 1.108 . . . . 71.11 109.29 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.458 ' O ' ' C ' ' A' ' 173' ' ' GLU . 1.0 OUTLIER -101.96 12.06 37.52 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.489 1.118 . . . . 72.32 109.307 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.468 ' CA ' ' HB1' ' A' ' 168' ' ' ALA . 8.5 pt-20 -33.75 105.57 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.529 1.143 . . . . 73.43 110.264 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.47 ' CD1' ' HA3' ' A' ' 205' ' ' GLY . 13.2 tp -119.46 107.12 12.94 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.484 1.115 . . . . 71.13 109.339 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.494 ' CG2' ' O ' ' A' ' 175' ' ' THR . 14.4 t -85.44 99.14 11.0 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.518 1.136 . . . . 63.04 110.419 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.41 HG21 ' N ' ' A' ' 177' ' ' TYR . 0.7 OUTLIER -107.46 176.08 5.28 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.545 1.153 . . . . 75.22 110.344 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.41 ' N ' HG21 ' A' ' 176' ' ' THR . 5.5 m-85 -120.77 159.97 24.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.614 1.196 . . . . 65.54 110.962 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 165' ' ' ASP . 3.5 m -62.0 146.65 12.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.421 1.076 . . . . 64.11 109.259 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.42 66.14 3.05 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.503 1.127 . . . . 54.53 111.014 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.522 ' CB ' HG21 ' A' ' 162' ' ' VAL . 1.8 tp10 -132.73 169.27 16.93 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.473 0.749 . . . . 72.51 110.278 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -117.43 146.77 43.24 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.438 1.086 . . . . 75.14 109.299 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.488 ' CD2' HG12 ' A' ' 162' ' ' VAL . 0.2 OUTLIER -159.23 152.19 22.02 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 73.42 109.392 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -108.65 119.67 40.2 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.468 1.105 . . . . 75.13 111.044 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.538 ' CD1' ' CB ' ' A' ' 160' ' ' ALA . 1.6 mp -64.82 155.95 6.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.411 1.069 . . . . 75.54 109.275 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . 0.455 ' N ' ' O ' ' A' ' 194' ' ' ILE . 0.2 OUTLIER -138.66 -51.09 0.56 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.52 1.137 . . . . 75.03 108.341 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.474 ' CB ' ' HB ' ' A' ' 194' ' ' ILE . . . -120.73 166.29 13.92 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.506 1.129 . . . . 64.24 109.333 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.422 ' CE1' HG23 ' A' ' 231' ' ' ILE . 0.1 OUTLIER -151.37 141.37 22.08 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.41 1.068 . . . . 73.03 109.638 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.624 ' CE1' ' HD3' ' B' ' 472' ' ' PRO . 0.1 OUTLIER -143.2 141.0 30.98 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.421 1.076 . . . . 75.13 109.623 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.486 ' C ' ' N ' ' A' ' 191' ' ' GLU . 39.1 t-20 48.13 25.68 0.87 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.498 1.124 . . . . 74.44 109.251 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.437 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.9 p 39.02 30.19 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.519 1.137 . . . . 63.32 108.308 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.486 ' N ' ' C ' ' A' ' 189' ' ' ASN . 8.6 tt0 -125.78 -37.92 2.26 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.504 1.128 . . . . 74.3 110.362 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.606 ' CB ' ' CE1' ' A' ' 188' ' ' HIS . 97.1 m95 -112.09 132.24 54.97 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.97 -1.122 . . . . 74.01 107.97 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.586 ' CE2' ' CG1' ' A' ' 209' ' ' VAL . 22.3 m-30 -125.12 129.31 49.93 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.541 1.151 . . . . 61.33 111.033 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.474 ' HB ' ' CB ' ' A' ' 186' ' ' ALA . 1.1 mp -91.27 98.12 8.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.541 1.15 . . . . 74.43 109.317 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -104.14 -175.73 2.88 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.541 1.151 . . . . 71.34 109.301 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . 0.493 ' CD ' ' O ' ' A' ' 197' ' ' PRO . 0.0 OUTLIER -157.12 158.68 31.2 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 63.14 109.286 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.493 ' O ' ' CD ' ' A' ' 196' ' ' LYS . 18.2 Cg_endo . . . . . 0 C--N 1.359 1.126 0 O-C-N 124.524 1.802 . . . . 74.35 111.024 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.435 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.531 1.066 0 N-CA-C 110.99 -0.844 . . . . 72.44 110.99 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.435 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.2 Cg_endo -75.05 133.25 30.59 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 121.008 -2.497 . . . . 74.41 110.925 0.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 195' ' ' ALA . . . -100.44 151.03 18.98 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.478 1.111 . . . . 63.52 110.925 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.556 HD22 ' CZ3' ' A' ' 192' ' ' TRP . 0.4 OUTLIER -90.45 144.2 26.03 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.539 0.788 . . . . 75.1 109.283 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.13 127.81 3.54 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.511 1.132 . . . . 73.24 109.288 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.89 179.44 6.05 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.508 1.794 . . . . 65.3 111.041 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.586 ' CG1' ' CE2' ' A' ' 193' ' ' PHE . 1.0 OUTLIER -98.66 4.41 10.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.596 1.185 . . . . 73.13 109.274 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . 0.489 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -106.43 0.96 37.17 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 124.491 1.119 . . . . 73.12 110.964 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.587 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 6.9 m-85 -130.26 6.58 4.92 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.58 0.812 . . . . 74.51 110.978 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.428 ' CG1' ' C ' ' A' ' 211' ' ' PHE . 1.5 m -150.88 153.82 9.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.473 1.108 . . . . 74.53 109.33 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.4 m -121.64 138.88 54.15 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.502 1.127 . . . . 55.21 110.025 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.498 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 3.8 mm -87.46 124.07 40.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 124.489 1.118 . . . . 75.25 109.268 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.498 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 10.8 pt . . . . . 0 C--N 1.325 -0.467 0 O-C-N 124.469 1.106 . . . . 75.22 109.304 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 229' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 109.318 -0.623 . . . . 53.2 109.318 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 3.7 p -48.28 -49.17 12.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.116 . . . . 75.14 109.318 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.51 ' O ' ' CE ' ' A' ' 232' ' ' LYS . 3.2 mp -59.11 -29.62 41.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.428 1.08 . . . . 72.05 109.319 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 226' ' ' ASP . 15.5 mt-10 -81.41 -15.0 56.49 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.485 1.115 . . . . 73.23 110.281 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -86.64 -15.76 38.7 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.499 1.125 . . . . 72.34 109.337 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.422 HG23 ' CE1' ' A' ' 187' ' ' HIS . 0.9 OUTLIER -72.71 -69.34 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 71.43 109.279 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.51 ' CE ' ' O ' ' A' ' 228' ' ' ILE . 0.0 OUTLIER -62.17 -17.55 58.34 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.51 1.131 . . . . 73.22 109.301 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.33 -39.61 60.85 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.504 1.127 . . . . 63.21 110.011 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 235' ' ' ASN . 1.6 m -117.17 27.43 3.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.532 1.145 . . . . 74.14 109.3 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 234' ' ' VAL . 6.8 m120 40.6 37.42 0.47 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.137 . . . . 73.33 109.222 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.8 tp -70.58 119.82 74.97 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.555 1.159 . . . . 73.13 109.268 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 165.36 31.51 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.459 1.768 . . . . 74.25 111.004 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.4 m -60.27 -177.65 0.07 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.507 1.129 . . . . 73.21 110.396 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.4 HG12 ' NE2' ' A' ' 240' ' ' GLN . 9.8 p -72.21 -35.06 51.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 74.32 109.35 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.4 ' NE2' HG12 ' A' ' 239' ' ' VAL . 0.5 OUTLIER -85.52 -17.56 36.03 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.455 1.097 . . . . 74.24 110.278 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -85.15 -42.08 15.08 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.465 1.103 . . . . 71.35 110.364 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -72.65 -60.47 2.22 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.039 -1.097 . . . . 74.31 108.039 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.566 ' HD3' ' CD2' ' B' ' 470' ' ' PHE . 4.1 mtmp? -57.41 -20.49 30.2 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.483 1.114 . . . . 74.1 109.322 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.435 0 O-C-N 124.512 1.132 . . . . 63.04 110.091 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 470' ' ' PHE . . . . . 0.566 ' CD2' ' HD3' ' A' ' 243' ' ' LYS . 4.0 m-30 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.496 0.188 . . . . 74.54 111.001 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 471' ' ' ILE . . . . . 0.438 ' CD1' ' N ' ' B' ' 471' ' ' ILE . 0.9 OUTLIER -100.59 138.91 20.24 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.46 1.1 . . . . 74.43 109.279 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 472' ' ' PRO . . . . . 0.624 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.99 -45.6 0.27 Allowed 'Trans proline' 0 C--N 1.359 1.117 0 O-C-N 124.502 1.791 . . . . 72.34 111.033 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 473' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' B' ' 472' ' ' PRO . 0.1 OUTLIER 80.36 5.7 1.68 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.481 1.113 . . . . 74.44 110.027 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -132.01 157.26 78.72 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.565 1.165 . . . . 73.2 110.325 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 475' ' ' PRO . . . . . 0.501 ' O ' ' CB ' ' B' ' 476' ' ' ALA . 18.0 Cg_endo -75.03 -48.09 0.18 Allowed 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.531 1.806 . . . . 61.3 110.971 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 476' ' ' ALA . . . . . 0.501 ' CB ' ' O ' ' B' ' 475' ' ' PRO . . . 162.94 136.64 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.522 1.139 . . . . 75.52 109.322 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 477' ' ' PRO . . . . . 0.555 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.8 Cg_endo -74.89 -177.35 3.38 Favored 'Trans proline' 0 C--N 1.359 1.115 0 O-C-N 124.484 1.781 . . . . 63.03 111.069 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.54 92.29 28.05 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 72.22 109.317 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 479' ' ' PRO . . . . . 0.587 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.2 Cg_endo -75.01 151.53 39.58 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.489 1.784 . . . . 74.24 110.968 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.144 0 O-C-N 124.533 1.807 . . . . 74.22 111.006 179.986 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.65 ' CD2' ' CG1' ' A' ' 215' ' ' ILE . 2.5 t80 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.544 0.211 . . . . 72.01 110.975 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.6 ' O ' ' CE1' ' A' ' 159' ' ' TYR . . . -110.71 147.67 33.89 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.52 1.138 . . . . 73.42 109.305 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.48 ' CG2' ' OG ' ' A' ' 213' ' ' SER . 0.1 OUTLIER -129.45 131.2 67.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.484 1.115 . . . . 72.25 109.38 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.465 HG21 ' CG1' ' A' ' 212' ' ' VAL . 1.5 t -88.73 125.61 41.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.462 1.101 . . . . 71.13 109.307 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.7 mt -101.11 -13.34 18.22 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.502 1.126 . . . . 74.24 109.296 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.4 ' O ' HG13 ' A' ' 162' ' ' VAL . 1.5 m-85 -148.27 156.26 42.33 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.471 1.107 . . . . 74.21 111.041 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -105.95 160.57 15.17 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.55 1.156 . . . . 74.11 109.295 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.566 ' HB3' ' CE1' ' A' ' 211' ' ' PHE . 0.3 OUTLIER -159.7 164.51 33.9 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.492 1.12 . . . . 72.45 110.979 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -89.84 130.77 36.03 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.513 1.133 . . . . 72.2 109.256 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.464 ' HB2' ' CA ' ' A' ' 173' ' ' GLU . . . -104.42 141.65 35.97 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.448 1.092 . . . . 63.41 109.315 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.747 ' H ' ' NZ ' ' A' ' 170' ' ' LYS . 7.7 pt-20 -151.91 21.68 0.68 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.461 1.101 . . . . 73.43 110.303 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.747 ' NZ ' ' H ' ' A' ' 169' ' ' GLU . 0.1 OUTLIER -98.12 -175.93 3.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.524 1.14 . . . . 75.11 109.338 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.12 -29.79 65.8 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.434 1.083 . . . . 54.33 109.328 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 173' ' ' GLU . 3.2 m-20 -110.08 22.81 15.14 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.53 1.143 . . . . 75.13 109.263 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.464 ' CA ' ' HB2' ' A' ' 168' ' ' ALA . 6.2 pt-20 -38.16 106.14 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.475 1.11 . . . . 75.23 110.322 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.485 ' CD2' ' HA3' ' A' ' 205' ' ' GLY . 0.6 OUTLIER -126.82 120.93 30.5 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.491 1.12 . . . . 73.54 109.34 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 11.9 t -87.65 118.49 27.17 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.558 1.162 . . . . 74.21 110.359 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 177' ' ' TYR . 0.6 OUTLIER -120.45 175.52 5.94 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.52 1.138 . . . . 75.32 110.363 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.412 ' N ' HG22 ' A' ' 176' ' ' THR . 14.9 m-85 -127.77 152.9 47.19 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 75.41 111.052 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 3.1 m -51.44 155.05 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 64.42 109.318 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 44.3 74.09 0.23 Allowed Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.519 1.137 . . . . 75.42 110.985 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -132.24 162.19 31.58 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.431 0.724 . . . . 71.3 110.347 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.16 120.54 40.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.529 1.143 . . . . 75.12 109.292 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.452 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 1.2 pt? -136.46 143.83 44.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.504 1.127 . . . . 72.33 109.32 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.403 ' C ' ' HB3' ' A' ' 195' ' ' ALA . 41.7 t80 -104.85 111.24 23.92 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.465 1.103 . . . . 74.22 111.014 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.516 ' CD1' ' HB3' ' A' ' 193' ' ' PHE . 19.0 mm -54.42 164.83 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.523 1.139 . . . . 62.43 109.313 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . 0.466 ' N ' ' CG2' ' A' ' 184' ' ' ILE . 0.1 OUTLIER -151.84 -45.91 0.11 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.498 1.124 . . . . 72.42 108.344 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.476 ' CB ' ' HB ' ' A' ' 194' ' ' ILE . . . -125.66 174.54 8.22 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.501 1.126 . . . . 71.14 109.344 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.619 ' C ' ' CD2' ' A' ' 188' ' ' HIS . 0.9 OUTLIER -155.02 154.02 31.86 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 71.32 109.639 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.705 ' CE1' ' CG1' ' A' ' 239' ' ' VAL . 0.1 OUTLIER -144.11 120.93 11.25 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.51 1.131 . . . . 73.41 109.535 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.453 ' C ' ' N ' ' A' ' 191' ' ' GLU . 55.4 t30 52.05 32.72 10.73 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.455 1.097 . . . . 74.24 109.345 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 9.6 m 41.67 29.24 0.1 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.511 1.132 . . . . 64.34 108.316 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.453 ' N ' ' C ' ' A' ' 189' ' ' ASN . 16.8 tt0 -120.92 -38.55 2.82 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.469 1.106 . . . . 75.43 110.294 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.582 ' CZ2' ' HD3' ' B' ' 477' ' ' PRO . 90.2 m95 -113.26 137.61 51.22 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.538 1.149 . . . . 70.45 108.009 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.584 ' CZ ' HG11 ' A' ' 209' ' ' VAL . 22.4 m-30 -125.83 135.63 52.19 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.469 1.106 . . . . 73.21 111.032 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.551 ' CG1' ' NE2' ' A' ' 188' ' ' HIS . 6.3 mm -100.74 95.63 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 75.44 109.261 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . . . -99.09 -179.72 4.34 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.516 1.135 . . . . 71.42 109.269 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . 0.453 ' CG ' ' C ' ' A' ' 195' ' ' ALA . 10.2 mtpt -151.1 162.98 25.21 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.447 1.092 . . . . 71.45 109.333 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 C--N 1.36 1.137 0 O-C-N 124.493 1.786 . . . . 74.3 110.967 -179.982 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.441 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.529 0.956 0 N-CA-C 111.062 -0.815 . . . . 70.25 111.062 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.441 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.5 Cg_endo -74.97 129.01 17.49 Favored 'Cis proline' 0 C--N 1.359 1.112 0 C-N-CA 120.949 -2.521 . . . . 74.45 111.024 -0.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.485 ' HA3' ' CD2' ' A' ' 174' ' ' LEU . . . -96.34 141.93 15.87 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.514 1.134 . . . . 75.04 111.025 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.482 ' CD2' ' HD3' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -91.2 147.21 23.21 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.552 0.795 . . . . 73.02 109.295 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.44 HG22 ' CD1' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -161.06 129.14 2.85 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.542 1.152 . . . . 64.22 109.336 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.484 ' O ' ' CG2' ' A' ' 212' ' ' VAL . 18.2 Cg_endo -75.03 179.91 5.64 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.565 1.824 . . . . 74.44 110.927 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.584 HG11 ' CZ ' ' A' ' 193' ' ' PHE . 0.6 OUTLIER -96.12 3.32 9.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 124.443 1.089 . . . . 74.42 109.306 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -103.89 -5.93 43.75 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.487 1.117 . . . . 55.12 111.033 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.572 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 5.2 m-85 -125.98 1.76 7.29 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.505 0.767 . . . . 72.32 110.983 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 208' ' ' PRO . 3.5 m -141.28 167.76 16.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.574 1.171 . . . . 72.33 109.306 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' SER . . . . . 0.48 ' OG ' ' CG2' ' A' ' 161' ' ' ILE . 13.1 p -136.2 132.98 36.62 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.445 1.091 . . . . 62.03 109.997 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.496 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 2.9 mm -76.4 144.68 11.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.475 1.109 . . . . 75.03 109.277 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.65 ' CG1' ' CD2' ' A' ' 159' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.428 0 O-C-N 124.459 1.1 . . . . 73.13 109.31 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 229' ' ' GLU . 14.0 t0 . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 109.211 -0.663 . . . . 75.22 109.211 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -39.85 -56.27 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.45 1.094 . . . . 75.21 109.282 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 9.9 mt -55.94 -42.46 71.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.499 1.125 . . . . 74.54 109.274 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 226' ' ' ASP . 21.2 mt-10 -66.45 -14.16 61.81 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.506 1.129 . . . . 55.5 110.329 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -88.67 -23.27 23.05 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.564 1.165 . . . . 74.41 109.299 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -63.66 -69.4 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.483 1.114 . . . . 75.22 109.323 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.439 ' CD ' ' HA ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -55.85 -30.58 61.71 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.44 1.088 . . . . 75.42 109.3 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.4 m -52.94 -50.63 63.63 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 60.53 109.954 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 235' ' ' ASN . 1.3 m -89.88 16.08 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.471 1.107 . . . . 75.03 109.26 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 234' ' ' VAL . 37.7 t30 40.56 44.53 1.78 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.516 1.135 . . . . 70.23 109.296 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.1 tp -83.02 119.74 74.79 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.457 1.098 . . . . 74.13 109.307 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 164.37 33.48 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.52 1.8 . . . . 74.32 111.023 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' THR . . . . . 0.53 ' HA ' ' CD2' ' A' ' 187' ' ' HIS . 3.4 m -58.81 -175.72 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.484 1.115 . . . . 63.35 110.364 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.705 ' CG1' ' CE1' ' A' ' 188' ' ' HIS . 2.6 p -74.17 -36.27 43.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.5 1.125 . . . . 74.51 109.333 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -82.65 -17.88 43.04 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.492 1.12 . . . . 74.25 110.315 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -87.07 -38.54 16.42 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.531 1.144 . . . . 71.42 110.299 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.433 ' CH2' ' HB3' ' A' ' 185' ' ' CYS . 6.1 t90 -78.35 -61.33 2.04 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.531 1.144 . . . . 74.34 108.001 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 9.3 mtmt -53.92 -20.53 6.2 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.428 1.08 . . . . 74.13 109.3 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 C--N 1.324 -0.504 0 O-C-N 124.542 1.152 . . . . 75.05 109.993 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 470' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.52 0.2 . . . . 74.24 111.009 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 471' ' ' ILE . . . . . . . . . . . . . 2.8 mm -84.82 140.32 37.67 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.491 1.12 . . . . 74.11 109.353 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 472' ' ' PRO . . . . . 0.404 ' HD3' ' ND1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.92 130.28 13.22 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.528 1.804 . . . . 73.42 111.04 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 46.3 t -78.54 -73.06 0.34 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.456 1.098 . . . . 71.44 109.981 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -65.1 160.03 60.22 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.523 1.139 . . . . 72.14 110.311 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 -167.27 0.41 Allowed 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.461 1.769 . . . . 74.22 110.994 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 476' ' ' ALA . . . . . . . . . . . . . . . -62.86 138.81 97.19 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.496 1.122 . . . . 73.55 109.281 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 477' ' ' PRO . . . . . 0.582 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -75.04 -162.43 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.491 1.785 . . . . 72.44 111.029 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.18 90.75 17.76 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.479 1.112 . . . . 72.21 109.278 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 479' ' ' PRO . . . . . 0.572 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.92 168.41 24.9 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.428 1.752 . . . . 64.14 110.973 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo . . . . . 0 C--N 1.36 1.174 0 O-C-N 124.565 1.824 . . . . 74.54 111.106 179.902 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 5.1 p90 . . . . . 0 N--CA 1.454 -0.25 0 CA-C-O 120.562 0.22 . . . . 74.42 110.973 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.455 ' O ' ' CD1' ' A' ' 182' ' ' LEU . . . -108.82 147.7 31.69 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.485 1.115 . . . . 73.14 109.305 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.449 HG23 ' CD2' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -120.82 135.14 61.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.509 1.131 . . . . 73.4 109.262 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.424 ' O ' ' CA ' ' A' ' 179' ' ' GLY . 2.3 t -93.32 121.01 43.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.455 1.097 . . . . 63.52 109.305 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.449 ' CD2' HG23 ' A' ' 161' ' ' ILE . 0.4 OUTLIER -101.44 -11.5 19.3 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.503 1.127 . . . . 64.41 109.295 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -144.6 160.29 41.41 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 74.32 111.003 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.461 ' CB ' HG11 ' A' ' 178' ' ' VAL . 21.7 p30 -107.95 157.71 17.98 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.554 1.159 . . . . 75.2 109.305 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.599 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 1.2 t80 -160.45 136.43 8.44 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.436 1.085 . . . . 74.11 111.012 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.599 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 12.0 mtpp -67.37 122.69 18.47 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.448 1.093 . . . . 74.4 109.313 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.419 ' HA ' ' NZ ' ' A' ' 170' ' ' LYS . . . -90.62 140.12 30.06 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.585 1.178 . . . . 72.23 109.3 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -152.19 21.69 0.65 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.508 1.13 . . . . 74.13 110.283 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.472 ' HD3' ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -98.72 -176.66 3.42 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.505 1.128 . . . . 65.4 109.335 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.93 -24.87 64.7 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.462 1.101 . . . . 73.31 109.326 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 173' ' ' GLU . 59.7 t0 -113.68 20.44 15.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.458 1.099 . . . . 62.53 109.281 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 172' ' ' ASP . 5.1 pt-20 -36.82 100.51 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 1.104 . . . . 72.45 110.352 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.484 ' HG ' ' CA ' ' A' ' 205' ' ' GLY . 0.1 OUTLIER -132.03 96.2 3.85 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.499 1.124 . . . . 73.3 109.344 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.6 t -59.55 148.82 31.93 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.483 1.115 . . . . 63.34 110.416 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 14.4 m -155.9 117.04 3.87 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.559 1.162 . . . . 71.21 110.435 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -63.94 157.58 24.53 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.512 1.132 . . . . 73.4 110.975 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.461 HG11 ' CB ' ' A' ' 165' ' ' ASP . 2.5 m -58.24 158.19 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.557 1.16 . . . . 75.21 109.249 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.424 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 52.54 62.54 5.71 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.479 1.112 . . . . 72.45 110.998 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -120.2 170.91 8.89 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.514 0.773 . . . . 74.43 110.244 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -129.17 117.56 20.98 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.552 1.157 . . . . 75.22 109.325 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.47 HD22 ' CG1' ' A' ' 207' ' ' VAL . 0.2 OUTLIER -130.58 149.71 52.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.538 1.149 . . . . 64.32 109.315 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.47 ' C ' ' HB1' ' A' ' 195' ' ' ALA . 8.2 t80 -104.13 104.34 14.26 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.531 1.145 . . . . 74.22 111.002 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.519 ' HA ' ' HA ' ' A' ' 195' ' ' ALA . 22.1 mt -68.56 158.46 5.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.468 1.105 . . . . 74.4 109.354 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . 0.603 ' SG ' ' CZ3' ' A' ' 242' ' ' TRP . 27.0 t -152.16 -41.59 0.11 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.522 1.139 . . . . 73.34 108.332 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.509 ' CB ' ' HB ' ' A' ' 194' ' ' ILE . . . -112.22 155.58 23.77 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.547 1.155 . . . . 73.44 109.297 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.33 145.04 27.95 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.497 1.123 . . . . 74.2 109.649 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.542 ' CE1' ' HD3' ' B' ' 472' ' ' PRO . 0.1 OUTLIER -143.55 141.41 30.68 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.525 1.141 . . . . 64.32 109.603 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.462 ' C ' ' N ' ' A' ' 191' ' ' GLU . 3.1 m120 49.44 23.34 0.86 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.46 1.1 . . . . 72.41 109.261 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.408 ' C ' ' O ' ' A' ' 189' ' ' ASN . 18.1 m 41.22 28.88 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.117 . . . . 72.5 108.293 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.462 ' N ' ' C ' ' A' ' 189' ' ' ASN . 8.5 tt0 -126.59 -38.58 2.07 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.575 1.172 . . . . 74.14 110.299 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.571 ' CE3' HD13 ' A' ' 206' ' ' LEU . 98.8 m95 -111.55 128.48 56.04 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.527 1.142 . . . . 74.13 108.058 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.592 ' CE2' HG13 ' A' ' 209' ' ' VAL . 22.1 m-30 -120.11 126.2 50.14 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.489 1.118 . . . . 74.44 111.001 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.509 ' HB ' ' CB ' ' A' ' 186' ' ' ALA . 5.6 mm -86.63 104.36 13.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.53 1.144 . . . . 72.42 109.262 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . . . -112.92 175.85 5.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.498 1.124 . . . . 71.23 109.263 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . 0.41 ' NZ ' ' CB ' ' A' ' 196' ' ' LYS . 2.3 ttmp? -137.99 142.66 36.7 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.131 . . . . 74.13 109.323 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 196' ' ' LYS . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.173 0 O-C-N 124.512 1.796 . . . . 73.42 110.993 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.969 0 N-CA-C 111.008 -0.837 . . . . 75.21 111.008 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 146.11 85.78 Favored 'Cis proline' 0 C--N 1.36 1.182 0 C-N-CA 121.028 -2.488 . . . . 74.0 111.009 -0.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 195' ' ' ALA . . . -104.7 138.56 14.22 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.494 1.121 . . . . 63.43 110.986 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.571 HD13 ' CE3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -83.37 146.76 28.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.574 0.808 . . . . 73.44 109.384 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.47 ' CG1' HD22 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -153.36 127.01 4.31 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.458 1.099 . . . . 61.44 109.288 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.495 ' O ' ' CG2' ' A' ' 212' ' ' VAL . 18.4 Cg_endo -74.92 174.9 11.96 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.455 1.766 . . . . 75.45 111.002 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.592 HG13 ' CE2' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -93.49 4.81 7.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.537 1.148 . . . . 74.34 109.297 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . 0.495 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -104.72 -8.3 37.47 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.5 1.125 . . . . 62.12 111.024 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.595 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 15.8 m-85 -125.53 -0.8 7.5 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.497 0.763 . . . . 75.14 111.002 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 208' ' ' PRO . 2.5 m -139.63 162.15 26.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.503 1.127 . . . . 73.42 109.267 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.6 t -134.72 133.56 40.09 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 75.42 109.967 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.488 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 2.9 mm -76.85 127.72 37.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.506 1.129 . . . . 74.54 109.28 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.488 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 5.3 pt . . . . . 0 C--N 1.326 -0.435 0 O-C-N 124.544 1.153 . . . . 72.41 109.241 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 229' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 109.329 -0.619 . . . . 75.32 109.329 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -40.38 -45.73 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.439 1.087 . . . . 72.25 109.349 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 7.8 mt -65.27 -46.53 90.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.5 1.125 . . . . 73.32 109.275 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.468 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 11.6 mt-10 -64.95 -17.19 64.17 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.566 1.166 . . . . 71.41 110.338 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.66 -16.44 32.38 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.453 1.095 . . . . 70.43 109.347 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 3.6 mt -76.1 -70.11 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 124.523 1.139 . . . . 72.22 109.323 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.468 ' CD ' ' HA ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -59.67 -26.79 65.83 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.555 1.16 . . . . 72.13 109.236 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.11 -48.1 12.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.474 1.108 . . . . 71.11 110.01 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.1 m -98.02 -15.85 7.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.483 1.115 . . . . 64.55 109.282 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 64.97 49.57 2.07 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 1.135 . . . . 70.15 109.316 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.5 ' CD1' ' O ' ' A' ' 237' ' ' PRO . 0.5 OUTLIER -71.08 146.75 93.08 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.457 1.098 . . . . 75.33 109.319 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.5 ' O ' ' CD1' ' A' ' 236' ' ' LEU . 18.6 Cg_endo -74.95 141.59 26.97 Favored 'Trans proline' 0 C--N 1.359 1.096 0 O-C-N 124.526 1.803 . . . . 74.24 110.995 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' THR . . . . . 0.404 HG23 ' NE2' ' A' ' 240' ' ' GLN . 1.1 m -58.36 176.38 0.18 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.431 1.082 . . . . 75.43 110.478 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.495 ' CG2' ' NZ ' ' A' ' 243' ' ' LYS . 9.9 p -72.09 -33.84 48.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.524 1.14 . . . . 51.31 109.311 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.404 ' NE2' HG23 ' A' ' 238' ' ' THR . 0.3 OUTLIER -85.58 -17.03 37.43 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.479 1.112 . . . . 72.33 110.243 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -87.05 -43.78 12.06 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.494 1.121 . . . . 75.21 110.336 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.603 ' CZ3' ' SG ' ' A' ' 185' ' ' CYS . 0.5 OUTLIER -72.08 -60.73 2.09 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.988 -1.116 . . . . 72.43 107.988 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.495 ' NZ ' ' CG2' ' A' ' 239' ' ' VAL . 4.8 mtmm -54.79 -20.62 8.95 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.498 1.124 . . . . 73.51 109.29 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 C--N 1.325 -0.476 0 O-C-N 124.564 1.165 . . . . 64.24 110.03 179.951 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 470' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.472 0.177 . . . . 74.12 110.993 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 471' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' B' ' 472' ' ' PRO . 26.4 mm -41.82 142.44 1.1 Allowed Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.505 1.128 . . . . 74.33 109.333 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 472' ' ' PRO . . . . . 0.542 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.91 173.38 14.57 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.473 1.775 . . . . 55.21 111.073 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.91 -46.02 2.94 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.473 1.108 . . . . 70.42 110.014 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 39.3 mtp85 -87.14 158.49 52.56 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.567 1.167 . . . . 71.33 110.3 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 475' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' B' ' 476' ' ' ALA . 18.3 Cg_endo -75.05 -30.94 6.57 Favored 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.469 1.773 . . . . 75.34 110.982 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 476' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' B' ' 475' ' ' PRO . . . 163.38 129.57 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.506 1.129 . . . . 63.12 109.281 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 477' ' ' PRO . . . . . 0.562 ' HG3' ' CE2' ' A' ' 166' ' ' PHE . 18.1 Cg_endo -75.02 -176.59 2.96 Favored 'Trans proline' 0 C--N 1.361 1.2 0 O-C-N 124.515 1.797 . . . . 64.34 110.985 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 478' ' ' LYS . . . . . 0.463 ' CD ' ' O ' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -116.46 95.11 44.86 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.536 1.148 . . . . 74.21 109.35 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 479' ' ' PRO . . . . . 0.595 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.99 150.11 37.69 Favored 'Trans proline' 0 C--N 1.359 1.105 0 O-C-N 124.563 1.823 . . . . 72.33 111.023 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 C--N 1.361 1.195 0 O-C-N 124.447 1.762 . . . . 72.02 111.009 179.997 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 2.6 p90 . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.514 0.197 . . . . 74.41 110.998 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.561 ' CB ' ' CD1' ' A' ' 184' ' ' ILE . . . -130.42 153.22 48.98 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.511 1.132 . . . . 71.02 109.304 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.502 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.2 OUTLIER -123.89 125.45 71.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.532 1.145 . . . . 74.12 109.265 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.465 ' CG2' HD23 ' A' ' 182' ' ' LEU . 1.9 t -80.51 122.45 35.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.559 1.162 . . . . 72.33 109.284 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.457 ' CD2' HG21 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -98.19 -13.74 20.71 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.519 1.137 . . . . 72.02 109.287 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -146.21 157.71 43.84 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.567 1.167 . . . . 75.34 111.042 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -98.04 158.25 15.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.527 1.142 . . . . 71.35 109.27 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.491 ' CE1' ' HB3' ' B' ' 477' ' ' PRO . 40.5 t80 -145.5 158.9 43.77 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.559 1.162 . . . . 73.11 111.051 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -94.34 127.87 40.5 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.459 1.099 . . . . 74.13 109.288 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.473 ' HB2' ' CA ' ' A' ' 173' ' ' GLU . . . -93.19 142.06 27.73 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.465 1.103 . . . . 71.14 109.329 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -157.87 24.64 0.27 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.503 1.127 . . . . 71.22 110.314 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.528 ' NZ ' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -122.41 -175.36 3.12 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.531 1.145 . . . . 75.05 109.362 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.14 -40.99 82.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.439 1.087 . . . . 71.04 109.325 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 174' ' ' LEU . 3.0 m-20 -85.86 10.99 12.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.54 1.15 . . . . 73.32 109.3 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.519 ' CG ' ' O ' ' A' ' 170' ' ' LYS . 5.4 pt-20 -36.34 96.56 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.432 1.083 . . . . 75.34 110.354 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.477 ' CD1' ' HA3' ' A' ' 205' ' ' GLY . 1.2 tm? -136.98 94.93 3.02 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.517 1.136 . . . . 73.5 109.296 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 9.0 t -59.53 153.36 19.8 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.563 1.164 . . . . 75.01 110.471 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 24.3 m -152.21 141.93 21.89 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.481 1.113 . . . . 74.35 110.374 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -88.37 153.33 21.27 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.408 1.068 . . . . 74.41 111.06 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.434 HG11 ' CB ' ' A' ' 165' ' ' ASP . 2.4 m -59.21 158.3 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.438 1.086 . . . . 70.24 109.299 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 48.81 66.98 1.87 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.455 1.097 . . . . 74.41 110.988 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.502 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 1.9 tt0 -131.15 171.76 12.9 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.552 0.795 . . . . 75.34 110.235 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -123.4 130.65 53.02 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.478 1.112 . . . . 74.5 109.318 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 0.6 OUTLIER -146.82 143.27 28.49 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.431 1.082 . . . . 72.55 109.341 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 73.4 t80 -100.57 117.99 35.83 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.537 1.148 . . . . 74.03 111.031 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.561 ' CD1' ' CB ' ' A' ' 160' ' ' ALA . 1.6 mp -62.69 151.99 7.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.41 1.068 . . . . 75.53 109.243 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . 0.573 ' O ' ' CZ3' ' A' ' 242' ' ' TRP . 0.9 OUTLIER -136.03 -47.87 0.66 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.569 1.168 . . . . 55.13 108.26 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.474 ' CB ' ' HB ' ' A' ' 194' ' ' ILE . . . -122.25 168.86 11.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.504 1.127 . . . . 72.22 109.279 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.625 ' C ' ' CD2' ' A' ' 188' ' ' HIS . 2.9 p80 -146.67 153.88 40.8 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.443 1.089 . . . . 72.34 109.592 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.703 ' CE1' ' CG1' ' A' ' 239' ' ' VAL . 0.1 OUTLIER -143.92 120.75 11.26 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.471 1.107 . . . . 75.13 109.555 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.473 ' C ' ' N ' ' A' ' 191' ' ' GLU . 86.1 m-20 50.85 35.21 11.76 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.526 1.141 . . . . 73.43 109.352 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.421 ' C ' ' O ' ' A' ' 189' ' ' ASN . 60.9 m 39.77 30.75 0.06 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.553 1.158 . . . . 61.02 108.254 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.473 ' N ' ' C ' ' A' ' 189' ' ' ASN . 11.4 tt0 -122.25 -42.16 2.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.546 1.154 . . . . 72.43 110.279 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.577 ' CH2' ' HD3' ' B' ' 477' ' ' PRO . 95.4 m95 -110.41 136.88 48.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.982 -1.118 . . . . 74.03 107.982 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.573 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.1 m-30 -127.52 124.41 38.18 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.507 1.13 . . . . 74.41 110.964 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.564 HG22 ' CD2' ' B' ' 470' ' ' PHE . 1.4 mp -87.61 97.02 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 70.54 109.317 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -101.99 -179.88 4.13 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.472 1.108 . . . . 61.1 109.295 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.9 ptmt -155.16 167.27 14.42 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.548 1.155 . . . . 75.44 109.303 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo . . . . . 0 C--N 1.36 1.16 0 O-C-N 124.412 1.743 . . . . 62.24 111.044 -180.0 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.964 0 N-CA-C 110.995 -0.842 . . . . 64.13 110.995 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 142.83 75.93 Favored 'Cis proline' 0 C--N 1.36 1.152 0 C-N-CA 121.012 -2.495 . . . . 62.13 111.006 0.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 195' ' ' ALA . . . -106.07 148.1 16.39 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.538 1.149 . . . . 74.52 110.976 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.575 HD12 ' CE3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -88.61 145.83 25.46 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.511 0.771 . . . . 72.51 109.325 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.484 HG21 ' CD1' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -156.02 126.26 3.36 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.544 1.153 . . . . 64.5 109.295 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.486 ' O ' ' CG2' ' A' ' 212' ' ' VAL . 18.2 Cg_endo -74.98 179.59 5.93 Favored 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.489 1.784 . . . . 75.04 110.926 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.573 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -96.93 6.59 8.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.479 1.112 . . . . 72.43 109.327 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . 0.49 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -108.32 -4.86 32.74 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.551 1.157 . . . . 74.23 110.972 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.586 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 8.1 m-85 -127.44 1.59 6.28 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.518 0.775 . . . . 75.24 111.017 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 208' ' ' PRO . 3.4 m -139.62 153.78 23.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.56 1.162 . . . . 74.34 109.329 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.17 124.3 44.38 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.633 1.208 . . . . 71.32 110.039 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.495 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 2.9 mm -68.32 145.03 13.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.13 . . . . 74.15 109.284 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.495 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 5.5 pt . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.539 1.149 . . . . 73.15 109.254 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 230' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.315 -0.624 . . . . 60.43 109.315 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.2 p -47.85 -56.56 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.459 1.1 . . . . 74.43 109.258 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.449 ' O ' ' CE ' ' A' ' 232' ' ' LYS . 3.4 mt -57.1 -32.09 39.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.124 . . . . 71.02 109.375 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.415 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 5.4 mt-10 -80.89 -14.54 57.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.571 1.169 . . . . 73.44 110.312 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 226' ' ' ASP . 0.7 OUTLIER -88.49 -17.9 29.34 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.475 1.109 . . . . 64.23 109.314 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.415 ' CG2' ' N ' ' A' ' 232' ' ' LYS . 0.5 OUTLIER -69.28 -69.2 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.508 1.13 . . . . 72.44 109.34 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.449 ' CE ' ' O ' ' A' ' 228' ' ' ILE . 0.0 OUTLIER -57.91 -20.73 39.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.563 1.164 . . . . 74.45 109.302 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.6 t -50.86 -57.93 7.25 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.54 1.15 . . . . 63.44 110.012 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.5 m -90.8 17.74 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.527 1.142 . . . . 73.42 109.346 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 47.53 34.85 3.74 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.506 1.129 . . . . 73.55 109.259 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.14 119.05 73.58 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.526 1.141 . . . . 72.44 109.287 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.13 167.2 27.44 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.5 1.789 . . . . 72.34 110.976 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' THR . . . . . 0.545 ' HA ' ' CD2' ' A' ' 187' ' ' HIS . 2.7 m -59.24 178.25 0.14 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.453 1.096 . . . . 71.4 110.383 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.703 ' CG1' ' CE1' ' A' ' 188' ' ' HIS . 0.2 OUTLIER -58.77 -67.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.133 . . . . 73.41 109.25 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.486 ' OE1' ' CD1' ' B' ' 471' ' ' ILE . 0.3 OUTLIER -63.91 -22.32 66.87 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.569 1.168 . . . . 74.42 110.339 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -75.85 -33.45 60.02 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.464 1.102 . . . . 75.22 110.246 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.573 ' CZ3' ' O ' ' A' ' 185' ' ' CYS . 2.6 t90 -85.28 -60.36 2.06 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.137 . . . . 73.11 108.007 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.429 ' NZ ' ' CG ' ' B' ' 470' ' ' PHE . 22.1 mtmt -56.18 -18.7 10.91 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.53 1.144 . . . . 71.01 109.308 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.145 . . . . 74.11 109.969 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 470' ' ' PHE . . . . . 0.564 ' CD2' HG22 ' A' ' 194' ' ' ILE . 3.3 m-85 . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 120.548 0.213 . . . . 74.43 110.938 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 471' ' ' ILE . . . . . 0.486 ' CD1' ' OE1' ' A' ' 240' ' ' GLN . 1.4 mp -75.17 136.8 72.35 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.451 1.094 . . . . 75.01 109.331 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 472' ' ' PRO . . . . . 0.432 ' HD3' ' ND1' ' A' ' 188' ' ' HIS . 18.3 Cg_endo -75.04 -162.66 0.16 Allowed 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.409 1.741 . . . . 74.01 110.977 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 6.2 t -133.08 -52.76 0.9 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.469 1.106 . . . . 61.41 109.958 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 31.9 mtt-85 -81.05 156.18 72.18 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.485 1.116 . . . . 74.33 110.27 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 475' ' ' PRO . . . . . 0.491 ' O ' ' CB ' ' B' ' 476' ' ' ALA . 18.4 Cg_endo -75.05 -30.64 6.88 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.425 1.75 . . . . 73.01 110.982 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 476' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' B' ' 475' ' ' PRO . . . 163.42 131.6 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.538 1.149 . . . . 70.44 109.301 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 477' ' ' PRO . . . . . 0.577 ' HD3' ' CH2' ' A' ' 192' ' ' TRP . 18.6 Cg_endo -74.94 -163.31 0.18 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.553 1.817 . . . . 75.4 111.012 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 478' ' ' LYS . . . . . 0.496 ' CD ' ' O ' ' B' ' 478' ' ' LYS . 0.3 OUTLIER -124.97 94.99 42.94 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 74.31 109.329 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 479' ' ' PRO . . . . . 0.586 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.5 Cg_endo -74.94 155.38 43.23 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.462 1.77 . . . . 73.43 111.066 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.164 0 O-C-N 124.459 1.768 . . . . 74.04 110.996 179.975 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.789 ' CD1' ' CE2' ' A' ' 183' ' ' PHE . 1.4 m-85 . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 120.457 0.17 . . . . 62.51 110.997 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.611 ' CB ' ' CD1' ' A' ' 184' ' ' ILE . . . -114.64 149.57 36.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.537 1.148 . . . . 63.1 109.302 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.5 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.2 OUTLIER -131.4 127.85 60.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 74.33 109.273 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.471 ' CG2' HD22 ' A' ' 182' ' ' LEU . 1.9 t -80.48 121.19 33.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.556 1.16 . . . . 71.23 109.333 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.438 HD21 ' CG2' ' A' ' 161' ' ' ILE . 0.9 OUTLIER -96.24 -14.48 22.64 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 73.45 109.361 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -146.9 159.23 43.79 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.48 1.113 . . . . 74.45 110.954 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.419 ' N ' HG12 ' A' ' 178' ' ' VAL . 10.4 p-10 -101.1 159.45 15.22 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.566 1.166 . . . . 73.41 109.347 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' B' ' 477' ' ' PRO . 9.0 t80 -158.33 135.71 10.17 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.433 1.083 . . . . 72.25 110.908 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -68.78 132.34 46.64 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.144 . . . . 74.23 109.337 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.473 ' HB1' ' CA ' ' A' ' 173' ' ' GLU . . . -112.98 141.82 46.39 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.539 1.149 . . . . 71.12 109.311 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -150.42 20.37 0.84 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.51 1.131 . . . . 75.3 110.346 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.478 ' NZ ' ' CH2' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -96.42 -176.57 3.67 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.496 1.123 . . . . 64.24 109.26 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.41 -20.63 63.29 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.501 1.126 . . . . 64.21 109.319 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.454 ' HB3' ' CB ' ' A' ' 206' ' ' LEU . 7.1 t0 -117.11 18.88 14.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.493 1.121 . . . . 71.44 109.307 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.473 ' CA ' ' HB1' ' A' ' 168' ' ' ALA . 6.5 pt-20 -36.52 106.44 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.483 1.114 . . . . 71.42 110.28 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.472 ' CD2' ' HA3' ' A' ' 205' ' ' GLY . 15.8 tp -116.55 105.94 13.01 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.422 1.076 . . . . 62.41 109.307 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 9.7 t -87.22 110.02 19.88 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.437 1.086 . . . . 74.14 110.367 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 87.8 m -130.97 169.98 15.09 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.581 1.176 . . . . 73.42 110.386 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -112.41 161.95 16.12 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.458 1.099 . . . . 72.44 111.015 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.7 m -55.4 158.16 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 65.41 109.3 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.44 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 50.24 68.55 1.38 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.462 1.101 . . . . 72.42 111.013 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.5 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 5.2 tp10 -126.48 164.79 20.39 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 124.547 0.792 . . . . 73.24 110.322 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -113.42 129.21 56.59 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.507 1.13 . . . . 74.51 109.256 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.544 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 0.4 OUTLIER -152.48 146.95 25.68 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.498 1.124 . . . . 65.3 109.274 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.789 ' CE2' ' CD1' ' A' ' 159' ' ' TYR . 3.8 m-85 -111.92 120.35 41.61 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.464 1.103 . . . . 72.42 111.021 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.611 ' CD1' ' CB ' ' A' ' 160' ' ' ALA . 1.7 mp -71.02 152.11 8.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.485 1.115 . . . . 75.03 109.281 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . 0.472 ' SG ' ' N ' ' A' ' 186' ' ' ALA . 15.5 p -142.25 -44.15 0.33 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.508 1.13 . . . . 74.3 108.327 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.494 ' CB ' ' HB ' ' A' ' 194' ' ' ILE . . . -116.19 159.1 22.27 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.49 1.119 . . . . 75.03 109.303 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.453 ' O ' ' N ' ' A' ' 239' ' ' VAL . 0.0 OUTLIER -147.85 148.93 31.4 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.463 1.102 . . . . 73.31 109.639 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.621 ' CD2' ' O ' ' A' ' 192' ' ' TRP . 0.5 OUTLIER -152.44 143.96 23.42 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.492 1.12 . . . . 74.03 109.584 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.473 ' C ' ' N ' ' A' ' 191' ' ' GLU . 27.3 t-20 51.11 22.88 1.38 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.547 1.154 . . . . 73.35 109.34 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.441 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.5 p 39.03 30.19 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.531 1.145 . . . . 62.43 108.292 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.473 ' N ' ' C ' ' A' ' 189' ' ' ASN . 9.9 tt0 -131.31 -40.15 1.14 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.438 1.086 . . . . 73.31 110.307 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.621 ' O ' ' CD2' ' A' ' 188' ' ' HIS . 96.4 m95 -107.33 131.72 53.92 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.035 -1.098 . . . . 74.42 108.035 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.625 ' CE2' ' CG1' ' A' ' 209' ' ' VAL . 22.4 m-30 -125.59 133.06 52.4 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.597 1.185 . . . . 64.32 111.048 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.55 ' CD1' ' NE2' ' A' ' 188' ' ' HIS . 0.7 OUTLIER -93.3 105.67 17.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.522 1.139 . . . . 72.41 109.289 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -109.13 176.73 4.99 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.392 1.057 . . . . 75.23 109.306 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.5 pttm -149.47 168.76 10.34 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.593 1.183 . . . . 72.53 109.362 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo . . . . . 0 C--N 1.36 1.135 0 O-C-N 124.528 1.804 . . . . 64.52 110.981 179.996 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.408 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.53 1.008 0 N-CA-C 111.035 -0.826 . . . . 74.15 111.035 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.408 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.1 Cg_endo -75.06 136.75 46.62 Favored 'Cis proline' 0 C--N 1.36 1.14 0 C-N-CA 121.002 -2.499 . . . . 61.54 111.0 0.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.472 ' HA3' ' CD2' ' A' ' 174' ' ' LEU . . . -99.72 156.74 19.77 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.529 1.143 . . . . 63.22 110.955 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.49 ' CD2' ' CZ3' ' A' ' 192' ' ' TRP . 0.3 OUTLIER -93.12 146.45 23.65 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.455 0.738 . . . . 71.33 109.345 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.432 ' N ' ' HG ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -159.99 127.05 2.6 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.534 1.146 . . . . 73.04 109.281 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 179.83 5.7 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.479 1.779 . . . . 71.13 110.964 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.625 ' CG1' ' CE2' ' A' ' 193' ' ' PHE . 1.4 m -96.91 4.27 9.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.441 1.088 . . . . 65.04 109.314 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . 0.5 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -108.01 1.84 33.53 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.546 1.153 . . . . 73.03 111.026 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.582 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 14.1 m-85 -133.3 7.64 3.93 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.56 0.8 . . . . 65.02 111.003 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.433 HG13 ' CG2' ' A' ' 162' ' ' VAL . 4.5 m -144.32 153.69 15.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.562 1.164 . . . . 73.22 109.296 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 5.4 t -126.7 137.73 53.31 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.523 1.14 . . . . 73.22 109.978 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.458 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 3.2 mm -75.76 147.75 7.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.434 1.084 . . . . 74.34 109.286 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.458 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 4.6 pt . . . . . 0 C--N 1.325 -0.48 0 O-C-N 124.518 1.136 . . . . 74.44 109.331 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 6.5 t70 . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.285 -0.635 . . . . 70.12 109.285 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 3.7 p -44.12 -50.89 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.469 1.106 . . . . 72.44 109.319 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.472 ' O ' ' NZ ' ' A' ' 232' ' ' LYS . 5.0 mt -53.75 -47.27 62.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.505 1.128 . . . . 75.41 109.274 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.402 ' O ' ' OG ' ' A' ' 233' ' ' SER . 13.9 mt-10 -66.28 -13.86 61.11 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.5 1.125 . . . . 63.35 110.334 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -88.52 -16.47 32.57 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.517 1.135 . . . . 75.45 109.289 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.423 HG21 ' NZ ' ' A' ' 232' ' ' LYS . 0.5 OUTLIER -73.59 -69.62 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.5 1.125 . . . . 74.15 109.291 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.537 ' H ' ' NZ ' ' A' ' 232' ' ' LYS . 0.0 OUTLIER -62.23 -16.83 55.99 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.41 1.069 . . . . 74.33 109.313 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 229' ' ' GLU . 0.5 OUTLIER -51.8 -56.25 15.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.501 1.125 . . . . 72.32 109.992 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.474 ' CG2' ' HB3' ' A' ' 236' ' ' LEU . 3.7 m -88.87 14.88 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.537 1.148 . . . . 74.54 109.309 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 49.4 t30 54.96 32.42 18.0 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.546 1.154 . . . . 73.22 109.27 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.474 ' HB3' ' CG2' ' A' ' 234' ' ' VAL . 0.0 OUTLIER -82.57 118.23 71.15 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.445 1.09 . . . . 73.41 109.332 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.99 -174.09 1.81 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.508 1.794 . . . . 63.13 110.998 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' THR . . . . . 0.546 ' CG2' ' NE2' ' A' ' 240' ' ' GLN . 0.8 OUTLIER -58.78 -170.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.456 1.098 . . . . 73.44 110.461 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.468 HG22 ' CB ' ' A' ' 186' ' ' ALA . 10.8 p -79.79 -43.64 22.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.478 1.111 . . . . 72.33 109.307 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.546 ' NE2' ' CG2' ' A' ' 238' ' ' THR . 0.0 OUTLIER -87.24 -12.83 45.54 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 1.114 . . . . 62.55 110.321 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.488 ' N ' ' OE1' ' A' ' 240' ' ' GLN . 2.0 mt-10 -82.88 -37.24 24.57 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.516 1.135 . . . . 74.42 110.296 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -77.38 -59.29 2.84 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.531 1.145 . . . . 72.41 107.977 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.643 ' NZ ' ' CD2' ' B' ' 470' ' ' PHE . 26.8 mtmt -56.56 -18.66 12.54 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.571 1.169 . . . . 72.44 109.391 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 243' ' ' LYS . 1.1 t . . . . . 0 C--N 1.326 -0.452 0 O-C-N 124.501 1.126 . . . . 72.23 109.939 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 470' ' ' PHE . . . . . 0.643 ' CD2' ' NZ ' ' A' ' 243' ' ' LYS . 3.2 m-30 . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.545 0.212 . . . . 63.43 111.073 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 471' ' ' ILE . . . . . . . . . . . . . 5.2 mm -65.91 135.23 95.28 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.483 1.115 . . . . 71.3 109.267 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 472' ' ' PRO . . . . . 0.588 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.95 149.92 37.65 Favored 'Trans proline' 0 C--N 1.361 1.225 0 O-C-N 124.522 1.801 . . . . 72.01 111.012 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 23.0 t -106.15 -37.18 6.68 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.486 1.116 . . . . 73.41 110.031 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -101.27 166.11 12.93 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.419 1.074 . . . . 75.14 110.27 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.06 -167.9 0.47 Allowed 'Trans proline' 0 C--N 1.361 1.203 0 O-C-N 124.511 1.795 . . . . 73.35 110.98 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 476' ' ' ALA . . . . . . . . . . . . . . . -71.33 134.05 84.99 Favored Pre-proline 0 C--N 1.326 -0.439 0 O-C-N 124.535 1.147 . . . . 41.14 109.293 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 477' ' ' PRO . . . . . 0.522 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -75.07 -167.85 0.46 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.56 1.821 . . . . 75.32 111.032 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.08 91.82 38.2 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 124.42 1.075 . . . . 62.23 109.302 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 479' ' ' PRO . . . . . 0.582 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.3 Cg_endo -74.96 151.21 39.43 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.535 1.808 . . . . 64.41 110.973 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.36 1.153 0 O-C-N 124.523 1.802 . . . . 74.31 110.938 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.502 0.192 . . . . 74.53 111.01 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.467 ' O ' ' CD1' ' A' ' 182' ' ' LEU . . . -115.82 144.45 43.99 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.549 1.155 . . . . 63.31 109.291 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.449 HG22 ' CD2' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -129.37 132.04 66.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 124.505 1.128 . . . . 73.3 109.358 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.407 ' O ' ' CA ' ' A' ' 179' ' ' GLY . 2.1 t -91.37 122.22 42.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.445 1.09 . . . . 72.14 109.312 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.449 ' CD2' HG22 ' A' ' 161' ' ' ILE . 0.7 OUTLIER -98.26 -14.36 20.32 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.457 1.098 . . . . 70.1 109.305 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -144.54 156.54 44.2 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.503 1.127 . . . . 74.4 111.033 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.472 ' CB ' HG11 ' A' ' 178' ' ' VAL . 5.8 t70 -98.96 158.38 15.69 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.422 1.076 . . . . 54.12 109.25 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.555 ' CE2' ' HG3' ' B' ' 477' ' ' PRO . 1.4 t80 -160.26 131.06 5.59 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.56 1.162 . . . . 74.33 110.993 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.552 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 16.8 mtpp -67.21 121.26 15.26 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.445 1.091 . . . . 63.02 109.268 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.22 140.39 29.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.416 1.073 . . . . 61.43 109.293 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -150.47 21.03 0.83 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.512 1.132 . . . . 72.12 110.308 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.472 ' HD3' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -99.33 -176.22 3.23 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.511 1.132 . . . . 74.14 109.248 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.44 -29.14 67.57 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.548 1.155 . . . . 65.34 109.295 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 173' ' ' GLU . 5.6 m-20 -107.83 18.73 20.97 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.522 1.139 . . . . 75.13 109.281 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.428 ' HB3' ' N ' ' A' ' 170' ' ' LYS . 6.8 pt-20 -36.62 104.06 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.539 1.149 . . . . 74.43 110.255 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.481 ' HG ' ' CA ' ' A' ' 205' ' ' GLY . 0.8 OUTLIER -141.15 95.31 2.82 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 75.02 109.278 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.01 153.66 33.15 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.462 1.101 . . . . 74.14 110.34 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 25.4 m -155.99 102.54 2.16 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.462 1.101 . . . . 74.41 110.387 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -44.17 160.56 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 71.34 111.019 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.472 HG11 ' CB ' ' A' ' 165' ' ' ASP . 1.9 m -62.08 158.48 3.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.529 1.143 . . . . 74.34 109.289 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.407 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 49.41 62.69 4.58 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.469 1.105 . . . . 71.2 110.98 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -118.56 165.55 13.8 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.516 0.774 . . . . 71.21 110.315 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -123.4 123.4 40.58 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.486 1.116 . . . . 74.11 109.26 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.467 ' CD1' ' O ' ' A' ' 160' ' ' ALA . 0.1 OUTLIER -141.65 155.14 45.72 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.422 1.076 . . . . 74.53 109.249 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.428 ' C ' ' HB2' ' A' ' 195' ' ' ALA . 7.3 t80 -109.59 112.61 24.8 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.546 1.154 . . . . 73.51 110.999 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.565 HD11 ' CD2' ' A' ' 193' ' ' PHE . 36.8 mt -70.96 151.43 9.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.463 1.102 . . . . 73.21 109.319 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . 0.607 ' SG ' ' CH2' ' A' ' 242' ' ' TRP . 1.8 t -139.99 -43.85 0.43 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.466 1.104 . . . . 74.45 108.276 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.503 ' CB ' ' HB ' ' A' ' 194' ' ' ILE . . . -112.17 166.8 10.94 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.525 1.141 . . . . 64.31 109.316 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.521 ' C ' ' CD2' ' A' ' 188' ' ' HIS . 2.9 p80 -159.37 149.55 19.06 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.123 . . . . 73.45 109.617 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.665 ' CD2' ' CG1' ' A' ' 239' ' ' VAL . 0.0 OUTLIER -141.61 133.14 26.87 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.438 1.086 . . . . 71.22 109.651 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 190' ' ' CYS . 95.7 m-20 49.02 31.16 3.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.564 1.165 . . . . 74.53 109.313 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.442 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.0 p 38.47 34.8 0.08 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.474 1.109 . . . . 74.31 108.352 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.422 ' N ' ' C ' ' A' ' 189' ' ' ASN . 8.6 tt0 -128.49 -39.32 1.67 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.505 1.128 . . . . 74.12 110.324 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.573 ' CZ2' ' HD3' ' B' ' 477' ' ' PRO . 98.6 m95 -111.56 126.43 54.98 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.483 1.115 . . . . 75.3 108.059 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.593 ' CZ ' HG11 ' A' ' 209' ' ' VAL . 20.9 m-30 -117.99 132.17 56.41 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.526 1.141 . . . . 73.52 110.979 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.503 ' HB ' ' CB ' ' A' ' 186' ' ' ALA . 10.1 mm -96.37 103.45 14.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.385 1.053 . . . . 73.53 109.294 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.506 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . . . -111.59 174.78 5.71 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.514 1.134 . . . . 73.31 109.299 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.36 165.56 19.74 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 124.525 1.14 . . . . 74.52 109.238 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.16 0 O-C-N 124.509 1.794 . . . . 63.42 111.042 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.031 0 N-CA-C 111.002 -0.839 . . . . 60.44 111.002 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.9 143.53 78.12 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.045 -2.481 . . . . 75.31 111.024 -0.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.481 ' CA ' ' HG ' ' A' ' 174' ' ' LEU . . . -105.76 150.98 17.05 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.582 1.176 . . . . 63.11 110.962 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.568 HD12 ' CE3' ' A' ' 192' ' ' TRP . 0.1 OUTLIER -87.34 146.21 26.01 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 0.763 . . . . 72.02 109.314 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.448 ' N ' ' HG ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -153.79 122.23 3.07 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.53 1.144 . . . . 71.0 109.242 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.498 ' O ' ' CG2' ' A' ' 212' ' ' VAL . 18.5 Cg_endo -74.97 170.96 19.25 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.509 1.794 . . . . 74.03 111.015 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.593 HG11 ' CZ ' ' A' ' 193' ' ' PHE . 0.8 OUTLIER -89.75 5.2 5.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.118 . . . . 73.35 109.221 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -103.47 -12.11 31.65 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.522 1.139 . . . . 75.05 110.995 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.595 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 10.8 m-85 -124.0 -1.24 8.32 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.478 0.752 . . . . 74.11 111.054 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.498 ' CG2' ' O ' ' A' ' 208' ' ' PRO . 2.2 m -140.4 160.67 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.501 1.125 . . . . 71.3 109.294 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.8 m -128.67 147.93 50.78 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.444 1.09 . . . . 75.1 110.07 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.466 ' CD1' HD13 ' A' ' 184' ' ' ILE . 2.7 mm -94.42 141.19 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 64.54 109.235 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.546 ' CD1' ' N ' ' A' ' 215' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.446 0 O-C-N 124.514 1.133 . . . . 74.33 109.218 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 229' ' ' GLU . 19.9 t0 . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 109.276 -0.638 . . . . 70.21 109.276 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -40.27 -45.63 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.532 1.145 . . . . 73.54 109.271 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.412 ' HA ' ' CD1' ' A' ' 231' ' ' ILE . 4.5 mp -64.78 -49.03 82.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.537 1.148 . . . . 73.42 109.316 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.472 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 34.0 mt-10 -62.4 -16.67 56.16 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.445 1.091 . . . . 73.5 110.29 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -89.16 -19.11 25.89 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.476 1.11 . . . . 54.12 109.332 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.412 ' CD1' ' HA ' ' A' ' 228' ' ' ILE . 3.0 mt -72.64 -69.89 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 124.565 1.166 . . . . 73.14 109.331 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.472 ' CD ' ' HA ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -57.5 -22.74 45.92 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.508 1.13 . . . . 63.42 109.283 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.21 -56.79 7.05 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.132 . . . . 74.13 109.945 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.6 m -98.49 24.65 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.499 1.124 . . . . 73.24 109.241 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 41.29 36.73 0.53 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.515 1.134 . . . . 53.31 109.291 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 4.2 tp -60.17 119.83 45.67 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.521 1.138 . . . . 74.53 109.312 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 162.79 36.57 Favored 'Trans proline' 0 C--N 1.359 1.115 0 O-C-N 124.499 1.789 . . . . 61.5 110.967 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.7 m -68.52 173.02 5.37 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.49 1.119 . . . . 62.01 110.419 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.665 ' CG1' ' CD2' ' A' ' 188' ' ' HIS . 10.5 p -65.3 -49.95 75.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.54 1.15 . . . . 63.25 109.281 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.481 ' OE1' ' CD1' ' B' ' 471' ' ' ILE . 7.6 pm0 -68.63 -14.95 63.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 75.01 110.353 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -88.49 -39.64 14.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.552 1.157 . . . . 71.31 110.381 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.607 ' CH2' ' SG ' ' A' ' 185' ' ' CYS . 0.2 OUTLIER -80.68 -63.07 1.49 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.506 1.129 . . . . 75.12 108.015 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.485 ' HD3' ' CG2' ' A' ' 239' ' ' VAL . 14.7 mtpp -51.5 -23.26 3.84 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.479 1.112 . . . . 73.43 109.292 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.129 . . . . 71.22 109.933 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 470' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 120.523 0.201 . . . . 72.41 110.938 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 471' ' ' ILE . . . . . 0.481 ' CD1' ' OE1' ' A' ' 240' ' ' GLN . 3.3 mm -95.95 140.59 22.35 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.478 1.111 . . . . 74.35 109.279 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 472' ' ' PRO . . . . . 0.43 ' HD3' ' ND1' ' A' ' 188' ' ' HIS . 18.3 Cg_endo -75.0 -170.16 0.74 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.417 1.746 . . . . 63.04 110.965 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.97 15.9 4.23 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.478 1.111 . . . . 71.25 109.986 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 474' ' ' ARG . . . . . 0.443 ' O ' ' NE1' ' A' ' 192' ' ' TRP . 17.0 mmt180 -145.82 154.51 51.57 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.466 1.104 . . . . 72.13 110.335 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 475' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' B' ' 476' ' ' ALA . 18.2 Cg_endo -74.94 -36.07 2.82 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.538 1.809 . . . . 71.21 110.939 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 476' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' B' ' 475' ' ' PRO . . . 164.38 133.04 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.543 1.152 . . . . 64.4 109.262 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 477' ' ' PRO . . . . . 0.573 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -74.93 -171.08 0.88 Allowed 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.556 1.819 . . . . 71.21 111.044 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.72 96.65 40.32 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.546 1.154 . . . . 73.15 109.319 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 479' ' ' PRO . . . . . 0.595 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -75.0 166.67 28.7 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.386 1.729 . . . . 74.33 111.032 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.36 1.157 0 O-C-N 124.44 1.758 . . . . 63.43 111.012 -179.973 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.565 ' CE2' ' CD1' ' A' ' 215' ' ' ILE . 2.3 p90 . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.532 0.206 . . . . 72.33 110.975 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.403 ' O ' ' O ' ' A' ' 182' ' ' LEU . . . -107.38 151.84 24.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 61.14 109.288 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.45 HG23 ' CD2' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -132.16 135.05 58.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.457 1.098 . . . . 72.22 109.331 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.455 ' CG2' HG11 ' A' ' 212' ' ' VAL . 1.8 t -89.99 118.43 35.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.511 1.132 . . . . 73.54 109.337 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.45 ' CD2' HG23 ' A' ' 161' ' ' ILE . 1.4 mt -94.56 -16.92 22.85 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.422 1.076 . . . . 74.3 109.328 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -148.61 157.07 43.21 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.439 1.087 . . . . 75.15 110.925 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -88.84 154.84 19.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.527 1.142 . . . . 72.34 109.281 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.645 ' CE2' ' NZ ' ' A' ' 170' ' ' LYS . 2.4 t80 -154.4 132.13 11.47 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.435 1.084 . . . . 70.33 111.003 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.542 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 6.2 mtpm? -75.82 125.65 29.48 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.544 1.152 . . . . 73.35 109.328 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.478 ' HB2' ' CA ' ' A' ' 173' ' ' GLU . . . -114.18 133.53 55.53 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.521 1.138 . . . . 61.22 109.299 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -136.68 9.37 3.1 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.485 1.116 . . . . 71.11 110.245 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.645 ' NZ ' ' CE2' ' A' ' 166' ' ' PHE . 0.1 OUTLIER -79.07 -175.79 4.76 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.489 1.118 . . . . 74.23 109.32 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.34 -21.76 66.26 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.537 1.148 . . . . 73.33 109.267 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 173' ' ' GLU . 0.5 OUTLIER -114.05 12.64 17.99 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.451 1.094 . . . . 72.31 109.303 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.478 ' CA ' ' HB2' ' A' ' 168' ' ' ALA . 6.5 pt-20 -32.99 112.95 0.13 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.123 . . . . 73.3 110.293 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.48 ' CG ' ' HA3' ' A' ' 205' ' ' GLY . 1.5 tm? -119.92 99.4 6.6 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.555 1.159 . . . . 74.51 109.283 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 14.5 t -80.82 130.75 35.23 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.434 1.083 . . . . 75.12 110.428 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.41 ' CG2' ' HG3' ' A' ' 180' ' ' GLU . 55.6 m -155.19 155.98 34.87 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.451 1.094 . . . . 73.3 110.373 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -93.71 167.09 11.88 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.467 1.104 . . . . 73.23 110.953 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.2 m -61.39 158.5 2.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.452 1.095 . . . . 75.52 109.3 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.422 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 48.55 56.92 8.88 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.524 1.14 . . . . 60.52 111.021 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.41 ' HG3' ' CG2' ' A' ' 176' ' ' THR . 3.9 mm-40 -114.86 175.47 5.48 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.472 0.749 . . . . 64.02 110.277 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -119.15 130.59 55.62 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.125 . . . . 75.12 109.321 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.454 ' CD1' HG23 ' A' ' 207' ' ' VAL . 2.5 pt? -145.28 133.37 21.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.455 1.097 . . . . 74.41 109.361 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.439 ' C ' ' HB2' ' A' ' 195' ' ' ALA . 58.9 m-85 -100.72 107.87 19.58 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.565 1.166 . . . . 74.12 110.979 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.522 ' HA ' ' CB ' ' A' ' 195' ' ' ALA . 13.3 mt -70.66 162.55 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.458 1.099 . . . . 71.31 109.353 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . 0.476 ' N ' ' CG2' ' A' ' 184' ' ' ILE . 2.0 p -156.44 -40.85 0.08 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.463 1.102 . . . . 63.4 108.296 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.487 ' CB ' ' HB ' ' A' ' 194' ' ' ILE . . . -112.21 152.17 28.71 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.451 1.094 . . . . 71.52 109.282 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -145.26 149.45 34.91 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.476 1.11 . . . . 74.22 109.554 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.608 ' CD2' ' O ' ' A' ' 192' ' ' TRP . 0.7 OUTLIER -155.82 143.51 19.59 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 124.434 1.084 . . . . 75.21 109.545 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.456 ' C ' ' N ' ' A' ' 191' ' ' GLU . 7.4 m-20 57.02 18.04 3.75 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.548 1.155 . . . . 75.31 109.329 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 3.3 m 43.24 26.94 0.11 Allowed 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.475 1.109 . . . . 63.33 108.315 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.456 ' N ' ' C ' ' A' ' 189' ' ' ASN . 18.1 tt0 -132.93 -40.58 0.93 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.134 . . . . 71.42 110.254 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.608 ' O ' ' CD2' ' A' ' 188' ' ' HIS . 96.9 m95 -103.88 127.83 51.38 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.042 -1.095 . . . . 74.14 108.042 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.601 ' CE2' ' CG1' ' A' ' 209' ' ' VAL . 15.7 m-30 -125.09 127.73 47.35 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.536 1.147 . . . . 74.41 110.922 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.548 HG23 ' CD2' ' B' ' 470' ' ' PHE . 1.6 mp -85.56 106.42 15.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.55 1.156 . . . . 75.12 109.277 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.522 ' CB ' ' HA ' ' A' ' 184' ' ' ILE . . . -120.85 163.07 18.75 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.557 1.161 . . . . 73.14 109.313 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.36 145.05 32.45 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.551 1.157 . . . . 73.34 109.263 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--N 1.361 1.192 0 O-C-N 124.475 1.776 . . . . 73.45 111.047 179.899 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.449 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.53 0.983 0 N-CA-C 111.059 -0.816 . . . . 64.14 111.059 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.449 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.3 Cg_endo -74.93 138.27 55.09 Favored 'Cis proline' 0 C--N 1.359 1.123 0 C-N-CA 120.97 -2.512 . . . . 75.32 110.988 -0.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 195' ' ' ALA . . . -99.56 -178.96 31.04 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.432 1.082 . . . . 73.21 110.971 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.584 ' CD2' ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -93.33 148.61 21.9 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.538 0.787 . . . . 63.14 109.295 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.498 ' N ' ' HG ' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -155.52 122.95 2.78 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 74.54 109.32 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.481 ' O ' ' CG2' ' A' ' 212' ' ' VAL . 18.5 Cg_endo -74.93 174.69 12.33 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.494 1.786 . . . . 71.0 111.038 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.601 ' CG1' ' CE2' ' A' ' 193' ' ' PHE . 1.5 m -93.59 -2.69 10.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.512 1.133 . . . . 75.1 109.228 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . 0.5 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -98.46 2.73 59.2 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.482 1.114 . . . . 60.24 110.967 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.473 ' CE2' ' HB3' ' B' ' 479' ' ' PRO . 13.5 m-85 -137.9 11.31 2.88 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.471 0.747 . . . . 73.41 110.985 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 208' ' ' PRO . 3.8 m -152.97 158.77 3.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 124.471 1.107 . . . . 73.33 109.339 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.8 t -134.91 148.07 49.98 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.532 1.145 . . . . 74.34 110.054 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 13.7 mm -86.27 132.76 31.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.441 1.088 . . . . 75.04 109.28 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.565 ' CD1' ' CE2' ' A' ' 159' ' ' TYR . 24.3 pt . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.547 1.154 . . . . 73.41 109.241 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 230' ' ' ASP . 2.4 m-20 . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 109.277 -0.638 . . . . 71.13 109.277 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 1.4 p -50.86 -41.08 21.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.461 1.1 . . . . 71.3 109.265 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.505 ' O ' ' CE ' ' A' ' 232' ' ' LYS . 4.1 mp -70.27 -41.66 78.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.54 1.15 . . . . 74.02 109.332 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -69.21 -19.55 63.96 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 1.114 . . . . 63.21 110.308 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 226' ' ' ASP . 7.1 m-20 -88.73 -16.3 32.59 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.461 1.1 . . . . 75.52 109.272 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.461 ' CD1' ' HA ' ' A' ' 228' ' ' ILE . 4.4 mt -70.77 -69.36 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.463 1.102 . . . . 64.51 109.342 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.505 ' CE ' ' O ' ' A' ' 228' ' ' ILE . 0.0 OUTLIER -57.03 -25.59 58.86 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.511 1.132 . . . . 75.12 109.322 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.3 m -49.38 -55.54 12.63 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.514 1.134 . . . . 71.41 109.953 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 235' ' ' ASN . 2.0 m -93.49 26.1 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 74.21 109.32 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 234' ' ' VAL . 68.5 m-80 40.17 35.64 0.27 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 75.52 109.271 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.2 tp -66.01 119.67 63.18 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 74.03 109.316 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.01 173.73 14.01 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.537 1.809 . . . . 74.5 110.981 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.56 -170.92 0.33 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.46 1.1 . . . . 71.1 110.367 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.444 ' CG2' ' HD3' ' A' ' 243' ' ' LYS . 10.5 p -82.89 -34.74 11.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.485 1.116 . . . . 75.52 109.295 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -85.39 -20.06 30.44 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.52 1.138 . . . . 71.33 110.333 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -80.22 -36.37 34.88 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.434 1.084 . . . . 74.21 110.299 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.406 ' CE3' ' HB1' ' A' ' 186' ' ' ALA . 1.5 t90 -84.0 -56.57 3.61 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 73.42 107.972 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.444 ' HD3' ' CG2' ' A' ' 239' ' ' VAL . 18.1 mtpp -58.17 -17.69 20.49 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.524 1.14 . . . . 64.24 109.291 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 2.8 t . . . . . 0 C--N 1.324 -0.516 0 O-C-N 124.546 1.154 . . . . 74.43 109.998 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 470' ' ' PHE . . . . . 0.548 ' CD2' HG23 ' A' ' 194' ' ' ILE . 3.4 m-30 . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 120.517 0.198 . . . . 74.53 111.028 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 471' ' ' ILE . . . . . 0.4 HG21 ' N ' ' B' ' 472' ' ' PRO . 0.7 OUTLIER -72.24 143.93 86.46 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.516 1.135 . . . . 74.1 109.28 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 472' ' ' PRO . . . . . 0.568 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.5 Cg_endo -74.96 153.47 41.98 Favored 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.475 1.777 . . . . 62.13 110.989 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.02 -63.07 1.29 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.546 1.153 . . . . 63.31 109.951 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.81 172.22 6.42 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.503 1.127 . . . . 74.22 110.259 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 -169.21 0.6 Allowed 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.479 1.778 . . . . 52.41 111.002 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 476' ' ' ALA . . . . . . . . . . . . . . . -62.51 134.61 95.14 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.509 1.131 . . . . 61.34 109.285 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 477' ' ' PRO . . . . . 0.596 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -75.0 -162.5 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.579 1.831 . . . . 63.42 111.047 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.72 89.95 20.55 Favored Pre-proline 0 C--N 1.324 -0.525 0 O-C-N 124.525 1.141 . . . . 74.14 109.299 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 479' ' ' PRO . . . . . 0.5 ' CG ' ' O ' ' A' ' 210' ' ' GLY . 18.0 Cg_endo -75.03 165.02 32.15 Favored 'Trans proline' 0 C--N 1.359 1.11 0 O-C-N 124.481 1.779 . . . . 64.21 110.977 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--N 1.361 1.187 0 O-C-N 124.501 1.79 . . . . 54.33 111.005 179.998 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.792 ' CD1' ' CD1' ' A' ' 183' ' ' PHE . 34.9 m-85 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.439 0.161 . . . . 75.1 111.048 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.486 ' HB1' ' CD2' ' A' ' 182' ' ' LEU . . . -124.93 148.24 48.45 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.51 1.131 . . . . 65.1 109.233 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.451 HG21 ' CD2' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -116.01 134.63 58.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.435 1.084 . . . . 73.52 109.311 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.472 ' CG2' HD13 ' A' ' 182' ' ' LEU . 1.0 OUTLIER -91.49 122.96 43.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.531 1.144 . . . . 55.4 109.287 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.451 ' CD2' HG21 ' A' ' 161' ' ' ILE . 0.3 OUTLIER -102.55 -11.92 18.16 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.522 1.139 . . . . 73.12 109.332 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -142.51 166.41 24.75 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.477 1.111 . . . . 74.32 110.986 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.424 ' N ' HG12 ' A' ' 178' ' ' VAL . 27.6 p-10 -115.12 146.42 41.37 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.477 1.11 . . . . 72.42 109.283 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.584 ' CE2' ' NZ ' ' A' ' 170' ' ' LYS . 1.6 t80 -149.51 128.59 12.73 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.446 1.091 . . . . 71.41 111.023 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.409 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 7.1 mtpt -66.99 104.99 1.51 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.545 1.153 . . . . 73.13 109.322 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -79.61 144.26 33.98 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.462 1.101 . . . . 70.12 109.309 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -151.33 20.97 0.74 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.499 1.124 . . . . 74.41 110.333 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.584 ' NZ ' ' CE2' ' A' ' 166' ' ' PHE . 0.1 OUTLIER -95.56 -176.06 3.64 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.465 1.103 . . . . 62.14 109.337 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.62 -37.11 75.19 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.511 1.132 . . . . 62.22 109.327 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 173' ' ' GLU . 0.7 OUTLIER -106.85 23.19 14.74 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.5 1.125 . . . . 74.03 109.345 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.49 ' CD ' ' N ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -35.26 111.19 0.12 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 1.118 . . . . 74.04 110.27 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.516 ' CG ' ' HA3' ' A' ' 205' ' ' GLY . 0.7 OUTLIER -118.51 98.07 6.07 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.532 1.145 . . . . 75.15 109.284 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.412 ' O ' ' CG2' ' A' ' 175' ' ' THR . 12.3 t -83.27 112.79 20.19 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.505 1.128 . . . . 72.44 110.447 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.1 m -137.55 137.17 38.32 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.548 1.155 . . . . 74.1 110.407 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -75.94 163.77 26.85 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.509 1.13 . . . . 75.44 110.962 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.3 m -58.08 157.79 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.529 1.143 . . . . 70.43 109.327 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.7 64.16 4.48 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.405 1.066 . . . . 63.43 111.026 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.434 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 1.2 tt0 -127.84 -173.67 2.99 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.546 0.792 . . . . 75.22 110.264 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -147.27 136.59 22.59 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.528 1.142 . . . . 75.51 109.311 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.572 ' CD1' ' N ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -148.96 146.27 27.75 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 72.2 109.294 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.792 ' CD1' ' CD1' ' A' ' 159' ' ' TYR . 6.8 m-30 -95.55 121.86 37.69 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.516 1.135 . . . . 74.45 110.899 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.474 ' CD1' ' HB1' ' A' ' 160' ' ' ALA . 1.7 mp -70.75 161.93 4.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.53 1.144 . . . . 74.04 109.29 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . 0.576 ' HB3' ' CH2' ' A' ' 242' ' ' TRP . 2.2 m -146.12 -47.37 0.2 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 72.43 108.259 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.482 ' CB ' ' HB ' ' A' ' 194' ' ' ILE . . . -119.78 166.07 13.72 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.479 1.112 . . . . 65.15 109.281 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.59 134.14 11.79 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 74.31 109.603 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.559 ' CE1' ' HD3' ' B' ' 472' ' ' PRO . 0.0 OUTLIER -146.73 149.28 33.09 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.444 1.09 . . . . 62.43 109.55 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.485 ' C ' ' N ' ' A' ' 191' ' ' GLU . 40.7 m-20 61.19 15.86 6.72 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 1.136 . . . . 71.53 109.316 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 14.1 p 41.84 27.83 0.08 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.138 . . . . 74.04 108.335 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.485 ' N ' ' C ' ' A' ' 189' ' ' ASN . 8.5 tt0 -136.42 -37.5 0.69 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.489 1.118 . . . . 73.31 110.258 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.59 ' CZ2' ' HD3' ' B' ' 477' ' ' PRO . 95.7 m95 -101.82 135.91 42.57 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.008 -1.108 . . . . 74.33 108.008 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.58 ' CZ ' HG13 ' A' ' 209' ' ' VAL . 22.0 m-30 -128.66 129.33 45.68 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 75.54 111.023 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.482 ' HB ' ' CB ' ' A' ' 186' ' ' ALA . 8.8 mm -89.68 102.07 12.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.503 1.127 . . . . 73.05 109.279 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -116.15 -178.85 3.5 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.438 1.086 . . . . 72.04 109.275 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . 0.47 ' CB ' ' HA ' ' A' ' 204' ' ' PRO . 23.3 pttt -153.27 158.62 32.76 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.464 1.103 . . . . 75.41 109.295 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.413 ' CD ' ' HA3' ' A' ' 203' ' ' GLY . 18.1 Cg_endo . . . . . 0 C--N 1.359 1.131 0 O-C-N 124.481 1.779 . . . . 72.11 110.974 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.413 ' HA3' ' CD ' ' A' ' 197' ' ' PRO . . . . . . . . 0 CA--C 1.53 1.027 0 N-CA-C 110.993 -0.843 . . . . 73.13 110.993 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.47 ' HA ' ' CB ' ' A' ' 196' ' ' LYS . 18.1 Cg_endo -75.09 129.27 18.21 Favored 'Cis proline' 0 C--N 1.36 1.144 0 C-N-CA 121.015 -2.494 . . . . 61.33 110.974 0.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.516 ' HA3' ' CG ' ' A' ' 174' ' ' LEU . . . -111.96 177.91 18.95 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.529 1.143 . . . . 73.13 110.951 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.579 HD13 ' CE3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -105.45 152.22 23.27 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.482 0.754 . . . . 74.41 109.341 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.531 ' N ' ' HG ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -156.76 132.41 5.71 Favored Pre-proline 0 C--N 1.324 -0.524 0 O-C-N 124.432 1.083 . . . . 54.12 109.315 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.436 ' O ' ' CG2' ' A' ' 212' ' ' VAL . 18.3 Cg_endo -74.94 171.67 17.85 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.489 1.783 . . . . 73.32 111.037 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.58 HG13 ' CZ ' ' A' ' 193' ' ' PHE . 1.2 m -91.48 -3.92 10.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.548 1.155 . . . . 75.42 109.304 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -90.26 -26.97 22.13 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.512 1.133 . . . . 65.3 110.981 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.594 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 17.6 m-85 -105.16 4.31 31.17 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.481 0.754 . . . . 74.31 111.011 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.459 HG13 ' CG2' ' A' ' 162' ' ' VAL . 1.8 m -146.51 157.85 11.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.531 1.144 . . . . 70.01 109.311 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 4.5 t -130.39 130.55 44.5 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.515 1.135 . . . . 73.24 110.006 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.415 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 2.6 mm -73.69 133.02 32.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.423 1.077 . . . . 74.23 109.254 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 1.8 pt . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.46 1.1 . . . . 75.24 109.277 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 229' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 109.257 -0.646 . . . . 73.12 109.257 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.401 ' C ' ' O ' ' A' ' 226' ' ' ASP . 0.2 OUTLIER -39.76 -55.71 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 124.462 1.101 . . . . 75.32 109.241 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 3.9 mt -55.85 -43.62 74.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.372 1.045 . . . . 73.1 109.27 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 226' ' ' ASP . 27.3 mt-10 -70.59 -14.58 62.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.477 1.11 . . . . 73.41 110.31 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 226' ' ' ASP . 0.4 OUTLIER -86.94 -24.27 24.82 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.514 1.134 . . . . 74.42 109.296 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -61.23 -68.73 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.505 1.128 . . . . 74.11 109.297 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.418 ' CD ' ' HA ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -56.27 -26.8 53.07 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.502 1.126 . . . . 71.5 109.349 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.9 t -52.14 -47.71 65.26 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.492 1.12 . . . . 73.24 109.934 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.461 HG21 ' CB ' ' A' ' 236' ' ' LEU . 8.9 m -98.45 19.44 2.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.493 1.12 . . . . 75.42 109.317 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 41.58 32.36 0.24 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.519 1.137 . . . . 73.43 109.26 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.461 ' CB ' HG21 ' A' ' 234' ' ' VAL . 4.3 tp -68.51 119.37 67.99 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.47 1.106 . . . . 75.02 109.335 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.04 171.73 17.74 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.438 1.757 . . . . 73.54 110.968 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.7 m -71.42 165.52 23.61 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.567 1.167 . . . . 74.45 110.429 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.486 ' CG2' ' NZ ' ' A' ' 243' ' ' LYS . 7.6 p -60.84 -33.34 54.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.536 1.147 . . . . 74.23 109.287 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -82.01 -15.43 53.68 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.532 1.145 . . . . 64.14 110.304 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -87.53 -38.66 15.82 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.554 1.159 . . . . 74.41 110.273 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.576 ' CH2' ' HB3' ' A' ' 185' ' ' CYS . 0.9 OUTLIER -79.42 -60.25 2.44 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.001 -1.111 . . . . 72.4 108.001 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.486 ' NZ ' ' CG2' ' A' ' 239' ' ' VAL . 14.3 mtmm -53.34 -20.86 4.85 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.523 1.139 . . . . 74.52 109.324 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 243' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.456 0 O-C-N 124.487 1.117 . . . . 72.44 110.018 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 470' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.479 0.181 . . . . 70.53 110.996 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 471' ' ' ILE . . . . . 0.405 ' HA ' ' HD3' ' B' ' 472' ' ' PRO . 1.4 mp -65.71 138.84 96.78 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.503 1.127 . . . . 72.52 109.263 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 472' ' ' PRO . . . . . 0.559 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.1 Cg_endo -75.0 -179.34 4.89 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.529 1.805 . . . . 74.44 110.978 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 36.6 t -114.24 -61.63 1.72 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.544 1.153 . . . . 64.33 110.001 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -61.84 155.71 60.53 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.473 1.108 . . . . 75.41 110.285 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 475' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' B' ' 476' ' ' ALA . 18.3 Cg_endo -75.07 -36.24 2.63 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.484 1.781 . . . . 75.24 111.005 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 476' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' B' ' 475' ' ' PRO . . . 165.01 126.91 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.529 1.143 . . . . 72.51 109.291 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 477' ' ' PRO . . . . . 0.59 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.5 Cg_endo -74.89 -162.13 0.14 Allowed 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.49 1.784 . . . . 62.52 111.049 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 478' ' ' LYS . . . . . 0.538 ' CD ' ' O ' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -145.2 112.32 4.76 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.506 1.129 . . . . 74.53 109.261 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 479' ' ' PRO . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.1 Cg_endo -74.97 154.06 42.35 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.452 1.764 . . . . 75.32 110.998 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--N 1.359 1.111 0 O-C-N 124.527 1.804 . . . . 74.5 111.083 179.956 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' A' ' 181' ' ' ASN . 1.4 t80 . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 120.514 0.197 . . . . 74.35 110.965 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -118.23 142.36 47.55 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.461 1.101 . . . . 63.13 109.306 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.443 HG23 ' CD2' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -119.41 131.66 71.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.468 1.105 . . . . 72.31 109.292 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.466 ' CG2' HD12 ' A' ' 182' ' ' LEU . 2.0 t -93.27 120.97 43.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 74.4 109.335 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.443 ' CD2' HG23 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -99.01 -13.58 19.83 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.519 1.137 . . . . 65.15 109.351 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -144.37 156.77 44.38 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.434 1.084 . . . . 74.22 111.05 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.419 ' N ' HG13 ' A' ' 178' ' ' VAL . 9.2 p-10 -92.06 154.03 19.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.512 1.133 . . . . 74.12 109.268 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.467 ' CZ ' ' O ' ' A' ' 167' ' ' LYS . 16.7 t80 -141.64 144.27 34.07 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.486 1.116 . . . . 72.42 110.969 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.467 ' O ' ' CZ ' ' A' ' 166' ' ' PHE . 14.2 mtpp -82.81 131.22 35.2 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.542 1.151 . . . . 75.53 109.283 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.34 142.37 28.55 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 70.12 109.272 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -158.03 24.88 0.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.473 1.108 . . . . 71.34 110.354 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.514 ' O ' ' CG ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -122.27 -175.46 3.13 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.427 1.08 . . . . 71.43 109.276 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.77 -40.03 82.76 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.487 1.117 . . . . 64.11 109.302 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 174' ' ' LEU . 26.6 m-20 -86.14 10.52 14.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 75.31 109.324 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.514 ' CG ' ' O ' ' A' ' 170' ' ' LYS . 6.5 pt-20 -36.77 96.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.57 1.169 . . . . 73.31 110.341 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 172' ' ' ASP . 0.3 OUTLIER -131.73 95.42 3.71 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.128 . . . . 73.11 109.315 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.4 t -59.18 153.39 18.38 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.536 1.147 . . . . 74.34 110.367 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 22.2 m -154.53 175.29 13.8 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.501 1.126 . . . . 72.14 110.398 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -122.57 157.79 31.33 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.47 1.106 . . . . 64.24 111.02 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.419 HG13 ' N ' ' A' ' 165' ' ' ASP . 2.8 m -59.51 158.39 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.518 1.136 . . . . 74.12 109.262 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.429 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 48.07 67.83 1.45 Allowed Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.479 1.112 . . . . 54.31 111.037 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -129.13 168.38 16.21 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.478 0.752 . . . . 75.33 110.309 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.448 ' HB3' ' CE2' ' A' ' 159' ' ' TYR . 8.5 m120 -118.77 126.42 51.82 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.527 1.142 . . . . 75.3 109.225 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.562 ' CD1' ' N ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -133.58 139.98 46.87 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.558 1.162 . . . . 72.03 109.325 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 5.4 t80 -98.97 97.47 8.63 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.489 1.118 . . . . 75.41 110.998 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.472 HD12 ' CB ' ' A' ' 195' ' ' ALA . 28.0 mm -52.01 156.67 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.405 1.065 . . . . 71.43 109.281 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 186' ' ' ALA . 7.3 p -149.96 -42.49 0.13 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.459 1.099 . . . . 70.23 108.327 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.49 ' N ' ' SG ' ' A' ' 185' ' ' CYS . . . -120.72 167.89 11.99 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.564 1.165 . . . . 71.22 109.309 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.559 ' CE1' HG22 ' A' ' 231' ' ' ILE . 0.2 OUTLIER -157.35 144.21 18.28 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.101 . . . . 74.41 109.613 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.577 ' CE1' ' HD3' ' B' ' 472' ' ' PRO . 0.1 OUTLIER -144.87 139.83 27.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.537 1.148 . . . . 72.44 109.55 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.49 ' C ' ' N ' ' A' ' 191' ' ' GLU . 57.7 t30 50.37 22.41 1.01 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.479 1.112 . . . . 74.21 109.27 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 189' ' ' ASN . 4.0 m 41.47 27.7 0.06 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.452 1.095 . . . . 72.34 108.272 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.49 ' N ' ' C ' ' A' ' 189' ' ' ASN . 3.6 tt0 -124.98 -38.14 2.37 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.528 1.142 . . . . 73.3 110.275 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.576 ' CZ2' ' HD3' ' B' ' 477' ' ' PRO . 90.5 m95 -113.95 128.07 56.24 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.0 -1.111 . . . . 75.21 108.0 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.583 ' CZ ' HG11 ' A' ' 209' ' ' VAL . 21.4 m-30 -117.03 157.0 26.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.48 1.112 . . . . 73.42 110.959 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.465 ' HB ' ' CB ' ' A' ' 186' ' ' ALA . 3.6 mm -118.48 104.15 15.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.54 1.15 . . . . 73.34 109.314 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.472 ' CB ' HD12 ' A' ' 184' ' ' ILE . . . -107.55 170.37 8.02 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.472 1.107 . . . . 62.51 109.35 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . 0.403 ' CG ' ' HA ' ' A' ' 204' ' ' PRO . 4.6 mtmp? -138.9 165.16 34.41 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.547 1.154 . . . . 54.4 109.294 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.152 0 O-C-N 124.459 1.768 . . . . 62.22 111.002 179.98 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.404 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.531 1.063 0 N-CA-C 110.949 -0.861 . . . . 71.33 110.949 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.404 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.2 Cg_endo -74.95 128.18 15.87 Favored 'Cis proline' 0 C--N 1.359 1.102 0 C-N-CA 121.065 -2.473 . . . . 70.31 110.992 -0.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.401 ' N ' ' HA2' ' A' ' 203' ' ' GLY . . . -92.49 122.13 6.75 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.504 1.127 . . . . 73.22 111.042 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.56 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.1 OUTLIER -79.96 146.77 31.9 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.556 0.798 . . . . 72.35 109.321 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.488 ' CG1' HG11 ' A' ' 212' ' ' VAL . 0.4 OUTLIER -160.44 129.05 2.99 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.136 . . . . 73.54 109.282 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 191' ' ' GLU . 18.4 Cg_endo -74.99 179.94 5.59 Favored 'Trans proline' 0 C--N 1.359 1.117 0 O-C-N 124.593 1.838 . . . . 71.35 111.027 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.583 HG11 ' CZ ' ' A' ' 193' ' ' PHE . 0.8 OUTLIER -98.06 4.2 9.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.477 1.111 . . . . 73.02 109.28 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -105.38 -2.79 41.14 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.496 1.122 . . . . 73.04 110.99 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.596 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 5.6 m-85 -127.5 0.85 6.25 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.428 0.722 . . . . 74.22 110.939 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.488 HG11 ' CG1' ' A' ' 207' ' ' VAL . 1.2 m -142.53 170.25 11.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.538 1.149 . . . . 73.42 109.29 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.3 t -129.37 140.57 51.32 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.508 1.13 . . . . 72.53 109.994 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.502 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 3.7 mm -83.35 138.37 19.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.452 1.095 . . . . 54.41 109.287 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.502 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 6.5 pt . . . . . 0 C--N 1.325 -0.459 0 O-C-N 124.542 1.151 . . . . 74.34 109.242 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 230' ' ' ASP . 2.9 t0 . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.297 -0.631 . . . . 71.1 109.297 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 230' ' ' ASP . 3.0 p -44.01 -59.19 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.465 1.103 . . . . 75.24 109.329 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.503 ' O ' ' CE ' ' A' ' 232' ' ' LYS . 3.8 mt -48.95 -47.54 16.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.53 1.144 . . . . 73.42 109.319 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.415 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 9.6 mt-10 -66.28 -23.48 66.4 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.574 1.171 . . . . 72.52 110.316 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 226' ' ' ASP . 31.1 m-20 -85.27 -15.92 41.85 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.494 1.122 . . . . 75.22 109.279 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.559 HG22 ' CE1' ' A' ' 187' ' ' HIS . 0.5 OUTLIER -72.84 -68.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.524 1.14 . . . . 72.43 109.277 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.503 ' CE ' ' O ' ' A' ' 228' ' ' ILE . 0.0 OUTLIER -61.48 -20.41 63.13 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.5 1.125 . . . . 73.54 109.272 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.65 -52.98 43.6 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.514 1.134 . . . . 71.42 110.062 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.5 m -94.65 26.68 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.515 1.134 . . . . 72.43 109.313 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 40.61 37.67 0.51 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.594 1.184 . . . . 73.4 109.347 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.6 tp -72.22 119.55 75.34 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.569 1.168 . . . . 71.12 109.331 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.99 167.72 26.42 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.544 1.813 . . . . 72.12 110.959 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.29 177.95 2.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.505 1.128 . . . . 73.32 110.438 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.467 HG21 ' CB ' ' A' ' 186' ' ' ALA . 13.1 p -72.01 -54.06 17.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 71.31 109.342 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.417 ' N ' ' CG1' ' A' ' 239' ' ' VAL . 13.0 pm0 -68.37 -14.85 63.29 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.464 1.103 . . . . 72.51 110.292 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -92.25 -37.21 12.8 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.136 . . . . 73.24 110.322 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.435 ' CZ3' ' O ' ' A' ' 185' ' ' CYS . 3.3 t90 -79.24 -59.78 2.63 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.004 -1.11 . . . . 74.31 108.004 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -54.77 -20.1 7.77 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.563 1.165 . . . . 71.23 109.357 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 21.0 t . . . . . 0 C--N 1.326 -0.447 0 O-C-N 124.454 1.097 . . . . 71.23 110.017 179.986 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 470' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 . . . . . 0 N--CA 1.453 -0.325 0 CA-C-O 120.549 0.214 . . . . 72.45 111.045 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 471' ' ' ILE . . . . . 0.408 ' HA ' ' HD3' ' B' ' 472' ' ' PRO . 13.0 mm -88.85 137.96 29.68 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.466 1.104 . . . . 74.23 109.269 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 472' ' ' PRO . . . . . 0.577 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -75.0 112.15 3.49 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.431 1.753 . . . . 54.41 110.994 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 42.0 t -55.15 -44.95 75.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.506 1.129 . . . . 74.45 109.959 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 474' ' ' ARG . . . . . 0.42 ' HG3' ' N ' ' B' ' 475' ' ' PRO . 5.4 tpp180 -84.37 137.72 39.27 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.485 1.116 . . . . 74.43 110.32 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 475' ' ' PRO . . . . . 0.42 ' N ' ' HG3' ' B' ' 474' ' ' ARG . 18.4 Cg_endo -74.99 -170.07 0.73 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.433 1.754 . . . . 63.03 111.019 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 476' ' ' ALA . . . . . . . . . . . . . . . -48.3 124.63 11.46 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.561 1.163 . . . . 74.34 109.277 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 477' ' ' PRO . . . . . 0.576 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.6 Cg_endo -74.91 -162.39 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.441 1.758 . . . . 72.31 111.038 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.28 90.28 25.59 Favored Pre-proline 0 C--N 1.326 -0.436 0 O-C-N 124.488 1.118 . . . . 72.42 109.319 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 479' ' ' PRO . . . . . 0.596 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.1 Cg_endo -75.03 162.05 37.68 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.525 1.802 . . . . 74.44 110.983 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.36 1.149 0 O-C-N 124.508 1.794 . . . . 71.43 110.967 179.99 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.495 ' CD1' ' N ' ' A' ' 159' ' ' TYR . 3.7 p90 . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 120.444 0.164 . . . . 72.43 111.078 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.462 ' CB ' HD13 ' A' ' 184' ' ' ILE . . . -127.77 154.67 45.11 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.56 1.162 . . . . 73.3 109.362 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.502 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.2 OUTLIER -126.44 119.65 54.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.477 1.111 . . . . 75.11 109.333 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.455 ' CG2' HG12 ' A' ' 212' ' ' VAL . 1.0 OUTLIER -70.84 125.35 29.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.488 1.118 . . . . 74.05 109.271 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.47 ' CD2' HG23 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -104.06 -9.14 19.0 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.586 1.179 . . . . 75.51 109.311 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -145.16 172.6 12.87 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.479 1.112 . . . . 74.32 110.998 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.422 ' N ' HG13 ' A' ' 178' ' ' VAL . 0.0 OUTLIER -87.65 129.77 35.01 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.484 1.115 . . . . 61.02 109.262 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -103.02 129.74 49.89 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.457 1.098 . . . . 74.23 111.009 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.76 106.97 19.36 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.468 1.105 . . . . 73.43 109.257 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 173' ' ' GLU . . . -114.01 150.29 34.11 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.556 1.16 . . . . 74.32 109.282 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -152.12 24.9 0.64 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.471 1.107 . . . . 74.32 110.268 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.487 ' CE ' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -112.82 -172.79 2.12 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 75.42 109.325 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.25 -43.99 75.14 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.534 1.146 . . . . 71.54 109.326 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -86.26 11.47 12.03 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.48 1.112 . . . . 74.23 109.322 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.481 ' CB ' ' O ' ' A' ' 170' ' ' LYS . 11.5 tt0 -35.22 98.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.497 1.123 . . . . 71.24 110.311 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.542 ' CD2' ' CA ' ' A' ' 205' ' ' GLY . 0.4 OUTLIER -109.37 94.76 5.2 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.538 1.149 . . . . 74.51 109.249 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 12.0 t -95.05 109.56 21.59 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.521 1.138 . . . . 54.31 110.453 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 90.6 m -130.71 174.85 9.54 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.476 1.11 . . . . 64.33 110.428 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.406 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 29.1 m-85 -105.26 169.42 8.46 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.504 1.127 . . . . 73.02 110.985 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.422 HG13 ' N ' ' A' ' 165' ' ' ASP . 1.5 m -66.14 158.02 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.467 1.104 . . . . 71.2 109.305 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 58.2 66.05 3.09 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.479 1.112 . . . . 34.2 110.983 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.502 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 9.1 tp10 -131.78 157.53 43.62 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.475 0.75 . . . . 72.24 110.32 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -118.61 129.12 55.14 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.499 1.124 . . . . 74.33 109.247 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.507 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 0.5 OUTLIER -140.67 150.02 42.98 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 63.53 109.244 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.416 ' C ' ' HB1' ' A' ' 195' ' ' ALA . 5.5 m-85 -104.1 114.38 28.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.485 1.116 . . . . 75.23 111.002 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.462 HD13 ' CB ' ' A' ' 160' ' ' ALA . 1.6 mp -62.08 156.5 4.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 124.508 1.13 . . . . 75.14 109.249 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . 0.458 ' N ' ' O ' ' A' ' 194' ' ' ILE . 0.1 OUTLIER -139.8 -48.15 0.46 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.461 1.1 . . . . 72.04 108.272 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -124.85 170.28 11.22 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.492 1.12 . . . . 70.51 109.324 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.457 ' CE1' HG21 ' A' ' 231' ' ' ILE . 0.2 OUTLIER -152.93 143.82 22.93 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.524 1.14 . . . . 74.14 109.603 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.511 ' CE1' ' CB ' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -145.58 140.59 27.51 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.474 1.109 . . . . 72.42 109.622 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.491 ' C ' ' N ' ' A' ' 191' ' ' GLU . 67.3 t30 49.26 23.17 0.76 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.497 1.123 . . . . 73.11 109.368 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.411 ' C ' ' O ' ' A' ' 189' ' ' ASN . 14.5 p 41.0 28.17 0.05 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.471 1.107 . . . . 71.45 108.308 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.491 ' N ' ' C ' ' A' ' 189' ' ' ASN . 7.7 tt0 -125.38 -39.0 2.22 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.422 1.077 . . . . 55.02 110.304 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.598 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 99.1 m95 -112.68 130.9 55.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.018 -1.105 . . . . 72.45 108.018 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.607 ' CZ ' HG11 ' A' ' 209' ' ' VAL . 22.9 m-30 -121.91 142.11 50.6 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.54 1.15 . . . . 75.24 110.97 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.505 ' CD1' ' NE2' ' A' ' 188' ' ' HIS . 4.3 mm -101.19 95.98 4.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.422 1.076 . . . . 73.23 109.263 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -103.93 -177.05 3.26 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.485 1.116 . . . . 63.45 109.293 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . 0.452 ' CD ' ' HB3' ' A' ' 204' ' ' PRO . 3.9 mtmm -148.45 159.61 38.48 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.506 1.129 . . . . 73.21 109.291 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.359 1.126 0 O-C-N 124.522 1.801 . . . . 72.22 110.954 -179.974 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.48 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.531 1.048 0 N-CA-C 111.011 -0.836 . . . . 70.21 111.011 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.48 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.3 Cg_endo -75.01 131.17 23.32 Favored 'Cis proline' 0 C--N 1.359 1.122 0 C-N-CA 121.034 -2.486 . . . . 72.02 111.008 0.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.542 ' CA ' ' CD2' ' A' ' 174' ' ' LEU . . . -101.05 165.73 18.74 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.485 1.116 . . . . 62.05 111.004 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.598 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -108.7 149.78 28.5 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.487 0.757 . . . . 72.04 109.281 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.476 ' N ' ' HG ' ' A' ' 206' ' ' LEU . 0.4 OUTLIER -157.04 133.68 6.36 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.449 1.093 . . . . 75.31 109.282 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 207' ' ' VAL . 18.2 Cg_endo -75.07 169.34 22.81 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.475 1.776 . . . . 72.44 110.995 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.607 HG11 ' CZ ' ' A' ' 193' ' ' PHE . 0.6 OUTLIER -93.74 6.86 6.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.438 1.086 . . . . 65.41 109.336 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . 0.487 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -106.69 -3.6 37.09 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.442 1.089 . . . . 72.11 111.014 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.588 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 23.3 m-85 -129.03 4.99 5.33 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.462 0.742 . . . . 72.44 110.973 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.468 ' CG1' HG21 ' A' ' 207' ' ' VAL . 2.1 m -141.43 150.55 19.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.468 1.105 . . . . 75.22 109.329 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.4 t -110.73 133.29 53.46 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.524 1.14 . . . . 55.01 109.974 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.423 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 4.8 mm -77.57 135.33 26.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.43 1.081 . . . . 74.32 109.338 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.423 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.501 0 O-C-N 124.5 1.125 . . . . 71.31 109.33 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 230' ' ' ASP . 7.6 m-20 . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 109.341 -0.614 . . . . 74.21 109.341 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.448 ' O ' ' CD1' ' A' ' 231' ' ' ILE . 2.7 p -49.36 -45.55 18.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.482 1.113 . . . . 73.13 109.318 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 3.9 mp -63.53 -30.56 50.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.455 1.097 . . . . 75.31 109.271 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.413 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 7.8 mt-10 -86.14 -14.56 43.78 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.429 1.081 . . . . 72.32 110.288 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 226' ' ' ASP . 8.9 t0 -88.39 -15.75 34.71 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.479 1.112 . . . . 74.32 109.311 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.457 HG21 ' CE1' ' A' ' 187' ' ' HIS . 0.6 OUTLIER -72.4 -69.37 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.559 1.162 . . . . 72.33 109.342 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.431 ' N ' ' CG2' ' A' ' 231' ' ' ILE . 0.0 OUTLIER -57.88 -20.87 39.94 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.568 1.168 . . . . 72.14 109.281 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.6 t -48.57 -57.49 6.11 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.54 1.15 . . . . 74.34 109.955 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.9 m -93.67 21.12 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.462 1.101 . . . . 71.24 109.294 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 49.33 29.21 2.64 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.474 1.109 . . . . 75.01 109.311 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 4.4 tp -65.27 119.11 56.55 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.465 1.103 . . . . 75.42 109.34 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.92 173.03 15.18 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.461 1.769 . . . . 73.44 111.008 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.5 m -66.25 -170.66 0.09 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.58 1.175 . . . . 73.54 110.389 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.475 ' CG2' ' HD3' ' A' ' 243' ' ' LYS . 9.8 p -79.96 -35.68 16.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.624 1.202 . . . . 74.21 109.351 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -84.94 -19.14 32.64 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.569 1.168 . . . . 74.31 110.282 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -81.51 -39.17 25.12 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.493 1.121 . . . . 70.11 110.338 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -77.98 -61.25 2.06 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 73.0 107.978 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.475 ' HD3' ' CG2' ' A' ' 239' ' ' VAL . 1.6 mtpm? -59.05 -17.38 25.1 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.462 1.101 . . . . 62.3 109.302 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 243' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.457 0 O-C-N 124.576 1.173 . . . . 73.2 109.988 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 470' ' ' PHE . . . . . 0.402 ' C ' ' OD1' ' A' ' 172' ' ' ASP . 8.6 m-30 . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 120.45 0.166 . . . . 74.12 110.972 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 471' ' ' ILE . . . . . 0.569 ' CD1' ' N ' ' B' ' 471' ' ' ILE . 1.1 mp -98.55 138.14 20.74 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.546 1.154 . . . . 71.12 109.291 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 472' ' ' PRO . . . . . 0.511 ' HG3' ' CG ' ' A' ' 192' ' ' TRP . 18.2 Cg_endo -75.03 138.63 23.21 Favored 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.485 1.782 . . . . 61.43 110.955 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 21.1 t -66.11 -72.25 0.17 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.54 1.15 . . . . 62.25 109.984 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.59 157.21 88.91 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.544 1.152 . . . . 71.4 110.309 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -167.59 0.44 Allowed 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.531 1.806 . . . . 75.4 110.947 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 476' ' ' ALA . . . . . 0.45 ' CB ' ' CD ' ' A' ' 191' ' ' GLU . . . -56.49 131.11 76.8 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 64.11 109.314 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 477' ' ' PRO . . . . . 0.596 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -75.04 -162.58 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.489 1.784 . . . . 71.22 111.022 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.54 91.37 18.51 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.509 1.13 . . . . 73.43 109.321 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 479' ' ' PRO . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.2 Cg_endo -74.99 154.92 42.88 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.463 1.77 . . . . 63.24 111.051 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.154 0 O-C-N 124.459 1.768 . . . . 70.03 111.042 179.933 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.741 ' CE2' ' CZ ' ' A' ' 183' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 120.487 0.184 . . . . 75.41 111.029 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.618 ' CB ' ' CD1' ' A' ' 184' ' ' ILE . . . -103.93 148.61 25.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.567 1.167 . . . . 75.13 109.311 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.509 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.2 OUTLIER -131.28 128.84 62.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.574 1.171 . . . . 74.44 109.228 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.483 ' HB ' ' CB ' ' A' ' 180' ' ' GLU . 2.6 t -80.83 119.23 30.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.529 1.143 . . . . 72.35 109.296 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.484 HD21 ' CG2' ' A' ' 161' ' ' ILE . 0.9 OUTLIER -94.3 -15.92 24.01 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.561 1.163 . . . . 71.03 109.321 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.421 ' CG ' ' C ' ' A' ' 163' ' ' LEU . 1.0 OUTLIER -150.0 155.96 40.86 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.466 1.104 . . . . 75.54 111.002 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -86.54 157.49 19.74 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.437 1.086 . . . . 72.13 109.29 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -154.35 140.57 18.53 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.548 1.155 . . . . 71.42 110.999 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -84.19 115.02 22.21 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.436 1.085 . . . . 74.43 109.3 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.436 ' HB2' ' CA ' ' A' ' 173' ' ' GLU . . . -103.55 131.54 50.59 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.49 1.119 . . . . 64.32 109.323 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -138.63 11.36 2.71 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.469 1.106 . . . . 74.45 110.265 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.518 ' HE3' ' CH2' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -83.0 -175.92 6.08 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.513 1.133 . . . . 75.01 109.272 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -64.04 -24.64 67.78 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.507 1.13 . . . . 73.5 109.307 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.475 ' HB3' ' CB ' ' A' ' 206' ' ' LEU . 72.4 m-20 -112.89 15.69 19.68 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.557 1.16 . . . . 72.23 109.351 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.471 ' HB3' ' N ' ' A' ' 170' ' ' LYS . 2.0 pp20? -34.0 108.99 0.07 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.424 1.078 . . . . 71.01 110.244 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.491 ' CD2' ' HA3' ' A' ' 205' ' ' GLY . 0.7 OUTLIER -115.75 96.27 5.53 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.54 1.15 . . . . 64.02 109.264 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 15.2 t -82.36 133.08 35.22 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.561 1.163 . . . . 74.25 110.401 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.414 HG22 ' N ' ' A' ' 177' ' ' TYR . 0.9 OUTLIER -160.76 146.46 14.71 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.478 1.111 . . . . 73.31 110.383 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.414 ' N ' HG22 ' A' ' 176' ' ' THR . 14.1 m-85 -81.43 168.81 17.91 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.544 1.153 . . . . 63.44 111.025 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.3 m -60.88 158.19 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.509 1.131 . . . . 72.23 109.298 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 53.33 59.23 9.85 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.551 1.157 . . . . 63.41 110.957 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.509 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 1.3 tp10 -116.59 179.81 3.9 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.483 0.755 . . . . 74.2 110.328 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -132.62 139.71 47.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.525 1.14 . . . . 74.14 109.252 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.431 ' CD2' HG12 ' A' ' 207' ' ' VAL . 0.1 OUTLIER -152.17 149.36 28.67 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 75.23 109.335 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.741 ' CZ ' ' CE2' ' A' ' 159' ' ' TYR . 2.1 m-85 -109.0 111.63 23.4 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.424 1.077 . . . . 72.25 110.995 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.618 ' CD1' ' CB ' ' A' ' 160' ' ' ALA . 1.6 mp -71.0 164.15 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.133 . . . . 64.42 109.314 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . 0.51 ' N ' ' CG2' ' A' ' 184' ' ' ILE . 3.5 p -159.9 -41.5 0.05 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.524 1.14 . . . . 73.1 108.283 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.485 ' CB ' ' HB ' ' A' ' 194' ' ' ILE . . . -114.69 152.5 31.87 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.528 1.142 . . . . 75.2 109.308 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.562 ' CD2' HD23 ' A' ' 236' ' ' LEU . 0.0 OUTLIER -145.18 151.13 37.95 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.127 . . . . 74.01 109.634 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.583 ' CD2' ' O ' ' A' ' 192' ' ' TRP . 1.3 p80 -156.39 146.51 21.3 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 72.2 109.612 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.477 ' C ' ' N ' ' A' ' 191' ' ' GLU . 0.1 OUTLIER 51.18 22.43 1.32 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 74.52 109.317 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.44 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.1 p 39.06 30.01 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.49 1.119 . . . . 74.13 108.229 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.477 ' N ' ' C ' ' A' ' 189' ' ' ASN . 11.6 tt0 -134.18 -40.39 0.83 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.542 1.151 . . . . 74.32 110.361 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.619 ' CZ2' ' HD3' ' B' ' 477' ' ' PRO . 97.2 m95 -105.61 127.7 53.2 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.987 -1.116 . . . . 72.31 107.987 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.629 ' CE2' ' CG1' ' A' ' 209' ' ' VAL . 16.9 m-30 -125.14 130.08 51.46 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.387 1.054 . . . . 75.21 111.02 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.555 ' CD1' ' NE2' ' A' ' 188' ' ' HIS . 1.5 mp -88.81 110.81 21.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.51 1.132 . . . . 74.41 109.358 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -118.87 177.38 4.87 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.489 1.118 . . . . 61.24 109.322 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' A' ' 197' ' ' PRO . 4.6 tptm -124.89 140.26 35.35 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.467 1.104 . . . . 75.43 109.333 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . 0.424 ' N ' ' HG3' ' A' ' 196' ' ' LYS . 18.1 Cg_endo . . . . . 0 C--N 1.36 1.171 0 O-C-N 124.5 1.79 . . . . 74.1 110.982 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.505 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.53 0.972 0 N-CA-C 111.015 -0.834 . . . . 75.33 111.015 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.505 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.2 Cg_endo -75.01 146.15 85.87 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.039 -2.484 . . . . 64.13 111.026 0.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.491 ' HA3' ' CD2' ' A' ' 174' ' ' LEU . . . -109.36 177.64 20.23 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.525 1.141 . . . . 71.14 111.01 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.575 HD22 ' CE3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -97.97 147.2 24.73 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.463 0.743 . . . . 73.32 109.347 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.474 ' N ' ' HG ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -155.01 125.57 3.41 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 124.525 1.14 . . . . 63.4 109.315 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.438 ' O ' ' CG2' ' A' ' 212' ' ' VAL . 18.4 Cg_endo -75.02 176.77 9.48 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.529 1.805 . . . . 65.41 111.076 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.629 ' CG1' ' CE2' ' A' ' 193' ' ' PHE . 1.6 m -96.85 5.33 8.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.587 1.179 . . . . 71.21 109.332 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -108.89 6.44 32.87 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.537 1.148 . . . . 70.54 111.024 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.571 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 11.6 m-85 -139.64 12.18 2.51 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.439 0.729 . . . . 75.21 111.043 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.47 HG13 ' CG2' ' A' ' 162' ' ' VAL . 11.4 m -154.39 157.7 4.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.483 1.114 . . . . 73.31 109.317 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 22.5 t -129.62 124.17 33.07 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.494 1.121 . . . . 75.32 110.042 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 3.4 mm -78.08 149.95 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.496 1.122 . . . . 74.52 109.35 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.441 ' N ' ' O ' ' A' ' 159' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 72.14 109.251 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 229' ' ' GLU . 6.2 t0 . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 109.266 -0.642 . . . . 62.1 109.266 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.402 ' CG2' ' CE2' ' A' ' 193' ' ' PHE . 0.6 OUTLIER -44.28 -44.53 2.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.495 1.122 . . . . 75.25 109.311 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.482 ' O ' ' CE ' ' A' ' 232' ' ' LYS . 29.4 mt -58.21 -41.49 81.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 73.54 109.342 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 226' ' ' ASP . 14.6 mt-10 -69.34 -17.53 63.71 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.559 1.162 . . . . 61.34 110.351 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.94 -16.4 31.89 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.543 1.152 . . . . 74.24 109.252 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 228' ' ' ILE . 2.5 mt -71.39 -69.37 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.57 1.169 . . . . 74.24 109.279 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.482 ' CE ' ' O ' ' A' ' 228' ' ' ILE . 0.0 OUTLIER -58.97 -21.23 58.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 72.25 109.278 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.6 -56.51 13.12 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.131 . . . . 64.11 109.97 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.1 m -97.92 19.11 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.447 1.092 . . . . 74.31 109.295 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 40.82 31.47 0.12 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.458 1.099 . . . . 73.41 109.282 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.562 HD23 ' CD2' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -61.23 124.01 78.53 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 74.33 109.29 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 -179.62 5.18 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.46 1.769 . . . . 71.23 110.947 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.3 m -69.45 -173.51 0.57 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.523 1.139 . . . . 74.03 110.416 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.421 ' CG2' ' HG3' ' A' ' 240' ' ' GLN . 1.2 m -78.45 -38.05 22.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.469 1.106 . . . . 65.32 109.33 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.421 ' HG3' ' CG2' ' A' ' 239' ' ' VAL . 0.4 OUTLIER -81.51 -15.39 55.06 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.435 1.085 . . . . 73.21 110.283 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -83.89 -38.81 20.64 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.443 1.09 . . . . 74.45 110.319 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -83.73 -63.06 1.42 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.966 -1.124 . . . . 75.52 107.966 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.599 ' NZ ' ' CG ' ' B' ' 470' ' ' PHE . 13.2 mtmt -51.36 -22.49 2.95 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.571 1.169 . . . . 73.21 109.285 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.532 1.145 . . . . 71.41 110.017 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 470' ' ' PHE . . . . . 0.599 ' CG ' ' NZ ' ' A' ' 243' ' ' LYS . 5.5 m-30 . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.486 0.184 . . . . 74.4 110.968 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 471' ' ' ILE . . . . . . . . . . . . . 19.2 mm -91.83 142.38 26.51 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.486 1.116 . . . . 65.11 109.262 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 472' ' ' PRO . . . . . 0.516 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -75.07 156.65 42.71 Favored 'Trans proline' 0 C--N 1.361 1.236 0 O-C-N 124.486 1.782 . . . . 71.54 111.027 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 19.1 t -99.43 -44.15 6.29 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.513 1.133 . . . . 73.12 110.046 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -102.17 167.94 9.71 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 72.13 110.348 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.95 -168.28 0.5 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.456 1.766 . . . . 62.41 110.997 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 476' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' B' ' 477' ' ' PRO . . . -59.03 140.29 87.1 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.51 1.131 . . . . 52.22 109.307 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 477' ' ' PRO . . . . . 0.619 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -75.09 -162.12 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.545 1.813 . . . . 74.2 111.027 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.74 87.93 11.01 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.573 1.17 . . . . 73.33 109.277 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 479' ' ' PRO . . . . . 0.571 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.3 Cg_endo -75.03 169.59 22.27 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.419 1.747 . . . . 64.51 110.986 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 C--N 1.36 1.149 0 O-C-N 124.485 1.781 . . . . 61.32 111.008 179.966 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.702 ' CE2' ' CE1' ' A' ' 183' ' ' PHE . 5.6 m-30 . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.548 0.213 . . . . 73.02 110.972 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.466 ' CB ' HD21 ' A' ' 182' ' ' LEU . . . -124.31 145.63 49.29 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.489 1.118 . . . . 72.5 109.282 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.498 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -123.32 127.36 74.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.496 1.123 . . . . 72.14 109.322 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.484 ' CG2' HD13 ' A' ' 182' ' ' LEU . 1.1 t -82.57 118.03 29.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 124.512 1.132 . . . . 72.02 109.248 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.443 ' CD2' HG23 ' A' ' 161' ' ' ILE . 1.7 mt -92.32 -16.21 26.35 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.523 1.139 . . . . 74.35 109.255 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -145.94 158.51 43.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.437 1.085 . . . . 73.24 111.058 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.446 ' CB ' HG13 ' A' ' 178' ' ' VAL . 0.6 OUTLIER -96.77 159.4 14.94 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.476 1.11 . . . . 71.31 109.321 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -160.63 131.81 5.63 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.554 1.159 . . . . 72.33 111.033 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -67.34 129.33 39.55 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.463 1.102 . . . . 74.3 109.305 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.466 ' HB2' ' CA ' ' A' ' 173' ' ' GLU . . . -107.28 141.13 39.1 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.442 1.089 . . . . 74.54 109.332 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -149.7 22.38 0.9 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.539 1.149 . . . . 73.25 110.315 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.562 ' HE3' ' CZ3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -99.88 -175.91 3.1 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.43 1.081 . . . . 75.51 109.282 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.25 -28.88 67.12 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.491 1.119 . . . . 73.11 109.336 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.45 ' CB ' ' CB ' ' A' ' 206' ' ' LEU . 76.1 m-20 -108.46 20.05 19.06 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.498 1.124 . . . . 73.32 109.282 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.466 ' CA ' ' HB2' ' A' ' 168' ' ' ALA . 8.0 pt-20 -38.02 106.33 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.395 1.059 . . . . 75.3 110.304 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.472 ' CD2' ' HA3' ' A' ' 205' ' ' GLY . 4.2 tp -124.39 113.7 18.53 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.522 1.139 . . . . 73.43 109.307 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 12.1 t -89.06 111.36 22.07 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.471 1.107 . . . . 71.44 110.427 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.464 ' CG2' ' HG3' ' A' ' 180' ' ' GLU . 59.2 m -128.87 142.76 50.86 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.473 1.108 . . . . 74.52 110.401 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -83.48 162.33 20.98 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.548 1.155 . . . . 72.43 110.945 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.446 HG13 ' CB ' ' A' ' 165' ' ' ASP . 2.4 m -60.37 158.24 2.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.488 1.117 . . . . 74.13 109.245 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.4 48.22 60.58 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.555 1.159 . . . . 72.33 110.979 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.498 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 11.9 mm-40 -105.07 168.51 9.01 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 0.766 . . . . 75.45 110.32 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -128.0 117.13 21.14 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.454 1.096 . . . . 75.41 109.312 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.541 ' CD1' ' N ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -134.89 146.89 49.64 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.521 1.138 . . . . 73.23 109.294 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.702 ' CE1' ' CE2' ' A' ' 159' ' ' TYR . 9.8 m-30 -100.21 116.82 33.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.472 1.107 . . . . 74.4 111.035 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.478 HD12 ' CB ' ' A' ' 195' ' ' ALA . 14.1 mm -59.52 151.04 5.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.579 1.175 . . . . 75.11 109.359 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . 0.559 ' O ' ' CZ3' ' A' ' 242' ' ' TRP . 2.8 m -133.83 -46.53 0.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.525 1.141 . . . . 75.14 108.303 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.47 ' CB ' ' HB ' ' A' ' 194' ' ' ILE . . . -127.63 174.07 9.37 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.506 1.129 . . . . 74.33 109.348 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -157.06 141.59 16.68 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 1.114 . . . . 73.24 109.636 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.596 ' CD2' ' O ' ' A' ' 192' ' ' TRP . 0.1 OUTLIER -143.21 139.35 30.23 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.458 1.099 . . . . 74.11 109.552 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.466 ' C ' ' N ' ' A' ' 191' ' ' GLU . 27.6 t-20 50.83 22.7 1.21 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.508 1.13 . . . . 70.4 109.345 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.402 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.8 m 41.54 29.02 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.475 1.109 . . . . 72.5 108.239 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.502 ' CD ' ' CB ' ' B' ' 476' ' ' ALA . 18.2 tt0 -127.59 -38.74 1.88 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.436 1.085 . . . . 63.35 110.309 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.596 ' O ' ' CD2' ' A' ' 188' ' ' HIS . 96.3 m95 -112.21 125.19 53.88 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.519 1.137 . . . . 72.44 108.017 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.586 ' CZ ' HG12 ' A' ' 209' ' ' VAL . 19.1 m-30 -115.15 150.69 35.65 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.498 1.124 . . . . 75.13 111.028 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.474 ' O ' ' N ' ' A' ' 185' ' ' CYS . 14.8 mm -112.16 91.24 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.557 1.161 . . . . 75.32 109.327 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.478 ' CB ' HD12 ' A' ' 184' ' ' ILE . . . -94.75 -175.24 3.52 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.514 1.134 . . . . 71.31 109.35 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . 0.481 ' CG ' ' SG ' ' A' ' 185' ' ' CYS . 0.0 OUTLIER -156.42 158.19 31.36 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.556 1.16 . . . . 72.44 109.249 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.145 0 O-C-N 124.491 1.785 . . . . 65.53 110.987 -179.981 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.417 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . . . . . . 0 CA--C 1.53 0.991 0 N-CA-C 110.992 -0.843 . . . . 74.33 110.992 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.415 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.2 Cg_endo -75.03 127.29 14.17 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.024 -2.49 . . . . 72.31 110.962 0.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.472 ' HA3' ' CD2' ' A' ' 174' ' ' LEU . . . -97.65 145.75 17.95 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.573 1.17 . . . . 72.22 111.021 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.571 HD21 ' CE3' ' A' ' 192' ' ' TRP . 0.3 OUTLIER -92.32 146.65 23.53 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.562 0.801 . . . . 70.45 109.351 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.469 ' CG1' HG11 ' A' ' 212' ' ' VAL . 0.4 OUTLIER -160.31 131.02 3.67 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.522 1.139 . . . . 74.33 109.275 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.06 168.5 24.67 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.471 1.774 . . . . 62.21 110.967 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.586 HG12 ' CZ ' ' A' ' 193' ' ' PHE . 0.9 OUTLIER -89.27 2.52 6.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.479 1.112 . . . . 75.31 109.228 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -101.76 -5.96 50.28 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.557 1.16 . . . . 72.11 110.951 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.587 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 12.0 m-85 -125.22 1.0 7.82 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 0.774 . . . . 72.33 111.013 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.469 HG11 ' CG1' ' A' ' 207' ' ' VAL . 1.3 m -142.63 160.85 18.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.407 1.067 . . . . 74.52 109.346 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 3.9 m -125.25 138.34 54.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.581 1.176 . . . . 72.52 110.015 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.5 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 3.5 mm -78.77 147.34 6.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.473 1.108 . . . . 74.3 109.246 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.5 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 7.6 pt . . . . . 0 C--N 1.325 -0.488 0 O-C-N 124.442 1.089 . . . . 74.15 109.287 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.245 -0.65 . . . . 64.01 109.245 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -42.94 -48.51 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.514 1.134 . . . . 75.33 109.246 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 231' ' ' ILE . 2.6 mp -60.21 -58.12 8.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.48 1.112 . . . . 75.51 109.257 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 233' ' ' SER . 7.5 mt-10 -46.12 -26.52 0.77 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.525 1.14 . . . . 75.21 110.337 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -77.09 -37.85 53.54 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 63.44 109.261 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.499 ' N ' ' O ' ' A' ' 228' ' ' ILE . 0.6 OUTLIER -59.54 -60.26 2.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.544 1.153 . . . . 75.11 109.272 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' A' ' 228' ' ' ILE . 0.0 OUTLIER -62.65 -44.56 95.95 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.508 1.13 . . . . 72.13 109.329 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 229' ' ' GLU . 1.5 m -41.15 -60.03 1.34 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.489 1.118 . . . . 64.24 109.982 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.446 ' O ' ' CB ' ' A' ' 235' ' ' ASN . 1.5 m -73.32 -22.49 19.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.478 1.111 . . . . 74.43 109.3 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 234' ' ' VAL . 5.7 m120 79.09 28.43 0.39 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.503 1.127 . . . . 75.31 109.29 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 237' ' ' PRO . 3.4 tp -66.44 125.93 91.26 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.51 1.131 . . . . 71.22 109.287 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 236' ' ' LEU . 18.5 Cg_endo -74.94 161.08 39.52 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.43 1.753 . . . . 70.22 111.057 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.8 m -60.25 178.49 0.19 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.539 1.149 . . . . 71.41 110.329 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 14.6 p -72.59 -37.83 57.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.506 1.129 . . . . 74.22 109.287 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -79.99 -22.54 42.41 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.543 1.152 . . . . 74.23 110.268 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -82.97 -43.2 16.69 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.431 1.082 . . . . 72.44 110.306 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.559 ' CZ3' ' O ' ' A' ' 185' ' ' CYS . 9.4 t90 -70.59 -58.79 3.31 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.139 . . . . 75.01 108.002 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -56.19 -18.98 11.75 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.555 1.159 . . . . 75.22 109.292 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 C--N 1.325 -0.478 0 O-C-N 124.437 1.085 . . . . 74.2 109.993 -179.961 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 470' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.487 0.184 . . . . 73.33 111.004 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 471' ' ' ILE . . . . . 0.405 ' HA ' ' HD3' ' B' ' 472' ' ' PRO . 27.6 mm -115.36 142.33 28.55 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.494 1.122 . . . . 74.23 109.353 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 472' ' ' PRO . . . . . 0.562 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.3 Cg_endo -75.0 127.51 10.73 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.539 1.81 . . . . 74.24 111.025 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 8.5 t -75.01 -52.87 10.02 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.446 1.091 . . . . 65.45 109.985 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 474' ' ' ARG . . . . . 0.407 ' NE ' ' HA ' ' B' ' 474' ' ' ARG . 5.2 mmp_? -82.89 160.52 60.66 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 74.42 110.338 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.01 -166.54 0.35 Allowed 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.441 1.759 . . . . 71.35 111.012 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 476' ' ' ALA . . . . . 0.502 ' CB ' ' CD ' ' A' ' 191' ' ' GLU . . . -60.31 136.52 91.64 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 74.31 109.288 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 477' ' ' PRO . . . . . 0.583 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -74.92 -164.77 0.25 Allowed 'Trans proline' 0 C--N 1.359 1.105 0 O-C-N 124.507 1.793 . . . . 75.22 110.978 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 90.89 10.98 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.473 1.108 . . . . 74.02 109.326 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 479' ' ' PRO . . . . . 0.587 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.3 Cg_endo -74.99 166.15 29.83 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.519 1.8 . . . . 72.13 111.007 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.36 1.133 0 O-C-N 124.443 1.759 . . . . 72.13 110.984 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.582 ' CD1' ' N ' ' A' ' 159' ' ' TYR . 1.1 p90 . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.488 0.185 . . . . 73.51 110.982 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.472 ' HB3' ' CD1' ' A' ' 184' ' ' ILE . . . -121.92 153.77 38.03 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.565 1.166 . . . . 71.51 109.297 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.501 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.2 OUTLIER -122.51 128.52 75.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.491 1.12 . . . . 74.41 109.318 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.477 ' CG2' HD11 ' A' ' 182' ' ' LEU . 0.9 OUTLIER -84.65 122.99 38.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.501 1.126 . . . . 75.32 109.324 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.35 -13.81 20.49 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.56 1.163 . . . . 75.3 109.258 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -145.7 161.24 40.35 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.522 1.139 . . . . 75.24 111.004 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.487 ' OD1' ' CG1' ' A' ' 178' ' ' VAL . 2.5 p30 -101.01 156.78 17.21 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.435 1.084 . . . . 74.3 109.277 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.603 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 1.3 t80 -153.26 131.42 11.91 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.456 1.098 . . . . 73.31 111.0 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.603 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 8.9 mtpt -67.04 124.52 23.27 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.471 1.107 . . . . 54.1 109.267 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.456 ' HB1' ' CA ' ' A' ' 173' ' ' GLU . . . -92.98 135.87 33.77 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.566 1.166 . . . . 72.54 109.299 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.751 ' H ' ' NZ ' ' A' ' 170' ' ' LYS . 7.8 pt-20 -150.48 20.69 0.83 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.458 1.099 . . . . 74.51 110.269 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.751 ' NZ ' ' H ' ' A' ' 169' ' ' GLU . 0.1 OUTLIER -106.19 -175.57 2.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.463 1.102 . . . . 72.55 109.333 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.62 -41.03 76.4 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.417 1.073 . . . . 72.5 109.301 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 174' ' ' LEU . 72.1 m-20 -94.4 16.93 13.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.54 1.15 . . . . 51.31 109.313 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.456 ' CA ' ' HB1' ' A' ' 168' ' ' ALA . 10.5 pt-20 -36.44 97.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 72.32 110.281 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.484 ' CB ' ' HA2' ' A' ' 205' ' ' GLY . 0.0 OUTLIER -138.22 95.52 3.03 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.439 1.087 . . . . 70.12 109.339 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.2 t -59.53 153.56 19.35 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.556 1.16 . . . . 73.15 110.446 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 4.9 m -152.51 109.34 3.48 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.436 1.085 . . . . 74.23 110.425 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -52.11 159.14 0.96 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.513 1.133 . . . . 72.13 111.004 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.487 ' CG1' ' OD1' ' A' ' 165' ' ' ASP . 1.5 m -65.68 158.62 4.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.446 1.091 . . . . 74.12 109.31 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 48.41 63.12 3.91 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.479 1.112 . . . . 74.23 111.032 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.501 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 2.0 tp10 -127.99 173.13 10.3 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.526 0.78 . . . . 74.1 110.278 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -122.68 123.07 40.28 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 71.44 109.318 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.54 ' CD1' ' N ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -130.65 135.06 47.48 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.554 1.159 . . . . 75.51 109.262 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 8.3 m-30 -89.19 96.83 10.88 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.488 1.117 . . . . 73.44 110.998 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.508 ' HA ' ' HA ' ' A' ' 195' ' ' ALA . 51.5 mt -64.34 153.82 7.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 73.1 109.334 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . 0.492 ' O ' ' CD1' ' A' ' 236' ' ' LEU . 4.3 m -146.52 -44.68 0.19 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.52 1.138 . . . . 73.22 108.242 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.48 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -112.25 170.91 7.84 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.5 1.125 . . . . 73.51 109.265 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.552 ' CD2' HD21 ' A' ' 236' ' ' LEU . 2.7 p80 -156.79 165.21 36.86 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 75.14 109.687 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.671 ' CE1' ' CG1' ' A' ' 239' ' ' VAL . 0.1 OUTLIER -143.7 113.29 7.02 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.49 1.119 . . . . 65.31 109.609 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.473 ' C ' ' N ' ' A' ' 191' ' ' GLU . 88.0 m-20 50.65 41.49 25.93 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.535 1.147 . . . . 75.11 109.359 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.418 ' C ' ' O ' ' A' ' 189' ' ' ASN . 3.6 m 40.04 30.01 0.06 Allowed 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.463 1.102 . . . . 74.14 108.333 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.495 ' OE2' ' CB ' ' B' ' 476' ' ' ALA . 17.3 tt0 -118.59 -39.69 2.97 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 1.123 . . . . 74.1 110.307 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.575 ' CH2' ' HD3' ' B' ' 477' ' ' PRO . 94.9 m95 -113.14 146.58 38.98 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.532 1.145 . . . . 74.43 107.927 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.622 ' CZ ' ' CG1' ' A' ' 209' ' ' VAL . 21.5 m-30 -132.87 128.46 36.66 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.475 1.109 . . . . 73.23 110.957 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.588 ' CG1' ' NE2' ' A' ' 188' ' ' HIS . 8.5 mm -95.71 100.5 11.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.548 1.155 . . . . 74.31 109.324 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -111.82 171.31 7.57 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.5 1.125 . . . . 72.13 109.333 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -134.91 148.11 65.61 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.558 1.162 . . . . 75.34 109.254 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 C--N 1.359 1.123 0 O-C-N 124.481 1.779 . . . . 74.35 111.003 179.996 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.494 ' HA3' ' C ' ' A' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.531 1.035 0 N-CA-C 111.029 -0.828 . . . . 71.13 111.029 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.494 ' C ' ' HA3' ' A' ' 203' ' ' GLY . 18.2 Cg_endo -75.02 152.99 98.89 Favored 'Cis proline' 0 C--N 1.36 1.153 0 C-N-CA 120.999 -2.501 . . . . 71.45 111.021 -0.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 195' ' ' ALA . . . -88.07 158.79 29.51 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.434 1.084 . . . . 50.0 110.979 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.49 ' CD2' ' HD3' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -104.55 143.96 32.34 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.466 0.745 . . . . 63.15 109.274 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.485 ' CG1' HG13 ' A' ' 212' ' ' VAL . 0.3 OUTLIER -154.44 135.33 8.63 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.461 1.1 . . . . 75.22 109.296 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 174.36 12.92 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.549 1.816 . . . . 51.12 110.992 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.622 ' CG1' ' CZ ' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -93.36 7.57 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.437 1.086 . . . . 74.44 109.332 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -108.47 -6.85 30.83 Favored Glycine 0 CA--C 1.529 0.929 0 O-C-N 124.485 1.116 . . . . 52.22 111.006 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.586 ' CE1' ' HB3' ' B' ' 479' ' ' PRO . 5.8 m-85 -121.31 1.64 10.22 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.45 0.735 . . . . 71.33 111.003 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.485 HG13 ' CG1' ' A' ' 207' ' ' VAL . 1.2 m -141.7 166.32 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.552 1.158 . . . . 74.51 109.226 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.1 t -134.76 134.14 40.64 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 64.25 110.042 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 3.4 mm -65.29 138.5 23.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.53 1.144 . . . . 74.42 109.276 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.552 ' CD1' ' CE2' ' A' ' 159' ' ' TYR . 4.1 pt . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.524 1.14 . . . . 71.24 109.324 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 229' ' ' GLU . 11.7 t0 . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 109.218 -0.66 . . . . 73.54 109.218 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -43.81 -44.59 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.528 1.143 . . . . 74.54 109.265 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.447 ' HA ' ' CD1' ' A' ' 231' ' ' ILE . 6.7 mt -66.22 -39.95 85.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 73.0 109.295 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 226' ' ' ASP . 18.6 mt-10 -71.82 -18.04 62.11 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.443 1.09 . . . . 63.03 110.318 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 226' ' ' ASP . 11.3 t70 -88.79 -15.73 33.87 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.135 . . . . 71.15 109.326 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.447 ' CD1' ' HA ' ' A' ' 228' ' ' ILE . 4.7 mt -72.68 -69.59 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.518 1.136 . . . . 73.42 109.281 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.45 ' CD ' ' HA ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -53.29 -31.71 45.17 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.44 1.087 . . . . 75.52 109.33 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.5 m -41.01 -61.06 1.05 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.53 1.144 . . . . 70.42 110.001 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.486 ' O ' ' CB ' ' A' ' 235' ' ' ASN . 1.4 m -74.96 -20.46 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.491 1.119 . . . . 74.35 109.315 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 234' ' ' VAL . 16.6 t-20 80.74 29.11 0.2 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.474 1.109 . . . . 73.44 109.272 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.552 HD21 ' CD2' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -72.99 119.43 75.52 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.467 1.104 . . . . 73.34 109.31 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.93 -174.02 1.77 Allowed 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.559 1.82 . . . . 74.22 111.064 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.4 m -73.57 -179.92 3.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.443 1.089 . . . . 73.35 110.407 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.671 ' CG1' ' CE1' ' A' ' 188' ' ' HIS . 1.0 OUTLIER -69.98 -50.75 45.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.528 1.142 . . . . 73.4 109.282 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.522 ' N ' ' CG2' ' A' ' 239' ' ' VAL . 0.1 OUTLIER -69.45 -15.3 63.25 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.371 1.044 . . . . 72.22 110.305 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -89.66 -37.47 14.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.55 1.156 . . . . 73.02 110.281 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.436 ' CH2' ' HB3' ' A' ' 185' ' ' CYS . 1.2 t90 -85.54 -62.5 1.51 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.529 1.143 . . . . 73.11 108.036 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -50.67 -24.2 3.17 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.481 1.113 . . . . 74.32 109.268 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.501 0 O-C-N 124.532 1.145 . . . . 73.12 109.971 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 470' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.484 0.183 . . . . 73.12 111.008 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 471' ' ' ILE . . . . . . . . . . . . . 27.0 mm -66.63 140.2 96.32 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.152 . . . . 75.52 109.293 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 472' ' ' PRO . . . . . 0.415 ' HD3' ' ND1' ' A' ' 188' ' ' HIS . 18.3 Cg_endo -74.92 173.65 14.11 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.492 1.785 . . . . 73.54 111.013 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 81.8 p -103.56 -47.36 4.28 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.482 1.114 . . . . 72.43 109.998 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 11.5 mmp_? -92.94 159.36 35.95 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.61 1.194 . . . . 74.14 110.319 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 475' ' ' PRO . . . . . 0.4 ' O ' ' OE1' ' A' ' 191' ' ' GLU . 18.3 Cg_endo -74.99 -38.68 1.48 Allowed 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.486 1.782 . . . . 74.11 110.965 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 476' ' ' ALA . . . . . 0.495 ' CB ' ' OE2' ' A' ' 191' ' ' GLU . . . 171.2 128.39 0.06 OUTLIER Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.531 1.144 . . . . 73.42 109.319 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 477' ' ' PRO . . . . . 0.575 ' HD3' ' CH2' ' A' ' 192' ' ' TRP . 18.2 Cg_endo -75.0 -161.77 0.13 Allowed 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.457 1.767 . . . . 61.33 110.978 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 478' ' ' LYS . . . . . 0.456 ' CD ' ' N ' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -139.92 107.14 6.89 Favored Pre-proline 0 C--N 1.324 -0.529 0 O-C-N 124.497 1.123 . . . . 74.42 109.329 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 479' ' ' PRO . . . . . 0.586 ' HB3' ' CE1' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.98 162.5 37.07 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.49 1.784 . . . . 62.44 111.027 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.153 0 O-C-N 124.476 1.777 . . . . 72.14 110.932 179.998 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.598 ' CZ ' ' CD2' ' A' ' 183' ' ' PHE . 9.2 m-85 . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 120.575 0.226 . . . . 75.55 110.941 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.498 ' CB ' ' CD2' ' A' ' 182' ' ' LEU . . . -132.1 130.71 41.58 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.458 1.099 . . . . 71.31 109.252 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.46 HG23 ' CD1' ' A' ' 215' ' ' ILE . 0.1 OUTLIER -107.96 118.29 55.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.487 1.117 . . . . 64.42 109.265 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.58 ' CG1' ' CD1' ' A' ' 182' ' ' LEU . 0.6 OUTLIER -84.15 123.26 38.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 74.23 109.251 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.78 -11.61 21.69 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 74.33 109.392 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -140.89 162.19 36.03 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.541 1.15 . . . . 74.4 111.01 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.471 ' CB ' HG11 ' A' ' 178' ' ' VAL . 1.1 p30 -93.29 160.14 14.96 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.501 1.126 . . . . 74.13 109.273 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.508 ' CE1' ' HB3' ' B' ' 477' ' ' PRO . 28.3 t80 -157.2 133.27 9.58 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.458 1.099 . . . . 74.42 110.954 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -79.45 123.6 27.68 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.533 1.145 . . . . 75.25 109.287 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.68 142.08 29.14 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.453 1.096 . . . . 74.43 109.326 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -153.73 22.67 0.52 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.406 1.066 . . . . 75.45 110.253 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.565 ' NZ ' ' CH2' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -102.75 -176.35 3.07 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.571 1.169 . . . . 74.03 109.267 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.89 -28.89 67.95 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.465 1.103 . . . . 71.51 109.284 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 173' ' ' GLU . 15.2 m-20 -105.8 16.07 25.78 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.463 1.102 . . . . 73.21 109.258 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.436 ' HB3' ' N ' ' A' ' 170' ' ' LYS . 5.3 pt-20 -36.27 105.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.54 1.15 . . . . 75.23 110.326 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.494 ' HG ' ' CA ' ' A' ' 205' ' ' GLY . 0.2 OUTLIER -141.59 95.04 2.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 63.4 109.281 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.2 t -62.86 153.16 34.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 72.15 110.434 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 81.8 m -152.91 110.75 3.6 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.554 1.159 . . . . 64.45 110.37 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -53.39 156.76 2.28 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.507 1.129 . . . . 74.32 110.991 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.471 HG11 ' CB ' ' A' ' 165' ' ' ASP . 2.5 m -58.21 158.19 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.431 1.082 . . . . 71.35 109.327 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.31 72.41 0.49 Allowed Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.568 1.168 . . . . 63.32 110.957 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.513 ' CB ' HG21 ' A' ' 162' ' ' VAL . 1.2 tt0 -137.19 168.12 20.24 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.507 0.769 . . . . 75.2 110.354 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.07 124.52 26.33 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.521 1.138 . . . . 72.0 109.293 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.58 ' CD1' ' CG1' ' A' ' 162' ' ' VAL . 0.0 OUTLIER -128.58 162.47 27.21 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.582 1.176 . . . . 74.24 109.258 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.598 ' CD2' ' CZ ' ' A' ' 159' ' ' TYR . 0.9 OUTLIER -104.75 105.35 15.39 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.594 1.184 . . . . 75.02 110.972 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 195' ' ' ALA . 45.3 mm -59.05 163.81 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.599 1.187 . . . . 74.32 109.32 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 194' ' ' ILE . 5.0 m -149.08 -45.41 0.14 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.478 1.111 . . . . 73.12 108.214 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.509 ' CB ' ' HB ' ' A' ' 194' ' ' ILE . . . -123.35 169.94 10.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.418 1.074 . . . . 74.42 109.34 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.571 ' CD2' HD21 ' A' ' 236' ' ' LEU . 0.2 OUTLIER -155.15 143.95 20.7 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.444 1.09 . . . . 74.04 109.634 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.554 ' CE1' ' HD3' ' B' ' 472' ' ' PRO . 0.2 OUTLIER -145.04 138.46 26.74 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 73.23 109.593 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.488 ' C ' ' N ' ' A' ' 191' ' ' GLU . 20.2 t-20 49.84 23.46 1.04 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.534 1.146 . . . . 75.12 109.284 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.42 ' HB3' ' CD1' ' A' ' 231' ' ' ILE . 6.4 m 40.74 28.9 0.06 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.46 1.1 . . . . 73.53 108.327 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.488 ' N ' ' C ' ' A' ' 189' ' ' ASN . 12.0 tt0 -124.34 -35.19 2.81 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 124.529 1.143 . . . . 72.33 110.283 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.571 ' CZ2' ' HD3' ' B' ' 477' ' ' PRO . 95.1 m95 -118.36 133.22 56.06 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.512 1.132 . . . . 75.21 108.047 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.583 ' CZ ' HG13 ' A' ' 209' ' ' VAL . 23.1 m-30 -123.48 144.3 49.61 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.548 1.155 . . . . 74.54 111.016 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.531 ' CD1' ' NE2' ' A' ' 188' ' ' HIS . 1.2 mp -101.78 96.15 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 124.457 1.098 . . . . 75.21 109.278 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . . . -103.65 -178.81 3.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.45 1.093 . . . . 73.13 109.288 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -150.17 157.51 37.25 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 75.02 109.296 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 C--N 1.361 1.185 0 O-C-N 124.446 1.761 . . . . 75.45 110.966 179.991 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.983 0 N-CA-C 111.018 -0.833 . . . . 73.4 111.018 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.06 143.41 77.67 Favored 'Cis proline' 0 C--N 1.36 1.133 0 C-N-CA 120.954 -2.519 . . . . 75.21 110.988 0.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.494 ' CA ' ' HG ' ' A' ' 174' ' ' LEU . . . -106.0 140.71 15.25 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.481 1.113 . . . . 64.22 111.038 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.489 ' CD2' ' HD3' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -89.57 145.02 25.56 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.487 0.757 . . . . 74.14 109.303 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.412 ' N ' ' HG ' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -153.29 132.69 7.11 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.47 1.106 . . . . 75.23 109.291 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 191' ' ' GLU . 18.1 Cg_endo -75.06 176.29 10.12 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.46 1.768 . . . . 73.52 111.017 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.583 HG13 ' CZ ' ' A' ' 193' ' ' PHE . 0.8 OUTLIER -98.17 -5.11 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.494 1.121 . . . . 72.12 109.298 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' B' ' 479' ' ' PRO . . . -90.73 -14.06 58.64 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.507 1.129 . . . . 74.53 110.948 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.584 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 15.6 m-85 -122.38 12.98 10.21 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.453 0.737 . . . . 75.1 110.939 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.461 ' CG1' ' C ' ' A' ' 211' ' ' PHE . 1.0 OUTLIER -152.45 160.14 3.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.424 1.077 . . . . 75.34 109.321 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.5 t -123.91 122.82 38.97 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.52 1.138 . . . . 74.04 109.997 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.519 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 4.0 mm -62.97 104.18 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.528 1.142 . . . . 70.13 109.346 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.519 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 3.1 pt . . . . . 0 C--N 1.324 -0.519 0 O-C-N 124.497 1.123 . . . . 73.43 109.262 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 229' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 109.301 -0.629 . . . . 73.15 109.301 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.8 p -42.63 -48.59 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.483 1.114 . . . . 75.43 109.306 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.497 ' O ' ' CE ' ' A' ' 232' ' ' LYS . 2.3 mp -61.7 -40.59 87.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.466 1.103 . . . . 72.24 109.273 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 226' ' ' ASP . 19.4 mt-10 -67.99 -17.65 64.49 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.555 1.159 . . . . 54.12 110.303 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -88.84 -15.7 33.85 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.54 1.15 . . . . 75.15 109.312 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.495 HG23 ' CE1' ' A' ' 187' ' ' HIS . 1.9 mt -77.13 -69.61 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.439 1.087 . . . . 74.34 109.311 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.497 ' CE ' ' O ' ' A' ' 228' ' ' ILE . 0.0 OUTLIER -62.37 -16.29 53.68 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.587 1.179 . . . . 74.24 109.297 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.74 -21.49 2.8 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.488 1.118 . . . . 61.41 109.984 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.422 ' O ' ' CG2' ' A' ' 234' ' ' VAL . 1.0 OUTLIER -138.54 28.39 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.468 1.105 . . . . 74.32 109.275 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . 0.409 ' C ' ' O ' ' A' ' 234' ' ' VAL . 1.9 m-80 39.83 44.69 1.39 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.564 1.165 . . . . 64.22 109.275 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.571 HD21 ' CD2' ' A' ' 187' ' ' HIS . 4.1 tp -74.4 119.47 76.67 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.491 1.12 . . . . 71.3 109.317 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.06 162.29 37.23 Favored 'Trans proline' 0 C--N 1.361 1.208 0 O-C-N 124.46 1.768 . . . . 70.1 110.995 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.6 m -59.75 159.6 8.56 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.483 1.114 . . . . 74.32 110.442 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.41 HG22 ' CB ' ' A' ' 186' ' ' ALA . 6.4 p -52.5 -59.43 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.564 1.165 . . . . 75.24 109.332 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.406 ' H ' ' CG1' ' A' ' 239' ' ' VAL . 0.0 OUTLIER -65.32 -15.98 63.11 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.55 1.156 . . . . 73.22 110.291 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -80.55 -37.69 30.98 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.536 1.148 . . . . 73.22 110.329 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.77 -57.15 3.44 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.511 1.132 . . . . 73.43 108.006 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.431 ' CD ' ' CD2' ' B' ' 470' ' ' PHE . 19.6 mtpp -58.33 -18.28 26.15 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.518 1.136 . . . . 73.13 109.312 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.517 0 O-C-N 124.492 1.12 . . . . 72.23 110.017 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 470' ' ' PHE . . . . . 0.491 ' CD2' HG21 ' A' ' 194' ' ' ILE . 4.8 m-30 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 120.42 0.152 . . . . 53.31 110.98 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 471' ' ' ILE . . . . . 0.402 ' HA ' ' HD3' ' B' ' 472' ' ' PRO . 3.1 mm -67.63 140.01 94.26 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.567 1.167 . . . . 75.3 109.296 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 472' ' ' PRO . . . . . 0.554 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.97 -174.37 1.9 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.487 1.783 . . . . 74.12 110.987 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.56 14.62 4.47 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.523 1.139 . . . . 64.03 109.994 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -143.21 159.32 56.06 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.516 1.135 . . . . 75.41 110.379 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -53.22 0.1 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 O-C-N 124.551 1.817 . . . . 70.13 111.013 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 476' ' ' ALA . . . . . . . . . . . . . . . 179.19 140.73 0.28 Allowed Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.482 1.113 . . . . 73.53 109.286 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 477' ' ' PRO . . . . . 0.571 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -74.96 -162.35 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.45 1.763 . . . . 75.52 110.991 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.5 90.93 22.85 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.545 1.153 . . . . 74.32 109.289 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 479' ' ' PRO . . . . . 0.584 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.92 144.32 30.42 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.559 1.821 . . . . 73.24 110.994 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.163 0 O-C-N 124.472 1.775 . . . . 71.4 111.054 179.925 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.485 ' CD1' ' N ' ' A' ' 159' ' ' TYR . 8.7 m-85 . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.55 0.214 . . . . 72.51 110.957 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -120.53 148.81 43.36 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.475 1.109 . . . . 74.24 109.37 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.461 HG22 ' CD2' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -132.8 134.13 58.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.512 1.132 . . . . 74.23 109.31 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.436 HG22 ' CG1' ' A' ' 212' ' ' VAL . 2.3 t -92.92 120.93 43.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.427 1.079 . . . . 75.3 109.327 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.461 ' CD2' HG22 ' A' ' 161' ' ' ILE . 0.7 OUTLIER -97.76 -14.14 20.99 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.522 1.139 . . . . 71.14 109.331 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -145.48 157.72 43.96 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.419 1.074 . . . . 74.33 111.03 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.465 ' CB ' HG11 ' A' ' 178' ' ' VAL . 16.8 p-10 -97.57 158.96 15.21 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.546 1.154 . . . . 74.13 109.291 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.555 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 1.6 t80 -157.89 131.3 7.7 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 73.41 111.048 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.555 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 2.9 mmpt? -67.9 123.54 20.86 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.514 1.134 . . . . 72.05 109.376 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.63 141.24 35.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.53 1.144 . . . . 74.42 109.293 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.417 ' OE2' ' NH2' ' B' ' 474' ' ' ARG . 10.5 pt-20 -151.39 21.33 0.73 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.488 1.117 . . . . 73.44 110.254 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.431 ' N ' ' HB3' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -96.0 -176.3 3.65 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.118 . . . . 71.42 109.298 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.23 -22.5 64.85 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.462 1.101 . . . . 74.12 109.311 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 173' ' ' GLU . 1.5 m-20 -116.07 20.77 14.2 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.512 1.132 . . . . 74.43 109.334 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.431 ' HB3' ' N ' ' A' ' 170' ' ' LYS . 6.9 pt-20 -38.11 109.71 0.11 Allowed 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.464 1.103 . . . . 73.42 110.295 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.467 ' CD2' ' HA3' ' A' ' 205' ' ' GLY . 9.6 tp -121.18 106.71 11.78 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.51 1.131 . . . . 73.22 109.308 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 11.2 t -81.12 107.67 14.12 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.528 1.142 . . . . 72.52 110.405 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.402 HG23 ' N ' ' A' ' 177' ' ' TYR . 0.9 OUTLIER -129.86 142.35 50.68 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.5 1.125 . . . . 75.05 110.322 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.402 ' N ' HG23 ' A' ' 176' ' ' THR . 23.4 m-85 -86.21 167.61 14.71 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.546 1.154 . . . . 74.44 110.959 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.465 HG11 ' CB ' ' A' ' 165' ' ' ASP . 1.8 m -63.19 158.16 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.503 1.127 . . . . 72.12 109.303 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 52.76 58.33 11.73 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.526 1.141 . . . . 75.15 111.033 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -114.14 170.69 8.1 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.461 0.742 . . . . 75.14 110.281 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -126.46 121.75 33.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.512 1.133 . . . . 74.43 109.35 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.471 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 1.5 pt? -142.91 140.64 31.24 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.496 1.122 . . . . 75.24 109.317 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.434 ' C ' ' HB2' ' A' ' 195' ' ' ALA . 32.7 t80 -100.4 114.33 27.8 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.406 1.066 . . . . 74.43 111.026 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.508 HD11 ' CD2' ' A' ' 193' ' ' PHE . 19.8 mt -72.82 145.69 11.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.554 1.159 . . . . 74.42 109.288 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . 0.5 ' O ' ' CD1' ' A' ' 236' ' ' LEU . 6.0 t -135.34 -41.01 0.72 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 74.11 108.275 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.537 ' CB ' ' HB ' ' A' ' 194' ' ' ILE . . . -112.87 167.46 10.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.475 1.109 . . . . 73.42 109.361 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.648 ' CD2' ' CD2' ' A' ' 236' ' ' LEU . 0.1 OUTLIER -156.94 155.34 31.2 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.521 1.138 . . . . 61.15 109.573 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.578 ' CE1' ' HD3' ' B' ' 472' ' ' PRO . 1.3 p80 -158.31 142.09 15.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.416 1.072 . . . . 74.41 109.642 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.472 ' C ' ' N ' ' A' ' 191' ' ' GLU . 61.6 t30 53.07 22.93 2.72 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.133 . . . . 74.43 109.338 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.432 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.8 p 38.92 30.32 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 74.12 108.277 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.472 ' N ' ' C ' ' A' ' 189' ' ' ASN . 3.1 tt0 -132.62 -39.26 1.0 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.485 1.115 . . . . 75.34 110.274 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.574 ' CZ2' ' HD3' ' B' ' 477' ' ' PRO . 99.0 m95 -108.53 129.03 55.3 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.568 1.168 . . . . 74.32 108.029 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.596 ' CZ ' HG11 ' A' ' 209' ' ' VAL . 22.3 m-30 -121.05 145.27 47.96 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.44 1.087 . . . . 71.12 111.018 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.537 ' HB ' ' CB ' ' A' ' 186' ' ' ALA . 4.2 mm -103.11 101.89 12.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.472 1.108 . . . . 65.23 109.259 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . . . -112.23 168.97 9.19 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.43 1.081 . . . . 62.31 109.296 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.04 149.7 72.31 Favored Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.453 1.095 . . . . 74.21 109.268 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 C--N 1.361 1.202 0 O-C-N 124.444 1.76 . . . . 65.02 110.966 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.405 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . . . . . . 0 CA--C 1.529 0.931 0 N-CA-C 111.01 -0.836 . . . . 51.3 111.01 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.98 123.15 8.79 Favored 'Cis proline' 0 C--N 1.36 1.184 0 C-N-CA 120.993 -2.503 . . . . 64.12 111.013 -0.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 195' ' ' ALA . . . -97.05 157.16 21.02 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.452 1.095 . . . . 73.21 111.019 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.56 HD12 ' CE3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -93.65 148.51 22.04 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.536 0.786 . . . . 73.12 109.33 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.486 ' N ' ' HG ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -157.15 125.93 3.0 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.551 1.157 . . . . 71.34 109.298 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.493 ' O ' ' CG2' ' A' ' 212' ' ' VAL . 18.3 Cg_endo -74.99 173.58 14.27 Favored 'Trans proline' 0 C--N 1.359 1.085 0 O-C-N 124.501 1.79 . . . . 71.01 110.977 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.596 HG11 ' CZ ' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -94.18 6.84 6.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.522 1.139 . . . . 75.12 109.309 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . 0.441 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -106.18 -7.46 35.26 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.536 1.148 . . . . 75.54 111.038 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.596 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 10.7 m-85 -127.73 2.79 6.08 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.507 0.769 . . . . 62.43 110.981 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.493 ' CG2' ' O ' ' A' ' 208' ' ' PRO . 2.6 m -143.62 162.53 16.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 74.44 109.268 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 30.5 t -132.63 142.49 49.13 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.515 1.134 . . . . 70.53 110.02 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.462 ' CD1' HD13 ' A' ' 184' ' ' ILE . 4.2 mm -86.13 113.77 24.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.528 1.143 . . . . 74.25 109.301 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.456 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 25.8 pt . . . . . 0 C--N 1.325 -0.493 0 O-C-N 124.523 1.139 . . . . 73.41 109.334 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 230' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 109.316 -0.624 . . . . 71.25 109.316 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 1.3 p -51.88 -39.67 25.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.507 1.129 . . . . 72.34 109.257 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 11.8 mt -71.51 -39.27 70.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.446 1.091 . . . . 74.31 109.337 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -73.24 -15.74 61.42 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.423 1.077 . . . . 75.32 110.29 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 226' ' ' ASP . 6.0 m-20 -88.55 -15.73 34.43 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.542 1.151 . . . . 74.44 109.241 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.472 HG22 ' CE1' ' A' ' 187' ' ' HIS . 3.4 mt -72.04 -69.45 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.497 1.123 . . . . 75.33 109.261 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -17.07 47.56 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.459 1.1 . . . . 61.24 109.275 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.86 -30.09 60.94 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.468 1.105 . . . . 63.41 109.929 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.432 HG21 ' CB ' ' A' ' 236' ' ' LEU . 10.7 m -120.89 22.21 5.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.505 1.128 . . . . 71.2 109.312 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 45.74 26.52 0.36 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.545 1.153 . . . . 73.32 109.312 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.648 ' CD2' ' CD2' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -61.97 123.18 76.63 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.455 1.097 . . . . 72.34 109.304 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 -177.48 3.49 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.421 1.748 . . . . 74.35 110.993 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' THR . . . . . 0.462 ' HB ' ' NE2' ' A' ' 240' ' ' GLN . 2.2 m -74.7 -171.04 1.17 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 73.24 110.388 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.575 ' HB ' ' CD2' ' A' ' 188' ' ' HIS . 12.9 p -79.09 -58.32 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 124.522 1.139 . . . . 71.24 109.3 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.489 ' O ' ' CB ' ' A' ' 244' ' ' SER . 2.0 pp0? -72.18 -10.99 60.52 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.504 1.128 . . . . 75.4 110.324 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.75 -44.51 27.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.529 1.143 . . . . 75.23 110.311 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.61 ' CD1' ' C ' ' A' ' 242' ' ' TRP . 0.0 OUTLIER -87.31 -68.61 0.74 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.002 -1.111 . . . . 73.34 108.002 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.602 ' HD3' ' CD2' ' A' ' 242' ' ' TRP . 0.1 OUTLIER -40.95 -29.11 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.476 1.11 . . . . 75.21 109.342 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 240' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.452 0 O-C-N 124.525 1.14 . . . . 63.14 110.003 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 470' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 120.516 0.198 . . . . 75.24 110.977 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 471' ' ' ILE . . . . . 0.481 ' CD1' HG13 ' A' ' 239' ' ' VAL . 1.2 mm -98.1 142.36 24.46 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.464 1.102 . . . . 62.44 109.278 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 472' ' ' PRO . . . . . 0.578 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.95 170.23 20.86 Favored 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.489 1.783 . . . . 75.41 111.029 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.86 -42.41 5.85 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.573 1.171 . . . . 75.54 110.027 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 474' ' ' ARG . . . . . 0.417 ' NH2' ' OE2' ' A' ' 169' ' ' GLU . 1.1 mtt-85 -96.34 161.1 28.11 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.127 . . . . 73.21 110.298 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 475' ' ' PRO . . . . . 0.408 ' O ' ' CB ' ' B' ' 476' ' ' ALA . 18.3 Cg_endo -74.98 -34.35 3.91 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.543 1.812 . . . . 71.34 110.996 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 476' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' B' ' 475' ' ' PRO . . . 169.72 134.62 0.06 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.545 1.153 . . . . 74.32 109.315 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 477' ' ' PRO . . . . . 0.574 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.2 Cg_endo -74.95 -162.92 0.16 Allowed 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.513 1.796 . . . . 73.31 111.052 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 478' ' ' LYS . . . . . 0.433 ' CD ' ' O ' ' B' ' 478' ' ' LYS . 0.1 OUTLIER -133.84 91.8 24.11 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.432 1.082 . . . . 75.22 109.275 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 479' ' ' PRO . . . . . 0.596 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.1 Cg_endo -75.01 162.49 37.01 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.449 1.763 . . . . 72.05 110.986 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.361 1.185 0 O-C-N 124.41 1.742 . . . . 74.32 111.004 179.995 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.569 ' CE2' HD12 ' A' ' 215' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.498 0.19 . . . . 71.24 110.997 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.529 ' O ' ' CE1' ' A' ' 159' ' ' TYR . . . -108.93 145.09 35.99 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.495 1.122 . . . . 55.11 109.26 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.502 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.2 OUTLIER -130.61 135.8 59.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.456 1.097 . . . . 72.45 109.279 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' A' ' 177' ' ' TYR . 2.6 t -93.03 135.39 27.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 124.475 1.11 . . . . 74.42 109.341 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.543 HD13 ' CE1' ' A' ' 164' ' ' TYR . 0.1 OUTLIER -115.25 -8.34 12.33 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.479 1.112 . . . . 72.12 109.267 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . 0.543 ' CE1' HD13 ' A' ' 163' ' ' LEU . 0.3 OUTLIER -146.98 151.96 37.84 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.486 1.116 . . . . 64.1 110.931 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.422 ' N ' HG12 ' A' ' 178' ' ' VAL . 1.7 p-10 -111.17 154.72 23.96 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.514 1.134 . . . . 73.14 109.291 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.58 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 0.6 OUTLIER -160.89 168.63 24.26 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.416 1.072 . . . . 70.44 110.989 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -92.93 133.98 35.56 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.415 1.072 . . . . 75.4 109.302 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.448 ' HB1' ' CA ' ' A' ' 173' ' ' GLU . . . -106.0 150.96 25.22 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.543 1.152 . . . . 70.03 109.329 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -155.03 27.45 0.42 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.544 1.153 . . . . 73.14 110.275 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.429 ' N ' ' HB3' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -101.49 -176.61 3.19 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.443 1.089 . . . . 75.02 109.273 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.98 -31.01 66.49 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.481 1.113 . . . . 73.45 109.237 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 173' ' ' GLU . 20.1 m-20 -111.47 23.06 14.4 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.48 1.113 . . . . 73.12 109.328 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.497 ' CD ' ' N ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -36.48 112.07 0.17 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.55 1.156 . . . . 62.43 110.241 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.478 ' CD2' ' HA3' ' A' ' 205' ' ' GLY . 0.4 OUTLIER -132.83 118.99 19.65 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.515 1.134 . . . . 75.12 109.28 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 175' ' ' THR . 10.6 t -86.45 108.46 18.52 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.487 1.117 . . . . 74.13 110.425 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.412 HG23 ' N ' ' A' ' 177' ' ' TYR . 1.2 t -102.07 178.86 4.49 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 72.32 110.416 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.481 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 2.6 m-85 -131.88 154.54 49.09 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 74.14 111.061 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.7 m -55.82 154.72 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.538 1.149 . . . . 73.15 109.302 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 40.51 72.2 0.25 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.48 1.113 . . . . 63.11 110.989 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.502 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 7.4 tt0 -131.03 167.25 19.37 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.514 0.773 . . . . 65.24 110.31 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.42 ' ND2' ' OH ' ' A' ' 159' ' ' TYR . 1.3 m-80 -113.89 139.4 49.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.532 1.145 . . . . 72.23 109.305 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.488 ' CD1' HG21 ' A' ' 207' ' ' VAL . 0.6 OUTLIER -154.11 148.44 26.02 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.499 1.125 . . . . 72.13 109.288 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 25.2 t80 -106.37 105.95 16.22 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 75.12 110.961 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.457 ' CA ' ' HB1' ' A' ' 195' ' ' ALA . 73.9 mt -83.95 120.23 34.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.502 1.126 . . . . 74.14 109.308 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . 0.605 ' SG ' ' CH2' ' A' ' 242' ' ' TRP . 33.4 t -124.7 -8.75 7.33 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.483 1.115 . . . . 71.24 108.278 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.514 ' HB3' ' CE3' ' A' ' 242' ' ' TRP . . . -129.78 150.02 51.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.429 1.081 . . . . 73.31 109.327 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.62 148.3 26.33 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.524 1.14 . . . . 74.04 109.53 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.589 ' CE1' ' HD3' ' B' ' 472' ' ' PRO . 2.4 p80 -152.5 144.81 23.97 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.497 1.123 . . . . 74.13 109.591 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.471 ' C ' ' N ' ' A' ' 191' ' ' GLU . 51.5 t-20 53.5 20.01 1.91 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.562 1.164 . . . . 73.22 109.278 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.411 ' C ' ' O ' ' A' ' 189' ' ' ASN . 15.9 p 41.02 27.53 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.461 1.101 . . . . 65.35 108.272 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.471 ' N ' ' C ' ' A' ' 189' ' ' ASN . 8.0 tt0 -129.81 -40.71 1.35 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.497 1.123 . . . . 73.24 110.321 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.591 ' CZ2' ' HD3' ' B' ' 477' ' ' PRO . 99.8 m95 -107.9 126.16 52.34 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.57 1.169 . . . . 74.23 107.971 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.604 ' CZ ' HG12 ' A' ' 209' ' ' VAL . 22.3 m-30 -119.43 134.61 55.13 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 1.122 . . . . 73.53 110.993 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.51 ' CD1' ' NE2' ' A' ' 188' ' ' HIS . 1.0 OUTLIER -100.07 110.9 28.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.567 1.167 . . . . 75.42 109.236 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.457 ' HB1' ' CA ' ' A' ' 184' ' ' ILE . . . -117.01 174.3 6.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.46 1.1 . . . . 72.13 109.237 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.76 139.15 34.13 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.459 1.099 . . . . 75.12 109.324 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.359 1.089 0 O-C-N 124.527 1.804 . . . . 73.23 110.97 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.454 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.529 0.944 0 N-CA-C 110.99 -0.844 . . . . 53.22 110.99 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.454 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.2 Cg_endo -75.03 147.42 89.19 Favored 'Cis proline' 0 C--N 1.36 1.141 0 C-N-CA 121.042 -2.482 . . . . 54.51 110.927 0.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.478 ' HA3' ' CD2' ' A' ' 174' ' ' LEU . . . -103.89 156.87 17.47 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.47 1.106 . . . . 72.34 111.048 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.571 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -94.68 146.16 24.35 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.489 0.758 . . . . 74.42 109.306 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.488 HG21 ' CD1' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -157.79 129.67 4.03 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.53 1.144 . . . . 75.13 109.195 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.468 ' O ' ' CG2' ' A' ' 212' ' ' VAL . 18.2 Cg_endo -75.1 175.93 10.6 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.48 1.779 . . . . 74.04 111.008 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.604 HG12 ' CZ ' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -93.41 4.65 7.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.428 1.08 . . . . 73.01 109.277 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -103.78 -13.06 28.63 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.418 1.074 . . . . 72.42 110.975 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.599 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 11.5 m-85 -119.43 -1.21 10.76 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.486 0.756 . . . . 75.35 110.98 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' A' ' 208' ' ' PRO . 2.6 m -141.06 160.43 23.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.487 1.117 . . . . 72.41 109.274 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.32 144.3 51.11 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.535 1.147 . . . . 75.32 110.036 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.469 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 2.7 mm -88.46 145.62 7.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 75.24 109.342 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.569 HD12 ' CE2' ' A' ' 159' ' ' TYR . 4.1 pt . . . . . 0 C--N 1.325 -0.499 0 O-C-N 124.45 1.093 . . . . 72.23 109.343 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 230' ' ' ASP . 8.8 t0 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.304 -0.628 . . . . 73.22 109.304 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.411 ' C ' ' O ' ' A' ' 226' ' ' ASP . 0.2 OUTLIER -38.59 -58.44 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.129 . . . . 71.43 109.286 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 3.2 mp -54.48 -45.51 70.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.518 1.136 . . . . 74.34 109.348 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 226' ' ' ASP . 18.5 mt-10 -67.16 -15.0 63.44 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 74.31 110.344 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 226' ' ' ASP . 5.5 t70 -88.61 -18.92 27.02 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.539 1.149 . . . . 64.43 109.302 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.457 ' CG2' ' N ' ' A' ' 232' ' ' LYS . 0.5 OUTLIER -69.44 -69.42 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.505 1.128 . . . . 75.15 109.27 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.457 ' N ' ' CG2' ' A' ' 231' ' ' ILE . 0.0 OUTLIER -59.89 -23.83 63.79 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.52 1.138 . . . . 75.32 109.329 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.86 -59.7 3.36 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.522 1.139 . . . . 71.0 110.023 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.2 m -98.96 24.31 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.107 . . . . 74.21 109.271 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 5.6 t30 46.07 41.69 8.7 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.445 1.091 . . . . 73.41 109.276 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 33.2 tp -55.54 123.98 53.47 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 124.511 1.132 . . . . 73.03 109.334 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 153.37 41.76 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.565 1.824 . . . . 71.11 111.002 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' THR . . . . . 0.457 ' CG2' ' NE2' ' A' ' 240' ' ' GLN . 0.5 OUTLIER -61.42 -170.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.581 1.176 . . . . 62.23 110.438 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 240' ' ' GLN . 12.3 p -80.27 -48.64 19.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.535 1.147 . . . . 75.53 109.354 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.489 ' OE1' ' N ' ' A' ' 241' ' ' GLU . 0.1 OUTLIER -87.43 -12.81 45.03 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.526 1.141 . . . . 72.2 110.281 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.489 ' N ' ' OE1' ' A' ' 240' ' ' GLN . 8.5 mt-10 -76.68 -36.27 57.39 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.562 1.164 . . . . 73.24 110.303 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.605 ' CH2' ' SG ' ' A' ' 185' ' ' CYS . 0.1 OUTLIER -87.01 -60.17 2.05 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.13 . . . . 64.11 108.012 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.646 ' NZ ' ' CD2' ' B' ' 470' ' ' PHE . 7.6 mtpt -53.19 -20.78 4.3 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.506 1.129 . . . . 75.15 109.328 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 243' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.481 1.113 . . . . 73.32 110.034 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 470' ' ' PHE . . . . . 0.646 ' CD2' ' NZ ' ' A' ' 243' ' ' LYS . 5.9 m-30 . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 120.521 0.2 . . . . 74.11 111.012 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 471' ' ' ILE . . . . . 0.547 ' CD1' ' N ' ' B' ' 471' ' ' ILE . 1.1 mm -71.31 135.67 84.36 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.482 1.114 . . . . 75.23 109.348 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 472' ' ' PRO . . . . . 0.589 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.94 170.97 19.22 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.504 1.792 . . . . 64.42 111.024 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 2.7 t -116.78 -8.86 11.33 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.455 1.097 . . . . 43.54 109.999 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -122.49 164.37 26.73 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.472 1.107 . . . . 71.0 110.294 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 475' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' B' ' 476' ' ' ALA . 18.2 Cg_endo -75.03 -38.54 1.53 Allowed 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.49 1.784 . . . . 63.55 110.97 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 476' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' B' ' 475' ' ' PRO . . . 162.73 139.66 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.484 1.115 . . . . 75.15 109.274 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 477' ' ' PRO . . . . . 0.591 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -74.94 -161.37 0.12 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.494 1.786 . . . . 65.43 110.999 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 478' ' ' LYS . . . . . 0.472 ' CD ' ' N ' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -140.51 103.41 6.51 Favored Pre-proline 0 C--N 1.324 -0.52 0 O-C-N 124.59 1.181 . . . . 61.12 109.364 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 479' ' ' PRO . . . . . 0.599 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.5 Cg_endo -74.92 166.08 30.01 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.497 1.788 . . . . 61.23 110.998 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.36 1.178 0 O-C-N 124.417 1.746 . . . . 65.53 110.985 179.992 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.545 0.212 . . . . 75.23 111.042 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.525 ' CB ' ' CD2' ' A' ' 182' ' ' LEU . . . -110.31 144.66 38.7 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.438 1.086 . . . . 73.42 109.303 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.507 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -123.99 123.84 67.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.545 1.153 . . . . 73.21 109.299 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.419 ' CG2' HD13 ' A' ' 182' ' ' LEU . 1.8 t -79.7 122.26 34.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.507 1.129 . . . . 73.41 109.364 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.46 ' CD2' HG23 ' A' ' 161' ' ' ILE . 0.7 OUTLIER -97.48 -14.83 20.89 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.551 1.157 . . . . 74.33 109.305 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -145.14 160.65 41.11 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.564 1.165 . . . . 70.41 111.067 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.46 ' CB ' HG11 ' A' ' 178' ' ' VAL . 8.5 p30 -97.99 157.03 16.35 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.401 1.063 . . . . 73.03 109.362 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -150.12 135.64 18.22 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.532 1.145 . . . . 72.14 110.979 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -75.86 126.06 30.28 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.491 1.119 . . . . 72.23 109.302 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.468 ' HB3' ' CA ' ' A' ' 173' ' ' GLU . . . -88.99 153.29 21.14 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.452 1.095 . . . . 72.22 109.295 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -166.31 29.41 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 63.42 110.293 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.623 ' NZ ' ' H ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -129.5 -176.08 3.78 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.483 1.115 . . . . 74.23 109.293 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.12 -40.93 78.07 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 60.23 109.318 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 174' ' ' LEU . 30.7 m-20 -88.67 16.99 5.89 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.457 1.098 . . . . 73.21 109.272 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.468 ' CA ' ' HB3' ' A' ' 168' ' ' ALA . 4.6 pt-20 -38.14 95.76 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.449 1.093 . . . . 63.0 110.309 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.623 ' H ' ' NZ ' ' A' ' 170' ' ' LYS . 5.7 tp -118.4 107.81 14.29 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.482 1.114 . . . . 72.24 109.29 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 12.7 t -87.36 115.9 25.09 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.479 1.112 . . . . 71.43 110.357 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 6.9 m -134.74 154.8 51.42 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.536 1.148 . . . . 70.13 110.402 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -94.35 167.54 11.46 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.453 1.096 . . . . 74.45 110.962 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.46 HG11 ' CB ' ' A' ' 165' ' ' ASP . 1.6 m -66.96 158.26 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 124.488 1.117 . . . . 72.21 109.316 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 57.11 50.42 64.51 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.479 1.112 . . . . 70.12 111.077 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.507 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -110.26 174.15 6.0 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.498 0.764 . . . . 74.44 110.289 -179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.495 ' N ' ' ND2' ' A' ' 181' ' ' ASN . 0.0 OUTLIER -137.36 117.45 13.42 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.527 1.142 . . . . 72.24 109.264 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.525 ' CD2' ' CB ' ' A' ' 160' ' ' ALA . 0.0 OUTLIER -129.99 154.88 46.95 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.453 1.096 . . . . 73.53 109.358 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.577 ' CE1' ' O ' ' A' ' 184' ' ' ILE . 1.0 OUTLIER -104.24 115.16 29.91 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.423 1.077 . . . . 74.34 110.982 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.577 ' O ' ' CE1' ' A' ' 183' ' ' PHE . 27.5 mm -65.32 160.59 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.493 1.121 . . . . 71.32 109.303 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . 0.439 ' HB3' ' CH2' ' A' ' 242' ' ' TRP . 37.0 m -150.99 -44.88 0.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.538 1.149 . . . . 74.14 108.27 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.488 ' CB ' ' HB ' ' A' ' 194' ' ' ILE . . . -120.71 165.75 14.66 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.5 1.125 . . . . 73.42 109.274 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.489 ' CE1' HG23 ' A' ' 231' ' ' ILE . 0.3 OUTLIER -152.97 146.22 24.77 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.522 1.139 . . . . 73.42 109.617 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.614 ' CE1' ' CB ' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -146.07 137.87 25.01 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.492 1.12 . . . . 73.44 109.625 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.479 ' C ' ' N ' ' A' ' 191' ' ' GLU . 24.5 t-20 50.17 25.58 1.82 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.531 1.144 . . . . 74.4 109.271 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . 0.439 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.9 p 38.93 30.9 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.451 1.094 . . . . 70.51 108.248 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.5 ' CD ' ' CB ' ' B' ' 476' ' ' ALA . 20.5 tt0 -127.36 -39.58 1.86 Allowed 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.495 1.122 . . . . 75.44 110.269 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' TRP . . . . . 0.614 ' CB ' ' CE1' ' A' ' 188' ' ' HIS . 97.0 m95 -113.79 131.9 56.06 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.518 1.136 . . . . 74.45 108.023 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.578 ' CZ ' HG11 ' A' ' 209' ' ' VAL . 23.3 m-30 -121.94 144.0 49.12 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.471 1.107 . . . . 75.53 111.02 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.488 ' HB ' ' CB ' ' A' ' 186' ' ' ALA . 0.8 OUTLIER -103.28 96.86 4.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.544 1.153 . . . . 75.25 109.341 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.465 ' CB ' HD12 ' A' ' 184' ' ' ILE . . . -99.64 -176.38 3.26 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.433 1.083 . . . . 52.33 109.224 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . 0.453 ' CG ' ' C ' ' A' ' 195' ' ' ALA . 7.3 mtmt -151.19 160.21 32.33 Favored Pre-proline 0 C--N 1.326 -0.43 0 O-C-N 124.549 1.156 . . . . 72.53 109.262 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 C--N 1.361 1.209 0 O-C-N 124.491 1.785 . . . . 75.32 111.002 179.961 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.426 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . . . . . . 0 CA--C 1.53 1.0 0 N-CA-C 111.087 -0.805 . . . . 61.34 111.087 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' PRO . . . . . 0.425 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.3 Cg_endo -75.07 127.63 14.85 Favored 'Cis proline' 0 C--N 1.359 1.118 0 C-N-CA 121.04 -2.483 . . . . 61.45 110.967 0.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.498 ' HA3' ' CD2' ' A' ' 174' ' ' LEU . . . -95.42 152.27 20.32 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.471 1.107 . . . . 72.31 110.934 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.45 ' CB ' ' HB3' ' A' ' 172' ' ' ASP . 0.1 OUTLIER -99.49 145.96 26.9 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 0.75 . . . . 73.32 109.312 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.44 ' N ' ' HG ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -159.75 127.84 2.86 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.54 1.15 . . . . 74.12 109.279 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.503 ' O ' ' CG2' ' A' ' 212' ' ' VAL . 18.3 Cg_endo -74.99 176.81 9.42 Favored 'Trans proline' 0 C--N 1.361 1.206 0 O-C-N 124.507 1.793 . . . . 71.4 110.946 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.578 HG11 ' CZ ' ' A' ' 193' ' ' PHE . 0.6 OUTLIER -97.09 5.14 9.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.41 1.069 . . . . 75.15 109.316 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -103.31 -12.22 31.72 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.518 1.136 . . . . 54.21 111.037 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.592 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 10.7 m-85 -123.02 3.28 9.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.473 0.749 . . . . 74.32 110.996 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.503 ' CG2' ' O ' ' A' ' 208' ' ' PRO . 1.9 m -140.35 154.26 22.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.49 1.119 . . . . 70.5 109.273 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 5.6 t -120.37 124.51 45.71 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.485 1.116 . . . . 72.24 110.013 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.458 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 2.7 mm -77.49 139.2 19.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.493 1.121 . . . . 74.22 109.294 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . 0.458 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 3.5 pt . . . . . 0 C--N 1.325 -0.473 0 O-C-N 124.421 1.076 . . . . 74.43 109.276 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.261 -0.644 . . . . 73.13 109.261 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -41.07 -52.61 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.455 1.097 . . . . 72.14 109.335 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.502 ' O ' ' HD3' ' A' ' 232' ' ' LYS . 4.3 mp -56.94 -58.91 3.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 O-C-N 124.519 1.137 . . . . 74.44 109.298 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -46.62 -29.16 1.71 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.547 1.155 . . . . 61.5 110.331 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -73.28 -37.19 66.35 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.54 1.15 . . . . 63.43 109.32 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.49 ' N ' ' O ' ' A' ' 228' ' ' ILE . 0.6 OUTLIER -62.26 -69.33 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.484 1.115 . . . . 74.02 109.295 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.502 ' HD3' ' O ' ' A' ' 228' ' ' ILE . 0.0 OUTLIER -51.42 -31.88 24.46 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.487 1.117 . . . . 74.33 109.288 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.03 -60.72 2.79 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.517 1.136 . . . . 75.33 109.936 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.2 m -92.03 15.39 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.549 1.155 . . . . 62.32 109.282 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 42.8 t30 40.43 36.35 0.35 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.477 1.11 . . . . 74.01 109.264 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.48 HD23 ' CD2' ' A' ' 187' ' ' HIS . 4.0 tp -49.25 134.48 16.5 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.126 . . . . 61.2 109.335 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 164.09 34.06 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.461 1.769 . . . . 60.41 110.997 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.82 -174.89 2.31 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.503 1.127 . . . . 72.53 110.43 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.533 HG11 ' CD2' ' A' ' 188' ' ' HIS . 1.0 OUTLIER -79.61 -49.33 19.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.503 1.127 . . . . 73.25 109.278 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.506 ' N ' ' CG2' ' A' ' 239' ' ' VAL . 0.0 OUTLIER -76.67 -14.75 59.94 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.454 1.096 . . . . 74.01 110.307 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -83.78 -49.82 8.71 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.55 1.156 . . . . 75.32 110.291 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.475 ' CD1' ' C ' ' A' ' 242' ' ' TRP . 0.1 OUTLIER -70.51 -62.49 1.37 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.007 -1.109 . . . . 75.25 108.007 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.633 ' NZ ' ' CE2' ' B' ' 470' ' ' PHE . 18.3 mtpp -49.56 -23.92 1.87 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.612 1.195 . . . . 72.11 109.329 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 243' ' ' LYS . 4.4 t . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.433 1.083 . . . . 73.52 109.969 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 470' ' ' PHE . . . . . 0.633 ' CE2' ' NZ ' ' A' ' 243' ' ' LYS . 6.3 m-30 . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 120.479 0.181 . . . . 71.11 110.981 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 471' ' ' ILE . . . . . 0.408 ' HA ' ' HD3' ' B' ' 472' ' ' PRO . 7.8 mm -97.51 139.81 21.62 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.145 . . . . 74.33 109.297 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 472' ' ' PRO . . . . . 0.55 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.3 Cg_endo -75.03 146.74 32.91 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.5 1.789 . . . . 70.03 111.018 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 8.2 t -79.21 -59.8 2.63 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.547 1.154 . . . . 61.14 110.075 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -84.67 163.49 46.53 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.52 1.137 . . . . 73.25 110.311 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 -166.59 0.35 Allowed 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.435 1.755 . . . . 74.42 111.01 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 476' ' ' ALA . . . . . 0.5 ' CB ' ' CD ' ' A' ' 191' ' ' GLU . . . -55.58 137.49 70.1 Favored Pre-proline 0 C--N 1.326 -0.417 0 O-C-N 124.489 1.118 . . . . 72.35 109.361 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 477' ' ' PRO . . . . . 0.572 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.2 Cg_endo -75.01 -162.28 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.484 1.781 . . . . 61.13 111.022 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.0 89.84 12.44 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.508 1.13 . . . . 75.42 109.29 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 479' ' ' PRO . . . . . 0.592 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.3 Cg_endo -74.92 161.29 39.2 Favored 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.523 1.801 . . . . 74.12 110.985 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.172 0 O-C-N 124.506 1.793 . . . . 74.14 111.035 179.936 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.987 0 N-CA-C 111.024 -0.831 . . . . 72.54 111.024 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.2 m -166.39 110.18 0.77 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.539 0.788 . . . . 64.13 110.027 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.449 ' C ' ' CD1' ' A' ' 159' ' ' TYR . 58.1 tp -119.73 -3.28 10.3 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.421 1.076 . . . . 72.3 109.37 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.716 ' CD1' ' CE2' ' A' ' 183' ' ' PHE . 3.2 m-85 -139.38 175.54 9.48 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.477 1.11 . . . . 73.22 111.007 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.515 ' CB ' ' CD1' ' A' ' 184' ' ' ILE . . . -128.51 160.96 30.71 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.514 1.134 . . . . 63.34 109.331 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.49 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.2 OUTLIER -144.69 124.3 6.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 74.42 109.337 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.478 HG22 ' CB ' ' A' ' 180' ' ' GLU . 6.4 m -83.3 127.24 39.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.486 1.116 . . . . 74.43 109.301 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.451 ' C ' ' CG ' ' A' ' 164' ' ' TYR . 0.4 OUTLIER -98.78 -2.95 36.74 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.465 1.103 . . . . 73.32 109.311 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.451 ' CG ' ' C ' ' A' ' 163' ' ' LEU . 1.5 m-85 -152.4 158.16 42.26 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.474 1.108 . . . . 74.33 111.021 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 166' ' ' PHE . 15.5 t0 -100.41 144.18 29.71 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.435 1.084 . . . . 74.03 109.268 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.439 ' N ' ' OD1' ' A' ' 165' ' ' ASP . 14.1 t80 -141.21 129.93 22.88 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.495 1.122 . . . . 75.44 110.949 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -68.56 131.06 44.6 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.439 1.087 . . . . 74.31 109.311 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.46 ' HB2' ' CA ' ' A' ' 173' ' ' GLU . . . -109.45 138.9 45.13 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.439 1.087 . . . . 74.43 109.307 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -144.6 16.55 1.64 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.506 1.129 . . . . 62.02 110.304 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.511 ' NZ ' ' CH2' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -94.92 -176.07 3.74 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.585 1.178 . . . . 71.11 109.257 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.47 -30.83 70.85 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.455 1.097 . . . . 72.32 109.306 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.445 ' OD2' ' N ' ' A' ' 206' ' ' LEU . 0.8 OUTLIER -104.59 16.45 26.04 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.473 1.108 . . . . 65.24 109.329 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.46 ' CA ' ' HB2' ' A' ' 168' ' ' ALA . 6.4 pt-20 -36.51 108.36 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.501 1.126 . . . . 73.42 110.321 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.485 ' CD1' ' HA3' ' A' ' 205' ' ' GLY . 5.4 tp -119.42 110.41 16.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.447 1.092 . . . . 72.34 109.316 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 12.9 t -84.98 108.62 17.68 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.48 1.112 . . . . 72.01 110.391 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.403 ' O ' ' OD1' ' A' ' 165' ' ' ASP . 0.7 OUTLIER -118.7 178.07 4.61 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.597 1.186 . . . . 75.23 110.432 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.424 ' O ' ' CG2' ' A' ' 162' ' ' VAL . 12.4 m-85 -121.76 162.78 20.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.577 1.173 . . . . 73.5 111.038 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.423 HG13 ' CB ' ' A' ' 165' ' ' ASP . 3.8 m -64.83 147.29 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.539 1.149 . . . . 75.24 109.244 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.419 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 53.28 62.1 6.31 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.548 1.155 . . . . 63.43 111.027 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.49 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 1.8 tp10 -126.31 161.62 27.38 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.505 0.767 . . . . 63.01 110.331 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -101.75 141.15 35.05 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.451 1.094 . . . . 73.24 109.262 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.47 ' CD2' HG12 ' A' ' 162' ' ' VAL . 2.6 pt? -159.2 141.59 13.88 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.45 1.094 . . . . 74.13 109.283 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.716 ' CE2' ' CD1' ' A' ' 159' ' ' TYR . 6.5 m-85 -106.23 126.43 52.21 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.423 1.077 . . . . 75.31 110.985 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.551 ' CD1' ' N ' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -63.0 153.42 6.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 74.25 109.331 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 194' ' ' ILE . 2.6 m -135.21 -48.25 0.72 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.424 1.078 . . . . 73.21 108.302 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.485 ' CB ' ' HB ' ' A' ' 194' ' ' ILE . . . -129.91 170.28 14.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.511 1.132 . . . . 71.44 109.231 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.36 147.45 27.61 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.413 1.071 . . . . 71.45 109.545 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.575 ' CE1' ' HB3' ' A' ' 192' ' ' TRP . 0.7 OUTLIER -152.61 138.83 18.35 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.592 1.183 . . . . 75.22 109.611 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.463 ' C ' ' N ' ' A' ' 191' ' ' GLU . 41.9 t30 53.28 22.4 2.7 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.446 1.091 . . . . 74.33 109.229 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.416 ' C ' ' O ' ' A' ' 189' ' ' ASN . 14.7 p 40.81 28.85 0.06 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.467 1.104 . . . . 60.33 108.271 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.463 ' N ' ' C ' ' A' ' 189' ' ' ASN . 7.8 tt0 -127.67 -40.4 1.75 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.409 1.068 . . . . 71.24 110.291 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.575 ' HB3' ' CE1' ' A' ' 188' ' ' HIS . 96.4 m95 -109.51 131.99 54.55 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.484 1.115 . . . . 75.02 108.002 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.615 ' CE2' ' CG1' ' A' ' 209' ' ' VAL . 20.8 m-30 -125.54 134.9 51.83 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.473 1.108 . . . . 64.34 110.972 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.485 ' HB ' ' CB ' ' A' ' 186' ' ' ALA . 5.7 mm -93.23 93.01 3.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.536 1.147 . . . . 75.41 109.282 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -97.07 -172.41 2.44 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.437 1.086 . . . . 73.54 109.381 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp -154.77 141.44 13.27 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 124.572 1.17 . . . . 71.4 109.285 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 177.95 7.9 Favored 'Trans proline' 0 C--N 1.361 1.215 0 O-C-N 124.547 1.814 . . . . 74.31 110.983 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 3.4 tp -113.88 29.51 2.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.611 1.194 . . . . 74.23 109.359 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -92.48 -120.02 2.7 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.464 1.102 . . . . 64.03 110.997 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.51 136.16 34.24 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.458 0.74 . . . . 71.11 110.292 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 46.45 32.33 1.56 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.511 1.132 . . . . 75.52 109.316 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -97.09 170.85 26.45 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.501 1.126 . . . . 73.01 111.012 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.412 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . 52.08 176.96 0.04 OUTLIER Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.997 -0.841 . . . . 72.14 110.997 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 123.77 9.42 Favored 'Cis proline' 0 C--N 1.361 1.21 0 C-N-CA 120.979 -2.509 . . . . 73.31 111.011 -0.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 195' ' ' ALA . . . -97.72 148.99 19.11 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.566 1.166 . . . . 75.21 110.991 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.574 HD23 ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -87.76 146.54 25.6 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.462 0.742 . . . . 73.14 109.324 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.442 HG22 ' CD1' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -161.12 127.64 2.48 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.537 1.148 . . . . 73.42 109.321 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.93 177.92 7.93 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.495 1.787 . . . . 70.21 110.991 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.615 ' CG1' ' CE2' ' A' ' 193' ' ' PHE . 1.4 m -96.94 5.08 9.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.54 1.15 . . . . 74.53 109.283 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . 0.497 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -108.05 0.35 33.58 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.455 1.097 . . . . 72.33 111.003 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.581 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 18.8 m-85 -131.66 8.61 4.56 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.509 0.77 . . . . 64.32 110.983 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.45 HG12 ' CG1' ' A' ' 162' ' ' VAL . 2.3 m -151.71 154.87 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.485 1.116 . . . . 72.43 109.293 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 39.9 t -123.9 147.07 47.98 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.504 1.127 . . . . 71.03 109.977 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 6.9 mm -90.87 129.33 41.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.531 1.144 . . . . 74.41 109.287 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.464 HD13 ' CG2' ' A' ' 161' ' ' ILE . 0.3 OUTLIER -152.41 -177.94 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.573 1.17 . . . . 75.4 109.237 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.434 ' OD2' ' N ' ' A' ' 216' ' ' ASP . 12.0 p-10 -127.62 15.78 7.02 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.459 1.099 . . . . 74.11 109.292 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 8.9 pt 45.03 28.98 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.49 1.119 . . . . 73.12 109.261 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.454 ' O ' ' CG2' ' A' ' 219' ' ' THR . . . -110.4 -69.42 0.87 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.482 1.114 . . . . 72.44 109.261 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.454 ' CG2' ' O ' ' A' ' 218' ' ' ALA . 3.2 p -157.92 160.54 37.71 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.548 1.155 . . . . 74.12 110.436 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 53.06 -172.85 0.42 Allowed Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.536 1.148 . . . . 62.2 110.965 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -125.63 115.77 20.66 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.477 0.751 . . . . 72.34 111.016 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.5 ' O ' ' CG2' ' A' ' 223' ' ' THR . . . 57.33 24.37 9.94 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.444 1.09 . . . . 73.54 109.294 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.5 ' CG2' ' O ' ' A' ' 222' ' ' ALA . 2.9 t 45.9 25.75 0.33 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.528 1.142 . . . . 53.45 110.408 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 71.9 39.45 59.24 Favored Glycine 0 CA--C 1.531 1.082 0 O-C-N 124.595 1.184 . . . . 64.34 110.985 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 222' ' ' ALA . 2.9 m-80 -131.52 162.6 29.89 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.557 0.798 . . . . 72.34 109.319 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -89.3 145.55 25.3 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.445 1.091 . . . . 65.23 109.347 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 1.5 p -54.03 -40.36 45.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.135 . . . . 73.4 109.276 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 9.0 mt -69.39 -30.8 46.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.51 1.131 . . . . 71.23 109.31 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.482 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 8.9 mt-10 -78.97 -21.08 47.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.54 1.15 . . . . 70.31 110.292 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -88.79 -15.9 33.46 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.511 1.132 . . . . 72.34 109.312 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 6.5 mt -72.5 -69.8 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.529 1.143 . . . . 74.52 109.296 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.482 ' CD ' ' HA ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -49.15 -30.67 7.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.515 1.135 . . . . 72.31 109.288 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -48.14 -50.23 29.45 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 74.23 109.987 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 236' ' ' LEU . 1.3 m -90.95 -14.36 8.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.516 1.135 . . . . 71.13 109.239 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 57.58 48.63 13.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.433 1.083 . . . . 75.12 109.286 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.474 ' CD1' ' O ' ' A' ' 237' ' ' PRO . 0.8 OUTLIER -71.29 142.93 87.51 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.507 1.129 . . . . 74.35 109.318 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.474 ' O ' ' CD1' ' A' ' 236' ' ' LEU . 18.3 Cg_endo -74.99 154.35 42.49 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.447 1.761 . . . . 71.12 110.997 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 2.6 m -58.88 175.5 0.27 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.529 1.143 . . . . 74.43 110.458 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.432 ' CG1' ' N ' ' A' ' 240' ' ' GLN . 7.2 p -76.81 -51.75 18.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 124.552 1.157 . . . . 75.15 109.295 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.433 ' OE1' ' CD1' ' B' ' 471' ' ' ILE . 4.3 pm0 -71.04 -14.93 62.5 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 75.12 110.278 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -92.2 -44.73 8.62 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.464 1.102 . . . . 71.42 110.302 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.436 ' CZ3' ' O ' ' A' ' 185' ' ' CYS . 9.9 t90 -69.47 -53.4 19.39 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.548 1.155 . . . . 74.14 108.018 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.738 ' NZ ' ' H ' ' B' ' 469' ' ' LYS . 5.9 mtmp? -62.9 -23.06 67.17 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.54 1.15 . . . . 63.21 109.274 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.6 t -40.97 -30.52 0.13 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.133 . . . . 62.04 110.038 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.403 ' N ' ' C ' ' A' ' 243' ' ' LYS . 12.4 t30 -175.82 108.58 0.09 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.519 1.137 . . . . 64.23 109.404 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.453 ' CG2' ' N ' ' A' ' 247' ' ' ALA . 1.3 tp -55.28 -49.62 71.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.485 1.116 . . . . 74.13 109.241 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.453 ' N ' ' CG2' ' A' ' 246' ' ' ILE . . . -44.7 97.27 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.458 1.099 . . . . 72.52 109.352 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 246' ' ' ILE . 0.4 OUTLIER -176.63 -166.03 0.15 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 72.14 110.27 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.552 ' CD1' ' O ' ' A' ' 249' ' ' TYR . 0.7 OUTLIER -173.27 128.85 0.45 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.538 1.149 . . . . 73.1 111.024 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.78 140.1 40.16 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.568 1.168 . . . . 75.13 109.35 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -107.69 161.86 14.5 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.468 1.105 . . . . 64.32 109.266 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 5.9 t -139.73 142.18 36.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.479 1.112 . . . . 71.14 110.018 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -73.98 149.31 41.39 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 64.1 109.323 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.5 ' CD1' ' N ' ' A' ' 254' ' ' ILE . 2.5 mp -81.54 123.91 38.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.477 1.111 . . . . 75.32 109.289 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.5 p -156.35 125.9 6.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.449 1.093 . . . . 62.23 110.025 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.406 ' CD1' ' O ' ' A' ' 257' ' ' GLY . 1.6 tm? -121.28 136.18 55.0 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.56 1.163 . . . . 73.14 109.351 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . 0.406 ' O ' ' CD1' ' A' ' 256' ' ' LEU . . . -95.1 160.54 23.08 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.428 1.08 . . . . 51.33 111.019 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 2.2 m -95.92 51.89 1.28 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.59 0.818 . . . . 74.15 109.959 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.4 p -161.3 119.95 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.532 1.145 . . . . 75.01 109.322 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 C--N 1.326 -0.448 0 O-C-N 124.452 1.095 . . . . 75.32 110.274 -179.991 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 109.971 -0.381 . . . . 73.22 109.971 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 2.3 t -124.88 149.45 47.51 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.504 1.127 . . . . 74.4 110.061 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 38.8 m -91.69 -175.62 4.22 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.491 1.119 . . . . 75.31 109.978 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -119.59 150.88 39.56 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.521 1.138 . . . . 74.42 109.213 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -114.78 -39.61 3.7 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.507 1.129 . . . . 62.35 109.338 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -66.5 164.42 41.74 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.491 1.12 . . . . 72.44 110.977 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . 0.738 ' H ' ' NZ ' ' A' ' 243' ' ' LYS . 32.4 mmtm -109.69 -15.33 14.17 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.455 0.738 . . . . 70.22 109.301 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 470' ' ' PHE . . . . . 0.561 ' CD2' ' HD3' ' A' ' 243' ' ' LYS . 8.8 m-30 -97.15 14.96 24.02 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.474 1.109 . . . . 74.54 111.0 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 471' ' ' ILE . . . . . 0.433 ' CD1' ' OE1' ' A' ' 240' ' ' GLN . 3.7 mm -70.31 140.18 87.57 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.516 1.135 . . . . 75.34 109.3 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 472' ' ' PRO . . . . . 0.568 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.2 Cg_endo -74.93 155.47 43.29 Favored 'Trans proline' 0 C--N 1.359 1.12 0 O-C-N 124.499 1.789 . . . . 73.44 111.055 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 38.7 t -97.49 -47.69 5.57 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.563 1.165 . . . . 73.52 110.062 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.86 165.4 17.99 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.537 1.148 . . . . 74.13 110.31 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 -166.81 0.37 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.458 1.767 . . . . 73.31 111.031 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 476' ' ' ALA . . . . . . . . . . . . . . . -65.25 134.1 95.71 Favored Pre-proline 0 C--N 1.326 -0.427 0 O-C-N 124.382 1.051 . . . . 73.43 109.302 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 477' ' ' PRO . . . . . 0.575 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -74.94 -162.65 0.16 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.5 1.789 . . . . 74.3 110.996 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 478' ' ' LYS . . . . . 0.401 ' N ' ' HD3' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -133.42 90.89 28.21 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 74.12 109.28 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 479' ' ' PRO . . . . . 0.581 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.98 152.39 40.78 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.489 1.784 . . . . 74.21 111.0 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 170.06 21.24 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.552 1.817 . . . . 71.3 111.005 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 481' ' ' SER . . . . . . . . . . . . . 1.1 t 50.3 43.72 26.49 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.479 1.112 . . . . 74.33 109.913 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 14.3 p -108.09 178.86 4.38 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.487 1.117 . . . . 74.3 110.021 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -117.6 56.52 0.83 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.495 1.122 . . . . 75.4 109.282 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 1.5 t -135.22 137.3 42.48 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.464 1.102 . . . . 72.3 110.008 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -103.3 153.4 20.46 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.456 1.098 . . . . 64.02 109.263 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 86.3 p . . . . . 0 C--N 1.324 -0.509 0 O-C-N 124.553 1.158 . . . . 63.33 109.992 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.964 0 N-CA-C 110.995 -0.842 . . . . 62.42 110.995 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.7 t -145.84 162.8 36.88 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.418 0.716 . . . . 61.22 110.053 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.1 pp -156.39 121.07 4.57 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.509 1.13 . . . . 74.12 109.272 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.556 ' CE2' HD12 ' A' ' 215' ' ' ILE . 0.7 OUTLIER -124.12 139.55 53.83 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.464 1.102 . . . . 73.54 110.966 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.615 ' CB ' ' CD1' ' A' ' 184' ' ' ILE . . . -119.89 148.28 43.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.464 1.102 . . . . 64.41 109.341 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.465 HG22 ' CD2' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -127.78 132.28 69.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.468 1.105 . . . . 74.12 109.287 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 164' ' ' TYR . 3.9 t -87.89 134.05 28.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.516 1.135 . . . . 73.1 109.336 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.465 ' CD2' HG22 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -117.97 -2.61 11.25 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.475 1.109 . . . . 73.13 109.361 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.502 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 16.9 m-85 -139.02 175.74 9.29 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.134 . . . . 71.43 110.995 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.428 ' CB ' ' HA ' ' A' ' 177' ' ' TYR . 6.5 p-10 -139.86 145.34 37.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.488 1.118 . . . . 73.12 109.332 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.567 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 1.9 p90 -160.28 166.33 29.72 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.552 1.158 . . . . 75.02 111.057 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -100.03 130.92 46.24 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.537 1.148 . . . . 65.55 109.321 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.43 ' HB2' ' CA ' ' A' ' 173' ' ' GLU . . . -100.9 157.8 16.46 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 71.23 109.271 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -156.72 24.53 0.33 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.493 1.121 . . . . 73.24 110.26 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.425 ' N ' ' HB3' ' A' ' 173' ' ' GLU . 0.3 OUTLIER -99.54 -177.25 3.52 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.527 1.142 . . . . 73.32 109.25 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.94 -27.89 65.74 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.525 1.14 . . . . 71.35 109.348 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.432 ' HB3' ' CB ' ' A' ' 206' ' ' LEU . 9.2 t0 -112.29 22.2 14.97 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 75.3 109.315 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.43 ' CA ' ' HB2' ' A' ' 168' ' ' ALA . 10.4 pt-20 -36.92 111.63 0.16 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.472 1.108 . . . . 73.05 110.29 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.482 ' CD1' ' HA3' ' A' ' 205' ' ' GLY . 4.6 tp -132.02 109.68 10.2 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.457 1.098 . . . . 74.44 109.293 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.0 t -87.26 133.17 33.71 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.444 1.09 . . . . 71.1 110.412 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 19.8 m -141.73 165.29 27.88 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.497 1.123 . . . . 75.23 110.412 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.428 ' HA ' ' CB ' ' A' ' 165' ' ' ASP . 8.1 m-85 -111.07 164.12 13.16 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.44 1.087 . . . . 75.3 110.999 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.427 HG11 ' N ' ' A' ' 165' ' ' ASP . 2.1 m -61.84 158.46 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.586 1.178 . . . . 65.23 109.281 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 46.3 70.14 0.72 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.444 1.09 . . . . 70.13 111.018 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -131.94 174.59 10.01 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 0.773 . . . . 72.21 110.353 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.445 ' ND2' ' OH ' ' A' ' 159' ' ' TYR . 0.4 OUTLIER -118.23 136.23 53.79 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.54 1.15 . . . . 74.52 109.314 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.462 HD22 ' CG2' ' A' ' 162' ' ' VAL . 2.6 pt? -157.25 146.09 19.8 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.568 1.167 . . . . 63.24 109.242 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -113.86 124.1 51.4 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.544 1.153 . . . . 74.2 110.955 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.615 ' CD1' ' CB ' ' A' ' 160' ' ' ALA . 1.7 mp -65.44 152.84 8.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.546 1.154 . . . . 72.22 109.261 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.549 ' O ' ' CZ3' ' A' ' 242' ' ' TRP . 0.1 OUTLIER -135.78 -47.26 0.67 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.467 1.105 . . . . 73.24 108.319 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.469 ' CB ' HG22 ' A' ' 239' ' ' VAL . . . -126.73 167.32 15.91 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.132 . . . . 73.41 109.313 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.506 ' CE1' HG21 ' A' ' 231' ' ' ILE . 0.2 OUTLIER -148.88 146.09 27.76 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.474 1.109 . . . . 71.1 109.598 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.6 ' CE1' ' CB ' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -149.8 141.81 23.9 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.503 1.127 . . . . 75.4 109.647 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.455 ' C ' ' N ' ' A' ' 191' ' ' GLU . 19.0 t-20 51.25 22.35 1.34 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.498 1.124 . . . . 75.24 109.287 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.402 ' C ' ' O ' ' A' ' 189' ' ' ASN . 53.8 m 41.57 28.33 0.08 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.549 1.155 . . . . 73.12 108.312 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.455 ' N ' ' C ' ' A' ' 189' ' ' ASN . 6.8 tt0 -128.15 -41.1 1.61 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.416 1.073 . . . . 70.13 110.326 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.6 ' CB ' ' CE1' ' A' ' 188' ' ' HIS . 98.8 m95 -106.63 131.35 53.88 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.01 -1.107 . . . . 74.42 108.01 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.625 ' CE2' ' CG1' ' A' ' 209' ' ' VAL . 20.8 m-30 -125.41 130.47 51.94 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.476 1.11 . . . . 74.15 111.033 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.554 ' CD1' ' NE2' ' A' ' 188' ' ' HIS . 1.5 mp -89.5 96.41 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.563 1.164 . . . . 74.22 109.313 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -104.16 -174.56 2.57 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.579 1.175 . . . . 63.24 109.237 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -150.48 141.24 14.58 Favored Pre-proline 0 C--N 1.326 -0.436 0 O-C-N 124.474 1.109 . . . . 74.44 109.274 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.05 153.74 41.75 Favored 'Trans proline' 0 C--N 1.361 1.213 0 O-C-N 124.506 1.793 . . . . 74.11 110.972 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 4.6 tp -58.82 114.49 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.518 1.136 . . . . 75.45 109.313 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 122.73 126.63 3.19 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 124.445 1.091 . . . . 74.3 110.98 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.431 ' CG ' ' N ' ' A' ' 201' ' ' LEU . 35.8 ptt-85 -44.36 -43.49 7.59 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.516 0.774 . . . . 75.41 110.31 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.431 ' N ' ' CG ' ' A' ' 200' ' ' ARG . 11.5 mt -72.13 79.86 0.96 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.5 1.125 . . . . 75.2 109.265 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 155.5 147.68 4.79 Favored Glycine 0 CA--C 1.531 1.057 0 O-C-N 124.482 1.114 . . . . 65.43 110.937 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.418 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . 71.89 179.04 31.89 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 111.039 -0.824 . . . . 54.45 111.039 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.03 122.65 8.37 Favored 'Cis proline' 0 C--N 1.359 1.121 0 C-N-CA 121.031 -2.487 . . . . 74.23 111.002 0.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 195' ' ' ALA . . . -98.19 153.17 19.96 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.449 1.093 . . . . 74.34 111.049 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.511 HD21 ' CE3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -86.94 146.43 26.16 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.478 0.752 . . . . 74.15 109.271 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.454 HG23 ' CD1' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -158.11 126.83 2.99 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.456 1.097 . . . . 74.1 109.287 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 174.48 12.73 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.573 1.828 . . . . 62.34 110.999 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.625 ' CG1' ' CE2' ' A' ' 193' ' ' PHE . 1.2 m -93.11 4.76 7.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.541 1.151 . . . . 72.13 109.307 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . 0.446 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -109.01 4.64 31.92 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.494 1.121 . . . . 74.3 110.914 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.62 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 15.7 m-85 -134.12 8.6 3.76 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.473 0.749 . . . . 72.54 111.058 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.465 HG12 ' CG2' ' A' ' 162' ' ' VAL . 3.1 m -151.66 162.17 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.45 1.094 . . . . 73.21 109.345 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 3.6 t -128.42 133.43 48.57 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.529 1.143 . . . . 71.25 110.032 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.421 ' CG2' ' CD1' ' A' ' 217' ' ' ILE . 2.7 mm -80.77 145.87 8.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.507 1.129 . . . . 74.42 109.196 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.556 HD12 ' CE2' ' A' ' 159' ' ' TYR . 1.0 OUTLIER -165.06 159.02 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.449 1.093 . . . . 74.52 109.299 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.447 ' CB ' ' HB3' ' A' ' 159' ' ' TYR . 8.4 t0 76.22 55.39 0.05 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.447 1.092 . . . . 72.44 109.264 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.421 ' CD1' ' CG2' ' A' ' 214' ' ' ILE . 3.1 mt -142.12 107.34 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.505 1.128 . . . . 75.31 109.26 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 74.04 25.93 1.78 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.44 1.087 . . . . 75.02 109.262 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 34.4 m 64.19 61.44 0.91 Allowed 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.574 1.171 . . . . 72.51 110.354 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 170.25 -178.28 43.09 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 124.497 1.123 . . . . 70.12 110.986 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 221' ' ' TYR . 4.1 m-30 -90.06 124.94 35.21 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.562 0.801 . . . . 74.52 110.966 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.432 ' O ' ' CG2' ' A' ' 223' ' ' THR . . . 54.24 27.25 7.63 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.568 1.167 . . . . 64.35 109.315 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.432 ' CG2' ' O ' ' A' ' 222' ' ' ALA . 14.0 t 48.63 26.33 1.19 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.506 1.129 . . . . 74.34 110.329 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 86.42 -51.3 4.35 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.54 1.15 . . . . 75.54 111.031 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.404 ' OD1' ' C ' ' A' ' 225' ' ' ASN . 40.7 p30 -70.81 174.73 5.69 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.473 0.749 . . . . 75.51 109.328 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 229' ' ' GLU . 25.6 t0 -76.4 149.99 36.84 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.435 1.084 . . . . 63.3 109.333 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.401 ' C ' ' O ' ' A' ' 226' ' ' ASP . 0.2 OUTLIER -40.37 -55.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.463 1.102 . . . . 65.23 109.322 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 4.0 mp -55.9 -42.22 70.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.119 . . . . 73.0 109.315 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 226' ' ' ASP . 9.4 mt-10 -68.22 -14.59 63.09 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.455 1.097 . . . . 75.21 110.253 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -88.73 -18.91 26.83 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.528 1.142 . . . . 74.24 109.317 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.506 HG21 ' CE1' ' A' ' 187' ' ' HIS . 0.5 OUTLIER -68.34 -69.14 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.537 1.148 . . . . 72.23 109.24 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.437 ' N ' ' CG2' ' A' ' 231' ' ' ILE . 0.0 OUTLIER -59.84 -24.97 64.62 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.43 1.081 . . . . 74.14 109.226 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.51 -57.4 6.2 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.537 1.148 . . . . 71.1 109.991 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.413 ' C ' ' N ' ' A' ' 236' ' ' LEU . 1.4 m -93.3 25.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.52 1.137 . . . . 70.42 109.24 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 3.4 m120 41.66 30.28 0.14 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.487 1.117 . . . . 74.23 109.292 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.413 ' N ' ' C ' ' A' ' 234' ' ' VAL . 7.9 tp -59.28 121.3 55.15 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.506 1.129 . . . . 74.53 109.334 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 160.5 39.98 Favored 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.48 1.779 . . . . 54.11 111.029 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 2.9 m -60.15 -179.35 0.1 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.5 1.125 . . . . 62.41 110.466 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.469 HG22 ' CB ' ' A' ' 186' ' ' ALA . 11.5 p -71.08 -34.42 54.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 65.15 109.329 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -85.32 -18.0 35.15 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.444 1.09 . . . . 72.35 110.302 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -84.84 -45.49 12.25 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.476 1.11 . . . . 75.22 110.293 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.549 ' CZ3' ' O ' ' A' ' 185' ' ' CYS . 7.5 t90 -67.77 -55.05 14.56 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.51 1.131 . . . . 74.12 107.962 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt -62.72 -18.39 62.45 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.522 1.138 . . . . 70.43 109.318 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.3 t -46.13 -66.49 0.4 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.474 1.109 . . . . 71.02 110.059 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -133.55 112.79 11.79 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.594 1.184 . . . . 64.25 109.314 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 14.0 mm -40.44 -63.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.429 1.08 . . . . 72.32 109.287 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -157.5 107.72 2.21 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.554 1.159 . . . . 72.13 109.3 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . 0.534 ' O ' ' CG ' ' A' ' 249' ' ' TYR . 0.5 OUTLIER -121.37 -3.77 9.41 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.528 1.142 . . . . 75.4 110.261 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.534 ' CG ' ' O ' ' A' ' 248' ' ' ARG . 2.0 m-85 -175.06 172.37 2.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.521 1.138 . . . . 64.33 111.047 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.433 ' C ' ' N ' ' A' ' 252' ' ' SER . 3.1 ptpp? 40.44 37.95 0.51 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.547 1.155 . . . . 72.42 109.307 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.53 -30.07 0.1 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 72.22 109.28 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' SER . . . . . 0.433 ' N ' ' C ' ' A' ' 250' ' ' LYS . 12.4 t -65.5 -177.54 0.44 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.475 1.11 . . . . 64.42 110.015 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -114.51 148.15 38.34 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.512 1.132 . . . . 72.44 109.332 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 50.1 mm -128.87 136.78 58.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.531 1.144 . . . . 72.22 109.355 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.5 t -145.85 153.33 40.75 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.441 1.088 . . . . 62.02 109.998 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.68 -179.88 3.94 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.503 1.127 . . . . 75.5 109.359 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -73.72 -136.63 0.34 Allowed Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.589 1.181 . . . . 43.55 111.101 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.7 m -141.67 -174.96 4.2 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.525 0.779 . . . . 72.32 109.986 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 30.2 m -127.56 -177.34 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.457 1.098 . . . . 73.25 109.258 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.434 1.084 . . . . 75.13 110.332 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.977 -0.379 . . . . 74.35 109.977 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 45.5 t -141.74 178.44 7.48 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.125 . . . . 74.31 109.994 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 86.1 p -97.83 -176.14 3.37 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.593 1.183 . . . . 73.44 109.973 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -113.61 -52.58 2.75 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.571 1.169 . . . . 72.31 109.299 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 53.58 29.0 8.51 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.533 1.146 . . . . 74.15 109.337 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -118.93 159.58 14.4 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.427 1.079 . . . . 73.22 111.003 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -118.94 8.56 11.69 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.442 0.731 . . . . 73.21 109.31 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 470' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -107.14 10.75 30.01 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.464 1.102 . . . . 74.32 110.979 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 471' ' ' ILE . . . . . . . . . . . . . 20.0 mm -83.82 142.06 41.81 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.494 1.121 . . . . 75.23 109.25 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 472' ' ' PRO . . . . . 0.532 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.2 Cg_endo -75.02 -175.95 2.63 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.456 1.766 . . . . 63.31 110.988 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 42.7 t -126.7 6.87 6.78 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.484 1.115 . . . . 63.45 109.997 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -142.44 157.04 63.47 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.545 1.153 . . . . 71.53 110.294 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 475' ' ' PRO . . . . . 0.505 ' O ' ' CB ' ' B' ' 476' ' ' ALA . 18.2 Cg_endo -75.06 -26.11 11.13 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.478 1.778 . . . . 75.32 111.002 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 476' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' B' ' 475' ' ' PRO . . . 163.1 140.1 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.489 1.118 . . . . 74.3 109.254 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 477' ' ' PRO . . . . . 0.573 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -75.02 -163.4 0.18 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.534 1.807 . . . . 73.33 111.041 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 478' ' ' LYS . . . . . 0.403 ' N ' ' HD3' ' B' ' 478' ' ' LYS . 0.1 OUTLIER -128.54 90.81 45.46 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.51 1.131 . . . . 75.23 109.277 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 479' ' ' PRO . . . . . 0.62 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.5 Cg_endo -74.96 147.16 33.72 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.512 1.796 . . . . 74.23 111.025 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 480' ' ' PRO . . . . . 0.53 ' O ' ' CB ' ' B' ' 481' ' ' SER . 18.4 Cg_endo -74.99 117.96 5.1 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.511 1.795 . . . . 72.52 111.016 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 481' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' B' ' 480' ' ' PRO . 1.4 t 156.98 129.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.557 1.16 . . . . 70.22 109.966 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 34.9 t -104.47 88.89 3.06 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 124.486 1.116 . . . . 72.51 109.986 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -54.06 -33.12 56.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.529 1.143 . . . . 75.34 109.305 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 3.9 t -45.88 -47.37 16.12 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.492 1.12 . . . . 51.44 110.002 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -46.02 124.53 5.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.463 1.102 . . . . 71.21 109.324 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 53.6 p . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.519 1.137 . . . . 73.01 110.022 179.967 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.97 0 N-CA-C 110.99 -0.844 . . . . 75.34 110.99 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.1 p -86.67 49.35 1.79 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.482 0.754 . . . . 75.43 109.986 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.497 ' CB ' ' OD1' ' A' ' 216' ' ' ASP . 1.8 pp -55.02 121.71 9.31 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.56 1.162 . . . . 73.43 109.266 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.56 ' CD1' ' O ' ' A' ' 215' ' ' ILE . 9.6 p90 -150.12 -179.06 6.87 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.564 1.165 . . . . 73.42 110.957 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.466 ' CB ' HD12 ' A' ' 184' ' ' ILE . . . -115.98 152.73 32.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.558 1.161 . . . . 75.14 109.323 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.462 ' CD1' ' C ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -126.72 120.81 56.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 124.533 1.146 . . . . 71.34 109.298 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.448 ' CG2' HD23 ' A' ' 182' ' ' LEU . 2.5 t -74.42 121.67 26.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.544 1.152 . . . . 74.22 109.3 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.441 ' O ' ' CD1' ' A' ' 164' ' ' TYR . 0.4 OUTLIER -100.11 -12.32 19.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.578 1.174 . . . . 75.13 109.307 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.601 ' CE1' ' OG ' ' B' ' 481' ' ' SER . 0.9 OUTLIER -150.9 154.45 37.21 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.483 1.114 . . . . 73.4 111.046 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.411 ' N ' HG13 ' A' ' 178' ' ' VAL . 2.9 p30 -74.62 158.73 33.15 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.478 1.111 . . . . 74.33 109.231 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -154.51 130.69 10.34 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.527 1.142 . . . . 75.35 111.002 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -88.95 126.51 35.43 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.46 1.1 . . . . 74.25 109.26 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -113.64 151.14 32.16 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.518 1.136 . . . . 75.42 109.325 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.71 24.08 0.39 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.419 1.074 . . . . 74.14 110.275 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.47 ' HD3' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -100.87 -175.78 2.98 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.615 1.197 . . . . 75.55 109.287 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.18 -26.08 66.05 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.456 1.097 . . . . 72.03 109.344 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.456 ' HB3' ' CB ' ' A' ' 206' ' ' LEU . 60.4 m-20 -109.68 15.5 22.77 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.44 1.088 . . . . 71.41 109.268 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.452 ' HB3' ' N ' ' A' ' 170' ' ' LYS . 17.7 pt-20 -36.1 110.01 0.1 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.439 1.087 . . . . 74.2 110.295 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.473 ' CD2' ' HA3' ' A' ' 205' ' ' GLY . 14.2 tp -128.93 103.91 7.29 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.546 1.154 . . . . 72.03 109.251 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.3 t -88.35 142.6 27.6 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.537 1.148 . . . . 53.15 110.368 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 17.0 m -155.16 162.89 40.85 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.533 1.146 . . . . 73.54 110.392 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -99.36 163.77 12.39 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.481 1.113 . . . . 74.12 111.027 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.411 HG13 ' N ' ' A' ' 165' ' ' ASP . 2.6 m -57.72 158.16 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 71.04 109.29 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.424 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 49.88 68.19 1.5 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.51 1.131 . . . . 74.43 110.99 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -128.31 167.77 16.47 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.501 0.765 . . . . 74.51 110.262 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.45 132.65 53.5 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.429 1.08 . . . . 65.23 109.328 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.448 HD23 ' CG2' ' A' ' 162' ' ' VAL . 0.4 OUTLIER -143.25 158.03 43.98 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.495 1.122 . . . . 72.43 109.36 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.403 ' C ' ' HB3' ' A' ' 195' ' ' ALA . 0.6 OUTLIER -114.55 113.09 23.95 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.483 1.115 . . . . 75.21 110.972 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.466 HD12 ' CB ' ' A' ' 160' ' ' ALA . 1.7 mp -65.54 159.96 3.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 124.453 1.096 . . . . 73.44 109.312 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 186' ' ' ALA . 9.7 p -147.03 -44.39 0.18 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.583 1.177 . . . . 63.2 108.334 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.505 ' N ' ' SG ' ' A' ' 185' ' ' CYS . . . -121.32 164.23 17.36 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.446 1.091 . . . . 74.55 109.32 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.03 140.23 18.5 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.484 1.115 . . . . 64.53 109.602 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.572 ' CD2' ' N ' ' A' ' 188' ' ' HIS . 0.1 OUTLIER -142.18 142.42 32.69 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.518 1.136 . . . . 74.12 109.577 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.48 ' C ' ' N ' ' A' ' 191' ' ' GLU . 19.2 t-20 50.62 22.1 1.02 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.469 1.105 . . . . 73.14 109.321 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.4 ' C ' ' O ' ' A' ' 189' ' ' ASN . 23.5 m 42.0 27.23 0.07 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.574 1.171 . . . . 74.51 108.245 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.48 ' N ' ' C ' ' A' ' 189' ' ' ASN . 9.3 tt0 -125.11 -37.1 2.45 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.479 1.112 . . . . 73.32 110.293 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.574 ' CD1' ' HG3' ' B' ' 472' ' ' PRO . 97.2 m95 -109.78 128.77 55.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.505 1.128 . . . . 72.14 107.96 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.596 ' CZ ' HG11 ' A' ' 209' ' ' VAL . 20.9 m-30 -122.18 127.04 49.56 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.488 1.118 . . . . 74.32 110.958 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.455 ' HB ' ' CB ' ' A' ' 186' ' ' ALA . 9.3 mm -89.23 106.34 16.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.493 1.12 . . . . 74.22 109.288 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -117.01 175.77 5.43 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.128 . . . . 74.01 109.333 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -147.56 165.56 18.42 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.442 1.089 . . . . 63.44 109.303 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.92 178.26 7.47 Favored 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.517 1.799 . . . . 74.33 110.96 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.495 ' O ' ' CD1' ' A' ' 198' ' ' ILE . 1.2 pp -105.06 68.8 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.56 1.162 . . . . 74.2 109.231 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 201' ' ' LEU . . . 160.97 122.79 0.64 Allowed Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.541 1.15 . . . . 73.34 110.984 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 199' ' ' GLY . 20.2 mmm180 -37.0 97.14 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.557 0.798 . . . . 75.11 110.31 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 199' ' ' GLY . 2.5 tp 173.8 137.48 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.513 1.133 . . . . 75.24 109.294 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 47.76 -157.69 0.76 Allowed Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.507 1.129 . . . . 73.32 110.931 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 52.83 171.44 0.03 OUTLIER Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.959 -0.856 . . . . 54.33 110.959 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.94 129.05 17.59 Favored 'Cis proline' 0 C--N 1.362 1.248 0 C-N-CA 121.011 -2.495 . . . . 65.33 111.053 -0.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 195' ' ' ALA . . . -92.63 163.31 27.19 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.519 1.137 . . . . 74.03 110.963 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.47 ' CD2' ' HD3' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -97.62 145.41 26.31 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.496 0.762 . . . . 73.13 109.326 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.414 ' N ' ' HG ' ' A' ' 206' ' ' LEU . 0.4 OUTLIER -153.61 127.35 4.37 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.583 1.177 . . . . 65.5 109.344 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.09 174.52 12.65 Favored 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.505 1.792 . . . . 74.2 110.995 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.596 HG11 ' CZ ' ' A' ' 193' ' ' PHE . 1.6 m -97.03 7.01 8.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.484 1.115 . . . . 73.31 109.267 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . 0.457 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -106.93 -0.9 36.22 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.506 1.129 . . . . 64.13 110.948 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.573 ' CE2' ' HB3' ' B' ' 479' ' ' PRO . 12.7 m-85 -133.27 15.53 4.14 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.556 0.798 . . . . 75.22 111.046 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.444 HG11 ' CG2' ' A' ' 162' ' ' VAL . 3.4 m -152.62 157.66 4.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.548 1.155 . . . . 73.44 109.36 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 46.6 t -128.23 119.94 26.2 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.527 1.142 . . . . 61.25 110.056 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.443 ' O ' ' N ' ' A' ' 222' ' ' ALA . 5.1 mm -64.48 153.22 7.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.495 1.122 . . . . 74.23 109.245 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.56 ' O ' ' CD1' ' A' ' 159' ' ' TYR . 0.4 OUTLIER 176.28 147.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.577 1.173 . . . . 73.01 109.309 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.497 ' OD1' ' CB ' ' A' ' 158' ' ' LEU . 0.0 OUTLIER -123.31 -59.91 1.53 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.511 1.132 . . . . 61.11 109.284 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.493 ' CD1' ' C ' ' A' ' 217' ' ' ILE . 0.0 OUTLIER -168.56 105.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.548 1.155 . . . . 64.51 109.304 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -175.02 -179.03 1.3 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.552 1.158 . . . . 74.4 109.289 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 14.6 t -102.58 27.77 6.61 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.486 1.116 . . . . 64.53 110.353 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -142.69 -152.95 5.78 Favored Glycine 0 CA--C 1.529 0.929 0 O-C-N 124.477 1.111 . . . . 53.4 111.028 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -128.76 131.11 47.83 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.413 0.714 . . . . 73.13 110.979 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 214' ' ' ILE . . . 69.05 15.93 8.73 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.498 1.124 . . . . 73.32 109.314 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.494 ' CG2' ' O ' ' A' ' 223' ' ' THR . 0.6 OUTLIER 71.19 4.91 5.26 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.509 1.131 . . . . 71.01 110.428 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 101.32 -32.87 6.97 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.527 1.142 . . . . 72.51 110.964 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -77.4 176.08 9.18 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.501 0.765 . . . . 73.25 109.27 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 230' ' ' ASP . 0.7 OUTLIER -93.68 137.82 32.54 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.13 . . . . 75.43 109.366 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 1.3 p -49.11 -41.12 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.536 1.147 . . . . 72.11 109.283 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 12.3 mt -66.9 -33.94 66.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.586 1.178 . . . . 74.32 109.315 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -81.75 -17.52 47.43 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.425 1.078 . . . . 72.3 110.289 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 226' ' ' ASP . 6.5 t70 -88.7 -15.73 34.09 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.532 1.145 . . . . 72.22 109.278 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 6.7 mt -71.03 -69.44 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.459 1.099 . . . . 71.1 109.356 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -21.19 27.48 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.468 1.105 . . . . 74.44 109.281 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.4 m -56.79 -17.92 10.92 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 72.45 110.019 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.14 22.27 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.508 1.13 . . . . 71.53 109.284 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 40.75 37.22 0.47 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.618 1.199 . . . . 73.14 109.333 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 5.7 tp -66.16 119.63 63.36 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.424 1.078 . . . . 74.24 109.285 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 166.95 28.13 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.478 1.778 . . . . 74.54 111.018 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.6 m -68.43 173.58 4.81 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.446 1.091 . . . . 74.44 110.416 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.49 HG12 ' CG ' ' A' ' 188' ' ' HIS . 14.9 p -69.04 -49.02 66.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.473 1.108 . . . . 75.51 109.347 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.471 ' OE1' ' CD1' ' B' ' 471' ' ' ILE . 7.7 pm0 -73.04 -14.53 61.43 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.117 . . . . 71.24 110.292 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -90.53 -36.33 14.55 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.543 1.152 . . . . 70.14 110.313 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.402 ' CZ3' ' O ' ' A' ' 185' ' ' CYS . 1.3 t90 -80.48 -54.88 5.28 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.513 1.133 . . . . 73.54 107.997 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.504 ' HD3' ' CE2' ' B' ' 470' ' ' PHE . 3.0 mtmp? -57.85 -17.3 15.37 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.53 1.144 . . . . 71.14 109.22 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 247' ' ' ALA . 17.1 m -38.15 -45.2 0.91 Allowed 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.502 1.126 . . . . 73.24 109.947 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -42.62 -50.61 5.39 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.556 1.16 . . . . 75.54 109.377 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.407 ' N ' ' O ' ' A' ' 243' ' ' LYS . 3.3 mp -55.16 -42.13 63.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.515 1.134 . . . . 73.33 109.298 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' A' ' 244' ' ' SER . . . -102.19 89.26 3.54 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 64.11 109.296 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 9.0 tpp85 -44.19 139.58 2.51 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.472 1.108 . . . . 72.25 110.339 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -144.26 -177.48 5.48 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.441 1.088 . . . . 75.51 110.981 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -47.79 147.47 1.93 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 72.2 109.286 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.99 -57.94 3.31 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.478 1.111 . . . . 72.42 109.306 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 5.0 m -60.36 112.27 1.88 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.388 1.055 . . . . 73.21 109.954 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . 0.551 ' H ' ' ND2' ' A' ' 253' ' ' ASN . 0.1 OUTLIER -114.46 -1.59 13.41 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.632 1.208 . . . . 70.04 109.314 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 1.3 mp -85.18 111.24 20.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.518 1.136 . . . . 72.21 109.263 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.6 p -158.46 111.31 2.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.468 1.105 . . . . 71.43 109.98 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 7.2 tt -168.82 135.68 1.86 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.508 1.13 . . . . 65.24 109.284 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 172.55 92.41 0.08 OUTLIER Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.533 1.146 . . . . 73.04 111.021 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.3 p -133.18 -62.05 0.81 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.538 0.787 . . . . 64.53 109.993 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 1.6 p -171.72 148.69 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.474 1.109 . . . . 74.11 109.316 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.468 1.105 . . . . 73.5 110.391 179.976 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.997 -0.372 . . . . 72.32 109.997 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 29.9 t -90.3 9.01 30.43 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.548 1.155 . . . . 63.31 110.034 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 3.9 m -165.63 -177.44 4.38 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.459 1.099 . . . . 75.45 110.059 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -117.58 -67.93 0.96 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.578 1.174 . . . . 73.12 109.274 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -168.31 131.03 1.46 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.497 1.123 . . . . 74.35 109.332 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -141.27 -179.35 18.41 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.508 1.13 . . . . 73.24 111.018 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -105.94 -17.03 14.48 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.502 0.766 . . . . 73.34 109.287 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 470' ' ' PHE . . . . . 0.504 ' CE2' ' HD3' ' A' ' 243' ' ' LYS . 4.9 m-30 -111.4 -2.78 15.48 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.537 1.148 . . . . 75.33 110.987 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 471' ' ' ILE . . . . . 0.471 ' CD1' ' OE1' ' A' ' 240' ' ' GLN . 1.4 mp -70.51 142.98 89.66 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.48 1.112 . . . . 74.54 109.259 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 472' ' ' PRO . . . . . 0.574 ' HG3' ' CD1' ' A' ' 192' ' ' TRP . 18.5 Cg_endo -74.92 161.53 38.81 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.513 1.796 . . . . 63.0 111.01 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 473' ' ' SER . . . . . 0.44 ' OG ' ' CZ ' ' B' ' 474' ' ' ARG . 29.6 t -98.72 -27.42 13.97 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.532 1.145 . . . . 61.45 109.989 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 474' ' ' ARG . . . . . 0.44 ' CZ ' ' OG ' ' B' ' 473' ' ' SER . 2.6 mmt180 -111.08 170.38 5.33 Favored Pre-proline 0 C--N 1.326 -0.428 0 O-C-N 124.527 1.142 . . . . 71.12 110.316 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -168.48 0.52 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.48 1.779 . . . . 74.24 110.974 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 476' ' ' ALA . . . . . . . . . . . . . . . -73.28 134.93 79.71 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 74.41 109.296 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 477' ' ' PRO . . . . . 0.566 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -75.0 170.79 19.64 Favored 'Trans proline' 0 C--N 1.358 1.077 0 O-C-N 124.505 1.792 . . . . 75.32 111.027 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -113.11 95.27 34.11 Favored Pre-proline 0 C--N 1.324 -0.54 0 O-C-N 124.509 1.131 . . . . 75.1 109.284 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 479' ' ' PRO . . . . . 0.573 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 18.1 Cg_endo -74.99 168.62 24.43 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.483 1.781 . . . . 74.22 110.974 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 -89.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.498 1.789 . . . . 73.44 110.977 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 481' ' ' SER . . . . . 0.601 ' OG ' ' CE1' ' A' ' 164' ' ' TYR . 3.3 p -86.89 101.08 13.05 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.483 1.114 . . . . 74.41 110.026 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 7.1 t -139.63 -50.32 0.5 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 74.3 110.036 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -107.32 123.92 49.05 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.468 1.105 . . . . 72.33 109.303 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 27.4 t -58.77 118.9 6.22 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 124.469 1.105 . . . . 74.02 110.04 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . 55.5 50.77 13.95 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.488 1.118 . . . . 73.41 109.315 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 62.7 m . . . . . 0 C--N 1.326 -0.454 0 O-C-N 124.487 1.117 . . . . 62.34 109.977 179.996 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.995 0 N-CA-C 111.07 -0.812 . . . . 62.35 111.07 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.0 m -121.51 52.44 1.23 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.457 0.739 . . . . 64.25 109.968 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.04 144.12 32.28 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.45 1.094 . . . . 73.04 109.276 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.403 ' O ' ' O ' ' A' ' 215' ' ' ILE . 1.2 t80 -137.19 166.8 22.87 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.48 1.113 . . . . 74.32 111.009 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.538 ' CB ' ' CD1' ' A' ' 184' ' ' ILE . . . -113.72 142.48 45.98 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.546 1.154 . . . . 74.33 109.289 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.431 ' CD1' ' C ' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -127.78 121.59 56.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.485 1.116 . . . . 74.44 109.302 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.522 HG21 ' CB ' ' A' ' 180' ' ' GLU . 7.0 m -83.47 126.88 40.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.442 1.089 . . . . 64.01 109.325 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.491 ' C ' ' CG ' ' A' ' 164' ' ' TYR . 0.3 OUTLIER -99.6 -1.95 36.85 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.499 1.125 . . . . 73.42 109.305 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.491 ' CG ' ' C ' ' A' ' 163' ' ' LEU . 0.9 OUTLIER -154.69 155.57 34.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.486 1.116 . . . . 74.34 111.071 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.423 ' N ' HG12 ' A' ' 178' ' ' VAL . 33.0 p-10 -96.49 154.03 17.5 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.465 1.103 . . . . 65.24 109.314 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.535 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 3.4 t80 -147.23 137.94 23.58 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.49 1.119 . . . . 74.52 111.019 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.535 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 5.9 mtmt -76.56 128.96 35.74 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.499 1.124 . . . . 74.32 109.292 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.468 ' HB1' ' CA ' ' A' ' 173' ' ' GLU . . . -110.86 141.99 43.5 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.46 1.1 . . . . 73.12 109.286 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -148.22 18.87 1.09 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.506 1.129 . . . . 72.12 110.266 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.455 ' O ' ' CG ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -100.25 -176.49 3.24 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.48 1.113 . . . . 71.42 109.306 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.06 -30.73 69.4 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.472 1.108 . . . . 71.11 109.29 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.458 ' O ' ' C ' ' A' ' 173' ' ' GLU . 1.0 OUTLIER -101.96 12.06 37.52 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.489 1.118 . . . . 72.32 109.307 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.468 ' CA ' ' HB1' ' A' ' 168' ' ' ALA . 8.5 pt-20 -33.75 105.57 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.529 1.143 . . . . 73.43 110.264 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.47 ' CD1' ' HA3' ' A' ' 205' ' ' GLY . 13.2 tp -119.46 107.12 12.94 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.484 1.115 . . . . 71.13 109.339 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.494 ' CG2' ' O ' ' A' ' 175' ' ' THR . 14.4 t -85.44 99.14 11.0 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.518 1.136 . . . . 63.04 110.419 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.41 HG21 ' N ' ' A' ' 177' ' ' TYR . 0.7 OUTLIER -107.46 176.08 5.28 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.545 1.153 . . . . 75.22 110.344 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.41 ' N ' HG21 ' A' ' 176' ' ' THR . 5.5 m-85 -120.77 159.97 24.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.614 1.196 . . . . 65.54 110.962 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 165' ' ' ASP . 3.5 m -62.0 146.65 12.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.421 1.076 . . . . 64.11 109.259 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.42 66.14 3.05 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.503 1.127 . . . . 54.53 111.014 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.522 ' CB ' HG21 ' A' ' 162' ' ' VAL . 1.8 tp10 -132.73 169.27 16.93 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.473 0.749 . . . . 72.51 110.278 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -117.43 146.77 43.24 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.438 1.086 . . . . 75.14 109.299 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.488 ' CD2' HG12 ' A' ' 162' ' ' VAL . 0.2 OUTLIER -159.23 152.19 22.02 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 73.42 109.392 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -108.65 119.67 40.2 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.468 1.105 . . . . 75.13 111.044 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.538 ' CD1' ' CB ' ' A' ' 160' ' ' ALA . 1.6 mp -64.82 155.95 6.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.411 1.069 . . . . 75.54 109.275 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.455 ' N ' ' O ' ' A' ' 194' ' ' ILE . 0.2 OUTLIER -138.66 -51.09 0.56 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.52 1.137 . . . . 75.03 108.341 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.474 ' CB ' ' HB ' ' A' ' 194' ' ' ILE . . . -120.73 166.29 13.92 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.506 1.129 . . . . 64.24 109.333 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.422 ' CE1' HG23 ' A' ' 231' ' ' ILE . 0.1 OUTLIER -151.37 141.37 22.08 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.41 1.068 . . . . 73.03 109.638 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.624 ' CE1' ' HD3' ' B' ' 472' ' ' PRO . 0.1 OUTLIER -143.2 141.0 30.98 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.421 1.076 . . . . 75.13 109.623 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.486 ' C ' ' N ' ' A' ' 191' ' ' GLU . 39.1 t-20 48.13 25.68 0.87 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.498 1.124 . . . . 74.44 109.251 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.437 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.9 p 39.02 30.19 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.519 1.137 . . . . 63.32 108.308 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.486 ' N ' ' C ' ' A' ' 189' ' ' ASN . 8.6 tt0 -125.78 -37.92 2.26 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.504 1.128 . . . . 74.3 110.362 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.606 ' CB ' ' CE1' ' A' ' 188' ' ' HIS . 97.1 m95 -112.09 132.24 54.97 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.97 -1.122 . . . . 74.01 107.97 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.586 ' CE2' ' CG1' ' A' ' 209' ' ' VAL . 22.3 m-30 -125.12 129.31 49.93 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.541 1.151 . . . . 61.33 111.033 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.474 ' HB ' ' CB ' ' A' ' 186' ' ' ALA . 1.1 mp -91.27 98.12 8.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.541 1.15 . . . . 74.43 109.317 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -104.14 -175.73 2.88 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.541 1.151 . . . . 71.34 109.301 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.493 ' CD ' ' O ' ' A' ' 197' ' ' PRO . 0.0 OUTLIER -157.12 158.68 31.2 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 63.14 109.286 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.493 ' O ' ' CD ' ' A' ' 196' ' ' LYS . 18.2 Cg_endo -75.04 150.44 37.96 Favored 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.524 1.802 . . . . 74.35 111.024 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 7.2 tp -65.99 -56.2 15.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.454 1.096 . . . . 72.35 109.316 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -72.17 -117.62 0.06 OUTLIER Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.524 1.14 . . . . 44.33 111.022 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -136.07 43.76 2.5 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.491 0.759 . . . . 75.24 110.349 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.26 -1.61 30.53 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 74.35 109.208 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 122.9 -141.19 13.72 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.528 1.142 . . . . 72.14 110.991 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.435 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . 94.43 169.01 37.29 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.99 -0.844 . . . . 72.44 110.99 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.435 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.2 Cg_endo -75.05 133.25 30.59 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 121.008 -2.497 . . . . 74.41 110.925 0.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 195' ' ' ALA . . . -100.44 151.03 18.98 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.478 1.111 . . . . 63.52 110.925 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.556 HD22 ' CZ3' ' A' ' 192' ' ' TRP . 0.4 OUTLIER -90.45 144.2 26.03 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.539 0.788 . . . . 75.1 109.283 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.13 127.81 3.54 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.511 1.132 . . . . 73.24 109.288 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.89 179.44 6.05 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.508 1.794 . . . . 65.3 111.041 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.586 ' CG1' ' CE2' ' A' ' 193' ' ' PHE . 1.0 OUTLIER -98.66 4.41 10.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.596 1.185 . . . . 73.13 109.274 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . 0.489 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -106.43 0.96 37.17 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 124.491 1.119 . . . . 73.12 110.964 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.587 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 6.9 m-85 -130.26 6.58 4.92 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.58 0.812 . . . . 74.51 110.978 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.428 ' CG1' ' C ' ' A' ' 211' ' ' PHE . 1.5 m -150.88 153.82 9.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.473 1.108 . . . . 74.53 109.33 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.4 m -121.64 138.88 54.15 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.502 1.127 . . . . 55.21 110.025 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.498 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 3.8 mm -87.46 124.07 40.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 124.489 1.118 . . . . 75.25 109.268 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.498 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 10.8 pt -158.35 170.82 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.469 1.106 . . . . 75.22 109.304 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -134.52 -47.26 0.75 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.466 1.104 . . . . 75.32 109.265 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 12.7 pt -134.99 -177.44 2.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 124.508 1.13 . . . . 75.25 109.272 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -84.61 -179.18 7.08 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.485 1.116 . . . . 65.3 109.284 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.3 m 68.62 59.88 0.38 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.454 1.096 . . . . 72.2 110.405 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 107.38 -162.39 13.37 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.553 1.158 . . . . 75.51 110.902 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -92.38 -173.12 3.31 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.436 0.727 . . . . 75.43 110.951 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.467 ' CA ' ' HA ' ' A' ' 215' ' ' ILE . . . -41.84 -73.78 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.513 1.133 . . . . 71.21 109.278 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.404 ' CB ' ' OD1' ' A' ' 225' ' ' ASN . 0.9 OUTLIER -120.78 -5.42 9.66 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.45 1.094 . . . . 74.3 110.433 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 93.47 18.39 38.81 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.468 1.105 . . . . 72.41 111.025 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' A' ' 225' ' ' ASN . 0.8 OUTLIER -112.04 167.03 10.71 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.486 0.756 . . . . 73.1 109.315 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 229' ' ' GLU . 0.4 OUTLIER -78.61 148.83 33.1 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.532 1.145 . . . . 53.2 109.318 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 3.7 p -48.28 -49.17 12.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.116 . . . . 75.14 109.318 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.51 ' O ' ' CE ' ' A' ' 232' ' ' LYS . 3.2 mp -59.11 -29.62 41.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.428 1.08 . . . . 72.05 109.319 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 226' ' ' ASP . 15.5 mt-10 -81.41 -15.0 56.49 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.485 1.115 . . . . 73.23 110.281 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.409 ' CG ' ' ND2' ' A' ' 225' ' ' ASN . 1.6 m-20 -86.64 -15.76 38.7 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.499 1.125 . . . . 72.34 109.337 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.422 HG23 ' CE1' ' A' ' 187' ' ' HIS . 0.9 OUTLIER -72.71 -69.34 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 71.43 109.279 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.51 ' CE ' ' O ' ' A' ' 228' ' ' ILE . 0.0 OUTLIER -62.17 -17.55 58.34 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.51 1.131 . . . . 73.22 109.301 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.33 -39.61 60.85 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.504 1.127 . . . . 63.21 110.011 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 235' ' ' ASN . 1.6 m -117.17 27.43 3.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.532 1.145 . . . . 74.14 109.3 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 234' ' ' VAL . 6.8 m120 40.6 37.42 0.47 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.137 . . . . 73.33 109.222 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.8 tp -70.58 119.82 74.97 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.555 1.159 . . . . 73.13 109.268 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 165.36 31.51 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.459 1.768 . . . . 74.25 111.004 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.4 m -60.27 -177.65 0.07 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.507 1.129 . . . . 73.21 110.396 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.4 HG12 ' NE2' ' A' ' 240' ' ' GLN . 9.8 p -72.21 -35.06 51.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 74.32 109.35 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.4 ' NE2' HG12 ' A' ' 239' ' ' VAL . 0.5 OUTLIER -85.52 -17.56 36.03 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.455 1.097 . . . . 74.24 110.278 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -85.15 -42.08 15.08 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.465 1.103 . . . . 71.35 110.364 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -72.65 -60.47 2.22 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.039 -1.097 . . . . 74.31 108.039 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.566 ' HD3' ' CD2' ' B' ' 470' ' ' PHE . 4.1 mtmp? -57.41 -20.49 30.2 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.483 1.114 . . . . 74.1 109.322 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -41.75 -68.12 0.21 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.512 1.132 . . . . 63.04 110.091 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -135.24 100.25 4.49 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.564 1.165 . . . . 61.32 109.31 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 3.8 mt -55.3 -19.69 5.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.495 1.122 . . . . 74.41 109.287 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -93.11 27.07 2.59 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.615 1.197 . . . . 54.42 109.301 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . 0.411 ' NH2' ' HB1' ' A' ' 251' ' ' ALA . 0.0 OUTLIER -48.27 139.66 8.37 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.449 1.093 . . . . 72.13 110.331 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.486 ' CG ' ' N ' ' A' ' 250' ' ' LYS . 17.5 p90 -127.08 -46.62 1.51 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.497 1.123 . . . . 75.41 110.984 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.486 ' N ' ' CG ' ' A' ' 249' ' ' TYR . 9.4 pttp -130.54 129.56 42.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.423 1.077 . . . . 73.3 109.354 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.411 ' HB1' ' NH2' ' A' ' 248' ' ' ARG . . . -82.25 175.03 10.61 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.397 1.061 . . . . 53.31 109.29 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 4.2 t -124.43 176.19 6.64 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.535 1.147 . . . . 73.13 109.997 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . 0.44 ' C ' ' ND2' ' A' ' 253' ' ' ASN . 0.0 OUTLIER -77.97 1.07 21.95 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.582 1.176 . . . . 72.13 109.305 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.66 131.48 33.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.573 1.171 . . . . 74.54 109.275 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 7.4 t -175.83 146.43 0.73 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.447 1.092 . . . . 72.52 110.075 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -62.14 -75.7 0.07 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.553 1.158 . . . . 74.23 109.303 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 131.96 -154.74 21.11 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 124.531 1.144 . . . . 73.3 110.942 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.4 m -122.02 97.68 5.59 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.554 0.796 . . . . 61.31 110.052 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 82.1 t -126.75 107.32 16.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.483 1.114 . . . . 53.42 109.25 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.55 1.156 . . . . 54.1 110.339 179.958 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 109.998 -0.371 . . . . 63.33 109.998 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 30.3 t -104.86 62.74 0.7 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.433 1.083 . . . . 73.13 109.979 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 5.5 m -111.47 -178.47 3.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.597 1.186 . . . . 71.05 109.939 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -62.14 173.64 1.08 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 60.13 109.304 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -116.01 -40.51 3.3 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.519 1.137 . . . . 65.04 109.273 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . 168.2 135.45 1.88 Allowed Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.475 1.109 . . . . 50.23 111.0 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.27 -24.28 13.14 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.521 0.777 . . . . 75.1 109.299 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 470' ' ' PHE . . . . . 0.566 ' CD2' ' HD3' ' A' ' 243' ' ' LYS . 4.0 m-30 -102.74 33.91 3.03 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.467 1.104 . . . . 74.54 111.001 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 471' ' ' ILE . . . . . 0.438 ' CD1' ' N ' ' B' ' 471' ' ' ILE . 0.9 OUTLIER -100.59 138.91 20.24 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.46 1.1 . . . . 74.43 109.279 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 472' ' ' PRO . . . . . 0.624 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.99 -45.6 0.27 Allowed 'Trans proline' 0 C--N 1.359 1.117 0 O-C-N 124.502 1.791 . . . . 72.34 111.033 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 473' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' B' ' 472' ' ' PRO . 0.1 OUTLIER 80.36 5.7 1.68 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.481 1.113 . . . . 74.44 110.027 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -132.01 157.26 78.72 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.565 1.165 . . . . 73.2 110.325 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 475' ' ' PRO . . . . . 0.501 ' O ' ' CB ' ' B' ' 476' ' ' ALA . 18.0 Cg_endo -75.03 -48.09 0.18 Allowed 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.531 1.806 . . . . 61.3 110.971 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 476' ' ' ALA . . . . . 0.501 ' CB ' ' O ' ' B' ' 475' ' ' PRO . . . 162.94 136.64 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.522 1.139 . . . . 75.52 109.322 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 477' ' ' PRO . . . . . 0.555 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.8 Cg_endo -74.89 -177.35 3.38 Favored 'Trans proline' 0 C--N 1.359 1.115 0 O-C-N 124.484 1.781 . . . . 63.03 111.069 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.54 92.29 28.05 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 72.22 109.317 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 479' ' ' PRO . . . . . 0.587 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.2 Cg_endo -75.01 151.53 39.58 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.489 1.784 . . . . 74.24 110.968 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 159.93 40.64 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.533 1.807 . . . . 74.22 111.006 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 481' ' ' SER . . . . . . . . . . . . . 3.7 m 42.35 48.8 4.46 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.45 1.094 . . . . 65.22 110.051 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 2.2 t -87.95 132.65 34.16 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.523 1.14 . . . . 74.25 109.969 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 483' ' ' ALA . . . . . 0.403 ' C ' ' N ' ' B' ' 485' ' ' ALA . . . -100.19 -21.47 15.51 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.443 1.089 . . . . 53.02 109.288 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 32.0 t -44.04 -27.4 0.37 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.539 1.15 . . . . 75.42 109.979 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . 0.403 ' N ' ' C ' ' B' ' 483' ' ' ALA . . . -153.03 156.82 39.51 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 1.114 . . . . 75.12 109.318 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 38.9 m . . . . . 0 C--N 1.325 -0.488 0 O-C-N 124.548 1.155 . . . . 75.04 109.99 -179.952 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.012 0 N-CA-C 111.103 -0.799 . . . . 63.42 111.103 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.1 m -107.26 125.52 51.25 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.542 0.789 . . . . 74.13 109.995 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.44 ' O ' ' CE1' ' A' ' 183' ' ' PHE . 25.2 mt -100.81 128.08 47.0 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 72.41 109.336 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.65 ' CD2' ' CG1' ' A' ' 215' ' ' ILE . 2.5 t80 -130.2 138.4 50.56 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.512 1.133 . . . . 72.01 110.975 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.6 ' O ' ' CE1' ' A' ' 159' ' ' TYR . . . -110.71 147.67 33.89 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.52 1.138 . . . . 73.42 109.305 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.48 ' CG2' ' OG ' ' A' ' 213' ' ' SER . 0.1 OUTLIER -129.45 131.2 67.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.484 1.115 . . . . 72.25 109.38 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.465 HG21 ' CG1' ' A' ' 212' ' ' VAL . 1.5 t -88.73 125.61 41.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.462 1.101 . . . . 71.13 109.307 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.7 mt -101.11 -13.34 18.22 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.502 1.126 . . . . 74.24 109.296 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.441 ' CZ ' ' HB3' ' B' ' 481' ' ' SER . 1.5 m-85 -148.27 156.26 42.33 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.471 1.107 . . . . 74.21 111.041 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -105.95 160.57 15.17 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.55 1.156 . . . . 74.11 109.295 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.566 ' HB3' ' CE1' ' A' ' 211' ' ' PHE . 0.3 OUTLIER -159.7 164.51 33.9 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.492 1.12 . . . . 72.45 110.979 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -89.84 130.77 36.03 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.513 1.133 . . . . 72.2 109.256 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.464 ' HB2' ' CA ' ' A' ' 173' ' ' GLU . . . -104.42 141.65 35.97 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.448 1.092 . . . . 63.41 109.315 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.747 ' H ' ' NZ ' ' A' ' 170' ' ' LYS . 7.7 pt-20 -151.91 21.68 0.68 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.461 1.101 . . . . 73.43 110.303 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.747 ' NZ ' ' H ' ' A' ' 169' ' ' GLU . 0.1 OUTLIER -98.12 -175.93 3.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.524 1.14 . . . . 75.11 109.338 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.12 -29.79 65.8 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.434 1.083 . . . . 54.33 109.328 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 173' ' ' GLU . 3.2 m-20 -110.08 22.81 15.14 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.53 1.143 . . . . 75.13 109.263 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.464 ' CA ' ' HB2' ' A' ' 168' ' ' ALA . 6.2 pt-20 -38.16 106.14 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.475 1.11 . . . . 75.23 110.322 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.485 ' CD2' ' HA3' ' A' ' 205' ' ' GLY . 0.6 OUTLIER -126.82 120.93 30.5 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.491 1.12 . . . . 73.54 109.34 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 11.9 t -87.65 118.49 27.17 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.558 1.162 . . . . 74.21 110.359 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 177' ' ' TYR . 0.6 OUTLIER -120.45 175.52 5.94 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.52 1.138 . . . . 75.32 110.363 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.412 ' N ' HG22 ' A' ' 176' ' ' THR . 14.9 m-85 -127.77 152.9 47.19 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 75.41 111.052 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 3.1 m -51.44 155.05 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 64.42 109.318 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 44.3 74.09 0.23 Allowed Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.519 1.137 . . . . 75.42 110.985 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -132.24 162.19 31.58 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.431 0.724 . . . . 71.3 110.347 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.16 120.54 40.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.529 1.143 . . . . 75.12 109.292 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.452 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 1.2 pt? -136.46 143.83 44.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.504 1.127 . . . . 72.33 109.32 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.44 ' CE1' ' O ' ' A' ' 158' ' ' LEU . 41.7 t80 -104.85 111.24 23.92 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.465 1.103 . . . . 74.22 111.014 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.516 ' CD1' ' HB3' ' A' ' 193' ' ' PHE . 19.0 mm -54.42 164.83 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.523 1.139 . . . . 62.43 109.313 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.466 ' N ' ' CG2' ' A' ' 184' ' ' ILE . 0.1 OUTLIER -151.84 -45.91 0.11 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.498 1.124 . . . . 72.42 108.344 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.476 ' CB ' ' HB ' ' A' ' 194' ' ' ILE . . . -125.66 174.54 8.22 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.501 1.126 . . . . 71.14 109.344 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.619 ' C ' ' CD2' ' A' ' 188' ' ' HIS . 0.9 OUTLIER -155.02 154.02 31.86 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 71.32 109.639 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.705 ' CE1' ' CG1' ' A' ' 239' ' ' VAL . 0.1 OUTLIER -144.11 120.93 11.25 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.51 1.131 . . . . 73.41 109.535 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.453 ' C ' ' N ' ' A' ' 191' ' ' GLU . 55.4 t30 52.05 32.72 10.73 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.455 1.097 . . . . 74.24 109.345 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 9.6 m 41.67 29.24 0.1 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.511 1.132 . . . . 64.34 108.316 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.453 ' N ' ' C ' ' A' ' 189' ' ' ASN . 16.8 tt0 -120.92 -38.55 2.82 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.469 1.106 . . . . 75.43 110.294 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.582 ' CZ2' ' HD3' ' B' ' 477' ' ' PRO . 90.2 m95 -113.26 137.61 51.22 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.538 1.149 . . . . 70.45 108.009 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.584 ' CZ ' HG11 ' A' ' 209' ' ' VAL . 22.4 m-30 -125.83 135.63 52.19 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.469 1.106 . . . . 73.21 111.032 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.551 ' CG1' ' NE2' ' A' ' 188' ' ' HIS . 6.3 mm -100.74 95.63 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 75.44 109.261 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . . . -99.09 -179.72 4.34 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.516 1.135 . . . . 71.42 109.269 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.453 ' CG ' ' C ' ' A' ' 195' ' ' ALA . 10.2 mtpt -151.1 162.98 25.21 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.447 1.092 . . . . 71.45 109.333 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 177.74 8.2 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.493 1.786 . . . . 74.3 110.967 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.453 ' O ' ' CG2' ' A' ' 198' ' ' ILE . 5.3 mp -110.12 14.55 8.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.523 1.14 . . . . 73.51 109.308 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -169.82 -44.53 0.03 OUTLIER Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.548 1.155 . . . . 72.4 111.051 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -58.55 172.75 0.46 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.484 0.755 . . . . 72.4 110.292 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 11.9 tp -114.52 -10.51 12.55 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.388 1.055 . . . . 74.13 109.263 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . -43.16 -53.51 5.62 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.509 1.13 . . . . 65.24 111.049 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.441 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . -42.73 167.05 0.01 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.062 -0.815 . . . . 70.25 111.062 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.441 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.5 Cg_endo -74.97 129.01 17.49 Favored 'Cis proline' 0 C--N 1.359 1.112 0 C-N-CA 120.949 -2.521 . . . . 74.45 111.024 -0.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.485 ' HA3' ' CD2' ' A' ' 174' ' ' LEU . . . -96.34 141.93 15.87 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.514 1.134 . . . . 75.04 111.025 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.482 ' CD2' ' HD3' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -91.2 147.21 23.21 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.552 0.795 . . . . 73.02 109.295 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.44 HG22 ' CD1' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -161.06 129.14 2.85 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.542 1.152 . . . . 64.22 109.336 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.484 ' O ' ' CG2' ' A' ' 212' ' ' VAL . 18.2 Cg_endo -75.03 179.91 5.64 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.565 1.824 . . . . 74.44 110.927 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.584 HG11 ' CZ ' ' A' ' 193' ' ' PHE . 0.6 OUTLIER -96.12 3.32 9.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 124.443 1.089 . . . . 74.42 109.306 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -103.89 -5.93 43.75 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.487 1.117 . . . . 55.12 111.033 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.572 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 5.2 m-85 -125.98 1.76 7.29 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.505 0.767 . . . . 72.32 110.983 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 208' ' ' PRO . 3.5 m -141.28 167.76 16.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.574 1.171 . . . . 72.33 109.306 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' SER . . . . . 0.48 ' OG ' ' CG2' ' A' ' 161' ' ' ILE . 13.1 p -136.2 132.98 36.62 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.445 1.091 . . . . 62.03 109.997 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.496 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 2.9 mm -76.4 144.68 11.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.475 1.109 . . . . 75.03 109.277 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.65 ' CG1' ' CD2' ' A' ' 159' ' ' TYR . 0.2 OUTLIER -156.2 153.84 6.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 124.459 1.1 . . . . 73.13 109.31 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -157.04 174.71 15.11 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 124.388 1.055 . . . . 74.12 109.247 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 4.7 mp -82.03 54.93 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.47 1.106 . . . . 74.02 109.264 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -116.05 15.58 16.1 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.462 1.101 . . . . 64.1 109.281 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 18.6 m 55.08 54.94 8.21 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.482 1.114 . . . . 73.01 110.427 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 174.37 -173.81 46.19 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.524 1.14 . . . . 71.13 110.971 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -120.16 138.77 53.41 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.482 0.754 . . . . 75.15 111.014 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.47 ' O ' ' CG2' ' A' ' 223' ' ' THR . . . 53.49 25.72 4.97 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.52 1.138 . . . . 70.1 109.273 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.47 ' CG2' ' O ' ' A' ' 222' ' ' ALA . 13.5 t 48.45 28.69 1.78 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.459 1.099 . . . . 70.4 110.367 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 81.92 -51.3 4.43 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.497 1.123 . . . . 71.33 111.024 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -68.44 169.52 10.63 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.499 0.764 . . . . 73.21 109.261 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 229' ' ' GLU . 14.0 t0 -73.37 147.7 44.08 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.55 1.156 . . . . 75.22 109.211 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -39.85 -56.27 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.45 1.094 . . . . 75.21 109.282 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 9.9 mt -55.94 -42.46 71.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.499 1.125 . . . . 74.54 109.274 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 226' ' ' ASP . 21.2 mt-10 -66.45 -14.16 61.81 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.506 1.129 . . . . 55.5 110.329 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -88.67 -23.27 23.05 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.564 1.165 . . . . 74.41 109.299 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -63.66 -69.4 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.483 1.114 . . . . 75.22 109.323 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.439 ' CD ' ' HA ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -55.85 -30.58 61.71 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.44 1.088 . . . . 75.42 109.3 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.4 m -52.94 -50.63 63.63 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 60.53 109.954 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 235' ' ' ASN . 1.3 m -89.88 16.08 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.471 1.107 . . . . 75.03 109.26 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 234' ' ' VAL . 37.7 t30 40.56 44.53 1.78 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.516 1.135 . . . . 70.23 109.296 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.1 tp -83.02 119.74 74.79 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.457 1.098 . . . . 74.13 109.307 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 164.37 33.48 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.52 1.8 . . . . 74.32 111.023 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' THR . . . . . 0.53 ' HA ' ' CD2' ' A' ' 187' ' ' HIS . 3.4 m -58.81 -175.72 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.484 1.115 . . . . 63.35 110.364 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.705 ' CG1' ' CE1' ' A' ' 188' ' ' HIS . 2.6 p -74.17 -36.27 43.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.5 1.125 . . . . 74.51 109.333 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -82.65 -17.88 43.04 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.492 1.12 . . . . 74.25 110.315 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -87.07 -38.54 16.42 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.531 1.144 . . . . 71.42 110.299 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.433 ' CH2' ' HB3' ' A' ' 185' ' ' CYS . 6.1 t90 -78.35 -61.33 2.04 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.531 1.144 . . . . 74.34 108.001 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 9.3 mtmt -53.92 -20.53 6.2 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.428 1.08 . . . . 74.13 109.3 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.9 p -39.17 -48.41 1.74 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.542 1.152 . . . . 75.05 109.993 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.414 ' C ' ' N ' ' A' ' 247' ' ' ALA . 3.7 t-20 -160.48 113.73 2.08 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.61 1.194 . . . . 75.43 109.295 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 4.9 mm -43.76 -28.59 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.471 1.107 . . . . 64.31 109.328 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.414 ' N ' ' C ' ' A' ' 245' ' ' ASN . . . -102.63 69.05 1.06 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.515 1.134 . . . . 72.52 109.313 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . 0.415 ' NE ' ' O ' ' A' ' 249' ' ' TYR . 3.3 tmm_? -48.2 104.9 0.06 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.526 1.142 . . . . 75.24 110.218 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.519 ' CD1' ' C ' ' A' ' 249' ' ' TYR . 0.1 OUTLIER -75.09 176.74 6.97 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.522 1.138 . . . . 63.24 110.956 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -44.92 141.42 2.19 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.513 1.133 . . . . 63.34 109.306 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -158.45 -179.31 7.98 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.51 1.131 . . . . 74.22 109.297 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 253' ' ' ASN . 1.7 t -114.37 172.46 7.0 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.478 1.112 . . . . 72.3 110.012 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . 0.435 ' CG ' ' N ' ' A' ' 254' ' ' ILE . 5.2 t30 -110.26 163.28 13.79 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.436 1.085 . . . . 54.51 109.321 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.435 ' N ' ' CG ' ' A' ' 253' ' ' ASN . 3.3 mp -141.28 158.16 22.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.485 1.115 . . . . 75.31 109.305 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 17.5 p -145.18 129.61 17.86 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.454 1.096 . . . . 73.12 110.028 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 97.4 mt -140.64 106.75 5.21 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.519 1.137 . . . . 74.21 109.291 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -38.17 124.77 1.45 Allowed Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.512 1.132 . . . . 73.3 111.066 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 13.9 m -125.15 145.45 49.94 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.524 0.779 . . . . 75.32 109.997 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.5 p -58.21 113.22 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.472 1.107 . . . . 74.04 109.339 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.5 0 O-C-N 124.471 1.107 . . . . 75.11 110.344 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 110.023 -0.362 . . . . 74.05 110.023 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 44.1 t -65.29 124.33 21.91 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.508 1.13 . . . . 74.24 110.034 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 28.6 m -125.76 12.49 7.93 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.579 1.174 . . . . 74.22 109.995 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -156.44 168.45 27.32 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.472 1.107 . . . . 74.14 109.252 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -112.64 -54.81 2.59 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.487 1.117 . . . . 73.15 109.31 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . 73.23 125.08 0.09 OUTLIER Glycine 0 CA--C 1.531 1.08 0 O-C-N 124.459 1.1 . . . . 75.54 110.976 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 9.3 tptp -111.41 -12.21 14.04 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.515 0.774 . . . . 75.11 109.317 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 470' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -86.94 13.99 8.11 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.463 1.102 . . . . 74.24 111.009 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 471' ' ' ILE . . . . . . . . . . . . . 2.8 mm -84.82 140.32 37.67 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.491 1.12 . . . . 74.11 109.353 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 472' ' ' PRO . . . . . 0.404 ' HD3' ' ND1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.92 130.28 13.22 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.528 1.804 . . . . 73.42 111.04 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 46.3 t -78.54 -73.06 0.34 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.456 1.098 . . . . 71.44 109.981 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -65.1 160.03 60.22 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.523 1.139 . . . . 72.14 110.311 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 -167.27 0.41 Allowed 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.461 1.769 . . . . 74.22 110.994 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 476' ' ' ALA . . . . . . . . . . . . . . . -62.86 138.81 97.19 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.496 1.122 . . . . 73.55 109.281 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 477' ' ' PRO . . . . . 0.582 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -75.04 -162.43 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.491 1.785 . . . . 72.44 111.029 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.18 90.75 17.76 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.479 1.112 . . . . 72.21 109.278 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 479' ' ' PRO . . . . . 0.572 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.92 168.41 24.9 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.428 1.752 . . . . 64.14 110.973 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 480' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' B' ' 482' ' ' SER . 18.5 Cg_endo -74.92 -44.84 0.32 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.565 1.824 . . . . 74.54 111.106 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 481' ' ' SER . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 164' ' ' TYR . 0.7 OUTLIER -38.92 -30.18 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.437 1.086 . . . . 73.31 110.054 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 482' ' ' SER . . . . . 0.444 ' N ' ' O ' ' B' ' 480' ' ' PRO . 1.5 t -85.73 108.23 17.96 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.585 1.178 . . . . 63.22 109.996 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -101.73 22.51 12.74 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.473 1.108 . . . . 72.1 109.332 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 24.2 t -124.71 48.79 1.92 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.493 1.121 . . . . 74.43 110.021 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -105.52 99.98 9.57 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.543 1.152 . . . . 60.33 109.359 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 20.2 p . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.513 1.133 . . . . 73.54 109.978 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.023 0 N-CA-C 110.965 -0.854 . . . . 72.35 110.965 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.1 p -52.72 -53.04 53.25 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.488 0.758 . . . . 75.3 110.025 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.6 pp -171.35 143.73 1.88 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.465 1.103 . . . . 73.21 109.29 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -156.87 -178.77 7.61 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.498 1.123 . . . . 74.42 110.973 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.455 ' O ' ' CD1' ' A' ' 182' ' ' LEU . . . -108.82 147.7 31.69 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.485 1.115 . . . . 73.14 109.305 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.449 HG23 ' CD2' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -120.82 135.14 61.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.509 1.131 . . . . 73.4 109.262 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.424 ' O ' ' CA ' ' A' ' 179' ' ' GLY . 2.3 t -93.32 121.01 43.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.455 1.097 . . . . 63.52 109.305 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.449 ' CD2' HG23 ' A' ' 161' ' ' ILE . 0.4 OUTLIER -101.44 -11.5 19.3 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.503 1.127 . . . . 64.41 109.295 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -144.6 160.29 41.41 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 74.32 111.003 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.461 ' CB ' HG11 ' A' ' 178' ' ' VAL . 21.7 p30 -107.95 157.71 17.98 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.554 1.159 . . . . 75.2 109.305 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.599 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 1.2 t80 -160.45 136.43 8.44 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.436 1.085 . . . . 74.11 111.012 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.599 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 12.0 mtpp -67.37 122.69 18.47 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.448 1.093 . . . . 74.4 109.313 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.419 ' HA ' ' NZ ' ' A' ' 170' ' ' LYS . . . -90.62 140.12 30.06 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.585 1.178 . . . . 72.23 109.3 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -152.19 21.69 0.65 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.508 1.13 . . . . 74.13 110.283 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.472 ' HD3' ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -98.72 -176.66 3.42 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.505 1.128 . . . . 65.4 109.335 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.93 -24.87 64.7 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.462 1.101 . . . . 73.31 109.326 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 173' ' ' GLU . 59.7 t0 -113.68 20.44 15.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.458 1.099 . . . . 62.53 109.281 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 172' ' ' ASP . 5.1 pt-20 -36.82 100.51 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 1.104 . . . . 72.45 110.352 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.484 ' HG ' ' CA ' ' A' ' 205' ' ' GLY . 0.1 OUTLIER -132.03 96.2 3.85 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.499 1.124 . . . . 73.3 109.344 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.6 t -59.55 148.82 31.93 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.483 1.115 . . . . 63.34 110.416 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 14.4 m -155.9 117.04 3.87 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.559 1.162 . . . . 71.21 110.435 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -63.94 157.58 24.53 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.512 1.132 . . . . 73.4 110.975 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.461 HG11 ' CB ' ' A' ' 165' ' ' ASP . 2.5 m -58.24 158.19 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.557 1.16 . . . . 75.21 109.249 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.424 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 52.54 62.54 5.71 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.479 1.112 . . . . 72.45 110.998 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -120.2 170.91 8.89 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.514 0.773 . . . . 74.43 110.244 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -129.17 117.56 20.98 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.552 1.157 . . . . 75.22 109.325 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.47 HD22 ' CG1' ' A' ' 207' ' ' VAL . 0.2 OUTLIER -130.58 149.71 52.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.538 1.149 . . . . 64.32 109.315 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.47 ' C ' ' HB1' ' A' ' 195' ' ' ALA . 8.2 t80 -104.13 104.34 14.26 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.531 1.145 . . . . 74.22 111.002 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.519 ' HA ' ' HA ' ' A' ' 195' ' ' ALA . 22.1 mt -68.56 158.46 5.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.468 1.105 . . . . 74.4 109.354 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.603 ' SG ' ' CZ3' ' A' ' 242' ' ' TRP . 27.0 t -152.16 -41.59 0.11 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.522 1.139 . . . . 73.34 108.332 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.509 ' CB ' ' HB ' ' A' ' 194' ' ' ILE . . . -112.22 155.58 23.77 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.547 1.155 . . . . 73.44 109.297 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -148.33 145.04 27.95 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.497 1.123 . . . . 74.2 109.649 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.542 ' CE1' ' HD3' ' B' ' 472' ' ' PRO . 0.1 OUTLIER -143.55 141.41 30.68 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.525 1.141 . . . . 64.32 109.603 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.462 ' C ' ' N ' ' A' ' 191' ' ' GLU . 3.1 m120 49.44 23.34 0.86 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.46 1.1 . . . . 72.41 109.261 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.408 ' C ' ' O ' ' A' ' 189' ' ' ASN . 18.1 m 41.22 28.88 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.117 . . . . 72.5 108.293 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.462 ' N ' ' C ' ' A' ' 189' ' ' ASN . 8.5 tt0 -126.59 -38.58 2.07 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.575 1.172 . . . . 74.14 110.299 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.571 ' CE3' HD13 ' A' ' 206' ' ' LEU . 98.8 m95 -111.55 128.48 56.04 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.527 1.142 . . . . 74.13 108.058 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.592 ' CE2' HG13 ' A' ' 209' ' ' VAL . 22.1 m-30 -120.11 126.2 50.14 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.489 1.118 . . . . 74.44 111.001 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.509 ' HB ' ' CB ' ' A' ' 186' ' ' ALA . 5.6 mm -86.63 104.36 13.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.53 1.144 . . . . 72.42 109.262 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . . . -112.92 175.85 5.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.498 1.124 . . . . 71.23 109.263 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.41 ' NZ ' ' CB ' ' A' ' 196' ' ' LYS . 2.3 ttmp? -137.99 142.66 36.7 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.131 . . . . 74.13 109.323 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 196' ' ' LYS . 18.3 Cg_endo -75.03 155.77 42.83 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.512 1.796 . . . . 73.42 110.993 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.23 123.14 69.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.478 1.111 . . . . 74.43 109.318 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 103.45 -34.97 5.34 Favored Glycine 0 CA--C 1.529 0.937 0 O-C-N 124.474 1.109 . . . . 65.04 111.051 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -90.75 169.48 10.92 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.492 0.76 . . . . 74.24 110.349 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 8.0 mp -109.24 115.96 31.0 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.443 1.09 . . . . 72.24 109.314 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 158.15 -131.34 2.8 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.471 1.107 . . . . 55.02 110.985 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 54.66 176.09 0.12 Allowed Glycine 0 CA--C 1.529 0.969 0 N-CA-C 111.008 -0.837 . . . . 75.21 111.008 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 146.11 85.78 Favored 'Cis proline' 0 C--N 1.36 1.182 0 C-N-CA 121.028 -2.488 . . . . 74.0 111.009 -0.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 195' ' ' ALA . . . -104.7 138.56 14.22 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.494 1.121 . . . . 63.43 110.986 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.571 HD13 ' CE3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -83.37 146.76 28.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.574 0.808 . . . . 73.44 109.384 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.47 ' CG1' HD22 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -153.36 127.01 4.31 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.458 1.099 . . . . 61.44 109.288 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.495 ' O ' ' CG2' ' A' ' 212' ' ' VAL . 18.4 Cg_endo -74.92 174.9 11.96 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.455 1.766 . . . . 75.45 111.002 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.592 HG13 ' CE2' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -93.49 4.81 7.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.537 1.148 . . . . 74.34 109.297 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . 0.495 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -104.72 -8.3 37.47 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.5 1.125 . . . . 62.12 111.024 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.595 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 15.8 m-85 -125.53 -0.8 7.5 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.497 0.763 . . . . 75.14 111.002 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 208' ' ' PRO . 2.5 m -139.63 162.15 26.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.503 1.127 . . . . 73.42 109.267 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.6 t -134.72 133.56 40.09 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 75.42 109.967 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.488 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 2.9 mm -76.85 127.72 37.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.506 1.129 . . . . 74.54 109.28 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.488 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 5.3 pt -161.89 167.24 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 124.544 1.153 . . . . 72.41 109.241 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -130.23 -46.77 1.1 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.41 1.069 . . . . 73.51 109.368 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 7.0 tp -142.56 159.27 19.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.499 1.124 . . . . 74.21 109.282 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.49 -172.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.511 1.132 . . . . 62.0 109.357 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 62.3 m 64.82 55.08 1.25 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.489 1.118 . . . . 70.24 110.443 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 108.06 -155.46 16.21 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.411 1.069 . . . . 72.34 111.008 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -102.95 -174.0 2.45 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.565 0.803 . . . . 72.4 111.038 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -43.06 -73.49 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.55 1.156 . . . . 75.44 109.316 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -117.69 -8.89 10.83 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.558 1.161 . . . . 64.22 110.366 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 96.44 7.25 58.2 Favored Glycine 0 CA--C 1.529 0.938 0 O-C-N 124.507 1.13 . . . . 54.14 111.075 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.446 ' N ' HD21 ' A' ' 225' ' ' ASN . 1.5 m-80 -101.95 160.19 14.7 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.463 0.743 . . . . 73.23 109.271 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 229' ' ' GLU . 0.4 OUTLIER -63.51 145.24 56.03 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.546 1.154 . . . . 75.32 109.329 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -40.38 -45.73 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.439 1.087 . . . . 72.25 109.349 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 7.8 mt -65.27 -46.53 90.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.5 1.125 . . . . 73.32 109.275 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.468 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 11.6 mt-10 -64.95 -17.19 64.17 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.566 1.166 . . . . 71.41 110.338 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.66 -16.44 32.38 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.453 1.095 . . . . 70.43 109.347 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 3.6 mt -76.1 -70.11 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 124.523 1.139 . . . . 72.22 109.323 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.468 ' CD ' ' HA ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -59.67 -26.79 65.83 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.555 1.16 . . . . 72.13 109.236 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.11 -48.1 12.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.474 1.108 . . . . 71.11 110.01 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.1 m -98.02 -15.85 7.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.483 1.115 . . . . 64.55 109.282 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 64.97 49.57 2.07 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 1.135 . . . . 70.15 109.316 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.5 ' CD1' ' O ' ' A' ' 237' ' ' PRO . 0.5 OUTLIER -71.08 146.75 93.08 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.457 1.098 . . . . 75.33 109.319 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.5 ' O ' ' CD1' ' A' ' 236' ' ' LEU . 18.6 Cg_endo -74.95 141.59 26.97 Favored 'Trans proline' 0 C--N 1.359 1.096 0 O-C-N 124.526 1.803 . . . . 74.24 110.995 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' THR . . . . . 0.404 HG23 ' NE2' ' A' ' 240' ' ' GLN . 1.1 m -58.36 176.38 0.18 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.431 1.082 . . . . 75.43 110.478 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.495 ' CG2' ' NZ ' ' A' ' 243' ' ' LYS . 9.9 p -72.09 -33.84 48.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.524 1.14 . . . . 51.31 109.311 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.404 ' NE2' HG23 ' A' ' 238' ' ' THR . 0.3 OUTLIER -85.58 -17.03 37.43 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.479 1.112 . . . . 72.33 110.243 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -87.05 -43.78 12.06 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.494 1.121 . . . . 75.21 110.336 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.603 ' CZ3' ' SG ' ' A' ' 185' ' ' CYS . 0.5 OUTLIER -72.08 -60.73 2.09 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.988 -1.116 . . . . 72.43 107.988 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.495 ' NZ ' ' CG2' ' A' ' 239' ' ' VAL . 4.8 mtmm -54.79 -20.62 8.95 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.498 1.124 . . . . 73.51 109.29 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 6.7 t -40.9 -65.39 0.43 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.564 1.165 . . . . 64.24 110.03 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -138.69 121.6 16.61 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.5 1.125 . . . . 74.45 109.298 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 43.4 mm -48.3 -31.44 3.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 O-C-N 124.514 1.134 . . . . 72.41 109.328 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -124.46 57.81 1.23 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 74.13 109.293 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -52.88 -175.39 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.468 1.105 . . . . 75.33 110.313 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -37.83 112.87 0.23 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.481 1.113 . . . . 70.24 110.965 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.418 ' C ' ' N ' ' A' ' 252' ' ' SER . 0.1 OUTLIER -41.4 149.22 0.12 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.462 1.102 . . . . 74.34 109.245 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -42.81 -29.23 0.3 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.548 1.155 . . . . 75.44 109.321 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' SER . . . . . 0.418 ' N ' ' C ' ' A' ' 250' ' ' LYS . 47.6 t -73.03 127.51 32.77 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.54 1.15 . . . . 74.02 110.075 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -154.42 126.71 7.88 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.514 1.134 . . . . 74.31 109.306 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 4.3 mp -130.26 143.53 40.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.486 1.116 . . . . 73.2 109.358 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.9 m -172.76 132.73 0.56 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 72.3 109.956 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.5 ' C ' ' CD2' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -80.65 -15.78 55.69 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.479 1.112 . . . . 72.33 109.319 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -103.07 165.14 15.92 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.435 1.084 . . . . 73.31 110.957 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 10.5 t -158.37 -175.78 5.52 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.488 0.758 . . . . 65.15 109.921 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.5 p -96.04 165.16 2.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.462 1.101 . . . . 74.23 109.285 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--N 1.325 -0.489 0 O-C-N 124.486 1.116 . . . . 73.43 110.26 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 37.5 t . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 109.979 -0.378 . . . . 64.32 109.979 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 78.9 p -101.61 78.2 1.82 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.516 1.135 . . . . 71.35 110.021 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 73.6 m -81.4 -62.54 1.62 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.514 1.134 . . . . 74.25 110.002 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -83.99 99.91 10.72 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.416 1.072 . . . . 71.33 109.265 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -81.98 121.7 26.85 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.539 1.15 . . . . 64.43 109.333 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -98.94 166.13 21.21 Favored Glycine 0 CA--C 1.529 0.908 0 O-C-N 124.562 1.164 . . . . 74.42 111.027 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 13.6 mtmm -114.09 -11.01 12.76 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.46 0.741 . . . . 71.15 109.295 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 470' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -102.94 -14.16 16.62 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.481 1.113 . . . . 74.12 110.993 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 471' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' B' ' 472' ' ' PRO . 26.4 mm -41.82 142.44 1.1 Allowed Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.505 1.128 . . . . 74.33 109.333 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 472' ' ' PRO . . . . . 0.542 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.91 173.38 14.57 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.473 1.775 . . . . 55.21 111.073 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.91 -46.02 2.94 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.473 1.108 . . . . 70.42 110.014 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 39.3 mtp85 -87.14 158.49 52.56 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.567 1.167 . . . . 71.33 110.3 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 475' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' B' ' 476' ' ' ALA . 18.3 Cg_endo -75.05 -30.94 6.57 Favored 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.469 1.773 . . . . 75.34 110.982 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 476' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' B' ' 475' ' ' PRO . . . 163.38 129.57 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.506 1.129 . . . . 63.12 109.281 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 477' ' ' PRO . . . . . 0.562 ' HG3' ' CE2' ' A' ' 166' ' ' PHE . 18.1 Cg_endo -75.02 -176.59 2.96 Favored 'Trans proline' 0 C--N 1.361 1.2 0 O-C-N 124.515 1.797 . . . . 64.34 110.985 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 478' ' ' LYS . . . . . 0.463 ' CD ' ' O ' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -116.46 95.11 44.86 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.536 1.148 . . . . 74.21 109.35 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 479' ' ' PRO . . . . . 0.595 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.99 150.11 37.69 Favored 'Trans proline' 0 C--N 1.359 1.105 0 O-C-N 124.563 1.823 . . . . 72.33 111.023 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.07 -179.91 5.46 Favored 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.447 1.762 . . . . 72.02 111.009 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 481' ' ' SER . . . . . . . . . . . . . 11.4 m 45.2 64.42 1.41 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 74.14 109.97 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 40.1 t -149.96 137.8 20.15 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.532 1.145 . . . . 72.3 110.009 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -82.72 52.9 2.22 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 74.32 109.334 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 37.3 p -76.72 120.27 21.67 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.511 1.132 . . . . 72.45 110.048 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -73.22 118.77 16.58 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.441 1.088 . . . . 62.4 109.279 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.517 1.136 . . . . 65.23 110.021 179.962 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.967 0 N-CA-C 111.03 -0.828 . . . . 73.13 111.03 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 28.8 t -113.5 81.51 1.52 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.491 0.76 . . . . 72.11 109.993 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.569 ' O ' ' CE1' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -132.8 148.4 52.31 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.554 1.159 . . . . 73.05 109.303 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -143.58 -178.09 5.72 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.552 1.158 . . . . 74.41 110.998 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.561 ' CB ' ' CD1' ' A' ' 184' ' ' ILE . . . -130.42 153.22 48.98 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.511 1.132 . . . . 71.02 109.304 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.502 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.2 OUTLIER -123.89 125.45 71.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.532 1.145 . . . . 74.12 109.265 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.465 ' CG2' HD23 ' A' ' 182' ' ' LEU . 1.9 t -80.51 122.45 35.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.559 1.162 . . . . 72.33 109.284 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.457 ' CD2' HG21 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -98.19 -13.74 20.71 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.519 1.137 . . . . 72.02 109.287 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -146.21 157.71 43.84 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.567 1.167 . . . . 75.34 111.042 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -98.04 158.25 15.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.527 1.142 . . . . 71.35 109.27 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.491 ' CE1' ' HB3' ' B' ' 477' ' ' PRO . 40.5 t80 -145.5 158.9 43.77 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.559 1.162 . . . . 73.11 111.051 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -94.34 127.87 40.5 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.459 1.099 . . . . 74.13 109.288 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.473 ' HB2' ' CA ' ' A' ' 173' ' ' GLU . . . -93.19 142.06 27.73 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.465 1.103 . . . . 71.14 109.329 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -157.87 24.64 0.27 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.503 1.127 . . . . 71.22 110.314 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.528 ' NZ ' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -122.41 -175.36 3.12 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.531 1.145 . . . . 75.05 109.362 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.14 -40.99 82.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.439 1.087 . . . . 71.04 109.325 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 174' ' ' LEU . 3.0 m-20 -85.86 10.99 12.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.54 1.15 . . . . 73.32 109.3 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.519 ' CG ' ' O ' ' A' ' 170' ' ' LYS . 5.4 pt-20 -36.34 96.56 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.432 1.083 . . . . 75.34 110.354 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.477 ' CD1' ' HA3' ' A' ' 205' ' ' GLY . 1.2 tm? -136.98 94.93 3.02 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.517 1.136 . . . . 73.5 109.296 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 9.0 t -59.53 153.36 19.8 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.563 1.164 . . . . 75.01 110.471 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 24.3 m -152.21 141.93 21.89 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.481 1.113 . . . . 74.35 110.374 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -88.37 153.33 21.27 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.408 1.068 . . . . 74.41 111.06 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.434 HG11 ' CB ' ' A' ' 165' ' ' ASP . 2.4 m -59.21 158.3 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.438 1.086 . . . . 70.24 109.299 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 48.81 66.98 1.87 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.455 1.097 . . . . 74.41 110.988 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.502 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 1.9 tt0 -131.15 171.76 12.9 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.552 0.795 . . . . 75.34 110.235 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -123.4 130.65 53.02 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.478 1.112 . . . . 74.5 109.318 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 0.6 OUTLIER -146.82 143.27 28.49 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.431 1.082 . . . . 72.55 109.341 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.569 ' CE1' ' O ' ' A' ' 158' ' ' LEU . 73.4 t80 -100.57 117.99 35.83 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.537 1.148 . . . . 74.03 111.031 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.561 ' CD1' ' CB ' ' A' ' 160' ' ' ALA . 1.6 mp -62.69 151.99 7.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.41 1.068 . . . . 75.53 109.243 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.573 ' O ' ' CZ3' ' A' ' 242' ' ' TRP . 0.9 OUTLIER -136.03 -47.87 0.66 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.569 1.168 . . . . 55.13 108.26 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.474 ' CB ' ' HB ' ' A' ' 194' ' ' ILE . . . -122.25 168.86 11.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.504 1.127 . . . . 72.22 109.279 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.625 ' C ' ' CD2' ' A' ' 188' ' ' HIS . 2.9 p80 -146.67 153.88 40.8 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.443 1.089 . . . . 72.34 109.592 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.703 ' CE1' ' CG1' ' A' ' 239' ' ' VAL . 0.1 OUTLIER -143.92 120.75 11.26 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.471 1.107 . . . . 75.13 109.555 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.473 ' C ' ' N ' ' A' ' 191' ' ' GLU . 86.1 m-20 50.85 35.21 11.76 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.526 1.141 . . . . 73.43 109.352 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.421 ' C ' ' O ' ' A' ' 189' ' ' ASN . 60.9 m 39.77 30.75 0.06 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.553 1.158 . . . . 61.02 108.254 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.473 ' N ' ' C ' ' A' ' 189' ' ' ASN . 11.4 tt0 -122.25 -42.16 2.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.546 1.154 . . . . 72.43 110.279 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.577 ' CH2' ' HD3' ' B' ' 477' ' ' PRO . 95.4 m95 -110.41 136.88 48.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.982 -1.118 . . . . 74.03 107.982 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.573 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.1 m-30 -127.52 124.41 38.18 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.507 1.13 . . . . 74.41 110.964 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.564 HG22 ' CD2' ' B' ' 470' ' ' PHE . 1.4 mp -87.61 97.02 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 70.54 109.317 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -101.99 -179.88 4.13 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.472 1.108 . . . . 61.1 109.295 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.9 ptmt -155.16 167.27 14.42 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.548 1.155 . . . . 75.44 109.303 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.91 169.39 22.7 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.412 1.743 . . . . 62.24 111.044 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 71.2 mt -110.02 -14.25 10.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 O-C-N 124.473 1.108 . . . . 71.52 109.332 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -131.97 -75.87 0.12 Allowed Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.433 1.083 . . . . 62.22 110.995 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -54.72 174.31 0.07 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.526 0.78 . . . . 75.01 110.302 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.11 -172.26 2.0 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.461 1.101 . . . . 74.23 109.351 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 115.85 -51.17 0.74 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.509 1.131 . . . . 71.12 110.984 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -50.4 -177.33 0.02 OUTLIER Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.995 -0.842 . . . . 64.13 110.995 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 142.83 75.93 Favored 'Cis proline' 0 C--N 1.36 1.152 0 C-N-CA 121.012 -2.495 . . . . 62.13 111.006 0.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 195' ' ' ALA . . . -106.07 148.1 16.39 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.538 1.149 . . . . 74.52 110.976 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.575 HD12 ' CE3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -88.61 145.83 25.46 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.511 0.771 . . . . 72.51 109.325 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.484 HG21 ' CD1' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -156.02 126.26 3.36 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.544 1.153 . . . . 64.5 109.295 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.486 ' O ' ' CG2' ' A' ' 212' ' ' VAL . 18.2 Cg_endo -74.98 179.59 5.93 Favored 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.489 1.784 . . . . 75.04 110.926 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.573 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -96.93 6.59 8.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.479 1.112 . . . . 72.43 109.327 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . 0.49 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -108.32 -4.86 32.74 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.551 1.157 . . . . 74.23 110.972 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.586 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 8.1 m-85 -127.44 1.59 6.28 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.518 0.775 . . . . 75.24 111.017 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 208' ' ' PRO . 3.4 m -139.62 153.78 23.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.56 1.162 . . . . 74.34 109.329 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.17 124.3 44.38 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.633 1.208 . . . . 71.32 110.039 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.495 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 2.9 mm -68.32 145.03 13.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.13 . . . . 74.15 109.284 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.495 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 5.5 pt -165.37 137.98 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.539 1.149 . . . . 73.15 109.254 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.08 -44.73 1.89 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.585 1.178 . . . . 72.5 109.236 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 7.2 mt -124.05 171.3 13.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.474 1.109 . . . . 74.41 109.288 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -94.75 35.1 1.26 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.466 1.104 . . . . 60.45 109.312 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 7.9 t -130.72 27.42 4.95 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.441 1.088 . . . . 73.42 110.371 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 144.45 -167.94 26.86 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.473 1.108 . . . . 73.4 111.022 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -135.37 136.6 41.61 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.477 0.751 . . . . 74.44 110.953 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.498 ' O ' ' CG2' ' A' ' 223' ' ' THR . . . 54.49 41.18 32.12 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.506 1.129 . . . . 54.0 109.301 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.498 ' CG2' ' O ' ' A' ' 222' ' ' ALA . 15.2 t 50.1 23.63 1.19 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.536 1.148 . . . . 73.52 110.414 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 86.78 -42.53 3.16 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.51 1.131 . . . . 72.23 111.037 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -63.18 160.24 15.94 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.556 0.797 . . . . 65.13 109.286 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 230' ' ' ASP . 0.4 OUTLIER -69.95 152.03 44.93 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.426 1.079 . . . . 60.43 109.315 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.2 p -47.85 -56.56 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.459 1.1 . . . . 74.43 109.258 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.449 ' O ' ' CE ' ' A' ' 232' ' ' LYS . 3.4 mt -57.1 -32.09 39.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.124 . . . . 71.02 109.375 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.415 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 5.4 mt-10 -80.89 -14.54 57.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.571 1.169 . . . . 73.44 110.312 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 226' ' ' ASP . 0.7 OUTLIER -88.49 -17.9 29.34 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.475 1.109 . . . . 64.23 109.314 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.415 ' CG2' ' N ' ' A' ' 232' ' ' LYS . 0.5 OUTLIER -69.28 -69.2 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.508 1.13 . . . . 72.44 109.34 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.449 ' CE ' ' O ' ' A' ' 228' ' ' ILE . 0.0 OUTLIER -57.91 -20.73 39.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.563 1.164 . . . . 74.45 109.302 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.6 t -50.86 -57.93 7.25 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.54 1.15 . . . . 63.44 110.012 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.5 m -90.8 17.74 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.527 1.142 . . . . 73.42 109.346 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 47.53 34.85 3.74 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.506 1.129 . . . . 73.55 109.259 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.14 119.05 73.58 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.526 1.141 . . . . 72.44 109.287 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.13 167.2 27.44 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.5 1.789 . . . . 72.34 110.976 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' THR . . . . . 0.545 ' HA ' ' CD2' ' A' ' 187' ' ' HIS . 2.7 m -59.24 178.25 0.14 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.453 1.096 . . . . 71.4 110.383 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.703 ' CG1' ' CE1' ' A' ' 188' ' ' HIS . 0.2 OUTLIER -58.77 -67.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.133 . . . . 73.41 109.25 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.486 ' OE1' ' CD1' ' B' ' 471' ' ' ILE . 0.3 OUTLIER -63.91 -22.32 66.87 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.569 1.168 . . . . 74.42 110.339 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -75.85 -33.45 60.02 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.464 1.102 . . . . 75.22 110.246 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.573 ' CZ3' ' O ' ' A' ' 185' ' ' CYS . 2.6 t90 -85.28 -60.36 2.06 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.137 . . . . 73.11 108.007 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.429 ' NZ ' ' CG ' ' B' ' 470' ' ' PHE . 22.1 mtmt -56.18 -18.7 10.91 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.53 1.144 . . . . 71.01 109.308 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -39.19 -48.13 1.71 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.145 . . . . 74.11 109.969 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -152.6 113.2 4.1 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.525 1.141 . . . . 62.33 109.287 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.496 ' CD1' ' N ' ' A' ' 246' ' ' ILE . 1.0 OUTLIER -67.22 -27.91 40.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.498 1.124 . . . . 70.22 109.28 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -82.07 71.73 9.12 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.497 1.123 . . . . 75.45 109.19 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.69 4.42 35.38 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 75.14 110.349 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 15.5 m-30 -40.51 -30.29 0.11 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.54 1.15 . . . . 74.15 111.024 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -75.29 74.02 2.39 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.522 1.139 . . . . 73.22 109.311 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -149.38 -179.44 7.07 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.559 1.162 . . . . 64.32 109.345 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 1.5 m -105.87 158.56 16.67 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.582 1.177 . . . . 73.42 109.974 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . 0.474 ' ND2' ' H ' ' A' ' 254' ' ' ILE . 11.8 t-20 -71.72 164.02 26.73 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.52 1.138 . . . . 73.13 109.319 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.474 ' H ' ' ND2' ' A' ' 253' ' ' ASN . 1.8 mp -128.29 162.36 34.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.554 1.159 . . . . 75.44 109.265 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 9.6 t -167.28 158.25 11.71 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.504 1.128 . . . . 73.43 110.047 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.1 pp -123.18 -179.57 4.34 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.512 1.133 . . . . 75.44 109.296 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -53.99 166.91 1.92 Allowed Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.517 1.136 . . . . 74.21 110.986 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 3.5 m -65.27 -71.7 0.18 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.491 0.759 . . . . 74.41 110.046 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 8.0 p -159.97 137.83 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.46 1.1 . . . . 74.4 109.339 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 . . . . . 0 C--N 1.326 -0.452 0 O-C-N 124.467 1.104 . . . . 72.35 110.266 -179.949 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 42.7 t . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 110.008 -0.367 . . . . 64.33 110.008 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 99.8 p -163.83 160.78 22.7 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.488 1.117 . . . . 71.11 109.91 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 50.3 m -81.36 175.86 10.21 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.521 1.138 . . . . 70.11 109.982 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -168.66 162.27 11.73 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.504 1.128 . . . . 74.04 109.258 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -152.21 144.6 24.05 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.508 1.13 . . . . 73.32 109.331 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . 178.22 -164.3 32.94 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.478 1.111 . . . . 72.21 110.98 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -100.19 -24.77 14.48 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.446 0.733 . . . . 72.54 109.259 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 470' ' ' PHE . . . . . 0.564 ' CD2' HG22 ' A' ' 194' ' ' ILE . 3.3 m-85 -104.92 -2.87 24.06 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.46 1.1 . . . . 74.43 110.938 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 471' ' ' ILE . . . . . 0.486 ' CD1' ' OE1' ' A' ' 240' ' ' GLN . 1.4 mp -75.17 136.8 72.35 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.451 1.094 . . . . 75.01 109.331 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 472' ' ' PRO . . . . . 0.432 ' HD3' ' ND1' ' A' ' 188' ' ' HIS . 18.3 Cg_endo -75.04 -162.66 0.16 Allowed 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.409 1.741 . . . . 74.01 110.977 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 6.2 t -133.08 -52.76 0.9 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.469 1.106 . . . . 61.41 109.958 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 31.9 mtt-85 -81.05 156.18 72.18 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.485 1.116 . . . . 74.33 110.27 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 475' ' ' PRO . . . . . 0.491 ' O ' ' CB ' ' B' ' 476' ' ' ALA . 18.4 Cg_endo -75.05 -30.64 6.88 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.425 1.75 . . . . 73.01 110.982 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 476' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' B' ' 475' ' ' PRO . . . 163.42 131.6 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.538 1.149 . . . . 70.44 109.301 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 477' ' ' PRO . . . . . 0.577 ' HD3' ' CH2' ' A' ' 192' ' ' TRP . 18.6 Cg_endo -74.94 -163.31 0.18 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.553 1.817 . . . . 75.4 111.012 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 478' ' ' LYS . . . . . 0.496 ' CD ' ' O ' ' B' ' 478' ' ' LYS . 0.3 OUTLIER -124.97 94.99 42.94 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 74.31 109.329 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 479' ' ' PRO . . . . . 0.586 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.5 Cg_endo -74.94 155.38 43.23 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.462 1.77 . . . . 73.43 111.066 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 480' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' B' ' 481' ' ' SER . 18.3 Cg_endo -74.96 -160.86 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.459 1.768 . . . . 74.04 110.996 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 481' ' ' SER . . . . . 0.452 ' C ' ' O ' ' B' ' 480' ' ' PRO . 13.8 t -35.63 100.35 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.47 1.107 . . . . 61.12 109.999 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 482' ' ' SER . . . . . 0.401 ' N ' ' O ' ' B' ' 480' ' ' PRO . 0.7 OUTLIER -173.12 166.88 4.95 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.467 1.105 . . . . 42.44 110.009 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -96.05 111.34 23.39 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.463 1.102 . . . . 71.33 109.294 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 46.9 t -103.7 156.48 17.77 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.486 1.116 . . . . 62.1 110.02 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -82.52 -57.25 3.43 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.442 1.089 . . . . 55.53 109.262 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.462 1.101 . . . . 64.11 109.974 179.981 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.966 0 N-CA-C 111.013 -0.835 . . . . 62.42 111.013 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 4.1 m -72.16 127.13 31.6 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.48 0.753 . . . . 74.22 109.994 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.444 ' C ' ' CD1' ' A' ' 159' ' ' TYR . 1.4 pp -124.39 143.73 50.44 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.502 1.126 . . . . 72.43 109.323 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.789 ' CD1' ' CE2' ' A' ' 183' ' ' PHE . 1.4 m-85 -126.82 154.13 44.72 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.538 1.149 . . . . 62.51 110.997 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.611 ' CB ' ' CD1' ' A' ' 184' ' ' ILE . . . -114.64 149.57 36.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.537 1.148 . . . . 63.1 109.302 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.5 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.2 OUTLIER -131.4 127.85 60.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 74.33 109.273 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.471 ' CG2' HD22 ' A' ' 182' ' ' LEU . 1.9 t -80.48 121.19 33.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.556 1.16 . . . . 71.23 109.333 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.438 HD21 ' CG2' ' A' ' 161' ' ' ILE . 0.9 OUTLIER -96.24 -14.48 22.64 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 73.45 109.361 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -146.9 159.23 43.79 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.48 1.113 . . . . 74.45 110.954 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.419 ' N ' HG12 ' A' ' 178' ' ' VAL . 10.4 p-10 -101.1 159.45 15.22 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.566 1.166 . . . . 73.41 109.347 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' B' ' 477' ' ' PRO . 9.0 t80 -158.33 135.71 10.17 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.433 1.083 . . . . 72.25 110.908 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -68.78 132.34 46.64 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.144 . . . . 74.23 109.337 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.473 ' HB1' ' CA ' ' A' ' 173' ' ' GLU . . . -112.98 141.82 46.39 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.539 1.149 . . . . 71.12 109.311 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -150.42 20.37 0.84 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.51 1.131 . . . . 75.3 110.346 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.478 ' NZ ' ' CH2' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -96.42 -176.57 3.67 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.496 1.123 . . . . 64.24 109.26 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.41 -20.63 63.29 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.501 1.126 . . . . 64.21 109.319 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.454 ' HB3' ' CB ' ' A' ' 206' ' ' LEU . 7.1 t0 -117.11 18.88 14.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.493 1.121 . . . . 71.44 109.307 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.473 ' CA ' ' HB1' ' A' ' 168' ' ' ALA . 6.5 pt-20 -36.52 106.44 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.483 1.114 . . . . 71.42 110.28 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.472 ' CD2' ' HA3' ' A' ' 205' ' ' GLY . 15.8 tp -116.55 105.94 13.01 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.422 1.076 . . . . 62.41 109.307 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 9.7 t -87.22 110.02 19.88 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.437 1.086 . . . . 74.14 110.367 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 87.8 m -130.97 169.98 15.09 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.581 1.176 . . . . 73.42 110.386 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -112.41 161.95 16.12 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.458 1.099 . . . . 72.44 111.015 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.7 m -55.4 158.16 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 65.41 109.3 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.44 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 50.24 68.55 1.38 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.462 1.101 . . . . 72.42 111.013 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.5 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 5.2 tp10 -126.48 164.79 20.39 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 124.547 0.792 . . . . 73.24 110.322 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -113.42 129.21 56.59 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.507 1.13 . . . . 74.51 109.256 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.544 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 0.4 OUTLIER -152.48 146.95 25.68 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.498 1.124 . . . . 65.3 109.274 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.789 ' CE2' ' CD1' ' A' ' 159' ' ' TYR . 3.8 m-85 -111.92 120.35 41.61 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.464 1.103 . . . . 72.42 111.021 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.611 ' CD1' ' CB ' ' A' ' 160' ' ' ALA . 1.7 mp -71.02 152.11 8.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.485 1.115 . . . . 75.03 109.281 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.472 ' SG ' ' N ' ' A' ' 186' ' ' ALA . 15.5 p -142.25 -44.15 0.33 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.508 1.13 . . . . 74.3 108.327 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.494 ' CB ' ' HB ' ' A' ' 194' ' ' ILE . . . -116.19 159.1 22.27 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.49 1.119 . . . . 75.03 109.303 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.453 ' O ' ' N ' ' A' ' 239' ' ' VAL . 0.0 OUTLIER -147.85 148.93 31.4 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.463 1.102 . . . . 73.31 109.639 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.621 ' CD2' ' O ' ' A' ' 192' ' ' TRP . 0.5 OUTLIER -152.44 143.96 23.42 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.492 1.12 . . . . 74.03 109.584 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.473 ' C ' ' N ' ' A' ' 191' ' ' GLU . 27.3 t-20 51.11 22.88 1.38 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.547 1.154 . . . . 73.35 109.34 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.441 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.5 p 39.03 30.19 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.531 1.145 . . . . 62.43 108.292 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.473 ' N ' ' C ' ' A' ' 189' ' ' ASN . 9.9 tt0 -131.31 -40.15 1.14 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.438 1.086 . . . . 73.31 110.307 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.621 ' O ' ' CD2' ' A' ' 188' ' ' HIS . 96.4 m95 -107.33 131.72 53.92 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.035 -1.098 . . . . 74.42 108.035 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.625 ' CE2' ' CG1' ' A' ' 209' ' ' VAL . 22.4 m-30 -125.59 133.06 52.4 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.597 1.185 . . . . 64.32 111.048 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.55 ' CD1' ' NE2' ' A' ' 188' ' ' HIS . 0.7 OUTLIER -93.3 105.67 17.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.522 1.139 . . . . 72.41 109.289 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -109.13 176.73 4.99 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.392 1.057 . . . . 75.23 109.306 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.5 pttm -149.47 168.76 10.34 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.593 1.183 . . . . 72.53 109.362 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.495 ' CG ' ' O ' ' A' ' 202' ' ' GLY . 18.5 Cg_endo -75.02 174.44 12.78 Favored 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.528 1.804 . . . . 64.52 110.981 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 6.6 tp -57.13 -29.85 33.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.542 1.151 . . . . 72.43 109.278 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 130.58 62.95 0.1 OUTLIER Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.445 1.09 . . . . 62.43 111.008 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -124.74 -76.2 0.59 Allowed 'General case' 0 C--N 1.323 -0.568 0 O-C-N 124.47 0.747 . . . . 74.52 110.336 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 8.2 tp -159.32 108.65 1.88 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.467 1.105 . . . . 72.25 109.325 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . 0.495 ' O ' ' CG ' ' A' ' 197' ' ' PRO . . . 129.86 157.88 9.25 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.47 1.106 . . . . 42.2 110.984 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.408 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . 95.25 170.79 36.44 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.035 -0.826 . . . . 74.15 111.035 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.408 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.1 Cg_endo -75.06 136.75 46.62 Favored 'Cis proline' 0 C--N 1.36 1.14 0 C-N-CA 121.002 -2.499 . . . . 61.54 111.0 0.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.472 ' HA3' ' CD2' ' A' ' 174' ' ' LEU . . . -99.72 156.74 19.77 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.529 1.143 . . . . 63.22 110.955 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.49 ' CD2' ' CZ3' ' A' ' 192' ' ' TRP . 0.3 OUTLIER -93.12 146.45 23.65 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.455 0.738 . . . . 71.33 109.345 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.432 ' N ' ' HG ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -159.99 127.05 2.6 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.534 1.146 . . . . 73.04 109.281 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 179.83 5.7 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.479 1.779 . . . . 71.13 110.964 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.625 ' CG1' ' CE2' ' A' ' 193' ' ' PHE . 1.4 m -96.91 4.27 9.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.441 1.088 . . . . 65.04 109.314 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . 0.5 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -108.01 1.84 33.53 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.546 1.153 . . . . 73.03 111.026 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.582 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 14.1 m-85 -133.3 7.64 3.93 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.56 0.8 . . . . 65.02 111.003 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.433 HG13 ' CG2' ' A' ' 162' ' ' VAL . 4.5 m -144.32 153.69 15.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.562 1.164 . . . . 73.22 109.296 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 5.4 t -126.7 137.73 53.31 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.523 1.14 . . . . 73.22 109.978 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.458 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 3.2 mm -75.76 147.75 7.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.434 1.084 . . . . 74.34 109.286 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.458 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 4.6 pt -160.1 135.45 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.518 1.136 . . . . 74.44 109.331 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.428 ' C ' ' N ' ' A' ' 218' ' ' ALA . 13.2 t0 -131.7 74.57 1.6 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.558 1.161 . . . . 74.23 109.244 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.492 ' CG2' ' O ' ' A' ' 217' ' ' ILE . 0.3 OUTLIER 40.53 30.64 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.472 1.107 . . . . 71.41 109.283 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.428 ' N ' ' C ' ' A' ' 216' ' ' ASP . . . -118.95 165.02 14.61 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.495 1.122 . . . . 73.13 109.249 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 7.8 t -96.02 -8.14 34.43 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.498 1.124 . . . . 73.34 110.387 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -80.83 -142.62 3.28 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.457 1.098 . . . . 74.43 111.012 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -148.07 122.73 9.86 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.573 0.808 . . . . 74.44 111.025 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 61.27 19.36 10.05 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.513 1.133 . . . . 75.13 109.275 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.472 ' O ' ' CG2' ' A' ' 223' ' ' THR . 0.3 OUTLIER 73.36 5.22 5.0 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.51 1.131 . . . . 64.25 110.417 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 115.36 -47.9 0.99 Allowed Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.485 1.116 . . . . 54.41 111.009 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -75.12 168.82 19.24 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.471 0.748 . . . . 73.24 109.336 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -81.31 150.25 28.58 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.449 1.093 . . . . 70.12 109.285 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 3.7 p -44.12 -50.89 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.469 1.106 . . . . 72.44 109.319 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.472 ' O ' ' NZ ' ' A' ' 232' ' ' LYS . 5.0 mt -53.75 -47.27 62.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.505 1.128 . . . . 75.41 109.274 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.402 ' O ' ' OG ' ' A' ' 233' ' ' SER . 13.9 mt-10 -66.28 -13.86 61.11 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.5 1.125 . . . . 63.35 110.334 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -88.52 -16.47 32.57 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.517 1.135 . . . . 75.45 109.289 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.423 HG21 ' NZ ' ' A' ' 232' ' ' LYS . 0.5 OUTLIER -73.59 -69.62 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.5 1.125 . . . . 74.15 109.291 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.537 ' H ' ' NZ ' ' A' ' 232' ' ' LYS . 0.0 OUTLIER -62.23 -16.83 55.99 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.41 1.069 . . . . 74.33 109.313 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 229' ' ' GLU . 0.5 OUTLIER -51.8 -56.25 15.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.501 1.125 . . . . 72.32 109.992 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.474 ' CG2' ' HB3' ' A' ' 236' ' ' LEU . 3.7 m -88.87 14.88 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.537 1.148 . . . . 74.54 109.309 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 49.4 t30 54.96 32.42 18.0 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.546 1.154 . . . . 73.22 109.27 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.474 ' HB3' ' CG2' ' A' ' 234' ' ' VAL . 0.0 OUTLIER -82.57 118.23 71.15 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.445 1.09 . . . . 73.41 109.332 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.99 -174.09 1.81 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.508 1.794 . . . . 63.13 110.998 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' THR . . . . . 0.546 ' CG2' ' NE2' ' A' ' 240' ' ' GLN . 0.8 OUTLIER -58.78 -170.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.456 1.098 . . . . 73.44 110.461 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.468 HG22 ' CB ' ' A' ' 186' ' ' ALA . 10.8 p -79.79 -43.64 22.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.478 1.111 . . . . 72.33 109.307 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.546 ' NE2' ' CG2' ' A' ' 238' ' ' THR . 0.0 OUTLIER -87.24 -12.83 45.54 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 1.114 . . . . 62.55 110.321 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.488 ' N ' ' OE1' ' A' ' 240' ' ' GLN . 2.0 mt-10 -82.88 -37.24 24.57 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.516 1.135 . . . . 74.42 110.296 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -77.38 -59.29 2.84 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.531 1.145 . . . . 72.41 107.977 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.643 ' NZ ' ' CD2' ' B' ' 470' ' ' PHE . 26.8 mtmt -56.56 -18.66 12.54 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.571 1.169 . . . . 72.44 109.391 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 243' ' ' LYS . 1.1 t -39.09 -56.48 1.44 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.501 1.126 . . . . 72.23 109.939 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -150.12 130.19 13.52 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.482 1.114 . . . . 63.44 109.376 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 13.2 mm -69.08 -56.3 12.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.544 1.152 . . . . 71.32 109.263 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -98.51 85.26 3.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.531 1.144 . . . . 74.4 109.341 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . 0.405 ' HD3' ' N ' ' A' ' 249' ' ' TYR . 0.0 OUTLIER -115.28 -31.65 5.9 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.515 1.134 . . . . 75.44 110.246 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 249' ' ' TYR . 0.6 OUTLIER 46.17 59.53 3.73 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.525 1.141 . . . . 75.24 110.988 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -168.86 158.79 9.12 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.509 1.13 . . . . 74.44 109.312 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -94.48 -173.0 2.92 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.597 1.186 . . . . 71.43 109.294 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 61.5 m -118.31 -81.91 0.63 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.481 1.113 . . . . 73.52 109.986 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -128.4 -170.79 2.32 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.491 1.119 . . . . 53.25 109.343 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 31.9 mm -149.32 111.6 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.495 1.122 . . . . 64.1 109.254 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.8 t -95.77 -47.41 6.18 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.467 1.104 . . . . 74.24 109.978 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.4 pt? 42.19 31.04 0.22 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.454 1.096 . . . . 72.43 109.289 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -92.89 -171.1 40.31 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 124.461 1.101 . . . . 72.31 111.024 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.3 m -142.16 175.0 10.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.528 0.781 . . . . 72.12 109.993 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 13.3 p -140.25 137.37 37.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.52 1.137 . . . . 71.21 109.255 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 . . . . . 0 C--N 1.325 -0.458 0 O-C-N 124.506 1.129 . . . . 70.11 110.294 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 463' ' ' SER . . . . . 0.437 ' O ' ' N ' ' B' ' 465' ' ' SER . 3.2 m . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 109.945 -0.391 . . . . 61.11 109.945 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.59 75.25 0.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.459 1.099 . . . . 74.22 110.004 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 465' ' ' SER . . . . . 0.437 ' N ' ' O ' ' B' ' 463' ' ' SER . 1.4 p -167.26 -175.79 3.06 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.522 1.139 . . . . 71.42 110.066 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -171.07 162.71 7.2 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.47 1.106 . . . . 62.33 109.359 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 60.97 37.07 18.42 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.5 1.125 . . . . 75.25 109.236 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -137.64 116.7 1.38 Allowed Glycine 0 CA--C 1.529 0.935 0 O-C-N 124.542 1.151 . . . . 65.33 111.048 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -113.2 -12.51 13.1 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.477 0.751 . . . . 63.23 109.22 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 470' ' ' PHE . . . . . 0.643 ' CD2' ' NZ ' ' A' ' 243' ' ' LYS . 3.2 m-30 -89.26 2.05 54.85 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.458 1.099 . . . . 63.43 111.073 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 471' ' ' ILE . . . . . . . . . . . . . 5.2 mm -65.91 135.23 95.28 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.483 1.115 . . . . 71.3 109.267 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 472' ' ' PRO . . . . . 0.588 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.95 149.92 37.65 Favored 'Trans proline' 0 C--N 1.361 1.225 0 O-C-N 124.522 1.801 . . . . 72.01 111.012 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 23.0 t -106.15 -37.18 6.68 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.486 1.116 . . . . 73.41 110.031 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -101.27 166.11 12.93 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.419 1.074 . . . . 75.14 110.27 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.06 -167.9 0.47 Allowed 'Trans proline' 0 C--N 1.361 1.203 0 O-C-N 124.511 1.795 . . . . 73.35 110.98 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 476' ' ' ALA . . . . . . . . . . . . . . . -71.33 134.05 84.99 Favored Pre-proline 0 C--N 1.326 -0.439 0 O-C-N 124.535 1.147 . . . . 41.14 109.293 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 477' ' ' PRO . . . . . 0.522 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -75.07 -167.85 0.46 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.56 1.821 . . . . 75.32 111.032 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.08 91.82 38.2 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 124.42 1.075 . . . . 62.23 109.302 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 479' ' ' PRO . . . . . 0.582 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.3 Cg_endo -74.96 151.21 39.43 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.535 1.808 . . . . 64.41 110.973 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.0 158.22 42.31 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.523 1.802 . . . . 74.31 110.938 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 481' ' ' SER . . . . . . . . . . . . . 3.7 t 54.25 32.7 16.65 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.427 1.079 . . . . 72.51 110.061 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 58.6 p -73.25 113.09 9.93 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.427 1.079 . . . . 73.55 109.973 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -89.4 14.94 10.04 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.471 1.107 . . . . 74.12 109.306 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 2.8 p -112.38 8.38 19.52 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.496 1.123 . . . . 73.44 110.034 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -137.54 178.86 6.78 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.518 1.136 . . . . 55.43 109.333 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 80.9 p . . . . . 0 C--N 1.324 -0.501 0 O-C-N 124.412 1.07 . . . . 75.14 109.984 179.999 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.967 0 N-CA-C 111.0 -0.84 . . . . 62.12 111.0 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.7 t -147.88 179.1 7.96 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.477 0.751 . . . . 71.32 109.988 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 mt 64.37 64.29 0.72 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.456 1.098 . . . . 73.32 109.349 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -118.93 155.62 30.99 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.546 1.154 . . . . 74.53 111.01 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.467 ' O ' ' CD1' ' A' ' 182' ' ' LEU . . . -115.82 144.45 43.99 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.549 1.155 . . . . 63.31 109.291 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.449 HG22 ' CD2' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -129.37 132.04 66.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 124.505 1.128 . . . . 73.3 109.358 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.407 ' O ' ' CA ' ' A' ' 179' ' ' GLY . 2.1 t -91.37 122.22 42.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.445 1.09 . . . . 72.14 109.312 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.449 ' CD2' HG22 ' A' ' 161' ' ' ILE . 0.7 OUTLIER -98.26 -14.36 20.32 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.457 1.098 . . . . 70.1 109.305 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.646 ' CZ ' ' CB ' ' B' ' 481' ' ' SER . 1.1 m-85 -144.54 156.54 44.2 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.503 1.127 . . . . 74.4 111.033 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.472 ' CB ' HG11 ' A' ' 178' ' ' VAL . 5.8 t70 -98.96 158.38 15.69 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.422 1.076 . . . . 54.12 109.25 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.555 ' CE2' ' HG3' ' B' ' 477' ' ' PRO . 1.4 t80 -160.26 131.06 5.59 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.56 1.162 . . . . 74.33 110.993 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.552 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 16.8 mtpp -67.21 121.26 15.26 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.445 1.091 . . . . 63.02 109.268 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.22 140.39 29.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.416 1.073 . . . . 61.43 109.293 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -150.47 21.03 0.83 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.512 1.132 . . . . 72.12 110.308 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.472 ' HD3' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -99.33 -176.22 3.23 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.511 1.132 . . . . 74.14 109.248 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.44 -29.14 67.57 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.548 1.155 . . . . 65.34 109.295 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 173' ' ' GLU . 5.6 m-20 -107.83 18.73 20.97 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.522 1.139 . . . . 75.13 109.281 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.428 ' HB3' ' N ' ' A' ' 170' ' ' LYS . 6.8 pt-20 -36.62 104.06 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.539 1.149 . . . . 74.43 110.255 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.481 ' HG ' ' CA ' ' A' ' 205' ' ' GLY . 0.8 OUTLIER -141.15 95.31 2.82 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 75.02 109.278 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.01 153.66 33.15 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.462 1.101 . . . . 74.14 110.34 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 25.4 m -155.99 102.54 2.16 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.462 1.101 . . . . 74.41 110.387 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -44.17 160.56 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 71.34 111.019 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.472 HG11 ' CB ' ' A' ' 165' ' ' ASP . 1.9 m -62.08 158.48 3.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.529 1.143 . . . . 74.34 109.289 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.407 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 49.41 62.69 4.58 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.469 1.105 . . . . 71.2 110.98 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -118.56 165.55 13.8 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.516 0.774 . . . . 71.21 110.315 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -123.4 123.4 40.58 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.486 1.116 . . . . 74.11 109.26 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.467 ' CD1' ' O ' ' A' ' 160' ' ' ALA . 0.1 OUTLIER -141.65 155.14 45.72 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.422 1.076 . . . . 74.53 109.249 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.428 ' C ' ' HB2' ' A' ' 195' ' ' ALA . 7.3 t80 -109.59 112.61 24.8 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.546 1.154 . . . . 73.51 110.999 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.565 HD11 ' CD2' ' A' ' 193' ' ' PHE . 36.8 mt -70.96 151.43 9.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.463 1.102 . . . . 73.21 109.319 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.607 ' SG ' ' CH2' ' A' ' 242' ' ' TRP . 1.8 t -139.99 -43.85 0.43 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.466 1.104 . . . . 74.45 108.276 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.503 ' CB ' ' HB ' ' A' ' 194' ' ' ILE . . . -112.17 166.8 10.94 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.525 1.141 . . . . 64.31 109.316 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.521 ' C ' ' CD2' ' A' ' 188' ' ' HIS . 2.9 p80 -159.37 149.55 19.06 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.123 . . . . 73.45 109.617 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.665 ' CD2' ' CG1' ' A' ' 239' ' ' VAL . 0.0 OUTLIER -141.61 133.14 26.87 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.438 1.086 . . . . 71.22 109.651 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 190' ' ' CYS . 95.7 m-20 49.02 31.16 3.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.564 1.165 . . . . 74.53 109.313 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.442 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.0 p 38.47 34.8 0.08 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.474 1.109 . . . . 74.31 108.352 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.422 ' N ' ' C ' ' A' ' 189' ' ' ASN . 8.6 tt0 -128.49 -39.32 1.67 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.505 1.128 . . . . 74.12 110.324 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.573 ' CZ2' ' HD3' ' B' ' 477' ' ' PRO . 98.6 m95 -111.56 126.43 54.98 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.483 1.115 . . . . 75.3 108.059 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.593 ' CZ ' HG11 ' A' ' 209' ' ' VAL . 20.9 m-30 -117.99 132.17 56.41 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.526 1.141 . . . . 73.52 110.979 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.503 ' HB ' ' CB ' ' A' ' 186' ' ' ALA . 10.1 mm -96.37 103.45 14.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.385 1.053 . . . . 73.53 109.294 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.506 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . . . -111.59 174.78 5.71 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.514 1.134 . . . . 73.31 109.299 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.36 165.56 19.74 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 124.525 1.14 . . . . 74.52 109.238 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.94 178.26 7.47 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.509 1.794 . . . . 63.42 111.042 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.57 15.28 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.536 1.147 . . . . 74.31 109.302 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -138.81 -122.66 2.04 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.575 1.172 . . . . 72.03 111.042 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -161.01 172.81 16.21 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.496 0.763 . . . . 74.41 110.26 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.7 tp 78.85 81.48 0.06 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.539 1.149 . . . . 73.34 109.3 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 143.16 -85.2 0.19 Allowed Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.451 1.094 . . . . 63.32 111.085 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -49.53 -179.72 0.02 OUTLIER Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.002 -0.839 . . . . 60.44 111.002 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.9 143.53 78.12 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.045 -2.481 . . . . 75.31 111.024 -0.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.481 ' CA ' ' HG ' ' A' ' 174' ' ' LEU . . . -105.76 150.98 17.05 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.582 1.176 . . . . 63.11 110.962 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.568 HD12 ' CE3' ' A' ' 192' ' ' TRP . 0.1 OUTLIER -87.34 146.21 26.01 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 0.763 . . . . 72.02 109.314 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.448 ' N ' ' HG ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -153.79 122.23 3.07 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.53 1.144 . . . . 71.0 109.242 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.498 ' O ' ' CG2' ' A' ' 212' ' ' VAL . 18.5 Cg_endo -74.97 170.96 19.25 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.509 1.794 . . . . 74.03 111.015 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.593 HG11 ' CZ ' ' A' ' 193' ' ' PHE . 0.8 OUTLIER -89.75 5.2 5.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.118 . . . . 73.35 109.221 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -103.47 -12.11 31.65 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.522 1.139 . . . . 75.05 110.995 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.595 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 10.8 m-85 -124.0 -1.24 8.32 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.478 0.752 . . . . 74.11 111.054 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.498 ' CG2' ' O ' ' A' ' 208' ' ' PRO . 2.2 m -140.4 160.67 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.501 1.125 . . . . 71.3 109.294 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.8 m -128.67 147.93 50.78 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.444 1.09 . . . . 75.1 110.07 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.466 ' CD1' HD13 ' A' ' 184' ' ' ILE . 2.7 mm -94.42 141.19 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 64.54 109.235 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.546 ' CD1' ' N ' ' A' ' 215' ' ' ILE . 0.0 OUTLIER -143.29 143.51 24.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.514 1.133 . . . . 74.33 109.218 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -93.8 -16.05 24.52 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.457 1.098 . . . . 73.04 109.312 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.42 ' CG2' ' O ' ' A' ' 219' ' ' THR . 4.4 tt -149.12 175.65 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.536 1.148 . . . . 75.34 109.276 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -46.85 -69.11 0.14 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.447 1.092 . . . . 62.04 109.332 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.42 ' O ' ' CG2' ' A' ' 217' ' ' ILE . 43.0 m -103.38 143.93 32.05 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.527 1.142 . . . . 74.43 110.36 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 125.4 -159.99 19.95 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.516 1.135 . . . . 71.45 110.969 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.415 ' O ' ' N ' ' A' ' 223' ' ' THR . 0.1 OUTLIER -119.88 -172.27 2.31 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.483 0.755 . . . . 64.2 111.021 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.506 ' O ' ' CG2' ' A' ' 223' ' ' THR . . . -69.43 70.35 0.27 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.479 1.112 . . . . 73.23 109.213 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.506 ' CG2' ' O ' ' A' ' 222' ' ' ALA . 15.2 t 50.49 18.19 0.43 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.559 1.162 . . . . 72.01 110.412 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.402 ' N ' ' C ' ' A' ' 222' ' ' ALA . . . 92.27 -45.37 2.62 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.489 1.118 . . . . 74.53 111.03 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -63.09 156.53 24.67 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.546 0.792 . . . . 74.12 109.271 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 229' ' ' GLU . 19.9 t0 -72.17 149.3 44.81 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.506 1.129 . . . . 70.21 109.276 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -40.27 -45.63 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.532 1.145 . . . . 73.54 109.271 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.412 ' HA ' ' CD1' ' A' ' 231' ' ' ILE . 4.5 mp -64.78 -49.03 82.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.537 1.148 . . . . 73.42 109.316 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.472 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 34.0 mt-10 -62.4 -16.67 56.16 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.445 1.091 . . . . 73.5 110.29 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -89.16 -19.11 25.89 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.476 1.11 . . . . 54.12 109.332 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.412 ' CD1' ' HA ' ' A' ' 228' ' ' ILE . 3.0 mt -72.64 -69.89 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 124.565 1.166 . . . . 73.14 109.331 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.472 ' CD ' ' HA ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -57.5 -22.74 45.92 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.508 1.13 . . . . 63.42 109.283 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.21 -56.79 7.05 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.132 . . . . 74.13 109.945 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.6 m -98.49 24.65 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.499 1.124 . . . . 73.24 109.241 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 41.29 36.73 0.53 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.515 1.134 . . . . 53.31 109.291 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 4.2 tp -60.17 119.83 45.67 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.521 1.138 . . . . 74.53 109.312 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 162.79 36.57 Favored 'Trans proline' 0 C--N 1.359 1.115 0 O-C-N 124.499 1.789 . . . . 61.5 110.967 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.7 m -68.52 173.02 5.37 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.49 1.119 . . . . 62.01 110.419 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.665 ' CG1' ' CD2' ' A' ' 188' ' ' HIS . 10.5 p -65.3 -49.95 75.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.54 1.15 . . . . 63.25 109.281 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.481 ' OE1' ' CD1' ' B' ' 471' ' ' ILE . 7.6 pm0 -68.63 -14.95 63.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 75.01 110.353 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -88.49 -39.64 14.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.552 1.157 . . . . 71.31 110.381 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.607 ' CH2' ' SG ' ' A' ' 185' ' ' CYS . 0.2 OUTLIER -80.68 -63.07 1.49 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.506 1.129 . . . . 75.12 108.015 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.485 ' HD3' ' CG2' ' A' ' 239' ' ' VAL . 14.7 mtpp -51.5 -23.26 3.84 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.479 1.112 . . . . 73.43 109.292 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -39.55 -67.59 0.21 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.129 . . . . 71.22 109.933 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -135.12 121.77 20.78 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.581 1.176 . . . . 71.54 109.32 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 23.1 mm -48.08 -53.7 5.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.564 1.165 . . . . 72.3 109.285 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -122.74 117.47 25.8 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.506 1.128 . . . . 74.45 109.29 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.31 173.74 11.98 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.455 1.097 . . . . 74.11 110.272 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -76.75 153.47 34.99 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.426 1.079 . . . . 63.23 110.919 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 131.04 49.8 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.44 1.087 . . . . 64.24 109.272 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -174.45 -178.02 1.32 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.515 1.135 . . . . 72.12 109.295 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 57.8 m 56.98 54.66 6.79 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.412 1.07 . . . . 73.32 109.975 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -106.12 134.2 49.62 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.459 1.099 . . . . 74.41 109.328 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 4.5 mp -125.74 141.42 45.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.518 1.136 . . . . 75.54 109.277 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 15.1 t -146.97 108.64 4.34 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.446 1.091 . . . . 71.53 110.005 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 4.8 mt -127.55 -179.28 4.83 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.443 1.089 . . . . 72.12 109.298 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -73.3 -140.58 0.46 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.51 1.131 . . . . 53.41 110.998 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 43.5 t -169.11 141.45 2.61 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.502 0.766 . . . . 54.12 110.04 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 35.0 m -140.26 -175.41 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.499 1.125 . . . . 71.54 109.347 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.324 -0.51 0 O-C-N 124.503 1.127 . . . . 64.04 110.349 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 90.8 p . . . . . 0 N--CA 1.452 -0.325 0 N-CA-C 109.993 -0.373 . . . . 75.14 109.993 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 48.7 m -129.0 43.86 3.07 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.418 1.074 . . . . 74.11 110.018 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 47.5 t -85.93 -62.62 1.48 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.479 1.112 . . . . 65.31 109.973 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -106.53 157.65 17.5 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 72.25 109.271 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -102.08 159.68 15.17 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.559 1.162 . . . . 74.12 109.321 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -147.9 163.33 28.84 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.493 1.121 . . . . 62.44 111.054 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . 0.421 ' O ' ' CD1' ' B' ' 471' ' ' ILE . 0.0 OUTLIER -128.74 144.37 51.15 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.494 0.761 . . . . 64.13 109.342 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 470' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 52.07 35.57 16.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.472 1.108 . . . . 72.41 110.938 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 471' ' ' ILE . . . . . 0.481 ' CD1' ' OE1' ' A' ' 240' ' ' GLN . 3.3 mm -95.95 140.59 22.35 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.478 1.111 . . . . 74.35 109.279 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 472' ' ' PRO . . . . . 0.43 ' HD3' ' ND1' ' A' ' 188' ' ' HIS . 18.3 Cg_endo -75.0 -170.16 0.74 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.417 1.746 . . . . 63.04 110.965 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.97 15.9 4.23 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.478 1.111 . . . . 71.25 109.986 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 474' ' ' ARG . . . . . 0.443 ' O ' ' NE1' ' A' ' 192' ' ' TRP . 17.0 mmt180 -145.82 154.51 51.57 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.466 1.104 . . . . 72.13 110.335 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 475' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' B' ' 476' ' ' ALA . 18.2 Cg_endo -74.94 -36.07 2.82 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.538 1.809 . . . . 71.21 110.939 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 476' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' B' ' 475' ' ' PRO . . . 164.38 133.04 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.543 1.152 . . . . 64.4 109.262 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 477' ' ' PRO . . . . . 0.573 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -74.93 -171.08 0.88 Allowed 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.556 1.819 . . . . 71.21 111.044 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.72 96.65 40.32 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.546 1.154 . . . . 73.15 109.319 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 479' ' ' PRO . . . . . 0.595 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -75.0 166.67 28.7 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.386 1.729 . . . . 74.33 111.032 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.87 -45.96 0.27 Allowed 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.44 1.758 . . . . 63.43 111.012 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 481' ' ' SER . . . . . 0.646 ' CB ' ' CZ ' ' A' ' 164' ' ' TYR . 1.0 OUTLIER -55.2 -26.41 39.08 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.559 1.162 . . . . 63.34 110.013 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.16 81.21 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.411 1.069 . . . . 73.41 110.004 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 483' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' B' ' 485' ' ' ALA . . . -41.36 -49.92 3.78 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.54 1.15 . . . . 72.22 109.332 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 9.5 t -46.54 94.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 O-C-N 124.431 1.082 . . . . 61.11 110.014 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' B' ' 483' ' ' ALA . . . -47.24 150.62 0.82 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.532 1.145 . . . . 75.15 109.263 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 82.4 p . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.455 1.097 . . . . 55.44 110.042 179.943 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.034 0 N-CA-C 110.995 -0.842 . . . . 73.24 110.995 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.0 t -67.17 136.55 55.23 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.539 0.788 . . . . 72.11 110.005 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.6 pp -45.05 139.35 3.25 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.484 1.115 . . . . 75.13 109.38 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.565 ' CE2' ' CD1' ' A' ' 215' ' ' ILE . 2.3 p90 -131.19 174.66 9.82 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.487 1.117 . . . . 72.33 110.975 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.403 ' O ' ' O ' ' A' ' 182' ' ' LEU . . . -107.38 151.84 24.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 61.14 109.288 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.45 HG23 ' CD2' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -132.16 135.05 58.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.457 1.098 . . . . 72.22 109.331 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.455 ' CG2' HG11 ' A' ' 212' ' ' VAL . 1.8 t -89.99 118.43 35.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.511 1.132 . . . . 73.54 109.337 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.45 ' CD2' HG23 ' A' ' 161' ' ' ILE . 1.4 mt -94.56 -16.92 22.85 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.422 1.076 . . . . 74.3 109.328 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.521 ' CZ ' ' O ' ' B' ' 481' ' ' SER . 1.9 m-85 -148.61 157.07 43.21 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.439 1.087 . . . . 75.15 110.925 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -88.84 154.84 19.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.527 1.142 . . . . 72.34 109.281 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.645 ' CE2' ' NZ ' ' A' ' 170' ' ' LYS . 2.4 t80 -154.4 132.13 11.47 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.435 1.084 . . . . 70.33 111.003 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.542 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 6.2 mtpm? -75.82 125.65 29.48 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.544 1.152 . . . . 73.35 109.328 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.478 ' HB2' ' CA ' ' A' ' 173' ' ' GLU . . . -114.18 133.53 55.53 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.521 1.138 . . . . 61.22 109.299 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -136.68 9.37 3.1 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.485 1.116 . . . . 71.11 110.245 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.645 ' NZ ' ' CE2' ' A' ' 166' ' ' PHE . 0.1 OUTLIER -79.07 -175.79 4.76 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.489 1.118 . . . . 74.23 109.32 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.34 -21.76 66.26 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.537 1.148 . . . . 73.33 109.267 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 173' ' ' GLU . 0.5 OUTLIER -114.05 12.64 17.99 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.451 1.094 . . . . 72.31 109.303 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.478 ' CA ' ' HB2' ' A' ' 168' ' ' ALA . 6.5 pt-20 -32.99 112.95 0.13 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.123 . . . . 73.3 110.293 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.48 ' CG ' ' HA3' ' A' ' 205' ' ' GLY . 1.5 tm? -119.92 99.4 6.6 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.555 1.159 . . . . 74.51 109.283 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 14.5 t -80.82 130.75 35.23 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.434 1.083 . . . . 75.12 110.428 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.41 ' CG2' ' HG3' ' A' ' 180' ' ' GLU . 55.6 m -155.19 155.98 34.87 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.451 1.094 . . . . 73.3 110.373 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -93.71 167.09 11.88 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.467 1.104 . . . . 73.23 110.953 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.2 m -61.39 158.5 2.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.452 1.095 . . . . 75.52 109.3 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.422 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 48.55 56.92 8.88 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.524 1.14 . . . . 60.52 111.021 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.41 ' HG3' ' CG2' ' A' ' 176' ' ' THR . 3.9 mm-40 -114.86 175.47 5.48 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.472 0.749 . . . . 64.02 110.277 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -119.15 130.59 55.62 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.125 . . . . 75.12 109.321 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.454 ' CD1' HG23 ' A' ' 207' ' ' VAL . 2.5 pt? -145.28 133.37 21.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.455 1.097 . . . . 74.41 109.361 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.439 ' C ' ' HB2' ' A' ' 195' ' ' ALA . 58.9 m-85 -100.72 107.87 19.58 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.565 1.166 . . . . 74.12 110.979 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.522 ' HA ' ' CB ' ' A' ' 195' ' ' ALA . 13.3 mt -70.66 162.55 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.458 1.099 . . . . 71.31 109.353 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.476 ' N ' ' CG2' ' A' ' 184' ' ' ILE . 2.0 p -156.44 -40.85 0.08 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.463 1.102 . . . . 63.4 108.296 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.487 ' CB ' ' HB ' ' A' ' 194' ' ' ILE . . . -112.21 152.17 28.71 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.451 1.094 . . . . 71.52 109.282 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -145.26 149.45 34.91 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.476 1.11 . . . . 74.22 109.554 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.608 ' CD2' ' O ' ' A' ' 192' ' ' TRP . 0.7 OUTLIER -155.82 143.51 19.59 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 124.434 1.084 . . . . 75.21 109.545 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.456 ' C ' ' N ' ' A' ' 191' ' ' GLU . 7.4 m-20 57.02 18.04 3.75 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.548 1.155 . . . . 75.31 109.329 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 3.3 m 43.24 26.94 0.11 Allowed 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.475 1.109 . . . . 63.33 108.315 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.456 ' N ' ' C ' ' A' ' 189' ' ' ASN . 18.1 tt0 -132.93 -40.58 0.93 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.134 . . . . 71.42 110.254 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.608 ' O ' ' CD2' ' A' ' 188' ' ' HIS . 96.9 m95 -103.88 127.83 51.38 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.042 -1.095 . . . . 74.14 108.042 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.601 ' CE2' ' CG1' ' A' ' 209' ' ' VAL . 15.7 m-30 -125.09 127.73 47.35 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.536 1.147 . . . . 74.41 110.922 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.548 HG23 ' CD2' ' B' ' 470' ' ' PHE . 1.6 mp -85.56 106.42 15.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.55 1.156 . . . . 75.12 109.277 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.522 ' CB ' ' HA ' ' A' ' 184' ' ' ILE . . . -120.85 163.07 18.75 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.557 1.161 . . . . 73.14 109.313 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.36 145.05 32.45 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.551 1.157 . . . . 73.34 109.263 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 172.19 16.85 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.475 1.776 . . . . 73.45 111.047 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -44.12 -41.61 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.518 1.136 . . . . 65.31 109.342 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.73 -78.11 0.05 OUTLIER Glycine 0 CA--C 1.531 1.07 0 O-C-N 124.507 1.129 . . . . 73.14 110.916 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 36.4 mtt85 -56.53 -177.25 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.485 0.756 . . . . 74.24 110.317 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 7.8 mt 72.92 9.94 5.42 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.403 1.065 . . . . 71.12 109.287 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 76.25 -132.09 12.36 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.577 1.173 . . . . 64.22 110.944 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.449 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . 107.82 166.73 21.61 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 111.059 -0.816 . . . . 64.14 111.059 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.449 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.3 Cg_endo -74.93 138.27 55.09 Favored 'Cis proline' 0 C--N 1.359 1.123 0 C-N-CA 120.97 -2.512 . . . . 75.32 110.988 -0.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 195' ' ' ALA . . . -99.56 -178.96 31.04 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.432 1.082 . . . . 73.21 110.971 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.584 ' CD2' ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -93.33 148.61 21.9 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.538 0.787 . . . . 63.14 109.295 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.498 ' N ' ' HG ' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -155.52 122.95 2.78 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 74.54 109.32 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.481 ' O ' ' CG2' ' A' ' 212' ' ' VAL . 18.5 Cg_endo -74.93 174.69 12.33 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.494 1.786 . . . . 71.0 111.038 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.601 ' CG1' ' CE2' ' A' ' 193' ' ' PHE . 1.5 m -93.59 -2.69 10.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.512 1.133 . . . . 75.1 109.228 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . 0.5 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -98.46 2.73 59.2 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.482 1.114 . . . . 60.24 110.967 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.473 ' CE2' ' HB3' ' B' ' 479' ' ' PRO . 13.5 m-85 -137.9 11.31 2.88 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.471 0.747 . . . . 73.41 110.985 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 208' ' ' PRO . 3.8 m -152.97 158.77 3.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 124.471 1.107 . . . . 73.33 109.339 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.8 t -134.91 148.07 49.98 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.532 1.145 . . . . 74.34 110.054 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 13.7 mm -86.27 132.76 31.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.441 1.088 . . . . 75.04 109.28 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.565 ' CD1' ' CE2' ' A' ' 159' ' ' TYR . 24.3 pt -147.45 140.74 19.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.547 1.154 . . . . 73.41 109.241 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.08 -176.66 3.94 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.513 1.133 . . . . 74.03 109.24 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.451 ' CD1' ' C ' ' A' ' 217' ' ' ILE . 0.9 OUTLIER -100.8 27.14 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.443 1.089 . . . . 72.21 109.323 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -101.57 21.81 13.73 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.578 1.173 . . . . 75.11 109.328 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 7.0 m 57.15 107.65 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.493 1.12 . . . . 72.4 110.415 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 126.11 169.16 12.77 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.489 1.118 . . . . 62.11 111.052 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -103.51 131.18 50.84 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.521 0.777 . . . . 73.54 110.994 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.422 ' O ' ' CG2' ' A' ' 223' ' ' THR . . . 52.74 26.82 4.75 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.597 1.185 . . . . 53.31 109.3 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.422 ' CG2' ' O ' ' A' ' 222' ' ' ALA . 8.9 t 45.58 25.63 0.26 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.498 1.123 . . . . 64.25 110.412 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 86.13 -48.37 3.93 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.425 1.078 . . . . 70.54 110.987 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -64.88 142.53 58.4 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.489 0.758 . . . . 55.21 109.356 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 230' ' ' ASP . 2.4 m-20 -63.31 157.09 23.78 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.515 1.134 . . . . 71.13 109.277 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 1.4 p -50.86 -41.08 21.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.461 1.1 . . . . 71.3 109.265 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.505 ' O ' ' CE ' ' A' ' 232' ' ' LYS . 4.1 mp -70.27 -41.66 78.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.54 1.15 . . . . 74.02 109.332 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -69.21 -19.55 63.96 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 1.114 . . . . 63.21 110.308 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 226' ' ' ASP . 7.1 m-20 -88.73 -16.3 32.59 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.461 1.1 . . . . 75.52 109.272 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.461 ' CD1' ' HA ' ' A' ' 228' ' ' ILE . 4.4 mt -70.77 -69.36 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.463 1.102 . . . . 64.51 109.342 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.505 ' CE ' ' O ' ' A' ' 228' ' ' ILE . 0.0 OUTLIER -57.03 -25.59 58.86 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.511 1.132 . . . . 75.12 109.322 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.3 m -49.38 -55.54 12.63 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.514 1.134 . . . . 71.41 109.953 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 235' ' ' ASN . 2.0 m -93.49 26.1 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 74.21 109.32 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 234' ' ' VAL . 68.5 m-80 40.17 35.64 0.27 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 75.52 109.271 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.2 tp -66.01 119.67 63.18 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 74.03 109.316 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.01 173.73 14.01 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.537 1.809 . . . . 74.5 110.981 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.56 -170.92 0.33 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.46 1.1 . . . . 71.1 110.367 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.444 ' CG2' ' HD3' ' A' ' 243' ' ' LYS . 10.5 p -82.89 -34.74 11.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.485 1.116 . . . . 75.52 109.295 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -85.39 -20.06 30.44 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.52 1.138 . . . . 71.33 110.333 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -80.22 -36.37 34.88 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.434 1.084 . . . . 74.21 110.299 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.406 ' CE3' ' HB1' ' A' ' 186' ' ' ALA . 1.5 t90 -84.0 -56.57 3.61 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 73.42 107.972 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.444 ' HD3' ' CG2' ' A' ' 239' ' ' VAL . 18.1 mtpp -58.17 -17.69 20.49 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.524 1.14 . . . . 64.24 109.291 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 2.8 t -39.02 -56.74 1.37 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.546 1.154 . . . . 74.43 109.998 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -144.72 135.03 24.28 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 74.54 109.259 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 9.9 mm -60.4 -51.75 69.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.492 1.12 . . . . 74.51 109.319 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -82.51 130.49 35.12 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.521 1.138 . . . . 62.53 109.251 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . 0.453 ' C ' ' CD1' ' A' ' 249' ' ' TYR . 0.1 OUTLIER -143.01 132.58 23.68 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.602 1.189 . . . . 64.22 110.341 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.453 ' CD1' ' C ' ' A' ' 248' ' ' ARG . 1.8 m-85 -133.05 82.95 2.02 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.51 1.131 . . . . 74.13 110.994 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.447 ' HA ' ' CE ' ' A' ' 250' ' ' LYS . 1.0 OUTLIER -51.52 172.81 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.581 1.175 . . . . 74.03 109.347 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -112.59 -35.55 5.49 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.519 1.137 . . . . 62.42 109.289 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 3.5 m -59.1 169.53 1.07 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.525 1.141 . . . . 71.52 109.958 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -95.51 162.15 13.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.545 1.153 . . . . 75.41 109.315 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 7.8 mm -126.73 138.98 53.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.527 1.142 . . . . 75.41 109.332 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 6.3 t -164.65 126.28 2.18 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.555 1.16 . . . . 43.31 110.005 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 87.4 mt -117.5 156.96 27.12 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.457 1.098 . . . . 72.43 109.341 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -40.81 -49.84 4.13 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.489 1.118 . . . . 70.33 111.048 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.1 t -40.23 125.91 2.11 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.545 0.791 . . . . 74.55 109.999 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.9 p -67.45 113.36 3.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.523 1.14 . . . . 71.24 109.258 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 . . . . . 0 C--N 1.324 -0.506 0 O-C-N 124.503 1.127 . . . . 74.32 110.264 179.939 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 110.001 -0.37 . . . . 65.53 110.001 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 5.5 m -127.12 177.48 6.64 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.483 1.114 . . . . 65.1 109.943 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 8.7 m -107.11 175.72 5.41 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.556 1.16 . . . . 64.01 110.051 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -164.29 122.1 1.75 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.47 1.106 . . . . 73.33 109.274 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -152.74 107.9 3.24 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.526 1.141 . . . . 75.55 109.301 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -177.03 126.01 1.07 Allowed Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.438 1.086 . . . . 74.43 110.999 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -90.95 -14.22 31.98 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.574 0.808 . . . . 73.31 109.294 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 470' ' ' PHE . . . . . 0.548 ' CD2' HG23 ' A' ' 194' ' ' ILE . 3.4 m-30 -89.26 3.92 50.46 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.516 1.135 . . . . 74.53 111.028 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 471' ' ' ILE . . . . . 0.4 HG21 ' N ' ' B' ' 472' ' ' PRO . 0.7 OUTLIER -72.24 143.93 86.46 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.516 1.135 . . . . 74.1 109.28 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 472' ' ' PRO . . . . . 0.568 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.5 Cg_endo -74.96 153.47 41.98 Favored 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.475 1.777 . . . . 62.13 110.989 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.02 -63.07 1.29 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.546 1.153 . . . . 63.31 109.951 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.81 172.22 6.42 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.503 1.127 . . . . 74.22 110.259 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 -169.21 0.6 Allowed 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.479 1.778 . . . . 52.41 111.002 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 476' ' ' ALA . . . . . . . . . . . . . . . -62.51 134.61 95.14 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.509 1.131 . . . . 61.34 109.285 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 477' ' ' PRO . . . . . 0.596 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -75.0 -162.5 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.579 1.831 . . . . 63.42 111.047 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.72 89.95 20.55 Favored Pre-proline 0 C--N 1.324 -0.525 0 O-C-N 124.525 1.141 . . . . 74.14 109.299 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 479' ' ' PRO . . . . . 0.5 ' CG ' ' O ' ' A' ' 210' ' ' GLY . 18.0 Cg_endo -75.03 165.02 32.15 Favored 'Trans proline' 0 C--N 1.359 1.11 0 O-C-N 124.481 1.779 . . . . 64.21 110.977 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.93 -89.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.501 1.79 . . . . 54.33 111.005 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 481' ' ' SER . . . . . 0.521 ' O ' ' CZ ' ' A' ' 164' ' ' TYR . 1.2 t -82.96 138.32 33.85 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.534 1.146 . . . . 65.02 109.994 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 5.6 t -173.44 179.59 2.09 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.48 1.112 . . . . 61.25 110.047 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -86.11 -39.41 16.76 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.475 1.11 . . . . 73.12 109.296 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 30.9 t -171.59 117.92 0.43 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.442 1.089 . . . . 73.42 109.989 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -100.56 76.45 1.83 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.557 1.16 . . . . 74.43 109.312 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 59.5 p . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.475 1.109 . . . . 74.12 109.988 -179.973 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.011 0 N-CA-C 111.053 -0.819 . . . . 63.42 111.053 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 69.4 m -150.03 109.72 4.05 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.563 0.802 . . . . 61.33 109.971 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.588 ' O ' ' CD1' ' A' ' 159' ' ' TYR . 0.4 OUTLIER -158.85 123.36 4.07 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.499 1.124 . . . . 71.13 109.332 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.792 ' CD1' ' CD1' ' A' ' 183' ' ' PHE . 34.9 m-85 -153.94 -172.31 4.18 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.442 1.088 . . . . 75.1 111.048 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.486 ' HB1' ' CD2' ' A' ' 182' ' ' LEU . . . -124.93 148.24 48.45 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.51 1.131 . . . . 65.1 109.233 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.451 HG21 ' CD2' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -116.01 134.63 58.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.435 1.084 . . . . 73.52 109.311 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.472 ' CG2' HD13 ' A' ' 182' ' ' LEU . 1.0 OUTLIER -91.49 122.96 43.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.531 1.144 . . . . 55.4 109.287 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.451 ' CD2' HG21 ' A' ' 161' ' ' ILE . 0.3 OUTLIER -102.55 -11.92 18.16 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.522 1.139 . . . . 73.12 109.332 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -142.51 166.41 24.75 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.477 1.111 . . . . 74.32 110.986 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.424 ' N ' HG12 ' A' ' 178' ' ' VAL . 27.6 p-10 -115.12 146.42 41.37 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.477 1.11 . . . . 72.42 109.283 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.584 ' CE2' ' NZ ' ' A' ' 170' ' ' LYS . 1.6 t80 -149.51 128.59 12.73 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.446 1.091 . . . . 71.41 111.023 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.409 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 7.1 mtpt -66.99 104.99 1.51 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.545 1.153 . . . . 73.13 109.322 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -79.61 144.26 33.98 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.462 1.101 . . . . 70.12 109.309 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -151.33 20.97 0.74 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.499 1.124 . . . . 74.41 110.333 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.584 ' NZ ' ' CE2' ' A' ' 166' ' ' PHE . 0.1 OUTLIER -95.56 -176.06 3.64 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.465 1.103 . . . . 62.14 109.337 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.62 -37.11 75.19 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.511 1.132 . . . . 62.22 109.327 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 173' ' ' GLU . 0.7 OUTLIER -106.85 23.19 14.74 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.5 1.125 . . . . 74.03 109.345 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.49 ' CD ' ' N ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -35.26 111.19 0.12 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 1.118 . . . . 74.04 110.27 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.516 ' CG ' ' HA3' ' A' ' 205' ' ' GLY . 0.7 OUTLIER -118.51 98.07 6.07 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.532 1.145 . . . . 75.15 109.284 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.412 ' O ' ' CG2' ' A' ' 175' ' ' THR . 12.3 t -83.27 112.79 20.19 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.505 1.128 . . . . 72.44 110.447 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.1 m -137.55 137.17 38.32 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.548 1.155 . . . . 74.1 110.407 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -75.94 163.77 26.85 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.509 1.13 . . . . 75.44 110.962 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.3 m -58.08 157.79 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.529 1.143 . . . . 70.43 109.327 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.7 64.16 4.48 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.405 1.066 . . . . 63.43 111.026 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.434 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 1.2 tt0 -127.84 -173.67 2.99 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.546 0.792 . . . . 75.22 110.264 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -147.27 136.59 22.59 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.528 1.142 . . . . 75.51 109.311 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.572 ' CD1' ' N ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -148.96 146.27 27.75 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 72.2 109.294 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.792 ' CD1' ' CD1' ' A' ' 159' ' ' TYR . 6.8 m-30 -95.55 121.86 37.69 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.516 1.135 . . . . 74.45 110.899 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.474 ' CD1' ' HB1' ' A' ' 160' ' ' ALA . 1.7 mp -70.75 161.93 4.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.53 1.144 . . . . 74.04 109.29 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.576 ' HB3' ' CH2' ' A' ' 242' ' ' TRP . 2.2 m -146.12 -47.37 0.2 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 72.43 108.259 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.482 ' CB ' ' HB ' ' A' ' 194' ' ' ILE . . . -119.78 166.07 13.72 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.479 1.112 . . . . 65.15 109.281 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.59 134.14 11.79 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 74.31 109.603 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.559 ' CE1' ' HD3' ' B' ' 472' ' ' PRO . 0.0 OUTLIER -146.73 149.28 33.09 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.444 1.09 . . . . 62.43 109.55 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.485 ' C ' ' N ' ' A' ' 191' ' ' GLU . 40.7 m-20 61.19 15.86 6.72 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 1.136 . . . . 71.53 109.316 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 189' ' ' ASN . 14.1 p 41.84 27.83 0.08 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.138 . . . . 74.04 108.335 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.485 ' N ' ' C ' ' A' ' 189' ' ' ASN . 8.5 tt0 -136.42 -37.5 0.69 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.489 1.118 . . . . 73.31 110.258 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.59 ' CZ2' ' HD3' ' B' ' 477' ' ' PRO . 95.7 m95 -101.82 135.91 42.57 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.008 -1.108 . . . . 74.33 108.008 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.58 ' CZ ' HG13 ' A' ' 209' ' ' VAL . 22.0 m-30 -128.66 129.33 45.68 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 75.54 111.023 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.482 ' HB ' ' CB ' ' A' ' 186' ' ' ALA . 8.8 mm -89.68 102.07 12.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.503 1.127 . . . . 73.05 109.279 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -116.15 -178.85 3.5 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.438 1.086 . . . . 72.04 109.275 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.47 ' CB ' ' HA ' ' A' ' 204' ' ' PRO . 23.3 pttt -153.27 158.62 32.76 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.464 1.103 . . . . 75.41 109.295 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.413 ' CD ' ' HA3' ' A' ' 203' ' ' GLY . 18.1 Cg_endo -74.98 173.76 13.95 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.481 1.779 . . . . 72.11 110.974 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.552 ' HB ' ' CE2' ' A' ' 183' ' ' PHE . 1.1 tp -123.28 105.52 15.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.546 1.154 . . . . 75.11 109.294 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 117.25 -78.11 0.29 Allowed Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.507 1.129 . . . . 73.33 111.03 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -49.33 165.33 0.06 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.472 0.748 . . . . 74.31 110.307 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 5.2 mt -89.72 43.09 1.13 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.562 1.164 . . . . 74.13 109.328 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -99.41 -173.16 31.04 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 124.454 1.096 . . . . 74.31 110.974 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.413 ' HA3' ' CD ' ' A' ' 197' ' ' PRO . . . 48.48 -178.23 0.01 OUTLIER Glycine 0 CA--C 1.53 1.027 0 N-CA-C 110.993 -0.843 . . . . 73.13 110.993 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.47 ' HA ' ' CB ' ' A' ' 196' ' ' LYS . 18.1 Cg_endo -75.09 129.27 18.21 Favored 'Cis proline' 0 C--N 1.36 1.144 0 C-N-CA 121.015 -2.494 . . . . 61.33 110.974 0.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.516 ' HA3' ' CG ' ' A' ' 174' ' ' LEU . . . -111.96 177.91 18.95 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.529 1.143 . . . . 73.13 110.951 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.579 HD13 ' CE3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -105.45 152.22 23.27 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.482 0.754 . . . . 74.41 109.341 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.531 ' N ' ' HG ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -156.76 132.41 5.71 Favored Pre-proline 0 C--N 1.324 -0.524 0 O-C-N 124.432 1.083 . . . . 54.12 109.315 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.436 ' O ' ' CG2' ' A' ' 212' ' ' VAL . 18.3 Cg_endo -74.94 171.67 17.85 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.489 1.783 . . . . 73.32 111.037 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.58 HG13 ' CZ ' ' A' ' 193' ' ' PHE . 1.2 m -91.48 -3.92 10.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.548 1.155 . . . . 75.42 109.304 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -90.26 -26.97 22.13 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.512 1.133 . . . . 65.3 110.981 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.594 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 17.6 m-85 -105.16 4.31 31.17 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.481 0.754 . . . . 74.31 111.011 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.459 HG13 ' CG2' ' A' ' 162' ' ' VAL . 1.8 m -146.51 157.85 11.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.531 1.144 . . . . 70.01 109.311 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 4.5 t -130.39 130.55 44.5 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.515 1.135 . . . . 73.24 110.006 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.415 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 2.6 mm -73.69 133.02 32.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.423 1.077 . . . . 74.23 109.254 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 1.8 pt -164.86 173.47 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.46 1.1 . . . . 75.24 109.277 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.1 -56.48 0.49 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.544 1.152 . . . . 74.2 109.278 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 6.6 mt -141.02 -49.63 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.535 1.147 . . . . 63.21 109.24 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -45.24 168.41 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.494 1.121 . . . . 73.24 109.292 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 9.2 p -85.57 -79.98 0.23 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.461 1.101 . . . . 75.14 110.469 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -38.39 -91.52 0.01 OUTLIER Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.518 1.136 . . . . 64.22 111.036 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' A' ' 222' ' ' ALA . 31.4 m-85 -120.04 176.02 5.63 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.438 0.728 . . . . 74.4 110.974 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.404 ' N ' HG22 ' A' ' 215' ' ' ILE . . . -40.06 -71.4 0.08 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.46 1.1 . . . . 72.43 109.339 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.77 -7.5 10.49 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.535 1.147 . . . . 63.1 110.393 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 112.66 19.21 7.07 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.509 1.131 . . . . 74.1 111.075 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.54 ' H ' ' ND2' ' A' ' 225' ' ' ASN . 0.1 OUTLIER -111.92 171.43 7.5 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.506 0.768 . . . . 74.24 109.261 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 229' ' ' GLU . 0.7 OUTLIER -79.84 146.58 32.16 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.42 1.075 . . . . 73.12 109.257 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.401 ' C ' ' O ' ' A' ' 226' ' ' ASP . 0.2 OUTLIER -39.76 -55.71 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 124.462 1.101 . . . . 75.32 109.241 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 3.9 mt -55.85 -43.62 74.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.372 1.045 . . . . 73.1 109.27 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 226' ' ' ASP . 27.3 mt-10 -70.59 -14.58 62.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.477 1.11 . . . . 73.41 110.31 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.441 ' CG ' ' ND2' ' A' ' 225' ' ' ASN . 0.4 OUTLIER -86.94 -24.27 24.82 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.514 1.134 . . . . 74.42 109.296 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -61.23 -68.73 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.505 1.128 . . . . 74.11 109.297 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.418 ' CD ' ' HA ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -56.27 -26.8 53.07 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.502 1.126 . . . . 71.5 109.349 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.9 t -52.14 -47.71 65.26 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.492 1.12 . . . . 73.24 109.934 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.461 HG21 ' CB ' ' A' ' 236' ' ' LEU . 8.9 m -98.45 19.44 2.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.493 1.12 . . . . 75.42 109.317 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 41.58 32.36 0.24 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.519 1.137 . . . . 73.43 109.26 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.461 ' CB ' HG21 ' A' ' 234' ' ' VAL . 4.3 tp -68.51 119.37 67.99 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.47 1.106 . . . . 75.02 109.335 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.04 171.73 17.74 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.438 1.757 . . . . 73.54 110.968 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.7 m -71.42 165.52 23.61 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.567 1.167 . . . . 74.45 110.429 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.486 ' CG2' ' NZ ' ' A' ' 243' ' ' LYS . 7.6 p -60.84 -33.34 54.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.536 1.147 . . . . 74.23 109.287 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -82.01 -15.43 53.68 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.532 1.145 . . . . 64.14 110.304 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -87.53 -38.66 15.82 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.554 1.159 . . . . 74.41 110.273 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.576 ' CH2' ' HB3' ' A' ' 185' ' ' CYS . 0.9 OUTLIER -79.42 -60.25 2.44 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.001 -1.111 . . . . 72.4 108.001 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.486 ' NZ ' ' CG2' ' A' ' 239' ' ' VAL . 14.3 mtmm -53.34 -20.86 4.85 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.523 1.139 . . . . 74.52 109.324 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 243' ' ' LYS . 0.5 OUTLIER -38.26 -67.57 0.2 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.487 1.117 . . . . 72.44 110.018 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -130.79 121.0 24.59 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.44 1.088 . . . . 62.35 109.327 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 24.8 mm -44.08 -30.08 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 O-C-N 124.562 1.163 . . . . 73.31 109.266 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -102.24 75.7 1.51 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.43 1.081 . . . . 72.35 109.303 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -102.88 -14.8 16.41 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.451 1.094 . . . . 72.42 110.291 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -51.1 116.54 2.06 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.498 1.124 . . . . 73.12 110.996 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -153.43 105.52 2.85 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.464 1.102 . . . . 74.13 109.38 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.459 ' CB ' ' CD1' ' A' ' 254' ' ' ILE . . . -86.85 163.43 17.21 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.436 1.085 . . . . 72.53 109.301 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 13.7 t -131.27 -88.47 0.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.472 1.107 . . . . 74.24 109.97 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . 0.553 ' H ' ' ND2' ' A' ' 253' ' ' ASN . 0.1 OUTLIER -114.32 -0.94 13.68 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 75.21 109.303 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.475 ' CG2' ' O ' ' A' ' 254' ' ' ILE . 1.2 mp 40.13 82.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.419 1.074 . . . . 75.44 109.329 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 11.3 t 172.22 131.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.53 1.144 . . . . 63.03 109.958 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -116.07 -49.55 2.69 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.559 1.162 . . . . 72.45 109.271 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.69 72.53 0.9 Allowed Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.503 1.127 . . . . 75.02 111.025 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 33.8 p -137.25 139.54 41.04 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 0.764 . . . . 74.31 110.009 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 1.9 m -154.02 158.11 4.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.459 1.1 . . . . 61.22 109.344 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.458 1.099 . . . . 74.31 110.311 179.976 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 22.2 m . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 110.023 -0.362 . . . . 53.31 110.023 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 89.4 p -123.5 107.45 11.57 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.447 1.092 . . . . 71.55 109.989 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.9 -15.58 14.88 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.516 1.135 . . . . 73.12 109.952 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -167.16 151.76 7.07 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.506 1.129 . . . . 72.24 109.292 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 467' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' B' ' 468' ' ' GLY . 67.2 m-20 -136.56 134.0 37.0 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.598 1.186 . . . . 65.34 109.259 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . 0.445 ' HA3' ' CD1' ' B' ' 471' ' ' ILE . . . -54.94 -165.41 0.02 OUTLIER Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.485 1.116 . . . . 35.05 110.987 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -110.62 -15.95 13.74 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.518 0.775 . . . . 74.24 109.264 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 470' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -110.66 20.41 17.66 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.553 1.158 . . . . 70.53 110.996 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 471' ' ' ILE . . . . . 0.445 ' CD1' ' HA3' ' B' ' 468' ' ' GLY . 1.4 mp -65.71 138.84 96.78 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.503 1.127 . . . . 72.52 109.263 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 472' ' ' PRO . . . . . 0.559 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.1 Cg_endo -75.0 -179.34 4.89 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.529 1.805 . . . . 74.44 110.978 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 36.6 t -114.24 -61.63 1.72 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.544 1.153 . . . . 64.33 110.001 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -61.84 155.71 60.53 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.473 1.108 . . . . 75.41 110.285 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 475' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' B' ' 476' ' ' ALA . 18.3 Cg_endo -75.07 -36.24 2.63 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.484 1.781 . . . . 75.24 111.005 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 476' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' B' ' 475' ' ' PRO . . . 165.01 126.91 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.529 1.143 . . . . 72.51 109.291 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 477' ' ' PRO . . . . . 0.59 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.5 Cg_endo -74.89 -162.13 0.14 Allowed 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.49 1.784 . . . . 62.52 111.049 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 478' ' ' LYS . . . . . 0.538 ' CD ' ' O ' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -145.2 112.32 4.76 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.506 1.129 . . . . 74.53 109.261 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 479' ' ' PRO . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.1 Cg_endo -74.97 154.06 42.35 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.452 1.764 . . . . 75.32 110.998 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.05 163.22 35.65 Favored 'Trans proline' 0 C--N 1.359 1.111 0 O-C-N 124.527 1.804 . . . . 74.5 111.083 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 481' ' ' SER . . . . . . . . . . . . . 1.1 t 45.76 52.46 9.57 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.583 1.177 . . . . 75.34 110.031 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 1.6 m -114.71 -54.61 2.56 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.557 1.161 . . . . 71.44 110.027 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -153.3 134.19 13.91 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.505 1.128 . . . . 73.04 109.358 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 8.1 m -117.75 118.69 32.74 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.489 1.118 . . . . 75.3 109.988 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -97.17 31.23 2.51 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.488 1.117 . . . . 62.34 109.315 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 92.1 p . . . . . 0 C--N 1.324 -0.509 0 O-C-N 124.531 1.144 . . . . 63.43 109.954 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.023 0 N-CA-C 111.041 -0.824 . . . . 74.5 111.041 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 67.8 p -123.35 49.78 1.65 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.542 0.79 . . . . 74.41 110.033 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 pp -81.63 149.39 28.58 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.54 1.15 . . . . 74.31 109.246 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' A' ' 181' ' ' ASN . 1.4 t80 -119.09 146.27 45.23 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.551 1.157 . . . . 74.35 110.965 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -118.23 142.36 47.55 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.461 1.101 . . . . 63.13 109.306 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.443 HG23 ' CD2' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -119.41 131.66 71.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.468 1.105 . . . . 72.31 109.292 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.466 ' CG2' HD12 ' A' ' 182' ' ' LEU . 2.0 t -93.27 120.97 43.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 74.4 109.335 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.443 ' CD2' HG23 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -99.01 -13.58 19.83 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.519 1.137 . . . . 65.15 109.351 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.547 ' CE1' ' HB3' ' B' ' 481' ' ' SER . 1.3 m-85 -144.37 156.77 44.38 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.434 1.084 . . . . 74.22 111.05 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.419 ' N ' HG13 ' A' ' 178' ' ' VAL . 9.2 p-10 -92.06 154.03 19.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.512 1.133 . . . . 74.12 109.268 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.467 ' CZ ' ' O ' ' A' ' 167' ' ' LYS . 16.7 t80 -141.64 144.27 34.07 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.486 1.116 . . . . 72.42 110.969 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.467 ' O ' ' CZ ' ' A' ' 166' ' ' PHE . 14.2 mtpp -82.81 131.22 35.2 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.542 1.151 . . . . 75.53 109.283 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.34 142.37 28.55 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 70.12 109.272 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -158.03 24.88 0.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.473 1.108 . . . . 71.34 110.354 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.514 ' O ' ' CG ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -122.27 -175.46 3.13 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.427 1.08 . . . . 71.43 109.276 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.77 -40.03 82.76 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.487 1.117 . . . . 64.11 109.302 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 174' ' ' LEU . 26.6 m-20 -86.14 10.52 14.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 75.31 109.324 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.514 ' CG ' ' O ' ' A' ' 170' ' ' LYS . 6.5 pt-20 -36.77 96.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.57 1.169 . . . . 73.31 110.341 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 172' ' ' ASP . 0.3 OUTLIER -131.73 95.42 3.71 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.128 . . . . 73.11 109.315 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.4 t -59.18 153.39 18.38 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.536 1.147 . . . . 74.34 110.367 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 22.2 m -154.53 175.29 13.8 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.501 1.126 . . . . 72.14 110.398 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -122.57 157.79 31.33 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.47 1.106 . . . . 64.24 111.02 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.419 HG13 ' N ' ' A' ' 165' ' ' ASP . 2.8 m -59.51 158.39 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.518 1.136 . . . . 74.12 109.262 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.429 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 48.07 67.83 1.45 Allowed Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.479 1.112 . . . . 54.31 111.037 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -129.13 168.38 16.21 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.478 0.752 . . . . 75.33 110.309 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.448 ' HB3' ' CE2' ' A' ' 159' ' ' TYR . 8.5 m120 -118.77 126.42 51.82 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.527 1.142 . . . . 75.3 109.225 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.562 ' CD1' ' N ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -133.58 139.98 46.87 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.558 1.162 . . . . 72.03 109.325 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 5.4 t80 -98.97 97.47 8.63 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.489 1.118 . . . . 75.41 110.998 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.472 HD12 ' CB ' ' A' ' 195' ' ' ALA . 28.0 mm -52.01 156.67 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.405 1.065 . . . . 71.43 109.281 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 186' ' ' ALA . 7.3 p -149.96 -42.49 0.13 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.459 1.099 . . . . 70.23 108.327 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.49 ' N ' ' SG ' ' A' ' 185' ' ' CYS . . . -120.72 167.89 11.99 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.564 1.165 . . . . 71.22 109.309 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.559 ' CE1' HG22 ' A' ' 231' ' ' ILE . 0.2 OUTLIER -157.35 144.21 18.28 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.101 . . . . 74.41 109.613 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.577 ' CE1' ' HD3' ' B' ' 472' ' ' PRO . 0.1 OUTLIER -144.87 139.83 27.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.537 1.148 . . . . 72.44 109.55 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.49 ' C ' ' N ' ' A' ' 191' ' ' GLU . 57.7 t30 50.37 22.41 1.01 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.479 1.112 . . . . 74.21 109.27 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 189' ' ' ASN . 4.0 m 41.47 27.7 0.06 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.452 1.095 . . . . 72.34 108.272 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.49 ' N ' ' C ' ' A' ' 189' ' ' ASN . 3.6 tt0 -124.98 -38.14 2.37 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.528 1.142 . . . . 73.3 110.275 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.576 ' CZ2' ' HD3' ' B' ' 477' ' ' PRO . 90.5 m95 -113.95 128.07 56.24 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.0 -1.111 . . . . 75.21 108.0 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.583 ' CZ ' HG11 ' A' ' 209' ' ' VAL . 21.4 m-30 -117.03 157.0 26.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.48 1.112 . . . . 73.42 110.959 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.465 ' HB ' ' CB ' ' A' ' 186' ' ' ALA . 3.6 mm -118.48 104.15 15.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.54 1.15 . . . . 73.34 109.314 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.472 ' CB ' HD12 ' A' ' 184' ' ' ILE . . . -107.55 170.37 8.02 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.472 1.107 . . . . 62.51 109.35 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.403 ' CG ' ' HA ' ' A' ' 204' ' ' PRO . 4.6 mtmp? -138.9 165.16 34.41 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.547 1.154 . . . . 54.4 109.294 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 171.24 18.7 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.459 1.768 . . . . 62.22 111.002 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.439 ' CG2' ' N ' ' A' ' 199' ' ' GLY . 7.4 tp -83.85 -51.69 13.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.535 1.147 . . . . 72.04 109.266 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . 0.439 ' N ' ' CG2' ' A' ' 198' ' ' ILE . . . -143.47 54.73 0.58 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.41 1.069 . . . . 60.22 110.984 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -149.07 -179.43 7.01 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.565 0.803 . . . . 75.14 110.289 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -108.15 22.02 16.53 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.475 1.109 . . . . 72.33 109.314 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -88.92 59.85 3.9 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.525 1.14 . . . . 62.21 110.999 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.404 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . -167.82 171.09 42.17 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 110.949 -0.861 . . . . 71.33 110.949 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.404 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.2 Cg_endo -74.95 128.18 15.87 Favored 'Cis proline' 0 C--N 1.359 1.102 0 C-N-CA 121.065 -2.473 . . . . 70.31 110.992 -0.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.401 ' N ' ' HA2' ' A' ' 203' ' ' GLY . . . -92.49 122.13 6.75 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.504 1.127 . . . . 73.22 111.042 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.56 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.1 OUTLIER -79.96 146.77 31.9 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.556 0.798 . . . . 72.35 109.321 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.488 ' CG1' HG11 ' A' ' 212' ' ' VAL . 0.4 OUTLIER -160.44 129.05 2.99 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.136 . . . . 73.54 109.282 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 191' ' ' GLU . 18.4 Cg_endo -74.99 179.94 5.59 Favored 'Trans proline' 0 C--N 1.359 1.117 0 O-C-N 124.593 1.838 . . . . 71.35 111.027 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.583 HG11 ' CZ ' ' A' ' 193' ' ' PHE . 0.8 OUTLIER -98.06 4.2 9.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.477 1.111 . . . . 73.02 109.28 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -105.38 -2.79 41.14 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.496 1.122 . . . . 73.04 110.99 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.596 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 5.6 m-85 -127.5 0.85 6.25 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.428 0.722 . . . . 74.22 110.939 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.488 HG11 ' CG1' ' A' ' 207' ' ' VAL . 1.2 m -142.53 170.25 11.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.538 1.149 . . . . 73.42 109.29 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.3 t -129.37 140.57 51.32 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.508 1.13 . . . . 72.53 109.994 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.502 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 3.7 mm -83.35 138.37 19.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.452 1.095 . . . . 54.41 109.287 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.502 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 6.5 pt -164.69 160.43 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.542 1.151 . . . . 74.34 109.242 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -119.14 -75.31 0.58 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.515 1.134 . . . . 51.22 109.311 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 15.6 tt -122.05 -43.04 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.449 1.093 . . . . 72.31 109.381 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -69.47 135.95 50.85 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.472 1.107 . . . . 72.43 109.344 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 14.1 t -73.86 -4.31 34.11 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.504 1.127 . . . . 73.44 110.422 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -68.86 -126.33 0.03 OUTLIER Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.557 1.16 . . . . 52.41 111.065 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.414 ' O ' ' N ' ' A' ' 223' ' ' THR . 3.9 m-85 -117.97 -172.55 2.27 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.557 0.798 . . . . 72.44 111.012 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.494 ' O ' ' CG2' ' A' ' 223' ' ' THR . . . -68.0 72.01 0.17 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.494 1.122 . . . . 75.01 109.222 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.494 ' CG2' ' O ' ' A' ' 222' ' ' ALA . 8.7 t 47.12 20.49 0.13 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.527 1.142 . . . . 75.43 110.413 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.434 ' N ' ' C ' ' A' ' 222' ' ' ALA . . . 89.19 -33.34 4.32 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.433 1.083 . . . . 74.03 110.989 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -63.14 164.42 8.61 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.49 0.759 . . . . 74.13 109.316 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 230' ' ' ASP . 2.9 t0 -87.17 144.41 26.85 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.453 1.096 . . . . 71.1 109.297 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.405 ' O ' ' N ' ' A' ' 230' ' ' ASP . 3.0 p -44.01 -59.19 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.465 1.103 . . . . 75.24 109.329 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.503 ' O ' ' CE ' ' A' ' 232' ' ' LYS . 3.8 mt -48.95 -47.54 16.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.53 1.144 . . . . 73.42 109.319 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.415 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 9.6 mt-10 -66.28 -23.48 66.4 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.574 1.171 . . . . 72.52 110.316 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 226' ' ' ASP . 31.1 m-20 -85.27 -15.92 41.85 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.494 1.122 . . . . 75.22 109.279 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.559 HG22 ' CE1' ' A' ' 187' ' ' HIS . 0.5 OUTLIER -72.84 -68.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.524 1.14 . . . . 72.43 109.277 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.503 ' CE ' ' O ' ' A' ' 228' ' ' ILE . 0.0 OUTLIER -61.48 -20.41 63.13 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.5 1.125 . . . . 73.54 109.272 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.65 -52.98 43.6 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.514 1.134 . . . . 71.42 110.062 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.5 m -94.65 26.68 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.515 1.134 . . . . 72.43 109.313 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 40.61 37.67 0.51 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.594 1.184 . . . . 73.4 109.347 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.6 tp -72.22 119.55 75.34 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.569 1.168 . . . . 71.12 109.331 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.99 167.72 26.42 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.544 1.813 . . . . 72.12 110.959 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.29 177.95 2.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.505 1.128 . . . . 73.32 110.438 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.467 HG21 ' CB ' ' A' ' 186' ' ' ALA . 13.1 p -72.01 -54.06 17.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 71.31 109.342 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.417 ' N ' ' CG1' ' A' ' 239' ' ' VAL . 13.0 pm0 -68.37 -14.85 63.29 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.464 1.103 . . . . 72.51 110.292 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -92.25 -37.21 12.8 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.136 . . . . 73.24 110.322 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.435 ' CZ3' ' O ' ' A' ' 185' ' ' CYS . 3.3 t90 -79.24 -59.78 2.63 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.004 -1.11 . . . . 74.31 108.004 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -54.77 -20.1 7.77 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.563 1.165 . . . . 71.23 109.357 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 21.0 t -39.63 -68.11 0.19 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.454 1.097 . . . . 71.23 110.017 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 246' ' ' ILE . 19.9 m120 -144.85 108.36 4.63 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.59 1.181 . . . . 74.41 109.3 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 245' ' ' ASN . 34.8 mm -40.43 -55.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.486 1.116 . . . . 73.3 109.303 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -97.51 122.9 41.1 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.481 1.113 . . . . 74.2 109.339 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 10.1 tpp85 -164.14 122.84 1.89 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.505 1.128 . . . . 75.34 110.349 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -41.39 127.35 2.94 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.524 1.14 . . . . 74.0 111.028 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -50.1 165.65 0.08 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.494 1.121 . . . . 73.1 109.282 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -99.01 -78.23 0.5 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.465 1.103 . . . . 70.11 109.272 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 11.2 p -152.06 172.23 16.63 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.471 1.107 . . . . 61.22 109.99 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -133.76 113.24 12.1 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.498 1.124 . . . . 72.14 109.275 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 40.7 mm -115.49 160.55 14.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 124.473 1.108 . . . . 74.53 109.297 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 4.0 p 73.17 38.9 0.65 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.505 1.128 . . . . 62.42 110.033 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.433 ' C ' ' CD2' ' A' ' 256' ' ' LEU . 0.0 OUTLIER -55.92 160.06 2.91 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.481 1.113 . . . . 72.54 109.297 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 114.32 -105.64 1.58 Allowed Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.417 1.073 . . . . 55.31 110.989 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.2 p -99.95 137.34 38.55 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.473 0.749 . . . . 65.43 110.033 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.2 t 67.68 51.82 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 124.532 1.145 . . . . 72.1 109.313 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 . . . . . 0 C--N 1.324 -0.5 0 O-C-N 124.563 1.164 . . . . 74.24 110.367 -179.993 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.98 -0.378 . . . . 71.44 109.98 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 6.1 p -109.15 149.22 29.67 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.505 1.128 . . . . 72.44 110.01 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 53.5 m -50.47 174.95 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 74.41 110.029 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -171.16 150.44 3.0 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.464 1.102 . . . . 73.33 109.258 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 467' ' ' ASN . . . . . 0.425 ' CG ' ' N ' ' B' ' 468' ' ' GLY . 9.6 p-10 -122.88 -44.83 2.18 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.505 1.128 . . . . 75.1 109.3 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . 0.425 ' N ' ' CG ' ' B' ' 467' ' ' ASN . . . 64.35 116.35 0.01 OUTLIER Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.472 1.108 . . . . 73.22 111.033 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -116.66 145.57 43.33 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.543 0.79 . . . . 72.03 109.311 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 470' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 56.53 29.7 15.94 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.483 1.114 . . . . 72.45 111.045 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 471' ' ' ILE . . . . . 0.408 ' HA ' ' HD3' ' B' ' 472' ' ' PRO . 13.0 mm -88.85 137.96 29.68 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.466 1.104 . . . . 74.23 109.269 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 472' ' ' PRO . . . . . 0.577 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -75.0 112.15 3.49 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.431 1.753 . . . . 54.41 110.994 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 42.0 t -55.15 -44.95 75.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.506 1.129 . . . . 74.45 109.959 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 474' ' ' ARG . . . . . 0.42 ' HG3' ' N ' ' B' ' 475' ' ' PRO . 5.4 tpp180 -84.37 137.72 39.27 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.485 1.116 . . . . 74.43 110.32 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 475' ' ' PRO . . . . . 0.42 ' N ' ' HG3' ' B' ' 474' ' ' ARG . 18.4 Cg_endo -74.99 -170.07 0.73 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.433 1.754 . . . . 63.03 111.019 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 476' ' ' ALA . . . . . . . . . . . . . . . -48.3 124.63 11.46 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.561 1.163 . . . . 74.34 109.277 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 477' ' ' PRO . . . . . 0.576 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.6 Cg_endo -74.91 -162.39 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.441 1.758 . . . . 72.31 111.038 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.28 90.28 25.59 Favored Pre-proline 0 C--N 1.326 -0.436 0 O-C-N 124.488 1.118 . . . . 72.42 109.319 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 479' ' ' PRO . . . . . 0.596 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.1 Cg_endo -75.03 162.05 37.68 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.525 1.802 . . . . 74.44 110.983 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -88.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.508 1.794 . . . . 71.43 110.967 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 481' ' ' SER . . . . . 0.547 ' HB3' ' CE1' ' A' ' 164' ' ' TYR . 0.8 OUTLIER -47.99 -70.16 0.1 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.517 1.135 . . . . 74.35 110.01 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 1.4 t -42.23 110.05 0.16 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.393 1.058 . . . . 74.41 109.976 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -111.27 124.8 52.96 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.476 1.11 . . . . 65.52 109.279 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 80.0 p -124.15 161.62 25.3 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.453 1.096 . . . . 64.31 110.002 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -100.66 141.27 33.77 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.512 1.133 . . . . 73.24 109.305 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 C--N 1.324 -0.509 0 O-C-N 124.522 1.139 . . . . 73.43 109.98 -179.91 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.009 0 N-CA-C 111.078 -0.809 . . . . 64.23 111.078 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.5 t -124.06 93.77 4.02 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.584 0.814 . . . . 61.13 110.002 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.9 mt -100.66 116.15 31.89 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.505 1.128 . . . . 75.21 109.315 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.495 ' CD1' ' N ' ' A' ' 159' ' ' TYR . 3.7 p90 -146.44 -178.76 6.33 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.496 1.122 . . . . 72.43 111.078 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.462 ' CB ' HD13 ' A' ' 184' ' ' ILE . . . -127.77 154.67 45.11 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.56 1.162 . . . . 73.3 109.362 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.502 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.2 OUTLIER -126.44 119.65 54.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.477 1.111 . . . . 75.11 109.333 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.455 ' CG2' HG12 ' A' ' 212' ' ' VAL . 1.0 OUTLIER -70.84 125.35 29.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.488 1.118 . . . . 74.05 109.271 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.47 ' CD2' HG23 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -104.06 -9.14 19.0 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.586 1.179 . . . . 75.51 109.311 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -145.16 172.6 12.87 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.479 1.112 . . . . 74.32 110.998 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.422 ' N ' HG13 ' A' ' 178' ' ' VAL . 0.0 OUTLIER -87.65 129.77 35.01 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.484 1.115 . . . . 61.02 109.262 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -103.02 129.74 49.89 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.457 1.098 . . . . 74.23 111.009 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.76 106.97 19.36 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.468 1.105 . . . . 73.43 109.257 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 173' ' ' GLU . . . -114.01 150.29 34.11 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.556 1.16 . . . . 74.32 109.282 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -152.12 24.9 0.64 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.471 1.107 . . . . 74.32 110.268 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.487 ' CE ' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -112.82 -172.79 2.12 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 75.42 109.325 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.25 -43.99 75.14 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.534 1.146 . . . . 71.54 109.326 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.442 ' O ' ' C ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -86.26 11.47 12.03 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.48 1.112 . . . . 74.23 109.322 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.481 ' CB ' ' O ' ' A' ' 170' ' ' LYS . 11.5 tt0 -35.22 98.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.497 1.123 . . . . 71.24 110.311 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.542 ' CD2' ' CA ' ' A' ' 205' ' ' GLY . 0.4 OUTLIER -109.37 94.76 5.2 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.538 1.149 . . . . 74.51 109.249 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 12.0 t -95.05 109.56 21.59 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.521 1.138 . . . . 54.31 110.453 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 90.6 m -130.71 174.85 9.54 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.476 1.11 . . . . 64.33 110.428 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.406 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 29.1 m-85 -105.26 169.42 8.46 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.504 1.127 . . . . 73.02 110.985 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.422 HG13 ' N ' ' A' ' 165' ' ' ASP . 1.5 m -66.14 158.02 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.467 1.104 . . . . 71.2 109.305 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 58.2 66.05 3.09 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.479 1.112 . . . . 34.2 110.983 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.502 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 9.1 tp10 -131.78 157.53 43.62 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.475 0.75 . . . . 72.24 110.32 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -118.61 129.12 55.14 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.499 1.124 . . . . 74.33 109.247 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.507 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 0.5 OUTLIER -140.67 150.02 42.98 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 63.53 109.244 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.416 ' C ' ' HB1' ' A' ' 195' ' ' ALA . 5.5 m-85 -104.1 114.38 28.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.485 1.116 . . . . 75.23 111.002 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.462 HD13 ' CB ' ' A' ' 160' ' ' ALA . 1.6 mp -62.08 156.5 4.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 124.508 1.13 . . . . 75.14 109.249 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.458 ' N ' ' O ' ' A' ' 194' ' ' ILE . 0.1 OUTLIER -139.8 -48.15 0.46 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.461 1.1 . . . . 72.04 108.272 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -124.85 170.28 11.22 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.492 1.12 . . . . 70.51 109.324 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.457 ' CE1' HG21 ' A' ' 231' ' ' ILE . 0.2 OUTLIER -152.93 143.82 22.93 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.524 1.14 . . . . 74.14 109.603 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.511 ' CE1' ' CB ' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -145.58 140.59 27.51 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.474 1.109 . . . . 72.42 109.622 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.491 ' C ' ' N ' ' A' ' 191' ' ' GLU . 67.3 t30 49.26 23.17 0.76 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.497 1.123 . . . . 73.11 109.368 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.411 ' C ' ' O ' ' A' ' 189' ' ' ASN . 14.5 p 41.0 28.17 0.05 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.471 1.107 . . . . 71.45 108.308 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.491 ' N ' ' C ' ' A' ' 189' ' ' ASN . 7.7 tt0 -125.38 -39.0 2.22 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.422 1.077 . . . . 55.02 110.304 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.598 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 99.1 m95 -112.68 130.9 55.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.018 -1.105 . . . . 72.45 108.018 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.607 ' CZ ' HG11 ' A' ' 209' ' ' VAL . 22.9 m-30 -121.91 142.11 50.6 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.54 1.15 . . . . 75.24 110.97 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.505 ' CD1' ' NE2' ' A' ' 188' ' ' HIS . 4.3 mm -101.19 95.98 4.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.422 1.076 . . . . 73.23 109.263 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -103.93 -177.05 3.26 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.485 1.116 . . . . 63.45 109.293 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.452 ' CD ' ' HB3' ' A' ' 204' ' ' PRO . 3.9 mtmm -148.45 159.61 38.48 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.506 1.129 . . . . 73.21 109.291 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.95 176.56 9.74 Favored 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.522 1.801 . . . . 72.22 110.954 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 1.4 pp -114.78 72.19 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.467 1.104 . . . . 75.03 109.271 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 102.28 -43.78 1.63 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.424 1.077 . . . . 43.13 110.98 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -54.7 118.97 4.66 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.487 0.757 . . . . 74.14 110.328 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -43.44 112.27 0.36 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.571 1.17 . . . . 73.3 109.278 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 154.5 169.78 19.59 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.577 1.173 . . . . 70.24 110.97 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.48 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . 91.05 162.86 38.46 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 111.011 -0.836 . . . . 70.21 111.011 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.48 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.3 Cg_endo -75.01 131.17 23.32 Favored 'Cis proline' 0 C--N 1.359 1.122 0 C-N-CA 121.034 -2.486 . . . . 72.02 111.008 0.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.542 ' CA ' ' CD2' ' A' ' 174' ' ' LEU . . . -101.05 165.73 18.74 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.485 1.116 . . . . 62.05 111.004 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.598 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -108.7 149.78 28.5 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.487 0.757 . . . . 72.04 109.281 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.476 ' N ' ' HG ' ' A' ' 206' ' ' LEU . 0.4 OUTLIER -157.04 133.68 6.36 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.449 1.093 . . . . 75.31 109.282 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 207' ' ' VAL . 18.2 Cg_endo -75.07 169.34 22.81 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.475 1.776 . . . . 72.44 110.995 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.607 HG11 ' CZ ' ' A' ' 193' ' ' PHE . 0.6 OUTLIER -93.74 6.86 6.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.438 1.086 . . . . 65.41 109.336 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . 0.487 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -106.69 -3.6 37.09 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.442 1.089 . . . . 72.11 111.014 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.588 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 23.3 m-85 -129.03 4.99 5.33 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.462 0.742 . . . . 72.44 110.973 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.468 ' CG1' HG21 ' A' ' 207' ' ' VAL . 2.1 m -141.43 150.55 19.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.468 1.105 . . . . 75.22 109.329 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.4 t -110.73 133.29 53.46 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.524 1.14 . . . . 55.01 109.974 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.423 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 4.8 mm -77.57 135.33 26.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.43 1.081 . . . . 74.32 109.338 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.423 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 0.2 OUTLIER -153.51 140.37 12.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.5 1.125 . . . . 71.31 109.33 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.427 ' O ' ' CG2' ' A' ' 217' ' ' ILE . 11.0 p-10 -110.67 -14.1 14.09 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.442 1.089 . . . . 74.22 109.246 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 216' ' ' ASP . 0.5 OUTLIER -170.92 -178.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.52 1.137 . . . . 72.13 109.282 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -85.06 74.96 10.42 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.54 1.15 . . . . 75.23 109.271 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.42 HG23 ' CD1' ' A' ' 217' ' ' ILE . 1.1 t -175.85 144.06 0.61 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.539 1.15 . . . . 71.15 110.352 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 38.85 -157.92 0.01 OUTLIER Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.497 1.123 . . . . 73.51 111.035 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -139.14 126.9 22.01 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.547 0.792 . . . . 75.4 110.963 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.406 ' O ' ' CG2' ' A' ' 223' ' ' THR . . . 51.9 26.94 3.93 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.518 1.136 . . . . 65.54 109.266 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.406 ' CG2' ' O ' ' A' ' 222' ' ' ALA . 10.8 t 45.5 25.96 0.27 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.574 1.171 . . . . 74.55 110.386 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 87.35 -41.69 3.1 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.557 1.16 . . . . 32.34 111.033 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -64.22 128.61 36.53 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.547 0.792 . . . . 65.31 109.279 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 230' ' ' ASP . 7.6 m-20 -62.1 152.02 33.99 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.553 1.158 . . . . 74.21 109.341 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.448 ' O ' ' CD1' ' A' ' 231' ' ' ILE . 2.7 p -49.36 -45.55 18.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.482 1.113 . . . . 73.13 109.318 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 3.9 mp -63.53 -30.56 50.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.455 1.097 . . . . 75.31 109.271 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.413 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 7.8 mt-10 -86.14 -14.56 43.78 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.429 1.081 . . . . 72.32 110.288 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 226' ' ' ASP . 8.9 t0 -88.39 -15.75 34.71 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.479 1.112 . . . . 74.32 109.311 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.457 HG21 ' CE1' ' A' ' 187' ' ' HIS . 0.6 OUTLIER -72.4 -69.37 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.559 1.162 . . . . 72.33 109.342 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.431 ' N ' ' CG2' ' A' ' 231' ' ' ILE . 0.0 OUTLIER -57.88 -20.87 39.94 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.568 1.168 . . . . 72.14 109.281 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.6 t -48.57 -57.49 6.11 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.54 1.15 . . . . 74.34 109.955 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.9 m -93.67 21.12 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.462 1.101 . . . . 71.24 109.294 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 49.33 29.21 2.64 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.474 1.109 . . . . 75.01 109.311 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 4.4 tp -65.27 119.11 56.55 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.465 1.103 . . . . 75.42 109.34 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.92 173.03 15.18 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.461 1.769 . . . . 73.44 111.008 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.5 m -66.25 -170.66 0.09 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.58 1.175 . . . . 73.54 110.389 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.475 ' CG2' ' HD3' ' A' ' 243' ' ' LYS . 9.8 p -79.96 -35.68 16.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.624 1.202 . . . . 74.21 109.351 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -84.94 -19.14 32.64 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.569 1.168 . . . . 74.31 110.282 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -81.51 -39.17 25.12 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.493 1.121 . . . . 70.11 110.338 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -77.98 -61.25 2.06 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 73.0 107.978 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.475 ' HD3' ' CG2' ' A' ' 239' ' ' VAL . 1.6 mtpm? -59.05 -17.38 25.1 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.462 1.101 . . . . 62.3 109.302 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 243' ' ' LYS . 0.3 OUTLIER -38.34 -65.39 0.35 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.576 1.173 . . . . 73.2 109.988 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -140.12 104.79 4.91 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.481 1.113 . . . . 64.45 109.309 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.473 ' CG2' ' N ' ' A' ' 247' ' ' ALA . 0.8 OUTLIER -59.72 -50.47 79.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.141 . . . . 73.43 109.301 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.473 ' N ' ' CG2' ' A' ' 246' ' ' ILE . . . -41.81 104.18 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.508 1.13 . . . . 72.24 109.286 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -168.94 111.88 0.53 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.518 1.136 . . . . 73.13 110.324 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.417 ' O ' ' CG ' ' A' ' 249' ' ' TYR . 34.8 p90 -45.05 128.65 7.33 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.506 1.129 . . . . 73.21 111.037 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 249' ' ' TYR . 9.6 mtpt -40.26 107.2 0.07 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.532 1.145 . . . . 73.41 109.313 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -88.29 -175.32 4.98 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.494 1.121 . . . . 71.5 109.262 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 46.6 m -116.65 -176.0 2.88 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.484 1.115 . . . . 73.14 110.045 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . 0.526 ' ND2' ' H ' ' A' ' 254' ' ' ILE . 9.2 t-20 -147.54 161.47 41.05 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.492 1.12 . . . . 73.43 109.307 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.526 ' H ' ' ND2' ' A' ' 253' ' ' ASN . 3.6 mp -121.14 142.66 36.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.574 1.171 . . . . 74.1 109.288 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 18.8 t -150.43 -179.46 7.23 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.491 1.12 . . . . 65.11 109.959 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 91.5 mt -105.43 -178.17 3.57 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.426 1.079 . . . . 72.52 109.287 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -82.42 -58.31 2.45 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.573 1.171 . . . . 74.03 111.052 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.0 t 51.43 34.57 12.28 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.463 0.743 . . . . 75.31 109.947 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 p -68.31 165.66 2.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.522 1.139 . . . . 73.14 109.332 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 . . . . . 0 C--N 1.325 -0.49 0 O-C-N 124.466 1.104 . . . . 73.5 110.272 -179.961 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 28.3 t . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 110.011 -0.366 . . . . 74.55 110.011 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 13.0 p -91.06 171.4 9.29 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.463 1.102 . . . . 75.15 110.002 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 63.5 m -77.27 168.87 19.32 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.426 1.079 . . . . 73.33 109.986 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -89.92 71.7 7.53 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.506 1.129 . . . . 65.31 109.307 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -91.41 -59.29 2.18 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.44 1.087 . . . . 71.33 109.313 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -67.9 -168.72 4.44 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.49 1.119 . . . . 74.24 110.976 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -139.71 -47.14 0.45 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 0.761 . . . . 64.44 109.354 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 470' ' ' PHE . . . . . 0.402 ' C ' ' OD1' ' A' ' 172' ' ' ASP . 8.6 m-30 -90.99 31.5 1.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.489 1.118 . . . . 74.12 110.972 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 471' ' ' ILE . . . . . 0.569 ' CD1' ' N ' ' B' ' 471' ' ' ILE . 1.1 mp -98.55 138.14 20.74 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.546 1.154 . . . . 71.12 109.291 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 472' ' ' PRO . . . . . 0.511 ' HG3' ' CG ' ' A' ' 192' ' ' TRP . 18.2 Cg_endo -75.03 138.63 23.21 Favored 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.485 1.782 . . . . 61.43 110.955 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 21.1 t -66.11 -72.25 0.17 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.54 1.15 . . . . 62.25 109.984 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.59 157.21 88.91 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.544 1.152 . . . . 71.4 110.309 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -167.59 0.44 Allowed 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.531 1.806 . . . . 75.4 110.947 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 476' ' ' ALA . . . . . 0.45 ' CB ' ' CD ' ' A' ' 191' ' ' GLU . . . -56.49 131.11 76.8 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 64.11 109.314 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 477' ' ' PRO . . . . . 0.596 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -75.04 -162.58 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.489 1.784 . . . . 71.22 111.022 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.54 91.37 18.51 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.509 1.13 . . . . 73.43 109.321 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 479' ' ' PRO . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.2 Cg_endo -74.99 154.92 42.88 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.463 1.77 . . . . 63.24 111.051 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.94 -177.46 3.47 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.459 1.768 . . . . 70.03 111.042 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 481' ' ' SER . . . . . . . . . . . . . 1.8 t 49.59 51.47 16.39 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.434 1.084 . . . . 71.44 110.054 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 14.2 t -144.29 137.07 26.97 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.454 1.096 . . . . 63.43 110.031 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -57.55 117.59 4.33 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.487 1.117 . . . . 63.32 109.294 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -122.4 93.27 3.93 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.47 1.106 . . . . 72.33 109.984 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -79.71 71.85 6.38 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.431 1.082 . . . . 65.21 109.308 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 90.7 p . . . . . 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.135 . . . . 73.43 109.98 -179.978 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.004 0 N-CA-C 110.975 -0.85 . . . . 71.35 110.975 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.444 ' C ' ' CD2' ' A' ' 158' ' ' LEU . 31.0 m -154.35 172.25 18.0 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.508 0.77 . . . . 75.4 110.019 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.444 ' CD2' ' C ' ' A' ' 157' ' ' SER . 1.4 pt? 41.71 66.54 0.68 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.401 1.063 . . . . 71.02 109.28 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.741 ' CE2' ' CZ ' ' A' ' 183' ' ' PHE . 0.1 OUTLIER -112.32 135.14 53.37 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.535 1.147 . . . . 75.41 111.029 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.618 ' CB ' ' CD1' ' A' ' 184' ' ' ILE . . . -103.93 148.61 25.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.567 1.167 . . . . 75.13 109.311 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.509 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.2 OUTLIER -131.28 128.84 62.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.574 1.171 . . . . 74.44 109.228 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.483 ' HB ' ' CB ' ' A' ' 180' ' ' GLU . 2.6 t -80.83 119.23 30.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.529 1.143 . . . . 72.35 109.296 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.484 HD21 ' CG2' ' A' ' 161' ' ' ILE . 0.9 OUTLIER -94.3 -15.92 24.01 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.561 1.163 . . . . 71.03 109.321 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.587 ' CE1' ' OG ' ' B' ' 481' ' ' SER . 1.0 OUTLIER -150.0 155.96 40.86 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.466 1.104 . . . . 75.54 111.002 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -86.54 157.49 19.74 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.437 1.086 . . . . 72.13 109.29 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -154.35 140.57 18.53 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.548 1.155 . . . . 71.42 110.999 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -84.19 115.02 22.21 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.436 1.085 . . . . 74.43 109.3 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.436 ' HB2' ' CA ' ' A' ' 173' ' ' GLU . . . -103.55 131.54 50.59 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.49 1.119 . . . . 64.32 109.323 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -138.63 11.36 2.71 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.469 1.106 . . . . 74.45 110.265 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.518 ' HE3' ' CH2' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -83.0 -175.92 6.08 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.513 1.133 . . . . 75.01 109.272 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -64.04 -24.64 67.78 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.507 1.13 . . . . 73.5 109.307 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.475 ' HB3' ' CB ' ' A' ' 206' ' ' LEU . 72.4 m-20 -112.89 15.69 19.68 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.557 1.16 . . . . 72.23 109.351 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.471 ' HB3' ' N ' ' A' ' 170' ' ' LYS . 2.0 pp20? -34.0 108.99 0.07 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.424 1.078 . . . . 71.01 110.244 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.491 ' CD2' ' HA3' ' A' ' 205' ' ' GLY . 0.7 OUTLIER -115.75 96.27 5.53 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.54 1.15 . . . . 64.02 109.264 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 15.2 t -82.36 133.08 35.22 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.561 1.163 . . . . 74.25 110.401 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.414 HG22 ' N ' ' A' ' 177' ' ' TYR . 0.9 OUTLIER -160.76 146.46 14.71 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.478 1.111 . . . . 73.31 110.383 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.414 ' N ' HG22 ' A' ' 176' ' ' THR . 14.1 m-85 -81.43 168.81 17.91 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.544 1.153 . . . . 63.44 111.025 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.3 m -60.88 158.19 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.509 1.131 . . . . 72.23 109.298 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 53.33 59.23 9.85 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.551 1.157 . . . . 63.41 110.957 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.509 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 1.3 tp10 -116.59 179.81 3.9 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.483 0.755 . . . . 74.2 110.328 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -132.62 139.71 47.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.525 1.14 . . . . 74.14 109.252 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.431 ' CD2' HG12 ' A' ' 207' ' ' VAL . 0.1 OUTLIER -152.17 149.36 28.67 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 75.23 109.335 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.741 ' CZ ' ' CE2' ' A' ' 159' ' ' TYR . 2.1 m-85 -109.0 111.63 23.4 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.424 1.077 . . . . 72.25 110.995 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.618 ' CD1' ' CB ' ' A' ' 160' ' ' ALA . 1.6 mp -71.0 164.15 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.133 . . . . 64.42 109.314 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.51 ' N ' ' CG2' ' A' ' 184' ' ' ILE . 3.5 p -159.9 -41.5 0.05 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.524 1.14 . . . . 73.1 108.283 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.485 ' CB ' ' HB ' ' A' ' 194' ' ' ILE . . . -114.69 152.5 31.87 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.528 1.142 . . . . 75.2 109.308 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.562 ' CD2' HD23 ' A' ' 236' ' ' LEU . 0.0 OUTLIER -145.18 151.13 37.95 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.127 . . . . 74.01 109.634 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.583 ' CD2' ' O ' ' A' ' 192' ' ' TRP . 1.3 p80 -156.39 146.51 21.3 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 72.2 109.612 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.477 ' C ' ' N ' ' A' ' 191' ' ' GLU . 0.1 OUTLIER 51.18 22.43 1.32 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 74.52 109.317 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.44 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.1 p 39.06 30.01 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.49 1.119 . . . . 74.13 108.229 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.477 ' N ' ' C ' ' A' ' 189' ' ' ASN . 11.6 tt0 -134.18 -40.39 0.83 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.542 1.151 . . . . 74.32 110.361 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.619 ' CZ2' ' HD3' ' B' ' 477' ' ' PRO . 97.2 m95 -105.61 127.7 53.2 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.987 -1.116 . . . . 72.31 107.987 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.629 ' CE2' ' CG1' ' A' ' 209' ' ' VAL . 16.9 m-30 -125.14 130.08 51.46 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.387 1.054 . . . . 75.21 111.02 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.555 ' CD1' ' NE2' ' A' ' 188' ' ' HIS . 1.5 mp -88.81 110.81 21.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.51 1.132 . . . . 74.41 109.358 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -118.87 177.38 4.87 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.489 1.118 . . . . 61.24 109.322 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' A' ' 197' ' ' PRO . 4.6 tptm -124.89 140.26 35.35 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.467 1.104 . . . . 75.43 109.333 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . 0.424 ' N ' ' HG3' ' A' ' 196' ' ' LYS . 18.1 Cg_endo -75.03 144.82 30.62 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.5 1.79 . . . . 74.1 110.982 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.417 HG13 ' N ' ' A' ' 199' ' ' GLY . 11.7 pt -39.62 -51.51 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.548 1.155 . . . . 73.23 109.337 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . 0.417 ' N ' HG13 ' A' ' 198' ' ' ILE . . . -169.01 65.94 0.18 Allowed Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.504 1.128 . . . . 62.42 111.027 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -106.04 163.02 13.1 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.469 0.747 . . . . 74.22 110.268 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 11.7 tp -75.2 74.09 2.33 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.536 1.148 . . . . 73.12 109.319 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 160.39 -130.57 2.43 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.452 1.095 . . . . 74.3 111.039 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.505 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . 65.97 151.26 0.12 Allowed Glycine 0 CA--C 1.53 0.972 0 N-CA-C 111.015 -0.834 . . . . 75.33 111.015 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.505 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.2 Cg_endo -75.01 146.15 85.87 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.039 -2.484 . . . . 64.13 111.026 0.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.491 ' HA3' ' CD2' ' A' ' 174' ' ' LEU . . . -109.36 177.64 20.23 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.525 1.141 . . . . 71.14 111.01 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.575 HD22 ' CE3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -97.97 147.2 24.73 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.463 0.743 . . . . 73.32 109.347 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.474 ' N ' ' HG ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -155.01 125.57 3.41 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 124.525 1.14 . . . . 63.4 109.315 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.438 ' O ' ' CG2' ' A' ' 212' ' ' VAL . 18.4 Cg_endo -75.02 176.77 9.48 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.529 1.805 . . . . 65.41 111.076 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.629 ' CG1' ' CE2' ' A' ' 193' ' ' PHE . 1.6 m -96.85 5.33 8.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.587 1.179 . . . . 71.21 109.332 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -108.89 6.44 32.87 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.537 1.148 . . . . 70.54 111.024 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.571 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 11.6 m-85 -139.64 12.18 2.51 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.439 0.729 . . . . 75.21 111.043 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.47 HG13 ' CG2' ' A' ' 162' ' ' VAL . 11.4 m -154.39 157.7 4.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.483 1.114 . . . . 73.31 109.317 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 22.5 t -129.62 124.17 33.07 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.494 1.121 . . . . 75.32 110.042 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 3.4 mm -78.08 149.95 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.496 1.122 . . . . 74.52 109.35 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.492 ' CD1' ' N ' ' A' ' 216' ' ' ASP . 0.1 OUTLIER 179.49 137.99 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 72.14 109.251 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.492 ' N ' ' CD1' ' A' ' 215' ' ' ILE . 1.1 t70 -71.31 -155.66 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.467 1.104 . . . . 74.11 109.312 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.435 ' C ' ' N ' ' A' ' 219' ' ' THR . 8.2 tp -43.13 155.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.452 1.095 . . . . 75.41 109.351 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -41.36 -29.45 0.15 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.449 1.093 . . . . 65.02 109.283 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.435 ' N ' ' C ' ' A' ' 217' ' ' ILE . 99.8 m -65.87 101.3 0.64 Allowed 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.556 1.16 . . . . 74.41 110.392 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.5 166.11 26.43 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.504 1.128 . . . . 65.13 110.99 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.415 ' C ' ' N ' ' A' ' 223' ' ' THR . 19.0 t80 -134.96 146.77 49.43 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.538 0.787 . . . . 71.43 110.977 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.491 ' O ' ' CG2' ' A' ' 223' ' ' THR . . . 47.39 24.92 0.52 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.593 1.183 . . . . 72.3 109.285 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.491 ' CG2' ' O ' ' A' ' 222' ' ' ALA . 1.0 OUTLIER 45.43 19.88 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.463 1.102 . . . . 75.12 110.393 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.446 ' N ' ' C ' ' A' ' 222' ' ' ALA . . . 62.91 3.14 5.59 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.561 1.163 . . . . 63.55 111.024 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.466 ' ND2' ' CG2' ' A' ' 223' ' ' THR . 6.5 p30 -133.24 176.84 8.16 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.525 0.78 . . . . 65.51 109.276 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 229' ' ' GLU . 6.2 t0 -92.59 145.79 24.16 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.514 1.134 . . . . 62.1 109.266 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.402 ' CG2' ' CE2' ' A' ' 193' ' ' PHE . 0.6 OUTLIER -44.28 -44.53 2.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.495 1.122 . . . . 75.25 109.311 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.482 ' O ' ' CE ' ' A' ' 232' ' ' LYS . 29.4 mt -58.21 -41.49 81.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 73.54 109.342 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 226' ' ' ASP . 14.6 mt-10 -69.34 -17.53 63.71 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.559 1.162 . . . . 61.34 110.351 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.94 -16.4 31.89 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.543 1.152 . . . . 74.24 109.252 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 228' ' ' ILE . 2.5 mt -71.39 -69.37 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.57 1.169 . . . . 74.24 109.279 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.482 ' CE ' ' O ' ' A' ' 228' ' ' ILE . 0.0 OUTLIER -58.97 -21.23 58.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 72.25 109.278 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.6 -56.51 13.12 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.131 . . . . 64.11 109.97 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.1 m -97.92 19.11 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.447 1.092 . . . . 74.31 109.295 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 40.82 31.47 0.12 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.458 1.099 . . . . 73.41 109.282 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.562 HD23 ' CD2' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -61.23 124.01 78.53 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 74.33 109.29 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 -179.62 5.18 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.46 1.769 . . . . 71.23 110.947 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.3 m -69.45 -173.51 0.57 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.523 1.139 . . . . 74.03 110.416 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.421 ' CG2' ' HG3' ' A' ' 240' ' ' GLN . 1.2 m -78.45 -38.05 22.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.469 1.106 . . . . 65.32 109.33 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.421 ' HG3' ' CG2' ' A' ' 239' ' ' VAL . 0.4 OUTLIER -81.51 -15.39 55.06 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.435 1.085 . . . . 73.21 110.283 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -83.89 -38.81 20.64 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.443 1.09 . . . . 74.45 110.319 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -83.73 -63.06 1.42 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.966 -1.124 . . . . 75.52 107.966 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.599 ' NZ ' ' CG ' ' B' ' 470' ' ' PHE . 13.2 mtmt -51.36 -22.49 2.95 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.571 1.169 . . . . 73.21 109.285 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -41.19 -65.73 0.4 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.532 1.145 . . . . 71.41 110.017 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -136.25 100.16 4.31 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.508 1.13 . . . . 62.52 109.305 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 248' ' ' ARG . 11.0 mt -52.29 -49.24 42.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 75.14 109.345 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 246' ' ' ILE . . . -40.27 99.35 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.512 1.132 . . . . 73.13 109.264 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 246' ' ' ILE . 9.7 tpp180 -99.72 147.61 25.26 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.528 1.143 . . . . 74.25 110.303 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.616 ' CD1' ' N ' ' A' ' 249' ' ' TYR . 0.6 OUTLIER -86.19 156.74 20.19 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.48 1.113 . . . . 74.32 110.967 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.58 179.49 7.1 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.486 1.116 . . . . 73.2 109.291 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 72.51 14.19 5.28 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.546 1.154 . . . . 74.11 109.327 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 25.3 t -97.26 135.68 38.83 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.503 1.127 . . . . 64.54 109.95 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -127.41 159.6 33.99 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.461 1.1 . . . . 74.5 109.292 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 2.2 mp -137.54 152.94 27.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.468 1.105 . . . . 74.32 109.246 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 8.9 p -152.66 165.08 36.36 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.438 1.086 . . . . 73.31 110.021 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -168.56 154.72 6.95 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.584 1.177 . . . . 75.14 109.308 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -93.16 -177.59 40.47 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 124.452 1.095 . . . . 61.24 111.056 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 8.8 m -168.02 147.22 4.69 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.465 0.744 . . . . 73.24 110.04 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 35.2 t -150.59 145.86 16.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.507 1.129 . . . . 75.0 109.295 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.446 0 O-C-N 124.45 1.094 . . . . 74.22 110.307 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 27.1 p . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 109.966 -0.383 . . . . 75.34 109.966 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 43.9 t -71.93 138.93 48.45 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.554 1.159 . . . . 72.32 110.071 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 93.7 p -72.5 173.33 9.0 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.501 1.126 . . . . 73.34 110.022 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -109.55 67.77 0.66 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.559 1.162 . . . . 75.14 109.254 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -97.35 81.55 3.01 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.497 1.123 . . . . 74.33 109.294 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . 177.96 145.73 6.06 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.494 1.121 . . . . 74.2 110.995 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.6 -15.28 17.84 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.443 0.731 . . . . 74.04 109.272 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 470' ' ' PHE . . . . . 0.599 ' CG ' ' NZ ' ' A' ' 243' ' ' LYS . 5.5 m-30 -94.0 20.24 8.08 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.523 1.139 . . . . 74.4 110.968 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 471' ' ' ILE . . . . . . . . . . . . . 19.2 mm -91.83 142.38 26.51 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.486 1.116 . . . . 65.11 109.262 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 472' ' ' PRO . . . . . 0.516 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -75.07 156.65 42.71 Favored 'Trans proline' 0 C--N 1.361 1.236 0 O-C-N 124.486 1.782 . . . . 71.54 111.027 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 19.1 t -99.43 -44.15 6.29 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.513 1.133 . . . . 73.12 110.046 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -102.17 167.94 9.71 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 72.13 110.348 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.95 -168.28 0.5 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.456 1.766 . . . . 62.41 110.997 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 476' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' B' ' 477' ' ' PRO . . . -59.03 140.29 87.1 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.51 1.131 . . . . 52.22 109.307 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 477' ' ' PRO . . . . . 0.619 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -75.09 -162.12 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.545 1.813 . . . . 74.2 111.027 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.74 87.93 11.01 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.573 1.17 . . . . 73.33 109.277 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 479' ' ' PRO . . . . . 0.571 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.3 Cg_endo -75.03 169.59 22.27 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.419 1.747 . . . . 64.51 110.986 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 480' ' ' PRO . . . . . 0.442 ' C ' ' N ' ' B' ' 482' ' ' SER . 18.1 Cg_endo -75.02 -70.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.485 1.781 . . . . 61.32 111.008 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 481' ' ' SER . . . . . 0.587 ' OG ' ' CE1' ' A' ' 164' ' ' TYR . 1.6 m -38.32 -30.87 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.465 1.103 . . . . 73.43 109.992 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 482' ' ' SER . . . . . 0.442 ' N ' ' C ' ' B' ' 480' ' ' PRO . 47.3 t -81.62 128.68 34.19 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.493 1.121 . . . . 65.21 110.023 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -78.37 81.1 4.74 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.53 1.144 . . . . 75.25 109.334 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 23.2 t -103.42 49.32 0.83 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.481 1.113 . . . . 62.11 109.954 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -163.64 109.75 1.1 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.49 1.119 . . . . 74.02 109.238 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 9.1 t . . . . . 0 C--N 1.326 -0.44 0 O-C-N 124.529 1.143 . . . . 74.35 110.013 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.503 ' HA2' ' CE2' ' A' ' 159' ' ' TYR . . . . . . . . 0 CA--C 1.529 0.966 0 N-CA-C 111.069 -0.813 . . . . 63.42 111.069 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 36.7 t -95.52 114.94 26.75 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.468 0.746 . . . . 53.41 109.982 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 12.6 tp 65.75 54.46 1.07 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.507 1.129 . . . . 74.42 109.241 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.702 ' CE2' ' CE1' ' A' ' 183' ' ' PHE . 5.6 m-30 -112.79 159.08 19.34 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.504 1.127 . . . . 73.02 110.972 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.466 ' CB ' HD21 ' A' ' 182' ' ' LEU . . . -124.31 145.63 49.29 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.489 1.118 . . . . 72.5 109.282 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.498 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -123.32 127.36 74.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.496 1.123 . . . . 72.14 109.322 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.484 ' CG2' HD13 ' A' ' 182' ' ' LEU . 1.1 t -82.57 118.03 29.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 124.512 1.132 . . . . 72.02 109.248 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.443 ' CD2' HG23 ' A' ' 161' ' ' ILE . 1.7 mt -92.32 -16.21 26.35 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.523 1.139 . . . . 74.35 109.255 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.561 ' CE1' ' HB3' ' B' ' 481' ' ' SER . 3.0 m-85 -145.94 158.51 43.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.437 1.085 . . . . 73.24 111.058 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.446 ' CB ' HG13 ' A' ' 178' ' ' VAL . 0.6 OUTLIER -96.77 159.4 14.94 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.476 1.11 . . . . 71.31 109.321 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -160.63 131.81 5.63 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.554 1.159 . . . . 72.33 111.033 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -67.34 129.33 39.55 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.463 1.102 . . . . 74.3 109.305 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.466 ' HB2' ' CA ' ' A' ' 173' ' ' GLU . . . -107.28 141.13 39.1 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.442 1.089 . . . . 74.54 109.332 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -149.7 22.38 0.9 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.539 1.149 . . . . 73.25 110.315 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.562 ' HE3' ' CZ3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -99.88 -175.91 3.1 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.43 1.081 . . . . 75.51 109.282 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.25 -28.88 67.12 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.491 1.119 . . . . 73.11 109.336 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.45 ' CB ' ' CB ' ' A' ' 206' ' ' LEU . 76.1 m-20 -108.46 20.05 19.06 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.498 1.124 . . . . 73.32 109.282 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.466 ' CA ' ' HB2' ' A' ' 168' ' ' ALA . 8.0 pt-20 -38.02 106.33 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.395 1.059 . . . . 75.3 110.304 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.472 ' CD2' ' HA3' ' A' ' 205' ' ' GLY . 4.2 tp -124.39 113.7 18.53 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.522 1.139 . . . . 73.43 109.307 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 12.1 t -89.06 111.36 22.07 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.471 1.107 . . . . 71.44 110.427 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.464 ' CG2' ' HG3' ' A' ' 180' ' ' GLU . 59.2 m -128.87 142.76 50.86 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.473 1.108 . . . . 74.52 110.401 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -83.48 162.33 20.98 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.548 1.155 . . . . 72.43 110.945 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.446 HG13 ' CB ' ' A' ' 165' ' ' ASP . 2.4 m -60.37 158.24 2.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.488 1.117 . . . . 74.13 109.245 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.4 48.22 60.58 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.555 1.159 . . . . 72.33 110.979 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.498 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 11.9 mm-40 -105.07 168.51 9.01 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 0.766 . . . . 75.45 110.32 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -128.0 117.13 21.14 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.454 1.096 . . . . 75.41 109.312 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.541 ' CD1' ' N ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -134.89 146.89 49.64 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.521 1.138 . . . . 73.23 109.294 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.702 ' CE1' ' CE2' ' A' ' 159' ' ' TYR . 9.8 m-30 -100.21 116.82 33.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.472 1.107 . . . . 74.4 111.035 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.478 HD12 ' CB ' ' A' ' 195' ' ' ALA . 14.1 mm -59.52 151.04 5.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.579 1.175 . . . . 75.11 109.359 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.559 ' O ' ' CZ3' ' A' ' 242' ' ' TRP . 2.8 m -133.83 -46.53 0.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.525 1.141 . . . . 75.14 108.303 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.47 ' CB ' ' HB ' ' A' ' 194' ' ' ILE . . . -127.63 174.07 9.37 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.506 1.129 . . . . 74.33 109.348 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -157.06 141.59 16.68 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 1.114 . . . . 73.24 109.636 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.596 ' CD2' ' O ' ' A' ' 192' ' ' TRP . 0.1 OUTLIER -143.21 139.35 30.23 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.458 1.099 . . . . 74.11 109.552 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.466 ' C ' ' N ' ' A' ' 191' ' ' GLU . 27.6 t-20 50.83 22.7 1.21 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.508 1.13 . . . . 70.4 109.345 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.402 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.8 m 41.54 29.02 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.475 1.109 . . . . 72.5 108.239 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.502 ' CD ' ' CB ' ' B' ' 476' ' ' ALA . 18.2 tt0 -127.59 -38.74 1.88 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.436 1.085 . . . . 63.35 110.309 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.596 ' O ' ' CD2' ' A' ' 188' ' ' HIS . 96.3 m95 -112.21 125.19 53.88 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.519 1.137 . . . . 72.44 108.017 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.586 ' CZ ' HG12 ' A' ' 209' ' ' VAL . 19.1 m-30 -115.15 150.69 35.65 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.498 1.124 . . . . 75.13 111.028 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.474 ' O ' ' N ' ' A' ' 185' ' ' CYS . 14.8 mm -112.16 91.24 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.557 1.161 . . . . 75.32 109.327 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.478 ' CB ' HD12 ' A' ' 184' ' ' ILE . . . -94.75 -175.24 3.52 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.514 1.134 . . . . 71.31 109.35 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.481 ' CG ' ' SG ' ' A' ' 185' ' ' CYS . 0.0 OUTLIER -156.42 158.19 31.36 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.556 1.16 . . . . 72.44 109.249 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.08 160.17 40.23 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.491 1.785 . . . . 65.53 110.987 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.47 ' CG1' ' CZ ' ' A' ' 183' ' ' PHE . 9.9 mt -49.85 -51.69 15.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.462 1.101 . . . . 75.51 109.292 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -174.74 84.25 0.08 OUTLIER Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.461 1.101 . . . . 73.44 111.015 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -167.12 131.95 2.01 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.561 0.801 . . . . 75.15 110.289 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.403 ' N ' HD22 ' A' ' 201' ' ' LEU . 1.1 pt? -43.67 102.6 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 72.24 109.283 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . -171.29 -81.04 0.05 OUTLIER Glycine 0 CA--C 1.531 1.068 0 O-C-N 124.46 1.1 . . . . 64.15 111.058 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.417 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . -45.23 171.45 0.01 OUTLIER Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.992 -0.843 . . . . 74.33 110.992 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.415 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.2 Cg_endo -75.03 127.29 14.17 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.024 -2.49 . . . . 72.31 110.962 0.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.472 ' HA3' ' CD2' ' A' ' 174' ' ' LEU . . . -97.65 145.75 17.95 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.573 1.17 . . . . 72.22 111.021 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.571 HD21 ' CE3' ' A' ' 192' ' ' TRP . 0.3 OUTLIER -92.32 146.65 23.53 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.562 0.801 . . . . 70.45 109.351 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.469 ' CG1' HG11 ' A' ' 212' ' ' VAL . 0.4 OUTLIER -160.31 131.02 3.67 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.522 1.139 . . . . 74.33 109.275 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.06 168.5 24.67 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.471 1.774 . . . . 62.21 110.967 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.586 HG12 ' CZ ' ' A' ' 193' ' ' PHE . 0.9 OUTLIER -89.27 2.52 6.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.479 1.112 . . . . 75.31 109.228 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -101.76 -5.96 50.28 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.557 1.16 . . . . 72.11 110.951 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.587 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 12.0 m-85 -125.22 1.0 7.82 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 0.774 . . . . 72.33 111.013 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.469 HG11 ' CG1' ' A' ' 207' ' ' VAL . 1.3 m -142.63 160.85 18.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.407 1.067 . . . . 74.52 109.346 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 3.9 m -125.25 138.34 54.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.581 1.176 . . . . 72.52 110.015 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.5 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 3.5 mm -78.77 147.34 6.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.473 1.108 . . . . 74.3 109.246 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.5 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 7.6 pt -162.5 125.33 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.442 1.089 . . . . 74.15 109.287 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -128.53 -75.48 0.56 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.446 1.091 . . . . 73.33 109.295 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.487 ' CG2' ' O ' ' A' ' 217' ' ' ILE . 54.6 mt -119.32 69.34 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.587 1.179 . . . . 71.12 109.301 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -173.09 135.29 0.59 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.533 1.145 . . . . 74.14 109.288 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 8.9 t -92.14 45.46 1.21 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.529 1.143 . . . . 74.34 110.386 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -161.95 -89.34 0.07 OUTLIER Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.456 1.098 . . . . 63.45 111.049 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.417 ' O ' ' N ' ' A' ' 223' ' ' THR . 3.5 m-85 -117.35 -172.53 2.24 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.527 0.781 . . . . 75.4 111.027 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.436 ' O ' ' CG2' ' A' ' 223' ' ' THR . . . -68.56 70.91 0.19 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.479 1.112 . . . . 75.42 109.322 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.436 ' CG2' ' O ' ' A' ' 222' ' ' ALA . 13.1 t 48.62 19.82 0.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.539 1.15 . . . . 70.12 110.409 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.428 ' N ' ' C ' ' A' ' 222' ' ' ALA . . . 92.36 -32.7 5.33 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.523 1.139 . . . . 62.44 111.007 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 -63.35 168.69 4.22 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.537 0.786 . . . . 70.52 109.271 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -86.77 150.92 23.81 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.539 1.149 . . . . 64.01 109.245 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -42.94 -48.51 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.514 1.134 . . . . 75.33 109.246 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 231' ' ' ILE . 2.6 mp -60.21 -58.12 8.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.48 1.112 . . . . 75.51 109.257 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 233' ' ' SER . 7.5 mt-10 -46.12 -26.52 0.77 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.525 1.14 . . . . 75.21 110.337 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -77.09 -37.85 53.54 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 63.44 109.261 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.499 ' N ' ' O ' ' A' ' 228' ' ' ILE . 0.6 OUTLIER -59.54 -60.26 2.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.544 1.153 . . . . 75.11 109.272 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' A' ' 228' ' ' ILE . 0.0 OUTLIER -62.65 -44.56 95.95 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.508 1.13 . . . . 72.13 109.329 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 229' ' ' GLU . 1.5 m -41.15 -60.03 1.34 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.489 1.118 . . . . 64.24 109.982 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.446 ' O ' ' CB ' ' A' ' 235' ' ' ASN . 1.5 m -73.32 -22.49 19.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.478 1.111 . . . . 74.43 109.3 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 234' ' ' VAL . 5.7 m120 79.09 28.43 0.39 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.503 1.127 . . . . 75.31 109.29 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 237' ' ' PRO . 3.4 tp -66.44 125.93 91.26 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.51 1.131 . . . . 71.22 109.287 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 236' ' ' LEU . 18.5 Cg_endo -74.94 161.08 39.52 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.43 1.753 . . . . 70.22 111.057 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.8 m -60.25 178.49 0.19 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.539 1.149 . . . . 71.41 110.329 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 14.6 p -72.59 -37.83 57.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.506 1.129 . . . . 74.22 109.287 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -79.99 -22.54 42.41 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.543 1.152 . . . . 74.23 110.268 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -82.97 -43.2 16.69 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.431 1.082 . . . . 72.44 110.306 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.559 ' CZ3' ' O ' ' A' ' 185' ' ' CYS . 9.4 t90 -70.59 -58.79 3.31 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.139 . . . . 75.01 108.002 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -56.19 -18.98 11.75 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.555 1.159 . . . . 75.22 109.292 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 8.2 t -39.12 -58.12 1.2 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.437 1.085 . . . . 74.2 109.993 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.406 ' C ' ' N ' ' A' ' 247' ' ' ALA . 0.9 OUTLIER -151.54 115.84 5.04 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.536 1.147 . . . . 74.23 109.314 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 40.4 mm -42.49 -28.67 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.461 1.101 . . . . 71.41 109.347 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.406 ' N ' ' C ' ' A' ' 245' ' ' ASN . . . -107.46 54.87 0.66 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.484 1.115 . . . . 74.15 109.28 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.59 96.49 6.18 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.499 1.124 . . . . 70.25 110.298 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.518 ' CD1' ' O ' ' A' ' 249' ' ' TYR . 0.7 OUTLIER -57.68 133.62 55.49 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.533 1.146 . . . . 75.32 111.064 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -67.5 114.02 5.82 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.491 1.119 . . . . 74.23 109.282 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.476 ' CB ' ' CE2' ' A' ' 249' ' ' TYR . . . -162.54 164.52 26.83 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.132 . . . . 74.4 109.286 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 1.3 m 67.65 52.97 0.73 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.483 1.114 . . . . 62.3 110.031 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -94.42 145.15 24.98 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.489 1.118 . . . . 72.02 109.268 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.403 ' CD1' ' N ' ' A' ' 254' ' ' ILE . 3.2 mp -92.7 153.68 3.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.559 1.162 . . . . 73.1 109.332 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 13.3 t -170.49 178.83 3.54 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.539 1.149 . . . . 54.4 109.965 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 5.5 tp 56.44 30.33 16.85 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.479 1.112 . . . . 75.25 109.301 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -48.31 170.0 0.08 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.499 1.124 . . . . 75.24 111.029 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 21.8 t -47.3 165.17 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.499 0.764 . . . . 75.05 109.976 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 9.4 p -123.85 137.34 57.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.606 1.191 . . . . 75.54 109.274 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.513 1.133 . . . . 71.53 110.314 179.992 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 110.001 -0.37 . . . . 73.34 110.001 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 93.5 p -124.45 24.61 7.89 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.578 1.173 . . . . 72.52 109.981 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 27.9 t -66.33 -65.92 0.62 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.486 1.116 . . . . 65.03 109.976 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -78.0 66.66 3.69 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.477 1.111 . . . . 63.14 109.328 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -92.53 -47.9 6.9 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.528 1.142 . . . . 72.22 109.309 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -84.6 160.72 36.17 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.499 1.124 . . . . 74.33 110.994 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -83.11 -28.42 29.47 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.537 0.787 . . . . 71.33 109.274 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 470' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -98.16 50.69 1.01 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.511 1.132 . . . . 73.33 111.004 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 471' ' ' ILE . . . . . 0.405 ' HA ' ' HD3' ' B' ' 472' ' ' PRO . 27.6 mm -115.36 142.33 28.55 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.494 1.122 . . . . 74.23 109.353 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 472' ' ' PRO . . . . . 0.562 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.3 Cg_endo -75.0 127.51 10.73 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.539 1.81 . . . . 74.24 111.025 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 8.5 t -75.01 -52.87 10.02 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.446 1.091 . . . . 65.45 109.985 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 474' ' ' ARG . . . . . 0.407 ' NE ' ' HA ' ' B' ' 474' ' ' ARG . 5.2 mmp_? -82.89 160.52 60.66 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 74.42 110.338 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.01 -166.54 0.35 Allowed 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.441 1.759 . . . . 71.35 111.012 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 476' ' ' ALA . . . . . 0.502 ' CB ' ' CD ' ' A' ' 191' ' ' GLU . . . -60.31 136.52 91.64 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 74.31 109.288 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 477' ' ' PRO . . . . . 0.583 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -74.92 -164.77 0.25 Allowed 'Trans proline' 0 C--N 1.359 1.105 0 O-C-N 124.507 1.793 . . . . 75.22 110.978 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 90.89 10.98 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.473 1.108 . . . . 74.02 109.326 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 479' ' ' PRO . . . . . 0.587 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.3 Cg_endo -74.99 166.15 29.83 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.519 1.8 . . . . 72.13 111.007 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.99 -88.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.443 1.759 . . . . 72.13 110.984 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 481' ' ' SER . . . . . 0.561 ' HB3' ' CE1' ' A' ' 164' ' ' TYR . 1.7 t -66.36 91.33 0.17 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.49 1.119 . . . . 61.32 109.972 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 17.5 t -156.89 179.13 9.58 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.592 1.183 . . . . 65.13 109.934 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -49.11 -53.64 19.8 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.506 1.129 . . . . 64.12 109.278 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 24.3 m 53.54 43.18 31.58 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.488 1.117 . . . . 73.45 109.94 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -64.48 100.53 0.37 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.505 1.128 . . . . 74.21 109.259 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 17.0 m . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 53.03 110.02 -179.972 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.999 0 N-CA-C 110.976 -0.85 . . . . 65.54 110.976 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 69.1 m -95.51 173.77 7.34 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.47 0.747 . . . . 60.23 109.932 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.4 pp -139.78 135.84 33.47 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.496 1.122 . . . . 72.1 109.362 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.582 ' CD1' ' N ' ' A' ' 159' ' ' TYR . 1.1 p90 -150.54 -171.38 3.91 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.535 1.147 . . . . 73.51 110.982 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.472 ' HB3' ' CD1' ' A' ' 184' ' ' ILE . . . -121.92 153.77 38.03 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.565 1.166 . . . . 71.51 109.297 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.501 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.2 OUTLIER -122.51 128.52 75.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.491 1.12 . . . . 74.41 109.318 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.477 ' CG2' HD11 ' A' ' 182' ' ' LEU . 0.9 OUTLIER -84.65 122.99 38.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.501 1.126 . . . . 75.32 109.324 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.35 -13.81 20.49 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.56 1.163 . . . . 75.3 109.258 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.483 ' CE1' ' HB3' ' B' ' 481' ' ' SER . 4.8 m-85 -145.7 161.24 40.35 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.522 1.139 . . . . 75.24 111.004 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.487 ' OD1' ' CG1' ' A' ' 178' ' ' VAL . 2.5 p30 -101.01 156.78 17.21 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.435 1.084 . . . . 74.3 109.277 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.603 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 1.3 t80 -153.26 131.42 11.91 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.456 1.098 . . . . 73.31 111.0 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.603 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 8.9 mtpt -67.04 124.52 23.27 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.471 1.107 . . . . 54.1 109.267 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.456 ' HB1' ' CA ' ' A' ' 173' ' ' GLU . . . -92.98 135.87 33.77 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.566 1.166 . . . . 72.54 109.299 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.751 ' H ' ' NZ ' ' A' ' 170' ' ' LYS . 7.8 pt-20 -150.48 20.69 0.83 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.458 1.099 . . . . 74.51 110.269 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.751 ' NZ ' ' H ' ' A' ' 169' ' ' GLU . 0.1 OUTLIER -106.19 -175.57 2.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.463 1.102 . . . . 72.55 109.333 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.62 -41.03 76.4 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.417 1.073 . . . . 72.5 109.301 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 174' ' ' LEU . 72.1 m-20 -94.4 16.93 13.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.54 1.15 . . . . 51.31 109.313 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.456 ' CA ' ' HB1' ' A' ' 168' ' ' ALA . 10.5 pt-20 -36.44 97.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 72.32 110.281 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.484 ' CB ' ' HA2' ' A' ' 205' ' ' GLY . 0.0 OUTLIER -138.22 95.52 3.03 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.439 1.087 . . . . 70.12 109.339 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.2 t -59.53 153.56 19.35 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.556 1.16 . . . . 73.15 110.446 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 4.9 m -152.51 109.34 3.48 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.436 1.085 . . . . 74.23 110.425 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -52.11 159.14 0.96 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.513 1.133 . . . . 72.13 111.004 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.487 ' CG1' ' OD1' ' A' ' 165' ' ' ASP . 1.5 m -65.68 158.62 4.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.446 1.091 . . . . 74.12 109.31 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 48.41 63.12 3.91 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.479 1.112 . . . . 74.23 111.032 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.501 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 2.0 tp10 -127.99 173.13 10.3 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.526 0.78 . . . . 74.1 110.278 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -122.68 123.07 40.28 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 71.44 109.318 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.54 ' CD1' ' N ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -130.65 135.06 47.48 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.554 1.159 . . . . 75.51 109.262 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 8.3 m-30 -89.19 96.83 10.88 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.488 1.117 . . . . 73.44 110.998 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.508 ' HA ' ' HA ' ' A' ' 195' ' ' ALA . 51.5 mt -64.34 153.82 7.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 73.1 109.334 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.492 ' O ' ' CD1' ' A' ' 236' ' ' LEU . 4.3 m -146.52 -44.68 0.19 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.52 1.138 . . . . 73.22 108.242 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.48 ' HB3' ' CG1' ' A' ' 194' ' ' ILE . . . -112.25 170.91 7.84 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.5 1.125 . . . . 73.51 109.265 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.552 ' CD2' HD21 ' A' ' 236' ' ' LEU . 2.7 p80 -156.79 165.21 36.86 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 75.14 109.687 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.671 ' CE1' ' CG1' ' A' ' 239' ' ' VAL . 0.1 OUTLIER -143.7 113.29 7.02 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.49 1.119 . . . . 65.31 109.609 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.473 ' C ' ' N ' ' A' ' 191' ' ' GLU . 88.0 m-20 50.65 41.49 25.93 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.535 1.147 . . . . 75.11 109.359 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.418 ' C ' ' O ' ' A' ' 189' ' ' ASN . 3.6 m 40.04 30.01 0.06 Allowed 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.463 1.102 . . . . 74.14 108.333 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.495 ' OE2' ' CB ' ' B' ' 476' ' ' ALA . 17.3 tt0 -118.59 -39.69 2.97 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 1.123 . . . . 74.1 110.307 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.575 ' CH2' ' HD3' ' B' ' 477' ' ' PRO . 94.9 m95 -113.14 146.58 38.98 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.532 1.145 . . . . 74.43 107.927 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.622 ' CZ ' ' CG1' ' A' ' 209' ' ' VAL . 21.5 m-30 -132.87 128.46 36.66 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.475 1.109 . . . . 73.23 110.957 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.588 ' CG1' ' NE2' ' A' ' 188' ' ' HIS . 8.5 mm -95.71 100.5 11.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.548 1.155 . . . . 74.31 109.324 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -111.82 171.31 7.57 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.5 1.125 . . . . 72.13 109.333 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -134.91 148.11 65.61 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.558 1.162 . . . . 75.34 109.254 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.94 177.51 8.47 Favored 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.481 1.779 . . . . 74.35 111.003 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 2.4 pt -126.97 67.33 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.576 1.172 . . . . 63.24 109.282 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -168.87 -84.97 0.06 OUTLIER Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.448 1.092 . . . . 65.15 111.026 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 39.4 mmt-85 -66.57 -177.94 0.63 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.431 0.724 . . . . 72.15 110.28 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 8.2 mp -42.19 -50.46 4.84 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.457 1.098 . . . . 75.21 109.308 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 117.66 168.3 14.5 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.54 1.15 . . . . 74.32 111.046 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.494 ' HA3' ' C ' ' A' ' 204' ' ' PRO . . . -83.73 -89.02 0.77 Allowed Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.029 -0.828 . . . . 71.13 111.029 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.494 ' C ' ' HA3' ' A' ' 203' ' ' GLY . 18.2 Cg_endo -75.02 152.99 98.89 Favored 'Cis proline' 0 C--N 1.36 1.153 0 C-N-CA 120.999 -2.501 . . . . 71.45 111.021 -0.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 195' ' ' ALA . . . -88.07 158.79 29.51 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.434 1.084 . . . . 50.0 110.979 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.49 ' CD2' ' HD3' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -104.55 143.96 32.34 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.466 0.745 . . . . 63.15 109.274 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.485 ' CG1' HG13 ' A' ' 212' ' ' VAL . 0.3 OUTLIER -154.44 135.33 8.63 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.461 1.1 . . . . 75.22 109.296 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 174.36 12.92 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.549 1.816 . . . . 51.12 110.992 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.622 ' CG1' ' CZ ' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -93.36 7.57 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.437 1.086 . . . . 74.44 109.332 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -108.47 -6.85 30.83 Favored Glycine 0 CA--C 1.529 0.929 0 O-C-N 124.485 1.116 . . . . 52.22 111.006 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.586 ' CE1' ' HB3' ' B' ' 479' ' ' PRO . 5.8 m-85 -121.31 1.64 10.22 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.45 0.735 . . . . 71.33 111.003 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.485 HG13 ' CG1' ' A' ' 207' ' ' VAL . 1.2 m -141.7 166.32 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.552 1.158 . . . . 74.51 109.226 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.1 t -134.76 134.14 40.64 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 64.25 110.042 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.435 ' CG2' ' HA ' ' A' ' 222' ' ' ALA . 3.4 mm -65.29 138.5 23.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.53 1.144 . . . . 74.42 109.276 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.552 ' CD1' ' CE2' ' A' ' 159' ' ' TYR . 4.1 pt -153.67 131.99 2.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.524 1.14 . . . . 71.24 109.324 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -133.17 19.83 4.05 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.465 1.103 . . . . 64.51 109.346 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.449 ' CG2' ' HA3' ' A' ' 220' ' ' GLY . 0.0 OUTLIER -173.65 144.21 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.521 1.138 . . . . 73.11 109.321 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -46.11 -68.69 0.17 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.526 1.141 . . . . 73.15 109.327 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 36.3 m -89.12 68.94 8.32 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.519 1.137 . . . . 75.02 110.388 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.449 ' HA3' ' CG2' ' A' ' 217' ' ' ILE . . . 178.2 160.41 24.48 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.464 1.103 . . . . 72.01 111.008 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.415 ' C ' ' N ' ' A' ' 223' ' ' THR . 3.1 p90 -154.18 136.4 14.83 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.571 0.806 . . . . 72.32 110.958 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 224' ' ' GLY . . . 43.77 27.49 0.18 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.499 1.124 . . . . 73.12 109.326 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.45 ' CG2' ' O ' ' A' ' 223' ' ' THR . 1.1 t 38.53 30.11 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.406 1.066 . . . . 71.5 110.414 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 222' ' ' ALA . . . 86.81 -45.65 3.46 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.489 1.118 . . . . 74.21 111.02 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -63.46 146.1 54.29 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.461 0.742 . . . . 71.54 109.277 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 229' ' ' GLU . 11.7 t0 -60.24 144.58 49.93 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.47 1.106 . . . . 73.54 109.218 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -43.81 -44.59 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.528 1.143 . . . . 74.54 109.265 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.447 ' HA ' ' CD1' ' A' ' 231' ' ' ILE . 6.7 mt -66.22 -39.95 85.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 73.0 109.295 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 226' ' ' ASP . 18.6 mt-10 -71.82 -18.04 62.11 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.443 1.09 . . . . 63.03 110.318 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 226' ' ' ASP . 11.3 t70 -88.79 -15.73 33.87 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.135 . . . . 71.15 109.326 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.447 ' CD1' ' HA ' ' A' ' 228' ' ' ILE . 4.7 mt -72.68 -69.59 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.518 1.136 . . . . 73.42 109.281 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.45 ' CD ' ' HA ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -53.29 -31.71 45.17 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.44 1.087 . . . . 75.52 109.33 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.5 m -41.01 -61.06 1.05 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.53 1.144 . . . . 70.42 110.001 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.486 ' O ' ' CB ' ' A' ' 235' ' ' ASN . 1.4 m -74.96 -20.46 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.491 1.119 . . . . 74.35 109.315 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 234' ' ' VAL . 16.6 t-20 80.74 29.11 0.2 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.474 1.109 . . . . 73.44 109.272 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.552 HD21 ' CD2' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -72.99 119.43 75.52 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.467 1.104 . . . . 73.34 109.31 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.93 -174.02 1.77 Allowed 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.559 1.82 . . . . 74.22 111.064 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.4 m -73.57 -179.92 3.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.443 1.089 . . . . 73.35 110.407 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.671 ' CG1' ' CE1' ' A' ' 188' ' ' HIS . 1.0 OUTLIER -69.98 -50.75 45.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.528 1.142 . . . . 73.4 109.282 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.522 ' N ' ' CG2' ' A' ' 239' ' ' VAL . 0.1 OUTLIER -69.45 -15.3 63.25 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.371 1.044 . . . . 72.22 110.305 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -89.66 -37.47 14.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.55 1.156 . . . . 73.02 110.281 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.436 ' CH2' ' HB3' ' A' ' 185' ' ' CYS . 1.2 t90 -85.54 -62.5 1.51 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.529 1.143 . . . . 73.11 108.036 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -50.67 -24.2 3.17 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.481 1.113 . . . . 74.32 109.268 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -39.44 -65.86 0.34 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.532 1.145 . . . . 73.12 109.971 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 247' ' ' ALA . 53.3 t30 -118.68 105.33 11.47 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.52 1.138 . . . . 73.32 109.32 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 2.8 mm -53.21 -39.39 34.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.39 1.056 . . . . 74.31 109.302 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.582 ' O ' ' CD1' ' A' ' 249' ' ' TYR . . . -91.92 92.82 8.51 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.565 1.165 . . . . 75.52 109.327 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . 0.412 ' O ' ' CG ' ' A' ' 248' ' ' ARG . 0.5 OUTLIER -42.74 129.15 4.22 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.552 1.157 . . . . 75.35 110.287 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 247' ' ' ALA . 5.7 m-30 -114.76 43.69 1.9 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.557 1.16 . . . . 65.45 110.957 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -98.44 130.0 45.06 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.555 1.159 . . . . 74.14 109.334 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -55.82 -56.39 21.18 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.544 1.153 . . . . 55.23 109.293 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 23.8 t -86.06 142.61 28.6 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 73.14 110.033 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -157.28 154.71 29.53 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.466 1.104 . . . . 75.42 109.304 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 6.0 mm -135.18 160.25 40.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.565 1.166 . . . . 74.03 109.344 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 2.9 t -174.04 140.65 0.72 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.523 1.14 . . . . 70.35 109.995 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.89 162.47 12.97 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.414 1.072 . . . . 75.43 109.285 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -95.14 144.34 17.15 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.433 1.083 . . . . 75.35 111.009 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 3.0 m -150.93 143.56 24.4 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.499 0.764 . . . . 74.41 109.976 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 46.2 t -117.53 82.32 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.567 1.167 . . . . 71.12 109.264 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.469 1.106 . . . . 74.34 110.252 -179.99 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 110.001 -0.37 . . . . 74.42 110.001 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 3.3 m -92.94 8.31 40.3 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.54 1.15 . . . . 73.42 110.06 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 33.7 p -112.88 -56.23 2.43 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.508 1.13 . . . . 73.41 110.041 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -119.01 125.92 50.5 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 73.54 109.319 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -136.09 126.51 26.77 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 74.23 109.342 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -66.54 -168.59 3.07 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.523 1.139 . . . . 74.11 111.005 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -121.91 144.11 49.05 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.474 0.75 . . . . 75.24 109.327 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 470' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 55.64 17.07 2.17 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.53 1.144 . . . . 73.12 111.008 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 471' ' ' ILE . . . . . . . . . . . . . 27.0 mm -66.63 140.2 96.32 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.152 . . . . 75.52 109.293 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 472' ' ' PRO . . . . . 0.415 ' HD3' ' ND1' ' A' ' 188' ' ' HIS . 18.3 Cg_endo -74.92 173.65 14.11 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.492 1.785 . . . . 73.54 111.013 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 81.8 p -103.56 -47.36 4.28 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.482 1.114 . . . . 72.43 109.998 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 11.5 mmp_? -92.94 159.36 35.95 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.61 1.194 . . . . 74.14 110.319 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 475' ' ' PRO . . . . . 0.4 ' O ' ' OE1' ' A' ' 191' ' ' GLU . 18.3 Cg_endo -74.99 -38.68 1.48 Allowed 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.486 1.782 . . . . 74.11 110.965 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 476' ' ' ALA . . . . . 0.495 ' CB ' ' OE2' ' A' ' 191' ' ' GLU . . . 171.2 128.39 0.06 OUTLIER Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.531 1.144 . . . . 73.42 109.319 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 477' ' ' PRO . . . . . 0.575 ' HD3' ' CH2' ' A' ' 192' ' ' TRP . 18.2 Cg_endo -75.0 -161.77 0.13 Allowed 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.457 1.767 . . . . 61.33 110.978 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 478' ' ' LYS . . . . . 0.456 ' CD ' ' N ' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -139.92 107.14 6.89 Favored Pre-proline 0 C--N 1.324 -0.529 0 O-C-N 124.497 1.123 . . . . 74.42 109.329 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 479' ' ' PRO . . . . . 0.586 ' HB3' ' CE1' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.98 162.5 37.07 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.49 1.784 . . . . 62.44 111.027 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.04 -84.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.476 1.777 . . . . 72.14 110.932 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 481' ' ' SER . . . . . 0.483 ' HB3' ' CE1' ' A' ' 164' ' ' TYR . 13.7 t -42.76 -31.06 0.43 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.496 1.123 . . . . 52.43 110.036 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 4.1 t -104.92 83.86 2.06 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.553 1.158 . . . . 73.35 110.0 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -116.13 170.66 8.34 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.469 1.105 . . . . 73.04 109.292 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 3.5 m -167.39 111.56 0.7 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.497 1.123 . . . . 71.13 109.995 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -82.54 164.52 20.81 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.489 1.118 . . . . 74.43 109.293 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.54 1.15 . . . . 74.15 109.954 -179.977 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.017 0 N-CA-C 111.005 -0.838 . . . . 73.34 111.005 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.6 p -123.32 146.57 47.81 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.501 0.766 . . . . 74.04 110.048 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.508 ' CD1' ' N ' ' A' ' 158' ' ' LEU . 0.0 OUTLIER -151.05 123.11 8.21 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.581 1.176 . . . . 75.34 109.332 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.598 ' CZ ' ' CD2' ' A' ' 183' ' ' PHE . 9.2 m-85 -124.42 -170.21 2.11 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 75.55 110.941 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.498 ' CB ' ' CD2' ' A' ' 182' ' ' LEU . . . -132.1 130.71 41.58 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.458 1.099 . . . . 71.31 109.252 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.46 HG23 ' CD1' ' A' ' 215' ' ' ILE . 0.1 OUTLIER -107.96 118.29 55.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.487 1.117 . . . . 64.42 109.265 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.58 ' CG1' ' CD1' ' A' ' 182' ' ' LEU . 0.6 OUTLIER -84.15 123.26 38.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 74.23 109.251 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.78 -11.61 21.69 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 74.33 109.392 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -140.89 162.19 36.03 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.541 1.15 . . . . 74.4 111.01 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.471 ' CB ' HG11 ' A' ' 178' ' ' VAL . 1.1 p30 -93.29 160.14 14.96 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.501 1.126 . . . . 74.13 109.273 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.508 ' CE1' ' HB3' ' B' ' 477' ' ' PRO . 28.3 t80 -157.2 133.27 9.58 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.458 1.099 . . . . 74.42 110.954 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -79.45 123.6 27.68 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.533 1.145 . . . . 75.25 109.287 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -96.68 142.08 29.14 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.453 1.096 . . . . 74.43 109.326 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -153.73 22.67 0.52 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.406 1.066 . . . . 75.45 110.253 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.565 ' NZ ' ' CH2' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -102.75 -176.35 3.07 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.571 1.169 . . . . 74.03 109.267 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.89 -28.89 67.95 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.465 1.103 . . . . 71.51 109.284 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 173' ' ' GLU . 15.2 m-20 -105.8 16.07 25.78 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.463 1.102 . . . . 73.21 109.258 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.436 ' HB3' ' N ' ' A' ' 170' ' ' LYS . 5.3 pt-20 -36.27 105.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.54 1.15 . . . . 75.23 110.326 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.494 ' HG ' ' CA ' ' A' ' 205' ' ' GLY . 0.2 OUTLIER -141.59 95.04 2.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 63.4 109.281 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.2 t -62.86 153.16 34.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 72.15 110.434 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 81.8 m -152.91 110.75 3.6 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.554 1.159 . . . . 64.45 110.37 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -53.39 156.76 2.28 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.507 1.129 . . . . 74.32 110.991 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.471 HG11 ' CB ' ' A' ' 165' ' ' ASP . 2.5 m -58.21 158.19 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.431 1.082 . . . . 71.35 109.327 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.31 72.41 0.49 Allowed Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.568 1.168 . . . . 63.32 110.957 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.513 ' CB ' HG21 ' A' ' 162' ' ' VAL . 1.2 tt0 -137.19 168.12 20.24 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.507 0.769 . . . . 75.2 110.354 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.07 124.52 26.33 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.521 1.138 . . . . 72.0 109.293 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.58 ' CD1' ' CG1' ' A' ' 162' ' ' VAL . 0.0 OUTLIER -128.58 162.47 27.21 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.582 1.176 . . . . 74.24 109.258 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.598 ' CD2' ' CZ ' ' A' ' 159' ' ' TYR . 0.9 OUTLIER -104.75 105.35 15.39 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.594 1.184 . . . . 75.02 110.972 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 195' ' ' ALA . 45.3 mm -59.05 163.81 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.599 1.187 . . . . 74.32 109.32 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 194' ' ' ILE . 5.0 m -149.08 -45.41 0.14 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.478 1.111 . . . . 73.12 108.214 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.509 ' CB ' ' HB ' ' A' ' 194' ' ' ILE . . . -123.35 169.94 10.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.418 1.074 . . . . 74.42 109.34 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.571 ' CD2' HD21 ' A' ' 236' ' ' LEU . 0.2 OUTLIER -155.15 143.95 20.7 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.444 1.09 . . . . 74.04 109.634 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.554 ' CE1' ' HD3' ' B' ' 472' ' ' PRO . 0.2 OUTLIER -145.04 138.46 26.74 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 73.23 109.593 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.488 ' C ' ' N ' ' A' ' 191' ' ' GLU . 20.2 t-20 49.84 23.46 1.04 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.534 1.146 . . . . 75.12 109.284 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.42 ' HB3' ' CD1' ' A' ' 231' ' ' ILE . 6.4 m 40.74 28.9 0.06 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.46 1.1 . . . . 73.53 108.327 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.488 ' N ' ' C ' ' A' ' 189' ' ' ASN . 12.0 tt0 -124.34 -35.19 2.81 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 124.529 1.143 . . . . 72.33 110.283 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.571 ' CZ2' ' HD3' ' B' ' 477' ' ' PRO . 95.1 m95 -118.36 133.22 56.06 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.512 1.132 . . . . 75.21 108.047 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.583 ' CZ ' HG13 ' A' ' 209' ' ' VAL . 23.1 m-30 -123.48 144.3 49.61 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.548 1.155 . . . . 74.54 111.016 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.531 ' CD1' ' NE2' ' A' ' 188' ' ' HIS . 1.2 mp -101.78 96.15 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 124.457 1.098 . . . . 75.21 109.278 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . . . -103.65 -178.81 3.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.45 1.093 . . . . 73.13 109.288 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -150.17 157.51 37.25 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 75.02 109.296 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 178.14 7.66 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.446 1.761 . . . . 75.45 110.966 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -97.26 3.1 10.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.458 1.099 . . . . 75.33 109.296 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 130.39 51.19 0.11 Allowed Glycine 0 CA--C 1.529 0.947 0 O-C-N 124.472 1.108 . . . . 65.33 111.039 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.434 ' CB ' ' CZ ' ' A' ' 200' ' ' ARG . 8.4 ttp-105 -140.28 -82.33 0.25 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.438 0.728 . . . . 64.5 110.349 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -59.55 -176.53 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.497 1.123 . . . . 73.23 109.252 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -105.29 54.85 0.59 Allowed Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.387 1.054 . . . . 73.01 111.006 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -48.58 178.39 0.01 OUTLIER Glycine 0 CA--C 1.53 0.983 0 N-CA-C 111.018 -0.833 . . . . 73.4 111.018 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.06 143.41 77.67 Favored 'Cis proline' 0 C--N 1.36 1.133 0 C-N-CA 120.954 -2.519 . . . . 75.21 110.988 0.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.494 ' CA ' ' HG ' ' A' ' 174' ' ' LEU . . . -106.0 140.71 15.25 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.481 1.113 . . . . 64.22 111.038 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.489 ' CD2' ' HD3' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -89.57 145.02 25.56 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.487 0.757 . . . . 74.14 109.303 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.412 ' N ' ' HG ' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -153.29 132.69 7.11 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.47 1.106 . . . . 75.23 109.291 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 191' ' ' GLU . 18.1 Cg_endo -75.06 176.29 10.12 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.46 1.768 . . . . 73.52 111.017 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.583 HG13 ' CZ ' ' A' ' 193' ' ' PHE . 0.8 OUTLIER -98.17 -5.11 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.494 1.121 . . . . 72.12 109.298 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' B' ' 479' ' ' PRO . . . -90.73 -14.06 58.64 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.507 1.129 . . . . 74.53 110.948 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.584 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 15.6 m-85 -122.38 12.98 10.21 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.453 0.737 . . . . 75.1 110.939 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.461 ' CG1' ' C ' ' A' ' 211' ' ' PHE . 1.0 OUTLIER -152.45 160.14 3.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.424 1.077 . . . . 75.34 109.321 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.5 t -123.91 122.82 38.97 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.52 1.138 . . . . 74.04 109.997 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.519 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 4.0 mm -62.97 104.18 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.528 1.142 . . . . 70.13 109.346 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.519 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 3.1 pt -163.71 -170.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.497 1.123 . . . . 73.43 109.262 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.537 ' OD1' ' CD1' ' A' ' 159' ' ' TYR . 3.5 t0 -126.57 -153.03 0.54 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.499 1.124 . . . . 73.24 109.278 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . 0.507 ' O ' ' CB ' ' A' ' 218' ' ' ALA . 12.5 tt -64.44 165.45 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.449 1.093 . . . . 71.21 109.334 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 217' ' ' ILE . . . 83.94 3.7 0.82 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.434 1.084 . . . . 72.11 109.343 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 8.7 p 50.17 22.45 0.95 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.526 1.141 . . . . 73.41 110.397 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -155.58 121.91 1.15 Allowed Glycine 0 CA--C 1.531 1.085 0 O-C-N 124.482 1.114 . . . . 70.25 110.969 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.447 ' C ' ' N ' ' A' ' 223' ' ' THR . 8.6 t80 -163.11 176.29 10.19 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.502 0.766 . . . . 73.25 111.019 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 225' ' ' ASN . . . 42.76 27.33 0.09 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.447 1.092 . . . . 72.21 109.313 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.447 ' N ' ' C ' ' A' ' 221' ' ' TYR . 13.1 t 37.85 30.37 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.496 1.123 . . . . 75.53 110.383 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 222' ' ' ALA . . . 69.05 50.71 32.51 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 124.475 1.109 . . . . 62.33 110.986 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 222' ' ' ALA . 14.2 m-20 -72.72 176.94 5.11 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.478 0.752 . . . . 72.12 109.304 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 229' ' ' GLU . 0.4 OUTLIER -81.66 128.78 34.31 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.478 1.111 . . . . 73.15 109.301 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.8 p -42.63 -48.59 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.483 1.114 . . . . 75.43 109.306 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.497 ' O ' ' CE ' ' A' ' 232' ' ' LYS . 2.3 mp -61.7 -40.59 87.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.466 1.103 . . . . 72.24 109.273 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 226' ' ' ASP . 19.4 mt-10 -67.99 -17.65 64.49 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.555 1.159 . . . . 54.12 110.303 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -88.84 -15.7 33.85 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.54 1.15 . . . . 75.15 109.312 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.495 HG23 ' CE1' ' A' ' 187' ' ' HIS . 1.9 mt -77.13 -69.61 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.439 1.087 . . . . 74.34 109.311 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.497 ' CE ' ' O ' ' A' ' 228' ' ' ILE . 0.0 OUTLIER -62.37 -16.29 53.68 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.587 1.179 . . . . 74.24 109.297 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.74 -21.49 2.8 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.488 1.118 . . . . 61.41 109.984 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.422 ' O ' ' CG2' ' A' ' 234' ' ' VAL . 1.0 OUTLIER -138.54 28.39 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.468 1.105 . . . . 74.32 109.275 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.409 ' C ' ' O ' ' A' ' 234' ' ' VAL . 1.9 m-80 39.83 44.69 1.39 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.564 1.165 . . . . 64.22 109.275 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.571 HD21 ' CD2' ' A' ' 187' ' ' HIS . 4.1 tp -74.4 119.47 76.67 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.491 1.12 . . . . 71.3 109.317 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.06 162.29 37.23 Favored 'Trans proline' 0 C--N 1.361 1.208 0 O-C-N 124.46 1.768 . . . . 70.1 110.995 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.6 m -59.75 159.6 8.56 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.483 1.114 . . . . 74.32 110.442 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.41 HG22 ' CB ' ' A' ' 186' ' ' ALA . 6.4 p -52.5 -59.43 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.564 1.165 . . . . 75.24 109.332 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.406 ' H ' ' CG1' ' A' ' 239' ' ' VAL . 0.0 OUTLIER -65.32 -15.98 63.11 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.55 1.156 . . . . 73.22 110.291 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -80.55 -37.69 30.98 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.536 1.148 . . . . 73.22 110.329 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -82.77 -57.15 3.44 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.511 1.132 . . . . 73.43 108.006 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.431 ' CD ' ' CD2' ' B' ' 470' ' ' PHE . 19.6 mtpp -58.33 -18.28 26.15 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.518 1.136 . . . . 73.13 109.312 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -42.58 -54.31 4.01 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.492 1.12 . . . . 72.23 110.017 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -155.32 137.38 14.64 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.419 1.074 . . . . 74.3 109.341 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 34.3 mm -74.77 -61.74 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.471 1.107 . . . . 73.43 109.302 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -93.8 108.75 20.48 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.116 . . . . 72.0 109.3 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -120.95 126.91 51.18 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.436 1.085 . . . . 74.22 110.286 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.428 ' CD1' ' O ' ' A' ' 249' ' ' TYR . 48.3 p90 -43.4 131.71 4.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.564 1.165 . . . . 73.13 110.978 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -140.73 137.99 33.86 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.507 1.129 . . . . 74.42 109.357 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 69.78 12.83 8.05 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.475 1.11 . . . . 72.22 109.297 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 3.1 p -95.67 162.39 13.63 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.531 1.144 . . . . 74.12 110.084 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -42.54 162.37 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.524 1.14 . . . . 73.51 109.358 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.54 159.42 42.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 O-C-N 124.492 1.12 . . . . 74.23 109.338 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 2.0 t -156.45 113.42 3.14 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.505 1.128 . . . . 63.13 110.012 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.36 -177.65 3.41 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.521 1.138 . . . . 75.45 109.313 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -139.66 -175.81 14.48 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.553 1.158 . . . . 75.42 110.992 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 7.8 p -133.99 45.77 2.59 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.522 0.778 . . . . 73.34 109.971 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.7 p -74.44 153.88 6.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.476 1.11 . . . . 74.22 109.301 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' A' ' 260' ' ' GLU . 9.1 pt-20 . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.459 1.099 . . . . 74.25 110.281 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 109.999 -0.371 . . . . 74.12 109.999 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 1.7 p -160.96 165.61 29.67 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.528 1.143 . . . . 75.42 110.011 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 1.9 t -111.52 -70.08 0.83 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.576 1.172 . . . . 71.23 109.953 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -130.4 177.29 7.46 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.383 1.052 . . . . 73.44 109.344 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -128.23 101.02 6.07 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 73.3 109.27 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -78.1 -164.01 23.33 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.457 1.098 . . . . 42.34 111.027 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -109.38 -14.82 14.37 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.486 0.756 . . . . 75.45 109.312 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 470' ' ' PHE . . . . . 0.491 ' CD2' HG21 ' A' ' 194' ' ' ILE . 4.8 m-30 -91.92 1.14 57.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.48 1.112 . . . . 53.31 110.98 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 471' ' ' ILE . . . . . 0.402 ' HA ' ' HD3' ' B' ' 472' ' ' PRO . 3.1 mm -67.63 140.01 94.26 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.567 1.167 . . . . 75.3 109.296 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 472' ' ' PRO . . . . . 0.554 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.97 -174.37 1.9 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.487 1.783 . . . . 74.12 110.987 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.56 14.62 4.47 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.523 1.139 . . . . 64.03 109.994 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -143.21 159.32 56.06 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.516 1.135 . . . . 75.41 110.379 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -53.22 0.1 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 O-C-N 124.551 1.817 . . . . 70.13 111.013 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 476' ' ' ALA . . . . . . . . . . . . . . . 179.19 140.73 0.28 Allowed Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.482 1.113 . . . . 73.53 109.286 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 477' ' ' PRO . . . . . 0.571 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -74.96 -162.35 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.45 1.763 . . . . 75.52 110.991 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.5 90.93 22.85 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.545 1.153 . . . . 74.32 109.289 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 479' ' ' PRO . . . . . 0.584 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.92 144.32 30.42 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.559 1.821 . . . . 73.24 110.994 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 163.23 35.74 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.472 1.775 . . . . 71.4 111.054 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 481' ' ' SER . . . . . . . . . . . . . 1.2 t 39.62 40.34 0.62 Allowed 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.455 1.097 . . . . 74.24 109.963 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 28.5 t -76.25 127.17 32.36 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.511 1.132 . . . . 70.34 109.919 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -88.16 -19.38 27.02 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.471 1.107 . . . . 74.51 109.309 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 1.3 t -93.37 21.1 6.4 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.524 1.14 . . . . 74.13 110.021 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -108.41 53.17 0.69 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.472 1.108 . . . . 74.44 109.287 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 76.0 p . . . . . 0 C--N 1.326 -0.454 0 O-C-N 124.419 1.075 . . . . 54.31 109.978 179.985 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.035 0 N-CA-C 110.985 -0.846 . . . . 42.31 110.985 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.9 t -105.0 112.89 26.19 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.556 0.797 . . . . 72.13 109.995 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -155.67 128.5 7.99 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.53 1.144 . . . . 71.34 109.227 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.485 ' CD1' ' N ' ' A' ' 159' ' ' TYR . 8.7 m-85 -122.74 -176.55 3.42 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.478 1.111 . . . . 72.51 110.957 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -120.53 148.81 43.36 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.475 1.109 . . . . 74.24 109.37 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.461 HG22 ' CD2' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -132.8 134.13 58.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.512 1.132 . . . . 74.23 109.31 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.436 HG22 ' CG1' ' A' ' 212' ' ' VAL . 2.3 t -92.92 120.93 43.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.427 1.079 . . . . 75.3 109.327 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.461 ' CD2' HG22 ' A' ' 161' ' ' ILE . 0.7 OUTLIER -97.76 -14.14 20.99 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.522 1.139 . . . . 71.14 109.331 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.546 ' CZ ' ' O ' ' B' ' 481' ' ' SER . 1.8 m-85 -145.48 157.72 43.96 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.419 1.074 . . . . 74.33 111.03 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.465 ' CB ' HG11 ' A' ' 178' ' ' VAL . 16.8 p-10 -97.57 158.96 15.21 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.546 1.154 . . . . 74.13 109.291 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.555 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 1.6 t80 -157.89 131.3 7.7 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 73.41 111.048 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.555 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 2.9 mmpt? -67.9 123.54 20.86 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.514 1.134 . . . . 72.05 109.376 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.63 141.24 35.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.53 1.144 . . . . 74.42 109.293 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.417 ' OE2' ' NH2' ' B' ' 474' ' ' ARG . 10.5 pt-20 -151.39 21.33 0.73 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.488 1.117 . . . . 73.44 110.254 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.431 ' N ' ' HB3' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -96.0 -176.3 3.65 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.118 . . . . 71.42 109.298 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.23 -22.5 64.85 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.462 1.101 . . . . 74.12 109.311 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 173' ' ' GLU . 1.5 m-20 -116.07 20.77 14.2 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.512 1.132 . . . . 74.43 109.334 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.431 ' HB3' ' N ' ' A' ' 170' ' ' LYS . 6.9 pt-20 -38.11 109.71 0.11 Allowed 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.464 1.103 . . . . 73.42 110.295 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.467 ' CD2' ' HA3' ' A' ' 205' ' ' GLY . 9.6 tp -121.18 106.71 11.78 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.51 1.131 . . . . 73.22 109.308 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 11.2 t -81.12 107.67 14.12 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.528 1.142 . . . . 72.52 110.405 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.402 HG23 ' N ' ' A' ' 177' ' ' TYR . 0.9 OUTLIER -129.86 142.35 50.68 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.5 1.125 . . . . 75.05 110.322 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.402 ' N ' HG23 ' A' ' 176' ' ' THR . 23.4 m-85 -86.21 167.61 14.71 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.546 1.154 . . . . 74.44 110.959 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.465 HG11 ' CB ' ' A' ' 165' ' ' ASP . 1.8 m -63.19 158.16 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.503 1.127 . . . . 72.12 109.303 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 52.76 58.33 11.73 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.526 1.141 . . . . 75.15 111.033 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -114.14 170.69 8.1 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.461 0.742 . . . . 75.14 110.281 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -126.46 121.75 33.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.512 1.133 . . . . 74.43 109.35 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.471 ' N ' ' CD2' ' A' ' 182' ' ' LEU . 1.5 pt? -142.91 140.64 31.24 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.496 1.122 . . . . 75.24 109.317 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.434 ' C ' ' HB2' ' A' ' 195' ' ' ALA . 32.7 t80 -100.4 114.33 27.8 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.406 1.066 . . . . 74.43 111.026 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.508 HD11 ' CD2' ' A' ' 193' ' ' PHE . 19.8 mt -72.82 145.69 11.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.554 1.159 . . . . 74.42 109.288 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.5 ' O ' ' CD1' ' A' ' 236' ' ' LEU . 6.0 t -135.34 -41.01 0.72 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 74.11 108.275 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.537 ' CB ' ' HB ' ' A' ' 194' ' ' ILE . . . -112.87 167.46 10.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.475 1.109 . . . . 73.42 109.361 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.648 ' CD2' ' CD2' ' A' ' 236' ' ' LEU . 0.1 OUTLIER -156.94 155.34 31.2 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.521 1.138 . . . . 61.15 109.573 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.578 ' CE1' ' HD3' ' B' ' 472' ' ' PRO . 1.3 p80 -158.31 142.09 15.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.416 1.072 . . . . 74.41 109.642 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.472 ' C ' ' N ' ' A' ' 191' ' ' GLU . 61.6 t30 53.07 22.93 2.72 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.133 . . . . 74.43 109.338 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.432 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.8 p 38.92 30.32 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 74.12 108.277 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.472 ' N ' ' C ' ' A' ' 189' ' ' ASN . 3.1 tt0 -132.62 -39.26 1.0 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.485 1.115 . . . . 75.34 110.274 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.574 ' CZ2' ' HD3' ' B' ' 477' ' ' PRO . 99.0 m95 -108.53 129.03 55.3 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.568 1.168 . . . . 74.32 108.029 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.596 ' CZ ' HG11 ' A' ' 209' ' ' VAL . 22.3 m-30 -121.05 145.27 47.96 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.44 1.087 . . . . 71.12 111.018 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.537 ' HB ' ' CB ' ' A' ' 186' ' ' ALA . 4.2 mm -103.11 101.89 12.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.472 1.108 . . . . 65.23 109.259 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . . . -112.23 168.97 9.19 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.43 1.081 . . . . 62.31 109.296 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.04 149.7 72.31 Favored Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.453 1.095 . . . . 74.21 109.268 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.98 178.1 7.71 Favored 'Trans proline' 0 C--N 1.361 1.202 0 O-C-N 124.444 1.76 . . . . 65.02 110.966 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.14 91.68 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.56 1.163 . . . . 74.14 109.305 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 146.75 -62.11 0.46 Allowed Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.561 1.163 . . . . 52.32 110.97 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -92.52 170.19 9.95 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 0.775 . . . . 64.3 110.316 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 14.8 tp -104.84 66.68 0.78 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.494 1.121 . . . . 72.04 109.29 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . -103.03 -57.49 0.77 Allowed Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.569 1.168 . . . . 53.3 110.941 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.405 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . -48.71 179.53 0.01 OUTLIER Glycine 0 CA--C 1.529 0.931 0 N-CA-C 111.01 -0.836 . . . . 51.3 111.01 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.98 123.15 8.79 Favored 'Cis proline' 0 C--N 1.36 1.184 0 C-N-CA 120.993 -2.503 . . . . 64.12 111.013 -0.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 195' ' ' ALA . . . -97.05 157.16 21.02 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.452 1.095 . . . . 73.21 111.019 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.56 HD12 ' CE3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -93.65 148.51 22.04 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.536 0.786 . . . . 73.12 109.33 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.486 ' N ' ' HG ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -157.15 125.93 3.0 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.551 1.157 . . . . 71.34 109.298 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.493 ' O ' ' CG2' ' A' ' 212' ' ' VAL . 18.3 Cg_endo -74.99 173.58 14.27 Favored 'Trans proline' 0 C--N 1.359 1.085 0 O-C-N 124.501 1.79 . . . . 71.01 110.977 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.596 HG11 ' CZ ' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -94.18 6.84 6.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.522 1.139 . . . . 75.12 109.309 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . 0.441 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -106.18 -7.46 35.26 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.536 1.148 . . . . 75.54 111.038 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.596 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 10.7 m-85 -127.73 2.79 6.08 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.507 0.769 . . . . 62.43 110.981 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.493 ' CG2' ' O ' ' A' ' 208' ' ' PRO . 2.6 m -143.62 162.53 16.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 74.44 109.268 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 30.5 t -132.63 142.49 49.13 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.515 1.134 . . . . 70.53 110.02 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.462 ' CD1' HD13 ' A' ' 184' ' ' ILE . 4.2 mm -86.13 113.77 24.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.528 1.143 . . . . 74.25 109.301 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.465 ' HA ' ' CA ' ' A' ' 222' ' ' ALA . 25.8 pt -156.14 179.58 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.523 1.139 . . . . 73.41 109.334 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -145.78 -174.38 4.4 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.498 1.124 . . . . 75.31 109.31 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 9.6 tp -59.63 -16.55 10.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.416 1.073 . . . . 64.44 109.306 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -71.18 169.1 15.82 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.506 1.129 . . . . 74.43 109.24 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.4 ' OG1' ' N ' ' A' ' 220' ' ' GLY . 9.1 t -76.31 -170.22 1.4 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.513 1.133 . . . . 73.11 110.383 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.4 ' N ' ' OG1' ' A' ' 219' ' ' THR . . . 41.91 -124.56 3.49 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.529 1.143 . . . . 74.12 111.001 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -107.94 -177.69 3.41 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.495 0.762 . . . . 74.24 111.041 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.465 ' CA ' ' HA ' ' A' ' 215' ' ' ILE . . . -43.25 -71.6 0.08 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.485 1.116 . . . . 73.22 109.321 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 7.6 t -135.49 9.6 3.42 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.514 1.134 . . . . 72.22 110.355 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 84.02 -10.66 59.93 Favored Glycine 0 CA--C 1.531 1.059 0 O-C-N 124.462 1.101 . . . . 72.45 110.994 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.444 ' CB ' ' OD2' ' A' ' 230' ' ' ASP . 3.3 m-80 -83.25 167.45 17.66 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.498 0.763 . . . . 73.33 109.31 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 230' ' ' ASP . 0.6 OUTLIER -79.1 151.46 31.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.545 1.153 . . . . 71.25 109.316 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 1.3 p -51.88 -39.67 25.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.507 1.129 . . . . 72.34 109.257 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 11.8 mt -71.51 -39.27 70.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.446 1.091 . . . . 74.31 109.337 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -73.24 -15.74 61.42 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.423 1.077 . . . . 75.32 110.29 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.444 ' OD2' ' CB ' ' A' ' 225' ' ' ASN . 6.0 m-20 -88.55 -15.73 34.43 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.542 1.151 . . . . 74.44 109.241 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.472 HG22 ' CE1' ' A' ' 187' ' ' HIS . 3.4 mt -72.04 -69.45 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.497 1.123 . . . . 75.33 109.261 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -17.07 47.56 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.459 1.1 . . . . 61.24 109.275 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.86 -30.09 60.94 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.468 1.105 . . . . 63.41 109.929 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.432 HG21 ' CB ' ' A' ' 236' ' ' LEU . 10.7 m -120.89 22.21 5.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.505 1.128 . . . . 71.2 109.312 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 45.74 26.52 0.36 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.545 1.153 . . . . 73.32 109.312 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.648 ' CD2' ' CD2' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -61.97 123.18 76.63 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.455 1.097 . . . . 72.34 109.304 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 -177.48 3.49 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.421 1.748 . . . . 74.35 110.993 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' THR . . . . . 0.462 ' HB ' ' NE2' ' A' ' 240' ' ' GLN . 2.2 m -74.7 -171.04 1.17 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 73.24 110.388 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.575 ' HB ' ' CD2' ' A' ' 188' ' ' HIS . 12.9 p -79.09 -58.32 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 124.522 1.139 . . . . 71.24 109.3 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.489 ' O ' ' CB ' ' A' ' 244' ' ' SER . 2.0 pp0? -72.18 -10.99 60.52 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.504 1.128 . . . . 75.4 110.324 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.75 -44.51 27.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.529 1.143 . . . . 75.23 110.311 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.61 ' CD1' ' C ' ' A' ' 242' ' ' TRP . 0.0 OUTLIER -87.31 -68.61 0.74 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.002 -1.111 . . . . 73.34 108.002 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.602 ' HD3' ' CD2' ' A' ' 242' ' ' TRP . 0.1 OUTLIER -40.95 -29.11 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.476 1.11 . . . . 75.21 109.342 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 240' ' ' GLN . 0.0 OUTLIER -38.33 -58.56 0.99 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.525 1.14 . . . . 63.14 110.003 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -143.43 127.64 17.64 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.492 1.12 . . . . 72.33 109.308 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 3.2 mp -83.73 -31.23 8.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.523 1.139 . . . . 72.23 109.304 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -91.58 57.75 3.36 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.477 1.111 . . . . 64.24 109.323 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -145.46 139.78 27.09 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.513 1.133 . . . . 75.55 110.383 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -51.21 179.43 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.516 1.135 . . . . 73.43 111.012 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -84.29 148.55 26.62 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.52 1.138 . . . . 71.32 109.26 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -156.02 179.2 9.45 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.497 1.123 . . . . 75.11 109.221 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 60.2 p -172.82 164.76 5.21 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.491 1.119 . . . . 62.33 109.923 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -153.78 143.51 21.81 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.483 1.115 . . . . 64.31 109.281 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 5.2 mp -106.14 125.81 61.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.51 1.131 . . . . 74.21 109.264 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.9 t -148.54 176.52 10.25 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.441 1.088 . . . . 71.44 109.996 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -169.72 153.57 5.02 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.542 1.151 . . . . 71.51 109.371 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 160.75 104.09 0.19 Allowed Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.484 1.115 . . . . 60.43 110.996 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.1 m -121.83 165.19 16.26 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.507 0.769 . . . . 61.13 109.991 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 1.4 m -155.72 125.73 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.532 1.145 . . . . 64.33 109.247 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 C--N 1.326 -0.445 0 O-C-N 124.52 1.138 . . . . 63.34 110.299 179.934 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 110.011 -0.366 . . . . 74.42 110.011 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 2.6 t -84.91 -14.7 46.89 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.46 1.1 . . . . 61.24 110.001 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 72.9 m -71.24 -21.91 62.05 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.448 1.092 . . . . 73.31 109.974 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -90.88 177.8 6.2 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.417 1.073 . . . . 43.11 109.249 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -132.77 171.64 13.61 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.476 1.11 . . . . 74.24 109.318 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -129.02 167.53 21.08 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 124.544 1.153 . . . . 72.42 111.021 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -111.15 -30.96 7.26 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.468 0.746 . . . . 74.35 109.3 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 470' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -95.64 39.28 1.13 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.521 1.138 . . . . 75.24 110.977 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 471' ' ' ILE . . . . . 0.481 ' CD1' HG13 ' A' ' 239' ' ' VAL . 1.2 mm -98.1 142.36 24.46 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.464 1.102 . . . . 62.44 109.278 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 472' ' ' PRO . . . . . 0.578 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.95 170.23 20.86 Favored 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.489 1.783 . . . . 75.41 111.029 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.86 -42.41 5.85 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.573 1.171 . . . . 75.54 110.027 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 474' ' ' ARG . . . . . 0.417 ' NH2' ' OE2' ' A' ' 169' ' ' GLU . 1.1 mtt-85 -96.34 161.1 28.11 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.127 . . . . 73.21 110.298 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 475' ' ' PRO . . . . . 0.408 ' O ' ' CB ' ' B' ' 476' ' ' ALA . 18.3 Cg_endo -74.98 -34.35 3.91 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.543 1.812 . . . . 71.34 110.996 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 476' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' B' ' 475' ' ' PRO . . . 169.72 134.62 0.06 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.545 1.153 . . . . 74.32 109.315 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 477' ' ' PRO . . . . . 0.574 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.2 Cg_endo -74.95 -162.92 0.16 Allowed 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.513 1.796 . . . . 73.31 111.052 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 478' ' ' LYS . . . . . 0.433 ' CD ' ' O ' ' B' ' 478' ' ' LYS . 0.1 OUTLIER -133.84 91.8 24.11 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.432 1.082 . . . . 75.22 109.275 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 479' ' ' PRO . . . . . 0.596 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.1 Cg_endo -75.01 162.49 37.01 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.449 1.763 . . . . 72.05 110.986 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.96 -88.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.41 1.742 . . . . 74.32 111.004 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 481' ' ' SER . . . . . 0.546 ' O ' ' CZ ' ' A' ' 164' ' ' TYR . 0.4 OUTLIER -82.33 142.33 32.12 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.506 1.129 . . . . 55.0 110.018 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 14.4 t -176.48 177.16 1.49 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.598 1.186 . . . . 72.14 109.956 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -80.81 -26.59 37.0 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.482 1.114 . . . . 63.44 109.343 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 1.6 t -166.04 124.84 1.57 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.517 1.136 . . . . 75.13 109.981 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -118.16 161.87 19.16 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.536 1.147 . . . . 64.22 109.278 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.547 1.155 . . . . 75.12 109.997 179.985 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.987 0 N-CA-C 110.963 -0.855 . . . . 61.11 110.963 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.8 t -84.08 -29.91 26.44 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.53 0.782 . . . . 74.22 110.013 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.403 HD23 ' N ' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -42.02 149.75 0.14 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.473 1.108 . . . . 75.31 109.284 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.569 ' CE2' HD12 ' A' ' 215' ' ' ILE . 0.7 OUTLIER -145.84 131.9 19.3 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.449 1.093 . . . . 71.24 110.997 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.529 ' O ' ' CE1' ' A' ' 159' ' ' TYR . . . -108.93 145.09 35.99 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.495 1.122 . . . . 55.11 109.26 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.502 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.2 OUTLIER -130.61 135.8 59.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.456 1.097 . . . . 72.45 109.279 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' A' ' 177' ' ' TYR . 2.6 t -93.03 135.39 27.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 124.475 1.11 . . . . 74.42 109.341 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.543 HD13 ' CE1' ' A' ' 164' ' ' TYR . 0.1 OUTLIER -115.25 -8.34 12.33 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.479 1.112 . . . . 72.12 109.267 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.543 ' CE1' HD13 ' A' ' 163' ' ' LEU . 0.3 OUTLIER -146.98 151.96 37.84 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.486 1.116 . . . . 64.1 110.931 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.422 ' N ' HG12 ' A' ' 178' ' ' VAL . 1.7 p-10 -111.17 154.72 23.96 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.514 1.134 . . . . 73.14 109.291 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.58 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 0.6 OUTLIER -160.89 168.63 24.26 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.416 1.072 . . . . 70.44 110.989 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -92.93 133.98 35.56 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.415 1.072 . . . . 75.4 109.302 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.448 ' HB1' ' CA ' ' A' ' 173' ' ' GLU . . . -106.0 150.96 25.22 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.543 1.152 . . . . 70.03 109.329 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -155.03 27.45 0.42 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.544 1.153 . . . . 73.14 110.275 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.429 ' N ' ' HB3' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -101.49 -176.61 3.19 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.443 1.089 . . . . 75.02 109.273 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.98 -31.01 66.49 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.481 1.113 . . . . 73.45 109.237 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 173' ' ' GLU . 20.1 m-20 -111.47 23.06 14.4 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.48 1.113 . . . . 73.12 109.328 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.497 ' CD ' ' N ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -36.48 112.07 0.17 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.55 1.156 . . . . 62.43 110.241 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.478 ' CD2' ' HA3' ' A' ' 205' ' ' GLY . 0.4 OUTLIER -132.83 118.99 19.65 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.515 1.134 . . . . 75.12 109.28 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 175' ' ' THR . 10.6 t -86.45 108.46 18.52 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.487 1.117 . . . . 74.13 110.425 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.412 HG23 ' N ' ' A' ' 177' ' ' TYR . 1.2 t -102.07 178.86 4.49 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 72.32 110.416 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.481 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 2.6 m-85 -131.88 154.54 49.09 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 74.14 111.061 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.7 m -55.82 154.72 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.538 1.149 . . . . 73.15 109.302 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 40.51 72.2 0.25 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.48 1.113 . . . . 63.11 110.989 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.502 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 7.4 tt0 -131.03 167.25 19.37 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.514 0.773 . . . . 65.24 110.31 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.42 ' ND2' ' OH ' ' A' ' 159' ' ' TYR . 1.3 m-80 -113.89 139.4 49.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.532 1.145 . . . . 72.23 109.305 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.488 ' CD1' HG21 ' A' ' 207' ' ' VAL . 0.6 OUTLIER -154.11 148.44 26.02 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.499 1.125 . . . . 72.13 109.288 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 25.2 t80 -106.37 105.95 16.22 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 75.12 110.961 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.457 ' CA ' ' HB1' ' A' ' 195' ' ' ALA . 73.9 mt -83.95 120.23 34.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.502 1.126 . . . . 74.14 109.308 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.605 ' SG ' ' CH2' ' A' ' 242' ' ' TRP . 33.4 t -124.7 -8.75 7.33 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.483 1.115 . . . . 71.24 108.278 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.514 ' HB3' ' CE3' ' A' ' 242' ' ' TRP . . . -129.78 150.02 51.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.429 1.081 . . . . 73.31 109.327 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.62 148.3 26.33 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.524 1.14 . . . . 74.04 109.53 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.589 ' CE1' ' HD3' ' B' ' 472' ' ' PRO . 2.4 p80 -152.5 144.81 23.97 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.497 1.123 . . . . 74.13 109.591 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.471 ' C ' ' N ' ' A' ' 191' ' ' GLU . 51.5 t-20 53.5 20.01 1.91 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.562 1.164 . . . . 73.22 109.278 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.411 ' C ' ' O ' ' A' ' 189' ' ' ASN . 15.9 p 41.02 27.53 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.461 1.101 . . . . 65.35 108.272 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.471 ' N ' ' C ' ' A' ' 189' ' ' ASN . 8.0 tt0 -129.81 -40.71 1.35 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.497 1.123 . . . . 73.24 110.321 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.591 ' CZ2' ' HD3' ' B' ' 477' ' ' PRO . 99.8 m95 -107.9 126.16 52.34 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.57 1.169 . . . . 74.23 107.971 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.604 ' CZ ' HG12 ' A' ' 209' ' ' VAL . 22.3 m-30 -119.43 134.61 55.13 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 1.122 . . . . 73.53 110.993 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.51 ' CD1' ' NE2' ' A' ' 188' ' ' HIS . 1.0 OUTLIER -100.07 110.9 28.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.567 1.167 . . . . 75.42 109.236 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.457 ' HB1' ' CA ' ' A' ' 184' ' ' ILE . . . -117.01 174.3 6.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.46 1.1 . . . . 72.13 109.237 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.76 139.15 34.13 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.459 1.099 . . . . 75.12 109.324 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 174.27 13.07 Favored 'Trans proline' 0 C--N 1.359 1.089 0 O-C-N 124.527 1.804 . . . . 73.23 110.97 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 97.4 mt -119.63 -52.32 3.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.516 1.135 . . . . 73.35 109.296 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -90.86 -55.66 1.85 Allowed Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.447 1.092 . . . . 75.22 110.998 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -58.25 120.5 8.8 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 0.762 . . . . 74.12 110.319 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 5.5 tp -64.14 133.89 53.81 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.519 1.137 . . . . 72.4 109.334 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 130.04 -155.58 21.07 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.464 1.102 . . . . 75.34 111.022 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.454 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . 93.03 165.66 38.18 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.99 -0.844 . . . . 53.22 110.99 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.454 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.2 Cg_endo -75.03 147.42 89.19 Favored 'Cis proline' 0 C--N 1.36 1.141 0 C-N-CA 121.042 -2.482 . . . . 54.51 110.927 0.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.478 ' HA3' ' CD2' ' A' ' 174' ' ' LEU . . . -103.89 156.87 17.47 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.47 1.106 . . . . 72.34 111.048 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.571 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -94.68 146.16 24.35 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.489 0.758 . . . . 74.42 109.306 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.488 HG21 ' CD1' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -157.79 129.67 4.03 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.53 1.144 . . . . 75.13 109.195 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.468 ' O ' ' CG2' ' A' ' 212' ' ' VAL . 18.2 Cg_endo -75.1 175.93 10.6 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.48 1.779 . . . . 74.04 111.008 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.604 HG12 ' CZ ' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -93.41 4.65 7.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.428 1.08 . . . . 73.01 109.277 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -103.78 -13.06 28.63 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.418 1.074 . . . . 72.42 110.975 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.599 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 11.5 m-85 -119.43 -1.21 10.76 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.486 0.756 . . . . 75.35 110.98 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' A' ' 208' ' ' PRO . 2.6 m -141.06 160.43 23.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.487 1.117 . . . . 72.41 109.274 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.32 144.3 51.11 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.535 1.147 . . . . 75.32 110.036 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.469 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 2.7 mm -88.46 145.62 7.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 75.24 109.342 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.569 HD12 ' CE2' ' A' ' 159' ' ' TYR . 4.1 pt -163.58 152.84 2.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.45 1.093 . . . . 72.23 109.343 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -139.1 15.57 2.63 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.52 1.137 . . . . 74.24 109.327 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 5.6 mm 72.56 59.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.476 1.11 . . . . 75.14 109.289 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -117.08 14.82 15.02 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.539 1.15 . . . . 65.52 109.285 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 5.1 m 63.38 56.76 1.61 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.519 1.137 . . . . 75.41 110.367 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 173.34 -132.93 2.45 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.428 1.08 . . . . 63.24 111.011 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -155.69 123.79 5.78 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.532 0.784 . . . . 72.14 111.014 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 225' ' ' ASN . . . 63.31 16.73 9.71 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.574 1.171 . . . . 63.13 109.362 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.502 ' CG2' ' O ' ' A' ' 223' ' ' THR . 2.0 m 43.99 52.14 6.83 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.499 1.124 . . . . 75.45 110.435 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 77.3 -53.4 3.5 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.566 1.166 . . . . 74.43 111.011 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.461 ' HB3' ' CB ' ' A' ' 229' ' ' GLU . 55.5 m-80 -66.8 120.92 14.34 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.591 0.819 . . . . 75.34 109.374 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 230' ' ' ASP . 8.8 t0 -49.85 158.36 0.5 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.498 1.124 . . . . 73.22 109.304 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.411 ' C ' ' O ' ' A' ' 226' ' ' ASP . 0.2 OUTLIER -38.59 -58.44 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.129 . . . . 71.43 109.286 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 3.2 mp -54.48 -45.51 70.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.518 1.136 . . . . 74.34 109.348 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.461 ' CB ' ' HB3' ' A' ' 225' ' ' ASN . 18.5 mt-10 -67.16 -15.0 63.44 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 74.31 110.344 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 226' ' ' ASP . 5.5 t70 -88.61 -18.92 27.02 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.539 1.149 . . . . 64.43 109.302 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.457 ' CG2' ' N ' ' A' ' 232' ' ' LYS . 0.5 OUTLIER -69.44 -69.42 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.505 1.128 . . . . 75.15 109.27 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.457 ' N ' ' CG2' ' A' ' 231' ' ' ILE . 0.0 OUTLIER -59.89 -23.83 63.79 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.52 1.138 . . . . 75.32 109.329 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.86 -59.7 3.36 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.522 1.139 . . . . 71.0 110.023 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.2 m -98.96 24.31 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.107 . . . . 74.21 109.271 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 5.6 t30 46.07 41.69 8.7 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.445 1.091 . . . . 73.41 109.276 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 33.2 tp -55.54 123.98 53.47 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 124.511 1.132 . . . . 73.03 109.334 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 153.37 41.76 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.565 1.824 . . . . 71.11 111.002 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' THR . . . . . 0.457 ' CG2' ' NE2' ' A' ' 240' ' ' GLN . 0.5 OUTLIER -61.42 -170.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.581 1.176 . . . . 62.23 110.438 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 240' ' ' GLN . 12.3 p -80.27 -48.64 19.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.535 1.147 . . . . 75.53 109.354 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.489 ' OE1' ' N ' ' A' ' 241' ' ' GLU . 0.1 OUTLIER -87.43 -12.81 45.03 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.526 1.141 . . . . 72.2 110.281 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.489 ' N ' ' OE1' ' A' ' 240' ' ' GLN . 8.5 mt-10 -76.68 -36.27 57.39 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.562 1.164 . . . . 73.24 110.303 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.605 ' CH2' ' SG ' ' A' ' 185' ' ' CYS . 0.1 OUTLIER -87.01 -60.17 2.05 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.13 . . . . 64.11 108.012 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.646 ' NZ ' ' CD2' ' B' ' 470' ' ' PHE . 7.6 mtpt -53.19 -20.78 4.3 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.506 1.129 . . . . 75.15 109.328 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 243' ' ' LYS . 0.2 OUTLIER -38.4 -67.57 0.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.481 1.113 . . . . 73.32 110.034 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -143.56 119.33 10.51 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.489 1.118 . . . . 73.3 109.293 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 12.3 mm -57.53 -24.97 23.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.444 1.09 . . . . 74.33 109.309 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -106.26 94.85 5.38 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 70.23 109.299 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . 0.436 ' HG3' ' N ' ' A' ' 249' ' ' TYR . 13.9 tpp85 -90.36 153.09 20.69 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.479 1.112 . . . . 74.31 110.349 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.436 ' N ' ' HG3' ' A' ' 248' ' ' ARG . 35.2 m-85 -36.13 -55.53 0.77 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.535 1.147 . . . . 75.21 111.014 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -114.78 153.77 29.77 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.407 1.067 . . . . 73.41 109.335 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -117.63 -57.41 2.13 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.547 1.154 . . . . 71.41 109.264 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 79.3 p -57.17 155.29 8.79 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.583 1.177 . . . . 63.15 109.951 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.76 122.58 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.469 1.105 . . . . 74.04 109.285 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.41 HG23 ' N ' ' A' ' 255' ' ' SER . 1.8 mt -118.18 157.03 19.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.461 1.1 . . . . 72.22 109.272 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.41 ' N ' HG23 ' A' ' 254' ' ' ILE . 48.1 t -156.8 116.12 3.43 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.534 1.146 . . . . 70.31 110.048 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -41.73 140.06 1.07 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 73.31 109.315 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -113.65 158.06 14.55 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.514 1.134 . . . . 73.14 111.002 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 49.5 m -146.66 152.66 39.23 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.561 0.8 . . . . 73.12 109.987 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.5 41.81 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.499 1.124 . . . . 53.3 109.221 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 . . . . . 0 C--N 1.324 -0.501 0 O-C-N 124.541 1.151 . . . . 73.43 110.309 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 110.019 -0.363 . . . . 61.23 110.019 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 70.6 m -86.32 149.7 24.86 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.525 1.141 . . . . 63.34 110.004 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 5.5 t -132.63 -48.87 0.89 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.559 1.162 . . . . 74.23 109.969 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -75.11 86.21 2.37 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.477 1.111 . . . . 74.44 109.302 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -110.77 -40.08 4.66 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.52 1.137 . . . . 72.33 109.253 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . 177.3 -174.77 47.26 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.487 1.117 . . . . 54.42 111.033 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -107.59 -15.08 14.68 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 124.577 0.81 . . . . 75.11 109.311 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 470' ' ' PHE . . . . . 0.646 ' CD2' ' NZ ' ' A' ' 243' ' ' LYS . 5.9 m-30 -91.48 1.33 57.21 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.417 1.073 . . . . 74.11 111.012 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 471' ' ' ILE . . . . . 0.547 ' CD1' ' N ' ' B' ' 471' ' ' ILE . 1.1 mm -71.31 135.67 84.36 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.482 1.114 . . . . 75.23 109.348 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 472' ' ' PRO . . . . . 0.589 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.94 170.97 19.22 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.504 1.792 . . . . 64.42 111.024 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 2.7 t -116.78 -8.86 11.33 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.455 1.097 . . . . 43.54 109.999 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -122.49 164.37 26.73 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.472 1.107 . . . . 71.0 110.294 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 475' ' ' PRO . . . . . 0.513 ' O ' ' CB ' ' B' ' 476' ' ' ALA . 18.2 Cg_endo -75.03 -38.54 1.53 Allowed 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.49 1.784 . . . . 63.55 110.97 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 476' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' B' ' 475' ' ' PRO . . . 162.73 139.66 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.484 1.115 . . . . 75.15 109.274 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 477' ' ' PRO . . . . . 0.591 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -74.94 -161.37 0.12 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.494 1.786 . . . . 65.43 110.999 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 478' ' ' LYS . . . . . 0.472 ' CD ' ' N ' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -140.51 103.41 6.51 Favored Pre-proline 0 C--N 1.324 -0.52 0 O-C-N 124.59 1.181 . . . . 61.12 109.364 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 479' ' ' PRO . . . . . 0.599 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.5 Cg_endo -74.92 166.08 30.01 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.497 1.788 . . . . 61.23 110.998 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -87.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.417 1.746 . . . . 65.53 110.985 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 481' ' ' SER . . . . . 0.496 ' O ' ' CE2' ' A' ' 164' ' ' TYR . 14.4 t -78.88 84.49 4.92 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.47 1.106 . . . . 74.43 109.952 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 28.4 t -139.81 156.94 46.48 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.529 1.143 . . . . 62.54 109.998 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -139.79 143.48 36.91 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.45 1.093 . . . . 75.31 109.298 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 82.9 p -160.82 144.24 13.28 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.432 1.082 . . . . 75.54 109.973 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -84.31 143.54 29.46 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.521 1.138 . . . . 70.41 109.236 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 53.7 p . . . . . 0 C--N 1.325 -0.497 0 O-C-N 124.511 1.132 . . . . 75.3 109.947 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.407 ' N ' HD12 ' A' ' 158' ' ' LEU . . . . . . . . 0 CA--C 1.529 0.964 0 N-CA-C 110.997 -0.841 . . . . 52.11 110.997 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.1 m -102.85 47.88 0.87 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.426 0.721 . . . . 62.52 109.991 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 156' ' ' GLY . 1.5 mp -109.49 132.68 53.91 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.544 1.152 . . . . 73.33 109.331 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -126.12 128.69 47.72 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.409 1.068 . . . . 75.23 111.042 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.525 ' CB ' ' CD2' ' A' ' 182' ' ' LEU . . . -110.31 144.66 38.7 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.438 1.086 . . . . 73.42 109.303 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.507 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -123.99 123.84 67.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.545 1.153 . . . . 73.21 109.299 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.419 ' CG2' HD13 ' A' ' 182' ' ' LEU . 1.8 t -79.7 122.26 34.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.507 1.129 . . . . 73.41 109.364 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.46 ' CD2' HG23 ' A' ' 161' ' ' ILE . 0.7 OUTLIER -97.48 -14.83 20.89 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.551 1.157 . . . . 74.33 109.305 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.482 ' CZ ' ' O ' ' B' ' 481' ' ' SER . 5.4 m-85 -145.14 160.65 41.11 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.564 1.165 . . . . 70.41 111.067 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.46 ' CB ' HG11 ' A' ' 178' ' ' VAL . 8.5 p30 -97.99 157.03 16.35 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.401 1.063 . . . . 73.03 109.362 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -150.12 135.64 18.22 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.532 1.145 . . . . 72.14 110.979 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -75.86 126.06 30.28 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.491 1.119 . . . . 72.23 109.302 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.468 ' HB3' ' CA ' ' A' ' 173' ' ' GLU . . . -88.99 153.29 21.14 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.452 1.095 . . . . 72.22 109.295 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -166.31 29.41 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 63.42 110.293 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.623 ' NZ ' ' H ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -129.5 -176.08 3.78 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.483 1.115 . . . . 74.23 109.293 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.12 -40.93 78.07 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 60.23 109.318 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 174' ' ' LEU . 30.7 m-20 -88.67 16.99 5.89 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.457 1.098 . . . . 73.21 109.272 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.468 ' CA ' ' HB3' ' A' ' 168' ' ' ALA . 4.6 pt-20 -38.14 95.76 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.449 1.093 . . . . 63.0 110.309 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.623 ' H ' ' NZ ' ' A' ' 170' ' ' LYS . 5.7 tp -118.4 107.81 14.29 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.482 1.114 . . . . 72.24 109.29 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 12.7 t -87.36 115.9 25.09 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.479 1.112 . . . . 71.43 110.357 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 6.9 m -134.74 154.8 51.42 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.536 1.148 . . . . 70.13 110.402 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -94.35 167.54 11.46 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.453 1.096 . . . . 74.45 110.962 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.46 HG11 ' CB ' ' A' ' 165' ' ' ASP . 1.6 m -66.96 158.26 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 124.488 1.117 . . . . 72.21 109.316 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 57.11 50.42 64.51 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.479 1.112 . . . . 70.12 111.077 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.507 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 0.0 OUTLIER -110.26 174.15 6.0 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.498 0.764 . . . . 74.44 110.289 -179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.495 ' N ' ' ND2' ' A' ' 181' ' ' ASN . 0.0 OUTLIER -137.36 117.45 13.42 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.527 1.142 . . . . 72.24 109.264 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.525 ' CD2' ' CB ' ' A' ' 160' ' ' ALA . 0.0 OUTLIER -129.99 154.88 46.95 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.453 1.096 . . . . 73.53 109.358 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.577 ' CE1' ' O ' ' A' ' 184' ' ' ILE . 1.0 OUTLIER -104.24 115.16 29.91 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.423 1.077 . . . . 74.34 110.982 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.577 ' O ' ' CE1' ' A' ' 183' ' ' PHE . 27.5 mm -65.32 160.59 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.493 1.121 . . . . 71.32 109.303 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . 0.439 ' HB3' ' CH2' ' A' ' 242' ' ' TRP . 37.0 m -150.99 -44.88 0.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.538 1.149 . . . . 74.14 108.27 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.488 ' CB ' ' HB ' ' A' ' 194' ' ' ILE . . . -120.71 165.75 14.66 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.5 1.125 . . . . 73.42 109.274 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.489 ' CE1' HG23 ' A' ' 231' ' ' ILE . 0.3 OUTLIER -152.97 146.22 24.77 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.522 1.139 . . . . 73.42 109.617 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.614 ' CE1' ' CB ' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -146.07 137.87 25.01 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.492 1.12 . . . . 73.44 109.625 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.479 ' C ' ' N ' ' A' ' 191' ' ' GLU . 24.5 t-20 50.17 25.58 1.82 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.531 1.144 . . . . 74.4 109.271 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . 0.439 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.9 p 38.93 30.9 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.451 1.094 . . . . 70.51 108.248 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.5 ' CD ' ' CB ' ' B' ' 476' ' ' ALA . 20.5 tt0 -127.36 -39.58 1.86 Allowed 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.495 1.122 . . . . 75.44 110.269 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.614 ' CB ' ' CE1' ' A' ' 188' ' ' HIS . 97.0 m95 -113.79 131.9 56.06 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.518 1.136 . . . . 74.45 108.023 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.578 ' CZ ' HG11 ' A' ' 209' ' ' VAL . 23.3 m-30 -121.94 144.0 49.12 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.471 1.107 . . . . 75.53 111.02 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.488 ' HB ' ' CB ' ' A' ' 186' ' ' ALA . 0.8 OUTLIER -103.28 96.86 4.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.544 1.153 . . . . 75.25 109.341 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.465 ' CB ' HD12 ' A' ' 184' ' ' ILE . . . -99.64 -176.38 3.26 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.433 1.083 . . . . 52.33 109.224 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.453 ' CG ' ' C ' ' A' ' 195' ' ' ALA . 7.3 mtmt -151.19 160.21 32.33 Favored Pre-proline 0 C--N 1.326 -0.43 0 O-C-N 124.549 1.156 . . . . 72.53 109.262 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.08 177.52 8.5 Favored 'Trans proline' 0 C--N 1.361 1.209 0 O-C-N 124.491 1.785 . . . . 75.32 111.002 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 6.7 tt -93.18 -4.91 10.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 124.449 1.093 . . . . 75.43 109.282 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -115.77 -15.29 7.48 Favored Glycine 0 CA--C 1.532 1.095 0 O-C-N 124.535 1.147 . . . . 51.34 110.942 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . 0.419 ' HB3' ' NH1' ' A' ' 200' ' ' ARG . 17.6 mtp-105 62.3 53.85 2.73 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.515 0.774 . . . . 75.25 110.311 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 2.1 tp -125.77 37.62 4.32 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 61.35 109.242 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 179.7 -52.28 0.09 OUTLIER Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.468 1.105 . . . . 51.35 111.032 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.426 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . -44.18 169.79 0.02 OUTLIER Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.087 -0.805 . . . . 61.34 111.087 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . 0.425 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.3 Cg_endo -75.07 127.63 14.85 Favored 'Cis proline' 0 C--N 1.359 1.118 0 C-N-CA 121.04 -2.483 . . . . 61.45 110.967 0.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.498 ' HA3' ' CD2' ' A' ' 174' ' ' LEU . . . -95.42 152.27 20.32 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.471 1.107 . . . . 72.31 110.934 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.45 ' CB ' ' HB3' ' A' ' 172' ' ' ASP . 0.1 OUTLIER -99.49 145.96 26.9 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 0.75 . . . . 73.32 109.312 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.44 ' N ' ' HG ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -159.75 127.84 2.86 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.54 1.15 . . . . 74.12 109.279 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.503 ' O ' ' CG2' ' A' ' 212' ' ' VAL . 18.3 Cg_endo -74.99 176.81 9.42 Favored 'Trans proline' 0 C--N 1.361 1.206 0 O-C-N 124.507 1.793 . . . . 71.4 110.946 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.578 HG11 ' CZ ' ' A' ' 193' ' ' PHE . 0.6 OUTLIER -97.09 5.14 9.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.41 1.069 . . . . 75.15 109.316 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -103.31 -12.22 31.72 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.518 1.136 . . . . 54.21 111.037 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.592 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 10.7 m-85 -123.02 3.28 9.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.473 0.749 . . . . 74.32 110.996 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.503 ' CG2' ' O ' ' A' ' 208' ' ' PRO . 1.9 m -140.35 154.26 22.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.49 1.119 . . . . 70.5 109.273 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 5.6 t -120.37 124.51 45.71 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.485 1.116 . . . . 72.24 110.013 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.458 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 2.7 mm -77.49 139.2 19.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.493 1.121 . . . . 74.22 109.294 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . 0.458 ' CG2' ' O ' ' A' ' 214' ' ' ILE . 3.5 pt -164.43 -179.0 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.421 1.076 . . . . 74.43 109.276 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -146.29 -72.01 0.24 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.497 1.123 . . . . 74.24 109.313 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 44.6 pt -139.65 61.49 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.46 1.1 . . . . 75.12 109.291 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -178.22 171.18 1.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.498 1.124 . . . . 74.53 109.361 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 221' ' ' TYR . 10.6 t -85.81 -161.82 0.66 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.488 1.118 . . . . 74.51 110.446 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 38.47 -97.96 0.01 OUTLIER Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.49 1.118 . . . . 63.52 110.971 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.416 ' O ' ' C ' ' A' ' 222' ' ' ALA . 8.2 m-85 -118.87 173.36 6.93 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.535 0.785 . . . . 75.33 110.97 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 221' ' ' TYR . . . -39.57 -70.22 0.11 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.553 1.158 . . . . 73.4 109.29 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.9 t -133.97 8.48 3.79 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.494 1.121 . . . . 74.31 110.367 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 109.64 8.07 26.94 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.477 1.111 . . . . 74.1 111.014 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -93.15 176.22 6.49 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.545 0.791 . . . . 74.04 109.263 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.66 143.48 26.4 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.529 1.143 . . . . 73.13 109.261 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -41.07 -52.61 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.455 1.097 . . . . 72.14 109.335 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.502 ' O ' ' HD3' ' A' ' 232' ' ' LYS . 4.3 mp -56.94 -58.91 3.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 O-C-N 124.519 1.137 . . . . 74.44 109.298 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -46.62 -29.16 1.71 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.547 1.155 . . . . 61.5 110.331 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -73.28 -37.19 66.35 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.54 1.15 . . . . 63.43 109.32 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.49 ' N ' ' O ' ' A' ' 228' ' ' ILE . 0.6 OUTLIER -62.26 -69.33 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.484 1.115 . . . . 74.02 109.295 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.502 ' HD3' ' O ' ' A' ' 228' ' ' ILE . 0.0 OUTLIER -51.42 -31.88 24.46 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.487 1.117 . . . . 74.33 109.288 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.03 -60.72 2.79 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.517 1.136 . . . . 75.33 109.936 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.2 m -92.03 15.39 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.549 1.155 . . . . 62.32 109.282 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 42.8 t30 40.43 36.35 0.35 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.477 1.11 . . . . 74.01 109.264 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.48 HD23 ' CD2' ' A' ' 187' ' ' HIS . 4.0 tp -49.25 134.48 16.5 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.126 . . . . 61.2 109.335 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 164.09 34.06 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.461 1.769 . . . . 60.41 110.997 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.82 -174.89 2.31 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.503 1.127 . . . . 72.53 110.43 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.533 HG11 ' CD2' ' A' ' 188' ' ' HIS . 1.0 OUTLIER -79.61 -49.33 19.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.503 1.127 . . . . 73.25 109.278 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.506 ' N ' ' CG2' ' A' ' 239' ' ' VAL . 0.0 OUTLIER -76.67 -14.75 59.94 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.454 1.096 . . . . 74.01 110.307 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -83.78 -49.82 8.71 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.55 1.156 . . . . 75.32 110.291 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.475 ' CD1' ' C ' ' A' ' 242' ' ' TRP . 0.1 OUTLIER -70.51 -62.49 1.37 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.007 -1.109 . . . . 75.25 108.007 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.633 ' NZ ' ' CE2' ' B' ' 470' ' ' PHE . 18.3 mtpp -49.56 -23.92 1.87 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.612 1.195 . . . . 72.11 109.329 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 243' ' ' LYS . 4.4 t -39.2 -40.89 0.79 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.433 1.083 . . . . 73.52 109.969 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -169.64 107.83 0.39 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 72.1 109.322 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 1.9 mp -40.52 -38.68 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.487 1.117 . . . . 73.4 109.299 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -144.39 134.2 23.74 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.498 1.124 . . . . 74.43 109.274 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.97 161.69 28.7 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.522 1.139 . . . . 75.53 110.256 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.435 ' CD1' ' O ' ' A' ' 249' ' ' TYR . 11.2 p90 -52.36 125.52 16.36 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.459 1.1 . . . . 74.14 110.97 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.15 118.71 23.28 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.447 1.092 . . . . 74.11 109.246 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.47 -75.27 0.29 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.548 1.155 . . . . 71.34 109.292 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 29.3 t -146.09 175.71 10.27 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.462 1.101 . . . . 74.01 109.987 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -149.65 117.95 6.44 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.52 1.138 . . . . 75.12 109.356 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 14.5 mm -121.96 153.85 26.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.412 1.07 . . . . 75.33 109.27 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 5.4 p -156.24 129.59 8.17 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.503 1.127 . . . . 44.21 109.983 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.8 tt -102.01 139.51 37.54 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.458 1.099 . . . . 74.13 109.28 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -54.82 152.78 11.91 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.451 1.094 . . . . 72.11 111.005 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 69.1 m -83.19 141.51 31.87 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.424 0.72 . . . . 74.34 109.933 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 11.3 t -88.55 167.17 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 124.427 1.079 . . . . 63.52 109.302 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 71.44 110.276 179.964 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 109.983 -0.377 . . . . 72.45 109.983 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 3.5 m -78.56 139.17 38.64 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.502 1.126 . . . . 50.32 109.982 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 63.3 m -68.48 -74.28 0.13 Allowed 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.513 1.133 . . . . 75.13 109.941 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -76.33 169.26 18.57 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.447 1.092 . . . . 75.14 109.375 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -127.15 111.78 14.39 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.411 1.069 . . . . 74.23 109.284 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -72.51 166.58 53.95 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 124.492 1.12 . . . . 65.13 111.01 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.14 -24.82 11.38 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.532 0.783 . . . . 71.13 109.291 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 470' ' ' PHE . . . . . 0.633 ' CE2' ' NZ ' ' A' ' 243' ' ' LYS . 6.3 m-30 -94.65 29.25 2.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 71.11 110.981 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 471' ' ' ILE . . . . . 0.408 ' HA ' ' HD3' ' B' ' 472' ' ' PRO . 7.8 mm -97.51 139.81 21.62 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.145 . . . . 74.33 109.297 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 472' ' ' PRO . . . . . 0.55 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.3 Cg_endo -75.03 146.74 32.91 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.5 1.789 . . . . 70.03 111.018 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 8.2 t -79.21 -59.8 2.63 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.547 1.154 . . . . 61.14 110.075 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -84.67 163.49 46.53 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.52 1.137 . . . . 73.25 110.311 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 -166.59 0.35 Allowed 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.435 1.755 . . . . 74.42 111.01 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 476' ' ' ALA . . . . . 0.5 ' CB ' ' CD ' ' A' ' 191' ' ' GLU . . . -55.58 137.49 70.1 Favored Pre-proline 0 C--N 1.326 -0.417 0 O-C-N 124.489 1.118 . . . . 72.35 109.361 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 477' ' ' PRO . . . . . 0.572 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.2 Cg_endo -75.01 -162.28 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.484 1.781 . . . . 61.13 111.022 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.0 89.84 12.44 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.508 1.13 . . . . 75.42 109.29 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 479' ' ' PRO . . . . . 0.592 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.3 Cg_endo -74.92 161.29 39.2 Favored 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.523 1.801 . . . . 74.12 110.985 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -45.97 0.26 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.506 1.793 . . . . 74.14 111.035 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 481' ' ' SER . . . . . 0.482 ' O ' ' CZ ' ' A' ' 164' ' ' TYR . 3.1 m -126.76 108.83 11.4 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.582 1.176 . . . . 64.42 110.052 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 18.1 t -111.63 -18.98 12.66 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.527 1.142 . . . . 73.44 110.017 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -154.96 -178.67 7.4 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.527 1.142 . . . . 74.3 109.297 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 15.2 m -114.5 21.53 14.47 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.477 1.11 . . . . 65.44 109.952 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -122.52 153.01 39.78 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.565 1.165 . . . . 75.0 109.3 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 80.2 p . . . . . 0 C--N 1.324 -0.523 0 O-C-N 124.494 1.122 . . . . 61.32 110.04 179.989 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.716 ' CD1' ' CE2' ' A' ' 183' ' ' PHE . 3.2 m-85 . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 120.508 0.195 . . . . 73.099999999999994 111.007 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.515 ' CB ' ' CD1' ' A' ' 184' ' ' ILE . . . -128.51 160.96 30.71 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.514 1.134 . . . . 55.229999999999997 109.331 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.711 ' HB ' HD11 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -144.69 124.3 6.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 74.239999999999995 109.337 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.978 HG13 HD22 ' A' ' 182' ' ' LEU . 6.4 m -83.3 127.24 39.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.486 1.116 . . . . 65.420000000000002 109.301 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.497 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 0.4 OUTLIER -98.78 -2.95 36.74 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.465 1.103 . . . . 63.439999999999998 109.311 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.497 ' CE2' ' HB2' ' A' ' 163' ' ' LEU . 1.5 m-85 -152.4 158.16 42.26 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.474 1.108 . . . . 73.239999999999995 111.021 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.799 ' N ' HG12 ' A' ' 178' ' ' VAL . 15.5 t0 -100.41 144.18 29.71 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.435 1.084 . . . . 74.030000000000001 109.268 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.439 ' N ' ' OD1' ' A' ' 165' ' ' ASP . 14.1 t80 -141.21 129.93 22.88 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.495 1.122 . . . . 64.310000000000002 110.949 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -68.56 131.06 44.6 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.439 1.087 . . . . 74.310000000000002 109.311 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.939 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -109.45 138.9 45.13 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.439 1.087 . . . . 41.43 109.307 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -144.6 16.55 1.64 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.506 1.129 . . . . 62.020000000000003 110.304 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.446 ' N ' ' HB3' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -94.92 -176.07 3.74 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.585 1.178 . . . . 71.109999999999999 109.257 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.47 -30.83 70.85 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.455 1.097 . . . . 72.319999999999993 109.306 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.445 ' OD2' ' N ' ' A' ' 206' ' ' LEU . 0.8 OUTLIER -104.59 16.45 26.04 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.473 1.108 . . . . 65.239999999999995 109.329 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.939 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 6.4 pt-20 -36.51 108.36 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.501 1.126 . . . . 71.430000000000007 110.321 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.719 HD13 ' HA3' ' A' ' 205' ' ' GLY . 5.4 tp -119.42 110.41 16.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.447 1.092 . . . . 72.299999999999997 109.316 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 175' ' ' THR . 12.9 t -84.98 108.62 17.68 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.48 1.112 . . . . 70.25 110.391 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.405 HG23 ' N ' ' A' ' 177' ' ' TYR . 0.7 OUTLIER -118.7 178.07 4.61 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.597 1.186 . . . . 75.230000000000004 110.432 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.424 ' O ' ' CG2' ' A' ' 162' ' ' VAL . 12.4 m-85 -121.76 162.78 20.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.577 1.173 . . . . 73.5 111.038 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.799 HG12 ' N ' ' A' ' 165' ' ' ASP . 3.8 m -64.83 147.29 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.539 1.149 . . . . 70.010000000000005 109.244 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.419 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 53.28 62.1 6.31 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.548 1.155 . . . . 32.229999999999997 111.027 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.533 ' O ' HD13 ' A' ' 161' ' ' ILE . 1.8 tp10 -126.31 161.62 27.38 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.505 0.767 . . . . 63.009999999999998 110.331 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -101.75 141.15 35.05 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.451 1.094 . . . . 73.129999999999995 109.262 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.978 HD22 HG13 ' A' ' 162' ' ' VAL . 2.6 pt? -159.2 141.59 13.88 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.45 1.094 . . . . 74.129999999999995 109.283 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.716 ' CE2' ' CD1' ' A' ' 159' ' ' TYR . 6.5 m-85 -106.23 126.43 52.21 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.423 1.077 . . . . 70.530000000000001 110.985 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.663 HD12 ' HB2' ' A' ' 195' ' ' ALA . 0.8 OUTLIER -63.0 153.42 6.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 74.25 109.331 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 194' ' ' ILE . 2.6 m -135.21 -48.25 0.72 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.424 1.078 . . . . 73.209999999999994 108.302 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.882 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -129.91 170.28 14.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.511 1.132 . . . . 71.439999999999998 109.231 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.49 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.2 OUTLIER -150.36 147.45 27.61 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.413 1.071 . . . . 71.450000000000003 109.545 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.576 ' CE1' ' HB3' ' A' ' 192' ' ' TRP . 0.7 OUTLIER -152.61 138.83 18.35 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.592 1.183 . . . . 75.219999999999999 109.611 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.463 ' C ' ' N ' ' A' ' 191' ' ' GLU . 41.9 t30 53.28 22.4 2.7 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.446 1.091 . . . . 74.329999999999998 109.229 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.416 ' C ' ' O ' ' A' ' 189' ' ' ASN . 14.7 p 40.81 28.85 0.06 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.467 1.104 . . . . 53.119999999999997 108.271 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.659 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 7.8 tt0 -127.67 -40.4 1.75 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.409 1.068 . . . . 71.239999999999995 110.291 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.78 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 96.4 m95 -109.51 131.99 54.55 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.484 1.115 . . . . 75.019999999999996 108.002 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.781 ' CE2' HG12 ' A' ' 209' ' ' VAL . 20.8 m-30 -125.54 134.9 51.83 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.473 1.108 . . . . 64.340000000000003 110.972 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.882 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 5.7 mm -93.23 93.01 3.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.536 1.147 . . . . 75.409999999999997 109.282 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.663 ' HB2' HD12 ' A' ' 184' ' ' ILE . . . -97.07 -172.41 2.44 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.437 1.086 . . . . 63.340000000000003 109.381 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 197' ' ' PRO . 3.1 ttpp -154.77 141.44 13.27 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 124.572 1.17 . . . . 71.400000000000006 109.285 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 196' ' ' LYS . 18.2 Cg_endo . . . . . 0 C--N 1.361 1.215 0 O-C-N 124.547 1.814 . . . . 74.310000000000002 110.983 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.412 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . . . . . . 0 CA--C 1.53 1.01 0 N-CA-C 110.997 -0.841 . . . . 72.140000000000001 110.997 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.543 ' HG2' ' CE2' ' B' ' 470' ' ' PHE . 18.4 Cg_endo -74.99 123.77 9.42 Favored 'Cis proline' 0 C--N 1.361 1.21 0 C-N-CA 120.979 -2.509 . . . . 73.310000000000002 111.011 -0.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.719 ' HA3' HD13 ' A' ' 174' ' ' LEU . . . -97.72 148.99 19.11 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.566 1.166 . . . . 75.209999999999994 110.991 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.78 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -87.76 146.54 25.6 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.462 0.742 . . . . 73.140000000000001 109.324 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.808 HG21 HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -161.12 127.64 2.48 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.537 1.148 . . . . 73.420000000000002 109.321 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.635 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.4 Cg_endo -74.93 177.92 7.93 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.495 1.787 . . . . 63.219999999999999 110.991 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.781 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.4 m -96.94 5.08 9.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.54 1.15 . . . . 74.530000000000001 109.283 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' GLY . . . . . 0.497 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -108.05 0.35 33.58 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.455 1.097 . . . . 41.119999999999997 111.003 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.603 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 18.8 m-85 -131.66 8.61 4.56 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.509 0.77 . . . . 64.319999999999993 110.983 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.819 HG12 HG12 ' A' ' 162' ' ' VAL . 2.3 m -151.71 154.87 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.485 1.116 . . . . 72.430000000000007 109.293 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 39.9 t -123.9 147.07 47.98 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.504 1.127 . . . . 54.149999999999999 109.977 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.42 HG13 HG23 ' A' ' 227' ' ' VAL . 6.9 mm -90.87 129.33 41.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.531 1.144 . . . . 74.120000000000005 109.287 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.711 HD11 ' HB ' ' A' ' 161' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.457 0 O-C-N 124.573 1.17 . . . . 52.229999999999997 109.237 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 10.0 t0 . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 109.347 -0.612 . . . . 65.230000000000004 109.347 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.57 HG21 ' HE2' ' A' ' 193' ' ' PHE . 1.5 p -54.03 -40.36 45.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.135 . . . . 65.109999999999999 109.276 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.797 ' HA ' HD12 ' A' ' 231' ' ' ILE . 9.0 mt -69.39 -30.8 46.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.51 1.131 . . . . 63.009999999999998 109.31 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.492 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 8.9 mt-10 -78.97 -21.08 47.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.54 1.15 . . . . 64.230000000000004 110.292 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -88.79 -15.9 33.46 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.511 1.132 . . . . 72.340000000000003 109.312 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.797 HD12 ' HA ' ' A' ' 228' ' ' ILE . 6.5 mt -72.5 -69.8 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.529 1.143 . . . . 70.209999999999994 109.296 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.492 ' CD ' ' HA ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -49.15 -30.67 7.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.515 1.135 . . . . 64.109999999999999 109.288 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.424 ' N ' ' HG2' ' A' ' 232' ' ' LYS . 0.6 OUTLIER -48.14 -50.23 29.45 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 74.230000000000004 109.987 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 236' ' ' LEU . 1.3 m -90.95 -14.36 8.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.516 1.135 . . . . 50.350000000000001 109.239 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 57.58 48.63 13.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.433 1.083 . . . . 75.120000000000005 109.286 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.638 ' C ' HD12 ' A' ' 236' ' ' LEU . 0.8 OUTLIER -71.29 142.93 87.51 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.507 1.129 . . . . 74.349999999999994 109.318 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.581 ' O ' HD12 ' A' ' 236' ' ' LEU . 18.3 Cg_endo -74.99 154.35 42.49 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.447 1.761 . . . . 71.120000000000005 110.997 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.433 HG22 ' H ' ' A' ' 239' ' ' VAL . 2.6 m -58.88 175.5 0.27 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.529 1.143 . . . . 74.430000000000007 110.458 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.569 HG23 ' CB ' ' A' ' 186' ' ' ALA . 7.2 p -76.81 -51.75 18.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 124.552 1.157 . . . . 71.540000000000006 109.295 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.515 ' N ' HG13 ' A' ' 239' ' ' VAL . 4.3 pm0 -71.04 -14.93 62.5 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 75.120000000000005 110.278 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -92.2 -44.73 8.62 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.464 1.102 . . . . 63.25 110.302 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.453 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 9.9 t90 -69.47 -53.4 19.39 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.548 1.155 . . . . 65.510000000000005 108.018 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.561 ' HD3' ' CD2' ' B' ' 470' ' ' PHE . 5.9 mtmp? -62.9 -23.06 67.17 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.54 1.15 . . . . 62.039999999999999 109.274 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.6 t . . . . . 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.133 . . . . 62.039999999999999 110.038 179.995 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 470' ' ' PHE . . . . . 0.561 ' CD2' ' HD3' ' A' ' 243' ' ' LYS . 8.8 m-30 . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 120.488 0.185 . . . . 74.540000000000006 111.0 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 471' ' ' ILE . . . . . 0.503 HG23 ' HD2' ' B' ' 472' ' ' PRO . 3.7 mm -70.31 140.18 87.57 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.516 1.135 . . . . 73.239999999999995 109.3 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 472' ' ' PRO . . . . . 0.569 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.2 Cg_endo -74.93 155.47 43.29 Favored 'Trans proline' 0 C--N 1.359 1.12 0 O-C-N 124.499 1.789 . . . . 70.439999999999998 111.055 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 38.7 t -97.49 -47.69 5.57 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.563 1.165 . . . . 73.519999999999996 110.062 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.86 165.4 17.99 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.537 1.148 . . . . 54.119999999999997 110.31 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 -166.81 0.37 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.458 1.767 . . . . 73.310000000000002 111.031 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 476' ' ' ALA . . . . . 0.659 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . -65.25 134.1 95.71 Favored Pre-proline 0 C--N 1.326 -0.427 0 O-C-N 124.382 1.051 . . . . 73.430000000000007 109.302 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 477' ' ' PRO . . . . . 0.576 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -74.94 -162.65 0.16 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.5 1.789 . . . . 74.299999999999997 110.996 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 478' ' ' LYS . . . . . 0.4 ' N ' ' HD3' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -133.42 90.89 28.21 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 64.219999999999999 109.28 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 479' ' ' PRO . . . . . 0.603 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.98 152.39 40.78 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.489 1.784 . . . . 74.209999999999994 111.0 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 480' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 479' ' ' PRO . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.141 0 O-C-N 124.552 1.817 . . . . 54.039999999999999 111.005 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.524 ' CE1' ' O ' ' A' ' 160' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.503 0.192 . . . . 71.5 110.966 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.857 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -119.89 148.28 43.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.464 1.102 . . . . 53.340000000000003 109.341 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.658 ' HB ' HD11 ' A' ' 215' ' ' ILE . 0.1 OUTLIER -127.78 132.28 69.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.468 1.105 . . . . 74.120000000000005 109.287 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.937 HG22 HG12 ' A' ' 212' ' ' VAL . 3.9 t -87.89 134.05 28.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.516 1.135 . . . . 65.140000000000001 109.336 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.619 HD21 HG23 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -117.97 -2.61 11.25 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.475 1.109 . . . . 73.129999999999995 109.361 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.502 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 16.9 m-85 -139.02 175.74 9.29 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.134 . . . . 71.430000000000007 110.995 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.431 ' CB ' ' HA ' ' A' ' 177' ' ' TYR . 6.5 p-10 -139.86 145.34 37.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.488 1.118 . . . . 73.120000000000005 109.332 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.66 ' HE2' ' HZ1' ' A' ' 170' ' ' LYS . 1.9 p90 -160.28 166.33 29.72 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.552 1.158 . . . . 75.019999999999996 111.057 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -100.03 130.92 46.24 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.537 1.148 . . . . 65.549999999999997 109.321 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.681 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -100.9 157.8 16.46 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 51.409999999999997 109.271 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -156.72 24.53 0.33 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.493 1.121 . . . . 73.239999999999995 110.26 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.66 ' HZ1' ' HE2' ' A' ' 166' ' ' PHE . 0.3 OUTLIER -99.54 -177.25 3.52 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.527 1.142 . . . . 73.319999999999993 109.25 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.94 -27.89 65.74 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.525 1.14 . . . . 60.130000000000003 109.348 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.434 ' HB3' ' CB ' ' A' ' 206' ' ' LEU . 9.2 t0 -112.29 22.2 14.97 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 75.299999999999997 109.315 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.681 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 10.4 pt-20 -36.92 111.63 0.16 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.472 1.108 . . . . 73.049999999999997 110.29 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.71 HD13 ' HA3' ' A' ' 205' ' ' GLY . 4.6 tp -132.02 109.68 10.2 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.457 1.098 . . . . 74.340000000000003 109.293 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.0 t -87.26 133.17 33.71 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.444 1.09 . . . . 71.099999999999994 110.412 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 19.8 m -141.73 165.29 27.88 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.497 1.123 . . . . 75.230000000000004 110.412 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.431 ' HA ' ' CB ' ' A' ' 165' ' ' ASP . 8.1 m-85 -111.07 164.12 13.16 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.44 1.087 . . . . 75.299999999999997 110.999 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 164' ' ' TYR . 2.1 m -61.84 158.46 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.586 1.178 . . . . 65.230000000000004 109.281 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 46.3 70.14 0.72 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.444 1.09 . . . . 70.129999999999995 111.018 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -131.94 174.59 10.01 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 0.773 . . . . 62.5 110.353 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.487 ' ND2' ' CE1' ' A' ' 159' ' ' TYR . 0.7 OUTLIER -118.23 136.23 53.79 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.54 1.15 . . . . 74.519999999999996 109.314 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.876 HD22 HG23 ' A' ' 162' ' ' VAL . 2.6 pt? -157.25 146.09 19.8 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.568 1.167 . . . . 63.240000000000002 109.242 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 7.7 m-85 -113.86 124.1 51.4 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.544 1.153 . . . . 73.400000000000006 110.955 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.857 HD13 ' HB2' ' A' ' 160' ' ' ALA . 1.7 mp -65.44 152.84 8.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.546 1.154 . . . . 72.219999999999999 109.261 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.549 ' O ' ' CZ3' ' A' ' 242' ' ' TRP . 0.1 OUTLIER -135.78 -47.26 0.67 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.467 1.105 . . . . 73.239999999999995 108.319 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.924 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -126.73 167.32 15.91 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.132 . . . . 73.409999999999997 109.313 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.487 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.2 OUTLIER -148.88 146.09 27.76 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.474 1.109 . . . . 71.099999999999994 109.598 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.6 ' CE1' ' CB ' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -149.8 141.81 23.9 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.503 1.127 . . . . 75.400000000000006 109.647 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.455 ' C ' ' N ' ' A' ' 191' ' ' GLU . 19.0 t-20 51.25 22.35 1.34 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.498 1.124 . . . . 75.239999999999995 109.287 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.402 ' C ' ' O ' ' A' ' 189' ' ' ASN . 53.8 m 41.57 28.33 0.08 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.549 1.155 . . . . 51.109999999999999 108.312 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.529 ' O ' HG13 ' A' ' 209' ' ' VAL . 6.8 tt0 -128.15 -41.1 1.61 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.416 1.073 . . . . 70.129999999999995 110.326 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.872 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 98.8 m95 -106.63 131.35 53.88 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.01 -1.107 . . . . 74.420000000000002 108.01 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.8 ' CE2' HG12 ' A' ' 209' ' ' VAL . 20.8 m-30 -125.41 130.47 51.94 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.476 1.11 . . . . 74.150000000000006 111.033 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.924 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 1.5 mp -89.5 96.41 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.563 1.164 . . . . 71.329999999999998 109.313 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -104.16 -174.56 2.57 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.579 1.175 . . . . 63.240000000000002 109.237 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 197' ' ' PRO . 1.1 tmtt? -150.48 141.24 14.58 Favored Pre-proline 0 C--N 1.326 -0.436 0 O-C-N 124.474 1.109 . . . . 74.439999999999998 109.274 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 196' ' ' LYS . 18.4 Cg_endo . . . . . 0 C--N 1.361 1.213 0 O-C-N 124.506 1.793 . . . . 74.109999999999999 110.972 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.418 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . . . . . . 0 CA--C 1.53 0.989 0 N-CA-C 111.039 -0.824 . . . . 51.119999999999997 111.039 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.544 ' HB2' HG23 ' A' ' 194' ' ' ILE . 18.4 Cg_endo -75.03 122.65 8.37 Favored 'Cis proline' 0 C--N 1.359 1.121 0 C-N-CA 121.031 -2.487 . . . . 60.43 111.002 0.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.71 ' HA3' HD13 ' A' ' 174' ' ' LEU . . . -98.19 153.17 19.96 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.449 1.093 . . . . 74.340000000000003 111.049 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.872 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -86.94 146.43 26.16 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.478 0.752 . . . . 71.319999999999993 109.271 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.747 HG21 HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -158.11 126.83 2.99 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.456 1.097 . . . . 74.099999999999994 109.287 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.595 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.3 Cg_endo -75.01 174.48 12.73 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.573 1.828 . . . . 62.340000000000003 110.999 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.8 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.2 m -93.11 4.76 7.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.541 1.151 . . . . 61.509999999999998 109.307 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' GLY . . . . . 0.446 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -109.01 4.64 31.92 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.494 1.121 . . . . 74.299999999999997 110.914 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.633 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 15.7 m-85 -134.12 8.6 3.76 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.473 0.749 . . . . 72.540000000000006 111.058 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.937 HG12 HG22 ' A' ' 162' ' ' VAL . 3.1 m -151.66 162.17 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.45 1.094 . . . . 71.049999999999997 109.345 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 3.6 t -128.42 133.43 48.57 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.529 1.143 . . . . 61.299999999999997 110.032 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.72 ' O ' HG23 ' A' ' 215' ' ' ILE . 2.7 mm -80.77 145.87 8.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.507 1.129 . . . . 74.420000000000002 109.196 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.72 HG23 ' O ' ' A' ' 214' ' ' ILE . 1.0 OUTLIER . . . . . 0 C--N 1.325 -0.457 0 O-C-N 124.449 1.093 . . . . 74.519999999999996 109.299 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 229' ' ' GLU . 25.6 t0 . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 109.333 -0.617 . . . . 63.299999999999997 109.333 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.634 HG13 HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -40.37 -55.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.463 1.102 . . . . 54.020000000000003 109.322 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.634 HD12 HG13 ' A' ' 227' ' ' VAL . 4.0 mp -55.9 -42.22 70.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.119 . . . . 70.140000000000001 109.315 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 226' ' ' ASP . 9.4 mt-10 -68.22 -14.59 63.09 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.455 1.097 . . . . 75.209999999999994 110.253 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -88.73 -18.91 26.83 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.528 1.142 . . . . 74.239999999999995 109.317 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.648 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.5 OUTLIER -68.34 -69.14 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.537 1.148 . . . . 62.25 109.24 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.648 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -59.84 -24.97 64.62 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.43 1.081 . . . . 74.140000000000001 109.226 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.51 -57.4 6.2 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.537 1.148 . . . . 60.119999999999997 109.991 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 234' ' ' VAL . 1.4 m -93.3 25.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.52 1.137 . . . . 70.420000000000002 109.24 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 3.4 m120 41.66 30.28 0.14 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.487 1.117 . . . . 72.310000000000002 109.292 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.563 HD12 ' HD2' ' A' ' 237' ' ' PRO . 7.9 tp -59.28 121.3 55.15 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.506 1.129 . . . . 61.109999999999999 109.334 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.563 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.3 Cg_endo -75.03 160.5 39.98 Favored 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.48 1.779 . . . . 50.200000000000003 111.029 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.516 HG22 ' H ' ' A' ' 239' ' ' VAL . 2.9 m -60.15 -179.35 0.1 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.5 1.125 . . . . 62.409999999999997 110.466 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.638 HG13 ' HG3' ' A' ' 240' ' ' GLN . 11.5 p -71.08 -34.42 54.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 54.119999999999997 109.329 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.638 ' HG3' HG13 ' A' ' 239' ' ' VAL . 2.4 mt-30 -85.32 -18.0 35.15 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.444 1.09 . . . . 55.130000000000003 110.302 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.413 ' HB2' ' N ' ' A' ' 238' ' ' THR . 34.1 mt-10 -84.84 -45.49 12.25 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.476 1.11 . . . . 75.219999999999999 110.293 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.549 ' CZ3' ' O ' ' A' ' 185' ' ' CYS . 7.5 t90 -67.77 -55.05 14.56 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.51 1.131 . . . . 74.120000000000005 107.962 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt -62.72 -18.39 62.45 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.522 1.138 . . . . 54.219999999999999 109.318 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.474 1.109 . . . . 54.210000000000001 110.059 179.967 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 470' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 120.536 0.208 . . . . 71.109999999999999 110.979 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 471' ' ' ILE . . . . . 0.705 HG23 ' HD2' ' B' ' 472' ' ' PRO . 20.0 mm -83.82 142.06 41.81 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.494 1.121 . . . . 75.230000000000004 109.25 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 472' ' ' PRO . . . . . 0.705 ' HD2' HG23 ' B' ' 471' ' ' ILE . 18.2 Cg_endo -75.02 -175.95 2.63 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.456 1.766 . . . . 44.439999999999998 110.988 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 42.7 t -126.7 6.87 6.78 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.484 1.115 . . . . 35.310000000000002 109.997 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -142.44 157.04 63.47 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.545 1.153 . . . . 71.530000000000001 110.294 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 475' ' ' PRO . . . . . 0.702 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.2 Cg_endo -75.06 -26.11 11.13 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.478 1.778 . . . . 75.319999999999993 111.002 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 476' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 163.1 140.1 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.489 1.118 . . . . 74.299999999999997 109.254 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 477' ' ' PRO . . . . . 0.574 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -75.02 -163.4 0.18 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.534 1.807 . . . . 73.329999999999998 111.041 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 478' ' ' LYS . . . . . 0.403 ' N ' ' HD3' ' B' ' 478' ' ' LYS . 0.1 OUTLIER -128.54 90.81 45.46 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.51 1.131 . . . . 65.209999999999994 109.277 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 479' ' ' PRO . . . . . 0.633 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.5 Cg_endo -74.96 147.16 33.72 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.512 1.796 . . . . 53.509999999999998 111.025 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 480' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' B' ' 479' ' ' PRO . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.166 0 O-C-N 124.511 1.795 . . . . 64.420000000000002 111.016 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.56 ' CD1' ' O ' ' A' ' 215' ' ' ILE . 9.6 p90 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.452 0.168 . . . . 73.420000000000002 110.957 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.437 ' CB ' HD11 ' A' ' 184' ' ' ILE . . . -115.98 152.73 32.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.558 1.161 . . . . 72.349999999999994 109.323 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.724 HD12 HD23 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -126.72 120.81 56.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 124.533 1.146 . . . . 43.399999999999999 109.298 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.781 HG22 HG12 ' A' ' 212' ' ' VAL . 2.5 t -74.42 121.67 26.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.544 1.152 . . . . 74.219999999999999 109.3 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.884 HD11 ' HB2' ' A' ' 213' ' ' SER . 0.4 OUTLIER -100.11 -12.32 19.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.578 1.174 . . . . 75.129999999999995 109.307 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.556 ' O ' HG13 ' A' ' 162' ' ' VAL . 0.9 OUTLIER -150.9 154.45 37.21 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.483 1.114 . . . . 73.400000000000006 111.046 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.661 ' N ' HG12 ' A' ' 178' ' ' VAL . 2.9 p30 -74.62 158.73 33.15 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.478 1.111 . . . . 74.329999999999998 109.231 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.488 ' HB2' ' CD1' ' A' ' 211' ' ' PHE . 8.8 t80 -154.51 130.69 10.34 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.527 1.142 . . . . 75.349999999999994 111.002 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -88.95 126.51 35.43 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.46 1.1 . . . . 74.25 109.26 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.798 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -113.64 151.14 32.16 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.518 1.136 . . . . 54.009999999999998 109.325 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.71 24.08 0.39 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.419 1.074 . . . . 74.109999999999999 110.275 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.471 ' HD3' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -100.87 -175.78 2.98 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.615 1.197 . . . . 60.130000000000003 109.287 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.18 -26.08 66.05 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.456 1.097 . . . . 71.140000000000001 109.344 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.456 ' HB3' ' CB ' ' A' ' 206' ' ' LEU . 60.4 m-20 -109.68 15.5 22.77 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.44 1.088 . . . . 71.409999999999997 109.268 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.798 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 17.7 pt-20 -36.1 110.01 0.1 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.439 1.087 . . . . 74.200000000000003 110.295 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.672 HD22 ' HA3' ' A' ' 205' ' ' GLY . 14.2 tp -128.93 103.91 7.29 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.546 1.154 . . . . 64.400000000000006 109.251 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.3 t -88.35 142.6 27.6 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.537 1.148 . . . . 53.149999999999999 110.368 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.464 ' CG2' ' HG2' ' A' ' 180' ' ' GLU . 17.0 m -155.16 162.89 40.85 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.533 1.146 . . . . 60.310000000000002 110.392 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -99.36 163.77 12.39 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.481 1.113 . . . . 74.120000000000005 111.027 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.661 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.6 m -57.72 158.16 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 71.040000000000006 109.29 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.424 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 49.88 68.19 1.5 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.51 1.131 . . . . 34.310000000000002 110.99 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.464 ' HG2' ' CG2' ' A' ' 176' ' ' THR . 3.8 tp10 -128.31 167.77 16.47 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.501 0.765 . . . . 74.510000000000005 110.262 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.45 132.65 53.5 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.429 1.08 . . . . 51.340000000000003 109.328 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.687 HD21 HG23 ' A' ' 162' ' ' VAL . 0.4 OUTLIER -143.25 158.03 43.98 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.495 1.122 . . . . 71.109999999999999 109.36 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 0.6 OUTLIER -114.55 113.09 23.95 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.483 1.115 . . . . 74.420000000000002 110.972 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.463 ' N ' HD12 ' A' ' 184' ' ' ILE . 1.7 mp -65.54 159.96 3.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 124.453 1.096 . . . . 62.299999999999997 109.312 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 186' ' ' ALA . 9.7 p -147.03 -44.39 0.18 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.583 1.177 . . . . 61.409999999999997 108.334 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.879 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -121.32 164.23 17.36 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.446 1.091 . . . . 74.549999999999997 109.32 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.416 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 1.3 p-80 -154.03 140.23 18.5 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.484 1.115 . . . . 60.299999999999997 109.602 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.681 ' NE2' HD11 ' A' ' 194' ' ' ILE . 0.1 OUTLIER -142.18 142.42 32.69 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.518 1.136 . . . . 74.120000000000005 109.577 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.48 ' C ' ' N ' ' A' ' 191' ' ' GLU . 19.2 t-20 50.62 22.1 1.02 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.469 1.105 . . . . 73.140000000000001 109.321 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.4 ' C ' ' O ' ' A' ' 189' ' ' ASN . 23.5 m 42.0 27.23 0.07 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.574 1.171 . . . . 54.119999999999997 108.245 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.524 ' O ' HG13 ' A' ' 209' ' ' VAL . 9.3 tt0 -125.11 -37.1 2.45 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.479 1.112 . . . . 64.430000000000007 110.293 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.821 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 97.2 m95 -109.78 128.77 55.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.505 1.128 . . . . 72.140000000000001 107.96 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.603 ' CE2' HG12 ' A' ' 209' ' ' VAL . 20.9 m-30 -122.18 127.04 49.56 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.488 1.118 . . . . 70.329999999999998 110.958 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.879 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 9.3 mm -89.23 106.34 16.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.493 1.12 . . . . 74.219999999999999 109.288 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -117.01 175.77 5.43 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.128 . . . . 72.549999999999997 109.333 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -147.56 165.56 18.42 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.442 1.089 . . . . 60.149999999999999 109.303 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--N 1.359 1.128 0 O-C-N 124.517 1.799 . . . . 71.439999999999998 110.96 -179.986 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.011 0 N-CA-C 110.959 -0.856 . . . . 54.329999999999998 110.959 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.524 ' HB2' HG22 ' A' ' 194' ' ' ILE . 18.3 Cg_endo -74.94 129.05 17.59 Favored 'Cis proline' 0 C--N 1.362 1.248 0 C-N-CA 121.011 -2.495 . . . . 65.329999999999998 111.053 -0.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.672 ' HA3' HD22 ' A' ' 174' ' ' LEU . . . -92.63 163.31 27.19 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.519 1.137 . . . . 40.43 110.963 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.821 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -97.62 145.41 26.31 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.496 0.762 . . . . 71.040000000000006 109.326 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.562 HG11 HD11 ' A' ' 182' ' ' LEU . 0.4 OUTLIER -153.61 127.35 4.37 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.583 1.177 . . . . 64.549999999999997 109.344 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.611 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.2 Cg_endo -75.09 174.52 12.65 Favored 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.505 1.792 . . . . 74.200000000000003 110.995 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.603 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.6 m -97.03 7.01 8.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.484 1.115 . . . . 63.210000000000001 109.267 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' GLY . . . . . 0.457 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -106.93 -0.9 36.22 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.506 1.129 . . . . 44.5 110.948 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.572 ' CE2' ' HB3' ' B' ' 479' ' ' PRO . 12.7 m-85 -133.27 15.53 4.14 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.556 0.798 . . . . 71.209999999999994 111.046 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.781 HG12 HG22 ' A' ' 162' ' ' VAL . 3.4 m -152.62 157.66 4.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.548 1.155 . . . . 73.439999999999998 109.36 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.884 ' HB2' HD11 ' A' ' 163' ' ' LEU . 46.6 t -128.23 119.94 26.2 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.527 1.142 . . . . 61.25 110.056 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.631 ' C ' HG22 ' A' ' 215' ' ' ILE . 5.1 mm -64.48 153.22 7.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.495 1.122 . . . . 74.230000000000004 109.245 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.631 HG22 ' C ' ' A' ' 214' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.577 1.173 . . . . 73.010000000000005 109.309 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 230' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.366 -0.605 . . . . 75.430000000000007 109.366 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.454 HG21 ' HE2' ' A' ' 193' ' ' PHE . 1.3 p -49.11 -41.12 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.536 1.147 . . . . 72.109999999999999 109.283 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.761 ' HA ' HD12 ' A' ' 231' ' ' ILE . 12.3 mt -66.9 -33.94 66.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.586 1.178 . . . . 72.230000000000004 109.315 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -81.75 -17.52 47.43 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.425 1.078 . . . . 72.239999999999995 110.289 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 226' ' ' ASP . 6.5 t70 -88.7 -15.73 34.09 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.532 1.145 . . . . 72.219999999999999 109.278 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.761 HD12 ' HA ' ' A' ' 228' ' ' ILE . 6.7 mt -71.03 -69.44 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.459 1.099 . . . . 63.229999999999997 109.356 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.435 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -56.86 -21.19 27.48 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.468 1.105 . . . . 74.439999999999998 109.281 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.4 m -56.79 -17.92 10.92 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 72.450000000000003 110.019 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 234' ' ' VAL . 1.2 m -133.14 22.27 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.508 1.13 . . . . 70.200000000000003 109.284 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 40.75 37.22 0.47 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.618 1.199 . . . . 73.140000000000001 109.333 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.468 ' HB2' ' CG2' ' A' ' 234' ' ' VAL . 5.7 tp -66.16 119.63 63.36 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.424 1.078 . . . . 72.040000000000006 109.285 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 166.95 28.13 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.478 1.778 . . . . 74.540000000000006 111.018 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.6 m -68.43 173.58 4.81 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.446 1.091 . . . . 54.119999999999997 110.416 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.719 HG23 ' HB1' ' A' ' 186' ' ' ALA . 14.9 p -69.04 -49.02 66.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.473 1.108 . . . . 44.43 109.347 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 1.015 ' OE1' HD11 ' B' ' 471' ' ' ILE . 7.7 pm0 -73.04 -14.53 61.43 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.117 . . . . 71.239999999999995 110.292 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -90.53 -36.33 14.55 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.543 1.152 . . . . 62.439999999999998 110.313 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.583 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 1.3 t90 -80.48 -54.88 5.28 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.513 1.133 . . . . 73.540000000000006 107.997 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.504 ' HD3' ' CE2' ' B' ' 470' ' ' PHE . 3.0 mtmp? -57.85 -17.3 15.37 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.53 1.144 . . . . 65.219999999999999 109.22 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 243' ' ' LYS . 17.1 m . . . . . 0 C--N 1.324 -0.536 0 O-C-N 124.502 1.126 . . . . 62.32 109.947 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 470' ' ' PHE . . . . . 0.683 ' CD2' HG21 ' A' ' 194' ' ' ILE . 4.9 m-30 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.461 0.172 . . . . 72.019999999999996 110.987 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 471' ' ' ILE . . . . . 1.015 HD11 ' OE1' ' A' ' 240' ' ' GLN . 1.4 mp -70.51 142.98 89.66 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.48 1.112 . . . . 74.540000000000006 109.259 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 472' ' ' PRO . . . . . 0.574 ' HG3' ' CD1' ' A' ' 192' ' ' TRP . 18.5 Cg_endo -74.92 161.53 38.81 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.513 1.796 . . . . 63.0 111.01 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 473' ' ' SER . . . . . 0.44 ' OG ' ' CZ ' ' B' ' 474' ' ' ARG . 29.6 t -98.72 -27.42 13.97 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.532 1.145 . . . . 61.450000000000003 109.989 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 474' ' ' ARG . . . . . 0.44 ' CZ ' ' OG ' ' B' ' 473' ' ' SER . 2.6 mmt180 -111.08 170.38 5.33 Favored Pre-proline 0 C--N 1.326 -0.428 0 O-C-N 124.527 1.142 . . . . 71.120000000000005 110.316 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -168.48 0.52 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.48 1.779 . . . . 74.239999999999995 110.974 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 476' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' B' ' 477' ' ' PRO . . . -73.28 134.93 79.71 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 52.439999999999998 109.296 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 477' ' ' PRO . . . . . 0.566 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -75.0 170.79 19.64 Favored 'Trans proline' 0 C--N 1.358 1.077 0 O-C-N 124.505 1.792 . . . . 63.299999999999997 111.027 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -113.11 95.27 34.11 Favored Pre-proline 0 C--N 1.324 -0.54 0 O-C-N 124.509 1.131 . . . . 61.100000000000001 109.284 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 479' ' ' PRO . . . . . 0.572 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 18.1 Cg_endo -74.99 168.62 24.43 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.483 1.781 . . . . 74.219999999999999 110.974 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 C--N 1.36 1.181 0 O-C-N 124.498 1.789 . . . . 73.409999999999997 110.977 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.559 ' CE1' ' HB2' ' A' ' 183' ' ' PHE . 1.2 t80 . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.461 0.172 . . . . 73.349999999999994 111.009 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.594 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -113.72 142.48 45.98 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.546 1.154 . . . . 74.329999999999998 109.289 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.71 HD13 ' N ' ' A' ' 162' ' ' VAL . 0.0 OUTLIER -127.78 121.59 56.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.485 1.116 . . . . 74.439999999999998 109.302 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.879 ' CG1' HD21 ' A' ' 182' ' ' LEU . 7.0 m -83.47 126.88 40.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.442 1.089 . . . . 64.010000000000005 109.325 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.661 HD23 HD12 ' A' ' 161' ' ' ILE . 0.3 OUTLIER -99.6 -1.95 36.85 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.499 1.125 . . . . 72.219999999999999 109.305 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.533 ' CE2' ' HB2' ' A' ' 163' ' ' LEU . 0.9 OUTLIER -154.69 155.57 34.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.486 1.116 . . . . 74.340000000000003 111.071 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.781 ' N ' HG12 ' A' ' 178' ' ' VAL . 33.0 p-10 -96.49 154.03 17.5 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.465 1.103 . . . . 65.239999999999995 109.314 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.535 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 3.4 t80 -147.23 137.94 23.58 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.49 1.119 . . . . 73.230000000000004 111.019 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.535 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 5.9 mtmt -76.56 128.96 35.74 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.499 1.124 . . . . 74.319999999999993 109.292 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.957 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -110.86 141.99 43.5 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.46 1.1 . . . . 73.120000000000005 109.286 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -148.22 18.87 1.09 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.506 1.129 . . . . 72.120000000000005 110.266 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.455 ' O ' ' CG ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -100.25 -176.49 3.24 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.48 1.113 . . . . 71.420000000000002 109.306 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.06 -30.73 69.4 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.472 1.108 . . . . 52.420000000000002 109.29 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.478 ' CB ' ' HB2' ' A' ' 206' ' ' LEU . 1.0 OUTLIER -101.96 12.06 37.52 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.489 1.118 . . . . 72.319999999999993 109.307 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.957 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 8.5 pt-20 -33.75 105.57 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.529 1.143 . . . . 64.430000000000007 110.264 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.706 HD13 ' HA3' ' A' ' 205' ' ' GLY . 13.2 tp -119.46 107.12 12.94 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.484 1.115 . . . . 55.229999999999997 109.339 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.645 HG23 ' O ' ' A' ' 175' ' ' THR . 14.4 t -85.44 99.14 11.0 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.518 1.136 . . . . 53.009999999999998 110.419 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.46 176.08 5.28 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.545 1.153 . . . . 60.340000000000003 110.344 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -120.77 159.97 24.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.614 1.196 . . . . 54.109999999999999 110.962 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.781 HG12 ' N ' ' A' ' 165' ' ' ASP . 3.5 m -62.0 146.65 12.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.421 1.076 . . . . 63.130000000000003 109.259 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.42 66.14 3.05 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.503 1.127 . . . . 54.530000000000001 111.014 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.499 ' CB ' HG22 ' A' ' 162' ' ' VAL . 1.8 tp10 -132.73 169.27 16.93 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.473 0.749 . . . . 64.319999999999993 110.278 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -117.43 146.77 43.24 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.438 1.086 . . . . 72.200000000000003 109.299 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.879 HD21 ' CG1' ' A' ' 162' ' ' VAL . 0.2 OUTLIER -159.23 152.19 22.02 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 72.140000000000001 109.392 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.559 ' HB2' ' CE1' ' A' ' 159' ' ' TYR . 14.9 t80 -108.65 119.67 40.2 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.468 1.105 . . . . 71.129999999999995 111.044 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 160' ' ' ALA . 1.6 mp -64.82 155.95 6.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.411 1.069 . . . . 74.019999999999996 109.275 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.455 ' N ' ' O ' ' A' ' 194' ' ' ILE . 0.2 OUTLIER -138.66 -51.09 0.56 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.52 1.137 . . . . 75.030000000000001 108.341 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.972 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -120.73 166.29 13.92 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.506 1.129 . . . . 64.239999999999995 109.333 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.487 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.1 OUTLIER -151.37 141.37 22.08 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.41 1.068 . . . . 62.420000000000002 109.638 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.72 ' NE2' HD13 ' A' ' 194' ' ' ILE . 0.1 OUTLIER -143.2 141.0 30.98 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.421 1.076 . . . . 72.200000000000003 109.623 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.486 ' C ' ' N ' ' A' ' 191' ' ' GLU . 39.1 t-20 48.13 25.68 0.87 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.498 1.124 . . . . 74.439999999999998 109.251 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.437 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.9 p 39.02 30.19 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.519 1.137 . . . . 63.32 108.308 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.507 ' O ' HG13 ' A' ' 209' ' ' VAL . 8.6 tt0 -125.78 -37.92 2.26 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.504 1.128 . . . . 74.299999999999997 110.362 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.636 ' HB3' HD11 ' A' ' 206' ' ' LEU . 97.1 m95 -112.09 132.24 54.97 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.97 -1.122 . . . . 73.129999999999995 107.97 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.761 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.3 m-30 -125.12 129.31 49.93 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.541 1.151 . . . . 60.520000000000003 111.033 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.972 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 1.1 mp -91.27 98.12 8.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.541 1.15 . . . . 74.430000000000007 109.317 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -104.14 -175.73 2.88 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.541 1.151 . . . . 71.340000000000003 109.301 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.493 ' CD ' ' O ' ' A' ' 197' ' ' PRO . 0.0 OUTLIER -157.12 158.68 31.2 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 63.140000000000001 109.286 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.493 ' O ' ' CD ' ' A' ' 196' ' ' LYS . 18.2 Cg_endo . . . . . 0 C--N 1.359 1.126 0 O-C-N 124.524 1.802 . . . . 74.349999999999994 111.024 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.434 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.531 1.066 0 N-CA-C 110.99 -0.844 . . . . 51.399999999999999 110.99 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.565 ' HG2' ' CZ ' ' B' ' 470' ' ' PHE . 18.2 Cg_endo -75.05 133.25 30.59 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 121.008 -2.497 . . . . 74.409999999999997 110.925 0.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.706 ' HA3' HD13 ' A' ' 174' ' ' LEU . . . -100.44 151.03 18.98 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.478 1.111 . . . . 63.520000000000003 110.925 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.684 HD12 ' CD1' ' A' ' 194' ' ' ILE . 0.4 OUTLIER -90.45 144.2 26.03 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.539 0.788 . . . . 73.329999999999998 109.283 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.66 HG13 HD23 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -157.13 127.81 3.54 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.511 1.132 . . . . 73.239999999999995 109.288 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.442 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.4 Cg_endo -74.89 179.44 6.05 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.508 1.794 . . . . 63.0 111.041 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.761 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.0 OUTLIER -98.66 4.41 10.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.596 1.185 . . . . 73.129999999999995 109.274 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 210' ' ' GLY . . . . . 0.489 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -106.43 0.96 37.17 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 124.491 1.119 . . . . 73.120000000000005 110.964 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.614 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 6.9 m-85 -130.26 6.58 4.92 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.58 0.812 . . . . 74.510000000000005 110.978 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.788 HG12 HG12 ' A' ' 162' ' ' VAL . 1.5 m -150.88 153.82 9.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.473 1.108 . . . . 72.019999999999996 109.33 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.4 m -121.64 138.88 54.15 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.502 1.127 . . . . 55.210000000000001 110.025 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.645 ' O ' HG23 ' A' ' 215' ' ' ILE . 3.8 mm -87.46 124.07 40.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 124.489 1.118 . . . . 75.200000000000003 109.268 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 214' ' ' ILE . 10.8 pt . . . . . 0 C--N 1.325 -0.467 0 O-C-N 124.469 1.106 . . . . 75.219999999999999 109.304 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 229' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 109.318 -0.623 . . . . 53.200000000000003 109.318 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.536 HG21 ' HE2' ' A' ' 193' ' ' PHE . 3.7 p -48.28 -49.17 12.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.116 . . . . 70.299999999999997 109.318 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.51 ' O ' ' CE ' ' A' ' 232' ' ' LYS . 3.2 mp -59.11 -29.62 41.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.428 1.08 . . . . 61.009999999999998 109.319 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 226' ' ' ASP . 15.5 mt-10 -81.41 -15.0 56.49 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.485 1.115 . . . . 73.230000000000004 110.281 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -86.64 -15.76 38.7 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.499 1.125 . . . . 71.120000000000005 109.337 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.603 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.9 OUTLIER -72.71 -69.34 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 71.430000000000007 109.279 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.603 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -62.17 -17.55 58.34 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.51 1.131 . . . . 73.219999999999999 109.301 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.33 -39.61 60.85 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.504 1.127 . . . . 63.210000000000001 110.011 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 234' ' ' VAL . 1.6 m -117.17 27.43 3.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.532 1.145 . . . . 74.140000000000001 109.3 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 234' ' ' VAL . 6.8 m120 40.6 37.42 0.47 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.137 . . . . 73.329999999999998 109.222 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.417 ' HB2' ' CG2' ' A' ' 234' ' ' VAL . 3.8 tp -70.58 119.82 74.97 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.555 1.159 . . . . 73.109999999999999 109.268 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.4 ' HB2' ' CB ' ' A' ' 241' ' ' GLU . 18.3 Cg_endo -74.96 165.36 31.51 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.459 1.768 . . . . 74.25 111.004 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 239' ' ' VAL . 1.4 m -60.27 -177.65 0.07 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.507 1.129 . . . . 72.340000000000003 110.396 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.629 HG23 ' HB1' ' A' ' 186' ' ' ALA . 9.8 p -72.21 -35.06 51.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 50.420000000000002 109.35 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.567 ' HG3' HG13 ' A' ' 239' ' ' VAL . 0.5 OUTLIER -85.52 -17.56 36.03 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.455 1.097 . . . . 74.239999999999995 110.278 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.42 ' HB2' ' N ' ' A' ' 238' ' ' THR . 7.3 mm-40 -85.15 -42.08 15.08 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.465 1.103 . . . . 71.349999999999994 110.364 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.445 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 6.5 t90 -72.65 -60.47 2.22 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.039 -1.097 . . . . 74.310000000000002 108.039 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.564 ' HD3' ' CD2' ' B' ' 470' ' ' PHE . 4.1 mtmp? -57.41 -20.49 30.2 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.483 1.114 . . . . 63.43 109.322 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.435 0 O-C-N 124.512 1.132 . . . . 55.25 110.091 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 470' ' ' PHE . . . . . 0.582 ' HB3' HG21 ' A' ' 239' ' ' VAL . 4.0 m-30 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.496 0.188 . . . . 72.230000000000004 111.001 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 471' ' ' ILE . . . . . 0.472 HG23 ' HD2' ' B' ' 472' ' ' PRO . 0.9 OUTLIER -100.59 138.91 20.24 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.46 1.1 . . . . 71.209999999999994 109.279 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 472' ' ' PRO . . . . . 0.625 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.99 -45.6 0.27 Allowed 'Trans proline' 0 C--N 1.359 1.117 0 O-C-N 124.502 1.791 . . . . 71.329999999999998 111.033 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 473' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' B' ' 472' ' ' PRO . 0.1 OUTLIER 80.36 5.7 1.68 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.481 1.113 . . . . 74.439999999999998 110.027 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -132.01 157.26 78.72 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.565 1.165 . . . . 73.200000000000003 110.325 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 475' ' ' PRO . . . . . 0.7 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.0 Cg_endo -75.03 -48.09 0.18 Allowed 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.531 1.806 . . . . 52.219999999999999 110.971 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 476' ' ' ALA . . . . . 0.7 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 162.94 136.64 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.522 1.139 . . . . 75.519999999999996 109.322 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 477' ' ' PRO . . . . . 0.554 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.8 Cg_endo -74.89 -177.35 3.38 Favored 'Trans proline' 0 C--N 1.359 1.115 0 O-C-N 124.484 1.781 . . . . 63.030000000000001 111.069 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.54 92.29 28.05 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 61.299999999999997 109.317 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 479' ' ' PRO . . . . . 0.614 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.2 Cg_endo -75.01 151.53 39.58 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.489 1.784 . . . . 53.549999999999997 110.968 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 480' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 479' ' ' PRO . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.144 0 O-C-N 124.533 1.807 . . . . 74.219999999999999 111.006 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.65 ' CD2' ' CG1' ' A' ' 215' ' ' ILE . 2.5 t80 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.544 0.211 . . . . 62.009999999999998 110.975 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.6 ' O ' ' CE1' ' A' ' 159' ' ' TYR . . . -110.71 147.67 33.89 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.52 1.138 . . . . 73.420000000000002 109.305 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.609 HD13 ' N ' ' A' ' 162' ' ' VAL . 0.1 OUTLIER -129.45 131.2 67.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.484 1.115 . . . . 65.209999999999994 109.38 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.941 HG22 HG12 ' A' ' 212' ' ' VAL . 1.5 t -88.73 125.61 41.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.462 1.101 . . . . 71.129999999999995 109.307 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.549 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 1.7 mt -101.11 -13.34 18.22 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.502 1.126 . . . . 74.239999999999995 109.296 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.567 ' O ' HG13 ' A' ' 162' ' ' VAL . 1.5 m-85 -148.27 156.26 42.33 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.471 1.107 . . . . 61.439999999999998 111.041 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.475 ' H ' HG12 ' A' ' 178' ' ' VAL . 5.6 p-10 -105.95 160.57 15.17 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.55 1.156 . . . . 63.310000000000002 109.295 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.566 ' HB3' ' CE1' ' A' ' 211' ' ' PHE . 0.3 OUTLIER -159.7 164.51 33.9 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.492 1.12 . . . . 72.450000000000003 110.979 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -89.84 130.77 36.03 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.513 1.133 . . . . 72.200000000000003 109.256 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.799 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -104.42 141.65 35.97 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.448 1.092 . . . . 51.409999999999997 109.315 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.8 ' H ' ' HZ3' ' A' ' 170' ' ' LYS . 7.7 pt-20 -151.91 21.68 0.68 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.461 1.101 . . . . 73.430000000000007 110.303 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.8 ' HZ3' ' H ' ' A' ' 169' ' ' GLU . 0.1 OUTLIER -98.12 -175.93 3.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.524 1.14 . . . . 75.109999999999999 109.338 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.12 -29.79 65.8 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.434 1.083 . . . . 54.25 109.328 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 173' ' ' GLU . 3.2 m-20 -110.08 22.81 15.14 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.53 1.143 . . . . 61.340000000000003 109.263 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.799 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 6.2 pt-20 -38.16 106.14 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.475 1.11 . . . . 75.230000000000004 110.322 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.712 HD13 ' CA ' ' A' ' 205' ' ' GLY . 0.6 OUTLIER -126.82 120.93 30.5 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.491 1.12 . . . . 62.109999999999999 109.34 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 11.9 t -87.65 118.49 27.17 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.558 1.162 . . . . 74.209999999999994 110.359 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.532 HG21 HG21 ' A' ' 162' ' ' VAL . 0.6 OUTLIER -120.45 175.52 5.94 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.52 1.138 . . . . 75.319999999999993 110.363 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -127.77 152.9 47.19 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 74.120000000000005 111.052 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 165' ' ' ASP . 3.1 m -51.44 155.05 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 60.340000000000003 109.318 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 44.3 74.09 0.23 Allowed Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.519 1.137 . . . . 75.420000000000002 110.985 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -132.24 162.19 31.58 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.431 0.724 . . . . 54.329999999999998 110.347 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.16 120.54 40.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.529 1.143 . . . . 75.120000000000005 109.292 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.943 HD12 HG21 ' A' ' 207' ' ' VAL . 1.2 pt? -136.46 143.83 44.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.504 1.127 . . . . 32.109999999999999 109.32 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 41.7 t80 -104.85 111.24 23.92 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.465 1.103 . . . . 53.229999999999997 111.014 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.995 HD13 ' HB2' ' A' ' 195' ' ' ALA . 19.0 mm -54.42 164.83 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.523 1.139 . . . . 53.210000000000001 109.313 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.466 ' N ' ' CG2' ' A' ' 184' ' ' ILE . 0.1 OUTLIER -151.84 -45.91 0.11 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.498 1.124 . . . . 70.409999999999997 108.344 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.881 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -125.66 174.54 8.22 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.501 1.126 . . . . 71.140000000000001 109.344 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.619 ' C ' ' CD2' ' A' ' 188' ' ' HIS . 3.2 p-80 -155.02 154.02 31.86 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 71.319999999999993 109.639 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 1.115 ' CE1' HG11 ' A' ' 239' ' ' VAL . 0.1 OUTLIER -144.11 120.93 11.25 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.51 1.131 . . . . 73.409999999999997 109.535 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.453 ' C ' ' N ' ' A' ' 191' ' ' GLU . 55.4 t30 52.05 32.72 10.73 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.455 1.097 . . . . 51.329999999999998 109.345 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.404 ' CB ' HG12 ' A' ' 228' ' ' ILE . 9.6 m 41.67 29.24 0.1 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.511 1.132 . . . . 64.340000000000003 108.316 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.659 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 16.8 tt0 -120.92 -38.55 2.82 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.469 1.106 . . . . 75.430000000000007 110.294 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.714 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 90.2 m95 -113.26 137.61 51.22 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.538 1.149 . . . . 62.409999999999997 108.009 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.894 ' HB3' HD12 ' A' ' 184' ' ' ILE . 22.4 m-30 -125.83 135.63 52.19 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.469 1.106 . . . . 73.209999999999994 111.032 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.881 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 6.3 mm -100.74 95.63 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 71.129999999999995 109.261 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.995 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -99.09 -179.72 4.34 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.516 1.135 . . . . 62.149999999999999 109.269 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.453 ' CG ' ' C ' ' A' ' 195' ' ' ALA . 10.2 mtpt -151.1 162.98 25.21 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.447 1.092 . . . . 71.450000000000003 109.333 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 C--N 1.36 1.137 0 O-C-N 124.493 1.786 . . . . 74.299999999999997 110.967 -179.982 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.441 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.529 0.956 0 N-CA-C 111.062 -0.815 . . . . 51.130000000000003 111.062 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.486 ' HB2' HG22 ' A' ' 194' ' ' ILE . 18.5 Cg_endo -74.97 129.01 17.49 Favored 'Cis proline' 0 C--N 1.359 1.112 0 C-N-CA 120.949 -2.521 . . . . 74.450000000000003 111.024 -0.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.712 ' CA ' HD13 ' A' ' 174' ' ' LEU . . . -96.34 141.93 15.87 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.514 1.134 . . . . 75.040000000000006 111.025 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.714 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -91.2 147.21 23.21 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.552 0.795 . . . . 72.040000000000006 109.295 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.943 HG21 HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -161.06 129.14 2.85 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.542 1.152 . . . . 51.119999999999997 109.336 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.889 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.2 Cg_endo -75.03 179.91 5.64 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.565 1.824 . . . . 70.030000000000001 110.927 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.791 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.6 OUTLIER -96.12 3.32 9.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 124.443 1.089 . . . . 65.129999999999995 109.306 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -103.89 -5.93 43.75 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.487 1.117 . . . . 55.119999999999997 111.033 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.619 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 5.2 m-85 -125.98 1.76 7.29 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.505 0.767 . . . . 61.549999999999997 110.983 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.941 HG12 HG22 ' A' ' 162' ' ' VAL . 3.5 m -141.28 167.76 16.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.574 1.171 . . . . 72.329999999999998 109.306 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.521 ' OG ' HD21 ' A' ' 163' ' ' LEU . 13.1 p -136.2 132.98 36.62 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.445 1.091 . . . . 55.140000000000001 109.997 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.496 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 2.9 mm -76.4 144.68 11.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.475 1.109 . . . . 71.510000000000005 109.277 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.65 ' CG1' ' CD2' ' A' ' 159' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.428 0 O-C-N 124.459 1.1 . . . . 62.219999999999999 109.31 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 229' ' ' GLU . 14.0 t0 . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 109.211 -0.663 . . . . 75.219999999999999 109.211 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.408 ' H ' HG12 ' A' ' 227' ' ' VAL . 0.2 OUTLIER -39.85 -56.27 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.45 1.094 . . . . 75.209999999999994 109.282 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.404 HG12 ' CB ' ' A' ' 190' ' ' CYS . 9.9 mt -55.94 -42.46 71.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.499 1.125 . . . . 74.109999999999999 109.274 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 226' ' ' ASP . 21.2 mt-10 -66.45 -14.16 61.81 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.506 1.129 . . . . 55.5 110.329 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.569 ' O ' HG13 ' A' ' 234' ' ' VAL . 33.7 t0 -88.67 -23.27 23.05 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.564 1.165 . . . . 72.299999999999997 109.299 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.61 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.6 OUTLIER -63.66 -69.4 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.483 1.114 . . . . 63.539999999999999 109.323 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.61 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -55.85 -30.58 61.71 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.44 1.088 . . . . 75.420000000000002 109.3 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.4 m -52.94 -50.63 63.63 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 44.130000000000003 109.954 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 230' ' ' ASP . 1.3 m -89.88 16.08 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.471 1.107 . . . . 53.32 109.26 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 234' ' ' VAL . 37.7 t30 40.56 44.53 1.78 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.516 1.135 . . . . 70.230000000000004 109.296 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.45 HD12 ' HD2' ' A' ' 237' ' ' PRO . 1.1 tp -83.02 119.74 74.79 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.457 1.098 . . . . 74.129999999999995 109.307 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.45 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.4 Cg_endo -75.01 164.37 33.48 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.52 1.8 . . . . 42.329999999999998 111.023 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.613 HG22 ' H ' ' A' ' 239' ' ' VAL . 3.4 m -58.81 -175.72 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.484 1.115 . . . . 63.350000000000001 110.364 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 1.115 HG11 ' CE1' ' A' ' 188' ' ' HIS . 2.6 p -74.17 -36.27 43.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.5 1.125 . . . . 74.25 109.333 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.536 ' HG3' HG13 ' A' ' 239' ' ' VAL . 5.3 mt-30 -82.65 -17.88 43.04 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.492 1.12 . . . . 74.25 110.315 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.405 ' CB ' ' HB2' ' A' ' 237' ' ' PRO . 16.3 mt-10 -87.07 -38.54 16.42 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.531 1.144 . . . . 71.420000000000002 110.299 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.433 ' CH2' ' HB3' ' A' ' 185' ' ' CYS . 6.1 t90 -78.35 -61.33 2.04 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.531 1.144 . . . . 74.109999999999999 108.001 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 9.3 mtmt -53.92 -20.53 6.2 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.428 1.08 . . . . 70.120000000000005 109.3 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 C--N 1.324 -0.504 0 O-C-N 124.542 1.152 . . . . 75.049999999999997 109.993 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 470' ' ' PHE . . . . . 0.447 ' CE2' ' HG2' ' A' ' 204' ' ' PRO . 5.2 m-30 . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.52 0.2 . . . . 74.239999999999995 111.009 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 471' ' ' ILE . . . . . 0.514 HG22 ' HD2' ' B' ' 472' ' ' PRO . 2.8 mm -84.82 140.32 37.67 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.491 1.12 . . . . 64.519999999999996 109.353 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 472' ' ' PRO . . . . . 0.514 ' HD2' HG22 ' B' ' 471' ' ' ILE . 18.4 Cg_endo -74.92 130.28 13.22 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.528 1.804 . . . . 73.420000000000002 111.04 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 46.3 t -78.54 -73.06 0.34 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.456 1.098 . . . . 21.219999999999999 109.981 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -65.1 160.03 60.22 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.523 1.139 . . . . 54.530000000000001 110.311 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 -167.27 0.41 Allowed 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.461 1.769 . . . . 51.329999999999998 110.994 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 476' ' ' ALA . . . . . 0.659 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . -62.86 138.81 97.19 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.496 1.122 . . . . 53.219999999999999 109.281 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 477' ' ' PRO . . . . . 0.581 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -75.04 -162.43 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.491 1.785 . . . . 72.439999999999998 111.029 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 478' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -136.18 90.75 17.76 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.479 1.112 . . . . 72.209999999999994 109.278 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 479' ' ' PRO . . . . . 0.619 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.92 168.41 24.9 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.428 1.752 . . . . 61.350000000000001 110.973 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo . . . . . 0 C--N 1.36 1.174 0 O-C-N 124.565 1.824 . . . . 74.540000000000006 111.106 179.902 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 5.1 p90 . . . . . 0 N--CA 1.454 -0.25 0 CA-C-O 120.562 0.22 . . . . 72.450000000000003 110.973 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.904 ' O ' HD12 ' A' ' 182' ' ' LEU . . . -108.82 147.7 31.69 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.485 1.115 . . . . 73.140000000000001 109.305 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.595 HD13 ' N ' ' A' ' 162' ' ' VAL . 0.1 OUTLIER -120.82 135.14 61.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.509 1.131 . . . . 62.32 109.262 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.853 HG22 HG12 ' A' ' 212' ' ' VAL . 2.3 t -93.32 121.01 43.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.455 1.097 . . . . 55.43 109.305 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.56 HD21 HG23 ' A' ' 161' ' ' ILE . 0.4 OUTLIER -101.44 -11.5 19.3 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.503 1.127 . . . . 55.350000000000001 109.295 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.657 ' O ' HG13 ' A' ' 162' ' ' VAL . 3.3 m-85 -144.6 160.29 41.41 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 73.329999999999998 111.003 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.762 ' N ' HG12 ' A' ' 178' ' ' VAL . 21.7 p30 -107.95 157.71 17.98 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.554 1.159 . . . . 75.200000000000003 109.305 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.599 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 1.2 t80 -160.45 136.43 8.44 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.436 1.085 . . . . 70.439999999999998 111.012 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.599 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 12.0 mtpp -67.37 122.69 18.47 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.448 1.093 . . . . 74.400000000000006 109.313 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.83 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -90.62 140.12 30.06 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.585 1.178 . . . . 62.200000000000003 109.3 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -152.19 21.69 0.65 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.508 1.13 . . . . 74.129999999999995 110.283 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.473 ' HD3' ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -98.72 -176.66 3.42 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.505 1.128 . . . . 65.400000000000006 109.335 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' B' ' 471' ' ' ILE . . . -59.93 -24.87 64.7 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.462 1.101 . . . . 73.310000000000002 109.326 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 173' ' ' GLU . 59.7 t0 -113.68 20.44 15.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.458 1.099 . . . . 62.530000000000001 109.281 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.83 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 5.1 pt-20 -36.82 100.51 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 1.104 . . . . 72.450000000000003 110.352 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.485 ' HG ' ' CA ' ' A' ' 205' ' ' GLY . 0.1 OUTLIER -132.03 96.2 3.85 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.499 1.124 . . . . 73.299999999999997 109.344 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.6 t -59.55 148.82 31.93 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.483 1.115 . . . . 63.340000000000003 110.416 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 14.4 m -155.9 117.04 3.87 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.559 1.162 . . . . 71.209999999999994 110.435 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -63.94 157.58 24.53 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.512 1.132 . . . . 73.040000000000006 110.975 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.762 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.5 m -58.24 158.19 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.557 1.16 . . . . 63.200000000000003 109.249 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.424 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 52.54 62.54 5.71 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.479 1.112 . . . . 63.340000000000003 110.998 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -120.2 170.91 8.89 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.514 0.773 . . . . 74.430000000000007 110.244 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -129.17 117.56 20.98 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.552 1.157 . . . . 60.130000000000003 109.325 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.913 ' CD2' HG11 ' A' ' 207' ' ' VAL . 0.2 OUTLIER -130.58 149.71 52.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.538 1.149 . . . . 54.210000000000001 109.315 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -104.13 104.34 14.26 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.531 1.145 . . . . 72.519999999999996 111.002 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.737 HD12 ' HB2' ' A' ' 160' ' ' ALA . 22.1 mt -68.56 158.46 5.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.468 1.105 . . . . 74.400000000000006 109.354 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.603 ' SG ' ' CZ3' ' A' ' 242' ' ' TRP . 27.0 t -152.16 -41.59 0.11 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.522 1.139 . . . . 73.340000000000003 108.332 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.989 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -112.22 155.58 23.77 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.547 1.155 . . . . 73.439999999999998 109.297 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.572 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.8 OUTLIER -148.33 145.04 27.95 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.497 1.123 . . . . 74.200000000000003 109.649 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.582 ' NE2' HD11 ' A' ' 194' ' ' ILE . 0.1 OUTLIER -143.55 141.41 30.68 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.525 1.141 . . . . 63.409999999999997 109.603 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.462 ' C ' ' N ' ' A' ' 191' ' ' GLU . 3.1 m120 49.44 23.34 0.86 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.46 1.1 . . . . 72.129999999999995 109.261 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.408 ' C ' ' O ' ' A' ' 189' ' ' ASN . 18.1 m 41.22 28.88 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.117 . . . . 72.5 108.293 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.485 ' O ' HG13 ' A' ' 209' ' ' VAL . 8.5 tt0 -126.59 -38.58 2.07 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.575 1.172 . . . . 74.140000000000001 110.299 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.878 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 98.8 m95 -111.55 128.48 56.04 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.527 1.142 . . . . 64.430000000000007 108.058 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.776 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.1 m-30 -120.11 126.2 50.14 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.489 1.118 . . . . 74.439999999999998 111.001 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.989 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 5.6 mm -86.63 104.36 13.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.53 1.144 . . . . 72.420000000000002 109.262 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.58 ' HB2' ' CG1' ' A' ' 184' ' ' ILE . . . -112.92 175.85 5.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.498 1.124 . . . . 61.409999999999997 109.263 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.474 ' CG ' ' HD2' ' A' ' 197' ' ' PRO . 2.3 ttmp? -137.99 142.66 36.7 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.131 . . . . 63.32 109.323 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.474 ' HD2' ' CG ' ' A' ' 196' ' ' LYS . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.173 0 O-C-N 124.512 1.796 . . . . 73.420000000000002 110.993 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.969 0 N-CA-C 111.008 -0.837 . . . . 75.209999999999994 111.008 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.444 ' HD2' ' CZ ' ' B' ' 470' ' ' PHE . 18.4 Cg_endo -74.96 146.11 85.78 Favored 'Cis proline' 0 C--N 1.36 1.182 0 C-N-CA 121.028 -2.488 . . . . 74.0 111.009 -0.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 195' ' ' ALA . . . -104.7 138.56 14.22 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.494 1.121 . . . . 41.32 110.986 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.878 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -83.37 146.76 28.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.574 0.808 . . . . 73.439999999999998 109.384 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.913 HG11 ' CD2' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -153.36 127.01 4.31 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.458 1.099 . . . . 61.439999999999998 109.288 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.943 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.4 Cg_endo -74.92 174.9 11.96 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.455 1.766 . . . . 75.450000000000003 111.002 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.776 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -93.49 4.81 7.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.537 1.148 . . . . 73.340000000000003 109.297 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 210' ' ' GLY . . . . . 0.495 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -104.72 -8.3 37.47 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.5 1.125 . . . . 62.119999999999997 111.024 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.622 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 15.8 m-85 -125.53 -0.8 7.5 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.497 0.763 . . . . 75.140000000000001 111.002 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.943 HG22 ' O ' ' A' ' 208' ' ' PRO . 2.5 m -139.63 162.15 26.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.503 1.127 . . . . 64.329999999999998 109.267 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.6 t -134.72 133.56 40.09 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 55.32 109.967 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.782 ' O ' HG23 ' A' ' 215' ' ' ILE . 2.9 mm -76.85 127.72 37.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.506 1.129 . . . . 74.540000000000006 109.28 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.782 HG23 ' O ' ' A' ' 214' ' ' ILE . 5.3 pt . . . . . 0 C--N 1.326 -0.435 0 O-C-N 124.544 1.153 . . . . 72.409999999999997 109.241 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 229' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 109.329 -0.619 . . . . 75.319999999999993 109.329 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -40.38 -45.73 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.439 1.087 . . . . 72.099999999999994 109.349 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.753 ' HA ' HD12 ' A' ' 231' ' ' ILE . 7.8 mt -65.27 -46.53 90.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.5 1.125 . . . . 64.239999999999995 109.275 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.473 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 11.6 mt-10 -64.95 -17.19 64.17 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.566 1.166 . . . . 71.409999999999997 110.338 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.66 -16.44 32.38 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.453 1.095 . . . . 62.549999999999997 109.347 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.753 HD12 ' HA ' ' A' ' 228' ' ' ILE . 3.6 mt -76.1 -70.11 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 124.523 1.139 . . . . 72.219999999999999 109.323 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.473 ' CD ' ' HA ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -59.67 -26.79 65.83 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.555 1.16 . . . . 63.240000000000002 109.236 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.11 -48.1 12.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.474 1.108 . . . . 71.109999999999999 110.01 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.1 m -98.02 -15.85 7.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.483 1.115 . . . . 64.549999999999997 109.282 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 64.97 49.57 2.07 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 1.135 . . . . 43.340000000000003 109.316 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 237' ' ' PRO . 0.5 OUTLIER -71.08 146.75 93.08 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.457 1.098 . . . . 75.329999999999998 109.319 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.664 ' O ' HD12 ' A' ' 236' ' ' LEU . 18.6 Cg_endo -74.95 141.59 26.97 Favored 'Trans proline' 0 C--N 1.359 1.096 0 O-C-N 124.526 1.803 . . . . 74.239999999999995 110.995 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.1 m -58.36 176.38 0.18 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.431 1.082 . . . . 75.430000000000007 110.478 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.558 HG13 ' HG3' ' A' ' 240' ' ' GLN . 9.9 p -72.09 -33.84 48.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.524 1.14 . . . . 51.310000000000002 109.311 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.558 ' HG3' HG13 ' A' ' 239' ' ' VAL . 0.3 OUTLIER -85.58 -17.03 37.43 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.479 1.112 . . . . 72.329999999999998 110.243 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -87.05 -43.78 12.06 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.494 1.121 . . . . 75.209999999999994 110.336 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.618 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 0.5 OUTLIER -72.08 -60.73 2.09 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.988 -1.116 . . . . 72.430000000000007 107.988 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.495 ' NZ ' ' CG2' ' A' ' 239' ' ' VAL . 4.8 mtmm -54.79 -20.62 8.95 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.498 1.124 . . . . 51.350000000000001 109.29 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 C--N 1.325 -0.476 0 O-C-N 124.564 1.165 . . . . 64.239999999999995 110.03 179.951 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 470' ' ' PHE . . . . . 0.444 ' CZ ' ' HD2' ' A' ' 204' ' ' PRO . 43.1 m-85 . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.472 0.177 . . . . 74.120000000000005 110.993 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 471' ' ' ILE . . . . . 0.707 ' O ' ' HB3' ' A' ' 171' ' ' ALA . 26.4 mm -41.82 142.44 1.1 Allowed Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.505 1.128 . . . . 64.409999999999997 109.333 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 472' ' ' PRO . . . . . 0.698 ' HD2' HG23 ' B' ' 471' ' ' ILE . 18.4 Cg_endo -74.91 173.38 14.57 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.473 1.775 . . . . 55.210000000000001 111.073 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.91 -46.02 2.94 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.473 1.108 . . . . 64.030000000000001 110.014 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 39.3 mtp85 -87.14 158.49 52.56 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.567 1.167 . . . . 71.329999999999998 110.3 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 475' ' ' PRO . . . . . 0.686 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.3 Cg_endo -75.05 -30.94 6.57 Favored 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.469 1.773 . . . . 75.340000000000003 110.982 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 476' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 163.38 129.57 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.506 1.129 . . . . 63.119999999999997 109.281 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 477' ' ' PRO . . . . . 0.562 ' HG3' ' CE2' ' A' ' 166' ' ' PHE . 18.1 Cg_endo -75.02 -176.59 2.96 Favored 'Trans proline' 0 C--N 1.361 1.2 0 O-C-N 124.515 1.797 . . . . 64.340000000000003 110.985 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 478' ' ' LYS . . . . . 0.463 ' O ' ' CD ' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -116.46 95.11 44.86 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.536 1.148 . . . . 63.140000000000001 109.35 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 479' ' ' PRO . . . . . 0.622 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.99 150.11 37.69 Favored 'Trans proline' 0 C--N 1.359 1.105 0 O-C-N 124.563 1.823 . . . . 72.329999999999998 111.023 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 480' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 479' ' ' PRO . 18.3 Cg_endo . . . . . 0 C--N 1.361 1.195 0 O-C-N 124.447 1.762 . . . . 72.019999999999996 111.009 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 2.6 p90 . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.514 0.197 . . . . 74.409999999999997 110.998 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.569 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -130.42 153.22 48.98 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.511 1.132 . . . . 71.019999999999996 109.304 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.912 ' HB ' HD11 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -123.89 125.45 71.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.532 1.145 . . . . 74.120000000000005 109.265 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.937 HG22 HG12 ' A' ' 212' ' ' VAL . 1.9 t -80.51 122.45 35.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.559 1.162 . . . . 72.329999999999998 109.284 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 213' ' ' SER . 0.6 OUTLIER -98.19 -13.74 20.71 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.519 1.137 . . . . 71.420000000000002 109.287 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.666 ' O ' HG13 ' A' ' 162' ' ' VAL . 1.7 m-85 -146.21 157.71 43.84 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.567 1.167 . . . . 75.340000000000003 111.042 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.782 ' N ' HG12 ' A' ' 178' ' ' VAL . 0.0 OUTLIER -98.04 158.25 15.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.527 1.142 . . . . 71.349999999999994 109.27 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.491 ' CE1' ' HB3' ' B' ' 477' ' ' PRO . 40.5 t80 -145.5 158.9 43.77 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.559 1.162 . . . . 63.420000000000002 111.051 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -94.34 127.87 40.5 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.459 1.099 . . . . 73.120000000000005 109.288 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.885 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -93.19 142.06 27.73 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.465 1.103 . . . . 63.439999999999998 109.329 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -157.87 24.64 0.27 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.503 1.127 . . . . 71.219999999999999 110.314 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.528 ' NZ ' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -122.41 -175.36 3.12 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.531 1.145 . . . . 75.010000000000005 109.362 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.14 -40.99 82.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.439 1.087 . . . . 71.040000000000006 109.325 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 174' ' ' LEU . 3.0 m-20 -85.86 10.99 12.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.54 1.15 . . . . 64.019999999999996 109.3 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.885 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 5.4 pt-20 -36.34 96.56 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.432 1.083 . . . . 74.140000000000001 110.354 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.692 HD12 ' HA3' ' A' ' 205' ' ' GLY . 1.2 tm? -136.98 94.93 3.02 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.517 1.136 . . . . 31.129999999999999 109.296 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.431 ' C ' ' HG1' ' A' ' 176' ' ' THR . 9.0 t -59.53 153.36 19.8 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.563 1.164 . . . . 62.109999999999999 110.471 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.431 ' HG1' ' C ' ' A' ' 175' ' ' THR . 24.3 m -152.21 141.93 21.89 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.481 1.113 . . . . 74.349999999999994 110.374 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -88.37 153.33 21.27 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.408 1.068 . . . . 74.049999999999997 111.06 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.782 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.4 m -59.21 158.3 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.438 1.086 . . . . 64.530000000000001 109.299 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 48.81 66.98 1.87 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.455 1.097 . . . . 74.409999999999997 110.988 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.525 ' O ' HD13 ' A' ' 161' ' ' ILE . 1.9 tt0 -131.15 171.76 12.9 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.552 0.795 . . . . 75.340000000000003 110.235 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -123.4 130.65 53.02 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.478 1.112 . . . . 74.5 109.318 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.759 HD23 ' N ' ' A' ' 182' ' ' LEU . 0.6 OUTLIER -146.82 143.27 28.49 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.431 1.082 . . . . 72.549999999999997 109.341 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 73.4 t80 -100.57 117.99 35.83 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.537 1.148 . . . . 74.030000000000001 111.031 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.569 HD13 ' HB2' ' A' ' 160' ' ' ALA . 1.6 mp -62.69 151.99 7.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.41 1.068 . . . . 75.530000000000001 109.243 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.573 ' O ' ' CZ3' ' A' ' 242' ' ' TRP . 0.9 OUTLIER -136.03 -47.87 0.66 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.569 1.168 . . . . 55.130000000000003 108.26 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.944 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -122.25 168.86 11.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.504 1.127 . . . . 65.120000000000005 109.279 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.625 ' C ' ' CD2' ' A' ' 188' ' ' HIS . 2.9 p80 -146.67 153.88 40.8 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.443 1.089 . . . . 71.340000000000003 109.592 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 1.056 ' CE1' HG11 ' A' ' 239' ' ' VAL . 0.1 OUTLIER -143.92 120.75 11.26 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.471 1.107 . . . . 75.129999999999995 109.555 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.473 ' C ' ' N ' ' A' ' 191' ' ' GLU . 86.1 m-20 50.85 35.21 11.76 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.526 1.141 . . . . 73.430000000000007 109.352 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.421 ' C ' ' O ' ' A' ' 189' ' ' ASN . 60.9 m 39.77 30.75 0.06 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.553 1.158 . . . . 61.020000000000003 108.254 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.571 ' O ' HG13 ' A' ' 209' ' ' VAL . 11.4 tt0 -122.25 -42.16 2.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.546 1.154 . . . . 72.430000000000007 110.279 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.665 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 95.4 m95 -110.41 136.88 48.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.982 -1.118 . . . . 73.239999999999995 107.982 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.843 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.1 m-30 -127.52 124.41 38.18 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.507 1.13 . . . . 74.030000000000001 110.964 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.944 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 1.4 mp -87.61 97.02 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 70.540000000000006 109.317 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -101.99 -179.88 4.13 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.472 1.108 . . . . 55.439999999999998 109.295 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.9 ptmt -155.16 167.27 14.42 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.548 1.155 . . . . 75.439999999999998 109.303 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo . . . . . 0 C--N 1.36 1.16 0 O-C-N 124.412 1.743 . . . . 44.130000000000003 111.044 -180.0 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.964 0 N-CA-C 110.995 -0.842 . . . . 54.0 110.995 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.438 ' HG2' ' CZ ' ' B' ' 470' ' ' PHE . 18.2 Cg_endo -74.97 142.83 75.93 Favored 'Cis proline' 0 C--N 1.36 1.152 0 C-N-CA 121.012 -2.495 . . . . 62.130000000000003 111.006 0.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.692 ' HA3' HD12 ' A' ' 174' ' ' LEU . . . -106.07 148.1 16.39 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.538 1.149 . . . . 44.109999999999999 110.976 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.665 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -88.61 145.83 25.46 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.511 0.771 . . . . 72.439999999999998 109.325 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.789 ' HB ' HG11 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -156.02 126.26 3.36 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.544 1.153 . . . . 64.5 109.295 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.89 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.2 Cg_endo -74.98 179.59 5.93 Favored 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.489 1.784 . . . . 61.140000000000001 110.926 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.843 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -96.93 6.59 8.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.479 1.112 . . . . 72.299999999999997 109.327 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 210' ' ' GLY . . . . . 0.49 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -108.32 -4.86 32.74 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.551 1.157 . . . . 74.230000000000004 110.972 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.617 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 8.1 m-85 -127.44 1.59 6.28 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.518 0.775 . . . . 75.239999999999995 111.017 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.937 HG12 HG22 ' A' ' 162' ' ' VAL . 3.4 m -139.62 153.78 23.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.56 1.162 . . . . 74.340000000000003 109.329 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.605 ' HB3' HD11 ' A' ' 163' ' ' LEU . 1.0 OUTLIER -121.17 124.3 44.38 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.633 1.208 . . . . 71.319999999999993 110.039 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.835 ' O ' HG23 ' A' ' 215' ' ' ILE . 2.9 mm -68.32 145.03 13.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.13 . . . . 74.150000000000006 109.284 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.912 HD11 ' HB ' ' A' ' 161' ' ' ILE . 5.5 pt . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.539 1.149 . . . . 73.150000000000006 109.254 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 230' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.315 -0.624 . . . . 60.43 109.315 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.513 HG13 ' H ' ' A' ' 228' ' ' ILE . 4.2 p -47.85 -56.56 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.459 1.1 . . . . 70.310000000000002 109.258 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.513 ' H ' HG13 ' A' ' 227' ' ' VAL . 3.4 mt -57.1 -32.09 39.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.124 . . . . 63.200000000000003 109.375 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.431 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 5.4 mt-10 -80.89 -14.54 57.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.571 1.169 . . . . 73.439999999999998 110.312 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 226' ' ' ASP . 0.7 OUTLIER -88.49 -17.9 29.34 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.475 1.109 . . . . 64.230000000000004 109.314 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.629 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.5 OUTLIER -69.28 -69.2 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.508 1.13 . . . . 72.439999999999998 109.34 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.629 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -57.91 -20.73 39.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.563 1.164 . . . . 71.239999999999995 109.302 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.6 t -50.86 -57.93 7.25 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.54 1.15 . . . . 63.439999999999998 110.012 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.5 m -90.8 17.74 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.527 1.142 . . . . 73.420000000000002 109.346 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 47.53 34.85 3.74 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.506 1.129 . . . . 71.319999999999993 109.259 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.14 119.05 73.58 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.526 1.141 . . . . 72.439999999999998 109.287 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.13 167.2 27.44 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.5 1.789 . . . . 53.109999999999999 110.976 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.518 ' HA ' ' CD2' ' A' ' 187' ' ' HIS . 2.7 m -59.24 178.25 0.14 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.453 1.096 . . . . 71.400000000000006 110.383 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 1.056 HG11 ' CE1' ' A' ' 188' ' ' HIS . 0.2 OUTLIER -58.77 -67.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.133 . . . . 63.32 109.25 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.878 ' OE1' HD11 ' B' ' 471' ' ' ILE . 0.3 OUTLIER -63.91 -22.32 66.87 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.569 1.168 . . . . 74.420000000000002 110.339 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.449 ' HB2' ' N ' ' A' ' 238' ' ' THR . 4.1 mm-40 -75.85 -33.45 60.02 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.464 1.102 . . . . 75.219999999999999 110.246 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.573 ' CZ3' ' O ' ' A' ' 185' ' ' CYS . 2.6 t90 -85.28 -60.36 2.06 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.137 . . . . 63.130000000000003 108.007 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.427 ' NZ ' ' CG ' ' B' ' 470' ' ' PHE . 22.1 mtmt -56.18 -18.7 10.91 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.53 1.144 . . . . 71.010000000000005 109.308 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.145 . . . . 74.109999999999999 109.969 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 470' ' ' PHE . . . . . 0.651 ' CD2' HG21 ' A' ' 194' ' ' ILE . 3.3 m-85 . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 120.548 0.213 . . . . 74.430000000000007 110.938 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 471' ' ' ILE . . . . . 0.878 HD11 ' OE1' ' A' ' 240' ' ' GLN . 1.4 mp -75.17 136.8 72.35 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.451 1.094 . . . . 72.340000000000003 109.331 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 472' ' ' PRO . . . . . 0.432 ' HD3' ' ND1' ' A' ' 188' ' ' HIS . 18.3 Cg_endo -75.04 -162.66 0.16 Allowed 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.409 1.741 . . . . 52.109999999999999 110.977 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 6.2 t -133.08 -52.76 0.9 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.469 1.106 . . . . 61.409999999999997 109.958 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 31.9 mtt-85 -81.05 156.18 72.18 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.485 1.116 . . . . 74.329999999999998 110.27 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 475' ' ' PRO . . . . . 0.679 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.4 Cg_endo -75.05 -30.64 6.88 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.425 1.75 . . . . 73.010000000000005 110.982 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 476' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 163.42 131.6 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.538 1.149 . . . . 70.439999999999998 109.301 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 477' ' ' PRO . . . . . 0.577 ' HD3' ' CH2' ' A' ' 192' ' ' TRP . 18.6 Cg_endo -74.94 -163.31 0.18 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.553 1.817 . . . . 61.420000000000002 111.012 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 478' ' ' LYS . . . . . 0.496 ' O ' ' CD ' ' B' ' 478' ' ' LYS . 0.3 OUTLIER -124.97 94.99 42.94 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 74.310000000000002 109.329 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 479' ' ' PRO . . . . . 0.617 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.5 Cg_endo -74.94 155.38 43.23 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.462 1.77 . . . . 72.310000000000002 111.066 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 480' ' ' PRO . . . . . 0.441 ' HG2' ' CD1' ' A' ' 164' ' ' TYR . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.164 0 O-C-N 124.459 1.768 . . . . 53.310000000000002 110.996 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.789 ' CD1' ' CE2' ' A' ' 183' ' ' PHE . 1.4 m-85 . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 120.457 0.17 . . . . 62.509999999999998 110.997 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.887 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -114.64 149.57 36.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.537 1.148 . . . . 63.100000000000001 109.302 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.53 HD13 ' O ' ' A' ' 180' ' ' GLU . 0.2 OUTLIER -131.4 127.85 60.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 74.329999999999998 109.273 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.802 HG22 HG12 ' A' ' 212' ' ' VAL . 1.9 t -80.48 121.19 33.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.556 1.16 . . . . 62.109999999999999 109.333 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.894 HD11 ' HB2' ' A' ' 213' ' ' SER . 0.9 OUTLIER -96.24 -14.48 22.64 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 62.140000000000001 109.361 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.691 ' O ' HG13 ' A' ' 162' ' ' VAL . 3.0 m-85 -146.9 159.23 43.79 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.48 1.113 . . . . 74.450000000000003 110.954 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.614 ' N ' HG12 ' A' ' 178' ' ' VAL . 10.4 p-10 -101.1 159.45 15.22 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.566 1.166 . . . . 73.409999999999997 109.347 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.54 ' HB2' ' CE1' ' A' ' 211' ' ' PHE . 9.0 t80 -158.33 135.71 10.17 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.433 1.083 . . . . 72.25 110.908 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -68.78 132.34 46.64 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.144 . . . . 55.240000000000002 109.337 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.926 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -112.98 141.82 46.39 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.539 1.149 . . . . 71.120000000000005 109.311 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -150.42 20.37 0.84 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.51 1.131 . . . . 73.450000000000003 110.346 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.478 ' NZ ' ' CH2' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -96.42 -176.57 3.67 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.496 1.123 . . . . 64.239999999999995 109.26 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.41 -20.63 63.29 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.501 1.126 . . . . 52.409999999999997 109.319 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.454 ' HB3' ' CB ' ' A' ' 206' ' ' LEU . 7.1 t0 -117.11 18.88 14.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.493 1.121 . . . . 71.439999999999998 109.307 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.926 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 6.5 pt-20 -36.52 106.44 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.483 1.114 . . . . 71.420000000000002 110.28 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.693 HD22 ' HA3' ' A' ' 205' ' ' GLY . 15.8 tp -116.55 105.94 13.01 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.422 1.076 . . . . 55.130000000000003 109.307 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 175' ' ' THR . 9.7 t -87.22 110.02 19.88 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.437 1.086 . . . . 74.140000000000001 110.367 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.466 ' CG2' ' HG2' ' A' ' 180' ' ' GLU . 87.8 m -130.97 169.98 15.09 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.581 1.176 . . . . 72.450000000000003 110.386 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.432 ' N ' HG22 ' A' ' 176' ' ' THR . 15.0 m-85 -112.41 161.95 16.12 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.458 1.099 . . . . 72.439999999999998 111.015 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.614 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.7 m -55.4 158.16 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 44.509999999999998 109.3 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.44 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 50.24 68.55 1.38 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.462 1.101 . . . . 72.420000000000002 111.013 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.53 ' O ' HD13 ' A' ' 161' ' ' ILE . 5.2 tp10 -126.48 164.79 20.39 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 124.547 0.792 . . . . 62.229999999999997 110.322 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -113.42 129.21 56.59 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.507 1.13 . . . . 74.510000000000005 109.256 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.836 HD12 HG21 ' A' ' 207' ' ' VAL . 0.4 OUTLIER -152.48 146.95 25.68 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.498 1.124 . . . . 54.439999999999998 109.274 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.789 ' CE2' ' CD1' ' A' ' 159' ' ' TYR . 3.8 m-85 -111.92 120.35 41.61 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.464 1.103 . . . . 72.409999999999997 111.021 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.887 HD13 ' HB2' ' A' ' 160' ' ' ALA . 1.7 mp -71.02 152.11 8.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.485 1.115 . . . . 75.030000000000001 109.281 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.483 ' SG ' HG22 ' A' ' 194' ' ' ILE . 15.5 p -142.25 -44.15 0.33 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.508 1.13 . . . . 73.549999999999997 108.327 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.994 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -116.19 159.1 22.27 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.49 1.119 . . . . 75.030000000000001 109.303 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.558 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -147.85 148.93 31.4 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.463 1.102 . . . . 54.43 109.639 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.621 ' CD2' ' O ' ' A' ' 192' ' ' TRP . 0.5 OUTLIER -152.44 143.96 23.42 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.492 1.12 . . . . 74.030000000000001 109.584 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.473 ' C ' ' N ' ' A' ' 191' ' ' GLU . 27.3 t-20 51.11 22.88 1.38 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.547 1.154 . . . . 63.009999999999998 109.34 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.441 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.5 p 39.03 30.19 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.531 1.145 . . . . 52.009999999999998 108.292 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.526 ' O ' HG13 ' A' ' 209' ' ' VAL . 9.9 tt0 -131.31 -40.15 1.14 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.438 1.086 . . . . 71.319999999999993 110.307 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.835 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 96.4 m95 -107.33 131.72 53.92 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.035 -1.098 . . . . 65.239999999999995 108.035 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.776 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.4 m-30 -125.59 133.06 52.4 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.597 1.185 . . . . 61.119999999999997 111.048 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.994 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 0.7 OUTLIER -93.3 105.67 17.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.522 1.139 . . . . 55.409999999999997 109.289 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -109.13 176.73 4.99 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.392 1.057 . . . . 75.230000000000004 109.306 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.5 pttm -149.47 168.76 10.34 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.593 1.183 . . . . 52.340000000000003 109.362 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo . . . . . 0 C--N 1.36 1.135 0 O-C-N 124.528 1.804 . . . . 54.109999999999999 110.981 179.996 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.408 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.53 1.008 0 N-CA-C 111.035 -0.826 . . . . 74.150000000000006 111.035 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.408 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.1 Cg_endo -75.06 136.75 46.62 Favored 'Cis proline' 0 C--N 1.36 1.14 0 C-N-CA 121.002 -2.499 . . . . 61.539999999999999 111.0 0.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.693 ' HA3' HD22 ' A' ' 174' ' ' LEU . . . -99.72 156.74 19.77 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.529 1.143 . . . . 52.43 110.955 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.835 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.3 OUTLIER -93.12 146.45 23.65 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.455 0.738 . . . . 52.439999999999998 109.345 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.836 HG21 HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -159.99 127.05 2.6 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.534 1.146 . . . . 72.230000000000004 109.281 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.774 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.4 Cg_endo -75.01 179.83 5.7 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.479 1.779 . . . . 71.129999999999995 110.964 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.776 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.4 m -96.91 4.27 9.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.441 1.088 . . . . 64.430000000000007 109.314 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' GLY . . . . . 0.5 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -108.01 1.84 33.53 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.546 1.153 . . . . 73.030000000000001 111.026 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 14.1 m-85 -133.3 7.64 3.93 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.56 0.8 . . . . 64.450000000000003 111.003 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.802 HG12 HG22 ' A' ' 162' ' ' VAL . 4.5 m -144.32 153.69 15.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.562 1.164 . . . . 70.329999999999998 109.296 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.894 ' HB2' HD11 ' A' ' 163' ' ' LEU . 5.4 t -126.7 137.73 53.31 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.523 1.14 . . . . 73.219999999999999 109.978 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.716 ' O ' HG23 ' A' ' 215' ' ' ILE . 3.2 mm -75.76 147.75 7.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.434 1.084 . . . . 64.109999999999999 109.286 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.716 HG23 ' O ' ' A' ' 214' ' ' ILE . 4.6 pt . . . . . 0 C--N 1.325 -0.48 0 O-C-N 124.518 1.136 . . . . 74.439999999999998 109.331 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 6.5 t70 . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.285 -0.635 . . . . 52.310000000000002 109.285 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.489 HG21 ' HE2' ' A' ' 193' ' ' PHE . 3.7 p -44.12 -50.89 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.469 1.106 . . . . 72.439999999999998 109.319 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.412 ' N ' HG13 ' A' ' 227' ' ' VAL . 5.0 mt -53.75 -47.27 62.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.505 1.128 . . . . 74.319999999999993 109.274 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -66.28 -13.86 61.11 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.5 1.125 . . . . 63.350000000000001 110.334 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -88.52 -16.47 32.57 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.517 1.135 . . . . 75.450000000000003 109.289 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.5 OUTLIER -73.59 -69.62 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.5 1.125 . . . . 72.140000000000001 109.291 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.625 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -62.23 -16.83 55.99 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.41 1.069 . . . . 73.439999999999998 109.313 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.8 -56.25 15.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.501 1.125 . . . . 72.319999999999993 109.992 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.473 ' CG2' ' HB3' ' A' ' 236' ' ' LEU . 3.7 m -88.87 14.88 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.537 1.148 . . . . 64.230000000000004 109.309 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 49.4 t30 54.96 32.42 18.0 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.546 1.154 . . . . 73.219999999999999 109.27 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.473 ' HB3' ' CG2' ' A' ' 234' ' ' VAL . 0.0 OUTLIER -82.57 118.23 71.15 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.445 1.09 . . . . 73.409999999999997 109.332 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.99 -174.09 1.81 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.508 1.794 . . . . 63.130000000000003 110.998 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.582 HG21 ' NE2' ' A' ' 240' ' ' GLN . 0.8 OUTLIER -58.78 -170.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.456 1.098 . . . . 73.439999999999998 110.461 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.935 HG23 ' HB1' ' A' ' 186' ' ' ALA . 10.8 p -79.79 -43.64 22.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.478 1.111 . . . . 72.329999999999998 109.307 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.582 ' NE2' HG21 ' A' ' 238' ' ' THR . 0.0 OUTLIER -87.24 -12.83 45.54 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 1.114 . . . . 62.549999999999997 110.321 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.488 ' N ' ' OE1' ' A' ' 240' ' ' GLN . 2.0 mt-10 -82.88 -37.24 24.57 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.516 1.135 . . . . 74.420000000000002 110.296 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.591 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 0.4 OUTLIER -77.38 -59.29 2.84 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.531 1.145 . . . . 72.409999999999997 107.977 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.615 ' NZ ' ' CD2' ' B' ' 470' ' ' PHE . 26.8 mtmt -56.56 -18.66 12.54 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.571 1.169 . . . . 72.439999999999998 109.391 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 243' ' ' LYS . 1.1 t . . . . . 0 C--N 1.326 -0.452 0 O-C-N 124.501 1.126 . . . . 72.230000000000004 109.939 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 470' ' ' PHE . . . . . 0.615 ' CD2' ' NZ ' ' A' ' 243' ' ' LYS . 3.2 m-30 . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.545 0.212 . . . . 63.43 111.073 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 471' ' ' ILE . . . . . 0.469 ' N ' HD13 ' B' ' 471' ' ' ILE . 5.2 mm -65.91 135.23 95.28 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.483 1.115 . . . . 55.409999999999997 109.267 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 472' ' ' PRO . . . . . 0.589 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.95 149.92 37.65 Favored 'Trans proline' 0 C--N 1.361 1.225 0 O-C-N 124.522 1.801 . . . . 72.010000000000005 111.012 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 23.0 t -106.15 -37.18 6.68 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.486 1.116 . . . . 73.409999999999997 110.031 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -101.27 166.11 12.93 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.419 1.074 . . . . 62.030000000000001 110.27 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.06 -167.9 0.47 Allowed 'Trans proline' 0 C--N 1.361 1.203 0 O-C-N 124.511 1.795 . . . . 71.239999999999995 110.98 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 476' ' ' ALA . . . . . . . . . . . . . . . -71.33 134.05 84.99 Favored Pre-proline 0 C--N 1.326 -0.439 0 O-C-N 124.535 1.147 . . . . 41.140000000000001 109.293 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 477' ' ' PRO . . . . . 0.523 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -75.07 -167.85 0.46 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.56 1.821 . . . . 75.099999999999994 111.032 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.08 91.82 38.2 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 124.42 1.075 . . . . 43.32 109.302 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 479' ' ' PRO . . . . . 0.604 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.3 Cg_endo -74.96 151.21 39.43 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.535 1.808 . . . . 64.409999999999997 110.973 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 480' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 479' ' ' PRO . 18.2 Cg_endo . . . . . 0 C--N 1.36 1.153 0 O-C-N 124.523 1.802 . . . . 74.310000000000002 110.938 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.502 0.192 . . . . 74.530000000000001 111.01 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.819 ' O ' HD12 ' A' ' 182' ' ' LEU . . . -115.82 144.45 43.99 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.549 1.155 . . . . 63.310000000000002 109.291 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.519 HD13 ' N ' ' A' ' 162' ' ' VAL . 0.1 OUTLIER -129.37 132.04 66.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 124.505 1.128 . . . . 72.200000000000003 109.358 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.988 HG22 HG12 ' A' ' 212' ' ' VAL . 2.1 t -91.37 122.22 42.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.445 1.09 . . . . 71.340000000000003 109.312 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.531 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 0.7 OUTLIER -98.26 -14.36 20.32 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.457 1.098 . . . . 70.099999999999994 109.305 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.665 ' O ' HG13 ' A' ' 162' ' ' VAL . 1.1 m-85 -144.54 156.54 44.2 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.503 1.127 . . . . 63.210000000000001 111.033 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.716 ' N ' HG12 ' A' ' 178' ' ' VAL . 5.8 t70 -98.96 158.38 15.69 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.422 1.076 . . . . 51.439999999999998 109.25 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.556 ' CE2' ' HG3' ' B' ' 477' ' ' PRO . 1.4 t80 -160.26 131.06 5.59 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.56 1.162 . . . . 74.150000000000006 110.993 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.552 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 16.8 mtpp -67.21 121.26 15.26 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.445 1.091 . . . . 63.020000000000003 109.268 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.836 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -91.22 140.39 29.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.416 1.073 . . . . 54.140000000000001 109.293 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -150.47 21.03 0.83 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.512 1.132 . . . . 72.120000000000005 110.308 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.47 ' HD3' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -99.33 -176.22 3.23 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.511 1.132 . . . . 74.140000000000001 109.248 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.44 -29.14 67.57 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.548 1.155 . . . . 62.399999999999999 109.295 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 173' ' ' GLU . 5.6 m-20 -107.83 18.73 20.97 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.522 1.139 . . . . 75.129999999999995 109.281 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.836 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 6.8 pt-20 -36.62 104.06 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.539 1.149 . . . . 74.430000000000007 110.255 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.589 HD12 ' HA3' ' A' ' 205' ' ' GLY . 0.8 OUTLIER -141.15 95.31 2.82 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 62.049999999999997 109.278 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.01 153.66 33.15 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.462 1.101 . . . . 62.240000000000002 110.34 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 25.4 m -155.99 102.54 2.16 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.462 1.101 . . . . 63.039999999999999 110.387 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -44.17 160.56 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 70.409999999999997 111.019 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.716 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.9 m -62.08 158.48 3.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.529 1.143 . . . . 74.340000000000003 109.289 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.407 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 49.41 62.69 4.58 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.469 1.105 . . . . 71.200000000000003 110.98 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -118.56 165.55 13.8 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.516 0.774 . . . . 71.209999999999994 110.315 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -123.4 123.4 40.58 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.486 1.116 . . . . 74.109999999999999 109.26 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.848 ' H ' HD12 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -141.65 155.14 45.72 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.422 1.076 . . . . 64.209999999999994 109.249 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 7.3 t80 -109.59 112.61 24.8 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.546 1.154 . . . . 73.510000000000005 110.999 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.528 HD12 ' HB2' ' A' ' 160' ' ' ALA . 36.8 mt -70.96 151.43 9.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.463 1.102 . . . . 71.25 109.319 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.607 ' SG ' ' CH2' ' A' ' 242' ' ' TRP . 1.8 t -139.99 -43.85 0.43 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.466 1.104 . . . . 74.450000000000003 108.276 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.995 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -112.17 166.8 10.94 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.525 1.141 . . . . 61.439999999999998 109.316 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.521 ' C ' ' CD2' ' A' ' 188' ' ' HIS . 2.9 p80 -159.37 149.55 19.06 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.123 . . . . 73.450000000000003 109.617 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.742 ' HE1' HD11 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -141.61 133.14 26.87 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.438 1.086 . . . . 64.409999999999997 109.651 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 190' ' ' CYS . 95.7 m-20 49.02 31.16 3.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.564 1.165 . . . . 74.530000000000001 109.313 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.442 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.0 p 38.47 34.8 0.08 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.474 1.109 . . . . 74.310000000000002 108.352 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.52 ' O ' HG13 ' A' ' 209' ' ' VAL . 8.6 tt0 -128.49 -39.32 1.67 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.505 1.128 . . . . 74.120000000000005 110.324 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.964 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 98.6 m95 -111.56 126.43 54.98 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.483 1.115 . . . . 70.010000000000005 108.059 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.781 ' CE2' HG12 ' A' ' 209' ' ' VAL . 20.9 m-30 -117.99 132.17 56.41 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.526 1.141 . . . . 73.519999999999996 110.979 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.995 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 10.1 mm -96.37 103.45 14.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.385 1.053 . . . . 73.530000000000001 109.294 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.482 ' HB2' ' CG1' ' A' ' 184' ' ' ILE . . . -111.59 174.78 5.71 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.514 1.134 . . . . 73.310000000000002 109.299 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.36 165.56 19.74 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 124.525 1.14 . . . . 65.319999999999993 109.238 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.16 0 O-C-N 124.509 1.794 . . . . 62.539999999999999 111.042 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.031 0 N-CA-C 111.002 -0.839 . . . . 60.439999999999998 111.002 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.568 ' HG2' ' CE2' ' B' ' 470' ' ' PHE . 18.4 Cg_endo -74.9 143.53 78.12 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.045 -2.481 . . . . 72.409999999999997 111.024 -0.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.589 ' HA3' HD12 ' A' ' 174' ' ' LEU . . . -105.76 150.98 17.05 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.582 1.176 . . . . 44.229999999999997 110.962 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.964 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.1 OUTLIER -87.34 146.21 26.01 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 0.763 . . . . 72.019999999999996 109.314 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.766 ' HB ' HG11 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -153.79 122.23 3.07 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.53 1.144 . . . . 71.0 109.242 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.987 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.5 Cg_endo -74.97 170.96 19.25 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.509 1.794 . . . . 34.310000000000002 111.015 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.781 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.8 OUTLIER -89.75 5.2 5.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.118 . . . . 63.020000000000003 109.221 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -103.47 -12.11 31.65 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.522 1.139 . . . . 75.049999999999997 110.995 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.626 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 10.8 m-85 -124.0 -1.24 8.32 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.478 0.752 . . . . 74.109999999999999 111.054 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.988 HG12 HG22 ' A' ' 162' ' ' VAL . 2.2 m -140.4 160.67 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.501 1.125 . . . . 71.299999999999997 109.294 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.8 m -128.67 147.93 50.78 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.444 1.09 . . . . 75.099999999999994 110.07 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.753 ' C ' HD13 ' A' ' 215' ' ' ILE . 2.7 mm -94.42 141.19 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 64.540000000000006 109.235 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.785 ' N ' HD13 ' A' ' 215' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.446 0 O-C-N 124.514 1.133 . . . . 74.329999999999998 109.218 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 229' ' ' GLU . 19.9 t0 . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 109.276 -0.638 . . . . 70.209999999999994 109.276 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.656 HG13 HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -40.27 -45.63 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.532 1.145 . . . . 72.010000000000005 109.271 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.752 ' HA ' HD12 ' A' ' 231' ' ' ILE . 4.5 mp -64.78 -49.03 82.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.537 1.148 . . . . 73.230000000000004 109.316 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.483 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 34.0 mt-10 -62.4 -16.67 56.16 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.445 1.091 . . . . 73.310000000000002 110.29 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -89.16 -19.11 25.89 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.476 1.11 . . . . 54.119999999999997 109.332 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.752 HD12 ' HA ' ' A' ' 228' ' ' ILE . 3.0 mt -72.64 -69.89 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 124.565 1.166 . . . . 72.030000000000001 109.331 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.483 ' CD ' ' HA ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -57.5 -22.74 45.92 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.508 1.13 . . . . 63.420000000000002 109.283 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.21 -56.79 7.05 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.132 . . . . 74.129999999999995 109.945 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 234' ' ' VAL . 1.6 m -98.49 24.65 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.499 1.124 . . . . 73.239999999999995 109.241 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 41.29 36.73 0.53 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.515 1.134 . . . . 53.310000000000002 109.291 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.489 HD12 ' HD2' ' A' ' 237' ' ' PRO . 4.2 tp -60.17 119.83 45.67 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.521 1.138 . . . . 74.420000000000002 109.312 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.489 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.3 Cg_endo -74.99 162.79 36.57 Favored 'Trans proline' 0 C--N 1.359 1.115 0 O-C-N 124.499 1.789 . . . . 54.100000000000001 110.967 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.7 m -68.52 173.02 5.37 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.49 1.119 . . . . 54.119999999999997 110.419 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.681 ' HB ' ' HB1' ' A' ' 186' ' ' ALA . 10.5 p -65.3 -49.95 75.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.54 1.15 . . . . 63.25 109.281 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.481 ' OE1' ' CD1' ' B' ' 471' ' ' ILE . 7.6 pm0 -68.63 -14.95 63.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 72.439999999999998 110.353 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -88.49 -39.64 14.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.552 1.157 . . . . 70.340000000000003 110.381 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.607 ' CH2' ' SG ' ' A' ' 185' ' ' CYS . 0.2 OUTLIER -80.68 -63.07 1.49 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.506 1.129 . . . . 72.219999999999999 108.015 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.553 ' HD2' ' CD2' ' B' ' 470' ' ' PHE . 14.7 mtpp -51.5 -23.26 3.84 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.479 1.112 . . . . 64.310000000000002 109.292 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.129 . . . . 53.25 109.933 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 470' ' ' PHE . . . . . 0.568 ' CE2' ' HG2' ' A' ' 204' ' ' PRO . 5.4 m-30 . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 120.523 0.201 . . . . 72.409999999999997 110.938 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 471' ' ' ILE . . . . . 0.528 HG22 ' HD2' ' B' ' 472' ' ' PRO . 3.3 mm -95.95 140.59 22.35 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.478 1.111 . . . . 74.349999999999994 109.279 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 472' ' ' PRO . . . . . 0.528 ' HD2' HG22 ' B' ' 471' ' ' ILE . 18.3 Cg_endo -75.0 -170.16 0.74 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.417 1.746 . . . . 34.140000000000001 110.965 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.97 15.9 4.23 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.478 1.111 . . . . 71.25 109.986 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 474' ' ' ARG . . . . . 0.443 ' O ' ' NE1' ' A' ' 192' ' ' TRP . 17.0 mmt180 -145.82 154.51 51.57 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.466 1.104 . . . . 72.049999999999997 110.335 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 475' ' ' PRO . . . . . 0.672 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.2 Cg_endo -74.94 -36.07 2.82 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.538 1.809 . . . . 71.209999999999994 110.939 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 476' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 164.38 133.04 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.543 1.152 . . . . 42.100000000000001 109.262 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 477' ' ' PRO . . . . . 0.573 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -74.93 -171.08 0.88 Allowed 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.556 1.819 . . . . 71.209999999999994 111.044 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.72 96.65 40.32 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.546 1.154 . . . . 73.150000000000006 109.319 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 479' ' ' PRO . . . . . 0.626 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -75.0 166.67 28.7 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.386 1.729 . . . . 74.329999999999998 111.032 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.36 1.157 0 O-C-N 124.44 1.758 . . . . 63.43 111.012 -179.973 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.565 ' CE2' ' CD1' ' A' ' 215' ' ' ILE . 2.3 p90 . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.532 0.206 . . . . 72.329999999999998 110.975 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.65 ' HB3' ' HG ' ' A' ' 182' ' ' LEU . . . -107.38 151.84 24.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 51.340000000000003 109.288 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.597 HD13 ' N ' ' A' ' 162' ' ' VAL . 0.1 OUTLIER -132.16 135.05 58.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.457 1.098 . . . . 72.219999999999999 109.331 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.768 HG23 HD22 ' A' ' 182' ' ' LEU . 1.8 t -89.99 118.43 35.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.511 1.132 . . . . 73.540000000000006 109.337 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.571 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 1.4 mt -94.56 -16.92 22.85 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.422 1.076 . . . . 74.299999999999997 109.328 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.571 ' CE2' ' HB2' ' A' ' 163' ' ' LEU . 1.9 m-85 -148.61 157.07 43.21 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.439 1.087 . . . . 75.150000000000006 110.925 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.71 ' H ' HG12 ' A' ' 178' ' ' VAL . 7.2 p30 -88.84 154.84 19.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.527 1.142 . . . . 72.340000000000003 109.281 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.645 ' CE2' ' NZ ' ' A' ' 170' ' ' LYS . 2.4 t80 -154.4 132.13 11.47 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.435 1.084 . . . . 70.329999999999998 111.003 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.542 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 6.2 mtpm? -75.82 125.65 29.48 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.544 1.152 . . . . 62.210000000000001 109.328 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.908 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -114.18 133.53 55.53 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.521 1.138 . . . . 61.219999999999999 109.299 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -136.68 9.37 3.1 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.485 1.116 . . . . 63.039999999999999 110.245 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.645 ' NZ ' ' CE2' ' A' ' 166' ' ' PHE . 0.1 OUTLIER -79.07 -175.79 4.76 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.489 1.118 . . . . 74.230000000000004 109.32 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.34 -21.76 66.26 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.537 1.148 . . . . 73.329999999999998 109.267 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 173' ' ' GLU . 0.5 OUTLIER -114.05 12.64 17.99 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.451 1.094 . . . . 70.430000000000007 109.303 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.908 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 6.5 pt-20 -32.99 112.95 0.13 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.123 . . . . 73.299999999999997 110.293 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.592 HD23 ' HA3' ' A' ' 205' ' ' GLY . 1.5 tm? -119.92 99.4 6.6 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.555 1.159 . . . . 74.510000000000005 109.283 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 14.5 t -80.82 130.75 35.23 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.434 1.083 . . . . 75.120000000000005 110.428 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.411 ' CG2' ' HG3' ' A' ' 180' ' ' GLU . 55.6 m -155.19 155.98 34.87 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.451 1.094 . . . . 64.540000000000006 110.373 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.488 ' O ' HG11 ' A' ' 162' ' ' VAL . 26.8 m-85 -93.71 167.09 11.88 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.467 1.104 . . . . 65.120000000000005 110.953 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.71 HG12 ' H ' ' A' ' 165' ' ' ASP . 2.2 m -61.39 158.5 2.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.452 1.095 . . . . 75.519999999999996 109.3 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.422 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 48.55 56.92 8.88 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.524 1.14 . . . . 60.520000000000003 111.021 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.411 ' HG3' ' CG2' ' A' ' 176' ' ' THR . 3.9 mm-40 -114.86 175.47 5.48 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.472 0.749 . . . . 63.109999999999999 110.277 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -119.15 130.59 55.62 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.125 . . . . 75.120000000000005 109.321 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.891 HD12 HG21 ' A' ' 207' ' ' VAL . 2.5 pt? -145.28 133.37 21.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.455 1.097 . . . . 72.200000000000003 109.361 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -100.72 107.87 19.58 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.565 1.166 . . . . 74.120000000000005 110.979 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.75 ' CG1' ' HB2' ' A' ' 195' ' ' ALA . 13.3 mt -70.66 162.55 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.458 1.099 . . . . 70.140000000000001 109.353 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.571 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 2.0 p -156.44 -40.85 0.08 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.463 1.102 . . . . 42.119999999999997 108.296 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.989 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -112.21 152.17 28.71 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.451 1.094 . . . . 54.219999999999999 109.282 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.478 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 2.1 p-80 -145.26 149.45 34.91 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.476 1.11 . . . . 74.219999999999999 109.554 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.608 ' CD2' ' O ' ' A' ' 192' ' ' TRP . 0.7 OUTLIER -155.82 143.51 19.59 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 124.434 1.084 . . . . 65.329999999999998 109.545 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.456 ' C ' ' N ' ' A' ' 191' ' ' GLU . 7.4 m-20 57.02 18.04 3.75 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.548 1.155 . . . . 73.310000000000002 109.329 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 3.3 m 43.24 26.94 0.11 Allowed 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.475 1.109 . . . . 52.140000000000001 108.315 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.863 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 18.1 tt0 -132.93 -40.58 0.93 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.134 . . . . 71.420000000000002 110.254 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.996 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 96.9 m95 -103.88 127.83 51.38 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.042 -1.095 . . . . 71.400000000000006 108.042 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.768 ' CE2' HG12 ' A' ' 209' ' ' VAL . 15.7 m-30 -125.09 127.73 47.35 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.536 1.147 . . . . 74.409999999999997 110.922 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.989 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 1.6 mp -85.56 106.42 15.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.55 1.156 . . . . 74.040000000000006 109.277 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.798 ' HB3' HG21 ' A' ' 207' ' ' VAL . . . -120.85 163.07 18.75 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.557 1.161 . . . . 73.140000000000001 109.313 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -113.36 145.05 32.45 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.551 1.157 . . . . 73.329999999999998 109.263 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--N 1.361 1.192 0 O-C-N 124.475 1.776 . . . . 73.450000000000003 111.047 179.899 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.449 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.53 0.983 0 N-CA-C 111.059 -0.816 . . . . 44.140000000000001 111.059 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.449 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.3 Cg_endo -74.93 138.27 55.09 Favored 'Cis proline' 0 C--N 1.359 1.123 0 C-N-CA 120.97 -2.512 . . . . 54.549999999999997 110.988 -0.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.592 ' HA3' HD23 ' A' ' 174' ' ' LEU . . . -99.56 -178.96 31.04 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.432 1.082 . . . . 35.140000000000001 110.971 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.996 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -93.33 148.61 21.9 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.538 0.787 . . . . 61.100000000000001 109.295 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.891 HG21 HD12 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -155.52 122.95 2.78 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 74.540000000000006 109.32 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.888 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.5 Cg_endo -74.93 174.69 12.33 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.494 1.786 . . . . 71.0 111.038 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.768 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.5 m -93.59 -2.69 10.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.512 1.133 . . . . 75.099999999999994 109.228 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' GLY . . . . . 0.5 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -98.46 2.73 59.2 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.482 1.114 . . . . 22.140000000000001 110.967 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.557 ' CD1' ' HB2' ' A' ' 166' ' ' PHE . 13.5 m-85 -137.9 11.31 2.88 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.471 0.747 . . . . 72.329999999999998 110.985 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 208' ' ' PRO . 3.8 m -152.97 158.77 3.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 124.471 1.107 . . . . 73.329999999999998 109.339 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.8 t -134.91 148.07 49.98 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.532 1.145 . . . . 74.340000000000003 110.054 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 13.7 mm -86.27 132.76 31.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.441 1.088 . . . . 72.450000000000003 109.28 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.565 ' CD1' ' CE2' ' A' ' 159' ' ' TYR . 24.3 pt . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.547 1.154 . . . . 65.310000000000002 109.241 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 230' ' ' ASP . 2.4 m-20 . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 109.277 -0.638 . . . . 71.129999999999995 109.277 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.566 HG13 HD12 ' A' ' 228' ' ' ILE . 1.4 p -50.86 -41.08 21.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.461 1.1 . . . . 71.299999999999997 109.265 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.926 ' HA ' HD12 ' A' ' 231' ' ' ILE . 4.1 mp -70.27 -41.66 78.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.54 1.15 . . . . 74.019999999999996 109.332 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -69.21 -19.55 63.96 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 1.114 . . . . 62.329999999999998 110.308 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 226' ' ' ASP . 7.1 m-20 -88.73 -16.3 32.59 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.461 1.1 . . . . 75.519999999999996 109.272 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.926 HD12 ' HA ' ' A' ' 228' ' ' ILE . 4.4 mt -70.77 -69.36 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.463 1.102 . . . . 60.310000000000002 109.342 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.505 ' CE ' ' O ' ' A' ' 228' ' ' ILE . 0.0 OUTLIER -57.03 -25.59 58.86 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.511 1.132 . . . . 75.120000000000005 109.322 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.3 m -49.38 -55.54 12.63 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.514 1.134 . . . . 71.409999999999997 109.953 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 234' ' ' VAL . 2.0 m -93.49 26.1 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 71.439999999999998 109.32 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 234' ' ' VAL . 68.5 m-80 40.17 35.64 0.27 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 75.519999999999996 109.271 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.465 HD11 ' O ' ' A' ' 185' ' ' CYS . 1.2 tp -66.01 119.67 63.18 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 74.030000000000001 109.316 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.01 173.73 14.01 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.537 1.809 . . . . 74.5 110.981 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 239' ' ' VAL . 0.8 OUTLIER -69.56 -170.92 0.33 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.46 1.1 . . . . 44.149999999999999 110.367 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.84 HG22 ' HD3' ' A' ' 243' ' ' LYS . 10.5 p -82.89 -34.74 11.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.485 1.116 . . . . 75.519999999999996 109.295 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.633 ' HG3' HG13 ' A' ' 239' ' ' VAL . 0.6 OUTLIER -85.39 -20.06 30.44 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.52 1.138 . . . . 64.200000000000003 110.333 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -80.22 -36.37 34.88 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.434 1.084 . . . . 62.439999999999998 110.299 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.714 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 1.5 t90 -84.0 -56.57 3.61 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 65.129999999999995 107.972 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.84 ' HD3' HG22 ' A' ' 239' ' ' VAL . 18.1 mtpp -58.17 -17.69 20.49 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.524 1.14 . . . . 64.239999999999995 109.291 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 2.8 t . . . . . 0 C--N 1.324 -0.516 0 O-C-N 124.546 1.154 . . . . 61.210000000000001 109.998 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 470' ' ' PHE . . . . . 0.559 ' CD2' ' HD2' ' A' ' 243' ' ' LYS . 3.4 m-30 . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 120.517 0.198 . . . . 72.239999999999995 111.028 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 471' ' ' ILE . . . . . 0.427 HG23 ' HD2' ' B' ' 472' ' ' PRO . 0.7 OUTLIER -72.24 143.93 86.46 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.516 1.135 . . . . 72.439999999999998 109.28 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 472' ' ' PRO . . . . . 0.567 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.5 Cg_endo -74.96 153.47 41.98 Favored 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.475 1.777 . . . . 62.130000000000003 110.989 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.02 -63.07 1.29 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.546 1.153 . . . . 63.310000000000002 109.951 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.81 172.22 6.42 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.503 1.127 . . . . 71.140000000000001 110.259 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 -169.21 0.6 Allowed 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.479 1.778 . . . . 51.32 111.002 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 476' ' ' ALA . . . . . 0.863 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . -62.51 134.61 95.14 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.509 1.131 . . . . 61.340000000000003 109.285 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 477' ' ' PRO . . . . . 0.596 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -75.0 -162.5 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.579 1.831 . . . . 63.420000000000002 111.047 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.72 89.95 20.55 Favored Pre-proline 0 C--N 1.324 -0.525 0 O-C-N 124.525 1.141 . . . . 51.32 109.299 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 479' ' ' PRO . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.0 Cg_endo -75.03 165.02 32.15 Favored 'Trans proline' 0 C--N 1.359 1.11 0 O-C-N 124.481 1.779 . . . . 64.209999999999994 110.977 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--N 1.361 1.187 0 O-C-N 124.501 1.79 . . . . 54.200000000000003 111.005 179.998 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.792 ' CD1' ' CD1' ' A' ' 183' ' ' PHE . 34.9 m-85 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.439 0.161 . . . . 75.099999999999994 111.048 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.561 ' HB3' ' CD2' ' A' ' 182' ' ' LEU . . . -124.93 148.24 48.45 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.51 1.131 . . . . 65.099999999999994 109.233 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.618 ' CG2' HD11 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -116.01 134.63 58.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.435 1.084 . . . . 73.010000000000005 109.311 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.714 HG22 HG12 ' A' ' 212' ' ' VAL . 1.0 OUTLIER -91.49 122.96 43.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.531 1.144 . . . . 55.399999999999999 109.287 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.583 ' HB2' ' CE1' ' A' ' 164' ' ' TYR . 0.3 OUTLIER -102.55 -11.92 18.16 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.522 1.139 . . . . 71.450000000000003 109.332 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.651 ' O ' HG13 ' A' ' 162' ' ' VAL . 12.8 m-85 -142.51 166.41 24.75 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.477 1.111 . . . . 74.319999999999993 110.986 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.606 ' N ' HG12 ' A' ' 178' ' ' VAL . 27.6 p-10 -115.12 146.42 41.37 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.477 1.11 . . . . 72.420000000000002 109.283 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.567 ' CE2' ' HG3' ' B' ' 477' ' ' PRO . 1.6 t80 -149.51 128.59 12.73 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.446 1.091 . . . . 52.32 111.023 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.409 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 7.1 mtpt -66.99 104.99 1.51 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.545 1.153 . . . . 71.409999999999997 109.322 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.696 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -79.61 144.26 33.98 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.462 1.101 . . . . 34.409999999999997 109.309 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -151.33 20.97 0.74 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.499 1.124 . . . . 65.019999999999996 110.333 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.541 ' NZ ' ' CE2' ' A' ' 166' ' ' PHE . 0.1 OUTLIER -95.56 -176.06 3.64 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.465 1.103 . . . . 62.140000000000001 109.337 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.62 -37.11 75.19 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.511 1.132 . . . . 54.140000000000001 109.327 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 173' ' ' GLU . 0.7 OUTLIER -106.85 23.19 14.74 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.5 1.125 . . . . 74.030000000000001 109.345 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.696 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -35.26 111.19 0.12 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 1.118 . . . . 74.040000000000006 110.27 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.592 HD23 ' HA3' ' A' ' 205' ' ' GLY . 0.7 OUTLIER -118.51 98.07 6.07 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.532 1.145 . . . . 75.150000000000006 109.284 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 175' ' ' THR . 12.3 t -83.27 112.79 20.19 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.505 1.128 . . . . 72.439999999999998 110.447 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.777 HG23 ' CD ' ' A' ' 180' ' ' GLU . 1.1 m -137.55 137.17 38.32 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.548 1.155 . . . . 74.099999999999994 110.407 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -75.94 163.77 26.85 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.509 1.13 . . . . 73.109999999999999 110.962 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.606 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.3 m -58.08 157.79 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.529 1.143 . . . . 54.119999999999997 109.327 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.7 64.16 4.48 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.405 1.066 . . . . 63.43 111.026 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.777 ' CD ' HG23 ' A' ' 176' ' ' THR . 1.2 tt0 -127.84 -173.67 2.99 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.546 0.792 . . . . 75.219999999999999 110.264 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.636 ' C ' HD13 ' A' ' 182' ' ' LEU . 0.4 OUTLIER -147.27 136.59 22.59 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.528 1.142 . . . . 75.510000000000005 109.311 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.835 ' N ' HD13 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -148.96 146.27 27.75 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 72.200000000000003 109.294 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.792 ' CD1' ' CD1' ' A' ' 159' ' ' TYR . 6.8 m-30 -95.55 121.86 37.69 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.516 1.135 . . . . 73.329999999999998 110.899 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 195' ' ' ALA . 1.7 mp -70.75 161.93 4.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.53 1.144 . . . . 71.319999999999993 109.29 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.575 ' HB3' ' CH2' ' A' ' 242' ' ' TRP . 2.2 m -146.12 -47.37 0.2 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 62.520000000000003 108.259 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.927 ' HB1' ' HB ' ' A' ' 239' ' ' VAL . . . -119.78 166.07 13.72 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.479 1.112 . . . . 64.540000000000006 109.281 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.59 134.14 11.79 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 74.310000000000002 109.603 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.783 ' HD1' HG11 ' A' ' 239' ' ' VAL . 0.0 OUTLIER -146.73 149.28 33.09 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.444 1.09 . . . . 62.43 109.55 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.485 ' C ' ' N ' ' A' ' 191' ' ' GLU . 40.7 m-20 61.19 15.86 6.72 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 1.136 . . . . 71.530000000000001 109.316 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 189' ' ' ASN . 14.1 p 41.84 27.83 0.08 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.138 . . . . 74.019999999999996 108.335 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.615 ' O ' HG13 ' A' ' 209' ' ' VAL . 8.5 tt0 -136.42 -37.5 0.69 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.489 1.118 . . . . 72.010000000000005 110.258 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.866 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 95.7 m95 -101.82 135.91 42.57 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.008 -1.108 . . . . 74.329999999999998 108.008 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.718 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.0 m-30 -128.66 129.33 45.68 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 62.229999999999997 111.023 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.896 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 8.8 mm -89.68 102.07 12.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.503 1.127 . . . . 73.049999999999997 109.279 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -116.15 -178.85 3.5 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.438 1.086 . . . . 72.040000000000006 109.275 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.532 ' CB ' ' HA ' ' A' ' 204' ' ' PRO . 23.3 pttt -153.27 158.62 32.76 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.464 1.103 . . . . 74.239999999999995 109.295 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.414 ' CD ' ' HA3' ' A' ' 203' ' ' GLY . 18.1 Cg_endo . . . . . 0 C--N 1.359 1.131 0 O-C-N 124.481 1.779 . . . . 63.130000000000003 110.974 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.414 ' HA3' ' CD ' ' A' ' 197' ' ' PRO . . . . . . . . 0 CA--C 1.53 1.027 0 N-CA-C 110.993 -0.843 . . . . 73.129999999999995 110.993 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.532 ' HA ' ' CB ' ' A' ' 196' ' ' LYS . 18.1 Cg_endo -75.09 129.27 18.21 Favored 'Cis proline' 0 C--N 1.36 1.144 0 C-N-CA 121.015 -2.494 . . . . 33.009999999999998 110.974 0.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.592 ' HA3' HD23 ' A' ' 174' ' ' LEU . . . -111.96 177.91 18.95 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.529 1.143 . . . . 71.310000000000002 110.951 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.866 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -105.45 152.22 23.27 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.482 0.754 . . . . 73.340000000000003 109.341 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.529 ' N ' ' HG ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -156.76 132.41 5.71 Favored Pre-proline 0 C--N 1.324 -0.524 0 O-C-N 124.432 1.083 . . . . 51.130000000000003 109.315 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.844 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.3 Cg_endo -74.94 171.67 17.85 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.489 1.783 . . . . 73.319999999999993 111.037 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.718 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.2 m -91.48 -3.92 10.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.548 1.155 . . . . 74.310000000000002 109.304 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -90.26 -26.97 22.13 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.512 1.133 . . . . 65.299999999999997 110.981 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.62 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 17.6 m-85 -105.16 4.31 31.17 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.481 0.754 . . . . 73.439999999999998 111.011 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 208' ' ' PRO . 1.8 m -146.51 157.85 11.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.531 1.144 . . . . 63.229999999999997 109.311 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 4.5 t -130.39 130.55 44.5 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.515 1.135 . . . . 72.439999999999998 110.006 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.769 ' O ' HG23 ' A' ' 215' ' ' ILE . 2.6 mm -73.69 133.02 32.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.423 1.077 . . . . 73.230000000000004 109.254 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.769 HG23 ' O ' ' A' ' 214' ' ' ILE . 1.8 pt . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.46 1.1 . . . . 75.239999999999995 109.277 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 229' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 109.257 -0.646 . . . . 73.120000000000005 109.257 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 227' ' ' VAL . 0.2 OUTLIER -39.76 -55.71 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 124.462 1.101 . . . . 63.039999999999999 109.241 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 3.9 mt -55.85 -43.62 74.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.372 1.045 . . . . 73.099999999999994 109.27 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 226' ' ' ASP . 27.3 mt-10 -70.59 -14.58 62.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.477 1.11 . . . . 73.409999999999997 110.31 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 226' ' ' ASP . 0.4 OUTLIER -86.94 -24.27 24.82 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.514 1.134 . . . . 74.420000000000002 109.296 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.596 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.6 OUTLIER -61.23 -68.73 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.505 1.128 . . . . 74.109999999999999 109.297 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.596 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -56.27 -26.8 53.07 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.502 1.126 . . . . 61.140000000000001 109.349 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.9 t -52.14 -47.71 65.26 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.492 1.12 . . . . 61.32 109.934 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.522 HG23 ' HB2' ' A' ' 236' ' ' LEU . 8.9 m -98.45 19.44 2.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.493 1.12 . . . . 54.409999999999997 109.317 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 41.58 32.36 0.24 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.519 1.137 . . . . 73.430000000000007 109.26 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.522 ' HB2' HG23 ' A' ' 234' ' ' VAL . 4.3 tp -68.51 119.37 67.99 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.47 1.106 . . . . 75.019999999999996 109.335 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.411 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.4 Cg_endo -75.04 171.73 17.74 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.438 1.757 . . . . 73.540000000000006 110.968 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.434 HG22 ' NE2' ' A' ' 240' ' ' GLN . 1.7 m -71.42 165.52 23.61 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.567 1.167 . . . . 73.049999999999997 110.429 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.963 HG22 ' NZ ' ' A' ' 243' ' ' LYS . 7.6 p -60.84 -33.34 54.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.536 1.147 . . . . 74.230000000000004 109.287 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.542 ' HG3' HG13 ' A' ' 239' ' ' VAL . 1.2 mp0 -82.01 -15.43 53.68 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.532 1.145 . . . . 64.140000000000001 110.304 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -87.53 -38.66 15.82 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.554 1.159 . . . . 74.409999999999997 110.273 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.575 ' CH2' ' HB3' ' A' ' 185' ' ' CYS . 0.9 OUTLIER -79.42 -60.25 2.44 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.001 -1.111 . . . . 72.400000000000006 108.001 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.963 ' NZ ' HG22 ' A' ' 239' ' ' VAL . 14.3 mtmm -53.34 -20.86 4.85 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.523 1.139 . . . . 63.32 109.324 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 243' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.456 0 O-C-N 124.487 1.117 . . . . 51.409999999999997 110.018 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 470' ' ' PHE . . . . . 0.407 ' HA ' ' OD2' ' A' ' 172' ' ' ASP . 19.3 m-85 . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.479 0.181 . . . . 70.530000000000001 110.996 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 471' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' B' ' 472' ' ' PRO . 1.4 mp -65.71 138.84 96.78 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.503 1.127 . . . . 72.049999999999997 109.263 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 472' ' ' PRO . . . . . 0.56 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.1 Cg_endo -75.0 -179.34 4.89 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.529 1.805 . . . . 74.439999999999998 110.978 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 36.6 t -114.24 -61.63 1.72 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.544 1.153 . . . . 64.329999999999998 110.001 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -61.84 155.71 60.53 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.473 1.108 . . . . 64.409999999999997 110.285 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 475' ' ' PRO . . . . . 0.665 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.3 Cg_endo -75.07 -36.24 2.63 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.484 1.781 . . . . 74.129999999999995 111.005 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 476' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 165.01 126.91 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.529 1.143 . . . . 72.319999999999993 109.291 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 477' ' ' PRO . . . . . 0.591 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.5 Cg_endo -74.89 -162.13 0.14 Allowed 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.49 1.784 . . . . 62.520000000000003 111.049 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 478' ' ' LYS . . . . . 0.538 ' O ' ' CD ' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -145.2 112.32 4.76 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.506 1.129 . . . . 74.530000000000001 109.261 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 479' ' ' PRO . . . . . 0.62 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.1 Cg_endo -74.97 154.06 42.35 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.452 1.764 . . . . 75.319999999999993 110.998 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 480' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' B' ' 479' ' ' PRO . 18.4 Cg_endo . . . . . 0 C--N 1.359 1.111 0 O-C-N 124.527 1.804 . . . . 74.5 111.083 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' A' ' 181' ' ' ASN . 1.4 t80 . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 120.514 0.197 . . . . 72.519999999999996 110.965 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.468 ' HB2' HG12 ' A' ' 184' ' ' ILE . . . -118.23 142.36 47.55 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.461 1.101 . . . . 63.130000000000003 109.306 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.617 ' HB ' HD11 ' A' ' 215' ' ' ILE . 0.0 OUTLIER -119.41 131.66 71.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.468 1.105 . . . . 61.350000000000001 109.292 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.877 HG22 HG12 ' A' ' 212' ' ' VAL . 2.0 t -93.27 120.97 43.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 74.400000000000006 109.335 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.606 HD21 HG23 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -99.01 -13.58 19.83 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.519 1.137 . . . . 65.150000000000006 109.351 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.639 ' O ' HG13 ' A' ' 162' ' ' VAL . 1.3 m-85 -144.37 156.77 44.38 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.434 1.084 . . . . 74.219999999999999 111.05 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.719 ' N ' HG12 ' A' ' 178' ' ' VAL . 9.2 p-10 -92.06 154.03 19.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.512 1.133 . . . . 74.120000000000005 109.268 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.467 ' CZ ' ' O ' ' A' ' 167' ' ' LYS . 16.7 t80 -141.64 144.27 34.07 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.486 1.116 . . . . 72.420000000000002 110.969 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.467 ' O ' ' CZ ' ' A' ' 166' ' ' PHE . 14.2 mtpp -82.81 131.22 35.2 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.542 1.151 . . . . 74.310000000000002 109.283 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.839 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -96.34 142.37 28.55 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 70.120000000000005 109.272 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -158.03 24.88 0.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.473 1.108 . . . . 71.340000000000003 110.354 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.687 ' HZ1' HD23 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -122.27 -175.46 3.13 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.427 1.08 . . . . 62.200000000000003 109.276 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.77 -40.03 82.76 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.487 1.117 . . . . 64.109999999999999 109.302 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 174' ' ' LEU . 26.6 m-20 -86.14 10.52 14.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 75.310000000000002 109.324 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.839 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 6.5 pt-20 -36.77 96.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.57 1.169 . . . . 73.310000000000002 110.341 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.621 ' H ' ' HZ2' ' A' ' 170' ' ' LYS . 0.3 OUTLIER -131.73 95.42 3.71 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.128 . . . . 63.219999999999999 109.315 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.4 t -59.18 153.39 18.38 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.536 1.147 . . . . 74.340000000000003 110.367 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 177' ' ' TYR . 22.2 m -154.53 175.29 13.8 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.501 1.126 . . . . 54.229999999999997 110.398 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.543 ' H ' HG22 ' A' ' 176' ' ' THR . 8.0 m-85 -122.57 157.79 31.33 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.47 1.106 . . . . 64.239999999999995 111.02 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.719 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.8 m -59.51 158.39 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.518 1.136 . . . . 70.400000000000006 109.262 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.429 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 48.07 67.83 1.45 Allowed Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.479 1.112 . . . . 43.520000000000003 111.037 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -129.13 168.38 16.21 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.478 0.752 . . . . 73.109999999999999 110.309 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.448 ' HB3' ' CE2' ' A' ' 159' ' ' TYR . 8.5 m120 -118.77 126.42 51.82 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.527 1.142 . . . . 72.530000000000001 109.225 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.816 ' N ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -133.58 139.98 46.87 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.558 1.162 . . . . 64.439999999999998 109.325 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 5.4 t80 -98.97 97.47 8.63 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.489 1.118 . . . . 74.230000000000004 110.998 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 1.044 HD13 ' HB2' ' A' ' 195' ' ' ALA . 28.0 mm -52.01 156.67 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.405 1.065 . . . . 71.430000000000007 109.281 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 186' ' ' ALA . 7.3 p -149.96 -42.49 0.13 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.459 1.099 . . . . 70.230000000000004 108.327 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.897 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -120.72 167.89 11.99 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.564 1.165 . . . . 71.219999999999999 109.309 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.456 ' CD2' HG12 ' A' ' 231' ' ' ILE . 1.7 p-80 -157.35 144.21 18.28 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.101 . . . . 74.409999999999997 109.613 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.578 ' CE1' ' HD3' ' B' ' 472' ' ' PRO . 0.1 OUTLIER -144.87 139.83 27.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.537 1.148 . . . . 71.120000000000005 109.55 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.49 ' C ' ' N ' ' A' ' 191' ' ' GLU . 57.7 t30 50.37 22.41 1.01 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.479 1.112 . . . . 74.209999999999994 109.27 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 189' ' ' ASN . 4.0 m 41.47 27.7 0.06 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.452 1.095 . . . . 72.340000000000003 108.272 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 208' ' ' PRO . 3.6 tt0 -124.98 -38.14 2.37 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.528 1.142 . . . . 73.299999999999997 110.275 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.76 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 90.5 m95 -113.95 128.07 56.24 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.0 -1.111 . . . . 75.209999999999994 108.0 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.904 ' HB3' HD12 ' A' ' 184' ' ' ILE . 21.4 m-30 -117.03 157.0 26.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.48 1.112 . . . . 71.299999999999997 110.959 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.897 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 3.6 mm -118.48 104.15 15.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.54 1.15 . . . . 72.319999999999993 109.314 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 1.044 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -107.55 170.37 8.02 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.472 1.107 . . . . 51.25 109.35 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.467 ' CG ' ' HA ' ' A' ' 204' ' ' PRO . 4.6 mtmp? -138.9 165.16 34.41 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.547 1.154 . . . . 54.399999999999999 109.294 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.152 0 O-C-N 124.459 1.768 . . . . 62.219999999999999 111.002 179.98 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.404 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.531 1.063 0 N-CA-C 110.949 -0.861 . . . . 71.329999999999998 110.949 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.484 ' HB2' ' CG2' ' A' ' 194' ' ' ILE . 18.2 Cg_endo -74.95 128.18 15.87 Favored 'Cis proline' 0 C--N 1.359 1.102 0 C-N-CA 121.065 -2.473 . . . . 63.140000000000001 110.992 -0.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.402 ' N ' ' HA2' ' A' ' 203' ' ' GLY . . . -92.49 122.13 6.75 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.504 1.127 . . . . 73.219999999999999 111.042 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.76 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.1 OUTLIER -79.96 146.77 31.9 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.556 0.798 . . . . 72.349999999999994 109.321 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.784 ' CG1' HG11 ' A' ' 212' ' ' VAL . 0.4 OUTLIER -160.44 129.05 2.99 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.136 . . . . 54.020000000000003 109.282 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.508 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.4 Cg_endo -74.99 179.94 5.59 Favored 'Trans proline' 0 C--N 1.359 1.117 0 O-C-N 124.593 1.838 . . . . 71.349999999999994 111.027 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.73 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.8 OUTLIER -98.06 4.2 9.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.477 1.111 . . . . 65.209999999999994 109.28 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -105.38 -2.79 41.14 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.496 1.122 . . . . 52.130000000000003 110.99 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.619 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 5.6 m-85 -127.5 0.85 6.25 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.428 0.722 . . . . 73.540000000000006 110.939 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.877 HG12 HG22 ' A' ' 162' ' ' VAL . 1.2 m -142.53 170.25 11.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.538 1.149 . . . . 73.420000000000002 109.29 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.3 t -129.37 140.57 51.32 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.508 1.13 . . . . 72.530000000000001 109.994 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.832 ' O ' HG23 ' A' ' 215' ' ' ILE . 3.7 mm -83.35 138.37 19.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.452 1.095 . . . . 53.439999999999998 109.287 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.832 HG23 ' O ' ' A' ' 214' ' ' ILE . 6.5 pt . . . . . 0 C--N 1.325 -0.459 0 O-C-N 124.542 1.151 . . . . 73.099999999999994 109.242 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 230' ' ' ASP . 2.9 t0 . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.297 -0.631 . . . . 53.119999999999997 109.297 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.593 HG13 ' H ' ' A' ' 228' ' ' ILE . 3.0 p -44.01 -59.19 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.465 1.103 . . . . 75.239999999999995 109.329 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.593 ' H ' HG13 ' A' ' 227' ' ' VAL . 3.8 mt -48.95 -47.54 16.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.53 1.144 . . . . 73.420000000000002 109.319 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.425 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 9.6 mt-10 -66.28 -23.48 66.4 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.574 1.171 . . . . 72.109999999999999 110.316 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 226' ' ' ASP . 31.1 m-20 -85.27 -15.92 41.85 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.494 1.122 . . . . 42.039999999999999 109.279 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.692 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.5 OUTLIER -72.84 -68.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.524 1.14 . . . . 72.430000000000007 109.277 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.692 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -61.48 -20.41 63.13 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.5 1.125 . . . . 73.540000000000006 109.272 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.65 -52.98 43.6 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.514 1.134 . . . . 61.149999999999999 110.062 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 234' ' ' VAL . 1.5 m -94.65 26.68 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.515 1.134 . . . . 65.200000000000003 109.313 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 40.61 37.67 0.51 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.594 1.184 . . . . 73.400000000000006 109.347 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.437 ' HB2' ' CG2' ' A' ' 234' ' ' VAL . 3.6 tp -72.22 119.55 75.34 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.569 1.168 . . . . 44.5 109.331 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.99 167.72 26.42 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.544 1.813 . . . . 45.520000000000003 110.959 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.29 177.95 2.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.505 1.128 . . . . 73.319999999999993 110.438 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.551 HG13 ' N ' ' A' ' 240' ' ' GLN . 13.1 p -72.01 -54.06 17.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 42.119999999999997 109.342 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.551 ' N ' HG13 ' A' ' 239' ' ' VAL . 13.0 pm0 -68.37 -14.85 63.29 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.464 1.103 . . . . 72.510000000000005 110.292 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -92.25 -37.21 12.8 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.136 . . . . 71.409999999999997 110.322 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.517 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 3.3 t90 -79.24 -59.78 2.63 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.004 -1.11 . . . . 71.519999999999996 108.004 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.577 ' HE2' ' CD2' ' B' ' 470' ' ' PHE . 4.6 mtmp? -54.77 -20.1 7.77 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.563 1.165 . . . . 64.200000000000003 109.357 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 21.0 t . . . . . 0 C--N 1.326 -0.447 0 O-C-N 124.454 1.097 . . . . 70.0 110.017 179.986 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 470' ' ' PHE . . . . . 0.577 ' CD2' ' HE2' ' A' ' 243' ' ' LYS . 2.2 m-30 . . . . . 0 N--CA 1.453 -0.325 0 CA-C-O 120.549 0.214 . . . . 72.450000000000003 111.045 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 471' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' B' ' 472' ' ' PRO . 13.0 mm -88.85 137.96 29.68 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.466 1.104 . . . . 73.099999999999994 109.269 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 472' ' ' PRO . . . . . 0.578 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -75.0 112.15 3.49 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.431 1.753 . . . . 54.409999999999997 110.994 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 42.0 t -55.15 -44.95 75.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.506 1.129 . . . . 74.450000000000003 109.959 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 474' ' ' ARG . . . . . 0.451 ' CD ' ' HD2' ' B' ' 475' ' ' PRO . 5.4 tpp180 -84.37 137.72 39.27 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.485 1.116 . . . . 71.019999999999996 110.32 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 475' ' ' PRO . . . . . 0.451 ' HD2' ' CD ' ' B' ' 474' ' ' ARG . 18.4 Cg_endo -74.99 -170.07 0.73 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.433 1.754 . . . . 44.399999999999999 111.019 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 476' ' ' ALA . . . . . 0.45 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . -48.3 124.63 11.46 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.561 1.163 . . . . 74.340000000000003 109.277 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 477' ' ' PRO . . . . . 0.576 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.6 Cg_endo -74.91 -162.39 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.441 1.758 . . . . 72.310000000000002 111.038 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.28 90.28 25.59 Favored Pre-proline 0 C--N 1.326 -0.436 0 O-C-N 124.488 1.118 . . . . 71.519999999999996 109.319 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 479' ' ' PRO . . . . . 0.619 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.1 Cg_endo -75.03 162.05 37.68 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.525 1.802 . . . . 73.219999999999999 110.983 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.36 1.149 0 O-C-N 124.508 1.794 . . . . 71.430000000000007 110.967 179.99 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.495 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 3.7 p90 . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 120.444 0.164 . . . . 72.430000000000007 111.078 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.589 ' HB3' HD11 ' A' ' 184' ' ' ILE . . . -127.77 154.67 45.11 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.56 1.162 . . . . 43.130000000000003 109.362 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.571 HG23 ' CD2' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -126.44 119.65 54.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.477 1.111 . . . . 75.109999999999999 109.333 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.709 ' CG2' HG12 ' A' ' 212' ' ' VAL . 1.0 OUTLIER -70.84 125.35 29.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.488 1.118 . . . . 65.25 109.271 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.688 HD11 ' HB2' ' A' ' 213' ' ' SER . 0.2 OUTLIER -104.06 -9.14 19.0 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.586 1.179 . . . . 74.239999999999995 109.311 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.582 ' O ' HG13 ' A' ' 162' ' ' VAL . 4.7 m-85 -145.16 172.6 12.87 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.479 1.112 . . . . 55.439999999999998 110.998 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.631 ' N ' HG12 ' A' ' 178' ' ' VAL . 0.0 OUTLIER -87.65 129.77 35.01 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.484 1.115 . . . . 61.020000000000003 109.262 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.667 ' CZ ' ' HB2' ' A' ' 168' ' ' ALA . 2.0 t80 -103.02 129.74 49.89 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.457 1.098 . . . . 72.310000000000002 111.009 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.76 106.97 19.36 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.468 1.105 . . . . 73.430000000000007 109.257 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.843 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -114.01 150.29 34.11 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.556 1.16 . . . . 74.319999999999993 109.282 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -152.12 24.9 0.64 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.471 1.107 . . . . 74.319999999999993 110.268 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.492 ' HZ1' ' HZ ' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -112.82 -172.79 2.12 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 75.420000000000002 109.325 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.25 -43.99 75.14 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.534 1.146 . . . . 71.109999999999999 109.326 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.49 ' HB2' HD22 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -86.26 11.47 12.03 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.48 1.112 . . . . 74.230000000000004 109.322 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.843 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 11.5 tt0 -35.22 98.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.497 1.123 . . . . 71.239999999999995 110.311 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.57 HD21 ' CA ' ' A' ' 205' ' ' GLY . 0.4 OUTLIER -109.37 94.76 5.2 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.538 1.149 . . . . 74.510000000000005 109.249 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 175' ' ' THR . 12.0 t -95.05 109.56 21.59 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.521 1.138 . . . . 54.310000000000002 110.453 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.539 HG22 ' H ' ' A' ' 177' ' ' TYR . 90.6 m -130.71 174.85 9.54 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.476 1.11 . . . . 64.109999999999999 110.428 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.553 ' O ' HG11 ' A' ' 162' ' ' VAL . 29.1 m-85 -105.26 169.42 8.46 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.504 1.127 . . . . 73.019999999999996 110.985 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.631 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.5 m -66.14 158.02 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.467 1.104 . . . . 70.420000000000002 109.305 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 58.2 66.05 3.09 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.479 1.112 . . . . 34.200000000000003 110.983 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.547 ' O ' HD13 ' A' ' 161' ' ' ILE . 9.1 tp10 -131.78 157.53 43.62 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.475 0.75 . . . . 64.0 110.32 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -118.61 129.12 55.14 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.499 1.124 . . . . 74.329999999999998 109.247 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.752 HD23 ' N ' ' A' ' 182' ' ' LEU . 0.5 OUTLIER -140.67 150.02 42.98 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 52.32 109.244 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 5.5 m-85 -104.1 114.38 28.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.485 1.116 . . . . 75.230000000000004 111.002 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.589 HD11 ' HB3' ' A' ' 160' ' ' ALA . 1.6 mp -62.08 156.5 4.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 124.508 1.13 . . . . 75.140000000000001 109.249 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.458 ' N ' ' O ' ' A' ' 194' ' ' ILE . 0.1 OUTLIER -139.8 -48.15 0.46 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.461 1.1 . . . . 45.229999999999997 108.272 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.692 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -124.85 170.28 11.22 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.492 1.12 . . . . 70.510000000000005 109.324 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.524 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.2 OUTLIER -152.93 143.82 22.93 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.524 1.14 . . . . 74.140000000000001 109.603 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.714 ' NE2' HD11 ' A' ' 194' ' ' ILE . 0.2 OUTLIER -145.58 140.59 27.51 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.474 1.109 . . . . 72.420000000000002 109.622 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.491 ' C ' ' N ' ' A' ' 191' ' ' GLU . 67.3 t30 49.26 23.17 0.76 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.497 1.123 . . . . 54.329999999999998 109.368 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.411 ' C ' ' O ' ' A' ' 189' ' ' ASN . 14.5 p 41.0 28.17 0.05 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.471 1.107 . . . . 71.450000000000003 108.308 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.798 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 7.7 tt0 -125.38 -39.0 2.22 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.422 1.077 . . . . 54.32 110.304 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.595 ' CZ2' ' HD3' ' B' ' 477' ' ' PRO . 99.1 m95 -112.68 130.9 55.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.018 -1.105 . . . . 72.450000000000003 108.018 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.754 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.9 m-30 -121.91 142.11 50.6 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.54 1.15 . . . . 75.239999999999995 110.97 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.714 HD11 ' NE2' ' A' ' 188' ' ' HIS . 4.3 mm -101.19 95.98 4.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.422 1.076 . . . . 73.230000000000004 109.263 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -103.93 -177.05 3.26 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.485 1.116 . . . . 61.039999999999999 109.293 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.452 ' CD ' ' HB3' ' A' ' 204' ' ' PRO . 3.9 mtmm -148.45 159.61 38.48 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.506 1.129 . . . . 71.120000000000005 109.291 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.359 1.126 0 O-C-N 124.522 1.801 . . . . 62.109999999999999 110.954 -179.974 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.477 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.531 1.048 0 N-CA-C 111.011 -0.836 . . . . 70.209999999999994 111.011 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.477 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.3 Cg_endo -75.01 131.17 23.32 Favored 'Cis proline' 0 C--N 1.359 1.122 0 C-N-CA 121.034 -2.486 . . . . 72.019999999999996 111.008 0.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.57 ' CA ' HD21 ' A' ' 174' ' ' LEU . . . -101.05 165.73 18.74 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.485 1.116 . . . . 62.049999999999997 111.004 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.584 HD11 ' CE3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -108.7 149.78 28.5 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.487 0.757 . . . . 64.409999999999997 109.281 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.778 ' CG1' HG11 ' A' ' 212' ' ' VAL . 0.4 OUTLIER -157.04 133.68 6.36 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.449 1.093 . . . . 72.230000000000004 109.282 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.557 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.2 Cg_endo -75.07 169.34 22.81 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.475 1.776 . . . . 72.439999999999998 110.995 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.754 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.6 OUTLIER -93.74 6.86 6.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.438 1.086 . . . . 62.130000000000003 109.336 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 210' ' ' GLY . . . . . 0.487 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -106.69 -3.6 37.09 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.442 1.089 . . . . 72.109999999999999 111.014 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.607 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 23.3 m-85 -129.03 4.99 5.33 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.462 0.742 . . . . 54.509999999999998 110.973 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.778 HG11 ' CG1' ' A' ' 207' ' ' VAL . 2.1 m -141.43 150.55 19.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.468 1.105 . . . . 75.140000000000001 109.329 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.688 ' HB2' HD11 ' A' ' 163' ' ' LEU . 1.4 t -110.73 133.29 53.46 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.524 1.14 . . . . 55.009999999999998 109.974 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.445 ' C ' HG23 ' A' ' 215' ' ' ILE . 4.8 mm -77.57 135.33 26.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.43 1.081 . . . . 73.519999999999996 109.338 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.479 HD13 ' HA ' ' A' ' 160' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.501 0 O-C-N 124.5 1.125 . . . . 53.229999999999997 109.33 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 230' ' ' ASP . 7.6 m-20 . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 109.341 -0.614 . . . . 74.209999999999994 109.341 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.788 ' O ' HD12 ' A' ' 231' ' ' ILE . 2.7 p -49.36 -45.55 18.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.482 1.113 . . . . 45.450000000000003 109.318 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.486 ' H ' HD12 ' A' ' 228' ' ' ILE . 3.9 mp -63.53 -30.56 50.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.455 1.097 . . . . 71.299999999999997 109.271 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.421 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 7.8 mt-10 -86.14 -14.56 43.78 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.429 1.081 . . . . 72.319999999999993 110.288 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 226' ' ' ASP . 8.9 t0 -88.39 -15.75 34.71 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.479 1.112 . . . . 74.319999999999993 109.311 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.788 HD12 ' O ' ' A' ' 227' ' ' VAL . 0.6 OUTLIER -72.4 -69.37 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.559 1.162 . . . . 72.329999999999998 109.342 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.638 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -57.88 -20.87 39.94 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.568 1.168 . . . . 72.140000000000001 109.281 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.6 t -48.57 -57.49 6.11 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.54 1.15 . . . . 50.25 109.955 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.9 m -93.67 21.12 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.462 1.101 . . . . 71.230000000000004 109.294 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 49.33 29.21 2.64 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.474 1.109 . . . . 73.450000000000003 109.311 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.469 HD12 ' HD2' ' A' ' 237' ' ' PRO . 4.4 tp -65.27 119.11 56.55 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.465 1.103 . . . . 71.329999999999998 109.34 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.469 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.4 Cg_endo -74.92 173.03 15.18 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.461 1.769 . . . . 73.439999999999998 111.008 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 239' ' ' VAL . 1.5 m -66.25 -170.66 0.09 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.58 1.175 . . . . 73.540000000000006 110.389 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.597 HG22 ' HD3' ' A' ' 243' ' ' LYS . 9.8 p -79.96 -35.68 16.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.624 1.202 . . . . 63.200000000000003 109.351 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.575 ' HG3' HG13 ' A' ' 239' ' ' VAL . 0.5 OUTLIER -84.94 -19.14 32.64 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.569 1.168 . . . . 64.510000000000005 110.282 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -81.51 -39.17 25.12 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.493 1.121 . . . . 70.109999999999999 110.338 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.497 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 5.8 t90 -77.98 -61.25 2.06 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 72.200000000000003 107.978 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.597 ' HD3' HG22 ' A' ' 239' ' ' VAL . 1.6 mtpm? -59.05 -17.38 25.1 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.462 1.101 . . . . 55.549999999999997 109.302 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 243' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.457 0 O-C-N 124.576 1.173 . . . . 72.030000000000001 109.988 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 470' ' ' PHE . . . . . 0.539 ' C ' HD12 ' B' ' 471' ' ' ILE . 8.6 m-30 . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 120.45 0.166 . . . . 74.120000000000005 110.972 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 471' ' ' ILE . . . . . 0.569 ' N ' ' CD1' ' B' ' 471' ' ' ILE . 1.1 mp -98.55 138.14 20.74 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.546 1.154 . . . . 54.539999999999999 109.291 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 472' ' ' PRO . . . . . 0.533 ' HD2' HG23 ' B' ' 471' ' ' ILE . 18.2 Cg_endo -75.03 138.63 23.21 Favored 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.485 1.782 . . . . 61.43 110.955 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 21.1 t -66.11 -72.25 0.17 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.54 1.15 . . . . 62.25 109.984 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.59 157.21 88.91 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.544 1.152 . . . . 71.400000000000006 110.309 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -167.59 0.44 Allowed 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.531 1.806 . . . . 75.400000000000006 110.947 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 476' ' ' ALA . . . . . 0.798 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . -56.49 131.11 76.8 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 23.399999999999999 109.314 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 477' ' ' PRO . . . . . 0.595 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -75.04 -162.58 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.489 1.784 . . . . 61.219999999999999 111.022 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 478' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -135.54 91.37 18.51 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.509 1.13 . . . . 73.019999999999996 109.321 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 479' ' ' PRO . . . . . 0.607 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.2 Cg_endo -74.99 154.92 42.88 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.463 1.77 . . . . 61.340000000000003 111.051 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 480' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' B' ' 479' ' ' PRO . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.154 0 O-C-N 124.459 1.768 . . . . 70.030000000000001 111.042 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.741 ' CE2' ' CZ ' ' A' ' 183' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 120.487 0.184 . . . . 75.409999999999997 111.029 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.949 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -103.93 148.61 25.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.567 1.167 . . . . 75.129999999999995 109.311 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.598 HG23 HD23 ' A' ' 163' ' ' LEU . 0.2 OUTLIER -131.28 128.84 62.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.574 1.171 . . . . 55.119999999999997 109.228 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.797 HG22 HG12 ' A' ' 212' ' ' VAL . 2.6 t -80.83 119.23 30.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.529 1.143 . . . . 70.319999999999993 109.296 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.598 HD23 HG23 ' A' ' 161' ' ' ILE . 0.9 OUTLIER -94.3 -15.92 24.01 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.561 1.163 . . . . 71.030000000000001 109.321 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.622 ' O ' HG13 ' A' ' 162' ' ' VAL . 1.0 OUTLIER -150.0 155.96 40.86 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.466 1.104 . . . . 75.540000000000006 111.002 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.685 ' H ' HG12 ' A' ' 178' ' ' VAL . 1.3 t70 -86.54 157.49 19.74 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.437 1.086 . . . . 72.129999999999995 109.29 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.51 ' HB2' ' CD1' ' A' ' 211' ' ' PHE . 11.7 t80 -154.35 140.57 18.53 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.548 1.155 . . . . 71.420000000000002 110.999 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -84.19 115.02 22.21 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.436 1.085 . . . . 74.430000000000007 109.3 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.934 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -103.55 131.54 50.59 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.49 1.119 . . . . 64.319999999999993 109.323 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -138.63 11.36 2.71 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.469 1.106 . . . . 74.450000000000003 110.265 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.519 ' HE3' ' CH2' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -83.0 -175.92 6.08 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.513 1.133 . . . . 62.229999999999997 109.272 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -64.04 -24.64 67.78 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.507 1.13 . . . . 73.5 109.307 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.475 ' HB3' ' CB ' ' A' ' 206' ' ' LEU . 72.4 m-20 -112.89 15.69 19.68 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.557 1.16 . . . . 72.230000000000004 109.351 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.934 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 2.0 pp20? -34.0 108.99 0.07 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.424 1.078 . . . . 71.010000000000005 110.244 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.608 HD23 ' HA3' ' A' ' 205' ' ' GLY . 0.7 OUTLIER -115.75 96.27 5.53 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.54 1.15 . . . . 44.43 109.264 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 15.2 t -82.36 133.08 35.22 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.561 1.163 . . . . 72.329999999999998 110.401 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.825 HG23 ' HG2' ' A' ' 180' ' ' GLU . 0.9 OUTLIER -160.76 146.46 14.71 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.478 1.111 . . . . 73.310000000000002 110.383 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -81.43 168.81 17.91 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.544 1.153 . . . . 62.109999999999999 111.025 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.685 HG12 ' H ' ' A' ' 165' ' ' ASP . 2.3 m -60.88 158.19 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.509 1.131 . . . . 64.340000000000003 109.298 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 53.33 59.23 9.85 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.551 1.157 . . . . 53.409999999999997 110.957 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.825 ' HG2' HG23 ' A' ' 176' ' ' THR . 1.3 tp10 -116.59 179.81 3.9 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.483 0.755 . . . . 74.200000000000003 110.328 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -132.62 139.71 47.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.525 1.14 . . . . 74.140000000000001 109.252 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.698 HD22 HG11 ' A' ' 207' ' ' VAL . 0.1 OUTLIER -152.17 149.36 28.67 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 75.230000000000004 109.335 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.741 ' CZ ' ' CE2' ' A' ' 159' ' ' TYR . 2.1 m-85 -109.0 111.63 23.4 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.424 1.077 . . . . 64.340000000000003 110.995 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.949 HD13 ' HB2' ' A' ' 160' ' ' ALA . 1.6 mp -71.0 164.15 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.133 . . . . 61.399999999999999 109.314 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.595 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 3.5 p -159.9 -41.5 0.05 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.524 1.14 . . . . 73.099999999999994 108.283 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.978 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -114.69 152.5 31.87 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.528 1.142 . . . . 71.209999999999994 109.308 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.524 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.5 OUTLIER -145.18 151.13 37.95 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.127 . . . . 53.240000000000002 109.634 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.834 ' HE1' ' CD1' ' A' ' 194' ' ' ILE . 2.1 p-80 -156.39 146.51 21.3 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 72.200000000000003 109.612 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.477 ' C ' ' N ' ' A' ' 191' ' ' GLU . 3.9 t-20 51.18 22.43 1.32 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 74.519999999999996 109.317 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.44 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.1 p 39.06 30.01 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.49 1.119 . . . . 74.129999999999995 108.229 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.551 ' O ' HG13 ' A' ' 209' ' ' VAL . 11.6 tt0 -134.18 -40.39 0.83 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.542 1.151 . . . . 74.319999999999993 110.361 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.933 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 97.2 m95 -105.61 127.7 53.2 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.987 -1.116 . . . . 70.209999999999994 107.987 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.742 ' CE2' HG12 ' A' ' 209' ' ' VAL . 16.9 m-30 -125.14 130.08 51.46 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.387 1.054 . . . . 75.209999999999994 111.02 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.978 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 1.5 mp -88.81 110.81 21.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.51 1.132 . . . . 74.409999999999997 109.358 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.527 ' HB2' HG13 ' A' ' 184' ' ' ILE . . . -118.87 177.38 4.87 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.489 1.118 . . . . 52.439999999999998 109.322 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.463 ' CD ' ' HD2' ' A' ' 197' ' ' PRO . 4.6 tptm -124.89 140.26 35.35 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.467 1.104 . . . . 71.310000000000002 109.333 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.463 ' HD2' ' CD ' ' A' ' 196' ' ' LYS . 18.1 Cg_endo . . . . . 0 C--N 1.36 1.171 0 O-C-N 124.5 1.79 . . . . 74.099999999999994 110.982 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.507 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.53 0.972 0 N-CA-C 111.015 -0.834 . . . . 60.140000000000001 111.015 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.507 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.2 Cg_endo -75.01 146.15 85.87 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.039 -2.484 . . . . 64.129999999999995 111.026 0.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.608 ' HA3' HD23 ' A' ' 174' ' ' LEU . . . -109.36 177.64 20.23 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.525 1.141 . . . . 71.140000000000001 111.01 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.933 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -97.97 147.2 24.73 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.463 0.743 . . . . 53.219999999999999 109.347 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.698 HG11 HD22 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -155.01 125.57 3.41 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 124.525 1.14 . . . . 60.119999999999997 109.315 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.844 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.4 Cg_endo -75.02 176.77 9.48 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.529 1.805 . . . . 60.200000000000003 111.076 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.742 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.6 m -96.85 5.33 8.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.587 1.179 . . . . 53.109999999999999 109.332 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -108.89 6.44 32.87 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.537 1.148 . . . . 70.540000000000006 111.024 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.6 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 11.6 m-85 -139.64 12.18 2.51 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.439 0.729 . . . . 74.25 111.043 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 208' ' ' PRO . 11.4 m -154.39 157.7 4.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.483 1.114 . . . . 73.310000000000002 109.317 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.541 ' HB2' HD11 ' A' ' 163' ' ' LEU . 22.5 t -129.62 124.17 33.07 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.494 1.121 . . . . 75.319999999999993 110.042 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.586 ' C ' HG22 ' A' ' 215' ' ' ILE . 3.4 mm -78.08 149.95 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.496 1.122 . . . . 72.129999999999995 109.35 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.586 HG22 ' C ' ' A' ' 214' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 71.530000000000001 109.251 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 229' ' ' GLU . 6.2 t0 . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 109.266 -0.642 . . . . 62.100000000000001 109.266 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.736 HG21 ' HE2' ' A' ' 193' ' ' PHE . 0.6 OUTLIER -44.28 -44.53 2.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.495 1.122 . . . . 64.530000000000001 109.311 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.812 ' HA ' HD12 ' A' ' 231' ' ' ILE . 29.4 mt -58.21 -41.49 81.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 73.540000000000006 109.342 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 226' ' ' ASP . 14.6 mt-10 -69.34 -17.53 63.71 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.559 1.162 . . . . 54.350000000000001 110.351 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.94 -16.4 31.89 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.543 1.152 . . . . 74.239999999999995 109.252 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.812 HD12 ' HA ' ' A' ' 228' ' ' ILE . 2.5 mt -71.39 -69.37 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.57 1.169 . . . . 74.239999999999995 109.279 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.505 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -58.97 -21.23 58.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 72.25 109.278 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.6 -56.51 13.12 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.131 . . . . 64.109999999999999 109.97 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.1 m -97.92 19.11 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.447 1.092 . . . . 72.129999999999995 109.295 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 40.82 31.47 0.12 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.458 1.099 . . . . 63.329999999999998 109.282 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.23 124.01 78.53 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 63.240000000000002 109.29 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 -179.62 5.18 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.46 1.769 . . . . 71.230000000000004 110.947 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 239' ' ' VAL . 1.3 m -69.45 -173.51 0.57 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.523 1.139 . . . . 74.030000000000001 110.416 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.586 HG12 ' HB1' ' A' ' 186' ' ' ALA . 1.2 m -78.45 -38.05 22.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.469 1.106 . . . . 65.319999999999993 109.33 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.421 ' HG3' ' CG2' ' A' ' 239' ' ' VAL . 0.4 OUTLIER -81.51 -15.39 55.06 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.435 1.085 . . . . 73.209999999999994 110.283 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -83.89 -38.81 20.64 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.443 1.09 . . . . 74.450000000000003 110.319 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.669 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 0.3 OUTLIER -83.73 -63.06 1.42 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.966 -1.124 . . . . 73.409999999999997 107.966 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.568 ' NZ ' ' CG ' ' B' ' 470' ' ' PHE . 13.2 mtmt -51.36 -22.49 2.95 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.571 1.169 . . . . 73.209999999999994 109.285 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.532 1.145 . . . . 71.409999999999997 110.017 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 470' ' ' PHE . . . . . 0.568 ' CG ' ' NZ ' ' A' ' 243' ' ' LYS . 5.5 m-30 . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.486 0.184 . . . . 74.400000000000006 110.968 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 471' ' ' ILE . . . . . 0.708 HG23 ' HD2' ' B' ' 472' ' ' PRO . 19.2 mm -91.83 142.38 26.51 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.486 1.116 . . . . 65.109999999999999 109.262 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 472' ' ' PRO . . . . . 0.708 ' HD2' HG23 ' B' ' 471' ' ' ILE . 18.4 Cg_endo -75.07 156.65 42.71 Favored 'Trans proline' 0 C--N 1.361 1.236 0 O-C-N 124.486 1.782 . . . . 71.540000000000006 111.027 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 19.1 t -99.43 -44.15 6.29 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.513 1.133 . . . . 61.119999999999997 110.046 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -102.17 167.94 9.71 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 72.129999999999995 110.348 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.95 -168.28 0.5 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.456 1.766 . . . . 62.409999999999997 110.997 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 476' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' B' ' 477' ' ' PRO . . . -59.03 140.29 87.1 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.51 1.131 . . . . 43.450000000000003 109.307 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 477' ' ' PRO . . . . . 0.619 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -75.09 -162.12 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.545 1.813 . . . . 74.200000000000003 111.027 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.74 87.93 11.01 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.573 1.17 . . . . 44.310000000000002 109.277 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 479' ' ' PRO . . . . . 0.6 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.3 Cg_endo -75.03 169.59 22.27 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.419 1.747 . . . . 64.510000000000005 110.986 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 C--N 1.36 1.149 0 O-C-N 124.485 1.781 . . . . 61.32 111.008 179.966 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.702 ' CE2' ' CE1' ' A' ' 183' ' ' PHE . 5.6 m-30 . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.548 0.213 . . . . 71.430000000000007 110.972 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.742 ' HB3' ' CD2' ' A' ' 182' ' ' LEU . . . -124.31 145.63 49.29 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.489 1.118 . . . . 72.5 109.282 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.498 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -123.32 127.36 74.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.496 1.123 . . . . 72.140000000000001 109.322 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.915 HG22 HG12 ' A' ' 212' ' ' VAL . 1.1 t -82.57 118.03 29.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 124.512 1.132 . . . . 72.019999999999996 109.248 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.66 HD11 ' OG ' ' A' ' 213' ' ' SER . 1.7 mt -92.32 -16.21 26.35 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.523 1.139 . . . . 73.549999999999997 109.255 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.653 ' O ' HG13 ' A' ' 162' ' ' VAL . 3.0 m-85 -145.94 158.51 43.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.437 1.085 . . . . 73.239999999999995 111.058 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.817 ' N ' HG12 ' A' ' 178' ' ' VAL . 0.6 OUTLIER -96.77 159.4 14.94 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.476 1.11 . . . . 71.310000000000002 109.321 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.57 ' HB2' ' CE2' ' A' ' 211' ' ' PHE . 28.3 t80 -160.63 131.81 5.63 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.554 1.159 . . . . 71.040000000000006 111.033 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -67.34 129.33 39.55 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.463 1.102 . . . . 72.340000000000003 109.305 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.854 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -107.28 141.13 39.1 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.442 1.089 . . . . 73.409999999999997 109.332 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -149.7 22.38 0.9 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.539 1.149 . . . . 73.25 110.315 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.562 ' HE3' ' CZ3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -99.88 -175.91 3.1 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.43 1.081 . . . . 75.510000000000005 109.282 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.25 -28.88 67.12 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.491 1.119 . . . . 64.530000000000001 109.336 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.461 ' CB ' ' HB2' ' A' ' 206' ' ' LEU . 76.1 m-20 -108.46 20.05 19.06 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.498 1.124 . . . . 73.319999999999993 109.282 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.854 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 8.0 pt-20 -38.02 106.33 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.395 1.059 . . . . 75.299999999999997 110.304 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.696 HD22 ' HA3' ' A' ' 205' ' ' GLY . 4.2 tp -124.39 113.7 18.53 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.522 1.139 . . . . 73.430000000000007 109.307 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 175' ' ' THR . 12.1 t -89.06 111.36 22.07 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.471 1.107 . . . . 70.140000000000001 110.427 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.481 HG22 ' HG3' ' A' ' 180' ' ' GLU . 59.2 m -128.87 142.76 50.86 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.473 1.108 . . . . 64.120000000000005 110.401 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -83.48 162.33 20.98 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.548 1.155 . . . . 72.430000000000007 110.945 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.817 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.4 m -60.37 158.24 2.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.488 1.117 . . . . 65.340000000000003 109.245 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.4 48.22 60.58 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.555 1.159 . . . . 72.329999999999998 110.979 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.498 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 11.9 mm-40 -105.07 168.51 9.01 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 0.766 . . . . 75.450000000000003 110.32 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -128.0 117.13 21.14 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.454 1.096 . . . . 70.319999999999993 109.312 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.784 ' N ' HD13 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -134.89 146.89 49.64 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.521 1.138 . . . . 70.120000000000005 109.294 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.702 ' CE1' ' CE2' ' A' ' 159' ' ' TYR . 9.8 m-30 -100.21 116.82 33.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.472 1.107 . . . . 72.329999999999998 111.035 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 1.043 HD13 ' HB2' ' A' ' 195' ' ' ALA . 14.1 mm -59.52 151.04 5.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.579 1.175 . . . . 73.5 109.359 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.559 ' O ' ' CZ3' ' A' ' 242' ' ' TRP . 2.8 m -133.83 -46.53 0.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.525 1.141 . . . . 75.140000000000001 108.303 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.869 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -127.63 174.07 9.37 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.506 1.129 . . . . 74.329999999999998 109.348 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -157.06 141.59 16.68 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 1.114 . . . . 73.239999999999995 109.636 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.599 ' CD2' ' HD3' ' B' ' 472' ' ' PRO . 0.1 OUTLIER -143.21 139.35 30.23 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.458 1.099 . . . . 74.109999999999999 109.552 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.466 ' C ' ' N ' ' A' ' 191' ' ' GLU . 27.6 t-20 50.83 22.7 1.21 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.508 1.13 . . . . 61.039999999999999 109.345 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.402 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.8 m 41.54 29.02 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.475 1.109 . . . . 72.5 108.239 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.94 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 18.2 tt0 -127.59 -38.74 1.88 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.436 1.085 . . . . 54.329999999999998 110.309 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.67 ' CE3' HD21 ' A' ' 206' ' ' LEU . 96.3 m95 -112.21 125.19 53.88 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.519 1.137 . . . . 72.049999999999997 108.017 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.877 ' HB3' HD12 ' A' ' 184' ' ' ILE . 19.1 m-30 -115.15 150.69 35.65 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.498 1.124 . . . . 75.129999999999995 111.028 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.869 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 14.8 mm -112.16 91.24 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.557 1.161 . . . . 74.420000000000002 109.327 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 1.043 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -94.75 -175.24 3.52 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.514 1.134 . . . . 71.310000000000002 109.35 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.481 ' CG ' ' SG ' ' A' ' 185' ' ' CYS . 0.0 OUTLIER -156.42 158.19 31.36 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.556 1.16 . . . . 61.119999999999997 109.249 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.145 0 O-C-N 124.491 1.785 . . . . 65.530000000000001 110.987 -179.981 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.417 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . . . . . . 0 CA--C 1.53 0.991 0 N-CA-C 110.992 -0.843 . . . . 74.329999999999998 110.992 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.511 ' HB2' HG22 ' A' ' 194' ' ' ILE . 18.2 Cg_endo -75.03 127.29 14.17 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.024 -2.49 . . . . 72.310000000000002 110.962 0.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.696 ' HA3' HD22 ' A' ' 174' ' ' LEU . . . -97.65 145.75 17.95 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.573 1.17 . . . . 72.219999999999999 111.021 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.67 HD21 ' CE3' ' A' ' 192' ' ' TRP . 0.3 OUTLIER -92.32 146.65 23.53 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.562 0.801 . . . . 70.450000000000003 109.351 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.759 ' CG1' HG11 ' A' ' 212' ' ' VAL . 0.4 OUTLIER -160.31 131.02 3.67 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.522 1.139 . . . . 74.329999999999998 109.275 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 191' ' ' GLU . 18.2 Cg_endo -75.06 168.5 24.67 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.471 1.774 . . . . 60.130000000000003 110.967 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.637 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.9 OUTLIER -89.27 2.52 6.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.479 1.112 . . . . 75.310000000000002 109.228 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -101.76 -5.96 50.28 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.557 1.16 . . . . 72.109999999999999 110.951 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.625 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 12.0 m-85 -125.22 1.0 7.82 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 0.774 . . . . 72.329999999999998 111.013 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.915 HG12 HG22 ' A' ' 162' ' ' VAL . 1.3 m -142.63 160.85 18.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.407 1.067 . . . . 74.349999999999994 109.346 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.66 ' OG ' HD11 ' A' ' 163' ' ' LEU . 3.9 m -125.25 138.34 54.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.581 1.176 . . . . 72.519999999999996 110.015 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.809 ' O ' HG23 ' A' ' 215' ' ' ILE . 3.5 mm -78.77 147.34 6.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.473 1.108 . . . . 74.299999999999997 109.246 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.809 HG23 ' O ' ' A' ' 214' ' ' ILE . 7.6 pt . . . . . 0 C--N 1.325 -0.488 0 O-C-N 124.442 1.089 . . . . 74.150000000000006 109.287 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.245 -0.65 . . . . 64.010000000000005 109.245 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.446 ' O ' HD12 ' A' ' 231' ' ' ILE . 0.4 OUTLIER -42.94 -48.51 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.514 1.134 . . . . 73.439999999999998 109.246 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 231' ' ' ILE . 2.6 mp -60.21 -58.12 8.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.48 1.112 . . . . 61.130000000000003 109.257 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 233' ' ' SER . 7.5 mt-10 -46.12 -26.52 0.77 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.525 1.14 . . . . 75.209999999999994 110.337 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.616 ' O ' HG13 ' A' ' 234' ' ' VAL . 9.9 t0 -77.09 -37.85 53.54 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 62.200000000000003 109.261 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.499 ' N ' ' O ' ' A' ' 228' ' ' ILE . 0.6 OUTLIER -59.54 -60.26 2.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.544 1.153 . . . . 64.049999999999997 109.272 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' A' ' 228' ' ' ILE . 0.0 OUTLIER -62.65 -44.56 95.95 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.508 1.13 . . . . 71.150000000000006 109.329 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 229' ' ' GLU . 1.5 m -41.15 -60.03 1.34 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.489 1.118 . . . . 64.239999999999995 109.982 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.616 HG13 ' O ' ' A' ' 230' ' ' ASP . 1.5 m -73.32 -22.49 19.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.478 1.111 . . . . 74.109999999999999 109.3 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 234' ' ' VAL . 5.7 m120 79.09 28.43 0.39 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.503 1.127 . . . . 71.200000000000003 109.29 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.479 HD12 ' HD2' ' A' ' 237' ' ' PRO . 3.4 tp -66.44 125.93 91.26 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.51 1.131 . . . . 71.219999999999999 109.287 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.479 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.5 Cg_endo -74.94 161.08 39.52 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.43 1.753 . . . . 62.039999999999999 111.057 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 239' ' ' VAL . 1.8 m -60.25 178.49 0.19 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.539 1.149 . . . . 54.329999999999998 110.329 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.635 HG13 ' HG3' ' A' ' 240' ' ' GLN . 14.6 p -72.59 -37.83 57.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.506 1.129 . . . . 63.450000000000003 109.287 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.635 ' HG3' HG13 ' A' ' 239' ' ' VAL . 2.3 mt-30 -79.99 -22.54 42.41 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.543 1.152 . . . . 74.230000000000004 110.268 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -82.97 -43.2 16.69 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.431 1.082 . . . . 72.439999999999998 110.306 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.559 ' CZ3' ' O ' ' A' ' 185' ' ' CYS . 9.4 t90 -70.59 -58.79 3.31 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.139 . . . . 75.010000000000005 108.002 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.464 ' NZ ' HG22 ' A' ' 239' ' ' VAL . 9.6 mtmm -56.19 -18.98 11.75 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.555 1.159 . . . . 55.530000000000001 109.292 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 C--N 1.325 -0.478 0 O-C-N 124.437 1.085 . . . . 71.409999999999997 109.993 -179.961 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 470' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.487 0.184 . . . . 70.340000000000003 111.004 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 471' ' ' ILE . . . . . 0.722 HG23 ' HD2' ' B' ' 472' ' ' PRO . 27.6 mm -115.36 142.33 28.55 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.494 1.122 . . . . 63.210000000000001 109.353 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 472' ' ' PRO . . . . . 0.722 ' HD2' HG23 ' B' ' 471' ' ' ILE . 18.3 Cg_endo -75.0 127.51 10.73 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.539 1.81 . . . . 70.150000000000006 111.025 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 8.5 t -75.01 -52.87 10.02 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.446 1.091 . . . . 65.450000000000003 109.985 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 474' ' ' ARG . . . . . 0.417 ' HA ' ' NE ' ' B' ' 474' ' ' ARG . 5.2 mmp_? -82.89 160.52 60.66 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 74.420000000000002 110.338 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.01 -166.54 0.35 Allowed 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.441 1.759 . . . . 71.349999999999994 111.012 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 476' ' ' ALA . . . . . 0.94 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . -60.31 136.52 91.64 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 71.230000000000004 109.288 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 477' ' ' PRO . . . . . 0.583 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -74.92 -164.77 0.25 Allowed 'Trans proline' 0 C--N 1.359 1.105 0 O-C-N 124.507 1.793 . . . . 64.120000000000005 110.978 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 90.89 10.98 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.473 1.108 . . . . 64.400000000000006 109.326 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 479' ' ' PRO . . . . . 0.625 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.3 Cg_endo -74.99 166.15 29.83 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.519 1.8 . . . . 71.409999999999997 111.007 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.36 1.133 0 O-C-N 124.443 1.759 . . . . 72.129999999999995 110.984 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.582 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 1.1 p90 . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.488 0.185 . . . . 73.510000000000005 110.982 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.917 ' HB3' ' CD2' ' A' ' 182' ' ' LEU . . . -121.92 153.77 38.03 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.565 1.166 . . . . 71.510000000000005 109.297 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.501 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.2 OUTLIER -122.51 128.52 75.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.491 1.12 . . . . 73.439999999999998 109.318 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.714 HG22 HG12 ' A' ' 212' ' ' VAL . 0.9 OUTLIER -84.65 122.99 38.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.501 1.126 . . . . 75.319999999999993 109.324 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.579 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 0.6 OUTLIER -98.35 -13.81 20.49 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.56 1.163 . . . . 75.299999999999997 109.258 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.605 ' O ' HG13 ' A' ' 162' ' ' VAL . 4.8 m-85 -145.7 161.24 40.35 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.522 1.139 . . . . 75.239999999999995 111.004 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.811 ' N ' HG12 ' A' ' 178' ' ' VAL . 2.5 p30 -101.01 156.78 17.21 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.435 1.084 . . . . 71.140000000000001 109.277 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.603 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 1.3 t80 -153.26 131.42 11.91 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.456 1.098 . . . . 72.219999999999999 111.0 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.603 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 8.9 mtpt -67.04 124.52 23.27 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.471 1.107 . . . . 54.100000000000001 109.267 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.809 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -92.98 135.87 33.77 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.566 1.166 . . . . 61.229999999999997 109.299 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.892 ' H ' ' HZ3' ' A' ' 170' ' ' LYS . 7.8 pt-20 -150.48 20.69 0.83 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.458 1.099 . . . . 70.109999999999999 110.269 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.892 ' HZ3' ' H ' ' A' ' 169' ' ' GLU . 0.1 OUTLIER -106.19 -175.57 2.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.463 1.102 . . . . 72.549999999999997 109.333 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.62 -41.03 76.4 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.417 1.073 . . . . 64.450000000000003 109.301 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.616 ' OD1' HD12 ' A' ' 194' ' ' ILE . 72.1 m-20 -94.4 16.93 13.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.54 1.15 . . . . 45.039999999999999 109.313 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.809 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 10.5 pt-20 -36.44 97.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 72.319999999999993 110.281 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.485 ' CB ' ' HA2' ' A' ' 205' ' ' GLY . 0.0 OUTLIER -138.22 95.52 3.03 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.439 1.087 . . . . 70.120000000000005 109.339 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.2 t -59.53 153.56 19.35 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.556 1.16 . . . . 72.219999999999999 110.446 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 4.9 m -152.51 109.34 3.48 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.436 1.085 . . . . 51.439999999999998 110.425 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.516 ' O ' HG11 ' A' ' 162' ' ' VAL . 14.8 m-85 -52.11 159.14 0.96 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.513 1.133 . . . . 71.439999999999998 111.004 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.811 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.5 m -65.68 158.62 4.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.446 1.091 . . . . 74.120000000000005 109.31 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 48.41 63.12 3.91 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.479 1.112 . . . . 61.340000000000003 111.032 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.501 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 2.0 tp10 -127.99 173.13 10.3 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.526 0.78 . . . . 74.099999999999994 110.278 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -122.68 123.07 40.28 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 71.439999999999998 109.318 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.917 ' CD2' ' HB3' ' A' ' 160' ' ' ALA . 0.0 OUTLIER -130.65 135.06 47.48 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.554 1.159 . . . . 74.400000000000006 109.262 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 8.3 m-30 -89.19 96.83 10.88 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.488 1.117 . . . . 73.439999999999998 110.998 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.858 HD12 ' HB2' ' A' ' 160' ' ' ALA . 51.5 mt -64.34 153.82 7.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 73.099999999999994 109.334 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.492 ' O ' ' CD1' ' A' ' 236' ' ' LEU . 4.3 m -146.52 -44.68 0.19 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.52 1.138 . . . . 73.219999999999999 108.242 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.931 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -112.25 170.91 7.84 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.5 1.125 . . . . 73.510000000000005 109.265 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.539 ' O ' HG13 ' A' ' 239' ' ' VAL . 13.0 p-80 -156.79 165.21 36.86 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 75.140000000000001 109.687 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 1.161 ' CE1' HG11 ' A' ' 239' ' ' VAL . 0.1 OUTLIER -143.7 113.29 7.02 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.49 1.119 . . . . 52.32 109.609 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.473 ' C ' ' N ' ' A' ' 191' ' ' GLU . 88.0 m-20 50.65 41.49 25.93 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.535 1.147 . . . . 75.109999999999999 109.359 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.418 ' C ' ' O ' ' A' ' 189' ' ' ASN . 3.6 m 40.04 30.01 0.06 Allowed 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.463 1.102 . . . . 71.040000000000006 108.333 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.812 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 17.3 tt0 -118.59 -39.69 2.97 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 1.123 . . . . 61.399999999999999 110.307 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.711 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 94.9 m95 -113.14 146.58 38.98 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.532 1.145 . . . . 74.430000000000007 107.927 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.792 ' CE2' HG12 ' A' ' 209' ' ' VAL . 21.5 m-30 -132.87 128.46 36.66 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.475 1.109 . . . . 64.439999999999998 110.957 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.931 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 8.5 mm -95.71 100.5 11.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.548 1.155 . . . . 64.530000000000001 109.324 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.542 ' HB2' ' CG1' ' A' ' 184' ' ' ILE . . . -111.82 171.31 7.57 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.5 1.125 . . . . 72.129999999999995 109.333 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -134.91 148.11 65.61 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.558 1.162 . . . . 74.099999999999994 109.254 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 C--N 1.359 1.123 0 O-C-N 124.481 1.779 . . . . 61.340000000000003 111.003 179.996 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.495 ' HA3' ' C ' ' A' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.531 1.035 0 N-CA-C 111.029 -0.828 . . . . 71.129999999999995 111.029 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.495 ' C ' ' HA3' ' A' ' 203' ' ' GLY . 18.2 Cg_endo -75.02 152.99 98.89 Favored 'Cis proline' 0 C--N 1.36 1.153 0 C-N-CA 120.999 -2.501 . . . . 64.150000000000006 111.021 -0.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 195' ' ' ALA . . . -88.07 158.79 29.51 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.434 1.084 . . . . 42.130000000000003 110.979 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.711 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -104.55 143.96 32.34 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.466 0.745 . . . . 62.109999999999999 109.274 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.771 ' CG1' HG11 ' A' ' 212' ' ' VAL . 0.3 OUTLIER -154.44 135.33 8.63 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.461 1.1 . . . . 75.219999999999999 109.296 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 191' ' ' GLU . 18.2 Cg_endo -74.98 174.36 12.92 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.549 1.816 . . . . 50.450000000000003 110.992 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.792 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -93.36 7.57 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.437 1.086 . . . . 74.439999999999998 109.332 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -108.47 -6.85 30.83 Favored Glycine 0 CA--C 1.529 0.929 0 O-C-N 124.485 1.116 . . . . 52.219999999999999 111.006 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.635 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 5.8 m-85 -121.31 1.64 10.22 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.45 0.735 . . . . 63.25 111.003 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.771 HG11 ' CG1' ' A' ' 207' ' ' VAL . 1.2 m -141.7 166.32 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.552 1.158 . . . . 74.420000000000002 109.226 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.1 t -134.76 134.14 40.64 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 42.32 110.042 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 215' ' ' ILE . 3.4 mm -65.29 138.5 23.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.53 1.144 . . . . 74.420000000000002 109.276 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.552 ' CD1' ' CE2' ' A' ' 159' ' ' TYR . 4.1 pt . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.524 1.14 . . . . 64.150000000000006 109.324 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 229' ' ' GLU . 11.7 t0 . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 109.218 -0.66 . . . . 73.540000000000006 109.218 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -43.81 -44.59 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.528 1.143 . . . . 74.019999999999996 109.265 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.884 ' HA ' HD12 ' A' ' 231' ' ' ILE . 6.7 mt -66.22 -39.95 85.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 70.219999999999999 109.295 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.463 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 18.6 mt-10 -71.82 -18.04 62.11 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.443 1.09 . . . . 63.030000000000001 110.318 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 226' ' ' ASP . 11.3 t70 -88.79 -15.73 33.87 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.135 . . . . 71.109999999999999 109.326 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.884 HD12 ' HA ' ' A' ' 228' ' ' ILE . 4.7 mt -72.68 -69.59 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.518 1.136 . . . . 64.010000000000005 109.281 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.463 ' CD ' ' HA ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -53.29 -31.71 45.17 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.44 1.087 . . . . 72.319999999999993 109.33 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.421 ' N ' ' HG2' ' A' ' 232' ' ' LYS . 1.5 m -41.01 -61.06 1.05 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.53 1.144 . . . . 50.049999999999997 110.001 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.486 ' O ' ' CB ' ' A' ' 235' ' ' ASN . 1.4 m -74.96 -20.46 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.491 1.119 . . . . 74.349999999999994 109.315 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 234' ' ' VAL . 16.6 t-20 80.74 29.11 0.2 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.474 1.109 . . . . 73.439999999999998 109.272 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.591 HD23 ' O ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER -72.99 119.43 75.52 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.467 1.104 . . . . 73.340000000000003 109.31 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.93 -174.02 1.77 Allowed 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.559 1.82 . . . . 74.219999999999999 111.064 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.429 HG22 ' H ' ' A' ' 239' ' ' VAL . 1.4 m -73.57 -179.92 3.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.443 1.089 . . . . 73.349999999999994 110.407 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 1.161 HG11 ' CE1' ' A' ' 188' ' ' HIS . 1.0 OUTLIER -69.98 -50.75 45.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.528 1.142 . . . . 73.400000000000006 109.282 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.522 ' N ' ' CG2' ' A' ' 239' ' ' VAL . 0.1 OUTLIER -69.45 -15.3 63.25 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.371 1.044 . . . . 72.219999999999999 110.305 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -89.66 -37.47 14.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.55 1.156 . . . . 73.019999999999996 110.281 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.488 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 1.2 t90 -85.54 -62.5 1.51 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.529 1.143 . . . . 61.020000000000003 108.036 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.514 ' HE2' ' CG ' ' B' ' 470' ' ' PHE . 17.6 mtpp -50.67 -24.2 3.17 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.481 1.113 . . . . 74.319999999999993 109.268 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.501 0 O-C-N 124.532 1.145 . . . . 73.120000000000005 109.971 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 470' ' ' PHE . . . . . 0.514 ' CG ' ' HE2' ' A' ' 243' ' ' LYS . 6.0 m-30 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.484 0.183 . . . . 73.120000000000005 111.008 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 471' ' ' ILE . . . . . 0.48 ' CG2' ' HD2' ' B' ' 472' ' ' PRO . 27.0 mm -66.63 140.2 96.32 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.152 . . . . 75.519999999999996 109.293 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 472' ' ' PRO . . . . . 0.48 ' HD2' ' CG2' ' B' ' 471' ' ' ILE . 18.3 Cg_endo -74.92 173.65 14.11 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.492 1.785 . . . . 73.540000000000006 111.013 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 81.8 p -103.56 -47.36 4.28 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.482 1.114 . . . . 34.219999999999999 109.998 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 474' ' ' ARG . . . . . 0.401 ' NE ' ' HA ' ' B' ' 474' ' ' ARG . 11.5 mmp_? -92.94 159.36 35.95 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.61 1.194 . . . . 65.329999999999998 110.319 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 475' ' ' PRO . . . . . 0.583 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.3 Cg_endo -74.99 -38.68 1.48 Allowed 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.486 1.782 . . . . 63.539999999999999 110.965 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 476' ' ' ALA . . . . . 0.812 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . 171.2 128.39 0.06 OUTLIER Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.531 1.144 . . . . 72.030000000000001 109.319 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 477' ' ' PRO . . . . . 0.575 ' HD3' ' CH2' ' A' ' 192' ' ' TRP . 18.2 Cg_endo -75.0 -161.77 0.13 Allowed 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.457 1.767 . . . . 61.329999999999998 110.978 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 478' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -139.92 107.14 6.89 Favored Pre-proline 0 C--N 1.324 -0.529 0 O-C-N 124.497 1.123 . . . . 74.420000000000002 109.329 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 479' ' ' PRO . . . . . 0.635 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.98 162.5 37.07 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.49 1.784 . . . . 44.140000000000001 111.027 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.153 0 O-C-N 124.476 1.777 . . . . 70.540000000000006 110.932 179.998 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.598 ' CZ ' ' CD2' ' A' ' 183' ' ' PHE . 9.2 m-85 . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 120.575 0.226 . . . . 74.409999999999997 110.941 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.938 ' HB3' ' CD2' ' A' ' 182' ' ' LEU . . . -132.1 130.71 41.58 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.458 1.099 . . . . 71.310000000000002 109.252 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.948 HG21 HD11 ' A' ' 215' ' ' ILE . 0.1 OUTLIER -107.96 118.29 55.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.487 1.117 . . . . 64.420000000000002 109.265 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 1.033 ' CG1' HD11 ' A' ' 182' ' ' LEU . 0.6 OUTLIER -84.15 123.26 38.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 74.230000000000004 109.251 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.441 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 0.3 OUTLIER -98.78 -11.61 21.69 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 74.329999999999998 109.392 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.441 ' CE2' ' HB2' ' A' ' 163' ' ' LEU . 8.4 m-85 -140.89 162.19 36.03 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.541 1.15 . . . . 74.400000000000006 111.01 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.822 ' N ' HG12 ' A' ' 178' ' ' VAL . 1.1 p30 -93.29 160.14 14.96 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.501 1.126 . . . . 42.200000000000003 109.273 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.677 ' HZ ' ' HZ1' ' A' ' 170' ' ' LYS . 28.3 t80 -157.2 133.27 9.58 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.458 1.099 . . . . 74.420000000000002 110.954 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -79.45 123.6 27.68 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.533 1.145 . . . . 75.25 109.287 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.852 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -96.68 142.08 29.14 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.453 1.096 . . . . 74.430000000000007 109.326 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -153.73 22.67 0.52 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.406 1.066 . . . . 75.450000000000003 110.253 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.677 ' HZ1' ' HZ ' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -102.75 -176.35 3.07 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.571 1.169 . . . . 62.439999999999998 109.267 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.89 -28.89 67.95 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.465 1.103 . . . . 71.510000000000005 109.284 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 173' ' ' GLU . 15.2 m-20 -105.8 16.07 25.78 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.463 1.102 . . . . 73.209999999999994 109.258 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.852 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 5.3 pt-20 -36.27 105.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.54 1.15 . . . . 75.230000000000004 110.326 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 173' ' ' GLU . 0.2 OUTLIER -141.59 95.04 2.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 55.229999999999997 109.281 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.2 t -62.86 153.16 34.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 72.150000000000006 110.434 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 81.8 m -152.91 110.75 3.6 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.554 1.159 . . . . 64.450000000000003 110.37 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -53.39 156.76 2.28 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.507 1.129 . . . . 61.130000000000003 110.991 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.822 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.5 m -58.21 158.19 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.431 1.082 . . . . 71.349999999999994 109.327 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.31 72.41 0.49 Allowed Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.568 1.168 . . . . 31.210000000000001 110.957 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.566 ' N ' HG22 ' A' ' 162' ' ' VAL . 1.2 tt0 -137.19 168.12 20.24 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.507 0.769 . . . . 64.450000000000003 110.354 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.483 ' C ' HD13 ' A' ' 182' ' ' LEU . 0.2 OUTLIER -134.07 124.52 26.33 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.521 1.138 . . . . 72.0 109.293 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 1.033 HD11 ' CG1' ' A' ' 162' ' ' VAL . 0.0 OUTLIER -128.58 162.47 27.21 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.582 1.176 . . . . 73.219999999999999 109.258 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.598 ' CD2' ' CZ ' ' A' ' 159' ' ' TYR . 0.9 OUTLIER -104.75 105.35 15.39 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.594 1.184 . . . . 75.019999999999996 110.972 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.967 HD13 ' HB2' ' A' ' 195' ' ' ALA . 45.3 mm -59.05 163.81 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.599 1.187 . . . . 60.509999999999998 109.32 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.47 ' N ' HG22 ' A' ' 184' ' ' ILE . 5.0 m -149.08 -45.41 0.14 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.478 1.111 . . . . 73.120000000000005 108.214 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 1.028 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -123.35 169.94 10.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.418 1.074 . . . . 74.420000000000002 109.34 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.563 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 1.2 p-80 -155.15 143.95 20.7 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.444 1.09 . . . . 72.319999999999993 109.634 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.554 ' CE1' ' HD3' ' B' ' 472' ' ' PRO . 0.2 OUTLIER -145.04 138.46 26.74 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 73.230000000000004 109.593 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.488 ' C ' ' N ' ' A' ' 191' ' ' GLU . 20.2 t-20 49.84 23.46 1.04 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.534 1.146 . . . . 73.329999999999998 109.284 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.53 ' HB3' HD13 ' A' ' 231' ' ' ILE . 6.4 m 40.74 28.9 0.06 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.46 1.1 . . . . 70.510000000000005 108.327 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.636 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 12.0 tt0 -124.34 -35.19 2.81 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 124.529 1.143 . . . . 72.329999999999998 110.283 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.595 ' CE3' HD21 ' A' ' 206' ' ' LEU . 95.1 m95 -118.36 133.22 56.06 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.512 1.132 . . . . 74.239999999999995 108.047 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.864 ' HB3' HD12 ' A' ' 184' ' ' ILE . 23.1 m-30 -123.48 144.3 49.61 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.548 1.155 . . . . 74.540000000000006 111.016 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 1.028 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 1.2 mp -101.78 96.15 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 124.457 1.098 . . . . 75.140000000000001 109.278 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.967 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -103.65 -178.81 3.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.45 1.093 . . . . 73.129999999999995 109.288 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -150.17 157.51 37.25 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 75.019999999999996 109.296 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 C--N 1.361 1.185 0 O-C-N 124.446 1.761 . . . . 75.450000000000003 110.966 179.991 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.983 0 N-CA-C 111.018 -0.833 . . . . 71.540000000000006 111.018 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.538 ' HG2' ' CZ ' ' B' ' 470' ' ' PHE . 18.2 Cg_endo -75.06 143.41 77.67 Favored 'Cis proline' 0 C--N 1.36 1.133 0 C-N-CA 120.954 -2.519 . . . . 75.209999999999994 110.988 0.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.491 ' CA ' ' HG ' ' A' ' 174' ' ' LEU . . . -106.0 140.71 15.25 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.481 1.113 . . . . 64.219999999999999 111.038 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.595 HD21 ' CE3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -89.57 145.02 25.56 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.487 0.757 . . . . 74.140000000000001 109.303 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.411 ' N ' ' HG ' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -153.29 132.69 7.11 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.47 1.106 . . . . 75.019999999999996 109.291 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.617 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.1 Cg_endo -75.06 176.29 10.12 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.46 1.768 . . . . 73.519999999999996 111.017 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.883 ' HB ' HG21 ' A' ' 227' ' ' VAL . 0.8 OUTLIER -98.17 -5.11 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.494 1.121 . . . . 64.219999999999999 109.298 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 210' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' B' ' 479' ' ' PRO . . . -90.73 -14.06 58.64 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.507 1.129 . . . . 65.349999999999994 110.948 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.609 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 15.6 m-85 -122.38 12.98 10.21 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.453 0.737 . . . . 75.099999999999994 110.939 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 208' ' ' PRO . 1.0 OUTLIER -152.45 160.14 3.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.424 1.077 . . . . 72.510000000000005 109.321 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.5 t -123.91 122.82 38.97 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.52 1.138 . . . . 74.040000000000006 109.997 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.835 ' O ' HG23 ' A' ' 215' ' ' ILE . 4.0 mm -62.97 104.18 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.528 1.142 . . . . 70.129999999999995 109.346 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.948 HD11 HG21 ' A' ' 161' ' ' ILE . 3.1 pt . . . . . 0 C--N 1.324 -0.519 0 O-C-N 124.497 1.123 . . . . 64.310000000000002 109.262 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 229' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 109.301 -0.629 . . . . 73.150000000000006 109.301 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.883 HG21 ' HB ' ' A' ' 209' ' ' VAL . 13.8 p -42.63 -48.59 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.483 1.114 . . . . 53.509999999999998 109.306 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.582 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.3 mp -61.7 -40.59 87.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.466 1.103 . . . . 72.239999999999995 109.273 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.458 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 19.4 mt-10 -67.99 -17.65 64.49 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.555 1.159 . . . . 54.119999999999997 110.303 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.65 ' HB3' HG21 ' A' ' 214' ' ' ILE . 13.2 m-20 -88.84 -15.7 33.85 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.54 1.15 . . . . 64.299999999999997 109.312 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 228' ' ' ILE . 1.9 mt -77.13 -69.61 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.439 1.087 . . . . 74.340000000000003 109.311 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.497 ' CE ' ' O ' ' A' ' 228' ' ' ILE . 0.0 OUTLIER -62.37 -16.29 53.68 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.587 1.179 . . . . 63.299999999999997 109.297 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.74 -21.49 2.8 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.488 1.118 . . . . 61.409999999999997 109.984 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 234' ' ' VAL . 1.0 OUTLIER -138.54 28.39 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.468 1.105 . . . . 74.319999999999993 109.275 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 235' ' ' ASN . . . . . 0.409 ' C ' ' O ' ' A' ' 234' ' ' VAL . 6.6 m120 39.83 44.69 1.39 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.564 1.165 . . . . 64.140000000000001 109.275 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' A' ' 187' ' ' HIS . 4.1 tp -74.4 119.47 76.67 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.491 1.12 . . . . 62.0 109.317 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.06 162.29 37.23 Favored 'Trans proline' 0 C--N 1.361 1.208 0 O-C-N 124.46 1.768 . . . . 63.539999999999999 110.995 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.43 ' N ' ' HB2' ' A' ' 241' ' ' GLU . 1.6 m -59.75 159.6 8.56 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.483 1.114 . . . . 74.319999999999993 110.442 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.591 HG13 ' H ' ' A' ' 240' ' ' GLN . 6.4 p -52.5 -59.43 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.564 1.165 . . . . 74.209999999999994 109.332 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.591 ' H ' HG13 ' A' ' 239' ' ' VAL . 0.0 OUTLIER -65.32 -15.98 63.11 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.55 1.156 . . . . 43.43 110.291 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.43 ' HB2' ' N ' ' A' ' 238' ' ' THR . 14.8 mm-40 -80.55 -37.69 30.98 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.536 1.148 . . . . 73.219999999999999 110.329 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.693 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 0.3 OUTLIER -82.77 -57.15 3.44 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.511 1.132 . . . . 73.430000000000007 108.006 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.584 ' HD2' ' CD2' ' B' ' 470' ' ' PHE . 19.6 mtpp -58.33 -18.28 26.15 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.518 1.136 . . . . 64.209999999999994 109.312 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.517 0 O-C-N 124.492 1.12 . . . . 51.130000000000003 110.017 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 470' ' ' PHE . . . . . 0.584 ' CD2' ' HD2' ' A' ' 243' ' ' LYS . 4.8 m-30 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 120.42 0.152 . . . . 53.310000000000002 110.98 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 471' ' ' ILE . . . . . 0.571 ' N ' HD13 ' B' ' 471' ' ' ILE . 3.1 mm -67.63 140.01 94.26 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.567 1.167 . . . . 75.299999999999997 109.296 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 472' ' ' PRO . . . . . 0.554 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.97 -174.37 1.9 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.487 1.783 . . . . 74.120000000000005 110.987 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.56 14.62 4.47 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.523 1.139 . . . . 64.030000000000001 109.994 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -143.21 159.32 56.06 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.516 1.135 . . . . 75.409999999999997 110.379 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 475' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.2 Cg_endo -74.97 -53.22 0.1 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 O-C-N 124.551 1.817 . . . . 70.129999999999995 111.013 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 476' ' ' ALA . . . . . 0.636 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . 179.19 140.73 0.28 Allowed Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.482 1.113 . . . . 73.530000000000001 109.286 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 477' ' ' PRO . . . . . 0.571 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -74.96 -162.35 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.45 1.763 . . . . 75.519999999999996 110.991 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.5 90.93 22.85 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.545 1.153 . . . . 61.140000000000001 109.289 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 479' ' ' PRO . . . . . 0.609 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.92 144.32 30.42 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.559 1.821 . . . . 73.239999999999995 110.994 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.163 0 O-C-N 124.472 1.775 . . . . 71.400000000000006 111.054 179.925 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 8.7 m-85 . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.55 0.214 . . . . 53.240000000000002 110.957 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 182' ' ' LEU . . . -120.53 148.81 43.36 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.475 1.109 . . . . 74.239999999999995 109.37 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.622 HG21 HD11 ' A' ' 215' ' ' ILE . 0.1 OUTLIER -132.8 134.13 58.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.512 1.132 . . . . 71.329999999999998 109.31 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.978 HG22 HG12 ' A' ' 212' ' ' VAL . 2.3 t -92.92 120.93 43.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.427 1.079 . . . . 72.219999999999999 109.327 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.511 ' CD2' HG23 ' A' ' 161' ' ' ILE . 0.7 OUTLIER -97.76 -14.14 20.99 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.522 1.139 . . . . 71.140000000000001 109.331 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.676 ' O ' HG13 ' A' ' 162' ' ' VAL . 1.8 m-85 -145.48 157.72 43.96 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.419 1.074 . . . . 73.209999999999994 111.03 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.776 ' N ' HG12 ' A' ' 178' ' ' VAL . 16.8 p-10 -97.57 158.96 15.21 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.546 1.154 . . . . 74.129999999999995 109.291 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.555 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 1.6 t80 -157.89 131.3 7.7 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 71.430000000000007 111.048 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.555 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 2.9 mmpt? -67.9 123.54 20.86 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.514 1.134 . . . . 72.049999999999997 109.376 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.831 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -102.63 141.24 35.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.53 1.144 . . . . 71.129999999999995 109.293 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -151.39 21.33 0.73 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.488 1.117 . . . . 73.439999999999998 110.254 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.464 ' HZ1' ' HZ ' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -96.0 -176.3 3.65 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.118 . . . . 64.420000000000002 109.298 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.23 -22.5 64.85 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.462 1.101 . . . . 74.120000000000005 109.311 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 173' ' ' GLU . 1.5 m-20 -116.07 20.77 14.2 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.512 1.132 . . . . 74.430000000000007 109.334 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.831 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 6.9 pt-20 -38.11 109.71 0.11 Allowed 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.464 1.103 . . . . 73.420000000000002 110.295 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.696 HD13 ' HA3' ' A' ' 205' ' ' GLY . 9.6 tp -121.18 106.71 11.78 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.51 1.131 . . . . 70.319999999999993 109.308 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 175' ' ' THR . 11.2 t -81.12 107.67 14.12 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.528 1.142 . . . . 72.519999999999996 110.405 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.753 HG23 ' CD ' ' A' ' 180' ' ' GLU . 0.9 OUTLIER -129.86 142.35 50.68 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.5 1.125 . . . . 72.420000000000002 110.322 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -86.21 167.61 14.71 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.546 1.154 . . . . 74.439999999999998 110.959 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.776 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.8 m -63.19 158.16 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.503 1.127 . . . . 53.210000000000001 109.303 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 52.76 58.33 11.73 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.526 1.141 . . . . 75.150000000000006 111.033 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.753 ' CD ' HG23 ' A' ' 176' ' ' THR . 1.4 tt0 -114.14 170.69 8.1 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.461 0.742 . . . . 75.040000000000006 110.281 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -126.46 121.75 33.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.512 1.133 . . . . 74.430000000000007 109.35 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.847 ' CD1' HG21 ' A' ' 207' ' ' VAL . 1.5 pt? -142.91 140.64 31.24 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.496 1.122 . . . . 73.140000000000001 109.317 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 32.7 t80 -100.4 114.33 27.8 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.406 1.066 . . . . 74.430000000000007 111.026 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.64 HG13 ' HB2' ' A' ' 195' ' ' ALA . 19.8 mt -72.82 145.69 11.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.554 1.159 . . . . 74.420000000000002 109.288 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.618 ' O ' HD12 ' A' ' 236' ' ' LEU . 6.0 t -135.34 -41.01 0.72 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 72.030000000000001 108.275 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 1.053 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -112.87 167.46 10.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.475 1.109 . . . . 73.420000000000002 109.361 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.674 ' ND1' HD21 ' A' ' 236' ' ' LEU . 0.8 OUTLIER -156.94 155.34 31.2 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.521 1.138 . . . . 61.149999999999999 109.573 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.611 ' CD2' ' HD3' ' B' ' 472' ' ' PRO . 1.2 p-80 -158.31 142.09 15.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.416 1.072 . . . . 74.409999999999997 109.642 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.472 ' C ' ' N ' ' A' ' 191' ' ' GLU . 61.6 t30 53.07 22.93 2.72 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.133 . . . . 73.420000000000002 109.338 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.432 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.8 p 38.92 30.32 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 61.32 108.277 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.525 ' O ' HG13 ' A' ' 209' ' ' VAL . 3.1 tt0 -132.62 -39.26 1.0 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.485 1.115 . . . . 74.019999999999996 110.274 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.726 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 99.0 m95 -108.53 129.03 55.3 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.568 1.168 . . . . 74.319999999999993 108.029 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.772 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.3 m-30 -121.05 145.27 47.96 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.44 1.087 . . . . 71.120000000000005 111.018 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 1.053 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 4.2 mm -103.11 101.89 12.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.472 1.108 . . . . 54.299999999999997 109.259 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.64 ' HB2' HG13 ' A' ' 184' ' ' ILE . . . -112.23 168.97 9.19 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.43 1.081 . . . . 62.310000000000002 109.296 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.04 149.7 72.31 Favored Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.453 1.095 . . . . 74.209999999999994 109.268 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 C--N 1.361 1.202 0 O-C-N 124.444 1.76 . . . . 65.019999999999996 110.966 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.406 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . . . . . . 0 CA--C 1.529 0.931 0 N-CA-C 111.01 -0.836 . . . . 51.299999999999997 111.01 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.98 123.15 8.79 Favored 'Cis proline' 0 C--N 1.36 1.184 0 C-N-CA 120.993 -2.503 . . . . 64.120000000000005 111.013 -0.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.696 ' HA3' HD13 ' A' ' 174' ' ' LEU . . . -97.05 157.16 21.02 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.452 1.095 . . . . 54.509999999999998 111.019 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.726 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -93.65 148.51 22.04 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.536 0.786 . . . . 73.109999999999999 109.33 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.847 HG21 ' CD1' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -157.15 125.93 3.0 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.551 1.157 . . . . 71.340000000000003 109.298 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.948 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.3 Cg_endo -74.99 173.58 14.27 Favored 'Trans proline' 0 C--N 1.359 1.085 0 O-C-N 124.501 1.79 . . . . 71.010000000000005 110.977 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.772 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -94.18 6.84 6.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.522 1.139 . . . . 42.210000000000001 109.309 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 210' ' ' GLY . . . . . 0.441 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -106.18 -7.46 35.26 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.536 1.148 . . . . 72.510000000000005 111.038 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.616 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 10.7 m-85 -127.73 2.79 6.08 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.507 0.769 . . . . 61.409999999999997 110.981 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.978 HG12 HG22 ' A' ' 162' ' ' VAL . 2.6 m -143.62 162.53 16.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 73.200000000000003 109.268 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 30.5 t -132.63 142.49 49.13 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.515 1.134 . . . . 70.530000000000001 110.02 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.557 ' O ' HG23 ' A' ' 215' ' ' ILE . 4.2 mm -86.13 113.77 24.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.528 1.143 . . . . 71.0 109.301 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.622 HD11 HG21 ' A' ' 161' ' ' ILE . 25.8 pt . . . . . 0 C--N 1.325 -0.493 0 O-C-N 124.523 1.139 . . . . 63.350000000000001 109.334 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 230' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 109.316 -0.624 . . . . 54.439999999999998 109.316 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.415 ' H ' HG12 ' A' ' 227' ' ' VAL . 1.3 p -51.88 -39.67 25.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.507 1.129 . . . . 61.219999999999999 109.257 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.812 ' HA ' HD12 ' A' ' 231' ' ' ILE . 11.8 mt -71.51 -39.27 70.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.446 1.091 . . . . 74.310000000000002 109.337 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -73.24 -15.74 61.42 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.423 1.077 . . . . 75.319999999999993 110.29 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 226' ' ' ASP . 6.0 m-20 -88.55 -15.73 34.43 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.542 1.151 . . . . 74.439999999999998 109.241 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.812 HD12 ' HA ' ' A' ' 228' ' ' ILE . 3.4 mt -72.04 -69.45 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.497 1.123 . . . . 75.329999999999998 109.261 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.485 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -60.82 -17.07 47.56 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.459 1.1 . . . . 60.119999999999997 109.275 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.86 -30.09 60.94 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.468 1.105 . . . . 63.409999999999997 109.929 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.419 ' C ' ' N ' ' A' ' 236' ' ' LEU . 10.7 m -120.89 22.21 5.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.505 1.128 . . . . 65.239999999999995 109.312 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 45.74 26.52 0.36 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.545 1.153 . . . . 73.319999999999993 109.312 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.761 HD23 HG23 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -61.97 123.18 76.63 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.455 1.097 . . . . 64.109999999999999 109.304 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 -177.48 3.49 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.421 1.748 . . . . 74.349999999999994 110.993 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.581 HG22 ' H ' ' A' ' 239' ' ' VAL . 2.2 m -74.7 -171.04 1.17 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 72.329999999999998 110.388 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.618 HG13 ' N ' ' A' ' 240' ' ' GLN . 12.9 p -79.09 -58.32 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 124.522 1.139 . . . . 41.009999999999998 109.3 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.618 ' N ' HG13 ' A' ' 239' ' ' VAL . 2.0 pp0? -72.18 -10.99 60.52 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.504 1.128 . . . . 75.400000000000006 110.324 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.75 -44.51 27.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.529 1.143 . . . . 73.439999999999998 110.311 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.962 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 0.0 OUTLIER -87.31 -68.61 0.74 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.002 -1.111 . . . . 73.340000000000003 108.002 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.601 ' HD3' ' CD2' ' A' ' 242' ' ' TRP . 0.1 OUTLIER -40.95 -29.11 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.476 1.11 . . . . 54.219999999999999 109.342 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 240' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.452 0 O-C-N 124.525 1.14 . . . . 63.140000000000001 110.003 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 470' ' ' PHE . . . . . 0.527 ' CD1' ' HG2' ' A' ' 243' ' ' LYS . 86.4 m-85 . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 120.516 0.198 . . . . 73.239999999999995 110.977 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 471' ' ' ILE . . . . . 0.71 HG22 ' HD2' ' B' ' 472' ' ' PRO . 1.2 mm -98.1 142.36 24.46 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.464 1.102 . . . . 62.439999999999998 109.278 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 472' ' ' PRO . . . . . 0.71 ' HD2' HG22 ' B' ' 471' ' ' ILE . 18.4 Cg_endo -74.95 170.23 20.86 Favored 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.489 1.783 . . . . 74.420000000000002 111.029 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.86 -42.41 5.85 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.573 1.171 . . . . 73.400000000000006 110.027 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -96.34 161.1 28.11 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.127 . . . . 72.030000000000001 110.298 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 475' ' ' PRO . . . . . 0.584 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.3 Cg_endo -74.98 -34.35 3.91 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.543 1.812 . . . . 71.129999999999995 110.996 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 476' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 169.72 134.62 0.06 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.545 1.153 . . . . 63.039999999999999 109.315 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 477' ' ' PRO . . . . . 0.575 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.2 Cg_endo -74.95 -162.92 0.16 Allowed 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.513 1.796 . . . . 73.310000000000002 111.052 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 478' ' ' LYS . . . . . 0.433 ' O ' ' CD ' ' B' ' 478' ' ' LYS . 0.1 OUTLIER -133.84 91.8 24.11 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.432 1.082 . . . . 70.200000000000003 109.275 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 479' ' ' PRO . . . . . 0.616 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.1 Cg_endo -75.01 162.49 37.01 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.449 1.763 . . . . 54.25 110.986 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.361 1.185 0 O-C-N 124.41 1.742 . . . . 53.299999999999997 111.004 179.995 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.529 ' CE1' ' O ' ' A' ' 160' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.498 0.19 . . . . 63.219999999999999 110.997 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.658 ' HB2' HD12 ' A' ' 184' ' ' ILE . . . -108.93 145.09 35.99 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.495 1.122 . . . . 55.109999999999999 109.26 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.719 ' HB ' HD11 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -130.61 135.8 59.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.456 1.097 . . . . 71.420000000000002 109.279 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.957 HG22 HG12 ' A' ' 212' ' ' VAL . 2.6 t -93.03 135.39 27.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 124.475 1.11 . . . . 74.420000000000002 109.341 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.624 HD12 ' CE1' ' A' ' 164' ' ' TYR . 0.1 OUTLIER -115.25 -8.34 12.33 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.479 1.112 . . . . 64.209999999999994 109.267 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.624 ' CE1' HD12 ' A' ' 163' ' ' LEU . 0.3 OUTLIER -146.98 151.96 37.84 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.486 1.116 . . . . 63.039999999999999 110.931 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -111.17 154.72 23.96 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.514 1.134 . . . . 73.140000000000001 109.291 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.581 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 0.6 OUTLIER -160.89 168.63 24.26 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.416 1.072 . . . . 70.439999999999998 110.989 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -92.93 133.98 35.56 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.415 1.072 . . . . 73.25 109.302 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.694 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -106.0 150.96 25.22 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.543 1.152 . . . . 70.030000000000001 109.329 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -155.03 27.45 0.42 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.544 1.153 . . . . 45.340000000000003 110.275 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.58 ' HE2' ' CH2' ' A' ' 192' ' ' TRP . 0.1 OUTLIER -101.49 -176.61 3.19 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.443 1.089 . . . . 63.340000000000003 109.273 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.98 -31.01 66.49 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.481 1.113 . . . . 73.450000000000003 109.237 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 173' ' ' GLU . 20.1 m-20 -111.47 23.06 14.4 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.48 1.113 . . . . 73.120000000000005 109.328 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.694 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -36.48 112.07 0.17 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.55 1.156 . . . . 62.43 110.241 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.678 HD22 ' HA3' ' A' ' 205' ' ' GLY . 0.4 OUTLIER -132.83 118.99 19.65 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.515 1.134 . . . . 75.120000000000005 109.28 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 175' ' ' THR . 10.6 t -86.45 108.46 18.52 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.487 1.117 . . . . 74.129999999999995 110.425 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.456 HG23 HG11 ' A' ' 162' ' ' VAL . 1.2 t -102.07 178.86 4.49 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 72.319999999999993 110.416 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.481 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 2.6 m-85 -131.88 154.54 49.09 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 63.329999999999998 111.061 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.7 m -55.82 154.72 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.538 1.149 . . . . 64.340000000000003 109.302 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 40.51 72.2 0.25 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.48 1.113 . . . . 63.109999999999999 110.989 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.502 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 7.4 tt0 -131.03 167.25 19.37 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.514 0.773 . . . . 63.149999999999999 110.31 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.401 ' ND2' ' OH ' ' A' ' 159' ' ' TYR . 2.5 m120 -113.89 139.4 49.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.532 1.145 . . . . 71.140000000000001 109.305 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.731 ' CD1' HG21 ' A' ' 207' ' ' VAL . 0.6 OUTLIER -154.11 148.44 26.02 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.499 1.125 . . . . 53.100000000000001 109.288 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.548 ' CE2' ' HB2' ' A' ' 185' ' ' CYS . 25.2 t80 -106.37 105.95 16.22 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 75.120000000000005 110.961 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.842 ' CG1' ' HB2' ' A' ' 195' ' ' ALA . 73.9 mt -83.95 120.23 34.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.502 1.126 . . . . 74.140000000000001 109.308 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.605 ' SG ' ' CH2' ' A' ' 242' ' ' TRP . 33.4 t -124.7 -8.75 7.33 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.483 1.115 . . . . 71.239999999999995 108.278 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.838 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -129.78 150.02 51.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.429 1.081 . . . . 73.310000000000002 109.327 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.582 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.1 OUTLIER -153.62 148.3 26.33 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.524 1.14 . . . . 74.040000000000006 109.53 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.758 ' NE2' HD13 ' A' ' 194' ' ' ILE . 2.4 p80 -152.5 144.81 23.97 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.497 1.123 . . . . 64.430000000000007 109.591 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.471 ' C ' ' N ' ' A' ' 191' ' ' GLU . 51.5 t-20 53.5 20.01 1.91 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.562 1.164 . . . . 73.219999999999999 109.278 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.411 ' C ' ' O ' ' A' ' 189' ' ' ASN . 15.9 p 41.02 27.53 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.461 1.101 . . . . 65.349999999999994 108.272 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.519 ' O ' HG13 ' A' ' 209' ' ' VAL . 8.0 tt0 -129.81 -40.71 1.35 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.497 1.123 . . . . 71.129999999999995 110.321 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.591 ' CZ2' ' HD3' ' B' ' 477' ' ' PRO . 99.8 m95 -107.9 126.16 52.34 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.57 1.169 . . . . 74.230000000000004 107.971 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.752 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.3 m-30 -119.43 134.61 55.13 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 1.122 . . . . 73.530000000000001 110.993 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.838 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 1.0 OUTLIER -100.07 110.9 28.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.567 1.167 . . . . 74.099999999999994 109.236 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.842 ' HB2' ' CG1' ' A' ' 184' ' ' ILE . . . -117.01 174.3 6.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.46 1.1 . . . . 55.310000000000002 109.237 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.419 ' HG2' ' HA ' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -126.76 139.15 34.13 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.459 1.099 . . . . 75.120000000000005 109.324 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.359 1.089 0 O-C-N 124.527 1.804 . . . . 73.230000000000004 110.97 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.455 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.529 0.944 0 N-CA-C 110.99 -0.844 . . . . 52.310000000000002 110.99 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.519 ' HG2' ' CE2' ' B' ' 470' ' ' PHE . 18.2 Cg_endo -75.03 147.42 89.19 Favored 'Cis proline' 0 C--N 1.36 1.141 0 C-N-CA 121.042 -2.482 . . . . 54.509999999999998 110.927 0.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.678 ' HA3' HD22 ' A' ' 174' ' ' LEU . . . -103.89 156.87 17.47 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.47 1.106 . . . . 62.240000000000002 111.048 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.598 HD12 ' CD1' ' A' ' 194' ' ' ILE . 0.2 OUTLIER -94.68 146.16 24.35 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.489 0.758 . . . . 74.420000000000002 109.306 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.731 HG21 ' CD1' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -157.79 129.67 4.03 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.53 1.144 . . . . 51.340000000000003 109.195 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.934 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.2 Cg_endo -75.1 175.93 10.6 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.48 1.779 . . . . 74.040000000000006 111.008 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.752 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -93.41 4.65 7.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.428 1.08 . . . . 54.530000000000001 109.277 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -103.78 -13.06 28.63 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.418 1.074 . . . . 43.130000000000003 110.975 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.619 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 11.5 m-85 -119.43 -1.21 10.76 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.486 0.756 . . . . 75.349999999999994 110.98 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.957 HG12 HG22 ' A' ' 162' ' ' VAL . 2.6 m -141.06 160.43 23.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.487 1.117 . . . . 72.409999999999997 109.274 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.32 144.3 51.11 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.535 1.147 . . . . 42.420000000000002 110.036 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.803 ' O ' HG23 ' A' ' 215' ' ' ILE . 2.7 mm -88.46 145.62 7.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 55.100000000000001 109.342 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.803 HG23 ' O ' ' A' ' 214' ' ' ILE . 4.1 pt . . . . . 0 C--N 1.325 -0.499 0 O-C-N 124.45 1.093 . . . . 54.340000000000003 109.343 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ASP . . . . . 0.457 ' OD1' HG12 ' A' ' 227' ' ' VAL . 8.8 t0 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.304 -0.628 . . . . 73.219999999999999 109.304 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.491 HG13 HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -38.59 -58.44 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.129 . . . . 71.430000000000007 109.286 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.491 HD12 HG13 ' A' ' 227' ' ' VAL . 3.2 mp -54.48 -45.51 70.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.518 1.136 . . . . 74.340000000000003 109.348 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 226' ' ' ASP . 18.5 mt-10 -67.16 -15.0 63.44 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 72.530000000000001 110.344 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 226' ' ' ASP . 5.5 t70 -88.61 -18.92 27.02 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.539 1.149 . . . . 64.430000000000007 109.302 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.655 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.5 OUTLIER -69.44 -69.42 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.505 1.128 . . . . 75.150000000000006 109.27 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.655 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -59.89 -23.83 63.79 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.52 1.138 . . . . 70.510000000000005 109.329 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.86 -59.7 3.36 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.522 1.139 . . . . 65.430000000000007 110.023 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 234' ' ' VAL . 1.2 m -98.96 24.31 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.107 . . . . 74.209999999999994 109.271 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 5.6 t30 46.07 41.69 8.7 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.445 1.091 . . . . 73.409999999999997 109.276 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.888 HD12 ' HD2' ' A' ' 237' ' ' PRO . 33.2 tp -55.54 123.98 53.47 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 124.511 1.132 . . . . 62.310000000000002 109.334 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.888 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.4 Cg_endo -74.99 153.37 41.76 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.565 1.824 . . . . 71.109999999999999 111.002 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' THR . . . . . 0.457 ' CG2' ' NE2' ' A' ' 240' ' ' GLN . 0.5 OUTLIER -61.42 -170.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.581 1.176 . . . . 62.149999999999999 110.438 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.489 ' HA ' ' HB1' ' A' ' 186' ' ' ALA . 12.3 p -80.27 -48.64 19.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.535 1.147 . . . . 62.219999999999999 109.354 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.489 ' OE1' ' N ' ' A' ' 241' ' ' GLU . 0.1 OUTLIER -87.43 -12.81 45.03 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.526 1.141 . . . . 53.43 110.281 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.489 ' N ' ' OE1' ' A' ' 240' ' ' GLN . 8.5 mt-10 -76.68 -36.27 57.39 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.562 1.164 . . . . 73.239999999999995 110.303 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.757 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 0.1 OUTLIER -87.01 -60.17 2.05 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.13 . . . . 62.340000000000003 108.012 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.644 ' NZ ' ' CD2' ' B' ' 470' ' ' PHE . 7.6 mtpt -53.19 -20.78 4.3 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.506 1.129 . . . . 53.219999999999999 109.328 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 243' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.481 1.113 . . . . 64.519999999999996 110.034 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 470' ' ' PHE . . . . . 0.644 ' CD2' ' NZ ' ' A' ' 243' ' ' LYS . 5.9 m-30 . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 120.521 0.2 . . . . 74.109999999999999 111.012 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 471' ' ' ILE . . . . . 0.767 ' N ' HD13 ' B' ' 471' ' ' ILE . 1.1 mm -71.31 135.67 84.36 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.482 1.114 . . . . 74.439999999999998 109.348 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 472' ' ' PRO . . . . . 0.589 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.94 170.97 19.22 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.504 1.792 . . . . 64.420000000000002 111.024 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 2.7 t -116.78 -8.86 11.33 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.455 1.097 . . . . 42.340000000000003 109.999 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -122.49 164.37 26.73 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.472 1.107 . . . . 52.210000000000001 110.294 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 475' ' ' PRO . . . . . 0.702 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.2 Cg_endo -75.03 -38.54 1.53 Allowed 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.49 1.784 . . . . 63.549999999999997 110.97 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 476' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 162.73 139.66 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.484 1.115 . . . . 34.32 109.274 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 477' ' ' PRO . . . . . 0.591 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -74.94 -161.37 0.12 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.494 1.786 . . . . 65.430000000000007 110.999 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 478' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -140.51 103.41 6.51 Favored Pre-proline 0 C--N 1.324 -0.52 0 O-C-N 124.59 1.181 . . . . 60.130000000000003 109.364 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 479' ' ' PRO . . . . . 0.619 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.5 Cg_endo -74.92 166.08 30.01 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.497 1.788 . . . . 61.229999999999997 110.998 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.36 1.178 0 O-C-N 124.417 1.746 . . . . 65.530000000000001 110.985 179.992 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.545 0.212 . . . . 60.450000000000003 111.042 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.953 ' HB3' ' CD2' ' A' ' 182' ' ' LEU . . . -110.31 144.66 38.7 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.438 1.086 . . . . 71.409999999999997 109.303 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.521 HD13 ' O ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -123.99 123.84 67.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.545 1.153 . . . . 72.329999999999998 109.299 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.945 HG23 HD11 ' A' ' 182' ' ' LEU . 1.8 t -79.7 122.26 34.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.507 1.129 . . . . 71.319999999999993 109.364 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.58 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 0.7 OUTLIER -97.48 -14.83 20.89 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.551 1.157 . . . . 74.329999999999998 109.305 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.701 ' O ' HG13 ' A' ' 162' ' ' VAL . 5.4 m-85 -145.14 160.65 41.11 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.564 1.165 . . . . 64.150000000000006 111.067 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.842 ' N ' HG12 ' A' ' 178' ' ' VAL . 8.5 p30 -97.99 157.03 16.35 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.401 1.063 . . . . 73.030000000000001 109.362 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -150.12 135.64 18.22 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.532 1.145 . . . . 72.140000000000001 110.979 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -75.86 126.06 30.28 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.491 1.119 . . . . 71.349999999999994 109.302 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.848 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -88.99 153.29 21.14 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.452 1.095 . . . . 53.020000000000003 109.295 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -166.31 29.41 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 63.32 110.293 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.747 ' HZ2' ' H ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -129.5 -176.08 3.78 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.483 1.115 . . . . 64.319999999999993 109.293 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.12 -40.93 78.07 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 60.229999999999997 109.318 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 174' ' ' LEU . 30.7 m-20 -88.67 16.99 5.89 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.457 1.098 . . . . 64.299999999999997 109.272 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.848 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 4.6 pt-20 -38.14 95.76 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.449 1.093 . . . . 63.0 110.309 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.747 ' H ' ' HZ2' ' A' ' 170' ' ' LYS . 5.7 tp -118.4 107.81 14.29 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.482 1.114 . . . . 72.239999999999995 109.29 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 175' ' ' THR . 12.7 t -87.36 115.9 25.09 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.479 1.112 . . . . 71.430000000000007 110.357 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 6.9 m -134.74 154.8 51.42 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.536 1.148 . . . . 63.310000000000002 110.402 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -94.35 167.54 11.46 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.453 1.096 . . . . 73.230000000000004 110.962 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.842 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.6 m -66.96 158.26 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 124.488 1.117 . . . . 72.209999999999994 109.316 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 57.11 50.42 64.51 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.479 1.112 . . . . 51.509999999999998 111.077 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.521 ' O ' HD13 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -110.26 174.15 6.0 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.498 0.764 . . . . 74.439999999999998 110.289 -179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -137.36 117.45 13.42 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.527 1.142 . . . . 70.439999999999998 109.264 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.953 ' CD2' ' HB3' ' A' ' 160' ' ' ALA . 0.0 OUTLIER -129.99 154.88 46.95 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.453 1.096 . . . . 73.530000000000001 109.358 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.577 ' CE1' ' O ' ' A' ' 184' ' ' ILE . 1.0 OUTLIER -104.24 115.16 29.91 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.423 1.077 . . . . 74.340000000000003 110.982 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 1.055 HD13 ' HB2' ' A' ' 195' ' ' ALA . 27.5 mm -65.32 160.59 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.493 1.121 . . . . 71.319999999999993 109.303 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' CYS . . . . . 0.44 ' HB3' ' CH2' ' A' ' 242' ' ' TRP . 37.0 m -150.99 -44.88 0.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.538 1.149 . . . . 74.140000000000001 108.27 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 1.041 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -120.71 165.75 14.66 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.5 1.125 . . . . 63.509999999999998 109.274 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.526 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 2.0 p-80 -152.97 146.22 24.77 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.522 1.139 . . . . 65.409999999999997 109.617 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 1.052 ' HE1' HD13 ' A' ' 194' ' ' ILE . 0.2 OUTLIER -146.07 137.87 25.01 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.492 1.12 . . . . 72.310000000000002 109.625 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.479 ' C ' ' N ' ' A' ' 191' ' ' GLU . 24.5 t-20 50.17 25.58 1.82 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.531 1.144 . . . . 74.400000000000006 109.271 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' CYS . . . . . 0.439 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.9 p 38.93 30.9 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.451 1.094 . . . . 63.340000000000003 108.248 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.93 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 20.5 tt0 -127.36 -39.58 1.86 Allowed 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.495 1.122 . . . . 75.439999999999998 110.269 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' TRP . . . . . 0.714 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 97.0 m95 -113.79 131.9 56.06 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.518 1.136 . . . . 74.450000000000003 108.023 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.909 ' HB3' HD12 ' A' ' 184' ' ' ILE . 23.3 m-30 -121.94 144.0 49.12 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.471 1.107 . . . . 75.530000000000001 111.02 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 1.052 HD13 ' HE1' ' A' ' 188' ' ' HIS . 0.8 OUTLIER -103.28 96.86 4.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.544 1.153 . . . . 75.25 109.341 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 1.055 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -99.64 -176.38 3.26 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.433 1.083 . . . . 52.329999999999998 109.224 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.453 ' CG ' ' C ' ' A' ' 195' ' ' ALA . 7.3 mtmt -151.19 160.21 32.33 Favored Pre-proline 0 C--N 1.326 -0.43 0 O-C-N 124.549 1.156 . . . . 72.530000000000001 109.262 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 C--N 1.361 1.209 0 O-C-N 124.491 1.785 . . . . 75.319999999999993 111.002 179.961 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.426 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . . . . . . 0 CA--C 1.53 1.0 0 N-CA-C 111.087 -0.805 . . . . 61.340000000000003 111.087 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' PRO . . . . . 0.569 ' HG2' ' CE2' ' B' ' 470' ' ' PHE . 18.3 Cg_endo -75.07 127.63 14.85 Favored 'Cis proline' 0 C--N 1.359 1.118 0 C-N-CA 121.04 -2.483 . . . . 61.450000000000003 110.967 0.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.688 ' HA3' HD22 ' A' ' 174' ' ' LEU . . . -95.42 152.27 20.32 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.471 1.107 . . . . 54.310000000000002 110.934 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.714 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.1 OUTLIER -99.49 145.96 26.9 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 0.75 . . . . 71.450000000000003 109.312 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.728 ' HB ' HG11 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -159.75 127.84 2.86 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.54 1.15 . . . . 72.430000000000007 109.279 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.845 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.3 Cg_endo -74.99 176.81 9.42 Favored 'Trans proline' 0 C--N 1.361 1.206 0 O-C-N 124.507 1.793 . . . . 65.519999999999996 110.946 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.756 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.6 OUTLIER -97.09 5.14 9.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.41 1.069 . . . . 75.150000000000006 109.316 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -103.31 -12.22 31.72 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.518 1.136 . . . . 52.539999999999999 111.037 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.634 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 10.7 m-85 -123.02 3.28 9.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.473 0.749 . . . . 74.319999999999993 110.996 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.859 HG12 HG22 ' A' ' 162' ' ' VAL . 1.9 m -140.35 154.26 22.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.49 1.119 . . . . 70.5 109.273 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' SER . . . . . 0.458 ' HB2' HD11 ' A' ' 163' ' ' LEU . 5.6 t -120.37 124.51 45.71 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.485 1.116 . . . . 53.399999999999999 110.013 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.792 ' O ' HG23 ' A' ' 215' ' ' ILE . 2.7 mm -77.49 139.2 19.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.493 1.121 . . . . 63.140000000000001 109.294 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ILE . . . . . 0.792 HG23 ' O ' ' A' ' 214' ' ' ILE . 3.5 pt . . . . . 0 C--N 1.325 -0.473 0 O-C-N 124.421 1.076 . . . . 74.129999999999995 109.276 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.261 -0.644 . . . . 73.129999999999995 109.261 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.632 HG13 HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -41.07 -52.61 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.455 1.097 . . . . 63.420000000000002 109.335 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.632 HD12 HG13 ' A' ' 227' ' ' VAL . 4.3 mp -56.94 -58.91 3.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 O-C-N 124.519 1.137 . . . . 74.439999999999998 109.298 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -46.62 -29.16 1.71 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.547 1.155 . . . . 61.5 110.331 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -73.28 -37.19 66.35 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.54 1.15 . . . . 63.43 109.32 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.636 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.6 OUTLIER -62.26 -69.33 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.484 1.115 . . . . 73.150000000000006 109.295 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.636 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -51.42 -31.88 24.46 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.487 1.117 . . . . 71.329999999999998 109.288 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.03 -60.72 2.79 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.517 1.136 . . . . 70.5 109.936 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.2 m -92.03 15.39 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.549 1.155 . . . . 52.420000000000002 109.282 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 42.8 t30 40.43 36.35 0.35 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.477 1.11 . . . . 73.140000000000001 109.264 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.857 HD12 ' HD2' ' A' ' 237' ' ' PRO . 4.0 tp -49.25 134.48 16.5 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.126 . . . . 61.200000000000003 109.335 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.857 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.3 Cg_endo -74.99 164.09 34.06 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.461 1.769 . . . . 60.409999999999997 110.997 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.82 -174.89 2.31 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.503 1.127 . . . . 72.439999999999998 110.43 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.552 HG11 ' ND1' ' A' ' 188' ' ' HIS . 1.0 OUTLIER -79.61 -49.33 19.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.503 1.127 . . . . 72.219999999999999 109.278 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.506 ' N ' ' CG2' ' A' ' 239' ' ' VAL . 0.0 OUTLIER -76.67 -14.75 59.94 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.454 1.096 . . . . 74.010000000000005 110.307 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -83.78 -49.82 8.71 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.55 1.156 . . . . 75.319999999999993 110.291 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.716 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 0.1 OUTLIER -70.51 -62.49 1.37 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.007 -1.109 . . . . 75.25 108.007 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.571 ' NZ ' ' CE2' ' B' ' 470' ' ' PHE . 18.3 mtpp -49.56 -23.92 1.87 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.612 1.195 . . . . 72.109999999999999 109.329 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 243' ' ' LYS . 4.4 t . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.433 1.083 . . . . 63.409999999999997 109.969 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 470' ' ' PHE . . . . . 0.571 ' CE2' ' NZ ' ' A' ' 243' ' ' LYS . 6.3 m-30 . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 120.479 0.181 . . . . 71.109999999999999 110.981 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 471' ' ' ILE . . . . . 0.468 ' CG2' ' HD2' ' B' ' 472' ' ' PRO . 7.8 mm -97.51 139.81 21.62 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.145 . . . . 72.209999999999994 109.297 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 472' ' ' PRO . . . . . 0.621 ' HD3' ' CD2' ' A' ' 188' ' ' HIS . 18.3 Cg_endo -75.03 146.74 32.91 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.5 1.789 . . . . 70.030000000000001 111.018 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 8.2 t -79.21 -59.8 2.63 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.547 1.154 . . . . 52.439999999999998 110.075 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -84.67 163.49 46.53 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.52 1.137 . . . . 72.099999999999994 110.311 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 -166.59 0.35 Allowed 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.435 1.755 . . . . 64.120000000000005 111.01 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 476' ' ' ALA . . . . . 0.93 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . -55.58 137.49 70.1 Favored Pre-proline 0 C--N 1.326 -0.417 0 O-C-N 124.489 1.118 . . . . 65.439999999999998 109.361 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 477' ' ' PRO . . . . . 0.574 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.2 Cg_endo -75.01 -162.28 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.484 1.781 . . . . 61.130000000000003 111.022 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.0 89.84 12.44 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.508 1.13 . . . . 75.420000000000002 109.29 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 479' ' ' PRO . . . . . 0.634 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.3 Cg_endo -74.92 161.29 39.2 Favored 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.523 1.801 . . . . 74.120000000000005 110.985 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.172 0 O-C-N 124.506 1.793 . . . . 74.140000000000001 111.035 179.936 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.987 0 N-CA-C 111.024 -0.831 . . . . 72.540000000000006 111.024 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.843 ' HB3' HG22 ' A' ' 214' ' ' ILE . 1.2 m -166.39 110.18 0.77 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.539 0.788 . . . . 62.109999999999999 110.027 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.449 ' C ' ' CD1' ' A' ' 159' ' ' TYR . 58.1 tp -119.73 -3.28 10.3 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.421 1.076 . . . . 54.530000000000001 109.37 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.716 ' CD1' ' CE2' ' A' ' 183' ' ' PHE . 3.2 m-85 -139.38 175.54 9.48 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.477 1.11 . . . . 73.099999999999994 111.007 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.515 ' CB ' ' CD1' ' A' ' 184' ' ' ILE . . . -128.51 160.96 30.71 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.514 1.134 . . . . 55.229999999999997 109.331 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.711 ' HB ' HD11 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -144.69 124.3 6.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 74.239999999999995 109.337 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.978 HG13 HD22 ' A' ' 182' ' ' LEU . 6.4 m -83.3 127.24 39.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.486 1.116 . . . . 65.420000000000002 109.301 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.497 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 0.4 OUTLIER -98.78 -2.95 36.74 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.465 1.103 . . . . 63.439999999999998 109.311 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.497 ' CE2' ' HB2' ' A' ' 163' ' ' LEU . 1.5 m-85 -152.4 158.16 42.26 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.474 1.108 . . . . 73.239999999999995 111.021 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.799 ' N ' HG12 ' A' ' 178' ' ' VAL . 15.5 t0 -100.41 144.18 29.71 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.435 1.084 . . . . 74.030000000000001 109.268 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.439 ' N ' ' OD1' ' A' ' 165' ' ' ASP . 14.1 t80 -141.21 129.93 22.88 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.495 1.122 . . . . 64.310000000000002 110.949 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -68.56 131.06 44.6 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.439 1.087 . . . . 74.310000000000002 109.311 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.939 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -109.45 138.9 45.13 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.439 1.087 . . . . 41.43 109.307 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -144.6 16.55 1.64 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.506 1.129 . . . . 62.020000000000003 110.304 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.446 ' N ' ' HB3' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -94.92 -176.07 3.74 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.585 1.178 . . . . 71.109999999999999 109.257 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.47 -30.83 70.85 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.455 1.097 . . . . 72.319999999999993 109.306 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.445 ' OD2' ' N ' ' A' ' 206' ' ' LEU . 0.8 OUTLIER -104.59 16.45 26.04 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.473 1.108 . . . . 65.239999999999995 109.329 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.939 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 6.4 pt-20 -36.51 108.36 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.501 1.126 . . . . 71.430000000000007 110.321 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.719 HD13 ' HA3' ' A' ' 205' ' ' GLY . 5.4 tp -119.42 110.41 16.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.447 1.092 . . . . 72.299999999999997 109.316 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 175' ' ' THR . 12.9 t -84.98 108.62 17.68 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.48 1.112 . . . . 70.25 110.391 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.405 HG23 ' N ' ' A' ' 177' ' ' TYR . 0.7 OUTLIER -118.7 178.07 4.61 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.597 1.186 . . . . 75.230000000000004 110.432 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.424 ' O ' ' CG2' ' A' ' 162' ' ' VAL . 12.4 m-85 -121.76 162.78 20.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.577 1.173 . . . . 73.5 111.038 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.799 HG12 ' N ' ' A' ' 165' ' ' ASP . 3.8 m -64.83 147.29 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.539 1.149 . . . . 70.010000000000005 109.244 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.419 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 53.28 62.1 6.31 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.548 1.155 . . . . 32.229999999999997 111.027 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.533 ' O ' HD13 ' A' ' 161' ' ' ILE . 1.8 tp10 -126.31 161.62 27.38 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.505 0.767 . . . . 63.009999999999998 110.331 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -101.75 141.15 35.05 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.451 1.094 . . . . 73.129999999999995 109.262 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.978 HD22 HG13 ' A' ' 162' ' ' VAL . 2.6 pt? -159.2 141.59 13.88 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.45 1.094 . . . . 74.129999999999995 109.283 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.716 ' CE2' ' CD1' ' A' ' 159' ' ' TYR . 6.5 m-85 -106.23 126.43 52.21 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.423 1.077 . . . . 70.530000000000001 110.985 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.663 HD12 ' HB2' ' A' ' 195' ' ' ALA . 0.8 OUTLIER -63.0 153.42 6.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 74.25 109.331 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 194' ' ' ILE . 2.6 m -135.21 -48.25 0.72 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.424 1.078 . . . . 73.209999999999994 108.302 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.882 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -129.91 170.28 14.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.511 1.132 . . . . 71.439999999999998 109.231 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.49 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.2 OUTLIER -150.36 147.45 27.61 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.413 1.071 . . . . 71.450000000000003 109.545 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.576 ' CE1' ' HB3' ' A' ' 192' ' ' TRP . 0.7 OUTLIER -152.61 138.83 18.35 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.592 1.183 . . . . 75.219999999999999 109.611 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.463 ' C ' ' N ' ' A' ' 191' ' ' GLU . 41.9 t30 53.28 22.4 2.7 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.446 1.091 . . . . 74.329999999999998 109.229 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.416 ' C ' ' O ' ' A' ' 189' ' ' ASN . 14.7 p 40.81 28.85 0.06 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.467 1.104 . . . . 53.119999999999997 108.271 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.659 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 7.8 tt0 -127.67 -40.4 1.75 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.409 1.068 . . . . 71.239999999999995 110.291 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.78 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 96.4 m95 -109.51 131.99 54.55 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.484 1.115 . . . . 75.019999999999996 108.002 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.781 ' CE2' HG12 ' A' ' 209' ' ' VAL . 20.8 m-30 -125.54 134.9 51.83 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.473 1.108 . . . . 64.340000000000003 110.972 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.882 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 5.7 mm -93.23 93.01 3.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.536 1.147 . . . . 75.409999999999997 109.282 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.663 ' HB2' HD12 ' A' ' 184' ' ' ILE . . . -97.07 -172.41 2.44 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.437 1.086 . . . . 63.340000000000003 109.381 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 197' ' ' PRO . 3.1 ttpp -154.77 141.44 13.27 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 124.572 1.17 . . . . 71.400000000000006 109.285 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 196' ' ' LYS . 18.2 Cg_endo -74.97 177.95 7.9 Favored 'Trans proline' 0 C--N 1.361 1.215 0 O-C-N 124.547 1.814 . . . . 74.310000000000002 110.983 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.405 ' O ' HG23 ' A' ' 198' ' ' ILE . 3.4 tp -113.88 29.51 2.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.611 1.194 . . . . 71.019999999999996 109.359 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -92.48 -120.02 2.7 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.464 1.102 . . . . 53.439999999999998 110.997 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.51 136.16 34.24 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.458 0.74 . . . . 71.109999999999999 110.292 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 201' ' ' LEU . 2.8 mm? 46.45 32.33 1.56 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.511 1.132 . . . . 75.519999999999996 109.316 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -97.09 170.85 26.45 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.501 1.126 . . . . 35.420000000000002 111.012 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.412 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . 52.08 176.96 0.04 OUTLIER Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.997 -0.841 . . . . 72.140000000000001 110.997 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.543 ' HG2' ' CE2' ' B' ' 470' ' ' PHE . 18.4 Cg_endo -74.99 123.77 9.42 Favored 'Cis proline' 0 C--N 1.361 1.21 0 C-N-CA 120.979 -2.509 . . . . 73.310000000000002 111.011 -0.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.719 ' HA3' HD13 ' A' ' 174' ' ' LEU . . . -97.72 148.99 19.11 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.566 1.166 . . . . 75.209999999999994 110.991 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.78 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -87.76 146.54 25.6 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.462 0.742 . . . . 73.140000000000001 109.324 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.808 HG21 HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -161.12 127.64 2.48 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.537 1.148 . . . . 73.420000000000002 109.321 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.635 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.4 Cg_endo -74.93 177.92 7.93 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.495 1.787 . . . . 63.219999999999999 110.991 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.781 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.4 m -96.94 5.08 9.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.54 1.15 . . . . 74.530000000000001 109.283 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLY . . . . . 0.497 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -108.05 0.35 33.58 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.455 1.097 . . . . 41.119999999999997 111.003 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.603 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 18.8 m-85 -131.66 8.61 4.56 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.509 0.77 . . . . 64.319999999999993 110.983 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.819 HG12 HG12 ' A' ' 162' ' ' VAL . 2.3 m -151.71 154.87 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.485 1.116 . . . . 72.430000000000007 109.293 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 39.9 t -123.9 147.07 47.98 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.504 1.127 . . . . 54.149999999999999 109.977 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.843 HG22 ' HB3' ' A' ' 157' ' ' SER . 6.9 mm -90.87 129.33 41.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.531 1.144 . . . . 74.120000000000005 109.287 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.711 HD11 ' HB ' ' A' ' 161' ' ' ILE . 0.3 OUTLIER -152.41 -177.94 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.573 1.17 . . . . 52.229999999999997 109.237 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.656 ' OD1' ' HB3' ' A' ' 218' ' ' ALA . 12.0 p-10 -127.62 15.78 7.02 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.459 1.099 . . . . 74.109999999999999 109.292 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 8.9 pt 45.03 28.98 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.49 1.119 . . . . 71.439999999999998 109.261 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.656 ' HB3' ' OD1' ' A' ' 216' ' ' ASP . . . -110.4 -69.42 0.87 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.482 1.114 . . . . 72.439999999999998 109.261 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.628 HG23 ' O ' ' A' ' 218' ' ' ALA . 3.2 p -157.92 160.54 37.71 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.548 1.155 . . . . 74.120000000000005 110.436 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 53.06 -172.85 0.42 Allowed Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.536 1.148 . . . . 62.200000000000003 110.965 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -125.63 115.77 20.66 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.477 0.751 . . . . 72.239999999999995 111.016 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.504 ' C ' HG22 ' A' ' 223' ' ' THR . . . 57.33 24.37 9.94 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.444 1.09 . . . . 71.400000000000006 109.294 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.504 HG22 ' C ' ' A' ' 222' ' ' ALA . 2.9 t 45.9 25.75 0.33 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.528 1.142 . . . . 53.450000000000003 110.408 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 71.9 39.45 59.24 Favored Glycine 0 CA--C 1.531 1.082 0 O-C-N 124.595 1.184 . . . . 64.340000000000003 110.985 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 222' ' ' ALA . 5.4 m120 -131.52 162.6 29.89 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.557 0.798 . . . . 72.340000000000003 109.319 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -89.3 145.55 25.3 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.445 1.091 . . . . 65.230000000000004 109.347 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.57 HG21 ' HE2' ' A' ' 193' ' ' PHE . 1.5 p -54.03 -40.36 45.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.135 . . . . 65.109999999999999 109.276 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.797 ' HA ' HD12 ' A' ' 231' ' ' ILE . 9.0 mt -69.39 -30.8 46.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.51 1.131 . . . . 63.009999999999998 109.31 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.492 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 8.9 mt-10 -78.97 -21.08 47.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.54 1.15 . . . . 64.230000000000004 110.292 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -88.79 -15.9 33.46 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.511 1.132 . . . . 72.340000000000003 109.312 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.797 HD12 ' HA ' ' A' ' 228' ' ' ILE . 6.5 mt -72.5 -69.8 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.529 1.143 . . . . 70.209999999999994 109.296 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.492 ' CD ' ' HA ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -49.15 -30.67 7.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.515 1.135 . . . . 64.109999999999999 109.288 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.424 ' N ' ' HG2' ' A' ' 232' ' ' LYS . 0.6 OUTLIER -48.14 -50.23 29.45 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 74.230000000000004 109.987 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 236' ' ' LEU . 1.3 m -90.95 -14.36 8.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.516 1.135 . . . . 50.350000000000001 109.239 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 57.58 48.63 13.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.433 1.083 . . . . 75.120000000000005 109.286 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.638 ' C ' HD12 ' A' ' 236' ' ' LEU . 0.8 OUTLIER -71.29 142.93 87.51 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.507 1.129 . . . . 74.349999999999994 109.318 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.581 ' O ' HD12 ' A' ' 236' ' ' LEU . 18.3 Cg_endo -74.99 154.35 42.49 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.447 1.761 . . . . 71.120000000000005 110.997 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.433 HG22 ' H ' ' A' ' 239' ' ' VAL . 2.6 m -58.88 175.5 0.27 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.529 1.143 . . . . 74.430000000000007 110.458 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.569 HG23 ' CB ' ' A' ' 186' ' ' ALA . 7.2 p -76.81 -51.75 18.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 124.552 1.157 . . . . 71.540000000000006 109.295 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.515 ' N ' HG13 ' A' ' 239' ' ' VAL . 4.3 pm0 -71.04 -14.93 62.5 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 75.120000000000005 110.278 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -92.2 -44.73 8.62 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.464 1.102 . . . . 63.25 110.302 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.453 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 9.9 t90 -69.47 -53.4 19.39 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.548 1.155 . . . . 65.510000000000005 108.018 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.786 ' HZ3' ' H ' ' B' ' 469' ' ' LYS . 5.9 mtmp? -62.9 -23.06 67.17 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.54 1.15 . . . . 62.039999999999999 109.274 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.6 t -40.97 -30.52 0.13 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.133 . . . . 62.039999999999999 110.038 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.453 ' OD1' ' HB3' ' A' ' 247' ' ' ALA . 4.6 t-20 -175.82 108.58 0.09 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.519 1.137 . . . . 64.230000000000004 109.404 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.453 ' CG2' ' N ' ' A' ' 247' ' ' ALA . 1.3 tp -55.28 -49.62 71.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.485 1.116 . . . . 74.129999999999995 109.241 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.453 ' HB3' ' OD1' ' A' ' 245' ' ' ASN . . . -44.7 97.27 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.458 1.099 . . . . 72.519999999999996 109.352 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 246' ' ' ILE . 0.4 OUTLIER -176.63 -166.03 0.15 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 62.140000000000001 110.27 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.552 ' CD1' ' O ' ' A' ' 249' ' ' TYR . 0.7 OUTLIER -173.27 128.85 0.45 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.538 1.149 . . . . 72.129999999999995 111.024 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.78 140.1 40.16 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.568 1.168 . . . . 74.409999999999997 109.35 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -107.69 161.86 14.5 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.468 1.105 . . . . 41.119999999999997 109.266 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 5.9 t -139.73 142.18 36.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.479 1.112 . . . . 71.140000000000001 110.018 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -73.98 149.31 41.39 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 54.32 109.323 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.734 HD12 ' N ' ' A' ' 254' ' ' ILE . 2.5 mp -81.54 123.91 38.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.477 1.111 . . . . 72.019999999999996 109.289 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.5 p -156.35 125.9 6.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.449 1.093 . . . . 62.229999999999997 110.025 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.635 HD13 ' O ' ' A' ' 257' ' ' GLY . 1.6 tm? -121.28 136.18 55.0 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.56 1.163 . . . . 64.150000000000006 109.351 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.635 ' O ' HD13 ' A' ' 256' ' ' LEU . . . -95.1 160.54 23.08 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.428 1.08 . . . . 43.240000000000002 111.019 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 2.2 m -95.92 51.89 1.28 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.59 0.818 . . . . 74.150000000000006 109.959 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.4 p -161.3 119.95 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.532 1.145 . . . . 63.509999999999998 109.322 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 C--N 1.326 -0.448 0 O-C-N 124.452 1.095 . . . . 71.030000000000001 110.274 -179.991 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 109.971 -0.381 . . . . 73.219999999999999 109.971 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 2.3 t -124.88 149.45 47.51 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.504 1.127 . . . . 74.400000000000006 110.061 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 38.8 m -91.69 -175.62 4.22 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.491 1.119 . . . . 64.030000000000001 109.978 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -119.59 150.88 39.56 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.521 1.138 . . . . 61.240000000000002 109.213 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -114.78 -39.61 3.7 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.507 1.129 . . . . 60.340000000000003 109.338 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -66.5 164.42 41.74 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.491 1.12 . . . . 72.109999999999999 110.977 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 469' ' ' LYS . . . . . 0.786 ' H ' ' HZ3' ' A' ' 243' ' ' LYS . 32.4 mmtm -109.69 -15.33 14.17 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.455 0.738 . . . . 70.219999999999999 109.301 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 470' ' ' PHE . . . . . 0.561 ' CD2' ' HD3' ' A' ' 243' ' ' LYS . 8.8 m-30 -97.15 14.96 24.02 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.474 1.109 . . . . 74.540000000000006 111.0 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 471' ' ' ILE . . . . . 0.503 HG23 ' HD2' ' B' ' 472' ' ' PRO . 3.7 mm -70.31 140.18 87.57 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.516 1.135 . . . . 73.239999999999995 109.3 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 472' ' ' PRO . . . . . 0.569 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.2 Cg_endo -74.93 155.47 43.29 Favored 'Trans proline' 0 C--N 1.359 1.12 0 O-C-N 124.499 1.789 . . . . 70.439999999999998 111.055 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 38.7 t -97.49 -47.69 5.57 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.563 1.165 . . . . 73.519999999999996 110.062 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.86 165.4 17.99 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.537 1.148 . . . . 54.119999999999997 110.31 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 -166.81 0.37 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.458 1.767 . . . . 73.310000000000002 111.031 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 476' ' ' ALA . . . . . 0.659 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . -65.25 134.1 95.71 Favored Pre-proline 0 C--N 1.326 -0.427 0 O-C-N 124.382 1.051 . . . . 73.430000000000007 109.302 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 477' ' ' PRO . . . . . 0.576 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -74.94 -162.65 0.16 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.5 1.789 . . . . 74.299999999999997 110.996 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 478' ' ' LYS . . . . . 0.4 ' N ' ' HD3' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -133.42 90.89 28.21 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 64.219999999999999 109.28 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 479' ' ' PRO . . . . . 0.603 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.98 152.39 40.78 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.489 1.784 . . . . 74.209999999999994 111.0 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 480' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 479' ' ' PRO . 18.4 Cg_endo -74.96 170.06 21.24 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.552 1.817 . . . . 54.039999999999999 111.005 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 481' ' ' SER . . . . . . . . . . . . . 1.1 t 50.3 43.72 26.49 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.479 1.112 . . . . 74.329999999999998 109.913 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 14.3 p -108.09 178.86 4.38 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.487 1.117 . . . . 74.299999999999997 110.021 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -117.6 56.52 0.83 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.495 1.122 . . . . 75.400000000000006 109.282 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 1.5 t -135.22 137.3 42.48 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.464 1.102 . . . . 72.299999999999997 110.008 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -103.3 153.4 20.46 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.456 1.098 . . . . 64.019999999999996 109.263 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 86.3 p . . . . . 0 C--N 1.324 -0.509 0 O-C-N 124.553 1.158 . . . . 61.210000000000001 109.992 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.964 0 N-CA-C 110.995 -0.842 . . . . 62.420000000000002 110.995 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.7 t -145.84 162.8 36.88 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.418 0.716 . . . . 54.219999999999999 110.053 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.655 HD12 ' O ' ' A' ' 158' ' ' LEU . 2.1 pp -156.39 121.07 4.57 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.509 1.13 . . . . 45.100000000000001 109.272 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.524 ' CE1' ' O ' ' A' ' 160' ' ' ALA . 0.7 OUTLIER -124.12 139.55 53.83 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.464 1.102 . . . . 71.5 110.966 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.857 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -119.89 148.28 43.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.464 1.102 . . . . 53.340000000000003 109.341 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.658 ' HB ' HD11 ' A' ' 215' ' ' ILE . 0.1 OUTLIER -127.78 132.28 69.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.468 1.105 . . . . 74.120000000000005 109.287 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.937 HG22 HG12 ' A' ' 212' ' ' VAL . 3.9 t -87.89 134.05 28.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.516 1.135 . . . . 65.140000000000001 109.336 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.619 HD21 HG23 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -117.97 -2.61 11.25 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.475 1.109 . . . . 73.129999999999995 109.361 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.502 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 16.9 m-85 -139.02 175.74 9.29 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.134 . . . . 71.430000000000007 110.995 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.431 ' CB ' ' HA ' ' A' ' 177' ' ' TYR . 6.5 p-10 -139.86 145.34 37.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.488 1.118 . . . . 73.120000000000005 109.332 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.66 ' HE2' ' HZ1' ' A' ' 170' ' ' LYS . 1.9 p90 -160.28 166.33 29.72 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.552 1.158 . . . . 75.019999999999996 111.057 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -100.03 130.92 46.24 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.537 1.148 . . . . 65.549999999999997 109.321 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.681 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -100.9 157.8 16.46 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 51.409999999999997 109.271 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -156.72 24.53 0.33 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.493 1.121 . . . . 73.239999999999995 110.26 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.66 ' HZ1' ' HE2' ' A' ' 166' ' ' PHE . 0.3 OUTLIER -99.54 -177.25 3.52 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.527 1.142 . . . . 73.319999999999993 109.25 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.94 -27.89 65.74 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.525 1.14 . . . . 60.130000000000003 109.348 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.434 ' HB3' ' CB ' ' A' ' 206' ' ' LEU . 9.2 t0 -112.29 22.2 14.97 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 75.299999999999997 109.315 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.681 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 10.4 pt-20 -36.92 111.63 0.16 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.472 1.108 . . . . 73.049999999999997 110.29 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.71 HD13 ' HA3' ' A' ' 205' ' ' GLY . 4.6 tp -132.02 109.68 10.2 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.457 1.098 . . . . 74.340000000000003 109.293 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.0 t -87.26 133.17 33.71 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.444 1.09 . . . . 71.099999999999994 110.412 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 19.8 m -141.73 165.29 27.88 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.497 1.123 . . . . 75.230000000000004 110.412 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.431 ' HA ' ' CB ' ' A' ' 165' ' ' ASP . 8.1 m-85 -111.07 164.12 13.16 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.44 1.087 . . . . 75.299999999999997 110.999 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 164' ' ' TYR . 2.1 m -61.84 158.46 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.586 1.178 . . . . 65.230000000000004 109.281 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 46.3 70.14 0.72 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.444 1.09 . . . . 70.129999999999995 111.018 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -131.94 174.59 10.01 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 0.773 . . . . 62.5 110.353 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.487 ' ND2' ' CE1' ' A' ' 159' ' ' TYR . 0.7 OUTLIER -118.23 136.23 53.79 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.54 1.15 . . . . 74.519999999999996 109.314 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.876 HD22 HG23 ' A' ' 162' ' ' VAL . 2.6 pt? -157.25 146.09 19.8 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.568 1.167 . . . . 63.240000000000002 109.242 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 7.7 m-85 -113.86 124.1 51.4 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.544 1.153 . . . . 73.400000000000006 110.955 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.857 HD13 ' HB2' ' A' ' 160' ' ' ALA . 1.7 mp -65.44 152.84 8.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.546 1.154 . . . . 72.219999999999999 109.261 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.549 ' O ' ' CZ3' ' A' ' 242' ' ' TRP . 0.1 OUTLIER -135.78 -47.26 0.67 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.467 1.105 . . . . 73.239999999999995 108.319 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.924 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -126.73 167.32 15.91 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.132 . . . . 73.409999999999997 109.313 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.487 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.2 OUTLIER -148.88 146.09 27.76 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.474 1.109 . . . . 71.099999999999994 109.598 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.6 ' CE1' ' CB ' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -149.8 141.81 23.9 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.503 1.127 . . . . 75.400000000000006 109.647 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.455 ' C ' ' N ' ' A' ' 191' ' ' GLU . 19.0 t-20 51.25 22.35 1.34 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.498 1.124 . . . . 75.239999999999995 109.287 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.402 ' C ' ' O ' ' A' ' 189' ' ' ASN . 53.8 m 41.57 28.33 0.08 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.549 1.155 . . . . 51.109999999999999 108.312 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.529 ' O ' HG13 ' A' ' 209' ' ' VAL . 6.8 tt0 -128.15 -41.1 1.61 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.416 1.073 . . . . 70.129999999999995 110.326 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.872 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 98.8 m95 -106.63 131.35 53.88 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.01 -1.107 . . . . 74.420000000000002 108.01 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.8 ' CE2' HG12 ' A' ' 209' ' ' VAL . 20.8 m-30 -125.41 130.47 51.94 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.476 1.11 . . . . 74.150000000000006 111.033 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.924 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 1.5 mp -89.5 96.41 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.563 1.164 . . . . 71.329999999999998 109.313 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -104.16 -174.56 2.57 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.579 1.175 . . . . 63.240000000000002 109.237 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 197' ' ' PRO . 1.1 tmtt? -150.48 141.24 14.58 Favored Pre-proline 0 C--N 1.326 -0.436 0 O-C-N 124.474 1.109 . . . . 74.439999999999998 109.274 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 196' ' ' LYS . 18.4 Cg_endo -75.05 153.74 41.75 Favored 'Trans proline' 0 C--N 1.361 1.213 0 O-C-N 124.506 1.793 . . . . 74.109999999999999 110.972 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 4.6 tp -58.82 114.49 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.518 1.136 . . . . 75.450000000000003 109.313 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 122.73 126.63 3.19 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 124.445 1.091 . . . . 73.230000000000004 110.98 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.431 ' CG ' ' N ' ' A' ' 201' ' ' LEU . 35.8 ptt-85 -44.36 -43.49 7.59 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.516 0.774 . . . . 75.409999999999997 110.31 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.431 ' N ' ' CG ' ' A' ' 200' ' ' ARG . 11.5 mt -72.13 79.86 0.96 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.5 1.125 . . . . 75.200000000000003 109.265 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 155.5 147.68 4.79 Favored Glycine 0 CA--C 1.531 1.057 0 O-C-N 124.482 1.114 . . . . 65.430000000000007 110.937 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.418 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . 71.89 179.04 31.89 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 111.039 -0.824 . . . . 51.119999999999997 111.039 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.544 ' HB2' HG23 ' A' ' 194' ' ' ILE . 18.4 Cg_endo -75.03 122.65 8.37 Favored 'Cis proline' 0 C--N 1.359 1.121 0 C-N-CA 121.031 -2.487 . . . . 60.43 111.002 0.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.71 ' HA3' HD13 ' A' ' 174' ' ' LEU . . . -98.19 153.17 19.96 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.449 1.093 . . . . 74.340000000000003 111.049 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.872 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -86.94 146.43 26.16 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.478 0.752 . . . . 71.319999999999993 109.271 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.747 HG21 HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -158.11 126.83 2.99 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.456 1.097 . . . . 74.099999999999994 109.287 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.595 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.3 Cg_endo -75.01 174.48 12.73 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.573 1.828 . . . . 62.340000000000003 110.999 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.8 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.2 m -93.11 4.76 7.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.541 1.151 . . . . 61.509999999999998 109.307 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLY . . . . . 0.446 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -109.01 4.64 31.92 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.494 1.121 . . . . 74.299999999999997 110.914 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.633 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 15.7 m-85 -134.12 8.6 3.76 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.473 0.749 . . . . 72.540000000000006 111.058 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.937 HG12 HG22 ' A' ' 162' ' ' VAL . 3.1 m -151.66 162.17 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.45 1.094 . . . . 71.049999999999997 109.345 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 3.6 t -128.42 133.43 48.57 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.529 1.143 . . . . 61.299999999999997 110.032 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.72 ' O ' HG23 ' A' ' 215' ' ' ILE . 2.7 mm -80.77 145.87 8.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.507 1.129 . . . . 74.420000000000002 109.196 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.72 HG23 ' O ' ' A' ' 214' ' ' ILE . 1.0 OUTLIER -165.06 159.02 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.449 1.093 . . . . 74.519999999999996 109.299 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.447 ' CB ' ' HB3' ' A' ' 159' ' ' TYR . 8.4 t0 76.22 55.39 0.05 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.447 1.092 . . . . 72.439999999999998 109.264 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.55 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 3.1 mt -142.12 107.34 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.505 1.128 . . . . 75.310000000000002 109.26 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 217' ' ' ILE . . . 74.04 25.93 1.78 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.44 1.087 . . . . 61.539999999999999 109.262 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.409 ' O ' HG22 ' A' ' 219' ' ' THR . 34.4 m 64.19 61.44 0.91 Allowed 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.574 1.171 . . . . 72.510000000000005 110.354 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 170.25 -178.28 43.09 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 124.497 1.123 . . . . 70.120000000000005 110.986 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 221' ' ' TYR . 4.1 m-30 -90.06 124.94 35.21 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.562 0.801 . . . . 74.519999999999996 110.966 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.687 ' O ' HG22 ' A' ' 223' ' ' THR . . . 54.24 27.25 7.63 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.568 1.167 . . . . 64.349999999999994 109.315 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.687 HG22 ' O ' ' A' ' 222' ' ' ALA . 14.0 t 48.63 26.33 1.19 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.506 1.129 . . . . 74.219999999999999 110.329 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 86.42 -51.3 4.35 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.54 1.15 . . . . 75.540000000000006 111.031 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.448 ' OD1' HG22 ' A' ' 223' ' ' THR . 40.7 p30 -70.81 174.73 5.69 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.473 0.749 . . . . 70.439999999999998 109.328 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 229' ' ' GLU . 25.6 t0 -76.4 149.99 36.84 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.435 1.084 . . . . 63.299999999999997 109.333 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.634 HG13 HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -40.37 -55.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.463 1.102 . . . . 54.020000000000003 109.322 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.634 HD12 HG13 ' A' ' 227' ' ' VAL . 4.0 mp -55.9 -42.22 70.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.119 . . . . 70.140000000000001 109.315 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 226' ' ' ASP . 9.4 mt-10 -68.22 -14.59 63.09 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.455 1.097 . . . . 75.209999999999994 110.253 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -88.73 -18.91 26.83 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.528 1.142 . . . . 74.239999999999995 109.317 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.648 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.5 OUTLIER -68.34 -69.14 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.537 1.148 . . . . 62.25 109.24 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.648 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -59.84 -24.97 64.62 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.43 1.081 . . . . 74.140000000000001 109.226 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.51 -57.4 6.2 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.537 1.148 . . . . 60.119999999999997 109.991 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 234' ' ' VAL . 1.4 m -93.3 25.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.52 1.137 . . . . 70.420000000000002 109.24 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 3.4 m120 41.66 30.28 0.14 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.487 1.117 . . . . 72.310000000000002 109.292 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.563 HD12 ' HD2' ' A' ' 237' ' ' PRO . 7.9 tp -59.28 121.3 55.15 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.506 1.129 . . . . 61.109999999999999 109.334 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.563 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.3 Cg_endo -75.03 160.5 39.98 Favored 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.48 1.779 . . . . 50.200000000000003 111.029 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.516 HG22 ' H ' ' A' ' 239' ' ' VAL . 2.9 m -60.15 -179.35 0.1 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.5 1.125 . . . . 62.409999999999997 110.466 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.638 HG13 ' HG3' ' A' ' 240' ' ' GLN . 11.5 p -71.08 -34.42 54.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 54.119999999999997 109.329 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.638 ' HG3' HG13 ' A' ' 239' ' ' VAL . 2.4 mt-30 -85.32 -18.0 35.15 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.444 1.09 . . . . 55.130000000000003 110.302 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.413 ' HB2' ' N ' ' A' ' 238' ' ' THR . 34.1 mt-10 -84.84 -45.49 12.25 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.476 1.11 . . . . 75.219999999999999 110.293 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.549 ' CZ3' ' O ' ' A' ' 185' ' ' CYS . 7.5 t90 -67.77 -55.05 14.56 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.51 1.131 . . . . 74.120000000000005 107.962 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt -62.72 -18.39 62.45 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.522 1.138 . . . . 54.219999999999999 109.318 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.3 t -46.13 -66.49 0.4 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.474 1.109 . . . . 54.210000000000001 110.059 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -133.55 112.79 11.79 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.594 1.184 . . . . 64.25 109.314 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.436 ' HA ' HD13 ' A' ' 246' ' ' ILE . 14.0 mm -40.44 -63.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.429 1.08 . . . . 64.450000000000003 109.287 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -157.5 107.72 2.21 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.554 1.159 . . . . 53.399999999999999 109.3 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ARG . . . . . 0.534 ' O ' ' CG ' ' A' ' 249' ' ' TYR . 0.5 OUTLIER -121.37 -3.77 9.41 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.528 1.142 . . . . 75.400000000000006 110.261 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.534 ' CG ' ' O ' ' A' ' 248' ' ' ARG . 2.0 m-85 -175.06 172.37 2.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.521 1.138 . . . . 62.5 111.047 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.433 ' C ' ' N ' ' A' ' 252' ' ' SER . 3.1 ptpp? 40.44 37.95 0.51 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.547 1.155 . . . . 63.43 109.307 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.53 -30.07 0.1 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 63.140000000000001 109.28 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' SER . . . . . 0.433 ' N ' ' C ' ' A' ' 250' ' ' LYS . 12.4 t -65.5 -177.54 0.44 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.475 1.11 . . . . 64.420000000000002 110.015 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.434 ' O ' HD13 ' A' ' 254' ' ' ILE . 8.0 t-20 -114.51 148.15 38.34 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.512 1.132 . . . . 72.439999999999998 109.332 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.434 HD13 ' O ' ' A' ' 253' ' ' ASN . 50.1 mm -128.87 136.78 58.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.531 1.144 . . . . 63.210000000000001 109.355 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.5 t -145.85 153.33 40.75 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.441 1.088 . . . . 62.020000000000003 109.998 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.68 -179.88 3.94 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.503 1.127 . . . . 61.25 109.359 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -73.72 -136.63 0.34 Allowed Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.589 1.181 . . . . 43.549999999999997 111.101 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.7 m -141.67 -174.96 4.2 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.525 0.779 . . . . 72.319999999999993 109.986 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 30.2 m -127.56 -177.34 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.457 1.098 . . . . 64.439999999999998 109.258 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.434 1.084 . . . . 70.109999999999999 110.332 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.977 -0.379 . . . . 74.349999999999994 109.977 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 45.5 t -141.74 178.44 7.48 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.125 . . . . 74.310000000000002 109.994 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 86.1 p -97.83 -176.14 3.37 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.593 1.183 . . . . 73.439999999999998 109.973 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -113.61 -52.58 2.75 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.571 1.169 . . . . 44.509999999999998 109.299 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 53.58 29.0 8.51 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.533 1.146 . . . . 65.299999999999997 109.337 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -118.93 159.58 14.4 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.427 1.079 . . . . 40.450000000000003 111.003 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -118.94 8.56 11.69 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.442 0.731 . . . . 73.209999999999994 109.31 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 470' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -107.14 10.75 30.01 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.464 1.102 . . . . 71.109999999999999 110.979 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 471' ' ' ILE . . . . . 0.705 HG23 ' HD2' ' B' ' 472' ' ' PRO . 20.0 mm -83.82 142.06 41.81 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.494 1.121 . . . . 75.230000000000004 109.25 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 472' ' ' PRO . . . . . 0.705 ' HD2' HG23 ' B' ' 471' ' ' ILE . 18.2 Cg_endo -75.02 -175.95 2.63 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.456 1.766 . . . . 44.439999999999998 110.988 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 42.7 t -126.7 6.87 6.78 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.484 1.115 . . . . 35.310000000000002 109.997 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -142.44 157.04 63.47 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.545 1.153 . . . . 71.530000000000001 110.294 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 475' ' ' PRO . . . . . 0.702 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.2 Cg_endo -75.06 -26.11 11.13 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.478 1.778 . . . . 75.319999999999993 111.002 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 476' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 163.1 140.1 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.489 1.118 . . . . 74.299999999999997 109.254 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 477' ' ' PRO . . . . . 0.574 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -75.02 -163.4 0.18 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.534 1.807 . . . . 73.329999999999998 111.041 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 478' ' ' LYS . . . . . 0.403 ' N ' ' HD3' ' B' ' 478' ' ' LYS . 0.1 OUTLIER -128.54 90.81 45.46 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.51 1.131 . . . . 65.209999999999994 109.277 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 479' ' ' PRO . . . . . 0.633 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.5 Cg_endo -74.96 147.16 33.72 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.512 1.796 . . . . 53.509999999999998 111.025 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 480' ' ' PRO . . . . . 0.53 ' O ' ' CB ' ' B' ' 481' ' ' SER . 18.4 Cg_endo -74.99 117.96 5.1 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.511 1.795 . . . . 64.420000000000002 111.016 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 481' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' B' ' 480' ' ' PRO . 1.4 t 156.98 129.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.557 1.16 . . . . 65.040000000000006 109.966 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 34.9 t -104.47 88.89 3.06 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 124.486 1.116 . . . . 72.510000000000005 109.986 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -54.06 -33.12 56.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.529 1.143 . . . . 64.030000000000001 109.305 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 3.9 t -45.88 -47.37 16.12 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.492 1.12 . . . . 51.219999999999999 110.002 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -46.02 124.53 5.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.463 1.102 . . . . 71.209999999999994 109.324 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 53.6 p . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.519 1.137 . . . . 73.010000000000005 110.022 179.967 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.97 0 N-CA-C 110.99 -0.844 . . . . 41.340000000000003 110.99 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.1 p -86.67 49.35 1.79 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.482 0.754 . . . . 75.430000000000007 109.986 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.497 ' CB ' ' OD1' ' A' ' 216' ' ' ASP . 1.8 pp -55.02 121.71 9.31 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.56 1.162 . . . . 73.430000000000007 109.266 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.56 ' CD1' ' O ' ' A' ' 215' ' ' ILE . 9.6 p90 -150.12 -179.06 6.87 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.564 1.165 . . . . 73.420000000000002 110.957 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.437 ' CB ' HD11 ' A' ' 184' ' ' ILE . . . -115.98 152.73 32.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.558 1.161 . . . . 72.349999999999994 109.323 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.724 HD12 HD23 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -126.72 120.81 56.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 124.533 1.146 . . . . 43.399999999999999 109.298 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.781 HG22 HG12 ' A' ' 212' ' ' VAL . 2.5 t -74.42 121.67 26.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.544 1.152 . . . . 74.219999999999999 109.3 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.884 HD11 ' HB2' ' A' ' 213' ' ' SER . 0.4 OUTLIER -100.11 -12.32 19.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.578 1.174 . . . . 75.129999999999995 109.307 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.601 ' CE1' ' OG ' ' B' ' 481' ' ' SER . 0.9 OUTLIER -150.9 154.45 37.21 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.483 1.114 . . . . 73.400000000000006 111.046 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.661 ' N ' HG12 ' A' ' 178' ' ' VAL . 2.9 p30 -74.62 158.73 33.15 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.478 1.111 . . . . 74.329999999999998 109.231 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.488 ' HB2' ' CD1' ' A' ' 211' ' ' PHE . 8.8 t80 -154.51 130.69 10.34 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.527 1.142 . . . . 75.349999999999994 111.002 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -88.95 126.51 35.43 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.46 1.1 . . . . 74.25 109.26 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.798 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -113.64 151.14 32.16 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.518 1.136 . . . . 54.009999999999998 109.325 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.71 24.08 0.39 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.419 1.074 . . . . 74.109999999999999 110.275 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.471 ' HD3' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -100.87 -175.78 2.98 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.615 1.197 . . . . 60.130000000000003 109.287 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.18 -26.08 66.05 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.456 1.097 . . . . 71.140000000000001 109.344 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.456 ' HB3' ' CB ' ' A' ' 206' ' ' LEU . 60.4 m-20 -109.68 15.5 22.77 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.44 1.088 . . . . 71.409999999999997 109.268 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.798 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 17.7 pt-20 -36.1 110.01 0.1 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.439 1.087 . . . . 74.200000000000003 110.295 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.672 HD22 ' HA3' ' A' ' 205' ' ' GLY . 14.2 tp -128.93 103.91 7.29 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.546 1.154 . . . . 64.400000000000006 109.251 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.3 t -88.35 142.6 27.6 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.537 1.148 . . . . 53.149999999999999 110.368 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.464 ' CG2' ' HG2' ' A' ' 180' ' ' GLU . 17.0 m -155.16 162.89 40.85 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.533 1.146 . . . . 60.310000000000002 110.392 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -99.36 163.77 12.39 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.481 1.113 . . . . 74.120000000000005 111.027 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.661 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.6 m -57.72 158.16 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 71.040000000000006 109.29 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.424 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 49.88 68.19 1.5 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.51 1.131 . . . . 34.310000000000002 110.99 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.464 ' HG2' ' CG2' ' A' ' 176' ' ' THR . 3.8 tp10 -128.31 167.77 16.47 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.501 0.765 . . . . 74.510000000000005 110.262 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.45 132.65 53.5 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.429 1.08 . . . . 51.340000000000003 109.328 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.687 HD21 HG23 ' A' ' 162' ' ' VAL . 0.4 OUTLIER -143.25 158.03 43.98 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.495 1.122 . . . . 71.109999999999999 109.36 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 0.6 OUTLIER -114.55 113.09 23.95 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.483 1.115 . . . . 74.420000000000002 110.972 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.463 ' N ' HD12 ' A' ' 184' ' ' ILE . 1.7 mp -65.54 159.96 3.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 124.453 1.096 . . . . 62.299999999999997 109.312 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 186' ' ' ALA . 9.7 p -147.03 -44.39 0.18 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.583 1.177 . . . . 61.409999999999997 108.334 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.879 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -121.32 164.23 17.36 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.446 1.091 . . . . 74.549999999999997 109.32 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.416 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 1.3 p-80 -154.03 140.23 18.5 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.484 1.115 . . . . 60.299999999999997 109.602 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.681 ' NE2' HD11 ' A' ' 194' ' ' ILE . 0.1 OUTLIER -142.18 142.42 32.69 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.518 1.136 . . . . 74.120000000000005 109.577 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.48 ' C ' ' N ' ' A' ' 191' ' ' GLU . 19.2 t-20 50.62 22.1 1.02 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.469 1.105 . . . . 73.140000000000001 109.321 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.4 ' C ' ' O ' ' A' ' 189' ' ' ASN . 23.5 m 42.0 27.23 0.07 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.574 1.171 . . . . 54.119999999999997 108.245 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.524 ' O ' HG13 ' A' ' 209' ' ' VAL . 9.3 tt0 -125.11 -37.1 2.45 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.479 1.112 . . . . 64.430000000000007 110.293 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.821 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 97.2 m95 -109.78 128.77 55.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.505 1.128 . . . . 72.140000000000001 107.96 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.603 ' CE2' HG12 ' A' ' 209' ' ' VAL . 20.9 m-30 -122.18 127.04 49.56 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.488 1.118 . . . . 70.329999999999998 110.958 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.879 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 9.3 mm -89.23 106.34 16.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.493 1.12 . . . . 74.219999999999999 109.288 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -117.01 175.77 5.43 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.128 . . . . 72.549999999999997 109.333 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -147.56 165.56 18.42 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.442 1.089 . . . . 60.149999999999999 109.303 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.92 178.26 7.47 Favored 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.517 1.799 . . . . 71.439999999999998 110.96 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.495 ' CD1' ' O ' ' A' ' 198' ' ' ILE . 1.2 pp -105.06 68.8 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.56 1.162 . . . . 74.200000000000003 109.231 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 201' ' ' LEU . . . 160.97 122.79 0.64 Allowed Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.541 1.15 . . . . 40.219999999999999 110.984 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 199' ' ' GLY . 20.2 mmm180 -37.0 97.14 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.557 0.798 . . . . 75.109999999999999 110.31 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 199' ' ' GLY . 2.5 tp 173.8 137.48 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.513 1.133 . . . . 74.310000000000002 109.294 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 47.76 -157.69 0.76 Allowed Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.507 1.129 . . . . 70.129999999999995 110.931 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 52.83 171.44 0.03 OUTLIER Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.959 -0.856 . . . . 54.329999999999998 110.959 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.524 ' HB2' HG22 ' A' ' 194' ' ' ILE . 18.3 Cg_endo -74.94 129.05 17.59 Favored 'Cis proline' 0 C--N 1.362 1.248 0 C-N-CA 121.011 -2.495 . . . . 65.329999999999998 111.053 -0.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.672 ' HA3' HD22 ' A' ' 174' ' ' LEU . . . -92.63 163.31 27.19 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.519 1.137 . . . . 40.43 110.963 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.821 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -97.62 145.41 26.31 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.496 0.762 . . . . 71.040000000000006 109.326 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.562 HG11 HD11 ' A' ' 182' ' ' LEU . 0.4 OUTLIER -153.61 127.35 4.37 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.583 1.177 . . . . 64.549999999999997 109.344 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.611 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.2 Cg_endo -75.09 174.52 12.65 Favored 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.505 1.792 . . . . 74.200000000000003 110.995 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.603 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.6 m -97.03 7.01 8.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.484 1.115 . . . . 63.210000000000001 109.267 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLY . . . . . 0.457 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -106.93 -0.9 36.22 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.506 1.129 . . . . 44.5 110.948 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.572 ' CE2' ' HB3' ' B' ' 479' ' ' PRO . 12.7 m-85 -133.27 15.53 4.14 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.556 0.798 . . . . 71.209999999999994 111.046 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.781 HG12 HG22 ' A' ' 162' ' ' VAL . 3.4 m -152.62 157.66 4.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.548 1.155 . . . . 73.439999999999998 109.36 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.884 ' HB2' HD11 ' A' ' 163' ' ' LEU . 46.6 t -128.23 119.94 26.2 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.527 1.142 . . . . 61.25 110.056 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.631 ' C ' HG22 ' A' ' 215' ' ' ILE . 5.1 mm -64.48 153.22 7.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.495 1.122 . . . . 74.230000000000004 109.245 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.78 HD12 ' H ' ' A' ' 216' ' ' ASP . 0.4 OUTLIER 176.28 147.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.577 1.173 . . . . 73.010000000000005 109.309 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.78 ' H ' HD12 ' A' ' 215' ' ' ILE . 0.0 OUTLIER -123.31 -59.91 1.53 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.511 1.132 . . . . 61.109999999999999 109.284 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.773 HD13 ' C ' ' A' ' 217' ' ' ILE . 0.0 OUTLIER -168.56 105.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.548 1.155 . . . . 51.539999999999999 109.304 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -175.02 -179.03 1.3 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.552 1.158 . . . . 74.400000000000006 109.289 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 14.6 t -102.58 27.77 6.61 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.486 1.116 . . . . 51.140000000000001 110.353 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -142.69 -152.95 5.78 Favored Glycine 0 CA--C 1.529 0.929 0 O-C-N 124.477 1.111 . . . . 43.119999999999997 111.028 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.457 ' O ' ' HB3' ' A' ' 222' ' ' ALA . 23.9 m-85 -128.76 131.11 47.83 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.413 0.714 . . . . 53.43 110.979 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 221' ' ' TYR . . . 69.05 15.93 8.73 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.498 1.124 . . . . 71.420000000000002 109.314 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.494 ' CG2' ' O ' ' A' ' 223' ' ' THR . 0.6 OUTLIER 71.19 4.91 5.26 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.509 1.131 . . . . 52.0 110.428 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 101.32 -32.87 6.97 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.527 1.142 . . . . 72.510000000000005 110.964 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -77.4 176.08 9.18 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.501 0.765 . . . . 73.25 109.27 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 230' ' ' ASP . 0.7 OUTLIER -93.68 137.82 32.54 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.13 . . . . 75.430000000000007 109.366 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.454 HG21 ' HE2' ' A' ' 193' ' ' PHE . 1.3 p -49.11 -41.12 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.536 1.147 . . . . 72.109999999999999 109.283 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.761 ' HA ' HD12 ' A' ' 231' ' ' ILE . 12.3 mt -66.9 -33.94 66.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.586 1.178 . . . . 72.230000000000004 109.315 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -81.75 -17.52 47.43 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.425 1.078 . . . . 72.239999999999995 110.289 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 226' ' ' ASP . 6.5 t70 -88.7 -15.73 34.09 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.532 1.145 . . . . 72.219999999999999 109.278 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.761 HD12 ' HA ' ' A' ' 228' ' ' ILE . 6.7 mt -71.03 -69.44 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.459 1.099 . . . . 63.229999999999997 109.356 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.435 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -56.86 -21.19 27.48 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.468 1.105 . . . . 74.439999999999998 109.281 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.4 m -56.79 -17.92 10.92 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 72.450000000000003 110.019 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 234' ' ' VAL . 1.2 m -133.14 22.27 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.508 1.13 . . . . 70.200000000000003 109.284 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 40.75 37.22 0.47 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.618 1.199 . . . . 73.140000000000001 109.333 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.468 ' HB2' ' CG2' ' A' ' 234' ' ' VAL . 5.7 tp -66.16 119.63 63.36 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.424 1.078 . . . . 72.040000000000006 109.285 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 166.95 28.13 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.478 1.778 . . . . 74.540000000000006 111.018 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.6 m -68.43 173.58 4.81 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.446 1.091 . . . . 54.119999999999997 110.416 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.719 HG23 ' HB1' ' A' ' 186' ' ' ALA . 14.9 p -69.04 -49.02 66.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.473 1.108 . . . . 44.43 109.347 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 1.015 ' OE1' HD11 ' B' ' 471' ' ' ILE . 7.7 pm0 -73.04 -14.53 61.43 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.117 . . . . 71.239999999999995 110.292 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -90.53 -36.33 14.55 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.543 1.152 . . . . 62.439999999999998 110.313 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.583 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 1.3 t90 -80.48 -54.88 5.28 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.513 1.133 . . . . 73.540000000000006 107.997 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.504 ' HD3' ' CE2' ' B' ' 470' ' ' PHE . 3.0 mtmp? -57.85 -17.3 15.37 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.53 1.144 . . . . 65.219999999999999 109.22 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 247' ' ' ALA . 17.1 m -38.15 -45.2 0.91 Allowed 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.502 1.126 . . . . 62.32 109.947 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -42.62 -50.61 5.39 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.556 1.16 . . . . 75.120000000000005 109.377 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.551 ' H ' HD12 ' A' ' 246' ' ' ILE . 3.3 mp -55.16 -42.13 63.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.515 1.134 . . . . 72.120000000000005 109.298 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' A' ' 244' ' ' SER . . . -102.19 89.26 3.54 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 42.409999999999997 109.296 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 9.0 tpp85 -44.19 139.58 2.51 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.472 1.108 . . . . 72.25 110.339 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -144.26 -177.48 5.48 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.441 1.088 . . . . 75.510000000000005 110.981 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -47.79 147.47 1.93 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 72.200000000000003 109.286 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.99 -57.94 3.31 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.478 1.111 . . . . 62.119999999999997 109.306 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 5.0 m -60.36 112.27 1.88 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.388 1.055 . . . . 72.329999999999998 109.954 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.46 -1.59 13.41 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.632 1.208 . . . . 65.530000000000001 109.314 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 1.3 mp -85.18 111.24 20.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.518 1.136 . . . . 72.209999999999994 109.263 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.6 p -158.46 111.31 2.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.468 1.105 . . . . 71.430000000000007 109.98 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 7.2 tt -168.82 135.68 1.86 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.508 1.13 . . . . 60.43 109.284 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 172.55 92.41 0.08 OUTLIER Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.533 1.146 . . . . 73.040000000000006 111.021 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.3 p -133.18 -62.05 0.81 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.538 0.787 . . . . 64.530000000000001 109.993 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 1.6 p -171.72 148.69 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.474 1.109 . . . . 74.109999999999999 109.316 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.468 1.105 . . . . 73.5 110.391 179.976 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.997 -0.372 . . . . 62.439999999999998 109.997 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 29.9 t -90.3 9.01 30.43 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.548 1.155 . . . . 63.310000000000002 110.034 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 3.9 m -165.63 -177.44 4.38 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.459 1.099 . . . . 60.229999999999997 110.059 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -117.58 -67.93 0.96 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.578 1.174 . . . . 32.229999999999997 109.274 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -168.31 131.03 1.46 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.497 1.123 . . . . 74.349999999999994 109.332 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 468' ' ' GLY . . . . . 0.583 ' HA3' HD13 ' B' ' 471' ' ' ILE . . . -141.27 -179.35 18.41 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.508 1.13 . . . . 55.119999999999997 111.018 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -105.94 -17.03 14.48 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.502 0.766 . . . . 71.140000000000001 109.287 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 470' ' ' PHE . . . . . 0.683 ' CD2' HG21 ' A' ' 194' ' ' ILE . 4.9 m-30 -111.4 -2.78 15.48 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.537 1.148 . . . . 72.019999999999996 110.987 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 471' ' ' ILE . . . . . 1.015 HD11 ' OE1' ' A' ' 240' ' ' GLN . 1.4 mp -70.51 142.98 89.66 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.48 1.112 . . . . 74.540000000000006 109.259 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 472' ' ' PRO . . . . . 0.574 ' HG3' ' CD1' ' A' ' 192' ' ' TRP . 18.5 Cg_endo -74.92 161.53 38.81 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.513 1.796 . . . . 63.0 111.01 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 473' ' ' SER . . . . . 0.44 ' OG ' ' CZ ' ' B' ' 474' ' ' ARG . 29.6 t -98.72 -27.42 13.97 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.532 1.145 . . . . 61.450000000000003 109.989 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 474' ' ' ARG . . . . . 0.44 ' CZ ' ' OG ' ' B' ' 473' ' ' SER . 2.6 mmt180 -111.08 170.38 5.33 Favored Pre-proline 0 C--N 1.326 -0.428 0 O-C-N 124.527 1.142 . . . . 71.120000000000005 110.316 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -168.48 0.52 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.48 1.779 . . . . 74.239999999999995 110.974 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 476' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' B' ' 477' ' ' PRO . . . -73.28 134.93 79.71 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 52.439999999999998 109.296 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 477' ' ' PRO . . . . . 0.566 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -75.0 170.79 19.64 Favored 'Trans proline' 0 C--N 1.358 1.077 0 O-C-N 124.505 1.792 . . . . 63.299999999999997 111.027 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -113.11 95.27 34.11 Favored Pre-proline 0 C--N 1.324 -0.54 0 O-C-N 124.509 1.131 . . . . 61.100000000000001 109.284 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 479' ' ' PRO . . . . . 0.572 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 18.1 Cg_endo -74.99 168.62 24.43 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.483 1.781 . . . . 74.219999999999999 110.974 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 -89.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.498 1.789 . . . . 73.409999999999997 110.977 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 481' ' ' SER . . . . . 0.601 ' OG ' ' CE1' ' A' ' 164' ' ' TYR . 3.3 p -86.89 101.08 13.05 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.483 1.114 . . . . 62.109999999999999 110.026 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 7.1 t -139.63 -50.32 0.5 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 61.130000000000003 110.036 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 483' ' ' ALA . . . . . 0.675 ' HB3' ' OG ' ' B' ' 486' ' ' SER . . . -107.32 123.92 49.05 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.468 1.105 . . . . 45.229999999999997 109.303 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 27.4 t -58.77 118.9 6.22 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 124.469 1.105 . . . . 71.150000000000006 110.04 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . 55.5 50.77 13.95 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.488 1.118 . . . . 73.409999999999997 109.315 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 486' ' ' SER . . . . . 0.675 ' OG ' ' HB3' ' B' ' 483' ' ' ALA . 62.7 m . . . . . 0 C--N 1.326 -0.454 0 O-C-N 124.487 1.117 . . . . 62.340000000000003 109.977 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.995 0 N-CA-C 111.07 -0.812 . . . . 62.350000000000001 111.07 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.0 m -121.51 52.44 1.23 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.457 0.739 . . . . 61.509999999999998 109.968 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.04 144.12 32.28 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.45 1.094 . . . . 65.209999999999994 109.276 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.559 ' CE1' ' HB2' ' A' ' 183' ' ' PHE . 1.2 t80 -137.19 166.8 22.87 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.48 1.113 . . . . 73.349999999999994 111.009 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.594 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -113.72 142.48 45.98 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.546 1.154 . . . . 74.329999999999998 109.289 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.71 HD13 ' N ' ' A' ' 162' ' ' VAL . 0.0 OUTLIER -127.78 121.59 56.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.485 1.116 . . . . 74.439999999999998 109.302 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.879 ' CG1' HD21 ' A' ' 182' ' ' LEU . 7.0 m -83.47 126.88 40.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.442 1.089 . . . . 64.010000000000005 109.325 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.661 HD23 HD12 ' A' ' 161' ' ' ILE . 0.3 OUTLIER -99.6 -1.95 36.85 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.499 1.125 . . . . 72.219999999999999 109.305 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.533 ' CE2' ' HB2' ' A' ' 163' ' ' LEU . 0.9 OUTLIER -154.69 155.57 34.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.486 1.116 . . . . 74.340000000000003 111.071 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.781 ' N ' HG12 ' A' ' 178' ' ' VAL . 33.0 p-10 -96.49 154.03 17.5 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.465 1.103 . . . . 65.239999999999995 109.314 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.535 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 3.4 t80 -147.23 137.94 23.58 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.49 1.119 . . . . 73.230000000000004 111.019 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.535 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 5.9 mtmt -76.56 128.96 35.74 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.499 1.124 . . . . 74.319999999999993 109.292 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.957 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -110.86 141.99 43.5 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.46 1.1 . . . . 73.120000000000005 109.286 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -148.22 18.87 1.09 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.506 1.129 . . . . 72.120000000000005 110.266 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.455 ' O ' ' CG ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -100.25 -176.49 3.24 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.48 1.113 . . . . 71.420000000000002 109.306 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.06 -30.73 69.4 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.472 1.108 . . . . 52.420000000000002 109.29 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.478 ' CB ' ' HB2' ' A' ' 206' ' ' LEU . 1.0 OUTLIER -101.96 12.06 37.52 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.489 1.118 . . . . 72.319999999999993 109.307 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.957 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 8.5 pt-20 -33.75 105.57 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.529 1.143 . . . . 64.430000000000007 110.264 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.706 HD13 ' HA3' ' A' ' 205' ' ' GLY . 13.2 tp -119.46 107.12 12.94 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.484 1.115 . . . . 55.229999999999997 109.339 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.645 HG23 ' O ' ' A' ' 175' ' ' THR . 14.4 t -85.44 99.14 11.0 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.518 1.136 . . . . 53.009999999999998 110.419 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.46 176.08 5.28 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.545 1.153 . . . . 60.340000000000003 110.344 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -120.77 159.97 24.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.614 1.196 . . . . 54.109999999999999 110.962 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.781 HG12 ' N ' ' A' ' 165' ' ' ASP . 3.5 m -62.0 146.65 12.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.421 1.076 . . . . 63.130000000000003 109.259 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.42 66.14 3.05 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.503 1.127 . . . . 54.530000000000001 111.014 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.499 ' CB ' HG22 ' A' ' 162' ' ' VAL . 1.8 tp10 -132.73 169.27 16.93 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.473 0.749 . . . . 64.319999999999993 110.278 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -117.43 146.77 43.24 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.438 1.086 . . . . 72.200000000000003 109.299 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.879 HD21 ' CG1' ' A' ' 162' ' ' VAL . 0.2 OUTLIER -159.23 152.19 22.02 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 72.140000000000001 109.392 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.559 ' HB2' ' CE1' ' A' ' 159' ' ' TYR . 14.9 t80 -108.65 119.67 40.2 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.468 1.105 . . . . 71.129999999999995 111.044 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 160' ' ' ALA . 1.6 mp -64.82 155.95 6.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.411 1.069 . . . . 74.019999999999996 109.275 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.455 ' N ' ' O ' ' A' ' 194' ' ' ILE . 0.2 OUTLIER -138.66 -51.09 0.56 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.52 1.137 . . . . 75.030000000000001 108.341 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.972 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -120.73 166.29 13.92 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.506 1.129 . . . . 64.239999999999995 109.333 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.487 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.1 OUTLIER -151.37 141.37 22.08 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.41 1.068 . . . . 62.420000000000002 109.638 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.72 ' NE2' HD13 ' A' ' 194' ' ' ILE . 0.1 OUTLIER -143.2 141.0 30.98 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.421 1.076 . . . . 72.200000000000003 109.623 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.486 ' C ' ' N ' ' A' ' 191' ' ' GLU . 39.1 t-20 48.13 25.68 0.87 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.498 1.124 . . . . 74.439999999999998 109.251 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.437 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.9 p 39.02 30.19 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.519 1.137 . . . . 63.32 108.308 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.507 ' O ' HG13 ' A' ' 209' ' ' VAL . 8.6 tt0 -125.78 -37.92 2.26 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.504 1.128 . . . . 74.299999999999997 110.362 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.636 ' HB3' HD11 ' A' ' 206' ' ' LEU . 97.1 m95 -112.09 132.24 54.97 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.97 -1.122 . . . . 73.129999999999995 107.97 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.761 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.3 m-30 -125.12 129.31 49.93 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.541 1.151 . . . . 60.520000000000003 111.033 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.972 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 1.1 mp -91.27 98.12 8.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.541 1.15 . . . . 74.430000000000007 109.317 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -104.14 -175.73 2.88 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.541 1.151 . . . . 71.340000000000003 109.301 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.493 ' CD ' ' O ' ' A' ' 197' ' ' PRO . 0.0 OUTLIER -157.12 158.68 31.2 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 63.140000000000001 109.286 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.493 ' O ' ' CD ' ' A' ' 196' ' ' LYS . 18.2 Cg_endo -75.04 150.44 37.96 Favored 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.524 1.802 . . . . 74.349999999999994 111.024 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.535 HG23 ' N ' ' A' ' 199' ' ' GLY . 7.2 tp -65.99 -56.2 15.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.454 1.096 . . . . 64.340000000000003 109.316 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.535 ' N ' HG23 ' A' ' 198' ' ' ILE . . . -72.17 -117.62 0.06 OUTLIER Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.524 1.14 . . . . 44.329999999999998 111.022 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -136.07 43.76 2.5 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.491 0.759 . . . . 75.239999999999995 110.349 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.438 ' HB2' ' CB ' ' A' ' 197' ' ' PRO . 6.9 mp -77.26 -1.61 30.53 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 74.019999999999996 109.208 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 122.9 -141.19 13.72 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.528 1.142 . . . . 72.140000000000001 110.991 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.434 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . 94.43 169.01 37.29 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.99 -0.844 . . . . 51.399999999999999 110.99 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.565 ' HG2' ' CZ ' ' B' ' 470' ' ' PHE . 18.2 Cg_endo -75.05 133.25 30.59 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 121.008 -2.497 . . . . 74.409999999999997 110.925 0.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.706 ' HA3' HD13 ' A' ' 174' ' ' LEU . . . -100.44 151.03 18.98 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.478 1.111 . . . . 63.520000000000003 110.925 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.684 HD12 ' CD1' ' A' ' 194' ' ' ILE . 0.4 OUTLIER -90.45 144.2 26.03 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.539 0.788 . . . . 73.329999999999998 109.283 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.66 HG13 HD23 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -157.13 127.81 3.54 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.511 1.132 . . . . 73.239999999999995 109.288 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.442 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.4 Cg_endo -74.89 179.44 6.05 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.508 1.794 . . . . 63.0 111.041 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.761 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.0 OUTLIER -98.66 4.41 10.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.596 1.185 . . . . 73.129999999999995 109.274 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLY . . . . . 0.489 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -106.43 0.96 37.17 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 124.491 1.119 . . . . 73.120000000000005 110.964 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.614 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 6.9 m-85 -130.26 6.58 4.92 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.58 0.812 . . . . 74.510000000000005 110.978 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.788 HG12 HG12 ' A' ' 162' ' ' VAL . 1.5 m -150.88 153.82 9.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.473 1.108 . . . . 72.019999999999996 109.33 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.4 m -121.64 138.88 54.15 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.502 1.127 . . . . 55.210000000000001 110.025 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.645 ' O ' HG23 ' A' ' 215' ' ' ILE . 3.8 mm -87.46 124.07 40.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 124.489 1.118 . . . . 75.200000000000003 109.268 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 214' ' ' ILE . 10.8 pt -158.35 170.82 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.469 1.106 . . . . 75.219999999999999 109.304 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -134.52 -47.26 0.75 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.466 1.104 . . . . 75.319999999999993 109.265 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 12.7 pt -134.99 -177.44 2.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 124.508 1.13 . . . . 55.030000000000001 109.272 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -84.61 -179.18 7.08 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.485 1.116 . . . . 65.299999999999997 109.284 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.3 m 68.62 59.88 0.38 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.454 1.096 . . . . 65.340000000000003 110.405 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 107.38 -162.39 13.37 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.553 1.158 . . . . 75.510000000000005 110.902 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.593 ' HA ' HG22 ' A' ' 215' ' ' ILE . 43.7 m-85 -92.38 -173.12 3.31 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.436 0.727 . . . . 75.430000000000007 110.951 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.52 ' HB2' ' HA ' ' A' ' 215' ' ' ILE . . . -41.84 -73.78 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.513 1.133 . . . . 71.209999999999994 109.278 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.462 HG22 ' OD1' ' A' ' 225' ' ' ASN . 0.9 OUTLIER -120.78 -5.42 9.66 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.45 1.094 . . . . 74.299999999999997 110.433 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 93.47 18.39 38.81 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.468 1.105 . . . . 72.409999999999997 111.025 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.462 ' OD1' HG22 ' A' ' 223' ' ' THR . 0.8 OUTLIER -112.04 167.03 10.71 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.486 0.756 . . . . 73.099999999999994 109.315 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 229' ' ' GLU . 0.4 OUTLIER -78.61 148.83 33.1 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.532 1.145 . . . . 53.200000000000003 109.318 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.536 HG21 ' HE2' ' A' ' 193' ' ' PHE . 3.7 p -48.28 -49.17 12.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.116 . . . . 70.299999999999997 109.318 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.51 ' O ' ' CE ' ' A' ' 232' ' ' LYS . 3.2 mp -59.11 -29.62 41.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.428 1.08 . . . . 61.009999999999998 109.319 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 226' ' ' ASP . 15.5 mt-10 -81.41 -15.0 56.49 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.485 1.115 . . . . 73.230000000000004 110.281 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.409 ' CG ' ' ND2' ' A' ' 225' ' ' ASN . 1.6 m-20 -86.64 -15.76 38.7 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.499 1.125 . . . . 71.120000000000005 109.337 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.603 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.9 OUTLIER -72.71 -69.34 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 71.430000000000007 109.279 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.603 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -62.17 -17.55 58.34 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.51 1.131 . . . . 73.219999999999999 109.301 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.33 -39.61 60.85 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.504 1.127 . . . . 63.210000000000001 110.011 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 234' ' ' VAL . 1.6 m -117.17 27.43 3.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.532 1.145 . . . . 74.140000000000001 109.3 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 234' ' ' VAL . 6.8 m120 40.6 37.42 0.47 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.137 . . . . 73.329999999999998 109.222 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.417 ' HB2' ' CG2' ' A' ' 234' ' ' VAL . 3.8 tp -70.58 119.82 74.97 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.555 1.159 . . . . 73.109999999999999 109.268 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.4 ' HB2' ' CB ' ' A' ' 241' ' ' GLU . 18.3 Cg_endo -74.96 165.36 31.51 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.459 1.768 . . . . 74.25 111.004 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 239' ' ' VAL . 1.4 m -60.27 -177.65 0.07 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.507 1.129 . . . . 72.340000000000003 110.396 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.629 HG23 ' HB1' ' A' ' 186' ' ' ALA . 9.8 p -72.21 -35.06 51.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 50.420000000000002 109.35 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.567 ' HG3' HG13 ' A' ' 239' ' ' VAL . 0.5 OUTLIER -85.52 -17.56 36.03 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.455 1.097 . . . . 74.239999999999995 110.278 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.42 ' HB2' ' N ' ' A' ' 238' ' ' THR . 7.3 mm-40 -85.15 -42.08 15.08 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.465 1.103 . . . . 71.349999999999994 110.364 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.445 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 6.5 t90 -72.65 -60.47 2.22 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.039 -1.097 . . . . 74.310000000000002 108.039 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.564 ' HD3' ' CD2' ' B' ' 470' ' ' PHE . 4.1 mtmp? -57.41 -20.49 30.2 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.483 1.114 . . . . 63.43 109.322 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -41.75 -68.12 0.21 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.512 1.132 . . . . 55.25 110.091 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -135.24 100.25 4.49 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.564 1.165 . . . . 61.32 109.31 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 3.8 mt -55.3 -19.69 5.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.495 1.122 . . . . 74.409999999999997 109.287 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -93.11 27.07 2.59 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.615 1.197 . . . . 53.109999999999999 109.301 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ARG . . . . . 0.79 HH21 ' HB2' ' A' ' 251' ' ' ALA . 0.0 OUTLIER -48.27 139.66 8.37 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.449 1.093 . . . . 72.129999999999995 110.331 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.548 ' CE2' ' HG2' ' A' ' 250' ' ' LYS . 17.5 p90 -127.08 -46.62 1.51 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.497 1.123 . . . . 74.349999999999994 110.984 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.548 ' HG2' ' CE2' ' A' ' 249' ' ' TYR . 9.4 pttp -130.54 129.56 42.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.423 1.077 . . . . 63.32 109.354 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.79 ' HB2' HH21 ' A' ' 248' ' ' ARG . . . -82.25 175.03 10.61 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.397 1.061 . . . . 53.310000000000002 109.29 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 4.2 t -124.43 176.19 6.64 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.535 1.147 . . . . 73.129999999999995 109.997 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -77.97 1.07 21.95 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.582 1.176 . . . . 72.129999999999995 109.305 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.66 131.48 33.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.573 1.171 . . . . 61.43 109.275 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 7.4 t -175.83 146.43 0.73 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.447 1.092 . . . . 72.519999999999996 110.075 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -62.14 -75.7 0.07 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.553 1.158 . . . . 72.530000000000001 109.303 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 131.96 -154.74 21.11 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 124.531 1.144 . . . . 73.299999999999997 110.942 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.4 m -122.02 97.68 5.59 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.554 0.796 . . . . 61.310000000000002 110.052 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 82.1 t -126.75 107.32 16.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.483 1.114 . . . . 53.219999999999999 109.25 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.55 1.156 . . . . 45.240000000000002 110.339 179.958 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 109.998 -0.371 . . . . 63.329999999999998 109.998 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 30.3 t -104.86 62.74 0.7 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.433 1.083 . . . . 63.149999999999999 109.979 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 5.5 m -111.47 -178.47 3.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.597 1.186 . . . . 51.420000000000002 109.939 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -62.14 173.64 1.08 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 51.109999999999999 109.304 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -116.01 -40.51 3.3 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.519 1.137 . . . . 65.040000000000006 109.273 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . 168.2 135.45 1.88 Allowed Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.475 1.109 . . . . 25.510000000000002 111.0 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 469' ' ' LYS . . . . . 0.41 ' HD2' ' N ' ' B' ' 469' ' ' LYS . 0.0 OUTLIER -104.27 -24.28 13.14 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.521 0.777 . . . . 74.409999999999997 109.299 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 470' ' ' PHE . . . . . 0.582 ' HB3' HG21 ' A' ' 239' ' ' VAL . 4.0 m-30 -102.74 33.91 3.03 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.467 1.104 . . . . 72.230000000000004 111.001 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 471' ' ' ILE . . . . . 0.472 HG23 ' HD2' ' B' ' 472' ' ' PRO . 0.9 OUTLIER -100.59 138.91 20.24 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.46 1.1 . . . . 71.209999999999994 109.279 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 472' ' ' PRO . . . . . 0.625 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.99 -45.6 0.27 Allowed 'Trans proline' 0 C--N 1.359 1.117 0 O-C-N 124.502 1.791 . . . . 71.329999999999998 111.033 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 473' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' B' ' 472' ' ' PRO . 0.1 OUTLIER 80.36 5.7 1.68 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.481 1.113 . . . . 74.439999999999998 110.027 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -132.01 157.26 78.72 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.565 1.165 . . . . 73.200000000000003 110.325 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 475' ' ' PRO . . . . . 0.7 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.0 Cg_endo -75.03 -48.09 0.18 Allowed 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.531 1.806 . . . . 52.219999999999999 110.971 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 476' ' ' ALA . . . . . 0.7 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 162.94 136.64 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.522 1.139 . . . . 75.519999999999996 109.322 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 477' ' ' PRO . . . . . 0.554 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.8 Cg_endo -74.89 -177.35 3.38 Favored 'Trans proline' 0 C--N 1.359 1.115 0 O-C-N 124.484 1.781 . . . . 63.030000000000001 111.069 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.54 92.29 28.05 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 61.299999999999997 109.317 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 479' ' ' PRO . . . . . 0.614 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.2 Cg_endo -75.01 151.53 39.58 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.489 1.784 . . . . 53.549999999999997 110.968 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 480' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 479' ' ' PRO . 18.3 Cg_endo -75.04 159.93 40.64 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.533 1.807 . . . . 74.219999999999999 111.006 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 481' ' ' SER . . . . . . . . . . . . . 3.7 m 42.35 48.8 4.46 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.45 1.094 . . . . 65.219999999999999 110.051 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 2.2 t -87.95 132.65 34.16 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.523 1.14 . . . . 74.25 109.969 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 483' ' ' ALA . . . . . 0.403 ' C ' ' N ' ' B' ' 485' ' ' ALA . . . -100.19 -21.47 15.51 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.443 1.089 . . . . 53.020000000000003 109.288 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 32.0 t -44.04 -27.4 0.37 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.539 1.15 . . . . 75.420000000000002 109.979 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 485' ' ' ALA . . . . . 0.403 ' N ' ' C ' ' B' ' 483' ' ' ALA . . . -153.03 156.82 39.51 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 1.114 . . . . 75.120000000000005 109.318 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 38.9 m . . . . . 0 C--N 1.325 -0.488 0 O-C-N 124.548 1.155 . . . . 75.040000000000006 109.99 -179.952 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.012 0 N-CA-C 111.103 -0.799 . . . . 63.420000000000002 111.103 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.1 m -107.26 125.52 51.25 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.542 0.789 . . . . 74.010000000000005 109.995 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.539 HD11 HG11 ' A' ' 234' ' ' VAL . 25.2 mt -100.81 128.08 47.0 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 72.409999999999997 109.336 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.65 ' CD2' ' CG1' ' A' ' 215' ' ' ILE . 2.5 t80 -130.2 138.4 50.56 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.512 1.133 . . . . 62.009999999999998 110.975 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.6 ' O ' ' CE1' ' A' ' 159' ' ' TYR . . . -110.71 147.67 33.89 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.52 1.138 . . . . 73.420000000000002 109.305 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.609 HD13 ' N ' ' A' ' 162' ' ' VAL . 0.1 OUTLIER -129.45 131.2 67.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.484 1.115 . . . . 65.209999999999994 109.38 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.941 HG22 HG12 ' A' ' 212' ' ' VAL . 1.5 t -88.73 125.61 41.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.462 1.101 . . . . 71.129999999999995 109.307 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.549 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 1.7 mt -101.11 -13.34 18.22 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.502 1.126 . . . . 74.239999999999995 109.296 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.567 ' O ' HG13 ' A' ' 162' ' ' VAL . 1.5 m-85 -148.27 156.26 42.33 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.471 1.107 . . . . 61.439999999999998 111.041 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.475 ' H ' HG12 ' A' ' 178' ' ' VAL . 5.6 p-10 -105.95 160.57 15.17 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.55 1.156 . . . . 63.310000000000002 109.295 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.566 ' HB3' ' CE1' ' A' ' 211' ' ' PHE . 0.3 OUTLIER -159.7 164.51 33.9 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.492 1.12 . . . . 72.450000000000003 110.979 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -89.84 130.77 36.03 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.513 1.133 . . . . 72.200000000000003 109.256 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.799 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -104.42 141.65 35.97 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.448 1.092 . . . . 51.409999999999997 109.315 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.8 ' H ' ' HZ3' ' A' ' 170' ' ' LYS . 7.7 pt-20 -151.91 21.68 0.68 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.461 1.101 . . . . 73.430000000000007 110.303 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.8 ' HZ3' ' H ' ' A' ' 169' ' ' GLU . 0.1 OUTLIER -98.12 -175.93 3.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.524 1.14 . . . . 75.109999999999999 109.338 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.12 -29.79 65.8 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.434 1.083 . . . . 54.25 109.328 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 173' ' ' GLU . 3.2 m-20 -110.08 22.81 15.14 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.53 1.143 . . . . 61.340000000000003 109.263 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.799 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 6.2 pt-20 -38.16 106.14 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.475 1.11 . . . . 75.230000000000004 110.322 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.712 HD13 ' CA ' ' A' ' 205' ' ' GLY . 0.6 OUTLIER -126.82 120.93 30.5 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.491 1.12 . . . . 62.109999999999999 109.34 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 11.9 t -87.65 118.49 27.17 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.558 1.162 . . . . 74.209999999999994 110.359 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.532 HG21 HG21 ' A' ' 162' ' ' VAL . 0.6 OUTLIER -120.45 175.52 5.94 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.52 1.138 . . . . 75.319999999999993 110.363 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -127.77 152.9 47.19 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 74.120000000000005 111.052 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 165' ' ' ASP . 3.1 m -51.44 155.05 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 60.340000000000003 109.318 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 44.3 74.09 0.23 Allowed Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.519 1.137 . . . . 75.420000000000002 110.985 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -132.24 162.19 31.58 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.431 0.724 . . . . 54.329999999999998 110.347 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.16 120.54 40.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.529 1.143 . . . . 75.120000000000005 109.292 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.943 HD12 HG21 ' A' ' 207' ' ' VAL . 1.2 pt? -136.46 143.83 44.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.504 1.127 . . . . 32.109999999999999 109.32 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 41.7 t80 -104.85 111.24 23.92 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.465 1.103 . . . . 53.229999999999997 111.014 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.995 HD13 ' HB2' ' A' ' 195' ' ' ALA . 19.0 mm -54.42 164.83 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.523 1.139 . . . . 53.210000000000001 109.313 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.466 ' N ' ' CG2' ' A' ' 184' ' ' ILE . 0.1 OUTLIER -151.84 -45.91 0.11 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.498 1.124 . . . . 70.409999999999997 108.344 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.881 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -125.66 174.54 8.22 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.501 1.126 . . . . 71.140000000000001 109.344 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.619 ' C ' ' CD2' ' A' ' 188' ' ' HIS . 3.2 p-80 -155.02 154.02 31.86 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 71.319999999999993 109.639 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 1.115 ' CE1' HG11 ' A' ' 239' ' ' VAL . 0.1 OUTLIER -144.11 120.93 11.25 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.51 1.131 . . . . 73.409999999999997 109.535 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.453 ' C ' ' N ' ' A' ' 191' ' ' GLU . 55.4 t30 52.05 32.72 10.73 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.455 1.097 . . . . 51.329999999999998 109.345 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.404 ' CB ' HG12 ' A' ' 228' ' ' ILE . 9.6 m 41.67 29.24 0.1 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.511 1.132 . . . . 64.340000000000003 108.316 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.659 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 16.8 tt0 -120.92 -38.55 2.82 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.469 1.106 . . . . 75.430000000000007 110.294 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.714 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 90.2 m95 -113.26 137.61 51.22 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.538 1.149 . . . . 62.409999999999997 108.009 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.894 ' HB3' HD12 ' A' ' 184' ' ' ILE . 22.4 m-30 -125.83 135.63 52.19 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.469 1.106 . . . . 73.209999999999994 111.032 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.881 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 6.3 mm -100.74 95.63 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 71.129999999999995 109.261 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.995 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -99.09 -179.72 4.34 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.516 1.135 . . . . 62.149999999999999 109.269 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.453 ' CG ' ' C ' ' A' ' 195' ' ' ALA . 10.2 mtpt -151.1 162.98 25.21 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.447 1.092 . . . . 71.450000000000003 109.333 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.467 ' CB ' ' HB2' ' A' ' 200' ' ' ARG . 18.1 Cg_endo -75.05 177.74 8.2 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.493 1.786 . . . . 74.299999999999997 110.967 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.643 ' O ' HG22 ' A' ' 198' ' ' ILE . 5.3 mp -110.12 14.55 8.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.523 1.14 . . . . 61.32 109.308 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -169.82 -44.53 0.03 OUTLIER Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.548 1.155 . . . . 54.030000000000001 111.051 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.467 ' HB2' ' CB ' ' A' ' 197' ' ' PRO . 1.9 mpt_? -58.55 172.75 0.46 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.484 0.755 . . . . 72.400000000000006 110.292 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 11.9 tp -114.52 -10.51 12.55 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.388 1.055 . . . . 71.209999999999994 109.263 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . -43.16 -53.51 5.62 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.509 1.13 . . . . 61.310000000000002 111.049 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.441 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . -42.73 167.05 0.01 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.062 -0.815 . . . . 51.130000000000003 111.062 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.486 ' HB2' HG22 ' A' ' 194' ' ' ILE . 18.5 Cg_endo -74.97 129.01 17.49 Favored 'Cis proline' 0 C--N 1.359 1.112 0 C-N-CA 120.949 -2.521 . . . . 74.450000000000003 111.024 -0.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.712 ' CA ' HD13 ' A' ' 174' ' ' LEU . . . -96.34 141.93 15.87 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.514 1.134 . . . . 75.040000000000006 111.025 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.714 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -91.2 147.21 23.21 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.552 0.795 . . . . 72.040000000000006 109.295 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.943 HG21 HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -161.06 129.14 2.85 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.542 1.152 . . . . 51.119999999999997 109.336 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.889 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.2 Cg_endo -75.03 179.91 5.64 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.565 1.824 . . . . 70.030000000000001 110.927 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.791 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.6 OUTLIER -96.12 3.32 9.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 124.443 1.089 . . . . 65.129999999999995 109.306 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -103.89 -5.93 43.75 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.487 1.117 . . . . 55.119999999999997 111.033 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.619 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 5.2 m-85 -125.98 1.76 7.29 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.505 0.767 . . . . 61.549999999999997 110.983 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.941 HG12 HG22 ' A' ' 162' ' ' VAL . 3.5 m -141.28 167.76 16.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.574 1.171 . . . . 72.329999999999998 109.306 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.521 ' OG ' HD21 ' A' ' 163' ' ' LEU . 13.1 p -136.2 132.98 36.62 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.445 1.091 . . . . 55.140000000000001 109.997 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.496 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 2.9 mm -76.4 144.68 11.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.475 1.109 . . . . 71.510000000000005 109.277 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.65 ' CG1' ' CD2' ' A' ' 159' ' ' TYR . 0.2 OUTLIER -156.2 153.84 6.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 124.459 1.1 . . . . 62.219999999999999 109.31 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -157.04 174.71 15.11 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 124.388 1.055 . . . . 74.120000000000005 109.247 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.577 ' H ' HD12 ' A' ' 217' ' ' ILE . 4.7 mp -82.03 54.93 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.47 1.106 . . . . 63.039999999999999 109.264 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -116.05 15.58 16.1 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.462 1.101 . . . . 64.099999999999994 109.281 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.54 ' O ' HG22 ' A' ' 219' ' ' THR . 18.6 m 55.08 54.94 8.21 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.482 1.114 . . . . 55.43 110.427 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 174.37 -173.81 46.19 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.524 1.14 . . . . 71.129999999999995 110.971 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -120.16 138.77 53.41 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.482 0.754 . . . . 71.230000000000004 111.014 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.682 ' O ' HG22 ' A' ' 223' ' ' THR . . . 53.49 25.72 4.97 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.52 1.138 . . . . 51.409999999999997 109.273 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.682 HG22 ' O ' ' A' ' 222' ' ' ALA . 13.5 t 48.45 28.69 1.78 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.459 1.099 . . . . 60.149999999999999 110.367 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 81.92 -51.3 4.43 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.497 1.123 . . . . 71.329999999999998 111.024 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -68.44 169.52 10.63 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.499 0.764 . . . . 73.150000000000006 109.261 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 229' ' ' GLU . 14.0 t0 -73.37 147.7 44.08 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.55 1.156 . . . . 75.219999999999999 109.211 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.408 ' H ' HG12 ' A' ' 227' ' ' VAL . 0.2 OUTLIER -39.85 -56.27 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.45 1.094 . . . . 75.209999999999994 109.282 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.404 HG12 ' CB ' ' A' ' 190' ' ' CYS . 9.9 mt -55.94 -42.46 71.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.499 1.125 . . . . 74.109999999999999 109.274 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 226' ' ' ASP . 21.2 mt-10 -66.45 -14.16 61.81 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.506 1.129 . . . . 55.5 110.329 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.569 ' O ' HG13 ' A' ' 234' ' ' VAL . 33.7 t0 -88.67 -23.27 23.05 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.564 1.165 . . . . 72.299999999999997 109.299 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.61 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.6 OUTLIER -63.66 -69.4 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.483 1.114 . . . . 63.539999999999999 109.323 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.61 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -55.85 -30.58 61.71 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.44 1.088 . . . . 75.420000000000002 109.3 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.4 m -52.94 -50.63 63.63 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 44.130000000000003 109.954 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 230' ' ' ASP . 1.3 m -89.88 16.08 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.471 1.107 . . . . 53.32 109.26 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 234' ' ' VAL . 37.7 t30 40.56 44.53 1.78 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.516 1.135 . . . . 70.230000000000004 109.296 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.45 HD12 ' HD2' ' A' ' 237' ' ' PRO . 1.1 tp -83.02 119.74 74.79 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.457 1.098 . . . . 74.129999999999995 109.307 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.45 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.4 Cg_endo -75.01 164.37 33.48 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.52 1.8 . . . . 42.329999999999998 111.023 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.613 HG22 ' H ' ' A' ' 239' ' ' VAL . 3.4 m -58.81 -175.72 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.484 1.115 . . . . 63.350000000000001 110.364 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 1.115 HG11 ' CE1' ' A' ' 188' ' ' HIS . 2.6 p -74.17 -36.27 43.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.5 1.125 . . . . 74.25 109.333 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.536 ' HG3' HG13 ' A' ' 239' ' ' VAL . 5.3 mt-30 -82.65 -17.88 43.04 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.492 1.12 . . . . 74.25 110.315 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.405 ' CB ' ' HB2' ' A' ' 237' ' ' PRO . 16.3 mt-10 -87.07 -38.54 16.42 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.531 1.144 . . . . 71.420000000000002 110.299 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.433 ' CH2' ' HB3' ' A' ' 185' ' ' CYS . 6.1 t90 -78.35 -61.33 2.04 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.531 1.144 . . . . 74.109999999999999 108.001 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 9.3 mtmt -53.92 -20.53 6.2 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.428 1.08 . . . . 70.120000000000005 109.3 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.9 p -39.17 -48.41 1.74 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.542 1.152 . . . . 75.049999999999997 109.993 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.414 ' C ' ' N ' ' A' ' 247' ' ' ALA . 3.7 t-20 -160.48 113.73 2.08 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.61 1.194 . . . . 75.430000000000007 109.295 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 4.9 mm -43.76 -28.59 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.471 1.107 . . . . 64.310000000000002 109.328 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.414 ' N ' ' C ' ' A' ' 245' ' ' ASN . . . -102.63 69.05 1.06 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.515 1.134 . . . . 72.519999999999996 109.313 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' ARG . . . . . 0.415 ' NE ' ' O ' ' A' ' 249' ' ' TYR . 3.3 tmm_? -48.2 104.9 0.06 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.526 1.142 . . . . 75.239999999999995 110.218 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.519 ' C ' ' CD1' ' A' ' 249' ' ' TYR . 0.1 OUTLIER -75.09 176.74 6.97 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.522 1.138 . . . . 41.32 110.956 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -44.92 141.42 2.19 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.513 1.133 . . . . 50.130000000000003 109.306 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -158.45 -179.31 7.98 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.51 1.131 . . . . 74.219999999999999 109.297 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 253' ' ' ASN . 1.7 t -114.37 172.46 7.0 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.478 1.112 . . . . 63.210000000000001 110.012 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.466 ' C ' HD12 ' A' ' 254' ' ' ILE . 18.7 t-20 -110.26 163.28 13.79 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.436 1.085 . . . . 54.509999999999998 109.321 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.556 HD12 ' N ' ' A' ' 254' ' ' ILE . 3.3 mp -141.28 158.16 22.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.485 1.115 . . . . 55.420000000000002 109.305 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 17.5 p -145.18 129.61 17.86 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.454 1.096 . . . . 42.25 110.028 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 97.4 mt -140.64 106.75 5.21 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.519 1.137 . . . . 73.310000000000002 109.291 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -38.17 124.77 1.45 Allowed Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.512 1.132 . . . . 73.209999999999994 111.066 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 13.9 m -125.15 145.45 49.94 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.524 0.779 . . . . 62.100000000000001 109.997 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.5 p -58.21 113.22 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.472 1.107 . . . . 62.450000000000003 109.339 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.5 0 O-C-N 124.471 1.107 . . . . 75.109999999999999 110.344 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 110.023 -0.362 . . . . 74.049999999999997 110.023 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 44.1 t -65.29 124.33 21.91 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.508 1.13 . . . . 54.299999999999997 110.034 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 28.6 m -125.76 12.49 7.93 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.579 1.174 . . . . 74.219999999999999 109.995 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -156.44 168.45 27.32 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.472 1.107 . . . . 72.340000000000003 109.252 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -112.64 -54.81 2.59 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.487 1.117 . . . . 72.430000000000007 109.31 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . 73.23 125.08 0.09 OUTLIER Glycine 0 CA--C 1.531 1.08 0 O-C-N 124.459 1.1 . . . . 75.540000000000006 110.976 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 9.3 tptp -111.41 -12.21 14.04 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.515 0.774 . . . . 75.109999999999999 109.317 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 470' ' ' PHE . . . . . 0.447 ' CE2' ' HG2' ' A' ' 204' ' ' PRO . 5.2 m-30 -86.94 13.99 8.11 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.463 1.102 . . . . 74.239999999999995 111.009 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 471' ' ' ILE . . . . . 0.514 HG22 ' HD2' ' B' ' 472' ' ' PRO . 2.8 mm -84.82 140.32 37.67 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.491 1.12 . . . . 64.519999999999996 109.353 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 472' ' ' PRO . . . . . 0.514 ' HD2' HG22 ' B' ' 471' ' ' ILE . 18.4 Cg_endo -74.92 130.28 13.22 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.528 1.804 . . . . 73.420000000000002 111.04 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 46.3 t -78.54 -73.06 0.34 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.456 1.098 . . . . 21.219999999999999 109.981 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -65.1 160.03 60.22 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.523 1.139 . . . . 54.530000000000001 110.311 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 -167.27 0.41 Allowed 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.461 1.769 . . . . 51.329999999999998 110.994 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 476' ' ' ALA . . . . . 0.659 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . -62.86 138.81 97.19 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.496 1.122 . . . . 53.219999999999999 109.281 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 477' ' ' PRO . . . . . 0.581 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -75.04 -162.43 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.491 1.785 . . . . 72.439999999999998 111.029 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 478' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -136.18 90.75 17.76 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.479 1.112 . . . . 72.209999999999994 109.278 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 479' ' ' PRO . . . . . 0.619 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.92 168.41 24.9 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.428 1.752 . . . . 61.350000000000001 110.973 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 480' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' B' ' 482' ' ' SER . 18.5 Cg_endo -74.92 -44.84 0.32 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.565 1.824 . . . . 74.540000000000006 111.106 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 481' ' ' SER . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 164' ' ' TYR . 0.7 OUTLIER -38.92 -30.18 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.437 1.086 . . . . 54.039999999999999 110.054 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 482' ' ' SER . . . . . 0.444 ' N ' ' O ' ' B' ' 480' ' ' PRO . 1.5 t -85.73 108.23 17.96 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.585 1.178 . . . . 63.0 109.996 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -101.73 22.51 12.74 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.473 1.108 . . . . 72.099999999999994 109.332 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 24.2 t -124.71 48.79 1.92 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.493 1.121 . . . . 74.430000000000007 110.021 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -105.52 99.98 9.57 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.543 1.152 . . . . 60.329999999999998 109.359 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 20.2 p . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.513 1.133 . . . . 73.540000000000006 109.978 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.023 0 N-CA-C 110.965 -0.854 . . . . 62.119999999999997 110.965 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.1 p -52.72 -53.04 53.25 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.488 0.758 . . . . 75.299999999999997 110.025 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 158' ' ' LEU . 4.6 pp -171.35 143.73 1.88 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.465 1.103 . . . . 63.310000000000002 109.29 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -156.87 -178.77 7.61 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.498 1.123 . . . . 72.450000000000003 110.973 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.904 ' O ' HD12 ' A' ' 182' ' ' LEU . . . -108.82 147.7 31.69 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.485 1.115 . . . . 73.140000000000001 109.305 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.595 HD13 ' N ' ' A' ' 162' ' ' VAL . 0.1 OUTLIER -120.82 135.14 61.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.509 1.131 . . . . 62.32 109.262 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.853 HG22 HG12 ' A' ' 212' ' ' VAL . 2.3 t -93.32 121.01 43.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.455 1.097 . . . . 55.43 109.305 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.56 HD21 HG23 ' A' ' 161' ' ' ILE . 0.4 OUTLIER -101.44 -11.5 19.3 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.503 1.127 . . . . 55.350000000000001 109.295 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.657 ' O ' HG13 ' A' ' 162' ' ' VAL . 3.3 m-85 -144.6 160.29 41.41 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 73.329999999999998 111.003 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.762 ' N ' HG12 ' A' ' 178' ' ' VAL . 21.7 p30 -107.95 157.71 17.98 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.554 1.159 . . . . 75.200000000000003 109.305 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.599 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 1.2 t80 -160.45 136.43 8.44 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.436 1.085 . . . . 70.439999999999998 111.012 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.599 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 12.0 mtpp -67.37 122.69 18.47 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.448 1.093 . . . . 74.400000000000006 109.313 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.83 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -90.62 140.12 30.06 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.585 1.178 . . . . 62.200000000000003 109.3 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -152.19 21.69 0.65 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.508 1.13 . . . . 74.129999999999995 110.283 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.473 ' HD3' ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -98.72 -176.66 3.42 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.505 1.128 . . . . 65.400000000000006 109.335 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' B' ' 471' ' ' ILE . . . -59.93 -24.87 64.7 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.462 1.101 . . . . 73.310000000000002 109.326 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 173' ' ' GLU . 59.7 t0 -113.68 20.44 15.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.458 1.099 . . . . 62.530000000000001 109.281 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.83 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 5.1 pt-20 -36.82 100.51 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 1.104 . . . . 72.450000000000003 110.352 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.485 ' HG ' ' CA ' ' A' ' 205' ' ' GLY . 0.1 OUTLIER -132.03 96.2 3.85 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.499 1.124 . . . . 73.299999999999997 109.344 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.6 t -59.55 148.82 31.93 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.483 1.115 . . . . 63.340000000000003 110.416 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 14.4 m -155.9 117.04 3.87 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.559 1.162 . . . . 71.209999999999994 110.435 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -63.94 157.58 24.53 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.512 1.132 . . . . 73.040000000000006 110.975 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.762 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.5 m -58.24 158.19 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.557 1.16 . . . . 63.200000000000003 109.249 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.424 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 52.54 62.54 5.71 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.479 1.112 . . . . 63.340000000000003 110.998 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -120.2 170.91 8.89 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.514 0.773 . . . . 74.430000000000007 110.244 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -129.17 117.56 20.98 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.552 1.157 . . . . 60.130000000000003 109.325 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.913 ' CD2' HG11 ' A' ' 207' ' ' VAL . 0.2 OUTLIER -130.58 149.71 52.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.538 1.149 . . . . 54.210000000000001 109.315 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -104.13 104.34 14.26 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.531 1.145 . . . . 72.519999999999996 111.002 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.737 HD12 ' HB2' ' A' ' 160' ' ' ALA . 22.1 mt -68.56 158.46 5.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.468 1.105 . . . . 74.400000000000006 109.354 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.603 ' SG ' ' CZ3' ' A' ' 242' ' ' TRP . 27.0 t -152.16 -41.59 0.11 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.522 1.139 . . . . 73.340000000000003 108.332 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.989 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -112.22 155.58 23.77 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.547 1.155 . . . . 73.439999999999998 109.297 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.572 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.8 OUTLIER -148.33 145.04 27.95 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.497 1.123 . . . . 74.200000000000003 109.649 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.582 ' NE2' HD11 ' A' ' 194' ' ' ILE . 0.1 OUTLIER -143.55 141.41 30.68 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.525 1.141 . . . . 63.409999999999997 109.603 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.462 ' C ' ' N ' ' A' ' 191' ' ' GLU . 3.1 m120 49.44 23.34 0.86 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.46 1.1 . . . . 72.129999999999995 109.261 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.408 ' C ' ' O ' ' A' ' 189' ' ' ASN . 18.1 m 41.22 28.88 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.117 . . . . 72.5 108.293 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.485 ' O ' HG13 ' A' ' 209' ' ' VAL . 8.5 tt0 -126.59 -38.58 2.07 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.575 1.172 . . . . 74.140000000000001 110.299 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.878 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 98.8 m95 -111.55 128.48 56.04 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.527 1.142 . . . . 64.430000000000007 108.058 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.776 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.1 m-30 -120.11 126.2 50.14 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.489 1.118 . . . . 74.439999999999998 111.001 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.989 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 5.6 mm -86.63 104.36 13.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.53 1.144 . . . . 72.420000000000002 109.262 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.58 ' HB2' ' CG1' ' A' ' 184' ' ' ILE . . . -112.92 175.85 5.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.498 1.124 . . . . 61.409999999999997 109.263 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.474 ' CG ' ' HD2' ' A' ' 197' ' ' PRO . 2.3 ttmp? -137.99 142.66 36.7 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.131 . . . . 63.32 109.323 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.474 ' HD2' ' CG ' ' A' ' 196' ' ' LYS . 18.3 Cg_endo -75.03 155.77 42.83 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.512 1.796 . . . . 73.420000000000002 110.993 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.675 HD13 ' N ' ' A' ' 199' ' ' GLY . 0.1 OUTLIER -121.23 123.14 69.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.478 1.111 . . . . 74.430000000000007 109.318 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.675 ' N ' HD13 ' A' ' 198' ' ' ILE . . . 103.45 -34.97 5.34 Favored Glycine 0 CA--C 1.529 0.937 0 O-C-N 124.474 1.109 . . . . 42.32 111.051 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -90.75 169.48 10.92 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.492 0.76 . . . . 74.239999999999995 110.349 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 8.0 mp -109.24 115.96 31.0 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.443 1.09 . . . . 72.239999999999995 109.314 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 158.15 -131.34 2.8 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.471 1.107 . . . . 54.420000000000002 110.985 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 54.66 176.09 0.12 Allowed Glycine 0 CA--C 1.529 0.969 0 N-CA-C 111.008 -0.837 . . . . 75.209999999999994 111.008 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.444 ' HD2' ' CZ ' ' B' ' 470' ' ' PHE . 18.4 Cg_endo -74.96 146.11 85.78 Favored 'Cis proline' 0 C--N 1.36 1.182 0 C-N-CA 121.028 -2.488 . . . . 74.0 111.009 -0.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 195' ' ' ALA . . . -104.7 138.56 14.22 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.494 1.121 . . . . 41.32 110.986 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.878 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -83.37 146.76 28.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.574 0.808 . . . . 73.439999999999998 109.384 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.913 HG11 ' CD2' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -153.36 127.01 4.31 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.458 1.099 . . . . 61.439999999999998 109.288 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.943 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.4 Cg_endo -74.92 174.9 11.96 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.455 1.766 . . . . 75.450000000000003 111.002 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.776 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -93.49 4.81 7.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.537 1.148 . . . . 73.340000000000003 109.297 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLY . . . . . 0.495 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -104.72 -8.3 37.47 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.5 1.125 . . . . 62.119999999999997 111.024 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.622 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 15.8 m-85 -125.53 -0.8 7.5 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.497 0.763 . . . . 75.140000000000001 111.002 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.943 HG22 ' O ' ' A' ' 208' ' ' PRO . 2.5 m -139.63 162.15 26.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.503 1.127 . . . . 64.329999999999998 109.267 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.6 t -134.72 133.56 40.09 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 55.32 109.967 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.782 ' O ' HG23 ' A' ' 215' ' ' ILE . 2.9 mm -76.85 127.72 37.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.506 1.129 . . . . 74.540000000000006 109.28 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.809 HG22 ' HA ' ' A' ' 221' ' ' TYR . 5.3 pt -161.89 167.24 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 124.544 1.153 . . . . 72.409999999999997 109.241 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -130.23 -46.77 1.1 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.41 1.069 . . . . 73.510000000000005 109.368 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 217' ' ' ILE . 7.0 tp -142.56 159.27 19.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.499 1.124 . . . . 62.210000000000001 109.282 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.49 -172.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.511 1.132 . . . . 51.32 109.357 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 62.3 m 64.82 55.08 1.25 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.489 1.118 . . . . 54.350000000000001 110.443 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 108.06 -155.46 16.21 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.411 1.069 . . . . 72.340000000000003 111.008 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.809 ' HA ' HG22 ' A' ' 215' ' ' ILE . 44.8 m-85 -102.95 -174.0 2.45 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.565 0.803 . . . . 72.400000000000006 111.038 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -43.06 -73.49 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.55 1.156 . . . . 70.219999999999999 109.316 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -117.69 -8.89 10.83 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.558 1.161 . . . . 61.43 110.366 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 96.44 7.25 58.2 Favored Glycine 0 CA--C 1.529 0.938 0 O-C-N 124.507 1.13 . . . . 45.350000000000001 111.075 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -101.95 160.19 14.7 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.463 0.743 . . . . 73.230000000000004 109.271 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 229' ' ' GLU . 0.4 OUTLIER -63.51 145.24 56.03 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.546 1.154 . . . . 75.319999999999993 109.329 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -40.38 -45.73 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.439 1.087 . . . . 72.099999999999994 109.349 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.753 ' HA ' HD12 ' A' ' 231' ' ' ILE . 7.8 mt -65.27 -46.53 90.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.5 1.125 . . . . 64.239999999999995 109.275 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.473 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 11.6 mt-10 -64.95 -17.19 64.17 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.566 1.166 . . . . 71.409999999999997 110.338 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.66 -16.44 32.38 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.453 1.095 . . . . 62.549999999999997 109.347 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.753 HD12 ' HA ' ' A' ' 228' ' ' ILE . 3.6 mt -76.1 -70.11 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 124.523 1.139 . . . . 72.219999999999999 109.323 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.473 ' CD ' ' HA ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -59.67 -26.79 65.83 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.555 1.16 . . . . 63.240000000000002 109.236 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.11 -48.1 12.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.474 1.108 . . . . 71.109999999999999 110.01 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.1 m -98.02 -15.85 7.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.483 1.115 . . . . 64.549999999999997 109.282 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 64.97 49.57 2.07 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 1.135 . . . . 43.340000000000003 109.316 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 237' ' ' PRO . 0.5 OUTLIER -71.08 146.75 93.08 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.457 1.098 . . . . 75.329999999999998 109.319 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.664 ' O ' HD12 ' A' ' 236' ' ' LEU . 18.6 Cg_endo -74.95 141.59 26.97 Favored 'Trans proline' 0 C--N 1.359 1.096 0 O-C-N 124.526 1.803 . . . . 74.239999999999995 110.995 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.1 m -58.36 176.38 0.18 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.431 1.082 . . . . 75.430000000000007 110.478 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.558 HG13 ' HG3' ' A' ' 240' ' ' GLN . 9.9 p -72.09 -33.84 48.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.524 1.14 . . . . 51.310000000000002 109.311 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.558 ' HG3' HG13 ' A' ' 239' ' ' VAL . 0.3 OUTLIER -85.58 -17.03 37.43 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.479 1.112 . . . . 72.329999999999998 110.243 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -87.05 -43.78 12.06 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.494 1.121 . . . . 75.209999999999994 110.336 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.618 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 0.5 OUTLIER -72.08 -60.73 2.09 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.988 -1.116 . . . . 72.430000000000007 107.988 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.495 ' NZ ' ' CG2' ' A' ' 239' ' ' VAL . 4.8 mtmm -54.79 -20.62 8.95 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.498 1.124 . . . . 51.350000000000001 109.29 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 6.7 t -40.9 -65.39 0.43 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.564 1.165 . . . . 64.239999999999995 110.03 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -138.69 121.6 16.61 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.5 1.125 . . . . 74.450000000000003 109.298 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 43.4 mm -48.3 -31.44 3.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 O-C-N 124.514 1.134 . . . . 71.329999999999998 109.328 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -124.46 57.81 1.23 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 64.140000000000001 109.293 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -52.88 -175.39 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.468 1.105 . . . . 75.329999999999998 110.313 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -37.83 112.87 0.23 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.481 1.113 . . . . 70.239999999999995 110.965 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.418 ' C ' ' N ' ' A' ' 252' ' ' SER . 0.1 OUTLIER -41.4 149.22 0.12 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.462 1.102 . . . . 74.340000000000003 109.245 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -42.81 -29.23 0.3 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.548 1.155 . . . . 53.420000000000002 109.321 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' SER . . . . . 0.418 ' N ' ' C ' ' A' ' 250' ' ' LYS . 47.6 t -73.03 127.51 32.77 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.54 1.15 . . . . 74.019999999999996 110.075 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -154.42 126.71 7.88 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.514 1.134 . . . . 72.420000000000002 109.306 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.437 HD12 ' N ' ' A' ' 254' ' ' ILE . 4.3 mp -130.26 143.53 40.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.486 1.116 . . . . 73.200000000000003 109.358 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.9 m -172.76 132.73 0.56 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 72.299999999999997 109.956 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.774 ' C ' HD22 ' A' ' 256' ' ' LEU . 0.0 OUTLIER -80.65 -15.78 55.69 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.479 1.112 . . . . 51.219999999999999 109.319 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -103.07 165.14 15.92 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.435 1.084 . . . . 73.310000000000002 110.957 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 10.5 t -158.37 -175.78 5.52 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.488 0.758 . . . . 64.540000000000006 109.921 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.5 p -96.04 165.16 2.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.462 1.101 . . . . 74.230000000000004 109.285 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--N 1.325 -0.489 0 O-C-N 124.486 1.116 . . . . 72.340000000000003 110.26 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 37.5 t . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 109.979 -0.378 . . . . 64.319999999999993 109.979 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 78.9 p -101.61 78.2 1.82 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.516 1.135 . . . . 71.349999999999994 110.021 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 73.6 m -81.4 -62.54 1.62 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.514 1.134 . . . . 74.25 110.002 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -83.99 99.91 10.72 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.416 1.072 . . . . 42.539999999999999 109.265 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -81.98 121.7 26.85 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.539 1.15 . . . . 45.450000000000003 109.333 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -98.94 166.13 21.21 Favored Glycine 0 CA--C 1.529 0.908 0 O-C-N 124.562 1.164 . . . . 63.399999999999999 111.027 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 13.6 mtmm -114.09 -11.01 12.76 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.46 0.741 . . . . 71.150000000000006 109.295 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 470' ' ' PHE . . . . . 0.444 ' CZ ' ' HD2' ' A' ' 204' ' ' PRO . 43.1 m-85 -102.94 -14.16 16.62 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.481 1.113 . . . . 74.120000000000005 110.993 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 471' ' ' ILE . . . . . 0.707 ' O ' ' HB3' ' A' ' 171' ' ' ALA . 26.4 mm -41.82 142.44 1.1 Allowed Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.505 1.128 . . . . 64.409999999999997 109.333 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 472' ' ' PRO . . . . . 0.698 ' HD2' HG23 ' B' ' 471' ' ' ILE . 18.4 Cg_endo -74.91 173.38 14.57 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.473 1.775 . . . . 55.210000000000001 111.073 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.91 -46.02 2.94 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.473 1.108 . . . . 64.030000000000001 110.014 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 39.3 mtp85 -87.14 158.49 52.56 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.567 1.167 . . . . 71.329999999999998 110.3 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 475' ' ' PRO . . . . . 0.686 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.3 Cg_endo -75.05 -30.94 6.57 Favored 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.469 1.773 . . . . 75.340000000000003 110.982 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 476' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 163.38 129.57 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.506 1.129 . . . . 63.119999999999997 109.281 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 477' ' ' PRO . . . . . 0.562 ' HG3' ' CE2' ' A' ' 166' ' ' PHE . 18.1 Cg_endo -75.02 -176.59 2.96 Favored 'Trans proline' 0 C--N 1.361 1.2 0 O-C-N 124.515 1.797 . . . . 64.340000000000003 110.985 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 478' ' ' LYS . . . . . 0.463 ' O ' ' CD ' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -116.46 95.11 44.86 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.536 1.148 . . . . 63.140000000000001 109.35 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 479' ' ' PRO . . . . . 0.622 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.99 150.11 37.69 Favored 'Trans proline' 0 C--N 1.359 1.105 0 O-C-N 124.563 1.823 . . . . 72.329999999999998 111.023 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 480' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 479' ' ' PRO . 18.3 Cg_endo -75.07 -179.91 5.46 Favored 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.447 1.762 . . . . 72.019999999999996 111.009 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 481' ' ' SER . . . . . . . . . . . . . 11.4 m 45.2 64.42 1.41 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 63.299999999999997 109.97 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 40.1 t -149.96 137.8 20.15 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.532 1.145 . . . . 72.299999999999997 110.009 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -82.72 52.9 2.22 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 74.319999999999993 109.334 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 37.3 p -76.72 120.27 21.67 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.511 1.132 . . . . 72.450000000000003 110.048 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -73.22 118.77 16.58 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.441 1.088 . . . . 62.399999999999999 109.279 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.517 1.136 . . . . 52.530000000000001 110.021 179.962 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.967 0 N-CA-C 111.03 -0.828 . . . . 73.129999999999995 111.03 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 28.8 t -113.5 81.51 1.52 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.491 0.76 . . . . 72.109999999999999 109.993 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.569 ' O ' ' CE1' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -132.8 148.4 52.31 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.554 1.159 . . . . 64.319999999999993 109.303 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -143.58 -178.09 5.72 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.552 1.158 . . . . 74.409999999999997 110.998 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.569 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -130.42 153.22 48.98 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.511 1.132 . . . . 71.019999999999996 109.304 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.912 ' HB ' HD11 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -123.89 125.45 71.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.532 1.145 . . . . 74.120000000000005 109.265 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.937 HG22 HG12 ' A' ' 212' ' ' VAL . 1.9 t -80.51 122.45 35.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.559 1.162 . . . . 72.329999999999998 109.284 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 213' ' ' SER . 0.6 OUTLIER -98.19 -13.74 20.71 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.519 1.137 . . . . 71.420000000000002 109.287 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.666 ' O ' HG13 ' A' ' 162' ' ' VAL . 1.7 m-85 -146.21 157.71 43.84 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.567 1.167 . . . . 75.340000000000003 111.042 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.782 ' N ' HG12 ' A' ' 178' ' ' VAL . 0.0 OUTLIER -98.04 158.25 15.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.527 1.142 . . . . 71.349999999999994 109.27 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.491 ' CE1' ' HB3' ' B' ' 477' ' ' PRO . 40.5 t80 -145.5 158.9 43.77 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.559 1.162 . . . . 63.420000000000002 111.051 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -94.34 127.87 40.5 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.459 1.099 . . . . 73.120000000000005 109.288 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.885 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -93.19 142.06 27.73 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.465 1.103 . . . . 63.439999999999998 109.329 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -157.87 24.64 0.27 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.503 1.127 . . . . 71.219999999999999 110.314 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.528 ' NZ ' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -122.41 -175.36 3.12 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.531 1.145 . . . . 75.010000000000005 109.362 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.14 -40.99 82.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.439 1.087 . . . . 71.040000000000006 109.325 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 174' ' ' LEU . 3.0 m-20 -85.86 10.99 12.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.54 1.15 . . . . 64.019999999999996 109.3 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.885 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 5.4 pt-20 -36.34 96.56 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.432 1.083 . . . . 74.140000000000001 110.354 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.692 HD12 ' HA3' ' A' ' 205' ' ' GLY . 1.2 tm? -136.98 94.93 3.02 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.517 1.136 . . . . 31.129999999999999 109.296 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.431 ' C ' ' HG1' ' A' ' 176' ' ' THR . 9.0 t -59.53 153.36 19.8 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.563 1.164 . . . . 62.109999999999999 110.471 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.431 ' HG1' ' C ' ' A' ' 175' ' ' THR . 24.3 m -152.21 141.93 21.89 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.481 1.113 . . . . 74.349999999999994 110.374 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -88.37 153.33 21.27 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.408 1.068 . . . . 74.049999999999997 111.06 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.782 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.4 m -59.21 158.3 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.438 1.086 . . . . 64.530000000000001 109.299 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 48.81 66.98 1.87 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.455 1.097 . . . . 74.409999999999997 110.988 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.525 ' O ' HD13 ' A' ' 161' ' ' ILE . 1.9 tt0 -131.15 171.76 12.9 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.552 0.795 . . . . 75.340000000000003 110.235 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -123.4 130.65 53.02 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.478 1.112 . . . . 74.5 109.318 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.759 HD23 ' N ' ' A' ' 182' ' ' LEU . 0.6 OUTLIER -146.82 143.27 28.49 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.431 1.082 . . . . 72.549999999999997 109.341 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.569 ' CE1' ' O ' ' A' ' 158' ' ' LEU . 73.4 t80 -100.57 117.99 35.83 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.537 1.148 . . . . 74.030000000000001 111.031 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.569 HD13 ' HB2' ' A' ' 160' ' ' ALA . 1.6 mp -62.69 151.99 7.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.41 1.068 . . . . 75.530000000000001 109.243 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.573 ' O ' ' CZ3' ' A' ' 242' ' ' TRP . 0.9 OUTLIER -136.03 -47.87 0.66 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.569 1.168 . . . . 55.130000000000003 108.26 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.944 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -122.25 168.86 11.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.504 1.127 . . . . 65.120000000000005 109.279 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.625 ' C ' ' CD2' ' A' ' 188' ' ' HIS . 2.9 p80 -146.67 153.88 40.8 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.443 1.089 . . . . 71.340000000000003 109.592 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 1.056 ' CE1' HG11 ' A' ' 239' ' ' VAL . 0.1 OUTLIER -143.92 120.75 11.26 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.471 1.107 . . . . 75.129999999999995 109.555 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.473 ' C ' ' N ' ' A' ' 191' ' ' GLU . 86.1 m-20 50.85 35.21 11.76 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.526 1.141 . . . . 73.430000000000007 109.352 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.421 ' C ' ' O ' ' A' ' 189' ' ' ASN . 60.9 m 39.77 30.75 0.06 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.553 1.158 . . . . 61.020000000000003 108.254 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.571 ' O ' HG13 ' A' ' 209' ' ' VAL . 11.4 tt0 -122.25 -42.16 2.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.546 1.154 . . . . 72.430000000000007 110.279 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.665 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 95.4 m95 -110.41 136.88 48.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.982 -1.118 . . . . 73.239999999999995 107.982 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.843 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.1 m-30 -127.52 124.41 38.18 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.507 1.13 . . . . 74.030000000000001 110.964 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.944 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 1.4 mp -87.61 97.02 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 70.540000000000006 109.317 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -101.99 -179.88 4.13 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.472 1.108 . . . . 55.439999999999998 109.295 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.9 ptmt -155.16 167.27 14.42 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.548 1.155 . . . . 75.439999999999998 109.303 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.91 169.39 22.7 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.412 1.743 . . . . 44.130000000000003 111.044 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 71.2 mt -110.02 -14.25 10.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 O-C-N 124.473 1.108 . . . . 55.420000000000002 109.332 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -131.97 -75.87 0.12 Allowed Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.433 1.083 . . . . 62.219999999999999 110.995 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -54.72 174.31 0.07 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.526 0.78 . . . . 75.010000000000005 110.302 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.11 -172.26 2.0 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.461 1.101 . . . . 64.540000000000006 109.351 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 115.85 -51.17 0.74 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.509 1.131 . . . . 61.530000000000001 110.984 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -50.4 -177.33 0.02 OUTLIER Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.995 -0.842 . . . . 54.0 110.995 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.438 ' HG2' ' CZ ' ' B' ' 470' ' ' PHE . 18.2 Cg_endo -74.97 142.83 75.93 Favored 'Cis proline' 0 C--N 1.36 1.152 0 C-N-CA 121.012 -2.495 . . . . 62.130000000000003 111.006 0.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.692 ' HA3' HD12 ' A' ' 174' ' ' LEU . . . -106.07 148.1 16.39 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.538 1.149 . . . . 44.109999999999999 110.976 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.665 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -88.61 145.83 25.46 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.511 0.771 . . . . 72.439999999999998 109.325 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.789 ' HB ' HG11 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -156.02 126.26 3.36 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.544 1.153 . . . . 64.5 109.295 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.89 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.2 Cg_endo -74.98 179.59 5.93 Favored 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.489 1.784 . . . . 61.140000000000001 110.926 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.843 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -96.93 6.59 8.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.479 1.112 . . . . 72.299999999999997 109.327 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLY . . . . . 0.49 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -108.32 -4.86 32.74 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.551 1.157 . . . . 74.230000000000004 110.972 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.617 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 8.1 m-85 -127.44 1.59 6.28 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.518 0.775 . . . . 75.239999999999995 111.017 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.937 HG12 HG22 ' A' ' 162' ' ' VAL . 3.4 m -139.62 153.78 23.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.56 1.162 . . . . 74.340000000000003 109.329 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.605 ' HB3' HD11 ' A' ' 163' ' ' LEU . 1.0 OUTLIER -121.17 124.3 44.38 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.633 1.208 . . . . 71.319999999999993 110.039 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.835 ' O ' HG23 ' A' ' 215' ' ' ILE . 2.9 mm -68.32 145.03 13.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.13 . . . . 74.150000000000006 109.284 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.912 HD11 ' HB ' ' A' ' 161' ' ' ILE . 5.5 pt -165.37 137.98 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.539 1.149 . . . . 73.150000000000006 109.254 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.08 -44.73 1.89 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.585 1.178 . . . . 72.5 109.236 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.553 HG22 ' H ' ' A' ' 218' ' ' ALA . 7.2 mt -124.05 171.3 13.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.474 1.109 . . . . 74.409999999999997 109.288 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.553 ' H ' HG22 ' A' ' 217' ' ' ILE . . . -94.75 35.1 1.26 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.466 1.104 . . . . 52.109999999999999 109.312 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 219' ' ' THR . 7.9 t -130.72 27.42 4.95 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.441 1.088 . . . . 73.420000000000002 110.371 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 144.45 -167.94 26.86 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.473 1.108 . . . . 73.400000000000006 111.022 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -135.37 136.6 41.61 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.477 0.751 . . . . 74.439999999999998 110.953 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.739 ' O ' HG22 ' A' ' 223' ' ' THR . . . 54.49 41.18 32.12 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.506 1.129 . . . . 51.549999999999997 109.301 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.739 HG22 ' O ' ' A' ' 222' ' ' ALA . 15.2 t 50.1 23.63 1.19 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.536 1.148 . . . . 55.240000000000002 110.414 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 86.78 -42.53 3.16 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.51 1.131 . . . . 64.400000000000006 111.037 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -63.18 160.24 15.94 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.556 0.797 . . . . 65.129999999999995 109.286 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 230' ' ' ASP . 0.4 OUTLIER -69.95 152.03 44.93 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.426 1.079 . . . . 60.43 109.315 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.513 HG13 ' H ' ' A' ' 228' ' ' ILE . 4.2 p -47.85 -56.56 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.459 1.1 . . . . 70.310000000000002 109.258 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.513 ' H ' HG13 ' A' ' 227' ' ' VAL . 3.4 mt -57.1 -32.09 39.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.124 . . . . 63.200000000000003 109.375 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.431 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 5.4 mt-10 -80.89 -14.54 57.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.571 1.169 . . . . 73.439999999999998 110.312 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 226' ' ' ASP . 0.7 OUTLIER -88.49 -17.9 29.34 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.475 1.109 . . . . 64.230000000000004 109.314 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.629 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.5 OUTLIER -69.28 -69.2 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.508 1.13 . . . . 72.439999999999998 109.34 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.629 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -57.91 -20.73 39.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.563 1.164 . . . . 71.239999999999995 109.302 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.6 t -50.86 -57.93 7.25 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.54 1.15 . . . . 63.439999999999998 110.012 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.5 m -90.8 17.74 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.527 1.142 . . . . 73.420000000000002 109.346 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 47.53 34.85 3.74 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.506 1.129 . . . . 71.319999999999993 109.259 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.14 119.05 73.58 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.526 1.141 . . . . 72.439999999999998 109.287 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.13 167.2 27.44 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.5 1.789 . . . . 53.109999999999999 110.976 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.518 ' HA ' ' CD2' ' A' ' 187' ' ' HIS . 2.7 m -59.24 178.25 0.14 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.453 1.096 . . . . 71.400000000000006 110.383 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 1.056 HG11 ' CE1' ' A' ' 188' ' ' HIS . 0.2 OUTLIER -58.77 -67.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.133 . . . . 63.32 109.25 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.878 ' OE1' HD11 ' B' ' 471' ' ' ILE . 0.3 OUTLIER -63.91 -22.32 66.87 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.569 1.168 . . . . 74.420000000000002 110.339 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.449 ' HB2' ' N ' ' A' ' 238' ' ' THR . 4.1 mm-40 -75.85 -33.45 60.02 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.464 1.102 . . . . 75.219999999999999 110.246 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.573 ' CZ3' ' O ' ' A' ' 185' ' ' CYS . 2.6 t90 -85.28 -60.36 2.06 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.137 . . . . 63.130000000000003 108.007 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.427 ' NZ ' ' CG ' ' B' ' 470' ' ' PHE . 22.1 mtmt -56.18 -18.7 10.91 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.53 1.144 . . . . 71.010000000000005 109.308 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -39.19 -48.13 1.71 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.145 . . . . 74.109999999999999 109.969 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -152.6 113.2 4.1 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.525 1.141 . . . . 62.329999999999998 109.287 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.496 ' CD1' ' N ' ' A' ' 246' ' ' ILE . 1.0 OUTLIER -67.22 -27.91 40.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.498 1.124 . . . . 70.219999999999999 109.28 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -82.07 71.73 9.12 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.497 1.123 . . . . 75.450000000000003 109.19 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.69 4.42 35.38 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 75.140000000000001 110.349 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 15.5 m-30 -40.51 -30.29 0.11 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.54 1.15 . . . . 74.150000000000006 111.024 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -75.29 74.02 2.39 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.522 1.139 . . . . 64.109999999999999 109.311 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -149.38 -179.44 7.07 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.559 1.162 . . . . 54.539999999999999 109.345 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 1.5 m -105.87 158.56 16.67 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.582 1.177 . . . . 73.420000000000002 109.974 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.408 ' CG ' ' N ' ' A' ' 254' ' ' ILE . 34.7 t30 -71.72 164.02 26.73 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.52 1.138 . . . . 73.129999999999995 109.319 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.718 HD12 ' N ' ' A' ' 254' ' ' ILE . 1.8 mp -128.29 162.36 34.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.554 1.159 . . . . 74.019999999999996 109.265 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 9.6 t -167.28 158.25 11.71 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.504 1.128 . . . . 73.430000000000007 110.047 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.1 pp -123.18 -179.57 4.34 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.512 1.133 . . . . 75.439999999999998 109.296 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -53.99 166.91 1.92 Allowed Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.517 1.136 . . . . 73.239999999999995 110.986 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 3.5 m -65.27 -71.7 0.18 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.491 0.759 . . . . 74.409999999999997 110.046 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 8.0 p -159.97 137.83 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.46 1.1 . . . . 74.400000000000006 109.339 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 . . . . . 0 C--N 1.326 -0.452 0 O-C-N 124.467 1.104 . . . . 63.200000000000003 110.266 -179.949 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 42.7 t . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 110.008 -0.367 . . . . 64.329999999999998 110.008 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 99.8 p -163.83 160.78 22.7 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.488 1.117 . . . . 71.109999999999999 109.91 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 50.3 m -81.36 175.86 10.21 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.521 1.138 . . . . 70.109999999999999 109.982 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -168.66 162.27 11.73 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.504 1.128 . . . . 43.200000000000003 109.258 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -152.21 144.6 24.05 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.508 1.13 . . . . 73.319999999999993 109.331 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 468' ' ' GLY . . . . . 0.655 ' HA3' HD13 ' B' ' 471' ' ' ILE . . . 178.22 -164.3 32.94 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.478 1.111 . . . . 65.340000000000003 110.98 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -100.19 -24.77 14.48 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.446 0.733 . . . . 61.43 109.259 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 470' ' ' PHE . . . . . 0.651 ' CD2' HG21 ' A' ' 194' ' ' ILE . 3.3 m-85 -104.92 -2.87 24.06 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.46 1.1 . . . . 74.430000000000007 110.938 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 471' ' ' ILE . . . . . 0.878 HD11 ' OE1' ' A' ' 240' ' ' GLN . 1.4 mp -75.17 136.8 72.35 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.451 1.094 . . . . 72.340000000000003 109.331 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 472' ' ' PRO . . . . . 0.432 ' HD3' ' ND1' ' A' ' 188' ' ' HIS . 18.3 Cg_endo -75.04 -162.66 0.16 Allowed 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.409 1.741 . . . . 52.109999999999999 110.977 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 6.2 t -133.08 -52.76 0.9 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.469 1.106 . . . . 61.409999999999997 109.958 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 31.9 mtt-85 -81.05 156.18 72.18 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.485 1.116 . . . . 74.329999999999998 110.27 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 475' ' ' PRO . . . . . 0.679 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.4 Cg_endo -75.05 -30.64 6.88 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.425 1.75 . . . . 73.010000000000005 110.982 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 476' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 163.42 131.6 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.538 1.149 . . . . 70.439999999999998 109.301 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 477' ' ' PRO . . . . . 0.577 ' HD3' ' CH2' ' A' ' 192' ' ' TRP . 18.6 Cg_endo -74.94 -163.31 0.18 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.553 1.817 . . . . 61.420000000000002 111.012 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 478' ' ' LYS . . . . . 0.496 ' O ' ' CD ' ' B' ' 478' ' ' LYS . 0.3 OUTLIER -124.97 94.99 42.94 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 74.310000000000002 109.329 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 479' ' ' PRO . . . . . 0.617 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.5 Cg_endo -74.94 155.38 43.23 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.462 1.77 . . . . 72.310000000000002 111.066 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 480' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' B' ' 481' ' ' SER . 18.3 Cg_endo -74.96 -160.86 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.459 1.768 . . . . 53.310000000000002 110.996 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 481' ' ' SER . . . . . 0.452 ' C ' ' O ' ' B' ' 480' ' ' PRO . 13.8 t -35.63 100.35 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.47 1.107 . . . . 60.420000000000002 109.999 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 482' ' ' SER . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 164' ' ' TYR . 0.7 OUTLIER -173.12 166.88 4.95 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.467 1.105 . . . . 42.340000000000003 110.009 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -96.05 111.34 23.39 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.463 1.102 . . . . 71.329999999999998 109.294 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 46.9 t -103.7 156.48 17.77 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.486 1.116 . . . . 62.100000000000001 110.02 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -82.52 -57.25 3.43 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.442 1.089 . . . . 55.530000000000001 109.262 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.462 1.101 . . . . 64.109999999999999 109.974 179.981 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.966 0 N-CA-C 111.013 -0.835 . . . . 62.420000000000002 111.013 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 4.1 m -72.16 127.13 31.6 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.48 0.753 . . . . 74.219999999999999 109.994 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.554 HD22 ' OD1' ' A' ' 230' ' ' ASP . 1.4 pp -124.39 143.73 50.44 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.502 1.126 . . . . 72.430000000000007 109.323 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.789 ' CD1' ' CE2' ' A' ' 183' ' ' PHE . 1.4 m-85 -126.82 154.13 44.72 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.538 1.149 . . . . 62.509999999999998 110.997 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.887 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -114.64 149.57 36.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.537 1.148 . . . . 63.100000000000001 109.302 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.53 HD13 ' O ' ' A' ' 180' ' ' GLU . 0.2 OUTLIER -131.4 127.85 60.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 74.329999999999998 109.273 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.802 HG22 HG12 ' A' ' 212' ' ' VAL . 1.9 t -80.48 121.19 33.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.556 1.16 . . . . 62.109999999999999 109.333 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.894 HD11 ' HB2' ' A' ' 213' ' ' SER . 0.9 OUTLIER -96.24 -14.48 22.64 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 62.140000000000001 109.361 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.691 ' O ' HG13 ' A' ' 162' ' ' VAL . 3.0 m-85 -146.9 159.23 43.79 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.48 1.113 . . . . 74.450000000000003 110.954 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.614 ' N ' HG12 ' A' ' 178' ' ' VAL . 10.4 p-10 -101.1 159.45 15.22 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.566 1.166 . . . . 73.409999999999997 109.347 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.54 ' HB2' ' CE1' ' A' ' 211' ' ' PHE . 9.0 t80 -158.33 135.71 10.17 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.433 1.083 . . . . 72.25 110.908 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -68.78 132.34 46.64 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.144 . . . . 55.240000000000002 109.337 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.926 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -112.98 141.82 46.39 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.539 1.149 . . . . 71.120000000000005 109.311 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -150.42 20.37 0.84 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.51 1.131 . . . . 73.450000000000003 110.346 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.478 ' NZ ' ' CH2' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -96.42 -176.57 3.67 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.496 1.123 . . . . 64.239999999999995 109.26 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.41 -20.63 63.29 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.501 1.126 . . . . 52.409999999999997 109.319 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.454 ' HB3' ' CB ' ' A' ' 206' ' ' LEU . 7.1 t0 -117.11 18.88 14.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.493 1.121 . . . . 71.439999999999998 109.307 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.926 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 6.5 pt-20 -36.52 106.44 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.483 1.114 . . . . 71.420000000000002 110.28 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.693 HD22 ' HA3' ' A' ' 205' ' ' GLY . 15.8 tp -116.55 105.94 13.01 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.422 1.076 . . . . 55.130000000000003 109.307 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 175' ' ' THR . 9.7 t -87.22 110.02 19.88 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.437 1.086 . . . . 74.140000000000001 110.367 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.466 ' CG2' ' HG2' ' A' ' 180' ' ' GLU . 87.8 m -130.97 169.98 15.09 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.581 1.176 . . . . 72.450000000000003 110.386 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.432 ' N ' HG22 ' A' ' 176' ' ' THR . 15.0 m-85 -112.41 161.95 16.12 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.458 1.099 . . . . 72.439999999999998 111.015 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.614 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.7 m -55.4 158.16 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 44.509999999999998 109.3 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.44 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 50.24 68.55 1.38 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.462 1.101 . . . . 72.420000000000002 111.013 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.53 ' O ' HD13 ' A' ' 161' ' ' ILE . 5.2 tp10 -126.48 164.79 20.39 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 124.547 0.792 . . . . 62.229999999999997 110.322 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -113.42 129.21 56.59 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.507 1.13 . . . . 74.510000000000005 109.256 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.836 HD12 HG21 ' A' ' 207' ' ' VAL . 0.4 OUTLIER -152.48 146.95 25.68 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.498 1.124 . . . . 54.439999999999998 109.274 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.789 ' CE2' ' CD1' ' A' ' 159' ' ' TYR . 3.8 m-85 -111.92 120.35 41.61 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.464 1.103 . . . . 72.409999999999997 111.021 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.887 HD13 ' HB2' ' A' ' 160' ' ' ALA . 1.7 mp -71.02 152.11 8.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.485 1.115 . . . . 75.030000000000001 109.281 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.483 ' SG ' HG22 ' A' ' 194' ' ' ILE . 15.5 p -142.25 -44.15 0.33 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.508 1.13 . . . . 73.549999999999997 108.327 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.994 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -116.19 159.1 22.27 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.49 1.119 . . . . 75.030000000000001 109.303 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.558 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -147.85 148.93 31.4 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.463 1.102 . . . . 54.43 109.639 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.621 ' CD2' ' O ' ' A' ' 192' ' ' TRP . 0.5 OUTLIER -152.44 143.96 23.42 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.492 1.12 . . . . 74.030000000000001 109.584 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.473 ' C ' ' N ' ' A' ' 191' ' ' GLU . 27.3 t-20 51.11 22.88 1.38 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.547 1.154 . . . . 63.009999999999998 109.34 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.441 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.5 p 39.03 30.19 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.531 1.145 . . . . 52.009999999999998 108.292 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.526 ' O ' HG13 ' A' ' 209' ' ' VAL . 9.9 tt0 -131.31 -40.15 1.14 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.438 1.086 . . . . 71.319999999999993 110.307 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.835 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 96.4 m95 -107.33 131.72 53.92 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.035 -1.098 . . . . 65.239999999999995 108.035 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.776 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.4 m-30 -125.59 133.06 52.4 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.597 1.185 . . . . 61.119999999999997 111.048 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.994 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 0.7 OUTLIER -93.3 105.67 17.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.522 1.139 . . . . 55.409999999999997 109.289 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -109.13 176.73 4.99 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.392 1.057 . . . . 75.230000000000004 109.306 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.5 pttm -149.47 168.76 10.34 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.593 1.183 . . . . 52.340000000000003 109.362 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.495 ' CG ' ' O ' ' A' ' 202' ' ' GLY . 18.5 Cg_endo -75.02 174.44 12.78 Favored 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.528 1.804 . . . . 54.109999999999999 110.981 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 6.6 tp -57.13 -29.85 33.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.542 1.151 . . . . 70.329999999999998 109.278 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 130.58 62.95 0.1 OUTLIER Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.445 1.09 . . . . 21.5 111.008 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -124.74 -76.2 0.59 Allowed 'General case' 0 C--N 1.323 -0.568 0 O-C-N 124.47 0.747 . . . . 73.420000000000002 110.336 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 8.2 tp -159.32 108.65 1.88 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.467 1.105 . . . . 71.109999999999999 109.325 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.495 ' O ' ' CG ' ' A' ' 197' ' ' PRO . . . 129.86 157.88 9.25 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.47 1.106 . . . . 42.200000000000003 110.984 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.408 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . 95.25 170.79 36.44 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.035 -0.826 . . . . 74.150000000000006 111.035 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.408 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.1 Cg_endo -75.06 136.75 46.62 Favored 'Cis proline' 0 C--N 1.36 1.14 0 C-N-CA 121.002 -2.499 . . . . 61.539999999999999 111.0 0.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.693 ' HA3' HD22 ' A' ' 174' ' ' LEU . . . -99.72 156.74 19.77 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.529 1.143 . . . . 52.43 110.955 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.835 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.3 OUTLIER -93.12 146.45 23.65 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.455 0.738 . . . . 52.439999999999998 109.345 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.836 HG21 HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -159.99 127.05 2.6 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.534 1.146 . . . . 72.230000000000004 109.281 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.774 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.4 Cg_endo -75.01 179.83 5.7 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.479 1.779 . . . . 71.129999999999995 110.964 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.776 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.4 m -96.91 4.27 9.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.441 1.088 . . . . 64.430000000000007 109.314 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLY . . . . . 0.5 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -108.01 1.84 33.53 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.546 1.153 . . . . 73.030000000000001 111.026 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 14.1 m-85 -133.3 7.64 3.93 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.56 0.8 . . . . 64.450000000000003 111.003 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.802 HG12 HG22 ' A' ' 162' ' ' VAL . 4.5 m -144.32 153.69 15.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.562 1.164 . . . . 70.329999999999998 109.296 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.894 ' HB2' HD11 ' A' ' 163' ' ' LEU . 5.4 t -126.7 137.73 53.31 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.523 1.14 . . . . 73.219999999999999 109.978 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.716 ' O ' HG23 ' A' ' 215' ' ' ILE . 3.2 mm -75.76 147.75 7.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.434 1.084 . . . . 64.109999999999999 109.286 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.716 HG23 ' O ' ' A' ' 214' ' ' ILE . 4.6 pt -160.1 135.45 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.518 1.136 . . . . 74.439999999999998 109.331 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.428 ' C ' ' N ' ' A' ' 218' ' ' ALA . 13.2 t0 -131.7 74.57 1.6 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.558 1.161 . . . . 74.230000000000004 109.244 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.706 HG23 ' O ' ' A' ' 217' ' ' ILE . 0.3 OUTLIER 40.53 30.64 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.472 1.107 . . . . 60.299999999999997 109.283 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.428 ' N ' ' C ' ' A' ' 216' ' ' ASP . . . -118.95 165.02 14.61 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.495 1.122 . . . . 73.129999999999995 109.249 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 7.8 t -96.02 -8.14 34.43 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.498 1.124 . . . . 73.340000000000003 110.387 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -80.83 -142.62 3.28 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.457 1.098 . . . . 74.430000000000007 111.012 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -148.07 122.73 9.86 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.573 0.808 . . . . 74.439999999999998 111.025 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.403 ' O ' ' HB ' ' A' ' 223' ' ' THR . . . 61.27 19.36 10.05 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.513 1.133 . . . . 32.229999999999997 109.275 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.472 ' O ' ' CG2' ' A' ' 223' ' ' THR . 0.3 OUTLIER 73.36 5.22 5.0 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.51 1.131 . . . . 64.25 110.417 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 115.36 -47.9 0.99 Allowed Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.485 1.116 . . . . 54.409999999999997 111.009 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -75.12 168.82 19.24 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.471 0.748 . . . . 73.239999999999995 109.336 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.46 ' OD1' HG11 ' A' ' 259' ' ' VAL . 6.5 t70 -81.31 150.25 28.58 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.449 1.093 . . . . 52.310000000000002 109.285 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.489 HG21 ' HE2' ' A' ' 193' ' ' PHE . 3.7 p -44.12 -50.89 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.469 1.106 . . . . 72.439999999999998 109.319 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.412 ' N ' HG13 ' A' ' 227' ' ' VAL . 5.0 mt -53.75 -47.27 62.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.505 1.128 . . . . 74.319999999999993 109.274 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -66.28 -13.86 61.11 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.5 1.125 . . . . 63.350000000000001 110.334 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.554 ' OD1' HD22 ' A' ' 158' ' ' LEU . 4.6 t70 -88.52 -16.47 32.57 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.517 1.135 . . . . 75.450000000000003 109.289 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.5 OUTLIER -73.59 -69.62 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.5 1.125 . . . . 72.140000000000001 109.291 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.625 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -62.23 -16.83 55.99 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.41 1.069 . . . . 73.439999999999998 109.313 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.8 -56.25 15.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.501 1.125 . . . . 72.319999999999993 109.992 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.473 ' CG2' ' HB3' ' A' ' 236' ' ' LEU . 3.7 m -88.87 14.88 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.537 1.148 . . . . 64.230000000000004 109.309 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 49.4 t30 54.96 32.42 18.0 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.546 1.154 . . . . 73.219999999999999 109.27 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.473 ' HB3' ' CG2' ' A' ' 234' ' ' VAL . 0.0 OUTLIER -82.57 118.23 71.15 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.445 1.09 . . . . 73.409999999999997 109.332 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.99 -174.09 1.81 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.508 1.794 . . . . 63.130000000000003 110.998 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.582 HG21 ' NE2' ' A' ' 240' ' ' GLN . 0.8 OUTLIER -58.78 -170.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.456 1.098 . . . . 73.439999999999998 110.461 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.935 HG23 ' HB1' ' A' ' 186' ' ' ALA . 10.8 p -79.79 -43.64 22.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.478 1.111 . . . . 72.329999999999998 109.307 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.582 ' NE2' HG21 ' A' ' 238' ' ' THR . 0.0 OUTLIER -87.24 -12.83 45.54 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 1.114 . . . . 62.549999999999997 110.321 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.488 ' N ' ' OE1' ' A' ' 240' ' ' GLN . 2.0 mt-10 -82.88 -37.24 24.57 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.516 1.135 . . . . 74.420000000000002 110.296 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.591 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 0.4 OUTLIER -77.38 -59.29 2.84 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.531 1.145 . . . . 72.409999999999997 107.977 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.615 ' NZ ' ' CD2' ' B' ' 470' ' ' PHE . 26.8 mtmt -56.56 -18.66 12.54 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.571 1.169 . . . . 72.439999999999998 109.391 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 243' ' ' LYS . 1.1 t -39.09 -56.48 1.44 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.501 1.126 . . . . 72.230000000000004 109.939 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -150.12 130.19 13.52 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.482 1.114 . . . . 63.439999999999998 109.376 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 13.2 mm -69.08 -56.3 12.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.544 1.152 . . . . 71.319999999999993 109.263 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.782 ' HB1' ' OH ' ' A' ' 249' ' ' TYR . . . -98.51 85.26 3.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.531 1.144 . . . . 74.400000000000006 109.341 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' ARG . . . . . 0.404 ' HD3' ' N ' ' A' ' 249' ' ' TYR . 0.0 OUTLIER -115.28 -31.65 5.9 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.515 1.134 . . . . 75.439999999999998 110.246 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.782 ' OH ' ' HB1' ' A' ' 247' ' ' ALA . 0.6 OUTLIER 46.17 59.53 3.73 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.525 1.141 . . . . 75.239999999999995 110.988 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -168.86 158.79 9.12 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.509 1.13 . . . . 74.439999999999998 109.312 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -94.48 -173.0 2.92 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.597 1.186 . . . . 64.349999999999994 109.294 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 61.5 m -118.31 -81.91 0.63 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.481 1.113 . . . . 73.519999999999996 109.986 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -128.4 -170.79 2.32 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.491 1.119 . . . . 53.25 109.343 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.797 HG22 HD22 ' A' ' 256' ' ' LEU . 31.9 mm -149.32 111.6 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.495 1.122 . . . . 63.310000000000002 109.254 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.772 ' C ' HD23 ' A' ' 256' ' ' LEU . 22.8 t -95.77 -47.41 6.18 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.467 1.104 . . . . 71.340000000000003 109.978 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.797 HD22 HG22 ' A' ' 254' ' ' ILE . 1.4 pt? 42.19 31.04 0.22 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.454 1.096 . . . . 71.340000000000003 109.289 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -92.89 -171.1 40.31 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 124.461 1.101 . . . . 72.310000000000002 111.024 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.3 m -142.16 175.0 10.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.528 0.781 . . . . 71.450000000000003 109.993 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.46 HG11 ' OD1' ' A' ' 226' ' ' ASP . 13.3 p -140.25 137.37 37.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.52 1.137 . . . . 65.439999999999998 109.255 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 . . . . . 0 C--N 1.325 -0.458 0 O-C-N 124.506 1.129 . . . . 70.109999999999999 110.294 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 463' ' ' SER . . . . . 0.437 ' O ' ' N ' ' B' ' 465' ' ' SER . 3.2 m . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 109.945 -0.391 . . . . 61.109999999999999 109.945 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.59 75.25 0.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.459 1.099 . . . . 74.219999999999999 110.004 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 465' ' ' SER . . . . . 0.437 ' N ' ' O ' ' B' ' 463' ' ' SER . 1.4 p -167.26 -175.79 3.06 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.522 1.139 . . . . 62.439999999999998 110.066 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -171.07 162.71 7.2 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.47 1.106 . . . . 60.420000000000002 109.359 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 60.97 37.07 18.42 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.5 1.125 . . . . 75.25 109.236 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -137.64 116.7 1.38 Allowed Glycine 0 CA--C 1.529 0.935 0 O-C-N 124.542 1.151 . . . . 44.5 111.048 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -113.2 -12.51 13.1 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.477 0.751 . . . . 61.43 109.22 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 470' ' ' PHE . . . . . 0.615 ' CD2' ' NZ ' ' A' ' 243' ' ' LYS . 3.2 m-30 -89.26 2.05 54.85 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.458 1.099 . . . . 63.43 111.073 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 471' ' ' ILE . . . . . 0.469 ' N ' HD13 ' B' ' 471' ' ' ILE . 5.2 mm -65.91 135.23 95.28 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.483 1.115 . . . . 55.409999999999997 109.267 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 472' ' ' PRO . . . . . 0.589 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.95 149.92 37.65 Favored 'Trans proline' 0 C--N 1.361 1.225 0 O-C-N 124.522 1.801 . . . . 72.010000000000005 111.012 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 23.0 t -106.15 -37.18 6.68 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.486 1.116 . . . . 73.409999999999997 110.031 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -101.27 166.11 12.93 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.419 1.074 . . . . 62.030000000000001 110.27 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.06 -167.9 0.47 Allowed 'Trans proline' 0 C--N 1.361 1.203 0 O-C-N 124.511 1.795 . . . . 71.239999999999995 110.98 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 476' ' ' ALA . . . . . . . . . . . . . . . -71.33 134.05 84.99 Favored Pre-proline 0 C--N 1.326 -0.439 0 O-C-N 124.535 1.147 . . . . 41.140000000000001 109.293 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 477' ' ' PRO . . . . . 0.523 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -75.07 -167.85 0.46 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.56 1.821 . . . . 75.099999999999994 111.032 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.08 91.82 38.2 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 124.42 1.075 . . . . 43.32 109.302 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 479' ' ' PRO . . . . . 0.604 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.3 Cg_endo -74.96 151.21 39.43 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.535 1.808 . . . . 64.409999999999997 110.973 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 480' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 479' ' ' PRO . 18.2 Cg_endo -75.0 158.22 42.31 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.523 1.802 . . . . 74.310000000000002 110.938 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 481' ' ' SER . . . . . . . . . . . . . 3.7 t 54.25 32.7 16.65 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.427 1.079 . . . . 72.510000000000005 110.061 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 58.6 p -73.25 113.09 9.93 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.427 1.079 . . . . 73.549999999999997 109.973 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -89.4 14.94 10.04 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.471 1.107 . . . . 32.020000000000003 109.306 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 2.8 p -112.38 8.38 19.52 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.496 1.123 . . . . 70.340000000000003 110.034 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -137.54 178.86 6.78 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.518 1.136 . . . . 55.43 109.333 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 80.9 p . . . . . 0 C--N 1.324 -0.501 0 O-C-N 124.412 1.07 . . . . 75.140000000000001 109.984 179.999 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.967 0 N-CA-C 111.0 -0.84 . . . . 15.34 111.0 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.7 t -147.88 179.1 7.96 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.477 0.751 . . . . 71.319999999999993 109.988 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 mt 64.37 64.29 0.72 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.456 1.098 . . . . 65.349999999999994 109.349 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -118.93 155.62 30.99 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.546 1.154 . . . . 74.530000000000001 111.01 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.819 ' O ' HD12 ' A' ' 182' ' ' LEU . . . -115.82 144.45 43.99 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.549 1.155 . . . . 63.310000000000002 109.291 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.519 HD13 ' N ' ' A' ' 162' ' ' VAL . 0.1 OUTLIER -129.37 132.04 66.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 124.505 1.128 . . . . 72.200000000000003 109.358 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.988 HG22 HG12 ' A' ' 212' ' ' VAL . 2.1 t -91.37 122.22 42.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.445 1.09 . . . . 71.340000000000003 109.312 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.531 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 0.7 OUTLIER -98.26 -14.36 20.32 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.457 1.098 . . . . 70.099999999999994 109.305 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.665 ' O ' HG13 ' A' ' 162' ' ' VAL . 1.1 m-85 -144.54 156.54 44.2 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.503 1.127 . . . . 63.210000000000001 111.033 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.716 ' N ' HG12 ' A' ' 178' ' ' VAL . 5.8 t70 -98.96 158.38 15.69 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.422 1.076 . . . . 51.439999999999998 109.25 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.556 ' CE2' ' HG3' ' B' ' 477' ' ' PRO . 1.4 t80 -160.26 131.06 5.59 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.56 1.162 . . . . 74.150000000000006 110.993 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.552 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 16.8 mtpp -67.21 121.26 15.26 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.445 1.091 . . . . 63.020000000000003 109.268 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.836 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -91.22 140.39 29.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.416 1.073 . . . . 54.140000000000001 109.293 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -150.47 21.03 0.83 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.512 1.132 . . . . 72.120000000000005 110.308 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.47 ' HD3' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -99.33 -176.22 3.23 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.511 1.132 . . . . 74.140000000000001 109.248 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.44 -29.14 67.57 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.548 1.155 . . . . 62.399999999999999 109.295 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 173' ' ' GLU . 5.6 m-20 -107.83 18.73 20.97 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.522 1.139 . . . . 75.129999999999995 109.281 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.836 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 6.8 pt-20 -36.62 104.06 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.539 1.149 . . . . 74.430000000000007 110.255 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.589 HD12 ' HA3' ' A' ' 205' ' ' GLY . 0.8 OUTLIER -141.15 95.31 2.82 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 62.049999999999997 109.278 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.01 153.66 33.15 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.462 1.101 . . . . 62.240000000000002 110.34 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 25.4 m -155.99 102.54 2.16 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.462 1.101 . . . . 63.039999999999999 110.387 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -44.17 160.56 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 70.409999999999997 111.019 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.716 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.9 m -62.08 158.48 3.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.529 1.143 . . . . 74.340000000000003 109.289 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.407 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 49.41 62.69 4.58 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.469 1.105 . . . . 71.200000000000003 110.98 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -118.56 165.55 13.8 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.516 0.774 . . . . 71.209999999999994 110.315 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -123.4 123.4 40.58 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.486 1.116 . . . . 74.109999999999999 109.26 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.848 ' H ' HD12 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -141.65 155.14 45.72 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.422 1.076 . . . . 64.209999999999994 109.249 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 7.3 t80 -109.59 112.61 24.8 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.546 1.154 . . . . 73.510000000000005 110.999 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.528 HD12 ' HB2' ' A' ' 160' ' ' ALA . 36.8 mt -70.96 151.43 9.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.463 1.102 . . . . 71.25 109.319 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.607 ' SG ' ' CH2' ' A' ' 242' ' ' TRP . 1.8 t -139.99 -43.85 0.43 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.466 1.104 . . . . 74.450000000000003 108.276 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.995 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -112.17 166.8 10.94 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.525 1.141 . . . . 61.439999999999998 109.316 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.521 ' C ' ' CD2' ' A' ' 188' ' ' HIS . 2.9 p80 -159.37 149.55 19.06 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.123 . . . . 73.450000000000003 109.617 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.742 ' HE1' HD11 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -141.61 133.14 26.87 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.438 1.086 . . . . 64.409999999999997 109.651 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 190' ' ' CYS . 95.7 m-20 49.02 31.16 3.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.564 1.165 . . . . 74.530000000000001 109.313 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.442 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.0 p 38.47 34.8 0.08 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.474 1.109 . . . . 74.310000000000002 108.352 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.52 ' O ' HG13 ' A' ' 209' ' ' VAL . 8.6 tt0 -128.49 -39.32 1.67 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.505 1.128 . . . . 74.120000000000005 110.324 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.964 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 98.6 m95 -111.56 126.43 54.98 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.483 1.115 . . . . 70.010000000000005 108.059 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.781 ' CE2' HG12 ' A' ' 209' ' ' VAL . 20.9 m-30 -117.99 132.17 56.41 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.526 1.141 . . . . 73.519999999999996 110.979 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.995 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 10.1 mm -96.37 103.45 14.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.385 1.053 . . . . 73.530000000000001 109.294 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.482 ' HB2' ' CG1' ' A' ' 184' ' ' ILE . . . -111.59 174.78 5.71 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.514 1.134 . . . . 73.310000000000002 109.299 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.36 165.56 19.74 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 124.525 1.14 . . . . 65.319999999999993 109.238 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.94 178.26 7.47 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.509 1.794 . . . . 62.539999999999999 111.042 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.515 ' H ' HD13 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -89.57 15.28 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.536 1.147 . . . . 72.519999999999996 109.302 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -138.81 -122.66 2.04 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.575 1.172 . . . . 62.219999999999999 111.042 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -161.01 172.81 16.21 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.496 0.763 . . . . 62.149999999999999 110.26 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 201' ' ' LEU . 12.7 tp 78.85 81.48 0.06 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.539 1.149 . . . . 73.340000000000003 109.3 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 143.16 -85.2 0.19 Allowed Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.451 1.094 . . . . 54.109999999999999 111.085 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -49.53 -179.72 0.02 OUTLIER Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.002 -0.839 . . . . 60.439999999999998 111.002 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.568 ' HG2' ' CE2' ' B' ' 470' ' ' PHE . 18.4 Cg_endo -74.9 143.53 78.12 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.045 -2.481 . . . . 72.409999999999997 111.024 -0.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.589 ' HA3' HD12 ' A' ' 174' ' ' LEU . . . -105.76 150.98 17.05 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.582 1.176 . . . . 44.229999999999997 110.962 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.964 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.1 OUTLIER -87.34 146.21 26.01 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 0.763 . . . . 72.019999999999996 109.314 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.766 ' HB ' HG11 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -153.79 122.23 3.07 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.53 1.144 . . . . 71.0 109.242 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.987 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.5 Cg_endo -74.97 170.96 19.25 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.509 1.794 . . . . 34.310000000000002 111.015 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.781 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.8 OUTLIER -89.75 5.2 5.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.118 . . . . 63.020000000000003 109.221 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -103.47 -12.11 31.65 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.522 1.139 . . . . 75.049999999999997 110.995 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.626 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 10.8 m-85 -124.0 -1.24 8.32 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.478 0.752 . . . . 74.109999999999999 111.054 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.988 HG12 HG22 ' A' ' 162' ' ' VAL . 2.2 m -140.4 160.67 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.501 1.125 . . . . 71.299999999999997 109.294 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.8 m -128.67 147.93 50.78 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.444 1.09 . . . . 75.099999999999994 110.07 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.753 ' C ' HD13 ' A' ' 215' ' ' ILE . 2.7 mm -94.42 141.19 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 64.540000000000006 109.235 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.785 ' N ' HD13 ' A' ' 215' ' ' ILE . 0.0 OUTLIER -143.29 143.51 24.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.514 1.133 . . . . 74.329999999999998 109.218 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -93.8 -16.05 24.52 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.457 1.098 . . . . 52.140000000000001 109.312 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.42 ' CG2' ' O ' ' A' ' 219' ' ' THR . 4.4 tt -149.12 175.65 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.536 1.148 . . . . 75.340000000000003 109.276 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -46.85 -69.11 0.14 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.447 1.092 . . . . 62.039999999999999 109.332 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.42 ' O ' ' CG2' ' A' ' 217' ' ' ILE . 43.0 m -103.38 143.93 32.05 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.527 1.142 . . . . 73.040000000000006 110.36 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 125.4 -159.99 19.95 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.516 1.135 . . . . 62.409999999999997 110.969 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.415 ' O ' ' N ' ' A' ' 223' ' ' THR . 0.1 OUTLIER -119.88 -172.27 2.31 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.483 0.755 . . . . 63.229999999999997 111.021 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.752 ' O ' HG22 ' A' ' 223' ' ' THR . . . -69.43 70.35 0.27 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.479 1.112 . . . . 73.230000000000004 109.213 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.752 HG22 ' O ' ' A' ' 222' ' ' ALA . 15.2 t 50.49 18.19 0.43 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.559 1.162 . . . . 72.010000000000005 110.412 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.402 ' N ' ' C ' ' A' ' 222' ' ' ALA . . . 92.27 -45.37 2.62 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.489 1.118 . . . . 64.510000000000005 111.03 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -63.09 156.53 24.67 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.546 0.792 . . . . 74.120000000000005 109.271 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 229' ' ' GLU . 19.9 t0 -72.17 149.3 44.81 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.506 1.129 . . . . 70.209999999999994 109.276 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.656 HG13 HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -40.27 -45.63 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.532 1.145 . . . . 72.010000000000005 109.271 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.752 ' HA ' HD12 ' A' ' 231' ' ' ILE . 4.5 mp -64.78 -49.03 82.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.537 1.148 . . . . 73.230000000000004 109.316 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.483 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 34.0 mt-10 -62.4 -16.67 56.16 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.445 1.091 . . . . 73.310000000000002 110.29 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -89.16 -19.11 25.89 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.476 1.11 . . . . 54.119999999999997 109.332 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.752 HD12 ' HA ' ' A' ' 228' ' ' ILE . 3.0 mt -72.64 -69.89 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 124.565 1.166 . . . . 72.030000000000001 109.331 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.483 ' CD ' ' HA ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -57.5 -22.74 45.92 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.508 1.13 . . . . 63.420000000000002 109.283 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.21 -56.79 7.05 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.132 . . . . 74.129999999999995 109.945 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 234' ' ' VAL . 1.6 m -98.49 24.65 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.499 1.124 . . . . 73.239999999999995 109.241 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 41.29 36.73 0.53 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.515 1.134 . . . . 53.310000000000002 109.291 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.489 HD12 ' HD2' ' A' ' 237' ' ' PRO . 4.2 tp -60.17 119.83 45.67 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.521 1.138 . . . . 74.420000000000002 109.312 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.489 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.3 Cg_endo -74.99 162.79 36.57 Favored 'Trans proline' 0 C--N 1.359 1.115 0 O-C-N 124.499 1.789 . . . . 54.100000000000001 110.967 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.7 m -68.52 173.02 5.37 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.49 1.119 . . . . 54.119999999999997 110.419 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.681 ' HB ' ' HB1' ' A' ' 186' ' ' ALA . 10.5 p -65.3 -49.95 75.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.54 1.15 . . . . 63.25 109.281 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.481 ' OE1' ' CD1' ' B' ' 471' ' ' ILE . 7.6 pm0 -68.63 -14.95 63.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 72.439999999999998 110.353 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -88.49 -39.64 14.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.552 1.157 . . . . 70.340000000000003 110.381 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.607 ' CH2' ' SG ' ' A' ' 185' ' ' CYS . 0.2 OUTLIER -80.68 -63.07 1.49 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.506 1.129 . . . . 72.219999999999999 108.015 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.553 ' HD2' ' CD2' ' B' ' 470' ' ' PHE . 14.7 mtpp -51.5 -23.26 3.84 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.479 1.112 . . . . 64.310000000000002 109.292 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -39.55 -67.59 0.21 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.129 . . . . 53.25 109.933 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -135.12 121.77 20.78 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.581 1.176 . . . . 71.540000000000006 109.32 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 23.1 mm -48.08 -53.7 5.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.564 1.165 . . . . 63.240000000000002 109.285 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -122.74 117.47 25.8 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.506 1.128 . . . . 64.129999999999995 109.29 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.31 173.74 11.98 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.455 1.097 . . . . 73.150000000000006 110.272 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -76.75 153.47 34.99 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.426 1.079 . . . . 51.5 110.919 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 131.04 49.8 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.44 1.087 . . . . 63.450000000000003 109.272 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -174.45 -178.02 1.32 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.515 1.135 . . . . 72.120000000000005 109.295 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 57.8 m 56.98 54.66 6.79 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.412 1.07 . . . . 63.450000000000003 109.975 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -106.12 134.2 49.62 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.459 1.099 . . . . 74.409999999999997 109.328 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.553 HD12 ' N ' ' A' ' 254' ' ' ILE . 4.5 mp -125.74 141.42 45.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.518 1.136 . . . . 74.120000000000005 109.277 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 15.1 t -146.97 108.64 4.34 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.446 1.091 . . . . 71.530000000000001 110.005 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 4.8 mt -127.55 -179.28 4.83 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.443 1.089 . . . . 72.120000000000005 109.298 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -73.3 -140.58 0.46 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.51 1.131 . . . . 53.409999999999997 110.998 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 43.5 t -169.11 141.45 2.61 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.502 0.766 . . . . 54.119999999999997 110.04 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 35.0 m -140.26 -175.41 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.499 1.125 . . . . 52.140000000000001 109.347 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.324 -0.51 0 O-C-N 124.503 1.127 . . . . 64.040000000000006 110.349 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 90.8 p . . . . . 0 N--CA 1.452 -0.325 0 N-CA-C 109.993 -0.373 . . . . 75.140000000000001 109.993 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 48.7 m -129.0 43.86 3.07 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.418 1.074 . . . . 74.109999999999999 110.018 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 47.5 t -85.93 -62.62 1.48 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.479 1.112 . . . . 65.310000000000002 109.973 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -106.53 157.65 17.5 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 72.25 109.271 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -102.08 159.68 15.17 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.559 1.162 . . . . 74.120000000000005 109.321 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -147.9 163.33 28.84 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.493 1.121 . . . . 55.009999999999998 111.054 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 469' ' ' LYS . . . . . 0.421 ' O ' ' CD1' ' B' ' 471' ' ' ILE . 0.0 OUTLIER -128.74 144.37 51.15 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.494 0.761 . . . . 64.129999999999995 109.342 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 470' ' ' PHE . . . . . 0.568 ' CE2' ' HG2' ' A' ' 204' ' ' PRO . 5.4 m-30 52.07 35.57 16.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.472 1.108 . . . . 72.409999999999997 110.938 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 471' ' ' ILE . . . . . 0.528 HG22 ' HD2' ' B' ' 472' ' ' PRO . 3.3 mm -95.95 140.59 22.35 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.478 1.111 . . . . 74.349999999999994 109.279 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 472' ' ' PRO . . . . . 0.528 ' HD2' HG22 ' B' ' 471' ' ' ILE . 18.3 Cg_endo -75.0 -170.16 0.74 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.417 1.746 . . . . 34.140000000000001 110.965 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.97 15.9 4.23 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.478 1.111 . . . . 71.25 109.986 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 474' ' ' ARG . . . . . 0.443 ' O ' ' NE1' ' A' ' 192' ' ' TRP . 17.0 mmt180 -145.82 154.51 51.57 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.466 1.104 . . . . 72.049999999999997 110.335 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 475' ' ' PRO . . . . . 0.672 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.2 Cg_endo -74.94 -36.07 2.82 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.538 1.809 . . . . 71.209999999999994 110.939 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 476' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 164.38 133.04 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.543 1.152 . . . . 42.100000000000001 109.262 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 477' ' ' PRO . . . . . 0.573 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -74.93 -171.08 0.88 Allowed 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.556 1.819 . . . . 71.209999999999994 111.044 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.72 96.65 40.32 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.546 1.154 . . . . 73.150000000000006 109.319 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 479' ' ' PRO . . . . . 0.626 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -75.0 166.67 28.7 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.386 1.729 . . . . 74.329999999999998 111.032 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.87 -45.96 0.27 Allowed 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.44 1.758 . . . . 63.43 111.012 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 481' ' ' SER . . . . . 0.646 ' CB ' ' CZ ' ' A' ' 164' ' ' TYR . 1.0 OUTLIER -55.2 -26.41 39.08 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.559 1.162 . . . . 63.340000000000003 110.013 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.16 81.21 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.411 1.069 . . . . 73.409999999999997 110.004 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 483' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' B' ' 485' ' ' ALA . . . -41.36 -49.92 3.78 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.54 1.15 . . . . 72.219999999999999 109.332 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 9.5 t -46.54 94.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 O-C-N 124.431 1.082 . . . . 42.119999999999997 110.014 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 485' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' B' ' 483' ' ' ALA . . . -47.24 150.62 0.82 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.532 1.145 . . . . 53.409999999999997 109.263 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 82.4 p . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.455 1.097 . . . . 43.100000000000001 110.042 179.943 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.034 0 N-CA-C 110.995 -0.842 . . . . 73.239999999999995 110.995 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.0 t -67.17 136.55 55.23 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.539 0.788 . . . . 43.130000000000003 110.005 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 158' ' ' LEU . 4.6 pp -45.05 139.35 3.25 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.484 1.115 . . . . 75.129999999999995 109.38 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.565 ' CE2' ' CD1' ' A' ' 215' ' ' ILE . 2.3 p90 -131.19 174.66 9.82 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.487 1.117 . . . . 72.329999999999998 110.975 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.65 ' HB3' ' HG ' ' A' ' 182' ' ' LEU . . . -107.38 151.84 24.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 51.340000000000003 109.288 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.597 HD13 ' N ' ' A' ' 162' ' ' VAL . 0.1 OUTLIER -132.16 135.05 58.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.457 1.098 . . . . 72.219999999999999 109.331 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.768 HG23 HD22 ' A' ' 182' ' ' LEU . 1.8 t -89.99 118.43 35.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.511 1.132 . . . . 73.540000000000006 109.337 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.571 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 1.4 mt -94.56 -16.92 22.85 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.422 1.076 . . . . 74.299999999999997 109.328 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.571 ' CE2' ' HB2' ' A' ' 163' ' ' LEU . 1.9 m-85 -148.61 157.07 43.21 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.439 1.087 . . . . 75.150000000000006 110.925 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.71 ' H ' HG12 ' A' ' 178' ' ' VAL . 7.2 p30 -88.84 154.84 19.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.527 1.142 . . . . 72.340000000000003 109.281 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.645 ' CE2' ' NZ ' ' A' ' 170' ' ' LYS . 2.4 t80 -154.4 132.13 11.47 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.435 1.084 . . . . 70.329999999999998 111.003 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.542 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 6.2 mtpm? -75.82 125.65 29.48 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.544 1.152 . . . . 62.210000000000001 109.328 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.908 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -114.18 133.53 55.53 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.521 1.138 . . . . 61.219999999999999 109.299 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -136.68 9.37 3.1 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.485 1.116 . . . . 63.039999999999999 110.245 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.645 ' NZ ' ' CE2' ' A' ' 166' ' ' PHE . 0.1 OUTLIER -79.07 -175.79 4.76 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.489 1.118 . . . . 74.230000000000004 109.32 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.34 -21.76 66.26 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.537 1.148 . . . . 73.329999999999998 109.267 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 173' ' ' GLU . 0.5 OUTLIER -114.05 12.64 17.99 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.451 1.094 . . . . 70.430000000000007 109.303 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.908 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 6.5 pt-20 -32.99 112.95 0.13 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.123 . . . . 73.299999999999997 110.293 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.592 HD23 ' HA3' ' A' ' 205' ' ' GLY . 1.5 tm? -119.92 99.4 6.6 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.555 1.159 . . . . 74.510000000000005 109.283 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 14.5 t -80.82 130.75 35.23 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.434 1.083 . . . . 75.120000000000005 110.428 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.411 ' CG2' ' HG3' ' A' ' 180' ' ' GLU . 55.6 m -155.19 155.98 34.87 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.451 1.094 . . . . 64.540000000000006 110.373 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.488 ' O ' HG11 ' A' ' 162' ' ' VAL . 26.8 m-85 -93.71 167.09 11.88 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.467 1.104 . . . . 65.120000000000005 110.953 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.71 HG12 ' H ' ' A' ' 165' ' ' ASP . 2.2 m -61.39 158.5 2.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.452 1.095 . . . . 75.519999999999996 109.3 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.422 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 48.55 56.92 8.88 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.524 1.14 . . . . 60.520000000000003 111.021 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.411 ' HG3' ' CG2' ' A' ' 176' ' ' THR . 3.9 mm-40 -114.86 175.47 5.48 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.472 0.749 . . . . 63.109999999999999 110.277 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -119.15 130.59 55.62 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.125 . . . . 75.120000000000005 109.321 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.891 HD12 HG21 ' A' ' 207' ' ' VAL . 2.5 pt? -145.28 133.37 21.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.455 1.097 . . . . 72.200000000000003 109.361 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -100.72 107.87 19.58 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.565 1.166 . . . . 74.120000000000005 110.979 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.75 ' CG1' ' HB2' ' A' ' 195' ' ' ALA . 13.3 mt -70.66 162.55 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.458 1.099 . . . . 70.140000000000001 109.353 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.571 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 2.0 p -156.44 -40.85 0.08 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.463 1.102 . . . . 42.119999999999997 108.296 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.989 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -112.21 152.17 28.71 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.451 1.094 . . . . 54.219999999999999 109.282 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.478 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 2.1 p-80 -145.26 149.45 34.91 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.476 1.11 . . . . 74.219999999999999 109.554 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.608 ' CD2' ' O ' ' A' ' 192' ' ' TRP . 0.7 OUTLIER -155.82 143.51 19.59 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 124.434 1.084 . . . . 65.329999999999998 109.545 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.456 ' C ' ' N ' ' A' ' 191' ' ' GLU . 7.4 m-20 57.02 18.04 3.75 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.548 1.155 . . . . 73.310000000000002 109.329 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 3.3 m 43.24 26.94 0.11 Allowed 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.475 1.109 . . . . 52.140000000000001 108.315 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.863 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 18.1 tt0 -132.93 -40.58 0.93 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.134 . . . . 71.420000000000002 110.254 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.996 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 96.9 m95 -103.88 127.83 51.38 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.042 -1.095 . . . . 71.400000000000006 108.042 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.768 ' CE2' HG12 ' A' ' 209' ' ' VAL . 15.7 m-30 -125.09 127.73 47.35 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.536 1.147 . . . . 74.409999999999997 110.922 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.989 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 1.6 mp -85.56 106.42 15.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.55 1.156 . . . . 74.040000000000006 109.277 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.798 ' HB3' HG21 ' A' ' 207' ' ' VAL . . . -120.85 163.07 18.75 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.557 1.161 . . . . 73.140000000000001 109.313 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -113.36 145.05 32.45 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.551 1.157 . . . . 73.329999999999998 109.263 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 172.19 16.85 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.475 1.776 . . . . 73.450000000000003 111.047 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -44.12 -41.61 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.518 1.136 . . . . 65.310000000000002 109.342 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.73 -78.11 0.05 OUTLIER Glycine 0 CA--C 1.531 1.07 0 O-C-N 124.507 1.129 . . . . 73.140000000000001 110.916 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 36.4 mtt85 -56.53 -177.25 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.485 0.756 . . . . 74.239999999999995 110.317 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 7.8 mt 72.92 9.94 5.42 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.403 1.065 . . . . 65.230000000000004 109.287 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 76.25 -132.09 12.36 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.577 1.173 . . . . 64.219999999999999 110.944 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.449 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . 107.82 166.73 21.61 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 111.059 -0.816 . . . . 44.140000000000001 111.059 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.449 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.3 Cg_endo -74.93 138.27 55.09 Favored 'Cis proline' 0 C--N 1.359 1.123 0 C-N-CA 120.97 -2.512 . . . . 54.549999999999997 110.988 -0.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.592 ' HA3' HD23 ' A' ' 174' ' ' LEU . . . -99.56 -178.96 31.04 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.432 1.082 . . . . 35.140000000000001 110.971 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.996 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -93.33 148.61 21.9 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.538 0.787 . . . . 61.100000000000001 109.295 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.891 HG21 HD12 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -155.52 122.95 2.78 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 74.540000000000006 109.32 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.888 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.5 Cg_endo -74.93 174.69 12.33 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.494 1.786 . . . . 71.0 111.038 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.768 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.5 m -93.59 -2.69 10.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.512 1.133 . . . . 75.099999999999994 109.228 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLY . . . . . 0.5 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -98.46 2.73 59.2 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.482 1.114 . . . . 22.140000000000001 110.967 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.557 ' CD1' ' HB2' ' A' ' 166' ' ' PHE . 13.5 m-85 -137.9 11.31 2.88 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.471 0.747 . . . . 72.329999999999998 110.985 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 208' ' ' PRO . 3.8 m -152.97 158.77 3.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 124.471 1.107 . . . . 73.329999999999998 109.339 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.8 t -134.91 148.07 49.98 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.532 1.145 . . . . 74.340000000000003 110.054 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 13.7 mm -86.27 132.76 31.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.441 1.088 . . . . 72.450000000000003 109.28 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.565 ' CD1' ' CE2' ' A' ' 159' ' ' TYR . 24.3 pt -147.45 140.74 19.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.547 1.154 . . . . 65.310000000000002 109.241 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.468 ' OD1' ' HB3' ' A' ' 218' ' ' ALA . 0.1 OUTLIER -129.08 -176.66 3.94 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.513 1.133 . . . . 64.319999999999993 109.24 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.5 ' C ' HD12 ' A' ' 217' ' ' ILE . 0.9 OUTLIER -100.8 27.14 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.443 1.089 . . . . 72.209999999999994 109.323 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.468 ' HB3' ' OD1' ' A' ' 216' ' ' ASP . . . -101.57 21.81 13.73 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.578 1.173 . . . . 70.209999999999994 109.328 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 7.0 m 57.15 107.65 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.493 1.12 . . . . 72.400000000000006 110.415 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 126.11 169.16 12.77 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.489 1.118 . . . . 55.439999999999998 111.052 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -103.51 131.18 50.84 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.521 0.777 . . . . 72.329999999999998 110.994 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.569 ' O ' HG22 ' A' ' 223' ' ' THR . . . 52.74 26.82 4.75 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.597 1.185 . . . . 53.310000000000002 109.3 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 222' ' ' ALA . 8.9 t 45.58 25.63 0.26 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.498 1.123 . . . . 51.32 110.412 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 86.13 -48.37 3.93 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.425 1.078 . . . . 70.540000000000006 110.987 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -64.88 142.53 58.4 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.489 0.758 . . . . 55.210000000000001 109.356 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 230' ' ' ASP . 2.4 m-20 -63.31 157.09 23.78 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.515 1.134 . . . . 71.129999999999995 109.277 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.566 HG13 HD12 ' A' ' 228' ' ' ILE . 1.4 p -50.86 -41.08 21.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.461 1.1 . . . . 71.299999999999997 109.265 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.926 ' HA ' HD12 ' A' ' 231' ' ' ILE . 4.1 mp -70.27 -41.66 78.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.54 1.15 . . . . 74.019999999999996 109.332 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -69.21 -19.55 63.96 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 1.114 . . . . 62.329999999999998 110.308 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 226' ' ' ASP . 7.1 m-20 -88.73 -16.3 32.59 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.461 1.1 . . . . 75.519999999999996 109.272 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.926 HD12 ' HA ' ' A' ' 228' ' ' ILE . 4.4 mt -70.77 -69.36 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.463 1.102 . . . . 60.310000000000002 109.342 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.505 ' CE ' ' O ' ' A' ' 228' ' ' ILE . 0.0 OUTLIER -57.03 -25.59 58.86 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.511 1.132 . . . . 75.120000000000005 109.322 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.3 m -49.38 -55.54 12.63 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.514 1.134 . . . . 71.409999999999997 109.953 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 234' ' ' VAL . 2.0 m -93.49 26.1 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 71.439999999999998 109.32 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 234' ' ' VAL . 68.5 m-80 40.17 35.64 0.27 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 75.519999999999996 109.271 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.465 HD11 ' O ' ' A' ' 185' ' ' CYS . 1.2 tp -66.01 119.67 63.18 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 74.030000000000001 109.316 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.01 173.73 14.01 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.537 1.809 . . . . 74.5 110.981 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 239' ' ' VAL . 0.8 OUTLIER -69.56 -170.92 0.33 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.46 1.1 . . . . 44.149999999999999 110.367 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.84 HG22 ' HD3' ' A' ' 243' ' ' LYS . 10.5 p -82.89 -34.74 11.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.485 1.116 . . . . 75.519999999999996 109.295 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.633 ' HG3' HG13 ' A' ' 239' ' ' VAL . 0.6 OUTLIER -85.39 -20.06 30.44 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.52 1.138 . . . . 64.200000000000003 110.333 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -80.22 -36.37 34.88 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.434 1.084 . . . . 62.439999999999998 110.299 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.714 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 1.5 t90 -84.0 -56.57 3.61 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 65.129999999999995 107.972 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.84 ' HD3' HG22 ' A' ' 239' ' ' VAL . 18.1 mtpp -58.17 -17.69 20.49 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.524 1.14 . . . . 64.239999999999995 109.291 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 2.8 t -39.02 -56.74 1.37 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.546 1.154 . . . . 61.210000000000001 109.998 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -144.72 135.03 24.28 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 74.540000000000006 109.259 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 9.9 mm -60.4 -51.75 69.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.492 1.12 . . . . 72.120000000000005 109.319 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.532 ' HB1' ' OH ' ' A' ' 249' ' ' TYR . . . -82.51 130.49 35.12 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.521 1.138 . . . . 54.520000000000003 109.251 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' ARG . . . . . 0.453 ' C ' ' CD1' ' A' ' 249' ' ' TYR . 0.1 OUTLIER -143.01 132.58 23.68 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.602 1.189 . . . . 63.439999999999998 110.341 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.532 ' OH ' ' HB1' ' A' ' 247' ' ' ALA . 1.8 m-85 -133.05 82.95 2.02 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.51 1.131 . . . . 74.129999999999995 110.994 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.466 ' CE ' ' HA ' ' A' ' 250' ' ' LYS . 1.0 OUTLIER -51.52 172.81 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.581 1.175 . . . . 74.030000000000001 109.347 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -112.59 -35.55 5.49 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.519 1.137 . . . . 51.32 109.289 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 3.5 m -59.1 169.53 1.07 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.525 1.141 . . . . 60.549999999999997 109.958 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.516 ' O ' HD13 ' A' ' 254' ' ' ILE . 40.2 t30 -95.51 162.15 13.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.545 1.153 . . . . 75.409999999999997 109.315 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.516 HD13 ' O ' ' A' ' 253' ' ' ASN . 7.8 mm -126.73 138.98 53.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.527 1.142 . . . . 75.409999999999997 109.332 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 6.3 t -164.65 126.28 2.18 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.555 1.16 . . . . 40.200000000000003 110.005 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 87.4 mt -117.5 156.96 27.12 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.457 1.098 . . . . 72.200000000000003 109.341 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -40.81 -49.84 4.13 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.489 1.118 . . . . 70.329999999999998 111.048 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.1 t -40.23 125.91 2.11 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.545 0.791 . . . . 74.549999999999997 109.999 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 259' ' ' VAL . 7.9 p -67.45 113.36 3.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.523 1.14 . . . . 63.420000000000002 109.258 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 . . . . . 0 C--N 1.324 -0.506 0 O-C-N 124.503 1.127 . . . . 60.109999999999999 110.264 179.939 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 110.001 -0.37 . . . . 64.430000000000007 110.001 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 5.5 m -127.12 177.48 6.64 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.483 1.114 . . . . 65.099999999999994 109.943 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 8.7 m -107.11 175.72 5.41 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.556 1.16 . . . . 64.010000000000005 110.051 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -164.29 122.1 1.75 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.47 1.106 . . . . 73.329999999999998 109.274 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -152.74 107.9 3.24 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.526 1.141 . . . . 63.43 109.301 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -177.03 126.01 1.07 Allowed Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.438 1.086 . . . . 74.430000000000007 110.999 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -90.95 -14.22 31.98 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.574 0.808 . . . . 73.310000000000002 109.294 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 470' ' ' PHE . . . . . 0.559 ' CD2' ' HD2' ' A' ' 243' ' ' LYS . 3.4 m-30 -89.26 3.92 50.46 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.516 1.135 . . . . 72.239999999999995 111.028 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 471' ' ' ILE . . . . . 0.427 HG23 ' HD2' ' B' ' 472' ' ' PRO . 0.7 OUTLIER -72.24 143.93 86.46 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.516 1.135 . . . . 72.439999999999998 109.28 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 472' ' ' PRO . . . . . 0.567 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.5 Cg_endo -74.96 153.47 41.98 Favored 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.475 1.777 . . . . 62.130000000000003 110.989 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.02 -63.07 1.29 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.546 1.153 . . . . 63.310000000000002 109.951 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.81 172.22 6.42 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.503 1.127 . . . . 71.140000000000001 110.259 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 -169.21 0.6 Allowed 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.479 1.778 . . . . 51.32 111.002 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 476' ' ' ALA . . . . . 0.863 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . -62.51 134.61 95.14 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.509 1.131 . . . . 61.340000000000003 109.285 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 477' ' ' PRO . . . . . 0.596 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -75.0 -162.5 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.579 1.831 . . . . 63.420000000000002 111.047 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.72 89.95 20.55 Favored Pre-proline 0 C--N 1.324 -0.525 0 O-C-N 124.525 1.141 . . . . 51.32 109.299 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 479' ' ' PRO . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.0 Cg_endo -75.03 165.02 32.15 Favored 'Trans proline' 0 C--N 1.359 1.11 0 O-C-N 124.481 1.779 . . . . 64.209999999999994 110.977 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.93 -89.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.501 1.79 . . . . 54.200000000000003 111.005 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 481' ' ' SER . . . . . 0.521 ' O ' ' CZ ' ' A' ' 164' ' ' TYR . 1.2 t -82.96 138.32 33.85 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.534 1.146 . . . . 65.019999999999996 109.994 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 5.6 t -173.44 179.59 2.09 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.48 1.112 . . . . 61.25 110.047 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -86.11 -39.41 16.76 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.475 1.11 . . . . 73.120000000000005 109.296 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 30.9 t -171.59 117.92 0.43 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.442 1.089 . . . . 62.130000000000003 109.989 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -100.56 76.45 1.83 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.557 1.16 . . . . 60.25 109.312 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 59.5 p . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.475 1.109 . . . . 74.120000000000005 109.988 -179.973 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.011 0 N-CA-C 111.053 -0.819 . . . . 63.420000000000002 111.053 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 69.4 m -150.03 109.72 4.05 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.563 0.802 . . . . 61.329999999999998 109.971 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.638 ' C ' HD13 ' A' ' 158' ' ' LEU . 0.4 OUTLIER -158.85 123.36 4.07 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.499 1.124 . . . . 65.510000000000005 109.332 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.792 ' CD1' ' CD1' ' A' ' 183' ' ' PHE . 34.9 m-85 -153.94 -172.31 4.18 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.442 1.088 . . . . 75.099999999999994 111.048 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.561 ' HB3' ' CD2' ' A' ' 182' ' ' LEU . . . -124.93 148.24 48.45 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.51 1.131 . . . . 65.099999999999994 109.233 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.618 ' CG2' HD11 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -116.01 134.63 58.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.435 1.084 . . . . 73.010000000000005 109.311 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.714 HG22 HG12 ' A' ' 212' ' ' VAL . 1.0 OUTLIER -91.49 122.96 43.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.531 1.144 . . . . 55.399999999999999 109.287 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.583 ' HB2' ' CE1' ' A' ' 164' ' ' TYR . 0.3 OUTLIER -102.55 -11.92 18.16 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.522 1.139 . . . . 71.450000000000003 109.332 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.651 ' O ' HG13 ' A' ' 162' ' ' VAL . 12.8 m-85 -142.51 166.41 24.75 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.477 1.111 . . . . 74.319999999999993 110.986 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.606 ' N ' HG12 ' A' ' 178' ' ' VAL . 27.6 p-10 -115.12 146.42 41.37 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.477 1.11 . . . . 72.420000000000002 109.283 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.567 ' CE2' ' HG3' ' B' ' 477' ' ' PRO . 1.6 t80 -149.51 128.59 12.73 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.446 1.091 . . . . 52.32 111.023 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.409 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 7.1 mtpt -66.99 104.99 1.51 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.545 1.153 . . . . 71.409999999999997 109.322 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.696 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -79.61 144.26 33.98 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.462 1.101 . . . . 34.409999999999997 109.309 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -151.33 20.97 0.74 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.499 1.124 . . . . 65.019999999999996 110.333 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.541 ' NZ ' ' CE2' ' A' ' 166' ' ' PHE . 0.1 OUTLIER -95.56 -176.06 3.64 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.465 1.103 . . . . 62.140000000000001 109.337 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.62 -37.11 75.19 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.511 1.132 . . . . 54.140000000000001 109.327 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 173' ' ' GLU . 0.7 OUTLIER -106.85 23.19 14.74 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.5 1.125 . . . . 74.030000000000001 109.345 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.696 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -35.26 111.19 0.12 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 1.118 . . . . 74.040000000000006 110.27 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.592 HD23 ' HA3' ' A' ' 205' ' ' GLY . 0.7 OUTLIER -118.51 98.07 6.07 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.532 1.145 . . . . 75.150000000000006 109.284 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 175' ' ' THR . 12.3 t -83.27 112.79 20.19 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.505 1.128 . . . . 72.439999999999998 110.447 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.777 HG23 ' CD ' ' A' ' 180' ' ' GLU . 1.1 m -137.55 137.17 38.32 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.548 1.155 . . . . 74.099999999999994 110.407 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -75.94 163.77 26.85 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.509 1.13 . . . . 73.109999999999999 110.962 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.606 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.3 m -58.08 157.79 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.529 1.143 . . . . 54.119999999999997 109.327 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.7 64.16 4.48 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.405 1.066 . . . . 63.43 111.026 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.777 ' CD ' HG23 ' A' ' 176' ' ' THR . 1.2 tt0 -127.84 -173.67 2.99 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.546 0.792 . . . . 75.219999999999999 110.264 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.636 ' C ' HD13 ' A' ' 182' ' ' LEU . 0.4 OUTLIER -147.27 136.59 22.59 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.528 1.142 . . . . 75.510000000000005 109.311 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.835 ' N ' HD13 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -148.96 146.27 27.75 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 72.200000000000003 109.294 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.792 ' CD1' ' CD1' ' A' ' 159' ' ' TYR . 6.8 m-30 -95.55 121.86 37.69 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.516 1.135 . . . . 73.329999999999998 110.899 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 195' ' ' ALA . 1.7 mp -70.75 161.93 4.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.53 1.144 . . . . 71.319999999999993 109.29 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.575 ' HB3' ' CH2' ' A' ' 242' ' ' TRP . 2.2 m -146.12 -47.37 0.2 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 62.520000000000003 108.259 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.927 ' HB1' ' HB ' ' A' ' 239' ' ' VAL . . . -119.78 166.07 13.72 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.479 1.112 . . . . 64.540000000000006 109.281 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.59 134.14 11.79 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 74.310000000000002 109.603 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.783 ' HD1' HG11 ' A' ' 239' ' ' VAL . 0.0 OUTLIER -146.73 149.28 33.09 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.444 1.09 . . . . 62.43 109.55 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.485 ' C ' ' N ' ' A' ' 191' ' ' GLU . 40.7 m-20 61.19 15.86 6.72 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 1.136 . . . . 71.530000000000001 109.316 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 189' ' ' ASN . 14.1 p 41.84 27.83 0.08 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.138 . . . . 74.019999999999996 108.335 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.615 ' O ' HG13 ' A' ' 209' ' ' VAL . 8.5 tt0 -136.42 -37.5 0.69 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.489 1.118 . . . . 72.010000000000005 110.258 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.866 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 95.7 m95 -101.82 135.91 42.57 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.008 -1.108 . . . . 74.329999999999998 108.008 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.718 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.0 m-30 -128.66 129.33 45.68 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 62.229999999999997 111.023 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.896 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 8.8 mm -89.68 102.07 12.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.503 1.127 . . . . 73.049999999999997 109.279 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -116.15 -178.85 3.5 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.438 1.086 . . . . 72.040000000000006 109.275 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.532 ' CB ' ' HA ' ' A' ' 204' ' ' PRO . 23.3 pttt -153.27 158.62 32.76 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.464 1.103 . . . . 74.239999999999995 109.295 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.414 ' CD ' ' HA3' ' A' ' 203' ' ' GLY . 18.1 Cg_endo -74.98 173.76 13.95 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.481 1.779 . . . . 63.130000000000003 110.974 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.552 ' HB ' ' CE2' ' A' ' 183' ' ' PHE . 1.1 tp -123.28 105.52 15.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.546 1.154 . . . . 74.510000000000005 109.294 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 117.25 -78.11 0.29 Allowed Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.507 1.129 . . . . 72.209999999999994 111.03 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -49.33 165.33 0.06 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.472 0.748 . . . . 62.240000000000002 110.307 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 5.2 mt -89.72 43.09 1.13 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.562 1.164 . . . . 74.129999999999995 109.328 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -99.41 -173.16 31.04 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 124.454 1.096 . . . . 73.010000000000005 110.974 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.414 ' HA3' ' CD ' ' A' ' 197' ' ' PRO . . . 48.48 -178.23 0.01 OUTLIER Glycine 0 CA--C 1.53 1.027 0 N-CA-C 110.993 -0.843 . . . . 73.129999999999995 110.993 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.532 ' HA ' ' CB ' ' A' ' 196' ' ' LYS . 18.1 Cg_endo -75.09 129.27 18.21 Favored 'Cis proline' 0 C--N 1.36 1.144 0 C-N-CA 121.015 -2.494 . . . . 33.009999999999998 110.974 0.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.592 ' HA3' HD23 ' A' ' 174' ' ' LEU . . . -111.96 177.91 18.95 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.529 1.143 . . . . 71.310000000000002 110.951 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.866 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -105.45 152.22 23.27 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.482 0.754 . . . . 73.340000000000003 109.341 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.529 ' N ' ' HG ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -156.76 132.41 5.71 Favored Pre-proline 0 C--N 1.324 -0.524 0 O-C-N 124.432 1.083 . . . . 51.130000000000003 109.315 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.844 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.3 Cg_endo -74.94 171.67 17.85 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.489 1.783 . . . . 73.319999999999993 111.037 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.718 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.2 m -91.48 -3.92 10.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.548 1.155 . . . . 74.310000000000002 109.304 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -90.26 -26.97 22.13 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.512 1.133 . . . . 65.299999999999997 110.981 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.62 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 17.6 m-85 -105.16 4.31 31.17 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.481 0.754 . . . . 73.439999999999998 111.011 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 208' ' ' PRO . 1.8 m -146.51 157.85 11.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.531 1.144 . . . . 63.229999999999997 109.311 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 4.5 t -130.39 130.55 44.5 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.515 1.135 . . . . 72.439999999999998 110.006 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.769 ' O ' HG23 ' A' ' 215' ' ' ILE . 2.6 mm -73.69 133.02 32.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.423 1.077 . . . . 73.230000000000004 109.254 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.769 HG23 ' O ' ' A' ' 214' ' ' ILE . 1.8 pt -164.86 173.47 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.46 1.1 . . . . 75.239999999999995 109.277 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.1 -56.48 0.49 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.544 1.152 . . . . 64.209999999999994 109.278 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 6.6 mt -141.02 -49.63 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.535 1.147 . . . . 63.210000000000001 109.24 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -45.24 168.41 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.494 1.121 . . . . 62.200000000000003 109.292 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 9.2 p -85.57 -79.98 0.23 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.461 1.101 . . . . 75.140000000000001 110.469 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -38.39 -91.52 0.01 OUTLIER Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.518 1.136 . . . . 64.219999999999999 111.036 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' A' ' 222' ' ' ALA . 31.4 m-85 -120.04 176.02 5.63 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.438 0.728 . . . . 74.400000000000006 110.974 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 221' ' ' TYR . . . -40.06 -71.4 0.08 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.46 1.1 . . . . 61.340000000000003 109.339 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.77 -7.5 10.49 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.535 1.147 . . . . 63.100000000000001 110.393 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 112.66 19.21 7.07 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.509 1.131 . . . . 50.140000000000001 111.075 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.555 ' H ' ' ND2' ' A' ' 225' ' ' ASN . 0.1 OUTLIER -111.92 171.43 7.5 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.506 0.768 . . . . 74.239999999999995 109.261 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 229' ' ' GLU . 0.7 OUTLIER -79.84 146.58 32.16 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.42 1.075 . . . . 73.120000000000005 109.257 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 227' ' ' VAL . 0.2 OUTLIER -39.76 -55.71 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 124.462 1.101 . . . . 63.039999999999999 109.241 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 3.9 mt -55.85 -43.62 74.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.372 1.045 . . . . 73.099999999999994 109.27 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 226' ' ' ASP . 27.3 mt-10 -70.59 -14.58 62.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.477 1.11 . . . . 73.409999999999997 110.31 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.441 ' CG ' ' ND2' ' A' ' 225' ' ' ASN . 0.4 OUTLIER -86.94 -24.27 24.82 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.514 1.134 . . . . 74.420000000000002 109.296 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.596 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.6 OUTLIER -61.23 -68.73 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.505 1.128 . . . . 74.109999999999999 109.297 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.596 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -56.27 -26.8 53.07 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.502 1.126 . . . . 61.140000000000001 109.349 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.9 t -52.14 -47.71 65.26 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.492 1.12 . . . . 61.32 109.934 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.522 HG23 ' HB2' ' A' ' 236' ' ' LEU . 8.9 m -98.45 19.44 2.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.493 1.12 . . . . 54.409999999999997 109.317 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 41.58 32.36 0.24 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.519 1.137 . . . . 73.430000000000007 109.26 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.522 ' HB2' HG23 ' A' ' 234' ' ' VAL . 4.3 tp -68.51 119.37 67.99 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.47 1.106 . . . . 75.019999999999996 109.335 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.411 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.4 Cg_endo -75.04 171.73 17.74 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.438 1.757 . . . . 73.540000000000006 110.968 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.434 HG22 ' NE2' ' A' ' 240' ' ' GLN . 1.7 m -71.42 165.52 23.61 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.567 1.167 . . . . 73.049999999999997 110.429 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.963 HG22 ' NZ ' ' A' ' 243' ' ' LYS . 7.6 p -60.84 -33.34 54.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.536 1.147 . . . . 74.230000000000004 109.287 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.542 ' HG3' HG13 ' A' ' 239' ' ' VAL . 1.2 mp0 -82.01 -15.43 53.68 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.532 1.145 . . . . 64.140000000000001 110.304 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -87.53 -38.66 15.82 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.554 1.159 . . . . 74.409999999999997 110.273 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.575 ' CH2' ' HB3' ' A' ' 185' ' ' CYS . 0.9 OUTLIER -79.42 -60.25 2.44 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.001 -1.111 . . . . 72.400000000000006 108.001 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.963 ' NZ ' HG22 ' A' ' 239' ' ' VAL . 14.3 mtmm -53.34 -20.86 4.85 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.523 1.139 . . . . 63.32 109.324 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 243' ' ' LYS . 0.5 OUTLIER -38.26 -67.57 0.2 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.487 1.117 . . . . 51.409999999999997 110.018 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -130.79 121.0 24.59 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.44 1.088 . . . . 62.350000000000001 109.327 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 24.8 mm -44.08 -30.08 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 O-C-N 124.562 1.163 . . . . 62.200000000000003 109.266 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -102.24 75.7 1.51 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.43 1.081 . . . . 72.349999999999994 109.303 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -102.88 -14.8 16.41 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.451 1.094 . . . . 72.209999999999994 110.291 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -51.1 116.54 2.06 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.498 1.124 . . . . 73.120000000000005 110.996 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -153.43 105.52 2.85 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.464 1.102 . . . . 74.129999999999995 109.38 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 1.019 ' HB1' HD11 ' A' ' 254' ' ' ILE . . . -86.85 163.43 17.21 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.436 1.085 . . . . 72.530000000000001 109.301 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 13.7 t -131.27 -88.47 0.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.472 1.107 . . . . 74.129999999999995 109.97 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 254' ' ' ILE . 0.4 OUTLIER -114.32 -0.94 13.68 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 75.209999999999994 109.303 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 1.019 HD11 ' HB1' ' A' ' 251' ' ' ALA . 1.2 mp 40.13 82.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.419 1.074 . . . . 75.439999999999998 109.329 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.428 ' C ' HD22 ' A' ' 256' ' ' LEU . 11.3 t 172.22 131.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.53 1.144 . . . . 63.030000000000001 109.958 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.428 HD22 ' C ' ' A' ' 255' ' ' SER . 4.5 mm? -116.07 -49.55 2.69 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.559 1.162 . . . . 72.450000000000003 109.271 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.69 72.53 0.9 Allowed Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.503 1.127 . . . . 75.019999999999996 111.025 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.496 ' O ' HG13 ' A' ' 259' ' ' VAL . 33.8 p -137.25 139.54 41.04 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 0.764 . . . . 74.310000000000002 110.009 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 258' ' ' SER . 1.9 m -154.02 158.11 4.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.459 1.1 . . . . 61.219999999999999 109.344 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.458 1.099 . . . . 74.310000000000002 110.311 179.976 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 22.2 m . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 110.023 -0.362 . . . . 53.310000000000002 110.023 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 89.4 p -123.5 107.45 11.57 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.447 1.092 . . . . 53.350000000000001 109.989 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.9 -15.58 14.88 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.516 1.135 . . . . 65.340000000000003 109.952 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -167.16 151.76 7.07 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.506 1.129 . . . . 72.239999999999995 109.292 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 467' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' B' ' 468' ' ' GLY . 67.2 m-20 -136.56 134.0 37.0 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.598 1.186 . . . . 65.340000000000003 109.259 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 468' ' ' GLY . . . . . 0.61 ' CA ' HD13 ' B' ' 471' ' ' ILE . . . -54.94 -165.41 0.02 OUTLIER Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.485 1.116 . . . . 35.049999999999997 110.987 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -110.62 -15.95 13.74 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.518 0.775 . . . . 74.140000000000001 109.264 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 470' ' ' PHE . . . . . 0.407 ' HA ' ' OD2' ' A' ' 172' ' ' ASP . 19.3 m-85 -110.66 20.41 17.66 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.553 1.158 . . . . 70.530000000000001 110.996 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 471' ' ' ILE . . . . . 0.61 HD13 ' CA ' ' B' ' 468' ' ' GLY . 1.4 mp -65.71 138.84 96.78 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.503 1.127 . . . . 72.049999999999997 109.263 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 472' ' ' PRO . . . . . 0.56 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.1 Cg_endo -75.0 -179.34 4.89 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.529 1.805 . . . . 74.439999999999998 110.978 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 36.6 t -114.24 -61.63 1.72 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.544 1.153 . . . . 64.329999999999998 110.001 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -61.84 155.71 60.53 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.473 1.108 . . . . 64.409999999999997 110.285 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 475' ' ' PRO . . . . . 0.665 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.3 Cg_endo -75.07 -36.24 2.63 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.484 1.781 . . . . 74.129999999999995 111.005 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 476' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 165.01 126.91 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.529 1.143 . . . . 72.319999999999993 109.291 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 477' ' ' PRO . . . . . 0.591 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.5 Cg_endo -74.89 -162.13 0.14 Allowed 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.49 1.784 . . . . 62.520000000000003 111.049 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 478' ' ' LYS . . . . . 0.538 ' O ' ' CD ' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -145.2 112.32 4.76 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.506 1.129 . . . . 74.530000000000001 109.261 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 479' ' ' PRO . . . . . 0.62 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.1 Cg_endo -74.97 154.06 42.35 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.452 1.764 . . . . 75.319999999999993 110.998 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 480' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' B' ' 479' ' ' PRO . 18.4 Cg_endo -75.05 163.22 35.65 Favored 'Trans proline' 0 C--N 1.359 1.111 0 O-C-N 124.527 1.804 . . . . 74.5 111.083 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 481' ' ' SER . . . . . . . . . . . . . 1.1 t 45.76 52.46 9.57 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.583 1.177 . . . . 75.340000000000003 110.031 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 1.6 m -114.71 -54.61 2.56 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.557 1.161 . . . . 71.439999999999998 110.027 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -153.3 134.19 13.91 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.505 1.128 . . . . 64.340000000000003 109.358 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 8.1 m -117.75 118.69 32.74 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.489 1.118 . . . . 73.430000000000007 109.988 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -97.17 31.23 2.51 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.488 1.117 . . . . 62.340000000000003 109.315 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 92.1 p . . . . . 0 C--N 1.324 -0.509 0 O-C-N 124.531 1.144 . . . . 42.340000000000003 109.954 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.023 0 N-CA-C 111.041 -0.824 . . . . 74.5 111.041 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 67.8 p -123.35 49.78 1.65 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.542 0.79 . . . . 74.129999999999995 110.033 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.477 HD13 HG23 ' A' ' 214' ' ' ILE . 1.2 pp -81.63 149.39 28.58 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.54 1.15 . . . . 71.349999999999994 109.246 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' A' ' 181' ' ' ASN . 1.4 t80 -119.09 146.27 45.23 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.551 1.157 . . . . 72.519999999999996 110.965 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.468 ' HB2' HG12 ' A' ' 184' ' ' ILE . . . -118.23 142.36 47.55 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.461 1.101 . . . . 63.130000000000003 109.306 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.617 ' HB ' HD11 ' A' ' 215' ' ' ILE . 0.0 OUTLIER -119.41 131.66 71.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.468 1.105 . . . . 61.350000000000001 109.292 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.877 HG22 HG12 ' A' ' 212' ' ' VAL . 2.0 t -93.27 120.97 43.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 74.400000000000006 109.335 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.606 HD21 HG23 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -99.01 -13.58 19.83 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.519 1.137 . . . . 65.150000000000006 109.351 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.639 ' O ' HG13 ' A' ' 162' ' ' VAL . 1.3 m-85 -144.37 156.77 44.38 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.434 1.084 . . . . 74.219999999999999 111.05 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.719 ' N ' HG12 ' A' ' 178' ' ' VAL . 9.2 p-10 -92.06 154.03 19.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.512 1.133 . . . . 74.120000000000005 109.268 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.467 ' CZ ' ' O ' ' A' ' 167' ' ' LYS . 16.7 t80 -141.64 144.27 34.07 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.486 1.116 . . . . 72.420000000000002 110.969 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.467 ' O ' ' CZ ' ' A' ' 166' ' ' PHE . 14.2 mtpp -82.81 131.22 35.2 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.542 1.151 . . . . 74.310000000000002 109.283 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.839 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -96.34 142.37 28.55 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 70.120000000000005 109.272 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -158.03 24.88 0.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.473 1.108 . . . . 71.340000000000003 110.354 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.687 ' HZ1' HD23 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -122.27 -175.46 3.13 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.427 1.08 . . . . 62.200000000000003 109.276 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.77 -40.03 82.76 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.487 1.117 . . . . 64.109999999999999 109.302 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 174' ' ' LEU . 26.6 m-20 -86.14 10.52 14.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 75.310000000000002 109.324 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.839 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 6.5 pt-20 -36.77 96.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.57 1.169 . . . . 73.310000000000002 110.341 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.621 ' H ' ' HZ2' ' A' ' 170' ' ' LYS . 0.3 OUTLIER -131.73 95.42 3.71 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.128 . . . . 63.219999999999999 109.315 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.4 t -59.18 153.39 18.38 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.536 1.147 . . . . 74.340000000000003 110.367 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 177' ' ' TYR . 22.2 m -154.53 175.29 13.8 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.501 1.126 . . . . 54.229999999999997 110.398 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.543 ' H ' HG22 ' A' ' 176' ' ' THR . 8.0 m-85 -122.57 157.79 31.33 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.47 1.106 . . . . 64.239999999999995 111.02 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.719 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.8 m -59.51 158.39 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.518 1.136 . . . . 70.400000000000006 109.262 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.429 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 48.07 67.83 1.45 Allowed Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.479 1.112 . . . . 43.520000000000003 111.037 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -129.13 168.38 16.21 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.478 0.752 . . . . 73.109999999999999 110.309 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.448 ' HB3' ' CE2' ' A' ' 159' ' ' TYR . 8.5 m120 -118.77 126.42 51.82 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.527 1.142 . . . . 72.530000000000001 109.225 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.816 ' N ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -133.58 139.98 46.87 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.558 1.162 . . . . 64.439999999999998 109.325 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 5.4 t80 -98.97 97.47 8.63 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.489 1.118 . . . . 74.230000000000004 110.998 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 1.044 HD13 ' HB2' ' A' ' 195' ' ' ALA . 28.0 mm -52.01 156.67 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.405 1.065 . . . . 71.430000000000007 109.281 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 186' ' ' ALA . 7.3 p -149.96 -42.49 0.13 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.459 1.099 . . . . 70.230000000000004 108.327 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.897 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -120.72 167.89 11.99 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.564 1.165 . . . . 71.219999999999999 109.309 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.456 ' CD2' HG12 ' A' ' 231' ' ' ILE . 1.7 p-80 -157.35 144.21 18.28 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.101 . . . . 74.409999999999997 109.613 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.578 ' CE1' ' HD3' ' B' ' 472' ' ' PRO . 0.1 OUTLIER -144.87 139.83 27.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.537 1.148 . . . . 71.120000000000005 109.55 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.49 ' C ' ' N ' ' A' ' 191' ' ' GLU . 57.7 t30 50.37 22.41 1.01 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.479 1.112 . . . . 74.209999999999994 109.27 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 189' ' ' ASN . 4.0 m 41.47 27.7 0.06 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.452 1.095 . . . . 72.340000000000003 108.272 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 208' ' ' PRO . 3.6 tt0 -124.98 -38.14 2.37 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.528 1.142 . . . . 73.299999999999997 110.275 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.76 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 90.5 m95 -113.95 128.07 56.24 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.0 -1.111 . . . . 75.209999999999994 108.0 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.904 ' HB3' HD12 ' A' ' 184' ' ' ILE . 21.4 m-30 -117.03 157.0 26.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.48 1.112 . . . . 71.299999999999997 110.959 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.897 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 3.6 mm -118.48 104.15 15.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.54 1.15 . . . . 72.319999999999993 109.314 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 1.044 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -107.55 170.37 8.02 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.472 1.107 . . . . 51.25 109.35 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.467 ' CG ' ' HA ' ' A' ' 204' ' ' PRO . 4.6 mtmp? -138.9 165.16 34.41 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.547 1.154 . . . . 54.399999999999999 109.294 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 171.24 18.7 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.459 1.768 . . . . 62.219999999999999 111.002 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.48 HD12 ' HA ' ' A' ' 198' ' ' ILE . 7.4 tp -83.85 -51.69 13.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.535 1.147 . . . . 72.040000000000006 109.266 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.46 ' N ' HG23 ' A' ' 198' ' ' ILE . . . -143.47 54.73 0.58 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.41 1.069 . . . . 60.219999999999999 110.984 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -149.07 -179.43 7.01 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.565 0.803 . . . . 70.439999999999998 110.289 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.414 ' H ' HD23 ' A' ' 201' ' ' LEU . 1.6 pt? -108.15 22.02 16.53 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.475 1.109 . . . . 70.349999999999994 109.314 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -88.92 59.85 3.9 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.525 1.14 . . . . 62.210000000000001 110.999 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.404 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . -167.82 171.09 42.17 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 110.949 -0.861 . . . . 71.329999999999998 110.949 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.484 ' HB2' ' CG2' ' A' ' 194' ' ' ILE . 18.2 Cg_endo -74.95 128.18 15.87 Favored 'Cis proline' 0 C--N 1.359 1.102 0 C-N-CA 121.065 -2.473 . . . . 63.140000000000001 110.992 -0.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.402 ' N ' ' HA2' ' A' ' 203' ' ' GLY . . . -92.49 122.13 6.75 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.504 1.127 . . . . 73.219999999999999 111.042 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.76 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.1 OUTLIER -79.96 146.77 31.9 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.556 0.798 . . . . 72.349999999999994 109.321 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.784 ' CG1' HG11 ' A' ' 212' ' ' VAL . 0.4 OUTLIER -160.44 129.05 2.99 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.136 . . . . 54.020000000000003 109.282 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.508 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.4 Cg_endo -74.99 179.94 5.59 Favored 'Trans proline' 0 C--N 1.359 1.117 0 O-C-N 124.593 1.838 . . . . 71.349999999999994 111.027 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.73 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.8 OUTLIER -98.06 4.2 9.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.477 1.111 . . . . 65.209999999999994 109.28 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -105.38 -2.79 41.14 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.496 1.122 . . . . 52.130000000000003 110.99 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.619 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 5.6 m-85 -127.5 0.85 6.25 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.428 0.722 . . . . 73.540000000000006 110.939 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.877 HG12 HG22 ' A' ' 162' ' ' VAL . 1.2 m -142.53 170.25 11.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.538 1.149 . . . . 73.420000000000002 109.29 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.3 t -129.37 140.57 51.32 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.508 1.13 . . . . 72.530000000000001 109.994 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.832 ' O ' HG23 ' A' ' 215' ' ' ILE . 3.7 mm -83.35 138.37 19.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.452 1.095 . . . . 53.439999999999998 109.287 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.832 HG23 ' O ' ' A' ' 214' ' ' ILE . 6.5 pt -164.69 160.43 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.542 1.151 . . . . 73.099999999999994 109.242 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -119.14 -75.31 0.58 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.515 1.134 . . . . 51.219999999999999 109.311 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 15.6 tt -122.05 -43.04 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.449 1.093 . . . . 71.299999999999997 109.381 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -69.47 135.95 50.85 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.472 1.107 . . . . 72.430000000000007 109.344 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 14.1 t -73.86 -4.31 34.11 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.504 1.127 . . . . 73.439999999999998 110.422 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -68.86 -126.33 0.03 OUTLIER Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.557 1.16 . . . . 52.409999999999997 111.065 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.414 ' O ' ' N ' ' A' ' 223' ' ' THR . 3.9 m-85 -117.97 -172.55 2.27 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.557 0.798 . . . . 53.539999999999999 111.012 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.609 ' O ' HG22 ' A' ' 223' ' ' THR . . . -68.0 72.01 0.17 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.494 1.122 . . . . 75.010000000000005 109.222 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.609 HG22 ' O ' ' A' ' 222' ' ' ALA . 8.7 t 47.12 20.49 0.13 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.527 1.142 . . . . 75.430000000000007 110.413 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.434 ' N ' ' C ' ' A' ' 222' ' ' ALA . . . 89.19 -33.34 4.32 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.433 1.083 . . . . 72.219999999999999 110.989 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -63.14 164.42 8.61 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.49 0.759 . . . . 74.129999999999995 109.316 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 230' ' ' ASP . 2.9 t0 -87.17 144.41 26.85 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.453 1.096 . . . . 53.119999999999997 109.297 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.593 HG13 ' H ' ' A' ' 228' ' ' ILE . 3.0 p -44.01 -59.19 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.465 1.103 . . . . 75.239999999999995 109.329 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.593 ' H ' HG13 ' A' ' 227' ' ' VAL . 3.8 mt -48.95 -47.54 16.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.53 1.144 . . . . 73.420000000000002 109.319 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.425 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 9.6 mt-10 -66.28 -23.48 66.4 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.574 1.171 . . . . 72.109999999999999 110.316 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 226' ' ' ASP . 31.1 m-20 -85.27 -15.92 41.85 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.494 1.122 . . . . 42.039999999999999 109.279 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.692 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.5 OUTLIER -72.84 -68.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.524 1.14 . . . . 72.430000000000007 109.277 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.692 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -61.48 -20.41 63.13 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.5 1.125 . . . . 73.540000000000006 109.272 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.65 -52.98 43.6 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.514 1.134 . . . . 61.149999999999999 110.062 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 234' ' ' VAL . 1.5 m -94.65 26.68 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.515 1.134 . . . . 65.200000000000003 109.313 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 40.61 37.67 0.51 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.594 1.184 . . . . 73.400000000000006 109.347 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.437 ' HB2' ' CG2' ' A' ' 234' ' ' VAL . 3.6 tp -72.22 119.55 75.34 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.569 1.168 . . . . 44.5 109.331 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.99 167.72 26.42 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.544 1.813 . . . . 45.520000000000003 110.959 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.29 177.95 2.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.505 1.128 . . . . 73.319999999999993 110.438 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.551 HG13 ' N ' ' A' ' 240' ' ' GLN . 13.1 p -72.01 -54.06 17.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 42.119999999999997 109.342 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.551 ' N ' HG13 ' A' ' 239' ' ' VAL . 13.0 pm0 -68.37 -14.85 63.29 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.464 1.103 . . . . 72.510000000000005 110.292 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -92.25 -37.21 12.8 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.136 . . . . 71.409999999999997 110.322 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.517 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 3.3 t90 -79.24 -59.78 2.63 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.004 -1.11 . . . . 71.519999999999996 108.004 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.577 ' HE2' ' CD2' ' B' ' 470' ' ' PHE . 4.6 mtmp? -54.77 -20.1 7.77 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.563 1.165 . . . . 64.200000000000003 109.357 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 21.0 t -39.63 -68.11 0.19 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.454 1.097 . . . . 70.0 110.017 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 246' ' ' ILE . 19.9 m120 -144.85 108.36 4.63 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.59 1.181 . . . . 74.409999999999997 109.3 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 245' ' ' ASN . 34.8 mm -40.43 -55.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.486 1.116 . . . . 45.240000000000002 109.303 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -97.51 122.9 41.1 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.481 1.113 . . . . 72.299999999999997 109.339 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 10.1 tpp85 -164.14 122.84 1.89 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.505 1.128 . . . . 72.239999999999995 110.349 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -41.39 127.35 2.94 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.524 1.14 . . . . 64.209999999999994 111.028 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -50.1 165.65 0.08 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.494 1.121 . . . . 73.099999999999994 109.282 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -99.01 -78.23 0.5 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.465 1.103 . . . . 52.109999999999999 109.272 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 11.2 p -152.06 172.23 16.63 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.471 1.107 . . . . 61.219999999999999 109.99 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -133.76 113.24 12.1 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.498 1.124 . . . . 71.319999999999993 109.275 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 255' ' ' SER . 40.7 mm -115.49 160.55 14.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 124.473 1.108 . . . . 74.530000000000001 109.297 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.417 ' N ' HG22 ' A' ' 254' ' ' ILE . 4.0 p 73.17 38.9 0.65 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.505 1.128 . . . . 31.25 110.033 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.71 ' C ' HD22 ' A' ' 256' ' ' LEU . 0.0 OUTLIER -55.92 160.06 2.91 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.481 1.113 . . . . 62.25 109.297 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.456 ' N ' HD22 ' A' ' 256' ' ' LEU . . . 114.32 -105.64 1.58 Allowed Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.417 1.073 . . . . 55.310000000000002 110.989 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.479 ' C ' HG23 ' A' ' 259' ' ' VAL . 5.2 p -99.95 137.34 38.55 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.473 0.749 . . . . 65.430000000000007 110.033 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.479 HG23 ' C ' ' A' ' 258' ' ' SER . 2.2 t 67.68 51.82 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 124.532 1.145 . . . . 54.210000000000001 109.313 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 . . . . . 0 C--N 1.324 -0.5 0 O-C-N 124.563 1.164 . . . . 74.239999999999995 110.367 -179.993 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.98 -0.378 . . . . 71.439999999999998 109.98 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 6.1 p -109.15 149.22 29.67 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.505 1.128 . . . . 65.099999999999994 110.01 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 53.5 m -50.47 174.95 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 74.409999999999997 110.029 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -171.16 150.44 3.0 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.464 1.102 . . . . 73.329999999999998 109.258 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 467' ' ' ASN . . . . . 0.425 ' CG ' ' N ' ' B' ' 468' ' ' GLY . 9.6 p-10 -122.88 -44.83 2.18 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.505 1.128 . . . . 73.540000000000006 109.3 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 468' ' ' GLY . . . . . 0.425 ' N ' ' CG ' ' B' ' 467' ' ' ASN . . . 64.35 116.35 0.01 OUTLIER Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.472 1.108 . . . . 73.219999999999999 111.033 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -116.66 145.57 43.33 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.543 0.79 . . . . 72.030000000000001 109.311 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 470' ' ' PHE . . . . . 0.577 ' CD2' ' HE2' ' A' ' 243' ' ' LYS . 2.2 m-30 56.53 29.7 15.94 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.483 1.114 . . . . 72.450000000000003 111.045 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 471' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' B' ' 472' ' ' PRO . 13.0 mm -88.85 137.96 29.68 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.466 1.104 . . . . 73.099999999999994 109.269 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 472' ' ' PRO . . . . . 0.578 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -75.0 112.15 3.49 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.431 1.753 . . . . 54.409999999999997 110.994 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 42.0 t -55.15 -44.95 75.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.506 1.129 . . . . 74.450000000000003 109.959 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 474' ' ' ARG . . . . . 0.451 ' CD ' ' HD2' ' B' ' 475' ' ' PRO . 5.4 tpp180 -84.37 137.72 39.27 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.485 1.116 . . . . 71.019999999999996 110.32 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 475' ' ' PRO . . . . . 0.451 ' HD2' ' CD ' ' B' ' 474' ' ' ARG . 18.4 Cg_endo -74.99 -170.07 0.73 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.433 1.754 . . . . 44.399999999999999 111.019 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 476' ' ' ALA . . . . . 0.45 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . -48.3 124.63 11.46 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.561 1.163 . . . . 74.340000000000003 109.277 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 477' ' ' PRO . . . . . 0.576 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.6 Cg_endo -74.91 -162.39 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.441 1.758 . . . . 72.310000000000002 111.038 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.28 90.28 25.59 Favored Pre-proline 0 C--N 1.326 -0.436 0 O-C-N 124.488 1.118 . . . . 71.519999999999996 109.319 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 479' ' ' PRO . . . . . 0.619 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.1 Cg_endo -75.03 162.05 37.68 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.525 1.802 . . . . 73.219999999999999 110.983 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -88.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.508 1.794 . . . . 71.430000000000007 110.967 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 481' ' ' SER . . . . . 0.547 ' HB3' ' CE1' ' A' ' 164' ' ' TYR . 0.8 OUTLIER -47.99 -70.16 0.1 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.517 1.135 . . . . 70.219999999999999 110.01 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 1.4 t -42.23 110.05 0.16 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.393 1.058 . . . . 74.239999999999995 109.976 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -111.27 124.8 52.96 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.476 1.11 . . . . 65.519999999999996 109.279 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 80.0 p -124.15 161.62 25.3 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.453 1.096 . . . . 53.229999999999997 110.002 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -100.66 141.27 33.77 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.512 1.133 . . . . 73.239999999999995 109.305 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 C--N 1.324 -0.509 0 O-C-N 124.522 1.139 . . . . 73.430000000000007 109.98 -179.91 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.009 0 N-CA-C 111.078 -0.809 . . . . 64.230000000000004 111.078 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.5 t -124.06 93.77 4.02 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.584 0.814 . . . . 61.130000000000003 110.002 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.9 mt -100.66 116.15 31.89 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.505 1.128 . . . . 61.030000000000001 109.315 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.495 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 3.7 p90 -146.44 -178.76 6.33 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.496 1.122 . . . . 72.430000000000007 111.078 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.589 ' HB3' HD11 ' A' ' 184' ' ' ILE . . . -127.77 154.67 45.11 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.56 1.162 . . . . 43.130000000000003 109.362 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.571 HG23 ' CD2' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -126.44 119.65 54.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.477 1.111 . . . . 75.109999999999999 109.333 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.709 ' CG2' HG12 ' A' ' 212' ' ' VAL . 1.0 OUTLIER -70.84 125.35 29.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.488 1.118 . . . . 65.25 109.271 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.688 HD11 ' HB2' ' A' ' 213' ' ' SER . 0.2 OUTLIER -104.06 -9.14 19.0 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.586 1.179 . . . . 74.239999999999995 109.311 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.582 ' O ' HG13 ' A' ' 162' ' ' VAL . 4.7 m-85 -145.16 172.6 12.87 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.479 1.112 . . . . 55.439999999999998 110.998 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.631 ' N ' HG12 ' A' ' 178' ' ' VAL . 0.0 OUTLIER -87.65 129.77 35.01 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.484 1.115 . . . . 61.020000000000003 109.262 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.667 ' CZ ' ' HB2' ' A' ' 168' ' ' ALA . 2.0 t80 -103.02 129.74 49.89 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.457 1.098 . . . . 72.310000000000002 111.009 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.76 106.97 19.36 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.468 1.105 . . . . 73.430000000000007 109.257 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.843 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -114.01 150.29 34.11 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.556 1.16 . . . . 74.319999999999993 109.282 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -152.12 24.9 0.64 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.471 1.107 . . . . 74.319999999999993 110.268 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.492 ' HZ1' ' HZ ' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -112.82 -172.79 2.12 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 75.420000000000002 109.325 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.25 -43.99 75.14 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.534 1.146 . . . . 71.109999999999999 109.326 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.49 ' HB2' HD22 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -86.26 11.47 12.03 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.48 1.112 . . . . 74.230000000000004 109.322 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.843 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 11.5 tt0 -35.22 98.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.497 1.123 . . . . 71.239999999999995 110.311 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.57 HD21 ' CA ' ' A' ' 205' ' ' GLY . 0.4 OUTLIER -109.37 94.76 5.2 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.538 1.149 . . . . 74.510000000000005 109.249 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 175' ' ' THR . 12.0 t -95.05 109.56 21.59 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.521 1.138 . . . . 54.310000000000002 110.453 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.539 HG22 ' H ' ' A' ' 177' ' ' TYR . 90.6 m -130.71 174.85 9.54 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.476 1.11 . . . . 64.109999999999999 110.428 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.553 ' O ' HG11 ' A' ' 162' ' ' VAL . 29.1 m-85 -105.26 169.42 8.46 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.504 1.127 . . . . 73.019999999999996 110.985 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.631 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.5 m -66.14 158.02 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.467 1.104 . . . . 70.420000000000002 109.305 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 58.2 66.05 3.09 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.479 1.112 . . . . 34.200000000000003 110.983 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.547 ' O ' HD13 ' A' ' 161' ' ' ILE . 9.1 tp10 -131.78 157.53 43.62 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.475 0.75 . . . . 64.0 110.32 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -118.61 129.12 55.14 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.499 1.124 . . . . 74.329999999999998 109.247 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.752 HD23 ' N ' ' A' ' 182' ' ' LEU . 0.5 OUTLIER -140.67 150.02 42.98 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 52.32 109.244 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 5.5 m-85 -104.1 114.38 28.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.485 1.116 . . . . 75.230000000000004 111.002 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.589 HD11 ' HB3' ' A' ' 160' ' ' ALA . 1.6 mp -62.08 156.5 4.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 124.508 1.13 . . . . 75.140000000000001 109.249 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.458 ' N ' ' O ' ' A' ' 194' ' ' ILE . 0.1 OUTLIER -139.8 -48.15 0.46 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.461 1.1 . . . . 45.229999999999997 108.272 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.692 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -124.85 170.28 11.22 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.492 1.12 . . . . 70.510000000000005 109.324 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.524 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.2 OUTLIER -152.93 143.82 22.93 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.524 1.14 . . . . 74.140000000000001 109.603 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.714 ' NE2' HD11 ' A' ' 194' ' ' ILE . 0.2 OUTLIER -145.58 140.59 27.51 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.474 1.109 . . . . 72.420000000000002 109.622 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.491 ' C ' ' N ' ' A' ' 191' ' ' GLU . 67.3 t30 49.26 23.17 0.76 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.497 1.123 . . . . 54.329999999999998 109.368 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.411 ' C ' ' O ' ' A' ' 189' ' ' ASN . 14.5 p 41.0 28.17 0.05 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.471 1.107 . . . . 71.450000000000003 108.308 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.798 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 7.7 tt0 -125.38 -39.0 2.22 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.422 1.077 . . . . 54.32 110.304 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.595 ' CZ2' ' HD3' ' B' ' 477' ' ' PRO . 99.1 m95 -112.68 130.9 55.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.018 -1.105 . . . . 72.450000000000003 108.018 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.754 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.9 m-30 -121.91 142.11 50.6 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.54 1.15 . . . . 75.239999999999995 110.97 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.714 HD11 ' NE2' ' A' ' 188' ' ' HIS . 4.3 mm -101.19 95.98 4.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.422 1.076 . . . . 73.230000000000004 109.263 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -103.93 -177.05 3.26 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.485 1.116 . . . . 61.039999999999999 109.293 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.452 ' CD ' ' HB3' ' A' ' 204' ' ' PRO . 3.9 mtmm -148.45 159.61 38.48 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.506 1.129 . . . . 71.120000000000005 109.291 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.95 176.56 9.74 Favored 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.522 1.801 . . . . 62.109999999999999 110.954 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 1.4 pp -114.78 72.19 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.467 1.104 . . . . 75.030000000000001 109.271 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 102.28 -43.78 1.63 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.424 1.077 . . . . 43.130000000000003 110.98 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -54.7 118.97 4.66 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.487 0.757 . . . . 74.140000000000001 110.328 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -43.44 112.27 0.36 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.571 1.17 . . . . 73.109999999999999 109.278 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 154.5 169.78 19.59 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.577 1.173 . . . . 70.239999999999995 110.97 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.477 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . 91.05 162.86 38.46 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 111.011 -0.836 . . . . 70.209999999999994 111.011 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.477 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.3 Cg_endo -75.01 131.17 23.32 Favored 'Cis proline' 0 C--N 1.359 1.122 0 C-N-CA 121.034 -2.486 . . . . 72.019999999999996 111.008 0.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.57 ' CA ' HD21 ' A' ' 174' ' ' LEU . . . -101.05 165.73 18.74 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.485 1.116 . . . . 62.049999999999997 111.004 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.584 HD11 ' CE3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -108.7 149.78 28.5 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.487 0.757 . . . . 64.409999999999997 109.281 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.778 ' CG1' HG11 ' A' ' 212' ' ' VAL . 0.4 OUTLIER -157.04 133.68 6.36 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.449 1.093 . . . . 72.230000000000004 109.282 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.557 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.2 Cg_endo -75.07 169.34 22.81 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.475 1.776 . . . . 72.439999999999998 110.995 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.754 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.6 OUTLIER -93.74 6.86 6.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.438 1.086 . . . . 62.130000000000003 109.336 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 210' ' ' GLY . . . . . 0.487 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -106.69 -3.6 37.09 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.442 1.089 . . . . 72.109999999999999 111.014 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.607 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 23.3 m-85 -129.03 4.99 5.33 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.462 0.742 . . . . 54.509999999999998 110.973 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.778 HG11 ' CG1' ' A' ' 207' ' ' VAL . 2.1 m -141.43 150.55 19.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.468 1.105 . . . . 75.140000000000001 109.329 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.688 ' HB2' HD11 ' A' ' 163' ' ' LEU . 1.4 t -110.73 133.29 53.46 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.524 1.14 . . . . 55.009999999999998 109.974 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.445 ' C ' HG23 ' A' ' 215' ' ' ILE . 4.8 mm -77.57 135.33 26.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.43 1.081 . . . . 73.519999999999996 109.338 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.479 HD13 ' HA ' ' A' ' 160' ' ' ALA . 0.2 OUTLIER -153.51 140.37 12.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.5 1.125 . . . . 53.229999999999997 109.33 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.81 ' O ' HG23 ' A' ' 217' ' ' ILE . 11.0 p-10 -110.67 -14.1 14.09 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.442 1.089 . . . . 74.219999999999999 109.246 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.966 HD13 HG22 ' A' ' 219' ' ' THR . 0.5 OUTLIER -170.92 -178.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.52 1.137 . . . . 62.399999999999999 109.282 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -85.06 74.96 10.42 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.54 1.15 . . . . 75.230000000000004 109.271 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.966 HG22 HD13 ' A' ' 217' ' ' ILE . 1.1 t -175.85 144.06 0.61 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.539 1.15 . . . . 71.150000000000006 110.352 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 38.85 -157.92 0.01 OUTLIER Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.497 1.123 . . . . 71.400000000000006 111.035 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -139.14 126.9 22.01 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.547 0.792 . . . . 75.400000000000006 110.963 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.572 ' O ' HG22 ' A' ' 223' ' ' THR . . . 51.9 26.94 3.93 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.518 1.136 . . . . 65.540000000000006 109.266 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 222' ' ' ALA . 10.8 t 45.5 25.96 0.27 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.574 1.171 . . . . 74.549999999999997 110.386 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 87.35 -41.69 3.1 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.557 1.16 . . . . 32.340000000000003 111.033 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -64.22 128.61 36.53 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.547 0.792 . . . . 64.409999999999997 109.279 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 230' ' ' ASP . 7.6 m-20 -62.1 152.02 33.99 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.553 1.158 . . . . 74.209999999999994 109.341 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.788 ' O ' HD12 ' A' ' 231' ' ' ILE . 2.7 p -49.36 -45.55 18.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.482 1.113 . . . . 45.450000000000003 109.318 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.486 ' H ' HD12 ' A' ' 228' ' ' ILE . 3.9 mp -63.53 -30.56 50.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.455 1.097 . . . . 71.299999999999997 109.271 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.421 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 7.8 mt-10 -86.14 -14.56 43.78 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.429 1.081 . . . . 72.319999999999993 110.288 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 226' ' ' ASP . 8.9 t0 -88.39 -15.75 34.71 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.479 1.112 . . . . 74.319999999999993 109.311 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.788 HD12 ' O ' ' A' ' 227' ' ' VAL . 0.6 OUTLIER -72.4 -69.37 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.559 1.162 . . . . 72.329999999999998 109.342 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.638 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -57.88 -20.87 39.94 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.568 1.168 . . . . 72.140000000000001 109.281 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.6 t -48.57 -57.49 6.11 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.54 1.15 . . . . 50.25 109.955 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.9 m -93.67 21.12 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.462 1.101 . . . . 71.230000000000004 109.294 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 49.33 29.21 2.64 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.474 1.109 . . . . 73.450000000000003 109.311 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.469 HD12 ' HD2' ' A' ' 237' ' ' PRO . 4.4 tp -65.27 119.11 56.55 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.465 1.103 . . . . 71.329999999999998 109.34 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.469 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.4 Cg_endo -74.92 173.03 15.18 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.461 1.769 . . . . 73.439999999999998 111.008 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 239' ' ' VAL . 1.5 m -66.25 -170.66 0.09 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.58 1.175 . . . . 73.540000000000006 110.389 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.597 HG22 ' HD3' ' A' ' 243' ' ' LYS . 9.8 p -79.96 -35.68 16.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.624 1.202 . . . . 63.200000000000003 109.351 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.575 ' HG3' HG13 ' A' ' 239' ' ' VAL . 0.5 OUTLIER -84.94 -19.14 32.64 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.569 1.168 . . . . 64.510000000000005 110.282 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -81.51 -39.17 25.12 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.493 1.121 . . . . 70.109999999999999 110.338 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.497 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 5.8 t90 -77.98 -61.25 2.06 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 72.200000000000003 107.978 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.597 ' HD3' HG22 ' A' ' 239' ' ' VAL . 1.6 mtpm? -59.05 -17.38 25.1 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.462 1.101 . . . . 55.549999999999997 109.302 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 243' ' ' LYS . 0.3 OUTLIER -38.34 -65.39 0.35 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.576 1.173 . . . . 72.030000000000001 109.988 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -140.12 104.79 4.91 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.481 1.113 . . . . 64.450000000000003 109.309 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.473 ' CG2' ' N ' ' A' ' 247' ' ' ALA . 0.8 OUTLIER -59.72 -50.47 79.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.141 . . . . 63.240000000000002 109.301 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.473 ' N ' ' CG2' ' A' ' 246' ' ' ILE . . . -41.81 104.18 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.508 1.13 . . . . 72.230000000000004 109.286 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -168.94 111.88 0.53 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.518 1.136 . . . . 73.129999999999995 110.324 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.417 ' O ' ' CG ' ' A' ' 249' ' ' TYR . 34.8 p90 -45.05 128.65 7.33 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.506 1.129 . . . . 73.209999999999994 111.037 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 249' ' ' TYR . 9.6 mtpt -40.26 107.2 0.07 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.532 1.145 . . . . 62.329999999999998 109.313 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -88.29 -175.32 4.98 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.494 1.121 . . . . 71.5 109.262 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 46.6 m -116.65 -176.0 2.88 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.484 1.115 . . . . 73.140000000000001 110.045 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -147.54 161.47 41.05 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.492 1.12 . . . . 61.240000000000002 109.307 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.598 HD12 ' N ' ' A' ' 254' ' ' ILE . 3.6 mp -121.14 142.66 36.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.574 1.171 . . . . 72.209999999999994 109.288 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 18.8 t -150.43 -179.46 7.23 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.491 1.12 . . . . 60.439999999999998 109.959 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 91.5 mt -105.43 -178.17 3.57 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.426 1.079 . . . . 72.519999999999996 109.287 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -82.42 -58.31 2.45 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.573 1.171 . . . . 74.030000000000001 111.052 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.0 t 51.43 34.57 12.28 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.463 0.743 . . . . 71.329999999999998 109.947 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 p -68.31 165.66 2.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.522 1.139 . . . . 73.140000000000001 109.332 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 . . . . . 0 C--N 1.325 -0.49 0 O-C-N 124.466 1.104 . . . . 43.32 110.272 -179.961 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 28.3 t . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 110.011 -0.366 . . . . 73.099999999999994 110.011 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 13.0 p -91.06 171.4 9.29 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.463 1.102 . . . . 75.150000000000006 110.002 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 63.5 m -77.27 168.87 19.32 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.426 1.079 . . . . 73.329999999999998 109.986 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -89.92 71.7 7.53 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.506 1.129 . . . . 65.310000000000002 109.307 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -91.41 -59.29 2.18 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.44 1.087 . . . . 71.329999999999998 109.313 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -67.9 -168.72 4.44 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.49 1.119 . . . . 74.239999999999995 110.976 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -139.71 -47.14 0.45 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 0.761 . . . . 64.25 109.354 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 470' ' ' PHE . . . . . 0.539 ' C ' HD12 ' B' ' 471' ' ' ILE . 8.6 m-30 -90.99 31.5 1.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.489 1.118 . . . . 74.120000000000005 110.972 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 471' ' ' ILE . . . . . 0.569 ' N ' ' CD1' ' B' ' 471' ' ' ILE . 1.1 mp -98.55 138.14 20.74 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.546 1.154 . . . . 54.539999999999999 109.291 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 472' ' ' PRO . . . . . 0.533 ' HD2' HG23 ' B' ' 471' ' ' ILE . 18.2 Cg_endo -75.03 138.63 23.21 Favored 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.485 1.782 . . . . 61.43 110.955 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 21.1 t -66.11 -72.25 0.17 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.54 1.15 . . . . 62.25 109.984 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.59 157.21 88.91 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.544 1.152 . . . . 71.400000000000006 110.309 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -167.59 0.44 Allowed 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.531 1.806 . . . . 75.400000000000006 110.947 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 476' ' ' ALA . . . . . 0.798 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . -56.49 131.11 76.8 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 23.399999999999999 109.314 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 477' ' ' PRO . . . . . 0.595 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -75.04 -162.58 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.489 1.784 . . . . 61.219999999999999 111.022 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 478' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -135.54 91.37 18.51 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.509 1.13 . . . . 73.019999999999996 109.321 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 479' ' ' PRO . . . . . 0.607 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.2 Cg_endo -74.99 154.92 42.88 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.463 1.77 . . . . 61.340000000000003 111.051 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 480' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' B' ' 479' ' ' PRO . 18.4 Cg_endo -74.94 -177.46 3.47 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.459 1.768 . . . . 70.030000000000001 111.042 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 481' ' ' SER . . . . . . . . . . . . . 1.8 t 49.59 51.47 16.39 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.434 1.084 . . . . 55.240000000000002 110.054 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 14.2 t -144.29 137.07 26.97 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.454 1.096 . . . . 63.43 110.031 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -57.55 117.59 4.33 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.487 1.117 . . . . 63.32 109.294 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -122.4 93.27 3.93 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.47 1.106 . . . . 72.329999999999998 109.984 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -79.71 71.85 6.38 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.431 1.082 . . . . 61.329999999999998 109.308 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 90.7 p . . . . . 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.135 . . . . 73.430000000000007 109.98 -179.978 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.004 0 N-CA-C 110.975 -0.85 . . . . 60.119999999999997 110.975 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.866 ' C ' HD23 ' A' ' 158' ' ' LEU . 31.0 m -154.35 172.25 18.0 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.508 0.77 . . . . 72.019999999999996 110.019 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.866 HD23 ' C ' ' A' ' 157' ' ' SER . 1.4 pt? 41.71 66.54 0.68 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.401 1.063 . . . . 53.030000000000001 109.28 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.741 ' CE2' ' CZ ' ' A' ' 183' ' ' PHE . 0.1 OUTLIER -112.32 135.14 53.37 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.535 1.147 . . . . 75.409999999999997 111.029 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.949 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -103.93 148.61 25.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.567 1.167 . . . . 75.129999999999995 109.311 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.598 HG23 HD23 ' A' ' 163' ' ' LEU . 0.2 OUTLIER -131.28 128.84 62.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.574 1.171 . . . . 55.119999999999997 109.228 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.797 HG22 HG12 ' A' ' 212' ' ' VAL . 2.6 t -80.83 119.23 30.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.529 1.143 . . . . 70.319999999999993 109.296 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.598 HD23 HG23 ' A' ' 161' ' ' ILE . 0.9 OUTLIER -94.3 -15.92 24.01 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.561 1.163 . . . . 71.030000000000001 109.321 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.622 ' O ' HG13 ' A' ' 162' ' ' VAL . 1.0 OUTLIER -150.0 155.96 40.86 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.466 1.104 . . . . 75.540000000000006 111.002 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.685 ' H ' HG12 ' A' ' 178' ' ' VAL . 1.3 t70 -86.54 157.49 19.74 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.437 1.086 . . . . 72.129999999999995 109.29 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.51 ' HB2' ' CD1' ' A' ' 211' ' ' PHE . 11.7 t80 -154.35 140.57 18.53 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.548 1.155 . . . . 71.420000000000002 110.999 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -84.19 115.02 22.21 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.436 1.085 . . . . 74.430000000000007 109.3 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.934 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -103.55 131.54 50.59 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.49 1.119 . . . . 64.319999999999993 109.323 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -138.63 11.36 2.71 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.469 1.106 . . . . 74.450000000000003 110.265 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.519 ' HE3' ' CH2' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -83.0 -175.92 6.08 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.513 1.133 . . . . 62.229999999999997 109.272 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -64.04 -24.64 67.78 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.507 1.13 . . . . 73.5 109.307 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.475 ' HB3' ' CB ' ' A' ' 206' ' ' LEU . 72.4 m-20 -112.89 15.69 19.68 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.557 1.16 . . . . 72.230000000000004 109.351 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.934 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 2.0 pp20? -34.0 108.99 0.07 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.424 1.078 . . . . 71.010000000000005 110.244 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.608 HD23 ' HA3' ' A' ' 205' ' ' GLY . 0.7 OUTLIER -115.75 96.27 5.53 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.54 1.15 . . . . 44.43 109.264 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 15.2 t -82.36 133.08 35.22 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.561 1.163 . . . . 72.329999999999998 110.401 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.825 HG23 ' HG2' ' A' ' 180' ' ' GLU . 0.9 OUTLIER -160.76 146.46 14.71 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.478 1.111 . . . . 73.310000000000002 110.383 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -81.43 168.81 17.91 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.544 1.153 . . . . 62.109999999999999 111.025 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.685 HG12 ' H ' ' A' ' 165' ' ' ASP . 2.3 m -60.88 158.19 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.509 1.131 . . . . 64.340000000000003 109.298 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 53.33 59.23 9.85 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.551 1.157 . . . . 53.409999999999997 110.957 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.825 ' HG2' HG23 ' A' ' 176' ' ' THR . 1.3 tp10 -116.59 179.81 3.9 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.483 0.755 . . . . 74.200000000000003 110.328 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -132.62 139.71 47.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.525 1.14 . . . . 74.140000000000001 109.252 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.698 HD22 HG11 ' A' ' 207' ' ' VAL . 0.1 OUTLIER -152.17 149.36 28.67 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 75.230000000000004 109.335 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.741 ' CZ ' ' CE2' ' A' ' 159' ' ' TYR . 2.1 m-85 -109.0 111.63 23.4 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.424 1.077 . . . . 64.340000000000003 110.995 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.949 HD13 ' HB2' ' A' ' 160' ' ' ALA . 1.6 mp -71.0 164.15 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.133 . . . . 61.399999999999999 109.314 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.595 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 3.5 p -159.9 -41.5 0.05 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.524 1.14 . . . . 73.099999999999994 108.283 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.978 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -114.69 152.5 31.87 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.528 1.142 . . . . 71.209999999999994 109.308 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.524 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.5 OUTLIER -145.18 151.13 37.95 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.127 . . . . 53.240000000000002 109.634 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.834 ' HE1' ' CD1' ' A' ' 194' ' ' ILE . 2.1 p-80 -156.39 146.51 21.3 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 72.200000000000003 109.612 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.477 ' C ' ' N ' ' A' ' 191' ' ' GLU . 3.9 t-20 51.18 22.43 1.32 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 74.519999999999996 109.317 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.44 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.1 p 39.06 30.01 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.49 1.119 . . . . 74.129999999999995 108.229 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.551 ' O ' HG13 ' A' ' 209' ' ' VAL . 11.6 tt0 -134.18 -40.39 0.83 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.542 1.151 . . . . 74.319999999999993 110.361 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.933 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 97.2 m95 -105.61 127.7 53.2 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.987 -1.116 . . . . 70.209999999999994 107.987 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.742 ' CE2' HG12 ' A' ' 209' ' ' VAL . 16.9 m-30 -125.14 130.08 51.46 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.387 1.054 . . . . 75.209999999999994 111.02 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.978 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 1.5 mp -88.81 110.81 21.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.51 1.132 . . . . 74.409999999999997 109.358 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.527 ' HB2' HG13 ' A' ' 184' ' ' ILE . . . -118.87 177.38 4.87 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.489 1.118 . . . . 52.439999999999998 109.322 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.463 ' CD ' ' HD2' ' A' ' 197' ' ' PRO . 4.6 tptm -124.89 140.26 35.35 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.467 1.104 . . . . 71.310000000000002 109.333 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.463 ' HD2' ' CD ' ' A' ' 196' ' ' LYS . 18.1 Cg_endo -75.03 144.82 30.62 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.5 1.79 . . . . 74.099999999999994 110.982 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.419 HG13 ' N ' ' A' ' 199' ' ' GLY . 11.7 pt -39.62 -51.51 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.548 1.155 . . . . 72.430000000000007 109.337 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.419 ' N ' HG13 ' A' ' 198' ' ' ILE . . . -169.01 65.94 0.18 Allowed Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.504 1.128 . . . . 54.310000000000002 111.027 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.446 ' CG ' ' HB2' ' A' ' 197' ' ' PRO . 32.3 mmt180 -106.04 163.02 13.1 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.469 0.747 . . . . 72.129999999999995 110.268 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 11.7 tp -75.2 74.09 2.33 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.536 1.148 . . . . 70.549999999999997 109.319 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 160.39 -130.57 2.43 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.452 1.095 . . . . 74.299999999999997 111.039 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.507 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . 65.97 151.26 0.12 Allowed Glycine 0 CA--C 1.53 0.972 0 N-CA-C 111.015 -0.834 . . . . 60.140000000000001 111.015 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.507 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.2 Cg_endo -75.01 146.15 85.87 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.039 -2.484 . . . . 64.129999999999995 111.026 0.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.608 ' HA3' HD23 ' A' ' 174' ' ' LEU . . . -109.36 177.64 20.23 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.525 1.141 . . . . 71.140000000000001 111.01 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.933 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -97.97 147.2 24.73 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.463 0.743 . . . . 53.219999999999999 109.347 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.698 HG11 HD22 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -155.01 125.57 3.41 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 124.525 1.14 . . . . 60.119999999999997 109.315 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.844 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.4 Cg_endo -75.02 176.77 9.48 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.529 1.805 . . . . 60.200000000000003 111.076 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.742 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.6 m -96.85 5.33 8.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.587 1.179 . . . . 53.109999999999999 109.332 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -108.89 6.44 32.87 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.537 1.148 . . . . 70.540000000000006 111.024 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.6 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 11.6 m-85 -139.64 12.18 2.51 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.439 0.729 . . . . 74.25 111.043 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 208' ' ' PRO . 11.4 m -154.39 157.7 4.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.483 1.114 . . . . 73.310000000000002 109.317 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.541 ' HB2' HD11 ' A' ' 163' ' ' LEU . 22.5 t -129.62 124.17 33.07 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.494 1.121 . . . . 75.319999999999993 110.042 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.586 ' C ' HG22 ' A' ' 215' ' ' ILE . 3.4 mm -78.08 149.95 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.496 1.122 . . . . 72.129999999999995 109.35 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.943 HD12 ' N ' ' A' ' 216' ' ' ASP . 0.1 OUTLIER 179.49 137.99 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 71.530000000000001 109.251 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.943 ' N ' HD12 ' A' ' 215' ' ' ILE . 1.1 t70 -71.31 -155.66 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.467 1.104 . . . . 74.109999999999999 109.312 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.55 HG23 ' HB ' ' A' ' 219' ' ' THR . 8.2 tp -43.13 155.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.452 1.095 . . . . 75.409999999999997 109.351 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -41.36 -29.45 0.15 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.449 1.093 . . . . 55.210000000000001 109.283 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.55 ' HB ' HG23 ' A' ' 217' ' ' ILE . 99.8 m -65.87 101.3 0.64 Allowed 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.556 1.16 . . . . 74.409999999999997 110.392 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.5 166.11 26.43 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.504 1.128 . . . . 65.129999999999995 110.99 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.415 ' C ' ' N ' ' A' ' 223' ' ' THR . 19.0 t80 -134.96 146.77 49.43 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.538 0.787 . . . . 64.319999999999993 110.977 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.525 ' C ' HG22 ' A' ' 223' ' ' THR . . . 47.39 24.92 0.52 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.593 1.183 . . . . 53.32 109.285 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.528 HG23 ' CG ' ' A' ' 225' ' ' ASN . 1.0 OUTLIER 45.43 19.88 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.463 1.102 . . . . 75.120000000000005 110.393 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.446 ' N ' ' C ' ' A' ' 222' ' ' ALA . . . 62.91 3.14 5.59 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.561 1.163 . . . . 63.549999999999997 111.024 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.528 ' CG ' HG23 ' A' ' 223' ' ' THR . 6.5 p30 -133.24 176.84 8.16 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.525 0.78 . . . . 65.510000000000005 109.276 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 229' ' ' GLU . 6.2 t0 -92.59 145.79 24.16 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.514 1.134 . . . . 62.100000000000001 109.266 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.736 HG21 ' HE2' ' A' ' 193' ' ' PHE . 0.6 OUTLIER -44.28 -44.53 2.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.495 1.122 . . . . 64.530000000000001 109.311 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.812 ' HA ' HD12 ' A' ' 231' ' ' ILE . 29.4 mt -58.21 -41.49 81.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 73.540000000000006 109.342 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 226' ' ' ASP . 14.6 mt-10 -69.34 -17.53 63.71 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.559 1.162 . . . . 54.350000000000001 110.351 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.94 -16.4 31.89 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.543 1.152 . . . . 74.239999999999995 109.252 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.812 HD12 ' HA ' ' A' ' 228' ' ' ILE . 2.5 mt -71.39 -69.37 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.57 1.169 . . . . 74.239999999999995 109.279 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.505 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -58.97 -21.23 58.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 72.25 109.278 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.6 -56.51 13.12 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.131 . . . . 64.109999999999999 109.97 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.1 m -97.92 19.11 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.447 1.092 . . . . 72.129999999999995 109.295 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 40.82 31.47 0.12 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.458 1.099 . . . . 63.329999999999998 109.282 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.23 124.01 78.53 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 63.240000000000002 109.29 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 -179.62 5.18 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.46 1.769 . . . . 71.230000000000004 110.947 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 239' ' ' VAL . 1.3 m -69.45 -173.51 0.57 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.523 1.139 . . . . 74.030000000000001 110.416 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.586 HG12 ' HB1' ' A' ' 186' ' ' ALA . 1.2 m -78.45 -38.05 22.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.469 1.106 . . . . 65.319999999999993 109.33 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.421 ' HG3' ' CG2' ' A' ' 239' ' ' VAL . 0.4 OUTLIER -81.51 -15.39 55.06 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.435 1.085 . . . . 73.209999999999994 110.283 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -83.89 -38.81 20.64 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.443 1.09 . . . . 74.450000000000003 110.319 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.669 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 0.3 OUTLIER -83.73 -63.06 1.42 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.966 -1.124 . . . . 73.409999999999997 107.966 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.568 ' NZ ' ' CG ' ' B' ' 470' ' ' PHE . 13.2 mtmt -51.36 -22.49 2.95 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.571 1.169 . . . . 73.209999999999994 109.285 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -41.19 -65.73 0.4 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.532 1.145 . . . . 71.409999999999997 110.017 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -136.25 100.16 4.31 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.508 1.13 . . . . 62.520000000000003 109.305 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 248' ' ' ARG . 11.0 mt -52.29 -49.24 42.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 61.229999999999997 109.345 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 246' ' ' ILE . . . -40.27 99.35 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.512 1.132 . . . . 70.310000000000002 109.264 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 246' ' ' ILE . 9.7 tpp180 -99.72 147.61 25.26 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.528 1.143 . . . . 74.25 110.303 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.616 ' CD1' ' N ' ' A' ' 249' ' ' TYR . 0.6 OUTLIER -86.19 156.74 20.19 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.48 1.113 . . . . 74.319999999999993 110.967 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 251' ' ' ALA . 0.0 OUTLIER -85.58 179.49 7.1 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.486 1.116 . . . . 73.200000000000003 109.291 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 250' ' ' LYS . . . 72.51 14.19 5.28 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.546 1.154 . . . . 74.109999999999999 109.327 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 25.3 t -97.26 135.68 38.83 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.503 1.127 . . . . 64.540000000000006 109.95 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -127.41 159.6 33.99 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.461 1.1 . . . . 63.240000000000002 109.292 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.58 HD12 ' N ' ' A' ' 254' ' ' ILE . 2.2 mp -137.54 152.94 27.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.468 1.105 . . . . 74.319999999999993 109.246 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 8.9 p -152.66 165.08 36.36 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.438 1.086 . . . . 54.119999999999997 110.021 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -168.56 154.72 6.95 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.584 1.177 . . . . 75.140000000000001 109.308 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -93.16 -177.59 40.47 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 124.452 1.095 . . . . 43.43 111.056 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 8.8 m -168.02 147.22 4.69 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.465 0.744 . . . . 73.219999999999999 110.04 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 35.2 t -150.59 145.86 16.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.507 1.129 . . . . 75.0 109.295 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.446 0 O-C-N 124.45 1.094 . . . . 74.219999999999999 110.307 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 27.1 p . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 109.966 -0.383 . . . . 43.439999999999998 109.966 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 43.9 t -71.93 138.93 48.45 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.554 1.159 . . . . 72.319999999999993 110.071 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 93.7 p -72.5 173.33 9.0 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.501 1.126 . . . . 73.340000000000003 110.022 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -109.55 67.77 0.66 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.559 1.162 . . . . 70.5 109.254 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -97.35 81.55 3.01 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.497 1.123 . . . . 74.129999999999995 109.294 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . 177.96 145.73 6.06 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.494 1.121 . . . . 72.400000000000006 110.995 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.6 -15.28 17.84 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.443 0.731 . . . . 73.120000000000005 109.272 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 470' ' ' PHE . . . . . 0.568 ' CG ' ' NZ ' ' A' ' 243' ' ' LYS . 5.5 m-30 -94.0 20.24 8.08 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.523 1.139 . . . . 74.400000000000006 110.968 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 471' ' ' ILE . . . . . 0.708 HG23 ' HD2' ' B' ' 472' ' ' PRO . 19.2 mm -91.83 142.38 26.51 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.486 1.116 . . . . 65.109999999999999 109.262 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 472' ' ' PRO . . . . . 0.708 ' HD2' HG23 ' B' ' 471' ' ' ILE . 18.4 Cg_endo -75.07 156.65 42.71 Favored 'Trans proline' 0 C--N 1.361 1.236 0 O-C-N 124.486 1.782 . . . . 71.540000000000006 111.027 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 19.1 t -99.43 -44.15 6.29 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.513 1.133 . . . . 61.119999999999997 110.046 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -102.17 167.94 9.71 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 72.129999999999995 110.348 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.95 -168.28 0.5 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.456 1.766 . . . . 62.409999999999997 110.997 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 476' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' B' ' 477' ' ' PRO . . . -59.03 140.29 87.1 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.51 1.131 . . . . 43.450000000000003 109.307 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 477' ' ' PRO . . . . . 0.619 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -75.09 -162.12 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.545 1.813 . . . . 74.200000000000003 111.027 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.74 87.93 11.01 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.573 1.17 . . . . 44.310000000000002 109.277 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 479' ' ' PRO . . . . . 0.6 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.3 Cg_endo -75.03 169.59 22.27 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.419 1.747 . . . . 64.510000000000005 110.986 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 480' ' ' PRO . . . . . 0.442 ' C ' ' N ' ' B' ' 482' ' ' SER . 18.1 Cg_endo -75.02 -70.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.485 1.781 . . . . 61.32 111.008 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 481' ' ' SER . . . . . 0.54 ' OG ' ' CE1' ' A' ' 164' ' ' TYR . 1.6 m -38.32 -30.87 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.465 1.103 . . . . 73.430000000000007 109.992 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 482' ' ' SER . . . . . 0.446 ' CB ' ' HG2' ' B' ' 479' ' ' PRO . 47.3 t -81.62 128.68 34.19 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.493 1.121 . . . . 53.100000000000001 110.023 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -78.37 81.1 4.74 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.53 1.144 . . . . 75.25 109.334 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 23.2 t -103.42 49.32 0.83 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.481 1.113 . . . . 54.030000000000001 109.954 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -163.64 109.75 1.1 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.49 1.119 . . . . 74.019999999999996 109.238 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 9.1 t . . . . . 0 C--N 1.326 -0.44 0 O-C-N 124.529 1.143 . . . . 23.030000000000001 110.013 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.501 ' HA2' ' CE2' ' A' ' 159' ' ' TYR . . . . . . . . 0 CA--C 1.529 0.966 0 N-CA-C 111.069 -0.813 . . . . 63.420000000000002 111.069 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 36.7 t -95.52 114.94 26.75 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.468 0.746 . . . . 31.300000000000001 109.982 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 12.6 tp 65.75 54.46 1.07 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.507 1.129 . . . . 74.420000000000002 109.241 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.702 ' CE2' ' CE1' ' A' ' 183' ' ' PHE . 5.6 m-30 -112.79 159.08 19.34 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.504 1.127 . . . . 71.430000000000007 110.972 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.742 ' HB3' ' CD2' ' A' ' 182' ' ' LEU . . . -124.31 145.63 49.29 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.489 1.118 . . . . 72.5 109.282 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.498 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -123.32 127.36 74.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.496 1.123 . . . . 72.140000000000001 109.322 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.915 HG22 HG12 ' A' ' 212' ' ' VAL . 1.1 t -82.57 118.03 29.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 124.512 1.132 . . . . 72.019999999999996 109.248 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.66 HD11 ' OG ' ' A' ' 213' ' ' SER . 1.7 mt -92.32 -16.21 26.35 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.523 1.139 . . . . 73.549999999999997 109.255 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.653 ' O ' HG13 ' A' ' 162' ' ' VAL . 3.0 m-85 -145.94 158.51 43.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.437 1.085 . . . . 73.239999999999995 111.058 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.817 ' N ' HG12 ' A' ' 178' ' ' VAL . 0.6 OUTLIER -96.77 159.4 14.94 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.476 1.11 . . . . 71.310000000000002 109.321 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.57 ' HB2' ' CE2' ' A' ' 211' ' ' PHE . 28.3 t80 -160.63 131.81 5.63 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.554 1.159 . . . . 71.040000000000006 111.033 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -67.34 129.33 39.55 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.463 1.102 . . . . 72.340000000000003 109.305 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.854 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -107.28 141.13 39.1 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.442 1.089 . . . . 73.409999999999997 109.332 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -149.7 22.38 0.9 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.539 1.149 . . . . 73.25 110.315 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.562 ' HE3' ' CZ3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -99.88 -175.91 3.1 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.43 1.081 . . . . 75.510000000000005 109.282 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.25 -28.88 67.12 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.491 1.119 . . . . 64.530000000000001 109.336 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.461 ' CB ' ' HB2' ' A' ' 206' ' ' LEU . 76.1 m-20 -108.46 20.05 19.06 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.498 1.124 . . . . 73.319999999999993 109.282 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.854 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 8.0 pt-20 -38.02 106.33 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.395 1.059 . . . . 75.299999999999997 110.304 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.696 HD22 ' HA3' ' A' ' 205' ' ' GLY . 4.2 tp -124.39 113.7 18.53 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.522 1.139 . . . . 73.430000000000007 109.307 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 175' ' ' THR . 12.1 t -89.06 111.36 22.07 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.471 1.107 . . . . 70.140000000000001 110.427 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.481 HG22 ' HG3' ' A' ' 180' ' ' GLU . 59.2 m -128.87 142.76 50.86 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.473 1.108 . . . . 64.120000000000005 110.401 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -83.48 162.33 20.98 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.548 1.155 . . . . 72.430000000000007 110.945 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.817 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.4 m -60.37 158.24 2.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.488 1.117 . . . . 65.340000000000003 109.245 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.4 48.22 60.58 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.555 1.159 . . . . 72.329999999999998 110.979 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.498 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 11.9 mm-40 -105.07 168.51 9.01 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 0.766 . . . . 75.450000000000003 110.32 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -128.0 117.13 21.14 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.454 1.096 . . . . 70.319999999999993 109.312 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.784 ' N ' HD13 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -134.89 146.89 49.64 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.521 1.138 . . . . 70.120000000000005 109.294 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.702 ' CE1' ' CE2' ' A' ' 159' ' ' TYR . 9.8 m-30 -100.21 116.82 33.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.472 1.107 . . . . 72.329999999999998 111.035 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 1.043 HD13 ' HB2' ' A' ' 195' ' ' ALA . 14.1 mm -59.52 151.04 5.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.579 1.175 . . . . 73.5 109.359 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.559 ' O ' ' CZ3' ' A' ' 242' ' ' TRP . 2.8 m -133.83 -46.53 0.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.525 1.141 . . . . 75.140000000000001 108.303 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.869 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -127.63 174.07 9.37 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.506 1.129 . . . . 74.329999999999998 109.348 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -157.06 141.59 16.68 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 1.114 . . . . 73.239999999999995 109.636 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.599 ' CD2' ' HD3' ' B' ' 472' ' ' PRO . 0.1 OUTLIER -143.21 139.35 30.23 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.458 1.099 . . . . 74.109999999999999 109.552 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.466 ' C ' ' N ' ' A' ' 191' ' ' GLU . 27.6 t-20 50.83 22.7 1.21 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.508 1.13 . . . . 61.039999999999999 109.345 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.402 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.8 m 41.54 29.02 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.475 1.109 . . . . 72.5 108.239 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.94 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 18.2 tt0 -127.59 -38.74 1.88 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.436 1.085 . . . . 54.329999999999998 110.309 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.67 ' CE3' HD21 ' A' ' 206' ' ' LEU . 96.3 m95 -112.21 125.19 53.88 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.519 1.137 . . . . 72.049999999999997 108.017 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.877 ' HB3' HD12 ' A' ' 184' ' ' ILE . 19.1 m-30 -115.15 150.69 35.65 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.498 1.124 . . . . 75.129999999999995 111.028 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.869 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 14.8 mm -112.16 91.24 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.557 1.161 . . . . 74.420000000000002 109.327 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 1.043 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -94.75 -175.24 3.52 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.514 1.134 . . . . 71.310000000000002 109.35 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.481 ' CG ' ' SG ' ' A' ' 185' ' ' CYS . 0.0 OUTLIER -156.42 158.19 31.36 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.556 1.16 . . . . 61.119999999999997 109.249 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.08 160.17 40.23 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.491 1.785 . . . . 65.530000000000001 110.987 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.47 ' CG1' ' CZ ' ' A' ' 183' ' ' PHE . 9.9 mt -49.85 -51.69 15.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.462 1.101 . . . . 75.510000000000005 109.292 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -174.74 84.25 0.08 OUTLIER Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.461 1.101 . . . . 61.149999999999999 111.015 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -167.12 131.95 2.01 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.561 0.801 . . . . 71.409999999999997 110.289 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 201' ' ' LEU . 1.1 pt? -43.67 102.6 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 64.219999999999999 109.283 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . -171.29 -81.04 0.05 OUTLIER Glycine 0 CA--C 1.531 1.068 0 O-C-N 124.46 1.1 . . . . 64.150000000000006 111.058 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.417 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . -45.23 171.45 0.01 OUTLIER Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.992 -0.843 . . . . 74.329999999999998 110.992 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.511 ' HB2' HG22 ' A' ' 194' ' ' ILE . 18.2 Cg_endo -75.03 127.29 14.17 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.024 -2.49 . . . . 72.310000000000002 110.962 0.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.696 ' HA3' HD22 ' A' ' 174' ' ' LEU . . . -97.65 145.75 17.95 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.573 1.17 . . . . 72.219999999999999 111.021 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.67 HD21 ' CE3' ' A' ' 192' ' ' TRP . 0.3 OUTLIER -92.32 146.65 23.53 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.562 0.801 . . . . 70.450000000000003 109.351 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.759 ' CG1' HG11 ' A' ' 212' ' ' VAL . 0.4 OUTLIER -160.31 131.02 3.67 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.522 1.139 . . . . 74.329999999999998 109.275 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 191' ' ' GLU . 18.2 Cg_endo -75.06 168.5 24.67 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.471 1.774 . . . . 60.130000000000003 110.967 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.637 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.9 OUTLIER -89.27 2.52 6.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.479 1.112 . . . . 75.310000000000002 109.228 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -101.76 -5.96 50.28 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.557 1.16 . . . . 72.109999999999999 110.951 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.625 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 12.0 m-85 -125.22 1.0 7.82 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 0.774 . . . . 72.329999999999998 111.013 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.915 HG12 HG22 ' A' ' 162' ' ' VAL . 1.3 m -142.63 160.85 18.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.407 1.067 . . . . 74.349999999999994 109.346 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.66 ' OG ' HD11 ' A' ' 163' ' ' LEU . 3.9 m -125.25 138.34 54.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.581 1.176 . . . . 72.519999999999996 110.015 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.809 ' O ' HG23 ' A' ' 215' ' ' ILE . 3.5 mm -78.77 147.34 6.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.473 1.108 . . . . 74.299999999999997 109.246 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.809 HG23 ' O ' ' A' ' 214' ' ' ILE . 7.6 pt -162.5 125.33 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.442 1.089 . . . . 74.150000000000006 109.287 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -128.53 -75.48 0.56 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.446 1.091 . . . . 73.329999999999998 109.295 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 217' ' ' ILE . 54.6 mt -119.32 69.34 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.587 1.179 . . . . 71.120000000000005 109.301 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -173.09 135.29 0.59 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.533 1.145 . . . . 72.319999999999993 109.288 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 219' ' ' THR . 8.9 t -92.14 45.46 1.21 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.529 1.143 . . . . 61.200000000000003 110.386 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -161.95 -89.34 0.07 OUTLIER Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.456 1.098 . . . . 22.030000000000001 111.049 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.417 ' O ' ' N ' ' A' ' 223' ' ' THR . 3.5 m-85 -117.35 -172.53 2.24 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.527 0.781 . . . . 74.109999999999999 111.027 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.693 ' O ' HG22 ' A' ' 223' ' ' THR . . . -68.56 70.91 0.19 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.479 1.112 . . . . 61.030000000000001 109.322 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.693 HG22 ' O ' ' A' ' 222' ' ' ALA . 13.1 t 48.62 19.82 0.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.539 1.15 . . . . 70.120000000000005 110.409 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.428 ' N ' ' C ' ' A' ' 222' ' ' ALA . . . 92.36 -32.7 5.33 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.523 1.139 . . . . 61.329999999999998 111.007 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 -63.35 168.69 4.22 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.537 0.786 . . . . 70.310000000000002 109.271 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -86.77 150.92 23.81 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.539 1.149 . . . . 64.010000000000005 109.245 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.446 ' O ' HD12 ' A' ' 231' ' ' ILE . 0.4 OUTLIER -42.94 -48.51 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.514 1.134 . . . . 73.439999999999998 109.246 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 231' ' ' ILE . 2.6 mp -60.21 -58.12 8.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.48 1.112 . . . . 61.130000000000003 109.257 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 233' ' ' SER . 7.5 mt-10 -46.12 -26.52 0.77 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.525 1.14 . . . . 75.209999999999994 110.337 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.616 ' O ' HG13 ' A' ' 234' ' ' VAL . 9.9 t0 -77.09 -37.85 53.54 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 62.200000000000003 109.261 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.499 ' N ' ' O ' ' A' ' 228' ' ' ILE . 0.6 OUTLIER -59.54 -60.26 2.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.544 1.153 . . . . 64.049999999999997 109.272 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' A' ' 228' ' ' ILE . 0.0 OUTLIER -62.65 -44.56 95.95 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.508 1.13 . . . . 71.150000000000006 109.329 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 229' ' ' GLU . 1.5 m -41.15 -60.03 1.34 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.489 1.118 . . . . 64.239999999999995 109.982 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.616 HG13 ' O ' ' A' ' 230' ' ' ASP . 1.5 m -73.32 -22.49 19.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.478 1.111 . . . . 74.109999999999999 109.3 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 234' ' ' VAL . 5.7 m120 79.09 28.43 0.39 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.503 1.127 . . . . 71.200000000000003 109.29 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.479 HD12 ' HD2' ' A' ' 237' ' ' PRO . 3.4 tp -66.44 125.93 91.26 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.51 1.131 . . . . 71.219999999999999 109.287 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.479 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.5 Cg_endo -74.94 161.08 39.52 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.43 1.753 . . . . 62.039999999999999 111.057 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 239' ' ' VAL . 1.8 m -60.25 178.49 0.19 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.539 1.149 . . . . 54.329999999999998 110.329 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.635 HG13 ' HG3' ' A' ' 240' ' ' GLN . 14.6 p -72.59 -37.83 57.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.506 1.129 . . . . 63.450000000000003 109.287 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.635 ' HG3' HG13 ' A' ' 239' ' ' VAL . 2.3 mt-30 -79.99 -22.54 42.41 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.543 1.152 . . . . 74.230000000000004 110.268 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -82.97 -43.2 16.69 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.431 1.082 . . . . 72.439999999999998 110.306 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.559 ' CZ3' ' O ' ' A' ' 185' ' ' CYS . 9.4 t90 -70.59 -58.79 3.31 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.139 . . . . 75.010000000000005 108.002 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.464 ' NZ ' HG22 ' A' ' 239' ' ' VAL . 9.6 mtmm -56.19 -18.98 11.75 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.555 1.159 . . . . 55.530000000000001 109.292 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 8.2 t -39.12 -58.12 1.2 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.437 1.085 . . . . 71.409999999999997 109.993 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.406 ' C ' ' N ' ' A' ' 247' ' ' ALA . 0.9 OUTLIER -151.54 115.84 5.04 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.536 1.147 . . . . 74.230000000000004 109.314 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 40.4 mm -42.49 -28.67 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.461 1.101 . . . . 71.409999999999997 109.347 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.406 ' N ' ' C ' ' A' ' 245' ' ' ASN . . . -107.46 54.87 0.66 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.484 1.115 . . . . 73.349999999999994 109.28 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.59 96.49 6.18 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.499 1.124 . . . . 61.450000000000003 110.298 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.518 ' CD1' ' O ' ' A' ' 249' ' ' TYR . 0.7 OUTLIER -57.68 133.62 55.49 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.533 1.146 . . . . 72.140000000000001 111.064 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -67.5 114.02 5.82 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.491 1.119 . . . . 72.519999999999996 109.282 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.476 ' CB ' ' CE2' ' A' ' 249' ' ' TYR . . . -162.54 164.52 26.83 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.132 . . . . 74.400000000000006 109.286 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 1.3 m 67.65 52.97 0.73 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.483 1.114 . . . . 62.299999999999997 110.031 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -94.42 145.15 24.98 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.489 1.118 . . . . 72.019999999999996 109.268 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.623 HD12 ' N ' ' A' ' 254' ' ' ILE . 3.2 mp -92.7 153.68 3.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.559 1.162 . . . . 73.099999999999994 109.332 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 13.3 t -170.49 178.83 3.54 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.539 1.149 . . . . 54.399999999999999 109.965 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 5.5 tp 56.44 30.33 16.85 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.479 1.112 . . . . 73.310000000000002 109.301 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -48.31 170.0 0.08 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.499 1.124 . . . . 44.520000000000003 111.029 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 21.8 t -47.3 165.17 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.499 0.764 . . . . 75.049999999999997 109.976 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 9.4 p -123.85 137.34 57.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.606 1.191 . . . . 75.540000000000006 109.274 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.513 1.133 . . . . 63.039999999999999 110.314 179.992 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 110.001 -0.37 . . . . 73.340000000000003 110.001 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 93.5 p -124.45 24.61 7.89 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.578 1.173 . . . . 64.420000000000002 109.981 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 27.9 t -66.33 -65.92 0.62 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.486 1.116 . . . . 65.030000000000001 109.976 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -78.0 66.66 3.69 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.477 1.111 . . . . 63.140000000000001 109.328 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -92.53 -47.9 6.9 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.528 1.142 . . . . 72.219999999999999 109.309 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -84.6 160.72 36.17 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.499 1.124 . . . . 74.329999999999998 110.994 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -83.11 -28.42 29.47 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.537 0.787 . . . . 71.329999999999998 109.274 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 470' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -98.16 50.69 1.01 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.511 1.132 . . . . 70.340000000000003 111.004 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 471' ' ' ILE . . . . . 0.722 HG23 ' HD2' ' B' ' 472' ' ' PRO . 27.6 mm -115.36 142.33 28.55 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.494 1.122 . . . . 63.210000000000001 109.353 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 472' ' ' PRO . . . . . 0.722 ' HD2' HG23 ' B' ' 471' ' ' ILE . 18.3 Cg_endo -75.0 127.51 10.73 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.539 1.81 . . . . 70.150000000000006 111.025 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 8.5 t -75.01 -52.87 10.02 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.446 1.091 . . . . 65.450000000000003 109.985 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 474' ' ' ARG . . . . . 0.417 ' HA ' ' NE ' ' B' ' 474' ' ' ARG . 5.2 mmp_? -82.89 160.52 60.66 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 74.420000000000002 110.338 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.01 -166.54 0.35 Allowed 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.441 1.759 . . . . 71.349999999999994 111.012 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 476' ' ' ALA . . . . . 0.94 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . -60.31 136.52 91.64 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 71.230000000000004 109.288 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 477' ' ' PRO . . . . . 0.583 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -74.92 -164.77 0.25 Allowed 'Trans proline' 0 C--N 1.359 1.105 0 O-C-N 124.507 1.793 . . . . 64.120000000000005 110.978 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 90.89 10.98 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.473 1.108 . . . . 64.400000000000006 109.326 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 479' ' ' PRO . . . . . 0.625 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.3 Cg_endo -74.99 166.15 29.83 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.519 1.8 . . . . 71.409999999999997 111.007 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.99 -88.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.443 1.759 . . . . 72.129999999999995 110.984 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 481' ' ' SER . . . . . 0.56 ' HB3' ' CE1' ' A' ' 164' ' ' TYR . 1.7 t -66.36 91.33 0.17 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.49 1.119 . . . . 61.32 109.972 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 17.5 t -156.89 179.13 9.58 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.592 1.183 . . . . 65.129999999999995 109.934 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -49.11 -53.64 19.8 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.506 1.129 . . . . 44.439999999999998 109.278 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 24.3 m 53.54 43.18 31.58 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.488 1.117 . . . . 61.409999999999997 109.94 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -64.48 100.53 0.37 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.505 1.128 . . . . 74.209999999999994 109.259 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 17.0 m . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 53.030000000000001 110.02 -179.972 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.999 0 N-CA-C 110.976 -0.85 . . . . 65.540000000000006 110.976 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 69.1 m -95.51 173.77 7.34 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.47 0.747 . . . . 35.219999999999999 109.932 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.432 HD12 ' O ' ' A' ' 158' ' ' LEU . 2.4 pp -139.78 135.84 33.47 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.496 1.122 . . . . 70.299999999999997 109.362 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.582 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 1.1 p90 -150.54 -171.38 3.91 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.535 1.147 . . . . 73.510000000000005 110.982 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.917 ' HB3' ' CD2' ' A' ' 182' ' ' LEU . . . -121.92 153.77 38.03 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.565 1.166 . . . . 71.510000000000005 109.297 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.501 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.2 OUTLIER -122.51 128.52 75.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.491 1.12 . . . . 73.439999999999998 109.318 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.714 HG22 HG12 ' A' ' 212' ' ' VAL . 0.9 OUTLIER -84.65 122.99 38.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.501 1.126 . . . . 75.319999999999993 109.324 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.579 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 0.6 OUTLIER -98.35 -13.81 20.49 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.56 1.163 . . . . 75.299999999999997 109.258 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.605 ' O ' HG13 ' A' ' 162' ' ' VAL . 4.8 m-85 -145.7 161.24 40.35 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.522 1.139 . . . . 75.239999999999995 111.004 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.811 ' N ' HG12 ' A' ' 178' ' ' VAL . 2.5 p30 -101.01 156.78 17.21 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.435 1.084 . . . . 71.140000000000001 109.277 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.603 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 1.3 t80 -153.26 131.42 11.91 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.456 1.098 . . . . 72.219999999999999 111.0 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.603 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 8.9 mtpt -67.04 124.52 23.27 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.471 1.107 . . . . 54.100000000000001 109.267 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.809 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -92.98 135.87 33.77 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.566 1.166 . . . . 61.229999999999997 109.299 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.892 ' H ' ' HZ3' ' A' ' 170' ' ' LYS . 7.8 pt-20 -150.48 20.69 0.83 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.458 1.099 . . . . 70.109999999999999 110.269 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.892 ' HZ3' ' H ' ' A' ' 169' ' ' GLU . 0.1 OUTLIER -106.19 -175.57 2.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.463 1.102 . . . . 72.549999999999997 109.333 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.62 -41.03 76.4 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.417 1.073 . . . . 64.450000000000003 109.301 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.616 ' OD1' HD12 ' A' ' 194' ' ' ILE . 72.1 m-20 -94.4 16.93 13.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.54 1.15 . . . . 45.039999999999999 109.313 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.809 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 10.5 pt-20 -36.44 97.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 72.319999999999993 110.281 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.485 ' CB ' ' HA2' ' A' ' 205' ' ' GLY . 0.0 OUTLIER -138.22 95.52 3.03 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.439 1.087 . . . . 70.120000000000005 109.339 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.2 t -59.53 153.56 19.35 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.556 1.16 . . . . 72.219999999999999 110.446 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 4.9 m -152.51 109.34 3.48 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.436 1.085 . . . . 51.439999999999998 110.425 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.516 ' O ' HG11 ' A' ' 162' ' ' VAL . 14.8 m-85 -52.11 159.14 0.96 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.513 1.133 . . . . 71.439999999999998 111.004 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.811 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.5 m -65.68 158.62 4.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.446 1.091 . . . . 74.120000000000005 109.31 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 48.41 63.12 3.91 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.479 1.112 . . . . 61.340000000000003 111.032 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.501 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 2.0 tp10 -127.99 173.13 10.3 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.526 0.78 . . . . 74.099999999999994 110.278 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -122.68 123.07 40.28 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 71.439999999999998 109.318 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.917 ' CD2' ' HB3' ' A' ' 160' ' ' ALA . 0.0 OUTLIER -130.65 135.06 47.48 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.554 1.159 . . . . 74.400000000000006 109.262 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 8.3 m-30 -89.19 96.83 10.88 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.488 1.117 . . . . 73.439999999999998 110.998 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.858 HD12 ' HB2' ' A' ' 160' ' ' ALA . 51.5 mt -64.34 153.82 7.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 73.099999999999994 109.334 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.492 ' O ' ' CD1' ' A' ' 236' ' ' LEU . 4.3 m -146.52 -44.68 0.19 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.52 1.138 . . . . 73.219999999999999 108.242 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.931 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -112.25 170.91 7.84 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.5 1.125 . . . . 73.510000000000005 109.265 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.539 ' O ' HG13 ' A' ' 239' ' ' VAL . 13.0 p-80 -156.79 165.21 36.86 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 75.140000000000001 109.687 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 1.161 ' CE1' HG11 ' A' ' 239' ' ' VAL . 0.1 OUTLIER -143.7 113.29 7.02 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.49 1.119 . . . . 52.32 109.609 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.473 ' C ' ' N ' ' A' ' 191' ' ' GLU . 88.0 m-20 50.65 41.49 25.93 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.535 1.147 . . . . 75.109999999999999 109.359 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.418 ' C ' ' O ' ' A' ' 189' ' ' ASN . 3.6 m 40.04 30.01 0.06 Allowed 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.463 1.102 . . . . 71.040000000000006 108.333 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.812 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 17.3 tt0 -118.59 -39.69 2.97 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 1.123 . . . . 61.399999999999999 110.307 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.711 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 94.9 m95 -113.14 146.58 38.98 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.532 1.145 . . . . 74.430000000000007 107.927 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.792 ' CE2' HG12 ' A' ' 209' ' ' VAL . 21.5 m-30 -132.87 128.46 36.66 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.475 1.109 . . . . 64.439999999999998 110.957 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.931 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 8.5 mm -95.71 100.5 11.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.548 1.155 . . . . 64.530000000000001 109.324 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.542 ' HB2' ' CG1' ' A' ' 184' ' ' ILE . . . -111.82 171.31 7.57 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.5 1.125 . . . . 72.129999999999995 109.333 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -134.91 148.11 65.61 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.558 1.162 . . . . 74.099999999999994 109.254 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.94 177.51 8.47 Favored 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.481 1.779 . . . . 61.340000000000003 111.003 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 2.4 pt -126.97 67.33 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.576 1.172 . . . . 63.240000000000002 109.282 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -168.87 -84.97 0.06 OUTLIER Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.448 1.092 . . . . 65.150000000000006 111.026 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 39.4 mmt-85 -66.57 -177.94 0.63 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.431 0.724 . . . . 64.319999999999993 110.28 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 8.2 mp -42.19 -50.46 4.84 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.457 1.098 . . . . 75.209999999999994 109.308 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 117.66 168.3 14.5 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.54 1.15 . . . . 72.099999999999994 111.046 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.495 ' HA3' ' C ' ' A' ' 204' ' ' PRO . . . -83.73 -89.02 0.77 Allowed Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.029 -0.828 . . . . 71.129999999999995 111.029 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.495 ' C ' ' HA3' ' A' ' 203' ' ' GLY . 18.2 Cg_endo -75.02 152.99 98.89 Favored 'Cis proline' 0 C--N 1.36 1.153 0 C-N-CA 120.999 -2.501 . . . . 64.150000000000006 111.021 -0.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 195' ' ' ALA . . . -88.07 158.79 29.51 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.434 1.084 . . . . 42.130000000000003 110.979 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.711 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -104.55 143.96 32.34 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.466 0.745 . . . . 62.109999999999999 109.274 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.771 ' CG1' HG11 ' A' ' 212' ' ' VAL . 0.3 OUTLIER -154.44 135.33 8.63 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.461 1.1 . . . . 75.219999999999999 109.296 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 191' ' ' GLU . 18.2 Cg_endo -74.98 174.36 12.92 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.549 1.816 . . . . 50.450000000000003 110.992 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.792 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -93.36 7.57 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.437 1.086 . . . . 74.439999999999998 109.332 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -108.47 -6.85 30.83 Favored Glycine 0 CA--C 1.529 0.929 0 O-C-N 124.485 1.116 . . . . 52.219999999999999 111.006 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.635 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 5.8 m-85 -121.31 1.64 10.22 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.45 0.735 . . . . 63.25 111.003 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.771 HG11 ' CG1' ' A' ' 207' ' ' VAL . 1.2 m -141.7 166.32 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.552 1.158 . . . . 74.420000000000002 109.226 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.1 t -134.76 134.14 40.64 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 42.32 110.042 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 215' ' ' ILE . 3.4 mm -65.29 138.5 23.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.53 1.144 . . . . 74.420000000000002 109.276 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.552 ' CD1' ' CE2' ' A' ' 159' ' ' TYR . 4.1 pt -153.67 131.99 2.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.524 1.14 . . . . 64.150000000000006 109.324 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -133.17 19.83 4.05 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.465 1.103 . . . . 62.240000000000002 109.346 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.778 HD13 ' N ' ' A' ' 218' ' ' ALA . 0.0 OUTLIER -173.65 144.21 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.521 1.138 . . . . 63.119999999999997 109.321 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.778 ' N ' HD13 ' A' ' 217' ' ' ILE . . . -46.11 -68.69 0.17 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.526 1.141 . . . . 73.150000000000006 109.327 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 36.3 m -89.12 68.94 8.32 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.519 1.137 . . . . 75.019999999999996 110.388 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.448 ' HA3' ' CG2' ' A' ' 217' ' ' ILE . . . 178.2 160.41 24.48 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.464 1.103 . . . . 72.010000000000005 111.008 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.415 ' C ' ' N ' ' A' ' 223' ' ' THR . 3.1 p90 -154.18 136.4 14.83 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.571 0.806 . . . . 72.319999999999993 110.958 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 225' ' ' ASN . . . 43.77 27.49 0.18 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.499 1.124 . . . . 73.120000000000005 109.326 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.681 HG23 ' O ' ' A' ' 223' ' ' THR . 1.1 t 38.53 30.11 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.406 1.066 . . . . 45.520000000000003 110.414 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 222' ' ' ALA . . . 86.81 -45.65 3.46 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.489 1.118 . . . . 53.119999999999997 111.02 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.542 ' O ' ' HB1' ' A' ' 222' ' ' ALA . 43.9 m-80 -63.46 146.1 54.29 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.461 0.742 . . . . 71.540000000000006 109.277 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 229' ' ' GLU . 11.7 t0 -60.24 144.58 49.93 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.47 1.106 . . . . 73.540000000000006 109.218 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -43.81 -44.59 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.528 1.143 . . . . 74.019999999999996 109.265 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.884 ' HA ' HD12 ' A' ' 231' ' ' ILE . 6.7 mt -66.22 -39.95 85.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 70.219999999999999 109.295 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.463 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 18.6 mt-10 -71.82 -18.04 62.11 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.443 1.09 . . . . 63.030000000000001 110.318 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 226' ' ' ASP . 11.3 t70 -88.79 -15.73 33.87 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.135 . . . . 71.109999999999999 109.326 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.884 HD12 ' HA ' ' A' ' 228' ' ' ILE . 4.7 mt -72.68 -69.59 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.518 1.136 . . . . 64.010000000000005 109.281 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.463 ' CD ' ' HA ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -53.29 -31.71 45.17 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.44 1.087 . . . . 72.319999999999993 109.33 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.421 ' N ' ' HG2' ' A' ' 232' ' ' LYS . 1.5 m -41.01 -61.06 1.05 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.53 1.144 . . . . 50.049999999999997 110.001 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.486 ' O ' ' CB ' ' A' ' 235' ' ' ASN . 1.4 m -74.96 -20.46 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.491 1.119 . . . . 74.349999999999994 109.315 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 234' ' ' VAL . 16.6 t-20 80.74 29.11 0.2 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.474 1.109 . . . . 73.439999999999998 109.272 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.591 HD23 ' O ' ' A' ' 236' ' ' LEU . 0.0 OUTLIER -72.99 119.43 75.52 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.467 1.104 . . . . 73.340000000000003 109.31 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.93 -174.02 1.77 Allowed 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.559 1.82 . . . . 74.219999999999999 111.064 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.429 HG22 ' H ' ' A' ' 239' ' ' VAL . 1.4 m -73.57 -179.92 3.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.443 1.089 . . . . 73.349999999999994 110.407 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 1.161 HG11 ' CE1' ' A' ' 188' ' ' HIS . 1.0 OUTLIER -69.98 -50.75 45.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.528 1.142 . . . . 73.400000000000006 109.282 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.522 ' N ' ' CG2' ' A' ' 239' ' ' VAL . 0.1 OUTLIER -69.45 -15.3 63.25 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.371 1.044 . . . . 72.219999999999999 110.305 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -89.66 -37.47 14.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.55 1.156 . . . . 73.019999999999996 110.281 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.488 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 1.2 t90 -85.54 -62.5 1.51 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.529 1.143 . . . . 61.020000000000003 108.036 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.514 ' HE2' ' CG ' ' B' ' 470' ' ' PHE . 17.6 mtpp -50.67 -24.2 3.17 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.481 1.113 . . . . 74.319999999999993 109.268 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -39.44 -65.86 0.34 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.532 1.145 . . . . 73.120000000000005 109.971 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 247' ' ' ALA . 53.3 t30 -118.68 105.33 11.47 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.52 1.138 . . . . 73.319999999999993 109.32 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 2.8 mm -53.21 -39.39 34.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.39 1.056 . . . . 64.319999999999993 109.302 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.582 ' O ' ' CD1' ' A' ' 249' ' ' TYR . . . -91.92 92.82 8.51 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.565 1.165 . . . . 75.519999999999996 109.327 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' ARG . . . . . 0.429 ' N ' ' HD2' ' A' ' 248' ' ' ARG . 0.5 OUTLIER -42.74 129.15 4.22 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.552 1.157 . . . . 75.349999999999994 110.287 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 247' ' ' ALA . 5.7 m-30 -114.76 43.69 1.9 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.557 1.16 . . . . 65.450000000000003 110.957 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -98.44 130.0 45.06 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.555 1.159 . . . . 74.140000000000001 109.334 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -55.82 -56.39 21.18 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.544 1.153 . . . . 55.229999999999997 109.293 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 23.8 t -86.06 142.61 28.6 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 72.430000000000007 110.033 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -157.28 154.71 29.53 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.466 1.104 . . . . 64.439999999999998 109.304 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 6.0 mm -135.18 160.25 40.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.565 1.166 . . . . 74.030000000000001 109.344 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 2.9 t -174.04 140.65 0.72 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.523 1.14 . . . . 62.439999999999998 109.995 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.89 162.47 12.97 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.414 1.072 . . . . 71.5 109.285 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -95.14 144.34 17.15 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.433 1.083 . . . . 74.219999999999999 111.009 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 3.0 m -150.93 143.56 24.4 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.499 0.764 . . . . 33.210000000000001 109.976 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 46.2 t -117.53 82.32 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.567 1.167 . . . . 71.120000000000005 109.264 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.469 1.106 . . . . 61.420000000000002 110.252 -179.99 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 110.001 -0.37 . . . . 74.420000000000002 110.001 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 3.3 m -92.94 8.31 40.3 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.54 1.15 . . . . 73.420000000000002 110.06 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 33.7 p -112.88 -56.23 2.43 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.508 1.13 . . . . 73.409999999999997 110.041 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -119.01 125.92 50.5 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 73.540000000000006 109.319 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -136.09 126.51 26.77 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 71.530000000000001 109.342 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -66.54 -168.59 3.07 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.523 1.139 . . . . 74.109999999999999 111.005 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -121.91 144.11 49.05 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.474 0.75 . . . . 75.239999999999995 109.327 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 470' ' ' PHE . . . . . 0.514 ' CG ' ' HE2' ' A' ' 243' ' ' LYS . 6.0 m-30 55.64 17.07 2.17 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.53 1.144 . . . . 73.120000000000005 111.008 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 471' ' ' ILE . . . . . 0.48 ' CG2' ' HD2' ' B' ' 472' ' ' PRO . 27.0 mm -66.63 140.2 96.32 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.152 . . . . 75.519999999999996 109.293 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 472' ' ' PRO . . . . . 0.48 ' HD2' ' CG2' ' B' ' 471' ' ' ILE . 18.3 Cg_endo -74.92 173.65 14.11 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.492 1.785 . . . . 73.540000000000006 111.013 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 81.8 p -103.56 -47.36 4.28 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.482 1.114 . . . . 34.219999999999999 109.998 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 474' ' ' ARG . . . . . 0.401 ' NE ' ' HA ' ' B' ' 474' ' ' ARG . 11.5 mmp_? -92.94 159.36 35.95 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.61 1.194 . . . . 65.329999999999998 110.319 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 475' ' ' PRO . . . . . 0.583 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.3 Cg_endo -74.99 -38.68 1.48 Allowed 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.486 1.782 . . . . 63.539999999999999 110.965 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 476' ' ' ALA . . . . . 0.812 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . 171.2 128.39 0.06 OUTLIER Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.531 1.144 . . . . 72.030000000000001 109.319 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 477' ' ' PRO . . . . . 0.575 ' HD3' ' CH2' ' A' ' 192' ' ' TRP . 18.2 Cg_endo -75.0 -161.77 0.13 Allowed 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.457 1.767 . . . . 61.329999999999998 110.978 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 478' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -139.92 107.14 6.89 Favored Pre-proline 0 C--N 1.324 -0.529 0 O-C-N 124.497 1.123 . . . . 74.420000000000002 109.329 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 479' ' ' PRO . . . . . 0.635 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.98 162.5 37.07 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.49 1.784 . . . . 44.140000000000001 111.027 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.04 -84.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.476 1.777 . . . . 70.540000000000006 110.932 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 481' ' ' SER . . . . . 0.484 ' HB3' ' CE1' ' A' ' 164' ' ' TYR . 13.7 t -42.76 -31.06 0.43 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.496 1.123 . . . . 52.43 110.036 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 4.1 t -104.92 83.86 2.06 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.553 1.158 . . . . 73.349999999999994 110.0 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -116.13 170.66 8.34 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.469 1.105 . . . . 64.340000000000003 109.292 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 3.5 m -167.39 111.56 0.7 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.497 1.123 . . . . 71.129999999999995 109.995 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -82.54 164.52 20.81 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.489 1.118 . . . . 73.129999999999995 109.293 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.54 1.15 . . . . 61.229999999999997 109.954 -179.977 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.017 0 N-CA-C 111.005 -0.838 . . . . 73.340000000000003 111.005 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.6 p -123.32 146.57 47.81 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.501 0.766 . . . . 72.450000000000003 110.048 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.946 ' O ' HD22 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -151.05 123.11 8.21 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.581 1.176 . . . . 75.340000000000003 109.332 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.598 ' CZ ' ' CD2' ' A' ' 183' ' ' PHE . 9.2 m-85 -124.42 -170.21 2.11 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 74.409999999999997 110.941 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.938 ' HB3' ' CD2' ' A' ' 182' ' ' LEU . . . -132.1 130.71 41.58 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.458 1.099 . . . . 71.310000000000002 109.252 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.948 HG21 HD11 ' A' ' 215' ' ' ILE . 0.1 OUTLIER -107.96 118.29 55.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.487 1.117 . . . . 64.420000000000002 109.265 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 1.033 ' CG1' HD11 ' A' ' 182' ' ' LEU . 0.6 OUTLIER -84.15 123.26 38.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 74.230000000000004 109.251 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.441 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 0.3 OUTLIER -98.78 -11.61 21.69 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 74.329999999999998 109.392 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.441 ' CE2' ' HB2' ' A' ' 163' ' ' LEU . 8.4 m-85 -140.89 162.19 36.03 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.541 1.15 . . . . 74.400000000000006 111.01 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.822 ' N ' HG12 ' A' ' 178' ' ' VAL . 1.1 p30 -93.29 160.14 14.96 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.501 1.126 . . . . 42.200000000000003 109.273 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.677 ' HZ ' ' HZ1' ' A' ' 170' ' ' LYS . 28.3 t80 -157.2 133.27 9.58 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.458 1.099 . . . . 74.420000000000002 110.954 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -79.45 123.6 27.68 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.533 1.145 . . . . 75.25 109.287 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.852 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -96.68 142.08 29.14 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.453 1.096 . . . . 74.430000000000007 109.326 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -153.73 22.67 0.52 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.406 1.066 . . . . 75.450000000000003 110.253 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.677 ' HZ1' ' HZ ' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -102.75 -176.35 3.07 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.571 1.169 . . . . 62.439999999999998 109.267 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.89 -28.89 67.95 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.465 1.103 . . . . 71.510000000000005 109.284 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 173' ' ' GLU . 15.2 m-20 -105.8 16.07 25.78 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.463 1.102 . . . . 73.209999999999994 109.258 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.852 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 5.3 pt-20 -36.27 105.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.54 1.15 . . . . 75.230000000000004 110.326 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 173' ' ' GLU . 0.2 OUTLIER -141.59 95.04 2.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 55.229999999999997 109.281 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.2 t -62.86 153.16 34.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 72.150000000000006 110.434 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 81.8 m -152.91 110.75 3.6 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.554 1.159 . . . . 64.450000000000003 110.37 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -53.39 156.76 2.28 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.507 1.129 . . . . 61.130000000000003 110.991 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.822 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.5 m -58.21 158.19 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.431 1.082 . . . . 71.349999999999994 109.327 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.31 72.41 0.49 Allowed Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.568 1.168 . . . . 31.210000000000001 110.957 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.566 ' N ' HG22 ' A' ' 162' ' ' VAL . 1.2 tt0 -137.19 168.12 20.24 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.507 0.769 . . . . 64.450000000000003 110.354 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.483 ' C ' HD13 ' A' ' 182' ' ' LEU . 0.2 OUTLIER -134.07 124.52 26.33 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.521 1.138 . . . . 72.0 109.293 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 1.033 HD11 ' CG1' ' A' ' 162' ' ' VAL . 0.0 OUTLIER -128.58 162.47 27.21 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.582 1.176 . . . . 73.219999999999999 109.258 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.598 ' CD2' ' CZ ' ' A' ' 159' ' ' TYR . 0.9 OUTLIER -104.75 105.35 15.39 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.594 1.184 . . . . 75.019999999999996 110.972 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.967 HD13 ' HB2' ' A' ' 195' ' ' ALA . 45.3 mm -59.05 163.81 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.599 1.187 . . . . 60.509999999999998 109.32 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.47 ' N ' HG22 ' A' ' 184' ' ' ILE . 5.0 m -149.08 -45.41 0.14 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.478 1.111 . . . . 73.120000000000005 108.214 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 1.028 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -123.35 169.94 10.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.418 1.074 . . . . 74.420000000000002 109.34 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.563 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 1.2 p-80 -155.15 143.95 20.7 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.444 1.09 . . . . 72.319999999999993 109.634 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.554 ' CE1' ' HD3' ' B' ' 472' ' ' PRO . 0.2 OUTLIER -145.04 138.46 26.74 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 73.230000000000004 109.593 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.488 ' C ' ' N ' ' A' ' 191' ' ' GLU . 20.2 t-20 49.84 23.46 1.04 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.534 1.146 . . . . 73.329999999999998 109.284 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.53 ' HB3' HD13 ' A' ' 231' ' ' ILE . 6.4 m 40.74 28.9 0.06 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.46 1.1 . . . . 70.510000000000005 108.327 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.636 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 12.0 tt0 -124.34 -35.19 2.81 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 124.529 1.143 . . . . 72.329999999999998 110.283 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.595 ' CE3' HD21 ' A' ' 206' ' ' LEU . 95.1 m95 -118.36 133.22 56.06 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.512 1.132 . . . . 74.239999999999995 108.047 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.864 ' HB3' HD12 ' A' ' 184' ' ' ILE . 23.1 m-30 -123.48 144.3 49.61 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.548 1.155 . . . . 74.540000000000006 111.016 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 1.028 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 1.2 mp -101.78 96.15 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 124.457 1.098 . . . . 75.140000000000001 109.278 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.967 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -103.65 -178.81 3.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.45 1.093 . . . . 73.129999999999995 109.288 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -150.17 157.51 37.25 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 75.019999999999996 109.296 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 178.14 7.66 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.446 1.761 . . . . 75.450000000000003 110.966 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -97.26 3.1 10.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.458 1.099 . . . . 73.129999999999995 109.296 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 130.39 51.19 0.11 Allowed Glycine 0 CA--C 1.529 0.947 0 O-C-N 124.472 1.108 . . . . 65.329999999999998 111.039 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.434 ' CB ' ' CZ ' ' A' ' 200' ' ' ARG . 8.4 ttp-105 -140.28 -82.33 0.25 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.438 0.728 . . . . 64.5 110.349 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.499 ' HA ' HD13 ' A' ' 201' ' ' LEU . 1.4 mm? -59.55 -176.53 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.497 1.123 . . . . 73.109999999999999 109.252 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -105.29 54.85 0.59 Allowed Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.387 1.054 . . . . 73.010000000000005 111.006 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -48.58 178.39 0.01 OUTLIER Glycine 0 CA--C 1.53 0.983 0 N-CA-C 111.018 -0.833 . . . . 71.540000000000006 111.018 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.538 ' HG2' ' CZ ' ' B' ' 470' ' ' PHE . 18.2 Cg_endo -75.06 143.41 77.67 Favored 'Cis proline' 0 C--N 1.36 1.133 0 C-N-CA 120.954 -2.519 . . . . 75.209999999999994 110.988 0.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.491 ' CA ' ' HG ' ' A' ' 174' ' ' LEU . . . -106.0 140.71 15.25 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.481 1.113 . . . . 64.219999999999999 111.038 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.595 HD21 ' CE3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -89.57 145.02 25.56 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.487 0.757 . . . . 74.140000000000001 109.303 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.411 ' N ' ' HG ' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -153.29 132.69 7.11 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.47 1.106 . . . . 75.019999999999996 109.291 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.617 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.1 Cg_endo -75.06 176.29 10.12 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.46 1.768 . . . . 73.519999999999996 111.017 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.883 ' HB ' HG21 ' A' ' 227' ' ' VAL . 0.8 OUTLIER -98.17 -5.11 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.494 1.121 . . . . 64.219999999999999 109.298 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 210' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' B' ' 479' ' ' PRO . . . -90.73 -14.06 58.64 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.507 1.129 . . . . 65.349999999999994 110.948 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.609 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 15.6 m-85 -122.38 12.98 10.21 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.453 0.737 . . . . 75.099999999999994 110.939 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 208' ' ' PRO . 1.0 OUTLIER -152.45 160.14 3.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.424 1.077 . . . . 72.510000000000005 109.321 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.5 t -123.91 122.82 38.97 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.52 1.138 . . . . 74.040000000000006 109.997 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.835 ' O ' HG23 ' A' ' 215' ' ' ILE . 4.0 mm -62.97 104.18 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.528 1.142 . . . . 70.129999999999995 109.346 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.948 HD11 HG21 ' A' ' 161' ' ' ILE . 3.1 pt -163.71 -170.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.497 1.123 . . . . 64.310000000000002 109.262 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.537 ' OD1' ' CD1' ' A' ' 159' ' ' TYR . 3.5 t0 -126.57 -153.03 0.54 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.499 1.124 . . . . 54.399999999999999 109.278 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' ILE . . . . . 0.702 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 12.5 tt -64.44 165.45 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.449 1.093 . . . . 64.239999999999995 109.334 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.702 ' HB3' ' O ' ' A' ' 217' ' ' ILE . . . 83.94 3.7 0.82 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.434 1.084 . . . . 71.430000000000007 109.343 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 8.7 p 50.17 22.45 0.95 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.526 1.141 . . . . 73.109999999999999 110.397 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -155.58 121.91 1.15 Allowed Glycine 0 CA--C 1.531 1.085 0 O-C-N 124.482 1.114 . . . . 70.25 110.969 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.653 ' HB3' HG22 ' A' ' 215' ' ' ILE . 8.6 t80 -163.11 176.29 10.19 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.502 0.766 . . . . 73.25 111.019 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.48 ' HB1' ' HB2' ' A' ' 225' ' ' ASN . . . 42.76 27.33 0.09 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.447 1.092 . . . . 72.209999999999994 109.313 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.447 ' N ' ' C ' ' A' ' 221' ' ' TYR . 13.1 t 37.85 30.37 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.496 1.123 . . . . 75.530000000000001 110.383 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 222' ' ' ALA . . . 69.05 50.71 32.51 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 124.475 1.109 . . . . 62.329999999999998 110.986 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.48 ' HB2' ' HB1' ' A' ' 222' ' ' ALA . 3.5 m120 -72.72 176.94 5.11 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.478 0.752 . . . . 72.120000000000005 109.304 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 229' ' ' GLU . 0.4 OUTLIER -81.66 128.78 34.31 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.478 1.111 . . . . 73.150000000000006 109.301 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.883 HG21 ' HB ' ' A' ' 209' ' ' VAL . 13.8 p -42.63 -48.59 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.483 1.114 . . . . 53.509999999999998 109.306 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.582 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.3 mp -61.7 -40.59 87.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.466 1.103 . . . . 72.239999999999995 109.273 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.458 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 19.4 mt-10 -67.99 -17.65 64.49 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.555 1.159 . . . . 54.119999999999997 110.303 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.65 ' HB3' HG21 ' A' ' 214' ' ' ILE . 13.2 m-20 -88.84 -15.7 33.85 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.54 1.15 . . . . 64.299999999999997 109.312 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 228' ' ' ILE . 1.9 mt -77.13 -69.61 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.439 1.087 . . . . 74.340000000000003 109.311 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.497 ' CE ' ' O ' ' A' ' 228' ' ' ILE . 0.0 OUTLIER -62.37 -16.29 53.68 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.587 1.179 . . . . 63.299999999999997 109.297 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.74 -21.49 2.8 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.488 1.118 . . . . 61.409999999999997 109.984 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 234' ' ' VAL . 1.0 OUTLIER -138.54 28.39 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.468 1.105 . . . . 74.319999999999993 109.275 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.409 ' C ' ' O ' ' A' ' 234' ' ' VAL . 6.6 m120 39.83 44.69 1.39 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.564 1.165 . . . . 64.140000000000001 109.275 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' A' ' 187' ' ' HIS . 4.1 tp -74.4 119.47 76.67 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.491 1.12 . . . . 62.0 109.317 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.06 162.29 37.23 Favored 'Trans proline' 0 C--N 1.361 1.208 0 O-C-N 124.46 1.768 . . . . 63.539999999999999 110.995 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.43 ' N ' ' HB2' ' A' ' 241' ' ' GLU . 1.6 m -59.75 159.6 8.56 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.483 1.114 . . . . 74.319999999999993 110.442 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.591 HG13 ' H ' ' A' ' 240' ' ' GLN . 6.4 p -52.5 -59.43 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.564 1.165 . . . . 74.209999999999994 109.332 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.591 ' H ' HG13 ' A' ' 239' ' ' VAL . 0.0 OUTLIER -65.32 -15.98 63.11 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.55 1.156 . . . . 43.43 110.291 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.43 ' HB2' ' N ' ' A' ' 238' ' ' THR . 14.8 mm-40 -80.55 -37.69 30.98 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.536 1.148 . . . . 73.219999999999999 110.329 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.693 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 0.3 OUTLIER -82.77 -57.15 3.44 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.511 1.132 . . . . 73.430000000000007 108.006 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.584 ' HD2' ' CD2' ' B' ' 470' ' ' PHE . 19.6 mtpp -58.33 -18.28 26.15 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.518 1.136 . . . . 64.209999999999994 109.312 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -42.58 -54.31 4.01 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.492 1.12 . . . . 51.130000000000003 110.017 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -155.32 137.38 14.64 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.419 1.074 . . . . 74.299999999999997 109.341 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 34.3 mm -74.77 -61.74 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.471 1.107 . . . . 73.430000000000007 109.302 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -93.8 108.75 20.48 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.116 . . . . 62.450000000000003 109.3 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' ARG . . . . . 0.496 ' HD2' ' CD2' ' A' ' 249' ' ' TYR . 6.1 tmm_? -120.95 126.91 51.18 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.436 1.085 . . . . 73.430000000000007 110.286 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.496 ' CD2' ' HD2' ' A' ' 248' ' ' ARG . 48.3 p90 -43.4 131.71 4.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.564 1.165 . . . . 72.129999999999995 110.978 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 251' ' ' ALA . 7.4 tptm -140.73 137.99 33.86 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.507 1.129 . . . . 74.420000000000002 109.357 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 250' ' ' LYS . . . 69.78 12.83 8.05 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.475 1.11 . . . . 72.219999999999999 109.297 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 3.1 p -95.67 162.39 13.63 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.531 1.144 . . . . 74.120000000000005 110.084 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -42.54 162.37 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.524 1.14 . . . . 71.439999999999998 109.358 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.5 HD12 ' N ' ' A' ' 254' ' ' ILE . 3.8 mp -130.54 159.42 42.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 O-C-N 124.492 1.12 . . . . 74.230000000000004 109.338 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 2.0 t -156.45 113.42 3.14 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.505 1.128 . . . . 63.130000000000003 110.012 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.402 ' N ' HD23 ' A' ' 256' ' ' LEU . 0.1 OUTLIER -119.36 -177.65 3.41 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.521 1.138 . . . . 75.450000000000003 109.313 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -139.66 -175.81 14.48 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.553 1.158 . . . . 61.350000000000001 110.992 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 7.8 p -133.99 45.77 2.59 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.522 0.778 . . . . 73.340000000000003 109.971 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.7 p -74.44 153.88 6.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.476 1.11 . . . . 65.319999999999993 109.301 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' A' ' 260' ' ' GLU . 9.1 pt-20 . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.459 1.099 . . . . 71.439999999999998 110.281 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 109.999 -0.371 . . . . 74.120000000000005 109.999 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 1.7 p -160.96 165.61 29.67 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.528 1.143 . . . . 75.420000000000002 110.011 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 1.9 t -111.52 -70.08 0.83 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.576 1.172 . . . . 71.230000000000004 109.953 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -130.4 177.29 7.46 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.383 1.052 . . . . 63.450000000000003 109.344 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -128.23 101.02 6.07 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 73.299999999999997 109.27 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -78.1 -164.01 23.33 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.457 1.098 . . . . 42.340000000000003 111.027 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -109.38 -14.82 14.37 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.486 0.756 . . . . 74.019999999999996 109.312 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 470' ' ' PHE . . . . . 0.584 ' CD2' ' HD2' ' A' ' 243' ' ' LYS . 4.8 m-30 -91.92 1.14 57.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.48 1.112 . . . . 53.310000000000002 110.98 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 471' ' ' ILE . . . . . 0.571 ' N ' HD13 ' B' ' 471' ' ' ILE . 3.1 mm -67.63 140.01 94.26 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.567 1.167 . . . . 75.299999999999997 109.296 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 472' ' ' PRO . . . . . 0.554 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.97 -174.37 1.9 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.487 1.783 . . . . 74.120000000000005 110.987 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.56 14.62 4.47 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.523 1.139 . . . . 64.030000000000001 109.994 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -143.21 159.32 56.06 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.516 1.135 . . . . 75.409999999999997 110.379 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 475' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.2 Cg_endo -74.97 -53.22 0.1 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 O-C-N 124.551 1.817 . . . . 70.129999999999995 111.013 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 476' ' ' ALA . . . . . 0.636 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . 179.19 140.73 0.28 Allowed Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.482 1.113 . . . . 73.530000000000001 109.286 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 477' ' ' PRO . . . . . 0.571 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -74.96 -162.35 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.45 1.763 . . . . 75.519999999999996 110.991 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.5 90.93 22.85 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.545 1.153 . . . . 61.140000000000001 109.289 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 479' ' ' PRO . . . . . 0.609 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.92 144.32 30.42 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.559 1.821 . . . . 73.239999999999995 110.994 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 163.23 35.74 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.472 1.775 . . . . 71.400000000000006 111.054 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 481' ' ' SER . . . . . . . . . . . . . 1.2 t 39.62 40.34 0.62 Allowed 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.455 1.097 . . . . 74.239999999999995 109.963 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 28.5 t -76.25 127.17 32.36 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.511 1.132 . . . . 70.340000000000003 109.919 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -88.16 -19.38 27.02 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.471 1.107 . . . . 74.450000000000003 109.309 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 1.3 t -93.37 21.1 6.4 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.524 1.14 . . . . 70.310000000000002 110.021 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -108.41 53.17 0.69 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.472 1.108 . . . . 64.299999999999997 109.287 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 76.0 p . . . . . 0 C--N 1.326 -0.454 0 O-C-N 124.419 1.075 . . . . 44.5 109.978 179.985 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.035 0 N-CA-C 110.985 -0.846 . . . . 42.310000000000002 110.985 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.9 t -105.0 112.89 26.19 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.556 0.797 . . . . 72.129999999999995 109.995 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -155.67 128.5 7.99 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.53 1.144 . . . . 70.120000000000005 109.227 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 8.7 m-85 -122.74 -176.55 3.42 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.478 1.111 . . . . 53.240000000000002 110.957 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 182' ' ' LEU . . . -120.53 148.81 43.36 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.475 1.109 . . . . 74.239999999999995 109.37 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.622 HG21 HD11 ' A' ' 215' ' ' ILE . 0.1 OUTLIER -132.8 134.13 58.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.512 1.132 . . . . 71.329999999999998 109.31 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.978 HG22 HG12 ' A' ' 212' ' ' VAL . 2.3 t -92.92 120.93 43.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.427 1.079 . . . . 72.219999999999999 109.327 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.511 ' CD2' HG23 ' A' ' 161' ' ' ILE . 0.7 OUTLIER -97.76 -14.14 20.99 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.522 1.139 . . . . 71.140000000000001 109.331 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.676 ' O ' HG13 ' A' ' 162' ' ' VAL . 1.8 m-85 -145.48 157.72 43.96 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.419 1.074 . . . . 73.209999999999994 111.03 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.776 ' N ' HG12 ' A' ' 178' ' ' VAL . 16.8 p-10 -97.57 158.96 15.21 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.546 1.154 . . . . 74.129999999999995 109.291 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.555 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 1.6 t80 -157.89 131.3 7.7 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 71.430000000000007 111.048 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.555 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 2.9 mmpt? -67.9 123.54 20.86 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.514 1.134 . . . . 72.049999999999997 109.376 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.831 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -102.63 141.24 35.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.53 1.144 . . . . 71.129999999999995 109.293 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -151.39 21.33 0.73 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.488 1.117 . . . . 73.439999999999998 110.254 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.464 ' HZ1' ' HZ ' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -96.0 -176.3 3.65 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.118 . . . . 64.420000000000002 109.298 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.23 -22.5 64.85 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.462 1.101 . . . . 74.120000000000005 109.311 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 173' ' ' GLU . 1.5 m-20 -116.07 20.77 14.2 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.512 1.132 . . . . 74.430000000000007 109.334 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.831 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 6.9 pt-20 -38.11 109.71 0.11 Allowed 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.464 1.103 . . . . 73.420000000000002 110.295 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.696 HD13 ' HA3' ' A' ' 205' ' ' GLY . 9.6 tp -121.18 106.71 11.78 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.51 1.131 . . . . 70.319999999999993 109.308 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 175' ' ' THR . 11.2 t -81.12 107.67 14.12 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.528 1.142 . . . . 72.519999999999996 110.405 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.753 HG23 ' CD ' ' A' ' 180' ' ' GLU . 0.9 OUTLIER -129.86 142.35 50.68 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.5 1.125 . . . . 72.420000000000002 110.322 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -86.21 167.61 14.71 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.546 1.154 . . . . 74.439999999999998 110.959 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.776 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.8 m -63.19 158.16 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.503 1.127 . . . . 53.210000000000001 109.303 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 52.76 58.33 11.73 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.526 1.141 . . . . 75.150000000000006 111.033 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.753 ' CD ' HG23 ' A' ' 176' ' ' THR . 1.4 tt0 -114.14 170.69 8.1 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.461 0.742 . . . . 75.040000000000006 110.281 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -126.46 121.75 33.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.512 1.133 . . . . 74.430000000000007 109.35 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.847 ' CD1' HG21 ' A' ' 207' ' ' VAL . 1.5 pt? -142.91 140.64 31.24 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.496 1.122 . . . . 73.140000000000001 109.317 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 32.7 t80 -100.4 114.33 27.8 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.406 1.066 . . . . 74.430000000000007 111.026 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.64 HG13 ' HB2' ' A' ' 195' ' ' ALA . 19.8 mt -72.82 145.69 11.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.554 1.159 . . . . 74.420000000000002 109.288 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.618 ' O ' HD12 ' A' ' 236' ' ' LEU . 6.0 t -135.34 -41.01 0.72 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 72.030000000000001 108.275 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 1.053 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -112.87 167.46 10.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.475 1.109 . . . . 73.420000000000002 109.361 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.674 ' ND1' HD21 ' A' ' 236' ' ' LEU . 0.8 OUTLIER -156.94 155.34 31.2 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.521 1.138 . . . . 61.149999999999999 109.573 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.611 ' CD2' ' HD3' ' B' ' 472' ' ' PRO . 1.2 p-80 -158.31 142.09 15.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.416 1.072 . . . . 74.409999999999997 109.642 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.472 ' C ' ' N ' ' A' ' 191' ' ' GLU . 61.6 t30 53.07 22.93 2.72 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.133 . . . . 73.420000000000002 109.338 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.432 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.8 p 38.92 30.32 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 61.32 108.277 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.525 ' O ' HG13 ' A' ' 209' ' ' VAL . 3.1 tt0 -132.62 -39.26 1.0 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.485 1.115 . . . . 74.019999999999996 110.274 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.726 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 99.0 m95 -108.53 129.03 55.3 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.568 1.168 . . . . 74.319999999999993 108.029 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.772 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.3 m-30 -121.05 145.27 47.96 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.44 1.087 . . . . 71.120000000000005 111.018 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 1.053 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 4.2 mm -103.11 101.89 12.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.472 1.108 . . . . 54.299999999999997 109.259 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.64 ' HB2' HG13 ' A' ' 184' ' ' ILE . . . -112.23 168.97 9.19 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.43 1.081 . . . . 62.310000000000002 109.296 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.04 149.7 72.31 Favored Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.453 1.095 . . . . 74.209999999999994 109.268 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.98 178.1 7.71 Favored 'Trans proline' 0 C--N 1.361 1.202 0 O-C-N 124.444 1.76 . . . . 65.019999999999996 110.966 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.435 ' N ' HD13 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -132.14 91.68 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.56 1.163 . . . . 74.140000000000001 109.305 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 146.75 -62.11 0.46 Allowed Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.561 1.163 . . . . 52.32 110.97 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -92.52 170.19 9.95 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 0.775 . . . . 61.329999999999998 110.316 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 14.8 tp -104.84 66.68 0.78 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.494 1.121 . . . . 54.520000000000003 109.29 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . -103.03 -57.49 0.77 Allowed Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.569 1.168 . . . . 43.520000000000003 110.941 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.406 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . -48.71 179.53 0.01 OUTLIER Glycine 0 CA--C 1.529 0.931 0 N-CA-C 111.01 -0.836 . . . . 51.299999999999997 111.01 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.98 123.15 8.79 Favored 'Cis proline' 0 C--N 1.36 1.184 0 C-N-CA 120.993 -2.503 . . . . 64.120000000000005 111.013 -0.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.696 ' HA3' HD13 ' A' ' 174' ' ' LEU . . . -97.05 157.16 21.02 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.452 1.095 . . . . 54.509999999999998 111.019 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.726 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -93.65 148.51 22.04 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.536 0.786 . . . . 73.109999999999999 109.33 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.847 HG21 ' CD1' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -157.15 125.93 3.0 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.551 1.157 . . . . 71.340000000000003 109.298 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.948 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.3 Cg_endo -74.99 173.58 14.27 Favored 'Trans proline' 0 C--N 1.359 1.085 0 O-C-N 124.501 1.79 . . . . 71.010000000000005 110.977 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.772 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -94.18 6.84 6.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.522 1.139 . . . . 42.210000000000001 109.309 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 210' ' ' GLY . . . . . 0.441 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -106.18 -7.46 35.26 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.536 1.148 . . . . 72.510000000000005 111.038 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.616 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 10.7 m-85 -127.73 2.79 6.08 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.507 0.769 . . . . 61.409999999999997 110.981 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.978 HG12 HG22 ' A' ' 162' ' ' VAL . 2.6 m -143.62 162.53 16.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 73.200000000000003 109.268 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 30.5 t -132.63 142.49 49.13 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.515 1.134 . . . . 70.530000000000001 110.02 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.557 ' O ' HG23 ' A' ' 215' ' ' ILE . 4.2 mm -86.13 113.77 24.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.528 1.143 . . . . 71.0 109.301 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.625 HG22 ' HA ' ' A' ' 221' ' ' TYR . 25.8 pt -156.14 179.58 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.523 1.139 . . . . 63.350000000000001 109.334 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.563 ' OD2' ' HB3' ' A' ' 218' ' ' ALA . 38.5 p-10 -145.78 -174.38 4.4 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.498 1.124 . . . . 75.310000000000002 109.31 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 9.6 tp -59.63 -16.55 10.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.416 1.073 . . . . 54.299999999999997 109.306 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.563 ' HB3' ' OD2' ' A' ' 216' ' ' ASP . . . -71.18 169.1 15.82 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.506 1.129 . . . . 72.450000000000003 109.24 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.4 ' OG1' ' N ' ' A' ' 220' ' ' GLY . 9.1 t -76.31 -170.22 1.4 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.513 1.133 . . . . 64.030000000000001 110.383 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.4 ' N ' ' OG1' ' A' ' 219' ' ' THR . . . 41.91 -124.56 3.49 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.529 1.143 . . . . 74.120000000000005 111.001 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.625 ' HA ' HG22 ' A' ' 215' ' ' ILE . 29.0 m-85 -107.94 -177.69 3.41 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.495 0.762 . . . . 65.120000000000005 111.041 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.464 ' CA ' ' HA ' ' A' ' 215' ' ' ILE . . . -43.25 -71.6 0.08 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.485 1.116 . . . . 73.219999999999999 109.321 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.533 HG23 ' HB2' ' A' ' 225' ' ' ASN . 7.6 t -135.49 9.6 3.42 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.514 1.134 . . . . 72.219999999999999 110.355 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 84.02 -10.66 59.93 Favored Glycine 0 CA--C 1.531 1.059 0 O-C-N 124.462 1.101 . . . . 72.450000000000003 110.994 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.533 ' HB2' HG23 ' A' ' 223' ' ' THR . 3.3 m-80 -83.25 167.45 17.66 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.498 0.763 . . . . 64.150000000000006 109.31 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 230' ' ' ASP . 0.6 OUTLIER -79.1 151.46 31.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.545 1.153 . . . . 54.439999999999998 109.316 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.415 ' H ' HG12 ' A' ' 227' ' ' VAL . 1.3 p -51.88 -39.67 25.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.507 1.129 . . . . 61.219999999999999 109.257 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.812 ' HA ' HD12 ' A' ' 231' ' ' ILE . 11.8 mt -71.51 -39.27 70.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.446 1.091 . . . . 74.310000000000002 109.337 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -73.24 -15.74 61.42 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.423 1.077 . . . . 75.319999999999993 110.29 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.444 ' OD2' ' CB ' ' A' ' 225' ' ' ASN . 6.0 m-20 -88.55 -15.73 34.43 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.542 1.151 . . . . 74.439999999999998 109.241 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.812 HD12 ' HA ' ' A' ' 228' ' ' ILE . 3.4 mt -72.04 -69.45 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.497 1.123 . . . . 75.329999999999998 109.261 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.485 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -60.82 -17.07 47.56 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.459 1.1 . . . . 60.119999999999997 109.275 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.86 -30.09 60.94 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.468 1.105 . . . . 63.409999999999997 109.929 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.419 ' C ' ' N ' ' A' ' 236' ' ' LEU . 10.7 m -120.89 22.21 5.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.505 1.128 . . . . 65.239999999999995 109.312 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 45.74 26.52 0.36 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.545 1.153 . . . . 73.319999999999993 109.312 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.761 HD23 HG23 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -61.97 123.18 76.63 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.455 1.097 . . . . 64.109999999999999 109.304 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 -177.48 3.49 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.421 1.748 . . . . 74.349999999999994 110.993 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.581 HG22 ' H ' ' A' ' 239' ' ' VAL . 2.2 m -74.7 -171.04 1.17 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 72.329999999999998 110.388 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.618 HG13 ' N ' ' A' ' 240' ' ' GLN . 12.9 p -79.09 -58.32 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 124.522 1.139 . . . . 41.009999999999998 109.3 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.618 ' N ' HG13 ' A' ' 239' ' ' VAL . 2.0 pp0? -72.18 -10.99 60.52 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.504 1.128 . . . . 75.400000000000006 110.324 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.75 -44.51 27.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.529 1.143 . . . . 73.439999999999998 110.311 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.962 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 0.0 OUTLIER -87.31 -68.61 0.74 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.002 -1.111 . . . . 73.340000000000003 108.002 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.601 ' HD3' ' CD2' ' A' ' 242' ' ' TRP . 0.1 OUTLIER -40.95 -29.11 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.476 1.11 . . . . 54.219999999999999 109.342 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 240' ' ' GLN . 0.0 OUTLIER -38.33 -58.56 0.99 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.525 1.14 . . . . 63.140000000000001 110.003 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -143.43 127.64 17.64 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.492 1.12 . . . . 72.329999999999998 109.308 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.425 ' N ' HD12 ' A' ' 246' ' ' ILE . 3.2 mp -83.73 -31.23 8.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.523 1.139 . . . . 72.230000000000004 109.304 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -91.58 57.75 3.36 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.477 1.111 . . . . 43.130000000000003 109.323 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -145.46 139.78 27.09 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.513 1.133 . . . . 75.549999999999997 110.383 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -51.21 179.43 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.516 1.135 . . . . 73.430000000000007 111.012 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -84.29 148.55 26.62 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.52 1.138 . . . . 54.520000000000003 109.26 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -156.02 179.2 9.45 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.497 1.123 . . . . 64.299999999999997 109.221 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 60.2 p -172.82 164.76 5.21 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.491 1.119 . . . . 62.329999999999998 109.923 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -153.78 143.51 21.81 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.483 1.115 . . . . 63.539999999999999 109.281 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.422 HD12 ' N ' ' A' ' 254' ' ' ILE . 5.2 mp -106.14 125.81 61.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.51 1.131 . . . . 65.239999999999995 109.264 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.9 t -148.54 176.52 10.25 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.441 1.088 . . . . 53.439999999999998 109.996 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -169.72 153.57 5.02 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.542 1.151 . . . . 71.510000000000005 109.371 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 160.75 104.09 0.19 Allowed Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.484 1.115 . . . . 31.420000000000002 110.996 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.545 ' O ' HG13 ' A' ' 259' ' ' VAL . 1.1 m -121.83 165.19 16.26 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.507 0.769 . . . . 50.020000000000003 109.991 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 258' ' ' SER . 1.4 m -155.72 125.73 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.532 1.145 . . . . 63.32 109.247 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 C--N 1.326 -0.445 0 O-C-N 124.52 1.138 . . . . 63.340000000000003 110.299 179.934 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 110.011 -0.366 . . . . 53.109999999999999 110.011 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 2.6 t -84.91 -14.7 46.89 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.46 1.1 . . . . 61.240000000000002 110.001 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 72.9 m -71.24 -21.91 62.05 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.448 1.092 . . . . 72.109999999999999 109.974 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -90.88 177.8 6.2 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.417 1.073 . . . . 40.549999999999997 109.249 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -132.77 171.64 13.61 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.476 1.11 . . . . 74.239999999999995 109.318 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 468' ' ' GLY . . . . . 0.723 ' HA3' HD11 ' B' ' 471' ' ' ILE . . . -129.02 167.53 21.08 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 124.544 1.153 . . . . 64.420000000000002 111.021 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -111.15 -30.96 7.26 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.468 0.746 . . . . 73.530000000000001 109.3 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 470' ' ' PHE . . . . . 0.527 ' CD1' ' HG2' ' A' ' 243' ' ' LYS . 86.4 m-85 -95.64 39.28 1.13 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.521 1.138 . . . . 73.239999999999995 110.977 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 471' ' ' ILE . . . . . 0.723 HD11 ' HA3' ' B' ' 468' ' ' GLY . 1.2 mm -98.1 142.36 24.46 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.464 1.102 . . . . 62.439999999999998 109.278 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 472' ' ' PRO . . . . . 0.71 ' HD2' HG22 ' B' ' 471' ' ' ILE . 18.4 Cg_endo -74.95 170.23 20.86 Favored 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.489 1.783 . . . . 74.420000000000002 111.029 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.86 -42.41 5.85 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.573 1.171 . . . . 73.400000000000006 110.027 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -96.34 161.1 28.11 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.127 . . . . 72.030000000000001 110.298 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 475' ' ' PRO . . . . . 0.584 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.3 Cg_endo -74.98 -34.35 3.91 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.543 1.812 . . . . 71.129999999999995 110.996 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 476' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 169.72 134.62 0.06 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.545 1.153 . . . . 63.039999999999999 109.315 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 477' ' ' PRO . . . . . 0.575 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.2 Cg_endo -74.95 -162.92 0.16 Allowed 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.513 1.796 . . . . 73.310000000000002 111.052 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 478' ' ' LYS . . . . . 0.433 ' O ' ' CD ' ' B' ' 478' ' ' LYS . 0.1 OUTLIER -133.84 91.8 24.11 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.432 1.082 . . . . 70.200000000000003 109.275 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 479' ' ' PRO . . . . . 0.616 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.1 Cg_endo -75.01 162.49 37.01 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.449 1.763 . . . . 54.25 110.986 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.96 -88.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.41 1.742 . . . . 53.299999999999997 111.004 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 481' ' ' SER . . . . . 0.546 ' O ' ' CZ ' ' A' ' 164' ' ' TYR . 0.4 OUTLIER -82.33 142.33 32.12 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.506 1.129 . . . . 55.0 110.018 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 14.4 t -176.48 177.16 1.49 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.598 1.186 . . . . 54.200000000000003 109.956 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -80.81 -26.59 37.0 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.482 1.114 . . . . 63.439999999999998 109.343 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 1.6 t -166.04 124.84 1.57 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.517 1.136 . . . . 64.230000000000004 109.981 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -118.16 161.87 19.16 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.536 1.147 . . . . 64.219999999999999 109.278 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.547 1.155 . . . . 75.120000000000005 109.997 179.985 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.987 0 N-CA-C 110.963 -0.855 . . . . 44.219999999999999 110.963 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.8 t -84.08 -29.91 26.44 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.53 0.782 . . . . 74.219999999999999 110.013 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.791 HD13 ' O ' ' A' ' 158' ' ' LEU . 0.0 OUTLIER -42.02 149.75 0.14 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.473 1.108 . . . . 75.200000000000003 109.284 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.545 ' N ' HD22 ' A' ' 158' ' ' LEU . 0.7 OUTLIER -145.84 131.9 19.3 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.449 1.093 . . . . 63.219999999999999 110.997 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.658 ' HB2' HD12 ' A' ' 184' ' ' ILE . . . -108.93 145.09 35.99 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.495 1.122 . . . . 55.109999999999999 109.26 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.719 ' HB ' HD11 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -130.61 135.8 59.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.456 1.097 . . . . 71.420000000000002 109.279 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.957 HG22 HG12 ' A' ' 212' ' ' VAL . 2.6 t -93.03 135.39 27.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 124.475 1.11 . . . . 74.420000000000002 109.341 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.624 HD12 ' CE1' ' A' ' 164' ' ' TYR . 0.1 OUTLIER -115.25 -8.34 12.33 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.479 1.112 . . . . 64.209999999999994 109.267 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.624 ' CE1' HD12 ' A' ' 163' ' ' LEU . 0.3 OUTLIER -146.98 151.96 37.84 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.486 1.116 . . . . 63.039999999999999 110.931 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -111.17 154.72 23.96 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.514 1.134 . . . . 73.140000000000001 109.291 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.581 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 0.6 OUTLIER -160.89 168.63 24.26 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.416 1.072 . . . . 70.439999999999998 110.989 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -92.93 133.98 35.56 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.415 1.072 . . . . 73.25 109.302 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.694 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -106.0 150.96 25.22 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.543 1.152 . . . . 70.030000000000001 109.329 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -155.03 27.45 0.42 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.544 1.153 . . . . 45.340000000000003 110.275 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.58 ' HE2' ' CH2' ' A' ' 192' ' ' TRP . 0.1 OUTLIER -101.49 -176.61 3.19 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.443 1.089 . . . . 63.340000000000003 109.273 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.98 -31.01 66.49 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.481 1.113 . . . . 73.450000000000003 109.237 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 173' ' ' GLU . 20.1 m-20 -111.47 23.06 14.4 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.48 1.113 . . . . 73.120000000000005 109.328 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.694 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -36.48 112.07 0.17 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.55 1.156 . . . . 62.43 110.241 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.678 HD22 ' HA3' ' A' ' 205' ' ' GLY . 0.4 OUTLIER -132.83 118.99 19.65 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.515 1.134 . . . . 75.120000000000005 109.28 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 175' ' ' THR . 10.6 t -86.45 108.46 18.52 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.487 1.117 . . . . 74.129999999999995 110.425 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.456 HG23 HG11 ' A' ' 162' ' ' VAL . 1.2 t -102.07 178.86 4.49 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 72.319999999999993 110.416 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.481 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 2.6 m-85 -131.88 154.54 49.09 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 63.329999999999998 111.061 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.7 m -55.82 154.72 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.538 1.149 . . . . 64.340000000000003 109.302 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 40.51 72.2 0.25 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.48 1.113 . . . . 63.109999999999999 110.989 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.502 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 7.4 tt0 -131.03 167.25 19.37 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.514 0.773 . . . . 63.149999999999999 110.31 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.401 ' ND2' ' OH ' ' A' ' 159' ' ' TYR . 2.5 m120 -113.89 139.4 49.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.532 1.145 . . . . 71.140000000000001 109.305 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.731 ' CD1' HG21 ' A' ' 207' ' ' VAL . 0.6 OUTLIER -154.11 148.44 26.02 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.499 1.125 . . . . 53.100000000000001 109.288 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.548 ' CE2' ' HB2' ' A' ' 185' ' ' CYS . 25.2 t80 -106.37 105.95 16.22 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 75.120000000000005 110.961 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.842 ' CG1' ' HB2' ' A' ' 195' ' ' ALA . 73.9 mt -83.95 120.23 34.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.502 1.126 . . . . 74.140000000000001 109.308 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.605 ' SG ' ' CH2' ' A' ' 242' ' ' TRP . 33.4 t -124.7 -8.75 7.33 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.483 1.115 . . . . 71.239999999999995 108.278 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.838 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -129.78 150.02 51.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.429 1.081 . . . . 73.310000000000002 109.327 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.582 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.1 OUTLIER -153.62 148.3 26.33 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.524 1.14 . . . . 74.040000000000006 109.53 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.758 ' NE2' HD13 ' A' ' 194' ' ' ILE . 2.4 p80 -152.5 144.81 23.97 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.497 1.123 . . . . 64.430000000000007 109.591 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.471 ' C ' ' N ' ' A' ' 191' ' ' GLU . 51.5 t-20 53.5 20.01 1.91 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.562 1.164 . . . . 73.219999999999999 109.278 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.411 ' C ' ' O ' ' A' ' 189' ' ' ASN . 15.9 p 41.02 27.53 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.461 1.101 . . . . 65.349999999999994 108.272 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.519 ' O ' HG13 ' A' ' 209' ' ' VAL . 8.0 tt0 -129.81 -40.71 1.35 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.497 1.123 . . . . 71.129999999999995 110.321 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.591 ' CZ2' ' HD3' ' B' ' 477' ' ' PRO . 99.8 m95 -107.9 126.16 52.34 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.57 1.169 . . . . 74.230000000000004 107.971 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.752 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.3 m-30 -119.43 134.61 55.13 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 1.122 . . . . 73.530000000000001 110.993 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.838 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 1.0 OUTLIER -100.07 110.9 28.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.567 1.167 . . . . 74.099999999999994 109.236 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.842 ' HB2' ' CG1' ' A' ' 184' ' ' ILE . . . -117.01 174.3 6.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.46 1.1 . . . . 55.310000000000002 109.237 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.419 ' HG2' ' HA ' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -126.76 139.15 34.13 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.459 1.099 . . . . 75.120000000000005 109.324 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 174.27 13.07 Favored 'Trans proline' 0 C--N 1.359 1.089 0 O-C-N 124.527 1.804 . . . . 73.230000000000004 110.97 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 97.4 mt -119.63 -52.32 3.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.516 1.135 . . . . 73.349999999999994 109.296 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -90.86 -55.66 1.85 Allowed Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.447 1.092 . . . . 75.219999999999999 110.998 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -58.25 120.5 8.8 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 0.762 . . . . 60.450000000000003 110.319 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 5.5 tp -64.14 133.89 53.81 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.519 1.137 . . . . 72.400000000000006 109.334 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 130.04 -155.58 21.07 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.464 1.102 . . . . 74.409999999999997 111.022 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.455 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . 93.03 165.66 38.18 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.99 -0.844 . . . . 52.310000000000002 110.99 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.519 ' HG2' ' CE2' ' B' ' 470' ' ' PHE . 18.2 Cg_endo -75.03 147.42 89.19 Favored 'Cis proline' 0 C--N 1.36 1.141 0 C-N-CA 121.042 -2.482 . . . . 54.509999999999998 110.927 0.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.678 ' HA3' HD22 ' A' ' 174' ' ' LEU . . . -103.89 156.87 17.47 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.47 1.106 . . . . 62.240000000000002 111.048 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.598 HD12 ' CD1' ' A' ' 194' ' ' ILE . 0.2 OUTLIER -94.68 146.16 24.35 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.489 0.758 . . . . 74.420000000000002 109.306 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.731 HG21 ' CD1' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -157.79 129.67 4.03 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.53 1.144 . . . . 51.340000000000003 109.195 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.934 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.2 Cg_endo -75.1 175.93 10.6 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.48 1.779 . . . . 74.040000000000006 111.008 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.752 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -93.41 4.65 7.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.428 1.08 . . . . 54.530000000000001 109.277 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -103.78 -13.06 28.63 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.418 1.074 . . . . 43.130000000000003 110.975 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.619 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 11.5 m-85 -119.43 -1.21 10.76 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.486 0.756 . . . . 75.349999999999994 110.98 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.957 HG12 HG22 ' A' ' 162' ' ' VAL . 2.6 m -141.06 160.43 23.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.487 1.117 . . . . 72.409999999999997 109.274 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.32 144.3 51.11 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.535 1.147 . . . . 42.420000000000002 110.036 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.803 ' O ' HG23 ' A' ' 215' ' ' ILE . 2.7 mm -88.46 145.62 7.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 55.100000000000001 109.342 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.803 HG23 ' O ' ' A' ' 214' ' ' ILE . 4.1 pt -163.58 152.84 2.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.45 1.093 . . . . 54.340000000000003 109.343 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -139.1 15.57 2.63 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.52 1.137 . . . . 74.239999999999995 109.327 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 5.6 mm 72.56 59.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.476 1.11 . . . . 75.140000000000001 109.289 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -117.08 14.82 15.02 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.539 1.15 . . . . 65.519999999999996 109.285 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.624 ' O ' HG22 ' A' ' 219' ' ' THR . 5.1 m 63.38 56.76 1.61 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.519 1.137 . . . . 75.409999999999997 110.367 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 173.34 -132.93 2.45 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.428 1.08 . . . . 63.240000000000002 111.011 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -155.69 123.79 5.78 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.532 0.784 . . . . 71.439999999999998 111.014 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.774 ' HB1' ' O ' ' A' ' 225' ' ' ASN . . . 63.31 16.73 9.71 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.574 1.171 . . . . 63.130000000000003 109.362 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.737 ' O ' HG22 ' A' ' 223' ' ' THR . 2.0 m 43.99 52.14 6.83 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.499 1.124 . . . . 75.450000000000003 110.435 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 77.3 -53.4 3.5 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.566 1.166 . . . . 74.430000000000007 111.011 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.774 ' O ' ' HB1' ' A' ' 222' ' ' ALA . 55.5 m-80 -66.8 120.92 14.34 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.591 0.819 . . . . 75.340000000000003 109.374 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ASP . . . . . 0.457 ' OD1' HG12 ' A' ' 227' ' ' VAL . 8.8 t0 -49.85 158.36 0.5 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.498 1.124 . . . . 73.219999999999999 109.304 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.491 HG13 HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -38.59 -58.44 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.129 . . . . 71.430000000000007 109.286 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.491 HD12 HG13 ' A' ' 227' ' ' VAL . 3.2 mp -54.48 -45.51 70.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.518 1.136 . . . . 74.340000000000003 109.348 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.461 ' CB ' ' HB3' ' A' ' 225' ' ' ASN . 18.5 mt-10 -67.16 -15.0 63.44 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 72.530000000000001 110.344 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 226' ' ' ASP . 5.5 t70 -88.61 -18.92 27.02 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.539 1.149 . . . . 64.430000000000007 109.302 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.655 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.5 OUTLIER -69.44 -69.42 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.505 1.128 . . . . 75.150000000000006 109.27 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.655 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -59.89 -23.83 63.79 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.52 1.138 . . . . 70.510000000000005 109.329 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.86 -59.7 3.36 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.522 1.139 . . . . 65.430000000000007 110.023 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 234' ' ' VAL . 1.2 m -98.96 24.31 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.107 . . . . 74.209999999999994 109.271 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 5.6 t30 46.07 41.69 8.7 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.445 1.091 . . . . 73.409999999999997 109.276 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.888 HD12 ' HD2' ' A' ' 237' ' ' PRO . 33.2 tp -55.54 123.98 53.47 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 124.511 1.132 . . . . 62.310000000000002 109.334 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.888 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.4 Cg_endo -74.99 153.37 41.76 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.565 1.824 . . . . 71.109999999999999 111.002 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' THR . . . . . 0.457 ' CG2' ' NE2' ' A' ' 240' ' ' GLN . 0.5 OUTLIER -61.42 -170.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.581 1.176 . . . . 62.149999999999999 110.438 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.489 ' HA ' ' HB1' ' A' ' 186' ' ' ALA . 12.3 p -80.27 -48.64 19.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.535 1.147 . . . . 62.219999999999999 109.354 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.489 ' OE1' ' N ' ' A' ' 241' ' ' GLU . 0.1 OUTLIER -87.43 -12.81 45.03 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.526 1.141 . . . . 53.43 110.281 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.489 ' N ' ' OE1' ' A' ' 240' ' ' GLN . 8.5 mt-10 -76.68 -36.27 57.39 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.562 1.164 . . . . 73.239999999999995 110.303 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.757 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 0.1 OUTLIER -87.01 -60.17 2.05 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.13 . . . . 62.340000000000003 108.012 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.644 ' NZ ' ' CD2' ' B' ' 470' ' ' PHE . 7.6 mtpt -53.19 -20.78 4.3 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.506 1.129 . . . . 53.219999999999999 109.328 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 243' ' ' LYS . 0.2 OUTLIER -38.4 -67.57 0.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.481 1.113 . . . . 64.519999999999996 110.034 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -143.56 119.33 10.51 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.489 1.118 . . . . 73.120000000000005 109.293 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 12.3 mm -57.53 -24.97 23.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.444 1.09 . . . . 63.299999999999997 109.309 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -106.26 94.85 5.38 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 62.439999999999998 109.299 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' ARG . . . . . 0.492 ' HD2' ' CD2' ' A' ' 249' ' ' TYR . 13.9 tpp85 -90.36 153.09 20.69 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.479 1.112 . . . . 74.310000000000002 110.349 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.492 ' CD2' ' HD2' ' A' ' 248' ' ' ARG . 35.2 m-85 -36.13 -55.53 0.77 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.535 1.147 . . . . 75.209999999999994 111.014 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -114.78 153.77 29.77 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.407 1.067 . . . . 61.229999999999997 109.335 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -117.63 -57.41 2.13 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.547 1.154 . . . . 61.450000000000003 109.264 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 79.3 p -57.17 155.29 8.79 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.583 1.177 . . . . 54.210000000000001 109.951 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 177.76 122.58 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.469 1.105 . . . . 64.209999999999994 109.285 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 1.8 mt -118.18 157.03 19.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.461 1.1 . . . . 72.219999999999999 109.272 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 48.1 t -156.8 116.12 3.43 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.534 1.146 . . . . 70.310000000000002 110.048 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.598 HD13 ' N ' ' A' ' 257' ' ' GLY . 0.6 OUTLIER -41.73 140.06 1.07 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 73.310000000000002 109.315 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.598 ' N ' HD13 ' A' ' 256' ' ' LEU . . . -113.65 158.06 14.55 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.514 1.134 . . . . 53.149999999999999 111.002 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 49.5 m -146.66 152.66 39.23 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.561 0.8 . . . . 73.120000000000005 109.987 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.44 ' O ' HG12 ' A' ' 259' ' ' VAL . 21.6 t -123.5 41.81 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.499 1.124 . . . . 53.299999999999997 109.221 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 . . . . . 0 C--N 1.324 -0.501 0 O-C-N 124.541 1.151 . . . . 73.430000000000007 110.309 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 110.019 -0.363 . . . . 61.229999999999997 110.019 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 70.6 m -86.32 149.7 24.86 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.525 1.141 . . . . 63.340000000000003 110.004 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 5.5 t -132.63 -48.87 0.89 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.559 1.162 . . . . 74.230000000000004 109.969 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -75.11 86.21 2.37 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.477 1.111 . . . . 73.420000000000002 109.302 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -110.77 -40.08 4.66 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.52 1.137 . . . . 72.329999999999998 109.253 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . 177.3 -174.77 47.26 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.487 1.117 . . . . 54.420000000000002 111.033 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -107.59 -15.08 14.68 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 124.577 0.81 . . . . 75.109999999999999 109.311 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 470' ' ' PHE . . . . . 0.644 ' CD2' ' NZ ' ' A' ' 243' ' ' LYS . 5.9 m-30 -91.48 1.33 57.21 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.417 1.073 . . . . 74.109999999999999 111.012 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 471' ' ' ILE . . . . . 0.767 ' N ' HD13 ' B' ' 471' ' ' ILE . 1.1 mm -71.31 135.67 84.36 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.482 1.114 . . . . 74.439999999999998 109.348 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 472' ' ' PRO . . . . . 0.589 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.94 170.97 19.22 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.504 1.792 . . . . 64.420000000000002 111.024 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 2.7 t -116.78 -8.86 11.33 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.455 1.097 . . . . 42.340000000000003 109.999 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -122.49 164.37 26.73 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.472 1.107 . . . . 52.210000000000001 110.294 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 475' ' ' PRO . . . . . 0.702 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.2 Cg_endo -75.03 -38.54 1.53 Allowed 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.49 1.784 . . . . 63.549999999999997 110.97 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 476' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 162.73 139.66 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.484 1.115 . . . . 34.32 109.274 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 477' ' ' PRO . . . . . 0.591 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -74.94 -161.37 0.12 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.494 1.786 . . . . 65.430000000000007 110.999 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 478' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -140.51 103.41 6.51 Favored Pre-proline 0 C--N 1.324 -0.52 0 O-C-N 124.59 1.181 . . . . 60.130000000000003 109.364 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 479' ' ' PRO . . . . . 0.619 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.5 Cg_endo -74.92 166.08 30.01 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.497 1.788 . . . . 61.229999999999997 110.998 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -87.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.417 1.746 . . . . 65.530000000000001 110.985 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 481' ' ' SER . . . . . 0.496 ' O ' ' CE2' ' A' ' 164' ' ' TYR . 14.4 t -78.88 84.49 4.92 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.47 1.106 . . . . 74.430000000000007 109.952 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 28.4 t -139.81 156.94 46.48 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.529 1.143 . . . . 61.219999999999999 109.998 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -139.79 143.48 36.91 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.45 1.093 . . . . 64.120000000000005 109.298 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 82.9 p -160.82 144.24 13.28 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.432 1.082 . . . . 75.540000000000006 109.973 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -84.31 143.54 29.46 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.521 1.138 . . . . 25.25 109.236 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 53.7 p . . . . . 0 C--N 1.325 -0.497 0 O-C-N 124.511 1.132 . . . . 75.299999999999997 109.947 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.964 0 N-CA-C 110.997 -0.841 . . . . 42.229999999999997 110.997 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.1 m -102.85 47.88 0.87 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.426 0.721 . . . . 62.520000000000003 109.991 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.5 mp -109.49 132.68 53.91 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.544 1.152 . . . . 73.329999999999998 109.331 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -126.12 128.69 47.72 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.409 1.068 . . . . 60.450000000000003 111.042 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.953 ' HB3' ' CD2' ' A' ' 182' ' ' LEU . . . -110.31 144.66 38.7 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.438 1.086 . . . . 71.409999999999997 109.303 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.521 HD13 ' O ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -123.99 123.84 67.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.545 1.153 . . . . 72.329999999999998 109.299 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.945 HG23 HD11 ' A' ' 182' ' ' LEU . 1.8 t -79.7 122.26 34.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.507 1.129 . . . . 71.319999999999993 109.364 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.58 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 0.7 OUTLIER -97.48 -14.83 20.89 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.551 1.157 . . . . 74.329999999999998 109.305 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.701 ' O ' HG13 ' A' ' 162' ' ' VAL . 5.4 m-85 -145.14 160.65 41.11 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.564 1.165 . . . . 64.150000000000006 111.067 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.842 ' N ' HG12 ' A' ' 178' ' ' VAL . 8.5 p30 -97.99 157.03 16.35 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.401 1.063 . . . . 73.030000000000001 109.362 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -150.12 135.64 18.22 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.532 1.145 . . . . 72.140000000000001 110.979 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -75.86 126.06 30.28 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.491 1.119 . . . . 71.349999999999994 109.302 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.848 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -88.99 153.29 21.14 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.452 1.095 . . . . 53.020000000000003 109.295 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -166.31 29.41 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 63.32 110.293 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.747 ' HZ2' ' H ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -129.5 -176.08 3.78 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.483 1.115 . . . . 64.319999999999993 109.293 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.12 -40.93 78.07 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 60.229999999999997 109.318 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 174' ' ' LEU . 30.7 m-20 -88.67 16.99 5.89 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.457 1.098 . . . . 64.299999999999997 109.272 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.848 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 4.6 pt-20 -38.14 95.76 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.449 1.093 . . . . 63.0 110.309 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.747 ' H ' ' HZ2' ' A' ' 170' ' ' LYS . 5.7 tp -118.4 107.81 14.29 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.482 1.114 . . . . 72.239999999999995 109.29 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 175' ' ' THR . 12.7 t -87.36 115.9 25.09 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.479 1.112 . . . . 71.430000000000007 110.357 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 6.9 m -134.74 154.8 51.42 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.536 1.148 . . . . 63.310000000000002 110.402 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -94.35 167.54 11.46 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.453 1.096 . . . . 73.230000000000004 110.962 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.842 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.6 m -66.96 158.26 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 124.488 1.117 . . . . 72.209999999999994 109.316 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 57.11 50.42 64.51 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.479 1.112 . . . . 51.509999999999998 111.077 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.521 ' O ' HD13 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -110.26 174.15 6.0 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.498 0.764 . . . . 74.439999999999998 110.289 -179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -137.36 117.45 13.42 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.527 1.142 . . . . 70.439999999999998 109.264 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.953 ' CD2' ' HB3' ' A' ' 160' ' ' ALA . 0.0 OUTLIER -129.99 154.88 46.95 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.453 1.096 . . . . 73.530000000000001 109.358 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.577 ' CE1' ' O ' ' A' ' 184' ' ' ILE . 1.0 OUTLIER -104.24 115.16 29.91 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.423 1.077 . . . . 74.340000000000003 110.982 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 1.055 HD13 ' HB2' ' A' ' 195' ' ' ALA . 27.5 mm -65.32 160.59 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.493 1.121 . . . . 71.319999999999993 109.303 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' CYS . . . . . 0.44 ' HB3' ' CH2' ' A' ' 242' ' ' TRP . 37.0 m -150.99 -44.88 0.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.538 1.149 . . . . 74.140000000000001 108.27 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 1.041 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -120.71 165.75 14.66 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.5 1.125 . . . . 63.509999999999998 109.274 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.526 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 2.0 p-80 -152.97 146.22 24.77 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.522 1.139 . . . . 65.409999999999997 109.617 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 1.052 ' HE1' HD13 ' A' ' 194' ' ' ILE . 0.2 OUTLIER -146.07 137.87 25.01 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.492 1.12 . . . . 72.310000000000002 109.625 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.479 ' C ' ' N ' ' A' ' 191' ' ' GLU . 24.5 t-20 50.17 25.58 1.82 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.531 1.144 . . . . 74.400000000000006 109.271 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' CYS . . . . . 0.439 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.9 p 38.93 30.9 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.451 1.094 . . . . 63.340000000000003 108.248 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.93 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 20.5 tt0 -127.36 -39.58 1.86 Allowed 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.495 1.122 . . . . 75.439999999999998 110.269 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.714 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 97.0 m95 -113.79 131.9 56.06 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.518 1.136 . . . . 74.450000000000003 108.023 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.909 ' HB3' HD12 ' A' ' 184' ' ' ILE . 23.3 m-30 -121.94 144.0 49.12 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.471 1.107 . . . . 75.530000000000001 111.02 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 1.052 HD13 ' HE1' ' A' ' 188' ' ' HIS . 0.8 OUTLIER -103.28 96.86 4.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.544 1.153 . . . . 75.25 109.341 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 1.055 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -99.64 -176.38 3.26 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.433 1.083 . . . . 52.329999999999998 109.224 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.453 ' CG ' ' C ' ' A' ' 195' ' ' ALA . 7.3 mtmt -151.19 160.21 32.33 Favored Pre-proline 0 C--N 1.326 -0.43 0 O-C-N 124.549 1.156 . . . . 72.530000000000001 109.262 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.08 177.52 8.5 Favored 'Trans proline' 0 C--N 1.361 1.209 0 O-C-N 124.491 1.785 . . . . 75.319999999999993 111.002 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 6.7 tt -93.18 -4.91 10.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 124.449 1.093 . . . . 75.430000000000007 109.282 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -115.77 -15.29 7.48 Favored Glycine 0 CA--C 1.532 1.095 0 O-C-N 124.535 1.147 . . . . 51.340000000000003 110.942 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ARG . . . . . 0.419 ' HB3' ' NH1' ' A' ' 200' ' ' ARG . 17.6 mtp-105 62.3 53.85 2.73 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.515 0.774 . . . . 75.120000000000005 110.311 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 2.1 tp -125.77 37.62 4.32 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 61.350000000000001 109.242 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 179.7 -52.28 0.09 OUTLIER Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.468 1.105 . . . . 51.350000000000001 111.032 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.426 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . -44.18 169.79 0.02 OUTLIER Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.087 -0.805 . . . . 61.340000000000003 111.087 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' PRO . . . . . 0.569 ' HG2' ' CE2' ' B' ' 470' ' ' PHE . 18.3 Cg_endo -75.07 127.63 14.85 Favored 'Cis proline' 0 C--N 1.359 1.118 0 C-N-CA 121.04 -2.483 . . . . 61.450000000000003 110.967 0.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.688 ' HA3' HD22 ' A' ' 174' ' ' LEU . . . -95.42 152.27 20.32 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.471 1.107 . . . . 54.310000000000002 110.934 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.714 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.1 OUTLIER -99.49 145.96 26.9 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 0.75 . . . . 71.450000000000003 109.312 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.728 ' HB ' HG11 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -159.75 127.84 2.86 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.54 1.15 . . . . 72.430000000000007 109.279 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.845 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.3 Cg_endo -74.99 176.81 9.42 Favored 'Trans proline' 0 C--N 1.361 1.206 0 O-C-N 124.507 1.793 . . . . 65.519999999999996 110.946 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.756 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.6 OUTLIER -97.09 5.14 9.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.41 1.069 . . . . 75.150000000000006 109.316 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -103.31 -12.22 31.72 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.518 1.136 . . . . 52.539999999999999 111.037 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.634 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 10.7 m-85 -123.02 3.28 9.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.473 0.749 . . . . 74.319999999999993 110.996 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.859 HG12 HG22 ' A' ' 162' ' ' VAL . 1.9 m -140.35 154.26 22.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.49 1.119 . . . . 70.5 109.273 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' SER . . . . . 0.458 ' HB2' HD11 ' A' ' 163' ' ' LEU . 5.6 t -120.37 124.51 45.71 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.485 1.116 . . . . 53.399999999999999 110.013 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.792 ' O ' HG23 ' A' ' 215' ' ' ILE . 2.7 mm -77.49 139.2 19.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.493 1.121 . . . . 63.140000000000001 109.294 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ILE . . . . . 0.792 HG23 ' O ' ' A' ' 214' ' ' ILE . 3.5 pt -164.43 -179.0 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.421 1.076 . . . . 74.129999999999995 109.276 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -146.29 -72.01 0.24 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.497 1.123 . . . . 74.239999999999995 109.313 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 44.6 pt -139.65 61.49 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.46 1.1 . . . . 75.120000000000005 109.291 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -178.22 171.18 1.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.498 1.124 . . . . 74.530000000000001 109.361 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.412 HG23 ' N ' ' A' ' 220' ' ' GLY . 10.6 t -85.81 -161.82 0.66 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.488 1.118 . . . . 74.510000000000005 110.446 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.412 ' N ' HG23 ' A' ' 219' ' ' THR . . . 38.47 -97.96 0.01 OUTLIER Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.49 1.118 . . . . 54.409999999999997 110.971 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.423 ' C ' HG22 ' A' ' 215' ' ' ILE . 8.2 m-85 -118.87 173.36 6.93 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.535 0.785 . . . . 74.510000000000005 110.97 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 221' ' ' TYR . . . -39.57 -70.22 0.11 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.553 1.158 . . . . 73.400000000000006 109.29 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.9 t -133.97 8.48 3.79 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.494 1.121 . . . . 73.319999999999993 110.367 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 109.64 8.07 26.94 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.477 1.111 . . . . 65.030000000000001 111.014 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -93.15 176.22 6.49 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.545 0.791 . . . . 74.040000000000006 109.263 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.66 143.48 26.4 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.529 1.143 . . . . 73.129999999999995 109.261 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.632 HG13 HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -41.07 -52.61 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.455 1.097 . . . . 63.420000000000002 109.335 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.632 HD12 HG13 ' A' ' 227' ' ' VAL . 4.3 mp -56.94 -58.91 3.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 O-C-N 124.519 1.137 . . . . 74.439999999999998 109.298 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -46.62 -29.16 1.71 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.547 1.155 . . . . 61.5 110.331 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -73.28 -37.19 66.35 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.54 1.15 . . . . 63.43 109.32 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.636 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.6 OUTLIER -62.26 -69.33 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.484 1.115 . . . . 73.150000000000006 109.295 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.636 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -51.42 -31.88 24.46 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.487 1.117 . . . . 71.329999999999998 109.288 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.03 -60.72 2.79 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.517 1.136 . . . . 70.5 109.936 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.2 m -92.03 15.39 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.549 1.155 . . . . 52.420000000000002 109.282 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 42.8 t30 40.43 36.35 0.35 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.477 1.11 . . . . 73.140000000000001 109.264 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.857 HD12 ' HD2' ' A' ' 237' ' ' PRO . 4.0 tp -49.25 134.48 16.5 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.126 . . . . 61.200000000000003 109.335 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.857 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.3 Cg_endo -74.99 164.09 34.06 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.461 1.769 . . . . 60.409999999999997 110.997 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.82 -174.89 2.31 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.503 1.127 . . . . 72.439999999999998 110.43 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.552 HG11 ' ND1' ' A' ' 188' ' ' HIS . 1.0 OUTLIER -79.61 -49.33 19.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.503 1.127 . . . . 72.219999999999999 109.278 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.506 ' N ' ' CG2' ' A' ' 239' ' ' VAL . 0.0 OUTLIER -76.67 -14.75 59.94 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.454 1.096 . . . . 74.010000000000005 110.307 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -83.78 -49.82 8.71 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.55 1.156 . . . . 75.319999999999993 110.291 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.716 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 0.1 OUTLIER -70.51 -62.49 1.37 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.007 -1.109 . . . . 75.25 108.007 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.571 ' NZ ' ' CE2' ' B' ' 470' ' ' PHE . 18.3 mtpp -49.56 -23.92 1.87 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.612 1.195 . . . . 72.109999999999999 109.329 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 243' ' ' LYS . 4.4 t -39.2 -40.89 0.79 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.433 1.083 . . . . 63.409999999999997 109.969 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -169.64 107.83 0.39 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 72.099999999999994 109.322 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.437 ' H ' HD12 ' A' ' 246' ' ' ILE . 1.9 mp -40.52 -38.68 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.487 1.117 . . . . 73.400000000000006 109.299 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -144.39 134.2 23.74 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.498 1.124 . . . . 74.430000000000007 109.274 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.97 161.69 28.7 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.522 1.139 . . . . 61.149999999999999 110.256 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.435 ' CD1' ' O ' ' A' ' 249' ' ' TYR . 11.2 p90 -52.36 125.52 16.36 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.459 1.1 . . . . 74.140000000000001 110.97 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.458 ' HB2' ' HZ2' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -82.15 118.71 23.28 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.447 1.092 . . . . 71.430000000000007 109.246 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.47 -75.27 0.29 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.548 1.155 . . . . 71.340000000000003 109.292 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 29.3 t -146.09 175.71 10.27 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.462 1.101 . . . . 72.239999999999995 109.987 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -149.65 117.95 6.44 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.52 1.138 . . . . 75.120000000000005 109.356 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 254' ' ' ILE . 14.5 mm -121.96 153.85 26.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.412 1.07 . . . . 74.340000000000003 109.27 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 5.4 p -156.24 129.59 8.17 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.503 1.127 . . . . 43.130000000000003 109.983 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.683 HD23 ' N ' ' A' ' 257' ' ' GLY . 1.8 tt -102.01 139.51 37.54 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.458 1.099 . . . . 74.129999999999995 109.28 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.683 ' N ' HD23 ' A' ' 256' ' ' LEU . . . -54.82 152.78 11.91 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.451 1.094 . . . . 52.420000000000002 111.005 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 69.1 m -83.19 141.51 31.87 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.424 0.72 . . . . 73.420000000000002 109.933 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 260' ' ' GLU . 11.3 t -88.55 167.17 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 124.427 1.079 . . . . 63.520000000000003 109.302 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' GLU . . . . . 0.438 ' N ' HG12 ' A' ' 259' ' ' VAL . 14.4 pt-20 . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 65.230000000000004 110.276 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 109.983 -0.377 . . . . 53.409999999999997 109.983 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 3.5 m -78.56 139.17 38.64 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.502 1.126 . . . . 50.32 109.982 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 63.3 m -68.48 -74.28 0.13 Allowed 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.513 1.133 . . . . 75.129999999999995 109.941 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -76.33 169.26 18.57 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.447 1.092 . . . . 75.140000000000001 109.375 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -127.15 111.78 14.39 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.411 1.069 . . . . 74.230000000000004 109.284 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -72.51 166.58 53.95 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 124.492 1.12 . . . . 64.25 111.01 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.14 -24.82 11.38 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.532 0.783 . . . . 71.129999999999995 109.291 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 470' ' ' PHE . . . . . 0.571 ' CE2' ' NZ ' ' A' ' 243' ' ' LYS . 6.3 m-30 -94.65 29.25 2.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 71.109999999999999 110.981 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 471' ' ' ILE . . . . . 0.468 ' CG2' ' HD2' ' B' ' 472' ' ' PRO . 7.8 mm -97.51 139.81 21.62 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.145 . . . . 72.209999999999994 109.297 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 472' ' ' PRO . . . . . 0.621 ' HD3' ' CD2' ' A' ' 188' ' ' HIS . 18.3 Cg_endo -75.03 146.74 32.91 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.5 1.789 . . . . 70.030000000000001 111.018 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 8.2 t -79.21 -59.8 2.63 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.547 1.154 . . . . 52.439999999999998 110.075 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -84.67 163.49 46.53 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.52 1.137 . . . . 72.099999999999994 110.311 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 -166.59 0.35 Allowed 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.435 1.755 . . . . 64.120000000000005 111.01 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 476' ' ' ALA . . . . . 0.93 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . -55.58 137.49 70.1 Favored Pre-proline 0 C--N 1.326 -0.417 0 O-C-N 124.489 1.118 . . . . 65.439999999999998 109.361 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 477' ' ' PRO . . . . . 0.574 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.2 Cg_endo -75.01 -162.28 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.484 1.781 . . . . 61.130000000000003 111.022 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.0 89.84 12.44 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.508 1.13 . . . . 75.420000000000002 109.29 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 479' ' ' PRO . . . . . 0.634 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.3 Cg_endo -74.92 161.29 39.2 Favored 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.523 1.801 . . . . 74.120000000000005 110.985 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -45.97 0.26 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.506 1.793 . . . . 74.140000000000001 111.035 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 481' ' ' SER . . . . . 0.508 ' HB2' ' CE1' ' A' ' 164' ' ' TYR . 3.1 m -126.76 108.83 11.4 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.582 1.176 . . . . 64.420000000000002 110.052 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 18.1 t -111.63 -18.98 12.66 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.527 1.142 . . . . 73.439999999999998 110.017 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -154.96 -178.67 7.4 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.527 1.142 . . . . 74.299999999999997 109.297 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 15.2 m -114.5 21.53 14.47 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.477 1.11 . . . . 65.439999999999998 109.952 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -122.52 153.01 39.78 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.565 1.165 . . . . 45.210000000000001 109.3 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 80.2 p . . . . . 0 C--N 1.324 -0.523 0 O-C-N 124.494 1.122 . . . . 54.219999999999999 110.04 179.989 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.716 ' CD1' ' CE2' ' A' ' 183' ' ' PHE . 3.2 m-85 . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 120.508 0.195 . . . . 73.099999999999994 111.007 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.515 ' CB ' ' CD1' ' A' ' 184' ' ' ILE . . . -128.51 160.96 30.71 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.514 1.134 . . . . 55.229999999999997 109.331 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.711 ' HB ' HD11 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -144.69 124.3 6.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 74.239999999999995 109.337 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.978 HG13 HD22 ' A' ' 182' ' ' LEU . 6.4 m -83.3 127.24 39.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.486 1.116 . . . . 65.420000000000002 109.301 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.497 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 0.4 OUTLIER -98.78 -2.95 36.74 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.465 1.103 . . . . 63.439999999999998 109.311 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.497 ' CE2' ' HB2' ' A' ' 163' ' ' LEU . 1.5 m-85 -152.4 158.16 42.26 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.474 1.108 . . . . 73.239999999999995 111.021 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.799 ' N ' HG12 ' A' ' 178' ' ' VAL . 15.5 t0 -100.41 144.18 29.71 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.435 1.084 . . . . 74.030000000000001 109.268 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.439 ' N ' ' OD1' ' A' ' 165' ' ' ASP . 14.1 t80 -141.21 129.93 22.88 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.495 1.122 . . . . 64.310000000000002 110.949 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -68.56 131.06 44.6 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.439 1.087 . . . . 74.310000000000002 109.311 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.939 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -109.45 138.9 45.13 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.439 1.087 . . . . 41.43 109.307 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -144.6 16.55 1.64 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.506 1.129 . . . . 62.020000000000003 110.304 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.446 ' N ' ' HB3' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -94.92 -176.07 3.74 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.585 1.178 . . . . 71.109999999999999 109.257 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.47 -30.83 70.85 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.455 1.097 . . . . 72.319999999999993 109.306 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.445 ' OD2' ' N ' ' A' ' 206' ' ' LEU . 0.8 OUTLIER -104.59 16.45 26.04 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.473 1.108 . . . . 65.239999999999995 109.329 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.939 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 6.4 pt-20 -36.51 108.36 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.501 1.126 . . . . 71.430000000000007 110.321 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.719 HD13 ' HA3' ' A' ' 205' ' ' GLY . 5.4 tp -119.42 110.41 16.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.447 1.092 . . . . 72.299999999999997 109.316 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 175' ' ' THR . 12.9 t -84.98 108.62 17.68 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.48 1.112 . . . . 70.25 110.391 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.405 HG23 ' N ' ' A' ' 177' ' ' TYR . 0.7 OUTLIER -118.7 178.07 4.61 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.597 1.186 . . . . 75.230000000000004 110.432 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.424 ' O ' ' CG2' ' A' ' 162' ' ' VAL . 12.4 m-85 -121.76 162.78 20.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.577 1.173 . . . . 73.5 111.038 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.799 HG12 ' N ' ' A' ' 165' ' ' ASP . 3.8 m -64.83 147.29 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.539 1.149 . . . . 70.010000000000005 109.244 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.419 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 53.28 62.1 6.31 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.548 1.155 . . . . 32.229999999999997 111.027 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.533 ' O ' HD13 ' A' ' 161' ' ' ILE . 1.8 tp10 -126.31 161.62 27.38 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.505 0.767 . . . . 63.009999999999998 110.331 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -101.75 141.15 35.05 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.451 1.094 . . . . 73.129999999999995 109.262 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.978 HD22 HG13 ' A' ' 162' ' ' VAL . 2.6 pt? -159.2 141.59 13.88 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.45 1.094 . . . . 74.129999999999995 109.283 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.716 ' CE2' ' CD1' ' A' ' 159' ' ' TYR . 6.5 m-85 -106.23 126.43 52.21 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.423 1.077 . . . . 70.530000000000001 110.985 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.663 HD12 ' HB2' ' A' ' 195' ' ' ALA . 0.8 OUTLIER -63.0 153.42 6.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 74.25 109.331 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 194' ' ' ILE . 2.6 m -135.21 -48.25 0.72 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.424 1.078 . . . . 73.209999999999994 108.302 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.882 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -129.91 170.28 14.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.511 1.132 . . . . 71.439999999999998 109.231 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.651 ' CD2' HD11 ' A' ' 236' ' ' LEU . 0.0 OUTLIER -150.36 147.45 27.61 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.413 1.071 . . . . 71.450000000000003 109.545 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.576 ' CE1' ' HB3' ' A' ' 192' ' ' TRP . 0.7 OUTLIER -152.61 138.83 18.35 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.592 1.183 . . . . 75.219999999999999 109.611 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.463 ' C ' ' N ' ' A' ' 191' ' ' GLU . 41.9 t30 53.28 22.4 2.7 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.446 1.091 . . . . 74.329999999999998 109.229 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.416 ' C ' ' O ' ' A' ' 189' ' ' ASN . 14.7 p 40.81 28.85 0.06 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.467 1.104 . . . . 53.119999999999997 108.271 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.659 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 7.8 tt0 -127.67 -40.4 1.75 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.409 1.068 . . . . 71.239999999999995 110.291 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.78 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 96.4 m95 -109.51 131.99 54.55 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.484 1.115 . . . . 75.019999999999996 108.002 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.781 ' CE2' HG12 ' A' ' 209' ' ' VAL . 20.8 m-30 -125.54 134.9 51.83 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.473 1.108 . . . . 64.340000000000003 110.972 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.882 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 5.7 mm -93.23 93.01 3.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.536 1.147 . . . . 75.409999999999997 109.282 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.663 ' HB2' HD12 ' A' ' 184' ' ' ILE . . . -97.07 -172.41 2.44 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.437 1.086 . . . . 63.340000000000003 109.381 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 197' ' ' PRO . 3.1 ttpp -154.77 141.44 13.27 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 124.572 1.17 . . . . 71.400000000000006 109.285 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 196' ' ' LYS . 18.2 Cg_endo . . . . . 0 C--N 1.361 1.215 0 O-C-N 124.547 1.814 . . . . 74.310000000000002 110.983 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.412 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . . . . . . 0 CA--C 1.53 1.01 0 N-CA-C 110.997 -0.841 . . . . 72.140000000000001 110.997 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.543 ' HG2' ' CE2' ' B' ' 470' ' ' PHE . 18.4 Cg_endo -74.99 123.77 9.42 Favored 'Cis proline' 0 C--N 1.361 1.21 0 C-N-CA 120.979 -2.509 . . . . 73.310000000000002 111.011 -0.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.719 ' HA3' HD13 ' A' ' 174' ' ' LEU . . . -97.72 148.99 19.11 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.566 1.166 . . . . 75.209999999999994 110.991 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.78 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -87.76 146.54 25.6 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.462 0.742 . . . . 73.140000000000001 109.324 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.808 HG21 HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -161.12 127.64 2.48 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.537 1.148 . . . . 73.420000000000002 109.321 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.635 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.4 Cg_endo -74.93 177.92 7.93 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.495 1.787 . . . . 63.219999999999999 110.991 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.781 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.4 m -96.94 5.08 9.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.54 1.15 . . . . 74.530000000000001 109.283 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . 0.497 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -108.05 0.35 33.58 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.455 1.097 . . . . 41.119999999999997 111.003 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.603 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 18.8 m-85 -131.66 8.61 4.56 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.509 0.77 . . . . 64.319999999999993 110.983 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.819 HG12 HG12 ' A' ' 162' ' ' VAL . 2.3 m -151.71 154.87 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.485 1.116 . . . . 72.430000000000007 109.293 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 39.9 t -123.9 147.07 47.98 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.504 1.127 . . . . 54.149999999999999 109.977 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.42 HG13 HG23 ' A' ' 227' ' ' VAL . 6.9 mm -90.87 129.33 41.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.531 1.144 . . . . 74.120000000000005 109.287 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.711 HD11 ' HB ' ' A' ' 161' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.457 0 O-C-N 124.573 1.17 . . . . 52.229999999999997 109.237 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 10.0 t0 . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 109.347 -0.612 . . . . 65.230000000000004 109.347 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.57 HG21 ' HE2' ' A' ' 193' ' ' PHE . 1.5 p -54.03 -40.36 45.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.135 . . . . 65.109999999999999 109.276 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.797 ' HA ' HD12 ' A' ' 231' ' ' ILE . 9.0 mt -69.39 -30.8 46.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.51 1.131 . . . . 63.009999999999998 109.31 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.492 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 8.9 mt-10 -78.97 -21.08 47.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.54 1.15 . . . . 64.230000000000004 110.292 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -88.79 -15.9 33.46 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.511 1.132 . . . . 72.340000000000003 109.312 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.797 HD12 ' HA ' ' A' ' 228' ' ' ILE . 6.5 mt -72.5 -69.8 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.529 1.143 . . . . 70.209999999999994 109.296 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.492 ' CD ' ' HA ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -49.15 -30.67 7.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.515 1.135 . . . . 64.109999999999999 109.288 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.424 ' N ' ' HG2' ' A' ' 232' ' ' LYS . 0.6 OUTLIER -48.14 -50.23 29.45 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 74.230000000000004 109.987 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 236' ' ' LEU . 1.3 m -90.95 -14.36 8.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.516 1.135 . . . . 50.350000000000001 109.239 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 57.58 48.63 13.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.433 1.083 . . . . 75.120000000000005 109.286 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.651 HD11 ' CD2' ' A' ' 187' ' ' HIS . 0.8 OUTLIER -71.29 142.93 87.51 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.507 1.129 . . . . 74.349999999999994 109.318 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.581 ' O ' HD12 ' A' ' 236' ' ' LEU . 18.3 Cg_endo -74.99 154.35 42.49 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.447 1.761 . . . . 71.120000000000005 110.997 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.433 HG22 ' H ' ' A' ' 239' ' ' VAL . 2.6 m -58.88 175.5 0.27 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.529 1.143 . . . . 74.430000000000007 110.458 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.569 HG23 ' CB ' ' A' ' 186' ' ' ALA . 7.2 p -76.81 -51.75 18.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 124.552 1.157 . . . . 71.540000000000006 109.295 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.515 ' N ' HG13 ' A' ' 239' ' ' VAL . 4.3 pm0 -71.04 -14.93 62.5 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 75.120000000000005 110.278 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -92.2 -44.73 8.62 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.464 1.102 . . . . 63.25 110.302 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.453 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 9.9 t90 -69.47 -53.4 19.39 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.548 1.155 . . . . 65.510000000000005 108.018 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.561 ' HD3' ' CD2' ' B' ' 470' ' ' PHE . 5.9 mtmp? -62.9 -23.06 67.17 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.54 1.15 . . . . 62.039999999999999 109.274 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.6 t . . . . . 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.133 . . . . 62.039999999999999 110.038 179.995 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 470' ' ' PHE . . . . . 0.561 ' CD2' ' HD3' ' A' ' 243' ' ' LYS . 8.8 m-30 . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 120.488 0.185 . . . . 74.540000000000006 111.0 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 471' ' ' ILE . . . . . 0.503 HG23 ' HD2' ' B' ' 472' ' ' PRO . 3.7 mm -70.31 140.18 87.57 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.516 1.135 . . . . 73.239999999999995 109.3 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 472' ' ' PRO . . . . . 0.569 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.2 Cg_endo -74.93 155.47 43.29 Favored 'Trans proline' 0 C--N 1.359 1.12 0 O-C-N 124.499 1.789 . . . . 70.439999999999998 111.055 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 38.7 t -97.49 -47.69 5.57 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.563 1.165 . . . . 73.519999999999996 110.062 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.86 165.4 17.99 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.537 1.148 . . . . 54.119999999999997 110.31 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 -166.81 0.37 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.458 1.767 . . . . 73.310000000000002 111.031 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 476' ' ' ALA . . . . . 0.659 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . -65.25 134.1 95.71 Favored Pre-proline 0 C--N 1.326 -0.427 0 O-C-N 124.382 1.051 . . . . 73.430000000000007 109.302 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 477' ' ' PRO . . . . . 0.576 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -74.94 -162.65 0.16 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.5 1.789 . . . . 74.299999999999997 110.996 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 478' ' ' LYS . . . . . 0.4 ' N ' ' HD3' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -133.42 90.89 28.21 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 64.219999999999999 109.28 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 479' ' ' PRO . . . . . 0.603 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.98 152.39 40.78 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.489 1.784 . . . . 74.209999999999994 111.0 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 480' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 479' ' ' PRO . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.141 0 O-C-N 124.552 1.817 . . . . 54.039999999999999 111.005 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.524 ' CE1' ' O ' ' A' ' 160' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.503 0.192 . . . . 71.5 110.966 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.857 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -119.89 148.28 43.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.464 1.102 . . . . 53.340000000000003 109.341 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.658 ' HB ' HD11 ' A' ' 215' ' ' ILE . 0.1 OUTLIER -127.78 132.28 69.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.468 1.105 . . . . 74.120000000000005 109.287 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.937 HG22 HG12 ' A' ' 212' ' ' VAL . 3.9 t -87.89 134.05 28.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.516 1.135 . . . . 65.140000000000001 109.336 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.619 HD21 HG23 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -117.97 -2.61 11.25 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.475 1.109 . . . . 73.129999999999995 109.361 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.502 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 16.9 m-85 -139.02 175.74 9.29 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.134 . . . . 71.430000000000007 110.995 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.431 ' CB ' ' HA ' ' A' ' 177' ' ' TYR . 6.5 p-10 -139.86 145.34 37.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.488 1.118 . . . . 73.120000000000005 109.332 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.66 ' HE2' ' HZ1' ' A' ' 170' ' ' LYS . 1.9 p90 -160.28 166.33 29.72 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.552 1.158 . . . . 75.019999999999996 111.057 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -100.03 130.92 46.24 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.537 1.148 . . . . 65.549999999999997 109.321 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.681 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -100.9 157.8 16.46 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 51.409999999999997 109.271 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -156.72 24.53 0.33 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.493 1.121 . . . . 73.239999999999995 110.26 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.66 ' HZ1' ' HE2' ' A' ' 166' ' ' PHE . 0.3 OUTLIER -99.54 -177.25 3.52 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.527 1.142 . . . . 73.319999999999993 109.25 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.94 -27.89 65.74 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.525 1.14 . . . . 60.130000000000003 109.348 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.434 ' HB3' ' CB ' ' A' ' 206' ' ' LEU . 9.2 t0 -112.29 22.2 14.97 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 75.299999999999997 109.315 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.681 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 10.4 pt-20 -36.92 111.63 0.16 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.472 1.108 . . . . 73.049999999999997 110.29 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.71 HD13 ' HA3' ' A' ' 205' ' ' GLY . 4.6 tp -132.02 109.68 10.2 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.457 1.098 . . . . 74.340000000000003 109.293 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.0 t -87.26 133.17 33.71 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.444 1.09 . . . . 71.099999999999994 110.412 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 19.8 m -141.73 165.29 27.88 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.497 1.123 . . . . 75.230000000000004 110.412 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.431 ' HA ' ' CB ' ' A' ' 165' ' ' ASP . 8.1 m-85 -111.07 164.12 13.16 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.44 1.087 . . . . 75.299999999999997 110.999 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 164' ' ' TYR . 2.1 m -61.84 158.46 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.586 1.178 . . . . 65.230000000000004 109.281 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 46.3 70.14 0.72 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.444 1.09 . . . . 70.129999999999995 111.018 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -131.94 174.59 10.01 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 0.773 . . . . 62.5 110.353 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.445 ' ND2' ' OH ' ' A' ' 159' ' ' TYR . 0.4 OUTLIER -118.23 136.23 53.79 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.54 1.15 . . . . 74.519999999999996 109.314 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.876 HD22 HG23 ' A' ' 162' ' ' VAL . 2.6 pt? -157.25 146.09 19.8 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.568 1.167 . . . . 63.240000000000002 109.242 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 7.7 m-85 -113.86 124.1 51.4 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.544 1.153 . . . . 73.400000000000006 110.955 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.857 HD13 ' HB2' ' A' ' 160' ' ' ALA . 1.7 mp -65.44 152.84 8.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.546 1.154 . . . . 72.219999999999999 109.261 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.549 ' O ' ' CZ3' ' A' ' 242' ' ' TRP . 0.1 OUTLIER -135.78 -47.26 0.67 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.467 1.105 . . . . 73.239999999999995 108.319 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.924 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -126.73 167.32 15.91 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.132 . . . . 73.409999999999997 109.313 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.487 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.2 OUTLIER -148.88 146.09 27.76 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.474 1.109 . . . . 71.099999999999994 109.598 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.6 ' CE1' ' CB ' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -149.8 141.81 23.9 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.503 1.127 . . . . 75.400000000000006 109.647 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.455 ' C ' ' N ' ' A' ' 191' ' ' GLU . 19.0 t-20 51.25 22.35 1.34 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.498 1.124 . . . . 75.239999999999995 109.287 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.402 ' C ' ' O ' ' A' ' 189' ' ' ASN . 53.8 m 41.57 28.33 0.08 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.549 1.155 . . . . 51.109999999999999 108.312 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.529 ' O ' HG13 ' A' ' 209' ' ' VAL . 6.8 tt0 -128.15 -41.1 1.61 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.416 1.073 . . . . 70.129999999999995 110.326 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.872 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 98.8 m95 -106.63 131.35 53.88 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.01 -1.107 . . . . 74.420000000000002 108.01 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.8 ' CE2' HG12 ' A' ' 209' ' ' VAL . 20.8 m-30 -125.41 130.47 51.94 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.476 1.11 . . . . 74.150000000000006 111.033 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.924 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 1.5 mp -89.5 96.41 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.563 1.164 . . . . 71.329999999999998 109.313 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -104.16 -174.56 2.57 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.579 1.175 . . . . 63.240000000000002 109.237 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 197' ' ' PRO . 1.1 tmtt? -150.48 141.24 14.58 Favored Pre-proline 0 C--N 1.326 -0.436 0 O-C-N 124.474 1.109 . . . . 74.439999999999998 109.274 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 196' ' ' LYS . 18.4 Cg_endo . . . . . 0 C--N 1.361 1.213 0 O-C-N 124.506 1.793 . . . . 74.109999999999999 110.972 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.418 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . . . . . . 0 CA--C 1.53 0.989 0 N-CA-C 111.039 -0.824 . . . . 51.119999999999997 111.039 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.544 ' HB2' HG23 ' A' ' 194' ' ' ILE . 18.4 Cg_endo -75.03 122.65 8.37 Favored 'Cis proline' 0 C--N 1.359 1.121 0 C-N-CA 121.031 -2.487 . . . . 60.43 111.002 0.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.71 ' HA3' HD13 ' A' ' 174' ' ' LEU . . . -98.19 153.17 19.96 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.449 1.093 . . . . 74.340000000000003 111.049 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.872 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -86.94 146.43 26.16 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.478 0.752 . . . . 71.319999999999993 109.271 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.747 HG21 HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -158.11 126.83 2.99 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.456 1.097 . . . . 74.099999999999994 109.287 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.595 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.3 Cg_endo -75.01 174.48 12.73 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.573 1.828 . . . . 62.340000000000003 110.999 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.8 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.2 m -93.11 4.76 7.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.541 1.151 . . . . 61.509999999999998 109.307 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . 0.446 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -109.01 4.64 31.92 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.494 1.121 . . . . 74.299999999999997 110.914 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.633 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 15.7 m-85 -134.12 8.6 3.76 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.473 0.749 . . . . 72.540000000000006 111.058 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.937 HG12 HG22 ' A' ' 162' ' ' VAL . 3.1 m -151.66 162.17 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.45 1.094 . . . . 71.049999999999997 109.345 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 3.6 t -128.42 133.43 48.57 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.529 1.143 . . . . 61.299999999999997 110.032 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.72 ' O ' HG23 ' A' ' 215' ' ' ILE . 2.7 mm -80.77 145.87 8.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.507 1.129 . . . . 74.420000000000002 109.196 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.72 HG23 ' O ' ' A' ' 214' ' ' ILE . 1.0 OUTLIER . . . . . 0 C--N 1.325 -0.457 0 O-C-N 124.449 1.093 . . . . 74.519999999999996 109.299 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 229' ' ' GLU . 25.6 t0 . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 109.333 -0.617 . . . . 63.299999999999997 109.333 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.634 HG13 HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -40.37 -55.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.463 1.102 . . . . 54.020000000000003 109.322 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.634 HD12 HG13 ' A' ' 227' ' ' VAL . 4.0 mp -55.9 -42.22 70.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.119 . . . . 70.140000000000001 109.315 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 226' ' ' ASP . 9.4 mt-10 -68.22 -14.59 63.09 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.455 1.097 . . . . 75.209999999999994 110.253 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -88.73 -18.91 26.83 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.528 1.142 . . . . 74.239999999999995 109.317 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.648 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.5 OUTLIER -68.34 -69.14 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.537 1.148 . . . . 62.25 109.24 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.648 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -59.84 -24.97 64.62 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.43 1.081 . . . . 74.140000000000001 109.226 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.51 -57.4 6.2 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.537 1.148 . . . . 60.119999999999997 109.991 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 234' ' ' VAL . 1.4 m -93.3 25.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.52 1.137 . . . . 70.420000000000002 109.24 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 3.4 m120 41.66 30.28 0.14 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.487 1.117 . . . . 72.310000000000002 109.292 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.563 HD12 ' HD2' ' A' ' 237' ' ' PRO . 7.9 tp -59.28 121.3 55.15 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.506 1.129 . . . . 61.109999999999999 109.334 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.563 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.3 Cg_endo -75.03 160.5 39.98 Favored 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.48 1.779 . . . . 50.200000000000003 111.029 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.516 HG22 ' H ' ' A' ' 239' ' ' VAL . 2.9 m -60.15 -179.35 0.1 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.5 1.125 . . . . 62.409999999999997 110.466 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.638 HG13 ' HG3' ' A' ' 240' ' ' GLN . 11.5 p -71.08 -34.42 54.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 54.119999999999997 109.329 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.638 ' HG3' HG13 ' A' ' 239' ' ' VAL . 2.4 mt-30 -85.32 -18.0 35.15 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.444 1.09 . . . . 55.130000000000003 110.302 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.413 ' HB2' ' N ' ' A' ' 238' ' ' THR . 34.1 mt-10 -84.84 -45.49 12.25 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.476 1.11 . . . . 75.219999999999999 110.293 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.549 ' CZ3' ' O ' ' A' ' 185' ' ' CYS . 7.5 t90 -67.77 -55.05 14.56 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.51 1.131 . . . . 74.120000000000005 107.962 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt -62.72 -18.39 62.45 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.522 1.138 . . . . 54.219999999999999 109.318 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.474 1.109 . . . . 54.210000000000001 110.059 179.967 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 470' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 120.536 0.208 . . . . 71.109999999999999 110.979 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 471' ' ' ILE . . . . . 0.705 HG23 ' HD2' ' B' ' 472' ' ' PRO . 20.0 mm -83.82 142.06 41.81 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.494 1.121 . . . . 75.230000000000004 109.25 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 472' ' ' PRO . . . . . 0.705 ' HD2' HG23 ' B' ' 471' ' ' ILE . 18.2 Cg_endo -75.02 -175.95 2.63 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.456 1.766 . . . . 44.439999999999998 110.988 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 42.7 t -126.7 6.87 6.78 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.484 1.115 . . . . 35.310000000000002 109.997 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -142.44 157.04 63.47 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.545 1.153 . . . . 71.530000000000001 110.294 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 475' ' ' PRO . . . . . 0.702 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.2 Cg_endo -75.06 -26.11 11.13 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.478 1.778 . . . . 75.319999999999993 111.002 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 476' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 163.1 140.1 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.489 1.118 . . . . 74.299999999999997 109.254 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 477' ' ' PRO . . . . . 0.574 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -75.02 -163.4 0.18 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.534 1.807 . . . . 73.329999999999998 111.041 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 478' ' ' LYS . . . . . 0.403 ' N ' ' HD3' ' B' ' 478' ' ' LYS . 0.1 OUTLIER -128.54 90.81 45.46 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.51 1.131 . . . . 65.209999999999994 109.277 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 479' ' ' PRO . . . . . 0.633 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.5 Cg_endo -74.96 147.16 33.72 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.512 1.796 . . . . 53.509999999999998 111.025 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 480' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' B' ' 479' ' ' PRO . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.166 0 O-C-N 124.511 1.795 . . . . 64.420000000000002 111.016 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.56 ' CD1' ' O ' ' A' ' 215' ' ' ILE . 9.6 p90 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.452 0.168 . . . . 73.420000000000002 110.957 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.437 ' CB ' HD11 ' A' ' 184' ' ' ILE . . . -115.98 152.73 32.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.558 1.161 . . . . 72.349999999999994 109.323 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.724 HD12 HD23 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -126.72 120.81 56.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 124.533 1.146 . . . . 43.399999999999999 109.298 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.781 HG22 HG12 ' A' ' 212' ' ' VAL . 2.5 t -74.42 121.67 26.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.544 1.152 . . . . 74.219999999999999 109.3 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.884 HD11 ' HB2' ' A' ' 213' ' ' SER . 0.4 OUTLIER -100.11 -12.32 19.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.578 1.174 . . . . 75.129999999999995 109.307 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.556 ' O ' HG13 ' A' ' 162' ' ' VAL . 0.9 OUTLIER -150.9 154.45 37.21 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.483 1.114 . . . . 73.400000000000006 111.046 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.661 ' N ' HG12 ' A' ' 178' ' ' VAL . 2.9 p30 -74.62 158.73 33.15 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.478 1.111 . . . . 74.329999999999998 109.231 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.488 ' HB2' ' CD1' ' A' ' 211' ' ' PHE . 8.8 t80 -154.51 130.69 10.34 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.527 1.142 . . . . 75.349999999999994 111.002 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -88.95 126.51 35.43 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.46 1.1 . . . . 74.25 109.26 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.798 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -113.64 151.14 32.16 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.518 1.136 . . . . 54.009999999999998 109.325 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.71 24.08 0.39 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.419 1.074 . . . . 74.109999999999999 110.275 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.471 ' HD3' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -100.87 -175.78 2.98 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.615 1.197 . . . . 60.130000000000003 109.287 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.18 -26.08 66.05 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.456 1.097 . . . . 71.140000000000001 109.344 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.456 ' HB3' ' CB ' ' A' ' 206' ' ' LEU . 60.4 m-20 -109.68 15.5 22.77 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.44 1.088 . . . . 71.409999999999997 109.268 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.798 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 17.7 pt-20 -36.1 110.01 0.1 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.439 1.087 . . . . 74.200000000000003 110.295 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.672 HD22 ' HA3' ' A' ' 205' ' ' GLY . 14.2 tp -128.93 103.91 7.29 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.546 1.154 . . . . 64.400000000000006 109.251 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.3 t -88.35 142.6 27.6 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.537 1.148 . . . . 53.149999999999999 110.368 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.464 ' CG2' ' HG2' ' A' ' 180' ' ' GLU . 17.0 m -155.16 162.89 40.85 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.533 1.146 . . . . 60.310000000000002 110.392 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -99.36 163.77 12.39 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.481 1.113 . . . . 74.120000000000005 111.027 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.661 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.6 m -57.72 158.16 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 71.040000000000006 109.29 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.424 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 49.88 68.19 1.5 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.51 1.131 . . . . 34.310000000000002 110.99 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.464 ' HG2' ' CG2' ' A' ' 176' ' ' THR . 3.8 tp10 -128.31 167.77 16.47 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.501 0.765 . . . . 74.510000000000005 110.262 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.45 132.65 53.5 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.429 1.08 . . . . 51.340000000000003 109.328 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.687 HD21 HG23 ' A' ' 162' ' ' VAL . 0.4 OUTLIER -143.25 158.03 43.98 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.495 1.122 . . . . 71.109999999999999 109.36 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 0.6 OUTLIER -114.55 113.09 23.95 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.483 1.115 . . . . 74.420000000000002 110.972 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.463 ' N ' HD12 ' A' ' 184' ' ' ILE . 1.7 mp -65.54 159.96 3.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 124.453 1.096 . . . . 62.299999999999997 109.312 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 186' ' ' ALA . 9.7 p -147.03 -44.39 0.18 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.583 1.177 . . . . 61.409999999999997 108.334 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.879 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -121.32 164.23 17.36 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.446 1.091 . . . . 74.549999999999997 109.32 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.416 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.2 OUTLIER -154.03 140.23 18.5 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.484 1.115 . . . . 60.299999999999997 109.602 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.681 ' NE2' HD11 ' A' ' 194' ' ' ILE . 0.1 OUTLIER -142.18 142.42 32.69 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.518 1.136 . . . . 74.120000000000005 109.577 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.48 ' C ' ' N ' ' A' ' 191' ' ' GLU . 19.2 t-20 50.62 22.1 1.02 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.469 1.105 . . . . 73.140000000000001 109.321 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.4 ' C ' ' O ' ' A' ' 189' ' ' ASN . 23.5 m 42.0 27.23 0.07 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.574 1.171 . . . . 54.119999999999997 108.245 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.524 ' O ' HG13 ' A' ' 209' ' ' VAL . 9.3 tt0 -125.11 -37.1 2.45 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.479 1.112 . . . . 64.430000000000007 110.293 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.821 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 97.2 m95 -109.78 128.77 55.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.505 1.128 . . . . 72.140000000000001 107.96 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.603 ' CE2' HG12 ' A' ' 209' ' ' VAL . 20.9 m-30 -122.18 127.04 49.56 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.488 1.118 . . . . 70.329999999999998 110.958 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.879 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 9.3 mm -89.23 106.34 16.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.493 1.12 . . . . 74.219999999999999 109.288 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -117.01 175.77 5.43 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.128 . . . . 72.549999999999997 109.333 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -147.56 165.56 18.42 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.442 1.089 . . . . 60.149999999999999 109.303 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--N 1.359 1.128 0 O-C-N 124.517 1.799 . . . . 71.439999999999998 110.96 -179.986 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.011 0 N-CA-C 110.959 -0.856 . . . . 54.329999999999998 110.959 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.524 ' HB2' HG22 ' A' ' 194' ' ' ILE . 18.3 Cg_endo -74.94 129.05 17.59 Favored 'Cis proline' 0 C--N 1.362 1.248 0 C-N-CA 121.011 -2.495 . . . . 65.329999999999998 111.053 -0.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.672 ' HA3' HD22 ' A' ' 174' ' ' LEU . . . -92.63 163.31 27.19 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.519 1.137 . . . . 40.43 110.963 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.821 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -97.62 145.41 26.31 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.496 0.762 . . . . 71.040000000000006 109.326 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.562 HG11 HD11 ' A' ' 182' ' ' LEU . 0.4 OUTLIER -153.61 127.35 4.37 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.583 1.177 . . . . 64.549999999999997 109.344 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.611 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.2 Cg_endo -75.09 174.52 12.65 Favored 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.505 1.792 . . . . 74.200000000000003 110.995 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.603 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.6 m -97.03 7.01 8.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.484 1.115 . . . . 63.210000000000001 109.267 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . 0.457 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -106.93 -0.9 36.22 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.506 1.129 . . . . 44.5 110.948 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.572 ' CE2' ' HB3' ' B' ' 479' ' ' PRO . 12.7 m-85 -133.27 15.53 4.14 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.556 0.798 . . . . 71.209999999999994 111.046 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.781 HG12 HG22 ' A' ' 162' ' ' VAL . 3.4 m -152.62 157.66 4.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.548 1.155 . . . . 73.439999999999998 109.36 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.884 ' HB2' HD11 ' A' ' 163' ' ' LEU . 46.6 t -128.23 119.94 26.2 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.527 1.142 . . . . 61.25 110.056 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.631 ' C ' HG22 ' A' ' 215' ' ' ILE . 5.1 mm -64.48 153.22 7.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.495 1.122 . . . . 74.230000000000004 109.245 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.631 HG22 ' C ' ' A' ' 214' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.577 1.173 . . . . 73.010000000000005 109.309 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 230' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.366 -0.605 . . . . 75.430000000000007 109.366 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.454 HG21 ' HE2' ' A' ' 193' ' ' PHE . 1.3 p -49.11 -41.12 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.536 1.147 . . . . 72.109999999999999 109.283 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.761 ' HA ' HD12 ' A' ' 231' ' ' ILE . 12.3 mt -66.9 -33.94 66.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.586 1.178 . . . . 72.230000000000004 109.315 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -81.75 -17.52 47.43 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.425 1.078 . . . . 72.239999999999995 110.289 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 226' ' ' ASP . 6.5 t70 -88.7 -15.73 34.09 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.532 1.145 . . . . 72.219999999999999 109.278 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.761 HD12 ' HA ' ' A' ' 228' ' ' ILE . 6.7 mt -71.03 -69.44 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.459 1.099 . . . . 63.229999999999997 109.356 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.435 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -56.86 -21.19 27.48 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.468 1.105 . . . . 74.439999999999998 109.281 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.4 m -56.79 -17.92 10.92 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 72.450000000000003 110.019 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 234' ' ' VAL . 1.2 m -133.14 22.27 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.508 1.13 . . . . 70.200000000000003 109.284 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 40.75 37.22 0.47 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.618 1.199 . . . . 73.140000000000001 109.333 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.468 ' HB2' ' CG2' ' A' ' 234' ' ' VAL . 5.7 tp -66.16 119.63 63.36 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.424 1.078 . . . . 72.040000000000006 109.285 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 166.95 28.13 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.478 1.778 . . . . 74.540000000000006 111.018 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.6 m -68.43 173.58 4.81 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.446 1.091 . . . . 54.119999999999997 110.416 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.719 HG23 ' HB1' ' A' ' 186' ' ' ALA . 14.9 p -69.04 -49.02 66.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.473 1.108 . . . . 44.43 109.347 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 1.015 ' OE1' HD11 ' B' ' 471' ' ' ILE . 7.7 pm0 -73.04 -14.53 61.43 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.117 . . . . 71.239999999999995 110.292 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -90.53 -36.33 14.55 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.543 1.152 . . . . 62.439999999999998 110.313 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.583 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 1.3 t90 -80.48 -54.88 5.28 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.513 1.133 . . . . 73.540000000000006 107.997 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.504 ' HD3' ' CE2' ' B' ' 470' ' ' PHE . 3.0 mtmp? -57.85 -17.3 15.37 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.53 1.144 . . . . 65.219999999999999 109.22 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 243' ' ' LYS . 17.1 m . . . . . 0 C--N 1.324 -0.536 0 O-C-N 124.502 1.126 . . . . 62.32 109.947 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 470' ' ' PHE . . . . . 0.683 ' CD2' HG21 ' A' ' 194' ' ' ILE . 4.9 m-30 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.461 0.172 . . . . 72.019999999999996 110.987 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 471' ' ' ILE . . . . . 1.015 HD11 ' OE1' ' A' ' 240' ' ' GLN . 1.4 mp -70.51 142.98 89.66 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.48 1.112 . . . . 74.540000000000006 109.259 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 472' ' ' PRO . . . . . 0.574 ' HG3' ' CD1' ' A' ' 192' ' ' TRP . 18.5 Cg_endo -74.92 161.53 38.81 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.513 1.796 . . . . 63.0 111.01 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 473' ' ' SER . . . . . 0.44 ' OG ' ' CZ ' ' B' ' 474' ' ' ARG . 29.6 t -98.72 -27.42 13.97 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.532 1.145 . . . . 61.450000000000003 109.989 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 474' ' ' ARG . . . . . 0.44 ' CZ ' ' OG ' ' B' ' 473' ' ' SER . 2.6 mmt180 -111.08 170.38 5.33 Favored Pre-proline 0 C--N 1.326 -0.428 0 O-C-N 124.527 1.142 . . . . 71.120000000000005 110.316 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -168.48 0.52 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.48 1.779 . . . . 74.239999999999995 110.974 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 476' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' B' ' 477' ' ' PRO . . . -73.28 134.93 79.71 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 52.439999999999998 109.296 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 477' ' ' PRO . . . . . 0.566 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -75.0 170.79 19.64 Favored 'Trans proline' 0 C--N 1.358 1.077 0 O-C-N 124.505 1.792 . . . . 63.299999999999997 111.027 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -113.11 95.27 34.11 Favored Pre-proline 0 C--N 1.324 -0.54 0 O-C-N 124.509 1.131 . . . . 61.100000000000001 109.284 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 479' ' ' PRO . . . . . 0.572 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 18.1 Cg_endo -74.99 168.62 24.43 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.483 1.781 . . . . 74.219999999999999 110.974 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 C--N 1.36 1.181 0 O-C-N 124.498 1.789 . . . . 73.409999999999997 110.977 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.559 ' CE1' ' HB2' ' A' ' 183' ' ' PHE . 1.2 t80 . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.461 0.172 . . . . 73.349999999999994 111.009 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.594 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -113.72 142.48 45.98 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.546 1.154 . . . . 74.329999999999998 109.289 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.71 HD13 ' N ' ' A' ' 162' ' ' VAL . 0.0 OUTLIER -127.78 121.59 56.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.485 1.116 . . . . 74.439999999999998 109.302 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.879 ' CG1' HD21 ' A' ' 182' ' ' LEU . 7.0 m -83.47 126.88 40.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.442 1.089 . . . . 64.010000000000005 109.325 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.661 HD23 HD12 ' A' ' 161' ' ' ILE . 0.3 OUTLIER -99.6 -1.95 36.85 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.499 1.125 . . . . 72.219999999999999 109.305 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.533 ' CE2' ' HB2' ' A' ' 163' ' ' LEU . 0.9 OUTLIER -154.69 155.57 34.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.486 1.116 . . . . 74.340000000000003 111.071 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.781 ' N ' HG12 ' A' ' 178' ' ' VAL . 33.0 p-10 -96.49 154.03 17.5 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.465 1.103 . . . . 65.239999999999995 109.314 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.535 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 3.4 t80 -147.23 137.94 23.58 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.49 1.119 . . . . 73.230000000000004 111.019 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.535 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 5.9 mtmt -76.56 128.96 35.74 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.499 1.124 . . . . 74.319999999999993 109.292 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.957 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -110.86 141.99 43.5 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.46 1.1 . . . . 73.120000000000005 109.286 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -148.22 18.87 1.09 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.506 1.129 . . . . 72.120000000000005 110.266 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.455 ' O ' ' CG ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -100.25 -176.49 3.24 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.48 1.113 . . . . 71.420000000000002 109.306 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.06 -30.73 69.4 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.472 1.108 . . . . 52.420000000000002 109.29 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.478 ' CB ' ' HB2' ' A' ' 206' ' ' LEU . 1.0 OUTLIER -101.96 12.06 37.52 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.489 1.118 . . . . 72.319999999999993 109.307 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.957 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 8.5 pt-20 -33.75 105.57 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.529 1.143 . . . . 64.430000000000007 110.264 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.706 HD13 ' HA3' ' A' ' 205' ' ' GLY . 13.2 tp -119.46 107.12 12.94 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.484 1.115 . . . . 55.229999999999997 109.339 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.645 HG23 ' O ' ' A' ' 175' ' ' THR . 14.4 t -85.44 99.14 11.0 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.518 1.136 . . . . 53.009999999999998 110.419 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.46 176.08 5.28 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.545 1.153 . . . . 60.340000000000003 110.344 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -120.77 159.97 24.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.614 1.196 . . . . 54.109999999999999 110.962 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.781 HG12 ' N ' ' A' ' 165' ' ' ASP . 3.5 m -62.0 146.65 12.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.421 1.076 . . . . 63.130000000000003 109.259 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.42 66.14 3.05 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.503 1.127 . . . . 54.530000000000001 111.014 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.499 ' CB ' HG22 ' A' ' 162' ' ' VAL . 1.8 tp10 -132.73 169.27 16.93 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.473 0.749 . . . . 64.319999999999993 110.278 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -117.43 146.77 43.24 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.438 1.086 . . . . 72.200000000000003 109.299 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.879 HD21 ' CG1' ' A' ' 162' ' ' VAL . 0.2 OUTLIER -159.23 152.19 22.02 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 72.140000000000001 109.392 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.559 ' HB2' ' CE1' ' A' ' 159' ' ' TYR . 14.9 t80 -108.65 119.67 40.2 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.468 1.105 . . . . 71.129999999999995 111.044 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 160' ' ' ALA . 1.6 mp -64.82 155.95 6.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.411 1.069 . . . . 74.019999999999996 109.275 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.455 ' N ' ' O ' ' A' ' 194' ' ' ILE . 0.2 OUTLIER -138.66 -51.09 0.56 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.52 1.137 . . . . 75.030000000000001 108.341 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.972 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -120.73 166.29 13.92 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.506 1.129 . . . . 64.239999999999995 109.333 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.487 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.1 OUTLIER -151.37 141.37 22.08 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.41 1.068 . . . . 62.420000000000002 109.638 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.72 ' NE2' HD13 ' A' ' 194' ' ' ILE . 0.1 OUTLIER -143.2 141.0 30.98 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.421 1.076 . . . . 72.200000000000003 109.623 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.486 ' C ' ' N ' ' A' ' 191' ' ' GLU . 39.1 t-20 48.13 25.68 0.87 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.498 1.124 . . . . 74.439999999999998 109.251 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.437 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.9 p 39.02 30.19 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.519 1.137 . . . . 63.32 108.308 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.507 ' O ' HG13 ' A' ' 209' ' ' VAL . 8.6 tt0 -125.78 -37.92 2.26 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.504 1.128 . . . . 74.299999999999997 110.362 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.636 ' HB3' HD11 ' A' ' 206' ' ' LEU . 97.1 m95 -112.09 132.24 54.97 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.97 -1.122 . . . . 73.129999999999995 107.97 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.761 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.3 m-30 -125.12 129.31 49.93 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.541 1.151 . . . . 60.520000000000003 111.033 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.972 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 1.1 mp -91.27 98.12 8.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.541 1.15 . . . . 74.430000000000007 109.317 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -104.14 -175.73 2.88 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.541 1.151 . . . . 71.340000000000003 109.301 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.493 ' CD ' ' O ' ' A' ' 197' ' ' PRO . 0.0 OUTLIER -157.12 158.68 31.2 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 63.140000000000001 109.286 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.493 ' O ' ' CD ' ' A' ' 196' ' ' LYS . 18.2 Cg_endo . . . . . 0 C--N 1.359 1.126 0 O-C-N 124.524 1.802 . . . . 74.349999999999994 111.024 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.434 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.531 1.066 0 N-CA-C 110.99 -0.844 . . . . 51.399999999999999 110.99 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.565 ' HG2' ' CZ ' ' B' ' 470' ' ' PHE . 18.2 Cg_endo -75.05 133.25 30.59 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 121.008 -2.497 . . . . 74.409999999999997 110.925 0.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.706 ' HA3' HD13 ' A' ' 174' ' ' LEU . . . -100.44 151.03 18.98 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.478 1.111 . . . . 63.520000000000003 110.925 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.684 HD12 ' CD1' ' A' ' 194' ' ' ILE . 0.4 OUTLIER -90.45 144.2 26.03 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.539 0.788 . . . . 73.329999999999998 109.283 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.66 HG13 HD23 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -157.13 127.81 3.54 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.511 1.132 . . . . 73.239999999999995 109.288 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.442 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.4 Cg_endo -74.89 179.44 6.05 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.508 1.794 . . . . 63.0 111.041 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.761 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.0 OUTLIER -98.66 4.41 10.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.596 1.185 . . . . 73.129999999999995 109.274 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . 0.489 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -106.43 0.96 37.17 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 124.491 1.119 . . . . 73.120000000000005 110.964 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.614 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 6.9 m-85 -130.26 6.58 4.92 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.58 0.812 . . . . 74.510000000000005 110.978 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.788 HG12 HG12 ' A' ' 162' ' ' VAL . 1.5 m -150.88 153.82 9.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.473 1.108 . . . . 72.019999999999996 109.33 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.4 m -121.64 138.88 54.15 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.502 1.127 . . . . 55.210000000000001 110.025 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.645 ' O ' HG23 ' A' ' 215' ' ' ILE . 3.8 mm -87.46 124.07 40.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 124.489 1.118 . . . . 75.200000000000003 109.268 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 214' ' ' ILE . 10.8 pt . . . . . 0 C--N 1.325 -0.467 0 O-C-N 124.469 1.106 . . . . 75.219999999999999 109.304 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 229' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 109.318 -0.623 . . . . 53.200000000000003 109.318 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.536 HG21 ' HE2' ' A' ' 193' ' ' PHE . 3.7 p -48.28 -49.17 12.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.116 . . . . 70.299999999999997 109.318 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.51 ' O ' ' CE ' ' A' ' 232' ' ' LYS . 3.2 mp -59.11 -29.62 41.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.428 1.08 . . . . 61.009999999999998 109.319 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 226' ' ' ASP . 15.5 mt-10 -81.41 -15.0 56.49 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.485 1.115 . . . . 73.230000000000004 110.281 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -86.64 -15.76 38.7 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.499 1.125 . . . . 71.120000000000005 109.337 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.603 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.9 OUTLIER -72.71 -69.34 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 71.430000000000007 109.279 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.603 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -62.17 -17.55 58.34 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.51 1.131 . . . . 73.219999999999999 109.301 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.33 -39.61 60.85 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.504 1.127 . . . . 63.210000000000001 110.011 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 234' ' ' VAL . 1.6 m -117.17 27.43 3.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.532 1.145 . . . . 74.140000000000001 109.3 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 234' ' ' VAL . 6.8 m120 40.6 37.42 0.47 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.137 . . . . 73.329999999999998 109.222 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.417 ' HB2' ' CG2' ' A' ' 234' ' ' VAL . 3.8 tp -70.58 119.82 74.97 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.555 1.159 . . . . 73.109999999999999 109.268 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.4 ' HB2' ' CB ' ' A' ' 241' ' ' GLU . 18.3 Cg_endo -74.96 165.36 31.51 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.459 1.768 . . . . 74.25 111.004 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 239' ' ' VAL . 1.4 m -60.27 -177.65 0.07 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.507 1.129 . . . . 72.340000000000003 110.396 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.629 HG23 ' HB1' ' A' ' 186' ' ' ALA . 9.8 p -72.21 -35.06 51.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 50.420000000000002 109.35 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.567 ' HG3' HG13 ' A' ' 239' ' ' VAL . 0.5 OUTLIER -85.52 -17.56 36.03 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.455 1.097 . . . . 74.239999999999995 110.278 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.42 ' HB2' ' N ' ' A' ' 238' ' ' THR . 7.3 mm-40 -85.15 -42.08 15.08 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.465 1.103 . . . . 71.349999999999994 110.364 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.445 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 6.5 t90 -72.65 -60.47 2.22 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.039 -1.097 . . . . 74.310000000000002 108.039 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.564 ' HD3' ' CD2' ' B' ' 470' ' ' PHE . 4.1 mtmp? -57.41 -20.49 30.2 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.483 1.114 . . . . 63.43 109.322 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.435 0 O-C-N 124.512 1.132 . . . . 55.25 110.091 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 470' ' ' PHE . . . . . 0.582 ' HB3' HG21 ' A' ' 239' ' ' VAL . 4.0 m-30 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.496 0.188 . . . . 72.230000000000004 111.001 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 471' ' ' ILE . . . . . 0.472 HG23 ' HD2' ' B' ' 472' ' ' PRO . 0.9 OUTLIER -100.59 138.91 20.24 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.46 1.1 . . . . 71.209999999999994 109.279 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 472' ' ' PRO . . . . . 0.625 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.99 -45.6 0.27 Allowed 'Trans proline' 0 C--N 1.359 1.117 0 O-C-N 124.502 1.791 . . . . 71.329999999999998 111.033 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 473' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' B' ' 472' ' ' PRO . 0.1 OUTLIER 80.36 5.7 1.68 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.481 1.113 . . . . 74.439999999999998 110.027 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -132.01 157.26 78.72 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.565 1.165 . . . . 73.200000000000003 110.325 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 475' ' ' PRO . . . . . 0.7 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.0 Cg_endo -75.03 -48.09 0.18 Allowed 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.531 1.806 . . . . 52.219999999999999 110.971 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 476' ' ' ALA . . . . . 0.7 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 162.94 136.64 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.522 1.139 . . . . 75.519999999999996 109.322 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 477' ' ' PRO . . . . . 0.554 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.8 Cg_endo -74.89 -177.35 3.38 Favored 'Trans proline' 0 C--N 1.359 1.115 0 O-C-N 124.484 1.781 . . . . 63.030000000000001 111.069 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.54 92.29 28.05 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 61.299999999999997 109.317 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 479' ' ' PRO . . . . . 0.614 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.2 Cg_endo -75.01 151.53 39.58 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.489 1.784 . . . . 53.549999999999997 110.968 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 480' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 479' ' ' PRO . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.144 0 O-C-N 124.533 1.807 . . . . 74.219999999999999 111.006 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.65 ' CD2' ' CG1' ' A' ' 215' ' ' ILE . 2.5 t80 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.544 0.211 . . . . 62.009999999999998 110.975 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.6 ' O ' ' CE1' ' A' ' 159' ' ' TYR . . . -110.71 147.67 33.89 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.52 1.138 . . . . 73.420000000000002 109.305 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.609 HD13 ' N ' ' A' ' 162' ' ' VAL . 0.1 OUTLIER -129.45 131.2 67.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.484 1.115 . . . . 65.209999999999994 109.38 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.941 HG22 HG12 ' A' ' 212' ' ' VAL . 1.5 t -88.73 125.61 41.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.462 1.101 . . . . 71.129999999999995 109.307 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.549 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 1.7 mt -101.11 -13.34 18.22 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.502 1.126 . . . . 74.239999999999995 109.296 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.567 ' O ' HG13 ' A' ' 162' ' ' VAL . 1.5 m-85 -148.27 156.26 42.33 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.471 1.107 . . . . 61.439999999999998 111.041 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.475 ' H ' HG12 ' A' ' 178' ' ' VAL . 5.6 p-10 -105.95 160.57 15.17 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.55 1.156 . . . . 63.310000000000002 109.295 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.566 ' HB3' ' CE1' ' A' ' 211' ' ' PHE . 0.3 OUTLIER -159.7 164.51 33.9 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.492 1.12 . . . . 72.450000000000003 110.979 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -89.84 130.77 36.03 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.513 1.133 . . . . 72.200000000000003 109.256 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.799 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -104.42 141.65 35.97 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.448 1.092 . . . . 51.409999999999997 109.315 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.8 ' H ' ' HZ3' ' A' ' 170' ' ' LYS . 7.7 pt-20 -151.91 21.68 0.68 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.461 1.101 . . . . 73.430000000000007 110.303 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.8 ' HZ3' ' H ' ' A' ' 169' ' ' GLU . 0.1 OUTLIER -98.12 -175.93 3.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.524 1.14 . . . . 75.109999999999999 109.338 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.12 -29.79 65.8 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.434 1.083 . . . . 54.25 109.328 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 173' ' ' GLU . 3.2 m-20 -110.08 22.81 15.14 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.53 1.143 . . . . 61.340000000000003 109.263 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.799 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 6.2 pt-20 -38.16 106.14 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.475 1.11 . . . . 75.230000000000004 110.322 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.712 HD13 ' CA ' ' A' ' 205' ' ' GLY . 0.6 OUTLIER -126.82 120.93 30.5 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.491 1.12 . . . . 62.109999999999999 109.34 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 11.9 t -87.65 118.49 27.17 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.558 1.162 . . . . 74.209999999999994 110.359 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.532 HG21 HG21 ' A' ' 162' ' ' VAL . 0.6 OUTLIER -120.45 175.52 5.94 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.52 1.138 . . . . 75.319999999999993 110.363 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -127.77 152.9 47.19 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 74.120000000000005 111.052 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 165' ' ' ASP . 3.1 m -51.44 155.05 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 60.340000000000003 109.318 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 44.3 74.09 0.23 Allowed Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.519 1.137 . . . . 75.420000000000002 110.985 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -132.24 162.19 31.58 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.431 0.724 . . . . 54.329999999999998 110.347 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.16 120.54 40.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.529 1.143 . . . . 75.120000000000005 109.292 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.943 HD12 HG21 ' A' ' 207' ' ' VAL . 1.2 pt? -136.46 143.83 44.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.504 1.127 . . . . 32.109999999999999 109.32 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 41.7 t80 -104.85 111.24 23.92 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.465 1.103 . . . . 53.229999999999997 111.014 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.995 HD13 ' HB2' ' A' ' 195' ' ' ALA . 19.0 mm -54.42 164.83 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.523 1.139 . . . . 53.210000000000001 109.313 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.466 ' N ' ' CG2' ' A' ' 184' ' ' ILE . 0.1 OUTLIER -151.84 -45.91 0.11 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.498 1.124 . . . . 70.409999999999997 108.344 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.881 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -125.66 174.54 8.22 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.501 1.126 . . . . 71.140000000000001 109.344 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.619 ' C ' ' CD2' ' A' ' 188' ' ' HIS . 0.9 OUTLIER -155.02 154.02 31.86 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 71.319999999999993 109.639 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 1.115 ' CE1' HG11 ' A' ' 239' ' ' VAL . 0.1 OUTLIER -144.11 120.93 11.25 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.51 1.131 . . . . 73.409999999999997 109.535 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.453 ' C ' ' N ' ' A' ' 191' ' ' GLU . 55.4 t30 52.05 32.72 10.73 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.455 1.097 . . . . 51.329999999999998 109.345 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.404 ' CB ' HG12 ' A' ' 228' ' ' ILE . 9.6 m 41.67 29.24 0.1 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.511 1.132 . . . . 64.340000000000003 108.316 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.659 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 16.8 tt0 -120.92 -38.55 2.82 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.469 1.106 . . . . 75.430000000000007 110.294 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.714 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 90.2 m95 -113.26 137.61 51.22 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.538 1.149 . . . . 62.409999999999997 108.009 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.894 ' HB3' HD12 ' A' ' 184' ' ' ILE . 22.4 m-30 -125.83 135.63 52.19 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.469 1.106 . . . . 73.209999999999994 111.032 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.881 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 6.3 mm -100.74 95.63 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 71.129999999999995 109.261 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.995 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -99.09 -179.72 4.34 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.516 1.135 . . . . 62.149999999999999 109.269 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.453 ' CG ' ' C ' ' A' ' 195' ' ' ALA . 10.2 mtpt -151.1 162.98 25.21 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.447 1.092 . . . . 71.450000000000003 109.333 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 C--N 1.36 1.137 0 O-C-N 124.493 1.786 . . . . 74.299999999999997 110.967 -179.982 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.441 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.529 0.956 0 N-CA-C 111.062 -0.815 . . . . 51.130000000000003 111.062 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.486 ' HB2' HG22 ' A' ' 194' ' ' ILE . 18.5 Cg_endo -74.97 129.01 17.49 Favored 'Cis proline' 0 C--N 1.359 1.112 0 C-N-CA 120.949 -2.521 . . . . 74.450000000000003 111.024 -0.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.712 ' CA ' HD13 ' A' ' 174' ' ' LEU . . . -96.34 141.93 15.87 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.514 1.134 . . . . 75.040000000000006 111.025 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.714 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -91.2 147.21 23.21 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.552 0.795 . . . . 72.040000000000006 109.295 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.943 HG21 HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -161.06 129.14 2.85 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.542 1.152 . . . . 51.119999999999997 109.336 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.889 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.2 Cg_endo -75.03 179.91 5.64 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.565 1.824 . . . . 70.030000000000001 110.927 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.791 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.6 OUTLIER -96.12 3.32 9.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 124.443 1.089 . . . . 65.129999999999995 109.306 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -103.89 -5.93 43.75 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.487 1.117 . . . . 55.119999999999997 111.033 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.619 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 5.2 m-85 -125.98 1.76 7.29 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.505 0.767 . . . . 61.549999999999997 110.983 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.941 HG12 HG22 ' A' ' 162' ' ' VAL . 3.5 m -141.28 167.76 16.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.574 1.171 . . . . 72.329999999999998 109.306 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.521 ' OG ' HD21 ' A' ' 163' ' ' LEU . 13.1 p -136.2 132.98 36.62 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.445 1.091 . . . . 55.140000000000001 109.997 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.496 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 2.9 mm -76.4 144.68 11.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.475 1.109 . . . . 71.510000000000005 109.277 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.65 ' CG1' ' CD2' ' A' ' 159' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.428 0 O-C-N 124.459 1.1 . . . . 62.219999999999999 109.31 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 229' ' ' GLU . 14.0 t0 . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 109.211 -0.663 . . . . 75.219999999999999 109.211 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.408 ' H ' HG12 ' A' ' 227' ' ' VAL . 0.2 OUTLIER -39.85 -56.27 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.45 1.094 . . . . 75.209999999999994 109.282 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.404 HG12 ' CB ' ' A' ' 190' ' ' CYS . 9.9 mt -55.94 -42.46 71.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.499 1.125 . . . . 74.109999999999999 109.274 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 226' ' ' ASP . 21.2 mt-10 -66.45 -14.16 61.81 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.506 1.129 . . . . 55.5 110.329 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.569 ' O ' HG13 ' A' ' 234' ' ' VAL . 33.7 t0 -88.67 -23.27 23.05 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.564 1.165 . . . . 72.299999999999997 109.299 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.61 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.6 OUTLIER -63.66 -69.4 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.483 1.114 . . . . 63.539999999999999 109.323 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.61 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -55.85 -30.58 61.71 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.44 1.088 . . . . 75.420000000000002 109.3 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.4 m -52.94 -50.63 63.63 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 44.130000000000003 109.954 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 230' ' ' ASP . 1.3 m -89.88 16.08 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.471 1.107 . . . . 53.32 109.26 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 234' ' ' VAL . 37.7 t30 40.56 44.53 1.78 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.516 1.135 . . . . 70.230000000000004 109.296 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.45 HD12 ' HD2' ' A' ' 237' ' ' PRO . 1.1 tp -83.02 119.74 74.79 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.457 1.098 . . . . 74.129999999999995 109.307 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.45 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.4 Cg_endo -75.01 164.37 33.48 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.52 1.8 . . . . 42.329999999999998 111.023 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.613 HG22 ' H ' ' A' ' 239' ' ' VAL . 3.4 m -58.81 -175.72 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.484 1.115 . . . . 63.350000000000001 110.364 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 1.115 HG11 ' CE1' ' A' ' 188' ' ' HIS . 2.6 p -74.17 -36.27 43.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.5 1.125 . . . . 74.25 109.333 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.536 ' HG3' HG13 ' A' ' 239' ' ' VAL . 5.3 mt-30 -82.65 -17.88 43.04 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.492 1.12 . . . . 74.25 110.315 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.405 ' CB ' ' HB2' ' A' ' 237' ' ' PRO . 16.3 mt-10 -87.07 -38.54 16.42 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.531 1.144 . . . . 71.420000000000002 110.299 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.433 ' CH2' ' HB3' ' A' ' 185' ' ' CYS . 6.1 t90 -78.35 -61.33 2.04 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.531 1.144 . . . . 74.109999999999999 108.001 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 9.3 mtmt -53.92 -20.53 6.2 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.428 1.08 . . . . 70.120000000000005 109.3 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 C--N 1.324 -0.504 0 O-C-N 124.542 1.152 . . . . 75.049999999999997 109.993 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 470' ' ' PHE . . . . . 0.447 ' CE2' ' HG2' ' A' ' 204' ' ' PRO . 5.2 m-30 . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.52 0.2 . . . . 74.239999999999995 111.009 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 471' ' ' ILE . . . . . 0.514 HG22 ' HD2' ' B' ' 472' ' ' PRO . 2.8 mm -84.82 140.32 37.67 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.491 1.12 . . . . 64.519999999999996 109.353 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 472' ' ' PRO . . . . . 0.514 ' HD2' HG22 ' B' ' 471' ' ' ILE . 18.4 Cg_endo -74.92 130.28 13.22 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.528 1.804 . . . . 73.420000000000002 111.04 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 46.3 t -78.54 -73.06 0.34 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.456 1.098 . . . . 21.219999999999999 109.981 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -65.1 160.03 60.22 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.523 1.139 . . . . 54.530000000000001 110.311 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 -167.27 0.41 Allowed 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.461 1.769 . . . . 51.329999999999998 110.994 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 476' ' ' ALA . . . . . 0.659 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . -62.86 138.81 97.19 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.496 1.122 . . . . 53.219999999999999 109.281 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 477' ' ' PRO . . . . . 0.581 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -75.04 -162.43 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.491 1.785 . . . . 72.439999999999998 111.029 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 478' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -136.18 90.75 17.76 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.479 1.112 . . . . 72.209999999999994 109.278 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 479' ' ' PRO . . . . . 0.619 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.92 168.41 24.9 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.428 1.752 . . . . 61.350000000000001 110.973 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo . . . . . 0 C--N 1.36 1.174 0 O-C-N 124.565 1.824 . . . . 74.540000000000006 111.106 179.902 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 5.1 p90 . . . . . 0 N--CA 1.454 -0.25 0 CA-C-O 120.562 0.22 . . . . 72.450000000000003 110.973 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.904 ' O ' HD12 ' A' ' 182' ' ' LEU . . . -108.82 147.7 31.69 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.485 1.115 . . . . 73.140000000000001 109.305 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.595 HD13 ' N ' ' A' ' 162' ' ' VAL . 0.1 OUTLIER -120.82 135.14 61.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.509 1.131 . . . . 62.32 109.262 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.853 HG22 HG12 ' A' ' 212' ' ' VAL . 2.3 t -93.32 121.01 43.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.455 1.097 . . . . 55.43 109.305 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.56 HD21 HG23 ' A' ' 161' ' ' ILE . 0.4 OUTLIER -101.44 -11.5 19.3 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.503 1.127 . . . . 55.350000000000001 109.295 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.657 ' O ' HG13 ' A' ' 162' ' ' VAL . 3.3 m-85 -144.6 160.29 41.41 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 73.329999999999998 111.003 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.762 ' N ' HG12 ' A' ' 178' ' ' VAL . 21.7 p30 -107.95 157.71 17.98 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.554 1.159 . . . . 75.200000000000003 109.305 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.599 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 1.2 t80 -160.45 136.43 8.44 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.436 1.085 . . . . 70.439999999999998 111.012 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.599 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 12.0 mtpp -67.37 122.69 18.47 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.448 1.093 . . . . 74.400000000000006 109.313 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.83 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -90.62 140.12 30.06 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.585 1.178 . . . . 62.200000000000003 109.3 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -152.19 21.69 0.65 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.508 1.13 . . . . 74.129999999999995 110.283 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.473 ' HD3' ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -98.72 -176.66 3.42 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.505 1.128 . . . . 65.400000000000006 109.335 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' B' ' 471' ' ' ILE . . . -59.93 -24.87 64.7 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.462 1.101 . . . . 73.310000000000002 109.326 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 173' ' ' GLU . 59.7 t0 -113.68 20.44 15.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.458 1.099 . . . . 62.530000000000001 109.281 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.83 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 5.1 pt-20 -36.82 100.51 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 1.104 . . . . 72.450000000000003 110.352 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.485 ' HG ' ' CA ' ' A' ' 205' ' ' GLY . 0.1 OUTLIER -132.03 96.2 3.85 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.499 1.124 . . . . 73.299999999999997 109.344 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.6 t -59.55 148.82 31.93 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.483 1.115 . . . . 63.340000000000003 110.416 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 14.4 m -155.9 117.04 3.87 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.559 1.162 . . . . 71.209999999999994 110.435 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -63.94 157.58 24.53 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.512 1.132 . . . . 73.040000000000006 110.975 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.762 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.5 m -58.24 158.19 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.557 1.16 . . . . 63.200000000000003 109.249 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.424 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 52.54 62.54 5.71 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.479 1.112 . . . . 63.340000000000003 110.998 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -120.2 170.91 8.89 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.514 0.773 . . . . 74.430000000000007 110.244 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -129.17 117.56 20.98 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.552 1.157 . . . . 60.130000000000003 109.325 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.913 ' CD2' HG11 ' A' ' 207' ' ' VAL . 0.2 OUTLIER -130.58 149.71 52.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.538 1.149 . . . . 54.210000000000001 109.315 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -104.13 104.34 14.26 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.531 1.145 . . . . 72.519999999999996 111.002 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.737 HD12 ' HB2' ' A' ' 160' ' ' ALA . 22.1 mt -68.56 158.46 5.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.468 1.105 . . . . 74.400000000000006 109.354 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.603 ' SG ' ' CZ3' ' A' ' 242' ' ' TRP . 27.0 t -152.16 -41.59 0.11 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.522 1.139 . . . . 73.340000000000003 108.332 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.989 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -112.22 155.58 23.77 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.547 1.155 . . . . 73.439999999999998 109.297 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.572 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.1 OUTLIER -148.33 145.04 27.95 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.497 1.123 . . . . 74.200000000000003 109.649 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.582 ' NE2' HD11 ' A' ' 194' ' ' ILE . 0.1 OUTLIER -143.55 141.41 30.68 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.525 1.141 . . . . 63.409999999999997 109.603 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.462 ' C ' ' N ' ' A' ' 191' ' ' GLU . 3.1 m120 49.44 23.34 0.86 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.46 1.1 . . . . 72.129999999999995 109.261 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.408 ' C ' ' O ' ' A' ' 189' ' ' ASN . 18.1 m 41.22 28.88 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.117 . . . . 72.5 108.293 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.485 ' O ' HG13 ' A' ' 209' ' ' VAL . 8.5 tt0 -126.59 -38.58 2.07 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.575 1.172 . . . . 74.140000000000001 110.299 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.878 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 98.8 m95 -111.55 128.48 56.04 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.527 1.142 . . . . 64.430000000000007 108.058 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.776 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.1 m-30 -120.11 126.2 50.14 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.489 1.118 . . . . 74.439999999999998 111.001 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.989 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 5.6 mm -86.63 104.36 13.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.53 1.144 . . . . 72.420000000000002 109.262 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.58 ' HB2' ' CG1' ' A' ' 184' ' ' ILE . . . -112.92 175.85 5.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.498 1.124 . . . . 61.409999999999997 109.263 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.474 ' CG ' ' HD2' ' A' ' 197' ' ' PRO . 2.3 ttmp? -137.99 142.66 36.7 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.131 . . . . 63.32 109.323 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.474 ' HD2' ' CG ' ' A' ' 196' ' ' LYS . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.173 0 O-C-N 124.512 1.796 . . . . 73.420000000000002 110.993 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.969 0 N-CA-C 111.008 -0.837 . . . . 75.209999999999994 111.008 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.444 ' HD2' ' CZ ' ' B' ' 470' ' ' PHE . 18.4 Cg_endo -74.96 146.11 85.78 Favored 'Cis proline' 0 C--N 1.36 1.182 0 C-N-CA 121.028 -2.488 . . . . 74.0 111.009 -0.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 195' ' ' ALA . . . -104.7 138.56 14.22 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.494 1.121 . . . . 41.32 110.986 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.878 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -83.37 146.76 28.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.574 0.808 . . . . 73.439999999999998 109.384 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.913 HG11 ' CD2' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -153.36 127.01 4.31 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.458 1.099 . . . . 61.439999999999998 109.288 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.943 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.4 Cg_endo -74.92 174.9 11.96 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.455 1.766 . . . . 75.450000000000003 111.002 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.776 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -93.49 4.81 7.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.537 1.148 . . . . 73.340000000000003 109.297 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . 0.495 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -104.72 -8.3 37.47 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.5 1.125 . . . . 62.119999999999997 111.024 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.622 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 15.8 m-85 -125.53 -0.8 7.5 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.497 0.763 . . . . 75.140000000000001 111.002 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.943 HG22 ' O ' ' A' ' 208' ' ' PRO . 2.5 m -139.63 162.15 26.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.503 1.127 . . . . 64.329999999999998 109.267 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.6 t -134.72 133.56 40.09 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 55.32 109.967 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.782 ' O ' HG23 ' A' ' 215' ' ' ILE . 2.9 mm -76.85 127.72 37.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.506 1.129 . . . . 74.540000000000006 109.28 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.782 HG23 ' O ' ' A' ' 214' ' ' ILE . 5.3 pt . . . . . 0 C--N 1.326 -0.435 0 O-C-N 124.544 1.153 . . . . 72.409999999999997 109.241 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 229' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 109.329 -0.619 . . . . 75.319999999999993 109.329 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -40.38 -45.73 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.439 1.087 . . . . 72.099999999999994 109.349 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.753 ' HA ' HD12 ' A' ' 231' ' ' ILE . 7.8 mt -65.27 -46.53 90.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.5 1.125 . . . . 64.239999999999995 109.275 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.473 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 11.6 mt-10 -64.95 -17.19 64.17 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.566 1.166 . . . . 71.409999999999997 110.338 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.66 -16.44 32.38 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.453 1.095 . . . . 62.549999999999997 109.347 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.753 HD12 ' HA ' ' A' ' 228' ' ' ILE . 3.6 mt -76.1 -70.11 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 124.523 1.139 . . . . 72.219999999999999 109.323 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.473 ' CD ' ' HA ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -59.67 -26.79 65.83 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.555 1.16 . . . . 63.240000000000002 109.236 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.11 -48.1 12.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.474 1.108 . . . . 71.109999999999999 110.01 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.1 m -98.02 -15.85 7.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.483 1.115 . . . . 64.549999999999997 109.282 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 64.97 49.57 2.07 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 1.135 . . . . 43.340000000000003 109.316 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 237' ' ' PRO . 0.5 OUTLIER -71.08 146.75 93.08 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.457 1.098 . . . . 75.329999999999998 109.319 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.664 ' O ' HD12 ' A' ' 236' ' ' LEU . 18.6 Cg_endo -74.95 141.59 26.97 Favored 'Trans proline' 0 C--N 1.359 1.096 0 O-C-N 124.526 1.803 . . . . 74.239999999999995 110.995 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.1 m -58.36 176.38 0.18 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.431 1.082 . . . . 75.430000000000007 110.478 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.558 HG13 ' HG3' ' A' ' 240' ' ' GLN . 9.9 p -72.09 -33.84 48.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.524 1.14 . . . . 51.310000000000002 109.311 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.558 ' HG3' HG13 ' A' ' 239' ' ' VAL . 0.3 OUTLIER -85.58 -17.03 37.43 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.479 1.112 . . . . 72.329999999999998 110.243 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -87.05 -43.78 12.06 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.494 1.121 . . . . 75.209999999999994 110.336 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.618 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 0.5 OUTLIER -72.08 -60.73 2.09 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.988 -1.116 . . . . 72.430000000000007 107.988 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.495 ' NZ ' ' CG2' ' A' ' 239' ' ' VAL . 4.8 mtmm -54.79 -20.62 8.95 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.498 1.124 . . . . 51.350000000000001 109.29 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 C--N 1.325 -0.476 0 O-C-N 124.564 1.165 . . . . 64.239999999999995 110.03 179.951 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 470' ' ' PHE . . . . . 0.444 ' CZ ' ' HD2' ' A' ' 204' ' ' PRO . 43.1 m-85 . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.472 0.177 . . . . 74.120000000000005 110.993 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 471' ' ' ILE . . . . . 0.707 ' O ' ' HB3' ' A' ' 171' ' ' ALA . 26.4 mm -41.82 142.44 1.1 Allowed Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.505 1.128 . . . . 64.409999999999997 109.333 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 472' ' ' PRO . . . . . 0.698 ' HD2' HG23 ' B' ' 471' ' ' ILE . 18.4 Cg_endo -74.91 173.38 14.57 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.473 1.775 . . . . 55.210000000000001 111.073 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.91 -46.02 2.94 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.473 1.108 . . . . 64.030000000000001 110.014 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 39.3 mtp85 -87.14 158.49 52.56 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.567 1.167 . . . . 71.329999999999998 110.3 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 475' ' ' PRO . . . . . 0.686 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.3 Cg_endo -75.05 -30.94 6.57 Favored 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.469 1.773 . . . . 75.340000000000003 110.982 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 476' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 163.38 129.57 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.506 1.129 . . . . 63.119999999999997 109.281 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 477' ' ' PRO . . . . . 0.562 ' HG3' ' CE2' ' A' ' 166' ' ' PHE . 18.1 Cg_endo -75.02 -176.59 2.96 Favored 'Trans proline' 0 C--N 1.361 1.2 0 O-C-N 124.515 1.797 . . . . 64.340000000000003 110.985 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 478' ' ' LYS . . . . . 0.463 ' O ' ' CD ' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -116.46 95.11 44.86 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.536 1.148 . . . . 63.140000000000001 109.35 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 479' ' ' PRO . . . . . 0.622 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.99 150.11 37.69 Favored 'Trans proline' 0 C--N 1.359 1.105 0 O-C-N 124.563 1.823 . . . . 72.329999999999998 111.023 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 480' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 479' ' ' PRO . 18.3 Cg_endo . . . . . 0 C--N 1.361 1.195 0 O-C-N 124.447 1.762 . . . . 72.019999999999996 111.009 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 2.6 p90 . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.514 0.197 . . . . 74.409999999999997 110.998 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.569 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -130.42 153.22 48.98 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.511 1.132 . . . . 71.019999999999996 109.304 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.912 ' HB ' HD11 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -123.89 125.45 71.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.532 1.145 . . . . 74.120000000000005 109.265 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.937 HG22 HG12 ' A' ' 212' ' ' VAL . 1.9 t -80.51 122.45 35.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.559 1.162 . . . . 72.329999999999998 109.284 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 213' ' ' SER . 0.6 OUTLIER -98.19 -13.74 20.71 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.519 1.137 . . . . 71.420000000000002 109.287 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.666 ' O ' HG13 ' A' ' 162' ' ' VAL . 1.7 m-85 -146.21 157.71 43.84 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.567 1.167 . . . . 75.340000000000003 111.042 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.782 ' N ' HG12 ' A' ' 178' ' ' VAL . 0.0 OUTLIER -98.04 158.25 15.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.527 1.142 . . . . 71.349999999999994 109.27 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.491 ' CE1' ' HB3' ' B' ' 477' ' ' PRO . 40.5 t80 -145.5 158.9 43.77 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.559 1.162 . . . . 63.420000000000002 111.051 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -94.34 127.87 40.5 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.459 1.099 . . . . 73.120000000000005 109.288 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.885 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -93.19 142.06 27.73 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.465 1.103 . . . . 63.439999999999998 109.329 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -157.87 24.64 0.27 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.503 1.127 . . . . 71.219999999999999 110.314 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.528 ' NZ ' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -122.41 -175.36 3.12 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.531 1.145 . . . . 75.010000000000005 109.362 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.14 -40.99 82.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.439 1.087 . . . . 71.040000000000006 109.325 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 174' ' ' LEU . 3.0 m-20 -85.86 10.99 12.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.54 1.15 . . . . 64.019999999999996 109.3 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.885 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 5.4 pt-20 -36.34 96.56 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.432 1.083 . . . . 74.140000000000001 110.354 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.692 HD12 ' HA3' ' A' ' 205' ' ' GLY . 1.2 tm? -136.98 94.93 3.02 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.517 1.136 . . . . 31.129999999999999 109.296 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.431 ' C ' ' HG1' ' A' ' 176' ' ' THR . 9.0 t -59.53 153.36 19.8 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.563 1.164 . . . . 62.109999999999999 110.471 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.431 ' HG1' ' C ' ' A' ' 175' ' ' THR . 24.3 m -152.21 141.93 21.89 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.481 1.113 . . . . 74.349999999999994 110.374 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -88.37 153.33 21.27 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.408 1.068 . . . . 74.049999999999997 111.06 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.782 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.4 m -59.21 158.3 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.438 1.086 . . . . 64.530000000000001 109.299 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 48.81 66.98 1.87 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.455 1.097 . . . . 74.409999999999997 110.988 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.525 ' O ' HD13 ' A' ' 161' ' ' ILE . 1.9 tt0 -131.15 171.76 12.9 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.552 0.795 . . . . 75.340000000000003 110.235 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -123.4 130.65 53.02 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.478 1.112 . . . . 74.5 109.318 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.759 HD23 ' N ' ' A' ' 182' ' ' LEU . 0.6 OUTLIER -146.82 143.27 28.49 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.431 1.082 . . . . 72.549999999999997 109.341 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 73.4 t80 -100.57 117.99 35.83 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.537 1.148 . . . . 74.030000000000001 111.031 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.569 HD13 ' HB2' ' A' ' 160' ' ' ALA . 1.6 mp -62.69 151.99 7.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.41 1.068 . . . . 75.530000000000001 109.243 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.573 ' O ' ' CZ3' ' A' ' 242' ' ' TRP . 0.9 OUTLIER -136.03 -47.87 0.66 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.569 1.168 . . . . 55.130000000000003 108.26 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.944 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -122.25 168.86 11.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.504 1.127 . . . . 65.120000000000005 109.279 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.625 ' C ' ' CD2' ' A' ' 188' ' ' HIS . 2.9 p80 -146.67 153.88 40.8 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.443 1.089 . . . . 71.340000000000003 109.592 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 1.056 ' CE1' HG11 ' A' ' 239' ' ' VAL . 0.1 OUTLIER -143.92 120.75 11.26 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.471 1.107 . . . . 75.129999999999995 109.555 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.473 ' C ' ' N ' ' A' ' 191' ' ' GLU . 86.1 m-20 50.85 35.21 11.76 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.526 1.141 . . . . 73.430000000000007 109.352 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.421 ' C ' ' O ' ' A' ' 189' ' ' ASN . 60.9 m 39.77 30.75 0.06 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.553 1.158 . . . . 61.020000000000003 108.254 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.571 ' O ' HG13 ' A' ' 209' ' ' VAL . 11.4 tt0 -122.25 -42.16 2.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.546 1.154 . . . . 72.430000000000007 110.279 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.665 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 95.4 m95 -110.41 136.88 48.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.982 -1.118 . . . . 73.239999999999995 107.982 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.843 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.1 m-30 -127.52 124.41 38.18 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.507 1.13 . . . . 74.030000000000001 110.964 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.944 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 1.4 mp -87.61 97.02 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 70.540000000000006 109.317 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -101.99 -179.88 4.13 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.472 1.108 . . . . 55.439999999999998 109.295 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.9 ptmt -155.16 167.27 14.42 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.548 1.155 . . . . 75.439999999999998 109.303 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo . . . . . 0 C--N 1.36 1.16 0 O-C-N 124.412 1.743 . . . . 44.130000000000003 111.044 -180.0 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.964 0 N-CA-C 110.995 -0.842 . . . . 54.0 110.995 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.438 ' HG2' ' CZ ' ' B' ' 470' ' ' PHE . 18.2 Cg_endo -74.97 142.83 75.93 Favored 'Cis proline' 0 C--N 1.36 1.152 0 C-N-CA 121.012 -2.495 . . . . 62.130000000000003 111.006 0.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.692 ' HA3' HD12 ' A' ' 174' ' ' LEU . . . -106.07 148.1 16.39 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.538 1.149 . . . . 44.109999999999999 110.976 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.665 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -88.61 145.83 25.46 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.511 0.771 . . . . 72.439999999999998 109.325 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.789 ' HB ' HG11 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -156.02 126.26 3.36 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.544 1.153 . . . . 64.5 109.295 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.89 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.2 Cg_endo -74.98 179.59 5.93 Favored 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.489 1.784 . . . . 61.140000000000001 110.926 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.843 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -96.93 6.59 8.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.479 1.112 . . . . 72.299999999999997 109.327 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . 0.49 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -108.32 -4.86 32.74 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.551 1.157 . . . . 74.230000000000004 110.972 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.617 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 8.1 m-85 -127.44 1.59 6.28 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.518 0.775 . . . . 75.239999999999995 111.017 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.937 HG12 HG22 ' A' ' 162' ' ' VAL . 3.4 m -139.62 153.78 23.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.56 1.162 . . . . 74.340000000000003 109.329 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.605 ' HB3' HD11 ' A' ' 163' ' ' LEU . 1.0 OUTLIER -121.17 124.3 44.38 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.633 1.208 . . . . 71.319999999999993 110.039 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.835 ' O ' HG23 ' A' ' 215' ' ' ILE . 2.9 mm -68.32 145.03 13.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.13 . . . . 74.150000000000006 109.284 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.912 HD11 ' HB ' ' A' ' 161' ' ' ILE . 5.5 pt . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.539 1.149 . . . . 73.150000000000006 109.254 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 230' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.315 -0.624 . . . . 60.43 109.315 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.513 HG13 ' H ' ' A' ' 228' ' ' ILE . 4.2 p -47.85 -56.56 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.459 1.1 . . . . 70.310000000000002 109.258 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.513 ' H ' HG13 ' A' ' 227' ' ' VAL . 3.4 mt -57.1 -32.09 39.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.124 . . . . 63.200000000000003 109.375 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.431 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 5.4 mt-10 -80.89 -14.54 57.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.571 1.169 . . . . 73.439999999999998 110.312 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 226' ' ' ASP . 0.7 OUTLIER -88.49 -17.9 29.34 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.475 1.109 . . . . 64.230000000000004 109.314 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.629 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.5 OUTLIER -69.28 -69.2 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.508 1.13 . . . . 72.439999999999998 109.34 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.629 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -57.91 -20.73 39.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.563 1.164 . . . . 71.239999999999995 109.302 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.6 t -50.86 -57.93 7.25 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.54 1.15 . . . . 63.439999999999998 110.012 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.5 m -90.8 17.74 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.527 1.142 . . . . 73.420000000000002 109.346 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 47.53 34.85 3.74 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.506 1.129 . . . . 71.319999999999993 109.259 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.14 119.05 73.58 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.526 1.141 . . . . 72.439999999999998 109.287 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.13 167.2 27.44 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.5 1.789 . . . . 53.109999999999999 110.976 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.518 ' HA ' ' CD2' ' A' ' 187' ' ' HIS . 2.7 m -59.24 178.25 0.14 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.453 1.096 . . . . 71.400000000000006 110.383 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 1.056 HG11 ' CE1' ' A' ' 188' ' ' HIS . 0.2 OUTLIER -58.77 -67.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.133 . . . . 63.32 109.25 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.878 ' OE1' HD11 ' B' ' 471' ' ' ILE . 0.3 OUTLIER -63.91 -22.32 66.87 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.569 1.168 . . . . 74.420000000000002 110.339 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.449 ' HB2' ' N ' ' A' ' 238' ' ' THR . 4.1 mm-40 -75.85 -33.45 60.02 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.464 1.102 . . . . 75.219999999999999 110.246 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.573 ' CZ3' ' O ' ' A' ' 185' ' ' CYS . 2.6 t90 -85.28 -60.36 2.06 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.137 . . . . 63.130000000000003 108.007 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.427 ' NZ ' ' CG ' ' B' ' 470' ' ' PHE . 22.1 mtmt -56.18 -18.7 10.91 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.53 1.144 . . . . 71.010000000000005 109.308 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.145 . . . . 74.109999999999999 109.969 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 470' ' ' PHE . . . . . 0.651 ' CD2' HG21 ' A' ' 194' ' ' ILE . 3.3 m-85 . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 120.548 0.213 . . . . 74.430000000000007 110.938 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 471' ' ' ILE . . . . . 0.878 HD11 ' OE1' ' A' ' 240' ' ' GLN . 1.4 mp -75.17 136.8 72.35 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.451 1.094 . . . . 72.340000000000003 109.331 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 472' ' ' PRO . . . . . 0.432 ' HD3' ' ND1' ' A' ' 188' ' ' HIS . 18.3 Cg_endo -75.04 -162.66 0.16 Allowed 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.409 1.741 . . . . 52.109999999999999 110.977 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 6.2 t -133.08 -52.76 0.9 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.469 1.106 . . . . 61.409999999999997 109.958 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 31.9 mtt-85 -81.05 156.18 72.18 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.485 1.116 . . . . 74.329999999999998 110.27 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 475' ' ' PRO . . . . . 0.679 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.4 Cg_endo -75.05 -30.64 6.88 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.425 1.75 . . . . 73.010000000000005 110.982 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 476' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 163.42 131.6 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.538 1.149 . . . . 70.439999999999998 109.301 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 477' ' ' PRO . . . . . 0.577 ' HD3' ' CH2' ' A' ' 192' ' ' TRP . 18.6 Cg_endo -74.94 -163.31 0.18 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.553 1.817 . . . . 61.420000000000002 111.012 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 478' ' ' LYS . . . . . 0.496 ' O ' ' CD ' ' B' ' 478' ' ' LYS . 0.3 OUTLIER -124.97 94.99 42.94 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 74.310000000000002 109.329 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 479' ' ' PRO . . . . . 0.617 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.5 Cg_endo -74.94 155.38 43.23 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.462 1.77 . . . . 72.310000000000002 111.066 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 480' ' ' PRO . . . . . 0.441 ' HG2' ' CD1' ' A' ' 164' ' ' TYR . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.164 0 O-C-N 124.459 1.768 . . . . 53.310000000000002 110.996 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.789 ' CD1' ' CE2' ' A' ' 183' ' ' PHE . 1.4 m-85 . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 120.457 0.17 . . . . 62.509999999999998 110.997 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.887 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -114.64 149.57 36.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.537 1.148 . . . . 63.100000000000001 109.302 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.53 HD13 ' O ' ' A' ' 180' ' ' GLU . 0.2 OUTLIER -131.4 127.85 60.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 74.329999999999998 109.273 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.802 HG22 HG12 ' A' ' 212' ' ' VAL . 1.9 t -80.48 121.19 33.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.556 1.16 . . . . 62.109999999999999 109.333 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.894 HD11 ' HB2' ' A' ' 213' ' ' SER . 0.9 OUTLIER -96.24 -14.48 22.64 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 62.140000000000001 109.361 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.691 ' O ' HG13 ' A' ' 162' ' ' VAL . 3.0 m-85 -146.9 159.23 43.79 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.48 1.113 . . . . 74.450000000000003 110.954 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.614 ' N ' HG12 ' A' ' 178' ' ' VAL . 10.4 p-10 -101.1 159.45 15.22 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.566 1.166 . . . . 73.409999999999997 109.347 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.54 ' HB2' ' CE1' ' A' ' 211' ' ' PHE . 9.0 t80 -158.33 135.71 10.17 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.433 1.083 . . . . 72.25 110.908 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -68.78 132.34 46.64 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.144 . . . . 55.240000000000002 109.337 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.926 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -112.98 141.82 46.39 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.539 1.149 . . . . 71.120000000000005 109.311 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -150.42 20.37 0.84 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.51 1.131 . . . . 73.450000000000003 110.346 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.478 ' NZ ' ' CH2' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -96.42 -176.57 3.67 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.496 1.123 . . . . 64.239999999999995 109.26 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.41 -20.63 63.29 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.501 1.126 . . . . 52.409999999999997 109.319 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.454 ' HB3' ' CB ' ' A' ' 206' ' ' LEU . 7.1 t0 -117.11 18.88 14.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.493 1.121 . . . . 71.439999999999998 109.307 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.926 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 6.5 pt-20 -36.52 106.44 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.483 1.114 . . . . 71.420000000000002 110.28 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.693 HD22 ' HA3' ' A' ' 205' ' ' GLY . 15.8 tp -116.55 105.94 13.01 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.422 1.076 . . . . 55.130000000000003 109.307 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 175' ' ' THR . 9.7 t -87.22 110.02 19.88 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.437 1.086 . . . . 74.140000000000001 110.367 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.466 ' CG2' ' HG2' ' A' ' 180' ' ' GLU . 87.8 m -130.97 169.98 15.09 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.581 1.176 . . . . 72.450000000000003 110.386 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.432 ' N ' HG22 ' A' ' 176' ' ' THR . 15.0 m-85 -112.41 161.95 16.12 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.458 1.099 . . . . 72.439999999999998 111.015 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.614 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.7 m -55.4 158.16 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 44.509999999999998 109.3 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.44 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 50.24 68.55 1.38 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.462 1.101 . . . . 72.420000000000002 111.013 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.53 ' O ' HD13 ' A' ' 161' ' ' ILE . 5.2 tp10 -126.48 164.79 20.39 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 124.547 0.792 . . . . 62.229999999999997 110.322 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -113.42 129.21 56.59 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.507 1.13 . . . . 74.510000000000005 109.256 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.836 HD12 HG21 ' A' ' 207' ' ' VAL . 0.4 OUTLIER -152.48 146.95 25.68 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.498 1.124 . . . . 54.439999999999998 109.274 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.789 ' CE2' ' CD1' ' A' ' 159' ' ' TYR . 3.8 m-85 -111.92 120.35 41.61 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.464 1.103 . . . . 72.409999999999997 111.021 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.887 HD13 ' HB2' ' A' ' 160' ' ' ALA . 1.7 mp -71.02 152.11 8.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.485 1.115 . . . . 75.030000000000001 109.281 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.483 ' SG ' HG22 ' A' ' 194' ' ' ILE . 15.5 p -142.25 -44.15 0.33 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.508 1.13 . . . . 73.549999999999997 108.327 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.994 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -116.19 159.1 22.27 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.49 1.119 . . . . 75.030000000000001 109.303 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.558 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -147.85 148.93 31.4 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.463 1.102 . . . . 54.43 109.639 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.621 ' CD2' ' O ' ' A' ' 192' ' ' TRP . 0.5 OUTLIER -152.44 143.96 23.42 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.492 1.12 . . . . 74.030000000000001 109.584 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.473 ' C ' ' N ' ' A' ' 191' ' ' GLU . 27.3 t-20 51.11 22.88 1.38 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.547 1.154 . . . . 63.009999999999998 109.34 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.441 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.5 p 39.03 30.19 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.531 1.145 . . . . 52.009999999999998 108.292 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.526 ' O ' HG13 ' A' ' 209' ' ' VAL . 9.9 tt0 -131.31 -40.15 1.14 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.438 1.086 . . . . 71.319999999999993 110.307 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.835 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 96.4 m95 -107.33 131.72 53.92 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.035 -1.098 . . . . 65.239999999999995 108.035 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.776 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.4 m-30 -125.59 133.06 52.4 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.597 1.185 . . . . 61.119999999999997 111.048 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.994 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 0.7 OUTLIER -93.3 105.67 17.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.522 1.139 . . . . 55.409999999999997 109.289 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -109.13 176.73 4.99 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.392 1.057 . . . . 75.230000000000004 109.306 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.5 pttm -149.47 168.76 10.34 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.593 1.183 . . . . 52.340000000000003 109.362 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo . . . . . 0 C--N 1.36 1.135 0 O-C-N 124.528 1.804 . . . . 54.109999999999999 110.981 179.996 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.408 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.53 1.008 0 N-CA-C 111.035 -0.826 . . . . 74.150000000000006 111.035 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.408 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.1 Cg_endo -75.06 136.75 46.62 Favored 'Cis proline' 0 C--N 1.36 1.14 0 C-N-CA 121.002 -2.499 . . . . 61.539999999999999 111.0 0.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.693 ' HA3' HD22 ' A' ' 174' ' ' LEU . . . -99.72 156.74 19.77 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.529 1.143 . . . . 52.43 110.955 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.835 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.3 OUTLIER -93.12 146.45 23.65 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.455 0.738 . . . . 52.439999999999998 109.345 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.836 HG21 HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -159.99 127.05 2.6 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.534 1.146 . . . . 72.230000000000004 109.281 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.774 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.4 Cg_endo -75.01 179.83 5.7 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.479 1.779 . . . . 71.129999999999995 110.964 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.776 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.4 m -96.91 4.27 9.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.441 1.088 . . . . 64.430000000000007 109.314 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . 0.5 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -108.01 1.84 33.53 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.546 1.153 . . . . 73.030000000000001 111.026 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 14.1 m-85 -133.3 7.64 3.93 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.56 0.8 . . . . 64.450000000000003 111.003 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.802 HG12 HG22 ' A' ' 162' ' ' VAL . 4.5 m -144.32 153.69 15.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.562 1.164 . . . . 70.329999999999998 109.296 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.894 ' HB2' HD11 ' A' ' 163' ' ' LEU . 5.4 t -126.7 137.73 53.31 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.523 1.14 . . . . 73.219999999999999 109.978 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.716 ' O ' HG23 ' A' ' 215' ' ' ILE . 3.2 mm -75.76 147.75 7.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.434 1.084 . . . . 64.109999999999999 109.286 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.716 HG23 ' O ' ' A' ' 214' ' ' ILE . 4.6 pt . . . . . 0 C--N 1.325 -0.48 0 O-C-N 124.518 1.136 . . . . 74.439999999999998 109.331 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 6.5 t70 . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.285 -0.635 . . . . 52.310000000000002 109.285 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.489 HG21 ' HE2' ' A' ' 193' ' ' PHE . 3.7 p -44.12 -50.89 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.469 1.106 . . . . 72.439999999999998 109.319 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.412 ' N ' HG13 ' A' ' 227' ' ' VAL . 5.0 mt -53.75 -47.27 62.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.505 1.128 . . . . 74.319999999999993 109.274 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -66.28 -13.86 61.11 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.5 1.125 . . . . 63.350000000000001 110.334 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -88.52 -16.47 32.57 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.517 1.135 . . . . 75.450000000000003 109.289 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.5 OUTLIER -73.59 -69.62 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.5 1.125 . . . . 72.140000000000001 109.291 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.625 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -62.23 -16.83 55.99 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.41 1.069 . . . . 73.439999999999998 109.313 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.8 -56.25 15.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.501 1.125 . . . . 72.319999999999993 109.992 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.473 ' CG2' ' HB3' ' A' ' 236' ' ' LEU . 3.7 m -88.87 14.88 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.537 1.148 . . . . 64.230000000000004 109.309 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 49.4 t30 54.96 32.42 18.0 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.546 1.154 . . . . 73.219999999999999 109.27 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.473 ' HB3' ' CG2' ' A' ' 234' ' ' VAL . 0.0 OUTLIER -82.57 118.23 71.15 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.445 1.09 . . . . 73.409999999999997 109.332 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.99 -174.09 1.81 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.508 1.794 . . . . 63.130000000000003 110.998 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.582 HG21 ' NE2' ' A' ' 240' ' ' GLN . 0.8 OUTLIER -58.78 -170.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.456 1.098 . . . . 73.439999999999998 110.461 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.935 HG23 ' HB1' ' A' ' 186' ' ' ALA . 10.8 p -79.79 -43.64 22.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.478 1.111 . . . . 72.329999999999998 109.307 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.582 ' NE2' HG21 ' A' ' 238' ' ' THR . 0.0 OUTLIER -87.24 -12.83 45.54 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 1.114 . . . . 62.549999999999997 110.321 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.488 ' N ' ' OE1' ' A' ' 240' ' ' GLN . 2.0 mt-10 -82.88 -37.24 24.57 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.516 1.135 . . . . 74.420000000000002 110.296 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.591 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 0.4 OUTLIER -77.38 -59.29 2.84 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.531 1.145 . . . . 72.409999999999997 107.977 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.615 ' NZ ' ' CD2' ' B' ' 470' ' ' PHE . 26.8 mtmt -56.56 -18.66 12.54 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.571 1.169 . . . . 72.439999999999998 109.391 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 243' ' ' LYS . 1.1 t . . . . . 0 C--N 1.326 -0.452 0 O-C-N 124.501 1.126 . . . . 72.230000000000004 109.939 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 470' ' ' PHE . . . . . 0.615 ' CD2' ' NZ ' ' A' ' 243' ' ' LYS . 3.2 m-30 . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.545 0.212 . . . . 63.43 111.073 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 471' ' ' ILE . . . . . 0.469 ' N ' HD13 ' B' ' 471' ' ' ILE . 5.2 mm -65.91 135.23 95.28 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.483 1.115 . . . . 55.409999999999997 109.267 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 472' ' ' PRO . . . . . 0.589 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.95 149.92 37.65 Favored 'Trans proline' 0 C--N 1.361 1.225 0 O-C-N 124.522 1.801 . . . . 72.010000000000005 111.012 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 23.0 t -106.15 -37.18 6.68 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.486 1.116 . . . . 73.409999999999997 110.031 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -101.27 166.11 12.93 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.419 1.074 . . . . 62.030000000000001 110.27 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.06 -167.9 0.47 Allowed 'Trans proline' 0 C--N 1.361 1.203 0 O-C-N 124.511 1.795 . . . . 71.239999999999995 110.98 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 476' ' ' ALA . . . . . . . . . . . . . . . -71.33 134.05 84.99 Favored Pre-proline 0 C--N 1.326 -0.439 0 O-C-N 124.535 1.147 . . . . 41.140000000000001 109.293 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 477' ' ' PRO . . . . . 0.523 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -75.07 -167.85 0.46 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.56 1.821 . . . . 75.099999999999994 111.032 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.08 91.82 38.2 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 124.42 1.075 . . . . 43.32 109.302 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 479' ' ' PRO . . . . . 0.604 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.3 Cg_endo -74.96 151.21 39.43 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.535 1.808 . . . . 64.409999999999997 110.973 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 480' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 479' ' ' PRO . 18.2 Cg_endo . . . . . 0 C--N 1.36 1.153 0 O-C-N 124.523 1.802 . . . . 74.310000000000002 110.938 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.502 0.192 . . . . 74.530000000000001 111.01 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.819 ' O ' HD12 ' A' ' 182' ' ' LEU . . . -115.82 144.45 43.99 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.549 1.155 . . . . 63.310000000000002 109.291 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.519 HD13 ' N ' ' A' ' 162' ' ' VAL . 0.1 OUTLIER -129.37 132.04 66.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 124.505 1.128 . . . . 72.200000000000003 109.358 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.988 HG22 HG12 ' A' ' 212' ' ' VAL . 2.1 t -91.37 122.22 42.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.445 1.09 . . . . 71.340000000000003 109.312 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.531 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 0.7 OUTLIER -98.26 -14.36 20.32 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.457 1.098 . . . . 70.099999999999994 109.305 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.665 ' O ' HG13 ' A' ' 162' ' ' VAL . 1.1 m-85 -144.54 156.54 44.2 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.503 1.127 . . . . 63.210000000000001 111.033 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.716 ' N ' HG12 ' A' ' 178' ' ' VAL . 5.8 t70 -98.96 158.38 15.69 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.422 1.076 . . . . 51.439999999999998 109.25 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.556 ' CE2' ' HG3' ' B' ' 477' ' ' PRO . 1.4 t80 -160.26 131.06 5.59 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.56 1.162 . . . . 74.150000000000006 110.993 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.552 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 16.8 mtpp -67.21 121.26 15.26 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.445 1.091 . . . . 63.020000000000003 109.268 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.836 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -91.22 140.39 29.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.416 1.073 . . . . 54.140000000000001 109.293 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -150.47 21.03 0.83 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.512 1.132 . . . . 72.120000000000005 110.308 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.47 ' HD3' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -99.33 -176.22 3.23 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.511 1.132 . . . . 74.140000000000001 109.248 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.44 -29.14 67.57 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.548 1.155 . . . . 62.399999999999999 109.295 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 173' ' ' GLU . 5.6 m-20 -107.83 18.73 20.97 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.522 1.139 . . . . 75.129999999999995 109.281 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.836 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 6.8 pt-20 -36.62 104.06 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.539 1.149 . . . . 74.430000000000007 110.255 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.589 HD12 ' HA3' ' A' ' 205' ' ' GLY . 0.8 OUTLIER -141.15 95.31 2.82 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 62.049999999999997 109.278 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.01 153.66 33.15 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.462 1.101 . . . . 62.240000000000002 110.34 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 25.4 m -155.99 102.54 2.16 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.462 1.101 . . . . 63.039999999999999 110.387 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -44.17 160.56 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 70.409999999999997 111.019 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.716 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.9 m -62.08 158.48 3.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.529 1.143 . . . . 74.340000000000003 109.289 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.407 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 49.41 62.69 4.58 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.469 1.105 . . . . 71.200000000000003 110.98 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -118.56 165.55 13.8 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.516 0.774 . . . . 71.209999999999994 110.315 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -123.4 123.4 40.58 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.486 1.116 . . . . 74.109999999999999 109.26 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.848 ' H ' HD12 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -141.65 155.14 45.72 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.422 1.076 . . . . 64.209999999999994 109.249 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 7.3 t80 -109.59 112.61 24.8 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.546 1.154 . . . . 73.510000000000005 110.999 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.528 HD12 ' HB2' ' A' ' 160' ' ' ALA . 36.8 mt -70.96 151.43 9.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.463 1.102 . . . . 71.25 109.319 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.607 ' SG ' ' CH2' ' A' ' 242' ' ' TRP . 1.8 t -139.99 -43.85 0.43 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.466 1.104 . . . . 74.450000000000003 108.276 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.995 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -112.17 166.8 10.94 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.525 1.141 . . . . 61.439999999999998 109.316 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.521 ' C ' ' CD2' ' A' ' 188' ' ' HIS . 2.9 p80 -159.37 149.55 19.06 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.123 . . . . 73.450000000000003 109.617 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.742 ' HE1' HD11 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -141.61 133.14 26.87 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.438 1.086 . . . . 64.409999999999997 109.651 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 190' ' ' CYS . 95.7 m-20 49.02 31.16 3.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.564 1.165 . . . . 74.530000000000001 109.313 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.442 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.0 p 38.47 34.8 0.08 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.474 1.109 . . . . 74.310000000000002 108.352 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.52 ' O ' HG13 ' A' ' 209' ' ' VAL . 8.6 tt0 -128.49 -39.32 1.67 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.505 1.128 . . . . 74.120000000000005 110.324 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.964 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 98.6 m95 -111.56 126.43 54.98 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.483 1.115 . . . . 70.010000000000005 108.059 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.781 ' CE2' HG12 ' A' ' 209' ' ' VAL . 20.9 m-30 -117.99 132.17 56.41 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.526 1.141 . . . . 73.519999999999996 110.979 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.995 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 10.1 mm -96.37 103.45 14.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.385 1.053 . . . . 73.530000000000001 109.294 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.482 ' HB2' ' CG1' ' A' ' 184' ' ' ILE . . . -111.59 174.78 5.71 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.514 1.134 . . . . 73.310000000000002 109.299 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.36 165.56 19.74 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 124.525 1.14 . . . . 65.319999999999993 109.238 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.16 0 O-C-N 124.509 1.794 . . . . 62.539999999999999 111.042 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.031 0 N-CA-C 111.002 -0.839 . . . . 60.439999999999998 111.002 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.568 ' HG2' ' CE2' ' B' ' 470' ' ' PHE . 18.4 Cg_endo -74.9 143.53 78.12 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.045 -2.481 . . . . 72.409999999999997 111.024 -0.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.589 ' HA3' HD12 ' A' ' 174' ' ' LEU . . . -105.76 150.98 17.05 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.582 1.176 . . . . 44.229999999999997 110.962 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.964 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.1 OUTLIER -87.34 146.21 26.01 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 0.763 . . . . 72.019999999999996 109.314 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.766 ' HB ' HG11 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -153.79 122.23 3.07 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.53 1.144 . . . . 71.0 109.242 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.987 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.5 Cg_endo -74.97 170.96 19.25 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.509 1.794 . . . . 34.310000000000002 111.015 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.781 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.8 OUTLIER -89.75 5.2 5.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.118 . . . . 63.020000000000003 109.221 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -103.47 -12.11 31.65 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.522 1.139 . . . . 75.049999999999997 110.995 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.626 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 10.8 m-85 -124.0 -1.24 8.32 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.478 0.752 . . . . 74.109999999999999 111.054 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.988 HG12 HG22 ' A' ' 162' ' ' VAL . 2.2 m -140.4 160.67 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.501 1.125 . . . . 71.299999999999997 109.294 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.8 m -128.67 147.93 50.78 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.444 1.09 . . . . 75.099999999999994 110.07 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.753 ' C ' HD13 ' A' ' 215' ' ' ILE . 2.7 mm -94.42 141.19 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 64.540000000000006 109.235 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.785 ' N ' HD13 ' A' ' 215' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.446 0 O-C-N 124.514 1.133 . . . . 74.329999999999998 109.218 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 229' ' ' GLU . 19.9 t0 . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 109.276 -0.638 . . . . 70.209999999999994 109.276 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.656 HG13 HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -40.27 -45.63 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.532 1.145 . . . . 72.010000000000005 109.271 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.752 ' HA ' HD12 ' A' ' 231' ' ' ILE . 4.5 mp -64.78 -49.03 82.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.537 1.148 . . . . 73.230000000000004 109.316 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.483 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 34.0 mt-10 -62.4 -16.67 56.16 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.445 1.091 . . . . 73.310000000000002 110.29 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -89.16 -19.11 25.89 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.476 1.11 . . . . 54.119999999999997 109.332 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.752 HD12 ' HA ' ' A' ' 228' ' ' ILE . 3.0 mt -72.64 -69.89 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 124.565 1.166 . . . . 72.030000000000001 109.331 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.483 ' CD ' ' HA ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -57.5 -22.74 45.92 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.508 1.13 . . . . 63.420000000000002 109.283 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.21 -56.79 7.05 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.132 . . . . 74.129999999999995 109.945 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 234' ' ' VAL . 1.6 m -98.49 24.65 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.499 1.124 . . . . 73.239999999999995 109.241 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 41.29 36.73 0.53 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.515 1.134 . . . . 53.310000000000002 109.291 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.489 HD12 ' HD2' ' A' ' 237' ' ' PRO . 4.2 tp -60.17 119.83 45.67 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.521 1.138 . . . . 74.420000000000002 109.312 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.489 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.3 Cg_endo -74.99 162.79 36.57 Favored 'Trans proline' 0 C--N 1.359 1.115 0 O-C-N 124.499 1.789 . . . . 54.100000000000001 110.967 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.7 m -68.52 173.02 5.37 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.49 1.119 . . . . 54.119999999999997 110.419 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.681 ' HB ' ' HB1' ' A' ' 186' ' ' ALA . 10.5 p -65.3 -49.95 75.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.54 1.15 . . . . 63.25 109.281 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.481 ' OE1' ' CD1' ' B' ' 471' ' ' ILE . 7.6 pm0 -68.63 -14.95 63.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 72.439999999999998 110.353 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -88.49 -39.64 14.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.552 1.157 . . . . 70.340000000000003 110.381 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.607 ' CH2' ' SG ' ' A' ' 185' ' ' CYS . 0.2 OUTLIER -80.68 -63.07 1.49 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.506 1.129 . . . . 72.219999999999999 108.015 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.553 ' HD2' ' CD2' ' B' ' 470' ' ' PHE . 14.7 mtpp -51.5 -23.26 3.84 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.479 1.112 . . . . 64.310000000000002 109.292 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.129 . . . . 53.25 109.933 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 470' ' ' PHE . . . . . 0.568 ' CE2' ' HG2' ' A' ' 204' ' ' PRO . 5.4 m-30 . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 120.523 0.201 . . . . 72.409999999999997 110.938 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 471' ' ' ILE . . . . . 0.528 HG22 ' HD2' ' B' ' 472' ' ' PRO . 3.3 mm -95.95 140.59 22.35 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.478 1.111 . . . . 74.349999999999994 109.279 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 472' ' ' PRO . . . . . 0.528 ' HD2' HG22 ' B' ' 471' ' ' ILE . 18.3 Cg_endo -75.0 -170.16 0.74 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.417 1.746 . . . . 34.140000000000001 110.965 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.97 15.9 4.23 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.478 1.111 . . . . 71.25 109.986 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 474' ' ' ARG . . . . . 0.443 ' O ' ' NE1' ' A' ' 192' ' ' TRP . 17.0 mmt180 -145.82 154.51 51.57 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.466 1.104 . . . . 72.049999999999997 110.335 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 475' ' ' PRO . . . . . 0.672 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.2 Cg_endo -74.94 -36.07 2.82 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.538 1.809 . . . . 71.209999999999994 110.939 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 476' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 164.38 133.04 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.543 1.152 . . . . 42.100000000000001 109.262 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 477' ' ' PRO . . . . . 0.573 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -74.93 -171.08 0.88 Allowed 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.556 1.819 . . . . 71.209999999999994 111.044 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.72 96.65 40.32 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.546 1.154 . . . . 73.150000000000006 109.319 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 479' ' ' PRO . . . . . 0.626 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -75.0 166.67 28.7 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.386 1.729 . . . . 74.329999999999998 111.032 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.36 1.157 0 O-C-N 124.44 1.758 . . . . 63.43 111.012 -179.973 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.565 ' CE2' ' CD1' ' A' ' 215' ' ' ILE . 2.3 p90 . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.532 0.206 . . . . 72.329999999999998 110.975 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.65 ' HB3' ' HG ' ' A' ' 182' ' ' LEU . . . -107.38 151.84 24.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 51.340000000000003 109.288 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.597 HD13 ' N ' ' A' ' 162' ' ' VAL . 0.1 OUTLIER -132.16 135.05 58.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.457 1.098 . . . . 72.219999999999999 109.331 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.768 HG23 HD22 ' A' ' 182' ' ' LEU . 1.8 t -89.99 118.43 35.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.511 1.132 . . . . 73.540000000000006 109.337 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.571 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 1.4 mt -94.56 -16.92 22.85 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.422 1.076 . . . . 74.299999999999997 109.328 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.571 ' CE2' ' HB2' ' A' ' 163' ' ' LEU . 1.9 m-85 -148.61 157.07 43.21 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.439 1.087 . . . . 75.150000000000006 110.925 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.71 ' H ' HG12 ' A' ' 178' ' ' VAL . 7.2 p30 -88.84 154.84 19.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.527 1.142 . . . . 72.340000000000003 109.281 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.645 ' CE2' ' NZ ' ' A' ' 170' ' ' LYS . 2.4 t80 -154.4 132.13 11.47 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.435 1.084 . . . . 70.329999999999998 111.003 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.542 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 6.2 mtpm? -75.82 125.65 29.48 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.544 1.152 . . . . 62.210000000000001 109.328 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.908 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -114.18 133.53 55.53 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.521 1.138 . . . . 61.219999999999999 109.299 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -136.68 9.37 3.1 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.485 1.116 . . . . 63.039999999999999 110.245 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.645 ' NZ ' ' CE2' ' A' ' 166' ' ' PHE . 0.1 OUTLIER -79.07 -175.79 4.76 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.489 1.118 . . . . 74.230000000000004 109.32 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.34 -21.76 66.26 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.537 1.148 . . . . 73.329999999999998 109.267 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 173' ' ' GLU . 0.5 OUTLIER -114.05 12.64 17.99 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.451 1.094 . . . . 70.430000000000007 109.303 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.908 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 6.5 pt-20 -32.99 112.95 0.13 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.123 . . . . 73.299999999999997 110.293 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.592 HD23 ' HA3' ' A' ' 205' ' ' GLY . 1.5 tm? -119.92 99.4 6.6 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.555 1.159 . . . . 74.510000000000005 109.283 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 14.5 t -80.82 130.75 35.23 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.434 1.083 . . . . 75.120000000000005 110.428 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.411 ' CG2' ' HG3' ' A' ' 180' ' ' GLU . 55.6 m -155.19 155.98 34.87 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.451 1.094 . . . . 64.540000000000006 110.373 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.488 ' O ' HG11 ' A' ' 162' ' ' VAL . 26.8 m-85 -93.71 167.09 11.88 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.467 1.104 . . . . 65.120000000000005 110.953 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.71 HG12 ' H ' ' A' ' 165' ' ' ASP . 2.2 m -61.39 158.5 2.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.452 1.095 . . . . 75.519999999999996 109.3 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.422 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 48.55 56.92 8.88 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.524 1.14 . . . . 60.520000000000003 111.021 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.411 ' HG3' ' CG2' ' A' ' 176' ' ' THR . 3.9 mm-40 -114.86 175.47 5.48 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.472 0.749 . . . . 63.109999999999999 110.277 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -119.15 130.59 55.62 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.125 . . . . 75.120000000000005 109.321 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.891 HD12 HG21 ' A' ' 207' ' ' VAL . 2.5 pt? -145.28 133.37 21.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.455 1.097 . . . . 72.200000000000003 109.361 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -100.72 107.87 19.58 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.565 1.166 . . . . 74.120000000000005 110.979 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.75 ' CG1' ' HB2' ' A' ' 195' ' ' ALA . 13.3 mt -70.66 162.55 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.458 1.099 . . . . 70.140000000000001 109.353 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.571 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 2.0 p -156.44 -40.85 0.08 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.463 1.102 . . . . 42.119999999999997 108.296 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.989 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -112.21 152.17 28.71 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.451 1.094 . . . . 54.219999999999999 109.282 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.478 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.4 OUTLIER -145.26 149.45 34.91 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.476 1.11 . . . . 74.219999999999999 109.554 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.608 ' CD2' ' O ' ' A' ' 192' ' ' TRP . 0.7 OUTLIER -155.82 143.51 19.59 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 124.434 1.084 . . . . 65.329999999999998 109.545 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.456 ' C ' ' N ' ' A' ' 191' ' ' GLU . 7.4 m-20 57.02 18.04 3.75 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.548 1.155 . . . . 73.310000000000002 109.329 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 3.3 m 43.24 26.94 0.11 Allowed 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.475 1.109 . . . . 52.140000000000001 108.315 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.863 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 18.1 tt0 -132.93 -40.58 0.93 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.134 . . . . 71.420000000000002 110.254 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.996 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 96.9 m95 -103.88 127.83 51.38 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.042 -1.095 . . . . 71.400000000000006 108.042 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.768 ' CE2' HG12 ' A' ' 209' ' ' VAL . 15.7 m-30 -125.09 127.73 47.35 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.536 1.147 . . . . 74.409999999999997 110.922 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.989 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 1.6 mp -85.56 106.42 15.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.55 1.156 . . . . 74.040000000000006 109.277 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.798 ' HB3' HG21 ' A' ' 207' ' ' VAL . . . -120.85 163.07 18.75 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.557 1.161 . . . . 73.140000000000001 109.313 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -113.36 145.05 32.45 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.551 1.157 . . . . 73.329999999999998 109.263 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--N 1.361 1.192 0 O-C-N 124.475 1.776 . . . . 73.450000000000003 111.047 179.899 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.449 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.53 0.983 0 N-CA-C 111.059 -0.816 . . . . 44.140000000000001 111.059 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.449 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.3 Cg_endo -74.93 138.27 55.09 Favored 'Cis proline' 0 C--N 1.359 1.123 0 C-N-CA 120.97 -2.512 . . . . 54.549999999999997 110.988 -0.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.592 ' HA3' HD23 ' A' ' 174' ' ' LEU . . . -99.56 -178.96 31.04 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.432 1.082 . . . . 35.140000000000001 110.971 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.996 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -93.33 148.61 21.9 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.538 0.787 . . . . 61.100000000000001 109.295 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.891 HG21 HD12 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -155.52 122.95 2.78 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 74.540000000000006 109.32 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.888 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.5 Cg_endo -74.93 174.69 12.33 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.494 1.786 . . . . 71.0 111.038 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.768 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.5 m -93.59 -2.69 10.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.512 1.133 . . . . 75.099999999999994 109.228 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . 0.5 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -98.46 2.73 59.2 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.482 1.114 . . . . 22.140000000000001 110.967 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.557 ' CD1' ' HB2' ' A' ' 166' ' ' PHE . 13.5 m-85 -137.9 11.31 2.88 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.471 0.747 . . . . 72.329999999999998 110.985 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 208' ' ' PRO . 3.8 m -152.97 158.77 3.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 124.471 1.107 . . . . 73.329999999999998 109.339 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.8 t -134.91 148.07 49.98 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.532 1.145 . . . . 74.340000000000003 110.054 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 13.7 mm -86.27 132.76 31.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.441 1.088 . . . . 72.450000000000003 109.28 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.565 ' CD1' ' CE2' ' A' ' 159' ' ' TYR . 24.3 pt . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.547 1.154 . . . . 65.310000000000002 109.241 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 230' ' ' ASP . 2.4 m-20 . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 109.277 -0.638 . . . . 71.129999999999995 109.277 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.566 HG13 HD12 ' A' ' 228' ' ' ILE . 1.4 p -50.86 -41.08 21.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.461 1.1 . . . . 71.299999999999997 109.265 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.926 ' HA ' HD12 ' A' ' 231' ' ' ILE . 4.1 mp -70.27 -41.66 78.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.54 1.15 . . . . 74.019999999999996 109.332 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -69.21 -19.55 63.96 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 1.114 . . . . 62.329999999999998 110.308 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 226' ' ' ASP . 7.1 m-20 -88.73 -16.3 32.59 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.461 1.1 . . . . 75.519999999999996 109.272 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.926 HD12 ' HA ' ' A' ' 228' ' ' ILE . 4.4 mt -70.77 -69.36 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.463 1.102 . . . . 60.310000000000002 109.342 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.505 ' CE ' ' O ' ' A' ' 228' ' ' ILE . 0.0 OUTLIER -57.03 -25.59 58.86 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.511 1.132 . . . . 75.120000000000005 109.322 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.3 m -49.38 -55.54 12.63 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.514 1.134 . . . . 71.409999999999997 109.953 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 234' ' ' VAL . 2.0 m -93.49 26.1 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 71.439999999999998 109.32 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 234' ' ' VAL . 68.5 m-80 40.17 35.64 0.27 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 75.519999999999996 109.271 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.465 HD11 ' O ' ' A' ' 185' ' ' CYS . 1.2 tp -66.01 119.67 63.18 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 74.030000000000001 109.316 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.01 173.73 14.01 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.537 1.809 . . . . 74.5 110.981 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 239' ' ' VAL . 0.8 OUTLIER -69.56 -170.92 0.33 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.46 1.1 . . . . 44.149999999999999 110.367 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.84 HG22 ' HD3' ' A' ' 243' ' ' LYS . 10.5 p -82.89 -34.74 11.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.485 1.116 . . . . 75.519999999999996 109.295 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.633 ' HG3' HG13 ' A' ' 239' ' ' VAL . 0.6 OUTLIER -85.39 -20.06 30.44 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.52 1.138 . . . . 64.200000000000003 110.333 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -80.22 -36.37 34.88 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.434 1.084 . . . . 62.439999999999998 110.299 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.714 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 1.5 t90 -84.0 -56.57 3.61 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 65.129999999999995 107.972 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.84 ' HD3' HG22 ' A' ' 239' ' ' VAL . 18.1 mtpp -58.17 -17.69 20.49 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.524 1.14 . . . . 64.239999999999995 109.291 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 2.8 t . . . . . 0 C--N 1.324 -0.516 0 O-C-N 124.546 1.154 . . . . 61.210000000000001 109.998 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 470' ' ' PHE . . . . . 0.559 ' CD2' ' HD2' ' A' ' 243' ' ' LYS . 3.4 m-30 . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 120.517 0.198 . . . . 72.239999999999995 111.028 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 471' ' ' ILE . . . . . 0.427 HG23 ' HD2' ' B' ' 472' ' ' PRO . 0.7 OUTLIER -72.24 143.93 86.46 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.516 1.135 . . . . 72.439999999999998 109.28 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 472' ' ' PRO . . . . . 0.567 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.5 Cg_endo -74.96 153.47 41.98 Favored 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.475 1.777 . . . . 62.130000000000003 110.989 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.02 -63.07 1.29 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.546 1.153 . . . . 63.310000000000002 109.951 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.81 172.22 6.42 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.503 1.127 . . . . 71.140000000000001 110.259 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 -169.21 0.6 Allowed 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.479 1.778 . . . . 51.32 111.002 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 476' ' ' ALA . . . . . 0.863 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . -62.51 134.61 95.14 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.509 1.131 . . . . 61.340000000000003 109.285 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 477' ' ' PRO . . . . . 0.596 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -75.0 -162.5 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.579 1.831 . . . . 63.420000000000002 111.047 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.72 89.95 20.55 Favored Pre-proline 0 C--N 1.324 -0.525 0 O-C-N 124.525 1.141 . . . . 51.32 109.299 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 479' ' ' PRO . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.0 Cg_endo -75.03 165.02 32.15 Favored 'Trans proline' 0 C--N 1.359 1.11 0 O-C-N 124.481 1.779 . . . . 64.209999999999994 110.977 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--N 1.361 1.187 0 O-C-N 124.501 1.79 . . . . 54.200000000000003 111.005 179.998 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.792 ' CD1' ' CD1' ' A' ' 183' ' ' PHE . 34.9 m-85 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.439 0.161 . . . . 75.099999999999994 111.048 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.561 ' HB3' ' CD2' ' A' ' 182' ' ' LEU . . . -124.93 148.24 48.45 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.51 1.131 . . . . 65.099999999999994 109.233 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.618 ' CG2' HD11 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -116.01 134.63 58.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.435 1.084 . . . . 73.010000000000005 109.311 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.714 HG22 HG12 ' A' ' 212' ' ' VAL . 1.0 OUTLIER -91.49 122.96 43.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.531 1.144 . . . . 55.399999999999999 109.287 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.583 ' HB2' ' CE1' ' A' ' 164' ' ' TYR . 0.3 OUTLIER -102.55 -11.92 18.16 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.522 1.139 . . . . 71.450000000000003 109.332 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.651 ' O ' HG13 ' A' ' 162' ' ' VAL . 12.8 m-85 -142.51 166.41 24.75 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.477 1.111 . . . . 74.319999999999993 110.986 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.606 ' N ' HG12 ' A' ' 178' ' ' VAL . 27.6 p-10 -115.12 146.42 41.37 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.477 1.11 . . . . 72.420000000000002 109.283 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.567 ' CE2' ' HG3' ' B' ' 477' ' ' PRO . 1.6 t80 -149.51 128.59 12.73 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.446 1.091 . . . . 52.32 111.023 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.409 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 7.1 mtpt -66.99 104.99 1.51 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.545 1.153 . . . . 71.409999999999997 109.322 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.696 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -79.61 144.26 33.98 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.462 1.101 . . . . 34.409999999999997 109.309 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -151.33 20.97 0.74 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.499 1.124 . . . . 65.019999999999996 110.333 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.541 ' NZ ' ' CE2' ' A' ' 166' ' ' PHE . 0.1 OUTLIER -95.56 -176.06 3.64 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.465 1.103 . . . . 62.140000000000001 109.337 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.62 -37.11 75.19 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.511 1.132 . . . . 54.140000000000001 109.327 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 173' ' ' GLU . 0.7 OUTLIER -106.85 23.19 14.74 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.5 1.125 . . . . 74.030000000000001 109.345 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.696 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -35.26 111.19 0.12 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 1.118 . . . . 74.040000000000006 110.27 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.592 HD23 ' HA3' ' A' ' 205' ' ' GLY . 0.7 OUTLIER -118.51 98.07 6.07 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.532 1.145 . . . . 75.150000000000006 109.284 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 175' ' ' THR . 12.3 t -83.27 112.79 20.19 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.505 1.128 . . . . 72.439999999999998 110.447 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.777 HG23 ' CD ' ' A' ' 180' ' ' GLU . 1.1 m -137.55 137.17 38.32 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.548 1.155 . . . . 74.099999999999994 110.407 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -75.94 163.77 26.85 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.509 1.13 . . . . 73.109999999999999 110.962 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.606 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.3 m -58.08 157.79 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.529 1.143 . . . . 54.119999999999997 109.327 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.7 64.16 4.48 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.405 1.066 . . . . 63.43 111.026 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.777 ' CD ' HG23 ' A' ' 176' ' ' THR . 1.2 tt0 -127.84 -173.67 2.99 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.546 0.792 . . . . 75.219999999999999 110.264 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.636 ' C ' HD13 ' A' ' 182' ' ' LEU . 0.7 OUTLIER -147.27 136.59 22.59 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.528 1.142 . . . . 75.510000000000005 109.311 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.835 ' N ' HD13 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -148.96 146.27 27.75 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 72.200000000000003 109.294 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.792 ' CD1' ' CD1' ' A' ' 159' ' ' TYR . 6.8 m-30 -95.55 121.86 37.69 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.516 1.135 . . . . 73.329999999999998 110.899 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 195' ' ' ALA . 1.7 mp -70.75 161.93 4.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.53 1.144 . . . . 71.319999999999993 109.29 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.575 ' HB3' ' CH2' ' A' ' 242' ' ' TRP . 2.2 m -146.12 -47.37 0.2 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 62.520000000000003 108.259 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.927 ' HB1' ' HB ' ' A' ' 239' ' ' VAL . . . -119.78 166.07 13.72 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.479 1.112 . . . . 64.540000000000006 109.281 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.59 134.14 11.79 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 74.310000000000002 109.603 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.783 ' HD1' HG11 ' A' ' 239' ' ' VAL . 0.0 OUTLIER -146.73 149.28 33.09 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.444 1.09 . . . . 62.43 109.55 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.485 ' C ' ' N ' ' A' ' 191' ' ' GLU . 40.7 m-20 61.19 15.86 6.72 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 1.136 . . . . 71.530000000000001 109.316 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 189' ' ' ASN . 14.1 p 41.84 27.83 0.08 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.138 . . . . 74.019999999999996 108.335 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.615 ' O ' HG13 ' A' ' 209' ' ' VAL . 8.5 tt0 -136.42 -37.5 0.69 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.489 1.118 . . . . 72.010000000000005 110.258 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.866 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 95.7 m95 -101.82 135.91 42.57 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.008 -1.108 . . . . 74.329999999999998 108.008 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.718 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.0 m-30 -128.66 129.33 45.68 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 62.229999999999997 111.023 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.896 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 8.8 mm -89.68 102.07 12.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.503 1.127 . . . . 73.049999999999997 109.279 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -116.15 -178.85 3.5 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.438 1.086 . . . . 72.040000000000006 109.275 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.532 ' CB ' ' HA ' ' A' ' 204' ' ' PRO . 23.3 pttt -153.27 158.62 32.76 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.464 1.103 . . . . 74.239999999999995 109.295 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.414 ' CD ' ' HA3' ' A' ' 203' ' ' GLY . 18.1 Cg_endo . . . . . 0 C--N 1.359 1.131 0 O-C-N 124.481 1.779 . . . . 63.130000000000003 110.974 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.414 ' HA3' ' CD ' ' A' ' 197' ' ' PRO . . . . . . . . 0 CA--C 1.53 1.027 0 N-CA-C 110.993 -0.843 . . . . 73.129999999999995 110.993 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.532 ' HA ' ' CB ' ' A' ' 196' ' ' LYS . 18.1 Cg_endo -75.09 129.27 18.21 Favored 'Cis proline' 0 C--N 1.36 1.144 0 C-N-CA 121.015 -2.494 . . . . 33.009999999999998 110.974 0.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.592 ' HA3' HD23 ' A' ' 174' ' ' LEU . . . -111.96 177.91 18.95 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.529 1.143 . . . . 71.310000000000002 110.951 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.866 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -105.45 152.22 23.27 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.482 0.754 . . . . 73.340000000000003 109.341 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.529 ' N ' ' HG ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -156.76 132.41 5.71 Favored Pre-proline 0 C--N 1.324 -0.524 0 O-C-N 124.432 1.083 . . . . 51.130000000000003 109.315 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.844 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.3 Cg_endo -74.94 171.67 17.85 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.489 1.783 . . . . 73.319999999999993 111.037 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.718 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.2 m -91.48 -3.92 10.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.548 1.155 . . . . 74.310000000000002 109.304 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -90.26 -26.97 22.13 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.512 1.133 . . . . 65.299999999999997 110.981 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.62 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 17.6 m-85 -105.16 4.31 31.17 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.481 0.754 . . . . 73.439999999999998 111.011 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 208' ' ' PRO . 1.8 m -146.51 157.85 11.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.531 1.144 . . . . 63.229999999999997 109.311 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 4.5 t -130.39 130.55 44.5 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.515 1.135 . . . . 72.439999999999998 110.006 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.769 ' O ' HG23 ' A' ' 215' ' ' ILE . 2.6 mm -73.69 133.02 32.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.423 1.077 . . . . 73.230000000000004 109.254 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.769 HG23 ' O ' ' A' ' 214' ' ' ILE . 1.8 pt . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.46 1.1 . . . . 75.239999999999995 109.277 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 229' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 109.257 -0.646 . . . . 73.120000000000005 109.257 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 227' ' ' VAL . 0.2 OUTLIER -39.76 -55.71 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 124.462 1.101 . . . . 63.039999999999999 109.241 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 3.9 mt -55.85 -43.62 74.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.372 1.045 . . . . 73.099999999999994 109.27 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 226' ' ' ASP . 27.3 mt-10 -70.59 -14.58 62.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.477 1.11 . . . . 73.409999999999997 110.31 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 226' ' ' ASP . 0.4 OUTLIER -86.94 -24.27 24.82 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.514 1.134 . . . . 74.420000000000002 109.296 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.596 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.6 OUTLIER -61.23 -68.73 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.505 1.128 . . . . 74.109999999999999 109.297 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.596 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -56.27 -26.8 53.07 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.502 1.126 . . . . 61.140000000000001 109.349 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.9 t -52.14 -47.71 65.26 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.492 1.12 . . . . 61.32 109.934 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.522 HG23 ' HB2' ' A' ' 236' ' ' LEU . 8.9 m -98.45 19.44 2.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.493 1.12 . . . . 54.409999999999997 109.317 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 41.58 32.36 0.24 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.519 1.137 . . . . 73.430000000000007 109.26 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.522 ' HB2' HG23 ' A' ' 234' ' ' VAL . 4.3 tp -68.51 119.37 67.99 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.47 1.106 . . . . 75.019999999999996 109.335 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.411 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.4 Cg_endo -75.04 171.73 17.74 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.438 1.757 . . . . 73.540000000000006 110.968 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.434 HG22 ' NE2' ' A' ' 240' ' ' GLN . 1.7 m -71.42 165.52 23.61 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.567 1.167 . . . . 73.049999999999997 110.429 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.963 HG22 ' NZ ' ' A' ' 243' ' ' LYS . 7.6 p -60.84 -33.34 54.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.536 1.147 . . . . 74.230000000000004 109.287 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.542 ' HG3' HG13 ' A' ' 239' ' ' VAL . 1.2 mp0 -82.01 -15.43 53.68 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.532 1.145 . . . . 64.140000000000001 110.304 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -87.53 -38.66 15.82 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.554 1.159 . . . . 74.409999999999997 110.273 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.575 ' CH2' ' HB3' ' A' ' 185' ' ' CYS . 0.9 OUTLIER -79.42 -60.25 2.44 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.001 -1.111 . . . . 72.400000000000006 108.001 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.963 ' NZ ' HG22 ' A' ' 239' ' ' VAL . 14.3 mtmm -53.34 -20.86 4.85 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.523 1.139 . . . . 63.32 109.324 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 243' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.456 0 O-C-N 124.487 1.117 . . . . 51.409999999999997 110.018 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 470' ' ' PHE . . . . . 0.407 ' HA ' ' OD2' ' A' ' 172' ' ' ASP . 19.3 m-85 . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.479 0.181 . . . . 70.530000000000001 110.996 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 471' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' B' ' 472' ' ' PRO . 1.4 mp -65.71 138.84 96.78 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.503 1.127 . . . . 72.049999999999997 109.263 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 472' ' ' PRO . . . . . 0.56 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.1 Cg_endo -75.0 -179.34 4.89 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.529 1.805 . . . . 74.439999999999998 110.978 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 36.6 t -114.24 -61.63 1.72 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.544 1.153 . . . . 64.329999999999998 110.001 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -61.84 155.71 60.53 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.473 1.108 . . . . 64.409999999999997 110.285 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 475' ' ' PRO . . . . . 0.665 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.3 Cg_endo -75.07 -36.24 2.63 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.484 1.781 . . . . 74.129999999999995 111.005 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 476' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 165.01 126.91 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.529 1.143 . . . . 72.319999999999993 109.291 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 477' ' ' PRO . . . . . 0.591 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.5 Cg_endo -74.89 -162.13 0.14 Allowed 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.49 1.784 . . . . 62.520000000000003 111.049 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 478' ' ' LYS . . . . . 0.538 ' O ' ' CD ' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -145.2 112.32 4.76 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.506 1.129 . . . . 74.530000000000001 109.261 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 479' ' ' PRO . . . . . 0.62 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.1 Cg_endo -74.97 154.06 42.35 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.452 1.764 . . . . 75.319999999999993 110.998 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 480' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' B' ' 479' ' ' PRO . 18.4 Cg_endo . . . . . 0 C--N 1.359 1.111 0 O-C-N 124.527 1.804 . . . . 74.5 111.083 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' A' ' 181' ' ' ASN . 1.4 t80 . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 120.514 0.197 . . . . 72.519999999999996 110.965 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.468 ' HB2' HG12 ' A' ' 184' ' ' ILE . . . -118.23 142.36 47.55 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.461 1.101 . . . . 63.130000000000003 109.306 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.617 ' HB ' HD11 ' A' ' 215' ' ' ILE . 0.0 OUTLIER -119.41 131.66 71.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.468 1.105 . . . . 61.350000000000001 109.292 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.877 HG22 HG12 ' A' ' 212' ' ' VAL . 2.0 t -93.27 120.97 43.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 74.400000000000006 109.335 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.606 HD21 HG23 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -99.01 -13.58 19.83 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.519 1.137 . . . . 65.150000000000006 109.351 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.639 ' O ' HG13 ' A' ' 162' ' ' VAL . 1.3 m-85 -144.37 156.77 44.38 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.434 1.084 . . . . 74.219999999999999 111.05 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.719 ' N ' HG12 ' A' ' 178' ' ' VAL . 9.2 p-10 -92.06 154.03 19.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.512 1.133 . . . . 74.120000000000005 109.268 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.467 ' CZ ' ' O ' ' A' ' 167' ' ' LYS . 16.7 t80 -141.64 144.27 34.07 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.486 1.116 . . . . 72.420000000000002 110.969 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.467 ' O ' ' CZ ' ' A' ' 166' ' ' PHE . 14.2 mtpp -82.81 131.22 35.2 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.542 1.151 . . . . 74.310000000000002 109.283 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.839 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -96.34 142.37 28.55 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 70.120000000000005 109.272 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -158.03 24.88 0.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.473 1.108 . . . . 71.340000000000003 110.354 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.687 ' HZ1' HD23 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -122.27 -175.46 3.13 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.427 1.08 . . . . 62.200000000000003 109.276 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.77 -40.03 82.76 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.487 1.117 . . . . 64.109999999999999 109.302 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 174' ' ' LEU . 26.6 m-20 -86.14 10.52 14.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 75.310000000000002 109.324 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.839 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 6.5 pt-20 -36.77 96.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.57 1.169 . . . . 73.310000000000002 110.341 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.621 ' H ' ' HZ2' ' A' ' 170' ' ' LYS . 0.3 OUTLIER -131.73 95.42 3.71 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.128 . . . . 63.219999999999999 109.315 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.4 t -59.18 153.39 18.38 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.536 1.147 . . . . 74.340000000000003 110.367 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 177' ' ' TYR . 22.2 m -154.53 175.29 13.8 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.501 1.126 . . . . 54.229999999999997 110.398 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.543 ' H ' HG22 ' A' ' 176' ' ' THR . 8.0 m-85 -122.57 157.79 31.33 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.47 1.106 . . . . 64.239999999999995 111.02 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.719 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.8 m -59.51 158.39 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.518 1.136 . . . . 70.400000000000006 109.262 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.429 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 48.07 67.83 1.45 Allowed Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.479 1.112 . . . . 43.520000000000003 111.037 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -129.13 168.38 16.21 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.478 0.752 . . . . 73.109999999999999 110.309 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.448 ' HB3' ' CE2' ' A' ' 159' ' ' TYR . 8.5 m120 -118.77 126.42 51.82 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.527 1.142 . . . . 72.530000000000001 109.225 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.816 ' N ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -133.58 139.98 46.87 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.558 1.162 . . . . 64.439999999999998 109.325 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 5.4 t80 -98.97 97.47 8.63 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.489 1.118 . . . . 74.230000000000004 110.998 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 1.044 HD13 ' HB2' ' A' ' 195' ' ' ALA . 28.0 mm -52.01 156.67 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.405 1.065 . . . . 71.430000000000007 109.281 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 186' ' ' ALA . 7.3 p -149.96 -42.49 0.13 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.459 1.099 . . . . 70.230000000000004 108.327 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.897 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -120.72 167.89 11.99 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.564 1.165 . . . . 71.219999999999999 109.309 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.425 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.2 OUTLIER -157.35 144.21 18.28 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.101 . . . . 74.409999999999997 109.613 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.578 ' CE1' ' HD3' ' B' ' 472' ' ' PRO . 0.1 OUTLIER -144.87 139.83 27.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.537 1.148 . . . . 71.120000000000005 109.55 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.49 ' C ' ' N ' ' A' ' 191' ' ' GLU . 57.7 t30 50.37 22.41 1.01 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.479 1.112 . . . . 74.209999999999994 109.27 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 189' ' ' ASN . 4.0 m 41.47 27.7 0.06 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.452 1.095 . . . . 72.340000000000003 108.272 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 208' ' ' PRO . 3.6 tt0 -124.98 -38.14 2.37 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.528 1.142 . . . . 73.299999999999997 110.275 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.76 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 90.5 m95 -113.95 128.07 56.24 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.0 -1.111 . . . . 75.209999999999994 108.0 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.904 ' HB3' HD12 ' A' ' 184' ' ' ILE . 21.4 m-30 -117.03 157.0 26.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.48 1.112 . . . . 71.299999999999997 110.959 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.897 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 3.6 mm -118.48 104.15 15.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.54 1.15 . . . . 72.319999999999993 109.314 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 1.044 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -107.55 170.37 8.02 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.472 1.107 . . . . 51.25 109.35 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.467 ' CG ' ' HA ' ' A' ' 204' ' ' PRO . 4.6 mtmp? -138.9 165.16 34.41 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.547 1.154 . . . . 54.399999999999999 109.294 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.152 0 O-C-N 124.459 1.768 . . . . 62.219999999999999 111.002 179.98 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.404 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.531 1.063 0 N-CA-C 110.949 -0.861 . . . . 71.329999999999998 110.949 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.484 ' HB2' ' CG2' ' A' ' 194' ' ' ILE . 18.2 Cg_endo -74.95 128.18 15.87 Favored 'Cis proline' 0 C--N 1.359 1.102 0 C-N-CA 121.065 -2.473 . . . . 63.140000000000001 110.992 -0.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.402 ' N ' ' HA2' ' A' ' 203' ' ' GLY . . . -92.49 122.13 6.75 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.504 1.127 . . . . 73.219999999999999 111.042 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.76 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.1 OUTLIER -79.96 146.77 31.9 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.556 0.798 . . . . 72.349999999999994 109.321 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.784 ' CG1' HG11 ' A' ' 212' ' ' VAL . 0.4 OUTLIER -160.44 129.05 2.99 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.136 . . . . 54.020000000000003 109.282 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.508 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.4 Cg_endo -74.99 179.94 5.59 Favored 'Trans proline' 0 C--N 1.359 1.117 0 O-C-N 124.593 1.838 . . . . 71.349999999999994 111.027 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.73 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.8 OUTLIER -98.06 4.2 9.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.477 1.111 . . . . 65.209999999999994 109.28 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -105.38 -2.79 41.14 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.496 1.122 . . . . 52.130000000000003 110.99 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.619 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 5.6 m-85 -127.5 0.85 6.25 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.428 0.722 . . . . 73.540000000000006 110.939 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.877 HG12 HG22 ' A' ' 162' ' ' VAL . 1.2 m -142.53 170.25 11.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.538 1.149 . . . . 73.420000000000002 109.29 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.3 t -129.37 140.57 51.32 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.508 1.13 . . . . 72.530000000000001 109.994 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.832 ' O ' HG23 ' A' ' 215' ' ' ILE . 3.7 mm -83.35 138.37 19.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.452 1.095 . . . . 53.439999999999998 109.287 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.832 HG23 ' O ' ' A' ' 214' ' ' ILE . 6.5 pt . . . . . 0 C--N 1.325 -0.459 0 O-C-N 124.542 1.151 . . . . 73.099999999999994 109.242 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 230' ' ' ASP . 2.9 t0 . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.297 -0.631 . . . . 53.119999999999997 109.297 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.593 HG13 ' H ' ' A' ' 228' ' ' ILE . 3.0 p -44.01 -59.19 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.465 1.103 . . . . 75.239999999999995 109.329 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.593 ' H ' HG13 ' A' ' 227' ' ' VAL . 3.8 mt -48.95 -47.54 16.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.53 1.144 . . . . 73.420000000000002 109.319 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.425 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 9.6 mt-10 -66.28 -23.48 66.4 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.574 1.171 . . . . 72.109999999999999 110.316 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 226' ' ' ASP . 31.1 m-20 -85.27 -15.92 41.85 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.494 1.122 . . . . 42.039999999999999 109.279 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.692 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.5 OUTLIER -72.84 -68.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.524 1.14 . . . . 72.430000000000007 109.277 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.692 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -61.48 -20.41 63.13 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.5 1.125 . . . . 73.540000000000006 109.272 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.65 -52.98 43.6 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.514 1.134 . . . . 61.149999999999999 110.062 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 234' ' ' VAL . 1.5 m -94.65 26.68 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.515 1.134 . . . . 65.200000000000003 109.313 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 40.61 37.67 0.51 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.594 1.184 . . . . 73.400000000000006 109.347 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.437 ' HB2' ' CG2' ' A' ' 234' ' ' VAL . 3.6 tp -72.22 119.55 75.34 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.569 1.168 . . . . 44.5 109.331 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.99 167.72 26.42 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.544 1.813 . . . . 45.520000000000003 110.959 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.29 177.95 2.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.505 1.128 . . . . 73.319999999999993 110.438 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.551 HG13 ' N ' ' A' ' 240' ' ' GLN . 13.1 p -72.01 -54.06 17.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 42.119999999999997 109.342 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.551 ' N ' HG13 ' A' ' 239' ' ' VAL . 13.0 pm0 -68.37 -14.85 63.29 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.464 1.103 . . . . 72.510000000000005 110.292 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -92.25 -37.21 12.8 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.136 . . . . 71.409999999999997 110.322 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.517 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 3.3 t90 -79.24 -59.78 2.63 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.004 -1.11 . . . . 71.519999999999996 108.004 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.577 ' HE2' ' CD2' ' B' ' 470' ' ' PHE . 4.6 mtmp? -54.77 -20.1 7.77 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.563 1.165 . . . . 64.200000000000003 109.357 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 21.0 t . . . . . 0 C--N 1.326 -0.447 0 O-C-N 124.454 1.097 . . . . 70.0 110.017 179.986 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 470' ' ' PHE . . . . . 0.577 ' CD2' ' HE2' ' A' ' 243' ' ' LYS . 2.2 m-30 . . . . . 0 N--CA 1.453 -0.325 0 CA-C-O 120.549 0.214 . . . . 72.450000000000003 111.045 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 471' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' B' ' 472' ' ' PRO . 13.0 mm -88.85 137.96 29.68 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.466 1.104 . . . . 73.099999999999994 109.269 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 472' ' ' PRO . . . . . 0.578 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -75.0 112.15 3.49 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.431 1.753 . . . . 54.409999999999997 110.994 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 42.0 t -55.15 -44.95 75.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.506 1.129 . . . . 74.450000000000003 109.959 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 474' ' ' ARG . . . . . 0.451 ' CD ' ' HD2' ' B' ' 475' ' ' PRO . 5.4 tpp180 -84.37 137.72 39.27 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.485 1.116 . . . . 71.019999999999996 110.32 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 475' ' ' PRO . . . . . 0.451 ' HD2' ' CD ' ' B' ' 474' ' ' ARG . 18.4 Cg_endo -74.99 -170.07 0.73 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.433 1.754 . . . . 44.399999999999999 111.019 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 476' ' ' ALA . . . . . 0.45 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . -48.3 124.63 11.46 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.561 1.163 . . . . 74.340000000000003 109.277 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 477' ' ' PRO . . . . . 0.576 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.6 Cg_endo -74.91 -162.39 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.441 1.758 . . . . 72.310000000000002 111.038 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.28 90.28 25.59 Favored Pre-proline 0 C--N 1.326 -0.436 0 O-C-N 124.488 1.118 . . . . 71.519999999999996 109.319 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 479' ' ' PRO . . . . . 0.619 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.1 Cg_endo -75.03 162.05 37.68 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.525 1.802 . . . . 73.219999999999999 110.983 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.36 1.149 0 O-C-N 124.508 1.794 . . . . 71.430000000000007 110.967 179.99 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.495 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 3.7 p90 . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 120.444 0.164 . . . . 72.430000000000007 111.078 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.589 ' HB3' HD11 ' A' ' 184' ' ' ILE . . . -127.77 154.67 45.11 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.56 1.162 . . . . 43.130000000000003 109.362 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.571 HG23 ' CD2' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -126.44 119.65 54.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.477 1.111 . . . . 75.109999999999999 109.333 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.709 ' CG2' HG12 ' A' ' 212' ' ' VAL . 1.0 OUTLIER -70.84 125.35 29.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.488 1.118 . . . . 65.25 109.271 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.688 HD11 ' HB2' ' A' ' 213' ' ' SER . 0.2 OUTLIER -104.06 -9.14 19.0 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.586 1.179 . . . . 74.239999999999995 109.311 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.582 ' O ' HG13 ' A' ' 162' ' ' VAL . 4.7 m-85 -145.16 172.6 12.87 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.479 1.112 . . . . 55.439999999999998 110.998 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.631 ' N ' HG12 ' A' ' 178' ' ' VAL . 0.0 OUTLIER -87.65 129.77 35.01 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.484 1.115 . . . . 61.020000000000003 109.262 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.667 ' CZ ' ' HB2' ' A' ' 168' ' ' ALA . 2.0 t80 -103.02 129.74 49.89 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.457 1.098 . . . . 72.310000000000002 111.009 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.76 106.97 19.36 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.468 1.105 . . . . 73.430000000000007 109.257 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.843 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -114.01 150.29 34.11 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.556 1.16 . . . . 74.319999999999993 109.282 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -152.12 24.9 0.64 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.471 1.107 . . . . 74.319999999999993 110.268 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.492 ' HZ1' ' HZ ' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -112.82 -172.79 2.12 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 75.420000000000002 109.325 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.25 -43.99 75.14 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.534 1.146 . . . . 71.109999999999999 109.326 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.49 ' HB2' HD22 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -86.26 11.47 12.03 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.48 1.112 . . . . 74.230000000000004 109.322 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.843 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 11.5 tt0 -35.22 98.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.497 1.123 . . . . 71.239999999999995 110.311 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.57 HD21 ' CA ' ' A' ' 205' ' ' GLY . 0.4 OUTLIER -109.37 94.76 5.2 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.538 1.149 . . . . 74.510000000000005 109.249 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 175' ' ' THR . 12.0 t -95.05 109.56 21.59 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.521 1.138 . . . . 54.310000000000002 110.453 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.539 HG22 ' H ' ' A' ' 177' ' ' TYR . 90.6 m -130.71 174.85 9.54 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.476 1.11 . . . . 64.109999999999999 110.428 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.553 ' O ' HG11 ' A' ' 162' ' ' VAL . 29.1 m-85 -105.26 169.42 8.46 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.504 1.127 . . . . 73.019999999999996 110.985 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.631 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.5 m -66.14 158.02 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.467 1.104 . . . . 70.420000000000002 109.305 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 58.2 66.05 3.09 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.479 1.112 . . . . 34.200000000000003 110.983 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.547 ' O ' HD13 ' A' ' 161' ' ' ILE . 9.1 tp10 -131.78 157.53 43.62 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.475 0.75 . . . . 64.0 110.32 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.418 ' ND2' HG12 ' A' ' 161' ' ' ILE . 2.3 m-80 -118.61 129.12 55.14 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.499 1.124 . . . . 74.329999999999998 109.247 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.752 HD23 ' N ' ' A' ' 182' ' ' LEU . 0.5 OUTLIER -140.67 150.02 42.98 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 52.32 109.244 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 5.5 m-85 -104.1 114.38 28.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.485 1.116 . . . . 75.230000000000004 111.002 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.589 HD11 ' HB3' ' A' ' 160' ' ' ALA . 1.6 mp -62.08 156.5 4.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 124.508 1.13 . . . . 75.140000000000001 109.249 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.458 ' N ' ' O ' ' A' ' 194' ' ' ILE . 0.1 OUTLIER -139.8 -48.15 0.46 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.461 1.1 . . . . 45.229999999999997 108.272 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.692 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -124.85 170.28 11.22 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.492 1.12 . . . . 70.510000000000005 109.324 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.524 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.2 OUTLIER -152.93 143.82 22.93 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.524 1.14 . . . . 74.140000000000001 109.603 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.714 ' NE2' HD11 ' A' ' 194' ' ' ILE . 0.2 OUTLIER -145.58 140.59 27.51 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.474 1.109 . . . . 72.420000000000002 109.622 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.491 ' C ' ' N ' ' A' ' 191' ' ' GLU . 67.3 t30 49.26 23.17 0.76 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.497 1.123 . . . . 54.329999999999998 109.368 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.411 ' C ' ' O ' ' A' ' 189' ' ' ASN . 14.5 p 41.0 28.17 0.05 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.471 1.107 . . . . 71.450000000000003 108.308 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.798 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 7.7 tt0 -125.38 -39.0 2.22 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.422 1.077 . . . . 54.32 110.304 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.595 ' CZ2' ' HD3' ' B' ' 477' ' ' PRO . 99.1 m95 -112.68 130.9 55.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.018 -1.105 . . . . 72.450000000000003 108.018 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.754 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.9 m-30 -121.91 142.11 50.6 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.54 1.15 . . . . 75.239999999999995 110.97 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.714 HD11 ' NE2' ' A' ' 188' ' ' HIS . 4.3 mm -101.19 95.98 4.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.422 1.076 . . . . 73.230000000000004 109.263 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -103.93 -177.05 3.26 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.485 1.116 . . . . 61.039999999999999 109.293 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.452 ' CD ' ' HB3' ' A' ' 204' ' ' PRO . 3.9 mtmm -148.45 159.61 38.48 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.506 1.129 . . . . 71.120000000000005 109.291 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.359 1.126 0 O-C-N 124.522 1.801 . . . . 62.109999999999999 110.954 -179.974 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.477 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.531 1.048 0 N-CA-C 111.011 -0.836 . . . . 70.209999999999994 111.011 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.477 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.3 Cg_endo -75.01 131.17 23.32 Favored 'Cis proline' 0 C--N 1.359 1.122 0 C-N-CA 121.034 -2.486 . . . . 72.019999999999996 111.008 0.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.57 ' CA ' HD21 ' A' ' 174' ' ' LEU . . . -101.05 165.73 18.74 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.485 1.116 . . . . 62.049999999999997 111.004 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.584 HD11 ' CE3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -108.7 149.78 28.5 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.487 0.757 . . . . 64.409999999999997 109.281 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.778 ' CG1' HG11 ' A' ' 212' ' ' VAL . 0.4 OUTLIER -157.04 133.68 6.36 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.449 1.093 . . . . 72.230000000000004 109.282 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.557 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.2 Cg_endo -75.07 169.34 22.81 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.475 1.776 . . . . 72.439999999999998 110.995 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.754 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.6 OUTLIER -93.74 6.86 6.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.438 1.086 . . . . 62.130000000000003 109.336 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . 0.487 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -106.69 -3.6 37.09 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.442 1.089 . . . . 72.109999999999999 111.014 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.607 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 23.3 m-85 -129.03 4.99 5.33 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.462 0.742 . . . . 54.509999999999998 110.973 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.778 HG11 ' CG1' ' A' ' 207' ' ' VAL . 2.1 m -141.43 150.55 19.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.468 1.105 . . . . 75.140000000000001 109.329 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.688 ' HB2' HD11 ' A' ' 163' ' ' LEU . 1.4 t -110.73 133.29 53.46 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.524 1.14 . . . . 55.009999999999998 109.974 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.445 ' C ' HG23 ' A' ' 215' ' ' ILE . 4.8 mm -77.57 135.33 26.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.43 1.081 . . . . 73.519999999999996 109.338 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.479 HD13 ' HA ' ' A' ' 160' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.501 0 O-C-N 124.5 1.125 . . . . 53.229999999999997 109.33 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 230' ' ' ASP . 7.6 m-20 . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 109.341 -0.614 . . . . 74.209999999999994 109.341 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.788 ' O ' HD12 ' A' ' 231' ' ' ILE . 2.7 p -49.36 -45.55 18.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.482 1.113 . . . . 45.450000000000003 109.318 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.486 ' H ' HD12 ' A' ' 228' ' ' ILE . 3.9 mp -63.53 -30.56 50.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.455 1.097 . . . . 71.299999999999997 109.271 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.421 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 7.8 mt-10 -86.14 -14.56 43.78 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.429 1.081 . . . . 72.319999999999993 110.288 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 226' ' ' ASP . 8.9 t0 -88.39 -15.75 34.71 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.479 1.112 . . . . 74.319999999999993 109.311 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.788 HD12 ' O ' ' A' ' 227' ' ' VAL . 0.6 OUTLIER -72.4 -69.37 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.559 1.162 . . . . 72.329999999999998 109.342 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.638 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -57.88 -20.87 39.94 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.568 1.168 . . . . 72.140000000000001 109.281 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.6 t -48.57 -57.49 6.11 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.54 1.15 . . . . 50.25 109.955 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.9 m -93.67 21.12 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.462 1.101 . . . . 71.230000000000004 109.294 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 49.33 29.21 2.64 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.474 1.109 . . . . 73.450000000000003 109.311 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.469 HD12 ' HD2' ' A' ' 237' ' ' PRO . 4.4 tp -65.27 119.11 56.55 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.465 1.103 . . . . 71.329999999999998 109.34 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.469 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.4 Cg_endo -74.92 173.03 15.18 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.461 1.769 . . . . 73.439999999999998 111.008 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 239' ' ' VAL . 1.5 m -66.25 -170.66 0.09 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.58 1.175 . . . . 73.540000000000006 110.389 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.597 HG22 ' HD3' ' A' ' 243' ' ' LYS . 9.8 p -79.96 -35.68 16.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.624 1.202 . . . . 63.200000000000003 109.351 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.575 ' HG3' HG13 ' A' ' 239' ' ' VAL . 0.5 OUTLIER -84.94 -19.14 32.64 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.569 1.168 . . . . 64.510000000000005 110.282 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -81.51 -39.17 25.12 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.493 1.121 . . . . 70.109999999999999 110.338 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.497 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 5.8 t90 -77.98 -61.25 2.06 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 72.200000000000003 107.978 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.597 ' HD3' HG22 ' A' ' 239' ' ' VAL . 1.6 mtpm? -59.05 -17.38 25.1 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.462 1.101 . . . . 55.549999999999997 109.302 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 243' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.457 0 O-C-N 124.576 1.173 . . . . 72.030000000000001 109.988 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 470' ' ' PHE . . . . . 0.539 ' C ' HD12 ' B' ' 471' ' ' ILE . 8.6 m-30 . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 120.45 0.166 . . . . 74.120000000000005 110.972 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 471' ' ' ILE . . . . . 0.569 ' N ' ' CD1' ' B' ' 471' ' ' ILE . 1.1 mp -98.55 138.14 20.74 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.546 1.154 . . . . 54.539999999999999 109.291 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 472' ' ' PRO . . . . . 0.533 ' HD2' HG23 ' B' ' 471' ' ' ILE . 18.2 Cg_endo -75.03 138.63 23.21 Favored 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.485 1.782 . . . . 61.43 110.955 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 21.1 t -66.11 -72.25 0.17 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.54 1.15 . . . . 62.25 109.984 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.59 157.21 88.91 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.544 1.152 . . . . 71.400000000000006 110.309 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -167.59 0.44 Allowed 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.531 1.806 . . . . 75.400000000000006 110.947 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 476' ' ' ALA . . . . . 0.798 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . -56.49 131.11 76.8 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 23.399999999999999 109.314 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 477' ' ' PRO . . . . . 0.595 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -75.04 -162.58 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.489 1.784 . . . . 61.219999999999999 111.022 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 478' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -135.54 91.37 18.51 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.509 1.13 . . . . 73.019999999999996 109.321 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 479' ' ' PRO . . . . . 0.607 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.2 Cg_endo -74.99 154.92 42.88 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.463 1.77 . . . . 61.340000000000003 111.051 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 480' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' B' ' 479' ' ' PRO . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.154 0 O-C-N 124.459 1.768 . . . . 70.030000000000001 111.042 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.741 ' CE2' ' CZ ' ' A' ' 183' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 120.487 0.184 . . . . 75.409999999999997 111.029 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.949 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -103.93 148.61 25.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.567 1.167 . . . . 75.129999999999995 109.311 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.598 HG23 HD23 ' A' ' 163' ' ' LEU . 0.2 OUTLIER -131.28 128.84 62.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.574 1.171 . . . . 55.119999999999997 109.228 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.797 HG22 HG12 ' A' ' 212' ' ' VAL . 2.6 t -80.83 119.23 30.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.529 1.143 . . . . 70.319999999999993 109.296 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.598 HD23 HG23 ' A' ' 161' ' ' ILE . 0.9 OUTLIER -94.3 -15.92 24.01 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.561 1.163 . . . . 71.030000000000001 109.321 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.622 ' O ' HG13 ' A' ' 162' ' ' VAL . 1.0 OUTLIER -150.0 155.96 40.86 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.466 1.104 . . . . 75.540000000000006 111.002 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.685 ' H ' HG12 ' A' ' 178' ' ' VAL . 1.3 t70 -86.54 157.49 19.74 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.437 1.086 . . . . 72.129999999999995 109.29 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.51 ' HB2' ' CD1' ' A' ' 211' ' ' PHE . 11.7 t80 -154.35 140.57 18.53 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.548 1.155 . . . . 71.420000000000002 110.999 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -84.19 115.02 22.21 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.436 1.085 . . . . 74.430000000000007 109.3 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.934 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -103.55 131.54 50.59 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.49 1.119 . . . . 64.319999999999993 109.323 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -138.63 11.36 2.71 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.469 1.106 . . . . 74.450000000000003 110.265 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.519 ' HE3' ' CH2' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -83.0 -175.92 6.08 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.513 1.133 . . . . 62.229999999999997 109.272 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -64.04 -24.64 67.78 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.507 1.13 . . . . 73.5 109.307 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.475 ' HB3' ' CB ' ' A' ' 206' ' ' LEU . 72.4 m-20 -112.89 15.69 19.68 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.557 1.16 . . . . 72.230000000000004 109.351 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.934 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 2.0 pp20? -34.0 108.99 0.07 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.424 1.078 . . . . 71.010000000000005 110.244 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.608 HD23 ' HA3' ' A' ' 205' ' ' GLY . 0.7 OUTLIER -115.75 96.27 5.53 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.54 1.15 . . . . 44.43 109.264 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 15.2 t -82.36 133.08 35.22 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.561 1.163 . . . . 72.329999999999998 110.401 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.825 HG23 ' HG2' ' A' ' 180' ' ' GLU . 0.9 OUTLIER -160.76 146.46 14.71 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.478 1.111 . . . . 73.310000000000002 110.383 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -81.43 168.81 17.91 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.544 1.153 . . . . 62.109999999999999 111.025 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.685 HG12 ' H ' ' A' ' 165' ' ' ASP . 2.3 m -60.88 158.19 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.509 1.131 . . . . 64.340000000000003 109.298 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 53.33 59.23 9.85 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.551 1.157 . . . . 53.409999999999997 110.957 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.825 ' HG2' HG23 ' A' ' 176' ' ' THR . 1.3 tp10 -116.59 179.81 3.9 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.483 0.755 . . . . 74.200000000000003 110.328 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.423 ' ND2' HG12 ' A' ' 161' ' ' ILE . 27.5 m120 -132.62 139.71 47.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.525 1.14 . . . . 74.140000000000001 109.252 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.698 HD22 HG11 ' A' ' 207' ' ' VAL . 0.1 OUTLIER -152.17 149.36 28.67 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 75.230000000000004 109.335 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.741 ' CZ ' ' CE2' ' A' ' 159' ' ' TYR . 2.1 m-85 -109.0 111.63 23.4 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.424 1.077 . . . . 64.340000000000003 110.995 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.949 HD13 ' HB2' ' A' ' 160' ' ' ALA . 1.6 mp -71.0 164.15 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.133 . . . . 61.399999999999999 109.314 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.595 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 3.5 p -159.9 -41.5 0.05 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.524 1.14 . . . . 73.099999999999994 108.283 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.978 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -114.69 152.5 31.87 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.528 1.142 . . . . 71.209999999999994 109.308 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.547 ' CD2' HD21 ' A' ' 236' ' ' LEU . 0.0 OUTLIER -145.18 151.13 37.95 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.127 . . . . 53.240000000000002 109.634 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.583 ' CD2' ' O ' ' A' ' 192' ' ' TRP . 1.3 p80 -156.39 146.51 21.3 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 72.200000000000003 109.612 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.477 ' C ' ' N ' ' A' ' 191' ' ' GLU . 0.1 OUTLIER 51.18 22.43 1.32 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 74.519999999999996 109.317 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.44 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.1 p 39.06 30.01 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.49 1.119 . . . . 74.129999999999995 108.229 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.551 ' O ' HG13 ' A' ' 209' ' ' VAL . 11.6 tt0 -134.18 -40.39 0.83 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.542 1.151 . . . . 74.319999999999993 110.361 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.933 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 97.2 m95 -105.61 127.7 53.2 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.987 -1.116 . . . . 70.209999999999994 107.987 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.742 ' CE2' HG12 ' A' ' 209' ' ' VAL . 16.9 m-30 -125.14 130.08 51.46 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.387 1.054 . . . . 75.209999999999994 111.02 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.978 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 1.5 mp -88.81 110.81 21.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.51 1.132 . . . . 74.409999999999997 109.358 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.527 ' HB2' HG13 ' A' ' 184' ' ' ILE . . . -118.87 177.38 4.87 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.489 1.118 . . . . 52.439999999999998 109.322 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.463 ' CD ' ' HD2' ' A' ' 197' ' ' PRO . 4.6 tptm -124.89 140.26 35.35 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.467 1.104 . . . . 71.310000000000002 109.333 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.463 ' HD2' ' CD ' ' A' ' 196' ' ' LYS . 18.1 Cg_endo . . . . . 0 C--N 1.36 1.171 0 O-C-N 124.5 1.79 . . . . 74.099999999999994 110.982 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.507 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.53 0.972 0 N-CA-C 111.015 -0.834 . . . . 60.140000000000001 111.015 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.507 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.2 Cg_endo -75.01 146.15 85.87 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.039 -2.484 . . . . 64.129999999999995 111.026 0.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.608 ' HA3' HD23 ' A' ' 174' ' ' LEU . . . -109.36 177.64 20.23 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.525 1.141 . . . . 71.140000000000001 111.01 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.933 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -97.97 147.2 24.73 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.463 0.743 . . . . 53.219999999999999 109.347 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.698 HG11 HD22 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -155.01 125.57 3.41 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 124.525 1.14 . . . . 60.119999999999997 109.315 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.844 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.4 Cg_endo -75.02 176.77 9.48 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.529 1.805 . . . . 60.200000000000003 111.076 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.742 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.6 m -96.85 5.33 8.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.587 1.179 . . . . 53.109999999999999 109.332 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -108.89 6.44 32.87 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.537 1.148 . . . . 70.540000000000006 111.024 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.6 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 11.6 m-85 -139.64 12.18 2.51 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.439 0.729 . . . . 74.25 111.043 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 208' ' ' PRO . 11.4 m -154.39 157.7 4.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.483 1.114 . . . . 73.310000000000002 109.317 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.541 ' HB2' HD11 ' A' ' 163' ' ' LEU . 22.5 t -129.62 124.17 33.07 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.494 1.121 . . . . 75.319999999999993 110.042 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.586 ' C ' HG22 ' A' ' 215' ' ' ILE . 3.4 mm -78.08 149.95 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.496 1.122 . . . . 72.129999999999995 109.35 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.586 HG22 ' C ' ' A' ' 214' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 71.530000000000001 109.251 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 229' ' ' GLU . 6.2 t0 . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 109.266 -0.642 . . . . 62.100000000000001 109.266 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.736 HG21 ' HE2' ' A' ' 193' ' ' PHE . 0.6 OUTLIER -44.28 -44.53 2.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.495 1.122 . . . . 64.530000000000001 109.311 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.812 ' HA ' HD12 ' A' ' 231' ' ' ILE . 29.4 mt -58.21 -41.49 81.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 73.540000000000006 109.342 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 226' ' ' ASP . 14.6 mt-10 -69.34 -17.53 63.71 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.559 1.162 . . . . 54.350000000000001 110.351 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.94 -16.4 31.89 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.543 1.152 . . . . 74.239999999999995 109.252 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.812 HD12 ' HA ' ' A' ' 228' ' ' ILE . 2.5 mt -71.39 -69.37 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.57 1.169 . . . . 74.239999999999995 109.279 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.505 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -58.97 -21.23 58.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 72.25 109.278 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.6 -56.51 13.12 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.131 . . . . 64.109999999999999 109.97 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.1 m -97.92 19.11 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.447 1.092 . . . . 72.129999999999995 109.295 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 40.82 31.47 0.12 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.458 1.099 . . . . 63.329999999999998 109.282 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.547 HD21 ' CD2' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -61.23 124.01 78.53 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 63.240000000000002 109.29 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 -179.62 5.18 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.46 1.769 . . . . 71.230000000000004 110.947 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 239' ' ' VAL . 1.3 m -69.45 -173.51 0.57 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.523 1.139 . . . . 74.030000000000001 110.416 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.586 HG12 ' HB1' ' A' ' 186' ' ' ALA . 1.2 m -78.45 -38.05 22.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.469 1.106 . . . . 65.319999999999993 109.33 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.421 ' HG3' ' CG2' ' A' ' 239' ' ' VAL . 0.4 OUTLIER -81.51 -15.39 55.06 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.435 1.085 . . . . 73.209999999999994 110.283 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -83.89 -38.81 20.64 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.443 1.09 . . . . 74.450000000000003 110.319 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.669 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 0.3 OUTLIER -83.73 -63.06 1.42 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.966 -1.124 . . . . 73.409999999999997 107.966 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.568 ' NZ ' ' CG ' ' B' ' 470' ' ' PHE . 13.2 mtmt -51.36 -22.49 2.95 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.571 1.169 . . . . 73.209999999999994 109.285 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.532 1.145 . . . . 71.409999999999997 110.017 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 470' ' ' PHE . . . . . 0.568 ' CG ' ' NZ ' ' A' ' 243' ' ' LYS . 5.5 m-30 . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.486 0.184 . . . . 74.400000000000006 110.968 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 471' ' ' ILE . . . . . 0.708 HG23 ' HD2' ' B' ' 472' ' ' PRO . 19.2 mm -91.83 142.38 26.51 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.486 1.116 . . . . 65.109999999999999 109.262 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 472' ' ' PRO . . . . . 0.708 ' HD2' HG23 ' B' ' 471' ' ' ILE . 18.4 Cg_endo -75.07 156.65 42.71 Favored 'Trans proline' 0 C--N 1.361 1.236 0 O-C-N 124.486 1.782 . . . . 71.540000000000006 111.027 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 19.1 t -99.43 -44.15 6.29 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.513 1.133 . . . . 61.119999999999997 110.046 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -102.17 167.94 9.71 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 72.129999999999995 110.348 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.95 -168.28 0.5 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.456 1.766 . . . . 62.409999999999997 110.997 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 476' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' B' ' 477' ' ' PRO . . . -59.03 140.29 87.1 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.51 1.131 . . . . 43.450000000000003 109.307 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 477' ' ' PRO . . . . . 0.619 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -75.09 -162.12 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.545 1.813 . . . . 74.200000000000003 111.027 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.74 87.93 11.01 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.573 1.17 . . . . 44.310000000000002 109.277 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 479' ' ' PRO . . . . . 0.6 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.3 Cg_endo -75.03 169.59 22.27 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.419 1.747 . . . . 64.510000000000005 110.986 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 C--N 1.36 1.149 0 O-C-N 124.485 1.781 . . . . 61.32 111.008 179.966 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.702 ' CE2' ' CE1' ' A' ' 183' ' ' PHE . 5.6 m-30 . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.548 0.213 . . . . 71.430000000000007 110.972 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.742 ' HB3' ' CD2' ' A' ' 182' ' ' LEU . . . -124.31 145.63 49.29 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.489 1.118 . . . . 72.5 109.282 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.498 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -123.32 127.36 74.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.496 1.123 . . . . 72.140000000000001 109.322 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.915 HG22 HG12 ' A' ' 212' ' ' VAL . 1.1 t -82.57 118.03 29.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 124.512 1.132 . . . . 72.019999999999996 109.248 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.66 HD11 ' OG ' ' A' ' 213' ' ' SER . 1.7 mt -92.32 -16.21 26.35 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.523 1.139 . . . . 73.549999999999997 109.255 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.653 ' O ' HG13 ' A' ' 162' ' ' VAL . 3.0 m-85 -145.94 158.51 43.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.437 1.085 . . . . 73.239999999999995 111.058 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.817 ' N ' HG12 ' A' ' 178' ' ' VAL . 0.6 OUTLIER -96.77 159.4 14.94 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.476 1.11 . . . . 71.310000000000002 109.321 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.57 ' HB2' ' CE2' ' A' ' 211' ' ' PHE . 28.3 t80 -160.63 131.81 5.63 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.554 1.159 . . . . 71.040000000000006 111.033 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -67.34 129.33 39.55 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.463 1.102 . . . . 72.340000000000003 109.305 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.854 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -107.28 141.13 39.1 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.442 1.089 . . . . 73.409999999999997 109.332 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -149.7 22.38 0.9 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.539 1.149 . . . . 73.25 110.315 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.562 ' HE3' ' CZ3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -99.88 -175.91 3.1 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.43 1.081 . . . . 75.510000000000005 109.282 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.25 -28.88 67.12 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.491 1.119 . . . . 64.530000000000001 109.336 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.461 ' CB ' ' HB2' ' A' ' 206' ' ' LEU . 76.1 m-20 -108.46 20.05 19.06 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.498 1.124 . . . . 73.319999999999993 109.282 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.854 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 8.0 pt-20 -38.02 106.33 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.395 1.059 . . . . 75.299999999999997 110.304 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.696 HD22 ' HA3' ' A' ' 205' ' ' GLY . 4.2 tp -124.39 113.7 18.53 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.522 1.139 . . . . 73.430000000000007 109.307 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 175' ' ' THR . 12.1 t -89.06 111.36 22.07 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.471 1.107 . . . . 70.140000000000001 110.427 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.481 HG22 ' HG3' ' A' ' 180' ' ' GLU . 59.2 m -128.87 142.76 50.86 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.473 1.108 . . . . 64.120000000000005 110.401 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -83.48 162.33 20.98 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.548 1.155 . . . . 72.430000000000007 110.945 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.817 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.4 m -60.37 158.24 2.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.488 1.117 . . . . 65.340000000000003 109.245 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.4 48.22 60.58 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.555 1.159 . . . . 72.329999999999998 110.979 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.498 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 11.9 mm-40 -105.07 168.51 9.01 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 0.766 . . . . 75.450000000000003 110.32 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.423 ' ND2' HG12 ' A' ' 161' ' ' ILE . 2.2 m-80 -128.0 117.13 21.14 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.454 1.096 . . . . 70.319999999999993 109.312 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.784 ' N ' HD13 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -134.89 146.89 49.64 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.521 1.138 . . . . 70.120000000000005 109.294 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.702 ' CE1' ' CE2' ' A' ' 159' ' ' TYR . 9.8 m-30 -100.21 116.82 33.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.472 1.107 . . . . 72.329999999999998 111.035 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 1.043 HD13 ' HB2' ' A' ' 195' ' ' ALA . 14.1 mm -59.52 151.04 5.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.579 1.175 . . . . 73.5 109.359 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.559 ' O ' ' CZ3' ' A' ' 242' ' ' TRP . 2.8 m -133.83 -46.53 0.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.525 1.141 . . . . 75.140000000000001 108.303 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.869 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -127.63 174.07 9.37 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.506 1.129 . . . . 74.329999999999998 109.348 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -157.06 141.59 16.68 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 1.114 . . . . 73.239999999999995 109.636 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.596 ' CD2' ' O ' ' A' ' 192' ' ' TRP . 0.1 OUTLIER -143.21 139.35 30.23 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.458 1.099 . . . . 74.109999999999999 109.552 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.466 ' C ' ' N ' ' A' ' 191' ' ' GLU . 27.6 t-20 50.83 22.7 1.21 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.508 1.13 . . . . 61.039999999999999 109.345 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.402 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.8 m 41.54 29.02 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.475 1.109 . . . . 72.5 108.239 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.94 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 18.2 tt0 -127.59 -38.74 1.88 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.436 1.085 . . . . 54.329999999999998 110.309 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.67 ' CE3' HD21 ' A' ' 206' ' ' LEU . 96.3 m95 -112.21 125.19 53.88 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.519 1.137 . . . . 72.049999999999997 108.017 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.877 ' HB3' HD12 ' A' ' 184' ' ' ILE . 19.1 m-30 -115.15 150.69 35.65 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.498 1.124 . . . . 75.129999999999995 111.028 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.869 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 14.8 mm -112.16 91.24 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.557 1.161 . . . . 74.420000000000002 109.327 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 1.043 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -94.75 -175.24 3.52 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.514 1.134 . . . . 71.310000000000002 109.35 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.481 ' CG ' ' SG ' ' A' ' 185' ' ' CYS . 0.0 OUTLIER -156.42 158.19 31.36 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.556 1.16 . . . . 61.119999999999997 109.249 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 C--N 1.36 1.145 0 O-C-N 124.491 1.785 . . . . 65.530000000000001 110.987 -179.981 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.417 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . . . . . . 0 CA--C 1.53 0.991 0 N-CA-C 110.992 -0.843 . . . . 74.329999999999998 110.992 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.511 ' HB2' HG22 ' A' ' 194' ' ' ILE . 18.2 Cg_endo -75.03 127.29 14.17 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.024 -2.49 . . . . 72.310000000000002 110.962 0.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.696 ' HA3' HD22 ' A' ' 174' ' ' LEU . . . -97.65 145.75 17.95 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.573 1.17 . . . . 72.219999999999999 111.021 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.67 HD21 ' CE3' ' A' ' 192' ' ' TRP . 0.3 OUTLIER -92.32 146.65 23.53 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.562 0.801 . . . . 70.450000000000003 109.351 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.759 ' CG1' HG11 ' A' ' 212' ' ' VAL . 0.4 OUTLIER -160.31 131.02 3.67 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.522 1.139 . . . . 74.329999999999998 109.275 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 191' ' ' GLU . 18.2 Cg_endo -75.06 168.5 24.67 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.471 1.774 . . . . 60.130000000000003 110.967 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.637 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.9 OUTLIER -89.27 2.52 6.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.479 1.112 . . . . 75.310000000000002 109.228 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -101.76 -5.96 50.28 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.557 1.16 . . . . 72.109999999999999 110.951 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.625 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 12.0 m-85 -125.22 1.0 7.82 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 0.774 . . . . 72.329999999999998 111.013 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.915 HG12 HG22 ' A' ' 162' ' ' VAL . 1.3 m -142.63 160.85 18.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.407 1.067 . . . . 74.349999999999994 109.346 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.66 ' OG ' HD11 ' A' ' 163' ' ' LEU . 3.9 m -125.25 138.34 54.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.581 1.176 . . . . 72.519999999999996 110.015 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.809 ' O ' HG23 ' A' ' 215' ' ' ILE . 3.5 mm -78.77 147.34 6.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.473 1.108 . . . . 74.299999999999997 109.246 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.809 HG23 ' O ' ' A' ' 214' ' ' ILE . 7.6 pt . . . . . 0 C--N 1.325 -0.488 0 O-C-N 124.442 1.089 . . . . 74.150000000000006 109.287 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.245 -0.65 . . . . 64.010000000000005 109.245 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.446 ' O ' HD12 ' A' ' 231' ' ' ILE . 0.4 OUTLIER -42.94 -48.51 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.514 1.134 . . . . 73.439999999999998 109.246 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 231' ' ' ILE . 2.6 mp -60.21 -58.12 8.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.48 1.112 . . . . 61.130000000000003 109.257 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 233' ' ' SER . 7.5 mt-10 -46.12 -26.52 0.77 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.525 1.14 . . . . 75.209999999999994 110.337 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.616 ' O ' HG13 ' A' ' 234' ' ' VAL . 9.9 t0 -77.09 -37.85 53.54 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 62.200000000000003 109.261 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.499 ' N ' ' O ' ' A' ' 228' ' ' ILE . 0.6 OUTLIER -59.54 -60.26 2.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.544 1.153 . . . . 64.049999999999997 109.272 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' A' ' 228' ' ' ILE . 0.0 OUTLIER -62.65 -44.56 95.95 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.508 1.13 . . . . 71.150000000000006 109.329 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 229' ' ' GLU . 1.5 m -41.15 -60.03 1.34 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.489 1.118 . . . . 64.239999999999995 109.982 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.616 HG13 ' O ' ' A' ' 230' ' ' ASP . 1.5 m -73.32 -22.49 19.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.478 1.111 . . . . 74.109999999999999 109.3 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 234' ' ' VAL . 5.7 m120 79.09 28.43 0.39 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.503 1.127 . . . . 71.200000000000003 109.29 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.479 HD12 ' HD2' ' A' ' 237' ' ' PRO . 3.4 tp -66.44 125.93 91.26 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.51 1.131 . . . . 71.219999999999999 109.287 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.479 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.5 Cg_endo -74.94 161.08 39.52 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.43 1.753 . . . . 62.039999999999999 111.057 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 239' ' ' VAL . 1.8 m -60.25 178.49 0.19 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.539 1.149 . . . . 54.329999999999998 110.329 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.635 HG13 ' HG3' ' A' ' 240' ' ' GLN . 14.6 p -72.59 -37.83 57.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.506 1.129 . . . . 63.450000000000003 109.287 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.635 ' HG3' HG13 ' A' ' 239' ' ' VAL . 2.3 mt-30 -79.99 -22.54 42.41 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.543 1.152 . . . . 74.230000000000004 110.268 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -82.97 -43.2 16.69 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.431 1.082 . . . . 72.439999999999998 110.306 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.559 ' CZ3' ' O ' ' A' ' 185' ' ' CYS . 9.4 t90 -70.59 -58.79 3.31 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.139 . . . . 75.010000000000005 108.002 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.464 ' NZ ' HG22 ' A' ' 239' ' ' VAL . 9.6 mtmm -56.19 -18.98 11.75 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.555 1.159 . . . . 55.530000000000001 109.292 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 C--N 1.325 -0.478 0 O-C-N 124.437 1.085 . . . . 71.409999999999997 109.993 -179.961 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 470' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.487 0.184 . . . . 70.340000000000003 111.004 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 471' ' ' ILE . . . . . 0.722 HG23 ' HD2' ' B' ' 472' ' ' PRO . 27.6 mm -115.36 142.33 28.55 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.494 1.122 . . . . 63.210000000000001 109.353 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 472' ' ' PRO . . . . . 0.722 ' HD2' HG23 ' B' ' 471' ' ' ILE . 18.3 Cg_endo -75.0 127.51 10.73 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.539 1.81 . . . . 70.150000000000006 111.025 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 8.5 t -75.01 -52.87 10.02 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.446 1.091 . . . . 65.450000000000003 109.985 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 474' ' ' ARG . . . . . 0.417 ' HA ' ' NE ' ' B' ' 474' ' ' ARG . 5.2 mmp_? -82.89 160.52 60.66 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 74.420000000000002 110.338 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.01 -166.54 0.35 Allowed 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.441 1.759 . . . . 71.349999999999994 111.012 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 476' ' ' ALA . . . . . 0.94 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . -60.31 136.52 91.64 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 71.230000000000004 109.288 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 477' ' ' PRO . . . . . 0.583 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -74.92 -164.77 0.25 Allowed 'Trans proline' 0 C--N 1.359 1.105 0 O-C-N 124.507 1.793 . . . . 64.120000000000005 110.978 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 90.89 10.98 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.473 1.108 . . . . 64.400000000000006 109.326 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 479' ' ' PRO . . . . . 0.625 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.3 Cg_endo -74.99 166.15 29.83 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.519 1.8 . . . . 71.409999999999997 111.007 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.36 1.133 0 O-C-N 124.443 1.759 . . . . 72.129999999999995 110.984 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.582 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 1.1 p90 . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.488 0.185 . . . . 73.510000000000005 110.982 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.917 ' HB3' ' CD2' ' A' ' 182' ' ' LEU . . . -121.92 153.77 38.03 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.565 1.166 . . . . 71.510000000000005 109.297 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.501 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.2 OUTLIER -122.51 128.52 75.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.491 1.12 . . . . 73.439999999999998 109.318 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.714 HG22 HG12 ' A' ' 212' ' ' VAL . 0.9 OUTLIER -84.65 122.99 38.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.501 1.126 . . . . 75.319999999999993 109.324 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.579 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 0.6 OUTLIER -98.35 -13.81 20.49 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.56 1.163 . . . . 75.299999999999997 109.258 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.605 ' O ' HG13 ' A' ' 162' ' ' VAL . 4.8 m-85 -145.7 161.24 40.35 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.522 1.139 . . . . 75.239999999999995 111.004 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.811 ' N ' HG12 ' A' ' 178' ' ' VAL . 2.5 p30 -101.01 156.78 17.21 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.435 1.084 . . . . 71.140000000000001 109.277 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.603 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 1.3 t80 -153.26 131.42 11.91 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.456 1.098 . . . . 72.219999999999999 111.0 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.603 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 8.9 mtpt -67.04 124.52 23.27 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.471 1.107 . . . . 54.100000000000001 109.267 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.809 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -92.98 135.87 33.77 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.566 1.166 . . . . 61.229999999999997 109.299 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.892 ' H ' ' HZ3' ' A' ' 170' ' ' LYS . 7.8 pt-20 -150.48 20.69 0.83 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.458 1.099 . . . . 70.109999999999999 110.269 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.892 ' HZ3' ' H ' ' A' ' 169' ' ' GLU . 0.1 OUTLIER -106.19 -175.57 2.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.463 1.102 . . . . 72.549999999999997 109.333 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.62 -41.03 76.4 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.417 1.073 . . . . 64.450000000000003 109.301 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.616 ' OD1' HD12 ' A' ' 194' ' ' ILE . 72.1 m-20 -94.4 16.93 13.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.54 1.15 . . . . 45.039999999999999 109.313 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.809 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 10.5 pt-20 -36.44 97.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 72.319999999999993 110.281 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.485 ' CB ' ' HA2' ' A' ' 205' ' ' GLY . 0.0 OUTLIER -138.22 95.52 3.03 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.439 1.087 . . . . 70.120000000000005 109.339 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.2 t -59.53 153.56 19.35 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.556 1.16 . . . . 72.219999999999999 110.446 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 4.9 m -152.51 109.34 3.48 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.436 1.085 . . . . 51.439999999999998 110.425 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.516 ' O ' HG11 ' A' ' 162' ' ' VAL . 14.8 m-85 -52.11 159.14 0.96 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.513 1.133 . . . . 71.439999999999998 111.004 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.811 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.5 m -65.68 158.62 4.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.446 1.091 . . . . 74.120000000000005 109.31 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 48.41 63.12 3.91 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.479 1.112 . . . . 61.340000000000003 111.032 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.501 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 2.0 tp10 -127.99 173.13 10.3 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.526 0.78 . . . . 74.099999999999994 110.278 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -122.68 123.07 40.28 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 71.439999999999998 109.318 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.917 ' CD2' ' HB3' ' A' ' 160' ' ' ALA . 0.0 OUTLIER -130.65 135.06 47.48 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.554 1.159 . . . . 74.400000000000006 109.262 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 8.3 m-30 -89.19 96.83 10.88 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.488 1.117 . . . . 73.439999999999998 110.998 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.858 HD12 ' HB2' ' A' ' 160' ' ' ALA . 51.5 mt -64.34 153.82 7.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 73.099999999999994 109.334 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.492 ' O ' ' CD1' ' A' ' 236' ' ' LEU . 4.3 m -146.52 -44.68 0.19 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.52 1.138 . . . . 73.219999999999999 108.242 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.931 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -112.25 170.91 7.84 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.5 1.125 . . . . 73.510000000000005 109.265 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.641 ' CD2' HD21 ' A' ' 236' ' ' LEU . 2.7 p80 -156.79 165.21 36.86 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 75.140000000000001 109.687 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 1.161 ' CE1' HG11 ' A' ' 239' ' ' VAL . 0.1 OUTLIER -143.7 113.29 7.02 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.49 1.119 . . . . 52.32 109.609 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.473 ' C ' ' N ' ' A' ' 191' ' ' GLU . 88.0 m-20 50.65 41.49 25.93 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.535 1.147 . . . . 75.109999999999999 109.359 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.418 ' C ' ' O ' ' A' ' 189' ' ' ASN . 3.6 m 40.04 30.01 0.06 Allowed 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.463 1.102 . . . . 71.040000000000006 108.333 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.812 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 17.3 tt0 -118.59 -39.69 2.97 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 1.123 . . . . 61.399999999999999 110.307 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.711 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 94.9 m95 -113.14 146.58 38.98 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.532 1.145 . . . . 74.430000000000007 107.927 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.792 ' CE2' HG12 ' A' ' 209' ' ' VAL . 21.5 m-30 -132.87 128.46 36.66 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.475 1.109 . . . . 64.439999999999998 110.957 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.931 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 8.5 mm -95.71 100.5 11.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.548 1.155 . . . . 64.530000000000001 109.324 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.542 ' HB2' ' CG1' ' A' ' 184' ' ' ILE . . . -111.82 171.31 7.57 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.5 1.125 . . . . 72.129999999999995 109.333 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -134.91 148.11 65.61 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.558 1.162 . . . . 74.099999999999994 109.254 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 C--N 1.359 1.123 0 O-C-N 124.481 1.779 . . . . 61.340000000000003 111.003 179.996 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.495 ' HA3' ' C ' ' A' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.531 1.035 0 N-CA-C 111.029 -0.828 . . . . 71.129999999999995 111.029 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.495 ' C ' ' HA3' ' A' ' 203' ' ' GLY . 18.2 Cg_endo -75.02 152.99 98.89 Favored 'Cis proline' 0 C--N 1.36 1.153 0 C-N-CA 120.999 -2.501 . . . . 64.150000000000006 111.021 -0.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 195' ' ' ALA . . . -88.07 158.79 29.51 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.434 1.084 . . . . 42.130000000000003 110.979 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.711 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -104.55 143.96 32.34 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.466 0.745 . . . . 62.109999999999999 109.274 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.771 ' CG1' HG11 ' A' ' 212' ' ' VAL . 0.3 OUTLIER -154.44 135.33 8.63 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.461 1.1 . . . . 75.219999999999999 109.296 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 191' ' ' GLU . 18.2 Cg_endo -74.98 174.36 12.92 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.549 1.816 . . . . 50.450000000000003 110.992 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.792 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -93.36 7.57 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.437 1.086 . . . . 74.439999999999998 109.332 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -108.47 -6.85 30.83 Favored Glycine 0 CA--C 1.529 0.929 0 O-C-N 124.485 1.116 . . . . 52.219999999999999 111.006 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.635 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 5.8 m-85 -121.31 1.64 10.22 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.45 0.735 . . . . 63.25 111.003 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.771 HG11 ' CG1' ' A' ' 207' ' ' VAL . 1.2 m -141.7 166.32 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.552 1.158 . . . . 74.420000000000002 109.226 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.1 t -134.76 134.14 40.64 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 42.32 110.042 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 215' ' ' ILE . 3.4 mm -65.29 138.5 23.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.53 1.144 . . . . 74.420000000000002 109.276 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.552 ' CD1' ' CE2' ' A' ' 159' ' ' TYR . 4.1 pt . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.524 1.14 . . . . 64.150000000000006 109.324 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 229' ' ' GLU . 11.7 t0 . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 109.218 -0.66 . . . . 73.540000000000006 109.218 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -43.81 -44.59 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.528 1.143 . . . . 74.019999999999996 109.265 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.884 ' HA ' HD12 ' A' ' 231' ' ' ILE . 6.7 mt -66.22 -39.95 85.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 70.219999999999999 109.295 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.463 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 18.6 mt-10 -71.82 -18.04 62.11 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.443 1.09 . . . . 63.030000000000001 110.318 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 226' ' ' ASP . 11.3 t70 -88.79 -15.73 33.87 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.135 . . . . 71.109999999999999 109.326 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.884 HD12 ' HA ' ' A' ' 228' ' ' ILE . 4.7 mt -72.68 -69.59 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.518 1.136 . . . . 64.010000000000005 109.281 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.463 ' CD ' ' HA ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -53.29 -31.71 45.17 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.44 1.087 . . . . 72.319999999999993 109.33 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.421 ' N ' ' HG2' ' A' ' 232' ' ' LYS . 1.5 m -41.01 -61.06 1.05 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.53 1.144 . . . . 50.049999999999997 110.001 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.486 ' O ' ' CB ' ' A' ' 235' ' ' ASN . 1.4 m -74.96 -20.46 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.491 1.119 . . . . 74.349999999999994 109.315 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 234' ' ' VAL . 16.6 t-20 80.74 29.11 0.2 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.474 1.109 . . . . 73.439999999999998 109.272 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.641 HD21 ' CD2' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -72.99 119.43 75.52 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.467 1.104 . . . . 73.340000000000003 109.31 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.93 -174.02 1.77 Allowed 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.559 1.82 . . . . 74.219999999999999 111.064 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.429 HG22 ' H ' ' A' ' 239' ' ' VAL . 1.4 m -73.57 -179.92 3.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.443 1.089 . . . . 73.349999999999994 110.407 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 1.161 HG11 ' CE1' ' A' ' 188' ' ' HIS . 1.0 OUTLIER -69.98 -50.75 45.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.528 1.142 . . . . 73.400000000000006 109.282 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.522 ' N ' ' CG2' ' A' ' 239' ' ' VAL . 0.1 OUTLIER -69.45 -15.3 63.25 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.371 1.044 . . . . 72.219999999999999 110.305 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -89.66 -37.47 14.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.55 1.156 . . . . 73.019999999999996 110.281 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.488 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 1.2 t90 -85.54 -62.5 1.51 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.529 1.143 . . . . 61.020000000000003 108.036 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.514 ' HE2' ' CG ' ' B' ' 470' ' ' PHE . 17.6 mtpp -50.67 -24.2 3.17 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.481 1.113 . . . . 74.319999999999993 109.268 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.501 0 O-C-N 124.532 1.145 . . . . 73.120000000000005 109.971 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 470' ' ' PHE . . . . . 0.514 ' CG ' ' HE2' ' A' ' 243' ' ' LYS . 6.0 m-30 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.484 0.183 . . . . 73.120000000000005 111.008 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 471' ' ' ILE . . . . . 0.48 ' CG2' ' HD2' ' B' ' 472' ' ' PRO . 27.0 mm -66.63 140.2 96.32 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.152 . . . . 75.519999999999996 109.293 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 472' ' ' PRO . . . . . 0.48 ' HD2' ' CG2' ' B' ' 471' ' ' ILE . 18.3 Cg_endo -74.92 173.65 14.11 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.492 1.785 . . . . 73.540000000000006 111.013 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 81.8 p -103.56 -47.36 4.28 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.482 1.114 . . . . 34.219999999999999 109.998 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 474' ' ' ARG . . . . . 0.401 ' NE ' ' HA ' ' B' ' 474' ' ' ARG . 11.5 mmp_? -92.94 159.36 35.95 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.61 1.194 . . . . 65.329999999999998 110.319 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 475' ' ' PRO . . . . . 0.583 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.3 Cg_endo -74.99 -38.68 1.48 Allowed 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.486 1.782 . . . . 63.539999999999999 110.965 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 476' ' ' ALA . . . . . 0.812 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . 171.2 128.39 0.06 OUTLIER Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.531 1.144 . . . . 72.030000000000001 109.319 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 477' ' ' PRO . . . . . 0.575 ' HD3' ' CH2' ' A' ' 192' ' ' TRP . 18.2 Cg_endo -75.0 -161.77 0.13 Allowed 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.457 1.767 . . . . 61.329999999999998 110.978 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 478' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -139.92 107.14 6.89 Favored Pre-proline 0 C--N 1.324 -0.529 0 O-C-N 124.497 1.123 . . . . 74.420000000000002 109.329 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 479' ' ' PRO . . . . . 0.635 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.98 162.5 37.07 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.49 1.784 . . . . 44.140000000000001 111.027 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.153 0 O-C-N 124.476 1.777 . . . . 70.540000000000006 110.932 179.998 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.598 ' CZ ' ' CD2' ' A' ' 183' ' ' PHE . 9.2 m-85 . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 120.575 0.226 . . . . 74.409999999999997 110.941 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.938 ' HB3' ' CD2' ' A' ' 182' ' ' LEU . . . -132.1 130.71 41.58 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.458 1.099 . . . . 71.310000000000002 109.252 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.948 HG21 HD11 ' A' ' 215' ' ' ILE . 0.1 OUTLIER -107.96 118.29 55.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.487 1.117 . . . . 64.420000000000002 109.265 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 1.033 ' CG1' HD11 ' A' ' 182' ' ' LEU . 0.6 OUTLIER -84.15 123.26 38.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 74.230000000000004 109.251 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.441 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 0.3 OUTLIER -98.78 -11.61 21.69 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 74.329999999999998 109.392 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.441 ' CE2' ' HB2' ' A' ' 163' ' ' LEU . 8.4 m-85 -140.89 162.19 36.03 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.541 1.15 . . . . 74.400000000000006 111.01 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.822 ' N ' HG12 ' A' ' 178' ' ' VAL . 1.1 p30 -93.29 160.14 14.96 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.501 1.126 . . . . 42.200000000000003 109.273 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.677 ' HZ ' ' HZ1' ' A' ' 170' ' ' LYS . 28.3 t80 -157.2 133.27 9.58 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.458 1.099 . . . . 74.420000000000002 110.954 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -79.45 123.6 27.68 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.533 1.145 . . . . 75.25 109.287 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.852 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -96.68 142.08 29.14 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.453 1.096 . . . . 74.430000000000007 109.326 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -153.73 22.67 0.52 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.406 1.066 . . . . 75.450000000000003 110.253 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.677 ' HZ1' ' HZ ' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -102.75 -176.35 3.07 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.571 1.169 . . . . 62.439999999999998 109.267 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.89 -28.89 67.95 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.465 1.103 . . . . 71.510000000000005 109.284 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 173' ' ' GLU . 15.2 m-20 -105.8 16.07 25.78 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.463 1.102 . . . . 73.209999999999994 109.258 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.852 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 5.3 pt-20 -36.27 105.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.54 1.15 . . . . 75.230000000000004 110.326 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 173' ' ' GLU . 0.2 OUTLIER -141.59 95.04 2.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 55.229999999999997 109.281 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.2 t -62.86 153.16 34.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 72.150000000000006 110.434 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 81.8 m -152.91 110.75 3.6 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.554 1.159 . . . . 64.450000000000003 110.37 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -53.39 156.76 2.28 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.507 1.129 . . . . 61.130000000000003 110.991 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.822 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.5 m -58.21 158.19 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.431 1.082 . . . . 71.349999999999994 109.327 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.31 72.41 0.49 Allowed Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.568 1.168 . . . . 31.210000000000001 110.957 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.566 ' N ' HG22 ' A' ' 162' ' ' VAL . 1.2 tt0 -137.19 168.12 20.24 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.507 0.769 . . . . 64.450000000000003 110.354 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.483 ' C ' HD13 ' A' ' 182' ' ' LEU . 0.5 OUTLIER -134.07 124.52 26.33 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.521 1.138 . . . . 72.0 109.293 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 1.033 HD11 ' CG1' ' A' ' 162' ' ' VAL . 0.0 OUTLIER -128.58 162.47 27.21 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.582 1.176 . . . . 73.219999999999999 109.258 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.598 ' CD2' ' CZ ' ' A' ' 159' ' ' TYR . 0.9 OUTLIER -104.75 105.35 15.39 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.594 1.184 . . . . 75.019999999999996 110.972 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.967 HD13 ' HB2' ' A' ' 195' ' ' ALA . 45.3 mm -59.05 163.81 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.599 1.187 . . . . 60.509999999999998 109.32 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.47 ' N ' HG22 ' A' ' 184' ' ' ILE . 5.0 m -149.08 -45.41 0.14 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.478 1.111 . . . . 73.120000000000005 108.214 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 1.028 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -123.35 169.94 10.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.418 1.074 . . . . 74.420000000000002 109.34 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.563 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.2 OUTLIER -155.15 143.95 20.7 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.444 1.09 . . . . 72.319999999999993 109.634 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.554 ' CE1' ' HD3' ' B' ' 472' ' ' PRO . 0.2 OUTLIER -145.04 138.46 26.74 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 73.230000000000004 109.593 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.488 ' C ' ' N ' ' A' ' 191' ' ' GLU . 20.2 t-20 49.84 23.46 1.04 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.534 1.146 . . . . 73.329999999999998 109.284 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.53 ' HB3' HD13 ' A' ' 231' ' ' ILE . 6.4 m 40.74 28.9 0.06 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.46 1.1 . . . . 70.510000000000005 108.327 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.636 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 12.0 tt0 -124.34 -35.19 2.81 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 124.529 1.143 . . . . 72.329999999999998 110.283 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.595 ' CE3' HD21 ' A' ' 206' ' ' LEU . 95.1 m95 -118.36 133.22 56.06 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.512 1.132 . . . . 74.239999999999995 108.047 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.864 ' HB3' HD12 ' A' ' 184' ' ' ILE . 23.1 m-30 -123.48 144.3 49.61 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.548 1.155 . . . . 74.540000000000006 111.016 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 1.028 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 1.2 mp -101.78 96.15 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 124.457 1.098 . . . . 75.140000000000001 109.278 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.967 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -103.65 -178.81 3.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.45 1.093 . . . . 73.129999999999995 109.288 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -150.17 157.51 37.25 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 75.019999999999996 109.296 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 C--N 1.361 1.185 0 O-C-N 124.446 1.761 . . . . 75.450000000000003 110.966 179.991 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.983 0 N-CA-C 111.018 -0.833 . . . . 71.540000000000006 111.018 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.538 ' HG2' ' CZ ' ' B' ' 470' ' ' PHE . 18.2 Cg_endo -75.06 143.41 77.67 Favored 'Cis proline' 0 C--N 1.36 1.133 0 C-N-CA 120.954 -2.519 . . . . 75.209999999999994 110.988 0.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.491 ' CA ' ' HG ' ' A' ' 174' ' ' LEU . . . -106.0 140.71 15.25 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.481 1.113 . . . . 64.219999999999999 111.038 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.595 HD21 ' CE3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -89.57 145.02 25.56 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.487 0.757 . . . . 74.140000000000001 109.303 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.411 ' N ' ' HG ' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -153.29 132.69 7.11 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.47 1.106 . . . . 75.019999999999996 109.291 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.617 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.1 Cg_endo -75.06 176.29 10.12 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.46 1.768 . . . . 73.519999999999996 111.017 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.883 ' HB ' HG21 ' A' ' 227' ' ' VAL . 0.8 OUTLIER -98.17 -5.11 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.494 1.121 . . . . 64.219999999999999 109.298 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' B' ' 479' ' ' PRO . . . -90.73 -14.06 58.64 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.507 1.129 . . . . 65.349999999999994 110.948 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.609 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 15.6 m-85 -122.38 12.98 10.21 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.453 0.737 . . . . 75.099999999999994 110.939 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 208' ' ' PRO . 1.0 OUTLIER -152.45 160.14 3.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.424 1.077 . . . . 72.510000000000005 109.321 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.5 t -123.91 122.82 38.97 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.52 1.138 . . . . 74.040000000000006 109.997 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.835 ' O ' HG23 ' A' ' 215' ' ' ILE . 4.0 mm -62.97 104.18 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.528 1.142 . . . . 70.129999999999995 109.346 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.948 HD11 HG21 ' A' ' 161' ' ' ILE . 3.1 pt . . . . . 0 C--N 1.324 -0.519 0 O-C-N 124.497 1.123 . . . . 64.310000000000002 109.262 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 229' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 109.301 -0.629 . . . . 73.150000000000006 109.301 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.883 HG21 ' HB ' ' A' ' 209' ' ' VAL . 13.8 p -42.63 -48.59 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.483 1.114 . . . . 53.509999999999998 109.306 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.582 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.3 mp -61.7 -40.59 87.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.466 1.103 . . . . 72.239999999999995 109.273 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.458 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 19.4 mt-10 -67.99 -17.65 64.49 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.555 1.159 . . . . 54.119999999999997 110.303 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.65 ' HB3' HG21 ' A' ' 214' ' ' ILE . 13.2 m-20 -88.84 -15.7 33.85 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.54 1.15 . . . . 64.299999999999997 109.312 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 228' ' ' ILE . 1.9 mt -77.13 -69.61 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.439 1.087 . . . . 74.340000000000003 109.311 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.497 ' CE ' ' O ' ' A' ' 228' ' ' ILE . 0.0 OUTLIER -62.37 -16.29 53.68 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.587 1.179 . . . . 63.299999999999997 109.297 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.74 -21.49 2.8 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.488 1.118 . . . . 61.409999999999997 109.984 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 234' ' ' VAL . 1.0 OUTLIER -138.54 28.39 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.468 1.105 . . . . 74.319999999999993 109.275 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . 0.409 ' C ' ' O ' ' A' ' 234' ' ' VAL . 1.9 m-80 39.83 44.69 1.39 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.564 1.165 . . . . 64.140000000000001 109.275 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' A' ' 187' ' ' HIS . 4.1 tp -74.4 119.47 76.67 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.491 1.12 . . . . 62.0 109.317 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.06 162.29 37.23 Favored 'Trans proline' 0 C--N 1.361 1.208 0 O-C-N 124.46 1.768 . . . . 63.539999999999999 110.995 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.43 ' N ' ' HB2' ' A' ' 241' ' ' GLU . 1.6 m -59.75 159.6 8.56 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.483 1.114 . . . . 74.319999999999993 110.442 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.591 HG13 ' H ' ' A' ' 240' ' ' GLN . 6.4 p -52.5 -59.43 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.564 1.165 . . . . 74.209999999999994 109.332 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.591 ' H ' HG13 ' A' ' 239' ' ' VAL . 0.0 OUTLIER -65.32 -15.98 63.11 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.55 1.156 . . . . 43.43 110.291 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.43 ' HB2' ' N ' ' A' ' 238' ' ' THR . 14.8 mm-40 -80.55 -37.69 30.98 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.536 1.148 . . . . 73.219999999999999 110.329 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.693 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 0.3 OUTLIER -82.77 -57.15 3.44 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.511 1.132 . . . . 73.430000000000007 108.006 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.584 ' HD2' ' CD2' ' B' ' 470' ' ' PHE . 19.6 mtpp -58.33 -18.28 26.15 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.518 1.136 . . . . 64.209999999999994 109.312 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.517 0 O-C-N 124.492 1.12 . . . . 51.130000000000003 110.017 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 470' ' ' PHE . . . . . 0.584 ' CD2' ' HD2' ' A' ' 243' ' ' LYS . 4.8 m-30 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 120.42 0.152 . . . . 53.310000000000002 110.98 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 471' ' ' ILE . . . . . 0.571 ' N ' HD13 ' B' ' 471' ' ' ILE . 3.1 mm -67.63 140.01 94.26 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.567 1.167 . . . . 75.299999999999997 109.296 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 472' ' ' PRO . . . . . 0.554 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.97 -174.37 1.9 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.487 1.783 . . . . 74.120000000000005 110.987 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.56 14.62 4.47 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.523 1.139 . . . . 64.030000000000001 109.994 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -143.21 159.32 56.06 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.516 1.135 . . . . 75.409999999999997 110.379 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 475' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.2 Cg_endo -74.97 -53.22 0.1 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 O-C-N 124.551 1.817 . . . . 70.129999999999995 111.013 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 476' ' ' ALA . . . . . 0.636 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . 179.19 140.73 0.28 Allowed Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.482 1.113 . . . . 73.530000000000001 109.286 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 477' ' ' PRO . . . . . 0.571 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -74.96 -162.35 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.45 1.763 . . . . 75.519999999999996 110.991 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.5 90.93 22.85 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.545 1.153 . . . . 61.140000000000001 109.289 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 479' ' ' PRO . . . . . 0.609 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.92 144.32 30.42 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.559 1.821 . . . . 73.239999999999995 110.994 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.163 0 O-C-N 124.472 1.775 . . . . 71.400000000000006 111.054 179.925 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 8.7 m-85 . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.55 0.214 . . . . 53.240000000000002 110.957 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 182' ' ' LEU . . . -120.53 148.81 43.36 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.475 1.109 . . . . 74.239999999999995 109.37 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.622 HG21 HD11 ' A' ' 215' ' ' ILE . 0.1 OUTLIER -132.8 134.13 58.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.512 1.132 . . . . 71.329999999999998 109.31 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.978 HG22 HG12 ' A' ' 212' ' ' VAL . 2.3 t -92.92 120.93 43.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.427 1.079 . . . . 72.219999999999999 109.327 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.511 ' CD2' HG23 ' A' ' 161' ' ' ILE . 0.7 OUTLIER -97.76 -14.14 20.99 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.522 1.139 . . . . 71.140000000000001 109.331 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.676 ' O ' HG13 ' A' ' 162' ' ' VAL . 1.8 m-85 -145.48 157.72 43.96 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.419 1.074 . . . . 73.209999999999994 111.03 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.776 ' N ' HG12 ' A' ' 178' ' ' VAL . 16.8 p-10 -97.57 158.96 15.21 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.546 1.154 . . . . 74.129999999999995 109.291 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.555 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 1.6 t80 -157.89 131.3 7.7 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 71.430000000000007 111.048 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.555 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 2.9 mmpt? -67.9 123.54 20.86 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.514 1.134 . . . . 72.049999999999997 109.376 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.831 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -102.63 141.24 35.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.53 1.144 . . . . 71.129999999999995 109.293 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -151.39 21.33 0.73 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.488 1.117 . . . . 73.439999999999998 110.254 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.464 ' HZ1' ' HZ ' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -96.0 -176.3 3.65 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.118 . . . . 64.420000000000002 109.298 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.23 -22.5 64.85 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.462 1.101 . . . . 74.120000000000005 109.311 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 173' ' ' GLU . 1.5 m-20 -116.07 20.77 14.2 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.512 1.132 . . . . 74.430000000000007 109.334 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.831 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 6.9 pt-20 -38.11 109.71 0.11 Allowed 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.464 1.103 . . . . 73.420000000000002 110.295 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.696 HD13 ' HA3' ' A' ' 205' ' ' GLY . 9.6 tp -121.18 106.71 11.78 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.51 1.131 . . . . 70.319999999999993 109.308 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 175' ' ' THR . 11.2 t -81.12 107.67 14.12 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.528 1.142 . . . . 72.519999999999996 110.405 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.753 HG23 ' CD ' ' A' ' 180' ' ' GLU . 0.9 OUTLIER -129.86 142.35 50.68 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.5 1.125 . . . . 72.420000000000002 110.322 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -86.21 167.61 14.71 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.546 1.154 . . . . 74.439999999999998 110.959 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.776 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.8 m -63.19 158.16 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.503 1.127 . . . . 53.210000000000001 109.303 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 52.76 58.33 11.73 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.526 1.141 . . . . 75.150000000000006 111.033 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.753 ' CD ' HG23 ' A' ' 176' ' ' THR . 1.4 tt0 -114.14 170.69 8.1 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.461 0.742 . . . . 75.040000000000006 110.281 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -126.46 121.75 33.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.512 1.133 . . . . 74.430000000000007 109.35 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.847 ' CD1' HG21 ' A' ' 207' ' ' VAL . 1.5 pt? -142.91 140.64 31.24 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.496 1.122 . . . . 73.140000000000001 109.317 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 32.7 t80 -100.4 114.33 27.8 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.406 1.066 . . . . 74.430000000000007 111.026 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.64 HG13 ' HB2' ' A' ' 195' ' ' ALA . 19.8 mt -72.82 145.69 11.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.554 1.159 . . . . 74.420000000000002 109.288 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.618 ' O ' HD12 ' A' ' 236' ' ' LEU . 6.0 t -135.34 -41.01 0.72 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 72.030000000000001 108.275 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 1.053 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -112.87 167.46 10.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.475 1.109 . . . . 73.420000000000002 109.361 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.868 ' CD2' HD21 ' A' ' 236' ' ' LEU . 0.1 OUTLIER -156.94 155.34 31.2 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.521 1.138 . . . . 61.149999999999999 109.573 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.578 ' CE1' ' HD3' ' B' ' 472' ' ' PRO . 1.3 p80 -158.31 142.09 15.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.416 1.072 . . . . 74.409999999999997 109.642 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.472 ' C ' ' N ' ' A' ' 191' ' ' GLU . 61.6 t30 53.07 22.93 2.72 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.133 . . . . 73.420000000000002 109.338 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.432 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.8 p 38.92 30.32 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 61.32 108.277 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.525 ' O ' HG13 ' A' ' 209' ' ' VAL . 3.1 tt0 -132.62 -39.26 1.0 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.485 1.115 . . . . 74.019999999999996 110.274 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.726 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 99.0 m95 -108.53 129.03 55.3 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.568 1.168 . . . . 74.319999999999993 108.029 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.772 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.3 m-30 -121.05 145.27 47.96 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.44 1.087 . . . . 71.120000000000005 111.018 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 1.053 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 4.2 mm -103.11 101.89 12.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.472 1.108 . . . . 54.299999999999997 109.259 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.64 ' HB2' HG13 ' A' ' 184' ' ' ILE . . . -112.23 168.97 9.19 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.43 1.081 . . . . 62.310000000000002 109.296 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.04 149.7 72.31 Favored Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.453 1.095 . . . . 74.209999999999994 109.268 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 C--N 1.361 1.202 0 O-C-N 124.444 1.76 . . . . 65.019999999999996 110.966 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.406 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . . . . . . 0 CA--C 1.529 0.931 0 N-CA-C 111.01 -0.836 . . . . 51.299999999999997 111.01 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.98 123.15 8.79 Favored 'Cis proline' 0 C--N 1.36 1.184 0 C-N-CA 120.993 -2.503 . . . . 64.120000000000005 111.013 -0.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.696 ' HA3' HD13 ' A' ' 174' ' ' LEU . . . -97.05 157.16 21.02 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.452 1.095 . . . . 54.509999999999998 111.019 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.726 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -93.65 148.51 22.04 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.536 0.786 . . . . 73.109999999999999 109.33 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.847 HG21 ' CD1' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -157.15 125.93 3.0 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.551 1.157 . . . . 71.340000000000003 109.298 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.948 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.3 Cg_endo -74.99 173.58 14.27 Favored 'Trans proline' 0 C--N 1.359 1.085 0 O-C-N 124.501 1.79 . . . . 71.010000000000005 110.977 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.772 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -94.18 6.84 6.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.522 1.139 . . . . 42.210000000000001 109.309 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . 0.441 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -106.18 -7.46 35.26 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.536 1.148 . . . . 72.510000000000005 111.038 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.616 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 10.7 m-85 -127.73 2.79 6.08 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.507 0.769 . . . . 61.409999999999997 110.981 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.978 HG12 HG22 ' A' ' 162' ' ' VAL . 2.6 m -143.62 162.53 16.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 73.200000000000003 109.268 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 30.5 t -132.63 142.49 49.13 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.515 1.134 . . . . 70.530000000000001 110.02 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.557 ' O ' HG23 ' A' ' 215' ' ' ILE . 4.2 mm -86.13 113.77 24.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.528 1.143 . . . . 71.0 109.301 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.622 HD11 HG21 ' A' ' 161' ' ' ILE . 25.8 pt . . . . . 0 C--N 1.325 -0.493 0 O-C-N 124.523 1.139 . . . . 63.350000000000001 109.334 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 230' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 109.316 -0.624 . . . . 54.439999999999998 109.316 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.415 ' H ' HG12 ' A' ' 227' ' ' VAL . 1.3 p -51.88 -39.67 25.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.507 1.129 . . . . 61.219999999999999 109.257 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.812 ' HA ' HD12 ' A' ' 231' ' ' ILE . 11.8 mt -71.51 -39.27 70.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.446 1.091 . . . . 74.310000000000002 109.337 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -73.24 -15.74 61.42 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.423 1.077 . . . . 75.319999999999993 110.29 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 226' ' ' ASP . 6.0 m-20 -88.55 -15.73 34.43 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.542 1.151 . . . . 74.439999999999998 109.241 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.812 HD12 ' HA ' ' A' ' 228' ' ' ILE . 3.4 mt -72.04 -69.45 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.497 1.123 . . . . 75.329999999999998 109.261 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.485 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -60.82 -17.07 47.56 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.459 1.1 . . . . 60.119999999999997 109.275 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.86 -30.09 60.94 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.468 1.105 . . . . 63.409999999999997 109.929 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.419 ' C ' ' N ' ' A' ' 236' ' ' LEU . 10.7 m -120.89 22.21 5.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.505 1.128 . . . . 65.239999999999995 109.312 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 45.74 26.52 0.36 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.545 1.153 . . . . 73.319999999999993 109.312 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.868 HD21 ' CD2' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -61.97 123.18 76.63 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.455 1.097 . . . . 64.109999999999999 109.304 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 -177.48 3.49 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.421 1.748 . . . . 74.349999999999994 110.993 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.581 HG22 ' H ' ' A' ' 239' ' ' VAL . 2.2 m -74.7 -171.04 1.17 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 72.329999999999998 110.388 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.618 HG13 ' N ' ' A' ' 240' ' ' GLN . 12.9 p -79.09 -58.32 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 124.522 1.139 . . . . 41.009999999999998 109.3 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.618 ' N ' HG13 ' A' ' 239' ' ' VAL . 2.0 pp0? -72.18 -10.99 60.52 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.504 1.128 . . . . 75.400000000000006 110.324 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.75 -44.51 27.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.529 1.143 . . . . 73.439999999999998 110.311 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.962 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 0.0 OUTLIER -87.31 -68.61 0.74 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.002 -1.111 . . . . 73.340000000000003 108.002 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.601 ' HD3' ' CD2' ' A' ' 242' ' ' TRP . 0.1 OUTLIER -40.95 -29.11 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.476 1.11 . . . . 54.219999999999999 109.342 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 240' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.452 0 O-C-N 124.525 1.14 . . . . 63.140000000000001 110.003 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 470' ' ' PHE . . . . . 0.527 ' CD1' ' HG2' ' A' ' 243' ' ' LYS . 86.4 m-85 . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 120.516 0.198 . . . . 73.239999999999995 110.977 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 471' ' ' ILE . . . . . 0.71 HG22 ' HD2' ' B' ' 472' ' ' PRO . 1.2 mm -98.1 142.36 24.46 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.464 1.102 . . . . 62.439999999999998 109.278 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 472' ' ' PRO . . . . . 0.71 ' HD2' HG22 ' B' ' 471' ' ' ILE . 18.4 Cg_endo -74.95 170.23 20.86 Favored 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.489 1.783 . . . . 74.420000000000002 111.029 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.86 -42.41 5.85 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.573 1.171 . . . . 73.400000000000006 110.027 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -96.34 161.1 28.11 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.127 . . . . 72.030000000000001 110.298 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 475' ' ' PRO . . . . . 0.584 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.3 Cg_endo -74.98 -34.35 3.91 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.543 1.812 . . . . 71.129999999999995 110.996 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 476' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 169.72 134.62 0.06 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.545 1.153 . . . . 63.039999999999999 109.315 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 477' ' ' PRO . . . . . 0.575 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.2 Cg_endo -74.95 -162.92 0.16 Allowed 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.513 1.796 . . . . 73.310000000000002 111.052 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 478' ' ' LYS . . . . . 0.433 ' O ' ' CD ' ' B' ' 478' ' ' LYS . 0.1 OUTLIER -133.84 91.8 24.11 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.432 1.082 . . . . 70.200000000000003 109.275 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 479' ' ' PRO . . . . . 0.616 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.1 Cg_endo -75.01 162.49 37.01 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.449 1.763 . . . . 54.25 110.986 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.361 1.185 0 O-C-N 124.41 1.742 . . . . 53.299999999999997 111.004 179.995 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.529 ' CE1' ' O ' ' A' ' 160' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.498 0.19 . . . . 63.219999999999999 110.997 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.658 ' HB2' HD12 ' A' ' 184' ' ' ILE . . . -108.93 145.09 35.99 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.495 1.122 . . . . 55.109999999999999 109.26 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.719 ' HB ' HD11 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -130.61 135.8 59.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.456 1.097 . . . . 71.420000000000002 109.279 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.957 HG22 HG12 ' A' ' 212' ' ' VAL . 2.6 t -93.03 135.39 27.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 124.475 1.11 . . . . 74.420000000000002 109.341 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.624 HD12 ' CE1' ' A' ' 164' ' ' TYR . 0.1 OUTLIER -115.25 -8.34 12.33 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.479 1.112 . . . . 64.209999999999994 109.267 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.624 ' CE1' HD12 ' A' ' 163' ' ' LEU . 0.3 OUTLIER -146.98 151.96 37.84 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.486 1.116 . . . . 63.039999999999999 110.931 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -111.17 154.72 23.96 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.514 1.134 . . . . 73.140000000000001 109.291 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.581 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 0.6 OUTLIER -160.89 168.63 24.26 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.416 1.072 . . . . 70.439999999999998 110.989 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -92.93 133.98 35.56 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.415 1.072 . . . . 73.25 109.302 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.694 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -106.0 150.96 25.22 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.543 1.152 . . . . 70.030000000000001 109.329 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -155.03 27.45 0.42 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.544 1.153 . . . . 45.340000000000003 110.275 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.58 ' HE2' ' CH2' ' A' ' 192' ' ' TRP . 0.1 OUTLIER -101.49 -176.61 3.19 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.443 1.089 . . . . 63.340000000000003 109.273 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.98 -31.01 66.49 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.481 1.113 . . . . 73.450000000000003 109.237 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 173' ' ' GLU . 20.1 m-20 -111.47 23.06 14.4 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.48 1.113 . . . . 73.120000000000005 109.328 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.694 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -36.48 112.07 0.17 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.55 1.156 . . . . 62.43 110.241 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.678 HD22 ' HA3' ' A' ' 205' ' ' GLY . 0.4 OUTLIER -132.83 118.99 19.65 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.515 1.134 . . . . 75.120000000000005 109.28 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 175' ' ' THR . 10.6 t -86.45 108.46 18.52 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.487 1.117 . . . . 74.129999999999995 110.425 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.456 HG23 HG11 ' A' ' 162' ' ' VAL . 1.2 t -102.07 178.86 4.49 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 72.319999999999993 110.416 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.481 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 2.6 m-85 -131.88 154.54 49.09 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 63.329999999999998 111.061 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.7 m -55.82 154.72 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.538 1.149 . . . . 64.340000000000003 109.302 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 40.51 72.2 0.25 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.48 1.113 . . . . 63.109999999999999 110.989 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.502 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 7.4 tt0 -131.03 167.25 19.37 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.514 0.773 . . . . 63.149999999999999 110.31 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.42 ' ND2' ' OH ' ' A' ' 159' ' ' TYR . 1.3 m-80 -113.89 139.4 49.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.532 1.145 . . . . 71.140000000000001 109.305 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.731 ' CD1' HG21 ' A' ' 207' ' ' VAL . 0.6 OUTLIER -154.11 148.44 26.02 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.499 1.125 . . . . 53.100000000000001 109.288 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.548 ' CE2' ' HB2' ' A' ' 185' ' ' CYS . 25.2 t80 -106.37 105.95 16.22 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 75.120000000000005 110.961 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.842 ' CG1' ' HB2' ' A' ' 195' ' ' ALA . 73.9 mt -83.95 120.23 34.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.502 1.126 . . . . 74.140000000000001 109.308 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.605 ' SG ' ' CH2' ' A' ' 242' ' ' TRP . 33.4 t -124.7 -8.75 7.33 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.483 1.115 . . . . 71.239999999999995 108.278 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.838 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -129.78 150.02 51.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.429 1.081 . . . . 73.310000000000002 109.327 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.582 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.1 OUTLIER -153.62 148.3 26.33 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.524 1.14 . . . . 74.040000000000006 109.53 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.758 ' NE2' HD13 ' A' ' 194' ' ' ILE . 2.4 p80 -152.5 144.81 23.97 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.497 1.123 . . . . 64.430000000000007 109.591 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.471 ' C ' ' N ' ' A' ' 191' ' ' GLU . 51.5 t-20 53.5 20.01 1.91 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.562 1.164 . . . . 73.219999999999999 109.278 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.411 ' C ' ' O ' ' A' ' 189' ' ' ASN . 15.9 p 41.02 27.53 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.461 1.101 . . . . 65.349999999999994 108.272 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.519 ' O ' HG13 ' A' ' 209' ' ' VAL . 8.0 tt0 -129.81 -40.71 1.35 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.497 1.123 . . . . 71.129999999999995 110.321 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.591 ' CZ2' ' HD3' ' B' ' 477' ' ' PRO . 99.8 m95 -107.9 126.16 52.34 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.57 1.169 . . . . 74.230000000000004 107.971 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.752 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.3 m-30 -119.43 134.61 55.13 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 1.122 . . . . 73.530000000000001 110.993 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.838 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 1.0 OUTLIER -100.07 110.9 28.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.567 1.167 . . . . 74.099999999999994 109.236 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.842 ' HB2' ' CG1' ' A' ' 184' ' ' ILE . . . -117.01 174.3 6.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.46 1.1 . . . . 55.310000000000002 109.237 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.419 ' HG2' ' HA ' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -126.76 139.15 34.13 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.459 1.099 . . . . 75.120000000000005 109.324 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.359 1.089 0 O-C-N 124.527 1.804 . . . . 73.230000000000004 110.97 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.455 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . . . . . . 0 CA--C 1.529 0.944 0 N-CA-C 110.99 -0.844 . . . . 52.310000000000002 110.99 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.519 ' HG2' ' CE2' ' B' ' 470' ' ' PHE . 18.2 Cg_endo -75.03 147.42 89.19 Favored 'Cis proline' 0 C--N 1.36 1.141 0 C-N-CA 121.042 -2.482 . . . . 54.509999999999998 110.927 0.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.678 ' HA3' HD22 ' A' ' 174' ' ' LEU . . . -103.89 156.87 17.47 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.47 1.106 . . . . 62.240000000000002 111.048 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.598 HD12 ' CD1' ' A' ' 194' ' ' ILE . 0.2 OUTLIER -94.68 146.16 24.35 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.489 0.758 . . . . 74.420000000000002 109.306 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.731 HG21 ' CD1' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -157.79 129.67 4.03 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.53 1.144 . . . . 51.340000000000003 109.195 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.934 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.2 Cg_endo -75.1 175.93 10.6 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.48 1.779 . . . . 74.040000000000006 111.008 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.752 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -93.41 4.65 7.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.428 1.08 . . . . 54.530000000000001 109.277 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -103.78 -13.06 28.63 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.418 1.074 . . . . 43.130000000000003 110.975 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.619 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 11.5 m-85 -119.43 -1.21 10.76 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.486 0.756 . . . . 75.349999999999994 110.98 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.957 HG12 HG22 ' A' ' 162' ' ' VAL . 2.6 m -141.06 160.43 23.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.487 1.117 . . . . 72.409999999999997 109.274 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.32 144.3 51.11 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.535 1.147 . . . . 42.420000000000002 110.036 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.803 ' O ' HG23 ' A' ' 215' ' ' ILE . 2.7 mm -88.46 145.62 7.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 55.100000000000001 109.342 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.803 HG23 ' O ' ' A' ' 214' ' ' ILE . 4.1 pt . . . . . 0 C--N 1.325 -0.499 0 O-C-N 124.45 1.093 . . . . 54.340000000000003 109.343 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . 0.457 ' OD1' HG12 ' A' ' 227' ' ' VAL . 8.8 t0 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.304 -0.628 . . . . 73.219999999999999 109.304 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.491 HG13 HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -38.59 -58.44 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.129 . . . . 71.430000000000007 109.286 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.491 HD12 HG13 ' A' ' 227' ' ' VAL . 3.2 mp -54.48 -45.51 70.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.518 1.136 . . . . 74.340000000000003 109.348 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 226' ' ' ASP . 18.5 mt-10 -67.16 -15.0 63.44 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 72.530000000000001 110.344 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 226' ' ' ASP . 5.5 t70 -88.61 -18.92 27.02 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.539 1.149 . . . . 64.430000000000007 109.302 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.655 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.5 OUTLIER -69.44 -69.42 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.505 1.128 . . . . 75.150000000000006 109.27 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.655 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -59.89 -23.83 63.79 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.52 1.138 . . . . 70.510000000000005 109.329 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.86 -59.7 3.36 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.522 1.139 . . . . 65.430000000000007 110.023 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 234' ' ' VAL . 1.2 m -98.96 24.31 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.107 . . . . 74.209999999999994 109.271 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 5.6 t30 46.07 41.69 8.7 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.445 1.091 . . . . 73.409999999999997 109.276 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.888 HD12 ' HD2' ' A' ' 237' ' ' PRO . 33.2 tp -55.54 123.98 53.47 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 124.511 1.132 . . . . 62.310000000000002 109.334 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.888 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.4 Cg_endo -74.99 153.37 41.76 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.565 1.824 . . . . 71.109999999999999 111.002 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . 0.457 ' CG2' ' NE2' ' A' ' 240' ' ' GLN . 0.5 OUTLIER -61.42 -170.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.581 1.176 . . . . 62.149999999999999 110.438 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.489 ' HA ' ' HB1' ' A' ' 186' ' ' ALA . 12.3 p -80.27 -48.64 19.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.535 1.147 . . . . 62.219999999999999 109.354 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.489 ' OE1' ' N ' ' A' ' 241' ' ' GLU . 0.1 OUTLIER -87.43 -12.81 45.03 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.526 1.141 . . . . 53.43 110.281 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.489 ' N ' ' OE1' ' A' ' 240' ' ' GLN . 8.5 mt-10 -76.68 -36.27 57.39 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.562 1.164 . . . . 73.239999999999995 110.303 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.757 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 0.1 OUTLIER -87.01 -60.17 2.05 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.13 . . . . 62.340000000000003 108.012 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.644 ' NZ ' ' CD2' ' B' ' 470' ' ' PHE . 7.6 mtpt -53.19 -20.78 4.3 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.506 1.129 . . . . 53.219999999999999 109.328 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 243' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.481 1.113 . . . . 64.519999999999996 110.034 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 470' ' ' PHE . . . . . 0.644 ' CD2' ' NZ ' ' A' ' 243' ' ' LYS . 5.9 m-30 . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 120.521 0.2 . . . . 74.109999999999999 111.012 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 471' ' ' ILE . . . . . 0.767 ' N ' HD13 ' B' ' 471' ' ' ILE . 1.1 mm -71.31 135.67 84.36 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.482 1.114 . . . . 74.439999999999998 109.348 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 472' ' ' PRO . . . . . 0.589 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.94 170.97 19.22 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.504 1.792 . . . . 64.420000000000002 111.024 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 2.7 t -116.78 -8.86 11.33 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.455 1.097 . . . . 42.340000000000003 109.999 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -122.49 164.37 26.73 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.472 1.107 . . . . 52.210000000000001 110.294 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 475' ' ' PRO . . . . . 0.702 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.2 Cg_endo -75.03 -38.54 1.53 Allowed 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.49 1.784 . . . . 63.549999999999997 110.97 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 476' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 162.73 139.66 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.484 1.115 . . . . 34.32 109.274 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 477' ' ' PRO . . . . . 0.591 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -74.94 -161.37 0.12 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.494 1.786 . . . . 65.430000000000007 110.999 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 478' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -140.51 103.41 6.51 Favored Pre-proline 0 C--N 1.324 -0.52 0 O-C-N 124.59 1.181 . . . . 60.130000000000003 109.364 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 479' ' ' PRO . . . . . 0.619 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.5 Cg_endo -74.92 166.08 30.01 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.497 1.788 . . . . 61.229999999999997 110.998 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 C--N 1.36 1.178 0 O-C-N 124.417 1.746 . . . . 65.530000000000001 110.985 179.992 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.545 0.212 . . . . 60.450000000000003 111.042 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.953 ' HB3' ' CD2' ' A' ' 182' ' ' LEU . . . -110.31 144.66 38.7 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.438 1.086 . . . . 71.409999999999997 109.303 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.521 HD13 ' O ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -123.99 123.84 67.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.545 1.153 . . . . 72.329999999999998 109.299 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.945 HG23 HD11 ' A' ' 182' ' ' LEU . 1.8 t -79.7 122.26 34.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.507 1.129 . . . . 71.319999999999993 109.364 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.58 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 0.7 OUTLIER -97.48 -14.83 20.89 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.551 1.157 . . . . 74.329999999999998 109.305 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.701 ' O ' HG13 ' A' ' 162' ' ' VAL . 5.4 m-85 -145.14 160.65 41.11 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.564 1.165 . . . . 64.150000000000006 111.067 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.842 ' N ' HG12 ' A' ' 178' ' ' VAL . 8.5 p30 -97.99 157.03 16.35 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.401 1.063 . . . . 73.030000000000001 109.362 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -150.12 135.64 18.22 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.532 1.145 . . . . 72.140000000000001 110.979 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -75.86 126.06 30.28 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.491 1.119 . . . . 71.349999999999994 109.302 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.848 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -88.99 153.29 21.14 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.452 1.095 . . . . 53.020000000000003 109.295 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -166.31 29.41 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 63.32 110.293 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.747 ' HZ2' ' H ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -129.5 -176.08 3.78 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.483 1.115 . . . . 64.319999999999993 109.293 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.12 -40.93 78.07 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 60.229999999999997 109.318 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 174' ' ' LEU . 30.7 m-20 -88.67 16.99 5.89 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.457 1.098 . . . . 64.299999999999997 109.272 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.848 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 4.6 pt-20 -38.14 95.76 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.449 1.093 . . . . 63.0 110.309 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.747 ' H ' ' HZ2' ' A' ' 170' ' ' LYS . 5.7 tp -118.4 107.81 14.29 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.482 1.114 . . . . 72.239999999999995 109.29 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 175' ' ' THR . 12.7 t -87.36 115.9 25.09 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.479 1.112 . . . . 71.430000000000007 110.357 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 6.9 m -134.74 154.8 51.42 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.536 1.148 . . . . 63.310000000000002 110.402 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -94.35 167.54 11.46 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.453 1.096 . . . . 73.230000000000004 110.962 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.842 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.6 m -66.96 158.26 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 124.488 1.117 . . . . 72.209999999999994 109.316 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 57.11 50.42 64.51 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.479 1.112 . . . . 51.509999999999998 111.077 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.521 ' O ' HD13 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -110.26 174.15 6.0 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.498 0.764 . . . . 74.439999999999998 110.289 -179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.495 ' N ' ' ND2' ' A' ' 181' ' ' ASN . 0.0 OUTLIER -137.36 117.45 13.42 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.527 1.142 . . . . 70.439999999999998 109.264 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.953 ' CD2' ' HB3' ' A' ' 160' ' ' ALA . 0.0 OUTLIER -129.99 154.88 46.95 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.453 1.096 . . . . 73.530000000000001 109.358 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.577 ' CE1' ' O ' ' A' ' 184' ' ' ILE . 1.0 OUTLIER -104.24 115.16 29.91 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.423 1.077 . . . . 74.340000000000003 110.982 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 1.055 HD13 ' HB2' ' A' ' 195' ' ' ALA . 27.5 mm -65.32 160.59 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.493 1.121 . . . . 71.319999999999993 109.303 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . 0.44 ' HB3' ' CH2' ' A' ' 242' ' ' TRP . 37.0 m -150.99 -44.88 0.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.538 1.149 . . . . 74.140000000000001 108.27 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 1.041 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -120.71 165.75 14.66 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.5 1.125 . . . . 63.509999999999998 109.274 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.526 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.3 OUTLIER -152.97 146.22 24.77 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.522 1.139 . . . . 65.409999999999997 109.617 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.752 ' CD2' HG11 ' A' ' 239' ' ' VAL . 0.2 OUTLIER -146.07 137.87 25.01 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.492 1.12 . . . . 72.310000000000002 109.625 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.479 ' C ' ' N ' ' A' ' 191' ' ' GLU . 24.5 t-20 50.17 25.58 1.82 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.531 1.144 . . . . 74.400000000000006 109.271 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . 0.439 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.9 p 38.93 30.9 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.451 1.094 . . . . 63.340000000000003 108.248 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.93 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 20.5 tt0 -127.36 -39.58 1.86 Allowed 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.495 1.122 . . . . 75.439999999999998 110.269 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' TRP . . . . . 0.714 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 97.0 m95 -113.79 131.9 56.06 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.518 1.136 . . . . 74.450000000000003 108.023 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.909 ' HB3' HD12 ' A' ' 184' ' ' ILE . 23.3 m-30 -121.94 144.0 49.12 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.471 1.107 . . . . 75.530000000000001 111.02 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 1.041 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 0.8 OUTLIER -103.28 96.86 4.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.544 1.153 . . . . 75.25 109.341 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 1.055 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -99.64 -176.38 3.26 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.433 1.083 . . . . 52.329999999999998 109.224 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.453 ' CG ' ' C ' ' A' ' 195' ' ' ALA . 7.3 mtmt -151.19 160.21 32.33 Favored Pre-proline 0 C--N 1.326 -0.43 0 O-C-N 124.549 1.156 . . . . 72.530000000000001 109.262 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 C--N 1.361 1.209 0 O-C-N 124.491 1.785 . . . . 75.319999999999993 111.002 179.961 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.426 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . . . . . . 0 CA--C 1.53 1.0 0 N-CA-C 111.087 -0.805 . . . . 61.340000000000003 111.087 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' PRO . . . . . 0.569 ' HG2' ' CE2' ' B' ' 470' ' ' PHE . 18.3 Cg_endo -75.07 127.63 14.85 Favored 'Cis proline' 0 C--N 1.359 1.118 0 C-N-CA 121.04 -2.483 . . . . 61.450000000000003 110.967 0.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.688 ' HA3' HD22 ' A' ' 174' ' ' LEU . . . -95.42 152.27 20.32 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.471 1.107 . . . . 54.310000000000002 110.934 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.714 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.1 OUTLIER -99.49 145.96 26.9 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 0.75 . . . . 71.450000000000003 109.312 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.728 ' HB ' HG11 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -159.75 127.84 2.86 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.54 1.15 . . . . 72.430000000000007 109.279 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.845 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.3 Cg_endo -74.99 176.81 9.42 Favored 'Trans proline' 0 C--N 1.361 1.206 0 O-C-N 124.507 1.793 . . . . 65.519999999999996 110.946 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.756 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.6 OUTLIER -97.09 5.14 9.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.41 1.069 . . . . 75.150000000000006 109.316 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -103.31 -12.22 31.72 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.518 1.136 . . . . 52.539999999999999 111.037 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.634 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 10.7 m-85 -123.02 3.28 9.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.473 0.749 . . . . 74.319999999999993 110.996 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.859 HG12 HG22 ' A' ' 162' ' ' VAL . 1.9 m -140.35 154.26 22.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.49 1.119 . . . . 70.5 109.273 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' SER . . . . . 0.458 ' HB2' HD11 ' A' ' 163' ' ' LEU . 5.6 t -120.37 124.51 45.71 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.485 1.116 . . . . 53.399999999999999 110.013 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.792 ' O ' HG23 ' A' ' 215' ' ' ILE . 2.7 mm -77.49 139.2 19.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.493 1.121 . . . . 63.140000000000001 109.294 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . 0.792 HG23 ' O ' ' A' ' 214' ' ' ILE . 3.5 pt . . . . . 0 C--N 1.325 -0.473 0 O-C-N 124.421 1.076 . . . . 74.129999999999995 109.276 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.261 -0.644 . . . . 73.129999999999995 109.261 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.632 HG13 HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -41.07 -52.61 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.455 1.097 . . . . 63.420000000000002 109.335 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.632 HD12 HG13 ' A' ' 227' ' ' VAL . 4.3 mp -56.94 -58.91 3.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 O-C-N 124.519 1.137 . . . . 74.439999999999998 109.298 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -46.62 -29.16 1.71 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.547 1.155 . . . . 61.5 110.331 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -73.28 -37.19 66.35 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.54 1.15 . . . . 63.43 109.32 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.636 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.6 OUTLIER -62.26 -69.33 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.484 1.115 . . . . 73.150000000000006 109.295 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.636 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -51.42 -31.88 24.46 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.487 1.117 . . . . 71.329999999999998 109.288 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.03 -60.72 2.79 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.517 1.136 . . . . 70.5 109.936 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.2 m -92.03 15.39 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.549 1.155 . . . . 52.420000000000002 109.282 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 42.8 t30 40.43 36.35 0.35 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.477 1.11 . . . . 73.140000000000001 109.264 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.857 HD12 ' HD2' ' A' ' 237' ' ' PRO . 4.0 tp -49.25 134.48 16.5 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.126 . . . . 61.200000000000003 109.335 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.857 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.3 Cg_endo -74.99 164.09 34.06 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.461 1.769 . . . . 60.409999999999997 110.997 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.82 -174.89 2.31 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.503 1.127 . . . . 72.439999999999998 110.43 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.752 HG11 ' CD2' ' A' ' 188' ' ' HIS . 1.0 OUTLIER -79.61 -49.33 19.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.503 1.127 . . . . 72.219999999999999 109.278 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.506 ' N ' ' CG2' ' A' ' 239' ' ' VAL . 0.0 OUTLIER -76.67 -14.75 59.94 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.454 1.096 . . . . 74.010000000000005 110.307 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -83.78 -49.82 8.71 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.55 1.156 . . . . 75.319999999999993 110.291 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.716 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 0.1 OUTLIER -70.51 -62.49 1.37 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.007 -1.109 . . . . 75.25 108.007 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.571 ' NZ ' ' CE2' ' B' ' 470' ' ' PHE . 18.3 mtpp -49.56 -23.92 1.87 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.612 1.195 . . . . 72.109999999999999 109.329 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 243' ' ' LYS . 4.4 t . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.433 1.083 . . . . 63.409999999999997 109.969 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 470' ' ' PHE . . . . . 0.571 ' CE2' ' NZ ' ' A' ' 243' ' ' LYS . 6.3 m-30 . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 120.479 0.181 . . . . 71.109999999999999 110.981 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 471' ' ' ILE . . . . . 0.468 ' CG2' ' HD2' ' B' ' 472' ' ' PRO . 7.8 mm -97.51 139.81 21.62 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.145 . . . . 72.209999999999994 109.297 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 472' ' ' PRO . . . . . 0.55 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.3 Cg_endo -75.03 146.74 32.91 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.5 1.789 . . . . 70.030000000000001 111.018 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 8.2 t -79.21 -59.8 2.63 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.547 1.154 . . . . 52.439999999999998 110.075 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -84.67 163.49 46.53 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.52 1.137 . . . . 72.099999999999994 110.311 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 -166.59 0.35 Allowed 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.435 1.755 . . . . 64.120000000000005 111.01 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 476' ' ' ALA . . . . . 0.93 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . -55.58 137.49 70.1 Favored Pre-proline 0 C--N 1.326 -0.417 0 O-C-N 124.489 1.118 . . . . 65.439999999999998 109.361 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 477' ' ' PRO . . . . . 0.574 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.2 Cg_endo -75.01 -162.28 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.484 1.781 . . . . 61.130000000000003 111.022 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.0 89.84 12.44 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.508 1.13 . . . . 75.420000000000002 109.29 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 479' ' ' PRO . . . . . 0.634 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.3 Cg_endo -74.92 161.29 39.2 Favored 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.523 1.801 . . . . 74.120000000000005 110.985 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo . . . . . 0 C--N 1.36 1.172 0 O-C-N 124.506 1.793 . . . . 74.140000000000001 111.035 179.936 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.987 0 N-CA-C 111.024 -0.831 . . . . 72.540000000000006 111.024 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.843 ' HB3' HG22 ' A' ' 214' ' ' ILE . 1.2 m -166.39 110.18 0.77 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.539 0.788 . . . . 62.109999999999999 110.027 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.449 ' C ' ' CD1' ' A' ' 159' ' ' TYR . 58.1 tp -119.73 -3.28 10.3 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.421 1.076 . . . . 54.530000000000001 109.37 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.716 ' CD1' ' CE2' ' A' ' 183' ' ' PHE . 3.2 m-85 -139.38 175.54 9.48 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.477 1.11 . . . . 73.099999999999994 111.007 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.515 ' CB ' ' CD1' ' A' ' 184' ' ' ILE . . . -128.51 160.96 30.71 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.514 1.134 . . . . 55.229999999999997 109.331 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.711 ' HB ' HD11 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -144.69 124.3 6.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 74.239999999999995 109.337 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.978 HG13 HD22 ' A' ' 182' ' ' LEU . 6.4 m -83.3 127.24 39.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.486 1.116 . . . . 65.420000000000002 109.301 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.497 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 0.4 OUTLIER -98.78 -2.95 36.74 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.465 1.103 . . . . 63.439999999999998 109.311 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.497 ' CE2' ' HB2' ' A' ' 163' ' ' LEU . 1.5 m-85 -152.4 158.16 42.26 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.474 1.108 . . . . 73.239999999999995 111.021 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.799 ' N ' HG12 ' A' ' 178' ' ' VAL . 15.5 t0 -100.41 144.18 29.71 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.435 1.084 . . . . 74.030000000000001 109.268 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.439 ' N ' ' OD1' ' A' ' 165' ' ' ASP . 14.1 t80 -141.21 129.93 22.88 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.495 1.122 . . . . 64.310000000000002 110.949 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -68.56 131.06 44.6 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.439 1.087 . . . . 74.310000000000002 109.311 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.939 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -109.45 138.9 45.13 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.439 1.087 . . . . 41.43 109.307 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -144.6 16.55 1.64 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.506 1.129 . . . . 62.020000000000003 110.304 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.446 ' N ' ' HB3' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -94.92 -176.07 3.74 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.585 1.178 . . . . 71.109999999999999 109.257 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.47 -30.83 70.85 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.455 1.097 . . . . 72.319999999999993 109.306 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.445 ' OD2' ' N ' ' A' ' 206' ' ' LEU . 0.8 OUTLIER -104.59 16.45 26.04 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.473 1.108 . . . . 65.239999999999995 109.329 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.939 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 6.4 pt-20 -36.51 108.36 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.501 1.126 . . . . 71.430000000000007 110.321 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.719 HD13 ' HA3' ' A' ' 205' ' ' GLY . 5.4 tp -119.42 110.41 16.9 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.447 1.092 . . . . 72.299999999999997 109.316 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 175' ' ' THR . 12.9 t -84.98 108.62 17.68 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.48 1.112 . . . . 70.25 110.391 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.405 HG23 ' N ' ' A' ' 177' ' ' TYR . 0.7 OUTLIER -118.7 178.07 4.61 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.597 1.186 . . . . 75.230000000000004 110.432 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.424 ' O ' ' CG2' ' A' ' 162' ' ' VAL . 12.4 m-85 -121.76 162.78 20.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.577 1.173 . . . . 73.5 111.038 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.799 HG12 ' N ' ' A' ' 165' ' ' ASP . 3.8 m -64.83 147.29 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.539 1.149 . . . . 70.010000000000005 109.244 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.419 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 53.28 62.1 6.31 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.548 1.155 . . . . 32.229999999999997 111.027 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.533 ' O ' HD13 ' A' ' 161' ' ' ILE . 1.8 tp10 -126.31 161.62 27.38 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.505 0.767 . . . . 63.009999999999998 110.331 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -101.75 141.15 35.05 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.451 1.094 . . . . 73.129999999999995 109.262 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.978 HD22 HG13 ' A' ' 162' ' ' VAL . 2.6 pt? -159.2 141.59 13.88 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.45 1.094 . . . . 74.129999999999995 109.283 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.716 ' CE2' ' CD1' ' A' ' 159' ' ' TYR . 6.5 m-85 -106.23 126.43 52.21 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.423 1.077 . . . . 70.530000000000001 110.985 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.663 HD12 ' HB2' ' A' ' 195' ' ' ALA . 0.8 OUTLIER -63.0 153.42 6.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 74.25 109.331 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 194' ' ' ILE . 2.6 m -135.21 -48.25 0.72 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.424 1.078 . . . . 73.209999999999994 108.302 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.882 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -129.91 170.28 14.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.511 1.132 . . . . 71.439999999999998 109.231 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.651 ' CD2' HD11 ' A' ' 236' ' ' LEU . 0.0 OUTLIER -150.36 147.45 27.61 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.413 1.071 . . . . 71.450000000000003 109.545 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.576 ' CE1' ' HB3' ' A' ' 192' ' ' TRP . 0.7 OUTLIER -152.61 138.83 18.35 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.592 1.183 . . . . 75.219999999999999 109.611 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.463 ' C ' ' N ' ' A' ' 191' ' ' GLU . 41.9 t30 53.28 22.4 2.7 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.446 1.091 . . . . 74.329999999999998 109.229 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.416 ' C ' ' O ' ' A' ' 189' ' ' ASN . 14.7 p 40.81 28.85 0.06 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.467 1.104 . . . . 53.119999999999997 108.271 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.659 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 7.8 tt0 -127.67 -40.4 1.75 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.409 1.068 . . . . 71.239999999999995 110.291 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.78 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 96.4 m95 -109.51 131.99 54.55 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.484 1.115 . . . . 75.019999999999996 108.002 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.781 ' CE2' HG12 ' A' ' 209' ' ' VAL . 20.8 m-30 -125.54 134.9 51.83 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.473 1.108 . . . . 64.340000000000003 110.972 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.882 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 5.7 mm -93.23 93.01 3.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.536 1.147 . . . . 75.409999999999997 109.282 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.663 ' HB2' HD12 ' A' ' 184' ' ' ILE . . . -97.07 -172.41 2.44 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.437 1.086 . . . . 63.340000000000003 109.381 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 197' ' ' PRO . 3.1 ttpp -154.77 141.44 13.27 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 124.572 1.17 . . . . 71.400000000000006 109.285 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 196' ' ' LYS . 18.2 Cg_endo -74.97 177.95 7.9 Favored 'Trans proline' 0 C--N 1.361 1.215 0 O-C-N 124.547 1.814 . . . . 74.310000000000002 110.983 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.405 ' O ' HG23 ' A' ' 198' ' ' ILE . 3.4 tp -113.88 29.51 2.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.611 1.194 . . . . 71.019999999999996 109.359 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -92.48 -120.02 2.7 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.464 1.102 . . . . 53.439999999999998 110.997 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.51 136.16 34.24 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.458 0.74 . . . . 71.109999999999999 110.292 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 201' ' ' LEU . 2.8 mm? 46.45 32.33 1.56 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.511 1.132 . . . . 75.519999999999996 109.316 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -97.09 170.85 26.45 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.501 1.126 . . . . 35.420000000000002 111.012 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.412 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . 52.08 176.96 0.04 OUTLIER Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.997 -0.841 . . . . 72.140000000000001 110.997 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.543 ' HG2' ' CE2' ' B' ' 470' ' ' PHE . 18.4 Cg_endo -74.99 123.77 9.42 Favored 'Cis proline' 0 C--N 1.361 1.21 0 C-N-CA 120.979 -2.509 . . . . 73.310000000000002 111.011 -0.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.719 ' HA3' HD13 ' A' ' 174' ' ' LEU . . . -97.72 148.99 19.11 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.566 1.166 . . . . 75.209999999999994 110.991 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.78 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -87.76 146.54 25.6 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.462 0.742 . . . . 73.140000000000001 109.324 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.808 HG21 HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -161.12 127.64 2.48 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.537 1.148 . . . . 73.420000000000002 109.321 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.635 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.4 Cg_endo -74.93 177.92 7.93 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.495 1.787 . . . . 63.219999999999999 110.991 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.781 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.4 m -96.94 5.08 9.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.54 1.15 . . . . 74.530000000000001 109.283 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . 0.497 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -108.05 0.35 33.58 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.455 1.097 . . . . 41.119999999999997 111.003 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.603 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 18.8 m-85 -131.66 8.61 4.56 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.509 0.77 . . . . 64.319999999999993 110.983 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.819 HG12 HG12 ' A' ' 162' ' ' VAL . 2.3 m -151.71 154.87 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.485 1.116 . . . . 72.430000000000007 109.293 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 39.9 t -123.9 147.07 47.98 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.504 1.127 . . . . 54.149999999999999 109.977 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.843 HG22 ' HB3' ' A' ' 157' ' ' SER . 6.9 mm -90.87 129.33 41.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.531 1.144 . . . . 74.120000000000005 109.287 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.711 HD11 ' HB ' ' A' ' 161' ' ' ILE . 0.3 OUTLIER -152.41 -177.94 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.573 1.17 . . . . 52.229999999999997 109.237 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.656 ' OD1' ' HB3' ' A' ' 218' ' ' ALA . 12.0 p-10 -127.62 15.78 7.02 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.459 1.099 . . . . 74.109999999999999 109.292 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 8.9 pt 45.03 28.98 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.49 1.119 . . . . 71.439999999999998 109.261 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.656 ' HB3' ' OD1' ' A' ' 216' ' ' ASP . . . -110.4 -69.42 0.87 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.482 1.114 . . . . 72.439999999999998 109.261 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.628 HG23 ' O ' ' A' ' 218' ' ' ALA . 3.2 p -157.92 160.54 37.71 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.548 1.155 . . . . 74.120000000000005 110.436 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 53.06 -172.85 0.42 Allowed Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.536 1.148 . . . . 62.200000000000003 110.965 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -125.63 115.77 20.66 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.477 0.751 . . . . 72.239999999999995 111.016 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.504 ' C ' HG22 ' A' ' 223' ' ' THR . . . 57.33 24.37 9.94 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.444 1.09 . . . . 71.400000000000006 109.294 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.504 HG22 ' C ' ' A' ' 222' ' ' ALA . 2.9 t 45.9 25.75 0.33 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.528 1.142 . . . . 53.450000000000003 110.408 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 71.9 39.45 59.24 Favored Glycine 0 CA--C 1.531 1.082 0 O-C-N 124.595 1.184 . . . . 64.340000000000003 110.985 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.425 ' ND2' HG23 ' A' ' 223' ' ' THR . 2.9 m-80 -131.52 162.6 29.89 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.557 0.798 . . . . 72.340000000000003 109.319 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -89.3 145.55 25.3 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.445 1.091 . . . . 65.230000000000004 109.347 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.57 HG21 ' HE2' ' A' ' 193' ' ' PHE . 1.5 p -54.03 -40.36 45.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.135 . . . . 65.109999999999999 109.276 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.797 ' HA ' HD12 ' A' ' 231' ' ' ILE . 9.0 mt -69.39 -30.8 46.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.51 1.131 . . . . 63.009999999999998 109.31 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.492 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 8.9 mt-10 -78.97 -21.08 47.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.54 1.15 . . . . 64.230000000000004 110.292 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -88.79 -15.9 33.46 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.511 1.132 . . . . 72.340000000000003 109.312 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.797 HD12 ' HA ' ' A' ' 228' ' ' ILE . 6.5 mt -72.5 -69.8 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.529 1.143 . . . . 70.209999999999994 109.296 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.492 ' CD ' ' HA ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -49.15 -30.67 7.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.515 1.135 . . . . 64.109999999999999 109.288 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.424 ' N ' ' HG2' ' A' ' 232' ' ' LYS . 0.6 OUTLIER -48.14 -50.23 29.45 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 74.230000000000004 109.987 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 236' ' ' LEU . 1.3 m -90.95 -14.36 8.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.516 1.135 . . . . 50.350000000000001 109.239 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 57.58 48.63 13.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.433 1.083 . . . . 75.120000000000005 109.286 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.651 HD11 ' CD2' ' A' ' 187' ' ' HIS . 0.8 OUTLIER -71.29 142.93 87.51 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.507 1.129 . . . . 74.349999999999994 109.318 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.581 ' O ' HD12 ' A' ' 236' ' ' LEU . 18.3 Cg_endo -74.99 154.35 42.49 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.447 1.761 . . . . 71.120000000000005 110.997 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.433 HG22 ' H ' ' A' ' 239' ' ' VAL . 2.6 m -58.88 175.5 0.27 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.529 1.143 . . . . 74.430000000000007 110.458 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.569 HG23 ' CB ' ' A' ' 186' ' ' ALA . 7.2 p -76.81 -51.75 18.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 124.552 1.157 . . . . 71.540000000000006 109.295 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.515 ' N ' HG13 ' A' ' 239' ' ' VAL . 4.3 pm0 -71.04 -14.93 62.5 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 75.120000000000005 110.278 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -92.2 -44.73 8.62 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.464 1.102 . . . . 63.25 110.302 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.453 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 9.9 t90 -69.47 -53.4 19.39 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.548 1.155 . . . . 65.510000000000005 108.018 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.786 ' HZ3' ' H ' ' B' ' 469' ' ' LYS . 5.9 mtmp? -62.9 -23.06 67.17 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.54 1.15 . . . . 62.039999999999999 109.274 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.6 t -40.97 -30.52 0.13 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.133 . . . . 62.039999999999999 110.038 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.603 ' ND2' ' HB3' ' A' ' 247' ' ' ALA . 12.4 t30 -175.82 108.58 0.09 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.519 1.137 . . . . 64.230000000000004 109.404 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.453 ' CG2' ' N ' ' A' ' 247' ' ' ALA . 1.3 tp -55.28 -49.62 71.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.485 1.116 . . . . 74.129999999999995 109.241 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.603 ' HB3' ' ND2' ' A' ' 245' ' ' ASN . . . -44.7 97.27 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.458 1.099 . . . . 72.519999999999996 109.352 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 246' ' ' ILE . 0.4 OUTLIER -176.63 -166.03 0.15 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 62.140000000000001 110.27 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.552 ' CD1' ' O ' ' A' ' 249' ' ' TYR . 0.7 OUTLIER -173.27 128.85 0.45 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.538 1.149 . . . . 72.129999999999995 111.024 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.78 140.1 40.16 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.568 1.168 . . . . 74.409999999999997 109.35 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -107.69 161.86 14.5 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.468 1.105 . . . . 41.119999999999997 109.266 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 5.9 t -139.73 142.18 36.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.479 1.112 . . . . 71.140000000000001 110.018 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -73.98 149.31 41.39 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.465 1.103 . . . . 54.32 109.323 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.734 HD12 ' N ' ' A' ' 254' ' ' ILE . 2.5 mp -81.54 123.91 38.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.477 1.111 . . . . 72.019999999999996 109.289 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.5 p -156.35 125.9 6.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.449 1.093 . . . . 62.229999999999997 110.025 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.635 HD13 ' O ' ' A' ' 257' ' ' GLY . 1.6 tm? -121.28 136.18 55.0 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.56 1.163 . . . . 64.150000000000006 109.351 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.635 ' O ' HD13 ' A' ' 256' ' ' LEU . . . -95.1 160.54 23.08 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.428 1.08 . . . . 43.240000000000002 111.019 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 2.2 m -95.92 51.89 1.28 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.59 0.818 . . . . 74.150000000000006 109.959 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.4 p -161.3 119.95 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.532 1.145 . . . . 63.509999999999998 109.322 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 C--N 1.326 -0.448 0 O-C-N 124.452 1.095 . . . . 71.030000000000001 110.274 -179.991 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 109.971 -0.381 . . . . 73.219999999999999 109.971 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 2.3 t -124.88 149.45 47.51 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.504 1.127 . . . . 74.400000000000006 110.061 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 38.8 m -91.69 -175.62 4.22 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.491 1.119 . . . . 64.030000000000001 109.978 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -119.59 150.88 39.56 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.521 1.138 . . . . 61.240000000000002 109.213 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -114.78 -39.61 3.7 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.507 1.129 . . . . 60.340000000000003 109.338 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -66.5 164.42 41.74 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.491 1.12 . . . . 72.109999999999999 110.977 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . 0.786 ' H ' ' HZ3' ' A' ' 243' ' ' LYS . 32.4 mmtm -109.69 -15.33 14.17 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.455 0.738 . . . . 70.219999999999999 109.301 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 470' ' ' PHE . . . . . 0.561 ' CD2' ' HD3' ' A' ' 243' ' ' LYS . 8.8 m-30 -97.15 14.96 24.02 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.474 1.109 . . . . 74.540000000000006 111.0 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 471' ' ' ILE . . . . . 0.503 HG23 ' HD2' ' B' ' 472' ' ' PRO . 3.7 mm -70.31 140.18 87.57 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.516 1.135 . . . . 73.239999999999995 109.3 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 472' ' ' PRO . . . . . 0.569 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.2 Cg_endo -74.93 155.47 43.29 Favored 'Trans proline' 0 C--N 1.359 1.12 0 O-C-N 124.499 1.789 . . . . 70.439999999999998 111.055 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 38.7 t -97.49 -47.69 5.57 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.563 1.165 . . . . 73.519999999999996 110.062 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.86 165.4 17.99 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.537 1.148 . . . . 54.119999999999997 110.31 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 -166.81 0.37 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.458 1.767 . . . . 73.310000000000002 111.031 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 476' ' ' ALA . . . . . 0.659 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . -65.25 134.1 95.71 Favored Pre-proline 0 C--N 1.326 -0.427 0 O-C-N 124.382 1.051 . . . . 73.430000000000007 109.302 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 477' ' ' PRO . . . . . 0.576 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -74.94 -162.65 0.16 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.5 1.789 . . . . 74.299999999999997 110.996 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 478' ' ' LYS . . . . . 0.4 ' N ' ' HD3' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -133.42 90.89 28.21 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 64.219999999999999 109.28 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 479' ' ' PRO . . . . . 0.603 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.98 152.39 40.78 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.489 1.784 . . . . 74.209999999999994 111.0 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 480' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 479' ' ' PRO . 18.4 Cg_endo -74.96 170.06 21.24 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.552 1.817 . . . . 54.039999999999999 111.005 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 481' ' ' SER . . . . . . . . . . . . . 1.1 t 50.3 43.72 26.49 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.479 1.112 . . . . 74.329999999999998 109.913 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 14.3 p -108.09 178.86 4.38 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.487 1.117 . . . . 74.299999999999997 110.021 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -117.6 56.52 0.83 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.495 1.122 . . . . 75.400000000000006 109.282 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 1.5 t -135.22 137.3 42.48 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.464 1.102 . . . . 72.299999999999997 110.008 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -103.3 153.4 20.46 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.456 1.098 . . . . 64.019999999999996 109.263 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 86.3 p . . . . . 0 C--N 1.324 -0.509 0 O-C-N 124.553 1.158 . . . . 61.210000000000001 109.992 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.964 0 N-CA-C 110.995 -0.842 . . . . 62.420000000000002 110.995 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.7 t -145.84 162.8 36.88 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.418 0.716 . . . . 54.219999999999999 110.053 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.655 HD12 ' O ' ' A' ' 158' ' ' LEU . 2.1 pp -156.39 121.07 4.57 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.509 1.13 . . . . 45.100000000000001 109.272 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.524 ' CE1' ' O ' ' A' ' 160' ' ' ALA . 0.7 OUTLIER -124.12 139.55 53.83 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.464 1.102 . . . . 71.5 110.966 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.857 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -119.89 148.28 43.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.464 1.102 . . . . 53.340000000000003 109.341 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.658 ' HB ' HD11 ' A' ' 215' ' ' ILE . 0.1 OUTLIER -127.78 132.28 69.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.468 1.105 . . . . 74.120000000000005 109.287 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.937 HG22 HG12 ' A' ' 212' ' ' VAL . 3.9 t -87.89 134.05 28.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.516 1.135 . . . . 65.140000000000001 109.336 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.619 HD21 HG23 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -117.97 -2.61 11.25 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.475 1.109 . . . . 73.129999999999995 109.361 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.502 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 16.9 m-85 -139.02 175.74 9.29 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.134 . . . . 71.430000000000007 110.995 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.431 ' CB ' ' HA ' ' A' ' 177' ' ' TYR . 6.5 p-10 -139.86 145.34 37.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.488 1.118 . . . . 73.120000000000005 109.332 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.66 ' HE2' ' HZ1' ' A' ' 170' ' ' LYS . 1.9 p90 -160.28 166.33 29.72 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.552 1.158 . . . . 75.019999999999996 111.057 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -100.03 130.92 46.24 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.537 1.148 . . . . 65.549999999999997 109.321 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.681 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -100.9 157.8 16.46 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.497 1.123 . . . . 51.409999999999997 109.271 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -156.72 24.53 0.33 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.493 1.121 . . . . 73.239999999999995 110.26 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.66 ' HZ1' ' HE2' ' A' ' 166' ' ' PHE . 0.3 OUTLIER -99.54 -177.25 3.52 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.527 1.142 . . . . 73.319999999999993 109.25 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.94 -27.89 65.74 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.525 1.14 . . . . 60.130000000000003 109.348 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.434 ' HB3' ' CB ' ' A' ' 206' ' ' LEU . 9.2 t0 -112.29 22.2 14.97 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.479 1.112 . . . . 75.299999999999997 109.315 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.681 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 10.4 pt-20 -36.92 111.63 0.16 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.472 1.108 . . . . 73.049999999999997 110.29 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.71 HD13 ' HA3' ' A' ' 205' ' ' GLY . 4.6 tp -132.02 109.68 10.2 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.457 1.098 . . . . 74.340000000000003 109.293 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.0 t -87.26 133.17 33.71 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.444 1.09 . . . . 71.099999999999994 110.412 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 19.8 m -141.73 165.29 27.88 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.497 1.123 . . . . 75.230000000000004 110.412 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.431 ' HA ' ' CB ' ' A' ' 165' ' ' ASP . 8.1 m-85 -111.07 164.12 13.16 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.44 1.087 . . . . 75.299999999999997 110.999 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 164' ' ' TYR . 2.1 m -61.84 158.46 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.586 1.178 . . . . 65.230000000000004 109.281 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 46.3 70.14 0.72 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.444 1.09 . . . . 70.129999999999995 111.018 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -131.94 174.59 10.01 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 0.773 . . . . 62.5 110.353 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.445 ' ND2' ' OH ' ' A' ' 159' ' ' TYR . 0.4 OUTLIER -118.23 136.23 53.79 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.54 1.15 . . . . 74.519999999999996 109.314 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.876 HD22 HG23 ' A' ' 162' ' ' VAL . 2.6 pt? -157.25 146.09 19.8 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.568 1.167 . . . . 63.240000000000002 109.242 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 7.7 m-85 -113.86 124.1 51.4 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.544 1.153 . . . . 73.400000000000006 110.955 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.857 HD13 ' HB2' ' A' ' 160' ' ' ALA . 1.7 mp -65.44 152.84 8.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.546 1.154 . . . . 72.219999999999999 109.261 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.549 ' O ' ' CZ3' ' A' ' 242' ' ' TRP . 0.1 OUTLIER -135.78 -47.26 0.67 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.467 1.105 . . . . 73.239999999999995 108.319 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.924 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -126.73 167.32 15.91 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.132 . . . . 73.409999999999997 109.313 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.487 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.2 OUTLIER -148.88 146.09 27.76 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.474 1.109 . . . . 71.099999999999994 109.598 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.6 ' CE1' ' CB ' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -149.8 141.81 23.9 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.503 1.127 . . . . 75.400000000000006 109.647 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.455 ' C ' ' N ' ' A' ' 191' ' ' GLU . 19.0 t-20 51.25 22.35 1.34 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.498 1.124 . . . . 75.239999999999995 109.287 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.402 ' C ' ' O ' ' A' ' 189' ' ' ASN . 53.8 m 41.57 28.33 0.08 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.549 1.155 . . . . 51.109999999999999 108.312 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.529 ' O ' HG13 ' A' ' 209' ' ' VAL . 6.8 tt0 -128.15 -41.1 1.61 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.416 1.073 . . . . 70.129999999999995 110.326 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.872 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 98.8 m95 -106.63 131.35 53.88 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.01 -1.107 . . . . 74.420000000000002 108.01 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.8 ' CE2' HG12 ' A' ' 209' ' ' VAL . 20.8 m-30 -125.41 130.47 51.94 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.476 1.11 . . . . 74.150000000000006 111.033 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.924 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 1.5 mp -89.5 96.41 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.563 1.164 . . . . 71.329999999999998 109.313 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -104.16 -174.56 2.57 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.579 1.175 . . . . 63.240000000000002 109.237 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 197' ' ' PRO . 1.1 tmtt? -150.48 141.24 14.58 Favored Pre-proline 0 C--N 1.326 -0.436 0 O-C-N 124.474 1.109 . . . . 74.439999999999998 109.274 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 196' ' ' LYS . 18.4 Cg_endo -75.05 153.74 41.75 Favored 'Trans proline' 0 C--N 1.361 1.213 0 O-C-N 124.506 1.793 . . . . 74.109999999999999 110.972 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 4.6 tp -58.82 114.49 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.518 1.136 . . . . 75.450000000000003 109.313 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 122.73 126.63 3.19 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 124.445 1.091 . . . . 73.230000000000004 110.98 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.431 ' CG ' ' N ' ' A' ' 201' ' ' LEU . 35.8 ptt-85 -44.36 -43.49 7.59 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.516 0.774 . . . . 75.409999999999997 110.31 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.431 ' N ' ' CG ' ' A' ' 200' ' ' ARG . 11.5 mt -72.13 79.86 0.96 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.5 1.125 . . . . 75.200000000000003 109.265 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 155.5 147.68 4.79 Favored Glycine 0 CA--C 1.531 1.057 0 O-C-N 124.482 1.114 . . . . 65.430000000000007 110.937 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.418 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . 71.89 179.04 31.89 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 111.039 -0.824 . . . . 51.119999999999997 111.039 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.544 ' HB2' HG23 ' A' ' 194' ' ' ILE . 18.4 Cg_endo -75.03 122.65 8.37 Favored 'Cis proline' 0 C--N 1.359 1.121 0 C-N-CA 121.031 -2.487 . . . . 60.43 111.002 0.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.71 ' HA3' HD13 ' A' ' 174' ' ' LEU . . . -98.19 153.17 19.96 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.449 1.093 . . . . 74.340000000000003 111.049 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.872 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -86.94 146.43 26.16 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.478 0.752 . . . . 71.319999999999993 109.271 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.747 HG21 HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -158.11 126.83 2.99 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.456 1.097 . . . . 74.099999999999994 109.287 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.595 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.3 Cg_endo -75.01 174.48 12.73 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.573 1.828 . . . . 62.340000000000003 110.999 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.8 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.2 m -93.11 4.76 7.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.541 1.151 . . . . 61.509999999999998 109.307 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . 0.446 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -109.01 4.64 31.92 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.494 1.121 . . . . 74.299999999999997 110.914 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.633 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 15.7 m-85 -134.12 8.6 3.76 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.473 0.749 . . . . 72.540000000000006 111.058 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.937 HG12 HG22 ' A' ' 162' ' ' VAL . 3.1 m -151.66 162.17 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.45 1.094 . . . . 71.049999999999997 109.345 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 3.6 t -128.42 133.43 48.57 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.529 1.143 . . . . 61.299999999999997 110.032 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.72 ' O ' HG23 ' A' ' 215' ' ' ILE . 2.7 mm -80.77 145.87 8.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.507 1.129 . . . . 74.420000000000002 109.196 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.72 HG23 ' O ' ' A' ' 214' ' ' ILE . 1.0 OUTLIER -165.06 159.02 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.449 1.093 . . . . 74.519999999999996 109.299 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.447 ' CB ' ' HB3' ' A' ' 159' ' ' TYR . 8.4 t0 76.22 55.39 0.05 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.447 1.092 . . . . 72.439999999999998 109.264 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.55 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 3.1 mt -142.12 107.34 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.505 1.128 . . . . 75.310000000000002 109.26 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 217' ' ' ILE . . . 74.04 25.93 1.78 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.44 1.087 . . . . 61.539999999999999 109.262 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.409 ' O ' HG22 ' A' ' 219' ' ' THR . 34.4 m 64.19 61.44 0.91 Allowed 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.574 1.171 . . . . 72.510000000000005 110.354 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 170.25 -178.28 43.09 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 124.497 1.123 . . . . 70.120000000000005 110.986 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 221' ' ' TYR . 4.1 m-30 -90.06 124.94 35.21 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.562 0.801 . . . . 74.519999999999996 110.966 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.687 ' O ' HG22 ' A' ' 223' ' ' THR . . . 54.24 27.25 7.63 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.568 1.167 . . . . 64.349999999999994 109.315 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.687 HG22 ' O ' ' A' ' 222' ' ' ALA . 14.0 t 48.63 26.33 1.19 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.506 1.129 . . . . 74.219999999999999 110.329 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 86.42 -51.3 4.35 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.54 1.15 . . . . 75.540000000000006 111.031 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.448 ' OD1' HG22 ' A' ' 223' ' ' THR . 40.7 p30 -70.81 174.73 5.69 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.473 0.749 . . . . 70.439999999999998 109.328 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' A' ' 229' ' ' GLU . 25.6 t0 -76.4 149.99 36.84 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.435 1.084 . . . . 63.299999999999997 109.333 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.634 HG13 HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -40.37 -55.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.463 1.102 . . . . 54.020000000000003 109.322 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.634 HD12 HG13 ' A' ' 227' ' ' VAL . 4.0 mp -55.9 -42.22 70.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.119 . . . . 70.140000000000001 109.315 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 226' ' ' ASP . 9.4 mt-10 -68.22 -14.59 63.09 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.455 1.097 . . . . 75.209999999999994 110.253 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -88.73 -18.91 26.83 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.528 1.142 . . . . 74.239999999999995 109.317 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.648 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.5 OUTLIER -68.34 -69.14 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.537 1.148 . . . . 62.25 109.24 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.648 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -59.84 -24.97 64.62 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.43 1.081 . . . . 74.140000000000001 109.226 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.51 -57.4 6.2 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.537 1.148 . . . . 60.119999999999997 109.991 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 234' ' ' VAL . 1.4 m -93.3 25.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.52 1.137 . . . . 70.420000000000002 109.24 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 3.4 m120 41.66 30.28 0.14 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.487 1.117 . . . . 72.310000000000002 109.292 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.563 HD12 ' HD2' ' A' ' 237' ' ' PRO . 7.9 tp -59.28 121.3 55.15 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.506 1.129 . . . . 61.109999999999999 109.334 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.563 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.3 Cg_endo -75.03 160.5 39.98 Favored 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.48 1.779 . . . . 50.200000000000003 111.029 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.516 HG22 ' H ' ' A' ' 239' ' ' VAL . 2.9 m -60.15 -179.35 0.1 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.5 1.125 . . . . 62.409999999999997 110.466 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.638 HG13 ' HG3' ' A' ' 240' ' ' GLN . 11.5 p -71.08 -34.42 54.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 54.119999999999997 109.329 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.638 ' HG3' HG13 ' A' ' 239' ' ' VAL . 2.4 mt-30 -85.32 -18.0 35.15 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.444 1.09 . . . . 55.130000000000003 110.302 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.413 ' HB2' ' N ' ' A' ' 238' ' ' THR . 34.1 mt-10 -84.84 -45.49 12.25 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.476 1.11 . . . . 75.219999999999999 110.293 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.549 ' CZ3' ' O ' ' A' ' 185' ' ' CYS . 7.5 t90 -67.77 -55.05 14.56 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.51 1.131 . . . . 74.120000000000005 107.962 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt -62.72 -18.39 62.45 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.522 1.138 . . . . 54.219999999999999 109.318 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.3 t -46.13 -66.49 0.4 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.474 1.109 . . . . 54.210000000000001 110.059 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -133.55 112.79 11.79 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.594 1.184 . . . . 64.25 109.314 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.436 ' HA ' HD13 ' A' ' 246' ' ' ILE . 14.0 mm -40.44 -63.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.429 1.08 . . . . 64.450000000000003 109.287 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -157.5 107.72 2.21 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.554 1.159 . . . . 53.399999999999999 109.3 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . 0.534 ' O ' ' CG ' ' A' ' 249' ' ' TYR . 0.5 OUTLIER -121.37 -3.77 9.41 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.528 1.142 . . . . 75.400000000000006 110.261 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.534 ' CG ' ' O ' ' A' ' 248' ' ' ARG . 2.0 m-85 -175.06 172.37 2.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.521 1.138 . . . . 62.5 111.047 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.433 ' C ' ' N ' ' A' ' 252' ' ' SER . 3.1 ptpp? 40.44 37.95 0.51 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.547 1.155 . . . . 63.43 109.307 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -40.53 -30.07 0.1 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 63.140000000000001 109.28 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . 0.433 ' N ' ' C ' ' A' ' 250' ' ' LYS . 12.4 t -65.5 -177.54 0.44 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.475 1.11 . . . . 64.420000000000002 110.015 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.434 ' O ' HD13 ' A' ' 254' ' ' ILE . 0.9 OUTLIER -114.51 148.15 38.34 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.512 1.132 . . . . 72.439999999999998 109.332 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.434 HD13 ' O ' ' A' ' 253' ' ' ASN . 50.1 mm -128.87 136.78 58.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.531 1.144 . . . . 63.210000000000001 109.355 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.5 t -145.85 153.33 40.75 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.441 1.088 . . . . 62.020000000000003 109.998 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.68 -179.88 3.94 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.503 1.127 . . . . 61.25 109.359 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -73.72 -136.63 0.34 Allowed Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.589 1.181 . . . . 43.549999999999997 111.101 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 5.7 m -141.67 -174.96 4.2 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.525 0.779 . . . . 72.319999999999993 109.986 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 30.2 m -127.56 -177.34 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.457 1.098 . . . . 64.439999999999998 109.258 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.434 1.084 . . . . 70.109999999999999 110.332 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.977 -0.379 . . . . 74.349999999999994 109.977 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 45.5 t -141.74 178.44 7.48 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.125 . . . . 74.310000000000002 109.994 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 86.1 p -97.83 -176.14 3.37 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.593 1.183 . . . . 73.439999999999998 109.973 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -113.61 -52.58 2.75 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.571 1.169 . . . . 44.509999999999998 109.299 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 53.58 29.0 8.51 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.533 1.146 . . . . 65.299999999999997 109.337 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -118.93 159.58 14.4 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.427 1.079 . . . . 40.450000000000003 111.003 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -118.94 8.56 11.69 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.442 0.731 . . . . 73.209999999999994 109.31 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 470' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -107.14 10.75 30.01 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.464 1.102 . . . . 71.109999999999999 110.979 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 471' ' ' ILE . . . . . 0.705 HG23 ' HD2' ' B' ' 472' ' ' PRO . 20.0 mm -83.82 142.06 41.81 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.494 1.121 . . . . 75.230000000000004 109.25 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 472' ' ' PRO . . . . . 0.705 ' HD2' HG23 ' B' ' 471' ' ' ILE . 18.2 Cg_endo -75.02 -175.95 2.63 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.456 1.766 . . . . 44.439999999999998 110.988 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 42.7 t -126.7 6.87 6.78 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.484 1.115 . . . . 35.310000000000002 109.997 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -142.44 157.04 63.47 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.545 1.153 . . . . 71.530000000000001 110.294 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 475' ' ' PRO . . . . . 0.702 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.2 Cg_endo -75.06 -26.11 11.13 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.478 1.778 . . . . 75.319999999999993 111.002 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 476' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 163.1 140.1 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.489 1.118 . . . . 74.299999999999997 109.254 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 477' ' ' PRO . . . . . 0.574 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -75.02 -163.4 0.18 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.534 1.807 . . . . 73.329999999999998 111.041 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 478' ' ' LYS . . . . . 0.403 ' N ' ' HD3' ' B' ' 478' ' ' LYS . 0.1 OUTLIER -128.54 90.81 45.46 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.51 1.131 . . . . 65.209999999999994 109.277 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 479' ' ' PRO . . . . . 0.633 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.5 Cg_endo -74.96 147.16 33.72 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.512 1.796 . . . . 53.509999999999998 111.025 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 480' ' ' PRO . . . . . 0.53 ' O ' ' CB ' ' B' ' 481' ' ' SER . 18.4 Cg_endo -74.99 117.96 5.1 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.511 1.795 . . . . 64.420000000000002 111.016 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 481' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' B' ' 480' ' ' PRO . 1.4 t 156.98 129.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.557 1.16 . . . . 65.040000000000006 109.966 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 34.9 t -104.47 88.89 3.06 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 124.486 1.116 . . . . 72.510000000000005 109.986 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -54.06 -33.12 56.65 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.529 1.143 . . . . 64.030000000000001 109.305 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 3.9 t -45.88 -47.37 16.12 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.492 1.12 . . . . 51.219999999999999 110.002 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -46.02 124.53 5.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.463 1.102 . . . . 71.209999999999994 109.324 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 53.6 p . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.519 1.137 . . . . 73.010000000000005 110.022 179.967 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.97 0 N-CA-C 110.99 -0.844 . . . . 41.340000000000003 110.99 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.1 p -86.67 49.35 1.79 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.482 0.754 . . . . 75.430000000000007 109.986 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.497 ' CB ' ' OD1' ' A' ' 216' ' ' ASP . 1.8 pp -55.02 121.71 9.31 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.56 1.162 . . . . 73.430000000000007 109.266 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.56 ' CD1' ' O ' ' A' ' 215' ' ' ILE . 9.6 p90 -150.12 -179.06 6.87 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.564 1.165 . . . . 73.420000000000002 110.957 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.437 ' CB ' HD11 ' A' ' 184' ' ' ILE . . . -115.98 152.73 32.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.558 1.161 . . . . 72.349999999999994 109.323 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.724 HD12 HD23 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -126.72 120.81 56.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 124.533 1.146 . . . . 43.399999999999999 109.298 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.781 HG22 HG12 ' A' ' 212' ' ' VAL . 2.5 t -74.42 121.67 26.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.544 1.152 . . . . 74.219999999999999 109.3 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.884 HD11 ' HB2' ' A' ' 213' ' ' SER . 0.4 OUTLIER -100.11 -12.32 19.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.578 1.174 . . . . 75.129999999999995 109.307 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.601 ' CE1' ' OG ' ' B' ' 481' ' ' SER . 0.9 OUTLIER -150.9 154.45 37.21 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.483 1.114 . . . . 73.400000000000006 111.046 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.661 ' N ' HG12 ' A' ' 178' ' ' VAL . 2.9 p30 -74.62 158.73 33.15 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.478 1.111 . . . . 74.329999999999998 109.231 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.488 ' HB2' ' CD1' ' A' ' 211' ' ' PHE . 8.8 t80 -154.51 130.69 10.34 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.527 1.142 . . . . 75.349999999999994 111.002 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -88.95 126.51 35.43 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.46 1.1 . . . . 74.25 109.26 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.798 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -113.64 151.14 32.16 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.518 1.136 . . . . 54.009999999999998 109.325 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -155.71 24.08 0.39 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.419 1.074 . . . . 74.109999999999999 110.275 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.471 ' HD3' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -100.87 -175.78 2.98 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.615 1.197 . . . . 60.130000000000003 109.287 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.18 -26.08 66.05 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.456 1.097 . . . . 71.140000000000001 109.344 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.456 ' HB3' ' CB ' ' A' ' 206' ' ' LEU . 60.4 m-20 -109.68 15.5 22.77 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.44 1.088 . . . . 71.409999999999997 109.268 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.798 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 17.7 pt-20 -36.1 110.01 0.1 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.439 1.087 . . . . 74.200000000000003 110.295 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.672 HD22 ' HA3' ' A' ' 205' ' ' GLY . 14.2 tp -128.93 103.91 7.29 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.546 1.154 . . . . 64.400000000000006 109.251 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.3 t -88.35 142.6 27.6 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.537 1.148 . . . . 53.149999999999999 110.368 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.464 ' CG2' ' HG2' ' A' ' 180' ' ' GLU . 17.0 m -155.16 162.89 40.85 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.533 1.146 . . . . 60.310000000000002 110.392 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -99.36 163.77 12.39 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.481 1.113 . . . . 74.120000000000005 111.027 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.661 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.6 m -57.72 158.16 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 71.040000000000006 109.29 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.424 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 49.88 68.19 1.5 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.51 1.131 . . . . 34.310000000000002 110.99 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.464 ' HG2' ' CG2' ' A' ' 176' ' ' THR . 3.8 tp10 -128.31 167.77 16.47 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.501 0.765 . . . . 74.510000000000005 110.262 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.45 132.65 53.5 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.429 1.08 . . . . 51.340000000000003 109.328 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.687 HD21 HG23 ' A' ' 162' ' ' VAL . 0.4 OUTLIER -143.25 158.03 43.98 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.495 1.122 . . . . 71.109999999999999 109.36 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 0.6 OUTLIER -114.55 113.09 23.95 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.483 1.115 . . . . 74.420000000000002 110.972 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.463 ' N ' HD12 ' A' ' 184' ' ' ILE . 1.7 mp -65.54 159.96 3.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 124.453 1.096 . . . . 62.299999999999997 109.312 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 186' ' ' ALA . 9.7 p -147.03 -44.39 0.18 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.583 1.177 . . . . 61.409999999999997 108.334 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.879 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -121.32 164.23 17.36 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.446 1.091 . . . . 74.549999999999997 109.32 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.416 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.2 OUTLIER -154.03 140.23 18.5 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.484 1.115 . . . . 60.299999999999997 109.602 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.681 ' NE2' HD11 ' A' ' 194' ' ' ILE . 0.1 OUTLIER -142.18 142.42 32.69 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.518 1.136 . . . . 74.120000000000005 109.577 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.48 ' C ' ' N ' ' A' ' 191' ' ' GLU . 19.2 t-20 50.62 22.1 1.02 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.469 1.105 . . . . 73.140000000000001 109.321 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.4 ' C ' ' O ' ' A' ' 189' ' ' ASN . 23.5 m 42.0 27.23 0.07 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.574 1.171 . . . . 54.119999999999997 108.245 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.524 ' O ' HG13 ' A' ' 209' ' ' VAL . 9.3 tt0 -125.11 -37.1 2.45 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.479 1.112 . . . . 64.430000000000007 110.293 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.821 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 97.2 m95 -109.78 128.77 55.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.505 1.128 . . . . 72.140000000000001 107.96 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.603 ' CE2' HG12 ' A' ' 209' ' ' VAL . 20.9 m-30 -122.18 127.04 49.56 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.488 1.118 . . . . 70.329999999999998 110.958 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.879 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 9.3 mm -89.23 106.34 16.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.493 1.12 . . . . 74.219999999999999 109.288 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -117.01 175.77 5.43 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 1.128 . . . . 72.549999999999997 109.333 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 1.8 pttm -147.56 165.56 18.42 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.442 1.089 . . . . 60.149999999999999 109.303 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.92 178.26 7.47 Favored 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.517 1.799 . . . . 71.439999999999998 110.96 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.495 ' CD1' ' O ' ' A' ' 198' ' ' ILE . 1.2 pp -105.06 68.8 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.56 1.162 . . . . 74.200000000000003 109.231 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 201' ' ' LEU . . . 160.97 122.79 0.64 Allowed Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.541 1.15 . . . . 40.219999999999999 110.984 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 199' ' ' GLY . 20.2 mmm180 -37.0 97.14 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.557 0.798 . . . . 75.109999999999999 110.31 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 199' ' ' GLY . 2.5 tp 173.8 137.48 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.513 1.133 . . . . 74.310000000000002 109.294 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 47.76 -157.69 0.76 Allowed Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.507 1.129 . . . . 70.129999999999995 110.931 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 52.83 171.44 0.03 OUTLIER Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.959 -0.856 . . . . 54.329999999999998 110.959 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.524 ' HB2' HG22 ' A' ' 194' ' ' ILE . 18.3 Cg_endo -74.94 129.05 17.59 Favored 'Cis proline' 0 C--N 1.362 1.248 0 C-N-CA 121.011 -2.495 . . . . 65.329999999999998 111.053 -0.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.672 ' HA3' HD22 ' A' ' 174' ' ' LEU . . . -92.63 163.31 27.19 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.519 1.137 . . . . 40.43 110.963 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.821 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -97.62 145.41 26.31 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.496 0.762 . . . . 71.040000000000006 109.326 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.562 HG11 HD11 ' A' ' 182' ' ' LEU . 0.4 OUTLIER -153.61 127.35 4.37 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.583 1.177 . . . . 64.549999999999997 109.344 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.611 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.2 Cg_endo -75.09 174.52 12.65 Favored 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.505 1.792 . . . . 74.200000000000003 110.995 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.603 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.6 m -97.03 7.01 8.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.484 1.115 . . . . 63.210000000000001 109.267 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . 0.457 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -106.93 -0.9 36.22 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.506 1.129 . . . . 44.5 110.948 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.572 ' CE2' ' HB3' ' B' ' 479' ' ' PRO . 12.7 m-85 -133.27 15.53 4.14 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.556 0.798 . . . . 71.209999999999994 111.046 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.781 HG12 HG22 ' A' ' 162' ' ' VAL . 3.4 m -152.62 157.66 4.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.548 1.155 . . . . 73.439999999999998 109.36 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.884 ' HB2' HD11 ' A' ' 163' ' ' LEU . 46.6 t -128.23 119.94 26.2 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.527 1.142 . . . . 61.25 110.056 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.631 ' C ' HG22 ' A' ' 215' ' ' ILE . 5.1 mm -64.48 153.22 7.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.495 1.122 . . . . 74.230000000000004 109.245 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.78 HD12 ' H ' ' A' ' 216' ' ' ASP . 0.4 OUTLIER 176.28 147.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.577 1.173 . . . . 73.010000000000005 109.309 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.78 ' H ' HD12 ' A' ' 215' ' ' ILE . 0.0 OUTLIER -123.31 -59.91 1.53 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.511 1.132 . . . . 61.109999999999999 109.284 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.773 HD13 ' C ' ' A' ' 217' ' ' ILE . 0.0 OUTLIER -168.56 105.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.548 1.155 . . . . 51.539999999999999 109.304 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -175.02 -179.03 1.3 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.552 1.158 . . . . 74.400000000000006 109.289 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 14.6 t -102.58 27.77 6.61 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.486 1.116 . . . . 51.140000000000001 110.353 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -142.69 -152.95 5.78 Favored Glycine 0 CA--C 1.529 0.929 0 O-C-N 124.477 1.111 . . . . 43.119999999999997 111.028 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.457 ' O ' ' HB3' ' A' ' 222' ' ' ALA . 23.9 m-85 -128.76 131.11 47.83 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.413 0.714 . . . . 53.43 110.979 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 221' ' ' TYR . . . 69.05 15.93 8.73 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.498 1.124 . . . . 71.420000000000002 109.314 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.494 ' CG2' ' O ' ' A' ' 223' ' ' THR . 0.6 OUTLIER 71.19 4.91 5.26 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.509 1.131 . . . . 52.0 110.428 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 101.32 -32.87 6.97 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.527 1.142 . . . . 72.510000000000005 110.964 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -77.4 176.08 9.18 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.501 0.765 . . . . 73.25 109.27 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 230' ' ' ASP . 0.7 OUTLIER -93.68 137.82 32.54 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.13 . . . . 75.430000000000007 109.366 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.454 HG21 ' HE2' ' A' ' 193' ' ' PHE . 1.3 p -49.11 -41.12 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.536 1.147 . . . . 72.109999999999999 109.283 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.761 ' HA ' HD12 ' A' ' 231' ' ' ILE . 12.3 mt -66.9 -33.94 66.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.586 1.178 . . . . 72.230000000000004 109.315 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -81.75 -17.52 47.43 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.425 1.078 . . . . 72.239999999999995 110.289 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 226' ' ' ASP . 6.5 t70 -88.7 -15.73 34.09 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.532 1.145 . . . . 72.219999999999999 109.278 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.761 HD12 ' HA ' ' A' ' 228' ' ' ILE . 6.7 mt -71.03 -69.44 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.459 1.099 . . . . 63.229999999999997 109.356 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.435 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -56.86 -21.19 27.48 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.468 1.105 . . . . 74.439999999999998 109.281 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.4 m -56.79 -17.92 10.92 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 72.450000000000003 110.019 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 234' ' ' VAL . 1.2 m -133.14 22.27 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.508 1.13 . . . . 70.200000000000003 109.284 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 40.75 37.22 0.47 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.618 1.199 . . . . 73.140000000000001 109.333 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.468 ' HB2' ' CG2' ' A' ' 234' ' ' VAL . 5.7 tp -66.16 119.63 63.36 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.424 1.078 . . . . 72.040000000000006 109.285 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 166.95 28.13 Favored 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.478 1.778 . . . . 74.540000000000006 111.018 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.6 m -68.43 173.58 4.81 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.446 1.091 . . . . 54.119999999999997 110.416 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.719 HG23 ' HB1' ' A' ' 186' ' ' ALA . 14.9 p -69.04 -49.02 66.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.473 1.108 . . . . 44.43 109.347 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 1.015 ' OE1' HD11 ' B' ' 471' ' ' ILE . 7.7 pm0 -73.04 -14.53 61.43 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.117 . . . . 71.239999999999995 110.292 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -90.53 -36.33 14.55 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.543 1.152 . . . . 62.439999999999998 110.313 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.583 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 1.3 t90 -80.48 -54.88 5.28 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.513 1.133 . . . . 73.540000000000006 107.997 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.504 ' HD3' ' CE2' ' B' ' 470' ' ' PHE . 3.0 mtmp? -57.85 -17.3 15.37 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.53 1.144 . . . . 65.219999999999999 109.22 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 247' ' ' ALA . 17.1 m -38.15 -45.2 0.91 Allowed 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.502 1.126 . . . . 62.32 109.947 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -42.62 -50.61 5.39 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.556 1.16 . . . . 75.120000000000005 109.377 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.551 ' H ' HD12 ' A' ' 246' ' ' ILE . 3.3 mp -55.16 -42.13 63.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.515 1.134 . . . . 72.120000000000005 109.298 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' A' ' 244' ' ' SER . . . -102.19 89.26 3.54 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 42.409999999999997 109.296 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 9.0 tpp85 -44.19 139.58 2.51 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.472 1.108 . . . . 72.25 110.339 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -144.26 -177.48 5.48 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.441 1.088 . . . . 75.510000000000005 110.981 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 16.3 ttpt -47.79 147.47 1.93 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 72.200000000000003 109.286 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -80.99 -57.94 3.31 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.478 1.111 . . . . 62.119999999999997 109.306 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 5.0 m -60.36 112.27 1.88 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.388 1.055 . . . . 72.329999999999998 109.954 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.568 ' H ' ' ND2' ' A' ' 253' ' ' ASN . 0.1 OUTLIER -114.46 -1.59 13.41 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.632 1.208 . . . . 65.530000000000001 109.314 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.422 HD12 ' ND2' ' A' ' 253' ' ' ASN . 1.3 mp -85.18 111.24 20.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.518 1.136 . . . . 72.209999999999994 109.263 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.6 p -158.46 111.31 2.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.468 1.105 . . . . 71.430000000000007 109.98 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 7.2 tt -168.82 135.68 1.86 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.508 1.13 . . . . 60.43 109.284 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 172.55 92.41 0.08 OUTLIER Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.533 1.146 . . . . 73.040000000000006 111.021 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.3 p -133.18 -62.05 0.81 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.538 0.787 . . . . 64.530000000000001 109.993 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 1.6 p -171.72 148.69 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.474 1.109 . . . . 74.109999999999999 109.316 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.468 1.105 . . . . 73.5 110.391 179.976 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.997 -0.372 . . . . 62.439999999999998 109.997 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 29.9 t -90.3 9.01 30.43 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.548 1.155 . . . . 63.310000000000002 110.034 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 3.9 m -165.63 -177.44 4.38 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.459 1.099 . . . . 60.229999999999997 110.059 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -117.58 -67.93 0.96 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.578 1.174 . . . . 32.229999999999997 109.274 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -168.31 131.03 1.46 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.497 1.123 . . . . 74.349999999999994 109.332 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . 0.583 ' HA3' HD13 ' B' ' 471' ' ' ILE . . . -141.27 -179.35 18.41 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.508 1.13 . . . . 55.119999999999997 111.018 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -105.94 -17.03 14.48 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.502 0.766 . . . . 71.140000000000001 109.287 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 470' ' ' PHE . . . . . 0.683 ' CD2' HG21 ' A' ' 194' ' ' ILE . 4.9 m-30 -111.4 -2.78 15.48 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.537 1.148 . . . . 72.019999999999996 110.987 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 471' ' ' ILE . . . . . 1.015 HD11 ' OE1' ' A' ' 240' ' ' GLN . 1.4 mp -70.51 142.98 89.66 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.48 1.112 . . . . 74.540000000000006 109.259 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 472' ' ' PRO . . . . . 0.574 ' HG3' ' CD1' ' A' ' 192' ' ' TRP . 18.5 Cg_endo -74.92 161.53 38.81 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.513 1.796 . . . . 63.0 111.01 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 473' ' ' SER . . . . . 0.44 ' OG ' ' CZ ' ' B' ' 474' ' ' ARG . 29.6 t -98.72 -27.42 13.97 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.532 1.145 . . . . 61.450000000000003 109.989 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 474' ' ' ARG . . . . . 0.44 ' CZ ' ' OG ' ' B' ' 473' ' ' SER . 2.6 mmt180 -111.08 170.38 5.33 Favored Pre-proline 0 C--N 1.326 -0.428 0 O-C-N 124.527 1.142 . . . . 71.120000000000005 110.316 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 -168.48 0.52 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.48 1.779 . . . . 74.239999999999995 110.974 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 476' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' B' ' 477' ' ' PRO . . . -73.28 134.93 79.71 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 52.439999999999998 109.296 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 477' ' ' PRO . . . . . 0.566 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -75.0 170.79 19.64 Favored 'Trans proline' 0 C--N 1.358 1.077 0 O-C-N 124.505 1.792 . . . . 63.299999999999997 111.027 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -113.11 95.27 34.11 Favored Pre-proline 0 C--N 1.324 -0.54 0 O-C-N 124.509 1.131 . . . . 61.100000000000001 109.284 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 479' ' ' PRO . . . . . 0.572 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 18.1 Cg_endo -74.99 168.62 24.43 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.483 1.781 . . . . 74.219999999999999 110.974 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 -89.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.498 1.789 . . . . 73.409999999999997 110.977 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 481' ' ' SER . . . . . 0.601 ' OG ' ' CE1' ' A' ' 164' ' ' TYR . 3.3 p -86.89 101.08 13.05 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.483 1.114 . . . . 62.109999999999999 110.026 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 7.1 t -139.63 -50.32 0.5 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 61.130000000000003 110.036 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 483' ' ' ALA . . . . . 0.675 ' HB3' ' OG ' ' B' ' 486' ' ' SER . . . -107.32 123.92 49.05 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.468 1.105 . . . . 45.229999999999997 109.303 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 27.4 t -58.77 118.9 6.22 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 124.469 1.105 . . . . 71.150000000000006 110.04 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . 55.5 50.77 13.95 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.488 1.118 . . . . 73.409999999999997 109.315 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 486' ' ' SER . . . . . 0.675 ' OG ' ' HB3' ' B' ' 483' ' ' ALA . 62.7 m . . . . . 0 C--N 1.326 -0.454 0 O-C-N 124.487 1.117 . . . . 62.340000000000003 109.977 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.995 0 N-CA-C 111.07 -0.812 . . . . 62.350000000000001 111.07 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.0 m -121.51 52.44 1.23 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.457 0.739 . . . . 61.509999999999998 109.968 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.04 144.12 32.28 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.45 1.094 . . . . 65.209999999999994 109.276 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.559 ' CE1' ' HB2' ' A' ' 183' ' ' PHE . 1.2 t80 -137.19 166.8 22.87 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.48 1.113 . . . . 73.349999999999994 111.009 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.594 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -113.72 142.48 45.98 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.546 1.154 . . . . 74.329999999999998 109.289 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.71 HD13 ' N ' ' A' ' 162' ' ' VAL . 0.0 OUTLIER -127.78 121.59 56.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.485 1.116 . . . . 74.439999999999998 109.302 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.879 ' CG1' HD21 ' A' ' 182' ' ' LEU . 7.0 m -83.47 126.88 40.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.442 1.089 . . . . 64.010000000000005 109.325 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.661 HD23 HD12 ' A' ' 161' ' ' ILE . 0.3 OUTLIER -99.6 -1.95 36.85 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.499 1.125 . . . . 72.219999999999999 109.305 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.533 ' CE2' ' HB2' ' A' ' 163' ' ' LEU . 0.9 OUTLIER -154.69 155.57 34.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.486 1.116 . . . . 74.340000000000003 111.071 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.781 ' N ' HG12 ' A' ' 178' ' ' VAL . 33.0 p-10 -96.49 154.03 17.5 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.465 1.103 . . . . 65.239999999999995 109.314 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.535 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 3.4 t80 -147.23 137.94 23.58 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.49 1.119 . . . . 73.230000000000004 111.019 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.535 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 5.9 mtmt -76.56 128.96 35.74 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.499 1.124 . . . . 74.319999999999993 109.292 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.957 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -110.86 141.99 43.5 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.46 1.1 . . . . 73.120000000000005 109.286 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -148.22 18.87 1.09 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.506 1.129 . . . . 72.120000000000005 110.266 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.455 ' O ' ' CG ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -100.25 -176.49 3.24 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.48 1.113 . . . . 71.420000000000002 109.306 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.06 -30.73 69.4 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.472 1.108 . . . . 52.420000000000002 109.29 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.478 ' CB ' ' HB2' ' A' ' 206' ' ' LEU . 1.0 OUTLIER -101.96 12.06 37.52 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.489 1.118 . . . . 72.319999999999993 109.307 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.957 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 8.5 pt-20 -33.75 105.57 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.529 1.143 . . . . 64.430000000000007 110.264 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.706 HD13 ' HA3' ' A' ' 205' ' ' GLY . 13.2 tp -119.46 107.12 12.94 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.484 1.115 . . . . 55.229999999999997 109.339 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.645 HG23 ' O ' ' A' ' 175' ' ' THR . 14.4 t -85.44 99.14 11.0 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.518 1.136 . . . . 53.009999999999998 110.419 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.46 176.08 5.28 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.545 1.153 . . . . 60.340000000000003 110.344 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -120.77 159.97 24.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.614 1.196 . . . . 54.109999999999999 110.962 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.781 HG12 ' N ' ' A' ' 165' ' ' ASP . 3.5 m -62.0 146.65 12.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.421 1.076 . . . . 63.130000000000003 109.259 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.42 66.14 3.05 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.503 1.127 . . . . 54.530000000000001 111.014 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.499 ' CB ' HG22 ' A' ' 162' ' ' VAL . 1.8 tp10 -132.73 169.27 16.93 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.473 0.749 . . . . 64.319999999999993 110.278 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -117.43 146.77 43.24 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.438 1.086 . . . . 72.200000000000003 109.299 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.879 HD21 ' CG1' ' A' ' 162' ' ' VAL . 0.2 OUTLIER -159.23 152.19 22.02 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 72.140000000000001 109.392 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.559 ' HB2' ' CE1' ' A' ' 159' ' ' TYR . 14.9 t80 -108.65 119.67 40.2 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.468 1.105 . . . . 71.129999999999995 111.044 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 160' ' ' ALA . 1.6 mp -64.82 155.95 6.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.411 1.069 . . . . 74.019999999999996 109.275 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.455 ' N ' ' O ' ' A' ' 194' ' ' ILE . 0.2 OUTLIER -138.66 -51.09 0.56 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.52 1.137 . . . . 75.030000000000001 108.341 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.972 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -120.73 166.29 13.92 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.506 1.129 . . . . 64.239999999999995 109.333 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.487 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.1 OUTLIER -151.37 141.37 22.08 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.41 1.068 . . . . 62.420000000000002 109.638 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.72 ' NE2' HD13 ' A' ' 194' ' ' ILE . 0.1 OUTLIER -143.2 141.0 30.98 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.421 1.076 . . . . 72.200000000000003 109.623 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.486 ' C ' ' N ' ' A' ' 191' ' ' GLU . 39.1 t-20 48.13 25.68 0.87 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.498 1.124 . . . . 74.439999999999998 109.251 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.437 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.9 p 39.02 30.19 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.519 1.137 . . . . 63.32 108.308 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.507 ' O ' HG13 ' A' ' 209' ' ' VAL . 8.6 tt0 -125.78 -37.92 2.26 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.504 1.128 . . . . 74.299999999999997 110.362 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.636 ' HB3' HD11 ' A' ' 206' ' ' LEU . 97.1 m95 -112.09 132.24 54.97 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.97 -1.122 . . . . 73.129999999999995 107.97 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.761 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.3 m-30 -125.12 129.31 49.93 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.541 1.151 . . . . 60.520000000000003 111.033 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.972 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 1.1 mp -91.27 98.12 8.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.541 1.15 . . . . 74.430000000000007 109.317 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -104.14 -175.73 2.88 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.541 1.151 . . . . 71.340000000000003 109.301 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.493 ' CD ' ' O ' ' A' ' 197' ' ' PRO . 0.0 OUTLIER -157.12 158.68 31.2 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 63.140000000000001 109.286 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.493 ' O ' ' CD ' ' A' ' 196' ' ' LYS . 18.2 Cg_endo -75.04 150.44 37.96 Favored 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.524 1.802 . . . . 74.349999999999994 111.024 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.535 HG23 ' N ' ' A' ' 199' ' ' GLY . 7.2 tp -65.99 -56.2 15.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.454 1.096 . . . . 64.340000000000003 109.316 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.535 ' N ' HG23 ' A' ' 198' ' ' ILE . . . -72.17 -117.62 0.06 OUTLIER Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.524 1.14 . . . . 44.329999999999998 111.022 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -136.07 43.76 2.5 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.491 0.759 . . . . 75.239999999999995 110.349 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.438 ' HB2' ' CB ' ' A' ' 197' ' ' PRO . 6.9 mp -77.26 -1.61 30.53 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 74.019999999999996 109.208 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 122.9 -141.19 13.72 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.528 1.142 . . . . 72.140000000000001 110.991 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.434 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . 94.43 169.01 37.29 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.99 -0.844 . . . . 51.399999999999999 110.99 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.565 ' HG2' ' CZ ' ' B' ' 470' ' ' PHE . 18.2 Cg_endo -75.05 133.25 30.59 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 121.008 -2.497 . . . . 74.409999999999997 110.925 0.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.706 ' HA3' HD13 ' A' ' 174' ' ' LEU . . . -100.44 151.03 18.98 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.478 1.111 . . . . 63.520000000000003 110.925 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.684 HD12 ' CD1' ' A' ' 194' ' ' ILE . 0.4 OUTLIER -90.45 144.2 26.03 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.539 0.788 . . . . 73.329999999999998 109.283 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.66 HG13 HD23 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -157.13 127.81 3.54 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.511 1.132 . . . . 73.239999999999995 109.288 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.442 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.4 Cg_endo -74.89 179.44 6.05 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.508 1.794 . . . . 63.0 111.041 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.761 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.0 OUTLIER -98.66 4.41 10.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.596 1.185 . . . . 73.129999999999995 109.274 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . 0.489 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -106.43 0.96 37.17 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 124.491 1.119 . . . . 73.120000000000005 110.964 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.614 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 6.9 m-85 -130.26 6.58 4.92 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.58 0.812 . . . . 74.510000000000005 110.978 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.788 HG12 HG12 ' A' ' 162' ' ' VAL . 1.5 m -150.88 153.82 9.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.473 1.108 . . . . 72.019999999999996 109.33 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.4 m -121.64 138.88 54.15 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.502 1.127 . . . . 55.210000000000001 110.025 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.645 ' O ' HG23 ' A' ' 215' ' ' ILE . 3.8 mm -87.46 124.07 40.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 124.489 1.118 . . . . 75.200000000000003 109.268 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 214' ' ' ILE . 10.8 pt -158.35 170.82 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.469 1.106 . . . . 75.219999999999999 109.304 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -134.52 -47.26 0.75 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.466 1.104 . . . . 75.319999999999993 109.265 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 12.7 pt -134.99 -177.44 2.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 124.508 1.13 . . . . 55.030000000000001 109.272 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -84.61 -179.18 7.08 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.485 1.116 . . . . 65.299999999999997 109.284 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.3 m 68.62 59.88 0.38 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.454 1.096 . . . . 65.340000000000003 110.405 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 107.38 -162.39 13.37 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.553 1.158 . . . . 75.510000000000005 110.902 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.593 ' HA ' HG22 ' A' ' 215' ' ' ILE . 43.7 m-85 -92.38 -173.12 3.31 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.436 0.727 . . . . 75.430000000000007 110.951 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.52 ' HB2' ' HA ' ' A' ' 215' ' ' ILE . . . -41.84 -73.78 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.513 1.133 . . . . 71.209999999999994 109.278 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.462 HG22 ' OD1' ' A' ' 225' ' ' ASN . 0.9 OUTLIER -120.78 -5.42 9.66 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.45 1.094 . . . . 74.299999999999997 110.433 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 93.47 18.39 38.81 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.468 1.105 . . . . 72.409999999999997 111.025 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.462 ' OD1' HG22 ' A' ' 223' ' ' THR . 0.8 OUTLIER -112.04 167.03 10.71 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.486 0.756 . . . . 73.099999999999994 109.315 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 229' ' ' GLU . 0.4 OUTLIER -78.61 148.83 33.1 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.532 1.145 . . . . 53.200000000000003 109.318 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.536 HG21 ' HE2' ' A' ' 193' ' ' PHE . 3.7 p -48.28 -49.17 12.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.116 . . . . 70.299999999999997 109.318 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.51 ' O ' ' CE ' ' A' ' 232' ' ' LYS . 3.2 mp -59.11 -29.62 41.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.428 1.08 . . . . 61.009999999999998 109.319 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 226' ' ' ASP . 15.5 mt-10 -81.41 -15.0 56.49 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.485 1.115 . . . . 73.230000000000004 110.281 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.409 ' CG ' ' ND2' ' A' ' 225' ' ' ASN . 1.6 m-20 -86.64 -15.76 38.7 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.499 1.125 . . . . 71.120000000000005 109.337 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.603 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.9 OUTLIER -72.71 -69.34 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 71.430000000000007 109.279 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.603 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -62.17 -17.55 58.34 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.51 1.131 . . . . 73.219999999999999 109.301 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.33 -39.61 60.85 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.504 1.127 . . . . 63.210000000000001 110.011 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 234' ' ' VAL . 1.6 m -117.17 27.43 3.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.532 1.145 . . . . 74.140000000000001 109.3 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 234' ' ' VAL . 6.8 m120 40.6 37.42 0.47 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.137 . . . . 73.329999999999998 109.222 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.417 ' HB2' ' CG2' ' A' ' 234' ' ' VAL . 3.8 tp -70.58 119.82 74.97 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.555 1.159 . . . . 73.109999999999999 109.268 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.4 ' HB2' ' CB ' ' A' ' 241' ' ' GLU . 18.3 Cg_endo -74.96 165.36 31.51 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.459 1.768 . . . . 74.25 111.004 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 239' ' ' VAL . 1.4 m -60.27 -177.65 0.07 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.507 1.129 . . . . 72.340000000000003 110.396 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.629 HG23 ' HB1' ' A' ' 186' ' ' ALA . 9.8 p -72.21 -35.06 51.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 50.420000000000002 109.35 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.567 ' HG3' HG13 ' A' ' 239' ' ' VAL . 0.5 OUTLIER -85.52 -17.56 36.03 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.455 1.097 . . . . 74.239999999999995 110.278 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.42 ' HB2' ' N ' ' A' ' 238' ' ' THR . 7.3 mm-40 -85.15 -42.08 15.08 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.465 1.103 . . . . 71.349999999999994 110.364 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.445 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 6.5 t90 -72.65 -60.47 2.22 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.039 -1.097 . . . . 74.310000000000002 108.039 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.564 ' HD3' ' CD2' ' B' ' 470' ' ' PHE . 4.1 mtmp? -57.41 -20.49 30.2 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.483 1.114 . . . . 63.43 109.322 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -41.75 -68.12 0.21 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.512 1.132 . . . . 55.25 110.091 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -135.24 100.25 4.49 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.564 1.165 . . . . 61.32 109.31 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 3.8 mt -55.3 -19.69 5.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.495 1.122 . . . . 74.409999999999997 109.287 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -93.11 27.07 2.59 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.615 1.197 . . . . 53.109999999999999 109.301 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . 0.79 HH21 ' HB2' ' A' ' 251' ' ' ALA . 0.0 OUTLIER -48.27 139.66 8.37 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.449 1.093 . . . . 72.129999999999995 110.331 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.548 ' CE2' ' HG2' ' A' ' 250' ' ' LYS . 17.5 p90 -127.08 -46.62 1.51 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.497 1.123 . . . . 74.349999999999994 110.984 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.548 ' HG2' ' CE2' ' A' ' 249' ' ' TYR . 9.4 pttp -130.54 129.56 42.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.423 1.077 . . . . 63.32 109.354 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.79 ' HB2' HH21 ' A' ' 248' ' ' ARG . . . -82.25 175.03 10.61 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.397 1.061 . . . . 53.310000000000002 109.29 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 4.2 t -124.43 176.19 6.64 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.535 1.147 . . . . 73.129999999999995 109.997 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.44 ' C ' ' ND2' ' A' ' 253' ' ' ASN . 0.0 OUTLIER -77.97 1.07 21.95 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.582 1.176 . . . . 72.129999999999995 109.305 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.66 131.48 33.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.573 1.171 . . . . 61.43 109.275 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 7.4 t -175.83 146.43 0.73 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.447 1.092 . . . . 72.519999999999996 110.075 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -62.14 -75.7 0.07 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.553 1.158 . . . . 72.530000000000001 109.303 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 131.96 -154.74 21.11 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 124.531 1.144 . . . . 73.299999999999997 110.942 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.4 m -122.02 97.68 5.59 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.554 0.796 . . . . 61.310000000000002 110.052 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 82.1 t -126.75 107.32 16.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.483 1.114 . . . . 53.219999999999999 109.25 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.55 1.156 . . . . 45.240000000000002 110.339 179.958 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 109.998 -0.371 . . . . 63.329999999999998 109.998 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 30.3 t -104.86 62.74 0.7 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.433 1.083 . . . . 63.149999999999999 109.979 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 5.5 m -111.47 -178.47 3.46 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.597 1.186 . . . . 51.420000000000002 109.939 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -62.14 173.64 1.08 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 51.109999999999999 109.304 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -116.01 -40.51 3.3 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.519 1.137 . . . . 65.040000000000006 109.273 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . 168.2 135.45 1.88 Allowed Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.475 1.109 . . . . 25.510000000000002 111.0 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . 0.41 ' HD2' ' N ' ' B' ' 469' ' ' LYS . 0.0 OUTLIER -104.27 -24.28 13.14 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.521 0.777 . . . . 74.409999999999997 109.299 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 470' ' ' PHE . . . . . 0.582 ' HB3' HG21 ' A' ' 239' ' ' VAL . 4.0 m-30 -102.74 33.91 3.03 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.467 1.104 . . . . 72.230000000000004 111.001 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 471' ' ' ILE . . . . . 0.472 HG23 ' HD2' ' B' ' 472' ' ' PRO . 0.9 OUTLIER -100.59 138.91 20.24 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.46 1.1 . . . . 71.209999999999994 109.279 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 472' ' ' PRO . . . . . 0.625 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.99 -45.6 0.27 Allowed 'Trans proline' 0 C--N 1.359 1.117 0 O-C-N 124.502 1.791 . . . . 71.329999999999998 111.033 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 473' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' B' ' 472' ' ' PRO . 0.1 OUTLIER 80.36 5.7 1.68 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.481 1.113 . . . . 74.439999999999998 110.027 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -132.01 157.26 78.72 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.565 1.165 . . . . 73.200000000000003 110.325 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 475' ' ' PRO . . . . . 0.7 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.0 Cg_endo -75.03 -48.09 0.18 Allowed 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.531 1.806 . . . . 52.219999999999999 110.971 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 476' ' ' ALA . . . . . 0.7 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 162.94 136.64 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.522 1.139 . . . . 75.519999999999996 109.322 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 477' ' ' PRO . . . . . 0.554 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.8 Cg_endo -74.89 -177.35 3.38 Favored 'Trans proline' 0 C--N 1.359 1.115 0 O-C-N 124.484 1.781 . . . . 63.030000000000001 111.069 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.54 92.29 28.05 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 61.299999999999997 109.317 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 479' ' ' PRO . . . . . 0.614 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.2 Cg_endo -75.01 151.53 39.58 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.489 1.784 . . . . 53.549999999999997 110.968 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 480' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 479' ' ' PRO . 18.3 Cg_endo -75.04 159.93 40.64 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.533 1.807 . . . . 74.219999999999999 111.006 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 481' ' ' SER . . . . . . . . . . . . . 3.7 m 42.35 48.8 4.46 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.45 1.094 . . . . 65.219999999999999 110.051 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 2.2 t -87.95 132.65 34.16 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.523 1.14 . . . . 74.25 109.969 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 483' ' ' ALA . . . . . 0.403 ' C ' ' N ' ' B' ' 485' ' ' ALA . . . -100.19 -21.47 15.51 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.443 1.089 . . . . 53.020000000000003 109.288 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 32.0 t -44.04 -27.4 0.37 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.539 1.15 . . . . 75.420000000000002 109.979 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . 0.403 ' N ' ' C ' ' B' ' 483' ' ' ALA . . . -153.03 156.82 39.51 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 1.114 . . . . 75.120000000000005 109.318 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 38.9 m . . . . . 0 C--N 1.325 -0.488 0 O-C-N 124.548 1.155 . . . . 75.040000000000006 109.99 -179.952 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.012 0 N-CA-C 111.103 -0.799 . . . . 63.420000000000002 111.103 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.1 m -107.26 125.52 51.25 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.542 0.789 . . . . 74.010000000000005 109.995 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.539 HD11 HG11 ' A' ' 234' ' ' VAL . 25.2 mt -100.81 128.08 47.0 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 72.409999999999997 109.336 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.65 ' CD2' ' CG1' ' A' ' 215' ' ' ILE . 2.5 t80 -130.2 138.4 50.56 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.512 1.133 . . . . 62.009999999999998 110.975 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.6 ' O ' ' CE1' ' A' ' 159' ' ' TYR . . . -110.71 147.67 33.89 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.52 1.138 . . . . 73.420000000000002 109.305 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.609 HD13 ' N ' ' A' ' 162' ' ' VAL . 0.1 OUTLIER -129.45 131.2 67.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.484 1.115 . . . . 65.209999999999994 109.38 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.941 HG22 HG12 ' A' ' 212' ' ' VAL . 1.5 t -88.73 125.61 41.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.462 1.101 . . . . 71.129999999999995 109.307 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.549 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 1.7 mt -101.11 -13.34 18.22 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.502 1.126 . . . . 74.239999999999995 109.296 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.567 ' O ' HG13 ' A' ' 162' ' ' VAL . 1.5 m-85 -148.27 156.26 42.33 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.471 1.107 . . . . 61.439999999999998 111.041 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.475 ' H ' HG12 ' A' ' 178' ' ' VAL . 5.6 p-10 -105.95 160.57 15.17 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.55 1.156 . . . . 63.310000000000002 109.295 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.566 ' HB3' ' CE1' ' A' ' 211' ' ' PHE . 0.3 OUTLIER -159.7 164.51 33.9 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.492 1.12 . . . . 72.450000000000003 110.979 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -89.84 130.77 36.03 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.513 1.133 . . . . 72.200000000000003 109.256 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.799 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -104.42 141.65 35.97 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.448 1.092 . . . . 51.409999999999997 109.315 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.8 ' H ' ' HZ3' ' A' ' 170' ' ' LYS . 7.7 pt-20 -151.91 21.68 0.68 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.461 1.101 . . . . 73.430000000000007 110.303 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.8 ' HZ3' ' H ' ' A' ' 169' ' ' GLU . 0.1 OUTLIER -98.12 -175.93 3.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.524 1.14 . . . . 75.109999999999999 109.338 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.12 -29.79 65.8 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.434 1.083 . . . . 54.25 109.328 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 173' ' ' GLU . 3.2 m-20 -110.08 22.81 15.14 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.53 1.143 . . . . 61.340000000000003 109.263 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.799 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 6.2 pt-20 -38.16 106.14 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.475 1.11 . . . . 75.230000000000004 110.322 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.712 HD13 ' CA ' ' A' ' 205' ' ' GLY . 0.6 OUTLIER -126.82 120.93 30.5 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.491 1.12 . . . . 62.109999999999999 109.34 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 11.9 t -87.65 118.49 27.17 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.558 1.162 . . . . 74.209999999999994 110.359 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.532 HG21 HG21 ' A' ' 162' ' ' VAL . 0.6 OUTLIER -120.45 175.52 5.94 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.52 1.138 . . . . 75.319999999999993 110.363 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -127.77 152.9 47.19 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 74.120000000000005 111.052 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.475 HG12 ' H ' ' A' ' 165' ' ' ASP . 3.1 m -51.44 155.05 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 60.340000000000003 109.318 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 44.3 74.09 0.23 Allowed Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.519 1.137 . . . . 75.420000000000002 110.985 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -132.24 162.19 31.58 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.431 0.724 . . . . 54.329999999999998 110.347 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.16 120.54 40.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.529 1.143 . . . . 75.120000000000005 109.292 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.943 HD12 HG21 ' A' ' 207' ' ' VAL . 1.2 pt? -136.46 143.83 44.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.504 1.127 . . . . 32.109999999999999 109.32 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 41.7 t80 -104.85 111.24 23.92 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.465 1.103 . . . . 53.229999999999997 111.014 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.995 HD13 ' HB2' ' A' ' 195' ' ' ALA . 19.0 mm -54.42 164.83 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.523 1.139 . . . . 53.210000000000001 109.313 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.466 ' N ' ' CG2' ' A' ' 184' ' ' ILE . 0.1 OUTLIER -151.84 -45.91 0.11 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.498 1.124 . . . . 70.409999999999997 108.344 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.881 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -125.66 174.54 8.22 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.501 1.126 . . . . 71.140000000000001 109.344 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.619 ' C ' ' CD2' ' A' ' 188' ' ' HIS . 0.9 OUTLIER -155.02 154.02 31.86 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 71.319999999999993 109.639 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 1.115 ' CE1' HG11 ' A' ' 239' ' ' VAL . 0.1 OUTLIER -144.11 120.93 11.25 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.51 1.131 . . . . 73.409999999999997 109.535 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.453 ' C ' ' N ' ' A' ' 191' ' ' GLU . 55.4 t30 52.05 32.72 10.73 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.455 1.097 . . . . 51.329999999999998 109.345 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.404 ' CB ' HG12 ' A' ' 228' ' ' ILE . 9.6 m 41.67 29.24 0.1 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.511 1.132 . . . . 64.340000000000003 108.316 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.659 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 16.8 tt0 -120.92 -38.55 2.82 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.469 1.106 . . . . 75.430000000000007 110.294 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.714 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 90.2 m95 -113.26 137.61 51.22 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.538 1.149 . . . . 62.409999999999997 108.009 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.894 ' HB3' HD12 ' A' ' 184' ' ' ILE . 22.4 m-30 -125.83 135.63 52.19 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.469 1.106 . . . . 73.209999999999994 111.032 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.881 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 6.3 mm -100.74 95.63 4.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 71.129999999999995 109.261 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.995 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -99.09 -179.72 4.34 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.516 1.135 . . . . 62.149999999999999 109.269 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.453 ' CG ' ' C ' ' A' ' 195' ' ' ALA . 10.2 mtpt -151.1 162.98 25.21 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.447 1.092 . . . . 71.450000000000003 109.333 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.467 ' CB ' ' HB2' ' A' ' 200' ' ' ARG . 18.1 Cg_endo -75.05 177.74 8.2 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.493 1.786 . . . . 74.299999999999997 110.967 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.643 ' O ' HG22 ' A' ' 198' ' ' ILE . 5.3 mp -110.12 14.55 8.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.523 1.14 . . . . 61.32 109.308 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -169.82 -44.53 0.03 OUTLIER Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.548 1.155 . . . . 54.030000000000001 111.051 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.467 ' HB2' ' CB ' ' A' ' 197' ' ' PRO . 1.9 mpt_? -58.55 172.75 0.46 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.484 0.755 . . . . 72.400000000000006 110.292 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 11.9 tp -114.52 -10.51 12.55 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.388 1.055 . . . . 71.209999999999994 109.263 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . -43.16 -53.51 5.62 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.509 1.13 . . . . 61.310000000000002 111.049 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.441 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . -42.73 167.05 0.01 OUTLIER Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.062 -0.815 . . . . 51.130000000000003 111.062 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.486 ' HB2' HG22 ' A' ' 194' ' ' ILE . 18.5 Cg_endo -74.97 129.01 17.49 Favored 'Cis proline' 0 C--N 1.359 1.112 0 C-N-CA 120.949 -2.521 . . . . 74.450000000000003 111.024 -0.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.712 ' CA ' HD13 ' A' ' 174' ' ' LEU . . . -96.34 141.93 15.87 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.514 1.134 . . . . 75.040000000000006 111.025 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.714 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -91.2 147.21 23.21 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.552 0.795 . . . . 72.040000000000006 109.295 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.943 HG21 HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -161.06 129.14 2.85 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.542 1.152 . . . . 51.119999999999997 109.336 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.889 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.2 Cg_endo -75.03 179.91 5.64 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.565 1.824 . . . . 70.030000000000001 110.927 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.791 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.6 OUTLIER -96.12 3.32 9.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 124.443 1.089 . . . . 65.129999999999995 109.306 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -103.89 -5.93 43.75 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.487 1.117 . . . . 55.119999999999997 111.033 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.619 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 5.2 m-85 -125.98 1.76 7.29 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.505 0.767 . . . . 61.549999999999997 110.983 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.941 HG12 HG22 ' A' ' 162' ' ' VAL . 3.5 m -141.28 167.76 16.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.574 1.171 . . . . 72.329999999999998 109.306 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.521 ' OG ' HD21 ' A' ' 163' ' ' LEU . 13.1 p -136.2 132.98 36.62 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.445 1.091 . . . . 55.140000000000001 109.997 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.496 ' O ' ' CG2' ' A' ' 215' ' ' ILE . 2.9 mm -76.4 144.68 11.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.475 1.109 . . . . 71.510000000000005 109.277 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.65 ' CG1' ' CD2' ' A' ' 159' ' ' TYR . 0.2 OUTLIER -156.2 153.84 6.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 124.459 1.1 . . . . 62.219999999999999 109.31 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -157.04 174.71 15.11 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 124.388 1.055 . . . . 74.120000000000005 109.247 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.577 ' H ' HD12 ' A' ' 217' ' ' ILE . 4.7 mp -82.03 54.93 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.47 1.106 . . . . 63.039999999999999 109.264 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -116.05 15.58 16.1 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.462 1.101 . . . . 64.099999999999994 109.281 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.54 ' O ' HG22 ' A' ' 219' ' ' THR . 18.6 m 55.08 54.94 8.21 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.482 1.114 . . . . 55.43 110.427 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 174.37 -173.81 46.19 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.524 1.14 . . . . 71.129999999999995 110.971 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -120.16 138.77 53.41 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.482 0.754 . . . . 71.230000000000004 111.014 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.682 ' O ' HG22 ' A' ' 223' ' ' THR . . . 53.49 25.72 4.97 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.52 1.138 . . . . 51.409999999999997 109.273 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.682 HG22 ' O ' ' A' ' 222' ' ' ALA . 13.5 t 48.45 28.69 1.78 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.459 1.099 . . . . 60.149999999999999 110.367 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 81.92 -51.3 4.43 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.497 1.123 . . . . 71.329999999999998 111.024 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -68.44 169.52 10.63 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.499 0.764 . . . . 73.150000000000006 109.261 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 229' ' ' GLU . 14.0 t0 -73.37 147.7 44.08 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.55 1.156 . . . . 75.219999999999999 109.211 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.408 ' H ' HG12 ' A' ' 227' ' ' VAL . 0.2 OUTLIER -39.85 -56.27 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.45 1.094 . . . . 75.209999999999994 109.282 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.404 HG12 ' CB ' ' A' ' 190' ' ' CYS . 9.9 mt -55.94 -42.46 71.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.499 1.125 . . . . 74.109999999999999 109.274 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 226' ' ' ASP . 21.2 mt-10 -66.45 -14.16 61.81 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.506 1.129 . . . . 55.5 110.329 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.569 ' O ' HG13 ' A' ' 234' ' ' VAL . 33.7 t0 -88.67 -23.27 23.05 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.564 1.165 . . . . 72.299999999999997 109.299 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.61 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.6 OUTLIER -63.66 -69.4 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.483 1.114 . . . . 63.539999999999999 109.323 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.61 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -55.85 -30.58 61.71 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.44 1.088 . . . . 75.420000000000002 109.3 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.4 m -52.94 -50.63 63.63 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 44.130000000000003 109.954 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 230' ' ' ASP . 1.3 m -89.88 16.08 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.471 1.107 . . . . 53.32 109.26 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 234' ' ' VAL . 37.7 t30 40.56 44.53 1.78 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.516 1.135 . . . . 70.230000000000004 109.296 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.45 HD12 ' HD2' ' A' ' 237' ' ' PRO . 1.1 tp -83.02 119.74 74.79 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.457 1.098 . . . . 74.129999999999995 109.307 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.45 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.4 Cg_endo -75.01 164.37 33.48 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.52 1.8 . . . . 42.329999999999998 111.023 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.613 HG22 ' H ' ' A' ' 239' ' ' VAL . 3.4 m -58.81 -175.72 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.484 1.115 . . . . 63.350000000000001 110.364 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 1.115 HG11 ' CE1' ' A' ' 188' ' ' HIS . 2.6 p -74.17 -36.27 43.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.5 1.125 . . . . 74.25 109.333 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.536 ' HG3' HG13 ' A' ' 239' ' ' VAL . 5.3 mt-30 -82.65 -17.88 43.04 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.492 1.12 . . . . 74.25 110.315 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.405 ' CB ' ' HB2' ' A' ' 237' ' ' PRO . 16.3 mt-10 -87.07 -38.54 16.42 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.531 1.144 . . . . 71.420000000000002 110.299 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.433 ' CH2' ' HB3' ' A' ' 185' ' ' CYS . 6.1 t90 -78.35 -61.33 2.04 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.531 1.144 . . . . 74.109999999999999 108.001 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 9.3 mtmt -53.92 -20.53 6.2 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.428 1.08 . . . . 70.120000000000005 109.3 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.9 p -39.17 -48.41 1.74 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.542 1.152 . . . . 75.049999999999997 109.993 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.414 ' C ' ' N ' ' A' ' 247' ' ' ALA . 3.7 t-20 -160.48 113.73 2.08 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.61 1.194 . . . . 75.430000000000007 109.295 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 4.9 mm -43.76 -28.59 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.471 1.107 . . . . 64.310000000000002 109.328 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.414 ' N ' ' C ' ' A' ' 245' ' ' ASN . . . -102.63 69.05 1.06 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.515 1.134 . . . . 72.519999999999996 109.313 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . 0.415 ' NE ' ' O ' ' A' ' 249' ' ' TYR . 3.3 tmm_? -48.2 104.9 0.06 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.526 1.142 . . . . 75.239999999999995 110.218 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.519 ' C ' ' CD1' ' A' ' 249' ' ' TYR . 0.1 OUTLIER -75.09 176.74 6.97 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.522 1.138 . . . . 41.32 110.956 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -44.92 141.42 2.19 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.513 1.133 . . . . 50.130000000000003 109.306 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -158.45 -179.31 7.98 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.51 1.131 . . . . 74.219999999999999 109.297 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 253' ' ' ASN . 1.7 t -114.37 172.46 7.0 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.478 1.112 . . . . 63.210000000000001 110.012 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.466 ' C ' HD12 ' A' ' 254' ' ' ILE . 5.2 t30 -110.26 163.28 13.79 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.436 1.085 . . . . 54.509999999999998 109.321 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.556 HD12 ' N ' ' A' ' 254' ' ' ILE . 3.3 mp -141.28 158.16 22.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.485 1.115 . . . . 55.420000000000002 109.305 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 17.5 p -145.18 129.61 17.86 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.454 1.096 . . . . 42.25 110.028 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 97.4 mt -140.64 106.75 5.21 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.519 1.137 . . . . 73.310000000000002 109.291 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -38.17 124.77 1.45 Allowed Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.512 1.132 . . . . 73.209999999999994 111.066 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 13.9 m -125.15 145.45 49.94 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.524 0.779 . . . . 62.100000000000001 109.997 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.5 p -58.21 113.22 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.472 1.107 . . . . 62.450000000000003 109.339 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.5 0 O-C-N 124.471 1.107 . . . . 75.109999999999999 110.344 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 110.023 -0.362 . . . . 74.049999999999997 110.023 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 44.1 t -65.29 124.33 21.91 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.508 1.13 . . . . 54.299999999999997 110.034 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 28.6 m -125.76 12.49 7.93 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.579 1.174 . . . . 74.219999999999999 109.995 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -156.44 168.45 27.32 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.472 1.107 . . . . 72.340000000000003 109.252 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -112.64 -54.81 2.59 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.487 1.117 . . . . 72.430000000000007 109.31 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . 73.23 125.08 0.09 OUTLIER Glycine 0 CA--C 1.531 1.08 0 O-C-N 124.459 1.1 . . . . 75.540000000000006 110.976 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 9.3 tptp -111.41 -12.21 14.04 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.515 0.774 . . . . 75.109999999999999 109.317 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 470' ' ' PHE . . . . . 0.447 ' CE2' ' HG2' ' A' ' 204' ' ' PRO . 5.2 m-30 -86.94 13.99 8.11 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.463 1.102 . . . . 74.239999999999995 111.009 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 471' ' ' ILE . . . . . 0.514 HG22 ' HD2' ' B' ' 472' ' ' PRO . 2.8 mm -84.82 140.32 37.67 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.491 1.12 . . . . 64.519999999999996 109.353 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 472' ' ' PRO . . . . . 0.514 ' HD2' HG22 ' B' ' 471' ' ' ILE . 18.4 Cg_endo -74.92 130.28 13.22 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.528 1.804 . . . . 73.420000000000002 111.04 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 46.3 t -78.54 -73.06 0.34 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.456 1.098 . . . . 21.219999999999999 109.981 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -65.1 160.03 60.22 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.523 1.139 . . . . 54.530000000000001 110.311 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 -167.27 0.41 Allowed 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.461 1.769 . . . . 51.329999999999998 110.994 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 476' ' ' ALA . . . . . 0.659 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . -62.86 138.81 97.19 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.496 1.122 . . . . 53.219999999999999 109.281 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 477' ' ' PRO . . . . . 0.581 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -75.04 -162.43 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.491 1.785 . . . . 72.439999999999998 111.029 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 478' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -136.18 90.75 17.76 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.479 1.112 . . . . 72.209999999999994 109.278 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 479' ' ' PRO . . . . . 0.619 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.92 168.41 24.9 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.428 1.752 . . . . 61.350000000000001 110.973 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 480' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' B' ' 482' ' ' SER . 18.5 Cg_endo -74.92 -44.84 0.32 Allowed 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.565 1.824 . . . . 74.540000000000006 111.106 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 481' ' ' SER . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 164' ' ' TYR . 0.7 OUTLIER -38.92 -30.18 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.437 1.086 . . . . 54.039999999999999 110.054 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 482' ' ' SER . . . . . 0.444 ' N ' ' O ' ' B' ' 480' ' ' PRO . 1.5 t -85.73 108.23 17.96 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.585 1.178 . . . . 63.0 109.996 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -101.73 22.51 12.74 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.473 1.108 . . . . 72.099999999999994 109.332 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 24.2 t -124.71 48.79 1.92 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.493 1.121 . . . . 74.430000000000007 110.021 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -105.52 99.98 9.57 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.543 1.152 . . . . 60.329999999999998 109.359 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 20.2 p . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.513 1.133 . . . . 73.540000000000006 109.978 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.023 0 N-CA-C 110.965 -0.854 . . . . 62.119999999999997 110.965 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.1 p -52.72 -53.04 53.25 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.488 0.758 . . . . 75.299999999999997 110.025 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 158' ' ' LEU . 4.6 pp -171.35 143.73 1.88 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.465 1.103 . . . . 63.310000000000002 109.29 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -156.87 -178.77 7.61 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.498 1.123 . . . . 72.450000000000003 110.973 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.904 ' O ' HD12 ' A' ' 182' ' ' LEU . . . -108.82 147.7 31.69 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.485 1.115 . . . . 73.140000000000001 109.305 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.595 HD13 ' N ' ' A' ' 162' ' ' VAL . 0.1 OUTLIER -120.82 135.14 61.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.509 1.131 . . . . 62.32 109.262 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.853 HG22 HG12 ' A' ' 212' ' ' VAL . 2.3 t -93.32 121.01 43.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.455 1.097 . . . . 55.43 109.305 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.56 HD21 HG23 ' A' ' 161' ' ' ILE . 0.4 OUTLIER -101.44 -11.5 19.3 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.503 1.127 . . . . 55.350000000000001 109.295 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.657 ' O ' HG13 ' A' ' 162' ' ' VAL . 3.3 m-85 -144.6 160.29 41.41 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 73.329999999999998 111.003 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.762 ' N ' HG12 ' A' ' 178' ' ' VAL . 21.7 p30 -107.95 157.71 17.98 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.554 1.159 . . . . 75.200000000000003 109.305 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.599 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 1.2 t80 -160.45 136.43 8.44 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.436 1.085 . . . . 70.439999999999998 111.012 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.599 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 12.0 mtpp -67.37 122.69 18.47 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.448 1.093 . . . . 74.400000000000006 109.313 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.83 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -90.62 140.12 30.06 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.585 1.178 . . . . 62.200000000000003 109.3 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -152.19 21.69 0.65 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.508 1.13 . . . . 74.129999999999995 110.283 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.473 ' HD3' ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -98.72 -176.66 3.42 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.505 1.128 . . . . 65.400000000000006 109.335 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' B' ' 471' ' ' ILE . . . -59.93 -24.87 64.7 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.462 1.101 . . . . 73.310000000000002 109.326 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 173' ' ' GLU . 59.7 t0 -113.68 20.44 15.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.458 1.099 . . . . 62.530000000000001 109.281 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.83 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 5.1 pt-20 -36.82 100.51 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 1.104 . . . . 72.450000000000003 110.352 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.485 ' HG ' ' CA ' ' A' ' 205' ' ' GLY . 0.1 OUTLIER -132.03 96.2 3.85 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.499 1.124 . . . . 73.299999999999997 109.344 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.6 t -59.55 148.82 31.93 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.483 1.115 . . . . 63.340000000000003 110.416 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 14.4 m -155.9 117.04 3.87 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.559 1.162 . . . . 71.209999999999994 110.435 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -63.94 157.58 24.53 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.512 1.132 . . . . 73.040000000000006 110.975 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.762 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.5 m -58.24 158.19 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.557 1.16 . . . . 63.200000000000003 109.249 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.424 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 52.54 62.54 5.71 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.479 1.112 . . . . 63.340000000000003 110.998 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -120.2 170.91 8.89 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.514 0.773 . . . . 74.430000000000007 110.244 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -129.17 117.56 20.98 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.552 1.157 . . . . 60.130000000000003 109.325 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.913 ' CD2' HG11 ' A' ' 207' ' ' VAL . 0.2 OUTLIER -130.58 149.71 52.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.538 1.149 . . . . 54.210000000000001 109.315 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -104.13 104.34 14.26 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.531 1.145 . . . . 72.519999999999996 111.002 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.737 HD12 ' HB2' ' A' ' 160' ' ' ALA . 22.1 mt -68.56 158.46 5.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.468 1.105 . . . . 74.400000000000006 109.354 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.603 ' SG ' ' CZ3' ' A' ' 242' ' ' TRP . 27.0 t -152.16 -41.59 0.11 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.522 1.139 . . . . 73.340000000000003 108.332 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.989 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -112.22 155.58 23.77 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.547 1.155 . . . . 73.439999999999998 109.297 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.572 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.1 OUTLIER -148.33 145.04 27.95 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.497 1.123 . . . . 74.200000000000003 109.649 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.582 ' NE2' HD11 ' A' ' 194' ' ' ILE . 0.1 OUTLIER -143.55 141.41 30.68 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.525 1.141 . . . . 63.409999999999997 109.603 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.462 ' C ' ' N ' ' A' ' 191' ' ' GLU . 3.1 m120 49.44 23.34 0.86 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.46 1.1 . . . . 72.129999999999995 109.261 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.408 ' C ' ' O ' ' A' ' 189' ' ' ASN . 18.1 m 41.22 28.88 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.117 . . . . 72.5 108.293 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.485 ' O ' HG13 ' A' ' 209' ' ' VAL . 8.5 tt0 -126.59 -38.58 2.07 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.575 1.172 . . . . 74.140000000000001 110.299 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.878 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 98.8 m95 -111.55 128.48 56.04 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.527 1.142 . . . . 64.430000000000007 108.058 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.776 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.1 m-30 -120.11 126.2 50.14 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.489 1.118 . . . . 74.439999999999998 111.001 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.989 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 5.6 mm -86.63 104.36 13.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.53 1.144 . . . . 72.420000000000002 109.262 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.58 ' HB2' ' CG1' ' A' ' 184' ' ' ILE . . . -112.92 175.85 5.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.498 1.124 . . . . 61.409999999999997 109.263 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.474 ' CG ' ' HD2' ' A' ' 197' ' ' PRO . 2.3 ttmp? -137.99 142.66 36.7 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.131 . . . . 63.32 109.323 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.474 ' HD2' ' CG ' ' A' ' 196' ' ' LYS . 18.3 Cg_endo -75.03 155.77 42.83 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.512 1.796 . . . . 73.420000000000002 110.993 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.675 HD13 ' N ' ' A' ' 199' ' ' GLY . 0.1 OUTLIER -121.23 123.14 69.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.478 1.111 . . . . 74.430000000000007 109.318 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.675 ' N ' HD13 ' A' ' 198' ' ' ILE . . . 103.45 -34.97 5.34 Favored Glycine 0 CA--C 1.529 0.937 0 O-C-N 124.474 1.109 . . . . 42.32 111.051 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -90.75 169.48 10.92 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.492 0.76 . . . . 74.239999999999995 110.349 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 8.0 mp -109.24 115.96 31.0 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.443 1.09 . . . . 72.239999999999995 109.314 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 158.15 -131.34 2.8 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.471 1.107 . . . . 54.420000000000002 110.985 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 54.66 176.09 0.12 Allowed Glycine 0 CA--C 1.529 0.969 0 N-CA-C 111.008 -0.837 . . . . 75.209999999999994 111.008 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.444 ' HD2' ' CZ ' ' B' ' 470' ' ' PHE . 18.4 Cg_endo -74.96 146.11 85.78 Favored 'Cis proline' 0 C--N 1.36 1.182 0 C-N-CA 121.028 -2.488 . . . . 74.0 111.009 -0.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 195' ' ' ALA . . . -104.7 138.56 14.22 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.494 1.121 . . . . 41.32 110.986 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.878 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -83.37 146.76 28.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.574 0.808 . . . . 73.439999999999998 109.384 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.913 HG11 ' CD2' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -153.36 127.01 4.31 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.458 1.099 . . . . 61.439999999999998 109.288 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.943 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.4 Cg_endo -74.92 174.9 11.96 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.455 1.766 . . . . 75.450000000000003 111.002 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.776 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -93.49 4.81 7.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.537 1.148 . . . . 73.340000000000003 109.297 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . 0.495 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -104.72 -8.3 37.47 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.5 1.125 . . . . 62.119999999999997 111.024 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.622 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 15.8 m-85 -125.53 -0.8 7.5 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.497 0.763 . . . . 75.140000000000001 111.002 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.943 HG22 ' O ' ' A' ' 208' ' ' PRO . 2.5 m -139.63 162.15 26.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.503 1.127 . . . . 64.329999999999998 109.267 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.6 t -134.72 133.56 40.09 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 55.32 109.967 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.782 ' O ' HG23 ' A' ' 215' ' ' ILE . 2.9 mm -76.85 127.72 37.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.506 1.129 . . . . 74.540000000000006 109.28 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.809 HG22 ' HA ' ' A' ' 221' ' ' TYR . 5.3 pt -161.89 167.24 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 124.544 1.153 . . . . 72.409999999999997 109.241 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -130.23 -46.77 1.1 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.41 1.069 . . . . 73.510000000000005 109.368 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 217' ' ' ILE . 7.0 tp -142.56 159.27 19.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.499 1.124 . . . . 62.210000000000001 109.282 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -59.49 -172.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.511 1.132 . . . . 51.32 109.357 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 62.3 m 64.82 55.08 1.25 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.489 1.118 . . . . 54.350000000000001 110.443 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 108.06 -155.46 16.21 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.411 1.069 . . . . 72.340000000000003 111.008 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.809 ' HA ' HG22 ' A' ' 215' ' ' ILE . 44.8 m-85 -102.95 -174.0 2.45 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.565 0.803 . . . . 72.400000000000006 111.038 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -43.06 -73.49 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.55 1.156 . . . . 70.219999999999999 109.316 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -117.69 -8.89 10.83 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.558 1.161 . . . . 61.43 110.366 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 96.44 7.25 58.2 Favored Glycine 0 CA--C 1.529 0.938 0 O-C-N 124.507 1.13 . . . . 45.350000000000001 111.075 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.458 ' N ' HD22 ' A' ' 225' ' ' ASN . 1.5 m-80 -101.95 160.19 14.7 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.463 0.743 . . . . 73.230000000000004 109.271 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.43 ' O ' ' N ' ' A' ' 229' ' ' GLU . 0.4 OUTLIER -63.51 145.24 56.03 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.546 1.154 . . . . 75.319999999999993 109.329 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -40.38 -45.73 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.439 1.087 . . . . 72.099999999999994 109.349 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.753 ' HA ' HD12 ' A' ' 231' ' ' ILE . 7.8 mt -65.27 -46.53 90.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.5 1.125 . . . . 64.239999999999995 109.275 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.473 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 11.6 mt-10 -64.95 -17.19 64.17 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.566 1.166 . . . . 71.409999999999997 110.338 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.66 -16.44 32.38 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.453 1.095 . . . . 62.549999999999997 109.347 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.753 HD12 ' HA ' ' A' ' 228' ' ' ILE . 3.6 mt -76.1 -70.11 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 124.523 1.139 . . . . 72.219999999999999 109.323 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.473 ' CD ' ' HA ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -59.67 -26.79 65.83 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.555 1.16 . . . . 63.240000000000002 109.236 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.11 -48.1 12.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.474 1.108 . . . . 71.109999999999999 110.01 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 1.1 m -98.02 -15.85 7.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.483 1.115 . . . . 64.549999999999997 109.282 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 64.97 49.57 2.07 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 1.135 . . . . 43.340000000000003 109.316 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.664 HD12 ' O ' ' A' ' 237' ' ' PRO . 0.5 OUTLIER -71.08 146.75 93.08 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.457 1.098 . . . . 75.329999999999998 109.319 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.664 ' O ' HD12 ' A' ' 236' ' ' LEU . 18.6 Cg_endo -74.95 141.59 26.97 Favored 'Trans proline' 0 C--N 1.359 1.096 0 O-C-N 124.526 1.803 . . . . 74.239999999999995 110.995 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.1 m -58.36 176.38 0.18 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.431 1.082 . . . . 75.430000000000007 110.478 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.558 HG13 ' HG3' ' A' ' 240' ' ' GLN . 9.9 p -72.09 -33.84 48.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.524 1.14 . . . . 51.310000000000002 109.311 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.558 ' HG3' HG13 ' A' ' 239' ' ' VAL . 0.3 OUTLIER -85.58 -17.03 37.43 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.479 1.112 . . . . 72.329999999999998 110.243 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -87.05 -43.78 12.06 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.494 1.121 . . . . 75.209999999999994 110.336 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.618 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 0.5 OUTLIER -72.08 -60.73 2.09 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.988 -1.116 . . . . 72.430000000000007 107.988 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.495 ' NZ ' ' CG2' ' A' ' 239' ' ' VAL . 4.8 mtmm -54.79 -20.62 8.95 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.498 1.124 . . . . 51.350000000000001 109.29 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 6.7 t -40.9 -65.39 0.43 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.564 1.165 . . . . 64.239999999999995 110.03 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -138.69 121.6 16.61 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.5 1.125 . . . . 74.450000000000003 109.298 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 43.4 mm -48.3 -31.44 3.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 O-C-N 124.514 1.134 . . . . 71.329999999999998 109.328 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -124.46 57.81 1.23 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 64.140000000000001 109.293 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -52.88 -175.39 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.468 1.105 . . . . 75.329999999999998 110.313 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -37.83 112.87 0.23 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.481 1.113 . . . . 70.239999999999995 110.965 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.418 ' C ' ' N ' ' A' ' 252' ' ' SER . 0.1 OUTLIER -41.4 149.22 0.12 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.462 1.102 . . . . 74.340000000000003 109.245 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -42.81 -29.23 0.3 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.548 1.155 . . . . 53.420000000000002 109.321 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . 0.418 ' N ' ' C ' ' A' ' 250' ' ' LYS . 47.6 t -73.03 127.51 32.77 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.54 1.15 . . . . 74.019999999999996 110.075 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -154.42 126.71 7.88 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.514 1.134 . . . . 72.420000000000002 109.306 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.437 HD12 ' N ' ' A' ' 254' ' ' ILE . 4.3 mp -130.26 143.53 40.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.486 1.116 . . . . 73.200000000000003 109.358 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.9 m -172.76 132.73 0.56 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 72.299999999999997 109.956 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.774 ' C ' HD22 ' A' ' 256' ' ' LEU . 0.0 OUTLIER -80.65 -15.78 55.69 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.479 1.112 . . . . 51.219999999999999 109.319 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -103.07 165.14 15.92 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.435 1.084 . . . . 73.310000000000002 110.957 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 10.5 t -158.37 -175.78 5.52 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.488 0.758 . . . . 64.540000000000006 109.921 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.5 p -96.04 165.16 2.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.462 1.101 . . . . 74.230000000000004 109.285 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--N 1.325 -0.489 0 O-C-N 124.486 1.116 . . . . 72.340000000000003 110.26 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 37.5 t . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 109.979 -0.378 . . . . 64.319999999999993 109.979 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 78.9 p -101.61 78.2 1.82 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.516 1.135 . . . . 71.349999999999994 110.021 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 73.6 m -81.4 -62.54 1.62 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.514 1.134 . . . . 74.25 110.002 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -83.99 99.91 10.72 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.416 1.072 . . . . 42.539999999999999 109.265 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -81.98 121.7 26.85 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.539 1.15 . . . . 45.450000000000003 109.333 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -98.94 166.13 21.21 Favored Glycine 0 CA--C 1.529 0.908 0 O-C-N 124.562 1.164 . . . . 63.399999999999999 111.027 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 13.6 mtmm -114.09 -11.01 12.76 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.46 0.741 . . . . 71.150000000000006 109.295 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 470' ' ' PHE . . . . . 0.444 ' CZ ' ' HD2' ' A' ' 204' ' ' PRO . 43.1 m-85 -102.94 -14.16 16.62 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.481 1.113 . . . . 74.120000000000005 110.993 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 471' ' ' ILE . . . . . 0.707 ' O ' ' HB3' ' A' ' 171' ' ' ALA . 26.4 mm -41.82 142.44 1.1 Allowed Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.505 1.128 . . . . 64.409999999999997 109.333 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 472' ' ' PRO . . . . . 0.698 ' HD2' HG23 ' B' ' 471' ' ' ILE . 18.4 Cg_endo -74.91 173.38 14.57 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.473 1.775 . . . . 55.210000000000001 111.073 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.91 -46.02 2.94 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.473 1.108 . . . . 64.030000000000001 110.014 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 39.3 mtp85 -87.14 158.49 52.56 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.567 1.167 . . . . 71.329999999999998 110.3 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 475' ' ' PRO . . . . . 0.686 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.3 Cg_endo -75.05 -30.94 6.57 Favored 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.469 1.773 . . . . 75.340000000000003 110.982 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 476' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 163.38 129.57 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.506 1.129 . . . . 63.119999999999997 109.281 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 477' ' ' PRO . . . . . 0.562 ' HG3' ' CE2' ' A' ' 166' ' ' PHE . 18.1 Cg_endo -75.02 -176.59 2.96 Favored 'Trans proline' 0 C--N 1.361 1.2 0 O-C-N 124.515 1.797 . . . . 64.340000000000003 110.985 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 478' ' ' LYS . . . . . 0.463 ' O ' ' CD ' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -116.46 95.11 44.86 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.536 1.148 . . . . 63.140000000000001 109.35 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 479' ' ' PRO . . . . . 0.622 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.99 150.11 37.69 Favored 'Trans proline' 0 C--N 1.359 1.105 0 O-C-N 124.563 1.823 . . . . 72.329999999999998 111.023 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 480' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 479' ' ' PRO . 18.3 Cg_endo -75.07 -179.91 5.46 Favored 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.447 1.762 . . . . 72.019999999999996 111.009 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 481' ' ' SER . . . . . . . . . . . . . 11.4 m 45.2 64.42 1.41 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.487 1.117 . . . . 63.299999999999997 109.97 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 40.1 t -149.96 137.8 20.15 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.532 1.145 . . . . 72.299999999999997 110.009 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -82.72 52.9 2.22 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 74.319999999999993 109.334 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 37.3 p -76.72 120.27 21.67 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.511 1.132 . . . . 72.450000000000003 110.048 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -73.22 118.77 16.58 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.441 1.088 . . . . 62.399999999999999 109.279 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.517 1.136 . . . . 52.530000000000001 110.021 179.962 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.967 0 N-CA-C 111.03 -0.828 . . . . 73.129999999999995 111.03 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 28.8 t -113.5 81.51 1.52 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.491 0.76 . . . . 72.109999999999999 109.993 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.569 ' O ' ' CE1' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -132.8 148.4 52.31 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.554 1.159 . . . . 64.319999999999993 109.303 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -143.58 -178.09 5.72 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.552 1.158 . . . . 74.409999999999997 110.998 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.569 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -130.42 153.22 48.98 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.511 1.132 . . . . 71.019999999999996 109.304 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.912 ' HB ' HD11 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -123.89 125.45 71.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.532 1.145 . . . . 74.120000000000005 109.265 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.937 HG22 HG12 ' A' ' 212' ' ' VAL . 1.9 t -80.51 122.45 35.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.559 1.162 . . . . 72.329999999999998 109.284 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 213' ' ' SER . 0.6 OUTLIER -98.19 -13.74 20.71 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.519 1.137 . . . . 71.420000000000002 109.287 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.666 ' O ' HG13 ' A' ' 162' ' ' VAL . 1.7 m-85 -146.21 157.71 43.84 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.567 1.167 . . . . 75.340000000000003 111.042 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.782 ' N ' HG12 ' A' ' 178' ' ' VAL . 0.0 OUTLIER -98.04 158.25 15.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.527 1.142 . . . . 71.349999999999994 109.27 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.491 ' CE1' ' HB3' ' B' ' 477' ' ' PRO . 40.5 t80 -145.5 158.9 43.77 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.559 1.162 . . . . 63.420000000000002 111.051 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -94.34 127.87 40.5 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.459 1.099 . . . . 73.120000000000005 109.288 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.885 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -93.19 142.06 27.73 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.465 1.103 . . . . 63.439999999999998 109.329 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -157.87 24.64 0.27 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.503 1.127 . . . . 71.219999999999999 110.314 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.528 ' NZ ' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -122.41 -175.36 3.12 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.531 1.145 . . . . 75.010000000000005 109.362 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.14 -40.99 82.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.439 1.087 . . . . 71.040000000000006 109.325 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 174' ' ' LEU . 3.0 m-20 -85.86 10.99 12.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.54 1.15 . . . . 64.019999999999996 109.3 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.885 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 5.4 pt-20 -36.34 96.56 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.432 1.083 . . . . 74.140000000000001 110.354 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.692 HD12 ' HA3' ' A' ' 205' ' ' GLY . 1.2 tm? -136.98 94.93 3.02 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.517 1.136 . . . . 31.129999999999999 109.296 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.431 ' C ' ' HG1' ' A' ' 176' ' ' THR . 9.0 t -59.53 153.36 19.8 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.563 1.164 . . . . 62.109999999999999 110.471 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.431 ' HG1' ' C ' ' A' ' 175' ' ' THR . 24.3 m -152.21 141.93 21.89 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.481 1.113 . . . . 74.349999999999994 110.374 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -88.37 153.33 21.27 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.408 1.068 . . . . 74.049999999999997 111.06 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.782 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.4 m -59.21 158.3 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.438 1.086 . . . . 64.530000000000001 109.299 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 48.81 66.98 1.87 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.455 1.097 . . . . 74.409999999999997 110.988 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.525 ' O ' HD13 ' A' ' 161' ' ' ILE . 1.9 tt0 -131.15 171.76 12.9 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.552 0.795 . . . . 75.340000000000003 110.235 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -123.4 130.65 53.02 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.478 1.112 . . . . 74.5 109.318 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.759 HD23 ' N ' ' A' ' 182' ' ' LEU . 0.6 OUTLIER -146.82 143.27 28.49 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.431 1.082 . . . . 72.549999999999997 109.341 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.569 ' CE1' ' O ' ' A' ' 158' ' ' LEU . 73.4 t80 -100.57 117.99 35.83 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.537 1.148 . . . . 74.030000000000001 111.031 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.569 HD13 ' HB2' ' A' ' 160' ' ' ALA . 1.6 mp -62.69 151.99 7.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.41 1.068 . . . . 75.530000000000001 109.243 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.573 ' O ' ' CZ3' ' A' ' 242' ' ' TRP . 0.9 OUTLIER -136.03 -47.87 0.66 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.569 1.168 . . . . 55.130000000000003 108.26 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.944 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -122.25 168.86 11.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.504 1.127 . . . . 65.120000000000005 109.279 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.625 ' C ' ' CD2' ' A' ' 188' ' ' HIS . 2.9 p80 -146.67 153.88 40.8 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.443 1.089 . . . . 71.340000000000003 109.592 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 1.056 ' CE1' HG11 ' A' ' 239' ' ' VAL . 0.1 OUTLIER -143.92 120.75 11.26 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.471 1.107 . . . . 75.129999999999995 109.555 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.473 ' C ' ' N ' ' A' ' 191' ' ' GLU . 86.1 m-20 50.85 35.21 11.76 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.526 1.141 . . . . 73.430000000000007 109.352 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.421 ' C ' ' O ' ' A' ' 189' ' ' ASN . 60.9 m 39.77 30.75 0.06 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.553 1.158 . . . . 61.020000000000003 108.254 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.571 ' O ' HG13 ' A' ' 209' ' ' VAL . 11.4 tt0 -122.25 -42.16 2.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.546 1.154 . . . . 72.430000000000007 110.279 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.665 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 95.4 m95 -110.41 136.88 48.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.982 -1.118 . . . . 73.239999999999995 107.982 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.843 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.1 m-30 -127.52 124.41 38.18 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.507 1.13 . . . . 74.030000000000001 110.964 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.944 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 1.4 mp -87.61 97.02 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 70.540000000000006 109.317 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -101.99 -179.88 4.13 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.472 1.108 . . . . 55.439999999999998 109.295 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 3.9 ptmt -155.16 167.27 14.42 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.548 1.155 . . . . 75.439999999999998 109.303 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.91 169.39 22.7 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.412 1.743 . . . . 44.130000000000003 111.044 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 71.2 mt -110.02 -14.25 10.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 O-C-N 124.473 1.108 . . . . 55.420000000000002 109.332 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -131.97 -75.87 0.12 Allowed Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.433 1.083 . . . . 62.219999999999999 110.995 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -54.72 174.31 0.07 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.526 0.78 . . . . 75.010000000000005 110.302 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.11 -172.26 2.0 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.461 1.101 . . . . 64.540000000000006 109.351 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 115.85 -51.17 0.74 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.509 1.131 . . . . 61.530000000000001 110.984 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -50.4 -177.33 0.02 OUTLIER Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.995 -0.842 . . . . 54.0 110.995 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.438 ' HG2' ' CZ ' ' B' ' 470' ' ' PHE . 18.2 Cg_endo -74.97 142.83 75.93 Favored 'Cis proline' 0 C--N 1.36 1.152 0 C-N-CA 121.012 -2.495 . . . . 62.130000000000003 111.006 0.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.692 ' HA3' HD12 ' A' ' 174' ' ' LEU . . . -106.07 148.1 16.39 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.538 1.149 . . . . 44.109999999999999 110.976 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.665 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -88.61 145.83 25.46 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.511 0.771 . . . . 72.439999999999998 109.325 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.789 ' HB ' HG11 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -156.02 126.26 3.36 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.544 1.153 . . . . 64.5 109.295 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.89 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.2 Cg_endo -74.98 179.59 5.93 Favored 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.489 1.784 . . . . 61.140000000000001 110.926 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.843 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -96.93 6.59 8.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.479 1.112 . . . . 72.299999999999997 109.327 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . 0.49 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -108.32 -4.86 32.74 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.551 1.157 . . . . 74.230000000000004 110.972 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.617 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 8.1 m-85 -127.44 1.59 6.28 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.518 0.775 . . . . 75.239999999999995 111.017 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.937 HG12 HG22 ' A' ' 162' ' ' VAL . 3.4 m -139.62 153.78 23.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.56 1.162 . . . . 74.340000000000003 109.329 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.605 ' HB3' HD11 ' A' ' 163' ' ' LEU . 1.0 OUTLIER -121.17 124.3 44.38 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.633 1.208 . . . . 71.319999999999993 110.039 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.835 ' O ' HG23 ' A' ' 215' ' ' ILE . 2.9 mm -68.32 145.03 13.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.13 . . . . 74.150000000000006 109.284 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.912 HD11 ' HB ' ' A' ' 161' ' ' ILE . 5.5 pt -165.37 137.98 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.539 1.149 . . . . 73.150000000000006 109.254 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.08 -44.73 1.89 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.585 1.178 . . . . 72.5 109.236 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.553 HG22 ' H ' ' A' ' 218' ' ' ALA . 7.2 mt -124.05 171.3 13.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.474 1.109 . . . . 74.409999999999997 109.288 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.553 ' H ' HG22 ' A' ' 217' ' ' ILE . . . -94.75 35.1 1.26 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.466 1.104 . . . . 52.109999999999999 109.312 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 219' ' ' THR . 7.9 t -130.72 27.42 4.95 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.441 1.088 . . . . 73.420000000000002 110.371 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 144.45 -167.94 26.86 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.473 1.108 . . . . 73.400000000000006 111.022 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -135.37 136.6 41.61 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.477 0.751 . . . . 74.439999999999998 110.953 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.739 ' O ' HG22 ' A' ' 223' ' ' THR . . . 54.49 41.18 32.12 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.506 1.129 . . . . 51.549999999999997 109.301 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.739 HG22 ' O ' ' A' ' 222' ' ' ALA . 15.2 t 50.1 23.63 1.19 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.536 1.148 . . . . 55.240000000000002 110.414 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 86.78 -42.53 3.16 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.51 1.131 . . . . 64.400000000000006 111.037 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -63.18 160.24 15.94 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.556 0.797 . . . . 65.129999999999995 109.286 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 230' ' ' ASP . 0.4 OUTLIER -69.95 152.03 44.93 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.426 1.079 . . . . 60.43 109.315 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.513 HG13 ' H ' ' A' ' 228' ' ' ILE . 4.2 p -47.85 -56.56 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.459 1.1 . . . . 70.310000000000002 109.258 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.513 ' H ' HG13 ' A' ' 227' ' ' VAL . 3.4 mt -57.1 -32.09 39.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.124 . . . . 63.200000000000003 109.375 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.431 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 5.4 mt-10 -80.89 -14.54 57.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.571 1.169 . . . . 73.439999999999998 110.312 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 226' ' ' ASP . 0.7 OUTLIER -88.49 -17.9 29.34 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.475 1.109 . . . . 64.230000000000004 109.314 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.629 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.5 OUTLIER -69.28 -69.2 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.508 1.13 . . . . 72.439999999999998 109.34 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.629 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -57.91 -20.73 39.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.563 1.164 . . . . 71.239999999999995 109.302 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.6 t -50.86 -57.93 7.25 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.54 1.15 . . . . 63.439999999999998 110.012 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 3.5 m -90.8 17.74 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.527 1.142 . . . . 73.420000000000002 109.346 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 47.53 34.85 3.74 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.506 1.129 . . . . 71.319999999999993 109.259 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.14 119.05 73.58 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.526 1.141 . . . . 72.439999999999998 109.287 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.13 167.2 27.44 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.5 1.789 . . . . 53.109999999999999 110.976 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.518 ' HA ' ' CD2' ' A' ' 187' ' ' HIS . 2.7 m -59.24 178.25 0.14 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.453 1.096 . . . . 71.400000000000006 110.383 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 1.056 HG11 ' CE1' ' A' ' 188' ' ' HIS . 0.2 OUTLIER -58.77 -67.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.133 . . . . 63.32 109.25 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.878 ' OE1' HD11 ' B' ' 471' ' ' ILE . 0.3 OUTLIER -63.91 -22.32 66.87 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.569 1.168 . . . . 74.420000000000002 110.339 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.449 ' HB2' ' N ' ' A' ' 238' ' ' THR . 4.1 mm-40 -75.85 -33.45 60.02 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.464 1.102 . . . . 75.219999999999999 110.246 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.573 ' CZ3' ' O ' ' A' ' 185' ' ' CYS . 2.6 t90 -85.28 -60.36 2.06 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.137 . . . . 63.130000000000003 108.007 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.427 ' NZ ' ' CG ' ' B' ' 470' ' ' PHE . 22.1 mtmt -56.18 -18.7 10.91 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.53 1.144 . . . . 71.010000000000005 109.308 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -39.19 -48.13 1.71 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.145 . . . . 74.109999999999999 109.969 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -152.6 113.2 4.1 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.525 1.141 . . . . 62.329999999999998 109.287 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.496 ' CD1' ' N ' ' A' ' 246' ' ' ILE . 1.0 OUTLIER -67.22 -27.91 40.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.498 1.124 . . . . 70.219999999999999 109.28 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -82.07 71.73 9.12 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.497 1.123 . . . . 75.450000000000003 109.19 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.69 4.42 35.38 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 75.140000000000001 110.349 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 15.5 m-30 -40.51 -30.29 0.11 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.54 1.15 . . . . 74.150000000000006 111.024 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 3.4 ptpt -75.29 74.02 2.39 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.522 1.139 . . . . 64.109999999999999 109.311 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -149.38 -179.44 7.07 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.559 1.162 . . . . 54.539999999999999 109.345 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 1.5 m -105.87 158.56 16.67 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.582 1.177 . . . . 73.420000000000002 109.974 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.486 ' ND2' ' H ' ' A' ' 254' ' ' ILE . 11.8 t-20 -71.72 164.02 26.73 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.52 1.138 . . . . 73.129999999999995 109.319 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.718 HD12 ' N ' ' A' ' 254' ' ' ILE . 1.8 mp -128.29 162.36 34.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.554 1.159 . . . . 74.019999999999996 109.265 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 9.6 t -167.28 158.25 11.71 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.504 1.128 . . . . 73.430000000000007 110.047 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.1 pp -123.18 -179.57 4.34 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.512 1.133 . . . . 75.439999999999998 109.296 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -53.99 166.91 1.92 Allowed Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.517 1.136 . . . . 73.239999999999995 110.986 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 3.5 m -65.27 -71.7 0.18 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.491 0.759 . . . . 74.409999999999997 110.046 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 8.0 p -159.97 137.83 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.46 1.1 . . . . 74.400000000000006 109.339 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 . . . . . 0 C--N 1.326 -0.452 0 O-C-N 124.467 1.104 . . . . 63.200000000000003 110.266 -179.949 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 42.7 t . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 110.008 -0.367 . . . . 64.329999999999998 110.008 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 99.8 p -163.83 160.78 22.7 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.488 1.117 . . . . 71.109999999999999 109.91 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 50.3 m -81.36 175.86 10.21 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.521 1.138 . . . . 70.109999999999999 109.982 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -168.66 162.27 11.73 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.504 1.128 . . . . 43.200000000000003 109.258 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -152.21 144.6 24.05 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.508 1.13 . . . . 73.319999999999993 109.331 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . 0.655 ' HA3' HD13 ' B' ' 471' ' ' ILE . . . 178.22 -164.3 32.94 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.478 1.111 . . . . 65.340000000000003 110.98 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -100.19 -24.77 14.48 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.446 0.733 . . . . 61.43 109.259 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 470' ' ' PHE . . . . . 0.651 ' CD2' HG21 ' A' ' 194' ' ' ILE . 3.3 m-85 -104.92 -2.87 24.06 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.46 1.1 . . . . 74.430000000000007 110.938 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 471' ' ' ILE . . . . . 0.878 HD11 ' OE1' ' A' ' 240' ' ' GLN . 1.4 mp -75.17 136.8 72.35 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.451 1.094 . . . . 72.340000000000003 109.331 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 472' ' ' PRO . . . . . 0.432 ' HD3' ' ND1' ' A' ' 188' ' ' HIS . 18.3 Cg_endo -75.04 -162.66 0.16 Allowed 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.409 1.741 . . . . 52.109999999999999 110.977 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 6.2 t -133.08 -52.76 0.9 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.469 1.106 . . . . 61.409999999999997 109.958 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 31.9 mtt-85 -81.05 156.18 72.18 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.485 1.116 . . . . 74.329999999999998 110.27 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 475' ' ' PRO . . . . . 0.679 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.4 Cg_endo -75.05 -30.64 6.88 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.425 1.75 . . . . 73.010000000000005 110.982 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 476' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 163.42 131.6 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.538 1.149 . . . . 70.439999999999998 109.301 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 477' ' ' PRO . . . . . 0.577 ' HD3' ' CH2' ' A' ' 192' ' ' TRP . 18.6 Cg_endo -74.94 -163.31 0.18 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.553 1.817 . . . . 61.420000000000002 111.012 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 478' ' ' LYS . . . . . 0.496 ' O ' ' CD ' ' B' ' 478' ' ' LYS . 0.3 OUTLIER -124.97 94.99 42.94 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 74.310000000000002 109.329 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 479' ' ' PRO . . . . . 0.617 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.5 Cg_endo -74.94 155.38 43.23 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.462 1.77 . . . . 72.310000000000002 111.066 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 480' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' B' ' 481' ' ' SER . 18.3 Cg_endo -74.96 -160.86 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.459 1.768 . . . . 53.310000000000002 110.996 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 481' ' ' SER . . . . . 0.452 ' C ' ' O ' ' B' ' 480' ' ' PRO . 13.8 t -35.63 100.35 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.47 1.107 . . . . 60.420000000000002 109.999 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 482' ' ' SER . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 164' ' ' TYR . 0.7 OUTLIER -173.12 166.88 4.95 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.467 1.105 . . . . 42.340000000000003 110.009 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -96.05 111.34 23.39 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.463 1.102 . . . . 71.329999999999998 109.294 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 46.9 t -103.7 156.48 17.77 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.486 1.116 . . . . 62.100000000000001 110.02 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -82.52 -57.25 3.43 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.442 1.089 . . . . 55.530000000000001 109.262 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.462 1.101 . . . . 64.109999999999999 109.974 179.981 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.966 0 N-CA-C 111.013 -0.835 . . . . 62.420000000000002 111.013 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 4.1 m -72.16 127.13 31.6 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.48 0.753 . . . . 74.219999999999999 109.994 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.554 HD22 ' OD1' ' A' ' 230' ' ' ASP . 1.4 pp -124.39 143.73 50.44 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.502 1.126 . . . . 72.430000000000007 109.323 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.789 ' CD1' ' CE2' ' A' ' 183' ' ' PHE . 1.4 m-85 -126.82 154.13 44.72 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.538 1.149 . . . . 62.509999999999998 110.997 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.887 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -114.64 149.57 36.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.537 1.148 . . . . 63.100000000000001 109.302 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.53 HD13 ' O ' ' A' ' 180' ' ' GLU . 0.2 OUTLIER -131.4 127.85 60.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 74.329999999999998 109.273 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.802 HG22 HG12 ' A' ' 212' ' ' VAL . 1.9 t -80.48 121.19 33.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.556 1.16 . . . . 62.109999999999999 109.333 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.894 HD11 ' HB2' ' A' ' 213' ' ' SER . 0.9 OUTLIER -96.24 -14.48 22.64 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 62.140000000000001 109.361 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.691 ' O ' HG13 ' A' ' 162' ' ' VAL . 3.0 m-85 -146.9 159.23 43.79 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.48 1.113 . . . . 74.450000000000003 110.954 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.614 ' N ' HG12 ' A' ' 178' ' ' VAL . 10.4 p-10 -101.1 159.45 15.22 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.566 1.166 . . . . 73.409999999999997 109.347 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.54 ' HB2' ' CE1' ' A' ' 211' ' ' PHE . 9.0 t80 -158.33 135.71 10.17 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.433 1.083 . . . . 72.25 110.908 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -68.78 132.34 46.64 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.144 . . . . 55.240000000000002 109.337 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.926 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -112.98 141.82 46.39 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.539 1.149 . . . . 71.120000000000005 109.311 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -150.42 20.37 0.84 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.51 1.131 . . . . 73.450000000000003 110.346 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.478 ' NZ ' ' CH2' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -96.42 -176.57 3.67 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.496 1.123 . . . . 64.239999999999995 109.26 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.41 -20.63 63.29 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.501 1.126 . . . . 52.409999999999997 109.319 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.454 ' HB3' ' CB ' ' A' ' 206' ' ' LEU . 7.1 t0 -117.11 18.88 14.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.493 1.121 . . . . 71.439999999999998 109.307 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.926 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 6.5 pt-20 -36.52 106.44 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.483 1.114 . . . . 71.420000000000002 110.28 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.693 HD22 ' HA3' ' A' ' 205' ' ' GLY . 15.8 tp -116.55 105.94 13.01 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.422 1.076 . . . . 55.130000000000003 109.307 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 175' ' ' THR . 9.7 t -87.22 110.02 19.88 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.437 1.086 . . . . 74.140000000000001 110.367 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.466 ' CG2' ' HG2' ' A' ' 180' ' ' GLU . 87.8 m -130.97 169.98 15.09 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.581 1.176 . . . . 72.450000000000003 110.386 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.432 ' N ' HG22 ' A' ' 176' ' ' THR . 15.0 m-85 -112.41 161.95 16.12 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.458 1.099 . . . . 72.439999999999998 111.015 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.614 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.7 m -55.4 158.16 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 44.509999999999998 109.3 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.44 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 50.24 68.55 1.38 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.462 1.101 . . . . 72.420000000000002 111.013 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.53 ' O ' HD13 ' A' ' 161' ' ' ILE . 5.2 tp10 -126.48 164.79 20.39 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 124.547 0.792 . . . . 62.229999999999997 110.322 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -113.42 129.21 56.59 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.507 1.13 . . . . 74.510000000000005 109.256 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.836 HD12 HG21 ' A' ' 207' ' ' VAL . 0.4 OUTLIER -152.48 146.95 25.68 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.498 1.124 . . . . 54.439999999999998 109.274 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.789 ' CE2' ' CD1' ' A' ' 159' ' ' TYR . 3.8 m-85 -111.92 120.35 41.61 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.464 1.103 . . . . 72.409999999999997 111.021 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.887 HD13 ' HB2' ' A' ' 160' ' ' ALA . 1.7 mp -71.02 152.11 8.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.485 1.115 . . . . 75.030000000000001 109.281 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.483 ' SG ' HG22 ' A' ' 194' ' ' ILE . 15.5 p -142.25 -44.15 0.33 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.508 1.13 . . . . 73.549999999999997 108.327 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.994 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -116.19 159.1 22.27 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.49 1.119 . . . . 75.030000000000001 109.303 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.558 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -147.85 148.93 31.4 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.463 1.102 . . . . 54.43 109.639 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.621 ' CD2' ' O ' ' A' ' 192' ' ' TRP . 0.5 OUTLIER -152.44 143.96 23.42 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.492 1.12 . . . . 74.030000000000001 109.584 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.473 ' C ' ' N ' ' A' ' 191' ' ' GLU . 27.3 t-20 51.11 22.88 1.38 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.547 1.154 . . . . 63.009999999999998 109.34 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.441 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.5 p 39.03 30.19 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.531 1.145 . . . . 52.009999999999998 108.292 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.526 ' O ' HG13 ' A' ' 209' ' ' VAL . 9.9 tt0 -131.31 -40.15 1.14 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.438 1.086 . . . . 71.319999999999993 110.307 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.835 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 96.4 m95 -107.33 131.72 53.92 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.035 -1.098 . . . . 65.239999999999995 108.035 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.776 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.4 m-30 -125.59 133.06 52.4 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.597 1.185 . . . . 61.119999999999997 111.048 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.994 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 0.7 OUTLIER -93.3 105.67 17.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.522 1.139 . . . . 55.409999999999997 109.289 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -109.13 176.73 4.99 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.392 1.057 . . . . 75.230000000000004 109.306 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.5 pttm -149.47 168.76 10.34 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.593 1.183 . . . . 52.340000000000003 109.362 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.495 ' CG ' ' O ' ' A' ' 202' ' ' GLY . 18.5 Cg_endo -75.02 174.44 12.78 Favored 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.528 1.804 . . . . 54.109999999999999 110.981 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 6.6 tp -57.13 -29.85 33.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.542 1.151 . . . . 70.329999999999998 109.278 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 130.58 62.95 0.1 OUTLIER Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.445 1.09 . . . . 21.5 111.008 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -124.74 -76.2 0.59 Allowed 'General case' 0 C--N 1.323 -0.568 0 O-C-N 124.47 0.747 . . . . 73.420000000000002 110.336 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 8.2 tp -159.32 108.65 1.88 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.467 1.105 . . . . 71.109999999999999 109.325 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.495 ' O ' ' CG ' ' A' ' 197' ' ' PRO . . . 129.86 157.88 9.25 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.47 1.106 . . . . 42.200000000000003 110.984 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.408 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . 95.25 170.79 36.44 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.035 -0.826 . . . . 74.150000000000006 111.035 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.408 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.1 Cg_endo -75.06 136.75 46.62 Favored 'Cis proline' 0 C--N 1.36 1.14 0 C-N-CA 121.002 -2.499 . . . . 61.539999999999999 111.0 0.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.693 ' HA3' HD22 ' A' ' 174' ' ' LEU . . . -99.72 156.74 19.77 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.529 1.143 . . . . 52.43 110.955 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.835 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.3 OUTLIER -93.12 146.45 23.65 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.455 0.738 . . . . 52.439999999999998 109.345 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.836 HG21 HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -159.99 127.05 2.6 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.534 1.146 . . . . 72.230000000000004 109.281 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.774 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.4 Cg_endo -75.01 179.83 5.7 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.479 1.779 . . . . 71.129999999999995 110.964 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.776 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.4 m -96.91 4.27 9.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.441 1.088 . . . . 64.430000000000007 109.314 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . 0.5 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -108.01 1.84 33.53 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.546 1.153 . . . . 73.030000000000001 111.026 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 14.1 m-85 -133.3 7.64 3.93 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.56 0.8 . . . . 64.450000000000003 111.003 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.802 HG12 HG22 ' A' ' 162' ' ' VAL . 4.5 m -144.32 153.69 15.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.562 1.164 . . . . 70.329999999999998 109.296 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.894 ' HB2' HD11 ' A' ' 163' ' ' LEU . 5.4 t -126.7 137.73 53.31 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.523 1.14 . . . . 73.219999999999999 109.978 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.716 ' O ' HG23 ' A' ' 215' ' ' ILE . 3.2 mm -75.76 147.75 7.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.434 1.084 . . . . 64.109999999999999 109.286 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.716 HG23 ' O ' ' A' ' 214' ' ' ILE . 4.6 pt -160.1 135.45 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.518 1.136 . . . . 74.439999999999998 109.331 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.428 ' C ' ' N ' ' A' ' 218' ' ' ALA . 13.2 t0 -131.7 74.57 1.6 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.558 1.161 . . . . 74.230000000000004 109.244 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.706 HG23 ' O ' ' A' ' 217' ' ' ILE . 0.3 OUTLIER 40.53 30.64 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.472 1.107 . . . . 60.299999999999997 109.283 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.428 ' N ' ' C ' ' A' ' 216' ' ' ASP . . . -118.95 165.02 14.61 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.495 1.122 . . . . 73.129999999999995 109.249 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 7.8 t -96.02 -8.14 34.43 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.498 1.124 . . . . 73.340000000000003 110.387 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -80.83 -142.62 3.28 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.457 1.098 . . . . 74.430000000000007 111.012 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -148.07 122.73 9.86 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.573 0.808 . . . . 74.439999999999998 111.025 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.403 ' O ' ' HB ' ' A' ' 223' ' ' THR . . . 61.27 19.36 10.05 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.513 1.133 . . . . 32.229999999999997 109.275 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.472 ' O ' ' CG2' ' A' ' 223' ' ' THR . 0.3 OUTLIER 73.36 5.22 5.0 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.51 1.131 . . . . 64.25 110.417 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 115.36 -47.9 0.99 Allowed Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.485 1.116 . . . . 54.409999999999997 111.009 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -75.12 168.82 19.24 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.471 0.748 . . . . 73.239999999999995 109.336 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.46 ' OD1' HG11 ' A' ' 259' ' ' VAL . 6.5 t70 -81.31 150.25 28.58 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.449 1.093 . . . . 52.310000000000002 109.285 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.489 HG21 ' HE2' ' A' ' 193' ' ' PHE . 3.7 p -44.12 -50.89 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.469 1.106 . . . . 72.439999999999998 109.319 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.412 ' N ' HG13 ' A' ' 227' ' ' VAL . 5.0 mt -53.75 -47.27 62.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.505 1.128 . . . . 74.319999999999993 109.274 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -66.28 -13.86 61.11 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.5 1.125 . . . . 63.350000000000001 110.334 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.554 ' OD1' HD22 ' A' ' 158' ' ' LEU . 4.6 t70 -88.52 -16.47 32.57 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.517 1.135 . . . . 75.450000000000003 109.289 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.5 OUTLIER -73.59 -69.62 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.5 1.125 . . . . 72.140000000000001 109.291 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.625 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -62.23 -16.83 55.99 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.41 1.069 . . . . 73.439999999999998 109.313 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.8 -56.25 15.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.501 1.125 . . . . 72.319999999999993 109.992 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.473 ' CG2' ' HB3' ' A' ' 236' ' ' LEU . 3.7 m -88.87 14.88 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.537 1.148 . . . . 64.230000000000004 109.309 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 49.4 t30 54.96 32.42 18.0 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.546 1.154 . . . . 73.219999999999999 109.27 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.473 ' HB3' ' CG2' ' A' ' 234' ' ' VAL . 0.0 OUTLIER -82.57 118.23 71.15 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.445 1.09 . . . . 73.409999999999997 109.332 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.99 -174.09 1.81 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.508 1.794 . . . . 63.130000000000003 110.998 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.582 HG21 ' NE2' ' A' ' 240' ' ' GLN . 0.8 OUTLIER -58.78 -170.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.456 1.098 . . . . 73.439999999999998 110.461 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.935 HG23 ' HB1' ' A' ' 186' ' ' ALA . 10.8 p -79.79 -43.64 22.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.478 1.111 . . . . 72.329999999999998 109.307 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.582 ' NE2' HG21 ' A' ' 238' ' ' THR . 0.0 OUTLIER -87.24 -12.83 45.54 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 1.114 . . . . 62.549999999999997 110.321 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.488 ' N ' ' OE1' ' A' ' 240' ' ' GLN . 2.0 mt-10 -82.88 -37.24 24.57 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.516 1.135 . . . . 74.420000000000002 110.296 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.591 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 0.4 OUTLIER -77.38 -59.29 2.84 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.531 1.145 . . . . 72.409999999999997 107.977 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.615 ' NZ ' ' CD2' ' B' ' 470' ' ' PHE . 26.8 mtmt -56.56 -18.66 12.54 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.571 1.169 . . . . 72.439999999999998 109.391 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 243' ' ' LYS . 1.1 t -39.09 -56.48 1.44 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.501 1.126 . . . . 72.230000000000004 109.939 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -150.12 130.19 13.52 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.482 1.114 . . . . 63.439999999999998 109.376 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 13.2 mm -69.08 -56.3 12.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.544 1.152 . . . . 71.319999999999993 109.263 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.782 ' HB1' ' OH ' ' A' ' 249' ' ' TYR . . . -98.51 85.26 3.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.531 1.144 . . . . 74.400000000000006 109.341 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . 0.404 ' HD3' ' N ' ' A' ' 249' ' ' TYR . 0.0 OUTLIER -115.28 -31.65 5.9 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.515 1.134 . . . . 75.439999999999998 110.246 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.782 ' OH ' ' HB1' ' A' ' 247' ' ' ALA . 0.6 OUTLIER 46.17 59.53 3.73 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.525 1.141 . . . . 75.239999999999995 110.988 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -168.86 158.79 9.12 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.509 1.13 . . . . 74.439999999999998 109.312 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -94.48 -173.0 2.92 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.597 1.186 . . . . 64.349999999999994 109.294 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 61.5 m -118.31 -81.91 0.63 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.481 1.113 . . . . 73.519999999999996 109.986 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.4 HD22 ' N ' ' A' ' 254' ' ' ILE . 3.1 p-10 -128.4 -170.79 2.32 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.491 1.119 . . . . 53.25 109.343 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.797 HG22 HD22 ' A' ' 256' ' ' LEU . 31.9 mm -149.32 111.6 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.495 1.122 . . . . 63.310000000000002 109.254 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.772 ' C ' HD23 ' A' ' 256' ' ' LEU . 22.8 t -95.77 -47.41 6.18 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.467 1.104 . . . . 71.340000000000003 109.978 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.797 HD22 HG22 ' A' ' 254' ' ' ILE . 1.4 pt? 42.19 31.04 0.22 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.454 1.096 . . . . 71.340000000000003 109.289 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -92.89 -171.1 40.31 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 124.461 1.101 . . . . 72.310000000000002 111.024 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.3 m -142.16 175.0 10.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.528 0.781 . . . . 71.450000000000003 109.993 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.46 HG11 ' OD1' ' A' ' 226' ' ' ASP . 13.3 p -140.25 137.37 37.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.52 1.137 . . . . 65.439999999999998 109.255 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 . . . . . 0 C--N 1.325 -0.458 0 O-C-N 124.506 1.129 . . . . 70.109999999999999 110.294 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 463' ' ' SER . . . . . 0.437 ' O ' ' N ' ' B' ' 465' ' ' SER . 3.2 m . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 109.945 -0.391 . . . . 61.109999999999999 109.945 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.59 75.25 0.07 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.459 1.099 . . . . 74.219999999999999 110.004 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 465' ' ' SER . . . . . 0.437 ' N ' ' O ' ' B' ' 463' ' ' SER . 1.4 p -167.26 -175.79 3.06 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.522 1.139 . . . . 62.439999999999998 110.066 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -171.07 162.71 7.2 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.47 1.106 . . . . 60.420000000000002 109.359 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 60.97 37.07 18.42 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.5 1.125 . . . . 75.25 109.236 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -137.64 116.7 1.38 Allowed Glycine 0 CA--C 1.529 0.935 0 O-C-N 124.542 1.151 . . . . 44.5 111.048 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -113.2 -12.51 13.1 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.477 0.751 . . . . 61.43 109.22 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 470' ' ' PHE . . . . . 0.615 ' CD2' ' NZ ' ' A' ' 243' ' ' LYS . 3.2 m-30 -89.26 2.05 54.85 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.458 1.099 . . . . 63.43 111.073 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 471' ' ' ILE . . . . . 0.469 ' N ' HD13 ' B' ' 471' ' ' ILE . 5.2 mm -65.91 135.23 95.28 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.483 1.115 . . . . 55.409999999999997 109.267 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 472' ' ' PRO . . . . . 0.589 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.95 149.92 37.65 Favored 'Trans proline' 0 C--N 1.361 1.225 0 O-C-N 124.522 1.801 . . . . 72.010000000000005 111.012 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 23.0 t -106.15 -37.18 6.68 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.486 1.116 . . . . 73.409999999999997 110.031 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -101.27 166.11 12.93 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.419 1.074 . . . . 62.030000000000001 110.27 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.06 -167.9 0.47 Allowed 'Trans proline' 0 C--N 1.361 1.203 0 O-C-N 124.511 1.795 . . . . 71.239999999999995 110.98 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 476' ' ' ALA . . . . . . . . . . . . . . . -71.33 134.05 84.99 Favored Pre-proline 0 C--N 1.326 -0.439 0 O-C-N 124.535 1.147 . . . . 41.140000000000001 109.293 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 477' ' ' PRO . . . . . 0.523 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -75.07 -167.85 0.46 Allowed 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.56 1.821 . . . . 75.099999999999994 111.032 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.08 91.82 38.2 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 124.42 1.075 . . . . 43.32 109.302 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 479' ' ' PRO . . . . . 0.604 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.3 Cg_endo -74.96 151.21 39.43 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.535 1.808 . . . . 64.409999999999997 110.973 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 480' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 479' ' ' PRO . 18.2 Cg_endo -75.0 158.22 42.31 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.523 1.802 . . . . 74.310000000000002 110.938 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 481' ' ' SER . . . . . . . . . . . . . 3.7 t 54.25 32.7 16.65 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.427 1.079 . . . . 72.510000000000005 110.061 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 58.6 p -73.25 113.09 9.93 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.427 1.079 . . . . 73.549999999999997 109.973 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -89.4 14.94 10.04 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.471 1.107 . . . . 32.020000000000003 109.306 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 2.8 p -112.38 8.38 19.52 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.496 1.123 . . . . 70.340000000000003 110.034 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -137.54 178.86 6.78 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.518 1.136 . . . . 55.43 109.333 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 80.9 p . . . . . 0 C--N 1.324 -0.501 0 O-C-N 124.412 1.07 . . . . 75.140000000000001 109.984 179.999 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.967 0 N-CA-C 111.0 -0.84 . . . . 15.34 111.0 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.7 t -147.88 179.1 7.96 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.477 0.751 . . . . 71.319999999999993 109.988 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 mt 64.37 64.29 0.72 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.456 1.098 . . . . 65.349999999999994 109.349 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -118.93 155.62 30.99 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.546 1.154 . . . . 74.530000000000001 111.01 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.819 ' O ' HD12 ' A' ' 182' ' ' LEU . . . -115.82 144.45 43.99 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.549 1.155 . . . . 63.310000000000002 109.291 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.519 HD13 ' N ' ' A' ' 162' ' ' VAL . 0.1 OUTLIER -129.37 132.04 66.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 124.505 1.128 . . . . 72.200000000000003 109.358 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.988 HG22 HG12 ' A' ' 212' ' ' VAL . 2.1 t -91.37 122.22 42.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.445 1.09 . . . . 71.340000000000003 109.312 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.531 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 0.7 OUTLIER -98.26 -14.36 20.32 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.457 1.098 . . . . 70.099999999999994 109.305 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.665 ' O ' HG13 ' A' ' 162' ' ' VAL . 1.1 m-85 -144.54 156.54 44.2 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.503 1.127 . . . . 63.210000000000001 111.033 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.716 ' N ' HG12 ' A' ' 178' ' ' VAL . 5.8 t70 -98.96 158.38 15.69 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.422 1.076 . . . . 51.439999999999998 109.25 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.556 ' CE2' ' HG3' ' B' ' 477' ' ' PRO . 1.4 t80 -160.26 131.06 5.59 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.56 1.162 . . . . 74.150000000000006 110.993 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.552 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 16.8 mtpp -67.21 121.26 15.26 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.445 1.091 . . . . 63.020000000000003 109.268 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.836 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -91.22 140.39 29.84 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.416 1.073 . . . . 54.140000000000001 109.293 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -150.47 21.03 0.83 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.512 1.132 . . . . 72.120000000000005 110.308 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.47 ' HD3' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -99.33 -176.22 3.23 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.511 1.132 . . . . 74.140000000000001 109.248 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.44 -29.14 67.57 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.548 1.155 . . . . 62.399999999999999 109.295 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 173' ' ' GLU . 5.6 m-20 -107.83 18.73 20.97 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.522 1.139 . . . . 75.129999999999995 109.281 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.836 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 6.8 pt-20 -36.62 104.06 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.539 1.149 . . . . 74.430000000000007 110.255 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.589 HD12 ' HA3' ' A' ' 205' ' ' GLY . 0.8 OUTLIER -141.15 95.31 2.82 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 62.049999999999997 109.278 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.01 153.66 33.15 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.462 1.101 . . . . 62.240000000000002 110.34 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 25.4 m -155.99 102.54 2.16 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.462 1.101 . . . . 63.039999999999999 110.387 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -44.17 160.56 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 70.409999999999997 111.019 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.716 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.9 m -62.08 158.48 3.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.529 1.143 . . . . 74.340000000000003 109.289 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.407 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 49.41 62.69 4.58 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.469 1.105 . . . . 71.200000000000003 110.98 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -118.56 165.55 13.8 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.516 0.774 . . . . 71.209999999999994 110.315 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -123.4 123.4 40.58 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.486 1.116 . . . . 74.109999999999999 109.26 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.848 ' H ' HD12 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -141.65 155.14 45.72 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.422 1.076 . . . . 64.209999999999994 109.249 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 7.3 t80 -109.59 112.61 24.8 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.546 1.154 . . . . 73.510000000000005 110.999 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.528 HD12 ' HB2' ' A' ' 160' ' ' ALA . 36.8 mt -70.96 151.43 9.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.463 1.102 . . . . 71.25 109.319 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.607 ' SG ' ' CH2' ' A' ' 242' ' ' TRP . 1.8 t -139.99 -43.85 0.43 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.466 1.104 . . . . 74.450000000000003 108.276 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.995 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -112.17 166.8 10.94 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.525 1.141 . . . . 61.439999999999998 109.316 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.521 ' C ' ' CD2' ' A' ' 188' ' ' HIS . 2.9 p80 -159.37 149.55 19.06 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.496 1.123 . . . . 73.450000000000003 109.617 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.742 ' HE1' HD11 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -141.61 133.14 26.87 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.438 1.086 . . . . 64.409999999999997 109.651 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 190' ' ' CYS . 95.7 m-20 49.02 31.16 3.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.564 1.165 . . . . 74.530000000000001 109.313 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.442 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.0 p 38.47 34.8 0.08 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.474 1.109 . . . . 74.310000000000002 108.352 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.52 ' O ' HG13 ' A' ' 209' ' ' VAL . 8.6 tt0 -128.49 -39.32 1.67 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.505 1.128 . . . . 74.120000000000005 110.324 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.964 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 98.6 m95 -111.56 126.43 54.98 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.483 1.115 . . . . 70.010000000000005 108.059 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.781 ' CE2' HG12 ' A' ' 209' ' ' VAL . 20.9 m-30 -117.99 132.17 56.41 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.526 1.141 . . . . 73.519999999999996 110.979 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.995 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 10.1 mm -96.37 103.45 14.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.385 1.053 . . . . 73.530000000000001 109.294 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.482 ' HB2' ' CG1' ' A' ' 184' ' ' ILE . . . -111.59 174.78 5.71 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.514 1.134 . . . . 73.310000000000002 109.299 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.36 165.56 19.74 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 124.525 1.14 . . . . 65.319999999999993 109.238 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.94 178.26 7.47 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.509 1.794 . . . . 62.539999999999999 111.042 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.515 ' H ' HD13 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -89.57 15.28 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.536 1.147 . . . . 72.519999999999996 109.302 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -138.81 -122.66 2.04 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.575 1.172 . . . . 62.219999999999999 111.042 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -161.01 172.81 16.21 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.496 0.763 . . . . 62.149999999999999 110.26 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 201' ' ' LEU . 12.7 tp 78.85 81.48 0.06 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.539 1.149 . . . . 73.340000000000003 109.3 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 143.16 -85.2 0.19 Allowed Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.451 1.094 . . . . 54.109999999999999 111.085 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -49.53 -179.72 0.02 OUTLIER Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.002 -0.839 . . . . 60.439999999999998 111.002 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.568 ' HG2' ' CE2' ' B' ' 470' ' ' PHE . 18.4 Cg_endo -74.9 143.53 78.12 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.045 -2.481 . . . . 72.409999999999997 111.024 -0.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.589 ' HA3' HD12 ' A' ' 174' ' ' LEU . . . -105.76 150.98 17.05 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.582 1.176 . . . . 44.229999999999997 110.962 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.964 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.1 OUTLIER -87.34 146.21 26.01 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 0.763 . . . . 72.019999999999996 109.314 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.766 ' HB ' HG11 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -153.79 122.23 3.07 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.53 1.144 . . . . 71.0 109.242 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.987 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.5 Cg_endo -74.97 170.96 19.25 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.509 1.794 . . . . 34.310000000000002 111.015 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.781 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.8 OUTLIER -89.75 5.2 5.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.118 . . . . 63.020000000000003 109.221 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -103.47 -12.11 31.65 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.522 1.139 . . . . 75.049999999999997 110.995 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.626 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 10.8 m-85 -124.0 -1.24 8.32 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.478 0.752 . . . . 74.109999999999999 111.054 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.988 HG12 HG22 ' A' ' 162' ' ' VAL . 2.2 m -140.4 160.67 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.501 1.125 . . . . 71.299999999999997 109.294 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.8 m -128.67 147.93 50.78 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.444 1.09 . . . . 75.099999999999994 110.07 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.753 ' C ' HD13 ' A' ' 215' ' ' ILE . 2.7 mm -94.42 141.19 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 64.540000000000006 109.235 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.785 ' N ' HD13 ' A' ' 215' ' ' ILE . 0.0 OUTLIER -143.29 143.51 24.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.514 1.133 . . . . 74.329999999999998 109.218 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -93.8 -16.05 24.52 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.457 1.098 . . . . 52.140000000000001 109.312 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.42 ' CG2' ' O ' ' A' ' 219' ' ' THR . 4.4 tt -149.12 175.65 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.536 1.148 . . . . 75.340000000000003 109.276 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -46.85 -69.11 0.14 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.447 1.092 . . . . 62.039999999999999 109.332 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.42 ' O ' ' CG2' ' A' ' 217' ' ' ILE . 43.0 m -103.38 143.93 32.05 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.527 1.142 . . . . 73.040000000000006 110.36 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 125.4 -159.99 19.95 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.516 1.135 . . . . 62.409999999999997 110.969 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.415 ' O ' ' N ' ' A' ' 223' ' ' THR . 0.1 OUTLIER -119.88 -172.27 2.31 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.483 0.755 . . . . 63.229999999999997 111.021 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.752 ' O ' HG22 ' A' ' 223' ' ' THR . . . -69.43 70.35 0.27 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.479 1.112 . . . . 73.230000000000004 109.213 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.752 HG22 ' O ' ' A' ' 222' ' ' ALA . 15.2 t 50.49 18.19 0.43 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.559 1.162 . . . . 72.010000000000005 110.412 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.402 ' N ' ' C ' ' A' ' 222' ' ' ALA . . . 92.27 -45.37 2.62 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.489 1.118 . . . . 64.510000000000005 111.03 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.465 ' ND2' HG23 ' A' ' 223' ' ' THR . 52.1 m-20 -63.09 156.53 24.67 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.546 0.792 . . . . 74.120000000000005 109.271 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.404 ' O ' ' N ' ' A' ' 229' ' ' GLU . 19.9 t0 -72.17 149.3 44.81 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.506 1.129 . . . . 70.209999999999994 109.276 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.656 HG13 HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -40.27 -45.63 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.532 1.145 . . . . 72.010000000000005 109.271 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.752 ' HA ' HD12 ' A' ' 231' ' ' ILE . 4.5 mp -64.78 -49.03 82.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.537 1.148 . . . . 73.230000000000004 109.316 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.483 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 34.0 mt-10 -62.4 -16.67 56.16 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.445 1.091 . . . . 73.310000000000002 110.29 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -89.16 -19.11 25.89 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.476 1.11 . . . . 54.119999999999997 109.332 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.752 HD12 ' HA ' ' A' ' 228' ' ' ILE . 3.0 mt -72.64 -69.89 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 124.565 1.166 . . . . 72.030000000000001 109.331 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.483 ' CD ' ' HA ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -57.5 -22.74 45.92 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.508 1.13 . . . . 63.420000000000002 109.283 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.21 -56.79 7.05 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.132 . . . . 74.129999999999995 109.945 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 234' ' ' VAL . 1.6 m -98.49 24.65 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.499 1.124 . . . . 73.239999999999995 109.241 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 41.29 36.73 0.53 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.515 1.134 . . . . 53.310000000000002 109.291 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.489 HD12 ' HD2' ' A' ' 237' ' ' PRO . 4.2 tp -60.17 119.83 45.67 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.521 1.138 . . . . 74.420000000000002 109.312 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.489 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.3 Cg_endo -74.99 162.79 36.57 Favored 'Trans proline' 0 C--N 1.359 1.115 0 O-C-N 124.499 1.789 . . . . 54.100000000000001 110.967 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 1.7 m -68.52 173.02 5.37 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.49 1.119 . . . . 54.119999999999997 110.419 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.681 ' HB ' ' HB1' ' A' ' 186' ' ' ALA . 10.5 p -65.3 -49.95 75.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.54 1.15 . . . . 63.25 109.281 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.481 ' OE1' ' CD1' ' B' ' 471' ' ' ILE . 7.6 pm0 -68.63 -14.95 63.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 72.439999999999998 110.353 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -88.49 -39.64 14.05 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.552 1.157 . . . . 70.340000000000003 110.381 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.607 ' CH2' ' SG ' ' A' ' 185' ' ' CYS . 0.2 OUTLIER -80.68 -63.07 1.49 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.506 1.129 . . . . 72.219999999999999 108.015 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.553 ' HD2' ' CD2' ' B' ' 470' ' ' PHE . 14.7 mtpp -51.5 -23.26 3.84 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.479 1.112 . . . . 64.310000000000002 109.292 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -39.55 -67.59 0.21 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.129 . . . . 53.25 109.933 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -135.12 121.77 20.78 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.581 1.176 . . . . 71.540000000000006 109.32 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 23.1 mm -48.08 -53.7 5.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.564 1.165 . . . . 63.240000000000002 109.285 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -122.74 117.47 25.8 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.506 1.128 . . . . 64.129999999999995 109.29 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.31 173.74 11.98 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.455 1.097 . . . . 73.150000000000006 110.272 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -76.75 153.47 34.99 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.426 1.079 . . . . 51.5 110.919 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 131.04 49.8 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.44 1.087 . . . . 63.450000000000003 109.272 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -174.45 -178.02 1.32 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.515 1.135 . . . . 72.120000000000005 109.295 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 57.8 m 56.98 54.66 6.79 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.412 1.07 . . . . 63.450000000000003 109.975 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -106.12 134.2 49.62 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.459 1.099 . . . . 74.409999999999997 109.328 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.553 HD12 ' N ' ' A' ' 254' ' ' ILE . 4.5 mp -125.74 141.42 45.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.518 1.136 . . . . 74.120000000000005 109.277 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 15.1 t -146.97 108.64 4.34 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.446 1.091 . . . . 71.530000000000001 110.005 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 4.8 mt -127.55 -179.28 4.83 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.443 1.089 . . . . 72.120000000000005 109.298 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -73.3 -140.58 0.46 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.51 1.131 . . . . 53.409999999999997 110.998 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 43.5 t -169.11 141.45 2.61 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.502 0.766 . . . . 54.119999999999997 110.04 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 35.0 m -140.26 -175.41 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.499 1.125 . . . . 52.140000000000001 109.347 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.324 -0.51 0 O-C-N 124.503 1.127 . . . . 64.040000000000006 110.349 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 90.8 p . . . . . 0 N--CA 1.452 -0.325 0 N-CA-C 109.993 -0.373 . . . . 75.140000000000001 109.993 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 48.7 m -129.0 43.86 3.07 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.418 1.074 . . . . 74.109999999999999 110.018 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 47.5 t -85.93 -62.62 1.48 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.479 1.112 . . . . 65.310000000000002 109.973 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -106.53 157.65 17.5 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 72.25 109.271 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -102.08 159.68 15.17 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.559 1.162 . . . . 74.120000000000005 109.321 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -147.9 163.33 28.84 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.493 1.121 . . . . 55.009999999999998 111.054 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . 0.421 ' O ' ' CD1' ' B' ' 471' ' ' ILE . 0.0 OUTLIER -128.74 144.37 51.15 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.494 0.761 . . . . 64.129999999999995 109.342 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 470' ' ' PHE . . . . . 0.568 ' CE2' ' HG2' ' A' ' 204' ' ' PRO . 5.4 m-30 52.07 35.57 16.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.472 1.108 . . . . 72.409999999999997 110.938 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 471' ' ' ILE . . . . . 0.528 HG22 ' HD2' ' B' ' 472' ' ' PRO . 3.3 mm -95.95 140.59 22.35 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.478 1.111 . . . . 74.349999999999994 109.279 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 472' ' ' PRO . . . . . 0.528 ' HD2' HG22 ' B' ' 471' ' ' ILE . 18.3 Cg_endo -75.0 -170.16 0.74 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.417 1.746 . . . . 34.140000000000001 110.965 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.97 15.9 4.23 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.478 1.111 . . . . 71.25 109.986 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 474' ' ' ARG . . . . . 0.443 ' O ' ' NE1' ' A' ' 192' ' ' TRP . 17.0 mmt180 -145.82 154.51 51.57 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.466 1.104 . . . . 72.049999999999997 110.335 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 475' ' ' PRO . . . . . 0.672 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.2 Cg_endo -74.94 -36.07 2.82 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.538 1.809 . . . . 71.209999999999994 110.939 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 476' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 164.38 133.04 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.543 1.152 . . . . 42.100000000000001 109.262 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 477' ' ' PRO . . . . . 0.573 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -74.93 -171.08 0.88 Allowed 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.556 1.819 . . . . 71.209999999999994 111.044 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.72 96.65 40.32 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.546 1.154 . . . . 73.150000000000006 109.319 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 479' ' ' PRO . . . . . 0.626 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -75.0 166.67 28.7 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.386 1.729 . . . . 74.329999999999998 111.032 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.87 -45.96 0.27 Allowed 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.44 1.758 . . . . 63.43 111.012 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 481' ' ' SER . . . . . 0.646 ' CB ' ' CZ ' ' A' ' 164' ' ' TYR . 1.0 OUTLIER -55.2 -26.41 39.08 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.559 1.162 . . . . 63.340000000000003 110.013 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.16 81.21 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.411 1.069 . . . . 73.409999999999997 110.004 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 483' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' B' ' 485' ' ' ALA . . . -41.36 -49.92 3.78 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.54 1.15 . . . . 72.219999999999999 109.332 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 9.5 t -46.54 94.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 O-C-N 124.431 1.082 . . . . 42.119999999999997 110.014 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' B' ' 483' ' ' ALA . . . -47.24 150.62 0.82 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.532 1.145 . . . . 53.409999999999997 109.263 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 82.4 p . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.455 1.097 . . . . 43.100000000000001 110.042 179.943 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.034 0 N-CA-C 110.995 -0.842 . . . . 73.239999999999995 110.995 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.0 t -67.17 136.55 55.23 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.539 0.788 . . . . 43.130000000000003 110.005 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 158' ' ' LEU . 4.6 pp -45.05 139.35 3.25 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.484 1.115 . . . . 75.129999999999995 109.38 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.565 ' CE2' ' CD1' ' A' ' 215' ' ' ILE . 2.3 p90 -131.19 174.66 9.82 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.487 1.117 . . . . 72.329999999999998 110.975 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.65 ' HB3' ' HG ' ' A' ' 182' ' ' LEU . . . -107.38 151.84 24.97 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.127 . . . . 51.340000000000003 109.288 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.597 HD13 ' N ' ' A' ' 162' ' ' VAL . 0.1 OUTLIER -132.16 135.05 58.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.457 1.098 . . . . 72.219999999999999 109.331 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.768 HG23 HD22 ' A' ' 182' ' ' LEU . 1.8 t -89.99 118.43 35.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.511 1.132 . . . . 73.540000000000006 109.337 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.571 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 1.4 mt -94.56 -16.92 22.85 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.422 1.076 . . . . 74.299999999999997 109.328 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.571 ' CE2' ' HB2' ' A' ' 163' ' ' LEU . 1.9 m-85 -148.61 157.07 43.21 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.439 1.087 . . . . 75.150000000000006 110.925 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.71 ' H ' HG12 ' A' ' 178' ' ' VAL . 7.2 p30 -88.84 154.84 19.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.527 1.142 . . . . 72.340000000000003 109.281 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.645 ' CE2' ' NZ ' ' A' ' 170' ' ' LYS . 2.4 t80 -154.4 132.13 11.47 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.435 1.084 . . . . 70.329999999999998 111.003 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.542 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 6.2 mtpm? -75.82 125.65 29.48 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.544 1.152 . . . . 62.210000000000001 109.328 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.908 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -114.18 133.53 55.53 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.521 1.138 . . . . 61.219999999999999 109.299 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -136.68 9.37 3.1 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.485 1.116 . . . . 63.039999999999999 110.245 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.645 ' NZ ' ' CE2' ' A' ' 166' ' ' PHE . 0.1 OUTLIER -79.07 -175.79 4.76 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.489 1.118 . . . . 74.230000000000004 109.32 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.34 -21.76 66.26 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.537 1.148 . . . . 73.329999999999998 109.267 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 173' ' ' GLU . 0.5 OUTLIER -114.05 12.64 17.99 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.451 1.094 . . . . 70.430000000000007 109.303 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.908 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 6.5 pt-20 -32.99 112.95 0.13 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.123 . . . . 73.299999999999997 110.293 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.592 HD23 ' HA3' ' A' ' 205' ' ' GLY . 1.5 tm? -119.92 99.4 6.6 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.555 1.159 . . . . 74.510000000000005 109.283 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 14.5 t -80.82 130.75 35.23 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.434 1.083 . . . . 75.120000000000005 110.428 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.411 ' CG2' ' HG3' ' A' ' 180' ' ' GLU . 55.6 m -155.19 155.98 34.87 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.451 1.094 . . . . 64.540000000000006 110.373 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.488 ' O ' HG11 ' A' ' 162' ' ' VAL . 26.8 m-85 -93.71 167.09 11.88 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.467 1.104 . . . . 65.120000000000005 110.953 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.71 HG12 ' H ' ' A' ' 165' ' ' ASP . 2.2 m -61.39 158.5 2.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.452 1.095 . . . . 75.519999999999996 109.3 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.422 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 48.55 56.92 8.88 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.524 1.14 . . . . 60.520000000000003 111.021 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.411 ' HG3' ' CG2' ' A' ' 176' ' ' THR . 3.9 mm-40 -114.86 175.47 5.48 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.472 0.749 . . . . 63.109999999999999 110.277 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -119.15 130.59 55.62 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.125 . . . . 75.120000000000005 109.321 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.891 HD12 HG21 ' A' ' 207' ' ' VAL . 2.5 pt? -145.28 133.37 21.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.455 1.097 . . . . 72.200000000000003 109.361 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -100.72 107.87 19.58 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.565 1.166 . . . . 74.120000000000005 110.979 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.75 ' CG1' ' HB2' ' A' ' 195' ' ' ALA . 13.3 mt -70.66 162.55 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.458 1.099 . . . . 70.140000000000001 109.353 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.571 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 2.0 p -156.44 -40.85 0.08 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.463 1.102 . . . . 42.119999999999997 108.296 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.989 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -112.21 152.17 28.71 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.451 1.094 . . . . 54.219999999999999 109.282 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.478 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.4 OUTLIER -145.26 149.45 34.91 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.476 1.11 . . . . 74.219999999999999 109.554 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.608 ' CD2' ' O ' ' A' ' 192' ' ' TRP . 0.7 OUTLIER -155.82 143.51 19.59 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 124.434 1.084 . . . . 65.329999999999998 109.545 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.456 ' C ' ' N ' ' A' ' 191' ' ' GLU . 7.4 m-20 57.02 18.04 3.75 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.548 1.155 . . . . 73.310000000000002 109.329 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 3.3 m 43.24 26.94 0.11 Allowed 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.475 1.109 . . . . 52.140000000000001 108.315 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.863 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 18.1 tt0 -132.93 -40.58 0.93 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.134 . . . . 71.420000000000002 110.254 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.996 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 96.9 m95 -103.88 127.83 51.38 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.042 -1.095 . . . . 71.400000000000006 108.042 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.768 ' CE2' HG12 ' A' ' 209' ' ' VAL . 15.7 m-30 -125.09 127.73 47.35 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.536 1.147 . . . . 74.409999999999997 110.922 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.989 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 1.6 mp -85.56 106.42 15.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.55 1.156 . . . . 74.040000000000006 109.277 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.798 ' HB3' HG21 ' A' ' 207' ' ' VAL . . . -120.85 163.07 18.75 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.557 1.161 . . . . 73.140000000000001 109.313 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -113.36 145.05 32.45 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.551 1.157 . . . . 73.329999999999998 109.263 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.96 172.19 16.85 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.475 1.776 . . . . 73.450000000000003 111.047 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -44.12 -41.61 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.518 1.136 . . . . 65.310000000000002 109.342 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -172.73 -78.11 0.05 OUTLIER Glycine 0 CA--C 1.531 1.07 0 O-C-N 124.507 1.129 . . . . 73.140000000000001 110.916 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 36.4 mtt85 -56.53 -177.25 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.485 0.756 . . . . 74.239999999999995 110.317 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 7.8 mt 72.92 9.94 5.42 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.403 1.065 . . . . 65.230000000000004 109.287 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 76.25 -132.09 12.36 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.577 1.173 . . . . 64.219999999999999 110.944 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.449 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . 107.82 166.73 21.61 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 111.059 -0.816 . . . . 44.140000000000001 111.059 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.449 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.3 Cg_endo -74.93 138.27 55.09 Favored 'Cis proline' 0 C--N 1.359 1.123 0 C-N-CA 120.97 -2.512 . . . . 54.549999999999997 110.988 -0.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.592 ' HA3' HD23 ' A' ' 174' ' ' LEU . . . -99.56 -178.96 31.04 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.432 1.082 . . . . 35.140000000000001 110.971 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.996 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -93.33 148.61 21.9 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.538 0.787 . . . . 61.100000000000001 109.295 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.891 HG21 HD12 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -155.52 122.95 2.78 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 74.540000000000006 109.32 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.888 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.5 Cg_endo -74.93 174.69 12.33 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.494 1.786 . . . . 71.0 111.038 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.768 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.5 m -93.59 -2.69 10.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.512 1.133 . . . . 75.099999999999994 109.228 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . 0.5 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -98.46 2.73 59.2 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.482 1.114 . . . . 22.140000000000001 110.967 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.557 ' CD1' ' HB2' ' A' ' 166' ' ' PHE . 13.5 m-85 -137.9 11.31 2.88 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.471 0.747 . . . . 72.329999999999998 110.985 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 208' ' ' PRO . 3.8 m -152.97 158.77 3.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 124.471 1.107 . . . . 73.329999999999998 109.339 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.8 t -134.91 148.07 49.98 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.532 1.145 . . . . 74.340000000000003 110.054 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 13.7 mm -86.27 132.76 31.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.441 1.088 . . . . 72.450000000000003 109.28 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.565 ' CD1' ' CE2' ' A' ' 159' ' ' TYR . 24.3 pt -147.45 140.74 19.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.547 1.154 . . . . 65.310000000000002 109.241 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.468 ' OD1' ' HB3' ' A' ' 218' ' ' ALA . 0.1 OUTLIER -129.08 -176.66 3.94 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.513 1.133 . . . . 64.319999999999993 109.24 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.5 ' C ' HD12 ' A' ' 217' ' ' ILE . 0.9 OUTLIER -100.8 27.14 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.443 1.089 . . . . 72.209999999999994 109.323 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.468 ' HB3' ' OD1' ' A' ' 216' ' ' ASP . . . -101.57 21.81 13.73 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.578 1.173 . . . . 70.209999999999994 109.328 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 7.0 m 57.15 107.65 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.493 1.12 . . . . 72.400000000000006 110.415 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 126.11 169.16 12.77 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.489 1.118 . . . . 55.439999999999998 111.052 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -103.51 131.18 50.84 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.521 0.777 . . . . 72.329999999999998 110.994 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.569 ' O ' HG22 ' A' ' 223' ' ' THR . . . 52.74 26.82 4.75 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.597 1.185 . . . . 53.310000000000002 109.3 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 222' ' ' ALA . 8.9 t 45.58 25.63 0.26 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.498 1.123 . . . . 51.32 110.412 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 86.13 -48.37 3.93 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.425 1.078 . . . . 70.540000000000006 110.987 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -64.88 142.53 58.4 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.489 0.758 . . . . 55.210000000000001 109.356 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 230' ' ' ASP . 2.4 m-20 -63.31 157.09 23.78 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.515 1.134 . . . . 71.129999999999995 109.277 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.566 HG13 HD12 ' A' ' 228' ' ' ILE . 1.4 p -50.86 -41.08 21.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.461 1.1 . . . . 71.299999999999997 109.265 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.926 ' HA ' HD12 ' A' ' 231' ' ' ILE . 4.1 mp -70.27 -41.66 78.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.54 1.15 . . . . 74.019999999999996 109.332 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -69.21 -19.55 63.96 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.482 1.114 . . . . 62.329999999999998 110.308 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 226' ' ' ASP . 7.1 m-20 -88.73 -16.3 32.59 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.461 1.1 . . . . 75.519999999999996 109.272 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.926 HD12 ' HA ' ' A' ' 228' ' ' ILE . 4.4 mt -70.77 -69.36 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.463 1.102 . . . . 60.310000000000002 109.342 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.505 ' CE ' ' O ' ' A' ' 228' ' ' ILE . 0.0 OUTLIER -57.03 -25.59 58.86 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.511 1.132 . . . . 75.120000000000005 109.322 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.3 m -49.38 -55.54 12.63 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.514 1.134 . . . . 71.409999999999997 109.953 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 234' ' ' VAL . 2.0 m -93.49 26.1 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 71.439999999999998 109.32 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 234' ' ' VAL . 68.5 m-80 40.17 35.64 0.27 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 75.519999999999996 109.271 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.465 HD11 ' O ' ' A' ' 185' ' ' CYS . 1.2 tp -66.01 119.67 63.18 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 74.030000000000001 109.316 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.01 173.73 14.01 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.537 1.809 . . . . 74.5 110.981 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 239' ' ' VAL . 0.8 OUTLIER -69.56 -170.92 0.33 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.46 1.1 . . . . 44.149999999999999 110.367 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.84 HG22 ' HD3' ' A' ' 243' ' ' LYS . 10.5 p -82.89 -34.74 11.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.485 1.116 . . . . 75.519999999999996 109.295 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.633 ' HG3' HG13 ' A' ' 239' ' ' VAL . 0.6 OUTLIER -85.39 -20.06 30.44 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.52 1.138 . . . . 64.200000000000003 110.333 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -80.22 -36.37 34.88 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.434 1.084 . . . . 62.439999999999998 110.299 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.714 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 1.5 t90 -84.0 -56.57 3.61 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 65.129999999999995 107.972 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.84 ' HD3' HG22 ' A' ' 239' ' ' VAL . 18.1 mtpp -58.17 -17.69 20.49 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.524 1.14 . . . . 64.239999999999995 109.291 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 2.8 t -39.02 -56.74 1.37 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.546 1.154 . . . . 61.210000000000001 109.998 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -144.72 135.03 24.28 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 74.540000000000006 109.259 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 9.9 mm -60.4 -51.75 69.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.492 1.12 . . . . 72.120000000000005 109.319 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.532 ' HB1' ' OH ' ' A' ' 249' ' ' TYR . . . -82.51 130.49 35.12 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.521 1.138 . . . . 54.520000000000003 109.251 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . 0.453 ' C ' ' CD1' ' A' ' 249' ' ' TYR . 0.1 OUTLIER -143.01 132.58 23.68 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.602 1.189 . . . . 63.439999999999998 110.341 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.532 ' OH ' ' HB1' ' A' ' 247' ' ' ALA . 1.8 m-85 -133.05 82.95 2.02 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.51 1.131 . . . . 74.129999999999995 110.994 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.466 ' CE ' ' HA ' ' A' ' 250' ' ' LYS . 1.0 OUTLIER -51.52 172.81 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.581 1.175 . . . . 74.030000000000001 109.347 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -112.59 -35.55 5.49 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.519 1.137 . . . . 51.32 109.289 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 3.5 m -59.1 169.53 1.07 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.525 1.141 . . . . 60.549999999999997 109.958 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.516 ' O ' HD13 ' A' ' 254' ' ' ILE . 14.2 t-20 -95.51 162.15 13.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.545 1.153 . . . . 75.409999999999997 109.315 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.516 HD13 ' O ' ' A' ' 253' ' ' ASN . 7.8 mm -126.73 138.98 53.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.527 1.142 . . . . 75.409999999999997 109.332 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 6.3 t -164.65 126.28 2.18 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.555 1.16 . . . . 40.200000000000003 110.005 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 87.4 mt -117.5 156.96 27.12 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.457 1.098 . . . . 72.200000000000003 109.341 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -40.81 -49.84 4.13 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.489 1.118 . . . . 70.329999999999998 111.048 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.1 t -40.23 125.91 2.11 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.545 0.791 . . . . 74.549999999999997 109.999 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 259' ' ' VAL . 7.9 p -67.45 113.36 3.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.523 1.14 . . . . 63.420000000000002 109.258 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 . . . . . 0 C--N 1.324 -0.506 0 O-C-N 124.503 1.127 . . . . 60.109999999999999 110.264 179.939 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 110.001 -0.37 . . . . 64.430000000000007 110.001 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 5.5 m -127.12 177.48 6.64 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.483 1.114 . . . . 65.099999999999994 109.943 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 8.7 m -107.11 175.72 5.41 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.556 1.16 . . . . 64.010000000000005 110.051 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -164.29 122.1 1.75 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.47 1.106 . . . . 73.329999999999998 109.274 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -152.74 107.9 3.24 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.526 1.141 . . . . 63.43 109.301 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -177.03 126.01 1.07 Allowed Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.438 1.086 . . . . 74.430000000000007 110.999 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -90.95 -14.22 31.98 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.574 0.808 . . . . 73.310000000000002 109.294 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 470' ' ' PHE . . . . . 0.559 ' CD2' ' HD2' ' A' ' 243' ' ' LYS . 3.4 m-30 -89.26 3.92 50.46 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.516 1.135 . . . . 72.239999999999995 111.028 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 471' ' ' ILE . . . . . 0.427 HG23 ' HD2' ' B' ' 472' ' ' PRO . 0.7 OUTLIER -72.24 143.93 86.46 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.516 1.135 . . . . 72.439999999999998 109.28 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 472' ' ' PRO . . . . . 0.567 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.5 Cg_endo -74.96 153.47 41.98 Favored 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.475 1.777 . . . . 62.130000000000003 110.989 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.02 -63.07 1.29 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.546 1.153 . . . . 63.310000000000002 109.951 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.81 172.22 6.42 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.503 1.127 . . . . 71.140000000000001 110.259 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 -169.21 0.6 Allowed 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.479 1.778 . . . . 51.32 111.002 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 476' ' ' ALA . . . . . 0.863 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . -62.51 134.61 95.14 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.509 1.131 . . . . 61.340000000000003 109.285 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 477' ' ' PRO . . . . . 0.596 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -75.0 -162.5 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.579 1.831 . . . . 63.420000000000002 111.047 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.72 89.95 20.55 Favored Pre-proline 0 C--N 1.324 -0.525 0 O-C-N 124.525 1.141 . . . . 51.32 109.299 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 479' ' ' PRO . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.0 Cg_endo -75.03 165.02 32.15 Favored 'Trans proline' 0 C--N 1.359 1.11 0 O-C-N 124.481 1.779 . . . . 64.209999999999994 110.977 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.93 -89.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.501 1.79 . . . . 54.200000000000003 111.005 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 481' ' ' SER . . . . . 0.521 ' O ' ' CZ ' ' A' ' 164' ' ' TYR . 1.2 t -82.96 138.32 33.85 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.534 1.146 . . . . 65.019999999999996 109.994 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 5.6 t -173.44 179.59 2.09 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.48 1.112 . . . . 61.25 110.047 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -86.11 -39.41 16.76 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.475 1.11 . . . . 73.120000000000005 109.296 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 30.9 t -171.59 117.92 0.43 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.442 1.089 . . . . 62.130000000000003 109.989 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -100.56 76.45 1.83 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.557 1.16 . . . . 60.25 109.312 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 59.5 p . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.475 1.109 . . . . 74.120000000000005 109.988 -179.973 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.011 0 N-CA-C 111.053 -0.819 . . . . 63.420000000000002 111.053 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 69.4 m -150.03 109.72 4.05 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.563 0.802 . . . . 61.329999999999998 109.971 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.638 ' C ' HD13 ' A' ' 158' ' ' LEU . 0.4 OUTLIER -158.85 123.36 4.07 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.499 1.124 . . . . 65.510000000000005 109.332 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.792 ' CD1' ' CD1' ' A' ' 183' ' ' PHE . 34.9 m-85 -153.94 -172.31 4.18 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.442 1.088 . . . . 75.099999999999994 111.048 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.561 ' HB3' ' CD2' ' A' ' 182' ' ' LEU . . . -124.93 148.24 48.45 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.51 1.131 . . . . 65.099999999999994 109.233 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.618 ' CG2' HD11 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -116.01 134.63 58.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.435 1.084 . . . . 73.010000000000005 109.311 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.714 HG22 HG12 ' A' ' 212' ' ' VAL . 1.0 OUTLIER -91.49 122.96 43.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.531 1.144 . . . . 55.399999999999999 109.287 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.583 ' HB2' ' CE1' ' A' ' 164' ' ' TYR . 0.3 OUTLIER -102.55 -11.92 18.16 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.522 1.139 . . . . 71.450000000000003 109.332 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.651 ' O ' HG13 ' A' ' 162' ' ' VAL . 12.8 m-85 -142.51 166.41 24.75 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.477 1.111 . . . . 74.319999999999993 110.986 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.606 ' N ' HG12 ' A' ' 178' ' ' VAL . 27.6 p-10 -115.12 146.42 41.37 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.477 1.11 . . . . 72.420000000000002 109.283 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.567 ' CE2' ' HG3' ' B' ' 477' ' ' PRO . 1.6 t80 -149.51 128.59 12.73 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.446 1.091 . . . . 52.32 111.023 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.409 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 7.1 mtpt -66.99 104.99 1.51 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.545 1.153 . . . . 71.409999999999997 109.322 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.696 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -79.61 144.26 33.98 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.462 1.101 . . . . 34.409999999999997 109.309 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -151.33 20.97 0.74 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.499 1.124 . . . . 65.019999999999996 110.333 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.541 ' NZ ' ' CE2' ' A' ' 166' ' ' PHE . 0.1 OUTLIER -95.56 -176.06 3.64 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.465 1.103 . . . . 62.140000000000001 109.337 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.62 -37.11 75.19 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.511 1.132 . . . . 54.140000000000001 109.327 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 173' ' ' GLU . 0.7 OUTLIER -106.85 23.19 14.74 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.5 1.125 . . . . 74.030000000000001 109.345 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.696 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -35.26 111.19 0.12 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 1.118 . . . . 74.040000000000006 110.27 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.592 HD23 ' HA3' ' A' ' 205' ' ' GLY . 0.7 OUTLIER -118.51 98.07 6.07 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.532 1.145 . . . . 75.150000000000006 109.284 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 175' ' ' THR . 12.3 t -83.27 112.79 20.19 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.505 1.128 . . . . 72.439999999999998 110.447 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.777 HG23 ' CD ' ' A' ' 180' ' ' GLU . 1.1 m -137.55 137.17 38.32 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.548 1.155 . . . . 74.099999999999994 110.407 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -75.94 163.77 26.85 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.509 1.13 . . . . 73.109999999999999 110.962 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.606 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.3 m -58.08 157.79 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.529 1.143 . . . . 54.119999999999997 109.327 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.7 64.16 4.48 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.405 1.066 . . . . 63.43 111.026 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.777 ' CD ' HG23 ' A' ' 176' ' ' THR . 1.2 tt0 -127.84 -173.67 2.99 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.546 0.792 . . . . 75.219999999999999 110.264 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.636 ' C ' HD13 ' A' ' 182' ' ' LEU . 0.7 OUTLIER -147.27 136.59 22.59 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.528 1.142 . . . . 75.510000000000005 109.311 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.835 ' N ' HD13 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -148.96 146.27 27.75 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.455 1.097 . . . . 72.200000000000003 109.294 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.792 ' CD1' ' CD1' ' A' ' 159' ' ' TYR . 6.8 m-30 -95.55 121.86 37.69 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.516 1.135 . . . . 73.329999999999998 110.899 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 195' ' ' ALA . 1.7 mp -70.75 161.93 4.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.53 1.144 . . . . 71.319999999999993 109.29 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.575 ' HB3' ' CH2' ' A' ' 242' ' ' TRP . 2.2 m -146.12 -47.37 0.2 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 62.520000000000003 108.259 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.927 ' HB1' ' HB ' ' A' ' 239' ' ' VAL . . . -119.78 166.07 13.72 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.479 1.112 . . . . 64.540000000000006 109.281 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.59 134.14 11.79 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 74.310000000000002 109.603 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.783 ' HD1' HG11 ' A' ' 239' ' ' VAL . 0.0 OUTLIER -146.73 149.28 33.09 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.444 1.09 . . . . 62.43 109.55 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.485 ' C ' ' N ' ' A' ' 191' ' ' GLU . 40.7 m-20 61.19 15.86 6.72 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 1.136 . . . . 71.530000000000001 109.316 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 189' ' ' ASN . 14.1 p 41.84 27.83 0.08 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.138 . . . . 74.019999999999996 108.335 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.615 ' O ' HG13 ' A' ' 209' ' ' VAL . 8.5 tt0 -136.42 -37.5 0.69 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.489 1.118 . . . . 72.010000000000005 110.258 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.866 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 95.7 m95 -101.82 135.91 42.57 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.008 -1.108 . . . . 74.329999999999998 108.008 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.718 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.0 m-30 -128.66 129.33 45.68 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 62.229999999999997 111.023 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.896 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 8.8 mm -89.68 102.07 12.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.503 1.127 . . . . 73.049999999999997 109.279 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.482 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -116.15 -178.85 3.5 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.438 1.086 . . . . 72.040000000000006 109.275 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.532 ' CB ' ' HA ' ' A' ' 204' ' ' PRO . 23.3 pttt -153.27 158.62 32.76 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.464 1.103 . . . . 74.239999999999995 109.295 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.414 ' CD ' ' HA3' ' A' ' 203' ' ' GLY . 18.1 Cg_endo -74.98 173.76 13.95 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.481 1.779 . . . . 63.130000000000003 110.974 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.552 ' HB ' ' CE2' ' A' ' 183' ' ' PHE . 1.1 tp -123.28 105.52 15.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.546 1.154 . . . . 74.510000000000005 109.294 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 117.25 -78.11 0.29 Allowed Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.507 1.129 . . . . 72.209999999999994 111.03 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 89.3 mmt-85 -49.33 165.33 0.06 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.472 0.748 . . . . 62.240000000000002 110.307 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 5.2 mt -89.72 43.09 1.13 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.562 1.164 . . . . 74.129999999999995 109.328 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -99.41 -173.16 31.04 Favored Glycine 0 CA--C 1.529 0.942 0 O-C-N 124.454 1.096 . . . . 73.010000000000005 110.974 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.414 ' HA3' ' CD ' ' A' ' 197' ' ' PRO . . . 48.48 -178.23 0.01 OUTLIER Glycine 0 CA--C 1.53 1.027 0 N-CA-C 110.993 -0.843 . . . . 73.129999999999995 110.993 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.532 ' HA ' ' CB ' ' A' ' 196' ' ' LYS . 18.1 Cg_endo -75.09 129.27 18.21 Favored 'Cis proline' 0 C--N 1.36 1.144 0 C-N-CA 121.015 -2.494 . . . . 33.009999999999998 110.974 0.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.592 ' HA3' HD23 ' A' ' 174' ' ' LEU . . . -111.96 177.91 18.95 Favored Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.529 1.143 . . . . 71.310000000000002 110.951 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.866 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -105.45 152.22 23.27 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.482 0.754 . . . . 73.340000000000003 109.341 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.529 ' N ' ' HG ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -156.76 132.41 5.71 Favored Pre-proline 0 C--N 1.324 -0.524 0 O-C-N 124.432 1.083 . . . . 51.130000000000003 109.315 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.844 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.3 Cg_endo -74.94 171.67 17.85 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.489 1.783 . . . . 73.319999999999993 111.037 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.718 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.2 m -91.48 -3.92 10.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.548 1.155 . . . . 74.310000000000002 109.304 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -90.26 -26.97 22.13 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.512 1.133 . . . . 65.299999999999997 110.981 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.62 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 17.6 m-85 -105.16 4.31 31.17 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.481 0.754 . . . . 73.439999999999998 111.011 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 208' ' ' PRO . 1.8 m -146.51 157.85 11.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.531 1.144 . . . . 63.229999999999997 109.311 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 4.5 t -130.39 130.55 44.5 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.515 1.135 . . . . 72.439999999999998 110.006 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.769 ' O ' HG23 ' A' ' 215' ' ' ILE . 2.6 mm -73.69 133.02 32.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.423 1.077 . . . . 73.230000000000004 109.254 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.769 HG23 ' O ' ' A' ' 214' ' ' ILE . 1.8 pt -164.86 173.47 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.46 1.1 . . . . 75.239999999999995 109.277 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.1 -56.48 0.49 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.544 1.152 . . . . 64.209999999999994 109.278 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 6.6 mt -141.02 -49.63 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.535 1.147 . . . . 63.210000000000001 109.24 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -45.24 168.41 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.494 1.121 . . . . 62.200000000000003 109.292 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 9.2 p -85.57 -79.98 0.23 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.461 1.101 . . . . 75.140000000000001 110.469 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -38.39 -91.52 0.01 OUTLIER Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.518 1.136 . . . . 64.219999999999999 111.036 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' A' ' 222' ' ' ALA . 31.4 m-85 -120.04 176.02 5.63 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.438 0.728 . . . . 74.400000000000006 110.974 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 221' ' ' TYR . . . -40.06 -71.4 0.08 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.46 1.1 . . . . 61.340000000000003 109.339 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.77 -7.5 10.49 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.535 1.147 . . . . 63.100000000000001 110.393 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 112.66 19.21 7.07 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.509 1.131 . . . . 50.140000000000001 111.075 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.555 ' H ' ' ND2' ' A' ' 225' ' ' ASN . 0.1 OUTLIER -111.92 171.43 7.5 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.506 0.768 . . . . 74.239999999999995 109.261 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 229' ' ' GLU . 0.7 OUTLIER -79.84 146.58 32.16 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.42 1.075 . . . . 73.120000000000005 109.257 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 227' ' ' VAL . 0.2 OUTLIER -39.76 -55.71 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 124.462 1.101 . . . . 63.039999999999999 109.241 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 3.9 mt -55.85 -43.62 74.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.372 1.045 . . . . 73.099999999999994 109.27 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 226' ' ' ASP . 27.3 mt-10 -70.59 -14.58 62.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.477 1.11 . . . . 73.409999999999997 110.31 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.441 ' CG ' ' ND2' ' A' ' 225' ' ' ASN . 0.4 OUTLIER -86.94 -24.27 24.82 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.514 1.134 . . . . 74.420000000000002 109.296 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.596 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.6 OUTLIER -61.23 -68.73 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.505 1.128 . . . . 74.109999999999999 109.297 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.596 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -56.27 -26.8 53.07 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.502 1.126 . . . . 61.140000000000001 109.349 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.9 t -52.14 -47.71 65.26 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.492 1.12 . . . . 61.32 109.934 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.522 HG23 ' HB2' ' A' ' 236' ' ' LEU . 8.9 m -98.45 19.44 2.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.493 1.12 . . . . 54.409999999999997 109.317 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 41.58 32.36 0.24 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.519 1.137 . . . . 73.430000000000007 109.26 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.522 ' HB2' HG23 ' A' ' 234' ' ' VAL . 4.3 tp -68.51 119.37 67.99 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.47 1.106 . . . . 75.019999999999996 109.335 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.411 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.4 Cg_endo -75.04 171.73 17.74 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.438 1.757 . . . . 73.540000000000006 110.968 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.434 HG22 ' NE2' ' A' ' 240' ' ' GLN . 1.7 m -71.42 165.52 23.61 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.567 1.167 . . . . 73.049999999999997 110.429 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.963 HG22 ' NZ ' ' A' ' 243' ' ' LYS . 7.6 p -60.84 -33.34 54.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.536 1.147 . . . . 74.230000000000004 109.287 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.542 ' HG3' HG13 ' A' ' 239' ' ' VAL . 1.2 mp0 -82.01 -15.43 53.68 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.532 1.145 . . . . 64.140000000000001 110.304 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -87.53 -38.66 15.82 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.554 1.159 . . . . 74.409999999999997 110.273 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.575 ' CH2' ' HB3' ' A' ' 185' ' ' CYS . 0.9 OUTLIER -79.42 -60.25 2.44 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.001 -1.111 . . . . 72.400000000000006 108.001 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.963 ' NZ ' HG22 ' A' ' 239' ' ' VAL . 14.3 mtmm -53.34 -20.86 4.85 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.523 1.139 . . . . 63.32 109.324 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 243' ' ' LYS . 0.5 OUTLIER -38.26 -67.57 0.2 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.487 1.117 . . . . 51.409999999999997 110.018 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -130.79 121.0 24.59 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.44 1.088 . . . . 62.350000000000001 109.327 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 24.8 mm -44.08 -30.08 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 O-C-N 124.562 1.163 . . . . 62.200000000000003 109.266 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -102.24 75.7 1.51 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.43 1.081 . . . . 72.349999999999994 109.303 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -102.88 -14.8 16.41 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.451 1.094 . . . . 72.209999999999994 110.291 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -51.1 116.54 2.06 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.498 1.124 . . . . 73.120000000000005 110.996 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -153.43 105.52 2.85 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.464 1.102 . . . . 74.129999999999995 109.38 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 1.019 ' HB1' HD11 ' A' ' 254' ' ' ILE . . . -86.85 163.43 17.21 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.436 1.085 . . . . 72.530000000000001 109.301 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 13.7 t -131.27 -88.47 0.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.472 1.107 . . . . 74.129999999999995 109.97 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.569 ' H ' ' ND2' ' A' ' 253' ' ' ASN . 0.1 OUTLIER -114.32 -0.94 13.68 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 75.209999999999994 109.303 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 1.019 HD11 ' HB1' ' A' ' 251' ' ' ALA . 1.2 mp 40.13 82.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.419 1.074 . . . . 75.439999999999998 109.329 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.428 ' C ' HD22 ' A' ' 256' ' ' LEU . 11.3 t 172.22 131.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.53 1.144 . . . . 63.030000000000001 109.958 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.428 HD22 ' C ' ' A' ' 255' ' ' SER . 4.5 mm? -116.07 -49.55 2.69 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.559 1.162 . . . . 72.450000000000003 109.271 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 103.69 72.53 0.9 Allowed Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.503 1.127 . . . . 75.019999999999996 111.025 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.496 ' O ' HG13 ' A' ' 259' ' ' VAL . 33.8 p -137.25 139.54 41.04 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 0.764 . . . . 74.310000000000002 110.009 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 258' ' ' SER . 1.9 m -154.02 158.11 4.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.459 1.1 . . . . 61.219999999999999 109.344 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.458 1.099 . . . . 74.310000000000002 110.311 179.976 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 22.2 m . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 110.023 -0.362 . . . . 53.310000000000002 110.023 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 89.4 p -123.5 107.45 11.57 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.447 1.092 . . . . 53.350000000000001 109.989 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.9 -15.58 14.88 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.516 1.135 . . . . 65.340000000000003 109.952 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -167.16 151.76 7.07 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.506 1.129 . . . . 72.239999999999995 109.292 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 467' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' B' ' 468' ' ' GLY . 67.2 m-20 -136.56 134.0 37.0 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.598 1.186 . . . . 65.340000000000003 109.259 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . 0.61 ' CA ' HD13 ' B' ' 471' ' ' ILE . . . -54.94 -165.41 0.02 OUTLIER Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.485 1.116 . . . . 35.049999999999997 110.987 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -110.62 -15.95 13.74 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.518 0.775 . . . . 74.140000000000001 109.264 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 470' ' ' PHE . . . . . 0.407 ' HA ' ' OD2' ' A' ' 172' ' ' ASP . 19.3 m-85 -110.66 20.41 17.66 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.553 1.158 . . . . 70.530000000000001 110.996 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 471' ' ' ILE . . . . . 0.61 HD13 ' CA ' ' B' ' 468' ' ' GLY . 1.4 mp -65.71 138.84 96.78 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.503 1.127 . . . . 72.049999999999997 109.263 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 472' ' ' PRO . . . . . 0.56 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.1 Cg_endo -75.0 -179.34 4.89 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.529 1.805 . . . . 74.439999999999998 110.978 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 36.6 t -114.24 -61.63 1.72 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.544 1.153 . . . . 64.329999999999998 110.001 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -61.84 155.71 60.53 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.473 1.108 . . . . 64.409999999999997 110.285 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 475' ' ' PRO . . . . . 0.665 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.3 Cg_endo -75.07 -36.24 2.63 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.484 1.781 . . . . 74.129999999999995 111.005 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 476' ' ' ALA . . . . . 0.665 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 165.01 126.91 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.529 1.143 . . . . 72.319999999999993 109.291 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 477' ' ' PRO . . . . . 0.591 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.5 Cg_endo -74.89 -162.13 0.14 Allowed 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.49 1.784 . . . . 62.520000000000003 111.049 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 478' ' ' LYS . . . . . 0.538 ' O ' ' CD ' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -145.2 112.32 4.76 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.506 1.129 . . . . 74.530000000000001 109.261 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 479' ' ' PRO . . . . . 0.62 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.1 Cg_endo -74.97 154.06 42.35 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.452 1.764 . . . . 75.319999999999993 110.998 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 480' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' B' ' 479' ' ' PRO . 18.4 Cg_endo -75.05 163.22 35.65 Favored 'Trans proline' 0 C--N 1.359 1.111 0 O-C-N 124.527 1.804 . . . . 74.5 111.083 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 481' ' ' SER . . . . . . . . . . . . . 1.1 t 45.76 52.46 9.57 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.583 1.177 . . . . 75.340000000000003 110.031 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 1.6 m -114.71 -54.61 2.56 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.557 1.161 . . . . 71.439999999999998 110.027 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -153.3 134.19 13.91 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.505 1.128 . . . . 64.340000000000003 109.358 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 8.1 m -117.75 118.69 32.74 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.489 1.118 . . . . 73.430000000000007 109.988 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -97.17 31.23 2.51 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.488 1.117 . . . . 62.340000000000003 109.315 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 92.1 p . . . . . 0 C--N 1.324 -0.509 0 O-C-N 124.531 1.144 . . . . 42.340000000000003 109.954 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.023 0 N-CA-C 111.041 -0.824 . . . . 74.5 111.041 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 67.8 p -123.35 49.78 1.65 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.542 0.79 . . . . 74.129999999999995 110.033 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.477 HD13 HG23 ' A' ' 214' ' ' ILE . 1.2 pp -81.63 149.39 28.58 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.54 1.15 . . . . 71.349999999999994 109.246 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' A' ' 181' ' ' ASN . 1.4 t80 -119.09 146.27 45.23 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.551 1.157 . . . . 72.519999999999996 110.965 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.468 ' HB2' HG12 ' A' ' 184' ' ' ILE . . . -118.23 142.36 47.55 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.461 1.101 . . . . 63.130000000000003 109.306 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.617 ' HB ' HD11 ' A' ' 215' ' ' ILE . 0.0 OUTLIER -119.41 131.66 71.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.468 1.105 . . . . 61.350000000000001 109.292 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.877 HG22 HG12 ' A' ' 212' ' ' VAL . 2.0 t -93.27 120.97 43.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 74.400000000000006 109.335 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.606 HD21 HG23 ' A' ' 161' ' ' ILE . 0.6 OUTLIER -99.01 -13.58 19.83 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.519 1.137 . . . . 65.150000000000006 109.351 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.639 ' O ' HG13 ' A' ' 162' ' ' VAL . 1.3 m-85 -144.37 156.77 44.38 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.434 1.084 . . . . 74.219999999999999 111.05 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.719 ' N ' HG12 ' A' ' 178' ' ' VAL . 9.2 p-10 -92.06 154.03 19.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.512 1.133 . . . . 74.120000000000005 109.268 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.467 ' CZ ' ' O ' ' A' ' 167' ' ' LYS . 16.7 t80 -141.64 144.27 34.07 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.486 1.116 . . . . 72.420000000000002 110.969 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.467 ' O ' ' CZ ' ' A' ' 166' ' ' PHE . 14.2 mtpp -82.81 131.22 35.2 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.542 1.151 . . . . 74.310000000000002 109.283 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.839 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -96.34 142.37 28.55 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 70.120000000000005 109.272 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -158.03 24.88 0.26 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.473 1.108 . . . . 71.340000000000003 110.354 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.687 ' HZ1' HD23 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -122.27 -175.46 3.13 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.427 1.08 . . . . 62.200000000000003 109.276 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.77 -40.03 82.76 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.487 1.117 . . . . 64.109999999999999 109.302 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 174' ' ' LEU . 26.6 m-20 -86.14 10.52 14.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 75.310000000000002 109.324 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.839 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 6.5 pt-20 -36.77 96.54 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.57 1.169 . . . . 73.310000000000002 110.341 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.621 ' H ' ' HZ2' ' A' ' 170' ' ' LYS . 0.3 OUTLIER -131.73 95.42 3.71 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.128 . . . . 63.219999999999999 109.315 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.4 t -59.18 153.39 18.38 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.536 1.147 . . . . 74.340000000000003 110.367 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 177' ' ' TYR . 22.2 m -154.53 175.29 13.8 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.501 1.126 . . . . 54.229999999999997 110.398 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.543 ' H ' HG22 ' A' ' 176' ' ' THR . 8.0 m-85 -122.57 157.79 31.33 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.47 1.106 . . . . 64.239999999999995 111.02 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.719 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.8 m -59.51 158.39 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.518 1.136 . . . . 70.400000000000006 109.262 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.429 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 48.07 67.83 1.45 Allowed Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.479 1.112 . . . . 43.520000000000003 111.037 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -129.13 168.38 16.21 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.478 0.752 . . . . 73.109999999999999 110.309 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.448 ' HB3' ' CE2' ' A' ' 159' ' ' TYR . 8.5 m120 -118.77 126.42 51.82 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.527 1.142 . . . . 72.530000000000001 109.225 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.816 ' N ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -133.58 139.98 46.87 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.558 1.162 . . . . 64.439999999999998 109.325 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 5.4 t80 -98.97 97.47 8.63 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.489 1.118 . . . . 74.230000000000004 110.998 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 1.044 HD13 ' HB2' ' A' ' 195' ' ' ALA . 28.0 mm -52.01 156.67 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.405 1.065 . . . . 71.430000000000007 109.281 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 186' ' ' ALA . 7.3 p -149.96 -42.49 0.13 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.459 1.099 . . . . 70.230000000000004 108.327 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.897 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -120.72 167.89 11.99 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.564 1.165 . . . . 71.219999999999999 109.309 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.425 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.2 OUTLIER -157.35 144.21 18.28 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.101 . . . . 74.409999999999997 109.613 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.578 ' CE1' ' HD3' ' B' ' 472' ' ' PRO . 0.1 OUTLIER -144.87 139.83 27.95 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.537 1.148 . . . . 71.120000000000005 109.55 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.49 ' C ' ' N ' ' A' ' 191' ' ' GLU . 57.7 t30 50.37 22.41 1.01 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.479 1.112 . . . . 74.209999999999994 109.27 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 189' ' ' ASN . 4.0 m 41.47 27.7 0.06 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.452 1.095 . . . . 72.340000000000003 108.272 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 208' ' ' PRO . 3.6 tt0 -124.98 -38.14 2.37 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.528 1.142 . . . . 73.299999999999997 110.275 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.76 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 90.5 m95 -113.95 128.07 56.24 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.0 -1.111 . . . . 75.209999999999994 108.0 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.904 ' HB3' HD12 ' A' ' 184' ' ' ILE . 21.4 m-30 -117.03 157.0 26.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.48 1.112 . . . . 71.299999999999997 110.959 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.897 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 3.6 mm -118.48 104.15 15.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.54 1.15 . . . . 72.319999999999993 109.314 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 1.044 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -107.55 170.37 8.02 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.472 1.107 . . . . 51.25 109.35 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.467 ' CG ' ' HA ' ' A' ' 204' ' ' PRO . 4.6 mtmp? -138.9 165.16 34.41 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.547 1.154 . . . . 54.399999999999999 109.294 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 171.24 18.7 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.459 1.768 . . . . 62.219999999999999 111.002 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.48 HD12 ' HA ' ' A' ' 198' ' ' ILE . 7.4 tp -83.85 -51.69 13.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.535 1.147 . . . . 72.040000000000006 109.266 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.46 ' N ' HG23 ' A' ' 198' ' ' ILE . . . -143.47 54.73 0.58 Allowed Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.41 1.069 . . . . 60.219999999999999 110.984 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -149.07 -179.43 7.01 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.565 0.803 . . . . 70.439999999999998 110.289 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.414 ' H ' HD23 ' A' ' 201' ' ' LEU . 1.6 pt? -108.15 22.02 16.53 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.475 1.109 . . . . 70.349999999999994 109.314 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -88.92 59.85 3.9 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.525 1.14 . . . . 62.210000000000001 110.999 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.404 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . -167.82 171.09 42.17 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 110.949 -0.861 . . . . 71.329999999999998 110.949 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.484 ' HB2' ' CG2' ' A' ' 194' ' ' ILE . 18.2 Cg_endo -74.95 128.18 15.87 Favored 'Cis proline' 0 C--N 1.359 1.102 0 C-N-CA 121.065 -2.473 . . . . 63.140000000000001 110.992 -0.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.402 ' N ' ' HA2' ' A' ' 203' ' ' GLY . . . -92.49 122.13 6.75 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.504 1.127 . . . . 73.219999999999999 111.042 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.76 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.1 OUTLIER -79.96 146.77 31.9 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.556 0.798 . . . . 72.349999999999994 109.321 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.784 ' CG1' HG11 ' A' ' 212' ' ' VAL . 0.4 OUTLIER -160.44 129.05 2.99 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.136 . . . . 54.020000000000003 109.282 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.508 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.4 Cg_endo -74.99 179.94 5.59 Favored 'Trans proline' 0 C--N 1.359 1.117 0 O-C-N 124.593 1.838 . . . . 71.349999999999994 111.027 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.73 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.8 OUTLIER -98.06 4.2 9.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.477 1.111 . . . . 65.209999999999994 109.28 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -105.38 -2.79 41.14 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.496 1.122 . . . . 52.130000000000003 110.99 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.619 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 5.6 m-85 -127.5 0.85 6.25 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.428 0.722 . . . . 73.540000000000006 110.939 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.877 HG12 HG22 ' A' ' 162' ' ' VAL . 1.2 m -142.53 170.25 11.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.538 1.149 . . . . 73.420000000000002 109.29 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.3 t -129.37 140.57 51.32 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.508 1.13 . . . . 72.530000000000001 109.994 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.832 ' O ' HG23 ' A' ' 215' ' ' ILE . 3.7 mm -83.35 138.37 19.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.452 1.095 . . . . 53.439999999999998 109.287 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.832 HG23 ' O ' ' A' ' 214' ' ' ILE . 6.5 pt -164.69 160.43 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.542 1.151 . . . . 73.099999999999994 109.242 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -119.14 -75.31 0.58 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.515 1.134 . . . . 51.219999999999999 109.311 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 15.6 tt -122.05 -43.04 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.449 1.093 . . . . 71.299999999999997 109.381 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -69.47 135.95 50.85 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.472 1.107 . . . . 72.430000000000007 109.344 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 14.1 t -73.86 -4.31 34.11 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.504 1.127 . . . . 73.439999999999998 110.422 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -68.86 -126.33 0.03 OUTLIER Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.557 1.16 . . . . 52.409999999999997 111.065 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.414 ' O ' ' N ' ' A' ' 223' ' ' THR . 3.9 m-85 -117.97 -172.55 2.27 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.557 0.798 . . . . 53.539999999999999 111.012 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.609 ' O ' HG22 ' A' ' 223' ' ' THR . . . -68.0 72.01 0.17 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.494 1.122 . . . . 75.010000000000005 109.222 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.609 HG22 ' O ' ' A' ' 222' ' ' ALA . 8.7 t 47.12 20.49 0.13 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.527 1.142 . . . . 75.430000000000007 110.413 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.434 ' N ' ' C ' ' A' ' 222' ' ' ALA . . . 89.19 -33.34 4.32 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.433 1.083 . . . . 72.219999999999999 110.989 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -63.14 164.42 8.61 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.49 0.759 . . . . 74.129999999999995 109.316 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 230' ' ' ASP . 2.9 t0 -87.17 144.41 26.85 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.453 1.096 . . . . 53.119999999999997 109.297 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.593 HG13 ' H ' ' A' ' 228' ' ' ILE . 3.0 p -44.01 -59.19 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.465 1.103 . . . . 75.239999999999995 109.329 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.593 ' H ' HG13 ' A' ' 227' ' ' VAL . 3.8 mt -48.95 -47.54 16.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.53 1.144 . . . . 73.420000000000002 109.319 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.425 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 9.6 mt-10 -66.28 -23.48 66.4 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.574 1.171 . . . . 72.109999999999999 110.316 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 226' ' ' ASP . 31.1 m-20 -85.27 -15.92 41.85 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.494 1.122 . . . . 42.039999999999999 109.279 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.692 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.5 OUTLIER -72.84 -68.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.524 1.14 . . . . 72.430000000000007 109.277 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.692 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -61.48 -20.41 63.13 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.5 1.125 . . . . 73.540000000000006 109.272 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.65 -52.98 43.6 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.514 1.134 . . . . 61.149999999999999 110.062 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 234' ' ' VAL . 1.5 m -94.65 26.68 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.515 1.134 . . . . 65.200000000000003 109.313 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 40.61 37.67 0.51 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.594 1.184 . . . . 73.400000000000006 109.347 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.437 ' HB2' ' CG2' ' A' ' 234' ' ' VAL . 3.6 tp -72.22 119.55 75.34 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.569 1.168 . . . . 44.5 109.331 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.99 167.72 26.42 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.544 1.813 . . . . 45.520000000000003 110.959 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.29 177.95 2.58 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.505 1.128 . . . . 73.319999999999993 110.438 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.551 HG13 ' N ' ' A' ' 240' ' ' GLN . 13.1 p -72.01 -54.06 17.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 42.119999999999997 109.342 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.551 ' N ' HG13 ' A' ' 239' ' ' VAL . 13.0 pm0 -68.37 -14.85 63.29 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.464 1.103 . . . . 72.510000000000005 110.292 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -92.25 -37.21 12.8 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.136 . . . . 71.409999999999997 110.322 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.517 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 3.3 t90 -79.24 -59.78 2.63 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.004 -1.11 . . . . 71.519999999999996 108.004 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.577 ' HE2' ' CD2' ' B' ' 470' ' ' PHE . 4.6 mtmp? -54.77 -20.1 7.77 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.563 1.165 . . . . 64.200000000000003 109.357 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 21.0 t -39.63 -68.11 0.19 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.454 1.097 . . . . 70.0 110.017 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 246' ' ' ILE . 19.9 m120 -144.85 108.36 4.63 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.59 1.181 . . . . 74.409999999999997 109.3 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 245' ' ' ASN . 34.8 mm -40.43 -55.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.486 1.116 . . . . 45.240000000000002 109.303 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -97.51 122.9 41.1 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.481 1.113 . . . . 72.299999999999997 109.339 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 10.1 tpp85 -164.14 122.84 1.89 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.505 1.128 . . . . 72.239999999999995 110.349 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -41.39 127.35 2.94 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.524 1.14 . . . . 64.209999999999994 111.028 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -50.1 165.65 0.08 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.494 1.121 . . . . 73.099999999999994 109.282 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -99.01 -78.23 0.5 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.465 1.103 . . . . 52.109999999999999 109.272 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 11.2 p -152.06 172.23 16.63 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.471 1.107 . . . . 61.219999999999999 109.99 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -133.76 113.24 12.1 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.498 1.124 . . . . 71.319999999999993 109.275 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 255' ' ' SER . 40.7 mm -115.49 160.55 14.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 124.473 1.108 . . . . 74.530000000000001 109.297 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.417 ' N ' HG22 ' A' ' 254' ' ' ILE . 4.0 p 73.17 38.9 0.65 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.505 1.128 . . . . 31.25 110.033 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.71 ' C ' HD22 ' A' ' 256' ' ' LEU . 0.0 OUTLIER -55.92 160.06 2.91 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.481 1.113 . . . . 62.25 109.297 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.456 ' N ' HD22 ' A' ' 256' ' ' LEU . . . 114.32 -105.64 1.58 Allowed Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.417 1.073 . . . . 55.310000000000002 110.989 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.479 ' C ' HG23 ' A' ' 259' ' ' VAL . 5.2 p -99.95 137.34 38.55 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.473 0.749 . . . . 65.430000000000007 110.033 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.479 HG23 ' C ' ' A' ' 258' ' ' SER . 2.2 t 67.68 51.82 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 124.532 1.145 . . . . 54.210000000000001 109.313 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 . . . . . 0 C--N 1.324 -0.5 0 O-C-N 124.563 1.164 . . . . 74.239999999999995 110.367 -179.993 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.98 -0.378 . . . . 71.439999999999998 109.98 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 6.1 p -109.15 149.22 29.67 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.505 1.128 . . . . 65.099999999999994 110.01 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 53.5 m -50.47 174.95 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 74.409999999999997 110.029 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -171.16 150.44 3.0 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.464 1.102 . . . . 73.329999999999998 109.258 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 467' ' ' ASN . . . . . 0.425 ' CG ' ' N ' ' B' ' 468' ' ' GLY . 9.6 p-10 -122.88 -44.83 2.18 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.505 1.128 . . . . 73.540000000000006 109.3 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . 0.425 ' N ' ' CG ' ' B' ' 467' ' ' ASN . . . 64.35 116.35 0.01 OUTLIER Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.472 1.108 . . . . 73.219999999999999 111.033 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -116.66 145.57 43.33 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.543 0.79 . . . . 72.030000000000001 109.311 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 470' ' ' PHE . . . . . 0.577 ' CD2' ' HE2' ' A' ' 243' ' ' LYS . 2.2 m-30 56.53 29.7 15.94 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.483 1.114 . . . . 72.450000000000003 111.045 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 471' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' B' ' 472' ' ' PRO . 13.0 mm -88.85 137.96 29.68 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.466 1.104 . . . . 73.099999999999994 109.269 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 472' ' ' PRO . . . . . 0.578 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -75.0 112.15 3.49 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.431 1.753 . . . . 54.409999999999997 110.994 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 42.0 t -55.15 -44.95 75.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.506 1.129 . . . . 74.450000000000003 109.959 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 474' ' ' ARG . . . . . 0.451 ' CD ' ' HD2' ' B' ' 475' ' ' PRO . 5.4 tpp180 -84.37 137.72 39.27 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.485 1.116 . . . . 71.019999999999996 110.32 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 475' ' ' PRO . . . . . 0.451 ' HD2' ' CD ' ' B' ' 474' ' ' ARG . 18.4 Cg_endo -74.99 -170.07 0.73 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.433 1.754 . . . . 44.399999999999999 111.019 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 476' ' ' ALA . . . . . 0.45 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . -48.3 124.63 11.46 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.561 1.163 . . . . 74.340000000000003 109.277 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 477' ' ' PRO . . . . . 0.576 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.6 Cg_endo -74.91 -162.39 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.441 1.758 . . . . 72.310000000000002 111.038 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.28 90.28 25.59 Favored Pre-proline 0 C--N 1.326 -0.436 0 O-C-N 124.488 1.118 . . . . 71.519999999999996 109.319 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 479' ' ' PRO . . . . . 0.619 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.1 Cg_endo -75.03 162.05 37.68 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.525 1.802 . . . . 73.219999999999999 110.983 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 -88.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.508 1.794 . . . . 71.430000000000007 110.967 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 481' ' ' SER . . . . . 0.547 ' HB3' ' CE1' ' A' ' 164' ' ' TYR . 0.8 OUTLIER -47.99 -70.16 0.1 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.517 1.135 . . . . 70.219999999999999 110.01 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 1.4 t -42.23 110.05 0.16 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.393 1.058 . . . . 74.239999999999995 109.976 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -111.27 124.8 52.96 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.476 1.11 . . . . 65.519999999999996 109.279 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 80.0 p -124.15 161.62 25.3 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.453 1.096 . . . . 53.229999999999997 110.002 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -100.66 141.27 33.77 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.512 1.133 . . . . 73.239999999999995 109.305 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 C--N 1.324 -0.509 0 O-C-N 124.522 1.139 . . . . 73.430000000000007 109.98 -179.91 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.009 0 N-CA-C 111.078 -0.809 . . . . 64.230000000000004 111.078 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.5 t -124.06 93.77 4.02 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.584 0.814 . . . . 61.130000000000003 110.002 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.9 mt -100.66 116.15 31.89 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.505 1.128 . . . . 61.030000000000001 109.315 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.495 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 3.7 p90 -146.44 -178.76 6.33 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.496 1.122 . . . . 72.430000000000007 111.078 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.589 ' HB3' HD11 ' A' ' 184' ' ' ILE . . . -127.77 154.67 45.11 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.56 1.162 . . . . 43.130000000000003 109.362 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.571 HG23 ' CD2' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -126.44 119.65 54.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.477 1.111 . . . . 75.109999999999999 109.333 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.709 ' CG2' HG12 ' A' ' 212' ' ' VAL . 1.0 OUTLIER -70.84 125.35 29.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.488 1.118 . . . . 65.25 109.271 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.688 HD11 ' HB2' ' A' ' 213' ' ' SER . 0.2 OUTLIER -104.06 -9.14 19.0 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.586 1.179 . . . . 74.239999999999995 109.311 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.582 ' O ' HG13 ' A' ' 162' ' ' VAL . 4.7 m-85 -145.16 172.6 12.87 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.479 1.112 . . . . 55.439999999999998 110.998 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.631 ' N ' HG12 ' A' ' 178' ' ' VAL . 0.0 OUTLIER -87.65 129.77 35.01 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.484 1.115 . . . . 61.020000000000003 109.262 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.667 ' CZ ' ' HB2' ' A' ' 168' ' ' ALA . 2.0 t80 -103.02 129.74 49.89 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.457 1.098 . . . . 72.310000000000002 111.009 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.76 106.97 19.36 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.468 1.105 . . . . 73.430000000000007 109.257 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.843 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -114.01 150.29 34.11 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.556 1.16 . . . . 74.319999999999993 109.282 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -152.12 24.9 0.64 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.471 1.107 . . . . 74.319999999999993 110.268 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.492 ' HZ1' ' HZ ' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -112.82 -172.79 2.12 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 75.420000000000002 109.325 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.25 -43.99 75.14 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.534 1.146 . . . . 71.109999999999999 109.326 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.49 ' HB2' HD22 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -86.26 11.47 12.03 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.48 1.112 . . . . 74.230000000000004 109.322 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.843 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 11.5 tt0 -35.22 98.1 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.497 1.123 . . . . 71.239999999999995 110.311 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.57 HD21 ' CA ' ' A' ' 205' ' ' GLY . 0.4 OUTLIER -109.37 94.76 5.2 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.538 1.149 . . . . 74.510000000000005 109.249 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 175' ' ' THR . 12.0 t -95.05 109.56 21.59 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.521 1.138 . . . . 54.310000000000002 110.453 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.539 HG22 ' H ' ' A' ' 177' ' ' TYR . 90.6 m -130.71 174.85 9.54 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.476 1.11 . . . . 64.109999999999999 110.428 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.553 ' O ' HG11 ' A' ' 162' ' ' VAL . 29.1 m-85 -105.26 169.42 8.46 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.504 1.127 . . . . 73.019999999999996 110.985 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.631 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.5 m -66.14 158.02 5.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.467 1.104 . . . . 70.420000000000002 109.305 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 58.2 66.05 3.09 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.479 1.112 . . . . 34.200000000000003 110.983 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.547 ' O ' HD13 ' A' ' 161' ' ' ILE . 9.1 tp10 -131.78 157.53 43.62 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.475 0.75 . . . . 64.0 110.32 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.418 ' ND2' HG12 ' A' ' 161' ' ' ILE . 2.3 m-80 -118.61 129.12 55.14 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.499 1.124 . . . . 74.329999999999998 109.247 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.752 HD23 ' N ' ' A' ' 182' ' ' LEU . 0.5 OUTLIER -140.67 150.02 42.98 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 52.32 109.244 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 5.5 m-85 -104.1 114.38 28.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.485 1.116 . . . . 75.230000000000004 111.002 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.589 HD11 ' HB3' ' A' ' 160' ' ' ALA . 1.6 mp -62.08 156.5 4.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 124.508 1.13 . . . . 75.140000000000001 109.249 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.458 ' N ' ' O ' ' A' ' 194' ' ' ILE . 0.1 OUTLIER -139.8 -48.15 0.46 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.461 1.1 . . . . 45.229999999999997 108.272 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.692 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -124.85 170.28 11.22 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.492 1.12 . . . . 70.510000000000005 109.324 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.524 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.2 OUTLIER -152.93 143.82 22.93 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.524 1.14 . . . . 74.140000000000001 109.603 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.714 ' NE2' HD11 ' A' ' 194' ' ' ILE . 0.2 OUTLIER -145.58 140.59 27.51 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.474 1.109 . . . . 72.420000000000002 109.622 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.491 ' C ' ' N ' ' A' ' 191' ' ' GLU . 67.3 t30 49.26 23.17 0.76 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.497 1.123 . . . . 54.329999999999998 109.368 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.411 ' C ' ' O ' ' A' ' 189' ' ' ASN . 14.5 p 41.0 28.17 0.05 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.471 1.107 . . . . 71.450000000000003 108.308 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.798 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 7.7 tt0 -125.38 -39.0 2.22 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.422 1.077 . . . . 54.32 110.304 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.595 ' CZ2' ' HD3' ' B' ' 477' ' ' PRO . 99.1 m95 -112.68 130.9 55.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.018 -1.105 . . . . 72.450000000000003 108.018 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.754 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.9 m-30 -121.91 142.11 50.6 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.54 1.15 . . . . 75.239999999999995 110.97 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.714 HD11 ' NE2' ' A' ' 188' ' ' HIS . 4.3 mm -101.19 95.98 4.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.422 1.076 . . . . 73.230000000000004 109.263 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 205' ' ' GLY . . . -103.93 -177.05 3.26 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.485 1.116 . . . . 61.039999999999999 109.293 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.452 ' CD ' ' HB3' ' A' ' 204' ' ' PRO . 3.9 mtmm -148.45 159.61 38.48 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.506 1.129 . . . . 71.120000000000005 109.291 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.95 176.56 9.74 Favored 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.522 1.801 . . . . 62.109999999999999 110.954 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 1.4 pp -114.78 72.19 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.467 1.104 . . . . 75.030000000000001 109.271 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 102.28 -43.78 1.63 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.424 1.077 . . . . 43.130000000000003 110.98 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -54.7 118.97 4.66 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.487 0.757 . . . . 74.140000000000001 110.328 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -43.44 112.27 0.36 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.571 1.17 . . . . 73.109999999999999 109.278 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 154.5 169.78 19.59 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.577 1.173 . . . . 70.239999999999995 110.97 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.477 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . 91.05 162.86 38.46 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 111.011 -0.836 . . . . 70.209999999999994 111.011 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.477 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.3 Cg_endo -75.01 131.17 23.32 Favored 'Cis proline' 0 C--N 1.359 1.122 0 C-N-CA 121.034 -2.486 . . . . 72.019999999999996 111.008 0.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.57 ' CA ' HD21 ' A' ' 174' ' ' LEU . . . -101.05 165.73 18.74 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.485 1.116 . . . . 62.049999999999997 111.004 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.584 HD11 ' CE3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -108.7 149.78 28.5 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.487 0.757 . . . . 64.409999999999997 109.281 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.778 ' CG1' HG11 ' A' ' 212' ' ' VAL . 0.4 OUTLIER -157.04 133.68 6.36 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.449 1.093 . . . . 72.230000000000004 109.282 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.557 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.2 Cg_endo -75.07 169.34 22.81 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.475 1.776 . . . . 72.439999999999998 110.995 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.754 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.6 OUTLIER -93.74 6.86 6.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.438 1.086 . . . . 62.130000000000003 109.336 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . 0.487 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -106.69 -3.6 37.09 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.442 1.089 . . . . 72.109999999999999 111.014 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.607 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 23.3 m-85 -129.03 4.99 5.33 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.462 0.742 . . . . 54.509999999999998 110.973 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.778 HG11 ' CG1' ' A' ' 207' ' ' VAL . 2.1 m -141.43 150.55 19.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.468 1.105 . . . . 75.140000000000001 109.329 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.688 ' HB2' HD11 ' A' ' 163' ' ' LEU . 1.4 t -110.73 133.29 53.46 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.524 1.14 . . . . 55.009999999999998 109.974 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.445 ' C ' HG23 ' A' ' 215' ' ' ILE . 4.8 mm -77.57 135.33 26.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.43 1.081 . . . . 73.519999999999996 109.338 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.479 HD13 ' HA ' ' A' ' 160' ' ' ALA . 0.2 OUTLIER -153.51 140.37 12.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.5 1.125 . . . . 53.229999999999997 109.33 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.81 ' O ' HG23 ' A' ' 217' ' ' ILE . 11.0 p-10 -110.67 -14.1 14.09 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.442 1.089 . . . . 74.219999999999999 109.246 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.966 HD13 HG22 ' A' ' 219' ' ' THR . 0.5 OUTLIER -170.92 -178.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.52 1.137 . . . . 62.399999999999999 109.282 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -85.06 74.96 10.42 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.54 1.15 . . . . 75.230000000000004 109.271 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.966 HG22 HD13 ' A' ' 217' ' ' ILE . 1.1 t -175.85 144.06 0.61 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.539 1.15 . . . . 71.150000000000006 110.352 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 38.85 -157.92 0.01 OUTLIER Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.497 1.123 . . . . 71.400000000000006 111.035 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -139.14 126.9 22.01 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.547 0.792 . . . . 75.400000000000006 110.963 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.572 ' O ' HG22 ' A' ' 223' ' ' THR . . . 51.9 26.94 3.93 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.518 1.136 . . . . 65.540000000000006 109.266 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 222' ' ' ALA . 10.8 t 45.5 25.96 0.27 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.574 1.171 . . . . 74.549999999999997 110.386 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 87.35 -41.69 3.1 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.557 1.16 . . . . 32.340000000000003 111.033 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -64.22 128.61 36.53 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.547 0.792 . . . . 64.409999999999997 109.279 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 230' ' ' ASP . 7.6 m-20 -62.1 152.02 33.99 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.553 1.158 . . . . 74.209999999999994 109.341 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.788 ' O ' HD12 ' A' ' 231' ' ' ILE . 2.7 p -49.36 -45.55 18.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.482 1.113 . . . . 45.450000000000003 109.318 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.486 ' H ' HD12 ' A' ' 228' ' ' ILE . 3.9 mp -63.53 -30.56 50.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.455 1.097 . . . . 71.299999999999997 109.271 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.421 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 7.8 mt-10 -86.14 -14.56 43.78 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.429 1.081 . . . . 72.319999999999993 110.288 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 226' ' ' ASP . 8.9 t0 -88.39 -15.75 34.71 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.479 1.112 . . . . 74.319999999999993 109.311 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.788 HD12 ' O ' ' A' ' 227' ' ' VAL . 0.6 OUTLIER -72.4 -69.37 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.559 1.162 . . . . 72.329999999999998 109.342 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.638 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -57.88 -20.87 39.94 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.568 1.168 . . . . 72.140000000000001 109.281 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.6 t -48.57 -57.49 6.11 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.54 1.15 . . . . 50.25 109.955 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.9 m -93.67 21.12 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.462 1.101 . . . . 71.230000000000004 109.294 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 49.33 29.21 2.64 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.474 1.109 . . . . 73.450000000000003 109.311 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.469 HD12 ' HD2' ' A' ' 237' ' ' PRO . 4.4 tp -65.27 119.11 56.55 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.465 1.103 . . . . 71.329999999999998 109.34 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.469 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.4 Cg_endo -74.92 173.03 15.18 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.461 1.769 . . . . 73.439999999999998 111.008 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 239' ' ' VAL . 1.5 m -66.25 -170.66 0.09 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.58 1.175 . . . . 73.540000000000006 110.389 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.597 HG22 ' HD3' ' A' ' 243' ' ' LYS . 9.8 p -79.96 -35.68 16.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.624 1.202 . . . . 63.200000000000003 109.351 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.575 ' HG3' HG13 ' A' ' 239' ' ' VAL . 0.5 OUTLIER -84.94 -19.14 32.64 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.569 1.168 . . . . 64.510000000000005 110.282 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -81.51 -39.17 25.12 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.493 1.121 . . . . 70.109999999999999 110.338 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.497 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 5.8 t90 -77.98 -61.25 2.06 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 72.200000000000003 107.978 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.597 ' HD3' HG22 ' A' ' 239' ' ' VAL . 1.6 mtpm? -59.05 -17.38 25.1 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.462 1.101 . . . . 55.549999999999997 109.302 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 243' ' ' LYS . 0.3 OUTLIER -38.34 -65.39 0.35 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.576 1.173 . . . . 72.030000000000001 109.988 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.414 ' ND2' ' HB3' ' A' ' 247' ' ' ALA . 3.9 t30 -140.12 104.79 4.91 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.481 1.113 . . . . 64.450000000000003 109.309 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.473 ' CG2' ' N ' ' A' ' 247' ' ' ALA . 0.8 OUTLIER -59.72 -50.47 79.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.141 . . . . 63.240000000000002 109.301 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.473 ' N ' ' CG2' ' A' ' 246' ' ' ILE . . . -41.81 104.18 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.508 1.13 . . . . 72.230000000000004 109.286 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -168.94 111.88 0.53 Allowed 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.518 1.136 . . . . 73.129999999999995 110.324 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.417 ' O ' ' CG ' ' A' ' 249' ' ' TYR . 34.8 p90 -45.05 128.65 7.33 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.506 1.129 . . . . 73.209999999999994 111.037 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 249' ' ' TYR . 9.6 mtpt -40.26 107.2 0.07 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.532 1.145 . . . . 62.329999999999998 109.313 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -88.29 -175.32 4.98 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.494 1.121 . . . . 71.5 109.262 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 46.6 m -116.65 -176.0 2.88 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.484 1.115 . . . . 73.140000000000001 110.045 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . 0.538 ' ND2' ' H ' ' A' ' 254' ' ' ILE . 9.2 t-20 -147.54 161.47 41.05 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.492 1.12 . . . . 61.240000000000002 109.307 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.598 HD12 ' N ' ' A' ' 254' ' ' ILE . 3.6 mp -121.14 142.66 36.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.574 1.171 . . . . 72.209999999999994 109.288 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 18.8 t -150.43 -179.46 7.23 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.491 1.12 . . . . 60.439999999999998 109.959 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 91.5 mt -105.43 -178.17 3.57 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.426 1.079 . . . . 72.519999999999996 109.287 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -82.42 -58.31 2.45 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.573 1.171 . . . . 74.030000000000001 111.052 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 6.0 t 51.43 34.57 12.28 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.463 0.743 . . . . 71.329999999999998 109.947 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 3.2 p -68.31 165.66 2.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.522 1.139 . . . . 73.140000000000001 109.332 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 . . . . . 0 C--N 1.325 -0.49 0 O-C-N 124.466 1.104 . . . . 43.32 110.272 -179.961 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 28.3 t . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 110.011 -0.366 . . . . 73.099999999999994 110.011 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 13.0 p -91.06 171.4 9.29 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.463 1.102 . . . . 75.150000000000006 110.002 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 63.5 m -77.27 168.87 19.32 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.426 1.079 . . . . 73.329999999999998 109.986 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -89.92 71.7 7.53 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.506 1.129 . . . . 65.310000000000002 109.307 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -91.41 -59.29 2.18 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.44 1.087 . . . . 71.329999999999998 109.313 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -67.9 -168.72 4.44 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.49 1.119 . . . . 74.239999999999995 110.976 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -139.71 -47.14 0.45 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 0.761 . . . . 64.25 109.354 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 470' ' ' PHE . . . . . 0.539 ' C ' HD12 ' B' ' 471' ' ' ILE . 8.6 m-30 -90.99 31.5 1.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.489 1.118 . . . . 74.120000000000005 110.972 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 471' ' ' ILE . . . . . 0.569 ' N ' ' CD1' ' B' ' 471' ' ' ILE . 1.1 mp -98.55 138.14 20.74 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.546 1.154 . . . . 54.539999999999999 109.291 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 472' ' ' PRO . . . . . 0.533 ' HD2' HG23 ' B' ' 471' ' ' ILE . 18.2 Cg_endo -75.03 138.63 23.21 Favored 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.485 1.782 . . . . 61.43 110.955 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 21.1 t -66.11 -72.25 0.17 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.54 1.15 . . . . 62.25 109.984 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.59 157.21 88.91 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.544 1.152 . . . . 71.400000000000006 110.309 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -167.59 0.44 Allowed 'Trans proline' 0 C--N 1.36 1.134 0 O-C-N 124.531 1.806 . . . . 75.400000000000006 110.947 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 476' ' ' ALA . . . . . 0.798 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . -56.49 131.11 76.8 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 23.399999999999999 109.314 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 477' ' ' PRO . . . . . 0.595 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -75.04 -162.58 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.489 1.784 . . . . 61.219999999999999 111.022 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 478' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -135.54 91.37 18.51 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.509 1.13 . . . . 73.019999999999996 109.321 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 479' ' ' PRO . . . . . 0.607 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.2 Cg_endo -74.99 154.92 42.88 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.463 1.77 . . . . 61.340000000000003 111.051 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 480' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' B' ' 479' ' ' PRO . 18.4 Cg_endo -74.94 -177.46 3.47 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.459 1.768 . . . . 70.030000000000001 111.042 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 481' ' ' SER . . . . . . . . . . . . . 1.8 t 49.59 51.47 16.39 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.434 1.084 . . . . 55.240000000000002 110.054 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 14.2 t -144.29 137.07 26.97 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.454 1.096 . . . . 63.43 110.031 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -57.55 117.59 4.33 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.487 1.117 . . . . 63.32 109.294 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -122.4 93.27 3.93 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.47 1.106 . . . . 72.329999999999998 109.984 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -79.71 71.85 6.38 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.431 1.082 . . . . 61.329999999999998 109.308 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 90.7 p . . . . . 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.135 . . . . 73.430000000000007 109.98 -179.978 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.004 0 N-CA-C 110.975 -0.85 . . . . 60.119999999999997 110.975 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.866 ' C ' HD23 ' A' ' 158' ' ' LEU . 31.0 m -154.35 172.25 18.0 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.508 0.77 . . . . 72.019999999999996 110.019 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.866 HD23 ' C ' ' A' ' 157' ' ' SER . 1.4 pt? 41.71 66.54 0.68 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.401 1.063 . . . . 53.030000000000001 109.28 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.741 ' CE2' ' CZ ' ' A' ' 183' ' ' PHE . 0.1 OUTLIER -112.32 135.14 53.37 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.535 1.147 . . . . 75.409999999999997 111.029 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.949 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -103.93 148.61 25.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.567 1.167 . . . . 75.129999999999995 109.311 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.598 HG23 HD23 ' A' ' 163' ' ' LEU . 0.2 OUTLIER -131.28 128.84 62.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.574 1.171 . . . . 55.119999999999997 109.228 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.797 HG22 HG12 ' A' ' 212' ' ' VAL . 2.6 t -80.83 119.23 30.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.529 1.143 . . . . 70.319999999999993 109.296 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.598 HD23 HG23 ' A' ' 161' ' ' ILE . 0.9 OUTLIER -94.3 -15.92 24.01 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.561 1.163 . . . . 71.030000000000001 109.321 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.622 ' O ' HG13 ' A' ' 162' ' ' VAL . 1.0 OUTLIER -150.0 155.96 40.86 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.466 1.104 . . . . 75.540000000000006 111.002 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.685 ' H ' HG12 ' A' ' 178' ' ' VAL . 1.3 t70 -86.54 157.49 19.74 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.437 1.086 . . . . 72.129999999999995 109.29 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.51 ' HB2' ' CD1' ' A' ' 211' ' ' PHE . 11.7 t80 -154.35 140.57 18.53 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.548 1.155 . . . . 71.420000000000002 110.999 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -84.19 115.02 22.21 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.436 1.085 . . . . 74.430000000000007 109.3 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.934 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -103.55 131.54 50.59 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.49 1.119 . . . . 64.319999999999993 109.323 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -138.63 11.36 2.71 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.469 1.106 . . . . 74.450000000000003 110.265 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.519 ' HE3' ' CH2' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -83.0 -175.92 6.08 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.513 1.133 . . . . 62.229999999999997 109.272 179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -64.04 -24.64 67.78 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.507 1.13 . . . . 73.5 109.307 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.475 ' HB3' ' CB ' ' A' ' 206' ' ' LEU . 72.4 m-20 -112.89 15.69 19.68 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.557 1.16 . . . . 72.230000000000004 109.351 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.934 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 2.0 pp20? -34.0 108.99 0.07 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.424 1.078 . . . . 71.010000000000005 110.244 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.608 HD23 ' HA3' ' A' ' 205' ' ' GLY . 0.7 OUTLIER -115.75 96.27 5.53 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.54 1.15 . . . . 44.43 109.264 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 15.2 t -82.36 133.08 35.22 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.561 1.163 . . . . 72.329999999999998 110.401 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.825 HG23 ' HG2' ' A' ' 180' ' ' GLU . 0.9 OUTLIER -160.76 146.46 14.71 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.478 1.111 . . . . 73.310000000000002 110.383 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -81.43 168.81 17.91 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.544 1.153 . . . . 62.109999999999999 111.025 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.685 HG12 ' H ' ' A' ' 165' ' ' ASP . 2.3 m -60.88 158.19 2.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.509 1.131 . . . . 64.340000000000003 109.298 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 53.33 59.23 9.85 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.551 1.157 . . . . 53.409999999999997 110.957 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.825 ' HG2' HG23 ' A' ' 176' ' ' THR . 1.3 tp10 -116.59 179.81 3.9 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.483 0.755 . . . . 74.200000000000003 110.328 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.423 ' ND2' HG12 ' A' ' 161' ' ' ILE . 27.5 m120 -132.62 139.71 47.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.525 1.14 . . . . 74.140000000000001 109.252 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.698 HD22 HG11 ' A' ' 207' ' ' VAL . 0.1 OUTLIER -152.17 149.36 28.67 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 75.230000000000004 109.335 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.741 ' CZ ' ' CE2' ' A' ' 159' ' ' TYR . 2.1 m-85 -109.0 111.63 23.4 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.424 1.077 . . . . 64.340000000000003 110.995 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.949 HD13 ' HB2' ' A' ' 160' ' ' ALA . 1.6 mp -71.0 164.15 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.133 . . . . 61.399999999999999 109.314 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.595 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 3.5 p -159.9 -41.5 0.05 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.524 1.14 . . . . 73.099999999999994 108.283 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.978 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -114.69 152.5 31.87 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.528 1.142 . . . . 71.209999999999994 109.308 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.547 ' CD2' HD21 ' A' ' 236' ' ' LEU . 0.0 OUTLIER -145.18 151.13 37.95 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.127 . . . . 53.240000000000002 109.634 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.583 ' CD2' ' O ' ' A' ' 192' ' ' TRP . 1.3 p80 -156.39 146.51 21.3 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 72.200000000000003 109.612 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.477 ' C ' ' N ' ' A' ' 191' ' ' GLU . 0.1 OUTLIER 51.18 22.43 1.32 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 74.519999999999996 109.317 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.44 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.1 p 39.06 30.01 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.49 1.119 . . . . 74.129999999999995 108.229 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.551 ' O ' HG13 ' A' ' 209' ' ' VAL . 11.6 tt0 -134.18 -40.39 0.83 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.542 1.151 . . . . 74.319999999999993 110.361 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.933 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 97.2 m95 -105.61 127.7 53.2 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.987 -1.116 . . . . 70.209999999999994 107.987 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.742 ' CE2' HG12 ' A' ' 209' ' ' VAL . 16.9 m-30 -125.14 130.08 51.46 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.387 1.054 . . . . 75.209999999999994 111.02 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.978 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 1.5 mp -88.81 110.81 21.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.51 1.132 . . . . 74.409999999999997 109.358 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.527 ' HB2' HG13 ' A' ' 184' ' ' ILE . . . -118.87 177.38 4.87 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.489 1.118 . . . . 52.439999999999998 109.322 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.463 ' CD ' ' HD2' ' A' ' 197' ' ' PRO . 4.6 tptm -124.89 140.26 35.35 Favored Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.467 1.104 . . . . 71.310000000000002 109.333 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.463 ' HD2' ' CD ' ' A' ' 196' ' ' LYS . 18.1 Cg_endo -75.03 144.82 30.62 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.5 1.79 . . . . 74.099999999999994 110.982 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.419 HG13 ' N ' ' A' ' 199' ' ' GLY . 11.7 pt -39.62 -51.51 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.548 1.155 . . . . 72.430000000000007 109.337 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.419 ' N ' HG13 ' A' ' 198' ' ' ILE . . . -169.01 65.94 0.18 Allowed Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.504 1.128 . . . . 54.310000000000002 111.027 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.446 ' CG ' ' HB2' ' A' ' 197' ' ' PRO . 32.3 mmt180 -106.04 163.02 13.1 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.469 0.747 . . . . 72.129999999999995 110.268 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 11.7 tp -75.2 74.09 2.33 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.536 1.148 . . . . 70.549999999999997 109.319 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 160.39 -130.57 2.43 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.452 1.095 . . . . 74.299999999999997 111.039 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.507 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . 65.97 151.26 0.12 Allowed Glycine 0 CA--C 1.53 0.972 0 N-CA-C 111.015 -0.834 . . . . 60.140000000000001 111.015 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.507 ' C ' ' HA2' ' A' ' 203' ' ' GLY . 18.2 Cg_endo -75.01 146.15 85.87 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.039 -2.484 . . . . 64.129999999999995 111.026 0.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.608 ' HA3' HD23 ' A' ' 174' ' ' LEU . . . -109.36 177.64 20.23 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.525 1.141 . . . . 71.140000000000001 111.01 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.933 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.2 OUTLIER -97.97 147.2 24.73 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.463 0.743 . . . . 53.219999999999999 109.347 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.698 HG11 HD22 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -155.01 125.57 3.41 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 124.525 1.14 . . . . 60.119999999999997 109.315 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.844 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.4 Cg_endo -75.02 176.77 9.48 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.529 1.805 . . . . 60.200000000000003 111.076 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.742 HG12 ' CE2' ' A' ' 193' ' ' PHE . 1.6 m -96.85 5.33 8.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.587 1.179 . . . . 53.109999999999999 109.332 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -108.89 6.44 32.87 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.537 1.148 . . . . 70.540000000000006 111.024 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.6 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 11.6 m-85 -139.64 12.18 2.51 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.439 0.729 . . . . 74.25 111.043 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 208' ' ' PRO . 11.4 m -154.39 157.7 4.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.483 1.114 . . . . 73.310000000000002 109.317 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.541 ' HB2' HD11 ' A' ' 163' ' ' LEU . 22.5 t -129.62 124.17 33.07 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.494 1.121 . . . . 75.319999999999993 110.042 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.586 ' C ' HG22 ' A' ' 215' ' ' ILE . 3.4 mm -78.08 149.95 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.496 1.122 . . . . 72.129999999999995 109.35 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.943 HD12 ' N ' ' A' ' 216' ' ' ASP . 0.1 OUTLIER 179.49 137.99 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 71.530000000000001 109.251 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.943 ' N ' HD12 ' A' ' 215' ' ' ILE . 1.1 t70 -71.31 -155.66 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.467 1.104 . . . . 74.109999999999999 109.312 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.55 HG23 ' HB ' ' A' ' 219' ' ' THR . 8.2 tp -43.13 155.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.452 1.095 . . . . 75.409999999999997 109.351 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -41.36 -29.45 0.15 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.449 1.093 . . . . 55.210000000000001 109.283 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.55 ' HB ' HG23 ' A' ' 217' ' ' ILE . 99.8 m -65.87 101.3 0.64 Allowed 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.556 1.16 . . . . 74.409999999999997 110.392 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 102.5 166.11 26.43 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.504 1.128 . . . . 65.129999999999995 110.99 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.415 ' C ' ' N ' ' A' ' 223' ' ' THR . 19.0 t80 -134.96 146.77 49.43 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.538 0.787 . . . . 64.319999999999993 110.977 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.525 ' C ' HG22 ' A' ' 223' ' ' THR . . . 47.39 24.92 0.52 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.593 1.183 . . . . 53.32 109.285 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.528 HG23 ' CG ' ' A' ' 225' ' ' ASN . 1.0 OUTLIER 45.43 19.88 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.463 1.102 . . . . 75.120000000000005 110.393 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.446 ' N ' ' C ' ' A' ' 222' ' ' ALA . . . 62.91 3.14 5.59 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.561 1.163 . . . . 63.549999999999997 111.024 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.528 ' CG ' HG23 ' A' ' 223' ' ' THR . 6.5 p30 -133.24 176.84 8.16 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.525 0.78 . . . . 65.510000000000005 109.276 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 229' ' ' GLU . 6.2 t0 -92.59 145.79 24.16 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.514 1.134 . . . . 62.100000000000001 109.266 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.736 HG21 ' HE2' ' A' ' 193' ' ' PHE . 0.6 OUTLIER -44.28 -44.53 2.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.495 1.122 . . . . 64.530000000000001 109.311 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.812 ' HA ' HD12 ' A' ' 231' ' ' ILE . 29.4 mt -58.21 -41.49 81.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 73.540000000000006 109.342 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 226' ' ' ASP . 14.6 mt-10 -69.34 -17.53 63.71 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.559 1.162 . . . . 54.350000000000001 110.351 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.94 -16.4 31.89 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.543 1.152 . . . . 74.239999999999995 109.252 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.812 HD12 ' HA ' ' A' ' 228' ' ' ILE . 2.5 mt -71.39 -69.37 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.57 1.169 . . . . 74.239999999999995 109.279 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.505 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -58.97 -21.23 58.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.5 1.125 . . . . 72.25 109.278 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.6 -56.51 13.12 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.51 1.131 . . . . 64.109999999999999 109.97 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.1 m -97.92 19.11 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.447 1.092 . . . . 72.129999999999995 109.295 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 40.82 31.47 0.12 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.458 1.099 . . . . 63.329999999999998 109.282 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.547 HD21 ' CD2' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -61.23 124.01 78.53 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.53 1.144 . . . . 63.240000000000002 109.29 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 -179.62 5.18 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.46 1.769 . . . . 71.230000000000004 110.947 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 239' ' ' VAL . 1.3 m -69.45 -173.51 0.57 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.523 1.139 . . . . 74.030000000000001 110.416 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.586 HG12 ' HB1' ' A' ' 186' ' ' ALA . 1.2 m -78.45 -38.05 22.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.469 1.106 . . . . 65.319999999999993 109.33 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.421 ' HG3' ' CG2' ' A' ' 239' ' ' VAL . 0.4 OUTLIER -81.51 -15.39 55.06 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.435 1.085 . . . . 73.209999999999994 110.283 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -83.89 -38.81 20.64 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.443 1.09 . . . . 74.450000000000003 110.319 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.669 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 0.3 OUTLIER -83.73 -63.06 1.42 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.966 -1.124 . . . . 73.409999999999997 107.966 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.568 ' NZ ' ' CG ' ' B' ' 470' ' ' PHE . 13.2 mtmt -51.36 -22.49 2.95 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.571 1.169 . . . . 73.209999999999994 109.285 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -41.19 -65.73 0.4 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.532 1.145 . . . . 71.409999999999997 110.017 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -136.25 100.16 4.31 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.508 1.13 . . . . 62.520000000000003 109.305 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 248' ' ' ARG . 11.0 mt -52.29 -49.24 42.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 61.229999999999997 109.345 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 246' ' ' ILE . . . -40.27 99.35 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.512 1.132 . . . . 70.310000000000002 109.264 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 246' ' ' ILE . 9.7 tpp180 -99.72 147.61 25.26 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.528 1.143 . . . . 74.25 110.303 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.616 ' CD1' ' N ' ' A' ' 249' ' ' TYR . 0.6 OUTLIER -86.19 156.74 20.19 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.48 1.113 . . . . 74.319999999999993 110.967 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 251' ' ' ALA . 0.0 OUTLIER -85.58 179.49 7.1 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.486 1.116 . . . . 73.200000000000003 109.291 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 250' ' ' LYS . . . 72.51 14.19 5.28 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.546 1.154 . . . . 74.109999999999999 109.327 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 25.3 t -97.26 135.68 38.83 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.503 1.127 . . . . 64.540000000000006 109.95 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -127.41 159.6 33.99 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.461 1.1 . . . . 63.240000000000002 109.292 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.58 HD12 ' N ' ' A' ' 254' ' ' ILE . 2.2 mp -137.54 152.94 27.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.468 1.105 . . . . 74.319999999999993 109.246 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 8.9 p -152.66 165.08 36.36 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.438 1.086 . . . . 54.119999999999997 110.021 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -168.56 154.72 6.95 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.584 1.177 . . . . 75.140000000000001 109.308 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -93.16 -177.59 40.47 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 124.452 1.095 . . . . 43.43 111.056 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 8.8 m -168.02 147.22 4.69 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.465 0.744 . . . . 73.219999999999999 110.04 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 35.2 t -150.59 145.86 16.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.507 1.129 . . . . 75.0 109.295 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.446 0 O-C-N 124.45 1.094 . . . . 74.219999999999999 110.307 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 27.1 p . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 109.966 -0.383 . . . . 43.439999999999998 109.966 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 43.9 t -71.93 138.93 48.45 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.554 1.159 . . . . 72.319999999999993 110.071 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 93.7 p -72.5 173.33 9.0 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.501 1.126 . . . . 73.340000000000003 110.022 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -109.55 67.77 0.66 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.559 1.162 . . . . 70.5 109.254 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -97.35 81.55 3.01 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.497 1.123 . . . . 74.129999999999995 109.294 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . 177.96 145.73 6.06 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.494 1.121 . . . . 72.400000000000006 110.995 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.6 -15.28 17.84 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.443 0.731 . . . . 73.120000000000005 109.272 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 470' ' ' PHE . . . . . 0.568 ' CG ' ' NZ ' ' A' ' 243' ' ' LYS . 5.5 m-30 -94.0 20.24 8.08 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.523 1.139 . . . . 74.400000000000006 110.968 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 471' ' ' ILE . . . . . 0.708 HG23 ' HD2' ' B' ' 472' ' ' PRO . 19.2 mm -91.83 142.38 26.51 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.486 1.116 . . . . 65.109999999999999 109.262 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 472' ' ' PRO . . . . . 0.708 ' HD2' HG23 ' B' ' 471' ' ' ILE . 18.4 Cg_endo -75.07 156.65 42.71 Favored 'Trans proline' 0 C--N 1.361 1.236 0 O-C-N 124.486 1.782 . . . . 71.540000000000006 111.027 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 19.1 t -99.43 -44.15 6.29 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.513 1.133 . . . . 61.119999999999997 110.046 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -102.17 167.94 9.71 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 72.129999999999995 110.348 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.95 -168.28 0.5 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.456 1.766 . . . . 62.409999999999997 110.997 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 476' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' B' ' 477' ' ' PRO . . . -59.03 140.29 87.1 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.51 1.131 . . . . 43.450000000000003 109.307 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 477' ' ' PRO . . . . . 0.619 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -75.09 -162.12 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.545 1.813 . . . . 74.200000000000003 111.027 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.74 87.93 11.01 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.573 1.17 . . . . 44.310000000000002 109.277 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 479' ' ' PRO . . . . . 0.6 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.3 Cg_endo -75.03 169.59 22.27 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.419 1.747 . . . . 64.510000000000005 110.986 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 480' ' ' PRO . . . . . 0.442 ' C ' ' N ' ' B' ' 482' ' ' SER . 18.1 Cg_endo -75.02 -70.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.485 1.781 . . . . 61.32 111.008 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 481' ' ' SER . . . . . 0.54 ' OG ' ' CE1' ' A' ' 164' ' ' TYR . 1.6 m -38.32 -30.87 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.465 1.103 . . . . 73.430000000000007 109.992 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 482' ' ' SER . . . . . 0.446 ' CB ' ' HG2' ' B' ' 479' ' ' PRO . 47.3 t -81.62 128.68 34.19 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.493 1.121 . . . . 53.100000000000001 110.023 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -78.37 81.1 4.74 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.53 1.144 . . . . 75.25 109.334 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 23.2 t -103.42 49.32 0.83 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.481 1.113 . . . . 54.030000000000001 109.954 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -163.64 109.75 1.1 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.49 1.119 . . . . 74.019999999999996 109.238 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 9.1 t . . . . . 0 C--N 1.326 -0.44 0 O-C-N 124.529 1.143 . . . . 23.030000000000001 110.013 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.501 ' HA2' ' CE2' ' A' ' 159' ' ' TYR . . . . . . . . 0 CA--C 1.529 0.966 0 N-CA-C 111.069 -0.813 . . . . 63.420000000000002 111.069 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 36.7 t -95.52 114.94 26.75 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.468 0.746 . . . . 31.300000000000001 109.982 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 12.6 tp 65.75 54.46 1.07 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.507 1.129 . . . . 74.420000000000002 109.241 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.702 ' CE2' ' CE1' ' A' ' 183' ' ' PHE . 5.6 m-30 -112.79 159.08 19.34 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.504 1.127 . . . . 71.430000000000007 110.972 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.742 ' HB3' ' CD2' ' A' ' 182' ' ' LEU . . . -124.31 145.63 49.29 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.489 1.118 . . . . 72.5 109.282 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.498 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -123.32 127.36 74.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.496 1.123 . . . . 72.140000000000001 109.322 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.915 HG22 HG12 ' A' ' 212' ' ' VAL . 1.1 t -82.57 118.03 29.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 124.512 1.132 . . . . 72.019999999999996 109.248 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.66 HD11 ' OG ' ' A' ' 213' ' ' SER . 1.7 mt -92.32 -16.21 26.35 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.523 1.139 . . . . 73.549999999999997 109.255 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.653 ' O ' HG13 ' A' ' 162' ' ' VAL . 3.0 m-85 -145.94 158.51 43.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.437 1.085 . . . . 73.239999999999995 111.058 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.817 ' N ' HG12 ' A' ' 178' ' ' VAL . 0.6 OUTLIER -96.77 159.4 14.94 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.476 1.11 . . . . 71.310000000000002 109.321 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.57 ' HB2' ' CE2' ' A' ' 211' ' ' PHE . 28.3 t80 -160.63 131.81 5.63 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.554 1.159 . . . . 71.040000000000006 111.033 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -67.34 129.33 39.55 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.463 1.102 . . . . 72.340000000000003 109.305 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.854 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -107.28 141.13 39.1 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.442 1.089 . . . . 73.409999999999997 109.332 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -149.7 22.38 0.9 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.539 1.149 . . . . 73.25 110.315 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.562 ' HE3' ' CZ3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -99.88 -175.91 3.1 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.43 1.081 . . . . 75.510000000000005 109.282 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.25 -28.88 67.12 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.491 1.119 . . . . 64.530000000000001 109.336 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.461 ' CB ' ' HB2' ' A' ' 206' ' ' LEU . 76.1 m-20 -108.46 20.05 19.06 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.498 1.124 . . . . 73.319999999999993 109.282 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.854 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 8.0 pt-20 -38.02 106.33 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.395 1.059 . . . . 75.299999999999997 110.304 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.696 HD22 ' HA3' ' A' ' 205' ' ' GLY . 4.2 tp -124.39 113.7 18.53 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.522 1.139 . . . . 73.430000000000007 109.307 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 175' ' ' THR . 12.1 t -89.06 111.36 22.07 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.471 1.107 . . . . 70.140000000000001 110.427 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.481 HG22 ' HG3' ' A' ' 180' ' ' GLU . 59.2 m -128.87 142.76 50.86 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.473 1.108 . . . . 64.120000000000005 110.401 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -83.48 162.33 20.98 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.548 1.155 . . . . 72.430000000000007 110.945 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.817 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.4 m -60.37 158.24 2.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.488 1.117 . . . . 65.340000000000003 109.245 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 53.4 48.22 60.58 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.555 1.159 . . . . 72.329999999999998 110.979 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.498 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 11.9 mm-40 -105.07 168.51 9.01 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 0.766 . . . . 75.450000000000003 110.32 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.423 ' ND2' HG12 ' A' ' 161' ' ' ILE . 2.2 m-80 -128.0 117.13 21.14 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.454 1.096 . . . . 70.319999999999993 109.312 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.784 ' N ' HD13 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -134.89 146.89 49.64 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.521 1.138 . . . . 70.120000000000005 109.294 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.702 ' CE1' ' CE2' ' A' ' 159' ' ' TYR . 9.8 m-30 -100.21 116.82 33.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.472 1.107 . . . . 72.329999999999998 111.035 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 1.043 HD13 ' HB2' ' A' ' 195' ' ' ALA . 14.1 mm -59.52 151.04 5.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.579 1.175 . . . . 73.5 109.359 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.559 ' O ' ' CZ3' ' A' ' 242' ' ' TRP . 2.8 m -133.83 -46.53 0.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.525 1.141 . . . . 75.140000000000001 108.303 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.869 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -127.63 174.07 9.37 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.506 1.129 . . . . 74.329999999999998 109.348 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -157.06 141.59 16.68 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 1.114 . . . . 73.239999999999995 109.636 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.596 ' CD2' ' O ' ' A' ' 192' ' ' TRP . 0.1 OUTLIER -143.21 139.35 30.23 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.458 1.099 . . . . 74.109999999999999 109.552 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.466 ' C ' ' N ' ' A' ' 191' ' ' GLU . 27.6 t-20 50.83 22.7 1.21 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.508 1.13 . . . . 61.039999999999999 109.345 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.402 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.8 m 41.54 29.02 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.475 1.109 . . . . 72.5 108.239 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.94 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 18.2 tt0 -127.59 -38.74 1.88 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.436 1.085 . . . . 54.329999999999998 110.309 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.67 ' CE3' HD21 ' A' ' 206' ' ' LEU . 96.3 m95 -112.21 125.19 53.88 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.519 1.137 . . . . 72.049999999999997 108.017 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.877 ' HB3' HD12 ' A' ' 184' ' ' ILE . 19.1 m-30 -115.15 150.69 35.65 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.498 1.124 . . . . 75.129999999999995 111.028 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.869 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 14.8 mm -112.16 91.24 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.557 1.161 . . . . 74.420000000000002 109.327 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 1.043 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -94.75 -175.24 3.52 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.514 1.134 . . . . 71.310000000000002 109.35 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.481 ' CG ' ' SG ' ' A' ' 185' ' ' CYS . 0.0 OUTLIER -156.42 158.19 31.36 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.556 1.16 . . . . 61.119999999999997 109.249 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.08 160.17 40.23 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.491 1.785 . . . . 65.530000000000001 110.987 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.47 ' CG1' ' CZ ' ' A' ' 183' ' ' PHE . 9.9 mt -49.85 -51.69 15.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.462 1.101 . . . . 75.510000000000005 109.292 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -174.74 84.25 0.08 OUTLIER Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.461 1.101 . . . . 61.149999999999999 111.015 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -167.12 131.95 2.01 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.561 0.801 . . . . 71.409999999999997 110.289 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 201' ' ' LEU . 1.1 pt? -43.67 102.6 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 64.219999999999999 109.283 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . -171.29 -81.04 0.05 OUTLIER Glycine 0 CA--C 1.531 1.068 0 O-C-N 124.46 1.1 . . . . 64.150000000000006 111.058 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.417 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . -45.23 171.45 0.01 OUTLIER Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.992 -0.843 . . . . 74.329999999999998 110.992 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.511 ' HB2' HG22 ' A' ' 194' ' ' ILE . 18.2 Cg_endo -75.03 127.29 14.17 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.024 -2.49 . . . . 72.310000000000002 110.962 0.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.696 ' HA3' HD22 ' A' ' 174' ' ' LEU . . . -97.65 145.75 17.95 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.573 1.17 . . . . 72.219999999999999 111.021 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.67 HD21 ' CE3' ' A' ' 192' ' ' TRP . 0.3 OUTLIER -92.32 146.65 23.53 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.562 0.801 . . . . 70.450000000000003 109.351 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.759 ' CG1' HG11 ' A' ' 212' ' ' VAL . 0.4 OUTLIER -160.31 131.02 3.67 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.522 1.139 . . . . 74.329999999999998 109.275 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 191' ' ' GLU . 18.2 Cg_endo -75.06 168.5 24.67 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.471 1.774 . . . . 60.130000000000003 110.967 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.637 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.9 OUTLIER -89.27 2.52 6.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.479 1.112 . . . . 75.310000000000002 109.228 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -101.76 -5.96 50.28 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.557 1.16 . . . . 72.109999999999999 110.951 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.625 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 12.0 m-85 -125.22 1.0 7.82 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 0.774 . . . . 72.329999999999998 111.013 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.915 HG12 HG22 ' A' ' 162' ' ' VAL . 1.3 m -142.63 160.85 18.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.407 1.067 . . . . 74.349999999999994 109.346 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.66 ' OG ' HD11 ' A' ' 163' ' ' LEU . 3.9 m -125.25 138.34 54.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.581 1.176 . . . . 72.519999999999996 110.015 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.809 ' O ' HG23 ' A' ' 215' ' ' ILE . 3.5 mm -78.77 147.34 6.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.473 1.108 . . . . 74.299999999999997 109.246 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.809 HG23 ' O ' ' A' ' 214' ' ' ILE . 7.6 pt -162.5 125.33 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.442 1.089 . . . . 74.150000000000006 109.287 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -128.53 -75.48 0.56 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.446 1.091 . . . . 73.329999999999998 109.295 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 217' ' ' ILE . 54.6 mt -119.32 69.34 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.587 1.179 . . . . 71.120000000000005 109.301 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -173.09 135.29 0.59 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.533 1.145 . . . . 72.319999999999993 109.288 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 219' ' ' THR . 8.9 t -92.14 45.46 1.21 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.529 1.143 . . . . 61.200000000000003 110.386 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -161.95 -89.34 0.07 OUTLIER Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.456 1.098 . . . . 22.030000000000001 111.049 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.417 ' O ' ' N ' ' A' ' 223' ' ' THR . 3.5 m-85 -117.35 -172.53 2.24 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.527 0.781 . . . . 74.109999999999999 111.027 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.693 ' O ' HG22 ' A' ' 223' ' ' THR . . . -68.56 70.91 0.19 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.479 1.112 . . . . 61.030000000000001 109.322 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.693 HG22 ' O ' ' A' ' 222' ' ' ALA . 13.1 t 48.62 19.82 0.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.539 1.15 . . . . 70.120000000000005 110.409 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.428 ' N ' ' C ' ' A' ' 222' ' ' ALA . . . 92.36 -32.7 5.33 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.523 1.139 . . . . 61.329999999999998 111.007 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 44.8 m-20 -63.35 168.69 4.22 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.537 0.786 . . . . 70.310000000000002 109.271 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -86.77 150.92 23.81 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.539 1.149 . . . . 64.010000000000005 109.245 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.446 ' O ' HD12 ' A' ' 231' ' ' ILE . 0.4 OUTLIER -42.94 -48.51 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.514 1.134 . . . . 73.439999999999998 109.246 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 231' ' ' ILE . 2.6 mp -60.21 -58.12 8.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.48 1.112 . . . . 61.130000000000003 109.257 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 233' ' ' SER . 7.5 mt-10 -46.12 -26.52 0.77 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.525 1.14 . . . . 75.209999999999994 110.337 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.616 ' O ' HG13 ' A' ' 234' ' ' VAL . 9.9 t0 -77.09 -37.85 53.54 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 62.200000000000003 109.261 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.499 ' N ' ' O ' ' A' ' 228' ' ' ILE . 0.6 OUTLIER -59.54 -60.26 2.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.544 1.153 . . . . 64.049999999999997 109.272 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' A' ' 228' ' ' ILE . 0.0 OUTLIER -62.65 -44.56 95.95 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.508 1.13 . . . . 71.150000000000006 109.329 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 229' ' ' GLU . 1.5 m -41.15 -60.03 1.34 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.489 1.118 . . . . 64.239999999999995 109.982 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.616 HG13 ' O ' ' A' ' 230' ' ' ASP . 1.5 m -73.32 -22.49 19.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.478 1.111 . . . . 74.109999999999999 109.3 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 234' ' ' VAL . 5.7 m120 79.09 28.43 0.39 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.503 1.127 . . . . 71.200000000000003 109.29 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.479 HD12 ' HD2' ' A' ' 237' ' ' PRO . 3.4 tp -66.44 125.93 91.26 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.51 1.131 . . . . 71.219999999999999 109.287 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.479 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.5 Cg_endo -74.94 161.08 39.52 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.43 1.753 . . . . 62.039999999999999 111.057 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 239' ' ' VAL . 1.8 m -60.25 178.49 0.19 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.539 1.149 . . . . 54.329999999999998 110.329 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.635 HG13 ' HG3' ' A' ' 240' ' ' GLN . 14.6 p -72.59 -37.83 57.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.506 1.129 . . . . 63.450000000000003 109.287 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.635 ' HG3' HG13 ' A' ' 239' ' ' VAL . 2.3 mt-30 -79.99 -22.54 42.41 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.543 1.152 . . . . 74.230000000000004 110.268 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -82.97 -43.2 16.69 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.431 1.082 . . . . 72.439999999999998 110.306 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.559 ' CZ3' ' O ' ' A' ' 185' ' ' CYS . 9.4 t90 -70.59 -58.79 3.31 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.139 . . . . 75.010000000000005 108.002 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.464 ' NZ ' HG22 ' A' ' 239' ' ' VAL . 9.6 mtmm -56.19 -18.98 11.75 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.555 1.159 . . . . 55.530000000000001 109.292 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 8.2 t -39.12 -58.12 1.2 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.437 1.085 . . . . 71.409999999999997 109.993 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.406 ' C ' ' N ' ' A' ' 247' ' ' ALA . 0.9 OUTLIER -151.54 115.84 5.04 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.536 1.147 . . . . 74.230000000000004 109.314 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 40.4 mm -42.49 -28.67 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.461 1.101 . . . . 71.409999999999997 109.347 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.406 ' N ' ' C ' ' A' ' 245' ' ' ASN . . . -107.46 54.87 0.66 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.484 1.115 . . . . 73.349999999999994 109.28 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.59 96.49 6.18 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.499 1.124 . . . . 61.450000000000003 110.298 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.518 ' CD1' ' O ' ' A' ' 249' ' ' TYR . 0.7 OUTLIER -57.68 133.62 55.49 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.533 1.146 . . . . 72.140000000000001 111.064 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -67.5 114.02 5.82 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.491 1.119 . . . . 72.519999999999996 109.282 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.476 ' CB ' ' CE2' ' A' ' 249' ' ' TYR . . . -162.54 164.52 26.83 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.132 . . . . 74.400000000000006 109.286 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 1.3 m 67.65 52.97 0.73 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.483 1.114 . . . . 62.299999999999997 110.031 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -94.42 145.15 24.98 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.489 1.118 . . . . 72.019999999999996 109.268 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.623 HD12 ' N ' ' A' ' 254' ' ' ILE . 3.2 mp -92.7 153.68 3.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.559 1.162 . . . . 73.099999999999994 109.332 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 13.3 t -170.49 178.83 3.54 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.539 1.149 . . . . 54.399999999999999 109.965 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 5.5 tp 56.44 30.33 16.85 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.479 1.112 . . . . 73.310000000000002 109.301 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -48.31 170.0 0.08 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.499 1.124 . . . . 44.520000000000003 111.029 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 21.8 t -47.3 165.17 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.499 0.764 . . . . 75.049999999999997 109.976 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 9.4 p -123.85 137.34 57.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.606 1.191 . . . . 75.540000000000006 109.274 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.513 1.133 . . . . 63.039999999999999 110.314 179.992 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 110.001 -0.37 . . . . 73.340000000000003 110.001 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 93.5 p -124.45 24.61 7.89 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.578 1.173 . . . . 64.420000000000002 109.981 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 27.9 t -66.33 -65.92 0.62 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.486 1.116 . . . . 65.030000000000001 109.976 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -78.0 66.66 3.69 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.477 1.111 . . . . 63.140000000000001 109.328 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -92.53 -47.9 6.9 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.528 1.142 . . . . 72.219999999999999 109.309 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -84.6 160.72 36.17 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.499 1.124 . . . . 74.329999999999998 110.994 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -83.11 -28.42 29.47 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.537 0.787 . . . . 71.329999999999998 109.274 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 470' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -98.16 50.69 1.01 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.511 1.132 . . . . 70.340000000000003 111.004 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 471' ' ' ILE . . . . . 0.722 HG23 ' HD2' ' B' ' 472' ' ' PRO . 27.6 mm -115.36 142.33 28.55 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.494 1.122 . . . . 63.210000000000001 109.353 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 472' ' ' PRO . . . . . 0.722 ' HD2' HG23 ' B' ' 471' ' ' ILE . 18.3 Cg_endo -75.0 127.51 10.73 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.539 1.81 . . . . 70.150000000000006 111.025 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 8.5 t -75.01 -52.87 10.02 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.446 1.091 . . . . 65.450000000000003 109.985 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 474' ' ' ARG . . . . . 0.417 ' HA ' ' NE ' ' B' ' 474' ' ' ARG . 5.2 mmp_? -82.89 160.52 60.66 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 74.420000000000002 110.338 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.01 -166.54 0.35 Allowed 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.441 1.759 . . . . 71.349999999999994 111.012 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 476' ' ' ALA . . . . . 0.94 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . -60.31 136.52 91.64 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 71.230000000000004 109.288 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 477' ' ' PRO . . . . . 0.583 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -74.92 -164.77 0.25 Allowed 'Trans proline' 0 C--N 1.359 1.105 0 O-C-N 124.507 1.793 . . . . 64.120000000000005 110.978 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 90.89 10.98 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.473 1.108 . . . . 64.400000000000006 109.326 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 479' ' ' PRO . . . . . 0.625 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.3 Cg_endo -74.99 166.15 29.83 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.519 1.8 . . . . 71.409999999999997 111.007 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.99 -88.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.443 1.759 . . . . 72.129999999999995 110.984 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 481' ' ' SER . . . . . 0.56 ' HB3' ' CE1' ' A' ' 164' ' ' TYR . 1.7 t -66.36 91.33 0.17 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.49 1.119 . . . . 61.32 109.972 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 17.5 t -156.89 179.13 9.58 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.592 1.183 . . . . 65.129999999999995 109.934 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -49.11 -53.64 19.8 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.506 1.129 . . . . 44.439999999999998 109.278 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 24.3 m 53.54 43.18 31.58 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.488 1.117 . . . . 61.409999999999997 109.94 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -64.48 100.53 0.37 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.505 1.128 . . . . 74.209999999999994 109.259 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 17.0 m . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 53.030000000000001 110.02 -179.972 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.999 0 N-CA-C 110.976 -0.85 . . . . 65.540000000000006 110.976 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 69.1 m -95.51 173.77 7.34 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.47 0.747 . . . . 35.219999999999999 109.932 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.432 HD12 ' O ' ' A' ' 158' ' ' LEU . 2.4 pp -139.78 135.84 33.47 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.496 1.122 . . . . 70.299999999999997 109.362 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.582 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 1.1 p90 -150.54 -171.38 3.91 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.535 1.147 . . . . 73.510000000000005 110.982 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.917 ' HB3' ' CD2' ' A' ' 182' ' ' LEU . . . -121.92 153.77 38.03 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.565 1.166 . . . . 71.510000000000005 109.297 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.501 ' CD1' ' O ' ' A' ' 180' ' ' GLU . 0.2 OUTLIER -122.51 128.52 75.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.491 1.12 . . . . 73.439999999999998 109.318 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.714 HG22 HG12 ' A' ' 212' ' ' VAL . 0.9 OUTLIER -84.65 122.99 38.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.501 1.126 . . . . 75.319999999999993 109.324 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.579 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 0.6 OUTLIER -98.35 -13.81 20.49 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.56 1.163 . . . . 75.299999999999997 109.258 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.605 ' O ' HG13 ' A' ' 162' ' ' VAL . 4.8 m-85 -145.7 161.24 40.35 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.522 1.139 . . . . 75.239999999999995 111.004 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.811 ' N ' HG12 ' A' ' 178' ' ' VAL . 2.5 p30 -101.01 156.78 17.21 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.435 1.084 . . . . 71.140000000000001 109.277 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.603 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 1.3 t80 -153.26 131.42 11.91 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.456 1.098 . . . . 72.219999999999999 111.0 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.603 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 8.9 mtpt -67.04 124.52 23.27 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.471 1.107 . . . . 54.100000000000001 109.267 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.809 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -92.98 135.87 33.77 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.566 1.166 . . . . 61.229999999999997 109.299 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.892 ' H ' ' HZ3' ' A' ' 170' ' ' LYS . 7.8 pt-20 -150.48 20.69 0.83 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.458 1.099 . . . . 70.109999999999999 110.269 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.892 ' HZ3' ' H ' ' A' ' 169' ' ' GLU . 0.1 OUTLIER -106.19 -175.57 2.83 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.463 1.102 . . . . 72.549999999999997 109.333 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.62 -41.03 76.4 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.417 1.073 . . . . 64.450000000000003 109.301 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.616 ' OD1' HD12 ' A' ' 194' ' ' ILE . 72.1 m-20 -94.4 16.93 13.93 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.54 1.15 . . . . 45.039999999999999 109.313 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.809 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 10.5 pt-20 -36.44 97.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 72.319999999999993 110.281 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.485 ' CB ' ' HA2' ' A' ' 205' ' ' GLY . 0.0 OUTLIER -138.22 95.52 3.03 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.439 1.087 . . . . 70.120000000000005 109.339 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 1.2 t -59.53 153.56 19.35 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.556 1.16 . . . . 72.219999999999999 110.446 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 4.9 m -152.51 109.34 3.48 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.436 1.085 . . . . 51.439999999999998 110.425 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.516 ' O ' HG11 ' A' ' 162' ' ' VAL . 14.8 m-85 -52.11 159.14 0.96 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.513 1.133 . . . . 71.439999999999998 111.004 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.811 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.5 m -65.68 158.62 4.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.446 1.091 . . . . 74.120000000000005 109.31 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 48.41 63.12 3.91 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.479 1.112 . . . . 61.340000000000003 111.032 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.501 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 2.0 tp10 -127.99 173.13 10.3 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.526 0.78 . . . . 74.099999999999994 110.278 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -122.68 123.07 40.28 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 71.439999999999998 109.318 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.917 ' CD2' ' HB3' ' A' ' 160' ' ' ALA . 0.0 OUTLIER -130.65 135.06 47.48 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.554 1.159 . . . . 74.400000000000006 109.262 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 8.3 m-30 -89.19 96.83 10.88 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.488 1.117 . . . . 73.439999999999998 110.998 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.858 HD12 ' HB2' ' A' ' 160' ' ' ALA . 51.5 mt -64.34 153.82 7.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 73.099999999999994 109.334 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.492 ' O ' ' CD1' ' A' ' 236' ' ' LEU . 4.3 m -146.52 -44.68 0.19 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.52 1.138 . . . . 73.219999999999999 108.242 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.931 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -112.25 170.91 7.84 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.5 1.125 . . . . 73.510000000000005 109.265 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.641 ' CD2' HD21 ' A' ' 236' ' ' LEU . 2.7 p80 -156.79 165.21 36.86 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 75.140000000000001 109.687 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 1.161 ' CE1' HG11 ' A' ' 239' ' ' VAL . 0.1 OUTLIER -143.7 113.29 7.02 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.49 1.119 . . . . 52.32 109.609 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.473 ' C ' ' N ' ' A' ' 191' ' ' GLU . 88.0 m-20 50.65 41.49 25.93 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.535 1.147 . . . . 75.109999999999999 109.359 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.418 ' C ' ' O ' ' A' ' 189' ' ' ASN . 3.6 m 40.04 30.01 0.06 Allowed 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.463 1.102 . . . . 71.040000000000006 108.333 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.812 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 17.3 tt0 -118.59 -39.69 2.97 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 1.123 . . . . 61.399999999999999 110.307 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.711 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 94.9 m95 -113.14 146.58 38.98 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.532 1.145 . . . . 74.430000000000007 107.927 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.792 ' CE2' HG12 ' A' ' 209' ' ' VAL . 21.5 m-30 -132.87 128.46 36.66 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.475 1.109 . . . . 64.439999999999998 110.957 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.931 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 8.5 mm -95.71 100.5 11.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.548 1.155 . . . . 64.530000000000001 109.324 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.542 ' HB2' ' CG1' ' A' ' 184' ' ' ILE . . . -111.82 171.31 7.57 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.5 1.125 . . . . 72.129999999999995 109.333 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -134.91 148.11 65.61 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.558 1.162 . . . . 74.099999999999994 109.254 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.94 177.51 8.47 Favored 'Trans proline' 0 C--N 1.359 1.123 0 O-C-N 124.481 1.779 . . . . 61.340000000000003 111.003 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 2.4 pt -126.97 67.33 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.576 1.172 . . . . 63.240000000000002 109.282 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -168.87 -84.97 0.06 OUTLIER Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.448 1.092 . . . . 65.150000000000006 111.026 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 39.4 mmt-85 -66.57 -177.94 0.63 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.431 0.724 . . . . 64.319999999999993 110.28 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 8.2 mp -42.19 -50.46 4.84 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.457 1.098 . . . . 75.209999999999994 109.308 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 117.66 168.3 14.5 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.54 1.15 . . . . 72.099999999999994 111.046 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.495 ' HA3' ' C ' ' A' ' 204' ' ' PRO . . . -83.73 -89.02 0.77 Allowed Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.029 -0.828 . . . . 71.129999999999995 111.029 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.495 ' C ' ' HA3' ' A' ' 203' ' ' GLY . 18.2 Cg_endo -75.02 152.99 98.89 Favored 'Cis proline' 0 C--N 1.36 1.153 0 C-N-CA 120.999 -2.501 . . . . 64.150000000000006 111.021 -0.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 195' ' ' ALA . . . -88.07 158.79 29.51 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.434 1.084 . . . . 42.130000000000003 110.979 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.711 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -104.55 143.96 32.34 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.466 0.745 . . . . 62.109999999999999 109.274 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.771 ' CG1' HG11 ' A' ' 212' ' ' VAL . 0.3 OUTLIER -154.44 135.33 8.63 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.461 1.1 . . . . 75.219999999999999 109.296 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 191' ' ' GLU . 18.2 Cg_endo -74.98 174.36 12.92 Favored 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.549 1.816 . . . . 50.450000000000003 110.992 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.792 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -93.36 7.57 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.437 1.086 . . . . 74.439999999999998 109.332 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -108.47 -6.85 30.83 Favored Glycine 0 CA--C 1.529 0.929 0 O-C-N 124.485 1.116 . . . . 52.219999999999999 111.006 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.635 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 5.8 m-85 -121.31 1.64 10.22 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.45 0.735 . . . . 63.25 111.003 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.771 HG11 ' CG1' ' A' ' 207' ' ' VAL . 1.2 m -141.7 166.32 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.552 1.158 . . . . 74.420000000000002 109.226 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 2.1 t -134.76 134.14 40.64 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 42.32 110.042 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 215' ' ' ILE . 3.4 mm -65.29 138.5 23.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.53 1.144 . . . . 74.420000000000002 109.276 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.552 ' CD1' ' CE2' ' A' ' 159' ' ' TYR . 4.1 pt -153.67 131.99 2.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.524 1.14 . . . . 64.150000000000006 109.324 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -133.17 19.83 4.05 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.465 1.103 . . . . 62.240000000000002 109.346 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.778 HD13 ' N ' ' A' ' 218' ' ' ALA . 0.0 OUTLIER -173.65 144.21 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 124.521 1.138 . . . . 63.119999999999997 109.321 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.778 ' N ' HD13 ' A' ' 217' ' ' ILE . . . -46.11 -68.69 0.17 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.526 1.141 . . . . 73.150000000000006 109.327 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 36.3 m -89.12 68.94 8.32 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.519 1.137 . . . . 75.019999999999996 110.388 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.448 ' HA3' ' CG2' ' A' ' 217' ' ' ILE . . . 178.2 160.41 24.48 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.464 1.103 . . . . 72.010000000000005 111.008 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.415 ' C ' ' N ' ' A' ' 223' ' ' THR . 3.1 p90 -154.18 136.4 14.83 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.571 0.806 . . . . 72.319999999999993 110.958 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 225' ' ' ASN . . . 43.77 27.49 0.18 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.499 1.124 . . . . 73.120000000000005 109.326 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.681 HG23 ' O ' ' A' ' 223' ' ' THR . 1.1 t 38.53 30.11 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.406 1.066 . . . . 45.520000000000003 110.414 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 222' ' ' ALA . . . 86.81 -45.65 3.46 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.489 1.118 . . . . 53.119999999999997 111.02 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.542 ' O ' ' HB1' ' A' ' 222' ' ' ALA . 43.9 m-80 -63.46 146.1 54.29 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.461 0.742 . . . . 71.540000000000006 109.277 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 229' ' ' GLU . 11.7 t0 -60.24 144.58 49.93 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.47 1.106 . . . . 73.540000000000006 109.218 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -43.81 -44.59 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.528 1.143 . . . . 74.019999999999996 109.265 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.884 ' HA ' HD12 ' A' ' 231' ' ' ILE . 6.7 mt -66.22 -39.95 85.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 70.219999999999999 109.295 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.463 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 18.6 mt-10 -71.82 -18.04 62.11 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.443 1.09 . . . . 63.030000000000001 110.318 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 226' ' ' ASP . 11.3 t70 -88.79 -15.73 33.87 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.135 . . . . 71.109999999999999 109.326 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.884 HD12 ' HA ' ' A' ' 228' ' ' ILE . 4.7 mt -72.68 -69.59 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.518 1.136 . . . . 64.010000000000005 109.281 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.463 ' CD ' ' HA ' ' A' ' 229' ' ' GLU . 0.0 OUTLIER -53.29 -31.71 45.17 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.44 1.087 . . . . 72.319999999999993 109.33 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.421 ' N ' ' HG2' ' A' ' 232' ' ' LYS . 1.5 m -41.01 -61.06 1.05 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.53 1.144 . . . . 50.049999999999997 110.001 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.486 ' O ' ' CB ' ' A' ' 235' ' ' ASN . 1.4 m -74.96 -20.46 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.491 1.119 . . . . 74.349999999999994 109.315 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 234' ' ' VAL . 16.6 t-20 80.74 29.11 0.2 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.474 1.109 . . . . 73.439999999999998 109.272 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.641 HD21 ' CD2' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -72.99 119.43 75.52 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.467 1.104 . . . . 73.340000000000003 109.31 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.93 -174.02 1.77 Allowed 'Trans proline' 0 C--N 1.36 1.151 0 O-C-N 124.559 1.82 . . . . 74.219999999999999 111.064 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.429 HG22 ' H ' ' A' ' 239' ' ' VAL . 1.4 m -73.57 -179.92 3.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.443 1.089 . . . . 73.349999999999994 110.407 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 1.161 HG11 ' CE1' ' A' ' 188' ' ' HIS . 1.0 OUTLIER -69.98 -50.75 45.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.528 1.142 . . . . 73.400000000000006 109.282 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.522 ' N ' ' CG2' ' A' ' 239' ' ' VAL . 0.1 OUTLIER -69.45 -15.3 63.25 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.371 1.044 . . . . 72.219999999999999 110.305 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -89.66 -37.47 14.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.55 1.156 . . . . 73.019999999999996 110.281 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.488 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 1.2 t90 -85.54 -62.5 1.51 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.529 1.143 . . . . 61.020000000000003 108.036 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.514 ' HE2' ' CG ' ' B' ' 470' ' ' PHE . 17.6 mtpp -50.67 -24.2 3.17 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.481 1.113 . . . . 74.319999999999993 109.268 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -39.44 -65.86 0.34 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.532 1.145 . . . . 73.120000000000005 109.971 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 247' ' ' ALA . 53.3 t30 -118.68 105.33 11.47 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.52 1.138 . . . . 73.319999999999993 109.32 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 2.8 mm -53.21 -39.39 34.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.39 1.056 . . . . 64.319999999999993 109.302 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.582 ' O ' ' CD1' ' A' ' 249' ' ' TYR . . . -91.92 92.82 8.51 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.565 1.165 . . . . 75.519999999999996 109.327 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . 0.429 ' N ' ' HD2' ' A' ' 248' ' ' ARG . 0.5 OUTLIER -42.74 129.15 4.22 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.552 1.157 . . . . 75.349999999999994 110.287 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 247' ' ' ALA . 5.7 m-30 -114.76 43.69 1.9 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.557 1.16 . . . . 65.450000000000003 110.957 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -98.44 130.0 45.06 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.555 1.159 . . . . 74.140000000000001 109.334 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -55.82 -56.39 21.18 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.544 1.153 . . . . 55.229999999999997 109.293 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 23.8 t -86.06 142.61 28.6 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.5 1.125 . . . . 72.430000000000007 110.033 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -157.28 154.71 29.53 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.466 1.104 . . . . 64.439999999999998 109.304 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 6.0 mm -135.18 160.25 40.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.565 1.166 . . . . 74.030000000000001 109.344 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 2.9 t -174.04 140.65 0.72 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.523 1.14 . . . . 62.439999999999998 109.995 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.89 162.47 12.97 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.414 1.072 . . . . 71.5 109.285 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -95.14 144.34 17.15 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.433 1.083 . . . . 74.219999999999999 111.009 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 3.0 m -150.93 143.56 24.4 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.499 0.764 . . . . 33.210000000000001 109.976 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 46.2 t -117.53 82.32 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.567 1.167 . . . . 71.120000000000005 109.264 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.469 1.106 . . . . 61.420000000000002 110.252 -179.99 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 110.001 -0.37 . . . . 74.420000000000002 110.001 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 3.3 m -92.94 8.31 40.3 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.54 1.15 . . . . 73.420000000000002 110.06 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 33.7 p -112.88 -56.23 2.43 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.508 1.13 . . . . 73.409999999999997 110.041 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -119.01 125.92 50.5 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 73.540000000000006 109.319 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -136.09 126.51 26.77 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 71.530000000000001 109.342 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -66.54 -168.59 3.07 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.523 1.139 . . . . 74.109999999999999 111.005 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -121.91 144.11 49.05 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.474 0.75 . . . . 75.239999999999995 109.327 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 470' ' ' PHE . . . . . 0.514 ' CG ' ' HE2' ' A' ' 243' ' ' LYS . 6.0 m-30 55.64 17.07 2.17 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.53 1.144 . . . . 73.120000000000005 111.008 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 471' ' ' ILE . . . . . 0.48 ' CG2' ' HD2' ' B' ' 472' ' ' PRO . 27.0 mm -66.63 140.2 96.32 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.544 1.152 . . . . 75.519999999999996 109.293 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 472' ' ' PRO . . . . . 0.48 ' HD2' ' CG2' ' B' ' 471' ' ' ILE . 18.3 Cg_endo -74.92 173.65 14.11 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.492 1.785 . . . . 73.540000000000006 111.013 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 81.8 p -103.56 -47.36 4.28 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.482 1.114 . . . . 34.219999999999999 109.998 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 474' ' ' ARG . . . . . 0.401 ' NE ' ' HA ' ' B' ' 474' ' ' ARG . 11.5 mmp_? -92.94 159.36 35.95 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.61 1.194 . . . . 65.329999999999998 110.319 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 475' ' ' PRO . . . . . 0.583 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.3 Cg_endo -74.99 -38.68 1.48 Allowed 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.486 1.782 . . . . 63.539999999999999 110.965 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 476' ' ' ALA . . . . . 0.812 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . 171.2 128.39 0.06 OUTLIER Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.531 1.144 . . . . 72.030000000000001 109.319 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 477' ' ' PRO . . . . . 0.575 ' HD3' ' CH2' ' A' ' 192' ' ' TRP . 18.2 Cg_endo -75.0 -161.77 0.13 Allowed 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.457 1.767 . . . . 61.329999999999998 110.978 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 478' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -139.92 107.14 6.89 Favored Pre-proline 0 C--N 1.324 -0.529 0 O-C-N 124.497 1.123 . . . . 74.420000000000002 109.329 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 479' ' ' PRO . . . . . 0.635 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.98 162.5 37.07 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.49 1.784 . . . . 44.140000000000001 111.027 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.04 -84.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.476 1.777 . . . . 70.540000000000006 110.932 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 481' ' ' SER . . . . . 0.484 ' HB3' ' CE1' ' A' ' 164' ' ' TYR . 13.7 t -42.76 -31.06 0.43 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.496 1.123 . . . . 52.43 110.036 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 4.1 t -104.92 83.86 2.06 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.553 1.158 . . . . 73.349999999999994 110.0 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -116.13 170.66 8.34 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.469 1.105 . . . . 64.340000000000003 109.292 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 3.5 m -167.39 111.56 0.7 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.497 1.123 . . . . 71.129999999999995 109.995 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -82.54 164.52 20.81 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.489 1.118 . . . . 73.129999999999995 109.293 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.54 1.15 . . . . 61.229999999999997 109.954 -179.977 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.017 0 N-CA-C 111.005 -0.838 . . . . 73.340000000000003 111.005 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.6 p -123.32 146.57 47.81 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.501 0.766 . . . . 72.450000000000003 110.048 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.946 ' O ' HD22 ' A' ' 158' ' ' LEU . 0.0 OUTLIER -151.05 123.11 8.21 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.581 1.176 . . . . 75.340000000000003 109.332 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.598 ' CZ ' ' CD2' ' A' ' 183' ' ' PHE . 9.2 m-85 -124.42 -170.21 2.11 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 74.409999999999997 110.941 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.938 ' HB3' ' CD2' ' A' ' 182' ' ' LEU . . . -132.1 130.71 41.58 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.458 1.099 . . . . 71.310000000000002 109.252 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.948 HG21 HD11 ' A' ' 215' ' ' ILE . 0.1 OUTLIER -107.96 118.29 55.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.487 1.117 . . . . 64.420000000000002 109.265 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 1.033 ' CG1' HD11 ' A' ' 182' ' ' LEU . 0.6 OUTLIER -84.15 123.26 38.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 74.230000000000004 109.251 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.441 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 0.3 OUTLIER -98.78 -11.61 21.69 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 74.329999999999998 109.392 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.441 ' CE2' ' HB2' ' A' ' 163' ' ' LEU . 8.4 m-85 -140.89 162.19 36.03 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.541 1.15 . . . . 74.400000000000006 111.01 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.822 ' N ' HG12 ' A' ' 178' ' ' VAL . 1.1 p30 -93.29 160.14 14.96 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.501 1.126 . . . . 42.200000000000003 109.273 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.677 ' HZ ' ' HZ1' ' A' ' 170' ' ' LYS . 28.3 t80 -157.2 133.27 9.58 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.458 1.099 . . . . 74.420000000000002 110.954 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -79.45 123.6 27.68 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.533 1.145 . . . . 75.25 109.287 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.852 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -96.68 142.08 29.14 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.453 1.096 . . . . 74.430000000000007 109.326 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -153.73 22.67 0.52 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.406 1.066 . . . . 75.450000000000003 110.253 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.677 ' HZ1' ' HZ ' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -102.75 -176.35 3.07 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.571 1.169 . . . . 62.439999999999998 109.267 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.89 -28.89 67.95 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.465 1.103 . . . . 71.510000000000005 109.284 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' A' ' 173' ' ' GLU . 15.2 m-20 -105.8 16.07 25.78 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.463 1.102 . . . . 73.209999999999994 109.258 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.852 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 5.3 pt-20 -36.27 105.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.54 1.15 . . . . 75.230000000000004 110.326 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 173' ' ' GLU . 0.2 OUTLIER -141.59 95.04 2.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 55.229999999999997 109.281 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.2 t -62.86 153.16 34.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 72.150000000000006 110.434 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 81.8 m -152.91 110.75 3.6 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.554 1.159 . . . . 64.450000000000003 110.37 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -53.39 156.76 2.28 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.507 1.129 . . . . 61.130000000000003 110.991 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.822 HG12 ' N ' ' A' ' 165' ' ' ASP . 2.5 m -58.21 158.19 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.431 1.082 . . . . 71.349999999999994 109.327 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.31 72.41 0.49 Allowed Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.568 1.168 . . . . 31.210000000000001 110.957 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.566 ' N ' HG22 ' A' ' 162' ' ' VAL . 1.2 tt0 -137.19 168.12 20.24 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.507 0.769 . . . . 64.450000000000003 110.354 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.483 ' C ' HD13 ' A' ' 182' ' ' LEU . 0.5 OUTLIER -134.07 124.52 26.33 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.521 1.138 . . . . 72.0 109.293 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 1.033 HD11 ' CG1' ' A' ' 162' ' ' VAL . 0.0 OUTLIER -128.58 162.47 27.21 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.582 1.176 . . . . 73.219999999999999 109.258 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.598 ' CD2' ' CZ ' ' A' ' 159' ' ' TYR . 0.9 OUTLIER -104.75 105.35 15.39 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.594 1.184 . . . . 75.019999999999996 110.972 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.967 HD13 ' HB2' ' A' ' 195' ' ' ALA . 45.3 mm -59.05 163.81 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.599 1.187 . . . . 60.509999999999998 109.32 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.47 ' N ' HG22 ' A' ' 184' ' ' ILE . 5.0 m -149.08 -45.41 0.14 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.478 1.111 . . . . 73.120000000000005 108.214 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 1.028 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -123.35 169.94 10.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.418 1.074 . . . . 74.420000000000002 109.34 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.563 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.2 OUTLIER -155.15 143.95 20.7 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.444 1.09 . . . . 72.319999999999993 109.634 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.554 ' CE1' ' HD3' ' B' ' 472' ' ' PRO . 0.2 OUTLIER -145.04 138.46 26.74 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 73.230000000000004 109.593 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.488 ' C ' ' N ' ' A' ' 191' ' ' GLU . 20.2 t-20 49.84 23.46 1.04 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.534 1.146 . . . . 73.329999999999998 109.284 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.53 ' HB3' HD13 ' A' ' 231' ' ' ILE . 6.4 m 40.74 28.9 0.06 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.46 1.1 . . . . 70.510000000000005 108.327 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.636 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 12.0 tt0 -124.34 -35.19 2.81 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 124.529 1.143 . . . . 72.329999999999998 110.283 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.595 ' CE3' HD21 ' A' ' 206' ' ' LEU . 95.1 m95 -118.36 133.22 56.06 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.512 1.132 . . . . 74.239999999999995 108.047 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.864 ' HB3' HD12 ' A' ' 184' ' ' ILE . 23.1 m-30 -123.48 144.3 49.61 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.548 1.155 . . . . 74.540000000000006 111.016 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 1.028 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 1.2 mp -101.78 96.15 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 124.457 1.098 . . . . 75.140000000000001 109.278 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.967 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -103.65 -178.81 3.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.45 1.093 . . . . 73.129999999999995 109.288 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -150.17 157.51 37.25 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 75.019999999999996 109.296 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 178.14 7.66 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.446 1.761 . . . . 75.450000000000003 110.966 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -97.26 3.1 10.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.458 1.099 . . . . 73.129999999999995 109.296 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 130.39 51.19 0.11 Allowed Glycine 0 CA--C 1.529 0.947 0 O-C-N 124.472 1.108 . . . . 65.329999999999998 111.039 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.434 ' CB ' ' CZ ' ' A' ' 200' ' ' ARG . 8.4 ttp-105 -140.28 -82.33 0.25 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.438 0.728 . . . . 64.5 110.349 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.499 ' HA ' HD13 ' A' ' 201' ' ' LEU . 1.4 mm? -59.55 -176.53 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.497 1.123 . . . . 73.109999999999999 109.252 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -105.29 54.85 0.59 Allowed Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.387 1.054 . . . . 73.010000000000005 111.006 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -48.58 178.39 0.01 OUTLIER Glycine 0 CA--C 1.53 0.983 0 N-CA-C 111.018 -0.833 . . . . 71.540000000000006 111.018 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.538 ' HG2' ' CZ ' ' B' ' 470' ' ' PHE . 18.2 Cg_endo -75.06 143.41 77.67 Favored 'Cis proline' 0 C--N 1.36 1.133 0 C-N-CA 120.954 -2.519 . . . . 75.209999999999994 110.988 0.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.491 ' CA ' ' HG ' ' A' ' 174' ' ' LEU . . . -106.0 140.71 15.25 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.481 1.113 . . . . 64.219999999999999 111.038 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.595 HD21 ' CE3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -89.57 145.02 25.56 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.487 0.757 . . . . 74.140000000000001 109.303 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.411 ' N ' ' HG ' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -153.29 132.69 7.11 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.47 1.106 . . . . 75.019999999999996 109.291 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.617 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.1 Cg_endo -75.06 176.29 10.12 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.46 1.768 . . . . 73.519999999999996 111.017 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.883 ' HB ' HG21 ' A' ' 227' ' ' VAL . 0.8 OUTLIER -98.17 -5.11 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.494 1.121 . . . . 64.219999999999999 109.298 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . 0.465 ' O ' ' CB ' ' B' ' 479' ' ' PRO . . . -90.73 -14.06 58.64 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.507 1.129 . . . . 65.349999999999994 110.948 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.609 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 15.6 m-85 -122.38 12.98 10.21 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.453 0.737 . . . . 75.099999999999994 110.939 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 208' ' ' PRO . 1.0 OUTLIER -152.45 160.14 3.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.424 1.077 . . . . 72.510000000000005 109.321 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 1.5 t -123.91 122.82 38.97 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.52 1.138 . . . . 74.040000000000006 109.997 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.835 ' O ' HG23 ' A' ' 215' ' ' ILE . 4.0 mm -62.97 104.18 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.528 1.142 . . . . 70.129999999999995 109.346 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.948 HD11 HG21 ' A' ' 161' ' ' ILE . 3.1 pt -163.71 -170.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.497 1.123 . . . . 64.310000000000002 109.262 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.537 ' OD1' ' CD1' ' A' ' 159' ' ' TYR . 3.5 t0 -126.57 -153.03 0.54 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.499 1.124 . . . . 54.399999999999999 109.278 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . 0.702 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 12.5 tt -64.44 165.45 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.449 1.093 . . . . 64.239999999999995 109.334 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.702 ' HB3' ' O ' ' A' ' 217' ' ' ILE . . . 83.94 3.7 0.82 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.434 1.084 . . . . 71.430000000000007 109.343 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 8.7 p 50.17 22.45 0.95 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.526 1.141 . . . . 73.109999999999999 110.397 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -155.58 121.91 1.15 Allowed Glycine 0 CA--C 1.531 1.085 0 O-C-N 124.482 1.114 . . . . 70.25 110.969 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.653 ' HB3' HG22 ' A' ' 215' ' ' ILE . 8.6 t80 -163.11 176.29 10.19 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.502 0.766 . . . . 73.25 111.019 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.48 ' HB1' ' HB2' ' A' ' 225' ' ' ASN . . . 42.76 27.33 0.09 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.447 1.092 . . . . 72.209999999999994 109.313 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.447 ' N ' ' C ' ' A' ' 221' ' ' TYR . 13.1 t 37.85 30.37 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.496 1.123 . . . . 75.530000000000001 110.383 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 222' ' ' ALA . . . 69.05 50.71 32.51 Favored Glycine 0 CA--C 1.531 1.047 0 O-C-N 124.475 1.109 . . . . 62.329999999999998 110.986 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.48 ' HB2' ' HB1' ' A' ' 222' ' ' ALA . 14.2 m-20 -72.72 176.94 5.11 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.478 0.752 . . . . 72.120000000000005 109.304 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 229' ' ' GLU . 0.4 OUTLIER -81.66 128.78 34.31 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.478 1.111 . . . . 73.150000000000006 109.301 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.883 HG21 ' HB ' ' A' ' 209' ' ' VAL . 13.8 p -42.63 -48.59 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.483 1.114 . . . . 53.509999999999998 109.306 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.582 ' HA ' HD12 ' A' ' 231' ' ' ILE . 2.3 mp -61.7 -40.59 87.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.466 1.103 . . . . 72.239999999999995 109.273 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.458 ' HA ' ' CD ' ' A' ' 232' ' ' LYS . 19.4 mt-10 -67.99 -17.65 64.49 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.555 1.159 . . . . 54.119999999999997 110.303 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.65 ' HB3' HG21 ' A' ' 214' ' ' ILE . 13.2 m-20 -88.84 -15.7 33.85 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.54 1.15 . . . . 64.299999999999997 109.312 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 228' ' ' ILE . 1.9 mt -77.13 -69.61 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.439 1.087 . . . . 74.340000000000003 109.311 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.497 ' CE ' ' O ' ' A' ' 228' ' ' ILE . 0.0 OUTLIER -62.37 -16.29 53.68 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.587 1.179 . . . . 63.299999999999997 109.297 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.74 -21.49 2.8 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.488 1.118 . . . . 61.409999999999997 109.984 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 234' ' ' VAL . 1.0 OUTLIER -138.54 28.39 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.468 1.105 . . . . 74.319999999999993 109.275 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.409 ' C ' ' O ' ' A' ' 234' ' ' VAL . 1.9 m-80 39.83 44.69 1.39 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.564 1.165 . . . . 64.140000000000001 109.275 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' A' ' 187' ' ' HIS . 4.1 tp -74.4 119.47 76.67 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.491 1.12 . . . . 62.0 109.317 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.06 162.29 37.23 Favored 'Trans proline' 0 C--N 1.361 1.208 0 O-C-N 124.46 1.768 . . . . 63.539999999999999 110.995 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.43 ' N ' ' HB2' ' A' ' 241' ' ' GLU . 1.6 m -59.75 159.6 8.56 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.483 1.114 . . . . 74.319999999999993 110.442 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.591 HG13 ' H ' ' A' ' 240' ' ' GLN . 6.4 p -52.5 -59.43 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.564 1.165 . . . . 74.209999999999994 109.332 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.591 ' H ' HG13 ' A' ' 239' ' ' VAL . 0.0 OUTLIER -65.32 -15.98 63.11 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.55 1.156 . . . . 43.43 110.291 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.43 ' HB2' ' N ' ' A' ' 238' ' ' THR . 14.8 mm-40 -80.55 -37.69 30.98 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.536 1.148 . . . . 73.219999999999999 110.329 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.693 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 0.3 OUTLIER -82.77 -57.15 3.44 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.511 1.132 . . . . 73.430000000000007 108.006 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.584 ' HD2' ' CD2' ' B' ' 470' ' ' PHE . 19.6 mtpp -58.33 -18.28 26.15 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.518 1.136 . . . . 64.209999999999994 109.312 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -42.58 -54.31 4.01 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.492 1.12 . . . . 51.130000000000003 110.017 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -155.32 137.38 14.64 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.419 1.074 . . . . 74.299999999999997 109.341 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 34.3 mm -74.77 -61.74 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.471 1.107 . . . . 73.430000000000007 109.302 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -93.8 108.75 20.48 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.116 . . . . 62.450000000000003 109.3 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . 0.496 ' HD2' ' CD2' ' A' ' 249' ' ' TYR . 6.1 tmm_? -120.95 126.91 51.18 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.436 1.085 . . . . 73.430000000000007 110.286 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.496 ' CD2' ' HD2' ' A' ' 248' ' ' ARG . 48.3 p90 -43.4 131.71 4.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.564 1.165 . . . . 72.129999999999995 110.978 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 251' ' ' ALA . 7.4 tptm -140.73 137.99 33.86 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.507 1.129 . . . . 74.420000000000002 109.357 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 250' ' ' LYS . . . 69.78 12.83 8.05 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.475 1.11 . . . . 72.219999999999999 109.297 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 3.1 p -95.67 162.39 13.63 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.531 1.144 . . . . 74.120000000000005 110.084 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -42.54 162.37 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.524 1.14 . . . . 71.439999999999998 109.358 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.5 HD12 ' N ' ' A' ' 254' ' ' ILE . 3.8 mp -130.54 159.42 42.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 O-C-N 124.492 1.12 . . . . 74.230000000000004 109.338 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 2.0 t -156.45 113.42 3.14 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.505 1.128 . . . . 63.130000000000003 110.012 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.402 ' N ' HD23 ' A' ' 256' ' ' LEU . 0.1 OUTLIER -119.36 -177.65 3.41 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.521 1.138 . . . . 75.450000000000003 109.313 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -139.66 -175.81 14.48 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.553 1.158 . . . . 61.350000000000001 110.992 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 7.8 p -133.99 45.77 2.59 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.522 0.778 . . . . 73.340000000000003 109.971 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 2.7 p -74.44 153.88 6.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.476 1.11 . . . . 65.319999999999993 109.301 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' A' ' 260' ' ' GLU . 9.1 pt-20 . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.459 1.099 . . . . 71.439999999999998 110.281 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 109.999 -0.371 . . . . 74.120000000000005 109.999 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 1.7 p -160.96 165.61 29.67 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.528 1.143 . . . . 75.420000000000002 110.011 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 1.9 t -111.52 -70.08 0.83 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.576 1.172 . . . . 71.230000000000004 109.953 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -130.4 177.29 7.46 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.383 1.052 . . . . 63.450000000000003 109.344 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -128.23 101.02 6.07 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 73.299999999999997 109.27 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -78.1 -164.01 23.33 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.457 1.098 . . . . 42.340000000000003 111.027 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -109.38 -14.82 14.37 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.486 0.756 . . . . 74.019999999999996 109.312 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 470' ' ' PHE . . . . . 0.584 ' CD2' ' HD2' ' A' ' 243' ' ' LYS . 4.8 m-30 -91.92 1.14 57.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.48 1.112 . . . . 53.310000000000002 110.98 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 471' ' ' ILE . . . . . 0.571 ' N ' HD13 ' B' ' 471' ' ' ILE . 3.1 mm -67.63 140.01 94.26 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.567 1.167 . . . . 75.299999999999997 109.296 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 472' ' ' PRO . . . . . 0.554 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.97 -174.37 1.9 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.487 1.783 . . . . 74.120000000000005 110.987 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.56 14.62 4.47 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.523 1.139 . . . . 64.030000000000001 109.994 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -143.21 159.32 56.06 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.516 1.135 . . . . 75.409999999999997 110.379 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 475' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.2 Cg_endo -74.97 -53.22 0.1 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 O-C-N 124.551 1.817 . . . . 70.129999999999995 111.013 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 476' ' ' ALA . . . . . 0.636 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . 179.19 140.73 0.28 Allowed Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.482 1.113 . . . . 73.530000000000001 109.286 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 477' ' ' PRO . . . . . 0.571 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.4 Cg_endo -74.96 -162.35 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.45 1.763 . . . . 75.519999999999996 110.991 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.5 90.93 22.85 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.545 1.153 . . . . 61.140000000000001 109.289 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 479' ' ' PRO . . . . . 0.609 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.4 Cg_endo -74.92 144.32 30.42 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.559 1.821 . . . . 73.239999999999995 110.994 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 163.23 35.74 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.472 1.775 . . . . 71.400000000000006 111.054 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 481' ' ' SER . . . . . . . . . . . . . 1.2 t 39.62 40.34 0.62 Allowed 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.455 1.097 . . . . 74.239999999999995 109.963 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 28.5 t -76.25 127.17 32.36 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.511 1.132 . . . . 70.340000000000003 109.919 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -88.16 -19.38 27.02 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.471 1.107 . . . . 74.450000000000003 109.309 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 1.3 t -93.37 21.1 6.4 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.524 1.14 . . . . 70.310000000000002 110.021 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -108.41 53.17 0.69 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.472 1.108 . . . . 64.299999999999997 109.287 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 76.0 p . . . . . 0 C--N 1.326 -0.454 0 O-C-N 124.419 1.075 . . . . 44.5 109.978 179.985 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.035 0 N-CA-C 110.985 -0.846 . . . . 42.310000000000002 110.985 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.9 t -105.0 112.89 26.19 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.556 0.797 . . . . 72.129999999999995 109.995 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -155.67 128.5 7.99 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.53 1.144 . . . . 70.120000000000005 109.227 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 8.7 m-85 -122.74 -176.55 3.42 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.478 1.111 . . . . 53.240000000000002 110.957 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 182' ' ' LEU . . . -120.53 148.81 43.36 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.475 1.109 . . . . 74.239999999999995 109.37 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.622 HG21 HD11 ' A' ' 215' ' ' ILE . 0.1 OUTLIER -132.8 134.13 58.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.512 1.132 . . . . 71.329999999999998 109.31 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.978 HG22 HG12 ' A' ' 212' ' ' VAL . 2.3 t -92.92 120.93 43.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.427 1.079 . . . . 72.219999999999999 109.327 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.511 ' CD2' HG23 ' A' ' 161' ' ' ILE . 0.7 OUTLIER -97.76 -14.14 20.99 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.522 1.139 . . . . 71.140000000000001 109.331 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.676 ' O ' HG13 ' A' ' 162' ' ' VAL . 1.8 m-85 -145.48 157.72 43.96 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.419 1.074 . . . . 73.209999999999994 111.03 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.776 ' N ' HG12 ' A' ' 178' ' ' VAL . 16.8 p-10 -97.57 158.96 15.21 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.546 1.154 . . . . 74.129999999999995 109.291 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.555 ' CE1' ' O ' ' A' ' 167' ' ' LYS . 1.6 t80 -157.89 131.3 7.7 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.466 1.104 . . . . 71.430000000000007 111.048 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.555 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 2.9 mmpt? -67.9 123.54 20.86 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.514 1.134 . . . . 72.049999999999997 109.376 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.831 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -102.63 141.24 35.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.53 1.144 . . . . 71.129999999999995 109.293 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -151.39 21.33 0.73 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.488 1.117 . . . . 73.439999999999998 110.254 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.464 ' HZ1' ' HZ ' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -96.0 -176.3 3.65 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.118 . . . . 64.420000000000002 109.298 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.23 -22.5 64.85 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.462 1.101 . . . . 74.120000000000005 109.311 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.412 ' O ' ' C ' ' A' ' 173' ' ' GLU . 1.5 m-20 -116.07 20.77 14.2 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.512 1.132 . . . . 74.430000000000007 109.334 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.831 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 6.9 pt-20 -38.11 109.71 0.11 Allowed 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.464 1.103 . . . . 73.420000000000002 110.295 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.696 HD13 ' HA3' ' A' ' 205' ' ' GLY . 9.6 tp -121.18 106.71 11.78 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.51 1.131 . . . . 70.319999999999993 109.308 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 175' ' ' THR . 11.2 t -81.12 107.67 14.12 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.528 1.142 . . . . 72.519999999999996 110.405 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.753 HG23 ' CD ' ' A' ' 180' ' ' GLU . 0.9 OUTLIER -129.86 142.35 50.68 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.5 1.125 . . . . 72.420000000000002 110.322 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -86.21 167.61 14.71 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.546 1.154 . . . . 74.439999999999998 110.959 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.776 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.8 m -63.19 158.16 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.503 1.127 . . . . 53.210000000000001 109.303 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 162' ' ' VAL . . . 52.76 58.33 11.73 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.526 1.141 . . . . 75.150000000000006 111.033 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.753 ' CD ' HG23 ' A' ' 176' ' ' THR . 1.4 tt0 -114.14 170.69 8.1 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.461 0.742 . . . . 75.040000000000006 110.281 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -126.46 121.75 33.27 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.512 1.133 . . . . 74.430000000000007 109.35 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.847 ' CD1' HG21 ' A' ' 207' ' ' VAL . 1.5 pt? -142.91 140.64 31.24 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.496 1.122 . . . . 73.140000000000001 109.317 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' A' ' 195' ' ' ALA . 32.7 t80 -100.4 114.33 27.8 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.406 1.066 . . . . 74.430000000000007 111.026 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.64 HG13 ' HB2' ' A' ' 195' ' ' ALA . 19.8 mt -72.82 145.69 11.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.554 1.159 . . . . 74.420000000000002 109.288 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.618 ' O ' HD12 ' A' ' 236' ' ' LEU . 6.0 t -135.34 -41.01 0.72 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 72.030000000000001 108.275 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 1.053 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -112.87 167.46 10.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.475 1.109 . . . . 73.420000000000002 109.361 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.868 ' CD2' HD21 ' A' ' 236' ' ' LEU . 0.1 OUTLIER -156.94 155.34 31.2 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.521 1.138 . . . . 61.149999999999999 109.573 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.578 ' CE1' ' HD3' ' B' ' 472' ' ' PRO . 1.3 p80 -158.31 142.09 15.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.416 1.072 . . . . 74.409999999999997 109.642 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.472 ' C ' ' N ' ' A' ' 191' ' ' GLU . 61.6 t30 53.07 22.93 2.72 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.133 . . . . 73.420000000000002 109.338 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.432 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.8 p 38.92 30.32 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 61.32 108.277 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.525 ' O ' HG13 ' A' ' 209' ' ' VAL . 3.1 tt0 -132.62 -39.26 1.0 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.485 1.115 . . . . 74.019999999999996 110.274 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.726 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 99.0 m95 -108.53 129.03 55.3 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.568 1.168 . . . . 74.319999999999993 108.029 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.772 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.3 m-30 -121.05 145.27 47.96 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.44 1.087 . . . . 71.120000000000005 111.018 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 1.053 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 4.2 mm -103.11 101.89 12.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.472 1.108 . . . . 54.299999999999997 109.259 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.64 ' HB2' HG13 ' A' ' 184' ' ' ILE . . . -112.23 168.97 9.19 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.43 1.081 . . . . 62.310000000000002 109.296 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.04 149.7 72.31 Favored Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.453 1.095 . . . . 74.209999999999994 109.268 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.98 178.1 7.71 Favored 'Trans proline' 0 C--N 1.361 1.202 0 O-C-N 124.444 1.76 . . . . 65.019999999999996 110.966 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.435 ' N ' HD13 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -132.14 91.68 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.56 1.163 . . . . 74.140000000000001 109.305 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 146.75 -62.11 0.46 Allowed Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.561 1.163 . . . . 52.32 110.97 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -92.52 170.19 9.95 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 0.775 . . . . 61.329999999999998 110.316 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 14.8 tp -104.84 66.68 0.78 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.494 1.121 . . . . 54.520000000000003 109.29 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . -103.03 -57.49 0.77 Allowed Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.569 1.168 . . . . 43.520000000000003 110.941 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.406 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . -48.71 179.53 0.01 OUTLIER Glycine 0 CA--C 1.529 0.931 0 N-CA-C 111.01 -0.836 . . . . 51.299999999999997 111.01 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.98 123.15 8.79 Favored 'Cis proline' 0 C--N 1.36 1.184 0 C-N-CA 120.993 -2.503 . . . . 64.120000000000005 111.013 -0.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.696 ' HA3' HD13 ' A' ' 174' ' ' LEU . . . -97.05 157.16 21.02 Favored Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.452 1.095 . . . . 54.509999999999998 111.019 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.726 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.0 OUTLIER -93.65 148.51 22.04 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.536 0.786 . . . . 73.109999999999999 109.33 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.847 HG21 ' CD1' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -157.15 125.93 3.0 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.551 1.157 . . . . 71.340000000000003 109.298 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.948 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.3 Cg_endo -74.99 173.58 14.27 Favored 'Trans proline' 0 C--N 1.359 1.085 0 O-C-N 124.501 1.79 . . . . 71.010000000000005 110.977 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.772 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -94.18 6.84 6.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.522 1.139 . . . . 42.210000000000001 109.309 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . 0.441 ' O ' ' CG ' ' B' ' 479' ' ' PRO . . . -106.18 -7.46 35.26 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.536 1.148 . . . . 72.510000000000005 111.038 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.616 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 10.7 m-85 -127.73 2.79 6.08 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.507 0.769 . . . . 61.409999999999997 110.981 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.978 HG12 HG22 ' A' ' 162' ' ' VAL . 2.6 m -143.62 162.53 16.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 73.200000000000003 109.268 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 30.5 t -132.63 142.49 49.13 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.515 1.134 . . . . 70.530000000000001 110.02 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.557 ' O ' HG23 ' A' ' 215' ' ' ILE . 4.2 mm -86.13 113.77 24.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.528 1.143 . . . . 71.0 109.301 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.625 HG22 ' HA ' ' A' ' 221' ' ' TYR . 25.8 pt -156.14 179.58 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.523 1.139 . . . . 63.350000000000001 109.334 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.563 ' OD2' ' HB3' ' A' ' 218' ' ' ALA . 38.5 p-10 -145.78 -174.38 4.4 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.498 1.124 . . . . 75.310000000000002 109.31 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 9.6 tp -59.63 -16.55 10.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.416 1.073 . . . . 54.299999999999997 109.306 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.563 ' HB3' ' OD2' ' A' ' 216' ' ' ASP . . . -71.18 169.1 15.82 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.506 1.129 . . . . 72.450000000000003 109.24 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.4 ' OG1' ' N ' ' A' ' 220' ' ' GLY . 9.1 t -76.31 -170.22 1.4 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.513 1.133 . . . . 64.030000000000001 110.383 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.4 ' N ' ' OG1' ' A' ' 219' ' ' THR . . . 41.91 -124.56 3.49 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.529 1.143 . . . . 74.120000000000005 111.001 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.625 ' HA ' HG22 ' A' ' 215' ' ' ILE . 29.0 m-85 -107.94 -177.69 3.41 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.495 0.762 . . . . 65.120000000000005 111.041 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.464 ' CA ' ' HA ' ' A' ' 215' ' ' ILE . . . -43.25 -71.6 0.08 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.485 1.116 . . . . 73.219999999999999 109.321 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.533 HG23 ' HB2' ' A' ' 225' ' ' ASN . 7.6 t -135.49 9.6 3.42 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.514 1.134 . . . . 72.219999999999999 110.355 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 84.02 -10.66 59.93 Favored Glycine 0 CA--C 1.531 1.059 0 O-C-N 124.462 1.101 . . . . 72.450000000000003 110.994 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.533 ' HB2' HG23 ' A' ' 223' ' ' THR . 3.3 m-80 -83.25 167.45 17.66 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.498 0.763 . . . . 64.150000000000006 109.31 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 230' ' ' ASP . 0.6 OUTLIER -79.1 151.46 31.38 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.545 1.153 . . . . 54.439999999999998 109.316 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.415 ' H ' HG12 ' A' ' 227' ' ' VAL . 1.3 p -51.88 -39.67 25.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.507 1.129 . . . . 61.219999999999999 109.257 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.812 ' HA ' HD12 ' A' ' 231' ' ' ILE . 11.8 mt -71.51 -39.27 70.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.446 1.091 . . . . 74.310000000000002 109.337 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -73.24 -15.74 61.42 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.423 1.077 . . . . 75.319999999999993 110.29 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.444 ' OD2' ' CB ' ' A' ' 225' ' ' ASN . 6.0 m-20 -88.55 -15.73 34.43 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.542 1.151 . . . . 74.439999999999998 109.241 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.812 HD12 ' HA ' ' A' ' 228' ' ' ILE . 3.4 mt -72.04 -69.45 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.497 1.123 . . . . 75.329999999999998 109.261 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.485 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -60.82 -17.07 47.56 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.459 1.1 . . . . 60.119999999999997 109.275 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.86 -30.09 60.94 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.468 1.105 . . . . 63.409999999999997 109.929 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.419 ' C ' ' N ' ' A' ' 236' ' ' LEU . 10.7 m -120.89 22.21 5.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.505 1.128 . . . . 65.239999999999995 109.312 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 45.74 26.52 0.36 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.545 1.153 . . . . 73.319999999999993 109.312 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.868 HD21 ' CD2' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -61.97 123.18 76.63 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.455 1.097 . . . . 64.109999999999999 109.304 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 -177.48 3.49 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.421 1.748 . . . . 74.349999999999994 110.993 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.581 HG22 ' H ' ' A' ' 239' ' ' VAL . 2.2 m -74.7 -171.04 1.17 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 72.329999999999998 110.388 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.618 HG13 ' N ' ' A' ' 240' ' ' GLN . 12.9 p -79.09 -58.32 4.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 124.522 1.139 . . . . 41.009999999999998 109.3 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.618 ' N ' HG13 ' A' ' 239' ' ' VAL . 2.0 pp0? -72.18 -10.99 60.52 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.504 1.128 . . . . 75.400000000000006 110.324 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.75 -44.51 27.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.529 1.143 . . . . 73.439999999999998 110.311 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.962 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 0.0 OUTLIER -87.31 -68.61 0.74 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.002 -1.111 . . . . 73.340000000000003 108.002 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.601 ' HD3' ' CD2' ' A' ' 242' ' ' TRP . 0.1 OUTLIER -40.95 -29.11 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.476 1.11 . . . . 54.219999999999999 109.342 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 240' ' ' GLN . 0.0 OUTLIER -38.33 -58.56 0.99 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.525 1.14 . . . . 63.140000000000001 110.003 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -143.43 127.64 17.64 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.492 1.12 . . . . 72.329999999999998 109.308 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.425 ' N ' HD12 ' A' ' 246' ' ' ILE . 3.2 mp -83.73 -31.23 8.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.523 1.139 . . . . 72.230000000000004 109.304 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -91.58 57.75 3.36 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.477 1.111 . . . . 43.130000000000003 109.323 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 10.8 tpp180 -145.46 139.78 27.09 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.513 1.133 . . . . 75.549999999999997 110.383 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -51.21 179.43 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.516 1.135 . . . . 73.430000000000007 111.012 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -84.29 148.55 26.62 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.52 1.138 . . . . 54.520000000000003 109.26 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -156.02 179.2 9.45 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.497 1.123 . . . . 64.299999999999997 109.221 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 60.2 p -172.82 164.76 5.21 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.491 1.119 . . . . 62.329999999999998 109.923 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -153.78 143.51 21.81 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.483 1.115 . . . . 63.539999999999999 109.281 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.422 HD12 ' N ' ' A' ' 254' ' ' ILE . 5.2 mp -106.14 125.81 61.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.51 1.131 . . . . 65.239999999999995 109.264 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 22.9 t -148.54 176.52 10.25 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.441 1.088 . . . . 53.439999999999998 109.996 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -169.72 153.57 5.02 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.542 1.151 . . . . 71.510000000000005 109.371 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 160.75 104.09 0.19 Allowed Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.484 1.115 . . . . 31.420000000000002 110.996 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.545 ' O ' HG13 ' A' ' 259' ' ' VAL . 1.1 m -121.83 165.19 16.26 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.507 0.769 . . . . 50.020000000000003 109.991 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 258' ' ' SER . 1.4 m -155.72 125.73 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.532 1.145 . . . . 63.32 109.247 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 C--N 1.326 -0.445 0 O-C-N 124.52 1.138 . . . . 63.340000000000003 110.299 179.934 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 110.011 -0.366 . . . . 53.109999999999999 110.011 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 2.6 t -84.91 -14.7 46.89 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.46 1.1 . . . . 61.240000000000002 110.001 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 72.9 m -71.24 -21.91 62.05 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.448 1.092 . . . . 72.109999999999999 109.974 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -90.88 177.8 6.2 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.417 1.073 . . . . 40.549999999999997 109.249 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -132.77 171.64 13.61 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.476 1.11 . . . . 74.239999999999995 109.318 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . 0.723 ' HA3' HD11 ' B' ' 471' ' ' ILE . . . -129.02 167.53 21.08 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 124.544 1.153 . . . . 64.420000000000002 111.021 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -111.15 -30.96 7.26 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.468 0.746 . . . . 73.530000000000001 109.3 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 470' ' ' PHE . . . . . 0.527 ' CD1' ' HG2' ' A' ' 243' ' ' LYS . 86.4 m-85 -95.64 39.28 1.13 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.521 1.138 . . . . 73.239999999999995 110.977 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 471' ' ' ILE . . . . . 0.723 HD11 ' HA3' ' B' ' 468' ' ' GLY . 1.2 mm -98.1 142.36 24.46 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.464 1.102 . . . . 62.439999999999998 109.278 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 472' ' ' PRO . . . . . 0.71 ' HD2' HG22 ' B' ' 471' ' ' ILE . 18.4 Cg_endo -74.95 170.23 20.86 Favored 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.489 1.783 . . . . 74.420000000000002 111.029 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.86 -42.41 5.85 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.573 1.171 . . . . 73.400000000000006 110.027 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 1.1 mtt-85 -96.34 161.1 28.11 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.127 . . . . 72.030000000000001 110.298 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 475' ' ' PRO . . . . . 0.584 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.3 Cg_endo -74.98 -34.35 3.91 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.543 1.812 . . . . 71.129999999999995 110.996 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 476' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 169.72 134.62 0.06 OUTLIER Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.545 1.153 . . . . 63.039999999999999 109.315 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 477' ' ' PRO . . . . . 0.575 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.2 Cg_endo -74.95 -162.92 0.16 Allowed 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.513 1.796 . . . . 73.310000000000002 111.052 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 478' ' ' LYS . . . . . 0.433 ' O ' ' CD ' ' B' ' 478' ' ' LYS . 0.1 OUTLIER -133.84 91.8 24.11 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.432 1.082 . . . . 70.200000000000003 109.275 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 479' ' ' PRO . . . . . 0.616 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.1 Cg_endo -75.01 162.49 37.01 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.449 1.763 . . . . 54.25 110.986 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.96 -88.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.41 1.742 . . . . 53.299999999999997 111.004 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 481' ' ' SER . . . . . 0.546 ' O ' ' CZ ' ' A' ' 164' ' ' TYR . 0.4 OUTLIER -82.33 142.33 32.12 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.506 1.129 . . . . 55.0 110.018 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 14.4 t -176.48 177.16 1.49 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.598 1.186 . . . . 54.200000000000003 109.956 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -80.81 -26.59 37.0 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.482 1.114 . . . . 63.439999999999998 109.343 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 1.6 t -166.04 124.84 1.57 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.517 1.136 . . . . 64.230000000000004 109.981 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -118.16 161.87 19.16 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.536 1.147 . . . . 64.219999999999999 109.278 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.547 1.155 . . . . 75.120000000000005 109.997 179.985 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.987 0 N-CA-C 110.963 -0.855 . . . . 44.219999999999999 110.963 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.8 t -84.08 -29.91 26.44 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.53 0.782 . . . . 74.219999999999999 110.013 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.791 HD13 ' O ' ' A' ' 158' ' ' LEU . 0.0 OUTLIER -42.02 149.75 0.14 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.473 1.108 . . . . 75.200000000000003 109.284 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.545 ' N ' HD22 ' A' ' 158' ' ' LEU . 0.7 OUTLIER -145.84 131.9 19.3 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.449 1.093 . . . . 63.219999999999999 110.997 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.658 ' HB2' HD12 ' A' ' 184' ' ' ILE . . . -108.93 145.09 35.99 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.495 1.122 . . . . 55.109999999999999 109.26 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.719 ' HB ' HD11 ' A' ' 215' ' ' ILE . 0.2 OUTLIER -130.61 135.8 59.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.456 1.097 . . . . 71.420000000000002 109.279 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.957 HG22 HG12 ' A' ' 212' ' ' VAL . 2.6 t -93.03 135.39 27.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 124.475 1.11 . . . . 74.420000000000002 109.341 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.624 HD12 ' CE1' ' A' ' 164' ' ' TYR . 0.1 OUTLIER -115.25 -8.34 12.33 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.479 1.112 . . . . 64.209999999999994 109.267 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.624 ' CE1' HD12 ' A' ' 163' ' ' LEU . 0.3 OUTLIER -146.98 151.96 37.84 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.486 1.116 . . . . 63.039999999999999 110.931 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -111.17 154.72 23.96 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.514 1.134 . . . . 73.140000000000001 109.291 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.581 ' HB3' ' CE2' ' A' ' 211' ' ' PHE . 0.6 OUTLIER -160.89 168.63 24.26 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.416 1.072 . . . . 70.439999999999998 110.989 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -92.93 133.98 35.56 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.415 1.072 . . . . 73.25 109.302 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.694 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -106.0 150.96 25.22 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.543 1.152 . . . . 70.030000000000001 109.329 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -155.03 27.45 0.42 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.544 1.153 . . . . 45.340000000000003 110.275 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.58 ' HE2' ' CH2' ' A' ' 192' ' ' TRP . 0.1 OUTLIER -101.49 -176.61 3.19 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.443 1.089 . . . . 63.340000000000003 109.273 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.98 -31.01 66.49 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.481 1.113 . . . . 73.450000000000003 109.237 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 173' ' ' GLU . 20.1 m-20 -111.47 23.06 14.4 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.48 1.113 . . . . 73.120000000000005 109.328 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.694 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 0.0 OUTLIER -36.48 112.07 0.17 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.55 1.156 . . . . 62.43 110.241 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.678 HD22 ' HA3' ' A' ' 205' ' ' GLY . 0.4 OUTLIER -132.83 118.99 19.65 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.515 1.134 . . . . 75.120000000000005 109.28 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 175' ' ' THR . 10.6 t -86.45 108.46 18.52 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.487 1.117 . . . . 74.129999999999995 110.425 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.456 HG23 HG11 ' A' ' 162' ' ' VAL . 1.2 t -102.07 178.86 4.49 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 72.319999999999993 110.416 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.481 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 2.6 m-85 -131.88 154.54 49.09 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 63.329999999999998 111.061 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.7 m -55.82 154.72 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.538 1.149 . . . . 64.340000000000003 109.302 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 40.51 72.2 0.25 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.48 1.113 . . . . 63.109999999999999 110.989 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.502 ' O ' ' CD1' ' A' ' 161' ' ' ILE . 7.4 tt0 -131.03 167.25 19.37 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.514 0.773 . . . . 63.149999999999999 110.31 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.42 ' ND2' ' OH ' ' A' ' 159' ' ' TYR . 1.3 m-80 -113.89 139.4 49.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.532 1.145 . . . . 71.140000000000001 109.305 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.731 ' CD1' HG21 ' A' ' 207' ' ' VAL . 0.6 OUTLIER -154.11 148.44 26.02 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.499 1.125 . . . . 53.100000000000001 109.288 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.548 ' CE2' ' HB2' ' A' ' 185' ' ' CYS . 25.2 t80 -106.37 105.95 16.22 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 75.120000000000005 110.961 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.842 ' CG1' ' HB2' ' A' ' 195' ' ' ALA . 73.9 mt -83.95 120.23 34.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.502 1.126 . . . . 74.140000000000001 109.308 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.605 ' SG ' ' CH2' ' A' ' 242' ' ' TRP . 33.4 t -124.7 -8.75 7.33 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.483 1.115 . . . . 71.239999999999995 108.278 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.838 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -129.78 150.02 51.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.429 1.081 . . . . 73.310000000000002 109.327 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.582 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.1 OUTLIER -153.62 148.3 26.33 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.524 1.14 . . . . 74.040000000000006 109.53 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.758 ' NE2' HD13 ' A' ' 194' ' ' ILE . 2.4 p80 -152.5 144.81 23.97 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.497 1.123 . . . . 64.430000000000007 109.591 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.471 ' C ' ' N ' ' A' ' 191' ' ' GLU . 51.5 t-20 53.5 20.01 1.91 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.562 1.164 . . . . 73.219999999999999 109.278 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.411 ' C ' ' O ' ' A' ' 189' ' ' ASN . 15.9 p 41.02 27.53 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.461 1.101 . . . . 65.349999999999994 108.272 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.519 ' O ' HG13 ' A' ' 209' ' ' VAL . 8.0 tt0 -129.81 -40.71 1.35 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.497 1.123 . . . . 71.129999999999995 110.321 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.591 ' CZ2' ' HD3' ' B' ' 477' ' ' PRO . 99.8 m95 -107.9 126.16 52.34 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.57 1.169 . . . . 74.230000000000004 107.971 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.752 ' CE2' HG12 ' A' ' 209' ' ' VAL . 22.3 m-30 -119.43 134.61 55.13 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 1.122 . . . . 73.530000000000001 110.993 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.838 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 1.0 OUTLIER -100.07 110.9 28.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.567 1.167 . . . . 74.099999999999994 109.236 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.842 ' HB2' ' CG1' ' A' ' 184' ' ' ILE . . . -117.01 174.3 6.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.46 1.1 . . . . 55.310000000000002 109.237 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.419 ' HG2' ' HA ' ' A' ' 204' ' ' PRO . 0.1 OUTLIER -126.76 139.15 34.13 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.459 1.099 . . . . 75.120000000000005 109.324 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 174.27 13.07 Favored 'Trans proline' 0 C--N 1.359 1.089 0 O-C-N 124.527 1.804 . . . . 73.230000000000004 110.97 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 97.4 mt -119.63 -52.32 3.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.516 1.135 . . . . 73.349999999999994 109.296 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -90.86 -55.66 1.85 Allowed Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.447 1.092 . . . . 75.219999999999999 110.998 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -58.25 120.5 8.8 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 0.762 . . . . 60.450000000000003 110.319 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 5.5 tp -64.14 133.89 53.81 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.519 1.137 . . . . 72.400000000000006 109.334 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 130.04 -155.58 21.07 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.464 1.102 . . . . 74.409999999999997 111.022 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.455 ' HA2' ' C ' ' A' ' 204' ' ' PRO . . . 93.03 165.66 38.18 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.99 -0.844 . . . . 52.310000000000002 110.99 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.519 ' HG2' ' CE2' ' B' ' 470' ' ' PHE . 18.2 Cg_endo -75.03 147.42 89.19 Favored 'Cis proline' 0 C--N 1.36 1.141 0 C-N-CA 121.042 -2.482 . . . . 54.509999999999998 110.927 0.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.678 ' HA3' HD22 ' A' ' 174' ' ' LEU . . . -103.89 156.87 17.47 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.47 1.106 . . . . 62.240000000000002 111.048 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.598 HD12 ' CD1' ' A' ' 194' ' ' ILE . 0.2 OUTLIER -94.68 146.16 24.35 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.489 0.758 . . . . 74.420000000000002 109.306 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.731 HG21 ' CD1' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -157.79 129.67 4.03 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.53 1.144 . . . . 51.340000000000003 109.195 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.934 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.2 Cg_endo -75.1 175.93 10.6 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.48 1.779 . . . . 74.040000000000006 111.008 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.752 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.7 OUTLIER -93.41 4.65 7.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.428 1.08 . . . . 54.530000000000001 109.277 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -103.78 -13.06 28.63 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.418 1.074 . . . . 43.130000000000003 110.975 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.619 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 11.5 m-85 -119.43 -1.21 10.76 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.486 0.756 . . . . 75.349999999999994 110.98 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.957 HG12 HG22 ' A' ' 162' ' ' VAL . 2.6 m -141.06 160.43 23.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.487 1.117 . . . . 72.409999999999997 109.274 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.32 144.3 51.11 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.535 1.147 . . . . 42.420000000000002 110.036 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.803 ' O ' HG23 ' A' ' 215' ' ' ILE . 2.7 mm -88.46 145.62 7.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.525 1.14 . . . . 55.100000000000001 109.342 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.803 HG23 ' O ' ' A' ' 214' ' ' ILE . 4.1 pt -163.58 152.84 2.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.45 1.093 . . . . 54.340000000000003 109.343 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -139.1 15.57 2.63 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.52 1.137 . . . . 74.239999999999995 109.327 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 5.6 mm 72.56 59.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.476 1.11 . . . . 75.140000000000001 109.289 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -117.08 14.82 15.02 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.539 1.15 . . . . 65.519999999999996 109.285 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.624 ' O ' HG22 ' A' ' 219' ' ' THR . 5.1 m 63.38 56.76 1.61 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.519 1.137 . . . . 75.409999999999997 110.367 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 173.34 -132.93 2.45 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.428 1.08 . . . . 63.240000000000002 111.011 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -155.69 123.79 5.78 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.532 0.784 . . . . 71.439999999999998 111.014 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.774 ' HB1' ' O ' ' A' ' 225' ' ' ASN . . . 63.31 16.73 9.71 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.574 1.171 . . . . 63.130000000000003 109.362 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.737 ' O ' HG22 ' A' ' 223' ' ' THR . 2.0 m 43.99 52.14 6.83 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.499 1.124 . . . . 75.450000000000003 110.435 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 77.3 -53.4 3.5 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.566 1.166 . . . . 74.430000000000007 111.011 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.774 ' O ' ' HB1' ' A' ' 222' ' ' ALA . 55.5 m-80 -66.8 120.92 14.34 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.591 0.819 . . . . 75.340000000000003 109.374 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . 0.457 ' OD1' HG12 ' A' ' 227' ' ' VAL . 8.8 t0 -49.85 158.36 0.5 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.498 1.124 . . . . 73.219999999999999 109.304 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.491 HG13 HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -38.59 -58.44 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.129 . . . . 71.430000000000007 109.286 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.491 HD12 HG13 ' A' ' 227' ' ' VAL . 3.2 mp -54.48 -45.51 70.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.518 1.136 . . . . 74.340000000000003 109.348 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.461 ' CB ' ' HB3' ' A' ' 225' ' ' ASN . 18.5 mt-10 -67.16 -15.0 63.44 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 72.530000000000001 110.344 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.436 ' N ' ' O ' ' A' ' 226' ' ' ASP . 5.5 t70 -88.61 -18.92 27.02 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.539 1.149 . . . . 64.430000000000007 109.302 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.655 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.5 OUTLIER -69.44 -69.42 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.505 1.128 . . . . 75.150000000000006 109.27 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.655 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -59.89 -23.83 63.79 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.52 1.138 . . . . 70.510000000000005 109.329 -179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.86 -59.7 3.36 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.522 1.139 . . . . 65.430000000000007 110.023 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 234' ' ' VAL . 1.2 m -98.96 24.31 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.107 . . . . 74.209999999999994 109.271 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 5.6 t30 46.07 41.69 8.7 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.445 1.091 . . . . 73.409999999999997 109.276 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.888 HD12 ' HD2' ' A' ' 237' ' ' PRO . 33.2 tp -55.54 123.98 53.47 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 124.511 1.132 . . . . 62.310000000000002 109.334 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.888 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.4 Cg_endo -74.99 153.37 41.76 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.565 1.824 . . . . 71.109999999999999 111.002 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . 0.457 ' CG2' ' NE2' ' A' ' 240' ' ' GLN . 0.5 OUTLIER -61.42 -170.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.581 1.176 . . . . 62.149999999999999 110.438 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.489 ' HA ' ' HB1' ' A' ' 186' ' ' ALA . 12.3 p -80.27 -48.64 19.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.535 1.147 . . . . 62.219999999999999 109.354 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.489 ' OE1' ' N ' ' A' ' 241' ' ' GLU . 0.1 OUTLIER -87.43 -12.81 45.03 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.526 1.141 . . . . 53.43 110.281 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.489 ' N ' ' OE1' ' A' ' 240' ' ' GLN . 8.5 mt-10 -76.68 -36.27 57.39 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.562 1.164 . . . . 73.239999999999995 110.303 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.757 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 0.1 OUTLIER -87.01 -60.17 2.05 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.13 . . . . 62.340000000000003 108.012 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.644 ' NZ ' ' CD2' ' B' ' 470' ' ' PHE . 7.6 mtpt -53.19 -20.78 4.3 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.506 1.129 . . . . 53.219999999999999 109.328 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 243' ' ' LYS . 0.2 OUTLIER -38.4 -67.57 0.2 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.481 1.113 . . . . 64.519999999999996 110.034 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -143.56 119.33 10.51 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.489 1.118 . . . . 73.120000000000005 109.293 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 12.3 mm -57.53 -24.97 23.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.444 1.09 . . . . 63.299999999999997 109.309 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -106.26 94.85 5.38 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 1.133 . . . . 62.439999999999998 109.299 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . 0.492 ' HD2' ' CD2' ' A' ' 249' ' ' TYR . 13.9 tpp85 -90.36 153.09 20.69 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.479 1.112 . . . . 74.310000000000002 110.349 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.492 ' CD2' ' HD2' ' A' ' 248' ' ' ARG . 35.2 m-85 -36.13 -55.53 0.77 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.535 1.147 . . . . 75.209999999999994 111.014 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -114.78 153.77 29.77 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.407 1.067 . . . . 61.229999999999997 109.335 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -117.63 -57.41 2.13 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.547 1.154 . . . . 61.450000000000003 109.264 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 79.3 p -57.17 155.29 8.79 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.583 1.177 . . . . 54.210000000000001 109.951 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.76 122.58 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.469 1.105 . . . . 64.209999999999994 109.285 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 1.8 mt -118.18 157.03 19.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.461 1.1 . . . . 72.219999999999999 109.272 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 48.1 t -156.8 116.12 3.43 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.534 1.146 . . . . 70.310000000000002 110.048 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.598 HD13 ' N ' ' A' ' 257' ' ' GLY . 0.6 OUTLIER -41.73 140.06 1.07 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.476 1.11 . . . . 73.310000000000002 109.315 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.598 ' N ' HD13 ' A' ' 256' ' ' LEU . . . -113.65 158.06 14.55 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.514 1.134 . . . . 53.149999999999999 111.002 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 49.5 m -146.66 152.66 39.23 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.561 0.8 . . . . 73.120000000000005 109.987 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.44 ' O ' HG12 ' A' ' 259' ' ' VAL . 21.6 t -123.5 41.81 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.499 1.124 . . . . 53.299999999999997 109.221 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 . . . . . 0 C--N 1.324 -0.501 0 O-C-N 124.541 1.151 . . . . 73.430000000000007 110.309 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 110.019 -0.363 . . . . 61.229999999999997 110.019 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 70.6 m -86.32 149.7 24.86 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.525 1.141 . . . . 63.340000000000003 110.004 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 5.5 t -132.63 -48.87 0.89 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.559 1.162 . . . . 74.230000000000004 109.969 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -75.11 86.21 2.37 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.477 1.111 . . . . 73.420000000000002 109.302 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -110.77 -40.08 4.66 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.52 1.137 . . . . 72.329999999999998 109.253 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . 177.3 -174.77 47.26 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.487 1.117 . . . . 54.420000000000002 111.033 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -107.59 -15.08 14.68 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 124.577 0.81 . . . . 75.109999999999999 109.311 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 470' ' ' PHE . . . . . 0.644 ' CD2' ' NZ ' ' A' ' 243' ' ' LYS . 5.9 m-30 -91.48 1.33 57.21 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.417 1.073 . . . . 74.109999999999999 111.012 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 471' ' ' ILE . . . . . 0.767 ' N ' HD13 ' B' ' 471' ' ' ILE . 1.1 mm -71.31 135.67 84.36 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.482 1.114 . . . . 74.439999999999998 109.348 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 472' ' ' PRO . . . . . 0.589 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.4 Cg_endo -74.94 170.97 19.22 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.504 1.792 . . . . 64.420000000000002 111.024 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 2.7 t -116.78 -8.86 11.33 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.455 1.097 . . . . 42.340000000000003 109.999 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -122.49 164.37 26.73 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.472 1.107 . . . . 52.210000000000001 110.294 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 475' ' ' PRO . . . . . 0.702 ' O ' ' HB2' ' B' ' 476' ' ' ALA . 18.2 Cg_endo -75.03 -38.54 1.53 Allowed 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.49 1.784 . . . . 63.549999999999997 110.97 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 476' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' B' ' 475' ' ' PRO . . . 162.73 139.66 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.484 1.115 . . . . 34.32 109.274 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 477' ' ' PRO . . . . . 0.591 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.3 Cg_endo -74.94 -161.37 0.12 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.494 1.786 . . . . 65.430000000000007 110.999 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 478' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' B' ' 478' ' ' LYS . 0.0 OUTLIER -140.51 103.41 6.51 Favored Pre-proline 0 C--N 1.324 -0.52 0 O-C-N 124.59 1.181 . . . . 60.130000000000003 109.364 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 479' ' ' PRO . . . . . 0.619 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.5 Cg_endo -74.92 166.08 30.01 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.497 1.788 . . . . 61.229999999999997 110.998 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.01 -87.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.417 1.746 . . . . 65.530000000000001 110.985 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 481' ' ' SER . . . . . 0.496 ' O ' ' CE2' ' A' ' 164' ' ' TYR . 14.4 t -78.88 84.49 4.92 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.47 1.106 . . . . 74.430000000000007 109.952 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 28.4 t -139.81 156.94 46.48 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.529 1.143 . . . . 61.219999999999999 109.998 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -139.79 143.48 36.91 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.45 1.093 . . . . 64.120000000000005 109.298 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 82.9 p -160.82 144.24 13.28 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.432 1.082 . . . . 75.540000000000006 109.973 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -84.31 143.54 29.46 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.521 1.138 . . . . 25.25 109.236 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 53.7 p . . . . . 0 C--N 1.325 -0.497 0 O-C-N 124.511 1.132 . . . . 75.299999999999997 109.947 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.964 0 N-CA-C 110.997 -0.841 . . . . 42.229999999999997 110.997 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.1 m -102.85 47.88 0.87 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.426 0.721 . . . . 62.520000000000003 109.991 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.5 mp -109.49 132.68 53.91 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.544 1.152 . . . . 73.329999999999998 109.331 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -126.12 128.69 47.72 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.409 1.068 . . . . 60.450000000000003 111.042 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.953 ' HB3' ' CD2' ' A' ' 182' ' ' LEU . . . -110.31 144.66 38.7 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.438 1.086 . . . . 71.409999999999997 109.303 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.521 HD13 ' O ' ' A' ' 180' ' ' GLU . 0.1 OUTLIER -123.99 123.84 67.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.545 1.153 . . . . 72.329999999999998 109.299 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.945 HG23 HD11 ' A' ' 182' ' ' LEU . 1.8 t -79.7 122.26 34.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.507 1.129 . . . . 71.319999999999993 109.364 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.58 ' HB2' ' CE2' ' A' ' 164' ' ' TYR . 0.7 OUTLIER -97.48 -14.83 20.89 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.551 1.157 . . . . 74.329999999999998 109.305 -179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.701 ' O ' HG13 ' A' ' 162' ' ' VAL . 5.4 m-85 -145.14 160.65 41.11 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.564 1.165 . . . . 64.150000000000006 111.067 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.842 ' N ' HG12 ' A' ' 178' ' ' VAL . 8.5 p30 -97.99 157.03 16.35 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.401 1.063 . . . . 73.030000000000001 109.362 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -150.12 135.64 18.22 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.532 1.145 . . . . 72.140000000000001 110.979 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -75.86 126.06 30.28 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.491 1.119 . . . . 71.349999999999994 109.302 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.848 ' HB1' ' HA ' ' A' ' 173' ' ' GLU . . . -88.99 153.29 21.14 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.452 1.095 . . . . 53.020000000000003 109.295 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -166.31 29.41 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.462 1.101 . . . . 63.32 110.293 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.747 ' HZ2' ' H ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -129.5 -176.08 3.78 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.483 1.115 . . . . 64.319999999999993 109.293 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.12 -40.93 78.07 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 60.229999999999997 109.318 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 174' ' ' LEU . 30.7 m-20 -88.67 16.99 5.89 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.457 1.098 . . . . 64.299999999999997 109.272 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.848 ' HA ' ' HB1' ' A' ' 168' ' ' ALA . 4.6 pt-20 -38.14 95.76 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.449 1.093 . . . . 63.0 110.309 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.747 ' H ' ' HZ2' ' A' ' 170' ' ' LYS . 5.7 tp -118.4 107.81 14.29 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.482 1.114 . . . . 72.239999999999995 109.29 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 175' ' ' THR . 12.7 t -87.36 115.9 25.09 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.479 1.112 . . . . 71.430000000000007 110.357 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 6.9 m -134.74 154.8 51.42 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.536 1.148 . . . . 63.310000000000002 110.402 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -94.35 167.54 11.46 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.453 1.096 . . . . 73.230000000000004 110.962 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.842 HG12 ' N ' ' A' ' 165' ' ' ASP . 1.6 m -66.96 158.26 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 124.488 1.117 . . . . 72.209999999999994 109.316 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 57.11 50.42 64.51 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.479 1.112 . . . . 51.509999999999998 111.077 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.521 ' O ' HD13 ' A' ' 161' ' ' ILE . 0.0 OUTLIER -110.26 174.15 6.0 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.498 0.764 . . . . 74.439999999999998 110.289 -179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.495 ' N ' ' ND2' ' A' ' 181' ' ' ASN . 0.0 OUTLIER -137.36 117.45 13.42 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.527 1.142 . . . . 70.439999999999998 109.264 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.953 ' CD2' ' HB3' ' A' ' 160' ' ' ALA . 0.0 OUTLIER -129.99 154.88 46.95 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.453 1.096 . . . . 73.530000000000001 109.358 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.577 ' CE1' ' O ' ' A' ' 184' ' ' ILE . 1.0 OUTLIER -104.24 115.16 29.91 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.423 1.077 . . . . 74.340000000000003 110.982 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 1.055 HD13 ' HB2' ' A' ' 195' ' ' ALA . 27.5 mm -65.32 160.59 3.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.493 1.121 . . . . 71.319999999999993 109.303 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . 0.44 ' HB3' ' CH2' ' A' ' 242' ' ' TRP . 37.0 m -150.99 -44.88 0.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.538 1.149 . . . . 74.140000000000001 108.27 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 1.041 ' HB3' ' HB ' ' A' ' 194' ' ' ILE . . . -120.71 165.75 14.66 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.5 1.125 . . . . 63.509999999999998 109.274 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.526 ' HB2' ' CD1' ' A' ' 193' ' ' PHE . 0.3 OUTLIER -152.97 146.22 24.77 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.522 1.139 . . . . 65.409999999999997 109.617 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.752 ' CD2' HG11 ' A' ' 239' ' ' VAL . 0.2 OUTLIER -146.07 137.87 25.01 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.492 1.12 . . . . 72.310000000000002 109.625 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.479 ' C ' ' N ' ' A' ' 191' ' ' GLU . 24.5 t-20 50.17 25.58 1.82 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.531 1.144 . . . . 74.400000000000006 109.271 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . 0.439 ' C ' ' O ' ' A' ' 189' ' ' ASN . 6.9 p 38.93 30.9 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.451 1.094 . . . . 63.340000000000003 108.248 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.93 ' CD ' ' HB2' ' B' ' 476' ' ' ALA . 20.5 tt0 -127.36 -39.58 1.86 Allowed 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.495 1.122 . . . . 75.439999999999998 110.269 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.714 ' CZ3' HD21 ' A' ' 206' ' ' LEU . 97.0 m95 -113.79 131.9 56.06 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.518 1.136 . . . . 74.450000000000003 108.023 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.909 ' HB3' HD12 ' A' ' 184' ' ' ILE . 23.3 m-30 -121.94 144.0 49.12 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.471 1.107 . . . . 75.530000000000001 111.02 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 1.041 ' HB ' ' HB3' ' A' ' 186' ' ' ALA . 0.8 OUTLIER -103.28 96.86 4.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.544 1.153 . . . . 75.25 109.341 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 1.055 ' HB2' HD13 ' A' ' 184' ' ' ILE . . . -99.64 -176.38 3.26 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.433 1.083 . . . . 52.329999999999998 109.224 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.453 ' CG ' ' C ' ' A' ' 195' ' ' ALA . 7.3 mtmt -151.19 160.21 32.33 Favored Pre-proline 0 C--N 1.326 -0.43 0 O-C-N 124.549 1.156 . . . . 72.530000000000001 109.262 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.08 177.52 8.5 Favored 'Trans proline' 0 C--N 1.361 1.209 0 O-C-N 124.491 1.785 . . . . 75.319999999999993 111.002 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 6.7 tt -93.18 -4.91 10.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 O-C-N 124.449 1.093 . . . . 75.430000000000007 109.282 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -115.77 -15.29 7.48 Favored Glycine 0 CA--C 1.532 1.095 0 O-C-N 124.535 1.147 . . . . 51.340000000000003 110.942 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . 0.419 ' HB3' ' NH1' ' A' ' 200' ' ' ARG . 17.6 mtp-105 62.3 53.85 2.73 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.515 0.774 . . . . 75.120000000000005 110.311 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 2.1 tp -125.77 37.62 4.32 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 61.350000000000001 109.242 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 179.7 -52.28 0.09 OUTLIER Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.468 1.105 . . . . 51.350000000000001 111.032 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.426 ' HA2' ' N ' ' A' ' 205' ' ' GLY . . . -44.18 169.79 0.02 OUTLIER Glycine 0 CA--C 1.53 1.0 0 N-CA-C 111.087 -0.805 . . . . 61.340000000000003 111.087 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . 0.569 ' HG2' ' CE2' ' B' ' 470' ' ' PHE . 18.3 Cg_endo -75.07 127.63 14.85 Favored 'Cis proline' 0 C--N 1.359 1.118 0 C-N-CA 121.04 -2.483 . . . . 61.450000000000003 110.967 0.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.688 ' HA3' HD22 ' A' ' 174' ' ' LEU . . . -95.42 152.27 20.32 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.471 1.107 . . . . 54.310000000000002 110.934 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.714 HD21 ' CZ3' ' A' ' 192' ' ' TRP . 0.1 OUTLIER -99.49 145.96 26.9 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.475 0.75 . . . . 71.450000000000003 109.312 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.728 ' HB ' HG11 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -159.75 127.84 2.86 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.54 1.15 . . . . 72.430000000000007 109.279 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.845 ' O ' HG22 ' A' ' 212' ' ' VAL . 18.3 Cg_endo -74.99 176.81 9.42 Favored 'Trans proline' 0 C--N 1.361 1.206 0 O-C-N 124.507 1.793 . . . . 65.519999999999996 110.946 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.756 HG12 ' CE2' ' A' ' 193' ' ' PHE . 0.6 OUTLIER -97.09 5.14 9.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.41 1.069 . . . . 75.150000000000006 109.316 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' GLY . . . . . . . . . . . . . . . -103.31 -12.22 31.72 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.518 1.136 . . . . 52.539999999999999 111.037 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.634 ' CZ ' ' HA ' ' B' ' 479' ' ' PRO . 10.7 m-85 -123.02 3.28 9.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.473 0.749 . . . . 74.319999999999993 110.996 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.859 HG12 HG22 ' A' ' 162' ' ' VAL . 1.9 m -140.35 154.26 22.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.49 1.119 . . . . 70.5 109.273 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' SER . . . . . 0.458 ' HB2' HD11 ' A' ' 163' ' ' LEU . 5.6 t -120.37 124.51 45.71 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.485 1.116 . . . . 53.399999999999999 110.013 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.792 ' O ' HG23 ' A' ' 215' ' ' ILE . 2.7 mm -77.49 139.2 19.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.493 1.121 . . . . 63.140000000000001 109.294 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . 0.792 HG23 ' O ' ' A' ' 214' ' ' ILE . 3.5 pt -164.43 -179.0 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.421 1.076 . . . . 74.129999999999995 109.276 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -146.29 -72.01 0.24 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.497 1.123 . . . . 74.239999999999995 109.313 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' ILE . . . . . . . . . . . . . 44.6 pt -139.65 61.49 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.46 1.1 . . . . 75.120000000000005 109.291 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -178.22 171.18 1.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.498 1.124 . . . . 74.530000000000001 109.361 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.412 HG23 ' N ' ' A' ' 220' ' ' GLY . 10.6 t -85.81 -161.82 0.66 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.488 1.118 . . . . 74.510000000000005 110.446 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.412 ' N ' HG23 ' A' ' 219' ' ' THR . . . 38.47 -97.96 0.01 OUTLIER Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.49 1.118 . . . . 54.409999999999997 110.971 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.423 ' C ' HG22 ' A' ' 215' ' ' ILE . 8.2 m-85 -118.87 173.36 6.93 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.535 0.785 . . . . 74.510000000000005 110.97 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 221' ' ' TYR . . . -39.57 -70.22 0.11 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.553 1.158 . . . . 73.400000000000006 109.29 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.9 t -133.97 8.48 3.79 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.494 1.121 . . . . 73.319999999999993 110.367 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 109.64 8.07 26.94 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.477 1.111 . . . . 65.030000000000001 111.014 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -93.15 176.22 6.49 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.545 0.791 . . . . 74.040000000000006 109.263 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.66 143.48 26.4 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.529 1.143 . . . . 73.129999999999995 109.261 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.632 HG13 HD12 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -41.07 -52.61 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.455 1.097 . . . . 63.420000000000002 109.335 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.632 HD12 HG13 ' A' ' 227' ' ' VAL . 4.3 mp -56.94 -58.91 3.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 O-C-N 124.519 1.137 . . . . 74.439999999999998 109.298 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -46.62 -29.16 1.71 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.547 1.155 . . . . 61.5 110.331 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -73.28 -37.19 66.35 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.54 1.15 . . . . 63.43 109.32 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.636 HG22 ' N ' ' A' ' 232' ' ' LYS . 0.6 OUTLIER -62.26 -69.33 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.484 1.115 . . . . 73.150000000000006 109.295 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.636 ' N ' HG22 ' A' ' 231' ' ' ILE . 0.0 OUTLIER -51.42 -31.88 24.46 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.487 1.117 . . . . 71.329999999999998 109.288 -179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.03 -60.72 2.79 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.517 1.136 . . . . 70.5 109.936 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 2.2 m -92.03 15.39 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.549 1.155 . . . . 52.420000000000002 109.282 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 42.8 t30 40.43 36.35 0.35 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.477 1.11 . . . . 73.140000000000001 109.264 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.857 HD12 ' HD2' ' A' ' 237' ' ' PRO . 4.0 tp -49.25 134.48 16.5 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.126 . . . . 61.200000000000003 109.335 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.857 ' HD2' HD12 ' A' ' 236' ' ' LEU . 18.3 Cg_endo -74.99 164.09 34.06 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.461 1.769 . . . . 60.409999999999997 110.997 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.82 -174.89 2.31 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.503 1.127 . . . . 72.439999999999998 110.43 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.752 HG11 ' CD2' ' A' ' 188' ' ' HIS . 1.0 OUTLIER -79.61 -49.33 19.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.503 1.127 . . . . 72.219999999999999 109.278 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.506 ' N ' ' CG2' ' A' ' 239' ' ' VAL . 0.0 OUTLIER -76.67 -14.75 59.94 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.454 1.096 . . . . 74.010000000000005 110.307 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -83.78 -49.82 8.71 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.55 1.156 . . . . 75.319999999999993 110.291 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.716 ' CZ3' ' HB2' ' A' ' 186' ' ' ALA . 0.1 OUTLIER -70.51 -62.49 1.37 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.007 -1.109 . . . . 75.25 108.007 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.571 ' NZ ' ' CE2' ' B' ' 470' ' ' PHE . 18.3 mtpp -49.56 -23.92 1.87 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.612 1.195 . . . . 72.109999999999999 109.329 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 243' ' ' LYS . 4.4 t -39.2 -40.89 0.79 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.433 1.083 . . . . 63.409999999999997 109.969 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -169.64 107.83 0.39 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 72.099999999999994 109.322 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.437 ' H ' HD12 ' A' ' 246' ' ' ILE . 1.9 mp -40.52 -38.68 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.487 1.117 . . . . 73.400000000000006 109.299 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -144.39 134.2 23.74 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.498 1.124 . . . . 74.430000000000007 109.274 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.97 161.69 28.7 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.522 1.139 . . . . 61.149999999999999 110.256 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.435 ' CD1' ' O ' ' A' ' 249' ' ' TYR . 11.2 p90 -52.36 125.52 16.36 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.459 1.1 . . . . 74.140000000000001 110.97 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.458 ' HB2' ' HZ2' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -82.15 118.71 23.28 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.447 1.092 . . . . 71.430000000000007 109.246 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -81.47 -75.27 0.29 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.548 1.155 . . . . 71.340000000000003 109.292 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 29.3 t -146.09 175.71 10.27 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.462 1.101 . . . . 72.239999999999995 109.987 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -149.65 117.95 6.44 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.52 1.138 . . . . 75.120000000000005 109.356 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 254' ' ' ILE . 14.5 mm -121.96 153.85 26.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.412 1.07 . . . . 74.340000000000003 109.27 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 5.4 p -156.24 129.59 8.17 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.503 1.127 . . . . 43.130000000000003 109.983 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.683 HD23 ' N ' ' A' ' 257' ' ' GLY . 1.8 tt -102.01 139.51 37.54 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.458 1.099 . . . . 74.129999999999995 109.28 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.683 ' N ' HD23 ' A' ' 256' ' ' LEU . . . -54.82 152.78 11.91 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 124.451 1.094 . . . . 52.420000000000002 111.005 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 69.1 m -83.19 141.51 31.87 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.424 0.72 . . . . 73.420000000000002 109.933 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 260' ' ' GLU . 11.3 t -88.55 167.17 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 124.427 1.079 . . . . 63.520000000000003 109.302 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' GLU . . . . . 0.438 ' N ' HG12 ' A' ' 259' ' ' VAL . 14.4 pt-20 . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 65.230000000000004 110.276 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 463' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 109.983 -0.377 . . . . 53.409999999999997 109.983 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 464' ' ' SER . . . . . . . . . . . . . 3.5 m -78.56 139.17 38.64 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.502 1.126 . . . . 50.32 109.982 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 465' ' ' SER . . . . . . . . . . . . . 63.3 m -68.48 -74.28 0.13 Allowed 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.513 1.133 . . . . 75.129999999999995 109.941 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 466' ' ' ALA . . . . . . . . . . . . . . . -76.33 169.26 18.57 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.447 1.092 . . . . 75.140000000000001 109.375 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 467' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -127.15 111.78 14.39 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.411 1.069 . . . . 74.230000000000004 109.284 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 468' ' ' GLY . . . . . . . . . . . . . . . -72.51 166.58 53.95 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 124.492 1.12 . . . . 64.25 111.01 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.14 -24.82 11.38 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.532 0.783 . . . . 71.129999999999995 109.291 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 470' ' ' PHE . . . . . 0.571 ' CE2' ' NZ ' ' A' ' 243' ' ' LYS . 6.3 m-30 -94.65 29.25 2.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 71.109999999999999 110.981 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 471' ' ' ILE . . . . . 0.468 ' CG2' ' HD2' ' B' ' 472' ' ' PRO . 7.8 mm -97.51 139.81 21.62 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.145 . . . . 72.209999999999994 109.297 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 472' ' ' PRO . . . . . 0.55 ' HD3' ' CE1' ' A' ' 188' ' ' HIS . 18.3 Cg_endo -75.03 146.74 32.91 Favored 'Trans proline' 0 C--N 1.361 1.199 0 O-C-N 124.5 1.789 . . . . 70.030000000000001 111.018 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 473' ' ' SER . . . . . . . . . . . . . 8.2 t -79.21 -59.8 2.63 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.547 1.154 . . . . 52.439999999999998 110.075 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 474' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -84.67 163.49 46.53 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.52 1.137 . . . . 72.099999999999994 110.311 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 475' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 -166.59 0.35 Allowed 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.435 1.755 . . . . 64.120000000000005 111.01 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 476' ' ' ALA . . . . . 0.93 ' HB2' ' CD ' ' A' ' 191' ' ' GLU . . . -55.58 137.49 70.1 Favored Pre-proline 0 C--N 1.326 -0.417 0 O-C-N 124.489 1.118 . . . . 65.439999999999998 109.361 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 477' ' ' PRO . . . . . 0.574 ' HD3' ' CZ2' ' A' ' 192' ' ' TRP . 18.2 Cg_endo -75.01 -162.28 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.484 1.781 . . . . 61.130000000000003 111.022 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 478' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.0 89.84 12.44 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.508 1.13 . . . . 75.420000000000002 109.29 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 479' ' ' PRO . . . . . 0.634 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 18.3 Cg_endo -74.92 161.29 39.2 Favored 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.523 1.801 . . . . 74.120000000000005 110.985 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 480' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -45.97 0.26 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.506 1.793 . . . . 74.140000000000001 111.035 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 481' ' ' SER . . . . . 0.508 ' HB2' ' CE1' ' A' ' 164' ' ' TYR . 3.1 m -126.76 108.83 11.4 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.582 1.176 . . . . 64.420000000000002 110.052 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 482' ' ' SER . . . . . . . . . . . . . 18.1 t -111.63 -18.98 12.66 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.527 1.142 . . . . 73.439999999999998 110.017 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 483' ' ' ALA . . . . . . . . . . . . . . . -154.96 -178.67 7.4 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.527 1.142 . . . . 74.299999999999997 109.297 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 484' ' ' SER . . . . . . . . . . . . . 15.2 m -114.5 21.53 14.47 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.477 1.11 . . . . 65.439999999999998 109.952 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -122.52 153.01 39.78 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.565 1.165 . . . . 45.210000000000001 109.3 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 486' ' ' SER . . . . . . . . . . . . . 80.2 p . . . . . 0 C--N 1.324 -0.523 0 O-C-N 124.494 1.122 . . . . 54.219999999999999 110.04 179.989 . . . . . . . . 0 0 . 1 stop_ save_